FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Abdad, MY
   Squires, RC
   Cognat, S
   Oxenford, CJ
   Konings, F
AF Abdad, Mohammad Yazid
   Squires, Raynal C.
   Cognat, Sebastien
   Oxenford, Christopher John
   Konings, Frank
TI External quality assessment for arbovirus diagnostics in the World
   Health Organization Western Pacific Region, 2013-2016: improving
   laboratory quality over the years
SO WESTERN PACIFIC SURVEILLANCE AND RESPONSE
LA English
DT Article
ID OUTBREAK; DENGUE
AB Arboviruses continue to pose serious public health threats in the World Health Organization (WHO) Western Pacific Region. As such, laboratories need to be equipped for their accurate detection. In 2011, to ensure test proficiency, the WHO Regional Office for the Western Pacific piloted an external quality assessment (EQA) programme for arbovirus diagnostics. By 2016, it had grown into a global programme with participation of 96 laboratories worldwide, including 25 laboratories from 19 countries, territories and areas in the Region. The test performance of the 25 laboratories in the Region in 2016 was high with 23 (92%) reporting correct results in all specimens for dengue and chikungunya viruses. For Zika virus, 18 (72%) of the 25 laboratories reported correct results in all specimens, while seven (28%) demonstrated at least one error. When comparing iterations of this EQA programme in the Region between 2013 and 2016, the number of participating laboratories increased from 18 to 25. The first round only included dengue virus, while the latest round additionally included chikungunya, Zika and yellow fever viruses. Proficiency for molecular detection of dengue virus remained high (83-94%) over the four-year period. The observed proficiency for arbovirus diagnostics between 2013 and 2016 is an indicator of laboratory quality improvement in the Region.
C1 [Abdad, Mohammad Yazid; Squires, Raynal C.; Konings, Frank] World Hlth Org Reg Off Western Pacific, Hlth Emergencies Programme, Manila, Philippines.
   [Cognat, Sebastien; Oxenford, Christopher John] WHO, Hlth Emergencies Programme, Lyon, France.
RP Konings, F (corresponding author), World Hlth Org Reg Off Western Pacific, Hlth Emergencies Programme, Manila, Philippines.
EM koningsf@who.int
OI Abdad, Mohammad Yazid/0000-0001-7772-9148
FU United States Agency for International DevelopmentUnited States Agency
   for International Development (USAID); Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA; Global Partnership Program of Global
   Affairs Canada
FX The regional and global programmes were supported by the United States
   Agency for International Development, the Centers for Disease Control
   and Prevention, and the Global Partnership Program of Global Affairs
   Canada.
CR [Anonymous], 2011, AS PAC STRAT EM DIS
   [Anonymous], 2016, DIS OUTBREAK NE 0422
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.003, 10.5365/WPSAR.2013.4.2.003]
   International Organization for Standardization (ISO), 2012, 151892012 ISO
   Pok KY, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.1.017, 10.5365/wpsar.2015.6.1.017]
   Soh LT, 2016, WEST PAC SURVEILL RE, V7, P26, DOI [10.5365/WPSAR.2016.7.1.002, 10.5365/wpsar.2016.7.1.002]
   Squires RC, 2016, WEST PAC SURVEILL RE, V7, P44, DOI 10.5365/wpsar.2016.7.1.007
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 10
TC 4
Z9 4
U1 0
U2 0
PU WORLD HEALTH ORGANIZATION, REGIONAL OFFICE WESTERN PACIFIC
PI MANILA
PA PO BOX 2932, MANILA, 1000, PHILIPPINES
SN 2094-7321
EI 2094-7313
J9 WEST PAC SURVEILL RE
JI West. Pa. Surveill. Response
PD JUL-SEP
PY 2017
VL 8
IS 3
DI 10.5365/wpsar.2017.8.3.001
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FN6AF
UT WOS:000416091600005
PM 29051839
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hashimoto, T
   Kutsuna, S
   Tajima, S
   Nakayama, E
   Maeki, T
   Taniguchi, S
   Lim, CK
   Katanami, Y
   Takeshita, N
   Hayakawa, K
   Kato, Y
   Ohmagari, N
AF Hashimoto, Takehiro
   Kutsuna, Satoshi
   Tajima, Shigeru
   Nakayama, Eri
   Maeki, Takahiro
   Taniguchi, Satoshi
   Lim, Chang-Kweng
   Katanami, Yuichi
   Takeshita, Nozomi
   Hayakawa, Kayoko
   Kato, Yasuyuki
   Ohmagari, Norio
TI Importation of Zika Virus from Vietnam to Japan, November 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID DISEASE
AB We report a case of Zika virus infection that was imported to Japan by a traveler returning from Vietnam. We detected Zika virus RNA in the patient's saliva, urine, and whole blood. In the Zika virus strain isolated from the urine, we found clearly smaller plaques than in previous strains.
C1 [Hashimoto, Takehiro; Kutsuna, Satoshi; Katanami, Yuichi; Takeshita, Nozomi; Hayakawa, Kayoko; Kato, Yasuyuki; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Tokyo, Japan.
   [Tajima, Shigeru; Nakayama, Eri; Maeki, Takahiro; Taniguchi, Satoshi; Lim, Chang-Kweng] Natl Inst Infect Dis, Tokyo, Japan.
RP Kutsuna, S (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.
EM sonare.since1192@gmail.com
OI Shigeru, Tajima/0000-0002-1981-9062
FU Japan National Center for Global Health and Medicine [27-6001]
FX This work was supported by a grant from the Japan National Center for
   Global Health and Medicine (27-6001).
CR [Anonymous], 2017, ZIK VIR 02 AM AS AFR
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
NR 7
TC 9
Z9 10
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2017
VL 23
IS 7
BP 1222
EP 1225
DI 10.3201/eid2307.170519
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EX9FS
UT WOS:000403563100036
PM 28445122
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hirschler, B
AF Hirschler, Ben
TI Austrian Biotech Themis Launches Zika Vaccine Clinical Trial
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2017
VL 65
IS 1
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EX7WE
UT WOS:000403459300003
DA 2020-07-08
ER

PT J
AU Steenhuysen, J
AF Steenhuysen, Julie
TI US Zika Vaccine Begins Second Phase of Testing
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2017
VL 65
IS 1
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EX7WE
UT WOS:000403459300002
DA 2020-07-08
ER

PT J
AU Steenhuysen, J
AF Steenhuysen, Julie
TI Texas Expands Zika Recommendations Ahead of 2017 Mosquito Season
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2017
VL 65
IS 1
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EX7WE
UT WOS:000403459300001
DA 2020-07-08
ER

PT J
AU Carossino, M
   Loynachan, AT
   Canisso, IF
   Cook, RF
   Campos, JR
   Nam, B
   Go, YY
   Squires, EL
   Troedsson, MHT
   Swerczek, T
   Del Piero, F
   Bailey, E
   Timoney, PJ
   Balasuriya, UBR
AF Carossino, Mariano
   Loynachan, Alan T.
   Canisso, Igor F.
   Cook, R. Frank
   Campos, Juliana R.
   Nam, Bora
   Go, Yun Young
   Squires, Edward L.
   Troedsson, Mats H. T.
   Swerczek, Thomas
   Del Piero, Fabio
   Bailey, Ernest
   Timoney, Peter J.
   Balasuriya, Udeni B. R.
TI Equine Arteritis Virus Has Specific Tropism for Stromal Cells and CD8(+)
   T and CD21(+) B Lymphocytes but Not for Glandular Epithelium at the
   Primary Site of Persistent Infection in the Stallion Reproductive Tract
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE arterivirus; equine arteritis virus; EAV; equine viral arteritis; EVA;
   persistent infection; male reproductive tract; immunohistochemistry;
   cellular tropism; immune response
ID RESPIRATORY SYNDROME VIRUS; MALE GENITAL-TRACT; MONOCLONAL-ANTIBODIES;
   VIRAL ARTERITIS; DENDRITIC CELLS; IMMUNE-RESPONSES; ZIKA VIRUS;
   IN-VITRO; CARRIER STATE; IMMUNOPEROXIDASE HISTOCHEMISTRY
AB Equine arteritis virus (EAV) has a global impact on the equine industry as the causative agent of equine viral arteritis (EVA), a respiratory, systemic, and reproductive disease of equids. A distinctive feature of EAV infection is that it establishes long-term persistent infection in 10 to 70% of infected stallions (carriers). In these stallions, EAV is detectable only in the reproductive tract, and viral persistence occurs despite the presence of high serum neutralizing antibody titers. Carrier stallions constitute the natural reservoir of the virus as they continuously shed EAV in their semen. Although the accessory sex glands have been implicated as the primary sites of EAV persistence, the viral host cell tropism and whether viral replication in carrier stallions occurs in the presence or absence of host inflammatory responses remain unknown. In this study, dual immunohistochemical and immunofluorescence techniques were employed to unequivocally demonstrate that the ampulla is the main EAV tissue reservoir rather than immunologically privileged tissues (i.e., testes). Furthermore, we demonstrate that EAV has specific tropism for stromal cells (fibrocytes and possibly tissue macrophages) and CD8(+) T and CD21 B lymphocytes but not glandular epithelium. Persistent EAV infection is associated with moderate, multifocal lymphoplasmacytic ampullitis comprising clusters of B (CD21) lymphocytes and significant infiltration of T (CD3(+), CD4(+), CD8(+), and CD25(+)) lymphocytes, tissue macrophages, and dendritic cells (lba-1(+) and CD83(+)), with a small number of tissue macrophages expressing CD163 and CD204 scavenger receptors. This study suggests that EAV employs complex immune evasion mechanisms that warrant further investigation.
   IMPORTANCE The major challenge for the worldwide control of EAV is that this virus has the distinctive ability to establish persistent infection in the stallion's reproductive tract as a mechanism to ensure its maintenance in equid populations. Therefore, the precise identification of tissue and cellular tropism of EAV is critical for understanding the molecular basis of viral persistence and for development of improved prophylactic or treatment strategies. This study significantly enhances our understanding of the EAV carrier state in stallions by unequivocally identifying the ampullae as the primary sites of viral persistence, combined with the fact that persistence involves continuous viral replication in fibrocytes (possibly including tissue macrophages) and T and B lymphocytes in the presence of detectable inflammatory responses, suggesting the involvement of complex viral mechanisms of immune evasion. Therefore, EAV persistence provides a powerful new natural animal model to study RNA virus persistence in the male reproductive tract.
C1 [Carossino, Mariano; Cook, R. Frank; Campos, Juliana R.; Nam, Bora; Go, Yun Young; Squires, Edward L.; Troedsson, Mats H. T.; Swerczek, Thomas; Bailey, Ernest; Timoney, Peter J.; Balasuriya, Udeni B. R.] Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Coll Agr Food & Environm, Lexington, KY 40506 USA.
   [Loynachan, Alan T.] Univ Kentucky, Vet Diagnost Lab, Coll Agr Food & Environm, Lexington, KY USA.
   [Canisso, Igor F.] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL USA.
   [Canisso, Igor F.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL USA.
   [Go, Yun Young] Korea Res Inst Chem Technol, Div Drug Discovery Res, Virus Res & Testing Grp, Daejeon, South Korea.
   [Del Piero, Fabio] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
RP Balasuriya, UBR (corresponding author), Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Coll Agr Food & Environm, Lexington, KY 40506 USA.
EM ubalasuriya@uky.edu
RI Bailey, Ernest/M-1859-2018
OI Bailey, Ernest/0000-0001-8246-9117
FU Agriculture and Food Research Initiative competitive grant from the USDA
   National Institute of Food and Agriculture (USDA-NIFA)
   [2013-68004-20360]; Hildegard Rosa Shapiro Endowed Equine Research Fund
   at the Maxwell H. Gluck Equine Research Center, Department of Veterinary
   Science, University of Kentucky
FX This work was supported by Agriculture and Food Research Initiative
   competitive grant number 2013-68004-20360 from the USDA National
   Institute of Food and Agriculture (USDA-NIFA) and the Hildegard Rosa
   Shapiro Endowed Equine Research Fund at the Maxwell H. Gluck Equine
   Research Center, Department of Veterinary Science, University of
   Kentucky.
CR Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535
   Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007
   Alvarez B, 2000, TISSUE ANTIGENS, V55, P342, DOI 10.1034/j.1399-0039.2000.550408.x
   Balasuriya U, 2013, EQUINE INFECT DIS, P169
   Balasuriya UBR, 2004, J GEN VIROL, V85, P379, DOI 10.1099/vir.0.19545-0
   Balasuriya UBR, 2002, J VIROL METHODS, V101, P21, DOI 10.1016/S0166-0934(01)00416-5
   Balasuriya UBR, 1999, VIROLOGY, V260, P201, DOI 10.1006/viro.1999.9817
   Balasuriya UBR, 2016, EQUINE VET ED
   Balasuriya UBR, 2007, J GEN VIROL, V88, P918, DOI 10.1099/vir.0.82415-0
   Balasuriya UBR, 2016, J EQUINE VET SCI, V43, pS11, DOI 10.1016/j.jevs.2016.05.017
   Balasuriya UBR, 2014, VET CLIN N AM-EQUINE, V30, P543, DOI 10.1016/j.cveq.2014.08.011
   Balasuriya UBR, 2013, VET MICROBIOL, V167, P93, DOI 10.1016/j.vetmic.2013.06.015
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bimczok D, 2006, VET RES, V37, P325, DOI 10.1051/vetres:2006004
   BLANCHARDCHANNELL M, 1994, IMMUNOLOGY, V82, P548
   BOHN W, 1992, EXP CELL RES, V201, P1, DOI 10.1016/0014-4827(92)90341-5
   Boliar S, 2010, VET IMMUNOL IMMUNOP, V136, P201, DOI 10.1016/j.vetimm.2010.03.004
   BRYANS J T, 1957, Cornell Vet, V47, P52
   Campos J.J.F., 2012, THESIS
   Campos JR, 2014, THERIOGENOLOGY, V82, P1068, DOI 10.1016/j.theriogenology.2014.07.004
   Carossino M, 2016, ARCH VIROL, V161, P3125, DOI 10.1007/s00705-016-3014-5
   Carossino M, 2016, J VIROL METHODS, V234, P7, DOI 10.1016/j.jviromet.2016.02.015
   Cavanagh D, 1997, ARCH VIROL, V142, P629
   Cecere TE, 2012, VET MICROBIOL, V160, P233, DOI 10.1016/j.vetmic.2012.04.040
   Cecere TE, 2012, VIRUSES-BASEL, V4, P833, DOI 10.3390/v4050833
   Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263
   Izquierdo MC, 2014, CYTOKINE GROWTH F R, V25, P317, DOI 10.1016/j.cytogfr.2014.04.002
   CRUMP AL, 1988, ANIM GENET, V19, P349, DOI 10.1111/j.1365-2052.1988.tb00826.x
   DANILENKO DM, 1995, J IMMUNOL, V155, P35
   DANILENKO DM, 1992, TISSUE ANTIGENS, V40, P13, DOI 10.1111/j.1399-0039.1992.tb01952.x
   Deininger MH, 2002, FEBS LETT, V514, P115, DOI 10.1016/S0014-5793(02)02430-4
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Del Piero F, 2000, VET PATHOL, V37, P486, DOI 10.1354/vp.37-5-486
   Del Piero F, 2000, VET PATHOL, V37, P287, DOI 10.1354/vp.37-4-287
   DelPiero F, 1997, EQUINE VET J, V29, P178, DOI 10.1111/j.2042-3306.1997.tb01666.x
   Di Carlo E, 2007, PROSTATE, V67, P1070, DOI 10.1002/pros.20604
   Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010
   FRITZ FJ, 1989, EUR J IMMUNOL, V19, P475, DOI 10.1002/eji.1830190310
   Fu HM, 2016, CELL MOL LIFE SCI, V73, P3009, DOI 10.1007/s00018-016-2211-4
   Go YY, 2012, J VIROL, V86, P12407, DOI 10.1128/JVI.01698-12
   Go YY, 2012, VET MICROBIOL, V157, P220, DOI 10.1016/j.vetmic.2011.11.031
   Go YY, 2011, J VIROL, V85, P13174, DOI 10.1128/JVI.06068-11
   Go YY, 2010, J VIROL, V84, P4898, DOI 10.1128/JVI.02743-09
   Gomez-Laguna J, 2012, VET MICROBIOL, V158, P187, DOI 10.1016/j.vetmic.2012.02.003
   Gown AM, 2008, MODERN PATHOL, V21, P1271, DOI 10.1038/modpathol.2008.83
   Grosche A, 2008, EQUINE VET J, V40, P393, DOI 10.2746/042516408X302500
   Gunther C, 2012, J INVEST DERMATOL, V132, P626, DOI 10.1038/jid.2011.371
   Gulbahar MY, 2006, VET PATHOL, V43, P67, DOI 10.1354/vp.43-1-67
   Hedges JF, 1999, J VIROL, V73, P3672, DOI 10.1128/JVI.73.5.3672-3681.1999
   Hedges JF, 2001, IMMUNOLOGY, V103, P498, DOI 10.1046/j.1365-2567.2001.01262.x
   HEIDNER HW, 1990, VIROLOGY, V176, P658, DOI 10.1016/0042-6822(90)90041-O
   Herrmann-Hoesing LM, 2010, VET PATHOL, V47, P518, DOI 10.1177/0300985809359605
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirayama K, 2003, VET PATHOL, V40, P86, DOI 10.1354/vp.40-1-86
   HOLYOAK GR, 1993, J COMP PATHOL, V109, P29, DOI 10.1016/S0021-9975(08)80238-1
   Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0
   Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641
   Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033
   Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241
   Landini G, 2015, COLOUR DECONVOLUTION
   Liu C, 2012, VET IMMUNOL IMMUNOP, V148, P302, DOI 10.1016/j.vetimm.2012.06.018
   Lopez JW, 1996, EQUINE VET J, V28, P77, DOI 10.1111/j.2042-3306.1996.tb01593.x
   LUNN DP, 1991, IMMUNOLOGY, V74, P251
   MacLachlan NJ, 1996, J VET DIAGN INVEST, V8, P367, DOI 10.1177/104063879600800316
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MCCOLLUM WH, 1995, J COMP PATHOL, V112, P207, DOI 10.1016/S0021-9975(05)80062-3
   MCCOLLUM WH, 1994, J COMP PATHOL, V111, P383, DOI 10.1016/S0021-9975(05)80096-9
   McNeilly TN, 2006, J HISTOCHEM CYTOCHEM, V54, P1021, DOI 10.1369/jhc.6A6940.2006
   Merant C, 2003, VET RES, V34, P791, DOI 10.1051/vetres:2003033
   Miszczak F, 2012, VIROLOGY, V423, P165, DOI 10.1016/j.virol.2011.11.028
   Miszczak F, 2011, J CLIN MICROBIOL, V49, P3694, DOI 10.1128/JCM.01187-11
   MOORE PF, 1990, TISSUE ANTIGENS, V36, P211, DOI 10.1111/j.1399-0039.1990.tb01831.x
   Morgan AJ, 2005, CLIN EXP ALLERGY, V35, P1572, DOI 10.1111/j.1365-2222.2005.02383.x
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nakayama M, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00672
   Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136
   Nalubarnba KS, 2007, VET IMMUNOL IMMUNOP, V118, P252, DOI 10.1016/j.vetimm.2007.05.018
   Nguyen PV, 2014, CELL MOL IMMUNOL, V11, P410, DOI 10.1038/cmi.2014.41
   Ni K, 1997, IMMUNOL CELL BIOL, V75, P223, DOI 10.1038/icb.1997.35
   Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698
   PrabhuDas M, 2014, J IMMUNOL, V192, P1997, DOI 10.4049/jimmunol.1490003
   Richardsen E, 2015, AM J PATHOL, V185, P2722, DOI 10.1016/j.ajpath.2015.06.013
   Roved J, 2017, HORM BEHAV, V88, P95, DOI 10.1016/j.yhbeh.2016.11.017
   Rugtveit J, 1996, J PATHOL, V180, P194
   Sarkar S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006467
   Sarkar S, 2016, J VIROL, V90, P3366, DOI 10.1128/JVI.02455-15
   Shashkin P, 2003, ARTERIOSCL THROM VAS, V23, P148, DOI 10.1161/01.ATV.0000043906.61088.4B
   Silva-Campa E, 2012, VIROLOGY, V430, P73, DOI 10.1016/j.virol.2012.04.009
   Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961
   Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0
   Stenfeldt C, 2016, TRANSBOUND EMERG DIS, V63, P152, DOI 10.1111/tbed.12235
   Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16
   Timoney P J, 1987, J Reprod Fertil Suppl, V35, P95
   Timoney P J, 2000, J Reprod Fertil Suppl, P3
   TIMONEY PJ, 1988, J EQUINE VET SCI, V8, P54, DOI 10.1016/S0737-0806(88)80112-6
   TIMONEY PJ, 1986, RES VET SCI, V41, P279, DOI 10.1016/S0034-5288(18)30616-7
   TIMONEY PJ, 1987, J AM VET MED ASSOC, V191, P36
   TIMONEY PJ, 1993, VET CLIN N AM-EQUINE, V9, P295, DOI 10.1016/S0749-0739(17)30397-8
   Timoney PJ, 2000, ANN NY ACAD SCI, V916, P55, DOI 10.1111/j.1749-6632.2000.tb05274.x
   Timoney PJ, 2000, VET CLIN N AM-EQUINE, V16, P537, DOI 10.1016/S0749-0739(17)30094-9
   Tomokiyo R, 2002, ATHEROSCLEROSIS, V161, P123, DOI 10.1016/S0021-9150(01)00624-4
   TUMAS DB, 1994, IMMUNOBIOLOGY, V192, P48, DOI 10.1016/S0171-2985(11)80407-9
   Vairo S, 2013, VET MICROBIOL, V167, P235, DOI 10.1016/j.vetmic.2013.07.020
   Vairo S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-22
   Vairo S, 2012, VET MICROBIOL, V157, P333, DOI 10.1016/j.vetmic.2012.01.014
   van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781
   van der Voort R, 2005, ARTHRITIS RHEUM-US, V52, P1381, DOI 10.1002/art.21004
   Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035
   Wongyanin P, 2012, J GEN VIROL, V93, P1236, DOI 10.1099/vir.0.040287-0
   [World Organisation for Animal Health (OIE) OIE Biological Standards Commission], 2016, MANUAL DIAGNOSTIC TE, V2
   Yamaguchi T, 2016, GASTRIC CANCER, V19, P1052, DOI 10.1007/s10120-015-0579-8
   Yamate J, 2000, VET PATHOL, V37, P168, DOI 10.1354/vp.37-2-168
   Zaneveld LJD, 1996, CONTRACEPTIVE RES DE, P430
   Zhang JQ, 2010, J GEN VIROL, V91, P2286, DOI 10.1099/vir.0.019737-0
   Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226
NR 119
TC 10
Z9 10
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2017
VL 91
IS 13
AR UNSP e00418-17
DI 10.1128/JVI.00418-17
PG 26
WC Virology
SC Virology
GA EX3CC
UT WOS:000403108600010
PM 28424285
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Naveca, FG
   do Nascimento, VA
   de Souza, VC
   Nunes, BTD
   Rodrigues, DSG
   Vasconcelos, PFD
AF Naveca, Felipe Gomes
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Diniz Nunes, Bruno Tardelli
   Guerreiro Rodrigues, Daniela Sueli
   da Costa Vasconcelos, Pedro Fernando
TI Multiplexed reverse transcription real-time polymerase chain reaction
   for simultaneous detection of Mayaro, Oropouche, and Oropouche-like
   viruses
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE real-time PCR; Mayaro virus; Oropouche virus; Amazon
ID FAMILY BUNYAVIRIDAE; BRAZIL; ORTHOBUNYAVIRUS; FEVER; IDENTIFICATION;
   EPIDEMIOLOGY; REASSORTANT; SEQUENCE; MANAUS
AB We describe a sensitive method for simultaneous detection of Oropouche and Oropouche-like viruses carrying the Oropouche S segment, as well as the Mayaro virus, using a multiplexed one-step reverse transcription real-time polymerase chain reaction (RT-qPCR). A chimeric plasmid containing both Mayaro and Oropouche targets was designed and evaluated for the in vitro production of transcribed RNA, which could be easily used as a non-infectious external control. To track false-negative results due to PCR inhibition or equipment malfunction, the MS2 bacteriophage was also included in the multiplex assay as an internal positive control. The specificity of the multiplex assay was evaluated by Primer-Blast analysis against the entire GenBank database, and further against a panel of 17 RNA arboviruses. The results indicated an accurate and highly sensitive assay with amplification efficiency greater than 98% for both targets, and a limit of detection between two and 20 copies per reaction. We believe that the assay described here will provide a tool for Mayaro and Oropouche virus detection, especially in areas where differential diagnosis of Dengue, Zika and Chikungunya viruses should be performed.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [Diniz Nunes, Bruno Tardelli; Guerreiro Rodrigues, Daniela Sueli; da Costa Vasconcelos, Pedro Fernando] Minist Saude, Secretaria Vigilancia Saude, Inst Evandro Chagas, Ananindeua, PA, Brazil.
   [da Costa Vasconcelos, Pedro Fernando] Unversidade Estado Para, Belem, Para, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Naveca, Felipe/H-1130-2012; Vasconcelos, Pedro/AAH-3142-2019
OI Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa
   de/0000-0002-3869-1519; Nascimento, Valdinete/0000-0002-7786-4718
FU FAPEAM PPP; DECIT/FAPEAM PPSUS; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX FAPEAM PPP, DECIT/FAPEAM PPSUS, CNPq.
CR Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   Ladner JT, 2014, J GEN VIROL, V95, P1055, DOI 10.1099/vir.0.061309-0
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 17
TC 18
Z9 18
U1 0
U2 13
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL
PY 2017
VL 112
IS 7
BP 510
EP 513
DI 10.1590/0074-02760160062
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EX5HL
UT WOS:000403270100007
PM 28591313
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Du Toit, A
AF Du Toit, Andrea
TI VIRAL EVOLUTION Zika is on point to increase spread
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Editorial Material
CR Liu Y., 2017, NATURE
NR 1
TC 0
Z9 0
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD JUL
PY 2017
VL 15
IS 7
BP 381
EP 381
DI 10.1038/nrmicro.2017.62
PG 1
WC Microbiology
SC Microbiology
GA EX3UR
UT WOS:000403159700001
PM 28555074
DA 2020-07-08
ER

PT J
AU Rosenbaum, JT
AF Rosenbaum, James T.
TI New developments in uveitis associated with HLA B27
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE ankylosing spondylitis; HLA B27; iritis; uveitis
ID INFLAMMATORY-BOWEL-DISEASE; ACUTE ANTERIOR UVEITIS; ZIKA
   VIRUS-INFECTION; ANKYLOSING-SPONDYLITIS; NONINFECTIOUS UVEITIS;
   PSORIATIC-ARTHRITIS; SPONDYLOARTHRITIS; PREVALENCE; ADALIMUMAB;
   MANAGEMENT
AB Purpose of review
   Uveitis is the most common, clinically apparent, extra-articular manifestation of axial spondyloarthritis. This review summarizes recent publications related to this form of uveitis.
   Recent findings
   Studies published since the start of 2015 address the worldwide prevalence of human leukocyte antigen (HLA) B27-associated uveitis, the prevalence of axial spondyloarthritis among patients with B27-associated acute anterior uveitis (AAU), the genetics of AAU and some of the clinical implications of AAU. Progress has been made in the treatment of uveitis in general and in the treatment of uveitis in association with spondyloarthropathy in particular. The pathogenesis of AAU might derive clues from the above as well as from an understanding of the microbiome and possibly from knowledge derived from uveitis in association with Ebola.
   Summary
   Although HLA B27-associated uveitis has been recognized since 1973, a variety of recent observations shed new light on this common clinical association with spondyloarthritis.
C1 [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA.
   [Rosenbaum, James T.] Legacy Devers Eye Inst, Portland, OR USA.
RP Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA.
EM rosenbaj@ohsu.edu
FU Spondylitis Association of America; William and Mary Bauman Foundation;
   Stan and Madelle Rosenfeld Family Trust
FX Spondylitis Association of America, William and Mary Bauman Foundation,
   Stan and Madelle Rosenfeld Family Trust.
CR Al Dhibi HA, 2016, OCUL IMMUNOL INFLAMM, V24, P1
   Arnbak B, 2016, ARTHRITIS RHEUMATOL, V68, P892, DOI 10.1002/art.39551
   Bai L, 2016, INVEST OPHTH VIS SCI, V57, P1847, DOI 10.1167/iovs.15-17960
   Baraliakos X, 2012, RHEUMATOLOGY, V51, P1378, DOI 10.1093/rheumatology/kes026
   BREWERTON DA, 1973, LANCET, V2, P994, DOI 10.1016/S0140-6736(73)91090-8
   Chen SC, 2016, OCUL IMMUNOL INFLAMM, V27, P1
   Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967
   Fanlo P, 2016, ARCH SOC ESP OFTALMO
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Ganapathy PS, 2018, OCUL IMMUNOL INFLAMM, V26, P425, DOI 10.1080/09273948.2016.1234626
   Gao F, 2016, OCUL IMMUNOL INFLAMM, P1
   Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014
   Haroon M, 2015, ANN RHEUM DIS, V74, P1990, DOI 10.1136/annrheumdis-2014-205358
   Hidehiko N, 2016, OCUL IMMUNOL INFLAMM, P1
   Hoeksema L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146956
   Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014
   Iwata D, 2016, OCUL IMMUNOL INFLAMM, P1
   Jaffe GJ, 2016, NEW ENGL J MED, V375, P932, DOI 10.1056/NEJMoa1509852
   Jones GT, 2016, ARTHRITIS CARE RES H
   Juanola X, 2016, OPHTHALMOLOGY, V123, P1632, DOI 10.1016/j.ophtha.2016.03.010
   Keck KM, 2014, JCR-J CLIN RHEUMATOL, V20, P141, DOI 10.1097/RHU.0000000000000087
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lee JJ, 2016, OCUL IMMUNOL INFLAMM, P1
   Li HY, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-016-0552-4
   Lim LL, 2007, ARTHRITIS RHEUM, V56, P3248, DOI 10.1002/art.22918
   Lin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105684
   Lyons JL, 1997, ARCH OPHTHALMOL-CHIC, V115, P61, DOI 10.1001/archopht.1997.01100150063010
   Manandhar A, 2017, OCUL IMMUNOL INFLAMM, V25, pS54, DOI 10.3109/09273948.2016.1161804
   Monnet D, 2004, OPHTHALMOLOGY, V111, P802, DOI 10.1016/j.ophtha.2003.07.011
   Nakamura YK, 2016, INVEST OPHTH VIS SCI, V57, P3747, DOI 10.1167/iovs.16-19733
   Nascimento H, 2016, OCUL IMMUNOL INFLAMM, V25, P1, DOI [10.3109/09273948.2015.1132741, DOI 10.3109/09273948.2015.1132741]
   Paiva ES, 2000, ANN RHEUM DIS, V59, P67, DOI 10.1136/ard.59.1.67
   Pathanapitoon K, 2017, OCUL IMMUNOL INFLAMM, V25, P569, DOI 10.1080/09273948.2016.1185527
   Nguyen QD, 2016, LANCET, V388, P1183, DOI 10.1016/S0140-6736(16)31339-3
   Robinson PC, 2015, ARTHRITIS RHEUMATOL, V67, P140, DOI 10.1002/art.38873
   Rosenbaum J, 2012, AM J MED SCI, V343, P364, DOI 10.1097/MAJ.0b013e3182514059
   Rosenbaum JT, 2016, OCUL IMMUNOL INFLAMM, V24, P440, DOI 10.3109/09273948.2016.1142574
   ROSENBAUM JT, 1981, ANN INTERN MED, V94, P261, DOI 10.7326/0003-4819-94-2-261
   ROSENBAUM JT, 1989, J RHEUMATOL, V16, P792
   Rudwaleit M, 2016, ARTHRIT CARE RES, V68, P838, DOI 10.1002/acr.22848
   Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645
   Scharl M, 2012, CURR OPIN GASTROEN, V28, P301, DOI 10.1097/MOG.0b013e328353e61e
   Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892
   Siak J, 2016, OCUL IMMUNOL INFLAMM, P1
   Sun L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004233
   Thorne JE, 2016, JAMA OPHTHALMOL, V134, P1237, DOI 10.1001/jamaophthalmol.2016.3229
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Verhagen FH, 2016, AM J OPHTHALMOL, V165, P179, DOI 10.1016/j.ajo.2016.02.024
   Win MZA, 2017, OCUL IMMUNOL INFLAMM, V25, pS69, DOI 10.3109/09273948.2015.1133839
   Wong A, 2016, OCUL IMMUNOL INFLAMM, P1
   Yalcindag FN, 2017, OCUL IMMUNOL INFLAMM, V25, P41, DOI 10.3109/09273948.2015.1108444
   Yazgan S, 2017, INT OPHTHALMOL, V37, P139, DOI 10.1007/s10792-016-0239-y
   Zagora SL, 2016, OCUL IMMUNOL INFLAMM, P1
NR 53
TC 12
Z9 13
U1 1
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD JUL
PY 2017
VL 29
IS 4
BP 298
EP 303
DI 10.1097/BOR.0000000000000403
PG 6
WC Rheumatology
SC Rheumatology
GA EW5PC
UT WOS:000402557500004
PM 28376061
DA 2020-07-08
ER

PT J
AU Ramaiah, A
   Dai, L
   Contreras, D
   Sinha, S
   Sun, R
   Arumugaswami, V
AF Ramaiah, Arunachalam
   Dai, Lei
   Contreras, Deisy
   Sinha, Sanjeev
   Sun, Ren
   Arumugaswami, Vaithilingaraja
TI Comparative analysis of protein evolution in the genome of pre-epidemic
   and epidemic Zika virus
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Host adaptation; Natural selection; Co-evolving sites;
   Immune epitopes
ID WEST-NILE-VIRUS; SWISS-MODEL; PHYLOGENETIC ANALYSIS; SELECTION;
   ENVIRONMENT; ADAPTATION; AMERICA; HELICASE; STRAINS; BIOLOGY
AB Zika virus (ZIKV) causes microcephaly in congenital infection, neurological disorders, and poor pregnancy outcome and no vaccine is available for use in humans or approved. Although ZIKV was first discovered in 1947, the exact mechanism of virus replication and pathogenesis remains unknown. Recent outbreaks of Zika virus in the Americas clearly suggest a human-mosquito cycle or urban cycle of transmission. Understanding the conserved and adaptive features in the evolution of ZIKV genome will provide a hint on the mechanism of ZIKV adaptation to a new cycle of transmission. Here, we show comprehensive analysis of protein evolution of ZIKV strains including the current 2015-16 outbreak. To identify the constraints on ZIKV evolution, selection pressure at individual codons, immune epitopes and co-evolving sites were analyzed. Phylogenetic trees show that the ZIKV strains of the Asian genotype form distinct cluster and share a common ancestor with African genotype. The TMRCA (Time to the Most Recent Common Ancestor) for the Asian lineage and the subsequently evolved Asian human strains was calculated at 88 and 34 years ago, respectively. The proteome of current 2015/16 epidemic ZIKV strains of Asian genotype was found to be genetically conserved due to genome-wide negative selection, with limited positive selection. We identified a total of 16 amino add substitutions in the epidemic and pre-epidemic strains from human, mosquito, and monkey hosts. Negatively selected amino acid sites of Envelope protein (E-protein) (positions 69, 166, and 174) and NS5 (292, 345, and 587) were located in central dimerization domains and C-terminal RNA-directed RNA polymerase regions, respectively. The predicted 137 (92 CD4 TCEs; 45 CD8 TCEs) immunogenic peptide chains comprising negatively selected amino acid sites can be considered as suitable target for sub-unit vaccine development, as these sites are less likely to generate immune-escape variants due to strong functional constrains operating on them. The targeted changes at the amino acid level may contribute to better adaptation of ZIKV strains to human-mosquito cycle or urban cycle of transmission. (C) 2017 Published by Elsevier B.V.
C1 [Ramaiah, Arunachalam] Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, KA, India.
   [Dai, Lei; Sun, Ren] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Dai, Lei] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.
   [Contreras, Deisy; Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Board Governors, Regenerat Med Inst, Los Angeles, CA 90048 USA.
   [Sinha, Sanjeev] All India Inst Med Sci, New Delhi, India.
   [Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA.
   [Ramaiah, Arunachalam] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30329 USA.
RP Sun, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Arumugaswami, V (corresponding author), Cedars Sinai Med Ctr, Board Governors, Regenerat Med Inst, Los Angeles, CA 90048 USA.
EM rsun@mednet.ucla.edu; arumugaswami@cshs.org
FU Cedars-Sinai Medical Center's Institutional Research Award [NIH P01
   CA177322]; HHMI Postdoctoral Fellowship from Jane Coffin Childs Memorial
   Fund for Medical Research
FX This work was funded by the Cedars-Sinai Medical Center's Institutional
   Research Award to V.A., and NIH P01 CA177322 to R.S. L.D. was supported
   by HHMI Postdoctoral Fellowship from Jane Coffin Childs Memorial Fund
   for Medical Research. The authors thank Dr. Laura Martinez, Cedars-Sinai
   Medical Center for her critical comments and help in improvising
   language of this manuscript.
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Arunachalam R, 2014, GENOMICS, V104, P545, DOI 10.1016/j.ygeno.2014.10.012
   Arunachalam R, 2013, GENETICA, V141, P143, DOI 10.1007/s10709-013-9713-x
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266
   Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590
   Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108
   Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746
   Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mahy B. W.J, 2010, EMERG INFECT DIS, V16, P899, DOI DOI 10.3201/EID1605.100164
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nandy A, 2016, CURR COMPUT-AID DRUG, V12, P87, DOI 10.2174/1573409912666160401115812
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quadeer AA, 2014, J VIROL, V88, P7628, DOI 10.1128/JVI.03812-13
   Ramaiah Arunachalam, 2016, VirusDisease, V27, P136, DOI 10.1007/s13337-016-0305-0
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Sanderson Michael J., 1994, American Journal of Botany, V81, P183
   Sanjuan R, 2005, GENETICS, V170, P1001, DOI 10.1534/genetics.105.040741
   Sant'Anna FH, 2014, ARCH VIROL, V159, P621, DOI 10.1007/s00705-013-1855-8
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   Suzuki Y, 2004, GENE, V328, P127, DOI 10.1016/j.gene.2003.11.020
   Tamura K, 1993, MOL BIOL EVOL, V11, P715
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 65
TC 13
Z9 14
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2017
VL 51
BP 74
EP 85
DI 10.1016/j.meegid.2017.03.012
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA EW4AJ
UT WOS:000402444100013
PM 28315476
DA 2020-07-08
ER

PT J
AU Zhang, RY
   Xu, CF
   Duan, ZY
AF Zhang, Ruiying
   Xu, Chongfeng
   Duan, Ziyuan
TI Novel antigenic shift in HA sequences of H1N1 viruses detected by big
   data analysis
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE H1N1; HAI; HA2; Cryptic antigenic shift; Genetic distance
ID INFLUENZA-VIRUSES; ZIKA VIRUS; H7N9; EVOLUTION; OUTBREAK; GENESIS;
   ORIGINS
AB The influenza virus HINI has been prevalent all over the world for nearly a century. Many studies on its evolutionary history, substitution rate and antigenicity-associated sites have been done with small datasets. To have a complete view, we analysed 3171 full-length HA sequences from human H1N1 viruses sampled from 1918 to 2016, and discovered a new Glade has formed with sequences isolated in Iran. Based on genetic distance calculations, we revealed an uneven evolutionary rate among sequences isolated in different years. We also found that the HAl fragment of the new Glade is like that of viruses that existed in the 1930s, while the HA2 fragment is closely associated with strains isolated after the 2009 pandemic. This new, "mixed" HA sequence indicates a cryptic antigenic shift event occurred, and it should draw more attention to the new Glade identified from sequences from Iran. (C) 2017 Published by Elsevier B.V.
C1 [Zhang, Ruiying; Xu, Chongfeng; Duan, Ziyuan] Chinese Acad Sci, Genet Resources Ctr, Inst Genet & Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China.
RP Duan, ZY (corresponding author), Chinese Acad Sci, Genet Resources Ctr, Inst Genet & Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China.
EM zyduan@genetics.ac.cn
CR Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7
   Alcorn T, 2013, LANCET RESP MED, V1, P286, DOI 10.1016/S2213-2600(13)70092-4
   Baker Aryn, 2014, Time, V184, P38
   Banerjee R, 2015, INFECT GENET EVOL, V32, P107, DOI 10.1016/j.meegid.2015.02.023
   Belser JA, 2013, LANCET RESP MED, V1, P501, DOI 10.1016/S2213-2600(13)70161-9
   Bhatt S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0382
   Bragstad K, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-40
   Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Drescher J, 1999, J MED VIROL, V57, P397, DOI 10.1002/(SICI)1096-9071(199904)57:4<397::AID-JMV12>3.0.CO;2-R
   Fung ICH, 2013, WEST PAC SURVEILL RE, V4, P1, DOI [10.5365/WPSAR.2013.4.3.005, 10.5365/wpsar.2013.4.3.005]
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225
   Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354
   Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14
   Lai KY, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.48
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Miller MA, 2010, GAT COMP ENV WORKSH, P1, DOI [10.1109/GCE.2010.5676129, DOI 10.1109/GCE.2010.5676129]
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112
   Qu YH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-250
   Ren XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126742
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83
   Shi WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014454
   SHOPE RICHARD E., 1931, JOUR EXP MED, V54, P349, DOI 10.1084/jem.54.3.349
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793
   Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572
   Watanabe Akira, 2013, Nihon Naika Gakkai Zasshi, V102, P2808
   World Health Organization, 2009, PAND H1N1
   Worobey M, 2014, P NATL ACAD SCI USA, V111, P8107, DOI 10.1073/pnas.1324197111
   Yamayoshi S, 2014, J VIROL, V88, P3127, DOI 10.1128/JVI.03155-13
   Yao LN, 2013, BIOSCI TRENDS, V7, P290, DOI 10.5582/bst.2013.v7.6.290
   Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379
NR 37
TC 2
Z9 2
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2017
VL 51
BP 138
EP 142
DI 10.1016/j.meegid.2017.03.028
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA EW4AJ
UT WOS:000402444100023
PM 28359834
DA 2020-07-08
ER

PT J
AU Siddharthan, V
   Van Wettere, AJ
   Li, R
   Miao, JX
   Wang, ZD
   Morrey, JD
   Julander, JG
AF Siddharthan, Venkatraman
   Van Wettere, Arnaud J.
   Li, Rong
   Miao, Jinxin
   Wang, Zhongde
   Morrey, John D.
   Julander, Justin G.
TI Zika virus infection of adult and fetal STAT2 knock-out hamsters
SO VIROLOGY
LA English
DT Article
DE Zika virus; STAT2; Hamsters; Fetus; Testes
ID WEST-NILE-VIRUS; ENCEPHALITIS-VIRUS; MICE; TRANSMISSION; PREGNANCY
AB Zika virus (ZIKV) infection was investigated in adult and fetal STAT2 knock-out (KO) hamsters. Subcutaneous injection of ZIKV of adults resulted in morbidity, mortality, and infection of the uterus, placenta, brain, spinal cord, and testicles, thus providing an opportunity to evaluate congenital ZIKV infection in a second rodent species besides mice. ZIKV-infected cells with morphologies of Sertoli cells and spermatogonia were observed in the testes, which may have implications for sexual transmission and male sterility. Neonates exposed as fetuses to ZIKV at 8 days post-coitus were not smaller than controls. Nevertheless, infectious virus and ZIKV RNA was detected in some, but not all, placentas and fetal brains of KO hamsters. STAT2 KO hamsters may be useful for addressing sexual transmission, pathogenesis, routes of fetal infection, and neurological disease outcomes, and may also be used in antiviral or vaccine studies to identify intervention strategies.
C1 [Siddharthan, Venkatraman; Miao, Jinxin; Morrey, John D.; Julander, Justin G.] Utah State Univ, Inst Antiviral Res, Anim Dairy & Vet Sci Dept, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Van Wettere, Arnaud J.] Utah State Univ, Utah Vet Diagnost Lab, Dept Anim Dairy & Vet Sci, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Li, Rong; Miao, Jinxin; Wang, Zhongde] Utah State Univ, Anim Dairy & Vet Sci Dept, 5600 Old Main Hill, Logan, UT 84322 USA.
RP Morrey, JD; Julander, JG (corresponding author), Utah State Univ, Inst Antiviral Res, Anim Dairy & Vet Sci Dept, 5600 Old Main Hill, Logan, UT 84322 USA.
EM venkat.siddharthan@usu.edu; arnaud.vanwettere@aggiemail.usu.edu;
   zonda.wang@usu.edu; john.morrey@usu.edu; justin.julander@usu.edu
RI Miao, Jinxin/K-4607-2019
OI Miao, Jinxin/0000-0003-1688-3066; Van Wettere,
   Arnaud/0000-0002-9611-1316; Ditton, Thomas/0000-0003-4622-2613; Wang,
   Zhongde/0000-0003-2441-4729
FU Public Health Service (PHS) from the National Institute of Neurological
   Disorders and Stroke (NINDS), National Institutes of Health (NIH)
   [1R21NS090133-01A1, 5R21NS088400-02]; PHS from the Virology Branch,
   National Institute of Allergy and Infectious Diseases (NIAID), NIH
   [5R33AI101483, HHSN272201000039I/HHSN27200004]; Utah Agriculture
   Research Station research from the Next Generation BioGreen 21 Program
   [UTA01176, PJ01107703]
FX The work was supported by Public Health Service (PHS) research grants
   1R21NS090133-01A1, 5R21NS088400-02 to J.D.M. from the National Institute
   of Neurological Disorders and Stroke (NINDS), National Institutes of
   Health (NIH), and PHS grant 5R33AI101483 and contract
   HHSN272201000039I/HHSN27200004 to J.D.M. from the Virology Branch,
   National Institute of Allergy and Infectious Diseases (NIAID), NIH, and
   Utah Agriculture Research Station research grant UTA01176 to J.D.M, and
   grants from the Next Generation BioGreen 21 Program (grant no.
   PJ01107703) to ZW. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   BARNARD BJH, 1986, ONDERSTEPOORT J VET, V53, P235
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Fan Z., 2014, PLOS ONE, V9
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981
   MATHUR A, 1982, J GEN VIROL, V59, P213, DOI 10.1099/0022-1317-59-1-213
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Toth K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005084
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 21
TC 26
Z9 27
U1 0
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JUL
PY 2017
VL 507
BP 89
EP 95
DI 10.1016/j.virol.2017.04.013
PG 7
WC Virology
SC Virology
GA EW0ZA
UT WOS:000402218500010
PM 28431283
OA Bronze
DA 2020-07-08
ER

PT J
AU Chen, LH
   Leder, K
   Wilson, ME
AF Chen, Lin H.
   Leder, Karin
   Wilson, Mary E.
TI Closing the gap in travel medicine: reframing research questions for a
   new era
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Review
DE Emerging economies; gap; travel medicine; research; guidelines; travel;
   knowledge
ID HEPATITIS-A VACCINATION; RISK; ENTEROBACTERIACEAE; SCHISTOSOMIASIS;
   TRANSMISSION; TROPICS; VIRUS; ZIKA
AB Background: Travel medicine needs are changing. New patterns of travel, including greater travel by individuals from emerging economies with different values in costs, risks and benefits, must be considered. This review aims to (1) highlight selected studies that have been published that address previously identified gaps in knowledge; (2) propose possible ways to consider questions regarding travel medicine practice for travelers from emerging economies, underscoring priorities for research focusing on these important populations; (3) highlight potential deficiencies in relevance of current international guidelines as they pertain to travelers from emerging economies; (4) frame research questions for travelers from emerging economies and (5) consider roles for ISTM in closing the gap.
   Methods: We reviewed past travel medicine research priorities published in 2010 to identify publications that responded to some research questions posed. We also reviewed CDC and WHO recommendations and assessed their applicability to travelers from emerging economies.
   Results: Recent publications have responded to some research questions, but gaps remain and new questions have emerged. Re-framing of several key research questions is needed for travelers from emerging economies.
   Discussion: A new challenge looms for traditional travel medicine fields to identify and attend to knowledge and guideline gaps, particularly to rethink questions regarding travel medicine to make them relevant for travelers from emerging economies. The International Society of Travel Medicine is well positioned to assist emerging economies assess their resources and needs, formulate research priorities and tailor the development of travel medicine into a framework aligned to their requirements.
C1 [Chen, Lin H.] Mt Auburn Hosp, Dept Med, Travel Med Ctr, Cambridge, MA 02138 USA.
   [Chen, Lin H.] Harvard Med Sch, Fac Med, Boston, MA 02115 USA.
   [Leder, Karin] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.
   [Leder, Karin] Royal Melbourne Hosp, Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia.
   [Wilson, Mary E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
   [Wilson, Mary E.] Univ Calif San Francisco, Sch Med, Epidemiol & Biostat, San Francisco, CA USA.
RP Chen, LH (corresponding author), Mt Auburn Hosp, Dept Med, Travel Med Ctr, Cambridge, MA 02138 USA.; Chen, LH (corresponding author), Harvard Med Sch, Fac Med, Boston, MA 02115 USA.
EM lchen@hms.harvard.edu
RI Leder, Karin/AAD-2388-2019
OI Leder, Karin/0000-0003-1368-1039; Chen, Lin/0000-0002-5684-8436
FU GlaxoSmithKlineGlaxoSmithKline
FX The authors report no financial disclosures relevant to this work. LHC
   is an advisor for Shoreland, Inc. and has received speaker travel
   support and honorarium from GSK. KL has received research funding and
   travel support from GlaxoSmithKline. MEW reports no disclosures.
CR Arcilla MS, 2016, LANCET INFECT DIS
   Askling HH, 2014, TRAVEL MED INFECT DI, V12, P134, DOI 10.1016/j.tmaid.2014.01.005
   Barnett ED, 2010, J TRAVEL MED, V17, P163, DOI 10.1111/j.1708-8305.2010.00411.x
   Barreto MS, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00190815
   Centers for Disease Control and Prevention, 2016, CDC HLTH INF INT TRA
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Enk MJ, 2003, MEM I OSWALDO CRUZ, V98, P745, DOI 10.1590/S0074-02762003000600006
   Garrido HMG, 2015, J INFECT DIS, V212, P378, DOI 10.1093/infdis/jiv060
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296
   Kantele A, 2015, CLIN INFECT DIS, V60, P837, DOI 10.1093/cid/ciu957
   Kogelman L, 2014, J TRAVEL MED, V21, P104, DOI 10.1111/jtm.12097
   Leder K, 2012, VACCINE, V30, P2600, DOI 10.1016/j.vaccine.2011.12.133
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lysaght T, 2016, SINGAP MED J, V57, P528, DOI 10.11622/smedj.2016161
   Martins DD, 2015, REV SOC BRAS MED TRO, V48, P354, DOI 10.1590/0037-8682-0240-2014
   Odedra A, 2014, TRAVEL MED INFECT DI, V12, P702, DOI 10.1016/j.tmaid.2014.04.002
   Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333
   Sang SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005095
   Soonawala D, 2014, AM J TROP MED HYG, V90, P835, DOI 10.4269/ajtmh.13-0594
   Talbot EA, 2010, J TRAVEL MED, V17, P410, DOI 10.1111/j.1708-8305.2010.00466.x
   Tam CC, 2016, LANCET, V388, P1374, DOI 10.1016/S0140-6736(16)31645-2
   van den Bijllaardt W, 2013, J TRAVEL MED, V20, P278, DOI 10.1111/jtm.12050
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Wazny K, 2014, J GLOB HEALTH, V4, P193, DOI 10.7189/jogh.04.020413
   Winter B, 2016, TRAVEL MED INFECT DI, V14, P599, DOI 10.1016/j.tmaid.2016.09.004
   World Health Organization, 2012, INT TRAV HLTH 2012 E
   Zhou S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1093-0
NR 28
TC 16
Z9 16
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD JUL-AUG
PY 2017
VL 24
IS 4
AR tax001
DI 10.1093/jtm/tax001
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA EU3BQ
UT WOS:000400904000001
PM 28426110
OA Bronze
DA 2020-07-08
ER

PT J
AU Van der Hoek, KH
   Eyre, NS
   Shue, B
   Khantisitthiporn, O
   Glab-Ampi, K
   Carr, JM
   Gartner, MJ
   Jolly, LA
   Thomas, PQ
   Adikusuma, F
   Jankovic-Karasoulos, T
   Roberts, CT
   Helbig, KJ
   Beard, MR
AF Van der Hoek, Kylie H.
   Eyre, Nicholas S.
   Shue, Byron
   Khantisitthiporn, Onruedee
   Glab-Ampi, Kittirat
   Carr, Jillian M.
   Gartner, Matthew J.
   Jolly, Lachlan A.
   Thomas, Paul Q.
   Adikusuma, Fatwa
   Jankovic-Karasoulos, Tanja
   Roberts, Claire T.
   Helbig, Karla J.
   Beard, Michael R.
TI Viperin is an important host restriction factor in control of Zika virus
   infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SEXUAL TRANSMISSION; NEURAL PROGENITORS; MOUSE MODEL; REPLICATION;
   DENGUE; PROTEIN; BRAIN; MACROPHAGES; CHIKUNGUNYA; EXPRESSION
AB XXX Zika virus (ZIKV) infection has emerged as a global health threat and infection of pregnant women causes intrauterine growth restriction, spontaneous abortion and microcephaly in newborns. Here we show using biologically relevant cells of neural and placental origin that following ZIKV infection, there is attenuation of the cellular innate response characterised by reduced expression of IFN-beta and associated interferon stimulated genes (ISGs). One such ISG is viperin that has well documented antiviral activity against a wide range of viruses. Expression of viperin in cultured cells resulted in significant impairment of ZIKV replication, while MEFs derived from CRISPR/Cas9 derived viperin(-/-) mice replicated ZIKV to higher titers compared to their WT counterparts. These results suggest that ZIKV can attenuate ISG expression to avoid the cellular antiviral innate response, thus allowing the virus to replicate unchecked. Moreover, we have identified that the ISG viperin has significant anti-ZIKV activity. Further understanding of how ZIKV perturbs the ISG response and the molecular mechanisms utilised by viperin to suppress ZIKV replication will aid in our understanding of ZIKV biology, pathogenesis and possible design of novel antiviral strategies.
C1 [Van der Hoek, Kylie H.; Eyre, Nicholas S.; Shue, Byron; Khantisitthiporn, Onruedee; Glab-Ampi, Kittirat; Gartner, Matthew J.; Thomas, Paul Q.; Adikusuma, Fatwa; Beard, Michael R.] Univ Adelaide, Res Ctr Infect Dis, Mol & Cellular Biol, Adelaide, SA 5005, Australia.
   [Jolly, Lachlan A.; Jankovic-Karasoulos, Tanja; Roberts, Claire T.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia.
   [Jolly, Lachlan A.; Jankovic-Karasoulos, Tanja; Roberts, Claire T.] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia.
   [Van der Hoek, Kylie H.; Eyre, Nicholas S.; Shue, Byron; Khantisitthiporn, Onruedee; Glab-Ampi, Kittirat; Gartner, Matthew J.; Beard, Michael R.] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.
   [Carr, Jillian M.] Flinders Univ S Australia, Sch Med, Microbiol & Infect Dis, Bedford Pk, SA 5042, Australia.
   [Helbig, Karla J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia.
RP Beard, MR (corresponding author), Univ Adelaide, Res Ctr Infect Dis, Mol & Cellular Biol, Adelaide, SA 5005, Australia.; Beard, MR (corresponding author), Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.
EM michael.beard@adelaide.edu.au
RI amsalu, ribka/G-8780-2019; Beard, Michael/AAS-3477-2020; Helbig,
   Karla/AAC-5515-2019; jolly, lachlan/B-5892-2015
OI Beard, Michael/0000-0002-4106-1016; Helbig, Karla/0000-0001-6306-2821;
   Van der Hoek, Kylie/0000-0002-7904-7340; jolly,
   lachlan/0000-0003-4538-2658; Carr, Jillian/0000-0002-1080-1472;
   Adikusuma, Fatwa/0000-0003-2163-0514; Eyre,
   Nicholas/0000-0002-5424-7573; Roberts, Claire/0000-0002-9250-2192; Shue,
   Byron/0000-0003-1686-1043
FU NHMRC of AustraliaNational Health and Medical Research Council of
   Australia [APP1053206]; Robinson Research Institute Innovation at The
   University of Adelaide
FX We would like to thank Sandy Piltz, Catherine Scougall and Ying Sun for
   technical assistance with generation of CRISPR/Cas9 viperin null mice,
   MEFS and neural progenitor cells respectively. This work was supported
   by grants from the NHMRC (APP1053206) of Australia and the Robinson
   Research Institute Innovation Seed Funding Program at The University of
   Adelaide.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyre NS, 2016, VIROLOGY, V491, P27, DOI 10.1016/j.virol.2016.01.018
   Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542
   Helbig KJ, 2009, J VIROL, V83, P836, DOI 10.1128/JVI.01388-08
   Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Jolly LA, 2013, HUM MOL GENET, V22, P4673, DOI 10.1093/hmg/ddt315
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346
   Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9
   Wati S, 2007, J VIROL, V81, P10161, DOI 10.1128/JVI.00313-07
   Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003
   Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 55
TC 44
Z9 44
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 30
PY 2017
VL 7
AR 4475
DI 10.1038/s41598-017-04138-1
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ1DX
UT WOS:000404451300081
PM 28667332
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ertel, KJ
   Benefield, D
   Castano-Diez, D
   Pennington, JG
   Horswill, M
   den Boon, JA
   Otegui, MS
   Ahlquist, P
AF Ertel, Kenneth J.
   Benefield, Desiree
   Castano-Diez, Daniel
   Pennington, Janice G.
   Horswill, Mark
   den Boon, Johan A.
   Otegui, Marisa S.
   Ahlquist, Paul
TI Cryo-electron tomography reveals novel features of a viral RNA
   replication compartment
SO ELIFE
LA English
DT Article
ID VIRUS-REPLICATION; PROTEIN-A; ULTRASTRUCTURAL CHARACTERIZATION;
   3-DIMENSIONAL ARCHITECTURE; ANTIVIRAL IMMUNITY; SUBGENOMIC RNA3;
   FINE-STRUCTURE; NODAVIRUS RNA; RIG-I; COMPLEX
AB Positive-strand RNA viruses, the largest genetic class of viruses, include numerous important pathogens such as Zika virus. These viruses replicate their RNA genomes in novel, membrane-bounded mini-organelles, but the organization of viral proteins and RNAs in these compartments has been largely unknown. We used cryo-electron tomography to reveal many previously unrecognized features of Flock house nodavirus (FHV) RNA replication compartments. These spherular invaginations of outer mitochondrial membranes are packed with electron-dense RNA fibrils and their volumes are closely correlated with RNA replication template length. Each spherule's necked aperture is crowned by a striking cupped ring structure containing multifunctional FHV RNA replication protein A. Subtomogram averaging of these crowns revealed twelve-fold symmetry, concentric flanking protrusions, and a central electron density. Many crowns were associated with long cytoplasmic fibrils, likely to be exported progeny RNA. These results provide new mechanistic insights into positive-strand RNA virus replication compartment structure, assembly, function and control.
C1 [Ertel, Kenneth J.; Benefield, Desiree; Pennington, Janice G.; Horswill, Mark; den Boon, Johan A.; Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.
   [Ertel, Kenneth J.; Pennington, Janice G.; Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.
   [Benefield, Desiree; Horswill, Mark; den Boon, Johan A.; Ahlquist, Paul] Univ Wisconsin, Morgridge Inst Res, Madison, WI 53706 USA.
   [Castano-Diez, Daniel] Univ Basel, Biozentrum, BioEM Lab, Basel, Switzerland.
   [Otegui, Marisa S.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.
   [Otegui, Marisa S.] Univ Wisconsin, Lab Cell & Mol Biol, Madison, WI 53706 USA.
   [Ertel, Kenneth J.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA.
RP Ahlquist, P (corresponding author), Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.; Ahlquist, P (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.; Ahlquist, P (corresponding author), Univ Wisconsin, Morgridge Inst Res, Madison, WI 53706 USA.
EM ahlquist@wisc.edu
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute;
   Morgridge Institute for Research; National Science FoundationNational
   Science Foundation (NSF) [DBI 1126441, MCB 1614965]; Rowe Family
   Virology Venture Fund; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [T32 AI078985]
FX Howard Hughes Medical Institute Investigator Paul Ahlquist; Morgridge
   Institute for Research Investigator Paul Ahlquist; National Science
   Foundation DBI 1126441 Marisa S Otegui Paul Ahlquist; National Science
   Foundation MCB 1614965 Marisa S Otegui; Rowe Family Virology Venture
   Fund Investigator Paul Ahlquist; National Institutes of Health T32
   AI078985 Desiree Benefield
CR Abels JA, 2005, BIOPHYS J, V88, P2737, DOI 10.1529/biophysj.104.052811
   Ahmad S, 2015, TRENDS BIOCHEM SCI, V40, P576, DOI 10.1016/j.tibs.2015.08.001
   Ahola T, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0050-0
   Amiry-Moghaddam M, 2013, NAT NEUROSCI, V16, P798, DOI 10.1038/nn.3418
   Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101
   Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10
   Balistreri G., 2010, STRUCTURE FUNCTION I
   BALL LA, 1995, J VIROL, V69, P2722, DOI 10.1128/JVI.69.4.2722-2722.1995
   BARTON DJ, 1995, J VIROL, V69, P5516, DOI 10.1128/JVI.69.9.5516-5527.1995
   Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06
   Belov GA, 2016, CURR OPIN VIROL, V19, P1, DOI 10.1016/j.coviro.2016.05.003
   Belov GA, 2014, J VIROL, V88, P9478, DOI 10.1128/JVI.00922-14
   Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11
   Bertin A, 2012, MOL BIOL CELL, V23, P423, DOI 10.1091/mbc.E11-10-0850
   Castano-Diez D, 2017, J STRUCT BIOL, V197, P135, DOI 10.1016/j.jsb.2016.06.005
   Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017
   Cerritelli ME, 1997, CELL, V91, P271, DOI 10.1016/S0092-8674(00)80409-2
   Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005
   Cheng LP, 2011, P NATL ACAD SCI USA, V108, P1373, DOI 10.1073/pnas.1014995108
   de Castro IF, 2017, J CELL SCI, V130, P260, DOI 10.1242/jcs.181586
   den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012
   den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010
   Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104
   Diaz A, 2012, J VIROL, V86, P821, DOI 10.1128/JVI.05684-11
   Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107
   Dye BT, 2005, J VIROL, V79, P8909, DOI 10.1128/JVI.79.14.8909-8919.2005
   Dye BT, 2005, CYTOM PART A, V63A, P77, DOI 10.1002/cyto.a.20112
   Eckerle LD, 2003, VIROLOGY, V317, P95, DOI 10.1016/j.virol.2003.08.029
   Eckerle LD, 2002, VIROLOGY, V296, P165, DOI 10.1006/viro.2002.1377
   Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002
   Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597
   FRIESEN PD, 1984, J VIROL, V49, P116, DOI 10.1128/JVI.49.1.116-124.1984
   Gold VAM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5129
   GRIMLEY PM, 1968, J VIROL, V2, P1326, DOI 10.1128/JVI.2.11.1326-1338.1968
   HATTA T, 1981, J ULTRA MOL STRUCT R, V74, P116, DOI 10.1016/S0022-5320(81)80114-1
   HATTA T, 1973, J GEN VIROL, V20, P37, DOI 10.1099/0022-1317-20-1-37
   Johnson KL, 1999, J VIROL, V73, P7933, DOI 10.1128/JVI.73.10.7933-7942.1999
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680
   Kallio K, 2013, J VIROL, V87, P9125, DOI 10.1128/JVI.00660-13
   King A.M.Q., 2012, VIRUS TAXONOMY CLASS
   Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11
   Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220
   Kopek BG, 2010, J VIROL, V84, P12492, DOI 10.1128/JVI.01495-10
   Kovalev N, 2016, J VIROL, V90, P3611, DOI 10.1128/JVI.02775-15
   Lanman J, 2008, J STRUCT BIOL, V161, P439, DOI 10.1016/j.jsb.2007.09.009
   LEE JY, 1994, VIROLOGY, V200, P307, DOI 10.1006/viro.1994.1192
   Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Lindenbach BD, 2002, J VIROL, V76, P3905, DOI 10.1128/JVI.76.8.3905-3919.2002
   Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583
   Liu HR, 2015, SCIENCE, V349, P1347, DOI 10.1126/science.aaa4938
   Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   McDonald KL, 2006, BIOTECHNIQUES, V41, P137, DOI 10.2144/000112226
   Meyerson JR, 2011, JOVE-J VIS EXP, DOI 10.3791/2770
   Miller DJ, 2003, J VIROL, V77, P12193, DOI 10.1128/JVI.77.22.12193-12202.2003
   Miller DJ, 2002, J VIROL, V76, P9856, DOI 10.1128/JVI.76.19.9856-9867.2002
   Miller DJ, 2001, J VIROL, V75, P11664, DOI 10.1128/JVI.75.23.11664-11676.2001
   MOTOYOSHI F, 1973, J GEN VIROL, V20, P177, DOI 10.1099/0022-1317-20-2-177
   Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383
   Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618
   Oudshoorri D, 2016, MBIO, V7, DOI [10.1128/m8io.01991-16, DOI 10.1128/M8IO.01991-16]
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056
   RUSSO M, 1983, J ULTRA MOL STRUCT R, V82, P52, DOI 10.1016/S0022-5320(83)90096-5
   Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4
   Short JR, 2016, J VIROL, V90, P3676, DOI 10.1128/JVI.03080-15
   Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129
   Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581
   Sosinsky GE, 2008, J STRUCT BIOL, V161, P359, DOI 10.1016/j.jsb.2007.09.002
   Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Van Wynsberghe PA, 2007, J VIROL, V81, P4633, DOI 10.1128/JVI.02267-06
   Van Wynsberghe PM, 2009, J VIROL, V83, P2976, DOI 10.1128/JVI.02040-08
   Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y
   Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902
   Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996
   Wu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094697
   Yi H, 2015, J HISTOCHEM CYTOCHEM, V63, P780, DOI 10.1369/0022155415593323
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009
   Zhang X, 2015, NATURE, V527, P531, DOI 10.1038/nature15767
   Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005
NR 88
TC 24
Z9 24
U1 0
U2 9
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JUN 27
PY 2017
VL 6
AR e25940
DI 10.7554/eLife.25940
PG 24
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FA8AP
UT WOS:000405668900001
PM 28653620
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Braga, JU
   Bressan, C
   Dalvi, APR
   Calvet, GA
   Daumas, RP
   Rodrigues, N
   Wakimoto, M
   Nogueira, RMR
   Nielsen-Saines, K
   Brito, C
   de Filippis, AMB
   Brasil, P
AF Braga, Jose Ueleres
   Bressan, Clarisse
   Razal Dalvi, Ana Paula
   Amaral Calvet, Guilherme
   Daumas, Regina Paiva
   Rodrigues, Nadia
   Wakimoto, Mayumi
   Ribeiro Nogueira, Rita Maria
   Nielsen-Saines, Karin
   Brito, Carlos
   Bispo de Filippis, Ana Maria
   Brasil, Patricia
TI Accuracy of Zika virus disease case definition during simultaneous
   Dengue and Chikungunya epidemics
SO PLOS ONE
LA English
DT Article
ID OUTBREAK; ILLNESS; BRAZIL
AB Background
   Zika is a new disease in the American continent and its surveillance is of utmost importance, especially because of its ability to cause neurological manifestations as Guillain-Barre A syndrome and serious congenital malformations through vertical transmission. The detection of suspected cases by the surveillance system depends on the case definition adopted. As the laboratory diagnosis of Zika infection still relies on the use of expensive and complex molecular techniques with low sensitivity due to a narrow window of detection, most suspected cases are not confirmed by laboratory tests, mainly reserved for pregnant women and new-borns. In this context, an accurate definition of a suspected Zika case is crucial in order for the surveillance system to gauge the magnitude of an epidemic.
   Methodology
   We evaluated the accuracy of various Zika case definitions in a scenario where Dengue and Chikungunya viruses co-circulate. Signs and symptoms that best discriminated PCR confirmed Zika from other laboratory confirmed febrile or exanthematic diseases were identified to propose and test predictive models for Zika infection based on these clinical features.
   Results and discussion
   Our derived score prediction model had the best performance because it demonstrated the highest sensitivity and specificity, 86.6% and 78.3%, respectively. This Zika case definition also had the highest values for auROC (0.903) and R-2 (0.417), and the lowest Brier score 0.096.
   Conclusions
   In areas where multiple arboviruses circulate, the presence of rash with pruritus or conjunctival hyperemia, without any other general clinical manifestations such as fever, petechia or anorexia is the best Zika case definition.
C1 [Braga, Jose Ueleres; Razal Dalvi, Ana Paula; Daumas, Regina Paiva; Rodrigues, Nadia] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Bressan, Clarisse; Amaral Calvet, Guilherme; Wakimoto, Mayumi; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [Brito, Carlos] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
RP Braga, JU (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
EM ueleres@gmail.com
RI amsalu, ribka/G-8780-2019; DAUMAS, REGINA/M-9387-2013; Calvet,
   Guilherme/G-6959-2013; Barros de Castro, Daniel/J-9358-2016
OI DAUMAS, REGINA/0000-0002-8923-7711; Calvet,
   Guilherme/0000-0002-3545-5238; Barros de Castro,
   Daniel/0000-0001-5969-544X
FU Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da Saude do
   Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]
FX Funding Departamento de Ciencia e Tecnologia (DECIT) do Ministerio da
   Saude do Brasil and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/88887.116627/2016-01).
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Sande Departamento de Vigilancia das Doencas Transmissiveis, 2016, SECR VIG SANDE DEP V
   Brasil. Secretaria de Vigilancia em Saude - Ministerio da Saude, 2016, SECRETARIA VIGILANCI
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Pan American Health Organization / World Health Organization, 2015, EP UPD ZIK VIR  1016
   Pan American Health Organization / World Health Organization (PAHO / WHO), 2014, EP AL CHIK DENG FEV
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Solet J. L., 2007, PLOS BIOL, V77, P727
   WHO, 2017, SIT REP
   World Health Organization, 2016, ZIKA VIRUS DIS  0212
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 17
TC 25
Z9 25
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2017
VL 12
IS 6
AR e0179725
DI 10.1371/journal.pone.0179725
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ2KD
UT WOS:000404537300015
PM 28650987
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Daaboul, GG
   Freedman, DS
   Scherr, SM
   Carter, E
   Rosca, A
   Bernstein, D
   Mire, CE
   Agans, KN
   Hoenen, T
   Geisbert, TW
   Unlu, MS
   Connor, JH
AF Daaboul, George G.
   Freedman, David S.
   Scherr, Steven M.
   Carter, Erik
   Rosca, Alexandru
   Bernstein, David
   Mire, Chad E.
   Agans, Krystle N.
   Hoenen, Thomas
   Geisbert, Thomas W.
   Unlu, M. Selim
   Connor, John H.
TI Enhanced light microscopy visualization of virus particles from Zika
   virus to filamentous ebolaviruses
SO PLOS ONE
LA English
DT Article
ID VESICULAR STOMATITIS-VIRUS; CRYOELECTRON TOMOGRAPHY;
   ELECTRON-MICROSCOPY; EBOLA-VIRUS; INFECTIVITY; VIRIONS; MASS
AB Light microscopy is a powerful tool in the detection and analysis of parasites, fungi, and pro-karyotes, but has been challenging to use for the detection of individual virus particles. Unlabeled virus particles are too small to be visualized using standard visible light microscopy. Characterization of virus particles is typically performed using higher resolution approaches such as electron microscopy or atomic force microscopy. These approaches require purification of virions away from their normal millieu, requiring significant levels of expertise, and can only enumerate small numbers of particles per field of view. Here, we utilize a visible light imaging approach called Single Particle Interferometric Reflectance Imaging Sensor (SP-IRIS) that allows automated counting and sizing of thousands of individual virions. Virions are captured directly from complex solutions onto a silicon chip and then detected using a reflectance interference imaging modality. We show that the use of different imaging wavelengths allows the visualization of a multitude of virus particles. Using Violet/UV illumination, the SP-IRIS technique is able to detect individual flavivirus particles (similar to 40 nm), while green light illumination is capable of identifying and discriminating between vesicular stomatitis virus and vaccinia virus (similar to 360 nm). Strikingly, the technology allows the clear identification of filamentous infectious ebolavirus particles and virus-like particles. The ability to differentiate and quantify unlabeled virus particles extends the usefulness of traditional light microscopy and can be embodied in a straightforward benchtop approach allowing widespread applications ranging from rapid detection in biological fluids to analysis of virus-like particles for vaccine development and production.
C1 [Daaboul, George G.; Freedman, David S.; Rosca, Alexandru; Bernstein, David] nanoView Diagnost Inc, Boston, MA USA.
   [Scherr, Steven M.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.
   [Carter, Erik; Connor, John H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
   [Mire, Chad E.; Agans, Krystle N.; Geisbert, Thomas W.] Galveston Natl Lab, Galveston, TX USA.
   [Mire, Chad E.; Agans, Krystle N.; Geisbert, Thomas W.] Dept Microbiol, Galveston, TX USA.
   [Mire, Chad E.; Agans, Krystle N.; Geisbert, Thomas W.] Univ Texas Med Branch, Immunol, Galveston, TX 77555 USA.
   [Hoenen, Thomas] NIAID, LabVirol, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA.
   [Hoenen, Thomas] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany.
   [Unlu, M. Selim] Boston Univ, Dept Elect Engn, Boston, MA 02215 USA.
   [Unlu, M. Selim; Connor, John H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Unlu, M. Selim] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.
RP Connor, JH (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.; Connor, JH (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
EM jhconnor@bu.edu
RI Hoenen, Thomas/H-8990-2019; Mire, Chad/Z-6338-2019
OI Hoenen, Thomas/0000-0002-5829-6305; Mire, Chad/0000-0001-7596-1808;
   Unlu, Selim/0000-0002-8594-892X; Connor, John/0000-0002-8867-7256
FU National Institutes of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01Al1096159, 1R43Al118254]
FX This work was funded in part by the National Institutes of Allergy and
   Infectious Diseases through awards to John H Connor (R01Al1096159) and
   David S Freedman (1R43Al118254). These funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. nanoView Diagnostics Inc provided support
   in the form of salaries for authors [GD, DS, AR, DB] and played a role
   in the study design, data collection and analysis, decision to publish,
   and prepare of the manuscript. The specific roles of these authors are
   articulated in the 'author contributions' section.
CR Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109
   Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196
   Cretich M, 2004, ANAL BIOCHEM, V332, P67, DOI 10.1016/j.ab.2004.05.041
   Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102
   Daaboul GG, 2010, NANO LETT, V10, P4727, DOI 10.1021/nl103210p
   Daaboul GG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37246
   Daaboul GG, 2014, ACS NANO, V8, P6047, DOI 10.1021/nn501312q
   Daaboul GG, 2014, ACS NANO
   Dadonaite B, 2016, J GEN VIROL, V97, P1755, DOI 10.1099/jgv.0.000535
   Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004
   Gaudin R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7022
   Goldsmith CS, 2009, CLIN MICROBIOL REV, V22, P552, DOI 10.1128/CMR.00027-09
   Heider S, 2014, VIROLOGY, V462, P199, DOI 10.1016/j.virol.2014.06.005
   Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10
   LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8
   Ma L, 2016, ANGEW CHEM
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monroe MR, 2011, ANAL CHEM, V83, P9485, DOI 10.1021/ac202212k
   Piliarik M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5495
   Scherr SM, 2016, ACS NANO
   Scherr SM, 2017, LAB CHIP, V17, P917, DOI 10.1039/c6lc01528j
   Spiegelberg L, 2011, J GEN VIROL, V92, P2900, DOI 10.1099/vir.0.036863-0
   Steen HB, 2004, CYTOM PART A, V57A, P94, DOI 10.1002/cyto.a.10115
   Sugita Y, 2011, J GEN VIROL, V92, P2485, DOI 10.1099/vir.0.036715-0
   THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985
   Vijayakrishnan S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003413
   Wang SP, 2010, P NATL ACAD SCI USA, V107, P16028, DOI 10.1073/pnas.1005264107
   Watt A, 2014, J VIROL, V88, P10511, DOI 10.1128/JVI.01272-14
   Ymeti A, 2007, NANO LETT, V7, P394, DOI 10.1021/nl062595n
NR 29
TC 6
Z9 6
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2017
VL 12
IS 6
AR e0179728
DI 10.1371/journal.pone.0179728
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ2KD
UT WOS:000404537300016
PM 28651016
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dallimore, T
   Hunter, T
   Medlock, JM
   Vaux, AGC
   Harbach, RE
   Strode, C
AF Dallimore, Thom
   Hunter, Tony
   Medlock, Jolyon M.
   Vaux, Alexander G. C.
   Harbach, Ralph E.
   Strode, Clare
TI Discovery of a single male Aedes aegypti (L.) in Merseyside, England
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Invasive; Mosquito; Surveillance; England; UK
ID MOSQUITO SURVEILLANCE; VECTOR; ALBOPICTUS; DENGUE; SURVIVAL; DIPTERA;
   TEMPERATURES; DISPERSAL; NETHERLANDS; POPULATION
AB Background: The mosquito Aedes aegypti (L.) is found in tropical and sub-tropical regions where it is the major vector of dengue fever, yellow fever, chikungunya and more recently Zika virus. Given its importance as a vector of arboviruses and its propensity to be transported to new regions, the European Centre for Disease Prevention and Control (ECDC) has placed Ae. aegypti on a list of potentially invasive mosquito species. It was previously reported in the United Kingdom (UK) in 1865 and 1919 but did not establish on either occasion. It is now beginning to reappear in European countries and has been recorded in the Netherlands (not established) and Madeira (Portugal), as well as southern Russia, Georgia and Turkey.
   Results: During summer 2014, a single male Ae. aegypti was captured during mosquito collections in north-western England using a sweep net. Morphological identification complimented by sequencing of the ITS2 rDNA, and cox1 mtDNA regions, confirmed the species. Following confirmation, a programme of targeted surveillance was implemented around the collection site by first identifying potential larval habitats in greenhouses, a cemetery, a farm and industrial units. Despite intensive surveillance around the location, no other Ae. aegypti specimens were collected using a combination of sweep netting, larval dipping, mosquito magnets, BG sentinel traps and ovitraps. All species collected were native to the UK.
   Conclusion: The finding of the single male Ae. aegypti, while significant, presents no apparent disease risk to public health, and the follow-up survey suggests that there was no established population. However, this report does highlight the need for vigilance and robust surveillance, and the requirement for procedures to be in place to investigate such findings.
C1 [Dallimore, Thom; Strode, Clare] Edge Hill Univ, Dept Biol, St Helens Rd, Ormskirk L39 4QP, Lancs, England.
   [Hunter, Tony] World Museum Liverpool, Zool Dept, William Brown St, Liverpool L3 8EN, Merseyside, England.
   [Medlock, Jolyon M.; Vaux, Alexander G. C.] Publ Hlth England, Emergency Response Dept, Med Entomol & Zoonoses Ecol Grp, Salisbury SP4 0JG, Wilts, England.
   [Harbach, Ralph E.] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.
RP Strode, C (corresponding author), Edge Hill Univ, Dept Biol, St Helens Rd, Ormskirk L39 4QP, Lancs, England.
EM strodecl@edgehill.ac.uk
CR Arrivillaga J, 2004, J VECTOR ECOL, V29, P11
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Canyon DV, 1999, J INSECT PHYSIOL, V45, P959, DOI 10.1016/S0022-1910(99)00085-2
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Chang LH, 2007, J MED ENTOMOL, V44, P205, DOI 10.1603/0022-2585(2007)44[205:DSOAAA]2.0.CO;2
   Cranston PS, 1987, KEYS ADULTS MALE HYP, V48
   Deblauwe I, 2015, PARASITOL RES, V114, P3469, DOI 10.1007/s00436-015-4575-z
   Demeulemeester J, 2014, J EUR MOSQ CONTROL A, V32, P14
   European Centre for Disease Prevention and Control, 2012, GUID SURV INV MOSQ E
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harwood JF, 2015, J AM MOSQUITO CONTR, V31, P242, DOI 10.2987/moco-31-03-242-247.1
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Medlock JM, 2012, EUR MOSQUITO B, V30, P15
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   SCHAFFNER E, 2001, MOUSTIQUES EUROPE LO
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10
   SURTEES G, 1971, B WORLD HEALTH ORGAN, V44, P707
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
NR 34
TC 7
Z9 7
U1 1
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 24
PY 2017
VL 10
AR 309
DI 10.1186/s13071-017-2251-0
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EY6EE
UT WOS:000404074500006
PM 28646879
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chaikham, N
   Sawangtong, W
AF Chaikham, Nonthamon
   Sawangtong, Wannika
TI Optimal control of Zika virus infection by vector elimination,
   vector-to-human and human-to-human contact reduction
SO ADVANCES IN DIFFERENCE EQUATIONS
LA English
DT Article
DE Zika virus; epidemic model; Pontryagin's maximum principle; optimal
   control; mosquito; sexual transmission
ID SEXUAL TRANSMISSION; DISEASE; BORNE; PREVENTION; STATES
AB The recent outbreak of mosquito-borne Zika virus (ZIKV) in Brazil, with estimated cases surpassing 1.5 million, has gained attention due to its rapid spread and neurological complications associated with the infection such as microcephaly and Guillain-Barre syndrome. Beside vector transmission, primarily via Aedes mosquitoes, sexual transmission also contributes to the virus outbreak. The epidemiological patterns of these viruses suggest that Zika virus could cause other outbreaks, particularly in tropical regions with high vector concentration. To plan and prepare for a counter-control measure, it is important to study the previous cases. Hence, the control model is proposed from the deterministic model of Zika virus infection. Regarding control measures, the control functions for these strategies; vector elimination, vector-to-human contact reduction, and human-to-human contact reduction are introduced into the system. The necessary conditions for the optimal controls are determined using Pontryagin's maximum principle and the optimality system is solved using Rung-Kutta fourth order scheme. Consequently, numerical results of the system with control and the system without control are shown and discussed.
C1 [Chaikham, Nonthamon; Sawangtong, Wannika] Mahidol Univ, Fac Sci, Dept Math, 272 Rama VI Rd, Bangkok 10400, Thailand.
   [Chaikham, Nonthamon; Sawangtong, Wannika] Commiss Higher Educ, Ctr Excellence Math, 328 Sri Ayuthya Rd, Bangkok 10400, Thailand.
RP Sawangtong, W (corresponding author), Mahidol Univ, Fac Sci, Dept Math, 272 Rama VI Rd, Bangkok 10400, Thailand.; Sawangtong, W (corresponding author), Commiss Higher Educ, Ctr Excellence Math, 328 Sri Ayuthya Rd, Bangkok 10400, Thailand.
EM wannika.saw@mahidol.ac.th
OI Sawangtong, Wannika/0000-0002-5363-0773
FU Centre of Excellence in Mathematics, Commission on Higher Education,
   Thailand; Faculty of Science, Mahidol University, Thailand
FX This research was supported by the Centre of Excellence in Mathematics,
   Commission on Higher Education, Thailand and Faculty of Science, Mahidol
   University, Thailand.
CR Aldila D, 2013, MATH BIOSCI, V242, P9, DOI 10.1016/j.mbs.2012.11.014
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Centers for Disease Control and Prevention (CDC), 2016, UPD INT GUID PREV SE
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming WH, 2012, DETERMINISTIC STOCHA, V1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gupta N.K., 1973, Mathematical Biosci, V18, P383, DOI 10.1016/0025-5564(73)90012-6
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10
   Lashari AA, 2012, NONLINEAR ANAL-REAL, V13, P203, DOI 10.1016/j.nonrwa.2011.07.026
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Rodrigues HS, 2014, MATH BIOSCI, V247, P1, DOI 10.1016/j.mbs.2013.10.006
   Thome RCA, 2010, MATH BIOSCI, V223, P12, DOI 10.1016/j.mbs.2009.08.009
   World Health Organization [WHO], 2016, MOSQ CONTR CAN IT ST
   Yan X., 2007, WORLD J MODEL SIMUL, V3, P202
NR 24
TC 2
Z9 2
U1 0
U2 7
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1687-1847
J9 ADV DIFFER EQU-NY
JI Adv. Differ. Equ.
PD JUN 23
PY 2017
AR 177
DI 10.1186/s13662-017-1220-4
PG 12
WC Mathematics, Applied; Mathematics
SC Mathematics
GA FF3ND
UT WOS:000408806500001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cumberworth, SL
   Barrie, JA
   Cunningham, ME
   de Figueiredo, DPG
   Schultz, V
   Wilder-Smith, AJ
   Brennan, B
   Pena, LJ
   Franca, RFD
   Linington, C
   Barnett, SC
   Willison, HJ
   Kohl, A
   Edgar, JM
AF Cumberworth, Stephanie L.
   Barrie, Jennifer A.
   Cunningham, Madeleine E.
   de Figueiredo, Daniely Paulino Gomes
   Schultz, Verena
   Wilder-Smith, Adrian J.
   Brennan, Benjamin
   Pena, Lindomar J.
   Franca, Rafael Freitas de Oliveira
   Linington, Christopher
   Barnett, Susan C.
   Willison, Hugh J.
   Kohl, Alain
   Edgar, Julia M.
TI Zika virus tropism and interactions in myelinating neural cell cultures:
   CNS cells and myelin are preferentially affected
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE Zika virus; Tropism; Murine; Central nervous system; Peripheral nervous
   system; Myelin; Axon
ID JAPANESE ENCEPHALITIS-VIRUS; MURINE SPINAL-CORD; AXONAL-TRANSPORT;
   NEURONAL DEATH; HUMAN BRAIN; INFECTION; MODEL; ACTIVATION; MICROGLIA;
   GROWTH
AB The recent global outbreak of Zika virus (ZIKV) infection has been linked to severe neurological disorders affecting the peripheral and central nervous systems (PNS and CNS, respectively). The pathobiology underlying these diverse clinical phenotypes are the subject of intense research; however, even the principal neural cell types vulnerable to productive Zika infection remain poorly characterised. Here we used CNS and PNS myelinating cultures from wild type and Ifnar1 knockout mice to examine neuronal and glial tropism and short-term consequences of direct infection with a Brazilian variant of ZIKV. Cell cultures were infected pre- or post-myelination for various intervals, then stained with cell-type and ZIKV-specific antibodies. In bypassing systemic immunity using ex vivo culture, and the type I interferon response in Ifnar1 deficient cells, we were able to evaluate the intrinsic infectivity of neural cells. Through systematic quantification of ZIKV infected cells in myelinating cultures, we found that ZIKV infection is enhanced in the absence of the type I interferon responses and that CNS cells are considerably more susceptible to infection than PNS cells. In particular, we demonstrate that CNS axons and myelinating oligodendrocytes are especially vulnerable to injury. These results have implications for understanding the pathobiology of neurological symptoms associated with ZIKV infection. Furthermore, we provide a quantifiable ex vivo infection model that can be used for fundamental and therapeutic studies on viral neuroinvasion and its consequences.
C1 [Cumberworth, Stephanie L.; Brennan, Benjamin; Kohl, Alain] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
   [Barrie, Jennifer A.; Cunningham, Madeleine E.; de Figueiredo, Daniely Paulino Gomes; Schultz, Verena; Wilder-Smith, Adrian J.; Linington, Christopher; Barnett, Susan C.; Willison, Hugh J.; Edgar, Julia M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland.
   [Pena, Lindomar J.; Franca, Rafael Freitas de Oliveira] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Virol, UFPE Campus,Cidade Univ, Recife, PE, Brazil.
   [Edgar, Julia M.] Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.
RP Kohl, A (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.; Edgar, JM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland.
EM alain.kohl@glasgow.ac.uk; Julia.Edgar@glasgow.ac.uk
RI Linington, Chris/M-4883-2019; Brennan, Benjamin/AAJ-9850-2020; Edgar,
   Julia M/U-8456-2019
OI Brennan, Benjamin/0000-0003-4707-726X; Edgar, Julia
   M/0000-0002-3869-0962; Schultz, Verena/0000-0002-8172-1525; Cunningham,
   Madeleine/0000-0002-7545-6868; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014, MR/N017552/1, MC_PC_15105, MR/K501335/1]; National Centre
   for Replacement, Reduction and Refinement [NC/L000423/1]; Wellcome
   TrustWellcome Trust [203680/Z/16/Z, WT092805]; European UnionEuropean
   Union (EU) [734584]
FX This study was funded by the UK Medical Research Council [MC_UU_12014,
   MR/N017552/1 (AK); ZIKA Rapid Response MC_PC_15105 (HW, JME, AK);
   MR/K501335/1 (Doctoral Training Grant; SLC)], National Centre for
   Replacement, Reduction and Refinement (NC/L000423/1; JME, CL) and
   Wellcome Trust (203680/Z/16/Z, WT092805; HJW). This project was
   partially funded through the European Union's Horizon 2020 research and
   innovation programme under ZikaPLAN grant agreement No 734584 (HJW, JME,
   SB, CL).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982
   Chen CJ, 2012, GLIA, V60, P487, DOI 10.1002/glia.22282
   Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0
   Chen CJ, 2004, J VIROL, V78, P12107, DOI 10.1128/JVI.78.22.12107-12119.2004
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012
   Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   He XL, 2010, INT J CLIN EXP PATHO, V3, P156
   Jiang R, 2014, J IMMUNOL RES, DOI 10.1155/2014/787023
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   KIMURAKURODA J, 1993, ARCH VIROL, V130, P477, DOI 10.1007/BF01309676
   Kiryu-Seo S, 2010, J NEUROSCI, V30, P6658, DOI 10.1523/JNEUROSCI.5265-09.2010
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Maximova OA, 2009, J HISTOCHEM CYTOCHEM, V57, P973, DOI 10.1369/jhc.2009.954180
   McGrath EL, 2017, STEM CELL REPORTS
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montgomery RR, 2017, CLIN EXP IMMUNOL, V187, P26, DOI 10.1111/cei.12863
   Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mukherjee S, 2015, CELL BIOL INT, V39, P224, DOI 10.1002/cbin.10354
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036
   Nazmi A, 2011, J NEUROIMMUNE PHARM, V6, P420, DOI 10.1007/s11481-011-9271-x
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Owens T, 2014, GLIA, V62, P339, DOI 10.1002/glia.22608
   Paivalainen S, 2008, MOL CELL NEUROSCI, V37, P568, DOI 10.1016/j.mcn.2007.12.005
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qiao ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114536
   Quick ED, 2014, J VIROL, V88, P13005, DOI 10.1128/JVI.01994-14
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rust RS, 2012, SEMIN PEDIATR NEUROL, V19, P130, DOI 10.1016/j.spen.2012.03.002
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Smith KJ, 2001, ANN NEUROL, V49, P470
   Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4
   Solomon T, 2003, J NEUROVIROL, V9, P274, DOI 10.1080/13550280390194037
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09
   Thomson CE, 2008, EUR J NEUROSCI, V28, P1518, DOI 10.1111/j.1460-9568.2008.06415.x
   Thomson CE, 2006, J NEUROSCI RES, V84, P1703, DOI 10.1002/jnr.21084
   Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586
   Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09
   Tseng YF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-20
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Winkelmann ER, 2016, NERVOUS SYSTEM, P5, DOI 10.12688/f1000research.7404.1
   Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 99
TC 19
Z9 19
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD JUN 23
PY 2017
VL 5
AR 50
DI 10.1186/s40478-017-0450-8
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA FF6RL
UT WOS:000409144200001
PM 28645311
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Reagan-Steiner, S
   Simeone, R
   Simon, E
   Bhatnagar, J
   Oduyebo, T
   Free, R
   Denison, AM
   Rabeneck, DB
   Ellington, S
   Petersen, E
   Gary, J
   Hale, G
   Keating, MK
   Martines, RB
   Muehlenbachs, A
   Ritter, J
   Lee, E
   Davidson, A
   Conners, E
   Scotland, S
   Sandhu, K
   Bingham, A
   Kassens, E
   Smith, L
   St George, K
   Ahmad, N
   Tanner, M
   Beavers, S
   Miers, B
   VanMaldeghem, K
   Khan, S
   Rabe, I
   Gould, C
   Meaney-Delman, D
   Honein, MA
   Shieh, WJ
   Jamieson, DJ
   Fischer, M
   Zaki, SR
AF Reagan-Steiner, Sarah
   Simeone, Regina
   Simon, Elizabeth
   Bhatnagar, Julu
   Oduyebo, Titilope
   Free, Rebecca
   Denison, Amy M.
   Rabeneck, Demi B.
   Ellington, Sascha
   Petersen, Emily
   Gary, Joy
   Hale, Gillian
   Keating, M. Kelly
   Martines, Roosecelis B.
   Muehlenbachs, Atis
   Ritter, Jana
   Lee, Ellen
   Davidson, Alexander
   Conners, Erin
   Scotland, Sarah
   Sandhu, Kayleigh
   Bingham, Andrea
   Kassens, Elizabeth
   Smith, Lou
   St George, Kirsten
   Ahmad, Nina
   Tanner, Mary
   Beavers, Suzanne
   Miers, Brooke
   VanMaldeghem, Kelley
   Khan, Sumaiya
   Rabe, Ingrid
   Gould, Carolyn
   Meaney-Delman, Dana
   Honein, Margaret A.
   Shieh, Wun-Ju
   Jamieson, Denise J.
   Fischer, Marc
   Zaki, Sherif R.
CA U S Zika Pregnancy Registry
   Zika Virus Response Epidemiology
TI Evaluation of Placental and Fetal Tissue Specimens for Zika Virus
   Infection-50 States and District of Columbia, January-December, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; BIRTH-DEFECTS; INFANTS;
   PATHOLOGY; PREGNANCY; EXPOSURE; WOMEN
C1 [Reagan-Steiner, Sarah; Bhatnagar, Julu; Denison, Amy M.; Rabeneck, Demi B.; Gary, Joy; Hale, Gillian; Keating, M. Kelly; Martines, Roosecelis B.; Muehlenbachs, Atis; Ritter, Jana; Miers, Brooke; Shieh, Wun-Ju; Zaki, Sherif R.] CDC, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Simeone, Regina; Simon, Elizabeth; Ellington, Sascha; Petersen, Emily; VanMaldeghem, Kelley; Khan, Sumaiya; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Free, Rebecca] CDC, Div Emergency Operat, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Lee, Ellen; Davidson, Alexander; Conners, Erin] New York City Dept Hlth & Mental Hyg, New York, NY USA.
   [Scotland, Sarah; Sandhu, Kayleigh] Massachusetts Dept Publ Hlth, Boston, MA 02111 USA.
   [Bingham, Andrea; Kassens, Elizabeth] Florida Dept Hlth, Tallahassee, FL USA.
   [Smith, Lou; St George, Kirsten; Ahmad, Nina] New York State Dept Hlth, Albany, NY 12237 USA.
   [Tanner, Mary] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Tanner, Mary] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Beavers, Suzanne] CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.
   [Miers, Brooke] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Rabe, Ingrid; Gould, Carolyn; Fischer, Marc] CDC, Div Vector Borne Infect Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Reagan-Steiner, S (corresponding author), CDC, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM sor1@cdc.gov
RI Denison, Amy/AAG-7959-2019
OI Lee, Christopher/0000-0001-7957-1524; Denison, Amy/0000-0002-2163-3849;
   Neary, Jillian/0000-0003-1166-0760; Jamieson,
   Denise/0000-0003-2597-1201; Lewis, Lillianne/0000-0002-0957-2190
FU Akonni Biosystems Inc.
FX Kirsten St. George reports grants from Akonni Biosystems Inc.,
   nonfinancial support from ThermoFisher, and a royalty generating
   collaborative agreement with Zeptometrix outside the submitted work. No
   other conflicts of interest were reported.
CR Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
NR 10
TC 21
Z9 21
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 23
PY 2017
VL 66
IS 24
BP 636
EP 643
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EY3TL
UT WOS:000403897100002
PM 28640798
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Pantoja, P
   Perez-Guzman, EX
   Rodriguez, IV
   White, LJ
   Gonzalez, O
   Serrano, C
   Giavedoni, L
   Hodara, V
   Cruz, L
   Arana, T
   Martinez, MI
   Hassert, MA
   Brien, JD
   Pinto, AK
   de Silva, A
   Sariol, CA
AF Pantoja, Petraleigh
   Perez-Guzman, Erick X.
   Rodriguez, Idia V.
   White, Laura J.
   Gonzalez, Olga
   Serrano, Crisanta
   Giavedoni, Luis
   Hodara, Vida
   Cruz, Lorna
   Arana, Teresa
   Martinez, Melween I.
   Hassert, Mariah A.
   Brien, James D.
   Pinto, Amelia K.
   de Silva, Aravinda
   Sariol, Carlos A.
TI Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing
   immunity to dengue virus
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; NONHUMAN-PRIMATES; CROSS-REACTIVITY;
   STRUCTURAL BASIS; TIME-INTERVAL; INFECTION; RESPONSES; AMERICA; VACCINE;
   BRAZIL
AB Zika virus (ZIKV) is a re-emerging virus that has recently spread into dengue virus (DENV) endemic regions and cross-reactive antibodies (Abs) could potentially affect ZIKV pathogenesis. Using DENV-immune serum, it has been shown in vitro that antibody-dependent enhancement (ADE) of ZIKV infection can occur. Here we study the effects of pre-existing DENV immunity on ZIKV infection in vivo. We infect two cohorts of rhesus macaques with ZIKV; one cohort has been exposed to DENV 2.8 years earlier and a second control cohort is naive to flaviviral infection. Our results, while confirming ADE in vitro, suggest that preexisting DENV immunity does not result in more severe ZIKV disease. Rather our results show a reduction in the number of days of ZIKV viremia compared to naive macaques and that the previous exposure to DENV may result in modulation of the immune response without resulting in enhancement of ZIKV pathogenesis.
C1 [Pantoja, Petraleigh; Rodriguez, Idia V.; Gonzalez, Olga; Cruz, Lorna; Martinez, Melween I.; Sariol, Carlos A.] Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00952 USA.
   [Pantoja, Petraleigh; Perez-Guzman, Erick X.; Arana, Teresa; Sariol, Carlos A.] Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.
   [White, Laura J.; de Silva, Aravinda] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Giavedoni, Luis; Hodara, Vida] Texas Biomed Res Inst, San Antonio, TX 78227 USA.
   [Hassert, Mariah A.; Brien, James D.; Pinto, Amelia K.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.
   [Sariol, Carlos A.] Univ Puerto Rico, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA.
RP Sariol, CA (corresponding author), Univ Puerto Rico, Caribbean Primate Res Ctr, Unit Comparat Med, Med Sci Campus, San Juan, PR 00952 USA.; Sariol, CA (corresponding author), Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.; Sariol, CA (corresponding author), Univ Puerto Rico, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA.
EM carlos.sariol1@upr.edu
RI Pinto, Amelia K/O-6658-2018; Pinto, Amelia/AAD-7059-2020; Sariol, Carlos
   A./W-6360-2019
OI Pinto, Amelia K/0000-0002-7147-3978; Pinto, Amelia/0000-0002-7147-3978;
   Sariol, Carlos A./0000-0001-7535-4303
FU OD, NIH [2 P40 OD012217, 2U42OD021458-15]; NIAIDUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [K22AI104794]; RCMI [G12MD007600]; NIGMS-RISE Program of UPR-Medical
   Sciences Campus [R25GM061838]
FX We thank the staff of the Caribbean Primate Research Center and the
   Animal Resources Center. We thank Laura M. Parodi for phenotyping of
   immune cells and multiplex cytokine analysis, and thank Mr Ian Cacho
   Santana for his technical support during the preparation of this
   manuscript. We also acknowledge American Science and Medical Writers
   (Fairlawn, OH) for editorial assistance in preparation of this
   manuscript. This work was supported by grants 2 P40 OD012217 and
   2U42OD021458-15 (OD, NIH) to M.I.M. and C.A.S. Partial support was also
   provided by grants K22AI104794 (NIAID) to J.D.B., G12MD007600 (RCMI) to
   P.P., and NIGMS-RISE Program (R25GM061838) of UPR-Medical Sciences
   Campus to E.X.P.-G.
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, TRIOPL REAL TIM RT P
   Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507
   Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015
   Gomez AM, 2015, J IMMUNOL, V194, P2300, DOI 10.4049/jimmunol.1402147
   GOULD EA, 1989, J GEN VIROL, V70, P1605, DOI 10.1099/0022-1317-70-6-1605
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113
   Hickey AC, 2013, AM J TROP MED HYG, V89, P1043, DOI 10.4269/ajtmh.13-0145
   Ittah M, 2011, J INNATE IMMUN, V3, P200, DOI 10.1159/000321194
   Johnson BW, 2004, AM J TROP MED HYG, V70, P89, DOI 10.4269/ajtmh.2004.70.89
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meyer C, 2015, METHODS MOL BIOL, V1343, P65, DOI 10.1007/978-1-4939-2963-4_6
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shi PY, 2001, J CLIN MICROBIOL, V39, P1264, DOI 10.1128/JCM.39.4.1264-1271.2001
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000
   [WHO TDR], 2009, DENG GUID DIAG TREAT
   World Health Organization, 2016, EM COMM ZIK VIR OBS
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 59
TC 104
Z9 104
U1 1
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 23
PY 2017
VL 8
AR 15674
DI 10.1038/ncomms15674
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EY6US
UT WOS:000404119400001
PM 28643775
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sheng, ZY
   Gao, N
   Wang, ZY
   Cui, XY
   Zhou, DS
   Fan, DY
   Chen, H
   Wang, PG
   An, J
AF Sheng, Zi-Yang
   Gao, Na
   Wang, Zhao-Yang
   Cui, Xiao-Yun
   Zhou, De-Shan
   Fan, Dong-Ying
   Chen, Hui
   Wang, Pei-Gang
   An, Jing
TI Sertoli Cells Are Susceptible to ZIKV Infection in Mouse Testis
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Zika virus; Dengue virus; testis; sertoli cells; tight junctions; sperm
   cells; AG6 mouse
ID SEXUAL TRANSMISSION; DENGUE VIRUS; MICE; MODEL; SPERMATOGENESIS;
   REPLICATION; MACROPHAGES; OCCLUDIN; TARGETS; BARRIER
AB Flaviviruses including Dengue virus (DENV), Yellow fever virus (YFV), West Nile virus (WNV), and Japanese encephalitis virus (JEV) are global health problems that caused several serious diseases such as fever, hemorrhagic fever, and encephalitis in the past century. Recently, Zika virus (ZIKV) which spreads from Asia to American and causes millions of infections emerges as a new dangerous member of the genus of Flavivirus. Unlike other well-known flaviviruses, ZIKV can be transmitted sexually and infect testes in murine models. Its impacts on sperm functions, and the exact susceptible cells, however, are not entirely clear. To investigate these issues, we infected interferon a/b and gamma receptors deficient AG6 mice with ZIKV and examined the outcomes of infection using an assortment of physiological, histopathological, immunological, and virological techniques. We found that infectedmice displayed signs of reproductive system disorder, altered androgen levels in serum, and high viral load in semen and testes. Additionally, histopathological examinations revealed marked atrophy of seminiferous tubules and significant reduction in lumen size. Notably, these were accompanied by positive staining of ZIKV antigens on sertoli cells, detection of viral particles and vacuole changes within cytoplasm of sertoli cells. The susceptibility of sertoli cells to ZIKV was further validated in vitro study using cell lines. Importantly, the disruption of tight junctions within testis and altered sperm morphology were also observed in ZIKV infected mice. It is well-known that tight junctions formed by adjacent sertoli cells are major component of blood testis barrier, which plays important roles in maintenance of microenvironment for spermagenesis in testis. Taken together, these results demonstrate that sertoli cells are susceptible to ZIKV infection, which results in the disruption of tight junctions in testis and causes abnormal spermatogenesis in mice. These results also imply that long-term impact of ZIKV infection on human male reproductive system requires close monitoring.
C1 [Sheng, Zi-Yang; Gao, Na; Wang, Zhao-Yang; Cui, Xiao-Yun; Fan, Dong-Ying; Chen, Hui; Wang, Pei-Gang; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China.
   [Zhou, De-Shan] Capital Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Beijing, Peoples R China.
   [An, Jing] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.
RP Wang, PG; An, J (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China.; An, J (corresponding author), Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.
EM pgwang@ccmu.edu.cn; anjing@ccmu.edu.cn
OI Wang, Peigang/0000-0001-6045-2007
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81471957, 81271839, 81671971, 81301435, 81372935,
   81401676, U1602223]
FX We thank Prof. George F. Gao at Institute of Microbiology, Chinese
   Academy of Sciences (CAS), Prof. Ai-Hua Zheng at Institute of Zoology,
   CAS, Dr. Ting-Ting Deng and Associate Prof. Zai Wang at China-Japan
   Friendship Hospital for providing reagents and materials. This work was
   supported by grants from the National Natural Science Foundation of
   China (Nos. 81471957, 81271839, 81671971, 81301435, 81372935, 81401676,
   and U1602223).
CR Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023
   Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481
   Chung NPY, 2001, BIOL REPROD, V65, P1340, DOI 10.1095/biolreprod65.5.1340
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Du Plessis Stefan Stephanus, 2013, Front Biosci (Elite Ed), V5, P224
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Han DS, 2016, ENCYCLOPEDIA OF IMMUNOBIOLOGY, VOL 5: PHYSIOLOGY AND IMMUNE SYSTEM DYSFUNCTION, P46, DOI 10.1016/B978-0-12-374279-7.19009-5
   Heuvelings CC, 2017, INT J INFECT DIS, V56, P77, DOI 10.1016/j.ijid.2016.12.025
   Johnson L, 2008, ANIM REPROD SCI, V105, P23, DOI 10.1016/j.anireprosci.2007.11.029
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mruk DD, 2015, ENDOCR REV, V36, P564, DOI [10.1210/er.2014-1101, 10.1210/er.2015-1127]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Paria BC, 1996, MOL REPROD DEV, V45, P183, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;183::AID-MRD11&gt;3.0.CO;2-2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tsukita S, 1998, GENES CELLS, V3, P569, DOI 10.1046/j.1365-2443.1998.00212.x
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2016, WHO LABORATORY MANUA
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Zhang H, 2013, TISSUE CELL, V45, P414, DOI 10.1016/j.tice.2013.07.004
NR 33
TC 28
Z9 30
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUN 21
PY 2017
VL 7
AR 272
DI 10.3389/fcimb.2017.00272
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EY1IB
UT WOS:000403718500002
PM 28680856
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hamer, DH
   Chen, LH
   Libman, M
   Grobusch, MP
   Esposito, DH
AF Hamer, Davidson H.
   Chen, Lin H.
   Libman, Michael
   Grobusch, Martin P.
   Esposito, Douglas H.
TI Travel-Associated Zika Virus Disease RESPONSE
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Letter
ID INFECTION
C1 [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.
   [Chen, Lin H.] Mt Auburn Hosp, Cambridge, MA USA.
   [Libman, Michael] McGill Univ, Montreal, PQ, Canada.
   [Grobusch, Martin P.] Univ Amsterdam, Amsterdam, Netherlands.
   [Esposito, Douglas H.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.
RI Hamer, Davidson/J-2020-2019
OI Hamer, Davidson/0000-0002-4700-1495; Chen, Lin/0000-0002-5684-8436
CR Centers for Disease Control and Prevention, 2017, CLIN GUID PREGN TRAV
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
NR 5
TC 1
Z9 1
U1 0
U2 0
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD JUN 20
PY 2017
VL 166
IS 12
BP 913
EP 914
DI 10.7326/L17-0195
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EX9LG
UT WOS:000403579000025
PM 28630988
DA 2020-07-08
ER

PT J
AU Liuzzi, G
   Castilletti, C
   Vairo, F
   Nicastri, E
   Ippolito, G
AF Liuzzi, Giuseppina
   Castilletti, Concetta
   Vairo, Francesco
   Nicastri, Emanuele
   Ippolito, Giuseppe
TI Travel-Associated Zika Virus Disease
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Letter
C1 [Liuzzi, Giuseppina; Castilletti, Concetta; Nicastri, Emanuele; Ippolito, Giuseppe] Natl Inst Infect Dis INMI L Spallanzani, Rome, Italy.
   [Vairo, Francesco] Natl Inst Infect Dis INMI L Spallanzani, Rome, Italy.
   [Vairo, Francesco] Reg Serv Infect Dis Surveillance Control & Respon, Rome, Italy.
RP Liuzzi, G (corresponding author), Natl Inst Infect Dis INMI L Spallanzani, Rome, Italy.
RI Castilletti, Concetta/B-6545-2016; Castilletti, Concetta/AAA-8408-2019;
   nicastri, emanuele/K-7780-2016; Ippolito, Giuseppe/J-7207-2017
OI Castilletti, Concetta/0000-0001-9819-236X; Castilletti,
   Concetta/0000-0001-9819-236X; nicastri, emanuele/0000-0002-5606-8712;
   PERNO, CARLO FEDERICO/0000-0002-0825-5388; Ippolito,
   Giuseppe/0000-0002-1076-2979
CR Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
NR 2
TC 0
Z9 0
U1 0
U2 3
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD JUN 20
PY 2017
VL 166
IS 12
BP 913
EP 913
DI 10.7326/L17-0196
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EX9LG
UT WOS:000403579000024
PM 28630989
DA 2020-07-08
ER

PT J
AU Tjaden, NB
   Suk, JE
   Fischer, D
   Thomas, SM
   Beierkuhnlein, C
   Semenza, JC
AF Tjaden, Nils B.
   Suk, Jonathan E.
   Fischer, Dominik
   Thomas, Stephanie Margarete
   Beierkuhnlein, Carl
   Semenza, Jan C.
TI Modelling the effects of global climate change on Chikungunya
   transmission in the 21st century
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS; EPIDEMIC; OUTBREAK; FUTURE
AB The arrival and rapid spread of the mosquito-borne viral disease Chikungunya across the Americas is one of the most significant public health developments of recent years, preceding and mirroring the subsequent spread of Zika. Globalization in trade and travel can lead to the importation of these viruses, but climatic conditions strongly affect the efficiency of transmission in local settings. In order to direct preparedness for future outbreaks, it is necessary to anticipate global regions that could become suitable for Chikungunya transmission. Here, we present global correlative niche models for autochthonous Chikungunya transmission. These models were used as the basis for projections under the representative concentration pathway (RCP) 4.5 and 8.5 climate change scenarios. In a further step, hazard maps, which account for population densities, were produced. The baseline models successfully delineate current areas of active Chikungunya transmission. Projections under the RCP 4.5 and 8.5 scenarios suggest the likelihood of expansion of transmission-suitable areas in many parts of the world, including China, sub-Saharan Africa, South America, the United States and continental Europe. The models presented here can be used to inform public health preparedness planning in a highly interconnected world.
C1 [Tjaden, Nils B.; Fischer, Dominik; Thomas, Stephanie Margarete; Beierkuhnlein, Carl] Univ Bayreuth, Dept Biogeog, Bayreuth, Germany.
   [Suk, Jonathan E.; Semenza, Jan C.] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
   [Fischer, Dominik] Tech Univ Munich, Munich, Germany.
RP Semenza, JC (corresponding author), European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
EM jan.semenza@ecdc.europa.eu
RI ; Suk, Jonathan E./L-2300-2017
OI Thomas, Stephanie Margarete/0000-0003-0507-2006; Beierkuhnlein,
   Carl/0000-0002-6456-4628; Suk, Jonathan E./0000-0003-4689-4583
FU ECDC [OCS-2014-OUT-1830-JGLuMu]; German Research Platform for Zoonoses
   [FKZ: 01KI1601]
FX This work was partially funded through the ECDC project
   OCS-2014-OUT-1830-JGLuMu. S.T. was partially funded by the German
   Research Platform for Zoonoses (FKZ: 01KI1601). The authors would like
   to thank Bertrand Sudre and Laura Espinosa for their support with
   Chikungunya data in the Caribbean.
CR Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Center for International Earth Science Information Network-CIESIN-Columbia University & Centro Internacional de Agricultura Tropical-CIAT, 2005, GRIDD POP WORLD VERS, DOI [10.7927/H4ST7MRB, DOI 10.7927/H4ST7MRB]
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   Llanes DAM, 2016, REV BIOL TROP, V64, P1237, DOI 10.15517/rbt.v64i3.20150
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551
   Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008
   Peterson AT, 2016, ACTA TROP, V162, P114, DOI 10.1016/j.actatropica.2016.06.012
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y
   Rogers DJ, 2000, SCIENCE, V289, P1763
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Samy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003250
   Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204.151073, 10.3201/eid2204]
   Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5
   Suk JE, 2016, WIRES CLIM CHANGE, V7, P551, DOI 10.1002/wcc.406
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Van Bortel W, 2014, EURO SURVEILL, V19
   van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI 10.1007/s10584-011-0148-z
   VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
NR 48
TC 27
Z9 27
U1 4
U2 32
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 19
PY 2017
VL 7
AR 3813
DI 10.1038/s41598-017-03566-3
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EY0LT
UT WOS:000403650300056
PM 28630444
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pacidonio, EC
   Caragata, EP
   Alves, DM
   Marques, JT
   Moreira, LA
AF Pacidonio, Etiene Casagrande
   Caragata, Eric Pearce
   Alves, Debora Magalhaes
   Marques, Joao Trindade
   Moreira, Luciano Andrade
TI The impact of Wolbachia infection on the rate of vertical transmission
   of dengue virus in Brazilian Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Wolbachia; Dengue virus; Aedes aegypti; Vertical transmission; Arbovirus
ID ZIKA VIRUS; DIPTERA-CULICIDAE; MOSQUITOS; POPULATIONS; CHIKUNGUNYA;
   STRAIN
AB Background: Wolbachia pipientis is a common endosymbiotic bacterium of arthropods that strongly inhibits dengue virus (DENV) infection and transmission in the primary vector, the mosquito Aedes aegypti. For that reason, Wolbachiainfected Ae. aegypti are currently being released into the field as part of a novel strategy to reduce DENV transmission. However, there is evidence that DENV can be transmitted vertically from mother to progeny, and this may help the virus persist in nature in the absence of regular human transmission. The effect of Wolbachia infection on this process had not previously been examined.
   Results: We challenged Ae. aegypti with different Brazilian DENV isolates either by oral feeding or intrathoracic injection to ensure disseminated infection. We examined the effect of Wolbachia infection on the prevalence of DENV infection, and viral load in the ovaries. For orally infected mosquitoes, Wolbachia decreased the prevalence of infection by 71.29%, but there was no such effect when the virus was injected. Interestingly, regardless of the method of infection, Wolbachia infection strongly reduced DENV load in the ovaries. We then looked at the effect of Wolbachia on vertical transmission, where we observed only very low rates of vertical transmission. There was a trend towards lower rates in the presence of Wolbachia, with overall maximum likelihood estimate of infection rates of 5.04 per 1000 larvae for mosquitoes without Wolbachia, and 1.93 per 1000 larvae for Wolbachia-infected mosquitoes, after DENV injection. However, this effect was not statistically significant.
   Conclusions: Our data support the idea that vertical transmission of DENV is rare in nature, even in the absence of Wolbachia. Indeed, we observed that vertical transmission rates were low even when the midgut barrier was bypassed, which might help to explain why we only observed a trend towards lower vertical transmission rates in the presence of Wolbachia. Nevertheless, the low prevalence of disseminated DENV infection and lower DENV load in the ovaries supports the hypothesis that the presence of Wolbachia in Ae. aegypti would have an effect on the vertical transmission of DENV in the field.
C1 [Pacidonio, Etiene Casagrande; Caragata, Eric Pearce; Alves, Debora Magalhaes; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
   [Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Pacidonio, Etiene Casagrande] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.
RP Moreira, LA (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
RI Marques, Joao T/F-7683-2012
OI Marques, Joao T/0000-0002-3457-3320
FU Brazilian Ministery of Health (Secretaria de Vigilancia em Saude/ SVS e
   Departamento de Ciencia e Tecnologia da Secretaria de Ciencia,
   Tecnologia e Insumos Estrategicos/DECIT/SCTIE); CAPESCAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq); Bill and
   Melinda Gates FoundationGates Foundation
FX This project was funded by the Brazilian Ministery of Health (Secretaria
   de Vigilancia em Saude/SVS e Departamento de Ciencia e Tecnologia da
   Secretaria de Ciencia, Tecnologia e Insumos Estrategicos/DECIT/SCTIE),
   CAPES, CNPq, and a grant to Monash University through the Bill and
   Melinda Gates Foundation.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   dos Santos CND, 2002, VIRUS RES, V90, P197, DOI 10.1016/S0168-1702(02)00180-6
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gu WD, 2003, J MED ENTOMOL, V40, P595, DOI 10.1603/0022-2585-40.5.595
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 24
TC 3
Z9 3
U1 1
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 17
PY 2017
VL 10
AR 296
DI 10.1186/s13071-017-2236-z
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EX8JR
UT WOS:000403496100003
PM 28623959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, JL
   Saha, TT
   Zhang, Y
   Zhang, CY
   Raikhel, AS
AF Wang, Jia-Lin
   Saha, Tusar T.
   Zhang, Yang
   Zhang, Changyu
   Raikhel, Alexander S.
TI Juvenile hormone and its receptor methoprene-tolerant promote ribosomal
   biogenesis and vitellogenesis in the Aedes aegypti mosquito
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID KRUPPEL HOMOLOG 1; FAT-BODY; SACCHAROMYCES-CEREVISIAE; REPRODUCTIVE
   PROCESSES; GENE-EXPRESSION; YELLOW-FEVER; PROTEINS; EMERGENCE;
   20-HYDROXYECDYSONE; DYNAMICS
AB Juvenile hormone (JH) controls many biological activities in insects, including development, metamorphosis, and reproduction. In the Aedes aegypti mosquito, a vector of dengue, yellow fever, chikungunya, and zika viruses, the metabolic tissue (the fat body, which is an analogue of the vertebrate liver) produces yolk proteins for developing oocytes. JH is important for the fat body to acquire competence for yolk protein production. However, the molecular mechanisms of how JH promotes mosquito reproduction are not completely understood. In this study we show that stimulation of the JH receptor methoprene-tolerant (Met) activates expression of genes encoding the regulator of ribosome synthesis 1 (RRS1) and six ribosomal proteins (two ribosomal large subunit proteins, two ribosomal small subunit proteins, and two mitochondrial ribosomal proteins). Moreover, RNAi-mediated depletion of RRS1 decreased biosynthesis of the ribosomal protein L32 (RpL32). Depletion of Met, RRS1, or RpL32 led to retardation of ovarian growth and reduced mosquito fecundity, which may at least in part have resulted from decreased vitellogenin protein production in the fat body. In summary, our results indicate that JH is critical for inducing the expression of ribosomal protein genes and demonstrate that RRS1 mediates the JH signal to enhance both ribosomal biogenesis and vitellogenesis.
C1 [Wang, Jia-Lin; Saha, Tusar T.; Zhang, Yang; Zhang, Changyu; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Wang, Jia-Lin] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.
   [Saha, Tusar T.; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.
   [Zhang, Yang] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.
   [Zhang, Changyu] Guizhou Univ, Coll Agr, Guizhou Key Lab Plant Pest Management Mt Reg, Guiyang 550025, Peoples R China.
RP Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (corresponding author), Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.
EM alexander.raikhel@ucr.edu
OI Zhang, Yang/0000-0002-0789-4938
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI036959]; China
   Scholarship Council of Chinese Ministry of Education [201506775010]
FX This work was supported by National Institutes of Health Grant R01
   AI036959 (to A. S. R.). This work was also supported by Scholar
   Fellowship 201506775010 (to J.-L. W.) from the China Scholarship Council
   of Chinese Ministry of Education. The authors declare that they have no
   conflicts of interest regarding the content of this article. The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Belles X, 2005, REPRO BIOL, V12, P157
   Bian GW, 2008, INSECT BIOCHEM MOLEC, V38, P190, DOI 10.1016/j.ibmb.2007.10.008
   Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109
   Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009
   Ernst KC, 2017, J MED ENTOMOL, V54, P204, DOI 10.1093/jme/tjw141
   Estep AS, 2016, J INSECT PHYSIOL, V90, P17, DOI 10.1016/j.jinsphys.2016.05.001
   Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702
   He F, 2015, CHROMOSOMA, V124, P191, DOI 10.1007/s00412-014-0490-9
   James A, 2013, NUCLEUS-PHILA, V4, P123, DOI 10.4161/nucl.23944
   Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394
   Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109
   Kim M, 2010, J COMP PHYSIOL B, V180, P171, DOI 10.1007/s00360-009-0406-9
   Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064
   Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108
   Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112
   Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000
   Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x
   Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087
   Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x
   Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006
   RAIKHEL AS, 1986, J INSECT PHYSIOL, V32, P879, DOI 10.1016/0022-1910(86)90103-4
   RAIKHEL AS, 1991, TISSUE CELL, V23, P577, DOI 10.1016/0040-8166(91)90015-L
   RAIKHEL AS, 1990, GEN COMP ENDOCR, V77, P423, DOI 10.1016/0016-6480(90)90233-C
   RAIKHEL AS, 1983, TISSUE CELL, V15, P281, DOI 10.1016/0040-8166(83)90023-X
   RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245
   Roy S, 2016, ADV INSECT PHYSIOL, V51, P115, DOI 10.1016/bs.aiip.2016.05.004
   Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004
   Saha TT, 2016, P NATL ACAD SCI USA, V113, pE735, DOI 10.1073/pnas.1523838113
   Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2
   Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307
   Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684
   Zhao B, 2016, INSECT BIOCHEM MOLEC, V77, P69, DOI 10.1016/j.ibmb.2016.08.003
   Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100
   Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110
NR 40
TC 12
Z9 12
U1 1
U2 43
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 16
PY 2017
VL 292
IS 24
BP 10306
EP 10315
DI 10.1074/jbc.M116.761387
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EX9LW
UT WOS:000403580600038
PM 28446607
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Shapiro-Mendoza, CK
   Rice, ME
   Galang, RR
   Fulton, AC
   VanMaldeghem, K
   Prado, MV
   Ellis, E
   Anesi, MS
   Simeone, RM
   Petersen, EE
   Ellington, SR
   Jones, AM
   Williams, T
   Reagan-Steiner, S
   Perez-Padilla, J
   Deseda, CC
   Beron, A
   Tufa, AJ
   Rosinger, A
   Roth, NM
   Green, C
   Martin, S
   Lopez, CD
   Dewilde, L
   Goodwin, M
   Pagano, HP
   Mai, CT
   Gould, C
   Zaki, S
   Ferrer, LN
   Davis, MS
   Lathrop, E
   Polen, K
   Cragan, JD
   Reynolds, M
   Newsome, KB
   Huertas, MM
   Bhatangar, J
   Quinones, AM
   Nahabedian, JF
   Adams, L
   Sharp, TM
   Hancock, WT
   Rasmussen, SA
   Moore, CA
   Jamieson, DJ
   Munoz-Jordan, JL
   Garstang, H
   Kambui, A
   Masao, C
   Honein, MA
   Meaney-Delman, D
AF Shapiro-Mendoza, Carrie K.
   Rice, Marion E.
   Galang, Romeo R.
   Fulton, Anna C.
   VanMaldeghem, Kelley
   Prado, Miguel Valencia
   Ellis, Esther
   Anesi, Magele Scott
   Simeone, Regina M.
   Petersen, Emily E.
   Ellington, Sascha R.
   Jones, Abbey M.
   Williams, Tonya
   Reagan-Steiner, Sarah
   Perez-Padilla, Janice
   Deseda, Carmen C.
   Beron, Andrew
   Tufa, Aifili John
   Rosinger, Asher
   Roth, Nicole M.
   Green, Caitlin
   Martin, Stacey
   Lopez, Camille Delgado
   deWilde, Leah
   Goodwin, Mary
   Pagano, H. Pamela
   Mai, Cara T.
   Gould, Carolyn
   Zaki, Sherif
   Ferrer, Leishla Nieves
   Davis, Michelle S.
   Lathrop, Eva
   Polen, Kara
   Cragan, Janet D.
   Reynolds, Megan
   Newsome, Kimberly B.
   Huertas, Mariam Marcano
   Bhatangar, Julu
   Quinones, Alma Martinez
   Nahabedian, John F.
   Adams, Laura
   Sharp, Tyler M.
   Hancock, W. Thane
   Rasmussen, Sonja A.
   Moore, Cynthia A.
   Jamieson, Denise J.
   Munoz-Jordan, Jorge L.
   Garstang, Helentina
   Kambui, Afeke
   Masao, Carolee
   Honein, Margaret A.
   Meaney-Delman, Dana
CA Zika Pregnancy Infant Registries W
TI Pregnancy Outcomes After Maternal Zika Virus Infection During
   Pregnancy-US Territories, January 1, 2016-April 25, 2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; BIRTH-DEFECTS; INFANTS; WOMEN;
   EXPOSURE
C1 [Shapiro-Mendoza, Carrie K.; Petersen, Emily E.; Ellington, Sascha R.; Goodwin, Mary; Pagano, H. Pamela; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Rice, Marion E.; Galang, Romeo R.; Fulton, Anna C.; VanMaldeghem, Kelley; Simeone, Regina M.; Jones, Abbey M.; Roth, Nicole M.; Green, Caitlin; Mai, Cara T.; Lathrop, Eva; Polen, Kara; Cragan, Janet D.; Reynolds, Megan; Newsome, Kimberly B.; Nahabedian, John F.; Moore, Cynthia A.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Rice, Marion E.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Prado, Miguel Valencia; Deseda, Carmen C.; Lopez, Camille Delgado; Ferrer, Leishla Nieves; Huertas, Mariam Marcano; Quinones, Alma Martinez] Puerto Rico Dept Hlth, Ponce, PR USA.
   [Ellis, Esther; Beron, Andrew; deWilde, Leah; Davis, Michelle S.] US Virgin Isl Dept Hlth, St Thomas, VI USA.
   [Anesi, Magele Scott] Amer Samoa Dept Hlth, Pago Pago, AS USA.
   [Williams, Tonya] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Reagan-Steiner, Sarah; Zaki, Sherif; Bhatangar, Julu] CDC, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Perez-Padilla, Janice; Martin, Stacey; Gould, Carolyn; Adams, Laura; Sharp, Tyler M.; Munoz-Jordan, Jorge L.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Atlanta, GA 30333 USA.
   [Tufa, Aifili John; Kambui, Afeke] Pacific Isl Hlth Officers Assoc, Agana, GU USA.
   [Rosinger, Asher] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Rosinger, Asher] CDC, Div Hlth Nutr Examinat Surveys, Natl Ctr Hlth Stat, Atlanta, GA 30333 USA.
   [Hancock, W. Thane] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] Ctr Surveillance Epidemiol & Lab Serv, Div Publ Hlth Informat Disseminat, Atlanta, GA USA.
   [Garstang, Helentina] Republ Marshall Isl Minist Hlth, Majuro, Marshall Island.
   [Masao, Carolee] Kosrae Dept Hlth Serv, Kosrae, Micronesia.
RP Honein, MA (corresponding author), CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM mrh7@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Danielson,
   Melissa/0000-0001-9461-0341; Jamieson, Denise/0000-0003-2597-1201
CR Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
NR 10
TC 100
Z9 100
U1 0
U2 9
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 16
PY 2017
VL 66
IS 23
BP 615
EP 621
DI 10.15585/mmwr.mm6623e1
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EX6AM
UT WOS:000403324300005
PM 28617773
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Huntington, MK
   Allison, J
   Nair, D
AF Huntington, Mark K.
   Allison, Jay
   Nair, Dilip
TI Clarification on Zika Vectors in the United States
SO AMERICAN FAMILY PHYSICIAN
LA English
DT Letter
RI Huntington, Mark K/U-8445-2019
OI Huntington, Mark K/0000-0001-6009-0464
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ACAD FAMILY PHYSICIANS
PI KANSAS CITY
PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA
SN 0002-838X
EI 1532-0650
J9 AM FAM PHYSICIAN
JI Am. Fam. Physician
PD JUN 15
PY 2017
VL 95
IS 12
BP 758
EP 758
PG 1
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA EY0FC
UT WOS:000403632600004
PM 28671429
DA 2020-07-08
ER

PT J
AU Moore, SJ
   MacDonald, JT
   Freemont, PS
AF Moore, Simon J.
   MacDonald, James T.
   Freemont, Paul S.
TI Cell-free synthetic biology for in vitro prototype engineering
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Review
ID FREE PROTEIN-SYNTHESIS; TRANSCRIPTION-TRANSLATION SYSTEM;
   ESCHERICHIA-COLI; REGULATORY ELEMENTS; MEMBRANE-PROTEINS;
   RNA-POLYMERASE; GENE NETWORKS; MINIMAL CELL; EXPRESSION; EFFICIENT
AB Cell-free transcription-translation is an expanding field in synthetic biology as a rapid prototyping platform for blueprinting the design of synthetic biological devices. Exemplar efforts include translation of prototype designs into medical test kits for on-site identification of viruses (Zika and Ebola), while gene circuit cascades can be tested, debugged and re-designed within rapid turnover times. Coupled with mathematical modelling, this discipline lends itself towards the precision engineering of new synthetic life. The next stages of cell-free look set to unlock new microbial hosts that remain slow to engineer and unsuited to rapid iterative design cycles. It is hoped that the development of such systems will provide new tools to aid the transition from cell-free prototype designs to functioning synthetic genetic circuits and engineered natural product pathways in living cells.
C1 [Moore, Simon J.; MacDonald, James T.; Freemont, Paul S.] Ctr Synthet Biol & Innovat, Dept Med, South Kensington Campus, London, England.
RP Freemont, PS (corresponding author), Ctr Synthet Biol & Innovat, Dept Med, South Kensington Campus, London, England.
EM p.freemont@imperial.ac.uk
OI Moore, Simon/0000-0002-1968-206X; MacDonald, James/0000-0001-9675-4429
CR Akabayov B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2620
   Albayrak C, 2013, NUCLEIC ACIDS RES, V41, P5949, DOI 10.1093/nar/gkt226
   Brustad EM, 2011, CURR OPIN CHEM BIOL, V15, P201, DOI 10.1016/j.cbpa.2010.11.020
   Bujara M, 2010, BIOTECHNOL BIOENG, V106, P376, DOI 10.1002/bit.22666
   Cai Q, 2015, BIOTECHNOL PROGR, V31, P823, DOI 10.1002/btpr.2082
   Calhoun Kara A., 2007, V375, P3
   Caschera F, 2014, CURR OPIN CHEM BIOL, V22, P85, DOI 10.1016/j.cbpa.2014.09.028
   Caschera F, 2014, BIOCHIMIE, V99, P162, DOI 10.1016/j.biochi.2013.11.025
   CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0
   Chappell J, 2013, NUCLEIC ACIDS RES, V41, P3471, DOI 10.1093/nar/gkt052
   Chizzolini F, 2017, ACS SYNTH BIOL, V6, P638, DOI 10.1021/acssynbio.6b00250
   Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034
   de Maddalena LL, 2016, ACS SYNTH BIOL, V5, P929, DOI 10.1021/acssynbio.6b00017
   Dudley QM, 2015, BIOTECHNOL J, V10, P69, DOI 10.1002/biot.201400330
   Eisenstein M, 2016, NATURE, V531, P401, DOI 10.1038/531401a
   Elani Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6305
   Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X
   ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54
   Findlay HE, 2016, SCI REP-UK, V6, DOI 10.1038/srep39349
   Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090
   Gan R, 2014, BIOTECHNOL J, V9, P641, DOI 10.1002/biot.201300545
   Garamella J, 2016, ACS SYNTH BIOL, V5, P344, DOI 10.1021/acssynbio.5b00296
   Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109
   Harris DC, 2012, CURR OPIN BIOTECH, V23, P672, DOI 10.1016/j.copbio.2012.02.002
   Hartley A D, 1996, Methods Mol Biol, V53, P249
   Heyman Y, 2012, NAT NANOTECHNOL, V7, P374, DOI [10.1038/nnano.2012.65, 10.1038/NNANO.2012.65]
   Hockenberry AJ, 2012, CURR OPIN CHEM BIOL, V16, P253, DOI 10.1016/j.cbpa.2012.05.179
   Hodgman CE, 2012, METAB ENG, V14, P261, DOI 10.1016/j.ymben.2011.09.002
   Jaenicke L, 2007, ANGEW CHEM INT EDIT, V46, P6776, DOI 10.1002/anie.200700390
   Jewett MC, 2004, BIOTECHNOL BIOENG, V86, P19, DOI 10.1002/bit.20026
   Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57
   JONES GH, 1975, J BACTERIOL, V124, P364, DOI 10.1128/JB.124.1.364-372.1975
   Karig DK, 2012, NUCLEIC ACIDS RES, V40, P3763, DOI 10.1093/nar/gkr1191
   Karim AS, 2016, METAB ENG, V36, P116, DOI 10.1016/j.ymben.2016.03.002
   Karzbrun E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048104
   Kelwick R, 2016, METAB ENG, V38, P370, DOI 10.1016/j.ymben.2016.09.008
   Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d
   Kim DM, 1996, EUR J BIOCHEM, V239, P881, DOI 10.1111/j.1432-1033.1996.0881u.x
   Kim DM, 2001, BIOTECHNOL BIOENG, V74, P309, DOI 10.1002/bit.1121
   Kim J, 2014, NUCLEIC ACIDS RES, V42, P6078, DOI 10.1093/nar/gku233
   Kuruma Y, 2015, NAT PROTOC, V10, P1328, DOI 10.1038/nprot.2015.082
   Kwon YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08663
   Li J, 2017, BIOTECHNOL BIOENG, V114, P1343, DOI 10.1002/bit.26253
   Li JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085373
   Liu DV, 2005, BIOTECHNOL PROGR, V21, P460, DOI 10.1021/bp049789y
   Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991
   MATTHAEI JH, 1961, P NATL ACAD SCI USA, V47, P1580, DOI 10.1073/pnas.47.10.1580
   MATTHAEI JH, 1962, P NATL ACAD SCI USA, V48, P666, DOI 10.1073/pnas.48.4.666
   Moore S.J., 2016, BIORXIV, DOI [10.1101/071100, DOI 10.1101/071100]
   Moore SJ, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600678
   Moore SJ, 2016, ACS SYNTH BIOL, V5, P1059, DOI 10.1021/acssynbio.6b00031
   Niederholtmeyer H, 2015, ELIFE, V4, DOI 10.7554/eLife.09771
   Niederholtmeyer H, 2013, P NATL ACAD SCI USA, V110, P15985, DOI 10.1073/pnas.1311166110
   Niederholtmeyer H, 2013, ACS SYNTH BIOL, V2, P411, DOI 10.1021/sb300104f
   Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341
   NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426
   Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802
   Shin J, 2012, ACS SYNTH BIOL, V1, P408, DOI 10.1021/sb300049p
   Siegal-Gaskins D, 2014, ACS SYNTH BIOL, V3, P416, DOI 10.1021/sb400203p
   Sun ZZ, 2014, ACS SYNTH BIOL, V3, P387, DOI 10.1021/sb400131a
   Sun ZZ, 2013, JOVE-J VIS EXP, DOI 10.3791/50762
   Takahashi MK, 2015, ACS SYNTH BIOL, V4, P503, DOI 10.1021/sb400206c
   THOMPSON J, 1984, MOL GEN GENET, V195, P39, DOI 10.1007/BF00332721
   Tuza ZA, 2013, IEEE DECIS CONTR P, P1404, DOI 10.1109/CDC.2013.6760079
   Vendeville A, 2011, FEMS MICROBIOL REV, V35, P395, DOI 10.1111/j.1574-6976.2010.00254.x
   Voloshin AM, 2005, BIOTECHNOL BIOENG, V91, P516, DOI 10.1002/bit.20528
   Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187
   Wang HM, 2012, MOD SIMUL ENG, V2012, DOI 10.1155/2012/931943
   Yang WC, 2012, BIOTECHNOL PROGR, V28, P413, DOI 10.1002/btpr.1509
   You C, 2014, ACS SYNTH BIOL, V3, P380, DOI 10.1021/sb4000993
   Zawada JF, 2011, BIOTECHNOL BIOENG, V108, P1570, DOI 10.1002/bit.23103
NR 74
TC 13
Z9 13
U1 3
U2 26
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0300-5127
EI 1470-8752
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD JUN 15
PY 2017
VL 45
BP 785
EP 791
DI 10.1042/BST20170011
PN 3
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EY3OR
UT WOS:000403882400018
PM 28620040
OA Green Published, Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU da Silva, SR
AF da Silva, Suzane Ramos
TI First Published Study with Embryonated Hen Egg Infected with Zika Virus
   Is Dated from 1952
SO STEM CELLS AND DEVELOPMENT
LA English
DT Letter
C1 [da Silva, Suzane Ramos] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
RP da Silva, SR (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
EM ramosdas@usc.edu
OI Ramos da Silva, Suzane/0000-0002-0768-8421
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   TAYLOR RM, 1952, J IMMUNOL, V68, P473
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD JUN 15
PY 2017
VL 26
IS 12
BP 875
EP 875
DI 10.1089/scd.2017.0056
PG 1
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA EX1OT
UT WOS:000402994900002
PM 28363252
DA 2020-07-08
ER

PT J
AU Bandeira, AC
   Campos, GS
   Ribeiro, GS
   Cardoso, CW
   Bastos, CJ
   Pessoa, TL
   Araujo, KA
   Grassi, MFR
   Castro, AP
   Carvalho, RH
   Prates, APPB
   Gois, LL
   Rocha, VF
   Sardi, SI
AF Bandeira, A. C.
   Campos, G. S.
   Ribeiro, G. S.
   Cardoso, C. W.
   Bastos, C. J.
   Pessoa, T. L.
   Araujo, K. A.
   Grassi, M. F. R.
   Castro, A. P.
   Carvalho, R. H.
   Prates, A. P. P. B.
   Gois, L. L.
   Rocha, V. F.
   Sardi, S. I.
TI Clinical and laboratory evidence of Haff disease - case series from an
   outbreak in Salvador, Brazil, December 2016 to April 2017
SO EUROSURVEILLANCE
LA English
DT Article
ID RHABDOMYOLYSIS; CHIKUNGUNYA; ZIKA
AB We describe a series of 15 Haff disease cases from an outbreak in Salvador, Brazil, starting early December 2016. Eleven cases were grouped in four family clusters of two to four individuals, four were isolated cases. All but one patient consumed cooked fish; 11 within 24h before symptoms onset. Cases consumed Olho de Boi' (Seriola spp.) and 'Badejo' (Mycteroperca spp.). A total of 67 cases were detected, the last case was reported on 5 April 2017.
C1 [Bandeira, A. C.; Bastos, C. J.; Pessoa, T. L.] Fac Tecnol & Ciencias, Med Sch, Salvador, BA, Brazil.
   [Bandeira, A. C.; Araujo, K. A.] Hosp Alianca, Salvador, BA, Brazil.
   [Bandeira, A. C.; Ribeiro, G. S.; Grassi, M. F. R.] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Campos, G. S.; Carvalho, R. H.; Sardi, S. I.] Univ Fed Bahia, Virol Lab, Salvador, BA, Brazil.
   [Ribeiro, G. S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Cardoso, C. W.; Prates, A. P. P. B.] Secretaria Municipal Saude, Salvador, BA, Brazil.
   [Castro, A. P.] Hosp Aeroporto, Salvador, BA, Brazil.
   [Gois, L. L.] Univ Catolica Salvador, Salvador, BA, Brazil.
   [Rocha, V. F.] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
RP Bandeira, AC (corresponding author), Fac Tecnol & Ciencias, Med Sch, Salvador, BA, Brazil.; Bandeira, AC (corresponding author), Hosp Alianca, Salvador, BA, Brazil.; Bandeira, AC (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
EM antoniobandeira@gmail.com
RI Grassi, Fernanda/X-7360-2019; Ribeiro, Guilherme/B-6624-2008
OI Grassi, Fernanda/0000-0002-7356-5569; Ribeiro,
   Guilherme/0000-0002-6798-2059; Cardoso, Cristiane/0000-0001-5432-1174
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Boletim Epidemiologico, 2017, SECR MUN SAUD SAL MI
   Botana Luis M., 2008, P149
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1091
   Diaz JH, 2015, CLIN TOXICOL, V53, P421, DOI 10.3109/15563650.2015.1016165
   dos Santos MC, 2009, REV PANAM SALUD PUBL, V26, P469, DOI 10.1590/S1020-49892009001100012
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Herman LL, 2014, WEST J EMERG MED, V15, P664, DOI 10.5811/westjem.2014.6.10.21794
   Kim SY, 2012, BIOMOL THER, V20, P268, DOI 10.4062/biomolther.2012.20.3.268
   Langley RL, 2007, SOUTH MED J, V100, P1147, DOI 10.1097/SMJ.0b013e3181583673
   Mizuta K, 2012, EMERG INFECT DIS, V18, P1787, DOI 10.3201/eid1811.111570
   Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06
   Oberste MS, 1999, J MED VIROL, V58, P178, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;178::AID-JMV13&gt;3.0.CO;2-Q
   Paul V, 2014, QJM-INT J MED, V107, P67, DOI 10.1093/qjmed/hct172
   Thoelen I, 2003, J MED VIROL, V70, P420, DOI 10.1002/jmv.10412
   Tolesani Junior Oswaldo, 2013, Rev. bras. ter. intensiva, V25, P348, DOI 10.5935/0103-507X.20130058
   Zhang B, 2012, INTERNAL MED, V51, P487, DOI 10.2169/internalmedicine.51.6786
   Zu J. B., 1939, ERGEBNISSE INNEREN M, V57, P138
NR 20
TC 1
Z9 1
U1 0
U2 12
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 15
PY 2017
VL 22
IS 24
BP 2
EP 6
DI 10.2807/1560-7917.ES.2017.22.24.30552
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA EX9RR
UT WOS:000403596000001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yu, L
   Wang, RK
   Gao, F
   Li, M
   Liu, JY
   Wang, J
   Hong, WX
   Zhao, LZ
   Wen, YF
   Yin, CB
   Wang, H
   Zhang, Q
   Li, YY
   Zhou, PP
   Zhang, RD
   Liu, Y
   Tang, XP
   Guan, YJ
   Qin, CF
   Chen, L
   Shi, XL
   Jin, X
   Cheng, G
   Zhang, FC
   Zhang, LQ
AF Yu, Lei
   Wang, Ruoke
   Gao, Fei
   Li, Min
   Liu, Jianying
   Wang, Jian
   Hong, Wenxin
   Zhao, Lingzhai
   Wen, Yingfen
   Yin, Chibiao
   Wang, Hua
   Zhang, Qi
   Li, Yangyang
   Zhou, Panpan
   Zhang, Rudian
   Liu, Yang
   Tang, Xiaoping
   Guan, Yongjun
   Qin, Cheng-Feng
   Chen, Ling
   Shi, Xuanling
   Jin, Xia
   Cheng, Gong
   Zhang, Fuchun
   Zhang, Linqi
TI Delineating antibody recognition against Zika virus during natural
   infection
SO JCI INSIGHT
LA English
DT Article
ID WEST-NILE VIRUS; BROADLY NEUTRALIZING ANTIBODIES; DENGUE-VIRUS;
   COMPREHENSIVE ANALYSIS; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY;
   STRUCTURAL BASIS; B-CELL; SPECIFICITY; PROTECTION
AB Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that shares a considerable degree of homology with dengue virus (DENV). Here, we examined longitudinal antibody response against ZIKV during natural infection in 2 convalescent individuals. By decomposing the antibody recognition into DI/DII and DIII of the E glycoprotein, we showed their development in humans followed a spatiotemporal hierarchy. Plasma binding to DI/DII appeared to peak and wane during early infection with extensive cross-reactivity with DI/DII of DENV. Binding to DIII, however, peaked early but persisted months into the infection without detectable cross-reactivity with DIII of DENV. A clear trend of increase in DIII-specific neutralizing activity was observed over the course of infection. mAbs isolated during early infection are largely DI/DII specific, weakly neutralizing, and highly cross-reactive with DENV, while those from later infection are more diverse in recognition, potently neutralizing, and ZIKV specific. The most potent neutralizing mAb targeting the DIII provided 100% protection in mice from lethal ZIKV infection and could therefore serve as a promising candidate for antibody-based therapy and prevention. The dynamic features unveiled here will assist us to better understand the pathogenesis of ZIKV infection and inform rational design of vaccines.
C1 [Yu, Lei; Wang, Jian; Hong, Wenxin; Zhao, Lingzhai; Wen, Yingfen; Yin, Chibiao; Tang, Xiaoping; Guan, Yongjun; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, 627 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China.
   [Wang, Ruoke; Gao, Fei; Wang, Hua; Zhang, Qi; Li, Yangyang; Zhou, Panpan; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med, Beijing, Peoples R China.
   [Li, Min; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Shanghai, Peoples R China.
   [Liu, Jianying; Zhang, Rudian; Liu, Yang; Cheng, Gong] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Chen, Ling] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
   [Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.
   Tsinghua Univ, Sch Med, Dept Basic Med Sci, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China.
RP Zhang, LQ (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, 627 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China.
EM gz8hzfc@126.com; zhanglinqi@tsinghua.edu.cn
RI Zhou, Panpan/X-7597-2019; Qin, Cheng-Feng/I-6839-2019; Guan,
   Yongjun/V-8117-2019; 张, 入典/D-2513-2017
OI Zhou, Panpan/0000-0001-5740-4303; Qin, Cheng-Feng/0000-0002-0632-2807;
   Guan, Yongjun/0000-0001-6546-2095; 张, 入典/0000-0003-2214-4892
FU Guangzhou Science and Technology Program for Public Wellbeing
   [2014Y2-00185, 2014Y2-00550, 201508020263]; Special Program of Guangdong
   Provincial Department of Science and Technology [2016A020248001];
   Guangzhou Health Care and Cooperation Innovation Major grant; National
   Natural Science Foundation AwardNational Natural Science Foundation of
   China [81530065, 81590762]; National Key Plan for Scientific Research
   and Development of China [2016YFC1200902]; Ministry of Science and
   Technology of ChinaMinistry of Science and Technology, China
   [2014CB542500-03]
FX The project was supported by Guangzhou Science and Technology Program
   for Public Wellbeing (2014Y2-00185, 2014Y2-00550, and 201508020263), the
   Special Program of Guangdong Provincial Department of Science and
   Technology (2016A020248001), the Guangzhou Health Care and Cooperation
   Innovation Major grant, the National Natural Science Foundation Award
   (81530065 and 81590762), the National Key Plan for Scientific Research
   and Development of China (2016YFC1200902), and Ministry of Science and
   Technology of China (2014CB542500-03).
CR Austin SK, 2014, VIRUSES-BASEL, V6, P1015, DOI 10.3390/v6031015
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan KR, 2011, P NATL ACAD SCI USA, V108, P12479, DOI 10.1073/pnas.1106568108
   Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106
   Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050
   Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Singer M, 2017, GLOB PUBLIC HEALTH, V12, P1, DOI 10.1080/17441692.2016.1225112
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Voss A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-4
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855
   Zuo T, 2011, J BIOL CHEM, V286, P33511, DOI 10.1074/jbc.M111.270553
NR 54
TC 27
Z9 28
U1 1
U2 8
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD JUN 15
PY 2017
VL 2
IS 12
AR UNSP e93042
DI 10.1172/jci.insight.93042
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EX8JJ
UT WOS:000403495200008
PM 28614803
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Worobey, M
AF Worobey, Michael
TI EPIDEMIOLOGY Molecular mapping of Zika spread
SO NATURE
LA English
DT Editorial Material
ID AMERICA; VIRUS
C1 [Worobey, Michael] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.
RP Worobey, M (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.
EM worobey@email.arizona.edu
CR Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lipkin WI., 2016, WALL STREET J
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Quick J., 2017, NATURE PROTOCOLS
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
NR 11
TC 11
Z9 12
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 355
EP 357
DI 10.1038/nature22495
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900021
PM 28538722
OA Bronze
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Ladner, JT
   Kraemer, MUG
   Dudas, G
   Tan, AL
   Gangavarapu, K
   Wiley, MR
   White, S
   Theze, J
   Magnani, DM
   Prieto, K
   Reyes, D
   Bingham, AM
   Paul, LM
   Robles-Sikisaka, R
   Oliveira, G
   Pronty, D
   Barcellona, CM
   Metsky, HC
   Baniecki, ML
   Barnes, KG
   Chak, B
   Freije, CA
   Gladden-Young, A
   Gnirke, A
   Luo, C
   MacInnis, B
   Matranga, CB
   Park, DJ
   Qu, J
   Schaffner, SF
   Tomkins-Tinch, C
   West, KL
   Winnicki, SM
   Wohl, S
   Yozwiak, NL
   Quick, J
   Fauver, JR
   Khan, K
   Brent, SE
   Reiner, RC
   Lichtenberger, PN
   Ricciardi, MJ
   Bailey, VK
   Watkins, DI
   Cone, MR
   Kopp, EW
   Hogan, KN
   Cannons, AC
   Jean, R
   Monaghan, AJ
   Garry, RF
   Loman, NJ
   Faria, NR
   Porcelli, MC
   Vasquez, C
   Agle, ERN
   Cummings, DAT
   Stanek, D
   Rambaut, A
   Sanchez-Lockhart, M
   Sabeti, PC
   Gillis, LD
   Michael, SF
   Bedford, T
   Pybus, OG
   Isern, S
   Palacios, G
   Andersen, KG
AF Grubaugh, Nathan D.
   Ladner, Jason T.
   Kraemer, Moritz U. G.
   Dudas, Gytis
   Tan, Amanda L.
   Gangavarapu, Karthik
   Wiley, Michael R.
   White, Stephen
   Theze, Julien
   Magnani, Diogo M.
   Prieto, Karla
   Reyes, Daniel
   Bingham, Andrea M.
   Paul, Lauren M.
   Robles-Sikisaka, Refugio
   Oliveira, Glenn
   Pronty, Darryl
   Barcellona, Carolyn M.
   Metsky, Hayden C.
   Baniecki, Mary Lynn
   Barnes, Kayla G.
   Chak, Bridget
   Freije, Catherine A.
   Gladden-Young, Adrianne
   Gnirke, Andreas
   Luo, Cynthia
   MacInnis, Bronwyn
   Matranga, Christian B.
   Park, Daniel J.
   Qu, James
   Schaffner, Stephen F.
   Tomkins-Tinch, Christopher
   West, Kendra L.
   Winnicki, Sarah M.
   Wohl, Shirlee
   Yozwiak, Nathan L.
   Quick, Joshua
   Fauver, Joseph R.
   Khan, Kamran
   Brent, Shannon E.
   Reiner, Robert C., Jr.
   Lichtenberger, Paola N.
   Ricciardi, Michael J.
   Bailey, Varian K.
   Watkins, David I.
   Cone, Marshall R.
   Kopp, Edgar W.
   Hogan, Kelly N.
   Cannons, Andrew C.
   Jean, Reynald
   Monaghan, Andrew J.
   Garry, Robert F.
   Loman, Nicholas J.
   Faria, Nuno R.
   Porcelli, Mario C.
   Vasquez, Chalmers
   Agle, Elyse R. N.
   Cummings, Derek A. T.
   Stanek, Danielle
   Rambaut, Andrew
   Sanchez-Lockhart, Mariano
   Sabeti, Pardis C.
   Gillis, Leah D.
   Michael, Scott F.
   Bedford, Trevor
   Pybus, Oliver G.
   Isern, Sharon
   Palacios, Gustavo
   Andersen, Kristian G.
TI Genomic epidemiology reveals multiple introductions of Zika virus into
   the United States
SO NATURE
LA English
DT Article
ID MAXIMUM-LIKELIHOOD; AEDES-AEGYPTI; SEQUENCE DATA; TRANSMISSION; AMERICA;
   DENGUE; INFECTION; OUTBREAK; FLORIDA; SPREAD
AB Zika virus (ZIKV) is causing an unprecedented epidemic linked to severe congenital abnormalities(1,2). In July 2016, mosquito-borne ZIKV transmission was reported in the continental United States; since then, hundreds of locally acquired infections have been reported in Florida(3,4). To gain insights into the timing, source, and likely route(s) of ZIKV introduction, we tracked the virus from its first detection in Florida by sequencing ZIKV genomes from infected patients and Aedes aegypti mosquitoes. We show that at least 4 introductions, but potentially as many as 40, contributed to the outbreak in Florida and that local transmission is likely to have started in the spring of 2016-several months before its initial detection. By analysing surveillance and genetic data, we show that ZIKV moved among transmission zones in Miami. Our analyses show that most introductions were linked to the Caribbean, a finding corroborated by the high incidence rates and traffic volumes from the region into the Miami area. Our study provides an understanding of how ZIKV initiates transmission in new regions.
C1 [Grubaugh, Nathan D.; Robles-Sikisaka, Refugio; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Ladner, Jason T.; Wiley, Michael R.; Prieto, Karla; Reyes, Daniel; Sanchez-Lockhart, Mariano; Palacios, Gustavo] US Army Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA.
   [Kraemer, Moritz U. G.; Theze, Julien; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Harbor Med Sch, Boston, MA 02115 USA.
   [Dudas, Gytis; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98109 USA.
   [Tan, Amanda L.; Paul, Lauren M.; Michael, Scott F.; Isern, Sharon] Florida Gulf Coast Univ, Coll Arts & Sci, Dept Biol Sci, Ft Myers, FL 33965 USA.
   [Wiley, Michael R.; Prieto, Karla] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE 68198 USA.
   [White, Stephen; Pronty, Darryl; Gillis, Leah D.] Florida Dept Hlth, Bur Publ Hlth Labs, Div Dis Control & Hlth Protect, Miami, FL 33125 USA.
   [Magnani, Diogo M.; Ricciardi, Michael J.; Bailey, Varian K.; Watkins, David I.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
   [Reyes, Daniel; Agle, Elyse R. N.; Sanchez-Lockhart, Mariano] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Bingham, Andrea M.] Florida Dept Hlth, Bur Epidemiol, Div Dis Control & Hlth Protect, Tallahassee, FL 32399 USA.
   [Oliveira, Glenn; Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA.
   [Metsky, Hayden C.; Baniecki, Mary Lynn; Barnes, Kayla G.; Chak, Bridget; Freije, Catherine A.; Gladden-Young, Adrianne; Gnirke, Andreas; Luo, Cynthia; MacInnis, Bronwyn; Matranga, Christian B.; Park, Daniel J.; Qu, James; Schaffner, Stephen F.; Tomkins-Tinch, Christopher; West, Kendra L.; Winnicki, Sarah M.; Wohl, Shirlee; Yozwiak, Nathan L.; Sabeti, Pardis C.] Broad Inst & Harvard, Cambridge, MA 02142 USA.
   [Quick, Joshua] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
   [Fauver, Joseph R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Khan, Kamran; Brent, Shannon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON M5S 1A8, Canada.
   [Reiner, Robert C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Lichtenberger, Paola N.] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA.
   [Cone, Marshall R.; Kopp, Edgar W.; Hogan, Kelly N.; Cannons, Andrew C.] Florida Dept Hlth, Bur Publ Hlth Labs, Div Dis Control & Hlth Protect, Tampa, FL 33612 USA.
   [Jean, Reynald] Florida Dept Hlth Miami Dade Cty, Miami, FL 33125 USA.
   [Monaghan, Andrew J.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA.
   [Garry, Robert F.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Porcelli, Mario C.; Vasquez, Chalmers] Miami Dade Cty Mosquito Control, Miami, FL 33178 USA.
   [Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA.
   [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.
   [Sabeti, Pardis C.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Andersen, Kristian G.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
RP Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Palacios, G (corresponding author), US Army Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA.; Andersen, KG (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
EM gustavo.f.palacios.ctr@mail.mil; andersen@scripps.edu
RI Loman, Nicholas/Z-1573-2019; Sanchez-Lockhart, Mariano/H-1321-2019;
   Dudas, Gytis/H-5968-2019; Sanchez-Lockhart, Mariano/M-6446-2019;
   Schaffner, Stephen F/D-1189-2011; Palacios, Gustavo/I-7773-2015;
   Rambaut, Andrew/B-2481-2009; Faria, Nuno/I-2975-2012; Pybus, Oliver
   g/B-2640-2012
OI Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Dudas,
   Gytis/0000-0002-0227-4158; Sanchez-Lockhart,
   Mariano/0000-0001-8009-7540; Palacios, Gustavo/0000-0001-5062-1938;
   Rambaut, Andrew/0000-0003-4337-3707; Faria, Nuno/0000-0001-8839-2798;
   Pybus, Oliver g/0000-0002-8797-2667; White, Stephen/0000-0002-2112-1560;
   Wiley, Michael/0000-0001-6688-007X; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X; Paul, Lauren/0000-0001-5503-7570; Magnani,
   Diogo/0000-0002-1773-2406; Tomkins-Tinch,
   Christopher/0000-0002-9114-6421; Grubaugh, Nathan/0000-0003-2031-1933;
   Loman, Nicholas/0000-0002-9843-8988; Garry, Robert/0000-0002-5683-3250
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33, R35 GM11977401];
   Mahan Postdoctoral Fellowship from the Computational Biology Program at
   Fred Hutch; ASTMH Shope Fellowship; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; US NIH MIDAS program [U54-GM088491]; CDCCentre National
   de la Recherche Scientifique (CNRS)United States Department of Health &
   Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK000510]; EUEuropean Union (EU) [278433-PREDEMICS]; ERCEuropean
   Research Council (ERC) [260864]; Horizon grant [643476-COMPARE]; NIH
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI110818, R01AI099210]; Howard Hughes
   Medical InstituteHoward Hughes Medical Institute; AWS Cloud Credits for
   Research; Broad Institute BroadNext10 program; EU ERCEuropean Union
   (EU)European Research Council (ERC) [614725-PATHPHYLODYN]; USAID
   Emerging Pandemic Threats Program-2 PREDICT-2United States Agency for
   International Development (USAID) [AID-OAA-A-14-00102]; DARPAUnited
   States Department of DefenseDefense Advanced Research Projects Agency
   (DARPA); NIH NCATS CTSAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001114]; NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272201400048C]; Ray Thomas Foundation
FX We thank J. Weger-Lucarelli, G. Ebel, C. Moore, B. Alto, G. Donatti, and
   S. Taylor for discussions; E. Spencer for IRB and logistics support; M.
   Pilcher for sequencing assistance; and G. Schroth and S. Gross for
   designing and providing enrichment probes. N.D.G. is supported by NIH
   training grant 5T32AI007244-33. G.D. is supported by the Mahan
   Postdoctoral Fellowship from the Computational Biology Program at Fred
   Hutch. K.G.B. is supported by the ASTMH Shope Fellowship. N.R.F. is
   funded by a Sir Henry Dale Fellowship (Wellcome Trust/Royal Society
   grant 204311/Z/16/Z). D.A.T.C. was supported by US NIH MIDAS program
   (U54-GM088491) and CDC Cooperative Agreement U01CK000510. A.R. is
   supported by EU Seventh Framework Programme (FP7/2007-2013) under grant
   278433-PREDEMICS, ERC grant 260864, Horizon 2020 grant 643476-COMPARE.
   P.C.S. is supported by Marc and Lynne Benioff; NIH NIAID U19AI110818;
   Howard Hughes Medical Institute; AWS Cloud Credits for Research; Broad
   Institute BroadNext10 program (also A. G.). T. B. is a Pew Biomedical
   Scholar and is supported by NIH R35 GM11977401. O.G.P. received funding
   from EU ERC Seventh Framework Programme (FP7/2007-2013)/ERC number
   614725-PATHPHYLODYN and the USAID Emerging Pandemic Threats Program-2
   PREDICT-2 (Cooperative Agreement No. AID-OAA-A-14-00102). S. I. and S.
   F. M. are supported by NIH NIAID R01AI099210. ZIKV sequencing at
   USAMRIID was supported by DARPA (PI: C. Kane). K. G. A. is a Pew
   Biomedical Scholar, and is supported by NIH NCATS CTSA UL1TR001114,
   NIAID contract HHSN272201400048C, and The Ray Thomas Foundation. The
   content of this publication does not necessarily reflect the views or
   policies of the US Army, the Department of Health and Human Services,
   the CDC, or the Florida Department of Health.
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   [Anonymous], 2017, NAT DIR EP SURV VECT
   [Anonymous], 2017, ZIK VIR
   [Anonymous], 2017, DENG PUERT RIC
   [Anonymous], 2017, DAIL ZIK UPD
   [Anonymous], 2016, ZIK CUM CAS
   [Anonymous], 2017, FCCA RES STAT
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Biggerstaff B. J., 2009, POOLEDINFRATE VERSIO
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Churcher TS, 2014, SCIENCE, V344, P1230, DOI 10.1126/science.1251449
   Corman VM, 2016, B WHO
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Faria N. R., 2017, NATURE
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauver JR, 2016, J MED ENTOMOL, V53, P425, DOI 10.1093/jme/tjv234
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Florida Department of Health, 2017, MOSQ BORN DIS SURV
   Gelman A, 1998, STAT SCI, V13, P163
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Hwang WH, 2011, METHODS ECOL EVOL, V2, P550, DOI 10.1111/j.2041-210X.2011.00105.x
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Koster J., 2012, OASICS OPENACCESS SE, V26
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee S, 2013, TOURISM MANAGE, V34, P236, DOI 10.1016/j.tourman.2012.03.009
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Metsky HC, 2017, NATURE
   Monaghan AJ, 2016, PLOS CURR
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Nelson B., 2016, PLOS CURR
   Nishiura H, 2012, J THEOR BIOL, V294, P48, DOI 10.1016/j.jtbi.2011.10.039
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Pan American Health Organisation, 2016, REG ZIK EP UPD AM
   Pan-American Health Organization, 2016, COUNTR TERR AUT TRAN
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Quick J., 2017, NAT PROTOCOLS
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rambaut A, 2016, VIRUS EVOL
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Teets Frank D, 2014, Virol Rep, V1-2, P2
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   World Health Organization, 2016, ZIK VIR COMPL
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
NR 79
TC 130
Z9 132
U1 7
U2 56
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 401
EP +
DI 10.1038/nature22400
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900034
PM 28538723
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Faria, NR
   Quick, J
   Claro, IM
   Theze, J
   de Jesus, JG
   Giovanetti, M
   Kraemer, MUG
   Hill, SC
   Black, A
   da Costa, AC
   Franco, LC
   Silva, SP
   Wu, CH
   Raghwani, J
   Cauchemez, S
   du Plessis, L
   Verotti, MP
   de Oliveira, WK
   Carmo, EH
   Coelho, GE
   Santelli, ACFS
   Vinhal, LC
   Henriques, CM
   Simpson, JT
   Loose, M
   Andersen, KG
   Grubaugh, ND
   Somasekar, S
   Chiu, CY
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Arias, CF
   Lewis-Ximenez, LL
   Baylis, SA
   Chieppe, AO
   Aguiar, SF
   Fernandes, CA
   Lemos, PS
   Nascimento, BLS
   Monteiro, HAO
   Siqueira, IC
   de Queiroz, MG
   de Souza, TR
   Bezerra, JF
   Lemos, MR
   Pereira, GF
   Loudal, D
   Moura, LC
   Dhalia, R
   Franca, RF
   Magalhaes, T
   Marques, ET
   Jaenisch, T
   Wallau, GL
   de Lima, MC
   Nascimento, V
   de Cerqueira, EM
   de Lima, MM
   Mascarenhas, DL
   Neto, JPM
   Levin, AS
   Tozetto-Mendoza, TR
   Fonseca, SN
   Mendes-Correa, MC
   Milagres, FP
   Segurado, A
   Holmes, EC
   Rambaut, A
   Bedford, T
   Nunes, MRT
   Sabino, EC
   Alcantara, LCJ
   Loman, NJ
   Pybus, OG
AF Faria, N. R.
   Quick, J.
   Claro, I. M.
   Theze, J.
   de Jesus, J. G.
   Giovanetti, M.
   Kraemer, M. U. G.
   Hill, S. C.
   Black, A.
   da Costa, A. C.
   Franco, L. C.
   Silva, S. P.
   Wu, C. -H.
   Raghwani, J.
   Cauchemez, S.
   du Plessis, L.
   Verotti, M. P.
   de Oliveira, W. K.
   Carmo, E. H.
   Coelho, G. E.
   Santelli, A. C. F. S.
   Vinhal, L. C.
   Henriques, C. M.
   Simpson, J. T.
   Loose, M.
   Andersen, K. G.
   Grubaugh, N. D.
   Somasekar, S.
   Chiu, C. Y.
   Munoz-Medina, J. E.
   Gonzalez-Bonilla, C. R.
   Arias, C. F.
   Lewis-Ximenez, L. L.
   Baylis, S. A.
   Chieppe, A. O.
   Aguiar, S. F.
   Fernandes, C. A.
   Lemos, P. S.
   Nascimento, B. L. S.
   Monteiro, H. A. O.
   Siqueira, I. C.
   de Queiroz, M. G.
   de Souza, T. R.
   Bezerra, J. F.
   Lemos, M. R.
   Pereira, G. F.
   Loudal, D.
   Moura, L. C.
   Dhalia, R.
   Franca, R. F.
   Magalhaes, T.
   Marques, E. T., Jr.
   Jaenisch, T.
   Wallau, G. L.
   de Lima, M. C.
   Nascimento, V.
   de Cerqueira, E. M.
   de Lima, M. M.
   Mascarenhas, D. L.
   Moura Neto, J. P.
   Levin, A. S.
   Tozetto-Mendoza, T. R.
   Fonseca, S. N.
   Mendes-Correa, M. C.
   Milagres, F. P.
   Segurado, A.
   Holmes, E. C.
   Rambaut, A.
   Bedford, T.
   Nunes, M. R. T.
   Sabino, E. C.
   Alcantara, L. C. J.
   Loman, N. J.
   Pybus, O. G.
TI Establishment and cryptic transmission of Zika virus in Brazil and the
   Americas
SO NATURE
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; EVOLUTION; TIME; EMERGENCE; MODELS; DENGUE;
   BAHIA; RECOMBINATION; SEQUENCES; SELECTION
AB Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil(1). Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 20162) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 20162). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease(3). However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.
C1 [Faria, N. R.; Theze, J.; Kraemer, M. U. G.; Hill, S. C.; Raghwani, J.; du Plessis, L.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England.
   [Faria, N. R.; Franco, L. C.; Silva, S. P.; Lemos, P. S.; Nascimento, B. L. S.; Monteiro, H. A. O.; Nunes, M. R. T.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, I. M.; da Costa, A. C.; Levin, A. S.; Tozetto-Mendoza, T. R.; Mendes-Correa, M. C.; Segurado, A.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [de Jesus, J. G.; Giovanetti, M.; Siqueira, I. C.; Alcantara, L. C. J.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, M.] Univ Roma Tor Vergata, Rome, Italy.
   [Kraemer, M. U. G.] Harvard Med Sch, Boston, MA USA.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Black, A.; Bedford, T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford OX1 3LB, England.
   [Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Cauchemez, S.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Cauchemez, S.] Ctr Natl Rech Sci, URA3012, Paris, France.
   [Verotti, M. P.] Minist Hlth, Coordena Lab Saude CGLAB DEVIT SVS, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Minist Hlth, Coordena Geral Vigilincia & Resposta Emergencias, Brasilia, DF, Brazil.
   [de Oliveira, W. K.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.
   [Carmo, E. H.; Henriques, C. M.] Minist Hlth, Dept Vigilincia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Coelho, G. E.; Santelli, A. C. F. S.; Vinhal, L. C.] Minist Hlth, Coordena Geral Programas Controle & Preven Malari, Brasilia, DF, Brazil.
   [Coelho, G. E.] PAHO, Buenos Aires, DF, Argentina.
   [Santelli, A. C. F. S.] Fundacao Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Simpson, J. T.] Ontario Inst Canc Res, Toronto, ON, Canada.
   [Loose, M.] Univ Nottingham, Nottingham, England.
   [Andersen, K. G.; Grubaugh, N. D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Somasekar, S.; Chiu, C. Y.] Univ Calif San Francisco, Dept Med Infect & Dis, San Francisco, CA 94143 USA.
   [Munoz-Medina, J. E.; Gonzalez-Bonilla, C. R.] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Arias, C. F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Lewis-Ximenez, L. L.] Inst Oswaldo Cruz FIOCRUZ, Rio De Janeiro, Brazil.
   [Baylis, S. A.] Paul Ehrlich Inst, Langen, Germany.
   [Chieppe, A. O.; Aguiar, S. F.; Fernandes, C. A.] Lab Cent Saude Publ Noel Nutels, Rio De Janeiro, Brazil.
   [de Queiroz, M. G.; de Souza, T. R.; Bezerra, J. F.] Labo Cent Saude Publ Estado Rio Grande Norte, Natal, RN, Brazil.
   [de Souza, T. R.] Univ Potiguar Rio Grande Norte, Natal, RN, Brazil.
   [Bezerra, J. F.] Fundacao Natalense Ensino & Cultura, Natal, RN, Brazil.
   [Lemos, M. R.; Pereira, G. F.; Loudal, D.; Moura, L. C.] Lab Cent Saude Publ Estado Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Dhalia, R.; Franca, R. F.; Magalhaes, T.; Marques, E. T., Jr.; Wallau, G. L.] Fundacao Oswaldo Cruz FIOCRUZ, Recife, PE, Brazil.
   [Magalhaes, T.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Jaenisch, T.] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [de Lima, M. C.; Nascimento, V.; de Cerqueira, E. M.] Lab Cent Saude Publ Estado Alagoas, Maceio, Brazil.
   [de Lima, M. M.] Univ Estadual Feira de Santana, Feira Santana, Bahia, Argentina.
   [Mascarenhas, D. L.] Secretaria Saude Feira Santana, Feira De Santana, Bahia, Brazil.
   [Moura Neto, J. P.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Fonseca, S. N.] Hosp Sao Francisco, Ribeirao Preto, Brazil.
   [Milagres, F. P.] Univ Fed Tocantins, Palmas, Brazil.
   [Holmes, E. C.] Univ Sydney, Sydney, NSW, Australia.
   [Rambaut, A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, A.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Nunes, M. R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Pybus, O. G.] Metabiota, San Francisco, CA 94104 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SY, England.; Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Sabino, EC (corresponding author), Univ Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil.; Sabino, EC (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.; Alcantara, LCJ (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.
EM sabinoec@usp.br; lalcan@bahia.fiocruz.br; n.j.loman@bham.ac.uk;
   oliver.pybus@zoo.ox.ac.uk
RI Pybus, Oliver g/B-2640-2012; Levin, Anna S/C-8831-2012; Bezerra, Joao
   Felipe/AAE-2500-2020; Marques, Ernesto T. A/L-4967-2013; Wallau, Gabriel
   Luz/B-5911-2008; Sabino, Ester Cerdeira/F-7750-2010; da-Costa, Antonio
   Charlys/G-1548-2010; Oliveira, Claudia DL/G-8618-2011; Segurado, Aluisio
   C/K-2229-2012; Magalhaes, Tereza/V-6632-2019; Dhalia,
   Rafael/AAD-5432-2020; milagres, flavio/Q-2403-2019; Arias,
   Carlos/O-4036-2019; Esteban, Munoz Medina Jose/B-6186-2015; Rambaut,
   Andrew/B-2481-2009; Loman, Nicholas/Z-1573-2019; de Siqueira, Isadora
   Cristina/R-9953-2016; Bezerrra, Joao/C-8867-2017; Faria,
   Nuno/I-2975-2012; Giovanetti, Marta/AAK-7408-2020
OI Pybus, Oliver g/0000-0002-8797-2667; Levin, Anna S/0000-0003-2427-8368;
   Marques, Ernesto T. A/0000-0003-3826-9358; Wallau, Gabriel
   Luz/0000-0002-1419-5713; Sabino, Ester Cerdeira/0000-0003-2623-5126;
   da-Costa, Antonio Charlys/0000-0001-5516-5177; Segurado, Aluisio
   C/0000-0002-6311-8036; Arias, Carlos/0000-0003-3130-4501; Esteban, Munoz
   Medina Jose/0000-0002-1289-4457; Rambaut, Andrew/0000-0003-4337-3707; de
   Siqueira, Isadora Cristina/0000-0002-2520-4099; Bezerrra,
   Joao/0000-0002-9978-628X; Faria, Nuno/0000-0001-8839-2798; Black,
   Allison/0000-0002-6618-4127; Holmes, Edward/0000-0001-9596-3552; Vinhal
   Frutuoso, Livia Carla/0000-0001-7926-1075; Loman,
   Nicholas/0000-0002-9843-8988; Loose, Matthew/0000-0002-5264-0929;
   Grubaugh, Nathan/0000-0003-2031-1933; Hill, Sarah/0000-0002-2995-2596;
   Raghwani, Jayna/0000-0001-8538-4995; Giovanetti,
   Marta/0000-0002-5849-7326; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Wu, Chieh-Hsi/0000-0001-9386-725X;
   Alcantara, Luiz/0000-0002-6769-9931
FU MRC/Wellcome Trust/Newton Fund Zika Rapid Response grant
   [MC_PC_15100/ZK/16-078]; USAID Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]; MRC Bioinformatics Fellowship; Sir Henry Dale
   Fellowship [204311/Z/16/Z]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [457480/2014-9, 302584/2015-3,
   439975/2016-6]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/03417-7]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R35 GM119774,
   R01 HL105704]; NSFNational Science Foundation (NSF) [DGE-1256082];
   Abbott Laboratories, Inc.Abbott Laboratories; National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [GNT1037231]; MRCMedical Research Council UK (MRC); CRUKCancer
   Research UK [ANR00310]; Wellcome TrustWellcome Trust; Royal SocietyRoyal
   Society of London [101237/Z/13/Z]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN, 278433-PREDEMICS]; EUEuropean Union (EU)
   [643476-COMPARE, 734548-ZIKAlliance]; IDAMS; DENFREE; DengueTools;
   PPSUSFACEPE [APQ-0302-4.01/13]; FACEPE [APQ-0044.2.11/16,
   APQ-0055.2.11/16]; German Ministry of Health
FX We thank Fundacao Oswaldo Cruz in Bahia and Pernambuco states,
   University of Sao Paulo, Instituto Evandro Chagas, and the Brazilian
   Zika virus surveillance network for their essential contributions. We
   thank the following for giving us permission to use their unpublished
   genomes available on GenBank: R. Lanciotti, J. Lednicky, A. Enfissi, F.
   Baldanti, R. Shabman, B. Picket, R. Schinazi, M. Bonaldo, M. Gale, M.
   Capobianchi and C. Concetta, M. Leguia, J. Alberto Diaz, E.
   Sevilla-Reyes, A. Franz, M. GarciaBlanco and M. J. van Hemert. We thank
   P. Fernando da Costa Vasconcelos, S. Guerreiro Rodrigues, J. Cardoso, J.
   Vasconcelos, J. Vianez Jr, J. Gil Melgaco, J. Blumel, M. C. Brito
   Lobato, L. Nunes Fava, C. Ayres, L. Abade and F. Campos. L. C. J. A.
   thanks QIAGEN for reagents and equipment and M. R. T. N. thanks FERPEL
   for consumables. We thank Oxford Nanopore for technical support,
   particularly R. Dokos, Z. McDougall, S. Cowan, G. Sanghera, and O.
   Hartwell. This work was supported by an MRC/Wellcome Trust/Newton Fund
   Zika Rapid Response grant (MC_PC_15100/ZK/16-078) and by the USAID
   Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement
   AID-OAA-A-14-00102). N. J. L. is supported by an MRC Bioinformatics
   Fellowship. N. R. F. is funded by a Sir Henry Dale Fellowship (grant
   204311/Z/16/Z). CNPq contributed to trip expenses (grant 457480/2014-9).
   A.C.d.C. was supported by FAPESP # 2012/03417-7 and M. R. T. N. by CNPq
   grant no. 302584/2015-3. A. B. and T. B. were supported by NIH award R35
   GM119774. A. B. is supported by the NSF Graduate Research Fellowship
   Program (grant DGE-1256082). T. B. is a Pew Biomedical Scholar. C.Y.C.
   is partially supported by NIH grant R01 HL105704 and an award from
   Abbott Laboratories, Inc. E. C. H. is supported by a National Health and
   Medical Research Council Australia Fellowship (GNT1037231). C.- H. W. is
   supported by the MRC and CRUK (ANR00310) and by the Wellcome Trust and
   Royal Society (grant 101237/Z/13/Z). S. C. H. is supported by the
   Wellcome Trust. This research received funding from the ERC under grant
   agreements 614725-PATHPHYLODYN and 278433-PREDEMICS, and from EU Horizon
   2020 under agreements 643476-COMPARE and 734548-ZIKAlliance. T. J. and
   E. T. M. acknowledge funding from IDAMS, DENFREE, DengueTools, and
   PPSUSFACEPE (project APQ-0302-4.01/13). R. F. F. received funding from
   FACEPE (APQ-0044.2.11/16 and APQ-0055.2.11/16) and from CNPq
   (439975/2016-6). S. A. B. was supported by the Sicherheit von Blut und
   Geweben hinsichtlich der Abwesenheit von Zikaviren from the German
   Ministry of Health.
CR [Anonymous], 2014, R LANG ENV COMP
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Brasil, 2017, B EP SECR VIG SAUD
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   De Maio N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005421
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grubaugh N. D., 2017, NATURE
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kozlov AM, 2015, BIOINFORMATICS, V31, P2577, DOI 10.1093/bioinformatics/btv184
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Metsky HC, 2017, NATURE
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pacheco O., 2016, NEW ENGL J MED
   PAHO/WHO, 2016, PAHO WHO ZIK EP UPD
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quick J., 2017, NAT PROTOCOLS
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schierup MH, 2000, GENETICS, V156, P879
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 197
Z9 201
U1 14
U2 76
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 406
EP +
DI 10.1038/nature22401
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900035
PM 28538727
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Metsky, HC
   Matranga, CB
   Wohl, S
   Schaffner, SF
   Freije, CA
   Winnicki, SM
   West, K
   Qu, J
   Baniecki, ML
   Gladden-Young, A
   Lin, AE
   Tomkins-Tinch, CH
   Ye, SH
   Park, DJ
   Luo, CY
   Barnes, KG
   Shah, RR
   Chak, B
   Barbosa-Lima, G
   Delatorre, E
   Vieira, YR
   Paul, LM
   Tan, AL
   Barcellona, CM
   Porcelli, MC
   Vasquez, C
   Cannons, AC
   Cone, MR
   Hogan, KN
   Kopp, EW
   Anzinger, JJ
   Garcia, KF
   Parham, LA
   Ramirez, RMG
   Montoya, MCM
   Rojas, DP
   Brown, CM
   Hennigan, S
   Sabina, B
   Scotland, S
   Gangavarapu, K
   Grubaugh, ND
   Oliveira, G
   Robles-Sikisaka, R
   Rambaut, A
   Gehrke, L
   Smole, S
   Halloran, ME
   Villar, L
   Mattar, S
   Lorenzana, I
   Cerbino-Neto, J
   Valim, C
   Degrave, W
   Bozza, PT
   Gnirke, A
   Andersen, KG
   Isern, S
   Michael, SF
   Bozza, FA
   Souza, TML
   Bosch, I
   Yozwiak, NL
   MacInnis, BL
   Sabeti, PC
AF Metsky, Hayden C.
   Matranga, Christian B.
   Wohl, Shirlee
   Schaffner, Stephen F.
   Freije, Catherine A.
   Winnicki, Sarah M.
   West, Kendra
   Qu, James
   Baniecki, Mary Lynn
   Gladden-Young, Adrianne
   Lin, Aaron E.
   Tomkins-Tinch, Christopher H.
   Ye, Simon H.
   Park, Daniel J.
   Luo, Cynthia Y.
   Barnes, Kayla G.
   Shah, Rickey R.
   Chak, Bridget
   Barbosa-Lima, Giselle
   Delatorre, Edson
   Vieira, Yasmine R.
   Paul, Lauren M.
   Tan, Amanda L.
   Barcellona, Carolyn M.
   Porcelli, Mario C.
   Vasquez, Chalmers
   Cannons, Andrew C.
   Cone, Marshall R.
   Hogan, Kelly N.
   Kopp, Edgar W.
   Anzinger, Joshua J.
   Garcia, Kimberly F.
   Parham, Leda A.
   Gelvez Ramirez, Rosa M.
   Miranda Montoya, Maria C.
   Rojas, Diana P.
   Brown, Catherine M.
   Hennigan, Scott
   Sabina, Brandon
   Scotland, Sarah
   Gangavarapu, Karthik
   Grubaugh, Nathan D.
   Oliveira, Glenn
   Robles-Sikisaka, Refugio
   Rambaut, Andrew
   Gehrke, Lee
   Smole, Sandra
   Halloran, M. Elizabeth
   Villar, Luis
   Mattar, Salim
   Lorenzana, Ivette
   Cerbino-Neto, Jose
   Valim, Clarissa
   Degrave, Wim
   Bozza, Patricia T.
   Gnirke, Andreas
   Andersen, Kristian G.
   Isern, Sharon
   Michael, Scott F.
   Bozza, Fernando A.
   Souza, Thiago M. L.
   Bosch, Irene
   Yozwiak, Nathan L.
   MacInnis, Bronwyn L.
   Sabeti, Pardis C.
TI Zika virus evolution and spread in the Americas
SO NATURE
LA English
DT Article
ID EBOLA; TRANSMISSION; PERFORMANCE; ACCURACY; DATABASE; MODELS
AB Although the recent Zika virus (ZIKV) epidemic in the Americas and its link to birth defects have attracted a great deal of attention(1,2), much remains unknown about ZIKV disease epidemiology and ZIKV evolution, in part owing to a lack of genomic data. Here we address this gap in knowledge by using multiple sequencing approaches to generate 110 ZIKV genomes from clinical and mosquito samples from 10 countries and territories, greatly expanding the observed viral genetic diversity from this outbreak. We analysed the timing and patterns of introductions into distinct geographic regions; our phylogenetic evidence suggests rapid expansion of the outbreak in Brazil and multiple introductions of outbreak strains into Puerto Rico, Honduras, Colombia, other Caribbean islands, and the continental United States. We find that ZIKV circulated undetected in multiple regions for many months before the first locally transmitted cases were confirmed, highlighting the importance of surveillance of viral infections. We identify mutations with possible functional implications for ZIKV biology and pathogenesis, as well as those that might be relevant to the effectiveness of diagnostic tests.
C1 [Metsky, Hayden C.; Matranga, Christian B.; Wohl, Shirlee; Schaffner, Stephen F.; Freije, Catherine A.; Winnicki, Sarah M.; West, Kendra; Qu, James; Baniecki, Mary Lynn; Gladden-Young, Adrianne; Lin, Aaron E.; Tomkins-Tinch, Christopher H.; Ye, Simon H.; Park, Daniel J.; Luo, Cynthia Y.; Barnes, Kayla G.; Shah, Rickey R.; Chak, Bridget; Gnirke, Andreas; Yozwiak, Nathan L.; MacInnis, Bronwyn L.; Sabeti, Pardis C.] Broad Inst MIT & Harvard, Cambridge, MA USA.
   [Metsky, Hayden C.] MIT, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Wohl, Shirlee; Schaffner, Stephen F.; Freije, Catherine A.; Lin, Aaron E.; Luo, Cynthia Y.; Barnes, Kayla G.; Chak, Bridget; Yozwiak, Nathan L.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.
   [Schaffner, Stephen F.; Barnes, Kayla G.; Valim, Clarissa; MacInnis, Bronwyn L.; Sabeti, Pardis C.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Ye, Simon H.] MIT, Harvard Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Shah, Rickey R.] Harvard Univ, Extens Sch, Cambridge, MA 02138 USA.
   [Barbosa-Lima, Giselle; Vieira, Yasmine R.; Cerbino-Neto, Jose; Bozza, Fernando A.] Fdn Oswaldo Cruz FIOCRUZ, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil.
   [Delatorre, Edson] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil.
   [Paul, Lauren M.; Tan, Amanda L.; Barcellona, Carolyn M.; Isern, Sharon; Michael, Scott F.] Florida Gulf Coast Univ, Coll Arts & Sci, Dept Biol Sci, Ft Myers, FL USA.
   [Porcelli, Mario C.; Vasquez, Chalmers] Miami Dade Cty Mosquito Control, Miami, FL USA.
   [Cannons, Andrew C.; Cone, Marshall R.; Hogan, Kelly N.; Kopp, Edgar W.] Bur Publ Hlth Labs, Div Dis Control & Hlth Protect, Florida Dept Hlth, Tampa, FL USA.
   [Anzinger, Joshua J.] Univ West Indies, Dept Microbiol, Kingston, Jamaica.
   [Garcia, Kimberly F.; Parham, Leda A.; Lorenzana, Ivette] Univ Nacl Autonoma Honduras, Inst Invest Microbiol, Tegucigalpa, Honduras.
   [Gelvez Ramirez, Rosa M.; Miranda Montoya, Maria C.; Villar, Luis] Univ Ind Santander, Grp Epidemiol Clin, Bucaramanga, Colombia.
   [Rojas, Diana P.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [Brown, Catherine M.; Hennigan, Scott; Sabina, Brandon; Scotland, Sarah; Smole, Sandra] Massachusetts Dept Publ Hlth, Jamaica, NY USA.
   [Gangavarapu, Karthik; Grubaugh, Nathan D.; Robles-Sikisaka, Refugio; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Oliveira, Glenn; Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA USA.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Gehrke, Lee; Bosch, Irene] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Mattar, Salim] Univ Cordoba, Inst Trop Biol Res, Monteria, Cordoba, Colombia.
   [Valim, Clarissa] Michigan State Univ, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA.
   [Degrave, Wim] Fiocruz MS, Inst Oswaldo Cruz, Lab Genem Func & Bioinformat, Rio De Janeiro, Brazil.
   [Bozza, Patricia T.] Inst Oswaldo Cruz, Fdn Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil.
   [Andersen, Kristian G.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
   [Bozza, Fernando A.] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Souza, Thiago M. L.] Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis, Rio De Janeiro, Brazil.
   [Souza, Thiago M. L.] Fiocruz MS, Ctr Technol Dev Hlth, Rio De Janeiro, Brazil.
   [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP MacInnis, BL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; MacInnis, BL (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Souza, TML (corresponding author), Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis, Rio De Janeiro, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth, Rio De Janeiro, Brazil.
EM tmoreno@cdts.fiocruz.br; bronwyn@broadinstitute.org
RI Souza, Thiago Moreno L./G-2900-2012; Rambaut, Andrew/B-2481-2009;
   Schaffner, Stephen F/D-1189-2011; Delatorre, Edson/J-8330-2015; Rojas,
   Diana Patricia/AAC-2469-2019; Bozza, Fernando A/A-2618-2013; Neto, Jose
   Cerbino/P-3713-2018
OI Souza, Thiago Moreno L./0000-0003-2212-3899; Rambaut,
   Andrew/0000-0003-4337-3707; Delatorre, Edson/0000-0002-5746-0820; Rojas,
   Diana Patricia/0000-0003-0241-6416; Bozza, Fernando
   A/0000-0003-4878-0256; Neto, Jose Cerbino/0000-0001-9254-917X;
   Tomkins-Tinch, Christopher/0000-0002-9114-6421; Lin,
   Aaron/0000-0001-7400-4125; Grubaugh, Nathan/0000-0003-2031-1933; Rambaut
   FRSE, Professor Andrew/0000-0002-1278-598X; Bozza,
   Patricia/0000-0001-8349-9529; Paul, Lauren/0000-0001-5503-7570; Metsky,
   Hayden/0000-0002-8871-2349; Shah, Rickey/0000-0002-3231-0367
FU Marc and Lynne Benioff; NIH NIAIDUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI110818,
   1R01AI099210, AI100190, HHSN272201400048C]; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute; Harvard University Burke
   Global Health Fellowship; Broad Institute BroadNext10 program; AWS Cloud
   Credits for Research; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq) [440909/2016-3]; Fundacao de Amparo a Pesquisa do Estado do Rio
   de JaneiroCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E 26/201.320/2016, E 26/201.332/2016,
   E 26/010.000194/2015]; MIDAS National Institute of General Medical
   Sciences [U54GM111274]; AEDES Network; Colombian Science, Technology and
   Innovation Fund of Sistema General de Regalias-BPIN [2013000100011];
   ASTMH Shope Fellowship; NSF DGENational Science Foundation (NSF)NSF-
   Directorate for Education & Human Resources (EHR) [1144152]; PNPD/CAPES
   Postdoctoral Fellowship; Fulbright Colciencias Doctoral Scholarship;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244 33]; EUEuropean Union
   (EU) [278433 PREDEMICS, 643476 COMPARE]; NIH NCATS CTSAUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001114]; Ray Thomas Foundation; Pew Biomedical Scholarship
FX We thank M. and L. Benioff for their vision and support; L. Brown, E.
   Lee, M. Giovanni, J. LevinAllerhand and E. S. Lander for support and
   guidance; M. Schleicher, E. Lipscomb, A. Felix, A. Saltzman, and S.
   Donnelly for assistance with IRB and ethics processes; E. Mair, L.
   Nogelo and E. Carmean for legal counsel; T. Mason and the Broad
   Institute Genomics Platform for sequencing support; A. Matthews, S.
   Chapman, D. Neafsey, and B. Birren for management and guidance; O. Pybus
   and ZiBRA Project colleagues for sharing data before publication; D.
   Olson, E. Asturias, M. Salit, and E. Simon-Loriere for sharing samples
   and reagents; and E. Holmes, G. Bello, R. Tewhey, A. Piantadosi, C.
   Edwards and the Sabeti Laboratory for discussions and reading of the
   manuscript. We are indebted to Zika patients and clinical teams for
   making this work possible. Funding was provided by: Marc and Lynne
   Benioff (P. C. S.); NIH NIAID U19AI110818 (Broad Institute); Howard
   Hughes Medical Institute (P. C. S.); Harvard University Burke Global
   Health Fellowship (P. C. S.); Broad Institute BroadNext10 program (A. G.
   and P. C. S.); AWS Cloud Credits for Research (P. C. S.); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (440909/2016-3) and
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (E
   26/201.320/2016, E 26/201.332/2016, E 26/010.000194/2015) (P. T. B. and
   F. A. B.); NIH NIAID 1R01AI099210 (S. I. and S. F. M.); MIDAS National
   Institute of General Medical Sciences U54GM111274 (M. E. H. and D. P.
   R.); NIH NIAID AI100190 (I. B. and L. G.); AEDES Network (I. B.) and
   Colombian Science, Technology and Innovation Fund of Sistema General de
   Regalias-BPIN 2013000100011 (L. V., R. M. G. R., M. C. M. M., and I.
   B.); ASTMH Shope Fellowship (K. G. B.); NSF DGE 1144152 (A. E. L.);
   PNPD/CAPES Postdoctoral Fellowship (E. D.); Fulbright Colciencias
   Doctoral Scholarship (D. P. R.); NIH training grant 5T32AI007244 33 (N.
   D. G.); EU under grant agreements 278433 PREDEMICS and 643476 COMPARE
   (A. R.); and NIH NCATS CTSA UL1TR001114, NIH NIAID contract
   HHSN272201400048C, The Ray Thomas Foundation, and Pew Biomedical
   Scholarship (K. G. A.).
CR Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290
   Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207
   Centers for Disease Control and Prevention, 2015, 1 CAS ZIK VIR REP PU
   Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276
   Corman VM, 2016, B WHO
   Cribari-Neto F, 2010, J STAT SOFTW, V34, P1
   de Vigilancia, 2016, PROTOCOLO VIGILANCIA
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duchene S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0312-6
   Faria N. R., 2017, NATURE
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Grubaugh N. D., 2017, NATURE
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429
   Josse J, 2016, J STAT SOFTW, V70
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882
   O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189
   Pan American Health Organization, 2017, ZIK EP REP DOM REP
   Pan American Health Organization, 2015, EP UPD ZIK VIR INF
   Pan American Health Organization, 2017, ZIK EP REP HOND
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Paz-Bailey G, 2017, N ENGL J MED
   Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e
   Pyke A. T., 2014, PLOS CURR
   Quick J., 2017, NAT PROTOCOLS
   R Core Team, 2016, R LANG ENV STAT COMP
   Rambaut A., 2014, FIGTREE VERSION 1 4
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sall AA, 2010, J VIROL, V84, P765, DOI 10.1128/JVI.01738-09
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tomkins-Tinch C., 2016, BROAD I VIRAL NGS V1
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   U. S. Food and Drug Administration, 2017, ZIK VIR RESP UPD FDA
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063496
   WHO, 2017, ZIK SIT REP ZIK VIR
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289
   Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001
NR 68
TC 134
Z9 141
U1 5
U2 66
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 15
PY 2017
VL 546
IS 7658
BP 411
EP +
DI 10.1038/nature22402
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5BK
UT WOS:000403250900036
PM 28538734
OA Green Published, Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Salinas, JL
   Major, CG
   Pastula, DM
   Dirlikov, E
   Styczynski, A
   Luciano, CA
   Wojna, V
   Sharp, TM
   Sejvar, JJ
   Rivera-Garcia, B
AF Salinas, Jorge L.
   Major, Chelsea G.
   Pastula, Daniel M.
   Dirlikov, Emilio
   Styczynski, Ashley
   Luciano, Carlos A.
   Wojna, Valerie
   Sharp, Tyler M.
   Sejvar, James J.
   Rivera-Garcia, Brenda
TI Incidence and clinical characteristics of Guillain-Barre syndrome before
   the introduction of Zika virus in Puerto Rico
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Guillain-Barre syndrome; Incidence; Puerto Rico; Intravenous
   immunoglobulin; Polyneuropathy
ID PUBLIC-HEALTH SURVEILLANCE; INFECTION; EPIDEMIOLOGY; TRANSMISSION; CARE
AB Background: Zika virus has been associated with increases in Guillain-Barre syndrome (GBS) incidence. A GBS incidence estimation and clinical description was performed to assess baseline GBS epidemiology before the introduction of Zika virus in Puerto Rico.
   Methods: Hospitalization administrative data from an island-wide insurance claims database and U.S. Census Bureau population estimates provided a crude GBS incidence for 2013. This estimate was adjusted using the proportion of GBS cases meeting Brighton criteria for confirmed GBS from nine reference hospitals. Characteristics of confirmed GBS cases in the same nine hospitals during 2012-2015 are described.
   Results: A total of 136 GBS hospitalization claims were filed in 2013 (crude GBS incidence was 3.8 per 100,000 population). The adjusted GBS incidence was 1.7 per 100,000 population. Of 67 confirmed GBS cases during 2012-2015, 66% had an antecedent illness. Median time from antecedent illness to GBS onset was 7 days. Most cases (67%) occurred during July September.
   Conclusions: Puerto Rico's GBS incidence for 2013 was estimated using a combination of administrative data and medical records review; this method could be employed in other regions to monitor GBS incidence before and after the introduction of GBS infectious triggers. Published by Elsevier B.V.
C1 [Salinas, Jorge L.; Dirlikov, Emilio; Styczynski, Ashley] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Major, Chelsea G.] CDC, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Pastula, Daniel M.; Sharp, Tyler M.; Sejvar, James J.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Pastula, Daniel M.] Univ Colorado Denver, Aurora, CO USA.
   [Dirlikov, Emilio; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Luciano, Carlos A.; Wojna, Valerie] Univ Puerto Rico, San Juan, PR 00936 USA.
RP Salinas, JL (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-10, Atlanta, GA 30333 USA.
EM jsalinas@cdc.gov
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459; Wojna,
   Valerie/0000-0002-4014-9921; Dirlikov, Emilio/0000-0003-4631-2643
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; Puerto Rico Department of Health
FX We thank Marrielle Mayshack from CDC for contributions to coordination
   and logistics. We also thank Jonathan Morales Gonzalez and Eddy Sanchez
   Hernandez from the Puerto Rico Department of Health for providing data
   from the Puerto Rico Health Study. We thank hospital leadership, medical
   records personnel, and infection control epidemiologists at the
   hospitals that assisted with this investigation (University District
   Hospital, Hospital Pediatrico Universitario, HIMA-San Pablo Caguas,
   HIMA-San Pablo Bayamon, University of Puerto Rico Hospital - Dr.
   Federico Trilla, Manati Medical Center, Mayaguez Medical Center, Damas
   Hospital, and Hospital Episcopal San Lucas Ponce). This study was funded
   by CDC and the Puerto Rico Department of Health. The findings and
   conclusions in this report are those of the authors and do not
   necessarily represent the official position of the Centers for Disease
   Control and Prevention.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bogliun G, 2002, NEUROL SCI, V23, P113, DOI 10.1007/s100720200036
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Departamento de Salud de Puerto Rico, 2014, RES GEN SAL PUERT RI
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Ellis EM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004939
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6
   KOOBATIAN TJ, 1991, ANN NEUROL, V30, P618, DOI 10.1002/ana.410300418
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Louis VR, 2005, APPL ENVIRON MICROB, V71, P85, DOI 10.1128/AEM.71.1.85-92.2005
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Suryapranata FST, 2016, AM J TROP MED HYG, V94, P1380, DOI 10.4269/ajtmh.15-0070
   van Koningsveld R, 2001, NEUROLOGY, V56, P1467, DOI 10.1212/WNL.56.11.1467
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 24
TC 7
Z9 7
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JUN 15
PY 2017
VL 377
BP 102
EP 106
DI 10.1016/j.jns.2017.04.006
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EV6KT
UT WOS:000401879000021
PM 28477675
DA 2020-07-08
ER

PT J
AU Monel, B
   Compton, AA
   Bruel, T
   Amraoui, S
   Burlaud-Gaillard, J
   Roy, N
   Guivel-Benhassine, F
   Porrot, F
   Genin, P
   Meertens, L
   Sinigaglia, L
   Jouvenet, N
   Weil, R
   Casartelli, N
   Demangel, C
   Simon-Loriere, E
   Moris, A
   Roingeard, P
   Amara, A
   Schwartz, O
AF Monel, Blandine
   Compton, Alex A.
   Bruel, Timothee
   Amraoui, Sonia
   Burlaud-Gaillard, Julien
   Roy, Nicolas
   Guivel-Benhassine, Florence
   Porrot, Francoise
   Genin, Pierre
   Meertens, Laurent
   Sinigaglia, Laura
   Jouvenet, Nolwenn
   Weil, Robert
   Casartelli, Nicoletta
   Demangel, Caroline
   Simon-Loriere, Etienne
   Moris, Arnaud
   Roingeard, Philippe
   Amara, Ali
   Schwartz, Olivier
TI Zika virus induces massive cytoplasmic vacuolization and paraptosis-like
   death in infected cells
SO EMBO JOURNAL
LA English
DT Article
DE cell death; cytopathic effect; IFITM; paraptosis; ZIKA virus
ID WEST-NILE-VIRUS; UNFOLDED PROTEIN RESPONSE; IFITM PROTEINS;
   ENDOPLASMIC-RETICULUM; INHIBITOR; INFLUENZA; AUTOPHAGY; MODEL;
   TRANSLOCATION; TRAFFICKING
AB The cytopathic effects of Zika virus (ZIKV) are poorly characterized. Innate immunity controls ZIKV infection and disease in most infected patients through mechanisms that remain to be understood. Here, we studied the morphological cellular changes induced by ZIKV and addressed the role of interferon-induced transmembrane proteins (IFITM), a family of broad-spectrum antiviral factors, during viral replication. We report that ZIKV induces massive vacuolization followed by "implosive" cell death in human epithelial cells, primary skin fibroblasts and astrocytes, a phenomenon which is exacerbated when IFITM3 levels are low. It is reminiscent of paraptosis, a caspase-independent, non-apoptotic form of cell death associated with the formation of large cytoplasmic vacuoles. We further show that ZIKV-induced vacuoles are derived from the endoplasmic reticulum (ER) and dependent on the PI3K/Akt signaling axis. Inhibiting the Sec61 ER translocon in ZIKV-infected cells blocked vacuole formation and viral production. Our results provide mechanistic insight behind the ZIKV-induced cytopathic effect and indicate that IFITM3, by acting as a gatekeeper for incoming virus, restricts virus takeover of the ER and subsequent cell death.
C1 [Monel, Blandine; Compton, Alex A.; Bruel, Timothee; Amraoui, Sonia; Roy, Nicolas; Guivel-Benhassine, Florence; Porrot, Francoise; Casartelli, Nicoletta; Schwartz, Olivier] Inst Pasteur, Virus & Immun Unit, Paris, France.
   [Burlaud-Gaillard, Julien; Roingeard, Philippe] Univ Tours, INSERM, U966, Paris, France.
   [Burlaud-Gaillard, Julien; Roingeard, Philippe] Univ Tours, Platefome IBiSA Microscopie Elect, Paris, France.
   [Burlaud-Gaillard, Julien; Roingeard, Philippe] CHRU Tours, Paris, France.
   [Genin, Pierre; Weil, Robert] Inst Pasteur, Signaling & Pathogenesis Lab, Paris, France.
   [Genin, Pierre; Weil, Robert] Inst Pasteur, CNRS, UMR3691, Paris, France.
   [Meertens, Laurent; Amara, Ali] Hop St Louis, INSERM U944, CNRS Lab Pathol & Virol Mol 7212, Inst Univ Hematol, Paris, France.
   [Sinigaglia, Laura; Jouvenet, Nolwenn] Inst Pasteur, Viral Genom & Vaccinat Unit, Paris, France.
   [Sinigaglia, Laura; Jouvenet, Nolwenn; Schwartz, Olivier] UMR CNRS 3569, Paris, France.
   [Demangel, Caroline] Inst Pasteur, Immunobiol Infect Unit, Paris, France.
   [Simon-Loriere, Etienne] Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France.
   [Simon-Loriere, Etienne] CNRS URA 3012, Paris, France.
   [Moris, Arnaud] UPMC Univ Paris 06, Sorbonne Univ, INSERM U1135, Ctr Immunol & Microbial Infect CIMI Paris,CNRS ER, Paris, France.
RP Compton, AA; Schwartz, O (corresponding author), Inst Pasteur, Virus & Immun Unit, Paris, France.; Schwartz, O (corresponding author), UMR CNRS 3569, Paris, France.
EM alex.compton@pasteur.fr; schwartz@pasteur.fr
RI Demangel, Caroline/H-9570-2014; Meertens, Laurent/E-8043-2017; jouvenet,
   nolwenn/K-2067-2019; Amara, Ali/E-8803-2017; Bruel,
   Timothee/AAI-4632-2020
OI Demangel, Caroline/0000-0001-7848-586X; Meertens,
   Laurent/0000-0003-2811-3675; jouvenet, nolwenn/0000-0001-6103-6048;
   SCHWARTZ, OLIVIER/0000-0002-0729-1475; , Etienne/0000-0001-8420-7743;
   Compton, Alex/0000-0002-7508-4953; AMARA, Ali/0000-0002-0283-1815;
   Moris, Arnaud/0000-0002-5052-1678; Bruel, Timothee/0000-0002-3952-4261
FU Pasteur Foundation; ANRSANRSFrench National Research Agency (ANR);
   CHIKV-Viro-Immuno project [ANR-14-CE14-0015-01]; TIMTAMDEN project
   [ANR-14-CE14-0029]; Labex IBEID program [ANR-10-IHUB-0002]; Labex VRI
   program [ANR-10-LABX-77]; Institut Pasteur
FX We thank members of the Virus & Immunity Unit for discussions. AC was
   supported from postdoctoral fellowships from the Pasteur Foundation and
   ANRS. Work was supported by grants from the "CHIKV-Viro-Immuno"
   ANR-14-CE14-0015-01 and "TIMTAMDEN" ANR-14-CE14-0029 projects, the Labex
   IBEID program ANR-10-IHUB-0002, the Labex VRI program ANR-10-LABX-77 and
   Institut Pasteur<SUP>dagger</SUP>. We thank Van-Mai Cao-Lormeau,
   Institut Louis Malarde (French Polynesia) and Myrielle Dupont-Rouzeyrol
   (Institut Pasteur Nouvelle Caledonie) for the gift of reagents. We thank
   Stephane Petres (Institut Pasteur) for preparation of the 4G2 antibody
   and the Imagopole (Institut Pasteur) for help in image acquisition.
CR Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baron L, 2016, J EXP MED, V213, P2885, DOI 10.1084/jem.20160662
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blanchard E, 2015, CELL MICROBIOL, V17, P45, DOI 10.1111/cmi.12372
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0
   Compton AA, 2016, EMBO REP, V17, P1657, DOI 10.15252/embr.201642771
   Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001
   Coulon PG, 2016, J IMMUNOL, V197, P517, DOI 10.4049/jimmunol.1600286
   Danthi P, 2015, ANNU REV VIROL, V3, P1
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Fu XL, 2014, BIOFACTORS, V40, P569, DOI 10.1002/biof.1194
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   Guenin-Mace L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0458
   Hall BS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004061
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Huang YH, 2015, FISH SHELLFISH IMMUN, V43, P241, DOI 10.1016/j.fsi.2014.12.031
   Hussain KM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21406
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262
   Kalies KU, 2015, TRAFFIC, V16, P1027, DOI 10.1111/tra.12308
   Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee D, 2016, PHARMACOL THERAPEUT, V162, P120, DOI 10.1016/j.pharmthera.2016.01.003
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McKenna M, 2016, J CELL SCI, V129, P1404, DOI 10.1242/jcs.182352
   Medina FA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003468
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ram BM, 2014, BBA-MOL CELL RES, V1843, P2497, DOI 10.1016/j.bbamcr.2014.06.020
   Ranjan A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122068
   Ravindran MS, 2016, NAT REV MICROBIOL, V14, P407, DOI 10.1038/nrmicro.2016.60
   Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465
   Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376
   Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000
   Suwanmanee S, 2017, VIRAL IMMUNOL, V30, P13, DOI 10.1089/vim.2016.0092
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343
   Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433
   Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339
NR 75
TC 46
Z9 46
U1 2
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUN 14
PY 2017
VL 36
IS 12
BP 1653
EP 1668
DI 10.15252/embj.201695597
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EX5JH
UT WOS:000403276700004
PM 28473450
OA Green Published
DA 2020-07-08
ER

PT J
AU Mattar, S
   Ojeda, C
   Arboleda, J
   Arrieta, G
   Bosch, I
   Botia, I
   Alvis-Guzman, N
   Perez-Yepes, C
   Gerhke, L
   Montero, G
AF Mattar, Salim
   Ojeda, Carolina
   Arboleda, Janna
   Arrieta, German
   Bosch, Irene
   Botia, Ingrid
   Alvis-Guzman, Nelson
   Perez-Yepes, Carlos
   Gerhke, Lee
   Montero, German
TI Case report: microcephaly associated with Zika virus infection, Colombia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Microcephaly; Colombia; Central nervous system vascular
   malformations; Pediatrics
ID PREGNANCY; EPIDEMIC
AB Background: Recently there has been a large outbreak of Zika virus infections in Colombia, South America. The epidemic began in September 2015 and continued to April 2017, for the total number of Zika cases reported of 107,870. For those confirmed Zika cases, there were nearly 20,000 (18.5%) suspected to be pregnant women, resulting in 157 confirmed cases of microcephaly in newborns reported by their health government agency. There is a clear under-estimation of the total number of cases and in addition no prior publications have been published to demonstrate the clinical aspects of the Zika infection in Colombia. We characterized one Zika presentation to be able to compare and contrast with other cases of Zika infection already reported in the literature.
   Case presentation: In this case report, we demonstrate congenital microcephaly at week 19 of gestation in a 34-year-old mother who showed symptoms compatible with Zika virus infection from Sincelejo, State of Sucre, in the Colombian Caribbean. Zika virus RNA was detected in the placenta using real-time reverse transcriptase polymerase chain reaction (RT-PCR). At week 25, the fetus weigh estimate was 770 g, had a cephalic perimeter of 20.2 cm (5th percentile), ventriculomegaly on the right side and dilatation of the fourth ventricle. At week 32, the microcephaly was confirmed with a cephalic perimeter of 22 cm, dilatation of the posterior atrium to 13 mm, an abnormally small cerebellum (29 mm), and an augmented cisterna magna. At birth (39 weeks by cesarean section), the head circumference was 27.5 cm, and computerized axial tomography (Siemens Corp, 32-slides) confirmed microcephaly with calcifications.
   Conclusion: We report a first case of maternal Zika virus infection associated with fetal microcephaly in Colombia and confirmed similar presentation to those observed previous in Brazil, 2015-2016.
C1 [Mattar, Salim; Arrieta, German] Univ Cordoba, Inst Invest Biol Trop, Monteria, Colombia.
   [Mattar, Salim; Ojeda, Carolina; Arboleda, Janna; Arrieta, German; Botia, Ingrid; Montero, German] Clin Salud Social, Sincelejo, Colombia.
   [Arrieta, German] Corp Univ Caribe, Publ Hlth Grp, CECAR, Sincelejo, Colombia.
   [Bosch, Irene; Gerhke, Lee] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Alvis-Guzman, Nelson] Univ Cartagena, Hlth Econ Grp, Cartagena, Colombia.
   [Perez-Yepes, Carlos] Clin IMAT, Monteria, Colombia.
RP Mattar, S (corresponding author), Univ Cordoba, Inst Invest Biol Trop, Monteria, Colombia.; Mattar, S (corresponding author), Clin Salud Social, Sincelejo, Colombia.
EM mattarsalim@hotmail.com
RI Alvis-Guzman, Nelson/D-4913-2013
OI Alvis-Guzman, Nelson/0000-0001-9458-864X; MATTAR,
   SALIM/0000-0003-0526-4630
FU University of Cordoba
FX To James Norman Mills, Ph. D and Ricardo J. Soares Magalhaes, for the
   style corrections and suggestions to improve the manuscript. To
   University of Cordoba, Investigation department for supporting the IIBT
   research group.
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GC, 2016, BRAZ J INFECT DIS, V20, P227, DOI 10.1016/j.bjid.2016.05.001
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Instituto Nacional de Salud, 2016, B EP SEM SEM EP, V52
   Instituto Nacional de Salud (Colombia), 2017, SEM EP
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 12
TC 9
Z9 9
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUN 13
PY 2017
VL 17
AR 423
DI 10.1186/s12879-017-2522-6
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EY0AO
UT WOS:000403620800004
PM 28610628
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nascimento, OJM
   Frontera, JA
   Amitrano, DA
   de Filippis, AMB
   Da Silva, IRF
AF Nascimento, Osvaldo J. M.
   Frontera, Jennifer A.
   Amitrano, Daniel A.
   de Filippis, Ana M. Bispo
   Da Silva, Ivan R. F.
CA RIO-GBS-ZIKV Res Grp
TI ZIKA VIRUS INFECTION-ASSOCIATED ACUTE TRANSIENT POLYNEURITIS
SO NEUROLOGY
LA English
DT Editorial Material
ID GUILLAIN-BARRE-SYNDROME
C1 [Nascimento, Osvaldo J. M.; Amitrano, Daniel A.] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Frontera, Jennifer A.] Cleveland Clin, Cerebrovasc Ctr Neurol Inst, Cleveland, OH 44106 USA.
   [de Filippis, Ana M. Bispo] Fundacao Oswaldo Cruz, Flavivirus Lab, Rio De Janeiro, Brazil.
   [Da Silva, Ivan R. F.] Rush Univ, Med Ctr, Chicago, IL 60612 USA.
RP Nascimento, OJM (corresponding author), Univ Fed Fluminense, Niteroi, RJ, Brazil.
EM osvaldo_nascimento@hotmail.com
FU Cleveland Clinic Foundation [RPC194-S2]
FX This study was funded by the Cleveland Clinic Foundation, award
   RPC194-S2.
CR Brizzi KT, 2014, NEUROHOSPITALIST, V4, P230, DOI 10.1177/1941874414535215
   Gupta Deepak, 2008, J Clin Neuromuscul Dis, V10, P42, DOI 10.1097/CND.0b013e31818e9510
   Kushnir M, 2008, ACTA NEUROL SCAND, V117, P347, DOI 10.1111/j.1600-0404.2007.00949.x
   Nascimento OJM, 2013, ARQ NEURO-PSIQUIAT, V71, P661, DOI 10.1590/0004-282X20130146
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 7
TC 11
Z9 13
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JUN 13
PY 2017
VL 88
IS 24
BP 2330
EP 2332
DI 10.1212/WNL.0000000000004026
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA EX2HG
UT WOS:000403046300017
PM 28500225
OA Bronze
DA 2020-07-08
ER

PT J
AU Duchemin, JB
   Mee, PT
   Lynch, SE
   Vedururu, R
   Trinidad, L
   Paradkar, P
AF Duchemin, Jean-Bernard
   Mee, Peter T.
   Lynch, Stacey E.
   Vedururu, Ravikiran
   Trinidad, Lee
   Paradkar, Prasad
TI Zika vector transmission risk in temperate Australia: a vector
   competence study
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Vector competence; Aedes aegypti; Aedes albopictus; Culex
   quinquefasciatus; Aedes notoscriptus; Australia; Invasive
ID AEDES-NOTOSCRIPTUS DIPTERA; ROSS-RIVER; POTENTIAL VECTOR; DENGUE VIRUS;
   MOSQUITOS; FEVER; WOLBACHIA; CULICIDAE; QUEENSLAND; ARBOVIRUS
AB Background: Zika virus is an emerging pathogen of global importance. It has been responsible for recent outbreaks in the Americas and in the Pacific region. This study assessed five different mosquito species from the temperate climatic zone in Australia and included Aedes albopictus as a potentially invasive species.
   Methods: Mosquitoes were orally challenged by membrane feeding with Zika virus strain of Cambodia 2010 origin, belonging to the Asian clade. Virus infection and dissemination were assessed by quantitative PCR on midgut and carcass after dissection. Transmission was assessed by determination of cytopathogenic effect of saliva (CPE) on Vero cells, followed by determination of 50% tissue culture infectious dose (TCID50) for CPE positive samples. Additionally, the presence of Wolbachia endosymbiont infection was assessed by qPCR and standard PCR.
   Results: Culex mosquitoes were found unable to present Zika virus in saliva, as demonstrated by molecular as well as virological methods. Aedes aegypti, was used as a positive control for Zika infection and showed a high level of virus infection, dissemination and transmission. Local Aedes species, Ae. notoscriptus and, to a lesser degree, Ae. camptorhynchus were found to expel virus in their saliva and contained viral nucleic acid within the midgut. Molecular assessment identified low or no dissemination for these species, possibly due to low virus loads. Ae. albopictus from Torres Strait islands origin was shown as an efficient vector. Cx quinquefasciatus was shown to harbour Wolbachia endosymbionts at high prevalence, whilst no Wolbachia was found in Cx annulirostris. The Australian Ae. albopictus population was shown to harbour Wolbachia at high frequency.
   Conclusions: The risk of local Aedes species triggering large Zika epidemics in the southern parts of Australia is low. The potentially invasive Ae. albopictus showed high prevalence of virus in the saliva and constitutes a potential threat if this mosquito species becomes established in mainland Australia. Complete risk analysis of Zika transmission in the temperate zone would require an assessment of the impact of temperature on Zika virus replication within local and invasive mosquito species.
C1 [Duchemin, Jean-Bernard; Mee, Peter T.; Vedururu, Ravikiran; Trinidad, Lee; Paradkar, Prasad] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, 5 Portarlington Rd, Geelong, Vic 3220, Australia.
   [Lynch, Stacey E.] Ctr AgriBiosci, AgriBio, Agr Victoria, BioSci Res, 5 Ring Rd,La Trobe Univ Campus, Bundoora, Vic 3083, Australia.
   [Vedururu, Ravikiran] RMIT Univ, Sch Appl Sci, Bundoora, Vic 3083, Australia.
RP Paradkar, P (corresponding author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, 5 Portarlington Rd, Geelong, Vic 3220, Australia.
EM Prasad.Paradkar@csiro.au
RI Duchemin, Jean-Bernard/AAE-8077-2020; Mee, Peter/AAP-4198-2020;
   Duchemin, Jean-Bernard/D-7000-2011
OI Duchemin, Jean-Bernard/0000-0001-5044-4855; Duchemin,
   Jean-Bernard/0000-0001-5044-4855; Vedururu,
   Ravikiran/0000-0002-8816-1807
FU CSIROCommonwealth Scientific & Industrial Research Organisation (CSIRO);
   Victorian Department of Health
FX Funding was obtained from CSIRO for laboratory work and Victorian
   Department of Health for mosquito collection.
CR Amraoui F, 2016, EURO SURVEILL, V21
   Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   BALLARD JWO, 1986, AUST J EXP BIOL MED, V64, P197, DOI 10.1038/icb.1986.21
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Dhileepan K, 1996, J MED ENTOMOL, V33, P180, DOI 10.1093/jmedent/33.1.180
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DOBROTWORSKY NV, 1965, MOSQUITOES VICTORIA
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Duschinka RD, 2016, ZIKA VIRUS REPLICATI
   Endersby NM, 2013, INFECT GENET EVOL, V18, P191, DOI 10.1016/j.meegid.2013.04.035
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hemmerter S, 2009, MOL PHYLOGENET EVOL, V50, P317, DOI 10.1016/j.ympev.2008.11.016
   Jansen CC, 2008, VECTOR-BORNE ZOONOT, V8, P805, DOI 10.1089/vbz.2008.0037
   Johnston E, 2014, J VECTOR ECOL, V39, P48, DOI 10.1111/j.1948-7134.2014.12069.x
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kay BH, 2007, AM J TROP MED HYG, V76, P417, DOI 10.4269/ajtmh.2007.76.417
   Knope KE, 2016, COMMUN DIS INTELL, V40, pE17
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCDONALD G, 1977, Journal of the Australian Entomological Society, V16, P353
   Mee PT, 2015, APPL ENVIRON MICROB, V81, P6177, DOI 10.1128/AEM.01239-15
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paradkar PN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005143
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Peterson AT, 2015, J VECTOR ECOL, V40, P191, DOI 10.1111/jvec.12151
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100
   RUSSELL RC, 1977, AUST J EXP BIOL MED, V55, P649, DOI 10.1038/icb.1977.64
   Russell RC, 2012, J AM MOSQUITO CONTR, V28, P24, DOI 10.2987/8756-971X-28.4s.24
   Skelton E, 2016, J MED ENTOMOL, V53, P401, DOI 10.1093/jme/tjv235
   van den Hurk AF, 2011, AM J TROP MED HYG, V85, P446, DOI 10.4269/ajtmh.2011.11-0061
   Watson TM, 2000, J MED ENTOMOL, V37, P380, DOI 10.1603/0022-2585(2000)037[0380:ANDCSA]2.0.CO;2
   Watson TM, 1999, J MED ENTOMOL, V36, P508, DOI 10.1093/jmedent/36.4.508
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
NR 54
TC 32
Z9 32
U1 1
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUN 9
PY 2017
VL 14
AR 108
DI 10.1186/s12985-017-0772-y
PG 10
WC Virology
SC Virology
GA EX1OJ
UT WOS:000402993700002
PM 28599659
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wichit, S
   Hamel, R
   Bernard, E
   Talignani, L
   Diop, F
   Ferraris, P
   Liegeois, F
   Ekchariyawat, P
   Luplertlop, N
   Surasombatpattana, P
   Thomas, F
   Merits, A
   Choumet, V
   Roques, P
   Yssel, H
   Briant, L
   Misse, D
AF Wichit, Sineewanlaya
   Hamel, Rodolphe
   Bernard, Eric
   Talignani, Loic
   Diop, Fode
   Ferraris, Pauline
   Liegeois, Florian
   Ekchariyawat, Peeraya
   Luplertlop, Natthanej
   Surasombatpattana, Pornapat
   Thomas, Frederic
   Merits, Andres
   Choumet, Valerie
   Roques, Pierre
   Yssel, Hans
   Briant, Laurence
   Misse, Dorothee
TI Imipramine Inhibits Chikungunya Virus Replication in Human Skin
   Fibroblasts through Interference with Intracellular Cholesterol
   Trafficking
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MEMBRANE-FUSION; ENTRY REQUIRES; SEMLIKI-FOREST; INFECTION; TRANSPORT;
   OUTBREAK; REEMERGENCE; LIPIDS; NPC1
AB Chikungunya virus (CHIKV) is an emerging arbovirus of the Togaviridae family that poses a present worldwide threat to human in the absence of any licensed vaccine or antiviral treatment to control viral infection. Here, we show that compounds interfering with intracellular cholesterol transport have the capacity to inhibit CHIKV replication in human skin fibroblasts, a major viral entry site in the human host. Pretreatment of these cells with the class II cationic amphiphilic compound U18666A, or treatment with the FDA-approved antidepressant drug imipramine resulted in a near total inhibition of viral replication and production at the highest concentration used without any cytotoxic effects. Imipramine was found to affect both the fusion and replication steps of the viral life cycle. The key contribution of cholesterol availability to the CHIKV life cycle was validated further by the use of fibroblasts from Niemann-Pick type C (NPC) patients in which the virus was unable to replicate. Interestingly, imipramine also strongly inhibited the replication of several Flaviviridae family members, including Zika, West Nile and Dengue virus. Together, these data show that this compound is a potential drug candidate for anti-arboviral treatment.
C1 [Wichit, Sineewanlaya; Hamel, Rodolphe; Talignani, Loic; Misse, Dorothee] UMR 224 IRD CNRS UM1, Lab MIVEGEC, F-534394 Montpellier, France.
   [Bernard, Eric] CNRS UMR 5236 UM, Ctr Etude Agents Pathogenes & Biotechnol Sante, F-34293 Montpellier 5, France.
   [Ekchariyawat, Peeraya] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10400, Thailand.
   [Surasombatpattana, Pornapat] Prince Songkla Univ, Dept Pathol, Fac Med, Hat Yai 90110, Thailand.
   [Merits, Andres] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia.
   [Choumet, Valerie] Inst Pasteur, Environm & Infect Risks Unit, F-75015 Paris, France.
   [Roques, Pierre] Univ Paris Sud, Div Immuno Virol, CEA, IMETI, Orsay, France.
   [Roques, Pierre] UMR 1184, Ctr Immunol Viral Infect & Autoimmune Dis Inst, F-91190 Fontenay Aux Roses, France.
   [Yssel, Hans] Sorbonne Univ, Ctr Immunol & Malad Inf, INSERM, UPMC, F-75013 Paris, France.
RP Misse, D (corresponding author), UMR 224 IRD CNRS UM1, Lab MIVEGEC, F-534394 Montpellier, France.
EM dorothee.misse@ird.fr
RI Hamel, Rodolphe/AAG-1714-2020; Yssel, Hans/C-6406-2009; Florian,
   Liegeois/D-3798-2013; Merits, Andres/H-3125-2015; Ferraris,
   Pauline/F-9077-2017
OI Hamel, Rodolphe/0000-0001-8603-7039; Yssel, Hans/0000-0001-7454-1836;
   Florian, Liegeois/0000-0003-1048-0661; Merits,
   Andres/0000-0001-8193-0071; Ferraris, Pauline/0000-0002-8796-3074;
   THOMAS, Frederic/0000-0003-2238-1978
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-12-BSV3-0004-01, ANR-14-CE14-0029]; European Union's Horizon
   research and innovation programme under ZIKAlliance grant [734548];
   Infectiopole Sud foundation
FX This work was supported by grants from the Agence Nationale de la
   Recherche (grants ANR-12-BSV3-0004-01 and ANR-14-CE14-0029) and the
   European Union's Horizon 2020 research and innovation programme under
   ZIKAlliance grant agreement No. 734548. Sineewanlaya Wichit was
   supported by a fellowship from the Infectiopole Sud foundation.
CR Aboukhatwa M, 2011, J ALZHEIMERS DIS, V24, P221, DOI 10.3233/JAD-2011-101113
   Bernard E, 2015, VIROLOGY, V476, P1, DOI 10.1016/j.virol.2014.11.013
   Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Ekchariyawat P, 2015, INFECT GENET EVOL, V32, P401, DOI 10.1016/j.meegid.2015.03.025
   Enserink M, 2006, SCIENCE, V311, P1085, DOI 10.1126/science.311.5764.1085a
   Funk RS, 2012, MOL PHARMACEUT, V9, P1384, DOI 10.1021/mp200641e
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2
   Herbert AS, 2015, MBIO, V6, DOI 10.1128/mBio.00565-15
   Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15
   Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105
   Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7
   KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459
   Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050
   Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640
   LISCUM L, 1989, J BIOL CHEM, V264, P11796
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Pakkanen K, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046004
   PENTCHEV PG, 1994, BBA-MOL BASIS DIS, V1225, P235, DOI 10.1016/0925-4439(94)90001-9
   PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615
   Pierro A., 2015, New Microbes and New Infections, V7, P23, DOI 10.1016/j.nmni.2015.04.002
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Rudorfer MV, 1999, CELL MOL NEUROBIOL, V19, P373, DOI 10.1023/A:1006949816036
   Salvador B, 2009, VIROLOGY, V393, P33, DOI 10.1016/j.virol.2009.07.013
   SEXTON RC, 1983, BIOCHEMISTRY-US, V22, P5687, DOI 10.1021/bi00294a001
   Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265
   SIMIZU B, 1984, J VIROL, V51, P254, DOI 10.1128/JVI.51.1.254-258.1984
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09
   Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z
   Thaa B, 2015, J VIROL, V89, P11420, DOI 10.1128/JVI.01579-15
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Underwood KW, 1996, J LIPID RES, V37, P1556
   Utt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151616
   Utt A, 2015, J VIROL, V89, P3145, DOI 10.1128/JVI.03213-14
   Vanier MT, 2015, METHOD CELL BIOL, V126, P357, DOI 10.1016/bs.mcb.2014.10.028
   Varghese FS., 2016, ANTIMICROB AGENTS CH
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Wang W, 2009, ARCH VIROL, V154, P595, DOI 10.1007/s00705-009-0348-2
NR 55
TC 22
Z9 22
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 9
PY 2017
VL 7
AR 3145
DI 10.1038/s41598-017-03316-5
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX1CM
UT WOS:000402957400026
PM 28600536
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cunha-Neto, E
   Rosa, DS
   Harris, PE
   Olson, T
   Morrow, A
   Ciotlos, S
   Herst, CV
   Rubsamen, RM
AF Cunha-Neto, Edecio
   Rosa, Daniela S.
   Harris, Paul E.
   Olson, Tim
   Morrow, Alex
   Ciotlos, Serban
   Herst, Charles V.
   Rubsamen, Reid Martin
TI An Approach for a Synthetic CTL Vaccine Design against Zika Flavivrus
   Using Class I and Class II Epitopes Identified by Computer Modeling
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika vaccine; epitope; CTL vaccine; protein folding; dengue; flavivirus;
   computer model
ID CD4(+) T-CELLS; ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS;
   CROSS-REACTIVITY; DENDRITIC CELLS; INFECTION; IMMUNITY; PROTECTION;
   RESPONSES; MICE
AB The threat posed by severe congenital abnormalities related to Zika virus (ZKV) infection during pregnancy has turned development of a ZKV vaccine into an emergency. Recent work suggests that the cytotoxic T lymphocyte (CTL) response to infection is an important defense mechanism in response to ZKV. Here, we develop the rationale and strategy for a new approach to developing cytotoxic T lymphocyte (CTL) vaccines for ZKV flavivirus infection. The proposed approach is based on recent studies using a protein structure computer model for HIV epitope selection designed to select epitopes for CTL attack optimized for viruses that exhibit antigenic drift. Because naturally processed and presented human ZKV T cell epitopes have not yet been described, we identified predicted class I peptide sequences on ZKV matching previously identified DNV (Dengue) class I epitopes and by using a Major Histocompatibility Complex (MHC) binding prediction tool. A subset of those met the criteria for optimal CD8+ attack based on physical chemistry parameters determined by analysis of the ZKV protein structure encoded in open source Protein Data File (PDB) format files. We also identified candidate ZKV epitopes predicted to bind promiscuously to multiple HLA class II molecules that could provide help to the CTL responses. This work suggests that a CTL vaccine for ZKV may be possible even if ZKV exhibits significant antigenic drift. We have previously described a microsphere-based CTL vaccine platform capable of eliciting an immune response for class I epitopes in mice and are currently working toward in vivo testing of class I and class II epitope delivery directed against ZKV epitopes using the same microsphere-based vaccine.
C1 [Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Sao Paulo, Brazil.
   [Cunha-Neto, Edecio; Rosa, Daniela S.] Inst Invest Immunol III INCT, Sao Paulo, Brazil.
   [Cunha-Neto, Edecio] Univ Sao Paulo, Heart Inst Incor, Sch Med, Sao Paulo, Brazil.
   [Rosa, Daniela S.] Fed Univ Sao Paulo UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.
   [Harris, Paul E.] Columbia Univ, Dept Med, Sch Med, Endocrinol Div, New York, NY USA.
   [Olson, Tim; Morrow, Alex; Ciotlos, Serban; Herst, Charles V.; Rubsamen, Reid Martin] Flow Pharma Inc, Redwood City, CA 94063 USA.
   [Rubsamen, Reid Martin] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.
RP Rubsamen, RM (corresponding author), Flow Pharma Inc, Redwood City, CA 94063 USA.; Rubsamen, RM (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.
EM reidrubsamen@alum.mit.edu
RI Cunha-Neto, Edecio/B-4157-2009; Rosa, Daniela S/D-2190-2012
OI Cunha-Neto, Edecio/0000-0002-3699-3345; Rosa, Daniela
   S/0000-0003-4536-891X; HARRIS, PAUL/0000-0003-4806-8242
FU Flow Pharma, Inc.; CNPq (Brazilian National Scientific Council)National
   Council for Scientific and Technological Development (CNPq); FAPESP (Sao
   Paulo State Research Foundation)Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [13/50302-3]
FX The work described was funded in part by Flow Pharma, Inc. and through
   an in-kind grant of Azure platform cloud computer time by Microsoft
   Corporation which was used for class I epitope SE calculations. EC-N is
   supported by grants from CNPq (Brazilian National Scientific Council)
   and FAPESP (Sao Paulo State Research Foundation) 13/50302-3.
CR Abbas W, 2015, VIRUSES-BASEL, V7, P1578, DOI 10.3390/v7041578
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   [Anonymous], 2016, VACCINE PIPELINE TRA
   [Anonymous], 2016, UNIPROTKB SWISS PROT
   [Anonymous], 2013, RCSB PDB POLICIES RE
   Ashfaq UA, 2016, VIRAL IMMUNOL, V29, P436, DOI 10.1089/vim.2016.0033
   Aslan N, 2006, J VIRAL HEPATITIS, V13, P505, DOI 10.1111/j.1365-2893.2006.00723.x
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK VIR CAS COUNTS U
   Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519
   Connick E, 2014, J IMMUNOL, V193, P5613, DOI 10.4049/jimmunol.1401161
   De Groot AS, 2005, VACCINE, V23, P2136, DOI 10.1016/j.vaccine.2005.01.097
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Douek Daniel C., 2003, AIDS Reviews, V5, P172
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcia TCM, 2008, ACTA TROP, V106, P162, DOI 10.1016/j.actatropica.2008.03.003
   Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456
   IEDB, 2013, IEDB MHC I BINDING P
   Iwai LK, 2003, MOL MED, V9, P209, DOI 10.1007/BF03402131
   Jain S, 2011, EXPERT REV VACCINES, V10, P1731, DOI [10.1586/ERV.11.126, 10.1586/erv.11.126]
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005
   Kimata JT, 2016, CURR OPIN IMMUNOL, V42, P65, DOI 10.1016/j.coi.2016.05.015
   Kopycinski J, 2012, CLIN VACCINE IMMUNOL, V19, P1557, DOI 10.1128/CVI.00327-12
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700
   Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602
   Martin-Banderas L, 2005, SMALL, V1, P688, DOI 10.1002/smll.200500087
   Mothe B., 2013, DNA MVA PRIME BOOST
   Mullins J., 2013, REFOCUSING CTL ANTIB
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14
   Rademeyer C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005742
   Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072
   Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012
   Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0
   Rubsamen RM, 2014, VACCINE, V32, P4111, DOI 10.1016/j.vaccine.2014.05.071
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004854
   Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682
   Salvadori Luana de Cassia, 2014, Rev. Bras. Hematol. Hemoter., V36, P108, DOI 10.5581/1516-8484.20140026
   Sanchez-Burgos G, 2010, VIRUS RES, V153, P113, DOI 10.1016/j.virusres.2010.07.014
   Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517
   Schein CH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-40
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387
   Shawan M. M. A. K., 2014, INDIAN J PHARM BIOL, V2, P44
   Shi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131461
   Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165
   Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003
   Sridhar S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00195
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09
   Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555
   Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152
   Waeckerle-Men Y, 2006, VACCINE, V24, P1847, DOI 10.1016/j.vaccine.2005.10.032
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   WHITTON JL, 1993, J VIROL, V67, P348, DOI 10.1128/JVI.67.1.348-352.1993
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang Q, 2016, BIORXIV, DOI [10.1101/066456, DOI 10.1101/066456]
   Zika-Strain, 2014, COMPLETE CODING SEQU
NR 87
TC 6
Z9 7
U1 0
U2 23
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUN 9
PY 2017
VL 8
AR 640
DI 10.3389/fimmu.2017.00640
PG 12
WC Immunology
SC Immunology
GA EX0KT
UT WOS:000402910200001
PM 28649242
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU D'Angelo, DV
   von Essen, BS
   Lamias, MJ
   Shulman, H
   Hernandez-Virella, WI
   Taraporewalla, AJ
   Vargas, MI
   Harrison, L
   Ellington, SR
   Soto, L
   Williams, T
   Rodriguez, A
   Shapiro-Mendoza, CK
   Rivera, B
   Cox, S
   Pazol, K
   Rice, ME
   Dee, DL
   Romero, L
   Lathrop, E
   Barfield, W
   Smith, RA
   Jamieson, DJ
   Honein, MA
   Deseda, C
   Warner, L
AF D'Angelo, Denise V.
   von Essen, Beatriz Salvesen
   Lamias, Mark J.
   Shulman, Holly
   Hernandez-Virella, Wanda I.
   Taraporewalla, Aspy J.
   Vargas, Manuel I.
   Harrison, Leslie
   Ellington, Sascha R.
   Soto, Leslianne
   Williams, Tanya
   Rodriguez, Aurea
   Shapiro-Mendoza, Carrie K.
   Rivera, Brenda
   Cox, Shanna
   Pazol, Karen
   Rice, Marion E.
   Dee, Deborah L.
   Romero, Lisa
   Lathrop, Eva
   Barfield, Wanda
   Smith, Ruben A.
   Jamieson, Denise J.
   Honein, Margaret A.
   Deseda, Carmen
   Warner, Lee
TI Measures Taken to Prevent Zika Virus Infection During Pregnancy - Puerto
   Rico, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
ID UNITED-STATES; WOMEN
C1 [D'Angelo, Denise V.; Lamias, Mark J.; Shulman, Holly; Taraporewalla, Aspy J.; Harrison, Leslie; Ellington, Sascha R.; Williams, Tanya; Shapiro-Mendoza, Carrie K.; Cox, Shanna; Pazol, Karen; Dee, Deborah L.; Romero, Lisa; Lathrop, Eva; Barfield, Wanda; Smith, Ruben A.; Jamieson, Denise J.; Warner, Lee] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [von Essen, Beatriz Salvesen; Hernandez-Virella, Wanda I.; Vargas, Manuel I.; Soto, Leslianne; Rodriguez, Aurea] Puerto Rico Dept Hlth, Div Maternal Child & Adolescent Hlth, San Juan, PR USA.
   [Rivera, Brenda; Deseda, Carmen] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
   [Rice, Marion E.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
RP D'Angelo, DV (corresponding author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM DDAngelo@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Jamieson,
   Denise/0000-0003-2597-1201
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   CDC Foundation, 2016, COMPR ZIK CAMP LAUNC
   Departamento de Salud de Puerto Rico, 2017, INF SEM ENF ARB ARBO
   Departamento de Salud de Puerto Rico, 2016, ORD ADM
   Noyd DH, 2015, P R HEALTH SCI J, V34, P65
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Shulman H. B., 2006, PUBLIC HLTH REPORTS, V121, P74, DOI DOI 10.1177/003335490612100114
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
NR 10
TC 10
Z9 11
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 9
PY 2017
VL 66
IS 22
BP 574
EP 578
DI 10.15585/mmwr.mm6622a2
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EW9YN
UT WOS:000402875400002
PM 28594787
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Sommerfeld, J
   Manderson, L
   Ramirez, B
   Guth, JA
   Reeder, JC
AF Sommerfeld, J.
   Manderson, L.
   Ramirez, B.
   Guth, J. A.
   Reeder, J. C.
TI Infectious disease research and the gender gap
SO GLOBAL HEALTH EPIDEMIOLOGY AND GENOMICS
LA English
DT Article
DE Capacity building; control; epidemiology; gender; infectious diseases;
   Women in Science
ID ONCHOCERCAL-SKIN-DISEASE; TROPICAL DISEASES; ZIKA VIRUS; WOMEN;
   PREGNANCY; MALARIA
AB Historically, women have been less likely to be supported through higher degree training programmes, and they continue to hold more junior positions in science. This paper reviews the current gender research and gender capacity-building efforts led by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Created more than 40 years ago as the only United Nations-based Special Programme dedicated to research and research capacity building on infectious diseases, TDR has a longstanding track record both in supporting research into gender-specific questions and in research capacity strengthening among women scientists. We provide an overview of these approaches, then describe a recent pilot programme on Women in Science, designed to understand and remedy the gender gaps in health research. The programme focused on Africa, but it is hoped that the replication of such schemes in TDR and other international funding agencies will lead to more attention being given to women in infectious diseases research in other continents.
C1 [Sommerfeld, J.; Ramirez, B.; Guth, J. A.; Reeder, J. C.] WHO, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland.
   [Sommerfeld, J.] WHO, Ctr Hlth Dev, WHO Kobe Ctr, Kobe, Hyogo, Japan.
   [Manderson, L.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
RP Sommerfeld, J (corresponding author), WHO, WKC, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM sommerfeldj@who.int
RI Sommerfeld, Johannes/AAI-5816-2020
FU TDR's Joint Coordinating Board
FX The TDR Programme thanks its gender research collaborators worldwide and
   particularly the Women in Science Network for their significant
   contributions and partnership. The Women in Science Pilot Programme
   presented here was supported through Strategic Development Funds
   provided by the government donors of the Programme as represented on
   TDR's Joint Coordinating Board.
CR Allotey P, 2005, TDRSTRSEBST051 WHO B
   Anagbogu MA, 2008, GHANA J DEV STUDIES, V5, P17
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   BRABIN L, 1990, EPIDEMIOL INFECT, V105, P335, DOI 10.1017/S0950268800047932
   Brieger WR, 1997, TROP MED INT HEALTH, V2, P529, DOI 10.1046/j.1365-3156.1997.d01-317.x
   Burstein D, 2015, SCIENCE, V350, P286, DOI 10.1126/science.350.6258.286-a
   Christinet V, 2016, INT J PARASITOL, V46, P395, DOI 10.1016/j.ijpara.2016.02.006
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Emambokus N, 2016, CELL METAB, V23, P747, DOI 10.1016/j.cmet.2016.04.027
   Lema V M, 2005, East Afr Med J, V82, P3
   Macaluso B, 2016, ACAD MED, V91, P1136, DOI 10.1097/ACM.0000000000001261
   MANDERSON L, 1994, ACTA TROP, V57, P97, DOI 10.1016/0001-706X(94)90001-9
   MANDERSON L, 1993, SOC SCI MED, V37, P441, DOI 10.1016/0277-9536(93)90279-D
   Mergo L., 2013, P NAT S EST ENH SUST
   Minja H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001351
   Nimmesgern H, 2016, CHEM-EUR J, V22, P3529, DOI 10.1002/chem.201600035
   Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007
   Ogundahunsi OAT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003380
   Pearson W, 2015, ADV WOMEN SCI INT PE
   Reeder JC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003355
   Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14
   Roy D., 2014, WOMEN SCI TECHNOLOGY, P223
   Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]
   Sommerfeld J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003378
   Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a
   TDR, 2013, TDR PERF ASS FRAM 20
   TDR, 2007, MAK DIFF 30 YEARS RE
   UNESCO, 2015, WOM IN SCI
   Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220
   Vlassoff C, 1997, ACTA TROP, V67, P173, DOI 10.1016/S0001-706X(97)00047-8
   Vlassoff C, 2000, SOC SCI MED, V50, P1353, DOI 10.1016/S0277-9536(99)00389-5
   VLASSOFF C, 1994, J BIOSOC SCI, V26, P37, DOI 10.1017/S0021932000021040
   Vlassoff C, 1998, TROP MED INT HEALTH, V3, P1011
   VLASSOFF C, 1994, ACTA TROP, V57, P103, DOI 10.1016/0001-706X(94)90002-7
   Wararu M., 2011, SCIDEVNET
   Weiss MG, 2008, INT J TUBERC LUNG D, V12, P829
NR 36
TC 1
Z9 1
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 2054-4200
J9 GLOB HEALTH EPIDEM G
JI Glob. Health Epidemiol. Genom.
PD JUN 8
PY 2017
VL 2
AR UNSP e9
DI 10.1017/gheg.2017.2
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GL0SJ
UT WOS:000436800300001
PM 29868220
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Widmar, NJO
   Dominick, SR
   Tyner, WE
   Ruple, A
AF Widmar, Nicole J. Olynk
   Dominick, S. R.
   Tyner, Wallace E.
   Ruple, Audrey
TI When is genetic modification socially acceptable? When used to advance
   human health through avenues other than food
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS-INFECTION; VACCINE DEVELOPMENT; DISEASE
AB Given the potential for genetic modification (GM) to impact human health, via food and health mechanisms, a greater understanding of the social acceptance of GM is necessary to facilitate improved health outcomes. This analysis sought to quantify U.S. residents' acceptance of GM across five potential uses (grain production, fruit or vegetable production, livestock production, human medicine, and human health, i.e. disease vector control) and provides an in-depth analysis of a timely case study-the Zika virus (ZIKV). The two categories with the highest levels of acceptance for GM use were human medicine (62% acceptance) and human health (68% acceptance); the proportions agreeing with the use of GM for these two categories were statistically different from all other categories. Acceptance of GM in food uses revealed 44% of the sample accepted the use of GM in livestock production while grain production and fruit and vegetable production showed similar levels of agreement with 49% and 48% of responses, respectively. Two variables were significant in all five models predicting GM acceptance; namely, being male and GM awareness. Being male was significant and positive for all models; respondents who reported being male were more likely (than those who reported female) to agree with all five of the uses of GM studied. Those who were reportedly aware of GM mosquito technology were also more likely to agree with all uses of GM technology investigated. The potential relationship between awareness of GM technology uses and acceptance of other uses could help inform rates of acceptance of new technologies by various population segments.
C1 [Widmar, Nicole J. Olynk; Dominick, S. R.; Tyner, Wallace E.] Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA.
   [Ruple, Audrey] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.
RP Dominick, SR (corresponding author), Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA.
EM sdominic@purdue.edu
FU Discretionary internal university funds
FX Discretionary internal university funds were used to fund this research.
CR [Anonymous], 2015, STAT STAT SOFTW REL
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Bar-Yam Y., 2014, PRECAUTION GMOS ALGO
   Baum C.F., 2006, INTRO MODERN ECONOME
   BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Chiang F.-S. F., 2005, PUBLIC COMMUNICATION
   Costa-Font J., APPL EC LETT, V12, P859
   Dawkins R., 1998, DO REAL DANGERS GENE
   Fernandez-Cornejo J., 2014, GENETICALLY ENG CROP, P60
   FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407
   Frewer L. J., 1995, Agriculture and Human Values, V12, P48, DOI 10.1007/BF02218074
   Giuseppina Migliore, 2015, BRIT FOOD J, V117, P1637
   Goeddel David V., 1979, P NATL ACAD SCI USA, V76, P106
   Larimer Sarah, 2016, WASHINGTON POST
   Lusk JL, 2005, J AGR RESOUR ECON, V30, P28
   Mahaffey H., 2016, Journal of Environmental Protection, V7, P1522, DOI 10.4236/jep.2016.711127
   Marshall JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-128
   MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073
   Rozansky, 2016, MICHEAL MOST FLORIDA
   Servick K., 2016, SCIENCE, DOI [10.1126/science.aal0350, DOI 10.1126/SCIENCE.AAL0350]
   Shoichet Catherine E., 2016, CNN
   Singer PA, 2000, NAT BIOTECHNOL, V18, P1225, DOI 10.1038/82256
   Snipes Robin L., EMPLOYEE RESPONSIBIL, V11, P81
   SPAETE RR, 1991, TRANSPLANT P, V23, P90
   U. S. Census Bureau, 2010, DP 1 PROF GEN POP HO
   Widmar N. J. O., 2017, PREVENTATIVE MED REP
   Wooldridge JM, 2013, INTRO ECONOMETRICS M
NR 31
TC 3
Z9 3
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 7
PY 2017
VL 12
IS 6
AR e0178227
DI 10.1371/journal.pone.0178227
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX0AO
UT WOS:000402880700024
PM 28591218
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Griffin, BD
   Muthumani, K
   Warner, BM
   Majer, A
   Hagan, M
   Audet, J
   Stein, DR
   Ranadheera, C
   Racine, T
   De la Vega, MA
   Piret, J
   Kucas, S
   Tran, KN
   Frost, KL
   De Graff, C
   Soule, G
   Scharikow, L
   Scott, J
   McTavish, G
   Smid, V
   Park, YK
   Maslow, JN
   Sardesai, NY
   Kim, JJ
   Yao, XJ
   Bello, A
   Lindsay, R
   Boivin, G
   Booth, SA
   Kobasa, D
   Embury-Hyatt, C
   Safronetz, D
   Weiner, DB
   Kobinger, GP
AF Griffin, Bryan D.
   Muthumani, Kar
   Warner, Bryce M.
   Majer, Anna
   Hagan, Mable
   Audet, Jonathan
   Stein, Derek R.
   Ranadheera, Charlene
   Racine, Trina
   De la Vega, Marc-Antoine
   Piret, Jocelyne
   Kucas, Stephanie
   Tran, Kaylie N.
   Frost, Kathy L.
   De Graff, Christine
   Soule, Geoff
   Scharikow, Leanne
   Scott, Jennifer
   McTavish, Gordon
   Smid, Valerie
   Park, Young K.
   Maslow, Joel N.
   Sardesai, Niranjan Y.
   Kim, J. Joseph
   Yao, Xiao-jian
   Bello, Alexander
   Lindsay, Robbin
   Boivin, Guy
   Booth, Stephanie A.
   Kobasa, Darwyn
   Embury-Hyatt, Carissa
   Safronetz, David
   Weiner, David B.
   Kobinger, Gary P.
TI DNA vaccination protects mice against Zika virus-induced damage to the
   testes
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SEXUAL TRANSMISSION; INFECTION; INHIBITORS; SEMEN
AB Zika virus (ZIKV) is an emerging pathogen causally associated with serious sequelae in fetuses, inducing fetal microcephaly and other neurodevelopment defects. ZIKV is primarily transmitted by mosquitoes, but can persist in human semen and sperm, and sexual transmission has been documented. Moreover, exposure of type-I interferon knockout mice to ZIKV results in severe damage to the testes, epididymis and sperm. Candidate ZIKV vaccines have shown protective efficacy in preclinical studies carried out in animal models, and several vaccines have entered clinical trials. Here, we report that administration of a synthetic DNA vaccine encoding ZIKV pre-membrane and envelope (prME) completely protects mice against ZIKV-associated damage to the testes and sperm and prevents viral persistence in the testes following challenge with a contemporary strain of ZIKV. These data suggest that DNA vaccination merits further investigation as a potential means to reduce ZIKV persistence in the male reproductive tract.
C1 [Griffin, Bryan D.; Hagan, Mable; Audet, Jonathan; Racine, Trina; Frost, Kathy L.; Soule, Geoff; Bello, Alexander; Kobasa, Darwyn] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
   [Griffin, Bryan D.; Warner, Bryce M.; Hagan, Mable; Audet, Jonathan; Stein, Derek R.; Ranadheera, Charlene; Yao, Xiao-jian; Bello, Alexander; Lindsay, Robbin; Booth, Stephanie A.; Kobasa, Darwyn; Safronetz, David] Univ Manitoba, Dept Med Microbiol & Infect Dis, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.
   [Muthumani, Kar; Weiner, David B.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Warner, Bryce M.; Stein, Derek R.; Ranadheera, Charlene; Kucas, Stephanie; Scharikow, Leanne; Lindsay, Robbin; Safronetz, David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
   [Majer, Anna; Frost, Kathy L.; Booth, Stephanie A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Mol Pathobiol, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
   [Racine, Trina; De la Vega, Marc-Antoine; Kobinger, Gary P.] Laval Univ, Fac Med, Dept Microbiol & Immunol, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.
   [Piret, Jocelyne; Boivin, Guy] CHU Quebec, Res Ctr Infect Dis, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.
   [Piret, Jocelyne; Boivin, Guy] Laval Univ, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.
   [Kucas, Stephanie; De Graff, Christine] Publ Hlth Agcy Canada, Natl Microbiol Lab, Vet Tech Serv, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
   [Scott, Jennifer; McTavish, Gordon] Heartland Fertil & Gynecol Clin, 701-1661 Portage Ave, Winnipeg, MB R3J 3T7, Canada.
   [Smid, Valerie; Embury-Hyatt, Carissa] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, 1015 Arlington St, Winnipeg, MB R3E 3M4, Canada.
   [Park, Young K.; Maslow, Joel N.] GeneOne Life Sci Inc, 223 Teheran Ro, Seoul, South Korea.
   [Sardesai, Niranjan Y.; Kim, J. Joseph] Inovio Pharmaceut Inc, 660 West Germantown Pike, Plymouth Meeting, PA 19462 USA.
   [Kobinger, Gary P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA.
RP Kobinger, GP (corresponding author), Laval Univ, Fac Med, Dept Microbiol & Immunol, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.; Kobinger, GP (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA.
EM gary.kobinger@crchudequebec.ulaval.ca
RI Muthumani, Kar/AAQ-4939-2020; Audet, Jonathan/AAH-5546-2019
OI Muthumani, Kar/0000-0002-6807-2065; Audet, Jonathan/0000-0002-0743-7489;
   Lindsay, Robbin/0000-0001-7236-2930; Sardesai,
   Niranjan/0000-0001-6920-1167; de La Vega,
   Marc-Antoine/0000-0002-5969-9990
FU Public Health Agency of Canada; Intramural Research Program, National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health [R01-AI092843]; DARPA- PROTECT; BMGF; Inovio Pharmaceuticals
FX We thank Michelle French and Kimberly Azaransky of the Veterinary
   Technical Services at the National Microbiology Laboratory (NML) for
   their technical assistance during the course of this work and Estella
   Moffat, Brad Collignon and Jill Graham of NCFAD for pathology technical
   work. We thank the Centers for Disease Control and Prevention (CDC) for
   providing the ZIKV isolate. We thank Sonja M. Best of the National
   Institute of Allergy and Infectious Disease for consultations regarding
   the ZIKV IHC. All protocols and procedures were approved by the
   institutional research ethics committees of the Canadian Science Centre
   for Human and Animal Health (CSCHAH) and Laval University. This study
   was supported by the Public Health Agency of Canada and D.B.W. was
   supported in part by the Intramural Research Program, National Institute
   of Allergy and Infectious Diseases, National Institutes of Health (grant
   R01-AI092843); DARPA- PROTECT to D.B.W. and K.M.; BMGF to D.B.W. and
   K.M. and Inovio Pharmaceuticals to D.B.W. and K.M.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Krieg AM, 1999, J GENE MED, V1, P56, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<56::AID-JGM5>3.3.CO;2-Y
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Osuna CE, 2017, NAT MED, V23, P264, DOI 10.1038/nm0217-264b
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   World Health Organization, 2010, WHO LAB MAN EX PROC
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 37
TC 54
Z9 56
U1 2
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 7
PY 2017
VL 8
AR 15743
DI 10.1038/ncomms15743
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW8ZO
UT WOS:000402806800002
PM 28589934
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Piyasena, TBH
   Setoh, YX
   Hobson-Peters, J
   Newton, ND
   Bielefeldt-Ohmann, H
   McLean, BJ
   Vet, LJ
   Khromykh, AA
   Hall, RA
AF Piyasena, Thisun B. H.
   Setoh, Yin X.
   Hobson-Peters, Jody
   Newton, Natalee D.
   Bielefeldt-Ohmann, Helle
   McLean, Breeanna J.
   Vet, Laura J.
   Khromykh, Alexander A.
   Hall, Roy A.
TI Infectious DNAs derived from insect-specific flavivirus genomes enable
   identification of pre- and post-entry host restrictions in vertebrate
   cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; EILAT VIRUS; HIGH PREVALENCE; CDNA-CLONE; RNA;
   EXPRESSION; RANGE; GENE; DETERMINANTS; TRANSMISSION
AB Flaviviruses such as West Nile virus (WNV), dengue virus and Zika virus are mosquito-borne pathogens that cause significant human diseases. A novel group of insect-specific flaviviruses (ISFs), which only replicate in mosquitoes, have also been identified. However, little is known about the mechanisms of ISF host restriction. We report the generation of infectious cDNA from two Australian ISFs, Parramatta River virus (PaRV) and Palm Creek virus (PCV). Using circular polymerase extension cloning (CPEC) with a modified OpIE2 insect promoter, infectious cDNA was generated and transfected directly into mosquito cells to produce infectious virus indistinguishable from wild-type virus. When infectious PaRV cDNA under transcriptional control of a mammalian promoter was used to transfect mouse embryo fibroblasts, the virus failed to initiate replication even when cell entry steps were by-passed and the type I interferon response was lacking. We also used CPEC to generate viable chimeric viruses between PCV and WNV. Analysis of these hybrid viruses revealed that ISFs are also restricted from replication in vertebrate cells at the point of entry. The approaches described here to generate infectious ISF DNAs and chimeric viruses provide unique tools to further dissect the mechanisms of their host restriction.
C1 [Piyasena, Thisun B. H.; Setoh, Yin X.; Hobson-Peters, Jody; Newton, Natalee D.; Bielefeldt-Ohmann, Helle; McLean, Breeanna J.; Vet, Laura J.; Khromykh, Alexander A.; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
RP Khromykh, AA; Hall, RA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.
EM alexander.khromykh@uq.edu.au; roy.hall@uq.edu.au
RI Khromykh, Alexander/X-7200-2018; Setoh, Yin Xiang/K-4503-2012; Piyasena,
   Thisun/I-3247-2016
OI Khromykh, Alexander/0000-0001-6206-6935; Setoh, Yin
   Xiang/0000-0002-1683-3555; Piyasena, Thisun/0000-0002-1657-8558; Newton,
   Natalee/0000-0002-5617-8639; Vet, Laura/0000-0001-7587-2936
FU Australian Research CouncilAustralian Research Council [ARC
   DP120103994]; Australian GovernmentAustralian Government
FX We would like to thank Agathe Colmant, Jessica Harrison and Caitlin
   O'Brien (all University of Queensland) for expert technical advice and
   assistance. We thank Renee Traves (University of Queensland) and
   Parthiban Periasamy (University of Queensland) for expert technical
   advice. We also thank Prof. Nikolai Petrovsky (Flinders University) for
   supplying the Advax adjuvant. This study was funded by the Australian
   Research Council (ARC DP120103994) and an Australian Government Research
   Training Program Scholarship to TBHP.
CR ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Audsley M, 2011, VIROLOGY, V414, P63, DOI 10.1016/j.virol.2011.03.008
   BLISSARD GW, 1989, VIROLOGY, V170, P537, DOI 10.1016/0042-6822(89)90445-5
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101
   Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Gorchakov RV, 2014, J GEN VIROL, V95, P2071, DOI 10.1099/vir.0.066019-0
   HALL RA, 1988, IMMUNOL CELL BIOL, V66, P51, DOI 10.1038/icb.1988.6
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Huhtamo E, 2012, VIROLOGY, V433, P471, DOI 10.1016/j.virol.2012.08.038
   Isawa H, 2012, ARCH VIROL, V157, P975, DOI 10.1007/s00705-012-1240-z
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Kempf J, 2002, J BIOTECHNOL, V95, P181, DOI 10.1016/S0168-1656(02)00008-1
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   KHROMYKH AA, 1994, J VIROL, V68, P4580, DOI 10.1128/JVI.68.7.4580-4588.1994
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kurnia Yudistira Wahyu, 2016, Journal of Insect Biotechnology and Sericology, V85, P39
   Liu Lihui, 2010, Front Biol (Beijing), V5, P286
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   Nandakumar R, 2013, GASTROENTEROLOGY, V145, P1414, DOI 10.1053/j.gastro.2013.08.037
   Nasar F, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0595-2
   Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Pfeifer TA, 1997, GENE, V188, P183, DOI 10.1016/S0378-1119(96)00756-1
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987
   Saiyasombat R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-150
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2015, J GEN VIROL, V96, P1297, DOI 10.1099/vir.0.000069
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   THEILMANN DA, 1992, VIROLOGY, V187, P84, DOI 10.1016/0042-6822(92)90297-3
   Tree MO, 2016, VIROLOGY, V497, P81, DOI 10.1016/j.virol.2016.07.005
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Volkova E, 2006, VIROLOGY, V344, P315, DOI 10.1016/j.virol.2005.09.010
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
NR 56
TC 11
Z9 11
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 7
PY 2017
VL 7
AR 2940
DI 10.1038/s41598-017-03120-1
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW9ZZ
UT WOS:000402879200025
PM 28592864
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hamid, PH
   Prastowo, J
   Widyasari, A
   Taubert, A
   Hermosilla, C
AF Hamid, Penny Humaidah
   Prastowo, Joko
   Widyasari, Anis
   Taubert, Anja
   Hermosilla, Carlos
TI Knockdown resistance (kdr) of the voltage-gated sodium channel gene of
   Aedes aegypti population in Denpasar, Bali, Indonesia
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Kdr; Resistance; Denpasar; Indonesia
ID INSECTICIDE RESISTANCE; PYRETHROID-RESISTANCE; MUTATIONS; DENGUE;
   THAILAND; F1534C; V1016G; IMPACT; ALLELE
AB Background: Aedes aegypti is the main vector of several arthropod-borne viral infections in the tropics profoundly affecting humans, such as dengue fever (DF), West Nile (WN), chikungunya and more recently Zika. Eradication of Aedes still largely depends on insecticides, which is the most cost-effective strategy, and often inefficient due to resistance development in exposed Aedes populations. We here conducted a study of Ae. aegypti resistance towards several insecticides regularly used in the city of Denpasar, Bali, Indonesia.
   Methods: Aedes aegypti egg samples were collected with ovitraps and thereafter hatched in the insectary of the Gadjah Mada University. The F0 generation was used for all bioassay-related experiments and knockdown resistance (kdr) assays.
   Results: Results clearly showed resistance development of Ae. aegypti against tested insecticides. Mortalities of Ae. aegypti were less than 90% with highest resistance observed against 0.75% permethrin. Mosquitoes from the southern parts of Denpasar presented high level of resistance pattern in comparison to those from the western and northern parts of Denpasar. Kdr analysis of voltage-gated sodium channel (Vgsc) gene showed significant association to S989P and V1016G mutations linked to resistance phenotypes against 0.75% permethrin. Conversely, Ae. aegypti F1534C gene mutation did not result in any significant correlation to resistance development.
   Conclusions: Periodically surveillance of insecticide resistances in Ae. aegypti mosquitoes will help local public health authorities to set better goals and allow proper evaluation of on-going mosquito control strategies. Initial detection of insecticide resistance will contribute to conduct proper actions in delaying mosquito resistance development such as insecticide rotation or combination of compounds in order to prolong chemical efficacy in combating Ae. aegypti vectors in Indonesia.
C1 [Hamid, Penny Humaidah; Prastowo, Joko] Gadjah Mada Univ, Dept Parasitol, Jl Fauna 2, Karangmalang, Yogyakarta, Indonesia.
   [Widyasari, Anis] RSUP Dr Sardjito, Jl Kesehatan 1, Sekip, Yogyakarta, Indonesia.
   [Taubert, Anja; Hermosilla, Carlos] Justus Liebig Univ Giessen, Inst Parasitol, Biomed Res Ctr Seltersberg, Schubertstr 81, Giessen, Germany.
RP Hamid, PH (corresponding author), Gadjah Mada Univ, Dept Parasitol, Jl Fauna 2, Karangmalang, Yogyakarta, Indonesia.
EM penny_hamid@ugm.ac.id
OI prastowo, joko/0000-0002-3487-4254
FU DIKTI (Direktorat Jenderal Pendidikan Tinggi of Indonesia)-INSINAS
   research grant [226/SP2H/LT/DRPM/III/2016]
FX Experiments of this work were supported and financed by the DIKTI
   (Direktorat Jenderal Pendidikan Tinggi of Indonesia)-INSINAS research
   grant No. 226/SP2H/LT/DRPM/III/2016 awarded to PHH.
CR Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Arnaud L, 2002, EVOLUTION, V56, P2435, DOI 10.1111/j.0014-3820.2002.tb00169.x
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brogdon William G, 2004, J Agromedicine, V9, P329
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Central Bureau of Statistic Republic of Indonesia, IND POP PROJ
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Ministry of Health Republic of Indonesia, 2015, DEM BERD BIAS MUL ME
   Ministry of Health Republic of Indonesia, WIL KLB DBD AD DI 11
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913
   Platt N, 2015, HEREDITY, V115, P243, DOI 10.1038/hdy.2015.33
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   Srisawat R, 2012, SE ASIAN J TROP MED, V43, P1380
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   WHO, 2013, TEST PROC INREMO
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 36
TC 22
Z9 23
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 5
PY 2017
VL 10
AR 283
DI 10.1186/s13071-017-2215-4
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EW7JI
UT WOS:000402685200004
PM 28583207
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Everts, S
AF Everts, Sarah
TI Zika virus needs a neural stem cell protein to replicate
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
OI Everts, Sarah/0000-0001-8898-0581
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUN 5
PY 2017
VL 95
IS 23
BP 9
EP 9
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA EW8QW
UT WOS:000402784200009
DA 2020-07-08
ER

PT J
AU Kiely, P
   Wood, EM
   Gambhir, M
   Cheng, AC
   McQuilten, ZK
   Seed, CR
AF Kiely, Philip
   Wood, Erica M.
   Gambhir, Manoj
   Cheng, Allen C.
   McQuilten, Zoe K.
   Seed, Clive R.
TI Emerging infectious disease agents and blood safety in Australia:
   spotlight on Zika virus
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Review
ID WEST-NILE-VIRUS; TRANSFUSION SAFETY; UNITED-STATES; SEXUAL TRANSMISSION;
   RISK; BRAZIL; PREPAREDNESS; PERCEPTION; OUTBREAK; AMERICA
AB Emerging infectious diseases (EIDs) are infectious diseases whose incidence has increased in humans in the past 20 years or could increase in the near future.
   EID agents may represent a threat to blood safety if they infect humans, cause a clinically significant illness, include an asymptomatic blood phase in the course of infection, and are transmissible by transfusion.
   EID agents are typically not well characterised, but there is a consensus that we can expect ongoing outbreaks.
   Strategies to manage the risk to blood safety from EIDs include ongoing surveillance, regular risk assessments, modelling transfusion transmission risk, and deferral of donors with a recent travel history to outbreak areas.
   The 2015-16 Zika virus (ZIKV) outbreak in the Americas is the largest reported ZIKV outbreak to date, and it highlights the unpredictable nature of EID outbreaks and how quickly they can become a major public health problem. This ZIKV outbreak has provided evidence of a causal link between the virus and microcephaly in newborns.
   In assessing the potential risk of ZIKV to blood safety in Australia, it should be noted that a relatively small number of imported ZIKV infections have been reported in Australia, there have been no reported cases of local ZIKV transmission, and the geographical distribution of the potential ZIKV mosquito vector in Australia (Aedes aegypti) is limited to northern Queensland. Moreover, reported transfusion-transmitted ZIKV cases worldwide are rare. At present, ZIKV represents a low risk to blood safety in Australia.
C1 [Kiely, Philip; Seed, Clive R.] Australian Red Cross Blood Serv, Melbourne, Vic, Australia.
   [Kiely, Philip; Wood, Erica M.; Gambhir, Manoj; Cheng, Allen C.; McQuilten, Zoe K.] Monash Univ, Melbourne, Vic, Australia.
   [Wood, Erica M.; McQuilten, Zoe K.] Monash Hlth, Melbourne, Vic, Australia.
RP Kiely, P (corresponding author), Australian Red Cross Blood Serv, Melbourne, Vic, Australia.; Kiely, P (corresponding author), Monash Univ, Melbourne, Vic, Australia.
EM pkiely@redcrossblood.org.au
RI ; Wood, Erica/I-1956-2014
OI Gambhir, Manoj/0000-0002-4831-6261; Wood, Erica/0000-0001-7527-2340
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Baggoley C, 2016, MED J AUSTRALIA, V204, P249, DOI 10.5694/mja16.00186
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Biggerstaff BJ, 2003, TRANSFUSION, V43, P1007, DOI 10.1046/j.1537-2995.2003.00480.x
   Boadle A., 2016, REUTERS NEW YOR 0204
   Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287
   Centers for Disease Control and Prevention, 2017, WORLD MAP AR RISKS Z
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coste J, 2009, VOX SANG, V96, P284, DOI 10.1111/j.1423-0410.2009.01161.x
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Department of Health, 2017, SUMM INF OV ACQ VECT
   Domanovi D, 2016, ISBT SCI SER, V11, P68
   European Centre for Disease Prevention and Control, 2015, RISK ASS ZIK VIR EP
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hanna JN, 2009, COMMUN DIS INTELL, V33, P198
   Herriman R, 2015, OUTBREAK NEWS T 1218
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Kiely P, 2015, ISBT SCI SER, V10, P65, DOI 10.1111/voxs.12114
   Kirchner VA, 2016, SURG INFECT, V17, P318, DOI 10.1089/sur.2016.009
   Kleinman S, 2010, TRANSFUSION, V50, P2592, DOI 10.1111/j.1537-2995.2010.02724.x
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Laperche S, 2011, ISBT Sci Ser, V6, P112, DOI 10.1111/j.1751-2824.2011.01452.x
   Lee D, 2006, TRANSFUS MED REV, V20, P141, DOI 10.1016/j.tmrv.2005.11.006
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Ngo LT, 2013, TRANSFUS MED REV, V27, P119, DOI 10.1016/j.tmrv.2013.02.003
   Marks PW, 2016, J INFECT DIS, V213, P1676, DOI 10.1093/infdis/jiw089
   Merz EM, 2016, VOX SANG, V110, P258, DOI 10.1111/vox.12362
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D., 2016, CLIN MICROBIOL REV
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Oei W, 2013, TRANSFUSION, V53, P1421, DOI 10.1111/j.1537-2995.2012.03941.x
   Pan American Health Organization, 2017, ZIK CAS CONG SYNDR A
   Patz JA, 2013, CURR TOP MICROBIOL, V366, P141, DOI 10.1007/82_2012_274
   Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Poggiolini Ilaria, 2013, Int J Cell Biol, V2013, P910314, DOI 10.1155/2013/910314
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Seed CR, 2014, ISBT SCI SER, V9, P268, DOI 10.1111/voxs.12093
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   US Food and Drug Administration, 2016, FDA ALL US INV TEST
   US Food and Drug Administration, 2016, REV REC RED RISK ZIK
   Venkatraman A, 2016, TRAVEL MED INFECT DI, V14, P421, DOI 10.1016/j.tmaid.2016.05.018
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Waggoner JJ, 2013, CLIN INFECT DIS, V57, P1182, DOI 10.1093/cid/cit456
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 59
TC 6
Z9 6
U1 0
U2 6
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD JUN 5
PY 2017
VL 206
IS 10
BP 455
EP 460
DI 10.5694/mja16.00833
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA EY2TF
UT WOS:000403823600012
PM 28566073
DA 2020-07-08
ER

PT J
AU Maistriau, M
   Carletti, T
   Zakaria, MK
   Braga, L
   Faoro, V
   Vasileiadis, V
   Marcello, A
AF Maistriau, Marylene
   Carletti, Tea
   Zakaria, Mohammad Khalid
   Braga, Luca
   Faoro, Valentina
   Vasileiadis, Vasileios
   Marcello, Alessandro
TI A method for the detection of virus infectivity in single cells and real
   time: Towards an automated fluorescence neutralization test
SO VIRUS RESEARCH
LA English
DT Article
DE Plaque reduction neutralization test; PRNT; IRF3; Diagnosis;
   Fluorescence neutralization test; FNT; Live imaging; Vesicular
   stomatitis virus; Zika; Tick-borne encephalitis
ID BORNE ENCEPHALITIS-VIRUS; VESICULAR STOMATITIS; REPLICATED RNA; LIVING
   CELLS; ANTIBODY; INDUCTION; SITES
AB Virus neutralizing antibodies are critical correlates of protection in vaccine development and are discriminatory in the plaque reduction neutralization test when used for the diagnosis of viral infections. However, neutralization assays are time consuming, labor intensive and highly variable, thus limiting their use. Advances in automated live imaging of cells opened new possibilities for standard virus diagnostic techniques such as neutralization assays. To this end, a reporter cell line based on the translocation of the transcription factor IRF3 in response to infection is proposed. Image acquisition of signal in a microplate format allowed the setup of a rapid, semi-automated and high-throughput fluorescent neutralization test. The study is extended to the live imaging of IRF3 translocations that could potentially cut the time of analysis to few hours. The fluorescent neutralization test is suitable for high-throughput assays and expandable to other viruses of global importance such as Zika virus.
C1 [Maistriau, Marylene; Carletti, Tea; Zakaria, Mohammad Khalid; Faoro, Valentina; Vasileiadis, Vasileios; Marcello, Alessandro] ICGEB, Mol Virol Lab, Padriciano 99, I-34149 Trieste, Italy.
   [Braga, Luca] ICGEB, High Throughput Screening Facil, Trieste, Italy.
RP Marcello, A (corresponding author), ICGEB, Mol Virol Lab, Padriciano 99, I-34149 Trieste, Italy.
EM marcello@icgeb.org
OI Braga, Luca/0000-0002-9827-6755
FU Beneficientia Stiftung, Vaduz Lichtenstein; FLAVIPOC; SEVARE project
   from the Regione FVG of Italy
FX We thank Jae Jung (University of Southern California) for plasmid
   encoding GFP-IRF3, Gualtiero Alvisi (University of Padova) for
   pWPI-based lentivectors, Miguel Mano (University of Coimbra) for
   pBOS_H2BRFP1-N1, Vivian Huerta Galindo (CIGB Cuba) for antibody 4G2 and
   Tatjana Avsic - Zupanc (University of Lubiana) for the Zika virus
   obtained through the European Virus Archive (EVA). Work on flaviviruses
   is supported by the Beneficientia Stiftung, Vaduz Lichtenstein, by the
   FLAVIPOC and SEVARE project from the Regione FVG of Italy.
CR Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Caracciolo I, 2015, J CLIN VIROL, V69, P48, DOI 10.1016/j.jcv.2015.05.019
   Carletti T., 2017, BIOCH BIOPHYS RES CO
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen S, 2010, VIROLOGY, V407, P247, DOI 10.1016/j.virol.2010.08.008
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748
   Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200
   Ikushima Hiroaki, 2013, Cold Spring Harb Symp Quant Biol, V78, P105, DOI 10.1101/sqb.2013.78.020321
   Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604
   Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3
   LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Miorin L, 2008, VIROLOGY, V379, P64, DOI 10.1016/j.virol.2008.06.025
   Miorin L, 2016, METHODS, V98, P82, DOI 10.1016/j.ymeth.2015.11.002
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rodriguez LL, 2002, VIRUS RES, V85, P211, DOI 10.1016/S0168-1702(02)00026-6
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
NR 22
TC 6
Z9 6
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JUN 2
PY 2017
VL 237
BP 1
EP 6
DI 10.1016/j.virusres.2017.05.004
PG 6
WC Virology
SC Virology
GA EZ9IQ
UT WOS:000405044100001
PM 28501626
DA 2020-07-08
ER

PT J
AU Corbel, V
   Fonseca, DM
   Weetman, D
   Pinto, J
   Achee, NL
   Chandre, F
   Coulibaly, MB
   Dusfour, I
   Grieco, J
   Juntarajumnong, W
   Lenhart, A
   Martins, AJ
   Moyes, C
   Ng, LC
   Raghavendra, K
   Vatandoost, H
   Vontas, J
   Muller, P
   Kasai, S
   Fouque, F
   Velayudhan, R
   Durot, C
   David, JP
AF Corbel, Vincent
   Fonseca, Dina M.
   Weetman, David
   Pinto, Joao
   Achee, Nicole L.
   Chandre, Fabrice
   Coulibaly, Mamadou B.
   Dusfour, Isabelle
   Grieco, John
   Juntarajumnong, Waraporn
   Lenhart, Audrey
   Martins, Ademir J.
   Moyes, Catherine
   Ng, Lee Ching
   Raghavendra, Kamaraju
   Vatandoost, Hassan
   Vontas, John
   Muller, Pie
   Kasai, Shinji
   Fouque, Florence
   Velayudhan, Raman
   Durot, Claire
   David, Jean-Philippe
TI International workshop on insecticide resistance in vectors of
   arboviruses, December 2016, Rio de Janeiro, Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Arbovirus; Mosquito; Insecticide resistance; Vector control; WIN
   network; Review; Standardization; Strategic planning
ID AEDES-AEGYPTI POPULATIONS; BACILLUS-THURINGIENSIS-ISRAELENSIS;
   RANDOMIZED CONTROLLED-TRIAL; FRENCH-WEST-INDIES; DIPTERA-CULICIDAE; ZIKA
   VIRUS; PYRETHROID RESISTANCE; SUSCEPTIBILITY STATUS; CULEX-PIPIENS; KDR
   MUTATION
AB Vector-borne diseases transmitted by insect vectors such as mosquitoes occur in over 100 countries and affect almost half of the world's population. Dengue is currently the most prevalent arboviral disease but chikungunya, Zika and yellow fever show increasing prevalence and severity. Vector control, mainly by the use of insecticides, play a key role in disease prevention but the use of the same chemicals for more than 40 years, together with the dissemination of mosquitoes by trade and environmental changes, resulted in the global spread of insecticide resistance. In this context, innovative tools and strategies for vector control, including the management of resistance, are urgently needed. This report summarizes the main outputs of the first international workshop on Insecticide resistance in vectors of arboviruses held in Rio de Janeiro, Brazil, 5-8 December 2016. The primary aims of this workshop were to identify strategies for the development and implementation of standardized insecticide resistance management, also to allow comparisons across nations and across time, and to define research priorities for control of vectors of arboviruses. The workshop brought together 163 participants from 28 nationalities and was accessible, live, through the web (> 70,000 web-accesses over 3 days).
C1 [Corbel, Vincent; Chandre, Fabrice; Durot, Claire] Malad Infectieuses & Vecteurs, Ecol Genet Evolut & Controle, MIVEGEC, UM1 CNRS 5290 IRD 224,IRD, BP 64501,911 Ave Agropolis, F-34394 Montpellier 5, France.
   [Fonseca, Dina M.] RU, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ 08901 USA.
   [Weetman, David] LSTM, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Pinto, Joao] Univ Nova Lisboa, IHMT, Inst Higiene & Med Trop, GHTM, Rua Junqueira 100, P-1349008 Lisbon, Portugal.
   [Achee, Nicole L.; Grieco, John] UND, Dept Biol Sci, Eck Inst Global Hlth, 239 Galvin Life Sci Ctr, Notre Dame, IN 46556 USA.
   [Coulibaly, Mamadou B.] MRTC, Point G, BP 1805, Bamako, Mali.
   [Dusfour, Isabelle] IPG, 23 Ave Pasteur BP 6010, Cayenne 97306, French Guiana.
   [Juntarajumnong, Waraporn] KU, Dept Entomol, 50 Ngam Wong Wan Rd, Bangkok 10900, Thailand.
   [Lenhart, Audrey] Ctr Dis Control & Prevent, Ctr Global Health, Div Parasit Dis & Malaria, Entomol Branch, 1600 Clifton Rd NE,MS G 49,Bldg 23, Atlanta, GA 30329 USA.
   [Martins, Ademir J.] Inst Oswaldo Cruz Fiocruz, Avenida Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
   [Moyes, Catherine] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford OX3 7LF, England.
   [Ng, Lee Ching] NEA, EHI, 11 Biopolis Way,Helios Block,04-03-04 & 06-05-08, Singapore, Singapore.
   [Raghavendra, Kamaraju] NIMR, Dept Hlth Res, GoI Sector 8, Delhi 110077, India.
   [Vatandoost, Hassan] Tehran Univ Med Sci, Dept Med Entomol & Vector Control, Sch Publ Hlth, Sina St,POB 14155-6446, Tehran, Iran.
   [Vatandoost, Hassan] Tehran Univ Med Sci, Inst Environm Res, Sina St,POB 14155-6446, Tehran, Iran.
   [Vontas, John] Fdn Res & Technol FORTH, Panepistimioupoli, IMBB, Iraklion 70013, Crete, Greece.
   [Vontas, John] Agr Univ Athens, Pesticide Sci Lab, Ieara Odoes 75, Athens 118, Greece.
   [Muller, Pie] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstrasse 57,POB 4002, Basel, Switzerland.
   [Kasai, Shinji] Natl Inst Infect Dis, Dept Med Entomol, Shinjuku Ku, 1-23-1 Toyama, Tokyo, Japan.
   [Fouque, Florence] Trop Dis World Hlth Org, Special Programme Res, Vector Environm & Soc Unit, Special Programme Res & Training, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [Velayudhan, Raman] WHO, Dept Control Neglected Trop Dis HTM NTD, Vector Ecol & Management, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [David, Jean-Philippe] Univ Grenoble Alpes, CNRS, UMR 5553, Lab Ecol Alpine LECA,Domaine Univ St Martin Here, 2233 Rue Piscine, F-38041 Grenoble 9, France.
RP Corbel, V (corresponding author), Malad Infectieuses & Vecteurs, Ecol Genet Evolut & Controle, MIVEGEC, UM1 CNRS 5290 IRD 224,IRD, BP 64501,911 Ave Agropolis, F-34394 Montpellier 5, France.; David, JP (corresponding author), Univ Grenoble Alpes, CNRS, UMR 5553, Lab Ecol Alpine LECA,Domaine Univ St Martin Here, 2233 Rue Piscine, F-38041 Grenoble 9, France.
EM vincent.corbel@ird.fr; jean-philippe.david@univ-grenoble-alpes.fr
RI Coulibaly, Mamadou/AAE-7006-2019; Chandre, Fabrice/Q-3429-2019; Martins,
   Ademir J./B-4117-2009; Martins, Ademir/W-3251-2019; DAVID,
   jean-philippe/F-3077-2012; Muller, Pie/R-7275-2018; Weetman,
   David/M-1261-2014; Pinto, Joao/C-2208-2012; Fonseca, Dina/B-9951-2011
OI Martins, Ademir/0000-0001-5739-1215; DAVID,
   jean-philippe/0000-0002-3950-5909; Vontas, John/0000-0002-8704-2574;
   Kamaraju, Raghavendra/0000-0002-4098-7095; Muller,
   Pie/0000-0003-0181-5781; Weetman, David/0000-0002-5820-1388; Chandre,
   Fabrice/0000-0002-1994-9705; Pinto, Joao/0000-0001-8572-7708; Moyes,
   Catherine/0000-0002-8028-4079; Fonseca, Dina/0000-0003-4726-7100
FU WHO Research & Training program on Tropical Diseases (TDR); Department
   of Neglected Tropical Diseases (NTDs) through the Worldwide Insecticide
   resistance Network (WIN); World Health OrganizationWorld Health
   Organization
FX The work was supported by the WHO Research & Training program on
   Tropical Diseases (TDR) and the Department of Neglected Tropical
   Diseases (NTDs) through the Worldwide Insecticide resistance Network
   (WIN). This work was funded by the WHO Research & Training program on
   Tropical Diseases (TDR, http://www.who.int/tdr/en/). Authors (VC, DF,
   DW, JP, NLA, FC, MBC, ID, JG, WJ, AL, AJM, CM, LCN, G, KR, HV, JV, PM,
   SK, CD, JPD) received salaries from academic or research institutions
   from their respective countries. Authors (FQ and RV) received salaries
   from the World Health Organization. The specific roles of these authors
   are articulated in the author contributions' section. The funder had no
   role in study design, data collection and analysis, and decision to
   publish.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abd-Ella A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126406
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alhag SKN, 2013, BIOSCI BIOTECHNO RES, V6, P138
   Alsheikh Adel A, 2016, J Egypt Soc Parasitol, V46, P209
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Apaire-Marchais V, 2016, ENV MICROBIOL REP, V8, P168, DOI 10.1111/1758-2229.12377
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Assogba BS, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000618
   Ayorinde A, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev045
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X
   Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   Darriet F, 2013, PEST MANAG SCI, V69, P905, DOI 10.1002/ps.3446
   Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Dhiman S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-295
   Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303
   Fonseca DM, 2010, MOL ECOL, V19, P1559, DOI 10.1111/j.1365-294X.2010.04576.x
   Fontoura NG, 2012, MEM I OSWALDO CRUZ, V107, P387, DOI 10.1590/S0074-02762012000300014
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Husham A. O., 2010, Sudanese Journal of Public Health, V5, P199
   IRAC, 2010, RES MAN SUST AGR IMP
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Mains JW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003406
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Muthusamy R, 2015, J VECTOR DIS, V52, P159
   Muthusamy R, 2015, ACTA TROP, V148, P137, DOI 10.1016/j.actatropica.2015.04.026
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Scott JM, 2017, J MED ENTOMOL, V54, P236, DOI 10.1093/jme/tjw133
   Setha T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004973
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Tan AWA, 2012, SE ASIAN J TROP MED, V43, P296
   WHO, 2004, GLOB STRAT FRAM INT
   World Health Organization, 2012, ACC WORK OV GLOB IMP, P22
   World Health Organization Pyriproxyfen in drinking water, 2004, WHOSDEWSH0304113
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 67
TC 13
Z9 13
U1 1
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 2
PY 2017
VL 10
AR 278
DI 10.1186/s13071-017-2224-3
PG 16
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EW5XJ
UT WOS:000402579500005
PM 28577363
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Calmels, C
   Ventura, M
   Aknin, C
   Metifiot, M
   Andreola, ML
AF Calmels, Christina
   Ventura, Michel
   Aknin, Cindy
   Metifiot, Mathieu
   Andreola, Marie-Line
TI De novo RNA synthesis catalyzed by the Zika Virus RNA polymerase domain
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROTEASE
AB Mosquito-and tick-borne pathogens including Chikungunya, Dengue, Japanese encephalitis, West Nile, Yellow fever and Zika virus, represent a new economic and public health challenge. In the absence of effective vaccines and specific therapies, only supportive regimens are administrated for most of these infections. Thus, the development of a targeted therapy is mandatory to stop the rapid progression of these pathogens and preoccupant associated burdens such as Guillain-Barre syndrome, microcephaly. For this, it is essential to develop biochemical tools to help study and target key viral enzymes involved in replication such as helicase complexes, methyl-transferases and RNA-dependent RNA polymerases. Here, we show that a highly purified ZIKV polymerase domain is active in vitro. Importantly, we show that this isolated domain is capable of de novo synthesis of the viral genome and efficient elongation without terminal nucleotide transferase activity. Altogether, this isolated polymerase domain will be a precious tool to screen and optimize specific nucleoside and non-nucleoside inhibitors to fight against Zika infections.
C1 [Calmels, Christina; Ventura, Michel; Aknin, Cindy; Metifiot, Mathieu; Andreola, Marie-Line] Univ Bordeaux, CNRS, MFP, UMR 5234, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
   [Calmels, Christina; Ventura, Michel; Aknin, Cindy; Metifiot, Mathieu; Andreola, Marie-Line] Federat Rech TransbioMed, Bordeaux, France.
RP Andreola, ML (corresponding author), Univ Bordeaux, CNRS, MFP, UMR 5234, 146 Rue Leo Saignat, F-33076 Bordeaux, France.; Andreola, ML (corresponding author), Federat Rech TransbioMed, Bordeaux, France.
EM marie-line.andreola@u-bordeaux.fr
FU Centre National de la Recherche Scientifique (CNRS), University of
   Bordeaux
FX This work was supported by the Centre National de la Recherche
   Scientifique (CNRS), the University of Bordeaux.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Xu H.-T, 2017, J ANTIMICROB CHEMOTH
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 21
TC 2
Z9 2
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 2
PY 2017
VL 7
AR 2697
DI 10.1038/s41598-017-03038-8
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW4ZX
UT WOS:000402515800015
PM 28577343
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Basak, SC
AF Basak, Subhash C.
TI Use of Mathematical Chemodescriptors and Biodescriptors for New Drug
   Discovery, Environmental Protection, and Surveillance of Emerging Global
   Pathogens
SO JOURNAL OF COMPUTER CHEMISTRY-JAPAN
LA English
DT Article
DE Mathematical chemodescriptors; Biodescriptors; New drug discovery;
   Environmental protection; Emerging global pathogens; Graph invariants;
   Topological index; Quantitative structure-activity/property relationship
   (QSaR/QSPR)
ID CHEMICALS
AB This article reviews results of research on the development of graph theoretical chemodescriptors, topological indices in particular, and proteomics as well as DNA/RNA sequence based biodescriptors and their applications in predicting property/bioactivity of chemicals as well as viruses. Use of biodescriptors in the characterization of emerging pathogens like the Zika virus (ZIKV) has been discussed. The use of proper statistical methods in model building is emphasized with special reference to research carried out by the author of this review.
C1 [Basak, Subhash C.] Univ Minnesota, Nat Resources Res Inst, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
   [Basak, Subhash C.] Univ Minnesota, Dept Chem & Biochem, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
RP Basak, SC (corresponding author), Univ Minnesota, Nat Resources Res Inst, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.; Basak, SC (corresponding author), Univ Minnesota, Dept Chem & Biochem, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
EM sbasak@nrri.umn.edu
CR [Anonymous], 2003, MOLCONNZ VERS 4 05
   Basak S., 1993, TRIPLET
   Basak S. C., POLLY V 2 3 1988
   BASAK SC, 1988, DISCRETE APPL MATH, V19, P17, DOI 10.1016/0166-218X(88)90004-2
   Basak SC, 2016, CURR COMPUT-AID DRUG, V12, P2, DOI 10.2174/1573409912999160315115502
   Basak SC, 2015, CURR COMPUT-AID DRUG, V11, P197, DOI 10.2174/157340991103151124190920
   Basak SC, 2013, CURR COMPUT-AID DRUG, V9, P449, DOI 10.2174/15734099113096660041
   Devillers J, 1999, TOPOLOGICAL INDICES
   Garcia-Domenech R, 2015, MOL DIVERS, V19, P357, DOI 10.1007/s11030-015-9575-5
   HOSOYA H, 1971, B CHEM SOC JPN, V44, P2332, DOI 10.1246/bcsj.44.2332
   Kier L.B., 1999, MOL STRUCTURE DESCRI
   LAJINESS MS, 1990, COMPUTATIONAL CHEM G, P299
   Nandy A., 2016, AIDED DRUG DES CURR, V12, P87, DOI [10.2174/1573409912666160401115812, DOI 10.2174/1573409912666160401115812]
   Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907
   Nandy A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050666
   NIEMI GJ, 1992, ENVIRON TOXICOL CHEM, V11, P893, DOI 10.1002/etc.5620110703
   Randic M, 2000, J CHEM INF COMP SCI, V40, P1235, DOI 10.1021/ci000034q
   Trinajstic N., 1992, CHEM GRAPH THEORY
   WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005
NR 19
TC 0
Z9 0
U1 0
U2 0
PU SOC COMPUTER CHEMISTRY, JAPAN
PI TOKYO
PA 2-1-13 HIGASHIUENO, TAITO-KU, TOWA HIGH TOWN UENO 607, TOKYO, 110-0015,
   JAPAN
SN 1347-1767
EI 1347-3824
J9 J COMPUT CHEM-JPN
JI J. Comput. Chem.-Jpn.
PD JUN
PY 2017
VL 16
IS 2
SI SI
BP 38
EP 41
DI 10.2477/jccj.2017-0020
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA FX7EL
UT WOS:000426250000003
OA Bronze
DA 2020-07-08
ER

PT J
AU Dempsey, LA
AF Dempsey, Laurie A.
TI Zika-neutralizing antibodies
SO NATURE IMMUNOLOGY
LA English
DT Editorial Material
NR 0
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD JUN
PY 2017
VL 18
IS 6
BP 603
EP 603
DI 10.1038/ni.3762
PG 1
WC Immunology
SC Immunology
GA FU7JO
UT WOS:000424028600003
PM 28518162
DA 2020-07-08
ER

PT J
AU Azarudeen, RMST
   Govindarajan, M
   AlShebly, MM
   AlQahtani, FS
   Amsath, A
   Senthilmurugan, S
   Vijayan, P
   Benelli, G
AF Azarudeen, Raja Mohamed Sait Thameem
   Govindarajan, Marimuthu
   AlShebly, Mashael Marzouq
   AlQahtani, Fatma Saeed
   Amsath, Abubucker
   Senthilmurugan, Sengamalai
   Vijayan, Periasamy
   Benelli, Giovanni
TI Size-controlled biofabrication of silver nanoparticles using the
   Merremia emarginata leaf extract: Toxicity on Anopheles stephensi, Aedes
   aegypti and Culex quinquefasciatus (Diptera: Culicidae) and non-target
   mosquito predators
SO JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
LA English
DT Article
DE Green nanosynthesis; SEM; Tem; AFM; Culicidae; Nanotechnology;
   Mosquito-borne diseases; St. Louis encephalitis
ID GREEN SYNTHESIS; ESSENTIAL OILS; VETERINARY IMPORTANCE; LARVICIDAL
   ACTIVITY; AQUATIC ORGANISMS; BORNE DISEASES; PLANT LATEX; MALARIA;
   VECTORS; DENGUE
AB Mosquito-borne diseases represent a major human and animal health problem in all tropical and subtropical countries worldwide. The synthesis of eco-friendly metal nanoparticles is a fast-growing branch of current nanoscience with a number of biomedical and entomological implications. In this study, we investigated the one-pot synthesis of silver nanoparticles (Ag NPs) using a cheap leaf extract of Merremia emarginata (Convolvulaceae). Bio-reduced Ag NPs were characterized by UV-visible spectrophotometry, Fourier transform infrared spectroscopy, X-ray diffraction analysis, atomic force microscopy, scanning electron microscopy and transmission electron microscopy. SEM, TEM and AFM morphological nanocharacterization showed that this synthesis led to the production of size-controlled Ag NPs, ranging from 25 to 65 nm. The acute toxicity of M. emarginata leaf extract and biosynthesized Ag NPs was evaluated against third instar larvae of the malaria vector Anopheles stephensi, the dengue and Zika virus vectorAedes aegypti and the filariasis vector Culex quinquefasciatus. Compared to the leaf aqueous extract, Ag NPs showed higher toxicity against A. stephensi, A. aegypti, and C quinquefasciatus with LC50 values of 8.36, 9.20 and 10.02 mu g/mL, respectively. M. emarginata-fabricated Ag NPs were found safer to non-target aquatic biocontrol agents Anisops bouyieri, Diplonychus indicts and Gambusia affinis, with LC50 ranging from 415.61 to 25,153.46 mu g/mL. However, although it has been proven the AgNPs fabricated in the present study are more effective if compared to the crude M. einarginata extract, they still exert some toxicity on biocontrol agents, thus further research is required to produce more eco-friendly formulations for field purposes. (C) 2017 Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society. Published by Elsevier B.V. All rights reserved.
C1 [Azarudeen, Raja Mohamed Sait Thameem; Amsath, Abubucker] Khadir Mohideen Coll, Dept Zool, Adirampattinam 614701, Tamil Nadu, India.
   [Govindarajan, Marimuthu; Senthilmurugan, Sengamalai; Vijayan, Periasamy] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [AlShebly, Mashael Marzouq] King Saud Univ, Coll Med, Dept Obstet & Gynecol, Riyadh, Saudi Arabia.
   [AlShebly, Mashael Marzouq; AlQahtani, Fatma Saeed] King Saud Univ Med City, Riyadh, Saudi Arabia.
   [AlQahtani, Fatma Saeed] King Saud Univ, Coll Med, Dept Pathol, Hematol Unit, Riyadh, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Benelli, Giovanni/A-9100-2013; S,
   Senthilmurugan/AAB-4374-2019
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Benelli,
   Giovanni/0000-0001-8971-6010; 
CR Babu A. V., 2009, RES J MED PLANT, V3, P134
   Benelli G., 2017, ENV SCI POLLUT RES
   Benelli G., 2016, PARASITOL RES MONOGR, P155
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, J CLUST SCI, V28, P3, DOI 10.1007/s10876-016-1131-7
   Benelli G, 2017, J CLUST SCI, V28, P11, DOI 10.1007/s10876-016-1143-3
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   DEO P G, 1988, International Pest Control, V30, P118
   Ecliriweera S., 2009, INT Q J RES AYURVEDA, V30, P373
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Geethalakshmi R, 2010, INT J ENG SCI TECHNO, V2, P976
   Govindarajan M., 2016, J CLUST SCI
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Machalova Z, 2015, IND CROP PROD, V67, P310, DOI 10.1016/j.indcrop.2015.01.070
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Murugan K, 2017, PARASITOL RES, V116, P495, DOI 10.1007/s00436-016-5310-0
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Nluthukumaran U., 2015, PARASITOL RES, V114, P989
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R, 2016, J PEST SCI
   Pavela R, 2017, IND CROP PROD, V97, P338, DOI 10.1016/j.indcrop.2016.12.046
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   SALAM HA, 2012, INT RES J BIOL SCI, V1, P85
   Sap-lam N, 2010, Journal of Applied Sciences, V10, P3132
   Seelaboyina R, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/27/279001
   Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Subramaniam J, 2017, J CLUST SCI, V28, P413, DOI 10.1007/s10876-016-1113-9
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   Ward M., 2017, PARASITOL RES
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
NR 51
TC 7
Z9 7
U1 2
U2 10
PU KOREAN SOC APPLIED ENTOMOLOGY
PI SUWON
PA NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA,
   249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA
SN 1226-8615
EI 1876-7990
J9 J ASIA-PAC ENTOMOL
JI J. Asia-Pac. Entomol.
PD JUN
PY 2017
VL 20
IS 2
BP 359
EP 366
DI 10.1016/j.aspen.2017.02.007
PG 8
WC Entomology
SC Entomology
GA FS4HG
UT WOS:000419749100009
DA 2020-07-08
ER

PT J
AU Li, JW
   Baird, MA
   Davis, MA
   Tai, WY
   Zweifel, LS
   Waldorf, KMA
   Gale, M
   Rajagopal, L
   Pierce, RH
   Gao, XH
AF Li, Junwei
   Baird, Madison A.
   Davis, Michael A.
   Tai, Wanyi
   Zweifel, Larry S.
   Waldorf, Kristina M. Adams
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Pierce, Robert H.
   Gao, Xiaohu
TI Dramatic enhancement of the detection limits of bioassays via ultrafast
   deposition of polydopamine
SO NATURE BIOMEDICAL ENGINEERING
LA English
DT Article
ID PROPHENOLOXIDASE-ACTIVATING SYSTEM; CORTICOTROPIN-RELEASING-FACTOR; CELL
   LUNG-CANCER; HIV P24 ANTIGEN; CRF RECEPTORS; QUANTUM DOTS; ZIKA VIRUS;
   SENSITIVITY; SAFETY; PEMBROLIZUMAB
AB The ability to detect biomarkers with ultrahigh sensitivity radically transformed biology and disease diagnosis. However, owing to incompatibilities with infrastructure in current biological and medical laboratories, recent innovations in analytical technology have not yet been adopted broadly. Here, we report a simple, universal 'add-on' technology (dubbed EASE) that converts the ordinary sensitivities of common bioassays to extraordinary ones, and that can be directly plugged into the routine practices of current research and clinical laboratories. The assay relies on the bioconjugation capabilities and ultrafast and localized deposition of polydopamine at the target site, which permit a large number of reporter molecules to be captured and lead to detection-sensitivity enhancements exceeding three orders of magnitude. The application of EASE in the enzyme-linkedimmunosorbent- assay-based detection of the HIV antigen in blood from patients leads to a sensitivity lower than 3 fg ml(-1). We also show that EASE allows for the direct visualization, in tissues, of the Zika virus and of low-abundance biomarkers related to neurological diseases and cancer immunotherapy.
C1 [Li, Junwei; Tai, Wanyi; Gao, Xiaohu] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Baird, Madison A.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98105 USA.
   [Davis, Michael A.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98105 USA.
   [Davis, Michael A.; Waldorf, Kristina M. Adams; Gale, Michael, Jr.; Rajagopal, Lakshmi] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98105 USA.
   [Zweifel, Larry S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98105 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98105 USA.
   [Waldorf, Kristina M. Adams; Gale, Michael, Jr.; Rajagopal, Lakshmi] Univ Washington, Dept Global Hlth, Seattle, WA 98105 USA.
   [Waldorf, Kristina M. Adams] Univ Gothenburg, Sahlgrenska Acad, Med Regatan 3, S-41390 Gothenburg, Sweden.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98105 USA.
   [Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.
   [Pierce, Robert H.] Fred Hutchinson Canc Res Ctr, Program Immunol, 1100 Fairview Ave N, Seattle, WA 98109 USA.
RP Gao, XH (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM xgao@uw.edu
RI Gao, Xiaohu/C-8869-2009; Adams Waldorf, Kristina/F-2608-2013
OI Adams Waldorf, Kristina/0000-0002-6939-7224
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21CA192985, R01AI100989, AI083019,
   AI104002, AI060389]; Department of Bioengineering at the University of
   WashingtonUniversity of Washington; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute
FX This work was supported in part by the NIH (R21CA192985, R01AI100989,
   AI083019, AI104002, and AI060389) and the Department of Bioengineering
   at the University of Washington. J. L. thanks the Howard Hughes Medical
   Institute for a student fellowship. We are also grateful to B. Lutz and
   D. Leon for help with the lateral flow test, and P. Zrazhevskiy for
   discussions on immunostaining.
CR [Anonymous], 2015, NATURE, V526, P609
   Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410
   Battersby BJ, 2001, DRUG DISCOV TODAY, V6, pS19
   Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817
   Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609
   Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Cooper MA, 2001, NAT BIOTECHNOL, V19, P833, DOI 10.1038/nbt0901-833
   Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023
   Fu E, 2011, ANAL CHEM, V83, P7941, DOI 10.1021/ac201950g
   Fulton RJ, 1997, CLIN CHEM, V43, P1749
   Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824
   Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133
   Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228
   Haun JB, 2010, NAT NANOTECHNOL, V5, P660, DOI [10.1038/nnano.2010.148, 10.1038/NNANO.2010.148]
   He LN, 2011, NAT NANOTECHNOL, V6, P428, DOI [10.1038/NNANO.2011.99, 10.1038/nnano.2011.99]
   Holodniy M, 2007, JAIDS-J ACQ IMM DEF, V44, P20, DOI 10.1097/01.qai.0000248354.63748.54
   Howes PD, 2014, SCIENCE, V346, P53, DOI 10.1126/science.1247390
   Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331
   Kelley SO, 2014, NAT NANOTECHNOL, V9, P969, DOI [10.1038/nnano.2014.261, 10.1038/NNANO.2014.261]
   Klein D, 2003, JAIDS-J ACQ IMM DEF, V32, P143, DOI 10.1097/00126334-200302010-00005
   Kosaka PM, 2014, NAT NANOTECHNOL, V9, P1047, DOI [10.1038/nnano.2014.250, 10.1038/NNANO.2014.250]
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Li JW, 2015, NANO LETT, V15, P8217, DOI 10.1021/acs.nanolett.5b03728
   Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Ma W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3689
   Mahler M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2548
   Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d
   Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   MILES SA, 1993, NEW ENGL J MED, V328, P297, DOI 10.1056/NEJM199302043280501
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702
   NISHANIAN P, 1990, J INFECT DIS, V162, P21, DOI 10.1093/infdis/162.1.21
   Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3
   Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007
   Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641
   Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9
   Rodriguez-Lorenzo L, 2012, NAT MATER, V11, P604, DOI [10.1038/NMAT3337, 10.1038/nmat3337]
   Sanford CA, 2017, NEURON, V93, P164, DOI 10.1016/j.neuron.2016.11.034
   Schallmeiner E, 2007, NAT METHODS, V4, P135, DOI 10.1038/nmeth974
   Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5
   Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437
   Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U
   Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862
   Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5519
   Weathington JM, 2012, ENDOCRINOLOGY, V153, P5701, DOI 10.1210/en.2012-1815
   WEBER R, 1991, J CLIN MICROBIOL, V29, P1323, DOI 10.1128/JCM.29.7.1323-1327.1991
   Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138
   Zorrilla EP, 2014, FRONT NEUROENDOCRIN, V35, P234, DOI 10.1016/j.yfrne.2014.01.001
   Zrazhevskiy P, 2016, ANGEW CHEM INT EDIT, V55, P8975, DOI 10.1002/anie.201603945
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
NR 59
TC 34
Z9 34
U1 18
U2 77
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2157-846X
J9 NAT BIOMED ENG
JI Nat. Biomed. Eng
PD JUN
PY 2017
VL 1
IS 6
AR UNSP 0082
DI 10.1038/s41551-017-0082
PG 12
WC Engineering, Biomedical
SC Engineering
GA FR1VZ
UT WOS:000418857100006
PM 29082104
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ng, V
   Fazil, A
   Gachon, P
   Deuymes, G
   Radojevic, M
   Mascarenhas, M
   Garasia, S
   Johansson, MA
   Ogden, NH
AF Ng, Victoria
   Fazil, Aamir
   Gachon, Philippe
   Deuymes, Guillaume
   Radojevic, Milka
   Mascarenhas, Mariola
   Garasia, Sophiya
   Johansson, Michael A.
   Ogden, Nicholas H.
TI Assessment of the Probability of Autochthonous Transmission of
   Chikungunya Virus in Canada under Recent and Projected Climate Change
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
ID ALBOPICTUS DIPTERA-CULICIDAE; AEDES-ALBOPICTUS; NORTH-AMERICA;
   UNITED-STATES; ZIKA VIRUS; AEGYPTI; EPIDEMIC; MODEL; INFECTION; OUTBREAK
AB BACKGROUND: Chikungunya virus (CHIKV) is a reemerging pathogen transmitted by Aedes aegypti and Aedes albopictus mosquitoes. The ongoing Caribbean outbreak is of concern due to the potential for infected travelers to spread the virus to countries where vectors are present and the population is susceptible. Although there has been no autochthonous transmission of CHIKV in Canada, there is concern that both Ae. albopictus and CHIKV will become established, particularly under projected climate change. We developed risk maps for autochthonous CHIKV transmission in Canada under recent (1981-2010) and projected climate (2011-2040 and 2041-2070).
   METHODS: The risk for CHIKV transmission was the combination of the climatic suitability for CHIKV transmission potential and the climatic suitability for the presence of Ae. albopictus; the former was assessed using a stochastic model to calculate R-0 and the latter was assessed by deriving a suitability indicator (SIG) that captures a set of climatic conditions known to influence the ecology of Ae. albopictus. R-0 and SIG were calculated for each grid cell in Canada south of 60 degrees N, for each time period and for two emission scenarios, and combined to produce overall risk categories that were mapped to identify areas suitable for transmission and the duration of transmissibility.
   FINDINGS: the risk for autochthonous CHIKV transmission under recent climate is very low with all of Canada classified as unsuitable or rather unsuitable for transmission. Small parts of southern coastal British Columbia become progressively suitable with short-term and long-term projected climate; the duration of potential transmission is limited to 1-2 months of the year.
   INTERPRETATION: Although the current risk for autochthonous CHIKV transmission in Canada is very low, our study could be further supported by the routine surveillance of Ae. albopictus in areas identified as potentially suitable for transmission given our uncertainty on the current distribution of this species in Canada.
C1 [Ng, Victoria; Fazil, Aamir; Mascarenhas, Mariola; Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada.
   [Ng, Victoria; Fazil, Aamir; Mascarenhas, Mariola; Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada.
   [Gachon, Philippe; Deuymes, Guillaume] Univ Quebec, ESCER Etud & Simulat Climat Echelle Reg Ctr, Montreal, PQ, Canada.
   [Radojevic, Milka] CERFACS, Toulouse, France.
   [Garasia, Sophiya] Univ Guelph, Dept Populat Med, Guelph, ON, Canada.
   [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, San Juan, PR USA.
RP Ng, V (corresponding author), Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Natl Microbiol Lab, Suite 206,160 Res Lane, Guelph, ON N1G 5B2, Canada.
EM victoria.ng@phac-aspc.gc.ca
OI Johansson, Michael/0000-0002-5090-7722; Gachon,
   Philippe/0000-0002-0711-0822
FU Compute Canada national HPC platform; Calcul Quebec regional HPC
   platform
FX We would like to thank L. Sushama and K. Winger [Centre pour I'etude et
   la simulation du climat a I'echelle regionale (ESCER), Universite du
   Quebec a Montreal (UQAM)], who provided the CRCM5 simulations. We also
   acknowledge the support of Compute Canada national HPC platform and the
   Calcul Quebec regional HPC platform to run the CRCM5 model.
CR Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270
   Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brady O, 2013, MODEL ADULT AEDES AL
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   BRIGHTON SW, 1983, S AFR MED J, V63, P313
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Capinha C, 2014, ECOHEALTH, V11, P420, DOI 10.1007/s10393-014-0918-y
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Centers for Disease Control and Prevention, 2015, CHIK INF VECT CONTR
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Christofferson RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110538
   Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Diaconescu EP, 2016, ATMOS OCEAN, V54, P418, DOI 10.1080/07055900.2016.1185005
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Drebot MA, 2014, CANADA COMMUNICABLE, V41, P2
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   European Center for Disease Prevention and Control, 2009, 0905 EUR CTR DIS PRE
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   Fischer D, 2010, GEOSPATIAL HEALTH, V5, P59, DOI 10.4081/gh.2010.187
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   FOURIE ED, 1979, S AFR MED J, V56, P130
   Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Government of Canada, 2016, CLIM DAT SCEN CAN SY
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hernandez-Diaz L, 2013, CLIM DYNAM, V40, P1415, DOI 10.1007/s00382-012-1387-z
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Jupp PG, 1988, ARBOVIRUSES EPIDEMIO, VII, P137
   Kalantri SP, 2006, NATL MED J INDIA, V19, P315
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Khan K, 2014, PLOS CURR, V6
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447
   Laprise R, 2013, CLIM DYNAM, V41, P3219, DOI 10.1007/s00382-012-1651-2
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lenderink G, 2007, HYDROL EARTH SYST SC, V11, P1143
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Martynov A, 2013, CLIM DYNAM, V41, P2973, DOI 10.1007/s00382-013-1778-9
   McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nicholson J, 2014, J MED ENTOMOL, V51, P948, DOI 10.1603/ME14079
   Ogden N H, 2015, Can Commun Dis Rep, V41, P11
   Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4
   Pan American Health Organization, 2016, EP WEEK, V11
   Pan American Health Organization and World Health Organization, 2013, EP ALER
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Public Health Ontario, 2013, VECT BORN DIS 2013 S
   Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Separovic L, 2013, CLIM DYNAM, V41, P3167, DOI 10.1007/s00382-013-1737-5
   Statistics Canada, 2016, THIS AN BAS STAT CAN
   Stocker T.F., 2013, CLIMATE CHANGE 2013
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Tilston N, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-61
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI 10.1007/s10584-011-0148-z
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   White RH, 2013, GEOPHYS RES LETT, V40, P2907, DOI 10.1002/grl.50612
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zender CS, 2015, NETCDF OPERATOR NCO
NR 95
TC 6
Z9 6
U1 1
U2 10
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD JUN
PY 2017
VL 125
IS 6
AR UNSP 067001
DI 10.1289/EHP669
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA FK8VK
UT WOS:000413788400010
PM 28731409
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alves, LS
   Estanislau, C
   Barreto, L
   Batista, F
   Toppa, N
AF Alves, Leonardo Souza
   Estanislau, Cesar
   Barreto, Lucio
   Batista, Francisco
   Toppa, Nivaldo
TI Concomitant testicular infection by Zika virus and Schistosoma mansoni
   in a Brazilian young boy
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE Zika virus; Schistosoma mansoni; testicle; orchiepididymitis
ID SEXUAL TRANSMISSION; UNITED-STATES; PREVENTION
AB The identification of a escrotal mass without pain or report of trauma should be investigated to rule out scrotal cancer. We report the case of a young Brazilian boy who underwent orchiectomy after magnetic resonance imaging (MRI) and duplex scan (DS) indicating a high possibility of cancer. Blood exams ruled out the possibility of cancer. Testicular biopsy was not indicated. After surgery the diagnostic was extensive orchiepididymitis by Schistosoma. In endemic areas orchiepididymis by Schistosoma should be investigate to avoid unnecessary surgeries. This patient was also infected with Zika virus.
C1 [Alves, Leonardo Souza] Amer Urol Assoc, Procriar Inst Urol & Androl, Sociedade Brasileira Urol, Belo Horizonte, MG, Brazil.
   [Estanislau, Cesar] Fac Newton Paiva, Dept Biol Sci, Belo Horizonte, MG, Brazil.
   [Barreto, Lucio; Batista, Francisco] FCM MG, Belo Horizonte, MG, Brazil.
   [Toppa, Nivaldo] Univ Fed Minas Gerais, Pathol, Belo Horizonte, MG, Brazil.
RP Alves, LS (corresponding author), Rua Bahia 2-696,Sala 1-303, BR-30120016 Belo Horizonte, MG, Brazil.
EM procriar@gmail.com
CR AREAN VM, 1956, AM J CLIN PATHOL, V26, P1010
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   de Silva S, 2006, CLIN INFECT DIS, V42, P303, DOI 10.1086/499109
   Francolugo-Velez VA, 2010, REV MEX UROL, V70, P187
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Iglesias JD, 1997, ASPECTOS MED PARASIT, P186
   Katz N, 2006, CIENC CULTURA, V55, P38
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NUSSENZWEIG RS, 1982, NEW ENGL J MED, V306, P423, DOI 10.1056/NEJM198202183060711
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rambau PF, 2011, CASE REP INFECT DIS, DOI 10.1155/2011/787961
NR 19
TC 2
Z9 2
U1 0
U2 2
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JUN
PY 2017
VL 63
IS 6
BP 500
EP 503
DI 10.1590/1806-9282.63.06.500
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA FG0NO
UT WOS:000409450200007
PM 28876425
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rosenberg, K
AF Rosenberg, Karen
TI ZIKA VIRUS CAN PERSIST IN BODY FLUIDS FOR PROLONGED PERIODS
SO AMERICAN JOURNAL OF NURSING
LA English
DT Editorial Material
CR Paz-Bailey G, 2017, N ENGL J MED
NR 1
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-936X
EI 1538-7488
J9 AM J NURS
JI Am. J. Nurs.
PD JUN
PY 2017
VL 117
IS 6
BP 71
EP 71
DI 10.1097/01.NAJ.0000520261.80330.32
PG 1
WC Nursing
SC Nursing
GA EW1RV
UT WOS:000402271200023
PM 28541997
DA 2020-07-08
ER

PT J
AU Rodrigues, LC
AF Rodrigues, Laura C.
TI Zika's Long Haul: Tackling the Causes of Human Vulnerability to
   Mosquito-Borne Viruses
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM laura.rodrigues@lshtm.ac.uk
FU European UnionEuropean Union (EU) [734584]
FX The author is partially funded by the European Union's Horizon 2020
   research and innovation program under Zika-PLAN grant agreement No.
   734584.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Chan M., 2017, ZIKA WE MUST BE READ
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
NR 7
TC 2
Z9 2
U1 0
U2 3
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JUN
PY 2017
VL 107
IS 6
BP 831
EP 833
DI 10.2105/AJPH.2017.303792
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE5CY
UT WOS:000408230800020
PM 28498761
OA Green Published
DA 2020-07-08
ER

PT J
AU Greer, SL
   Singer, PM
AF Greer, Scott L.
   Singer, Phillip M.
TI Addressing Zika in the United States: Polarization, Fragmentation, and
   Public Health
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Greer, Scott L.] Univ Michigan, Sch Publ Hlth, Hlth Management & Policy, Ann Arbor, MI 48109 USA.
   [Singer, Phillip M.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, 1415 Washington Hts,SPH 2 M3050, Ann Arbor, MI 48109 USA.
RP Singer, PM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, 1415 Washington Hts,SPH 2 M3050, Ann Arbor, MI 48109 USA.
EM pmsinger@umich.edu
OI Greer, Scott Edward Lennarson/0000-0002-5288-0471
CR Democratic Policy and Communications Center, 2016, MOR AM CONTR ZIK VIR
   Greer SL, 2017, HEALTH ECON POLICY L, V12, P81, DOI [10.1017/S1744133116000244, 10.1017/s1744133116000244]
   Hetherington Marc J, 2015, WHY WASHINGTON WONT
   Huetteman E, 2016, NY TIMES, pA14
   Klain R., 2016, DEMOCRACY, P20
   Lee Frances E., 2009, IDEOLOGY POLITICS PR
NR 6
TC 3
Z9 3
U1 0
U2 0
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JUN
PY 2017
VL 107
IS 6
BP 861
EP 862
DI 10.2105/AJPH.2017.303772
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE5CY
UT WOS:000408230800035
PM 28498743
OA Green Published
DA 2020-07-08
ER

PT J
AU Osorio-De-Castro, CGS
   Miranda, ES
   de Freitas, CM
   de Camargo, KR
   Cranmer, HH
AF Serpa Osorio-de-Castro, Claudia Garcia
   Miranda, Elaine Silva
   de Freitas, Carlos Machado
   de Camargo, Kenneth Rochel, Jr.
   Cranmer, Hilarie Hartel
TI The Zika Virus Outbreak in Brazil: Knowledge Gaps and Challenges for
   Risk Reduction
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID EPIDEMIOLOGY; AMERICA
AB We analyzed uncertainties and complexities of the Zika virus outbreak in Brazil, and we discuss risk reduction for future emergencies. We present the public health situation in Brazil and concurrent determinants of the epidemic and the knowledge gaps that persist despite building evidence from research, making public health decisions difficult.
   Brazil has adopted active measures, but producing desired outcomes may be uncertain because of partial or unavailable information. Reducing population group vulnerabilities and acting on environmental issues are medium- to long-term measures.
   Simultaneously dealing with information gaps, uncontrolled disease spread, and vulnerabilities is a new risk scenario and must be approached decisively to face emerging biothreats.
C1 [Serpa Osorio-de-Castro, Claudia Garcia] Escola Nacl Saude Publ Sergio Arouca, Dept Polit Medicamentos & Assistencia Farmaceut, Rio De Janeiro, Brazil.
   [Miranda, Elaine Silva] Univ Fed Fluminense, Dept Farm & Adm Farmaceut, Niteroi, RJ, Brazil.
   [de Freitas, Carlos Machado] Escola Nacl Saude Publ Sergio Arouca, Ctr Estudos & Pesquisas Emergencias & Desastres S, Rio De Janeiro, Brazil.
   [de Camargo, Kenneth Rochel, Jr.] Univ Estado Rio de Janeiro, Dept Planejamento & Adm Saude, Rio De Janeiro, Brazil.
   [Cranmer, Hilarie Hartel] Massachusetts Gen Hosp, Dept Global Hlth & Populat, Boston, MA 02114 USA.
RP Osorio-De-Castro, CGS (corresponding author), Escola Nacl Saude Publ Sergio Arouca, Rua Leopoldo Bulhoes 1480 Sala 625, BR-21040210 Rio De Janeiro, RJ, Brazil.
EM claudiaosorio.soc@gmail.com
RI de Castro, Claudia Garcia Serpa Osorio/H-1549-2012; Miranda, Elaine
   S/J-8268-2012
OI de Castro, Claudia Garcia Serpa Osorio/0000-0003-4875-7216; Miranda,
   Elaine/0000-0002-6204-5023
CR [Anonymous], 2002, SAL PUBL AM NUEV CON
   [Anonymous], 2016, PROT VIG RESP OC MIC
   Associacao Brasileira de Saude Coletiva, 2016, NOT TECN MICR DOENC
   Attaran A, 2016, PODIUM WHY PUBLIC HL
   Attaran A, 2016, COMMUNICATION
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil Ministry of Health, 2015, B EP SIF, V2015
   Brazil Ministry of Health, 2014, MON CAS DENG AT SEM
   Brazil Ministry of Health, 2013, SURT SAR PERN
   Brazil Ministry of Health, 2016, MON CAS SE MICR BRAS
   Brazil Ministry of Health, 2016, CRIT OR PROC DEC INT
   Camargo TMCR, 2016, CAD SAUDE PUBLICA, V32
   Carvalho CN, 2011, REV SAUDE PUBL, V45, P548, DOI [10.1590/S0034-89102011005000021, 10.1590/s0034-89102011000300013]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan M, 2016, COMMUNICATION
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   FUNTOWICZ S, 1994, FUTURES, V26, P568, DOI 10.1016/0016-3287(94)90029-9
   Funtowicz S., 2003, POSTNORMAL SCI
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lavell A., DECISION MAKING RISK
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, 2016, LIN PREL VIG MICR RE
   Singapore Government National Environment Agency, 2016, LAT DENG DAT
   United Nations International Strategy for Disaster Risk Reduction, 2016, BANGK PRINC IMPL HLT
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, 2007, RISK RED EM PREP WHO
   World Health Organization, 2012, SUMM 2011 STAT PART
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   WYNNE B, 1992, GLOBAL ENVIRON CHANG, V2, P111, DOI 10.1016/0959-3780(92)90017-2
NR 37
TC 11
Z9 11
U1 1
U2 4
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JUN
PY 2017
VL 107
IS 6
BP 960
EP 965
DI 10.2105/AJPH.2017.303705
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE5CY
UT WOS:000408230800053
PM 28426311
OA Green Published
DA 2020-07-08
ER

PT J
AU Walker, JL
   Conway, JH
   Svenson, JE
AF Walker, Jessica L.
   Conway, James H.
   Svenson, James E.
TI Zika: information in the nick of time
SO JOURNAL OF GLOBAL HEALTH
LA English
DT Editorial Material
C1 [Walker, Jessica L.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA.
   [Conway, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Emergency Med, 800 Univ Bay Dr,Suite 349, Madison, WI 53705 USA.
   [Svenson, James E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA.
RP Svenson, JE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Emergency Med, 800 Univ Bay Dr,Suite 349, Madison, WI 53705 USA.
EM jes@medicine.wisc.edu
CR [Anonymous], 2015, CHIK FEV CAS CAR AM
   [Anonymous], 2016, NATL GEOGRAPHIC
   Guatemalteca CR, 2016, SC JOHNSON SE ACCION
   Libre P, 2016, SOLO MINISTERIO DEPE
   New York Times, 2016, NY TIMES
   World Health Organization, 2016, DENG SEV DENG FACTSH
   Zika virus test limits of mosquito research, MIAMI HERALD
   CBS NEWS
NR 8
TC 1
Z9 1
U1 0
U2 0
PU UNIV EDINBURGH, GLOBAL HEALTH SOC
PI EDINBURGH
PA CENTRE POPULATION HEALTH SCIENCES, TEVIOT PL, EDINBURGH, EH8 9AG,
   SCOTLAND
SN 2047-2978
EI 2047-2986
J9 J GLOB HEALTH
JI J. Glob. Health
PD JUN
PY 2017
VL 7
IS 1
AR 010305
DI 10.7189/jogh.07.010305
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FB5OY
UT WOS:000406192700006
PM 28400948
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rey, FA
   Stiasny, K
   Heinz, FX
AF Rey, Felix A.
   Stiasny, Karin
   Heinz, Franz X.
TI Flavivirus structural heterogeneity: implications for cell entry
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID ZIKA VIRUS-INFECTION; WEST-NILE-VIRUS; DENGUE VIRUS; ENDOTHELIAL-CELLS;
   DC-SIGNR; RECEPTORS; IMMATURE; BIOLOGY; BINDING; NEUTRALIZATION
AB The explosive spread of Zika virus is the most recent example of the threat imposed to human health by flaviviruses. High resolution structures are available for several of these arthropod-borne viruses, revealing alternative icosahedral organizations of immature and mature virions. Incomplete proteolytic maturation, however, results in a cloud of highly heterogeneous mosaic particles. This heterogeneity is further expanded by a dynamic behavior of the viral envelope glycoproteins. The ensemble of heterogeneous and dynamic infectious particles circulating in infected hosts offers a range of alternative possible receptor interaction sites at their surfaces, potentially contributing to the broad flavivirus host-range and variation in tissue tropism. The potential synergy between heterogeneous particles in the circulating cloud thus provides an additional dimension to understand the unanticipated properties of Zika virus in its recent outbreaks.
C1 [Rey, Felix A.] Inst Pasteur, Virol Dept, Struct Virol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France.
   [Rey, Felix A.] CNRS, UMR 3569, 25-28 Rue Dr Roux, F-75015 Paris, France.
   [Stiasny, Karin; Heinz, Franz X.] Med Univ Vienna, Ctr Virol, Kinderspitalgasse 15, A-1090 Vienna, Austria.
RP Rey, FA (corresponding author), Inst Pasteur, Virol Dept, Struct Virol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France.; Rey, FA (corresponding author), CNRS, UMR 3569, 25-28 Rue Dr Roux, F-75015 Paris, France.; Heinz, FX (corresponding author), Med Univ Vienna, Ctr Virol, Kinderspitalgasse 15, A-1090 Vienna, Austria.
EM Felix.rey@pasteur.fr; Franz.X.Heinz@meduniwien.ac.at
OI Stiasny, Karin/0000-0002-1902-8674
FU ANRFrench National Research Agency (ANR); LABEX IBEID; Austrian Science
   Fund (FWF)Austrian Science Fund (FWF)
FX FAR acknowledges funding from the ANR and from the LABEX IBEID; KS and
   FXH from the Austrian Science Fund (FWF).
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Andersen JP, 2016, FRONT PHYSIOL, V7, DOI [10.3339/fphys.2016.00275, 10.3389/fphys.2016.00275]
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Diamond M.S., FIELDS VIROLOGY, P747
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erb SM, 2010, VIROLOGY, V406, P328, DOI 10.1016/j.virol.2010.07.024
   Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936
   Kindhauser MK, 2016, B WHO
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mercer J, 2010, ANN NY ACAD SCI, V1209, P49, DOI 10.1111/j.1749-6632.2010.05772.x
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   MICHAEL FW, 2016, CELL STEM CELL, V19, P703
   Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2015, PROG MOL BIOL TRANSL, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398
   Prasad VM, 2017, NAT STRUCT MOL BIOL
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   VANMEER O, 2008, NAT REV MOL CELL BIO, V9, P112, DOI DOI 10.1091/MBC.E11-11-0936
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 60
TC 24
Z9 24
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD JUN
PY 2017
VL 24
BP 132
EP 139
DI 10.1016/j.coviro.2017.06.009
PG 8
WC Virology
SC Virology
GA FD3DC
UT WOS:000407412700018
PM 28683393
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Weger-Lucarelli, J
   Duggal, NK
   Brault, AC
   Geiss, BJ
   Ebel, GD
AF Weger-Lucarelli, James
   Duggal, Nisha K.
   Brault, Aaron C.
   Geiss, Brian J.
   Ebel, Gregory D.
TI Rescue and Characterization of Recombinant Virus from a New World Zika
   Virus Infectious Clone
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology; Issue 124; Zika virus; ZIKV; cDNA clone; infectious clone;
   arbovirus; molecular clone; flavivirus
ID CDNA; GENOME; STRAIN
AB Infectious cDNA clones allow for genetic manipulation of a virus, thus facilitating work on vaccines, pathogenesis, replication, transmission and viral evolution. Here we describe the construction of an infectious clone for Zika virus (ZIKV), which is currently causing an explosive outbreak in the Americas. To prevent toxicity to bacteria that is commonly observed with flavivirus-derived plasmids, we generated a two-plasmid system which separates the genome at the NS1 gene and is more stable than full-length constructs that could not be successfully recovered without mutations. After digestion and ligation to join the two fragments, full-length viral RNA can be generated by in vitro transcription with T7 RNA polymerase. Following electroporation of transcribed RNA into cells, virus was recovered that exhibited similar in vitro growth kinetics and in vivo virulence and infection phenotypes in mice and mosquitoes, respectively.
C1 [Weger-Lucarelli, James; Geiss, Brian J.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Duggal, Nisha K.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA USA.
RP Ebel, GD (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM gregory.ebel@colostate.edu
OI Weger-Lucarelli, James/0000-0002-9483-1694
FU National Institute of Allergy and Infectious Diseases, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI114675, AI067380]
FX The authors would like to thank Kristen Bullard-Feibelman, Milena
   Veselinovic and Claudia Ruckert for their assistance in characterizing
   the clone-derived virus. This work was supported in part by grants from
   the National Institute of Allergy and Infectious Diseases, NIH under
   grants AI114675 (BJG) and AI067380 (GDE).
CR Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437
   Johansen IE, 1996, P NATL ACAD SCI USA, V93, P12400, DOI 10.1073/pnas.93.22.12400
   KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0
   Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018197
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pu SY, 2014, J GEN VIROL, V95, P1493, DOI 10.1099/vir.0.064915-0
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   RICE C M, 1989, New Biologist, V1, P285
   Roberts PL, 2007, BIOLOGICALS, V35, P343, DOI 10.1016/j.biologicals.2007.02.005
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Weger-Lucarelli J, 2016, J VIROL
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
NR 22
TC 2
Z9 2
U1 2
U2 7
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUN
PY 2017
IS 124
AR e55857
DI 10.3791/55857
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD3QS
UT WOS:000407448100066
PM 28654045
OA Green Published
DA 2020-07-08
ER

PT J
AU Canizares-Carmenate, Y
   Hernandez-Morfa, M
   Torrens, F
   Castellano, G
   Castillo-Garit, JA
AF Canizares-Carmenate, Yudith
   Hernandez-Morfa, Mirelys
   Torrens, Francisco
   Castellano, Gloria
   Castillo-Garit, Juan A.
TI Larvicidal activity prediction against Aedes aegypti mosquito using
   computational tools
SO JOURNAL OF VECTOR BORNE DISEASES
LA English
DT Article
DE Aedes aegypti; larvicide; QSARINS software; vector-borne disease; Zika
ID DIFFERENT VALIDATION CRITERIA; REAL EXTERNAL PREDICTIVITY;
   CORRELATION-COEFFICIENT; QSAR MODELS; EVALUATE; SET
AB Background & objectives: Aedes aegypti is an important vector for transmission of dengue, yellow fever, chikungunya, arthritis, and Zika fever. According to the World Health Organization, it is estimated that Ae. aegypti causes 50 million infections and 25,000 deaths per year. Use of larvicidal agents is one of the recommendations of health organizations to control mosquito populations and limit their distribution. The aim of present study was to deduce a mathematical model to predict the larvicidal action of chemical compounds, based on their structure.
   Methods: A series of different compounds with experimental evidence of larvicidal activity were selected to develop a predictive model, using multiple linear regression and a genetic algorithm for the selection of variables, implemented in the QSARINS software. The model was assessed and validated using the OECDs principles.
   Results: The best model showed good value for the determination coefficient (R-2 = 0.752), and others parameters were appropriate for fitting (s = 0.278 and RMSEtr = 0.261). The validation results confirmed that the model has good robustness (Q(LOO)(2) = 0.682) and stability (R-2-Q(LOO)(2) = 0.070) with low correlation between the descriptors (K-XX = 0.241), an excellent predictive power (R-ext(2) = 0.834) and was product of a non-random correlation (R-Y-scr(2) = 0.100).
   Interpretation & conclusion: The present model shows better parameters than the models reported earlier in the literature, using the same dataset, indicating that the proposed computational tools are more efficient in identifying novel larvicidal compounds against Ae. aegypti.
C1 [Canizares-Carmenate, Yudith; Hernandez-Morfa, Mirelys; Castillo-Garit, Juan A.] Univ Cent Marta Abreu, Unit Comp Aided Mol Biosil Discovery & Bioinforma, CAMD BIR Unit, Fac Quim Farm, Santa Clara, Cuba.
   [Torrens, Francisco] Univ Valencia, Inst Univ Ciencia Mol, Edifici Inst Paterna, Valencia, Spain.
   [Castellano, Gloria] Univ Catolica Valencia San Vicente Martir, Fac Vet & Ciencias Expt, Dept Ciencias Expt & Matemat, Valencia, Spain.
   [Castillo-Garit, Juan A.] Univ Ciencias Med Villa Clara, Unidad Toxicol Expt, Santa Clara 50200, Villa Clara, Cuba.
RP Castillo-Garit, JA (corresponding author), Univ Ciencias Med Villa Clara, Unidad Toxicol Expt, Santa Clara 50200, Villa Clara, Cuba.
EM jacgarit@yahoo.es
RI Estornell, Castellano G/Q-7145-2017; Castillo-Garit, Juan
   A./J-1648-2015; Torrens, Francisco/AAB-2897-2019
OI Estornell, Castellano G/0000-0001-7284-880X; Castillo-Garit, Juan
   A./0000-0003-0896-9484; Torrens, Francisco/0000-0002-8534-208X
FU Generalitat ValencianaGeneralitat Valenciana [PROME-TEO/2016/094];
   Valencia Catholic University Saint Vincent Martyr [PRUCV/2015/617, 2017]
FX The authors are grateful to Prof. Paola Gramatica and her group of the
   University of Insubria for providing the QSARINS software for this
   study. This work was supported by Generalitat Valenciana (Project No.
   PROME-TEO/2016/094) and Valencia Catholic University Saint Vincent
   Martyr (Projects Nos. PRUCV/2015/617 and 2017).
CR Castillo-Garit JA, 2015, EUR J MED CHEM, V96, P238, DOI 10.1016/j.ejmech.2015.03.063
   Atkinson AC, 1985, PLOTS TRANSFORMATION, Vxi, P282
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Brito-Sanchez Y, 2013, SAR QSAR ENVIRON RES, V24, P235, DOI 10.1080/1062936X.2013.766260
   Canizares-Carmenate Y, 2016, ARAB J CHEM
   Castillo-Garit JA, 2017, MED CHEM, V13, P664, DOI 10.2174/1573406413666170209124302
   Castillo-Garit JA, 2015, J BRAZIL CHEM SOC, V26, P1218, DOI 10.5935/0103-5053.20150087
   Castillo-Garit JA, 2012, CHEM BIOL DRUG DES, V80, P38, DOI 10.1111/j.1747-0285.2012.01378.x
   Castillo-Garit JA, 2009, QSAR COMB SCI, V28, P1465, DOI 10.1002/qsar.200960085
   Chirico N, 2012, J CHEM INF MODEL, V52, P2044, DOI 10.1021/ci300084j
   Chirico N, 2011, J CHEM INF MODEL, V51, P2320, DOI 10.1021/ci200211n
   Consonni V, 2009, J CHEM INF MODEL, V49, P1669, DOI 10.1021/ci900115y
   FRIEDMAN JH, 1991, ANN STAT, V19, P123, DOI 10.1214/aos/1176347973
   FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963
   Garza-Robledo AA, 2011, J AM MOSQUITO CONTR, V27, P404, DOI 10.2987/11-6133.1
   Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1
   Gramatica P., 2013, QSARINS SOFTWARE QSA
   Gramatica P, 2013, J COMPUT CHEM, V34, P2121, DOI 10.1002/jcc.23361
   Huong LTT, 2016, LETT DRUG DES DISCOV, V13, P161, DOI 10.2174/1570180812666150630183511
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Magadula JJ, 2009, J MED PLANTS RES, V3, P674
   Marrero-Ponce Y, 2010, MOL DIVERS, V14, P731, DOI 10.1007/s11030-009-9201-5
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ojha PK, 2011, CHEMOMETR INTELL LAB, V107, P194, DOI 10.1016/j.chemolab.2011.03.011
   Rucker C, 2007, J CHEM INF MODEL, V47, P2345, DOI 10.1021/ci700157b
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Schuurmann G, 2008, J CHEM INF MODEL, V48, P2140, DOI 10.1021/ci800253u
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Shi LM, 2001, J CHEM INF COMP SCI, V41, P186, DOI 10.1021/ci000066d
   Talete srl. DRAGON for Windows, 2007, DRAGON WIND SOFTW MO
   Todeschini R, 1999, CHEMOMETR INTELL LAB, V46, P13, DOI 10.1016/S0169-7439(98)00124-5
   Wang ZQ, 2012, PEST MANAG SCI, V68, P1041, DOI 10.1002/ps.3265
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Worth AP, 2007, SAR QSAR ENVIRON RES, V18, P111, DOI 10.1080/10629360601054255
NR 34
TC 5
Z9 5
U1 0
U2 8
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-9062
J9 J VECTOR DIS
JI J. Vector Borne Dis.
PD JUN
PY 2017
VL 54
IS 2
BP 164
EP 171
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FB8ZN
UT WOS:000406429500007
PM 28748838
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Alaniz, AJ
   Bacigalupo, A
   Cattan, PE
AF Alaniz, Alberto J.
   Bacigalupo, Antonella
   Cattan, Pedro E.
TI Spatial quantification of the world population potentially exposed to
   Zika virus
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE ZIKV; Aedes aegypti; viral contagion risk; vectorial transmission;
   vector niche modelling; exposure level
ID SPECIES DISTRIBUTION MODELS; FRENCH-POLYNESIA; CLIMATE-CHANGE;
   SAMPLE-SIZE; WEST NILE; TRANSMISSION; CONSERVATION; PERFORMANCE; POVERTY
AB Background: Zika virus is an emerging Flaviviridae virus, which has spread rapidly in the last few years. It has raised concern because it has been associated with fetus microcephaly when pregnant women are infected. The main vector is the mosquito Aedes aegypti, distributed in tropical areas.
   Methods: Niche modelling techniques were used to estimate the potential distribution area of A. aegypti. This was overlapped with human population density, determining areas of potential transmission risk worldwide. Afterwards, we quantified the population at risk according to risk level.
   Results: The vector transmission risk is distributed mainly in Asia and Oceania on the shores of the Indian Ocean. In America, the risk concentrates in the Atlantic coast of South America and in the Caribbean Sea shores in Central and North America. In Africa, the major risk is concentrated in the Pacific and Atlantic coasts of Central and South Africa. The world population under high and very high risk levels includes 2.261 billion people.
   Conclusions: These results illustrate Zika virus risk at the global level and provide maps to target the prevention and control measures especially in areas with higher risk, in countries with less sanitation and poorer resources. Many countries without previous vector reports could become active transmission zones in the future, so vector surveillance should be implemented or reinforced in these areas.
C1 [Alaniz, Alberto J.] Univ Chile, Fac Ciencias Vet & Pecuarias, Dept Ciencias Biol Anim, Lab Ecol Ambientes Fragmentados, Santiago, Chile.
   [Alaniz, Alberto J.] Univ Chile, Fac Ciencias Agron, Dept Recursos Nat Renovables, Lab Ecol Ecosistemas, Santiago, Chile.
   [Bacigalupo, Antonella; Cattan, Pedro E.] Univ Chile, Fac Ciencias Vet & Pecuarias, Dept Ciencias Biol Anim, Lab Ecol, Santiago, Chile.
RP Alaniz, AJ (corresponding author), Santa Rosa 11735, Santiago, Chile.
EM alberto.alaniz@ug.uchile.cl
RI CATTAN, PEDRO E/A-2780-2008; Bacigalupo, Antonella/Q-7189-2019; Alaniz,
   Alberto J./J-3104-2019
OI Bacigalupo, Antonella/0000-0003-1661-8916; 
FU Fondo Nacional de Desarrollo de Ciencia y Tecnologia FONDECYT [1140650]
FX This work was supported by Fondo Nacional de Desarrollo de Ciencia y
   Tecnologia FONDECYT (grant number 1140650) to A.B. and P.E.C.
CR Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708
   Alsan MM, 2011, INFECT DIS CLIN N AM, V25, P611, DOI 10.1016/j.idc.2011.05.004
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BRADLEY C, 1985, MATH GAZ, V69, P12, DOI 10.2307/3616441
   CDC (Centers for Disease Control and Prevention), 2016, ALL COUNTR TERR ACT
   Center for International Earth Science Information Network (CIESIN) Columbia University and Centro Internacional de Agricultura Tropical (CIAT)., GRIDD POP WORLD VERS
   [Center for International Earth Science Information Network CUNY Institute for Demographic Research International Food Policy Research Institute World Bank Centro Internacional de Agricultura Tropical], GLOB RUR URB MAPP PR
   Conley AK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-289
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dicko AH, 2014, P NATL ACAD SCI USA, V111, P10149, DOI 10.1073/pnas.1407773111
   Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foley DH, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-11
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franklin J, 2013, DIVERS DISTRIB, V19, P1217, DOI 10.1111/ddi.12125
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P1
   Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x
   Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   Illoldi-Rangel P, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/959101
   Institute de Salud Publica de Chile, 2016, ISPCH B, V6, p[1, 2010]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Larson SR, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11001
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI DOI 10.1145/1015330.1015412
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Pyke CR, 2005, BIOL CONSERV, V125, P1, DOI 10.1016/j.biocon.2004.08.004
   Rapacciuolo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040212
   Rodriguez-Morales AJ, 2015, IMEDPUB J ARCH MED, V11, P1
   ROYSTON JP, 1983, J ROY STAT SOC D-STA, V32, P297, DOI 10.2307/2987935
   ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115
   UN Dept. of Economic and Social Affairs Population Division, 2013, 19502010 UN DEP EC S
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Vries P, 2001, WORKSH SPAT ASP DEM, P1
   Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wongkoon S, 2013, INDIAN J MED RES, V138, P347
   Xia S, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-27
   Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023
NR 51
TC 12
Z9 13
U1 0
U2 23
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD JUN
PY 2017
VL 46
IS 3
BP 966
EP 975
DI 10.1093/ije/dyw366
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FB6HP
UT WOS:000406242600030
PM 28338754
OA Bronze
DA 2020-07-08
ER

PT J
AU Collins, M
   de Silva, A
AF Collins, Matthew
   de Silva, Aravinda
TI Cross-fit T cells battle Zika virus
SO NATURE MICROBIOLOGY
LA English
DT Editorial Material
ID DENGUE VIRUS; INFECTION; PROTECTION; MICE
AB Flaviviruses stimulate cross-reactive immune responses that may reduce or exacerbate manifestations of subsequent flavivirus infection. Recent work demonstrates that cross-reactive T cells protect against Zika in HLA transgenic mice, a key step in the development of safe and effective vaccines.
C1 [Collins, Matthew] Univ N Carolina, Div Infect Dis, Dept Med, Sch Med, Chapel Hill, NC 27599 USA.
   [de Silva, Aravinda] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA.
RP de Silva, A (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA.
EM aravinda_desilva@med.unc.edu
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Halstead SB, 2015, F1000RES
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
NR 12
TC 4
Z9 4
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JUN
PY 2017
VL 2
IS 6
AR 17082
DI 10.1038/nmicrobiol.2017.82
PG 2
WC Microbiology
SC Microbiology
GA FB2VI
UT WOS:000406000900020
PM 28540930
DA 2020-07-08
ER

PT J
AU Zou, J
   Shi, PY
AF Zou, Jing
   Shi, Pei-Yong
TI Adulthood Sequelae of Congenital Zika Virus Infection in Mice
SO EBIOMEDICINE
LA English
DT Editorial Material
C1 [Zou, Jing; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cui L., 2017, EBIOMEDICINE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
NR 11
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUN
PY 2017
VL 20
BP 11
EP 12
DI 10.1016/j.ebiom.2017.05.005
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FA8TT
UT WOS:000405719700006
PM 28487052
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cui, LY
   Zou, P
   Chen, E
   Yao, H
   Zheng, H
   Wang, Q
   Zhu, JN
   Jiang, SB
   Lu, L
   Zhang, JY
AF Cui, Liyuan
   Zou, Peng
   Chen, Er
   Yao, Hao
   Zheng, Hao
   Wang, Qian
   Zhu, Jing-Ning
   Jiang, Shibo
   Lu, Lu
   Zhang, Jiayi
TI Visual and Motor Deficits in Grown-up Mice with Congenital Zika Virus
   Infection
SO EBIOMEDICINE
LA English
DT Article
DE ZIKV; Congenital Zika syndrome; Intracranial calcifications; Visual and
   motor dysfunctions; Prognosis evaluation
ID NEURAL PROGENITORS; BRAIN; NIGERIA
AB Human infants with congenital Zika virus (ZIKV) infection exhibit a range of symptoms including microcephaly, intracranial calcifications, macular atrophy and arthrogryposis. More importantly, prognosis data have lagged far behind the recent outbreak of ZIKV in 2015. In this work, we allow congenitally ZIKV-infected mice to grow into puberty. These mice exhibited motor incoordination and visual dysfunctions, which can be accounted by anatomical defects in the retina and cerebellar cortex. In contrary, anxiety level of the ZIKV-infected mice is normal. The spectrum of anatomical and behavioral deficits is consistent across different mice. Our data provided evidence that may help predict the public health burden in terms of prognosis of ZIKV-related congenital brain malformations in an animal model. Our study provided behavioral evaluation for the prognosis of congenital ZIKV infection and provides a platform for screening and evaluation of drugs candidates and treatment aiming at improving regeneration of infected neurons to prevent sequelae caused by ZIKV infection of fetus.
   (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Cui, Liyuan; Zou, Peng; Chen, Er; Zheng, Hao; Wang, Qian; Jiang, Shibo; Lu, Lu; Zhang, Jiayi] Fudan Univ, State Key Lab Med Neurobiol, Collaborat Innovat Ctr Brain Sci,Minist Educ, Minist Hlth,Inst Brain Sci,Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
   [Cui, Liyuan; Zou, Peng; Chen, Er; Zheng, Hao; Wang, Qian; Jiang, Shibo; Lu, Lu; Zhang, Jiayi] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.
   [Yao, Hao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, 600 Wan Ping Nan Rd, Shanghai 200030, Peoples R China.
   [Zhu, Jing-Ning] Nanjing Univ, Sch Life Sci, Dept Biol Sci & Technol, State Key Lab Pharmaceut Biotechnol, 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
RP Jiang, SB; Lu, L; Zhang, JY (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Collaborat Innovat Ctr Brain Sci,Minist Educ, Minist Hlth,Inst Brain Sci,Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.; Jiang, SB; Lu, L; Zhang, JY (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.
EM shibojiang@fudan.edu.cn; lul@fudan.edu.cn; jiayizhang@fudan.edu.cn
RI Jiang, Shibo/L-4500-2014; Zhu, Jing-Ning/C-7482-2014; Lu, Lu/K-7070-2014
OI Lu, Lu/0000-0002-2255-0391; Yao, Hao/0000-0002-7230-6928; Zhu,
   Jing-Ning/0000-0002-3695-9200; Zhang, Jiayi/0000-0002-1575-0723
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31271158, 31421091, 31422025]; Young 1000 Plan and
   Ministry of Science and Technology of the People's Republic of China
   [2015AA020512]; Ministry of Science and Technology of the People's
   Republic of ChinaMinistry of Science and Technology, China
   [2015AA020930, 2016YFC1202901, 2016YFC1201000]; Shanghai Rising-Star
   Program [16QA1400300]
FX J.Z. thanks the following funding agencies for supporting this work: the
   National Natural Science Foundation of China (31271158, 31421091 and
   31422025), the Young 1000 Plan and Ministry of Science and Technology of
   the People's Republic of China (2015AA020512). L.L. and S.J. thank the
   following funding agencies for supporting this work: Ministry of Science
   and Technology of the People's Republic of China (2015AA020930,
   2016YFC1202901 and 2016YFC1201000) and the Shanghai Rising-Star Program
   (16QA1400300). We thank Dr. Boyin Qin for aid inmicro-CT data collection
   and Dr. Qian Huang for aid in behavioral data analysis.
CR Blokland A, 2002, J PSYCHOPHARMACOL, V16, P39, DOI 10.1177/026988110201600112
   Brasil P, 2016, N ENGL J MED
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cornet M., 1979, SERIE ENTOMOLOGIE ME, V17, P47
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jampol LM, 2016, JAMA OPHTHALMOL
   Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   Malone A, 2014, CEREBELLUM, V13, P666, DOI 10.1007/s12311-014-0601-4
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Melo AS, 2016, JAMA NEUROL
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 40
TC 31
Z9 32
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUN
PY 2017
VL 20
BP 193
EP 201
DI 10.1016/j.ebiom.2017.04.029
PG 9
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FA8TT
UT WOS:000405719700026
PM 28583742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McArthur, MA
AF McArthur, Monica A.
TI Zika Virus: Recent Advances towards the Development of Vaccines and
   Therapeutics
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; animal models; immunology; vaccines; congenital Zika
   syndrome
ID ANTIBODY-DEPENDENT ENHANCEMENT; GUILLAIN-BARRE-SYNDROME; T-CELL
   RESPONSES; DENGUE VIRUS; DNA VACCINE; NEUTRALIZING ANTIBODY;
   CROSS-NEUTRALIZATION; HEALTHY-ADULTS; CLINICAL-TRIAL; MOUSE MODEL
AB Zika is a rapidly emerging public health threat. Although clinical infection is frequently mild, significant neurological manifestations have been demonstrated in infants born to Zika virus (ZIKV) infected mothers. Due to the substantial ramifications of intrauterine infection, effective counter-measures are urgently needed. In order to develop effective anti-ZIKV vaccines and therapeutics, improved animal models and a better understanding of immunological correlates of protection against ZIKV are required. This review will summarize what is currently known about ZIKV, the clinical manifestations and epidemiology of Zika as well as, the development of animal models to study ZIKV infection, host immune responses against ZIKV, and the current state of development of vaccines and therapeutics against ZIKV.
C1 [McArthur, Monica A.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
RP McArthur, MA (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
EM mmcarthu@som.umaryland.edu
RI McArthur, Monica/AAD-9682-2019
FU Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF);
   Harold Amos Medical Faculty Development Program [73307]; National
   Institute of Allergy and Infectious Diseases Cooperative Centers on
   Human Immunity (NIAID) [U19 AI-110820]
FX This work was supported, in part, by the Robert Wood Johnson Foundation,
   Harold Amos Medical Faculty Development Program (73307) and the National
   Institute of Allergy and Infectious Diseases Cooperative Centers on
   Human Immunity (NIAID, U19 AI-110820).
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Best SM, 2017, J VIROL, V91
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cong Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004709
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Danko JR, 2011, VACCINE, V29, P7261, DOI 10.1016/j.vaccine.2011.07.019
   De Paula Freitas B., 2016, OPHTHALMOLOGY
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Felix AC, 2017, J MED VIROL
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, P21
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grossi-Soyster E. N, 2016, CURR OPIN PEDIAT
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Huzly D, 2016, EUROSURVEILLANCE, P21
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim JH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0656-x
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kramps T, 2017, METHODS MOL BIOL, V1499, P1, DOI 10.1007/978-1-4939-6481-9_1
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lehrer Axel T, 2011, J Bioterror Biodef, V2011, P3
   Levine MM, 2004, NAT IMMUNOL, V5, P460, DOI 10.1038/ni0504-460
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McArthur M. A., 2011, J BIOTERROR BIODEF, V2
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Rasmussen SA, 2016, N ENGL J MED
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rivino L., 2016, IMMUNOLOGY
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salam A. P, 2017, ANN INTERN MED
   Sandhu SK, 2017, VACCINE, V35, P2986, DOI 10.1016/j.vaccine.2017.03.087
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Song BH, 2017, J NEUROIMMUNOL
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 127
TC 15
Z9 17
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2017
VL 9
IS 6
AR 143
DI 10.3390/v9060143
PG 18
WC Virology
SC Virology
GA FB0JS
UT WOS:000405832000019
PM 28608813
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singer, L
   Vest, KG
   Beadling, CW
AF Singer, Laura
   Vest, Kelly G.
   Beadling, Charles W.
TI Zika Virus: A Review of Management Considerations and Controversies at
   Six Months
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Review
DE risk; surveillance; transmission; vector; Zika virus
ID PUBLIC-HEALTH; INFECTION; DENGUE; BRAZIL
AB Zika virus continues to pose a significant global health threat. While the outbreak pattern may seemingly mirror those of other arboviruses, unique transmission characteristics and clinical outcomes warrant a different approach to traditional public health practices. Sexual transmission and virus-associated fetal and nonfetal neurologic disorders specifically challenge conventional methods of disease protection and prevention with regard to vector control, disease surveillance, and health risk communication. The protocols for outbreak and case limitation led by the World Health Organization (in accordance with Public Health Emergency of International Concern declaration) may be augmented by localized risk categorization and assignment for Zika and future emergent outbreaks. There is currently a great deal of behind the scenes discussion about modifications to the formal process described in the International Health Regulations. A scalable, adaptable, and flexible process is needed that can be customized to a specific threat.
C1 [Singer, Laura; Vest, Kelly G.; Beadling, Charles W.] Uniformed Serv Univ Hlth Sci, Ctr Global Hlth Engagement, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.
RP Singer, L (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Global Hlth Engagement, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.
EM lsinger@cghe.org
CR [Anonymous], 2014, EARL DET ASS RESP AC
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burkle FM, 2016, DISASTER MED PUBLIC, V10, P296, DOI 10.1017/dmp.2016.27
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Davidson A, 2016, MMWR MORB MORTAL WKL
   Duchin JS, 2016, DISASTER MED PUBLIC, V10, P298, DOI 10.1017/dmp.2016.26
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GV, LANCET, DOI [10.1016/S0140-6736(1016)30902-30903, DOI 10.1016/S0140-6736(1016)30902-30903]
   Grills A, 2016, MMWR MORB MORTAL WKL
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Halstead Scott B., 2000, Dengue Bulletin, V24, P60
   Katz Rebecca, 2010, GLOBAL HLTH GOVERNAN, P1
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   McAllister J., 2016, VECTOR SURVEILLANCE
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naccache SN, BIORXIV, DOI [10.1101/049916, DOI 10.1101/049916]
   Rabe IB, MMWR MORB MORTAL WKL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   *WHO, 2009, WHO PAND PHAS DESCR
   World Health Organization, 2016, WHO PUBL HTLH ADV RE
   World Health Organization, 2016, SURV ZIK VIR INF MIC
NR 25
TC 0
Z9 0
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD JUN
PY 2017
VL 11
IS 3
BP 279
EP 284
DI 10.1017/dmp.2016.141
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FA7WM
UT WOS:000405658100002
PM 27572275
OA Bronze
DA 2020-07-08
ER

PT J
AU Riou, J
   Poletto, C
   Boelle, PY
AF Riou, Julien
   Poletto, Chiara
   Boelle, Pierre-Yves
TI A comparative analysis of Chikungunya and Zika transmission
SO EPIDEMICS
LA English
DT Article
DE Zika virus; Chikungunya virus; Outbreak analysis; Multilevel analysis;
   Weather
ID AEDES-AEGYPTI; DENGUE TRANSMISSION; VIRUS-INFECTION; MOSQUITO-BORNE;
   FEVER; VECTOR; MODEL; EPIDEMIC; OUTBREAK; PATTERNS
AB The recent global dissemination of Chikungunya and Zika has fostered public health concern worldwide. To better understand the drivers of transmission of these two arboviral diseases, we propose a joint analysis of Chikungunya and Zika epidemics in the same territories, taking into account the common epidemiological features of the epidemics: transmitted by the same vector, in the same environments, and observed by the same surveillance systems. We analyse eighteen outbreaks in French Polynesia and the French West Indies using a hierarchical time-dependent SIR model accounting for the effect of virus, location and weather on transmission, and based on a disease specific serial interval. We show that Chikungunya and Zika have similar transmission potential in the same territories (transmissibility ratio between Zika and Chikungunya of 1.04 [95% credible interval: 0.97; 1.13]), but that detection and reporting rates were different (around 19% for Zika and 40% for Chikungunya). Temperature variations between 22 degrees C and 29 degrees C did not alter transmission, but increased precipitation showed a dual effect, first reducing transmission after a two-week delay, then increasing it around five weeks later. The present study provides valuable information for risk assessment and introduces a modelling framework for the comparative analysis of arboviral infections that can be extended to other viruses and territories. (C) 2017 The Author(s). Published by Elsevier B.V.
C1 [Riou, Julien; Poletto, Chiara; Boelle, Pierre-Yves] UPMC Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM,UMRS 1136, F-75012 Paris, France.
RP Riou, J (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM,UMRS 1136, F-75012 Paris, France.
EM julien.riou@iplesp.upmc.fr
OI Boelle, Pierre-Yves/0000-0002-5367-8232
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Banu S, 2011, TROP MED INT HEALTH, V16, P598, DOI 10.1111/j.1365-3156.2011.02734.x
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Carpenter B., 2015, J STAT SOFTW
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Centre D'Hygiene et de Salubrite Publique, 2014, SURV DENG ZIK POL FR
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chowell G, 2016, PLOS CURR
   Christophers S. R., 1960, BIONOMICS STRUCTURE
   CIRE Antilles Guyane, 2016, POINT EP 38
   CIRE Antilles Guyane, 2015, POINT EP 2
   Direction de la sante Bureau de veille sanitaire, 2015, SURV VEILL SAN POL F
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gelman A., 2014, BAYESIAN DATA ANAL, V2
   Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Halide H, 2008, INT J ENVIRON HEAL R, V18, P253, DOI 10.1080/09603120801966043
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   HO BC, 1971, B WORLD HEALTH ORGAN, V44, P635
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Kucharski A. J, 2016, PLOS NEGL TROP DIS, V10
   Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Mordecai E., 2016, 063735 BIORXIV
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Perkins T. A., 2015, PLOS CURR, V7, DOI 10.1371
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Souty C, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0019-8
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Su GLS, 2008, AMBIO, V37, P292, DOI 10.1579/0044-7447(2008)37[292:COCFAD]2.0.CO;2
   Thammapalo S., 2005, SE ASIAN J TROP MED, V30, P191
   Vehtari A., ARXIV150704544
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2016, ZIK VIR OUTBR GLOB R
   Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P73
   Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zhang Q, 2016, PROJECTED SPREAD ZIK
NR 62
TC 16
Z9 16
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD JUN
PY 2017
VL 19
BP 43
EP 52
DI 10.1016/j.epidem.2017.01.001
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA FA7MW
UT WOS:000405631800005
PM 28139388
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lustig, Y
   Zelena, H
   Venturi, G
   Van Esbroeck, M
   Rothe, C
   Perret, C
   Koren, R
   Katz-Likvornik, S
   Mendelson, E
   Schwartzh, E
AF Lustig, Yaniv
   Zelena, Hana
   Venturi, Giulietta
   Van Esbroeck, Marjan
   Rothe, Camilla
   Perret, Cecilia
   Koren, Ravit
   Katz-Likvornik, Shiri
   Mendelson, Ella
   Schwartzh, Eli
TI Sensitivity and Kinetics of an NS1-Based Zika Virus Enzyme-Linked
   Immunosorbent Assay in Zika Virus-Infected Travelers from Israel, the
   Czech Republic, Italy, Belgium, Germany, and Chile
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Zika; NS1; ELISA; travelers; sensitivity
ID DIAGNOSIS
AB Serological diagnosis of Zika virus is challenging due to high cross-reactivity of Zika virus with other flavivirus antibodies. Recently, a Zika NS1-based enzyme-linked immunosorbent assay (ELISA) was developed and shown to be highly specific for Zika antibody detection; however, sensitivity was evaluated for only a small number of confirmed Zika-infected patients. In this study, we measured the sensitivity and kinetics of Zika IgM and IgG antibodies using the Zika NS1-based ELISA in 105 samples from 63 returning travelers infected with Zika virus (proven by PCR or neutralization assay) from Israel, Czech Republic, Italy, Belgium, Germany, and Chile. Zika virus IgM was detected from 2 to 42 days post-symptom onset (PSO) with an overall sensitivity of 79% in the first month and 68% until 2 months PSO, while IgG antibodies were detected from 5 days to 3 years PSO with 79% sensitivity. Interestingly, significant differences in IgM sensitivity and IgM detection period were observed between Israeli and European/Chilean Zika-infected travelers, adding to the complexity of Zika infection diagnosis and suggesting that other diagnostic methods should be complemented to reduce false-negative results.
C1 [Lustig, Yaniv; Koren, Ravit; Katz-Likvornik, Shiri; Mendelson, Ella] Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.
   [Zelena, Hana] Inst Publ Hlth, Ostrava, Czech Republic.
   [Zelena, Hana] Univ Def, Fac Mil Hlth Sci, Hradec Kralove, Czech Republic.
   [Venturi, Giulietta] Ist Super Sanita, Rome, Italy.
   [Van Esbroeck, Marjan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Rothe, Camilla] Univ Med Ctr Hamburg Eppendorf, Dept Med, Div Infect Dis & Trop Med, Hamburg, Germany.
   [Perret, Cecilia] Pontificia Univ Catolica Chile, Lab Virol, Sch Med, Santiago, Chile.
   [Mendelson, Ella; Schwartzh, Eli] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Schwartzh, Eli] Sheba Med Ctr, Inst Trop & Travel Med, Tel Hashomer, Israel.
RP Lustig, Y (corresponding author), Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.
EM yaniv.lustig@sheba.health.gov.il
RI VENTURI, GIULIETTA/O-8123-2015
OI VENTURI, GIULIETTA/0000-0002-9078-8350; Van Esbroeck,
   Marjan/0000-0002-7294-6319
CR Cohen D, 1999, Public Health Rev, V27, P217
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Litzba N, 2014, VECTOR-BORNE ZOONOT, V14, P149, DOI 10.1089/vbz.2012.1287
   Lustig Y, 2016, EURO SURVEILL, V21
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Steinhagen K, 2016, EURO SURVEILL, V21
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 18
TC 40
Z9 43
U1 1
U2 22
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JUN
PY 2017
VL 55
IS 6
BP 1894
EP 1901
DI 10.1128/JCM.00346-17
PG 8
WC Microbiology
SC Microbiology
GA FA3IH
UT WOS:000405336200033
PM 28381608
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Yang, KH
   Narayan, RJ
AF Yang, Kai-Hung
   Narayan, Roger J.
TI Analytical methods for detection of Zika virus
SO MRS COMMUNICATIONS
LA English
DT Article
ID BLOOD-DONORS; YELLOW-FEVER; TRANSMISSION; INFECTIONS; MOSQUITOS;
   OUTBREAK; TRANSFUSION; ARBOVIRUSES; CHIKUNGUNYA; VECTOR
AB Due to the recent outbreak of the Zika virus (ZIKV) in several regions, rapid, and accurate methods to diagnose Zika infection are in demand, particularly in regions that are on the frontline of a ZIKV outbreak. In this paper, three diagnostic methods for ZIKV are considered. Viral isolation is the gold standard for detection; this approach can involve incubation of cell cultures. Serological identification is based on the interactions between viral antigens and immunoglobulin G or immunoglobulin M antibodies; cross-reactivity with other types of flaviviruses can cause reduced specificity with this approach. Molecular confirmation, such as reverse transcription polymerase chain reaction (RT-PCR), involves reverse transcription of RNA and amplification of DNA. Quantitative analysis based on real-time RT-PCR can be undertaken by comparing fluorescence measurements against previously developed standards. A recently developed programmable paper-based detection approach can provide low-cost and rapid analysis. These viral identification and viral genetic analysis approaches play crucial roles in understanding the transmission of ZIKV.
C1 [Yang, Kai-Hung; Narayan, Roger J.] North Carolina State Univ, Dept Mat Sci Engn, Box 7907, Raleigh, NC 27695 USA.
   [Narayan, Roger J.] Univ N Carolina, Joint Dept Biomed Engn, Box 7115, Raleigh, NC 27695 USA.
   [Narayan, Roger J.] North Carolina State Univ, Box 7115, Raleigh, NC 27695 USA.
RP Narayan, RJ (corresponding author), North Carolina State Univ, Dept Mat Sci Engn, Box 7907, Raleigh, NC 27695 USA.; Narayan, RJ (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Box 7115, Raleigh, NC 27695 USA.; Narayan, RJ (corresponding author), North Carolina State Univ, Box 7115, Raleigh, NC 27695 USA.
EM roger_narayan@unc.edu
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhalla N, 2016, ESSAYS BIOCHEM, V60, P1, DOI 10.1042/EBC20150001
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, REV DIAGN TEST ZIK C, V6
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   Lindenbach B. D., 2003, ADV VIRUS RES, V59, P1887
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Sin MLY, 2014, EXPERT REV MOL DIAGN, V14, P225, DOI 10.1586/14737159.2014.888313
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, DOI [10.2807/1560-7917.ES2014.19.4.20685, DOI 10.2807/1560-7917.ES2014.19.4.20685]
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 69
TC 2
Z9 2
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 2159-6859
EI 2159-6867
J9 MRS COMMUN
JI MRS Commun.
PD JUN
PY 2017
VL 7
IS 2
BP 121
EP 130
DI 10.1557/mrc.2017.20
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA EZ8KE
UT WOS:000404973600004
DA 2020-07-08
ER

PT J
AU Turelli, M
   Barton, NH
AF Turelli, Michael
   Barton, Nicholas H.
TI Deploying dengue-suppressing Wolbachia: Robust models predict slow but
   effective spatial spread in Aedes aegypti
SO THEORETICAL POPULATION BIOLOGY
LA English
DT Article
DE Population transformation; Population replacement; Bistable wave
   dynamics; Disease suppression; Zika; Biocontrol
ID INCOMPATIBILITY-INDUCING MICROBES; CYTOPLASMIC INCOMPATIBILITY;
   DROSOPHILA-SIMULANS; POPULATION-DYNAMICS; NATURAL-POPULATIONS;
   SHORTENING WOLBACHIA; INFECTION; DISPERSAL; HOST; EVOLUTION
AB A novel strategy for controlling the spread of arboviral diseases such as dengue, Zika and chikungunya is to transform mosquito populations with virus-suppressing Wolbachia. In general, Wolbachia transinfected into mosquitoes induce fitness costs through lower viability or fecundity. These maternally inherited bacteria also produce a frequency-dependent advantage for infected females by inducing cytoplasmic incompatibility (CI), which kills the embryos produced by uninfected females mated to infected males. These competing effects, a frequency-dependent advantage and frequency-independent costs, produce bistable Wolbachia frequency dynamics. Above a threshold frequency, denoted (p) over cap, CI drives fitness decreasing Wolbachia transinfections through local populations; but below (p) over cap, infection frequencies tend to decline to zero. If (p) over cap is not too high, CI also drives spatial spread once infections become established over sufficiently large areas. We illustrate how simple models provide testable predictions concerning the spatial and temporal dynamics of Wolbachia introductions, focusing on rate of spatial spread, the shape of spreading waves, and the conditions for initiating spread from local introductions. First, we consider the robustness of diffusion-based predictions to incorporating two important features of wMel-Aedes aegypti biology that may be inconsistent with the diffusion approximations, namely fast local dynamics induced by complete CI (i.e., all embryos produced from incompatible crosses die) and long-tailed, non-Gaussian dispersal. With complete CI, our numerical analyses show that long-tailed dispersal changes wave-width predictions only slightly; but it can significantly reduce wave speed relative to the diffusion prediction; it also allows smaller local introductions to initiate spatial spread. Second, we use approximations for (p) over cap and dispersal distances to predict the outcome of 2013 releases of wMel-infected Aedes aegypti in Cairns, Australia, Third, we describe new data from Ae. aegypti populations near Cairns, Australia that demonstrate long-distance dispersal and provide an approximate lower bound on (p) over cap for wMel in northeastern Australia. Finally, we apply our analyses to produce operational guidelines for efficient transformation of vector populations over large areas. We demonstrate that even very slow spatial spread, on the order of 10-20 m/month (as predicted), can produce area-wide population transformation within a few years following initial releases covering about 20-30% of the target area. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Turelli, Michael] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.
   [Barton, Nicholas H.] IST Austria, Am Campus 1, A-3400 Klosterneuburg, Austria.
RP Turelli, M (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.
EM mturelli@ucdavis.edu; nick.barton@ist.ac.at
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01-GM-104325-01];
   Joel Keizer Endowment; Foundation for the National Institutes of Health
   through the Grand Challenges in Global Health Initiative of the Bill and
   Melinda Gates Foundation
FX We thank Brandon S. Cooper, Ary A. Hoffmann, Scott L. O'Neill, two
   reviewers and the editor for constructive comments on earlier drafts. We
   thank S. L. O'Neill for allowing us to publish the Pyramid Estates data
   from his Eliminate Dengue Program (http:
   //www.eliminatedengue.com/program). This work was supported by grants
   from the Foundation for the National Institutes of Health through the
   Grand Challenges in Global Health Initiative of the Bill and Melinda
   Gates Foundation, the Joel Keizer Endowment to UC Davis, and the
   National Institutes of Health [grant R01-GM-104325-01].
CR Altrock PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002260
   Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246
   BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553
   BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Beckmann JF, 2013, INSECT BIOCHEM MOLEC, V43, P867, DOI 10.1016/j.ibmb.2013.07.002
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022565
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   COYNE JA, 1982, AM NAT, V119, P589, DOI 10.1086/283936
   COYNE JA, 1987, AM NAT, V129, P847, DOI 10.1086/284679
   Dobzhansky T, 1943, GENETICS, V28, P304
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Endler J. A., 1977, GEOGRAPHIC VARIATION
   Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gill AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003224
   Haldane JBS, 1930, P CAMB PHILOS SOC, V26, P220
   HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626
   Hamm CA, 2014, MOL ECOL, V23, P4871, DOI 10.1111/mec.12901
   Hancock PA, 2016, J APPL ECOL, V53, P785, DOI 10.1111/1365-2664.12620
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   Harcombe W, 2004, J INVERTEBR PATHOL, V87, P45, DOI 10.1016/j.jip.2004.07.003
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Haygood R, 2009, EVOLUTION, V63, P432, DOI 10.1111/j.1558-5646.2008.00550.x
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1
   HOFFMANN AA, 1988, GENETICS, V119, P435
   Hoffmann AA, 1998, GENETICS, V148, P221
   HOFFMANN AA, 1990, GENETICS, V126, P933
   Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42
   HOFFMANN AA, 1988, ENTOMOL EXP APPL, V48, P61, DOI 10.1007/BF00343386
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914
   Kawasaki K., 1997, BIOL INVASIONS THEOR
   Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   MCINNIS DO, 1982, AM NAT, V119, P319, DOI 10.1086/283912
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   NAGYLAKI T, 1975, GENETICS, V80, P595
   NIGRO L, 1990, GENETICS, V125, P551
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Poinsot D, 1998, GENETICS, V150, P227
   POWELL JR, 1976, GENETICS, V82, P493
   Prout T., 1980, Evolutionary Biology (New York), V13, P1
   Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827
   Richardson MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003129
   Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   Schraiber JG, 2012, J THEOR BIOL, V297, P26, DOI 10.1016/j.jtbi.2011.12.006
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sinkins SP, 1997, INFLUENTIAL PASSENGERS, P155
   SLATKIN M, 1973, GENETICS, V75, P733
   Soboleva TK, 2003, ECOL MODEL, V163, P33, DOI 10.1016/S0304-3800(02)00357-5
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   TURELLI M, 1995, GENETICS, V140, P1319
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walsh RK, 2013, AM J TROP MED HYG, V89, P68, DOI 10.4269/ajtmh.12-0378
   Wang MH, 2002, J MATH BIOL, V44, P150, DOI 10.1007/s002850100116
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
NR 80
TC 27
Z9 27
U1 4
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0040-5809
EI 1096-0325
J9 THEOR POPUL BIOL
JI Theor. Popul. Biol.
PD JUN
PY 2017
VL 115
BP 45
EP 60
DI 10.1016/j.tpb.2017.03.003
PG 16
WC Ecology; Evolutionary Biology; Genetics & Heredity; Mathematical &
   Computational Biology
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity; Mathematical & Computational Biology
GA EX2CL
UT WOS:000403033000005
PM 28411063
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Doubled dosage of sofosbuviris expected for inhibiting Zika virus
   infection
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Sofosbuvir; Inhibiting; Zika virus; Dosage
ID QUANTUM-CHEMICAL ANALYSIS; DRUG
AB Sofosbuvir is a new antiviral drug that has been recommended for management of hepatitis C virus (HCV) for a few years. New researches support that sofosbuvir might he useful for the management of Zika virus infection. Based on the pharmacological activity, inhibiting the HCV RNA-dependent RNA polymerase (RdRp or NS5 protein). sofosbuvir is proposed for its effectiveness against Zika virus infection. Here, the authors used a mathematical modelling theoretical approach to predict the expected dosage of sofosbuvir for inhibiting Zika virus infection. Based on the modeling study, if sofosbuvir is assigned for management of Zika virus. infection, doubled dosage of the present dosage for hepatitis C management is recommended.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Navi Mumbai, India.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Osun State, Nigeria.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Reznik SE, 2016, INT J INFECT DIS
   Sofosbuvir (Sovaldi), 2015, PRESCRIRE INT, V24, P5
   Vannice KS, 2016, VACCINE
   Wiwanitkit S, 2015, J PHARMACOL PHARMACO, V6, P34, DOI 10.4103/0976-500X.149142
   Wiwanitkit V., 2011, ADV LAB MED INT, V1, P6
   Wiwanitkit V, 2006, INT J NANOMED, V1, P111, DOI 10.2147/nano.2006.1.1.111
   Wiwanitkit V, 2006, J INFECTION, V53, P148, DOI 10.1016/j.jinf.2005.11.011
NR 11
TC 3
Z9 3
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUN
PY 2017
VL 10
IS 6
BP 682
EP +
DI 10.1016/j.apjtm.2017.06.012
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FA0SZ
UT WOS:000405147200014
PM 28756928
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cross, CIW
   Segars, JH
AF Cross, Chantel I. Washington
   Segars, James H.
TI Preconception assisted reproductive technology counseling in the age of
   Zika
SO FERTILITY AND STERILITY
LA English
DT Editorial Material
C1 [Cross, Chantel I. Washington] Johns Hopkins Sch Med, Reprod Endocrinol & Infertil, Baltimore, MD 21205 USA.
   [Segars, James H.] Johns Hopkins Sch Med, Gynecol & Obstet, Baltimore, MD USA.
RP Cross, CIW (corresponding author), Johns Hopkins Sch Med, Reprod Endocrinol & Infertil, Baltimore, MD 21205 USA.
FU Howard and Georgeanna Seegar Jones Endowment
FX This research was supported by the Howard and Georgeanna Seegar Jones
   Endowment.
CR American Society for Reproductive Medicine, GUID PROV CAR WOM ME
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Centers for Disease Control and Prevention, 2016, PREC COUNS WOM MEN L
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD JUN
PY 2017
VL 107
IS 6
BP 1296
EP 1297
DI 10.1016/j.fertnstert.2017.04.006
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FA3RG
UT WOS:000405361500010
PM 28487032
OA Bronze
DA 2020-07-08
ER

PT J
AU Benjamin, I
   Fernandez, G
   Figueira, JV
   Parpacen, L
   Urbina, MT
   Medina, R
AF Benjamin, Isaac
   Fernandez, Gissel
   Figueira, Jose Valentin
   Parpacen, Leticia
   Urbina, Maria Teresa
   Medina, Randolfo
TI Zika virus detected in amniotic fluid and umbilical cord blood in an in
   vitro fertilization-conceived pregnancy in Venezuela
SO FERTILITY AND STERILITY
LA English
DT Article
DE Zika virus; microcephaly; congenital malformations; ventriculomegaly;
   amniotic fluid
AB Objective: To describe the consequences of Zika virus infection at 10 weeks of gestation in an IVF-conceived pregnancy in Venezuela.
   Design: A case report.
   Setting: Private assisted reproduction unit.
   Patient(s): A 36-year-old patient who conceived her first pregnancy through IVF and became infected with Zika virus at 10 weeks' gestation in Venezuela.
   Intervention(s): In vitro fertilization with fresh ET. Clinical, laboratory, and imaging Zika diagnostic methods.
   Main Outcome Measure(s): Zika virus detection by real-time polymerase chain reaction (PCR) in maternal plasma, PCR in amniotic fluid and umbilical cord blood. Ultrasonography findings of anatomic abnormalities.
   Result(s): Zika infection was confirmed at 10 weeks' gestation by real-time PCR; ultrasound results appeared normal. At 19 weeks' gestation, an ultrasound revealed biometry on three SDs below the means for all parameters but with no apparent anatomic abnormality. Zika virus was positive in maternal urine and amniotic fluid by PCR at 19 weeks' gestation. Ultrasound at 21 weeks + 4 days of gestation showed fetal cerebellar hypoplasia with ventricular dysmorphia, particularly marked on the left, consistent with microcephaly and ventriculomegaly. Because of the poor prognosis, pregnancy was interrupted at 24 weeks' gestation, in France. The PCR in umbilical cord blood taken in this procedure was positive for Zika virus.
   Conclusion(s): Initial ultrasound findings in pregnancy may not be informative. Only at 21 weeks + 4 days of gestation did an ultrasound reveal fetal microcephaly and ventriculomegaly. Combined clinical, laboratory, and imaging findings provided a complete picture of the severe damage caused by Zika infection. (C) 2017 The Authors. Published by Elsevier Inc.
C1 [Benjamin, Isaac; Fernandez, Gissel; Figueira, Jose Valentin; Parpacen, Leticia; Urbina, Maria Teresa; Medina, Randolfo] Unifertes, Clin El Avila, Fertil Unit, Caracas, Venezuela.
RP Benjamin, I (corresponding author), Unifertes Fertil Unit, Caracas 1062, Distrito Capita, Venezuela.
EM ibenjaminf@gmail.com
OI , Leticia Parpacen/0000-0001-6898-1173
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Minassian ML, 2016, REV ARGENT MICROBIOL, V48, P97, DOI 10.1016/j.ram.2016.06.001
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Pan American Health Organization/World Health Organization (PAHO/WHO), ZIK EP UPD
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Suarez R, TECHNICAL REPORT
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P7
   World Health Organization, WHO STAT 1 M INT HLT
NR 11
TC 8
Z9 9
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD JUN
PY 2017
VL 107
IS 6
BP 1319
EP 1322
DI 10.1016/j.fertnstert.2017.02.112
PG 4
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA FA3RG
UT WOS:000405361500015
PM 28390691
OA Other Gold
DA 2020-07-08
ER

PT J
AU Brody, T
   Yavatkar, AS
   Park, DS
   Kuzin, A
   Ross, J
   Odenwald, WF
AF Brody, Thomas
   Yavatkar, Amarendra S.
   Park, Dong Sun
   Kuzin, Alexander
   Ross, Jermaine
   Odenwald, Ward F.
TI Flavivirus and Filovirus EvoPrinters: New alignment tools for the
   comparative analysis of viral evolution
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WHOLE-GENOME SEQUENCES; EBOLA-VIRUS DISEASE; ZIKA VIRUS; MARBURG VIRUS;
   HOMOLOGOUS RECOMBINATION; GENETIC DIVERSITY; GENUS FLAVIVIRUS;
   SIERRA-LEONE; TRANSMISSION; HISTORY
AB Background
   Flavivirus and Filovirus infections are serious epidemic threats to human populations. Multi-genome comparative analysis of these evolving pathogens affords a view of their essential, conserved sequence elements as well as progressive evolutionary changes. While phylogenetic analysis has yielded important insights, the growing number of available genomic sequences makes comparisons between hundreds of viral strains challenging. We report here a new approach for the comparative analysis of these hemorrhagic fever viruses that can superimpose an unlimited number of one-on-one alignments to identify important features within genomes of interest.
   Methodology/Principal finding
   We have adapted EvoPrinter alignment algorithms for the rapid comparative analysis of Flavivirus or Filovirus sequences including Zika and Ebola strains. The user can input a full genome or partial viral sequence and then view either individual comparisons or generate color-coded readouts that superimpose hundreds of one-on-one alignments to identify unique or shared identity SNPs that reveal ancestral relationships between strains. The user can also opt to select a database genome in order to access a library of pre-aligned genomes of either 1,094 Flaviviruses or 460 Filoviruses for rapid comparative analysis with all database entries or a select subset. Using EvoPrinter search and alignment programs, we show the following: 1) superimposing alignment data from many related strains identifies lineage identity SNPs, which enable the assessment of sublineage complexity within viral outbreaks; 2) whole-genome SNP profile screens uncover novel Dengue2 and Zika recombinant strains and their parental lineages; 3) differential SNP profiling identifies host cell A-to-I hyper-editing within Ebola and Marburg viruses, and 4) hundreds of superimposed one-on-one Ebola genome alignments highlight ultra-conserved regulatory sequences, invariant amino acid codons and evolutionarily variable protein-encoding domains within a single genome.
   Conclusions/Significance
   EvoPrinter allows for the assessment of lineage complexity within Flavivirus or Filovirus outbreaks, identification of recombinant strains, highlights sequences that have undergone host cell A-to-I editing, and identifies unique input and database SNPs within highly conserved sequences. EvoPrinter's ability to superimpose alignment data from hundreds of strains onto a single genome has allowed us to identify unique Zika virus sublineages that are currently spreading in South, Central and North America, the Caribbean, and in China. This new set of integrated alignment programs should serve as a useful addition to existing tools for the comparative analysis of these viruses.
C1 [Brody, Thomas; Kuzin, Alexander; Ross, Jermaine; Odenwald, Ward F.] NINDS, Neural Cell Fate Determinants Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Yavatkar, Amarendra S.; Park, Dong Sun] NINDS, Div Intramural Res Informat Technol Program, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
RP Brody, T (corresponding author), NINDS, Neural Cell Fate Determinants Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
EM brodyt@ninds.nih.gov; odenwaldw@ninds.nih.gov
OI Odenwald, Ward/0000-0001-5791-9729
CR Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138900
   Anthony SM, 2015, VIRUSES-BASEL, V7, P5172, DOI 10.3390/v7102867
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195
   Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Calvignac-Spencer S, 2014, PLOS CURR, V6
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12
   Crary SM, 2003, VIROLOGY, V306, P210, DOI 10.1016/S0042-6822(02)00014-4
   Crozier I, 2016, J INFECT DIS, V214, P1467, DOI 10.1093/infdis/jiw079
   Dudas Gytis, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gao XY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0270-z
   de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goodfellow I, 2015, RECENT EVOLUTION PAT
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hafiz MY, 2016, INFECT DRUG RESIST, V9, DOI 10.2147/IDR.S108057
   Han JF, 2016, J INFECTION, V73, P87, DOI 10.1016/j.jinf.2016.04.011
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202
   Kidd KK, 2014, FORENSIC SCI INT-GEN, V10, P23, DOI 10.1016/j.fsigen.2014.01.002
   KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuhn JH, 2014, VIRUSES-BASEL, V6, P3663, DOI 10.3390/v6093663
   Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lea D., 1999, CONCURRENT PROGRAMMI
   Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Li YH, 2014, EPIDEMIOL INFECT, V142, P1138, DOI 10.1017/S0950268813002215
   Liu BQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2982-x
   Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304
   Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102
   Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041
   Pan YY, 2014, ARCH VIROL, V159, P1129, DOI 10.1007/s00705-012-1477-6
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Peterson AT, 2012, ECOL EVOL, V2, P1826, DOI 10.1002/ece3.297
   Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pigott DM, 2016, ELIFE, V5, DOI 10.7554/eLife.16412
   Punzel M, 2014, EMERG INFECT DIS, V20, P1366, DOI 10.3201/eid2008.140508
   Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014
   Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792
   Samuel CE, 2012, CURR TOP MICROBIOL, V353, P163, DOI 10.1007/82_2011_148
   Shah-Hosseini N, 2014, EMERG INFECT DIS, V20, P1419, DOI 10.3201/eid2008.131321
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Slenczka W, 2007, J INFECT DIS, V196, pS131, DOI 10.1086/520551
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212
   Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0
   Uzcategui NY, 2001, J GEN VIROL, V82, P2945, DOI 10.1099/0022-1317-82-12-2945
   Waman VP, 2017, INFECT GENET EVOL, V49, P234, DOI 10.1016/j.meegid.2017.01.022
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Westesson O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000318
   Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106
   Zehender G, 2016, INFECT GENET EVOL, V44, P8, DOI 10.1016/j.meegid.2016.06.014
   Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087630
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 73
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2017
VL 11
IS 6
AR e0005673
DI 10.1371/journal.pntd.0005673
PG 30
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EZ9WL
UT WOS:000405080700052
PM 28622346
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Costa-da-Silva, AL
   Ioshino, RS
   Petersen, V
   Lima, AF
   Cunha, MDP
   Wiley, MR
   Ladner, JT
   Prieto, K
   Palacios, G
   Costa, DD
   Suesdek, L
   Zanotto, PMD
   Capurro, ML
AF Costa-da-Silva, Andre Luis
   Ioshino, Rafaella Sayuri
   Petersen, Vivian
   Lima, Antonio Fernando
   Cunha, Marielton dos Passos
   Wiley, Michael R.
   Ladner, Jason T.
   Prieto, Karla
   Palacios, Gustavo
   Costa, Danuza Duarte
   Suesdek, Lincoln
   de Andrade Zanotto, Paolo Marinho
   Capurro, Margareth Lara
TI First report of naturally infected Aedes aegypti with chikungunya virus
   genotype ECSA in the Americas
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; ENCEPHALITIS-VIRUS; EPIDEMIC; TRANSMISSION; BRAZIL;
   ALBOPICTUS; SPREAD
AB Background
   The worldwide expansion of new emergent arboviruses such as Chikungunya and Zika reinforces the importance in understanding the role of mosquito species in spreading these pathogens in affected regions. This knowledge is essential for developing effective programs based on species specificity to avoid the establishment of endemic transmission cycles sustained by the identified local vectors. Although the first autochthonous transmission of Chikungunya virus was described in 2014 in the north of Brazil, the main outbreaks were reported in 2015 and 2016 in the northeast of Brazil.
   Methodology/Principal findings
   During 5 days of February 2016, we collected mosquitoes in homes of 6 neighborhoods of Aracaju city, the capital of Sergipe state. Four mosquito species were identified but Culex quinquefasciatus and Aedes aegypti were the most abundant. Field-caught mosquitoes were tested for Chikungunya (CHIKV), Zika (ZIKV) and Dengue viruses (DENV) by qRT-PCR and one CHIKV-infected Ae. aegypti female was detected. The complete sequence of CHIKV genome was obtained from this sample and phylogenetic analysis revealed that this isolate belongs to the East-Central-South-African (ECSA) genotype.
   Conclusions
   Our study describes the first identification of a naturally CHIKV-infected Ae. aegypti in Brazil and the first report of a CHIKV from ECSA genotype identified in this species in the Americas. These findings support the notion of Ae. aegypti being a vector involved in CHIKV outbreaks in northeast of Brazil.
C1 [Costa-da-Silva, Andre Luis; Ioshino, Rafaella Sayuri; Petersen, Vivian; Capurro, Margareth Lara] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
   [Costa-da-Silva, Andre Luis; Ioshino, Rafaella Sayuri; Capurro, Margareth Lara] INCT EM, Rio De Janeiro, RJ, Brazil.
   [Petersen, Vivian; Suesdek, Lincoln] Inst Butantan, Lab Parasitol, Sao Paulo, Brazil.
   [Lima, Antonio Fernando; Costa, Danuza Duarte] Fundacao Saude Parreiras Horta LACEN, Aracaju, Sergipe, Brazil.
   [Cunha, Marielton dos Passos; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
   [Wiley, Michael R.; Ladner, Jason T.; Prieto, Karla; Palacios, Gustavo] US Army Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD USA.
   [Suesdek, Lincoln] Univ Sao Paulo, Programa Posgrad Inst Med Trop, Sao Paulo, SP, Brazil.
RP Costa-da-Silva, AL; Capurro, ML (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.; Costa-da-Silva, AL; Capurro, ML (corresponding author), INCT EM, Rio De Janeiro, RJ, Brazil.
EM costadasilva.andreluis@gmail.com; mcapurro@icb.usp.br
RI Costa-Da-Silva, Andre Luis/J-8913-2019; Capurro, Margareth/M-5286-2019;
   de A. Zanotto, Paolo M./B-9286-2019; Suesdek, Lincoln/C-7943-2013;
   Palacios, Gustavo/I-7773-2015
OI Costa-Da-Silva, Andre Luis/0000-0002-7615-7376; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Suesdek, Lincoln/0000-0001-6829-738X; Palacios,
   Gustavo/0000-0001-5062-1938; Wiley, Michael/0000-0001-6688-007X
FU Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/19921-9, 2014/27172-9, 2014/17766-9];
   National Institutes of Health/National Institute of Allergy and
   Infectious Diseases (NIH/NIAID)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01 AI115595];
   National Institute of Science and Technology Molecular Entomology -
   INCT-EM; Defense Advanced Research Projects Agency (DARPA)United States
   Department of DefenseDefense Advanced Research Projects Agency (DARPA);
   Pan American Health Organization (PAHO); Postdoctoral National Program
   of the Coordination for the Improvement of Higher Education Personnel -
   PNPD/CAPES [1252482]; Coordination for the Improvement of Higher
   Education Personnel - CAPESCAPES; Brazilian National Research Council -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [140032/2013-4]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/08204-2]
FX This work was funded by grants #2013/19921-9, #2014/27172-9 and
   #2014/17766-9 from Sao Paulo Research Foundation - FAPESP (www.
   fapesp.br), National Institutes of Health/National Institute of Allergy
   and Infectious Diseases (NIH/NIAID) U01 AI115595 (https://www.nih.gov/),
   National Institute of Science and Technology Molecular Entomology -
   INCT-EM (http://inct.cnpq. br/web/inct-ern) and by a grant from The
   Defense Advanced Research Projects Agency (DARPA, PI: C. Kane). The
   views expressed in this article are those of the authors and do not
   reflect the official policy or position of the U.S. Department of
   Defense or the U.S. Army. This work was supported by Pan American Health
   Organization (PAHO). ALCS was supported by fellowship #1252482 from
   Postdoctoral National Program of the Coordination for the Improvement of
   Higher Education Personnel - PNPD/CAPES (http://www.capes.gov.br/). RSI
   was supported by graduate fellowship from Coordination for the
   Improvement of Higher Education Personnel - CAPES. VP was supported by
   fellowship 140032/2013-4 from Brazilian National Research Council - CNPq
   (http://cnpq.br/). MPC was supported by fellowship 2016/08204-2 from
   FAPESP. MLC and LS are fellows of CNPq 305042/2015-7 and #311805/2014-0,
   respectively. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Badolato-Correa J, 2017, PLOS CURR
   Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Donalisio Maria Rita, 2015, Rev. bras. epidemiol., V18, P283, DOI 10.1590/1980-5497201500010022
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Eastwood G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01519
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   IBGE, 2016, SERG AR INF DAD GER
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO
   MITCHELL CJ, 1984, J MED ENTOMOL, V21, P34, DOI 10.1093/jmedent/21.1.34
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Patel P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004953
   Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Rao T, 1966, SCI CULT, V32
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Secretaria de Estado da Saude-Governo de Sergipe, 2016, EPIDEMIOLOGICAL B
   Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011
   SPENCE L, 1962, AM J TROP MED HYG, V11, P687, DOI 10.4269/ajtmh.1962.11.687
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529
NR 43
TC 29
Z9 29
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2017
VL 11
IS 6
AR e0005630
DI 10.1371/journal.pntd.0005630
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EZ9WL
UT WOS:000405080700028
PM 28614394
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goertz, GP
   Vogels, CBF
   Geertsema, C
   Koenraadt, CJM
   Pijlman, GP
AF Goertz, Giel P.
   Vogels, Chantal B. F.
   Geertsema, Corinne
   Koenraadt, Constantianus J. M.
   Pijlman, Gorben P.
TI Mosquito co-infection with Zika and chikungunya virus allows
   simultaneous transmission without affecting vector competence of Aedes
   aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ORAL-SUSCEPTIBILITY; DIPTERA-CULICIDAE; RNA REPLICATION; DENGUE VIRUS;
   ALBOPICTUS; INFECTION; LINNAEUS
AB Background
   Zika virus (ZIKV) and chikungunya virus (CHIKV) are highly pathogenic arthropod-borne viruses that are currently a serious health burden in the Americas, and elsewhere in the world. ZIKV and CHIKV co-circulate in the same geographical regions and are mainly transmitted by Aedes aegypti mosquitoes. There is a growing number of case reports of ZIKV and CHIKV co-infections in humans, but it is uncertain whether co-infection occurs via single or multiple mosquito bites. Here we investigate the potential of Ae. aegypti mosquitoes to transmit both ZIKV and CHIKV in one bite, and we assess the consequences of co-infection on vector competence.
   Methodology/Principal findings
   First, growth curves indicated that co-infection with CHIKV negatively affects ZIKV production in mammalian, but not in mosquito cells. Next, Ae. aegypti mosquitoes were infected with ZIKV, CHIKV, or co-infected via an infectious blood meal or intrathoracic injections. Infection and transmission rates, as well as viral titers of positive mosquitoes, were determined at 14 days after blood meal or 7 days after injection. Saliva and bodies of (co-) infected mosquitoes were scored concurrently for the presence of ZIKV and/or CHIKV using a dual-colour immunofluorescence assay. The results show that orally exposed Ae. aegypti mosquitoes are highly competent, with transmission rates of up to 73% for ZIKV, 21% for CHIKV, and 12% of mosquitoes transmitting both viruses in one bite. However, simultaneous oral exposure to both viruses did not change infection and transmission rates compared to exposure to a single virus. Intrathoracic injections indicate that the selected strain of Ae. aegypti has a strong salivary gland barrier for CHIKV, but a less profound barrier for ZIKV.
   Conclusions/Significance
   This study shows that Ae. aegypti can transmit both ZIKV and CHIKV via a single bite. Furthermore, co-infection of ZIKV and CHIKV does not influence the vector competence of Ae. aegypti.
C1 [Goertz, Giel P.; Geertsema, Corinne; Pijlman, Gorben P.] Wageningen Univ & Res, Lab Virol, Wageningen, Netherlands.
   [Vogels, Chantal B. F.; Koenraadt, Constantianus J. M.] Wageningen Univ & Res, Lab Entomol, Wageningen, Netherlands.
RP Pijlman, GP (corresponding author), Wageningen Univ & Res, Lab Virol, Wageningen, Netherlands.
EM gorben.pijlman@wur.nl
OI Goertz, Giel/0000-0002-8194-3574; Vogels, Chantal/0000-0003-0027-6480;
   Pijlman, Gorben/0000-0001-9301-0408
FU Strategic Fund of the graduate school Production Ecology & Resource
   Conservation, Wageningen University, Netherlands
FX This work is supported by the Strategic Fund of the graduate school
   Production Ecology & Resource Conservation, Wageningen University,
   Netherlands. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Arias-Goeta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057548
   CDC, 2016, ALL COUNTR TERR ACT
   CENTERS FOR DISEASE CONTROL AND PRE-VENTION, 2016, COUNTR TERR CHIK CAS
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cherabuddi K, 2016, JMM CASE REPORTS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2014, AM J TROP MED HYG, V91, P635, DOI 10.4269/ajtmh.13-0627
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dong SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24729
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fros JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060166
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Johansson MA, 2016, NEW ENGL J MED, V374, P951
   Kallio K, 2016, J VIROL, V90, P1687, DOI 10.1128/JVI.02484-15
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7
   Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353
   Minh Nguyen N, 2013, P NATL ACAD SCI USA, V110, P9072
   MOURYA DT, 1994, AM J TROP MED HYG, V51, P295, DOI 10.4269/ajtmh.1994.51.295
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Muturi EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0667-y
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   PAHO, 2016, NUMB REP CAS CHIK FE
   Pas SD, 2016, NEW ENGL J MED, V375, P1002
   Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228
   R Core Team, 2016, R LANG ENV STAT COMP
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P443
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 46
TC 44
Z9 45
U1 1
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2017
VL 11
IS 6
AR e0005654
DI 10.1371/journal.pntd.0005654
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EZ9WL
UT WOS:000405080700037
PM 28570693
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lourenco-de-Oliveira, R
   Failloux, AB
AF Lourenco-de-Oliveira, Ricardo
   Failloux, Anna-Bella
TI Lessons learned on Zika virus vectors
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CULEX-PIPIENS; MOSQUITOS
C1 [Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Lourenco-de-Oliveira, Ricardo; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Paris, France.
RP Lourenco-de-Oliveira, R (corresponding author), Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.; Lourenco-de-Oliveira, R (corresponding author), Inst Pasteur, Arboviruses & Insect Vectors, Paris, France.
EM lourenco@ioc.fiocruz.br
OI Lourenco-de-Oliveira, Ricardo/0000-0003-0423-5694
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EURO SURVEILL, V21
   Boccolini D, 2016, EURO SURVEILL, V21
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   World Health Organization, 2016, ZIK SIT REP
NR 15
TC 7
Z9 9
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2017
VL 11
IS 6
AR e0005511
DI 10.1371/journal.pntd.0005511
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EZ9WL
UT WOS:000405080700009
PM 28617808
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Magnani, DM
   Silveira, CGT
   Rosen, BC
   Ricciardi, MJ
   Pedreno-Lopez, N
   Gutman, MJ
   Bailey, VK
   Maxwell, HS
   Domingues, A
   Gonzalez-Nieto, L
   Avelino-Silva, VI
   Trindade, M
   Nogueira, J
   Oliveira, CS
   Maestri, A
   Felix, AC
   Levi, JE
   Nogueira, ML
   Martins, MA
   Martinez-Navio, JM
   Fuchs, SP
   Whitehead, SS
   Burton, DR
   Desrosiers, RC
   Kallas, EG
   Watkins, DI
AF Magnani, Diogo M.
   Silveira, Cassia G. T.
   Rosen, Brandon C.
   Ricciardi, Michael J.
   Pedreno-Lopez, Nuria
   Gutman, Martin J.
   Bailey, Varian K.
   Maxwell, Helen S.
   Domingues, Aline
   Gonzalez-Nieto, Lucas
   Avelino-Silva, Vivian I.
   Trindade, Mateus
   Nogueira, Juliana
   Oliveira, Consuelo S.
   Maestri, Alvino
   Felix, Alvina Clara
   Levi, Jose Eduardo
   Nogueira, Mauricio L.
   Martins, Mauricio A.
   Martinez-Navio, Jose M.
   Fuchs, Sebastian P.
   Whitehead, Stephen S.
   Burton, Dennis R.
   Desrosiers, Ronald C.
   Kallas, Esper G.
   Watkins, David I.
TI A human inferred germline antibody binds to an immunodominant epitope
   and neutralizes Zika virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MEMORY B-CELLS; DENGUE VIRUS; INTERIM GUIDELINES; UNITED-STATES;
   MONOCLONAL-ANTIBODIES; SOMATIC HYPERMUTATION; PREGNANT-WOMEN; HIV-1
   VACCINE; INFECTION; RESPONSES
AB The isolation of neutralizing monoclonal antibodies (nmAbs) against the Zika virus (ZIKV) might lead to novel preventative strategies for infections in at-risk individuals, primarily pregnant women. Here we describe the characterization of human mAbs from the plasmablasts of an acutely infected patient. One of the 18 mAbs had the unusual feature of binding to and neutralizing ZIKV despite not appearing to have been diversified by affinity maturation. This mAb neutralized ZIKV (Neut(50) similar to 2 mu g/ml) but did not react with any of the four dengue virus serotypes. Except for the expected junctional diversity created by the joining of the V-(D)-J genes, there was no deviation from immunoglobulin germline genes. This is a rare example of a human mAb with neutralizing activity in the absence of detectable somatic hypermutation. Importantly, binding of this mAb to ZIKV was specifically inhibited by human plasma from ZIKV-exposed individuals, suggesting that it may be of value in a diagnostic setting.
C1 [Magnani, Diogo M.; Rosen, Brandon C.; Ricciardi, Michael J.; Pedreno-Lopez, Nuria; Gutman, Martin J.; Bailey, Varian K.; Maxwell, Helen S.; Domingues, Aline; Gonzalez-Nieto, Lucas; Martins, Mauricio A.; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Desrosiers, Ronald C.; Watkins, David I.] Univ Miami, Dept Pathol, Miami, FL 33136 USA.
   [Silveira, Cassia G. T.; Maestri, Alvino; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, SP, Brazil.
   [Avelino-Silva, Vivian I.; Trindade, Mateus] Hosp Sirio Libanes, Sao Paulo, SP, Brazil.
   [Trindade, Mateus] Univ Sao Paulo, Sch Med, Neurol Dept, Sao Paulo, SP, Brazil.
   [Nogueira, Juliana] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Oliveira, Consuelo S.] Inst Evandro Chagas, Belem, Para, Brazil.
   [Felix, Alvina Clara; Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop Sao Paulo, Dept Molestias Infecciosas & Parasitarias LIM 52, Sao Paulo, SP, Brazil.
   [Felix, Alvina Clara; Levi, Jose Eduardo] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Dept Doencas Dermatol Infecciosas & Parasitarias, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [Whitehead, Stephen S.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA.
RP Watkins, DI (corresponding author), Univ Miami, Dept Pathol, Miami, FL 33136 USA.
EM dwatkins@med.miami.edu
RI Nogueira, Mauricio L/B-7599-2012; Whitehead, Stephen/AAG-2787-2019;
   Terrassani Silveira, Cassia/M-8057-2017; Avelino-Silva, Vivian
   I/L-2640-2013; amsalu, ribka/G-8780-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; Terrassani Silveira,
   Cassia/0000-0002-0932-7769; Avelino-Silva, Vivian I/0000-0002-6660-3088;
   Martins, Mauricio/0000-0001-8336-216X; Kallas,
   Esper/0000-0003-2026-6925; Magnani, Diogo/0000-0002-1773-2406
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [4P01AI094420-05]; Wallace H. Coulter
   Center for Translational Research at University of Miami; Miami Clinical
   and Translational Science Institute (CTSI)
FX This work was supported by the NIH grant 4P01AI094420-05, the Wallace H.
   Coulter Center for Translational Research at the University of Miami
   [http://www.miami.edu/index.php/u innovation/about_us/whcc/], and the
   Miami Clinical and Translational Science Institute (CTSI) [http://
   miamictsi.org].The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fields B. N., 2007, FIELDS VIROLOGY
   Fink K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00078
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633
   Godoy-Lozano EE, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0276-1
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Honein MA, 2016, JAMA J AM MED ASS
   Huzly D, 2016, EURO SURVEILL, V21
   Kalinke U, 2000, P NATL ACAD SCI USA, V97, P10126, DOI 10.1073/pnas.97.18.10126
   Kalinke U, 1996, IMMUNITY, V5, P639, DOI 10.1016/S1074-7613(00)80277-0
   Kato M, 2015, J VIROL, V89, P1468, DOI 10.1128/JVI.02293-14
   KAVERI SV, 1991, CLIN EXP IMMUNOL, V86, P192
   Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144
   Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716
   Thornburg NJ, 2016, J CLIN INVEST, V126, P1482, DOI 10.1172/JCI85317
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
NR 72
TC 10
Z9 10
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2017
VL 11
IS 6
AR e0005655
DI 10.1371/journal.pntd.0005655
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EZ9WL
UT WOS:000405080700038
PM 28604797
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dub, T
   Fontanet, A
AF Dub, T.
   Fontanet, A.
TI Zika virus and Guillain-Barre syndrome
SO REVUE NEUROLOGIQUE
LA English
DT Editorial Material
ID INFECTION; OUTBREAK
C1 [Dub, T.; Fontanet, A.] Inst Pasteur, Unit Epidemiol Emerging Dis, 25-28 Rue Docteur Roux, F-75015 Paris, France.
   [Fontanet, A.] Inst Pasteur, CGH, CNAM, 25-28 Rue Docteur Roux, F-75015 Paris, France.
RP Fontanet, A (corresponding author), Inst Pasteur, Unit Epidemiol Emerging Dis, 25-28 Rue Docteur Roux, F-75015 Paris, France.; Fontanet, A (corresponding author), Inst Pasteur, CGH, CNAM, 25-28 Rue Docteur Roux, F-75015 Paris, France.
EM arnaud.fontanet@pasteur.fr
CR [Anonymous], WHO GUILL BARR SYNDR
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Cao-Lormeau V. M., 2016, LANCET
   Carteaux G, 2016, N ENGL J MED
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paploski I. A., 2016, EMERG INFECT DIS, V22
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rasmussen SA, 2016, N ENGL J MED
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Willison HJ, 2016, LANCET LOND ENGL
NR 14
TC 4
Z9 4
U1 0
U2 2
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD JUN
PY 2017
VL 173
IS 6
BP 361
EP 363
DI 10.1016/j.neurol.2017.03.033
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA EZ8BO
UT WOS:000404949600001
PM 28483386
DA 2020-07-08
ER

PT J
AU van der Linden, V
   van der Linden, H
   Leal, MD
   Rolim, EL
   van der Linden, A
   Aragao, MDVV
   Brainer-Lima, AM
   Cruz, DDS
   Ventura, LO
   Florencio, TLT
   Cordeiro, MT
   Neto, SDC
   Ramos, RC
AF van der Linden, Vanessa
   van der Linden Junior, Helio
   Leal, Mariana de Carvalho
   Rolim Filho, Epitacio Leite
   van der Linden, Ana
   Viana Vasco Aragao, Maria de Faima
   Brainer-Lima, Alessandra Mertens
   Sousa Cruz, Danielle Di Cavalcanti
   Ventura, Liana O.
   Tabosa Florencio, Telma Lucia
   Cordeiro, Marli Tenorio
   Caudas Neto, Silvio da Silva
   Ramos, Regina Coeli
TI Discordant clinical outcomes of congenital Zika virus infection in twin
   pregnancies
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE Zika virus; Zika virus infection; twins; dizygotic
ID CYTOMEGALOVIRUS-INFECTION; INFANTS; HIV
AB Congenital Zika syndrome is an emergent cause of a congenital infectious disorder, resulting in severe damage to the central nervous system and microcephaly. Despite advances in understanding the pathophysiology of the disease, we still do not know all the mechanisms enrolled in the vertical transmission of the virus. As has already been reported in other types of congenital infectious disorders in dizygotic twin pregnancies, it is possible that the virus affects only one of the fetuses. In this article, we report on two cases of twin pregnancies exposed to the Zika virus, but with only one of the fetuses affected with microcephaly and brain damage. This indicates the urgent need for more studies regarding the pathophysiology of viral infection and the mechanisms involved in the natural protection against the virus.
C1 [van der Linden, Vanessa] Hosp Barao Lucena, Recife, PE, Brazil.
   [van der Linden, Vanessa; Rolim Filho, Epitacio Leite] AACD, Recife, PE, Brazil.
   [van der Linden Junior, Helio] Ctr Reabilitacao Dr Henrique Santillo, Goiania, Go, Brazil.
   [Leal, Mariana de Carvalho; Rolim Filho, Epitacio Leite; Caudas Neto, Silvio da Silva] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Leal, Mariana de Carvalho] Hosp Agamenon Magalhaes, Recife, PE, Brazil.
   [van der Linden, Ana; Sousa Cruz, Danielle Di Cavalcanti] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Faima] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Faima] Univ Mauricio Nassau, Recife, PE, Brazil.
   [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, Recife, PE, Brazil.
   [Ventura, Liana O.] Fundacao Altino Ventura, Recife, PE, Brazil.
   [Ventura, Liana O.] Hosp Olhos Pernambuco HOPE, Recife, PE, Brazil.
   [Tabosa Florencio, Telma Lucia] UniVision, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Ramos, Regina Coeli] Hosp Univ Oswaldo Cruz, Recife, PE, Brazil.
RP van der Linden, V (corresponding author), AACD Pernambuco, Ave Adv Jose Paulo Cavalcanti 155, BR-50080810 Recife, PE, Brazil.
EM vanessavdlinden@hotmail.com
RI Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Liana Vieira O/0000-0001-6529-6883; VAN DER LINDEN JUNIOR,
   HELIO/0000-0002-3123-2264
CR BARLOW KM, 1993, ARCH DIS CHILD, V68, P507, DOI 10.1136/adc.68.4.507
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   DEMARTINO M, 1991, ARCH DIS CHILD, V66, P1235, DOI 10.1136/adc.66.10.1235
   Egana-Ugrinovic G, 2016, J MATERN-FETAL NEO M, V29, P3439, DOI 10.3109/14767058.2015.1130818
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Lazzarotto T, 2003, PEDIATRICS, V112, pE153, DOI 10.1542/peds.112.2.e153
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   SEGUIN J, 1988, JAMA-J AM MED ASSOC, V260, P3277, DOI 10.1001/jama.1988.03410220061021
   Thapa R, 2009, INDIAN J PEDIATR, V76, P1069, DOI 10.1007/s12098-009-0208-9
   Tomasik Tomasz, 2012, Med Wieku Rozwoj, V16, P252
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   WHO, 2007, WHO CHILD GROWTH STA
   Wu HY, 2011, TAIWAN J OBSTET GYNE, V50, P230, DOI 10.1016/j.tjog.2011.01.008
NR 26
TC 15
Z9 16
U1 0
U2 7
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2017
VL 75
IS 6
BP 381
EP 386
DI 10.1590/0004-282X20170066
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EZ1MZ
UT WOS:000404476400010
PM 28658408
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hanzlik, E
   Gigante, J
AF Hanzlik, Emily
   Gigante, Joseph
TI Microcephaly
SO CHILDREN-BASEL
LA English
DT Review
DE head circumference; microcephaly; syndromes; genetic abnormalities;
   neuroimaging; Zika virus
ID ZIKA VIRUS-INFECTION
AB Microcephaly is defined as a head circumference more than two standard deviations below the mean for gender and age. Congenital microcephaly is present at birth, whereas postnatal microcephaly occurs later in life. Genetic abnormalities, syndromes, metabolic disorders, teratogens, infections, prenatal, perinatal, and postnatal injuries can cause both congenital and postnatal microcephaly. Evaluation of patients with microcephaly begins with a thorough history and physical examination. In cases of worsening microcephaly or neurological signs or symptoms, neuroimaging, metabolic, or genetic testing should be strongly considered. Any further studies and workup should be directed by the presence of signs or symptoms pointing to an underlying diagnosis and are usually used as confirmatory testing for certain conditions. Neuroimaging with magnetic resonance imaging (MRI) is often the first diagnostic test in evaluating children with microcephaly. Genetic testing is becoming more common and is often the next step following neuroimaging when there is no specific evidence in the history or physical examination suggesting a diagnosis. Microcephaly is a lifelong condition with no known cure. The prognosis is usually worse for children who experienced an intrauterine infection or have a chromosomal or metabolic abnormality. Zika virus has rapidly spread since 2015, and maternal infection with this virus is associated with microcephaly and other serious brain abnormalities. Microcephaly has become much more prevalent in the news and scientific community with the recent emergence of Zika virus as a cause of congenital microcephaly.
C1 [Hanzlik, Emily; Gigante, Joseph] Vanderbilt Univ, Dept Pediat, Sch Med, 8161 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.
RP Gigante, J (corresponding author), Vanderbilt Univ, Dept Pediat, Sch Med, 8161 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.
EM emily.hanzlik@vanderbilt.edu; joseph.gigante@vanderbilt.edu
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Alamo-Junquera D, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.001
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Ashwal S., 2009, PRACTICE PARAMETER E
   Basit S, 2016, HUM GENET, V135, P1199, DOI 10.1007/s00439-016-1724-0
   Baxter PS, 2009, PEDIATRICS, V124, P590, DOI 10.1542/peds.2008-2784
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Custer DA, 2000, J DEV BEHAV PEDIATR, V21, P12, DOI 10.1097/00004703-200002000-00003
   Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x
   Doobin DJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12551
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hashmi JA, 2016, ANN SAUDI MED, V36, P391, DOI 10.5144/0256-4947.2016.391
   Kadir R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pgen.1005919
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Lalaguna-Mallada P, 2004, REV NEUROLOGIA, V38, P106, DOI 10.33588/rn.3802.2003339
   Leroy Jules G, 2005, Adv Pediatr, V52, P261, DOI 10.1016/j.yapd.2005.04.003
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rump P, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0167-8
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16
   Shimada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158236
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   SUGIMOTO T, 1993, NEUROPEDIATRICS, V24, P4, DOI 10.1055/s-2008-1071504
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Ye Y., 2015, COLD SPRING HARB MOL, V1, DOI DOI 10.1101/MCS.A00045527148570
NR 35
TC 9
Z9 9
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9067
J9 CHILDREN-BASEL
JI Children-Basel
PD JUN
PY 2017
VL 4
IS 6
AR 47
DI 10.3390/children4060047
PG 8
WC Pediatrics
SC Pediatrics
GA EZ0TW
UT WOS:000404419400005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jiggins, FM
AF Jiggins, Francis M.
TI The spread of Wolbachia through mosquito populations
SO PLOS BIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; DENGUE; ESTABLISHMENT;
   CHIKUNGUNYA; INFECTION; DISEASES
AB In many regions of the world, mosquito-borne viruses pose a growing threat to human health. As an alternative to traditional control measures, the bacterial symbiont Wolbachia has been transferred from Drosophila into the mosquito Aedes aegypti, where it can block the transmission of dengue and Zika viruses. A recent paper has reported large-scale releases of Wolbachia-infected Ae. aegypti in the city of Cairns, Australia. Wolbachia, which is maternally transmitted, invaded and spread through the populations due to a sperm-egg incompatibility called cytoplasmic incompatibility. Over a period of 2 years, a wave of Wolbachia infection slowly spread out from 2 release sites, demonstrating that it will be possible to deploy this strategy in large urban areas. In line with theoretical predictions, Wolbachia infection at a third, smaller release site collapsed due to the immigration of Wolbachia-free mosquitoes from surrounding areas. This remarkable field experiment has both validated theoretical models of Wolbachia population dynamics and demonstrated that this is a viable strategy to modify mosquito populations.
C1 [Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge, England.
RP Jiggins, FM (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.
EM fmj1001@cam.ac.uk
OI Jiggins, Francis Michael/0000-0001-7470-8157
CR Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, P8
   Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   Turelli M, 2017, THEOR POPUL BIOL, V115, P45, DOI 10.1016/j.tpb.2017.03.003
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
NR 24
TC 25
Z9 25
U1 1
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JUN
PY 2017
VL 15
IS 6
AR e2002780
DI 10.1371/journal.pbio.2002780
PG 6
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA EZ1ZX
UT WOS:000404510400024
PM 28570608
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cairns, TM
   Ditto, NT
   Lou, H
   Brooks, BD
   Atanasiu, D
   Eisenberg, RJ
   Cohen, GH
AF Cairns, Tina M.
   Ditto, Noah T.
   Lou, Huan
   Brooks, Benjamin D.
   Atanasiu, Doina
   Eisenberg, Roselyn J.
   Cohen, Gary H.
TI Global sensing of the antigenic structure of herpes simplex virus gD
   using high-throughput array-based SPR imaging
SO PLOS PATHOGENS
LA English
DT Article
ID TYPE-1 GLYCOPROTEIN-D; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; GENITAL
   HERPES; LOW-PH; NEUTRALIZATION SITE; PROFUSION DOMAIN; DELETION MUTANTS;
   RECEPTOR-BINDING; MAMMALIAN-CELLS
AB While HSV-2 typically causes genital lesions, HSV-1 is increasingly the cause of genital herpes. In addition, neonatal HSV infections are associated with a high rate of mortality and HSV-2 may increase the risk for HIV or Zika infections, reinforcing the need to develop an effective vaccine. In the GSK Herpevac trial, doubly sero-negative women were vaccinated with a truncated form of gD2 [gD2(284t)], then examined for anti-gD serum titers and clinical manifestations of disease. Surprisingly, few vaccinees were protected against genital HSV-2 but 86% were protected from genital HSV-1. These observations suggest that subtle differences in gD structure might influence a protective response. To better understand the antigenic structure of gD and how it impacts a protective response, we previously utilized several key anti-gD monoclonal antibodies (mAbs) to dissect epitopes in vaccinee sera. Several correlations were observed but the methodology limited the number of sera and mAbs that could be tested. Here, we used array-based surface plasmon imaging (SPRi) to simultaneously measure a larger number of protein-protein interactions. We carried out cross-competition or "epitope binning" studies with 39 anti-gD mAbs and four soluble forms of gD, including a form [gD2(285t)] that resembles the Herpevac antigen. The results from these experiments allowed us to organize the mAbs into four epitope communities. Notably, relationships within and between communities differed depending on the form of gD, and off-rate analysis suggested differences in mAb-gD avidity depending on the gD serotype and length. Together, these results show that gD1 and gD2 differ in their structural topography. Consistent with the Herpevac results, several mAbs that bind both gD1 and gD2 neutralize only HSV-1. Thus, this technology provides new insights into the antigenic structure of gD and provides a rationale as to how vaccination with a gD2 subunit may lead to protection from HSV-1 infection.
C1 [Cairns, Tina M.; Lou, Huan; Atanasiu, Doina; Cohen, Gary H.] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Ditto, Noah T.; Brooks, Benjamin D.] Wasatch Microfluid, Salt Lake City, UT USA.
   [Eisenberg, Roselyn J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.
RP Cairns, TM (corresponding author), Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA.
EM tmcairns@upenn.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-18289, AI-127039]
FX This research was supported by grants AI-18289 (GHC) and AI-127039 (RJE,
   GHC, BDB) from the National Institutes of Health (www.nih.gov). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abdiche YN, 2016, MABS-AUSTIN, V8, P264, DOI 10.1080/19420862.2015.1118596
   Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451
   Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Atanasiu D, 2016, J VIROL, V90, P10535, DOI 10.1128/JVI.01501-16
   Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10
   Awasthi S, 2014, CURR OPIN VIROL, V6, P6, DOI 10.1016/j.coviro.2014.02.006
   Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177
   Awasthi S, 2014, J INFECT DIS, V209, P813, DOI 10.1093/infdis/jit658
   Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005
   Brooks BD, 2014, DRUG DISCOV TODAY, V19, P1040, DOI 10.1016/j.drudis.2014.05.011
   Cairns TM, 2015, J VIROL, V89, P9213, DOI 10.1128/JVI.01213-15
   Cairns TM, 2014, J VIROL, V88, P12612, DOI 10.1128/JVI.01930-14
   Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2
   CHIANG HY, 1994, J VIROL, V68, P2529, DOI 10.1128/JVI.68.4.2529-2543.1994
   Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101
   COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988
   COHEN GH, 1986, J VIROL, V60, P157, DOI 10.1128/JVI.60.1.157-166.1986
   Connolly SA, 2005, J VIROL, V79, P1282, DOI 10.1128/JVI.79.2.1282-1295.2005
   Connolly SA, 2003, J VIROL, V77, P8127, DOI 10.1128/JVI.77.14.8127-8140.2003
   Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548
   Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277
   EISENBERG RJ, 1985, J VIROL, V53, P634, DOI 10.1128/JVI.53.2.634-644.1985
   Fan Q, 2014, J VIROL, V88, P6470, DOI 10.1128/JVI.00465-14
   Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7
   Gallagher JR, 2013, J VIROL, V87, P12656, DOI 10.1128/JVI.01727-13
   Gianni T, 2009, J BIOL CHEM, V284, P17370, DOI 10.1074/jbc.M109.005728
   Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z
   Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548
   ISOLA VJ, 1989, J VIROL, V63, P2325, DOI 10.1128/JVI.63.5.2325-2334.1989
   Johnston C, 2013, VACCINE
   Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875
   Krummenacher C, 1999, J VIROL, V73, P8127, DOI 10.1128/JVI.73.10.8127-8137.1999
   Krummenacher C, 1998, J VIROL, V72, P7064, DOI 10.1128/JVI.72.9.7064-7074.1998
   Lazear E, 2008, J VIROL, V82, P700, DOI 10.1128/JVI.02192-07
   Lazear E, 2012, J VIROL, V86, P1563, DOI 10.1128/JVI.06480-11
   Lee CC, 2013, ACTA CRYSTALLOGR D, V69, P1935, DOI 10.1107/S0907444913016776
   Lu GW, 2014, J VIROL, V88, P13678, DOI 10.1128/JVI.01906-14
   Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005
   MINSON AC, 1986, J GEN VIROL, V67, P1001, DOI 10.1099/0022-1317-67-6-1001
   MUGGERIDGE MI, 1990, VIROLOGY, V174, P375, DOI 10.1016/0042-6822(90)90091-5
   Muggeridge MI, 2000, J GEN VIROL, V81, P2017, DOI 10.1099/0022-1317-81-8-2017
   MUGGERIDGE MI, 1988, J VIROL, V62, P3274, DOI 10.1128/JVI.62.9.3274-3280.1988
   MUGGERIDGE MI, 1990, J VIROL, V64, P3617, DOI 10.1128/JVI.64.8.3617-3626.1990
   Muggeridge MI, 1990, IMMUNOCHEMISTRY VIRU, P459
   Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005
   Nicola AV, 1998, J VIROL, V72, P3595, DOI 10.1128/JVI.72.5.3595-3601.1998
   Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004
   Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003
   Nicola AV, 1997, J VIROL, V71, P2940, DOI 10.1128/JVI.71.4.2940-2946.1997
   Pinninti SG, 2013, PEDIATR CLIN N AM, V60, P351, DOI 10.1016/j.pcl.2012.12.005
   Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683
   Rux AH, 1998, J VIROL, V72, P7091, DOI 10.1128/JVI.72.9.7091-7098.1998
   Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53
   Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x
   Stampfer SD, 2013, CURR OPIN VIROL, V3, P13, DOI 10.1016/j.coviro.2012.10.005
   van Kooij A, 2002, PROTEIN EXPRES PURIF, V25, P400, DOI 10.1016/S1046-5928(02)00034-7
   Whitbeck JC, 2014, J VIROL, V88, P7786, DOI 10.1128/JVI.00544-14
   Whitbeck JC, 1999, J VIROL, V73, P9879, DOI 10.1128/JVI.73.12.9879-9890.1999
   Whitbeck JC, 1997, J VIROL, V71, P6083, DOI 10.1128/JVI.71.8.6083-6093.1997
   Willis SH, 1998, J VIROL, V72, P5937, DOI 10.1128/JVI.72.7.5937-5947.1998
   Zeev-Ben-Mordehai T, 2016, P NATL ACAD SCI USA, V113, P4176, DOI 10.1073/pnas.1523234113
NR 64
TC 10
Z9 10
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2017
VL 13
IS 6
AR e1006430
DI 10.1371/journal.ppat.1006430
PG 28
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EZ2AI
UT WOS:000404511700029
PM 28614387
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aziz, H
   Zia, A
   Anwer, A
   Aziz, M
   Fatima, S
   Faheem, M
AF Aziz, Hafsa
   Zia, Aadarash
   Anwer, Amania
   Aziz, Muneeba
   Fatima, Shazia
   Faheem, Muhammad
TI Zika virus: Global health challenge, threat and current situation
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE flavirus; virus classification; pandemics; epidemiology; immunoglobulin;
   immune responses
ID WEST-NILE-VIRUS; FRENCH-POLYNESIA; TRANSMISSION; DENGUE; INFECTION;
   PERSISTENCE; AMERICA; PROTEIN; STRAIN; PREGNANCY
AB ZIKV has emerged as grave global health issue in the past few years. ZIKV was firstly isolated in 1947 from a rhesus sentinel monkey in the Zika forest in Uganda. It is usually transmitted by the bite of infected mosquitoes and infects skin fibroblasts, skin keratinocytes, etc. ZIKV until now was under reported because of its clinical similarity with the dengue and chikungunya. It is usually spread through the course of the sylvatic cycle. In this cycle, the virus or pathogen lifespan is spent between the wild animal and vectors. The intrinsic incubation period is not yet fully known but it is observed that the very first symptoms of ZIKV infection can appear or develop within 3-12 days of time period and usually subside within 7 days of time. There is a strong relationship between prenatal Zika virus infection and microcephaly; other serious brain anomalies to the infant or newborn are Guillain-Barre syndrome. To date no vaccines are available for ZIKV prevention hence only symptomatic treatment is recommended in infected patients. Usually ZIKV is detected by serologic (IgM ELISA), plaque reduction neutralization test (PRNT) along with in-house molecular techniques (RT-PCR). ZIKV infection being imminent global health issue warrants strong protective measures to prevent it from becoming an epidemic. Early detection and prevention is the key to tackle this grave potential health hazard. J. Med. Virol. 89:943-951, 2017. (c) 2017 Wiley Periodicals, Inc.
C1 [Aziz, Hafsa; Zia, Aadarash; Anwer, Amania; Fatima, Shazia; Faheem, Muhammad] Nucl Med Oncol & Radiotherapy Inst Islamabad, Islamabad, Pakistan.
   [Aziz, Muneeba] Med Doctor Dist Headquarter Hosp, Faisalabad, Pakistan.
RP Aziz, H (corresponding author), Nucl Med Oncol & Radiotherapy Inst Islamabad, Islamabad, Pakistan.
EM hafsa.aziz@gmail.com
RI Fatima, Shazia/Y-2984-2019
OI Sheikh, Amania Anwar/0000-0003-0769-2081
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bagla P, 2016, HUFFINGTON POST
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR MORBIDITY MORTA, V65
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Broxmeyer L, 2016, MOD RES INFLAMM, V5, P20
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Centers for Disease Control and Prevention, 2016, CDC ISS INT GUID PRE
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   CHANG GJJ, 1994, J CLIN MICROBIOL, V32, P477, DOI 10.1128/JCM.32.2.477-483.1994
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   ECDC Epidemiological Update, 2016, OUTBR ZIK VIR COMPL
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Madhukar GY, 2016, WORLD J PHARM PHARM, V5, P2191
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Rabe IB, 2016, MMWR MORBIDITY MORTA, V65
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Waddell LA, 2016, PLOS ONE, V11
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WHO (World Health Organization) report, 2016, NEUR SYNDR CONG AN
   World Health Organization, 2016, ZIK VIR
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 70
TC 11
Z9 14
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUN
PY 2017
VL 89
IS 6
BP 943
EP 951
DI 10.1002/jmv.24731
PG 9
WC Virology
SC Virology
GA ER6DA
UT WOS:000398893900002
PM 27862008
DA 2020-07-08
ER

PT J
AU Oguntade, S
   Ramharack, P
   Soliman, MES
AF Oguntade, Sofiat
   Ramharack, Pritika
   Soliman, Mahmoud E. S.
TI Characterizing the ligand-binding landscape of Zika NS3
   helicase-promising lead compounds as potential inhibitors
SO FUTURE VIROLOGY
LA English
DT Article
DE free binding energy; molecular dynamic simulations; NS3 helicase; Zika
   virus
ID MOLECULAR-DYNAMICS SIMULATIONS; VIRUS-INFECTION; DRUG DISCOVERY; AMBER;
   TRANSMISSION; MECHANICS; DOCKING
AB Aim: This study aims to provide insight into the binding features of the ATPase and ssRNA sites of the NS3 helicase. Methods: Clinically approved Flavivirus inhibitors were docked to the corresponding active sites of the protein, and the three best compounds were validated with molecular dynamic simulations. Result: Binding of Ivermectin to ssRNA site and Lapachol and HMC-HO1 alpha to the ATPase site allowed for conformational rigidity of the Zika NS3 helicase, thus stabilizing residue fluctuations and allowing for protein stability. Favorable free binding energies were also noted between compounds and the helicase, thus supporting the intermolecular forces at the helicase active site. Conclusion: The pharmacophoric characteristics found in Lapachol, HMC-HO1a and Ivermectin may be utilized in the design of a potent hybrid drug that is able to show efficient inhibition of a multitude of diseases including the detrimental co-infection of Zika virus, dengue and chikungunya.
C1 [Oguntade, Sofiat; Ramharack, Pritika; Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Westville Campus, ZA-4001 Durban, South Africa.
   [Soliman, Mahmoud E. S.] Zagazig Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Zagazig, Egypt.
   [Soliman, Mahmoud E. S.] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
RP Soliman, MES (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Discipline Pharmaceut Sci, Westville Campus, ZA-4001 Durban, South Africa.; Soliman, MES (corresponding author), Zagazig Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Zagazig, Egypt.; Soliman, MES (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
EM soliman@ukzn.ac.za
OI Ramharack, Pritika/0000-0001-5850-6782
FU College of Health Sciences, UKZN; National Research Foundation
FX The authors acknowledge the College of Health Sciences, UKZN, and the
   National Research Foundation for their financial support and the Center
   for High Performance Computing [53] for their computational resources.
   The authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR [Anonymous], 2011, WIND MMV X MOS MOL M
   Appiah-Kubi P, 2016, J BIOMOL STRUCT DYN, V1102, P1
   Arodola Olayide A, 2015, Drug Des Devel Ther, V9, P6055, DOI 10.2147/DDDT.S87653
   Baharuddin A, 2014, CURR PHARM DESIGN, V20, P3428, DOI 10.2174/13816128113199990635
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Borowski P, 2002, ANTIMICROB AGENTS CH, V46, P1231, DOI 10.1128/AAC.46.5.1231-1239.2002
   Briguglio I, 2011, INT J MED CHEM, DOI 10.1155/2011/213135
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   da Costa ECB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082504
   de Oliveira AS, 2014, J BRAZIL CHEM SOC, V25, P1759, DOI 10.5935/0103-5053.20140057
   Ferreira LG, 2015, MOLECULES, V20, P13384, DOI 10.3390/molecules200713384
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Godschalk F, 2013, PHYS CHEM CHEM PHYS, V15, P7731, DOI 10.1039/c3cp00116d
   Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j
   Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/cI300025v, 10.1021/ci300425v]
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Incicco JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058508
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Karubiu W, 2014, PROTEIN J, V33, P432, DOI 10.1007/s10930-014-9576-8
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Kumalo HM, 2016, CELL MOL BIOENG, V9, P175, DOI 10.1007/s12195-015-0421-8
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lindert S, 2013, J CHEM THEORY COMPUT, V9, P1
   Mahfuz M., 2014, INDIAN J PHARM BIOL, V2, P44
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Miao YL, 2015, J COMPUT CHEM, V36, P1536, DOI 10.1002/jcc.23964
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Plourde A. R., 2016, EMERG INFECT DIS, V22, P1
   Salsbury FR, 2010, CURR OPIN PHARMACOL, V10, P738, DOI 10.1016/j.coph.2010.09.016
   Seifert E, 2014, J CHEM INF MODEL, V54, P1552, DOI 10.1021/ci500161d
   Sing A, 2015, DRUG DES DEV THER, V9, P1
   Sreedharan J., 2016, SCIENTIA, V11, P9
   Steffen C, 2010, J COMPUT CHEM, V31, P2967, DOI 10.1002/jcc.21576
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 52
TC 8
Z9 8
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUN
PY 2017
VL 12
IS 6
BP 261
EP 273
DI 10.2217/fvl-2017-0014
PG 13
WC Virology
SC Virology
GA EY5SR
UT WOS:000404040400005
DA 2020-07-08
ER

PT J
AU Gonzalez-Salazar, C
   Stephens, CR
   Sanchez-Cordero, V
AF Gonzalez-Salazar, Constantino
   Stephens, Christopher R.
   Sanchez-Cordero, Victor
TI RESPONSE TO LETTER TO THE EDITOR "NON-HUMAN HOSTS AND ZIKA VIRUS
   MAINTENANCE''
SO ECOHEALTH
LA English
DT Letter
C1 [Gonzalez-Salazar, Constantino; Stephens, Christopher R.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad C3, Mexico City 04510, DF, Mexico.
   [Stephens, Christopher R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico.
   [Sanchez-Cordero, Victor] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico.
RP Gonzalez-Salazar, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad C3, Mexico City 04510, DF, Mexico.
EM cgsalazar7@gmail.com
RI Gonzalez-Salazar, Constantino/M-3913-2015
OI Gonzalez-Salazar, Constantino/0000-0001-7347-714X
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Davoust B, 2016, VECTOR-BORNE ZOONOT, V16, P359, DOI 10.1089/vbz.2015.1881
   Gonzalez-Salazar C, 2017, ECOHEALTH, V14, P171, DOI 10.1007/s10393-017-1206-4
   Ho SH, 2017, EPIDEMIOL INFECT, V145, P54, DOI 10.1017/S0950268816002090
   Joob B, 2017, ASIAN PAC J TROP MED, V10, P199, DOI 10.1016/j.apjtm.2017.01.011
   Maquart M, 2016, INT J INFECT DIS, V53, P58, DOI 10.1016/j.ijid.2016.11.148
   Singh R., 2015, J TROP DIS S, VS1-004, P1, DOI DOI 10.4172/2329-891X.1000115
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
NR 9
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD JUN
PY 2017
VL 14
IS 2
BP 200
EP 202
PG 3
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA EY7FD
UT WOS:000404153600002
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Non-human Hosts and Zika Virus Maintenance
SO ECOHEALTH
LA English
DT Letter
C1 [Yasri, Sora; Wiwanitkit, Viroj] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Gonzalez-Salazar C, 2017, ECOHEALTH, V14, P171, DOI 10.1007/s10393-017-1206-4
   Joob B, 2017, ASIAN PAC J TROP MED
   Joob B, 2016, J VECTOR DIS, V53, P192
NR 3
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD JUN
PY 2017
VL 14
IS 2
BP 200
EP 200
DI 10.1007/s10393-017-1246-9
PG 1
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA EY7FD
UT WOS:000404153600001
PM 28536757
DA 2020-07-08
ER

PT J
AU Wong, N
   Ahmed, A
   Ahmed, O
   Elsanousi, F
   Veater, J
   Osborne, J
   Aarons, E
   Tang, JW
AF Wong, Nicholas
   Ahmed, Aleem
   Ahmed, Osama
   Elsanousi, Fadwa
   Veater, James
   Osborne, Jane
   Aarons, Emma
   Tang, Julian W.
TI A series of Zika virus cases imported into the UK 2016: Comparative
   epidemiological and clinical features
SO JOURNAL OF INFECTION
LA English
DT Letter
ID GUILLAIN-BARRE-SYNDROME; INFECTION
C1 [Wong, Nicholas; Ahmed, Osama; Elsanousi, Fadwa; Veater, James; Tang, Julian W.] Univ Hosp Leicester NHS Trust, Clin Microbiol, Leicester, Leics, England.
   [Ahmed, Aleem; Osborne, Jane; Aarons, Emma] Rare & Imported Pathogens Lab, Porton Down, England.
RP Tang, JW (corresponding author), Univ Hosp Leicester NHS Trust, Clin Microbiol, Leicester Royal Infirm, Level 5 Sandringham Bldg,Infirm Sq, Leicester LE1 5WW, Leics, England.
EM julian.tang@uhl-tr.nhs.uk
OI Tang, Julian/0000-0002-4963-1028
CR Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pomar L, 2017, ULTRASOUND OBSTET GY
   Public Health England, REV ALG ASS PREGN WO
   Xiang B, 2017, J INFECTION, V74, P328, DOI 10.1016/j.jinf.2017.01.004
NR 9
TC 3
Z9 3
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUN
PY 2017
VL 74
IS 6
BP 616
EP 618
DI 10.1016/j.jinf.2017.03.004
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EY5MJ
UT WOS:000404021000011
PM 28344115
OA Bronze
DA 2020-07-08
ER

PT J
AU Piontkivska, H
   Frederick, M
   Miyamoto, MM
   Wayne, ML
AF Piontkivska, Helen
   Frederick, Madeline
   Miyamoto, Michael M.
   Wayne, Marta L.
TI RNA editing by the host ADAR system affects the molecular evolution of
   the Zika virus
SO ECOLOGY AND EVOLUTION
LA English
DT Article
DE ADAR; molecular evolution; RNA editing; RNA virus; Zika virus
ID CODON USAGE BIAS; SEXUAL TRANSMISSION; OUTBREAK; PATTERNS; RATES
AB Zika virus (ZIKV) is a mosquito-transmitted flavivirus, linked to microcephaly and fetal death in humans. Here, we investigate whether host-mediated RNA editing of adenosines (ADAR) plays a role in the molecular evolution of ZIKV. Using complete coding sequences for the ZIKV polyprotein, we show that potential ADAR substitutions are underrepresented at the ADAR-resistant GA dinucleotides of both the positive and negative strands, that these changes are spatially and temporally clustered (as expected of ADAR editing) for three branches of the viral phylogeny, and that ADAR mutagenesis can be linked to its codon usage. Furthermore, resistant GA dinucleotides are enriched on the positive (but not negative) strand, indicating that the former is under stronger purifying selection than the latter. ADAR editing also affects the evolution of the rhabdovirus sigma. Our study now documents that host ADAR editing is a mutation and evolutionary force of positive- as well as negative-strand RNA viruses.
C1 [Piontkivska, Helen; Frederick, Madeline] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.
   [Piontkivska, Helen; Frederick, Madeline] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA.
   [Miyamoto, Michael M.; Wayne, Marta L.] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Wayne, Marta L.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
RP Piontkivska, H (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.
EM opiontki@kent.edu
RI Piontkivska, Helen/AAK-3915-2020
OI Piontkivska, Helen/0000-0003-1844-864X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM083192, GM106174]
FX National Institutes of Health, Grant/Award Number: GM083192 and GM106174
CR Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carpenter JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-75
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324
   Fajardo A, 2016, J MED VIROL, V88, P1672, DOI 10.1002/jmv.24596
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Felsenstein F., 2003, INFERRING PHYLOGENIE, P580
   Fields B. N., 2013, FIELDS VIROLOGY, P2664
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Graur D, 2016, MOLECULAR AND GENOME EVOLUTION, P1
   Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Jin YF, 2009, IUBMB LIFE, V61, P572, DOI 10.1002/iub.207
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   KARLIN S, 1995, TRENDS GENET, V11, P283
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Piontkivska H, 2016, GENOME BIOL EVOL, V8, P2952, DOI 10.1093/gbe/evw212
   Ryu W.-S., 2016, MOLECULAR VIROLOGY H, P440
   Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004
   Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936
   Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Swofford DL, 2003, PAUP PHYLOGENETIC AN
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang W., 2006, SEQOOL V2 0
NR 59
TC 10
Z9 10
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-7758
J9 ECOL EVOL
JI Ecol. Evol.
PD JUN
PY 2017
VL 7
IS 12
BP 4475
EP 4485
DI 10.1002/ece3.3033
PG 11
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA EY3PN
UT WOS:000403884700037
PM 28649357
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, JX
   Li, Y
   Liu, P
   Lin, JP
AF Sun, Jixue
   Li, Yang
   Liu, Pi
   Lin, Jianping
TI Study of the mechanism of protonated histidine-induced conformational
   changes in the Zika virus dimeric envelope protein using accelerated
   molecular dynamic simulations
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE Zika virus; Accelerated dynamic simulations; Envelope protein;
   Conformational change
ID VIRAL MEMBRANE-FUSION; FREE-ENERGY CALCULATIONS; DENGUE VIRUS;
   ENCEPHALITIS-VIRUS; CRYSTAL-STRUCTURE; FORCE-FIELD; GLYCOPROTEIN;
   MATURATION; COMPLEX; BRAZIL
AB The Zika virus has drawn worldwide attention because of the epidemic diseases it causes. It is a flavivirus that has an icosahedral protein shell constituted by an envelope glycoprotein (E-protein) and membrane protein (M-protein) in the mature virion. The multistep process of membrane fusion to infect the host cell is pH-induced. To understand the mechanism of the conformational changes in the (E-M)(2) protein homodimer embedded in the membrane, two 200-ns accelerated dynamic simulations were performed under different pH conditions. The low pH condition weakens the interactions and correlations in both E-protein monomers and in the E-M heterodimer. The highly conserved residues, His249, His288, His323 and His446, are protonated under low pH conditions and play key roles in driving the fusion process. The analysis and discussion in this study may provide some insight into the molecular mechanism of Zika virus infection. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Sun, Jixue; Li, Yang; Lin, Jianping] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.
   [Sun, Jixue; Li, Yang; Lin, Jianping] Nankai Univ, Tianjin Key Lab Mol Drug Res, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.
   [Liu, Pi; Lin, Jianping] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin Airport Econ Area, 32 West 7th Ave, Tianjin 300308, Peoples R China.
RP Lin, JP (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.; Lin, JP (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.; Liu, P (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin Airport Econ Area, 32 West 7th Ave, Tianjin 300308, Peoples R China.
EM liu_p@tib.cas.cn; jianpinglin@nankai.edu.cn
OI Li, Yang/0000-0002-9509-8199
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China [31070640]; Nankai University
FX This study was supported by the National Science Foundation of China
   (No. 31070640) and the Ph.D. Candidate Research Innovation Fund of
   Nankai University.
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Case D. A., 2015, AMBER 14
   Chong LT, 1999, P NATL ACAD SCI USA, V96, P14330, DOI 10.1073/pnas.96.25.14330
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307
   Dubey KD, 2011, BBA-PROTEINS PROTEOM, V1814, P1796, DOI 10.1016/j.bbapap.2011.09.012
   Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25
   Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149
   FLETCHER R, 1963, COMPUT J, V6, P163, DOI 10.1093/comjnl/6.2.163
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Fuzo CA, 2014, J BIOMOL STRUCT DYN, V32, P1563, DOI 10.1080/07391102.2013.827132
   Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482
   Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jardetzky TS, 2004, NATURE, V427, P307, DOI 10.1038/427307a
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036
   Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   McCarthy M., 2016, BR MED J, V353
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mendes Y. S., 2012, PLOS ONE, V7
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mueller DS, 2008, BIOCHEM SOC T, V36, P43, DOI 10.1042/BST0360043
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pangerl K, 2011, J VIROL, V85, P8495, DOI 10.1128/JVI.05129-11
   PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Prakash MK, 2010, BIOPHYS J, V99, P588, DOI 10.1016/j.bpj.2010.04.024
   Reddy T, 2016, BBA-BIOMEMBRANES, V1858, P1610, DOI 10.1016/j.bbamem.2016.02.007
   Reddy T, 2016, STRUCTURE, V24, P375, DOI 10.1016/j.str.2015.12.011
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Rogers DM, 2015, BBA-BIOMEMBRANES, V1848, P1041, DOI 10.1016/j.bbamem.2014.12.018
   ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tikhonova IG, 2013, BIOCHEMISTRY-US, V52, P5593, DOI 10.1021/bi400499n
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 71
TC 3
Z9 3
U1 0
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1093-3263
EI 1873-4243
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD JUN
PY 2017
VL 74
BP 203
EP 214
DI 10.1016/j.jmgm.2017.04.009
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA EY0CB
UT WOS:000403624700022
PM 28445832
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus infection and pregnancy: Issue for further concern
SO OBSTETRIC MEDICINE
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Publ Hlth Curriculum, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Publ Hlth Curriculum, Surin, Thailand.
EM wviroj@yhoo.com
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Kim S, 2016, ADV LAB MED INT, V16, P37
   Nebbia G, 2016, OBSTET MED, V9, P53, DOI 10.1177/1753495X16648078
   Ropero-Alvarez AM, 2015, VACCINE, V33, P187, DOI 10.1016/j.vaccine.2014.10.070
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 5
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1753-495X
EI 1753-4968
J9 OBSTET MED
JI Obstet. Med.
PD JUN
PY 2017
VL 10
IS 2
BP 99
EP 99
DI 10.1177/1753495X16677873
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EY3YX
UT WOS:000403913300013
PM 28680473
OA Green Published
DA 2020-07-08
ER

PT J
AU Marteleto, LJ
   Weitzman, A
   Coutinho, RZ
   Alves, SV
AF Marteleto, Leticia J.
   Weitzman, Abigail
   Coutinho, Raquel Zanatta
   Alves, Sandra Valongueiro
TI Women's Reproductive Intentions and Behaviors during the Zika Epidemic
   in Brazil
SO POPULATION AND DEVELOPMENT REVIEW
LA English
DT Article
ID FAMILY HEALTH STRATEGY; PLANNED BEHAVIOR; CONDOM USE; FERTILITY; VIRUS;
   CARE; CONTRACEPTION; POPULATION; MORTALITY; ABORTION
AB This study uses focus group data from women of reproductive age to investigate whether and how women's fertility intentions and prevention strategies are changing in response to the Zika virus (ZIKV) epidemic in Brazil. Our findings indicate that many women fear the intrauterine consequences of ZIKV infection. Women of low socioeconomic status commonly report not desiring more children irrespective of the epidemic, but also report facing obstacles to using contraception. Women of high status report wanting to postpone pregnancy in light of the epidemic and making a more concerted effort to use contraception, sometimes changing contraceptive method. Some older high-status women who have not completed their desired fertility report actively trying to conceive during the epidemic, doing so primarily during the dry season when mosquito infestation is lowest. Many women report considering or resorting to abortion if they have been infected with ZIKV.
C1 [Marteleto, Leticia J.; Weitzman, Abigail] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA.
   [Marteleto, Leticia J.; Weitzman, Abigail] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA.
   [Coutinho, Raquel Zanatta] Univ Fed Minas Gerais, Ctr Reg Dev & Planning Cedeplar, Belo Horizonte, MG, Brazil.
   [Alves, Sandra Valongueiro] Univ Fed Pernambuco, Sch Social Med, Recife, PE, Brazil.
   [Alves, Sandra Valongueiro] MERG, Recife, PE, Brazil.
RP Marteleto, LJ (corresponding author), Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA.; Marteleto, LJ (corresponding author), Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA.
FU Population Research Center (NICHD) [R24HD042849]; Population Health
   Initiative at the University of Texas at Austin
FX Funds for this research were provided by a seed grant from the
   Population Research Center (NICHD, R24HD042849) and the Population
   Health Initiative at the University of Texas at Austin. The authors are
   grateful to Kathleen Gerson for generous feedback on the design of the
   focus group protocol; to Abigail Aiken, Jennifer Barber, Suzana
   Cavenaghi, Rob Crosnoe, Gilvan Guedes, Deb Umberson, and Ana Paula
   Verona for feedback on this study's overall design; to Constancia Ayres,
   Andre Monteiro Costa, and Marcia Castro for generous exchanges on the
   ZIKV epidemic; to Breno Bittencourt, Gabriela Bonifacio, and Bruna
   Firmino for excellent research assistance.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Spinelli MBAD, 2014, SAUDE SOC-SAO PAULO, V23, P227, DOI 10.1590/S0104-12902014000100018
   Amaral E. F. L., 2015, RAND WORKING PAPER S, V1093
   Bachrach CA, 2013, POPUL DEV REV, V39, P459, DOI 10.1111/j.1728-4457.2013.00612.x
   Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1
   Behrman JA, 2016, STUD FAMILY PLANN, V47, P3, DOI 10.1111/j.1728-4465.2016.00045.x
   BEMFAM, 1997, DHS FINAL REPORTS BR
   Berquo E., 2004, ANN 14 NAT M BRAZ PO
   Bhalotra S., 2016, 201616 I SOC EC RES
   BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149
   Brasil, 2017, VIRUS ZIKA BRASIL RE
   Brasil, 2012, CENSO DEMOGRAFICO 20
   Brasil, 2017, B EPIDEMIOLOGICO SEC, V48
   Brasil, 2015, BRAZIL POPULAR PHARM
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Caetano André Junqueira, 2014, Rev. bras. estud. popul., V31, P309, DOI 10.1590/S0102-30982014000200005
   Camarano A. A. O., 2014, NOVO REGIME DEMOGRAF
   Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavenaghi S., 2014, COMPORTAMIENTO REPRO, P220
   CEBRAP, 2008, PESQUISA NACL DEMOGR
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Coffey A., 1996, MAKING SENSE QUALITA, P54
   Costa A. M., 2016, DESAFIOS DESENVOLVIM
   Costa ND, 2016, CIENC SAUDE COLETIVA, V21, P1389, DOI 10.1590/1413-81232015215.24842015
   Creswell JW, 2009, RES DESIGN QUALITATI
   CURTIS SI, 1995, INT FAM PLAN PERSPEC, V21, P58, DOI 10.2307/2133524
   de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/s0034-89102009000400013
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dennis A, 2012, PERSPECT SEX REPRO H, V44, P84, DOI 10.1363/4408412
   Diniz C., 2002, DESENVOLVIMENTO DEBA
   DINIZ Debora, 2016, SERTAO NORDESTINO AM
   Diniz SG, 2012, REPROD HEALTH MATTER, V20, P94, DOI 10.1016/S0968-8080(12)40657-7
   Finlay J., 2009, FERTILITY RESPONSE N
   Fishbein M., 2011, PREDICTING CHANGING
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fusco CLB, 2012, CAD SAUDE PUBLICA, V28, P709, DOI 10.1590/S0102-311X2012000400010
   Goldberg RE, 2013, DEMOGRAPHY, V50, P725, DOI 10.1007/s13524-012-0150-8
   Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6
   Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069
   IBGE, 2015, EST REG CIV I BRAS G, V42
   IPEA, 2010, 58 IPEA
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Knodel J., 1993, SUCCESSFUL FOCUS GRO, P35, DOI DOI 10.4135/9781483349008
   Le HH, 2014, IN J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543
   Leite Iuri C, 2007, Reprod Health, V4, P6, DOI 10.1186/1742-4755-4-6
   Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140
   Malagutti W., 2012, ASSISTENCIA DOMICILI, P336
   Malta M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-18
   MaranhAo T. A., 2012, REV INTERDISCIPLINAR, V5, P58
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Marteleto L. J., 2016, ANN M POP ASS AM WAS
   Marteleto LJ, 2013, DEMOGR RES, V28, P793, DOI 10.4054/DemRes.2013.28.28
   Maxwell JA, 2004, FIELD METHOD, V16, P243, DOI DOI 10.1177/1525822X04266831
   Maxwell JA, 2012, QUAL INQ, V18, P655, DOI 10.1177/1077800412452856
   McCord GC, 2017, ECON HUM BIOL, V24, P1, DOI 10.1016/j.ehb.2016.10.011
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moreau C, 2013, HUM REPROD, V28, P642, DOI 10.1093/humrep/des421
   MORGAN DL, 1993, SUCCESSFUL FOCUS GRO, P3, DOI DOI 10.4135/9781483349008
   Nobles J, 2015, DEMOGRAPHY, V52, P15, DOI 10.1007/s13524-014-0362-1
   Oliveira W. K., 2017, NEW ENGLAND J MED
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Pereira C. C. B., 2013, REV BRASILEIRA SAUDE, V13
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PNDS, 2006, PESQ NAC DEM SAUD MU
   Potter JE, 2003, CONTRACEPTION, V67, P385, DOI 10.1016/S0010-7824(03)00039-8
   Potter JE, 2002, DEMOGRAPHY, V39, P739, DOI 10.2307/3180829
   Potter JE, 1999, POPUL DEV REV, V25, P703, DOI 10.1111/j.1728-4457.1999.00703.x
   Prietsch S. O. M., 2011, CADERNOS SAUDE PUBLI, V27
   Reinecke J, 1996, J APPL SOC PSYCHOL, V26, P749, DOI 10.1111/j.1559-1816.1996.tb01128.x
   Romero S., 2015, NY TIMES
   Rosenstock I. M., 1994, PREVENTING AIDS
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405
   Sandy M., 2016, TIME
   SINASC, 2017, SINASC GMVEV DG IAEV
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Sutton S, 1999, HEALTH PSYCHOL, V18, P72, DOI 10.1037/0278-6133.18.1.72
   Szwarcwald CL, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-16
   Szwarcwald CL, 2005, AIDS, V19, pS51, DOI 10.1097/01.aids.0000191491.66736.16
   Theme-Filha MM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0227-8
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Trinitapoli J, 2011, AM SOCIOL REV, V76, P935, DOI 10.1177/0003122411427672
   Vrachnis N, 2014, LANCET, V383, P692, DOI 10.1016/S0140-6736(14)60252-X
   Weiss R. S., 1994, LEARNING STRANGERS A
   World Bank, 2016, GINI IND
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 89
TC 10
Z9 10
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0098-7921
EI 1728-4457
J9 POPUL DEV REV
JI Popul. Dev. Rev.
PD JUN
PY 2017
VL 43
IS 2
BP 199
EP 227
DI 10.1111/padr.12074
PG 29
WC Demography; Sociology
SC Demography; Sociology
GA EY4BI
UT WOS:000403920900001
PM 31359895
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Lichter, DT
   Parisi, D
   Taquino, MC
AF Lichter, Daniel T.
   Parisi, Domenico
   Taquino, Michael C.
TI Together but Apart: Do US Whites Live in Racially Diverse Cities and
   Neighborhoods?
SO POPULATION AND DEVELOPMENT REVIEW
LA English
DT Article
ID FAMILY HEALTH STRATEGY; ZIKA VIRUS; PLANNED BEHAVIOR; CONDOM USE;
   FERTILITY; POPULATION; BRAZIL; CARE; CONTRACEPTION; MORTALITY
AB Are whites increasingly living in racially diverse communities? Or are they clustering together in mostly white communities or with white neighbors? We link cross-sectional data from the household records in the 1989, 1999, and 2009 waves of the Panel Study of Income Dynamics (PSID) to metropolitan, place, and block data from the US decennial censuses. Our analyses provide little evidence that whites are increasingly choosing to live in all-white or mostly white cities or suburban communities or that they mostly avoid places with diverse minority populations. Moreover, whites on average are not only increasingly living in racially diverse communities but also living with minorities-including blacks-on the same city blocks in these communities. Still, these emerging patterns of white exposure to minorities-both at the place and block levels-vary significantly by socioeconomic status. We show that white population responses to growing ethnoracial diversity are highly segmented and that clustering together is expressed differently at different levels of geography, i.e., between and within metropolitan cities and suburbs. White residential integration and segregation are important but uncharted demographic components of America's evolving system of stratification and societal cohesion.
C1 [Lichter, Daniel T.] Cornell Univ, Dept Policy Anal, Ithaca, NY 14853 USA.
   [Lichter, Daniel T.] Cornell Univ, Dept Management & Sociol, Ithaca, NY 14853 USA.
   [Parisi, Domenico] Mississippi State Univ, Sociol, Starkville, MS USA.
   [Parisi, Domenico; Taquino, Michael C.] Mississippi State Univ, Natl Strateg Planning & Anal Res Ctr, Starkville, MS USA.
RP Lichter, DT (corresponding author), Cornell Univ, Dept Policy Anal, Ithaca, NY 14853 USA.; Lichter, DT (corresponding author), Cornell Univ, Dept Management & Sociol, Ithaca, NY 14853 USA.
FU Cornell Population Center; National Strategic Planning & Analysis
   Research Center (NSPARC) at Mississippi State University
FX An earlier version of this article was presented at the Annual Meeting
   of the Population Association of America, Washington, DC, April 2, 2016.
   The authors acknowledge the support of the Cornell Population Center and
   the National Strategic Planning & Analysis Research Center (NSPARC) at
   Mississippi State University. They also appreciate the helpful comments
   of Matthew Hall. Address e-correspondence to Daniel T. Lichter at
   dtl28@cornell.edu.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Spinelli MBAD, 2014, SAUDE SOC-SAO PAULO, V23, P227, DOI 10.1590/S0104-12902014000100018
   Amaral E. F. L., 2015, RAND WORKING PAPER S
   Bachrach CA, 2013, POPUL DEV REV, V39, P459, DOI 10.1111/j.1728-4457.2013.00612.x
   Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1
   Behrman JA, 2016, STUD FAMILY PLANN, V47, P3, DOI 10.1111/j.1728-4465.2016.00045.x
   BEMFAM, 1997, DHS FIN REP
   Berquo E., 2004, ANN 14 NAT M BRAZ PO
   Bhalotra S., 2016, 201616 I SOC EC RES
   BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149
   Brasil, 2017, VIR ZIK BRAS RESP SU
   Brasil, 2017, IBGE CIDADES
   Brasil, 2012, CENS DEM 2010 NUPC F
   Brasil, 2015, BRAZ POP PHARM PROGR
   Brasil, 2017, B EP SECR VIG SAUD, V48
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Caetano AJ, 2014, REV BRASILEIRA ESTUD, V31, P309
   Camarano A. A. O., 2014, NOVO REGIME DEMOGRAF
   Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavenaghi S., 2014, COMPORTAMIENTO REPRO, P220
   CEBRAP, 2008, CTR BRAS AN PLAN DEC
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Coffey A., 1996, MAKING SENSE QUALITA, P54
   Costa A. M., 2016, DESAFIOS DESENVOLVIM
   Costa ND, 2016, CIENC SAUDE COLETIVA, V21, P1389, DOI 10.1590/1413-81232015215.24842015
   Creswell JW, 2009, RES DESIGN QUALITATI
   CURTIS SI, 1995, INT FAM PLAN PERSPEC, V21, P58, DOI 10.2307/2133524
   de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/s0034-89102009000400013
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dennis A, 2012, PERSPECT SEX REPRO H, V44, P84, DOI 10.1363/4408412
   Diniz C., 2002, DESENVOLVIMENTO DEBA
   DINIZ Debora, 2016, SERTAO NORDESTINO AM
   Diniz SG, 2012, REPROD HEALTH MATTER, V20, P94, DOI 10.1016/S0968-8080(12)40657-7
   Finlay J., 2009, FERTILITY RESPONSE N
   Fishbein M., 2011, PREDICTING CHANGING
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fusco CLB, 2012, CAD SAUDE PUBLICA, V28, P709, DOI 10.1590/S0102-311X2012000400010
   Goldberg RE, 2013, DEMOGRAPHY, V50, P725, DOI 10.1007/s13524-012-0150-8
   Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6
   Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069
   IBGE, 2015, EST REG CIV, V42
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Knodel J., 1993, SUCCESSFUL FOCUS GRO, P35, DOI DOI 10.4135/9781483349008
   Le HH, 2014, IN J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543
   Leite Iuri C, 2007, Reprod Health, V4, P6, DOI 10.1186/1742-4755-4-6
   LIRAa, 2015, LEV IND RAP AED AEG
   LIRAa, 2016, LEV IND RAP AED AEG
   Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140
   Malagutti W., 2012, ASSISTENCIA DOMICILI, P336
   Malta M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-18
   MaranhAo T. A., 2012, REV INTERDISCIPLINAR, V5, P58
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Marteleto L. J., 2016, ANN M POP ASS AM WAS
   Marteleto LJ, 2013, DEMOGR RES, V28, P793, DOI 10.4054/DemRes.2013.28.28
   Maxwell JA, 2004, FIELD METHOD, V16, P243, DOI DOI 10.1177/1525822X04266831
   Maxwell JA, 2012, QUAL INQ, V18, P655, DOI 10.1177/1077800412452856
   McCord GC, 2017, ECON HUM BIOL, V24, P1, DOI 10.1016/j.ehb.2016.10.011
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moreau C, 2013, HUM REPROD, V28, P642, DOI 10.1093/humrep/des421
   MORGAN DL, 1993, SUCCESSFUL FOCUS GRO, P3, DOI DOI 10.4135/9781483349008
   Nobles J, 2015, DEMOGRAPHY, V52, P15, DOI 10.1007/s13524-014-0362-1
   Oliveira W. K., 2017, NEW ENGLAND J MED
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Pereira C. C. B., 2013, REV BRASILEIRA SAUDE, V13
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PNDS, 2006, PESQ NAC DEM SAUD MU
   PNS, 2013, PESQ NAC SAUD
   Potter JE, 2003, CONTRACEPTION, V67, P385, DOI 10.1016/S0010-7824(03)00039-8
   Potter JE, 2002, DEMOGRAPHY, V39, P739, DOI 10.2307/3180829
   Potter JE, 1999, POPUL DEV REV, V25, P703, DOI 10.1111/j.1728-4457.1999.00703.x
   Prietsch S. O. M., 2011, CADERNOS SAUDE PUBLI, V27
   Reinecke J, 1996, J APPL SOC PSYCHOL, V26, P749, DOI 10.1111/j.1559-1816.1996.tb01128.x
   Romero S., 2015, NY TIMES
   Rosenstock I, 1994, HLTH BELIEF MODEL HI
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405
   Sandy M., 2016, TIME
   SINASC, 2017, SINASC GMVEV DG IAEV
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Sutton S, 1999, HEALTH PSYCHOL, V18, P72, DOI 10.1037/0278-6133.18.1.72
   Szwarcwald CL, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-16
   Szwarcwald CL, 2005, AIDS, V19, pS51, DOI 10.1097/01.aids.0000191491.66736.16
   Theme-Filha MM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0227-8
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Trinitapoli J, 2011, AM SOCIOL REV, V76, P935, DOI 10.1177/0003122411427672
   Vrachnis N, 2014, LANCET, V383, P692, DOI 10.1016/S0140-6736(14)60252-X
   Weiss R. S., 1994, LEARNING STRANGERS A
   World Bank, 2016, GINI IND
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   POPUL DEV REV
NR 93
TC 5
Z9 5
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0098-7921
EI 1728-4457
J9 POPUL DEV REV
JI Popul. Dev. Rev.
PD JUN
PY 2017
VL 43
IS 2
BP 229
EP 255
DI 10.1111/padr.12068
PG 27
WC Demography; Sociology
SC Demography; Sociology
GA EY4BI
UT WOS:000403920900002
DA 2020-07-08
ER

PT J
AU Reynolds, ES
   Hart, CE
   Hermance, ME
   Brining, DL
   Thangamani, S
AF Reynolds, Erin S.
   Hart, Charles E.
   Hermance, Meghan E.
   Brining, Douglas L.
   Thangamani, Saravanan
TI An Overview of Animal Models for Arthropod-Borne Viruses
SO COMPARATIVE MEDICINE
LA English
DT Article
ID VENEZUELAN EQUINE ENCEPHALITIS; AFRICAN-SWINE-FEVER; PERIPHERAL
   CHALLENGE MODEL; RHESUS MACAQUE MODEL; MOUSE MODEL; ZIKA VIRUS;
   HEMORRHAGIC-FEVER; COMPARATIVE PATHOGENESIS; NEUTRALIZING ANTIBODIES;
   THOGOTOVIRUS INFECTION
AB Arthropod-borne viruses (arboviruses) have continued to emerge in recent years, posing a significant health threat to millions of people worldwide. The majority of arboviruses that are pathogenic to humans are transmitted by mosquitoes and ticks, but other types of arthropod vectors can also be involved in the transmission of these viruses. To alleviate the health burdens associated with arbovirus infections, it is necessary to focus today's research on disease control and therapeutic strategies. Animal models for arboviruses are valuable experimental tools that can shed light on the pathophysiology of infection and will enable the evaluation of future treatments and vaccine candidates. Ideally an animal model will closely mimic the disease manifestations observed in humans. In this review, we outline the currently available animal models for several viruses vectored by mosquitoes, ticks, and midges, for which there are no standardly available vaccines or therapeutics.
C1 [Reynolds, Erin S.; Hart, Charles E.; Hermance, Meghan E.; Thangamani, Saravanan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Brining, Douglas L.] Univ Texas Med Branch, Anim Resources Ctr, Galveston, TX 77555 USA.
   [Thangamani, Saravanan] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Thangamani, Saravanan] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
RP Thangamani, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Thangamani, S (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Thangamani, S (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
EM sathanga@utmb.edu
RI Thangamani, Saravanan/E-7371-2010
OI Thangamani, Saravanan/0000-0002-4269-5993
CR Adams AP, 2008, J VIROL, V82, P9035, DOI 10.1128/JVI.00674-08
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Barbour AG, 2017, SEMIN CELL DEV BIOL, V61, P115, DOI 10.1016/j.semcdb.2016.07.002
   Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372
   Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883
   Bosco-Lauth AM, 2016, EMERG INFECT DIS, V22, P2070, DOI 10.3201/eid2212.160472
   Bosco-Lauth AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130150
   Calvert AE, 2014, VACCINE, V32, P258, DOI 10.1016/j.vaccine.2013.11.016
   Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503
   Centers for Disease Control and Prevention, 2016, TECHN FACT SHEET E E
   Charlier N, 2004, ANTIVIR RES, V63, P67, DOI 10.1016/j.antiviral.2004.06.007
   Chen CI, 2010, AM J TROP MED HYG, V83, P1249, DOI 10.4269/ajtmh.2010.10-0290
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Craigo JK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004610
   Dohm DJ, 1996, J MED ENTOMOL, V33, P848, DOI 10.1093/jmedent/33.5.848
   Dowall SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156637
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dupuy LC, 2011, CLIN VACCINE IMMUNOL, V18, P707, DOI 10.1128/CVI.00030-11
   Ershova AS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1884-5
   Feenstra F, 2014, VACCINE, V32, P7108, DOI 10.1016/j.vaccine.2014.10.033
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Godsey MS, 2016, J MED ENTOMOL, V53, P1226, DOI 10.1093/jme/tjw080
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hermance ME, 2015, J VIROL, V89, P7852, DOI 10.1128/JVI.01056-15
   Hofmeister EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167876
   Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177
   Ishihara Y, 2016, J VET MED SCI, V78, P1391, DOI 10.1292/jvms.16-0140
   Janowicz A, 2015, J VIROL, V89, P5238, DOI 10.1128/JVI.00395-15
   Julander JG, 2008, ANTIVIR RES, V78, P230, DOI 10.1016/j.antiviral.2008.01.007
   Karalyan Z, 2016, VET IMMUNOL IMMUNOP, V179, P58, DOI 10.1016/j.vetimm.2016.08.005
   Kochs G, 2016, J VIROL, V90, P9330, DOI 10.1128/JVI.00744-16
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kortekaas J, 2015, VECTOR-BORNE ZOONOT, V15, P759, DOI 10.1089/vbz.2015.1855
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lee H, 2016, VET RES, V47, DOI 10.1186/s13567-016-0349-6
   Li GY, 2008, AM J TROP MED HYG, V78, P675, DOI 10.4269/ajtmh.2008.78.675
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Liu R, 2015, VIRAL IMMUNOL, V28, P113, DOI 10.1089/vim.2014.0100
   Lokhandwala S, 2016, CLIN VACCINE IMMUNOL, V23, P888, DOI 10.1128/CVI.00395-16
   Maffioli C, 2014, J NEUROPATH EXP NEUR, V73, P1107, DOI 10.1097/NEN.0000000000000131
   Mateo RI, 2007, AM J TROP MED HYG, V76, P785, DOI 10.4269/ajtmh.2007.76.785
   Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7
   Melzi E, 2016, P NATL ACAD SCI USA, V113, pE6238, DOI 10.1073/pnas.1610012113
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Michlmayr D, 2016, J IMMUNOL, V196, P4622, DOI 10.4049/jimmunol.1502452
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monath TP, 2000, J VIROL, V74, P1742, DOI 10.1128/JVI.74.4.1742-1751.2000
   Nuttall PA, 2004, PARASITOLOGY, V129, pS177, DOI 10.1017/S0031182004005633
   Paessler S, 2004, J INFECT DIS, V189, P2072, DOI 10.1086/383246
   Pichlmair A, 2004, J VIROL, V78, P11422, DOI 10.1128/JVI.78.20.11422-11424.2004
   Pripuzova NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061094
   Ross TM, 2012, VIRUS RES, V163, P417, DOI 10.1016/j.virusres.2011.10.023
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Santos RI, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080220
   Sawatsky B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002934
   Sbrana E, 2006, AM J TROP MED HYG, V74, P1084, DOI 10.4269/ajtmh.2006.74.1084
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Sheahan BJ, 2002, J COMP PATHOL, V126, P137, DOI 10.1053/jcpa.2001.0533
   Shimada S, 2015, VIROLOGY, V482, P19, DOI 10.1016/j.virol.2015.03.010
   Sievert C, 2017, VET RADIOL ULTRASOUN, V58, P53, DOI 10.1111/vru.12427
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Takamatsu H, 1999, J GEN VIROL, V80, P1453, DOI 10.1099/0022-1317-80-6-1453
   Tani H, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00061-15
   Taylor KG, 2013, VET MICROBIOL, V167, P145, DOI 10.1016/j.vetmic.2013.07.012
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   World Health Organization, 2017, ZIK VIR COMPL
   Zhang XW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0665-9
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 72
TC 7
Z9 7
U1 0
U2 9
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1532-0820
J9 COMPARATIVE MED
JI Comparative Med.
PD JUN
PY 2017
VL 67
IS 3
BP 232
EP 241
PG 10
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA EX8UG
UT WOS:000403525100006
PM 28662752
DA 2020-07-08
ER

PT J
AU Bradley, MP
   Nagamine, CM
AF Bradley, Michael P.
   Nagamine, Claude M.
TI Animal Models of Zika Virus
SO COMPARATIVE MEDICINE
LA English
DT Article
ID YELLOW-FEVER; HEMORRHAGIC-FEVER; MOUSE MODEL; SEXUAL TRANSMISSION;
   INFECTION; MICE; BRAIN; DEFICIENT; OUTBREAK; VACCINE
AB Zika virus has garnered great attention over the last several years, as outbreaks of the disease have emerged throughout the Western Hemisphere. Until quite recently Zika virus was considered a fairly benign virus, with limited clinical severity in both people and animals. The size and scope of the outbreak in the Western Hemisphere has allowed for the identification of severe clinical disease that is associated with Zika virus infection, most notably microcephaly among newborns, and an association with Guillian-Barre syndrome in adults. This recent association with severe clinical disease, of which further analysis strongly suggested causation by Zika virus, has resulted in a massive increase in the amount of both basic and applied research of this virus. Both small and large animal models are being used to uncover the pathogenesis of this emerging disease and to develop vaccine and therapeutic strategies. Here we review the animal-model based Zika virus research that has been performed to date.
C1 [Bradley, Michael P.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.
   [Nagamine, Claude M.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA.
RP Bradley, MP (corresponding author), Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.
EM mpbradle@med.umich.edu
FU Unit for Laboratory Animal Medicine at The University of Michigan, NIH
   Center for Excellence in Translation Research: ViRx@Stanford
   administrative supplement [U19]; Stanford Discovery Innovation Fund in
   Basic Biomedical Sciences; Stanford Department of Comparative Medicine
   (CMN)
FX This research was funded in part by The Unit for Laboratory Animal
   Medicine at The University of Michigan (MPB), an NIH U19 Center for
   Excellence in Translation Research: ViRx@Stanford administrative
   supplement (CMN), the Stanford Discovery Innovation Fund in Basic
   Biomedical Sciences (CMN), and the Stanford Department of Comparative
   Medicine (CMN).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aoki K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-105
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0
   Broeckel R, 2015, PATHOGENS, V4, P662, DOI 10.3390/pathogens4030662
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1657, DOI 10.1002/jmv.24582
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowall SD, 2012, J GEN VIROL, V93, P560, DOI 10.1099/vir.0.038455-0
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Julander JG, 2016, CURR OPIN VIROL, V18, P64, DOI 10.1016/j.coviro.2016.03.010
   LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lever MS, 2012, J MED MICROBIOL, V61, P8, DOI 10.1099/jmm.0.036210-0
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li LQ, 2015, INT J FUZZY SYST, V2015, P12, DOI DOI 10.1016/J.ARCH0RALBI0.2015.12.002
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McCrae AW KB, 1970, VIRUS RES I ANN REPO, P20
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Institutes of Health, 2016, NOT NICHD NINDS NIDC
   Oregon Health and Science University, 2016, ONPRC ZIK VIR NHP MO
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON
   Pantoja P, 2016, SEC ZIK VIR INF DO N
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Seymour RL, 2013, AM J TROP MED HYG, V88, P1170, DOI 10.4269/ajtmh.12-0674
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   Southern Research, 2016, CYN MAC MOD ZIK VIR
   Stavrou S, 2010, J VIROL, V84, P9181, DOI 10.1128/JVI.00603-10
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   UC Davis California National Primate Research Center, 2016, U CAL ZIK VIR PROJ
   vandenBroek MF, 1995, IMMUNOL REV, V148, P5
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Weger-Lucarelli J, 2016, J VIROL, V91
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
   Zika Open-Research Portal, 2016, ZIK EXP SCI TEAM ZES
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 99
TC 9
Z9 10
U1 0
U2 7
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1532-0820
J9 COMPARATIVE MED
JI Comparative Med.
PD JUN
PY 2017
VL 67
IS 3
BP 242
EP 252
PG 11
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA EX8UG
UT WOS:000403525100007
PM 28662753
DA 2020-07-08
ER

PT J
AU Saiz, JC
   Martin-Acebes, MA
AF Saiz, Juan-Carlos
   Martin-Acebes, Miguel A.
TI The Race To Find Antivirals for Zika Virus
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Review
DE antiviral agents; Zika virus
ID SMALL-MOLECULE INHIBITORS; INFECTION; BRAIN; ANTIBODIES; PREGNANCY;
   IDENTIFICATION; HELICASE; PROTEASE; SCREEN
AB Zika virus (ZIKV), a flavivirus transmitted by mosquitoes, was an almost neglected pathogen until its introduction in the Americas in 2015 and its subsequent explosive spread throughout the continent, where it has infected millions of people. The virus has caused social and sanitary alarm, mainly due to its association with severe neurological disorders (Guillain-BarrE syndrome and microcephaly in fetuses and newborns). Nowadays, no specific antiviral therapy against ZIKV is available. However, during the past months, a great effort has been made to search for antiviral candidates using different approaches and methodologies, ranging from testing specific compounds with known antiviral activity to the screening of libraries with hundreds of bioactive molecules. The identified antiviral candidates include drugs targeting viral components as well as cellular ones. Here, an updated review of what has been done in this line is presented.
C1 [Saiz, Juan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
RP Saiz, JC; Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
EM jcsaiz@inia.es; martin.mangel@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Saiz,
   Juan-Carlos/0000-0001-8269-5544
FU [ZIKA-BIO-2016-2];  [RTA2013-0013-C04-01-E];  [RTA2015-00009]; 
   [AGL2014-56518-JIN]
FX This work was supported by grants ZIKA-BIO-2016-2 (J.-C.S.),
   RTA2013-0013-C04-01-E (J.-C.S.), RTA2015-00009 (J.-C.S.), and
   AGL2014-56518-JIN (M.A.M.-A.).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan W, 2017, EMBO J
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, pIV, DOI 10.1016/j.coviro.2014.08.002
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053900
   Moreira J., 2017, CLIN MICROBIOL INFEC
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 52
TC 35
Z9 36
U1 0
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUN
PY 2017
VL 61
IS 6
AR e00411-17
DI 10.1128/AAC.00411-17
PG 9
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA EY2FH
UT WOS:000403783400058
PM 28348160
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Zika virus infection and cervical cytology specimen
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou Shi, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Raposo-Amaral CE, 2016, J CRANIOFAC SURG, V27, P1383, DOI 10.1097/SCS.0000000000002997
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
NR 4
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD JUN
PY 2017
VL 77
IS 6
AR e12681
DI 10.1111/aji.12681
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EX6QF
UT WOS:000403366400001
PM 28370583
DA 2020-07-08
ER

PT J
AU Pastula, DM
   Yeargin-Allsopp, M
   Kobau, R
AF Pastula, Daniel M.
   Yeargin-Allsopp, Marshalyn
   Kobau, Rosemarie
TI Enhanced Epilepsy Surveillance and Awareness in the Age of Zika
SO JAMA NEUROLOGY
LA English
DT Editorial Material
ID INFECTION; INFANTS
C1 [Pastula, Daniel M.] Univ Colorado Denver, Dept Neurol, Div Infect Dis, Neuroinfect Dis Grp, 12401 E 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
   [Pastula, Daniel M.; Kobau, Rosemarie] Ctr Dis Control & Prevent, Epilepsy Program, Div Populat Hlth, Atlanta, GA USA.
   [Yeargin-Allsopp, Marshalyn] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA USA.
RP Pastula, DM (corresponding author), Univ Colorado Denver, Dept Neurol, Div Infect Dis, Neuroinfect Dis Grp, 12401 E 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
EM daniel.pastula@ucdenver.edu
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459
FU Intramural CDC HHS [CC999999]
CR da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Suzuki Y, 2008, BRAIN DEV-JPN, V30, P420, DOI 10.1016/j.braindev.2007.12.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   US Centers for Disease Control and Prevention, ZIK VIR
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   WHO, NEUR DIS PUBL HLTH C
NR 7
TC 2
Z9 2
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD JUN
PY 2017
VL 74
IS 6
BP 631
EP 632
DI 10.1001/jamaneurol.2017.0215
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EX4KT
UT WOS:000403204100001
PM 28418503
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Lloyd, AM
   Farooq, M
   Estep, AS
   Xue, RD
   Kline, DL
AF Lloyd, Aaron M.
   Farooq, Muhammad
   Estep, Alden S.
   Xue, Rui-De
   Kline, Daniel L.
TI EVALUATION OF PYRIPROXYFEN DISSEMINATION VIA AEDES ALBOPICTUS FROM A
   POINT-SOURCE LARVICIDE APPLICATION IN NORTHEAST FLORIDA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes albopictus; Asian tiger mosquito; autodissemination larvicide;
   pyriproxyfen; skip oviposition
ID DIPTERA-CULICIDAE; VECTOR COMPETENCE; LARVAL HABITATS; AEGYPTI DIPTERA;
   DENGUE VIRUS; ZIKA VIRUS; MOSQUITOS; FIELD; AREA; MANAGEMENT
AB The Asian tiger mosquito, Aedes albopictus, ranks among the most important vectors of dengue fever, Zika virus, and chikungunya virus. With no specific medications or vaccines available, vector control is the only way to combat these diseases. Autodissemination of the insect growth regulator pyriproxyfen (NyGuard (R)) from a point-source treatment was evaluated in field settings in northeast Florida. The objective of this study was to investigate the possibility of pyriproxyfen dissemination from a treatment site to nontreated oviposition sites via the skip oviposition behavior of Ae. albopictus. A spray application was made to a tire pile using a Stihl (R) SR 420 backpack sprayer. Autodissemination oviposition vases containing oak infusion water were positioned in groups of five at 25 to 400 m in 4 transects surrounding the tire pile. Two sets of 5 control vases containing oak infusion water were placed 1,500 m from the tire pile and oak infusion water samples were collected directly from the tire pile. Fifty milliliter samples were extracted from each vase weekly and preserved for pyriproxyfen residue analysis. All vases were analyzed at week 0 (4 h post-treatment), 1, 2, 4, and 6. Overall, there were no differences in pupal mortality between the control and autodissemination vases. The tire pile samples had significantly more mortality (P < 0.0001) out to 4 wk when compared to autodissemination and control vases.
C1 [Lloyd, Aaron M.] Pasco Cty Mosquito Control Dist, 2308 Marathon Rd, Odessa, FL 33556 USA.
   [Farooq, Muhammad; Estep, Alden S.] US Navy, Navy Entomol Ctr Excellence, Box 43,Bldg 937,Naval Air Stn, Jacksonville, FL 32212 USA.
   [Xue, Rui-De] Anastasia Mosquito Control Dist, 120 EOC Dr, St Augustine, FL 32092 USA.
   [Kline, Daniel L.] ARS, USDA, CMAVE, 1600 SW 23rd Dr, Gainesville, FL 32608 USA.
RP Lloyd, AM (corresponding author), Pasco Cty Mosquito Control Dist, 2308 Marathon Rd, Odessa, FL 33556 USA.
OI Estep, Alden/0000-0002-8281-3229
FU Deployed War-Fighter Protection Research Program of the US Department of
   Defense through the Armed Forces Pest Management Board; Center for
   Vector Biology group at Rutgers University
FX We acknowledge the financial support for this study by Deployed
   War-Fighter Protection Research Program of the US Department of Defense
   through the Armed Forces Pest Management Board and the collaboration
   with Randy Gaugler and the Center for Vector Biology group at Rutgers
   University. We thank Vince Smith, Todd Walker, Anthony Hanley, Raul
   Pomales, and Ray Platt for their help during sample collections, and
   Anastasia Mosquito Control District personnel for assisting in the setup
   of this study.
CR Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259
   Connelly CR, 2009, FLORIDA MOSQUITO CON
   Daiker D, 2011, FLORIDA DEP AGR CONS
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181
   Florida Mosquito Control Association's Ad Hoc Committee on Dengue/Chikungunya Vector Management and Response, 2014, DENG CHIK VECT MAN P
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gaugler R., 2011, WING BEATS, V22, P22
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lavery JV, 2008, AM J TROP MED HYG, V79, P312, DOI 10.4269/ajtmh.2008.79.312
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Lloyd A, 2013, WING BEATS, V24, P16
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   OMEARA GF, 1997, ASIAN TIGER MOSQUITO
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Suman DS, 2014, ACTA TROP, V135, P96, DOI 10.1016/j.actatropica.2014.03.026
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   United States Centers for Disease Control and Prevention, 2014, CHIK VIR
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
   Wheeler AS, 2009, J AM MOSQUITO CONTR, V25, P251, DOI 10.2987/08-5794.1
   Zeichner Brian C, 2011, US Army Med Dep J, P4
NR 33
TC 3
Z9 3
U1 1
U2 8
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD JUN
PY 2017
VL 33
IS 2
BP 151
EP 155
PG 5
WC Entomology
SC Entomology
GA EX5EO
UT WOS:000403260900013
PM 28590221
DA 2020-07-08
ER

PT J
AU Pastula, DM
   Durrant, JC
   Smith, DE
   Beckham, JD
   Tyler, KL
AF Pastula, Daniel M.
   Durrant, Julia C.
   Smith, Daniel E.
   Beckham, J. David
   Tyler, Kenneth L.
TI Zika Virus Disease for the Neurointensivist
SO NEUROCRITICAL CARE
LA English
DT Review
DE Zika; Zika virus; Arbovirus; Flavivirus; Guillain-Barre syndrome;
   Thrombocytopenia; Myelitis; Encephalitis; Seizures; Neurocritical care;
   Neurology
ID GUILLAIN-BARRE-SYNDROME; UPDATE INTERIM GUIDANCE; UNITED-STATES;
   INFECTION; TRANSMISSION; MANAGEMENT; INFANTS; NIGERIA; CARE
AB Zika virus (ZIKV) is a mosquito-borne and sexually transmitted flavivirus currently spreading throughout the Pacific and Western Hemisphere. ZIKV infection is often either asymptomatic or causes a self-limiting illness with symptoms such as rash, fever, myalgia, arthralgia, headache, or conjunctivitis. Rarely, ZIKV infection has been associated with conditions such as severe thrombocytopenia, microcephaly and other developmental abnormalities, acute polyneuropathy/Guillain-Barr, syndrome, myelitis, meningoencephalitis, transient encephalopathy, provoked seizures, and various ophthalmologic conditions. Optimal treatment of these ZIKV-associated conditions is currently unclear and is largely guided by expert opinion or case reports/series. Further studies are needed to establish best treatment practices. This review concentrates on caring by neurointensivists for the patient affected with Zika virus-expected to flare up again in the summer.
C1 [Pastula, Daniel M.; Smith, Daniel E.; Beckham, J. David; Tyler, Kenneth L.] Univ Colorado Denver, Neuro Infect Dis Grp, Dept Neurol, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
   [Pastula, Daniel M.; Smith, Daniel E.; Beckham, J. David; Tyler, Kenneth L.] Univ Colorado Denver, Div Infect Dis, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
   [Durrant, Julia C.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.
RP Pastula, DM (corresponding author), Univ Colorado Denver, Neuro Infect Dis Grp, Dept Neurol, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.; Pastula, DM (corresponding author), Univ Colorado Denver, Div Infect Dis, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
EM Daniel.Pastula@ucdenver.edu
RI Pastula, Daniel M./M-1325-2019; Tyler, Kenneth L./J-2420-2019; Beckham,
   John/AAE-6694-2020
OI Pastula, Daniel M./0000-0001-9342-4459; Tyler, Kenneth
   L./0000-0003-3294-5888; Beckham, John/0000-0001-9305-2683
FU BLRD VA [I01 BX003863]
CR Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Styczynski AMJ, 2016, CDC 65 EIS C 2016
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 4
Z9 4
U1 0
U2 4
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1541-6933
EI 1556-0961
J9 NEUROCRIT CARE
JI Neurocrit. Care
PD JUN
PY 2017
VL 26
IS 3
BP 457
EP 463
DI 10.1007/s12028-016-0333-z
PG 7
WC Critical Care Medicine; Clinical Neurology
SC General & Internal Medicine; Neurosciences & Neurology
GA EV9JA
UT WOS:000402101100020
PM 27995511
DA 2020-07-08
ER

PT J
AU Villela, DAM
   Bastos, LS
   De Carvalho, LM
   Cruz, OG
   Gomes, MFC
   Durovni, B
   Lemos, MC
   Saraceni, V
   Coelho, FC
   Codeco, CT
AF Villela, D. A. M.
   Bastos, L. S.
   De Carvalho, L. M.
   Cruz, O. G.
   Gomes, M. F. C.
   Durovni, B.
   Lemos, M. C.
   Saraceni, V.
   Coelho, F. C.
   Codeco, C. T.
TI Zika in Rio de Janeiro: Assessment of basic reproduction number and
   comparison with dengue outbreaks
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Basic reproduction number; dengue; Zika
ID AEDES-AEGYPTI MOSQUITOS; VECTOR-BORNE INFECTION; DAILY SURVIVAL RATES;
   SEXUAL TRANSMISSION; VIRUS OUTBREAK; APRIL 2016; EPIDEMIC; BRAZIL; RISK;
   DISPERSAL
AB Zika virus infection was declared a public health emergency of international concern in February 2016 in response to the outbreak in Brazil and its suspected link with congenital anomalies. In this study, we use notification data and disease natural history parameters to estimate the basic reproduction number (R-0) of Zika in Rio de Janeiro, Brazil. We also obtain estimates of R-0 of dengue from time series of dengue cases in the outbreaks registered in 2002 and 2012 in the city, when DENV-3 and DENV-4 serotypes, respectively, had just emerged. Our estimates of the basic reproduction number for Zika in Rio de Janeiro based on surveillance notifications (R-0 = 2.33, 95% CI: 1.97- 2.97) were higher than those obtained for dengue in the city (year 2002: R-0 = 1.70 [1.50-2.02]; year 2012: R-0 = 1.25 [1.18-1.36]). Given the role of Aedes aegypti as vector of both the Zika and dengue viruses, we also derive R-0 of Zika as a function of both dengue reproduction number and entomological and epidemiological parameters for dengue and Zika. Using the dengue outbreaks from previous years allowed us to estimate the potential R-0 of Zika. Our estimates were closely in agreement with our first Zika's R-0 estimation from notification data. Hence, these results validate deriving the potential risk of Zika transmission in areas with recurring dengue outbreaks. Whether transmission routes other than vector-based can sustain a Zika epidemic still deserves attention, but our results suggest that the Zika outbreak in Rio de Janeiro emerged due to population susceptibility and ubiquitous presence of Ae. aegypti.
C1 [Villela, D. A. M.; Bastos, L. S.; De Carvalho, L. M.; Cruz, O. G.; Gomes, M. F. C.; Codeco, C. T.] Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, RJ, Brazil.
   [De Carvalho, L. M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Durovni, B.; Lemos, M. C.; Saraceni, V.] Secretaria Municipal Saude Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Coelho, F. C.] FGV, Escola Matemat Aplicada, Rio De Janeiro, RJ, Brazil.
RP Villela, DAM (corresponding author), Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, RJ, Brazil.
EM daniel.villela@fiocruz.br
RI Coelho, Flavio Codeco/L-1089-2018; Villela, Daniel/AAG-6445-2019;
   Bastos, Leonardo Soares/AAD-5335-2019; Coelho, Flavio/L-1089-2018
OI Coelho, Flavio Codeco/0000-0003-0635-8989; Villela,
   Daniel/0000-0001-8371-2959; Bastos, Leonardo Soares/0000-0002-1406-0122;
   Coelho, Flavio/0000-0003-3868-4391
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [211356/2015]
FX We would like to thank Dr Claudio Struchiner and Dr Marilia S. Carvalho
   for their helpful comments during the development of this study. We also
   acknowledge CNPq and FAPERJ (Ref. 211356/2015) for financial support.
CR Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caraco T, 2001, THEOR POPUL BIOL, V59, P185, DOI 10.1006/tpbi.2000.1517
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 38
TC 21
Z9 21
U1 2
U2 16
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUN
PY 2017
VL 145
IS 8
BP 1649
EP 1657
DI 10.1017/S0950268817000358
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EX0NS
UT WOS:000402918700016
PM 28240195
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Herrera, TT
   Goodridge, A
   Britton, GB
AF Herrera, T. T.
   Goodridge, A.
   Britton, G. B.
TI Ascertaining fetal Zika virus infection based on IgM antibody test in
   endemic settings
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Letter
C1 [Herrera, T. T.] Johns Hopkins Med Int, Hosp Punta Pacif, Dept Obstet & Gynecol, Calle Darien, Panama.
   [Goodridge, A.] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biol Celular & Mol Enfermedades, Ciudad Del Saber, Panama.
   [Britton, G. B.] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Neurociencias, Ciudad Del Saber, Panama.
   [Britton, G. B.] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Unidad Invest Clin, Ciudad Del Saber, Panama.
RP Herrera, TT (corresponding author), Johns Hopkins Med Int, Hosp Punta Pacif, Dept Obstet & Gynecol, Calle Darien, Panama.
EM taniah30@gmail.com
RI Herrera, Tania/AAK-5183-2020; Herrera, Tania/R-7662-2019; Goodridge,
   Amador/Q-7109-2019; Goodridge, Amador/F-9026-2011
OI Herrera, Tania/0000-0002-3603-1103; Goodridge,
   Amador/0000-0003-3910-0482; Britton, Gabrielle/0000-0002-1758-2495
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Guibaud L, 2016, ULTRASOUND OBST GYN, V48, P16, DOI 10.1002/uog.15926
   Pacheco O, 2016, N ENGL J MED
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
NR 6
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD JUN
PY 2017
VL 49
IS 6
BP 809
EP 809
DI 10.1002/uog.17509
PG 1
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA EW6TA
UT WOS:000402642000024
PM 28573776
OA Bronze
DA 2020-07-08
ER

PT J
AU Carvalho, FD
   Moreira, LA
AF Carvalho, F. D.
   Moreira, L. A.
TI Why is Aedes aegypti Linnaeus so Successful as a Species?
SO NEOTROPICAL ENTOMOLOGY
LA English
DT Article
DE Mosquitoes; Wolbachia; transgenics; control; arboviruses
ID MOSQUITO-BORNE DISEASES; CYTOPLASMIC INCOMPATIBILITY; VERTICAL
   TRANSMISSION; WOLBACHIA INFECTION; CONTROL STRATEGIES;
   SUSTAINED-RELEASE; INCREMENTAL COST; ZIKA VIRUS; DENGUE; CULICIDAE
AB Diseases transmitted by mosquitoes impose enormous burden towards human morbidity and mortality. Over the last three decades, Brazil has suffered from severe Dengue epidemics. In September 2014, this situation is further complicated by the introduction of two other viruses, Zika and Chikungunya, placing Brazil in a triple epidemic. In this article, we discuss the biology of Aedes aegypti Linnaeus, and the principal initiatives currently used to control mosquito populations and the diseases they transmit. Aedes aegypti has broad global distribution and is involved in the transmission of various arboviral diseases such as Dengue, Zika, and Chikungunya. Several factors contribute to the success of the species, particularly behavioral plasticity, rapid development, desiccation-resistant eggs, resistance to the principle insecticide classes currently available on the market, preference for the urban environment, and proximity to humans. Vector control programs are the best way to reduce the burden of mosquito-borne diseases. Chemical control is most commonly used in recent times, and unfortunately, the results have not been satisfactory but instead, there is increased vector dispersal and, subsequently, the spread of disease epidemics. Investigations of alternative control methods such as release of Wolbachia-infected mosquitoes for blocking vector-borne pathogens, release of transgenic mosquitoes carrying a lethal gene for offspring, and the use of insecticide-dispersing mosquitoes are under way in Brazil, and some have shown promising results. Special emphasis should be placed on integrated management of all available tactics, so as to maximize efforts towards mosquito control. Finally, we emphasize that continuous actions and community participation control initiatives are critically important for success.
C1 [Carvalho, F. D.; Moreira, L. A.] Fundacao Oswaldo Cruz CPqRR Fiocruz, Ctr Pesquisas Rene Rachou, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
RP Carvalho, FD (corresponding author), Fundacao Oswaldo Cruz CPqRR Fiocruz, Ctr Pesquisas Rene Rachou, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
EM fabiano.carvalho@cpqrr.fiocruz.br
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, P1
   Albeny DS, 2011, ZOOLOGIA-CURITIBA, V28, P538, DOI 10.1590/S1984-46702011000400017
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, P1
   Almerao MP, 2012, GENET MOL BIOL, V35, P980, DOI 10.1590/S1415-47572012000600013
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Andrade CFS, 2007, SALMERON MANEJO PRAG, P55
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Azevedo-Santos VM, 2016, SCIENCE, V351, P675, DOI 10.1126/science.351.6274.675
   Baly A, 2016, REV SOC BRAS MED TRO, V49, P418, DOI 10.1590/0037-8682-0368-2015
   Baly A, 2012, TROP MED INT HEALTH, V17, P123, DOI 10.1111/j.1365-3156.2011.02881.x
   Baly A, 2011, AM J TROP MED HYG, V84, P747, DOI 10.4269/ajtmh.2011.10-0532
   Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591
   Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Brasil, 2009, DIR NAC PREV CONTR A, P160
   Brasil, 2016, ALF US PEIX COMB AO
   Brasil, 2014, DENG 117 MUN SIT RIS
   Brasil, 2015, GOV AC AC EM DIANT A
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   CDC, 2016, MOSQ LIF CYCL
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   CROW JF, 1957, ANNU REV ENTOMOL, V2, P227, DOI 10.1146/annurev.en.02.010157.001303
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Cavalcanti LPD, 2007, REV SAUDE PUBL, V41, P638, DOI 10.1590/s0034-89102006005000041
   de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085
   de Oliveira R Lourenco, 2015, DENGUE TEORIAS PRATI, P75
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Paploski IAD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1705-0
   Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145
   Eiras AE, 2011, PARASITOLOGIA HUMANA, P387
   Fares R C G, 2015, BIO MED RES INT, V2015, P1
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   Faull KJ, 2015, J VECTOR ECOL, V40, P292, DOI 10.1111/jvec.12167
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Ferreira CP, 2008, J BIOL SYST, V16, P565, DOI 10.1142/S0218339008002691
   Fiocruz, 2016, FIOCR APR DENGUETECH
   Fiocruz, 2016, 10 MIN AED
   Forattini OP, 2002, CULICIDOLOGIA MED, P860
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gonçalves Karen dos Santos, 2008, Biota Neotrop., V8, P235, DOI 10.1590/S1676-06032008000100027
   Gotoh T, 2003, HEREDITY, V91, P208, DOI 10.1038/sj.hdy.6800329
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hertig M, 1924, J MED RES, V44, P329
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Juliano SA, 2010, COMPETING MOSQUITOES, V130, P458
   Kamtchum-Tatuene J, 2016, CURR OPIN INFECT DIS, P1
   Kant R, 2013, J VECTOR DIS, V50, P1
   KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Mocellin MG, 2009, MEM I OSWALDO CRUZ, V104, P1171, DOI 10.1590/S0074-02762009000800015
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Oliveira LB, 2015, SEMIN CIENCIAS BIOL, V36, P79
   Oliveira-Carvalho D, 2011, REV BIOL B, V6, P38
   ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699
   Oxitec Brasil, 2016, CONH RES PROJ QUE US
   Parra JRP, 2002, CONTROLE BIOL BRASIL, P609
   Polaszek A, 2006, TRENDS PARASITOL, V22, P8, DOI 10.1016/j.pt.2005.11.003
   Popovici J, 2010, MEM I OSWALDO CRUZ, V105, P957, DOI 10.1590/S0074-02762010000800002
   Rapley LP, 2009, AM J TROP MED HYG, V81, P94, DOI 10.4269/ajtmh.2009.81.94
   Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   Ross PA, 2017, PLOS PATHOG, P1
   Santos da Silva Antonia, 2014, Rev Cubana Med Trop, V66, P174
   de Abreu FVS, 2015, MEM I OSWALDO CRUZ, V110, P669, DOI 10.1590/0074-02760140490
   Shulse CD, 2013, J APPL ECOL, V50, P1244, DOI 10.1111/1365-2664.12126
   Silva HHG, 1999, REV SOC BRAS MED TRO, V32, P349, DOI DOI 10.1590/S0037-86821999000400003
   SVS, 2016, BRAS MANT SIT EM CON
   SVS, 2015, B EP SECR VIG SAUD
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tozan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108017
   Valenca MA, 2013, NEOTROP ENTOMOL, V42, P311, DOI 10.1007/s13744-013-0118-4
   Valle D., 2015, DENGUE TEORIAS PRATI, P93
   Van Lenteren JC, 2009, BUENO VHP CONTROLE B, P430
   Varejao JBM, 2005, REV SOC BRAS MED TRO, V38, P238, DOI 10.1590/S0037-86822005000300006
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wallace H, 2013, MOSQUITOS GENETICAME, P97
   Wermelinger ED, 2015, REV SOC BRAS MED TRO, V48, P770, DOI 10.1590/0037-8682-0087-2015
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO, 2016, ORG MUND SAUD AN EM
   Wilder-Smith A, 2011, MED HYPOTHESES, V76, P861, DOI 10.1016/j.mehy.2011.02.037
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
   Wilkerson R., 2015, PLOS ONE, V10, P1
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zeidler JD, 2008, REV SAUDE PUBL, V42, P2
NR 102
TC 19
Z9 19
U1 2
U2 30
PU ENTOMOLOGICAL SOC BRASIL
PI LONDRINA,
PA CAIXA POSTAL 481, 86001-970 LONDRINA,, PR, BRAZIL
SN 1519-566X
EI 1678-8052
J9 NEOTROP ENTOMOL
JI Neotrop. Entomol.
PD JUN
PY 2017
VL 46
IS 3
BP 243
EP 255
DI 10.1007/s13744-017-0520-4
PG 13
WC Entomology
SC Entomology
GA EW7YO
UT WOS:000402734700001
PM 28401481
OA Green Published
DA 2020-07-08
ER

PT J
AU Ming, GL
   Song, HJ
   Tang, HL
AF Ming, Guo-li
   Song, Hongjun
   Tang, Hengli
TI Racing to Uncover the Link between Zika Virus and Microcephaly
SO CELL STEM CELL
LA English
DT Editorial Material
OI Ming, Guo-li/0000-0002-2517-6075
NR 0
TC 4
Z9 4
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD JUN 1
PY 2017
VL 20
IS 6
BP 749
EP 753
DI 10.1016/j.stem.2017.05.010
PG 5
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EW7ST
UT WOS:000402716800008
PM 28575689
OA Bronze
DA 2020-07-08
ER

PT J
AU Lin, JC
   Kost, GJ
   Ferguson, W
AF Lin, Jesse C.
   Kost, Gerald J.
   Ferguson, William
TI Bio-Innovation in Taiwan, the First Survey of Point-of-Care Professional
   Needs, and Geospatially Enhanced Resilience in At-Risk Settings
SO POINT OF CARE
LA English
DT Article
DE acute coronary syndromes; empowerment; evidence-based medicine (EBM);
   geographic information systems (GIS); geospatial sciences; Hualien
   County; innovation; invention; microeconomics; point of careology;
   primary care; small-world network (SWN); telemedicine
ID QUANTITATIVE-ANALYSIS; SYSTEM; PERFORMANCE; TIME; TELEMEDICINE;
   BIOSENSOR; COUNTRIES; THAILAND; DESIGN; IMPACT
AB Goals: The aims of this article were to report the first Taiwan point-of-care testing (POCT) needs assessment survey, to analyze distance/time/economic metrics for POC diagnosis in Hualien, an eastern seaboard county vulnerable to typhoons, and to recommend national policy and guidelines (P&G) for enhancing POCT and resilience.
   Methods: We organized a Bio-Innovation Symposium at Taiwan National University, before which participants (68) from Taipei and other regions responded to an English/Chinese survey with views on how to implement POCT. We analyzed Hualien County geospatially and compared geometrics with/without POCT.
   Results: Multidisciplinary respondents (34%, 23/68) suggested medical technologists be coordinators responsible for device management, education/training, communications across departments, preparation/maintenance of compliance documents, and performance assurance; 93% suggested P&G cover highly infectious diseases (Ebola, Middle East respiratory syndrome coronavirus, and Zika); and 81% agreed POCT-equipped isolation laboratories are necessary. Ranked priorities for POCT were acute myocardial infarction (34%), infectious diseases (22%), diabetes (21%), acute heart failure (13%), and blood gas/electrolytes (9%). Most (75%) suggested P&G be integrated, created by both local and national agencies (52%). Reliability (29%) and device management (18%) were top priorities. Most (71%) said hospitals should select instruments, whereas medical technologists administrate (59%) and perform (50%) POCT.
   Conclusions: Bio-innovators are enthusiastically creating POC technologies in Taiwan, including low marginal cost assay modules capable of transforming public health paradigms. Geospatial analysis showed that POCT can speed acute response in rural areas of Hualien County. At a national convocation of the Taiwan Association of Medical Technologists, P&G receptivity and support were strong, suggesting Taiwan will publish national POCT P& G. Priorities include rural areas and vulnerable populations.
C1 [Lin, Jesse C.] Taiwan Natl Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan.
   [Kost, Gerald J.] Univ Calif Davis, Point Of Care Testing Ctr Teaching & Res, Sch Med, 506 Citadel Dr, Davis, CA 95616 USA.
   [Ferguson, William] Chulalongkorn Univ, Coll Populat Studies, Bangkok, Thailand.
   [Kost, Gerald J.] Mahidol Univ, Siriraj Hosp, Fac Med, Clin Pathol, Bangkok, Thailand.
   [Kost, Gerald J.] Knowledge Optimizat, Davis, CA USA.
RP Kost, GJ (corresponding author), Univ Calif Davis, Point Of Care Testing Ctr Teaching & Res, Sch Med, 506 Citadel Dr, Davis, CA 95616 USA.
EM GeraldKost@gmail.com
FU POCT CTR; Association of Bio-Innovation Taiwan; Science and Technology
   Policy Research and Information Center branch of National Applied
   Research Laboratories of Taiwan
FX this article was supported by the POCT CTR and by Dr Kost, Director. We
   are grateful to the creative students and staff who participate in the
   POCT CTR and contribute substantially to the knowledge base for
   point-of-care, including Hualien County geospatial analysis and graphics
   created by William Ferguson, BS, MS (Geospatial Sciences).r We also want
   to give our appreciation to the sponsors of the symposium, the
   Association of Bio-Innovation Taiwan, and to the Science and Technology
   Policy Research and Information Center branch of National Applied
   Research Laboratories of Taiwan. Elements of Figure 10 were contributed
   by iXensor (http://www.ixensor.com/ix_web/), the manufacturer of the
   PixoTest (https://www.ixensor.com/ix_web/ pixotest/) in Taiwan.
CR Chang KW, 2015, BIOSENS BIOELECTRON, V68, P397, DOI 10.1016/j.bios.2015.01.027
   Chang LH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012233
   Chang YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01863
   Chen CY, 2015, INT J NANOMED, V10, P2475, DOI 10.2147/IJN.S81201
   Chen CH, 2015, DIABETES, V64, pA46
   Chien DK, 2016, TAIWAN J OBSTET GYNE, V55, P563, DOI 10.1016/j.tjog.2016.06.015
   Chuang CH, 2016, BIOSENS BIOELECTRON, V84, P126, DOI 10.1016/j.bios.2015.12.103
   Chuang L, 2004, CLIN CHIM ACTA, V348, P87, DOI 10.1016/j.cccn.2004.05.010
   Ferguson WJ, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0037-9
   Ferguson WJ, 2015, GLOBAL POINT CARE ST, P393
   Gerald J Kost, 2014, EJIFCC, V25, P134
   Huang JMY, 2015, ANAL CHEM, V87, P7738, DOI 10.1021/acs.analchem.5b01270
   Jaya Z, 2016, POINT CARE, V15, P152, DOI 10.1097/POC.0000000000000111
   Kan SC, 2015, ANAL BIOCHEM, V471, P61, DOI 10.1016/j.ab.2014.11.015
   Kost GJ, 2006, POINT CARE, V5, P199, DOI 10.1097/00134384-200606000-00010
   Kost GJ, 2017, POINT CARE, V16, P12, DOI 10.1097/POC.0000000000000122
   Kost GJ, 2016, POINT CARE, V15, P43, DOI 10.1097/POC.0000000000000080
   Kost GJ, 2013, POINT CARE, V12, P1
   Kost GJ, 2015, EXPERT REV MOL DIAGN, V15, P1245, DOI 10.1586/14737159.2015.1079776
   Kost Gerald J, 2015, Am J Disaster Med, V10, P121, DOI 10.5055/ajdm.2015.0196
   Kost GJ, 2011, CLIN CHEM LAB MED, V49, P1637, DOI 10.1515/CCLM.2011.655
   Kost GJ, 2017, PRACTICAL GUIDE GLOB
   Kost GJ, 2015, GLOBAL POINT CARE ST, P595
   Kost GJ, 2015, CLIN LAB INT, V39, P6
   Kost GJ, 2015, GLOBAL POINT CARE ST, P3
   Kost GJ, 2015, GLOBAL POINT CARE ST
   Kost GJ, 2015, GLOBAL POINT CARE ST, P539
   Kost GJ, 2015, GLOBAL POINT CARE ST, P471
   Kost GJ, 2016, 8 ASIAN PACIFIC FORU
   Kulrattanamaneeporn S, 2009, POINT CARE, V8, P77, DOI 10.1097/POC.0b013e3181a52c7c
   Kulrattanamaneeporn S, 2006, POINT CARE, V5, P160, DOI 10.1097/01.poc.0000243981.30761.4d
   Lee CH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001066
   Lee DS, 2010, SENSORS-BASEL, V10, P697, DOI 10.3390/s100100697
   Lee D, 2010, BIOSENS BIOELECTRON, V25, P1820, DOI 10.1016/j.bios.2009.11.021
   Lee WB, 2017, BIOSENS BIOELECTRON, V87, P669, DOI 10.1016/j.bios.2016.09.008
   Lei KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076243
   Liao LT, 2014, CLIN CHIM ACTA, V436, P72, DOI 10.1016/j.cca.2014.04.033
   Louie RFFW, 2015, GLOBAL POINT CARE ST, P293
   Ministry of Public Health (MOPH), 2015, THAIL NAT GUID POINT, P2558
   Ministry ofHealth, 2012, MAL NAT POINT CAR PO
   Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389
   Weng KY, 2008, LAB CHIP, V8, P1216, DOI 10.1039/b801878b
   Wu CC, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0105-7
   Yang CL, 2013, TALANTA, V116, P704, DOI 10.1016/j.talanta.2013.07.064
   Yeh CH, 2014, SENSORS-BASEL, V14, P16148, DOI 10.3390/s140916148
NR 45
TC 2
Z9 2
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1533-029X
EI 1533-0303
J9 POINT CARE
JI Point Care
PD JUN
PY 2017
VL 16
IS 2
BP 78
EP 88
DI 10.1097/POC.0000000000000134
PG 11
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA EW3GJ
UT WOS:000402383200002
DA 2020-07-08
ER

PT J
AU Acosta-Reyes, J
   Navarro, E
   Herrera, MJ
   Goenaga, E
   Ospina, ML
   Parra, E
   Mercado, M
   Chaparro, P
   Beltran, M
   Gunturiz, ML
   Pardo, L
   Valencia, C
   Huertas, S
   Rodriguez, J
   Ruiz, G
   Valencia, D
   Haddad, LB
   Tinker, SC
   Moore, CA
   Baquero, H
AF Acosta-Reyes, Jorge
   Navarro, Edgar
   Jose Herrera, Maria
   Goenaga, Eloina
   Ospina, Martha L.
   Parra, Edgar
   Mercado, Marcela
   Chaparro, Pablo
   Beltran, Mauricio
   Luz Gunturiz, Maria
   Pardo, Lissethe
   Valencia, Catalina
   Huertas, Sandra
   Rodriguez, Jorge
   Ruiz, German
   Valencia, Diana
   Haddad, Lisa B.
   Tinker, Sarah C.
   Moore, Cynthia A.
   Baquero, Hernando
TI Severe Neurologic Disorders in 2 Fetuses with Zika Virus Infection,
   Colombia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RNA; BRAIN; PCR
AB We report the results of pathologic examinations of 2 fetuses from women in Colombia with Zika virus infection during pregnancy that revealed severe central nervous system defects and potential associated abnormalities of the eye, spleen, and placenta. Amniotic fluid and tissues from multiple fetal organs tested positive for Zika virus.
C1 [Acosta-Reyes, Jorge; Navarro, Edgar; Jose Herrera, Maria; Baquero, Hernando] Univ Norte, Km 5 Via Puerto Colombia, Barranquilla, Colombia.
   [Goenaga, Eloina] Secretaria Salud Barranquilla, Barranquilla, Colombia.
   [Ospina, Martha L.; Parra, Edgar; Mercado, Marcela; Chaparro, Pablo; Beltran, Mauricio; Luz Gunturiz, Maria; Pardo, Lissethe] Inst Nacl Salud, Bogota, Colombia.
   [Valencia, Catalina; Huertas, Sandra; Rodriguez, Jorge; Ruiz, German] Clin Colsanitas, Clin Reina Sofia, Bogota, Colombia.
   [Valencia, Diana; Tinker, Sarah C.; Moore, Cynthia A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Haddad, Lisa B.] Emory Univ, Sch Med, Atlanta, GA USA.
RP Acosta-Reyes, J (corresponding author), Univ Norte, Km 5 Via Puerto Colombia, Barranquilla, Colombia.
EM acostajl@uninorte.edu.co
RI Acosta-Reyes, Jorge/D-1906-2011; Carneiro D'Albuquerque, Luiz
   Augusto/A-8812-2013
OI Acosta-Reyes, Jorge/0000-0003-4303-3243; Baquero,
   Hernando/0000-0002-1284-7853; HERRERA BEDOYA, MARIA
   JOSE/0000-0003-2395-7457; GUNTURIZ, MARIA LUZ/0000-0001-9803-7909;
   Carneiro D'Albuquerque, Luiz Augusto/0000-0001-7607-7168
CR Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   BOSMA TJ, 1995, J CLIN MICROBIOL, V33, P1075, DOI 10.1128/JCM.33.5.1075-1079.1995
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Cortes LJ, 2014, BIOMEDICA, V34, P556, DOI [10.7705/biomedica.v34i4.2132, 10.1590/S0120-41572014000400008]
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2016, JAMA PEDIAT
   Pacheco O, 2016, NEW ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 15
TC 8
Z9 8
U1 0
U2 8
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2017
VL 23
IS 6
BP 982
EP 984
DI 10.3201/eid2306.161702
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EW1OB
UT WOS:000402259100014
PM 28296632
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika Virus Infection
SO PEDIATRIC EMERGENCY CARE
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Darko R, 2016, PEDIATR EMERG CARE, V32, P705, DOI 10.1097/PEC.0000000000000932
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0749-5161
EI 1535-1815
J9 PEDIATR EMERG CARE
JI Pediatr. Emerg. Care
PD JUN
PY 2017
VL 33
IS 6
BP E6
EP E6
DI 10.1097/PEC.0000000000001165
PG 1
WC Emergency Medicine; Pediatrics
SC Emergency Medicine; Pediatrics
GA EW5BV
UT WOS:000402521100001
PM 28441244
DA 2020-07-08
ER

PT J
AU Pando-Robles, V
   Batista, CV
AF Pando-Robles, Victoria
   Batista, Cesar V.
TI Aedes-Borne Virus-Mosquito Interactions: Mass Spectrometry Strategies
   and Findings
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Review
DE Aedes aegypti; Chikungunya virus; Dengue virus; proteomics; vector
   biology
ID ASIAN TIGER MOSQUITO; DENGUE VIRUS; CHIKUNGUNYA VIRUS; PROTEIN
   EXPRESSION; PROTEOMIC ANALYSIS; VECTOR COMPETENCE; SALIVARY-GLAND;
   POSTTRANSLATIONAL MODIFICATIONS; ARBOVIRUS INFECTION; FEMALE MOSQUITO
AB Aedes-borne viruses are responsible for high-impact neglected tropical diseases and unpredictable outbreaks such as the ongoing Zika epidemics. Aedes mosquitoes spread different arboviruses such as Dengue virus (DENV), Chikungunya virus (CHIKV), and Zika virus, among others, and are responsible for the continuous emergence and reemergence of these pathogens. These viruses have complex transmission cycles that include two hosts, namely the Aedes mosquito as a vector and susceptible vertebrate hosts. Human infection with arboviruses causes diseases that range from subclinical or mild to febrile diseases, encephalitis, and hemorrhagic fever. Infected mosquitoes do not show detectable signs of disease, even though the virus maintains a lifelong persistent infection. The infection of the Aedes mosquito by viruses involves a molecular crosstalk between cell and viral proteins. An understanding of how mosquito vectors and viruses interact is of fundamental interest, and it also offers novel perspectives for disease control. In recent years, mass spectrometry (MS)-based strategies in combination with bioinformatics have been successfully applied to identify and quantify global changes in cellular proteins, lipids, peptides, and metabolites in response to viral infection. Although the information about proteomics in the Aedes mosquito is limited, the information that has been reported can set up the basis for future studies. This review reflects how MS-based approaches have extended our understanding of Aedes mosquito biology and the development of DENV and CHIKV infection in the vector. Finally, this review discusses future challenges in the field.
C1 [Pando-Robles, Victoria] Inst Nacl Salud Publ, Lab Prote, Dept Infecc & Inmunidad, Ctr Invest Enfermedades Infecciosas, Av Univ 655,St Ma Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
   [Batista, Cesar V.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Lab Univ Prote, Cuernavaca, Morelos, Mexico.
RP Pando-Robles, V (corresponding author), Inst Nacl Salud Publ, Lab Prote, Dept Infecc & Inmunidad, Ctr Invest Enfermedades Infecciosas, Av Univ 655,St Ma Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
EM victoria.pando@insp.mx
OI Batista, Cesar/0000-0003-1726-8460; PANDO-ROBLES,
   VICTORIA/0000-0002-9633-5627
FU CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [179865];
   UCMexus
FX This work was partially financed by CONACYT grant 179865 and UCMexus
   2015 to V.P.R. This article was edited for English language by American
   Journal Experts (AJE).
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042
   Altstein M, 2010, ADV EXP MED BIOL, V692, P155
   Arias-Goeta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057548
   Avila FW, 2012, MOL REPROD DEV, V79, P816, DOI 10.1002/mrd.22133
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Bennett KE, 2005, J MED ENTOMOL, V42, P110, DOI 10.1603/0022-2585(2005)042[0110:SODAAA]2.0.CO;2
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Beyenbach KW, 2009, J EXP BIOL, V212, P329, DOI 10.1242/jeb.024646
   Black WC, 2009, INSECT MOL BIOL, V18, P705, DOI 10.1111/j.1365-2583.2009.00925.x
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182
   Boes KE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002946
   Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252
   Chisenhall DM, 2014, AM J TROP MED HYG, V90, P431, DOI 10.4269/ajtmh.13-0412
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Choy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078077
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Cime-Castillo J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504187
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107
   Doll S, 2015, ACS CHEM BIOL, V10, P63, DOI 10.1021/cb500904b
   Doucoure S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001487
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Florens Laurence, 2006, V328, P159
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006
   Frolova EI, 2010, J VIROL, V84, P11679, DOI 10.1128/JVI.01441-10
   Fros JJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1070-4
   Fros JJ, 2012, J VIROL, V86, P10873, DOI 10.1128/JVI.01506-12
   Gaffigan T.V., 2011, SYSTEMATIC CATALOG C
   Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479
   Gorchakov R, 2008, J VIROL, V82, P10088, DOI 10.1128/JVI.01011-08
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   HASE T, 1989, ARCH VIROL, V104, P129, DOI 10.1007/BF01313814
   Hidari Kazuya I P J, 2011, Trop Med Health, V39, P37, DOI 10.2149/tmh.2011-S03
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   Hugo LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058656
   Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055
   Idris F, 2016, ARCH VIROL, V161, P1751, DOI 10.1007/s00705-016-2855-2
   Iovinella I, 2015, J PROTEOMICS, V128, P272, DOI 10.1016/j.jprot.2015.08.002
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002
   Kanlaya R, 2010, J PROTEOME RES, V9, P4960, DOI 10.1021/pr100219y
   Karabatsos NK, 1985, INT CATALOGUE ARBOVI
   Karpe YA, 2016, VIRUS GENES, V52, P716, DOI 10.1007/s11262-016-1355-5
   Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040
   Kim SR, 2005, INSECT MOL BIOL, V14, P185, DOI 10.1111/j.1365-2583.2004.00547.x
   Lancaster C, 2016, J CHROMATOGR B, p[S1570, 30244]
   Lee JJ, 1999, J AM MOSQUITO CONTR, V15, P4
   Lee RCH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003544
   Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050
   Lei Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132122
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Marinotti O, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-15
   Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3
   McClatchy DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016039
   McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Nasirudeen AMA, 2008, MICROBES INFECT, V10, P1124, DOI 10.1016/j.micinf.2008.06.005
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112
   Oktarianti R, 2015, J INFECT PUBLIC HEAL, V8, P575, DOI 10.1016/j.jiph.2015.04.022
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008
   Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p
   Rabilloud T, 2011, J PROTEOMICS, V74, P1829, DOI 10.1016/j.jprot.2011.05.040
   Rauniyar N, 2014, J PROTEOME RES, V13, P5293, DOI 10.1021/pr500880b
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P13, DOI 10.1016/S0965-1748(02)00078-4
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400
   Sabido E, 2012, CURR OPIN BIOTECH, V23, P591, DOI 10.1016/j.copbio.2011.11.014
   Saboia-Vahia L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-253
   Saboia-Vahia L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-290
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Schwammle V, 2015, J PROTEOMICS, V129, P3, DOI 10.1016/j.jprot.2015.07.016
   Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007
   Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989
   Smith DR, 2015, REV MED VIROL, V25, P3, DOI 10.1002/rmv.1802
   Spuul P, 2011, J VIROL, V85, P4739, DOI 10.1128/JVI.00085-11
   Sury MD, 2010, MOL CELL PROTEOMICS, V9, P2173, DOI 10.1074/mcp.M110.000323
   Tchankouo-Nguetcheu S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-264
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Thaisomboonsuk BK, 2005, AM J TROP MED HYG, V72, P375, DOI 10.4269/ajtmh.2005.72.375
   Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372
   Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yao RL, 2003, PROTEOMICS, V3, P2036, DOI 10.1002/pmic.200300536
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Zhang MC, 2013, VIROLOGY, V444, P109, DOI 10.1016/j.virol.2013.06.001
   Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 122
TC 2
Z9 2
U1 1
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JUN
PY 2017
VL 17
IS 6
BP 361
EP 375
DI 10.1089/vbz.2016.2040
PG 15
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EW1IP
UT WOS:000402243800001
PM 28192064
DA 2020-07-08
ER

PT J
AU Relich, RF
   Loeffelholz, M
AF Relich, Ryan F.
   Loeffelholz, Michael
TI Zika Virus
SO CLINICS IN LABORATORY MEDICINE
LA English
DT Article
DE Arbovirus; Autochthonous; Birth defects; Flavivirus; Flaviviridae;
   Guillain-Barre syndrome; Microcephaply
ID TRANSMISSION; INFECTION; EPIDEMIC; OUTBREAK; DISEASE; BIOLOGY; URINE;
   BRAIN; RNA
AB The ongoing epidemic of Zika fever in the Western Hemisphere has drawn considerable attention from the medical and scientific communities as well as the general public, largely because of its association with birth defects and postinfectious sequelae. Since its appearance in Brazil in 2015, Zika virus has spread to more than 45 countries in the Western Hemisphere and has caused countless infections. To date, no treatment or vaccine exists, but a considerable multinational effort to halt Zika virus transmission is underway. This article reviews the basic biology, epidemiology, pathophysiology, diagnosis, and treatment of Zika virus and Zika fever.
C1 [Relich, Ryan F.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, 350 West 11th St,Suite 6027, Indianapolis, IN 46202 USA.
   [Loeffelholz, Michael] Univ Texas Med Branch, Dept Pathol, Clin Microbiol Lab, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Relich, RF (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, 350 West 11th St,Suite 6027, Indianapolis, IN 46202 USA.
EM rrelich@iupui.edu
CR Agencia Saude, 2015, MICROCEFALIA MIN SAU
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, ZIK VIR
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2014, MON CURR THREATS ECD
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Huzly D, 2016, EURO SURVEIL, V21
   Jimenez Corona ME, 2016, PLOS CURR, V8
   Kading RC, 2016, AM J TROP MED HYG, V95, P993, DOI 10.4269/ajtmh.16-0625
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P286
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organization, 2014, PAC SYNDR SURV REP W
NR 57
TC 10
Z9 10
U1 0
U2 16
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0272-2712
EI 1557-9832
J9 CLIN LAB MED
JI Clin. Lab. Med.
PD JUN
PY 2017
VL 37
IS 2
BP 253
EP +
DI 10.1016/j.cll.2017.01.002
PG 16
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA EW1CT
UT WOS:000402228200003
PM 28457349
DA 2020-07-08
ER

PT J
AU Wiwanikit, V
AF Wiwanikit, Viroj
TI Capillary Fragility, Zika Virus Infection, and Basic Screening Test
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Wiwanikit, Viroj] Hainan Med Univ, Hainan Sheng, Peoples R China.
RP Wiwanikit, V (corresponding author), Hainan Med Univ, Hainan Sheng, Peoples R China.
CR Kulkarni SA, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.10.008
   Wiwanitkit V, 2005, TROP DOCT, V35, P127, DOI 10.1258/0049475054037093
NR 2
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD JUN
PY 2017
VL 130
IS 6
BP E277
EP E277
DI 10.1016/j.amjmed.2017.01.047
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EV8BY
UT WOS:000402006500018
PM 28532852
OA Bronze
DA 2020-07-08
ER

PT J
AU Dey, S
   Nandy, A
   Basak, SC
   Nandy, P
   Das, S
AF Dey, Sumanta
   Nandy, Ashesh
   Basak, Subhash C.
   Nandy, Papiya
   Das, Sukhen
TI A Bioinformatics approach to designing a Zika virus vaccine
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Zika virus; Zika vaccine; 2D graphical representation; Alignment-free
   models; Epitope regions
ID GRAPHICAL REPRESENTATION; OUTBREAK; SEQUENCES; EPITOPES; HEALTH
AB The Zika virus infections have reached epidemic proportions in the Latin American countries causing severe birth defects and neurological disorders. While several organizations have begun research into design of prophylactic vaccines and therapeutic drugs, computer assisted methods with adequate data resources can be expected to assist in these measures to reduce lead times through bioinformatics approaches. Using 60 sequences of the Zika virus envelope protein available in the GenBank database, our analysis with numerical characterization techniques and several web based bioinformatics servers identified four peptide stretches on the Zika virus envelope protein that are well conserved and surface exposed and are predicted to have reasonable epitope binding efficiency. These peptides can be expected to form the basis for a nascent peptide vaccine which, enhanced by incorporation of suitable adjuvants, can elicit immune response against the Zika virus infections. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Dey, Sumanta; Nandy, Ashesh; Nandy, Papiya; Das, Sukhen] Ctr Interdisciplinary Res & Educ, 404 B Jodhpur Pk, Kolkata 700068, India.
   [Dey, Sumanta; Das, Sukhen] Jadavpur Univ, Dept Phys, Kolkata 700032, India.
   [Basak, Subhash C.] Univ Minnesota Duluth, Nat Resources Res Inst, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
   [Basak, Subhash C.] Univ Minnesota Duluth, Dept Chem & Biochem, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
RP Nandy, A (corresponding author), Ctr Interdisciplinary Res & Educ, 404 B Jodhpur Pk, Kolkata 700068, India.
EM anandy43@yahoo.com
OI Das, Sukhen/0000-0001-8372-3076
CR Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020
   Bagla P, 2016, HUFFINGTON POST
   Basak SC, 2016, CURR COMPUT-AID DRUG, V12, P2, DOI 10.2174/1573409912999160315115502
   Cantor JR, 2011, P NATL ACAD SCI USA, V108, P1272, DOI 10.1073/pnas.1014739108
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115343
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ghosh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040749
   Ghosh A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-6
   Gu Y, 2008, EXP PARASITOL, V118, P66, DOI 10.1016/j.exppara.2007.06.014
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   IPCC 4th, 2007, HUM HLTH 8 2 8 VECT, P403
   Moisa A. A., 2012, INSIGHT CONTROL INFE, DOI [10.5772/33496, DOI 10.5772/33496]
   NANDY A, 1994, CURR SCI INDIA, V66, P309
   Nandy A., 2016, SOJ VACC, V1, P3
   Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907
   Nandy A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050666
   Nandy Ashesh, 2009, In Silico Biology, V9, P77, DOI 10.3233/ISB-2009-0389
   Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224
   Randic M, 2011, CHEM REV, V111, P790, DOI 10.1021/cr800198j
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sarkar T, 2015, COMPUT BIOL CHEM, V59, P8, DOI 10.1016/j.compbiolchem.2015.08.003
   Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931
   Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009432
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sobolev BN, 2005, CURR COMPUT-AID DRUG, V1, P207, DOI 10.2174/1573409053585681
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, WHO EXP PRIOR VACC D
   Yu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064328
   Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254
NR 36
TC 5
Z9 5
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD JUN
PY 2017
VL 68
BP 143
EP 152
DI 10.1016/j.compbiolchem.2017.03.002
PG 10
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA EV6JN
UT WOS:000401875800017
PM 28342423
DA 2020-07-08
ER

PT J
AU Tutiven, JL
   Pruden, BT
   Banks, JS
   Stevenson, M
   Birnbach, DJ
AF Tutiven, Jacqueline L.
   Pruden, Benjamin T.
   Banks, James S.
   Stevenson, Mario
   Birnbach, David J.
TI Zika Virus: Obstetric and Pediatric Anesthesia Considerations
SO ANESTHESIA AND ANALGESIA
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; UPDATE INTERIM GUIDANCE; UNITED-STATES;
   EPIDURAL ANALGESIA; MANAGEMENT; INFECTION; RESUSCITATION; LABOR; CARE;
   TRANSMISSION
AB As of November 2016, the Florida Department of Health (FDH) and the Centers for Disease Control and Prevention have confirmed more than 4000 travel-related Zika virus (ZIKV) infections in the United States with > 700 of those in Florida. There have been 139 cases of locally acquired infection, all occurring in Miami, Florida. Within the US territories (eg, Puerto Rico, US Virgin Islands), > 30,000 cases of ZIKV infection have been reported. The projected number of individuals at risk for ZIKV infection in the Caribbean and Latin America approximates 5 million. Similar to Dengue and Chikungunya viruses, ZIKV is spread to humans by infected Aedes aegypti mosquitoes, through travel-associated local transmission, via sexual contact, and through blood transfusions. South Florida is an epicenter for ZIKV infection in the United States and the year-round warm climate along with an abundance of mosquito vectors that can harbor the flavivirus raise health care concerns. ZIKV infection is generally mild with clinical manifestations of fever, rash, conjunctivitis, and arthralgia. Of greatest concern, however, is growing evidence for the relationship between ZIKV infection of pregnant women and increased incidence of abnormal pregnancies and congenital abnormalities in the newborn, now medically termed ZIKA Congenital Syndrome. Federal health officials are observing 899 confirmed Zika-positive pregnancies and the FDH is currently monitoring 110 pregnant women with evidence of Zika infection. The University of Miami/Jackson Memorial Hospital is uniquely positioned just north of downtown Miami and within the vicinity of Liberty City, Little Haiti, and Miami Beach, which are currently "hot spots" for Zika virus exposure and transmissions. As the FDH works fervently to prevent a Zika epidemic in the region, health care providers at the University of Miami and Jackson Memorial Hospital prepare for the clinical spectrum of ZIKV effects as well as the safe perioperative care of the parturients and their affected newborns. In an effort to meet anesthetic preparedness for the care of potential Zika-positive patients and perinatal management of babies born with ZIKA Congenital Syndrome, this review highlights the interim guidelines from the Centers for Disease Control and Prevention and also suggest anesthetic implications and recommendations. In addition, this article reviews guidance for the evaluation and anesthetic management of infants with congenital ZIKV infection. To better manage the perioperative care of affected newborns, this article also reviews the comparative anesthetic implications of babies born with related congenital malformations.
C1 [Tutiven, Jacqueline L.] Univ Miami, Miller Sch Med, Dept Anesthesiol, Miami, FL 33136 USA.
   [Pruden, Benjamin T.] Jackson Mem Hosp, Miami, FL 33136 USA.
   [Banks, James S.] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA.
   [Stevenson, Mario] Univ Miami, Dept Med, Div Infect Dis, Miami Miller Sch Med, Miami, FL USA.
   [Birnbach, David J.] Univ Miami, Miller Sch Med, Dept Anesthesiol, UM JMH Ctr Patient Safety, 1611 NW 12th Ave, Miami, FL 33136 USA.
RP Birnbach, DJ (corresponding author), Univ Miami, Miller Sch Med, Dept Anesthesiol, UM JMH Ctr Patient Safety, 1611 NW 12th Ave, Miami, FL 33136 USA.
EM dbirnbach@miami.edu
RI amsalu, ribka/G-8780-2019
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aerial spraying and mosquito control, 2016, AER SPR MOSQ CONTR
   Aggarwal A, 2012, J ANESTH CLIN RES, V3, P256
   Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2
   [Anonymous], ZIK TRANSM RISKS
   [Anonymous], EPID AL NEUR SYNDR C
   [Anonymous], ZIK VIR
   [Anonymous], GUID COMPL REG INF B
   [Anonymous], LAB SAF WHEN WORK ZI
   [Anonymous], RAP RISK ASS ZIK VIR
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Center for Disease Control and Prevention (CDC), ZIK BLOOD TRANSF
   Chan LYS, 2004, ACTA OBSTET GYN SCAN, V83, P319, DOI 10.1111/j.0001-6349.2004.0473.x
   Cheng Q, 1998, EPIDEMIOLOGY, V9, P601
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Corwin M J, 1996, Curr Probl Pediatr, V26, P325
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141852
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1
   ELLIOTT RD, 1994, CAN J ANAESTH, V41, P742, DOI 10.1007/BF03015632
   Furara S, 2008, OBSTET MED, V1, P99, DOI 10.1258/om.2008.080011
   Grosselin RE, 1984, CLIN TOXICOLOGY COMM
   Hall JG, 1998, ARTHROGRYPOSIS TEXT, P1
   Harless Jeff, 2014, Int J Crit Illn Inj Sci, V4, P65, DOI 10.4103/2229-5151.128015
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119
   Kheterpal S, 2006, ANESTHESIOLOGY, V105, P885, DOI 10.1097/00000542-200611000-00007
   Kocabas S, 2007, J CLIN ANESTH, V19, P299, DOI 10.1016/j.jclinane.2006.09.008
   Koh Jeffrey L, 2012, Anesthesiol Clin, V30, P191, DOI 10.1016/j.anclin.2012.05.001
   MILNER AD, 1984, BRIT MED J, V289, P1563, DOI 10.1136/bmj.289.6458.1563
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   MORRAY JP, 1993, ANESTHESIOLOGY, V78, P461, DOI 10.1097/00000542-199303000-00009
   Mortensen A, 2011, PEDIATR ANESTH, V21, P623, DOI 10.1111/j.1460-9592.2011.03559.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Munoz-Price LS, 2013, AM J INFECT CONTROL, V41, P922, DOI 10.1016/j.ajic.2013.03.306
   Naled for mosquito control, NAL MASQ CONTR
   National Institute for Occupational Safety and Health, INT GUID PROT WORK O
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Padilla C, 2016, J CLIN ANESTH, V35, P136, DOI 10.1016/j.jclinane.2016.07.034
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   PATERSON SJ, 1994, ANESTHESIOLOGY, V80, P1248, DOI 10.1097/00000542-199406000-00012
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Puhringer FK, 2010, BRIT J ANAESTH, V105, P657, DOI 10.1093/bja/aeq227
   QUANCE DR, 1988, CAN J ANAESTH, V35, P612, DOI 10.1007/BF03020349
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706
   Diaz MAR, 2012, BIOMED SIGNAL PROCES, V7, P43, DOI 10.1016/j.bspc.2011.06.011
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Segal S, 2010, ANESTH ANALG, V111, P1467, DOI 10.1213/ANE.0b013e3181f713d4
   Simmins CH, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171223, DOI 10.2471/BLT.16.171223]
   Soyoral L, 2014, REV BRAS ANESTHESIOL
   SUDO N, 1975, OBSTET GYNECOL, V45, P39
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Thomas K, 2012, PEDIATR ANESTH, V22, P1033, DOI 10.1111/j.1460-9592.2012.03927.x
   US Department for Health and Human Service, BIOSAFETY MICROBIOLO
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vassiliev DV, 2001, REGION ANESTH PAIN M, V26, P174, DOI 10.1053/rapm.2001.21090
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   VINSON DC, 1993, J FAM PRACTICE, V36, P617
   Weiss M, 2010, PEDIATR ANESTH, V20, P454, DOI 10.1111/j.1460-9592.2010.03284.x
   World Health Organization, ZIK VIR MICR GUILL B
   Zambouri A, 2007, Hippokratia, V11, P13
NR 75
TC 2
Z9 2
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD JUN
PY 2017
VL 124
IS 6
BP 1918
EP 1929
DI 10.1213/ANE.0000000000002047
PG 12
WC Anesthesiology
SC Anesthesiology
GA EV3XU
UT WOS:000401693200026
PM 28525510
DA 2020-07-08
ER

PT J
AU Beckham, JD
AF Beckham, J. David
TI Zika virus, a novel mosquito-borne congenital virus infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Editorial Material
C1 [Beckham, J. David] Univ Colorado, Sch Med, Dept Med Infect Dis, Aurora, CO 80045 USA.
   [Beckham, J. David] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA.
   [Beckham, J. David] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.
RP Beckham, JD (corresponding author), Univ Colorado, Sch Med, Dept Med Infect Dis, Aurora, CO 80045 USA.; Beckham, JD (corresponding author), Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA.; Beckham, JD (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.
EM david.beckham@ucdenver.edu
RI Beckham, John/AAE-6694-2020
OI Beckham, John/0000-0001-9305-2683
FU BLRD VA [I01 BX003863]
CR Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59
   Singh MV, 2017, J NEUROVIROL
   Zhou K, 2017, J NEUROVIROL
NR 4
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2017
VL 23
IS 3
BP 339
EP 340
DI 10.1007/s13365-017-0528-x
PG 2
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA EV7FJ
UT WOS:000401940500001
PM 28429288
OA Bronze
DA 2020-07-08
ER

PT J
AU Singh, MV
   Weber, EA
   Singh, VB
   Stirpe, NE
   Maggirwar, SB
AF Singh, Meera V.
   Weber, Emily A.
   Singh, Vir B.
   Stirpe, Nicole E.
   Maggirwar, Sanjay B.
TI Preventive and therapeutic challenges in combating Zika virus infection:
   are we getting any closer?
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Review
DE Zika virus; Microcephaly; Antibody dependent enhancement of infection;
   Therapeutics
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; 1ST TRIMESTER; CELL-DEATH; BIRTH;
   HOST; DISEASE; VACCINE; BRAIN; PROLIFERATION
AB The neuroteratogenic nature of Zika Virus (ZIKV) infection has converted what would have been a tropical disease into a global threat. Zika is transmitted vertically via infected placental cells especially in the first and second trimesters. In the developing central nervous system (CNS), ZIKV can infect and induce apoptosis of neural progenitor cells subsequently causing microcephaly as well as other neuronal complications in infants. Its ability to infect multiple cell types (placental, dermal, and neural) and increased environmental stability as compared to other flaviviruses (FVs) has broadened the transmission routes for ZIKV infection from vector-mediated to transmitted via body fluids. To further complicate the matters, it is genetically similar (about 40%) with the four serotypes of dengue virus (DENV), so much so that it can almost be called a fifth DENV serotype. This homology poses the risk of causing cross-reactive immune responses and subsequent antibody-dependent enhancement (ADE) of infection in case of secondary infections or for immunized individuals. All of these factors complicate the development of a single preventive vaccine candidate or a pharmacological intervention that will completely eliminate or cure ZIKV infection. We discuss all of these factors in detail in this review and conclude that a combinatorial approach including immunization and treatment might prove to be the winning strategy.
C1 [Singh, Meera V.; Weber, Emily A.; Singh, Vir B.; Stirpe, Nicole E.; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.
RP Singh, MV (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.
EM meera_singh@urmc.rochester.edu
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS054578,
   RO1 NS066801, RO1 HL1281555]
FX We would like to thank Dr. Joseph Jackson and Ryan Connor for their
   valuable comments during manuscript revisions. This work was supported
   by the National Institute of Health (NIH) grants RO1 NS054578, RO1
   NS066801, and RO1 HL1281555 to SBM.
CR Alonzo MTG, 2012, J INFECT DIS, V205, P1321, DOI 10.1093/infdis/jis180
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bambakidis NC, 2010, NEUROSURGERY, V67, P1709, DOI 10.1227/NEU.0b013e3181f9b0a5
   Barba-Spaeth G, 2016, NATURE
   Barrows NJ, 2016, CELL HOST MICROBE
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P46, DOI 10.1111/j.1574-695X.2008.00399.x
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2016, EURO SURVEILLANCE B
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bragina O, 2010, NEUROSCI LETT, V482, P81, DOI 10.1016/j.neulet.2010.06.068
   Brasil P., 2016, NEW ENGLAND J MED
   Brault JB, 2016, EBIOMEDICINE
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Choi KY, 2016, J VIROLOGY
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Cooper JA, 2013, J CELL BIOL, V202, P725, DOI 10.1083/jcb.201305021
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J., 2016, CELL STEM CELL
   David A, 2014, CELL CYCLE, V13, P2859, DOI 10.4161/15384101.2014.946830
   de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Dejnirattisai W, 2016, NATURE IMMUNOLOGY
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Franca GV, 2016, LANCET
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Hughes BW, 2016, EBIOMEDICINE
   HUTCHINGS PR, 1986, IMMUNOLOGY, V59, P445
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jenum PA, 1998, J CLIN MICROBIOL, V36, P2900, DOI 10.1128/JCM.36.10.2900-2906.1998
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larocca RA, 2016, NATURE
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang HB, 2016, CELL MOL IMMUNOL, V13, P36, DOI 10.1038/cmi.2015.76
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L
   Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339
   Liuzzi G, 2016, EUROPEAN J INTERNAL
   Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Martinez-Palomo A, 2016, J PUBLIC HLTH POLICY
   Matheron S, 2016, LONG LASTING PERSIST
   MATHUR A, 1982, J GEN VIROL, V59, P213, DOI 10.1099/0022-1317-59-1-213
   Matondang Asnath Vera, 2004, Acta Med Indones, V36, P62
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   MILLER E, 1982, LANCET, V2, P781
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Moshfeghi DM, 2016, JAMA OPHTHALMOLOGY
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Murgue B, 1997, J INFECT DIS, V175, P1497, DOI 10.1086/516486
   NAKAO S, 1989, BLOOD, V74, P1235
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pacheco O, 2016, NEW ENGLAND J MED
   Parke DW, 2016, OPHTHALMOLOGY
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Reusken C, 2016, EURO SURVEILLANCE B, V21
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rinaldi S, 2008, CURR OPIN NEUROL, V21, P540, DOI 10.1097/WCO.0b013e32830b84b7
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EURO SURVEILLANCE B, V21
   Sapparapu G, 2016, NATURE
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314
   Sharp TM, 2016, ZIKA VIRUS INFECT AS
   Silva ML, 2011, VACCINE, V29, P583, DOI 10.1016/j.vaccine.2010.08.046
   Singh VB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26876
   Soares de Souza A, 2016, CLIN INFECT DIS
   Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028
   SRICHAIKUL T, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P19
   Stettler K., 2016, SCIENCE
   Strafela P, 2016, ARCH PATHOL LAB MED
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Valentine G, 2016, J PEDIAT INFECT DIS
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   White MK, 2016, ANN NEUROLOGY
   Willison HJ, 2007, J NEUROCHEM, V103, P143, DOI 10.1111/j.1471-4159.2007.04718.x
   Wiwanitkit V, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0076
   World Health Organization, 2016, DENG VACC WHO POS PA, V91, P349
   World Health Organization, 2016, CURR ZIK PROD PIP
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yamaguchi Y, 2015, DEV CELL, V32, P478, DOI 10.1016/j.devcel.2015.01.019
   Zhao H, 2016, CELL
NR 119
TC 4
Z9 5
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2017
VL 23
IS 3
BP 347
EP 357
DI 10.1007/s13365-017-0513-4
PG 11
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA EV7FJ
UT WOS:000401940500003
PM 28116673
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chimelli, L
   Melo, ASO
   Avvad-Portari, E
   Wiley, CA
   Camacho, AHS
   Lopes, VS
   Machado, HN
   Andrade, CV
   Dock, DCA
   Moreira, ME
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Carvalho, ACG
   Ugarte, ON
   Batista, AGM
   Amorim, MMR
   Melo, FO
   Ferreira, TA
   Marinho, JRL
   Azevedo, GS
   Leal, JIBF
   da Costa, RFM
   Rehen, S
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Aguiar, RS
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Avvad-Portari, Elyzabeth
   Wiley, Clayton A.
   Camacho, Aline H. S.
   Lopes, Vania S.
   Machado, Heloisa N.
   Andrade, Cecilia V.
   Dock, Dione C. A.
   Moreira, Maria Elisabeth
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Carvalho, Angela C. G.
   Ugarte, Odile N.
   Batista, Alba G. M.
   Amorim, Melania M. R.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Marinho, Jacqueline R. L.
   Azevedo, Girlene S.
   Leal, Jeime I. B. F.
   Madeiro da Costa, Rodrigo F.
   Rehen, Stevens
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Aguiar, Renato S.
   Tanuri, Amilcar
TI The spectrum of neuropathological changes associated with congenital
   Zika virus infection
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Zika virus; Congenital ZIKV infection; Microcephaly; Calcification; In
   situ hybridization; Neuropathology
ID TRANSMISSION; OUTBREAK; BRAZIL
AB A major concern associated with ZIKV infection is the increased incidence of microcephaly with frequent calcifications in infants born from infected mothers. To date, postmortem analysis of the central nervous system (CNS) in congenital infection is limited to individual reports or small series. We report a comprehensive neuropathological study in ten newborn babies infected with ZIKV during pregnancy, including the spinal cords and dorsal root ganglia (DRG), and also muscle, pituitaries, eye, systemic organs, and placentas. Using in situ hybridization (ISH) and electron microscopy, we investigated the role of direct viral infection in the pathogenesis of the lesions. Nine women had Zika symptoms between the 4th and 18th and one in the 28th gestational week. Two babies were born at 32, one at 34 and 36 weeks each and six at term. The cephalic perimeter was reduced in four, and normal or enlarged in six patients, although the brain weights were lower than expected. All had arthrogryposis, except the patient infected at 28 weeks gestation. We defined three patterns of CNS lesions, with different patterns of destructive, calcification, hypoplasia, and migration disturbances. Ventriculomegaly was severe in the first pattern due to midbrain damage with aqueduct stenosis/distortion. The second pattern had small brains and mild/moderate (ex-vacuo) ventriculomegaly. The third pattern, a well-formed brain with mild calcification, coincided with late infection. The absence of descending fibres resulted in hypoplastic basis pontis, pyramids, and cortico-spinal tracts. Spinal motor cell loss explained the intrauterine akinesia, arthrogryposis, and neurogenic muscle atrophy. DRG, dorsal nerve roots, and columns were normal. Lymphohistiocytic inflammation was mild. ISH showed meningeal, germinal matrix, and neocortical infection, consistent with neural progenitors death leading to proliferation and migration disorders. A secondary ischemic process may explain the destructive lesions. In conclusion, we characterized the destructive and malformative consequences of ZIKV in the nervous system, as reflected in the topography and severity of lesions, anatomic localization of the virus, and timing of infection during gestation. Our findings indicate a developmental vulnerability of the immature CNS, and shed light on possible mechanisms of brain injury of this newly recognized public health threat.
C1 [Chimelli, Leila; Camacho, Aline H. S.] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila; Camacho, Aline H. S.] Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Amorim, Melania M. R.; Melo, Fabiana O.; Ferreira, Thales A.; Azevedo, Girlene S.] Res Inst Prof Amorim Neto, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.; Marinho, Jacqueline R. L.; Leal, Jeime I. B. F.] Hlth Secretary Campina Grande, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Avvad-Portari, Elyzabeth; Machado, Heloisa N.; Andrade, Cecilia V.; Dock, Dione C. A.; Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, S701 Scaife Hall 200 Lothrop St, Pittsburgh, PA 15213 USA.
   [Lopes, Vania S.; Carvalho, Angela C. G.; Ugarte, Odile N.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Pathol, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] Univ Fed Rio de Janeiro, Rua Diniz Cordeiro 30, BR-22281100 Rio de Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Rua Napoleao Barros 800, BR-04024002 Sao Paulo, SP, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Med Virol,Dept Genet, Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Ferreira, Thales Araujo/AAA-6252-2019; Melo, Adriana S O/H-5650-2016;
   Rehen, Stevens K/J-5874-2012; Amorim, Melania M/C-5807-2013; Aguiar,
   Renato S/G-3542-2015; ANDRADE, CECILIA/B-5916-2017
OI Rehen, Stevens K/0000-0003-4216-9501; Amorim, Melania
   M/0000-0003-1047-2514; Aguiar, Renato S/0000-0001-5180-3717; FERREIRA,
   THALES/0000-0002-6699-5886; ANDRADE, CECILIA/0000-0001-7980-4367
FU National Institute of Health (NIH) IH NIAID grant [U01 AI 111598];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [CNPq]National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ]Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX We thank DEbora Silva, Diego Santos, and Luciana Bitana for technical
   assistance in histological and immunohistochemical preparations, and
   Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO) for
   technical assistance in transmission electron microscopy. These studies
   received partial support from the National Institute of Health (NIH) IH
   NIAID grant U01 AI 111598 (C.A.W.) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a
   Pesquisa do Rio de Janeiro [FAPERJ] (A.T).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison D, 2012, NEUROPATHOLOGY REFER
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larroche J-C, 1977, DEV PATHOLOGY NEONAT, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Love S, 2015, GREENFIELDS NEUROPAT, P1087
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tadros MA, 2015, J NEUROPHYSIOL, V114, P2661, DOI 10.1152/jn.00682.2015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 64
Z9 67
U1 1
U2 29
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2017
VL 133
IS 6
BP 983
EP 999
DI 10.1007/s00401-017-1699-5
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EU6HB
UT WOS:000401134000008
PM 28332092
DA 2020-07-08
ER

PT J
AU Blair, TR
AF Blair, Thomas R.
TI Safe Sex in the 1970s: Community Practitioners on the Eve of AIDS
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID PREEXPOSURE PROPHYLAXIS; VIRUS
AB In the 1970s, groups of gay and gay-allied health professionals began to formulate guidelines for safer sexual activity, several years before HIV/AIDS. Through such organizations as the National Coalition of Gay Sexually Transmitted Disease Services, Bay Area Physicians for Human Rights, and the Sisters of Perpetual Indulgence, these practitioners developed materials that would define sexual health education for the next four decades, as well as such concepts as "bodily fluids" and the "safe sex hanky." To do so, they used their dual membership in the community and the health professions. Although the dichotomy between the gay community and the medical establishment helped define the early history of HIV/AIDS, the creative work of these socially "amphibious" activists played an equally important part. Amid current debates over preexposure prophylaxis against HIV and Zika virus transmission, lessons for sexual health include the importance of messaging, the difficulty of behavioral change, and the vitality of community-driven strategies to mitigate risk.
C1 [Blair, Thomas R.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.
RP Blair, TR (corresponding author), 9449 Imperial Hwy,Suite A 206, Downey, CA 90242 USA.
EM trblair@mednet.ucla.edu
CR Altman Dennis, 1986, AIDS MIND AM
   Andriote J.-M., 1999, VICTORY DEFERRED
   [Anonymous], 1984, TIME
   [Anonymous], 1987, ATLANTIC MONTHLY
   Becker V., 1989, SAFE SEX, P31
   Berkowitz R., 2003, STAYIN ALIVE
   Blair TR, 2016, B HIST MED, V90, P279, DOI 10.1353/bhm.2016.0058
   Bolan R. K., 2016, COMMUNICATION
   BOLAN RK, 1981, SEX TRANSM DIS, V8, P293, DOI 10.1097/00007435-198110000-00011
   Brandt A. M., 1988, AIDS BURDENS HIST, P151
   Brayton C., 2016, COMMUNICATION
   Brier S., 2009, INFECT IDEAS
   Bunch K., 2016, COMMUNICATION
   Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816
   Callen M., 1983, HAVE SEX EPIDEMIC ON
   Chevallier E., 1993, THE CONDOM
   Cochrane M., 2004, WHEN AIDS BEGAN
   Cochrane M., 2004, WHEN AIDS BEGAN, pxxiv
   Cossey D., 1978, SAFE SEX TEENAGERS
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Epstein S., 1996, IMPURE SCI
   Fee E., 1988, AIDS BURDENS HIST, P137
   Folkers F. M., ZIKA MILLENNIALS STD
   GOEDERT JJ, 1987, NEW ENGL J MED, V316, P1339, DOI 10.1056/NEJM198705213162111
   Goldblum P., 2012, COMMUNICATION
   Golden B., 2016, COMMUNICATION
   GOLDEN JS, 1971, CALIF MED, V115, P60
   Harvey Milk Lesbian & Gay Democratic Club, 1984, CAN WE TALK
   Hughes S. S., COMMUNICATION
   Jay K., 1977, THE GAY REPORT
   King E., 1993, FATAL ADVICE
   Kubrick Stanley, 1964, DR STRANGELOVE I LEA
   Levine M. P., 1979, GAY MEN SOCIOLOGY MA
   Locke R., 1987, HEAT PASSION
   Mayer KH, 2016, JAMA-J AM MED ASSOC, V315, P867, DOI 10.1001/jama.2016.0318
   McGraw P., 2012, COMMUNICATION
   Miller B., 1980, QUALITATIVE SOCIOLOG, V3, P169
   Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273
   Moran J., 2000, TEACHING SEX
   National Coalition of Gay Sexually Transmitted Disease Services, 1981, OFFICIAL NEWSLETTER, V3
   National Coalition of Gay Sexually Transmitted Disease Services, 1982, OFFICIAL NEWSLETTER, V4
   National Coalition of Gay Sexually Transmitted Disease Services, 1981, OFFICIAL NEWSLETTER, V2, P14
   Oppenheimer G., 1992, AIDS MAKING CHRONIC
   Patton C., 1996, FATAL ADVICE, P111
   Shilts R., 1987, BAND PLAYED, P569
   Siegel K, 1986, J Community Health, V11, P233, DOI 10.1007/BF01325119
   Sisters of Perpetual Indulgence, 1982, PLAY FAIR
   Stine R., 2016, COMMUNICATION
   TREICHLER PA, 1999, HAVE THEORY EPIDEMIC
   Volberding P., 2012, COMMUNICATION
   Woods W., 2012, COMMUNICATION
NR 51
TC 0
Z9 0
U1 1
U2 3
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JUN
PY 2017
VL 107
IS 6
BP 872
EP 879
DI 10.2105/AJPH.2017.303704
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE5CY
UT WOS:000408230800038
PM 28426312
OA Green Published
DA 2020-07-08
ER

PT J
AU Ikejezie, J
   Shapiro, CN
   Kim, J
   Chiu, M
   Almiron, M
   Ugarte, C
   Espinal, MA
   Aldighieri, S
AF Ikejezie, J.
   Shapiro, C. N.
   Kim, J.
   Chiu, M.
   Almiron, M.
   Ugarte, C.
   Espinal, M. A.
   Aldighieri, S.
TI Zika Virus Transmission-Region of the Americas, May15, 2015-December 15,
   2016
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Editorial Material
C1 [Ikejezie, J.; Kim, J.; Chiu, M.; Almiron, M.; Ugarte, C.; Espinal, M. A.; Aldighieri, S.] Pan Amer Hlth Org, Washington, DC 20037 USA.
   [Shapiro, C. N.] CDC, Div Emergency Operat, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
RP Ikejezie, J (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.
EM ikejezijun@paho.org
CR Brazil Ministry of Health, 2016, PROC ZIK VIR SURV BR
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Pan American Health Organization, 2016, STRAT ENH NAT CAP RE
   Pan American Health Organization, 2016, PAHO WHO REG RES AG
   Pan American Health Organization/ World Health Organization, 2016, GUID SURV ZIK VIR DI
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 9
TC 13
Z9 13
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD JUN
PY 2017
VL 17
IS 6
BP 1681
EP 1686
DI 10.1111/ajt.14333
PG 6
WC Surgery; Transplantation
SC Surgery; Transplantation
GA EW8HY
UT WOS:000402761000031
PM 28544280
OA Bronze
DA 2020-07-08
ER

PT J
AU Akkina, R
   Ellerbrok, H
   Hall, W
   Hasegawa, H
   Kawaguchi, Y
   Kleanthous, H
   McSweegan, E
   Mercer, N
   Romanowski, V
   Sawa, H
   Vahlne, A
AF Akkina, Ramesh
   Ellerbrok, Heinz
   Hall, William
   Hasegawa, Hideki
   Kawaguchi, Yasushi
   Kleanthous, Harold
   McSweegan, Edward
   Mercer, Natalia
   Romanowski, Victor
   Sawa, Hirofumi
   Vahlne, Anders
TI 2016 International meeting of the Global Virus Network
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Global Virus Network; Emerging viruses; International collaborations;
   Medical virology
ID IMMUNITY
AB The Global Virus Network (GVN) was established in 2011 in order to strengthen research and responses to current viral causes of human disease and to prepare against new viral pandemic threats. There are now 38 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. GVN scientists meet annually to learn about each other's current research, address collaborative priorities and plan future programs. The 2016 meeting was held from October 23-25 in Hokkaido, Japan, in partnership with the Japanese Society for Virology, the National Institute of Infectious Diseases of Japan and the Research Center for Zoonosis Control of Hokkaido University. This report highlights the accomplishments of GVN researchers in many priority areas of medical virology, including the current Zika epidemic, infections by human papillomavirus, influenza, Ebola, Lassa, dengue, HIV, hepatitis C, and chikungunya viruses, and the development of improved diagnostics and new vaccines. Published by Elsevier B.V.
C1 [Akkina, Ramesh] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Ellerbrok, Heinz] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany.
   [Hall, William] Univ Coll Dublin, Dept Med Microbiol, Dublin, Ireland.
   [Hasegawa, Hideki] Natl Inst Infect Dis, Tokyo, Japan.
   [Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan.
   [Kleanthous, Harold] Sanofi Pasteur, Discovery Res, Boston, MA USA.
   [McSweegan, Edward; Mercer, Natalia] Global Virus Network, 725 W Lombard St,Rm S-420, Baltimore, MD 21201 USA.
   [Romanowski, Victor] Univ Nacl La Plata, Inst Biotechnol & Mol Biol, La Plata, Argentina.
   [Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan.
   [Vahlne, Anders] Karolinska Inst, Dept Lab Med, Stockholm, Sweden.
RP McSweegan, E (corresponding author), Global Virus Network, 725 W Lombard St,Rm S-420, Baltimore, MD 21201 USA.
EM emcsweegan@gvn.org
RI Sawa, Hirofumi/F-6954-2012
CR Anindita PD, 2016, VIRUS RES, V215, P121, DOI 10.1016/j.virusres.2016.02.002
   Annunziata C, 2012, PATHOL ONCOL RES, V18, P803, DOI 10.1007/s12253-012-9507-y
   Caporale M, 2014, J VIROL, V88, P10399, DOI 10.1128/JVI.01641-14
   de Avilla AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164691
   Delagreverie HM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw189
   DiMaio D, 2014, MBIO, V5, DOI 10.1128/mBio.01003-14
   Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Furuyama W, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006139
   Gallo RC, 2005, ONCOGENE, V24, P5926, DOI 10.1038/sj.onc.1208980
   Gallo RC, 2016, BLOOD, V128, P3029, DOI 10.1182/blood-2016-09-739433
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gillet NA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005588
   Griffin DE, 2016, NEUROTHERAPEUTICS, V13, P455, DOI 10.1007/s13311-016-0434-6
   Haredy AM, 2013, CLIN VACCINE IMMUNOL, V20, P998, DOI 10.1128/CVI.00024-13
   Jazwinski Alison B, 2011, Gastroenterol Hepatol (N Y), V7, P154
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Kobayashi S, 2016, J BIOL CHEM, V291, P6559, DOI 10.1074/jbc.M115.712760
   Lederman Michael M, 2016, Pathog Immun, V1, P154
   Mann A, 2011, NAT MED, V17, P394, DOI 10.1038/nm0411-394a
   McSweegan E, 2015, ANTIVIR RES, V120, P147, DOI 10.1016/j.antiviral.2015.06.003
   Melzi E, 2016, P NATL ACAD SCI USA, V113, pE6238, DOI 10.1073/pnas.1610012113
   Mire CE, 2016, J INFECT DIS, V214, pS367, DOI 10.1093/infdis/jiw333
   Oda S, 2016, J VIROL, V90, P8754, DOI 10.1128/JVI.01258-16
   Phongphaew W, 2017, VIRUS RES, V228, P114, DOI 10.1016/j.virusres.2016.11.029
   Qin XC, 2014, P NATL ACAD SCI USA, V111, P6744, DOI 10.1073/pnas.1324194111
   Ryvkin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041469
   Saphire EO, 2017, NATURE, V541, P283, DOI 10.1038/541283a
   Saphire EO, 2016, TRENDS MICROBIOL, V24, P684, DOI 10.1016/j.tim.2016.05.008
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Suzuki T, 2015, P NATL ACAD SCI USA, V112, P7809, DOI 10.1073/pnas.1503885112
   Tornesello ML, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0255-5
   Tran EEH, 2016, MBIO, V7, DOI 10.1128/mBio.00257-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiss-Ottolenghi Y, 2014, FEBS LETT, V588, P318, DOI 10.1016/j.febslet.2013.11.005
   Willems L, 2017, ANTIVIR RES, V137, P41, DOI 10.1016/j.antiviral.2016.10.015
NR 36
TC 3
Z9 3
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2017
VL 142
BP 21
EP 29
DI 10.1016/j.antiviral.2017.03.005
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EU7GK
UT WOS:000401203100004
PM 28315708
OA Green Published
DA 2020-07-08
ER

PT J
AU Eyer, L
   Zouharova, D
   Sirmarova, J
   Fojtikova, M
   Stefanik, M
   Haviernik, J
   Nencka, R
   de Clercq, E
   Ruzek, D
AF Eyer, Ludek
   Zouharova, Darina
   Sirmarova, Jana
   Fojtikova, Martina
   Stefanik, Michal
   Haviernik, Jan
   Nencka, Radim
   de Clercq, Erik
   Ruzek, Daniel
TI Antiviral activity of the adenosine analogue BCX4430 against West Nile
   virus and tick-borne flaviviruses
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE BCX4430; Flavivirus; Adenosine analogue; Nucleoside inhibitor; Antiviral
   activity; Cytotoxicity
ID ENCEPHALITIS-VIRUS; NUCLEOSIDE INHIBITORS; MOUSE MODEL; ZIKA VIRUS;
   ARBOVIRUSES; VIRULENCE; CULTURE; FEVER
AB There are currently no approved antiviral therapies against medically important human flaviviruses. The imino-C-nucleoside BCX4430 shows broad-spectrum antiviral activity against a wide range of RNA viruses. Here, we demonstrate that BCX4430 inhibits tick-borne species of the genus Flavivirus; however, the antiviral effect varies against individual species. Micro-molar BCX4430 levels inhibited tick-borne encephalitis virus (TBEV); while, approximately 3-8-fold higher concentrations were needed to inhibit louping ill virus and Kyasanur Forest disease virus. Moreover, the compound strongly inhibited in vitro replication of West Nile virus, a typical mosquito-transmitted flavivirus. Two chemical forms of the compound, i.e. BCX4430 and BCX4430 hydrochloride, were compared and both exerted similar inhibitory profiles in our in vitro antiviral assay systems and no or negligible cytotoxicity in porcine kidney stable and Vero cells. The obtained data indicate that, in addition to mosquito-borne flaviviruses, the compound has strong antiviral activity against members of the TBEV serocomplex. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Eyer, Ludek; Zouharova, Darina; Sirmarova, Jana; Fojtikova, Martina; Stefanik, Michal; Haviernik, Jan; Ruzek, Daniel] Vet Res Inst, Dept Virol, Hudcova 70, CZ-62100 Brno, Czech Republic.
   [Eyer, Ludek; Ruzek, Daniel] Czech Acad Sci, Biol Ctr, Inst Parasitol, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
   [Nencka, Radim] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, CZ-16610 Prague 6, Czech Republic.
   [de Clercq, Erik] Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.
RP Ruzek, D (corresponding author), Vet Res Inst, Hudcova 70, CZ-62100 Brno, Czech Republic.
EM ruzekd@paru.cas.cz
RI Eyer, Ludek/U-4883-2018; Nencka, Radim/G-5296-2014; Ruzek,
   Daniel/G-9275-2014
OI Eyer, Ludek/0000-0001-7761-0702; Ruzek, Daniel/0000-0003-4655-2380; De
   Clercq, Erik/0000-0002-2985-8890; Bojcukova, Jana/0000-0002-7612-8807
FU Czech Science FoundationGrant Agency of the Czech Republic
   [GA16-20054S]; Czech Agency for Medical Research, Ministry of Health of
   the Czech Republic [16-34238A]; Ministry of Education, Youth, and Sports
   of the Czech Republic under the NPU I program [LO1218];  [RVO: 61388963]
FX The authors are greatly indebted to Dr. Ivana Huvarova for excellent
   technical assistance. This study was supported by the Czech Science
   Foundation project GA16-20054S; Czech Agency for Medical Research,
   Ministry of Health of the Czech Republic (grant No. 16-34238A); and by
   project LO1218, with financial support from the Ministry of Education,
   Youth, and Sports of the Czech Republic under the NPU I program. We also
   acknowledge a grant for the development of research organizations (RVO:
   61388963).
CR Asghar N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39265
   Asghar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103264
   Baier A., 2011, FLAVIVIRUS ENCEPHALI
   Borowski P, 2002, ANTIMICROB AGENTS CH, V46, P1231, DOI 10.1128/AAC.46.5.1231-1239.2002
   De Clercq E, 2016, J MED CHEM, V59, P2301, DOI 10.1021/acs.jmedchem.5b01157
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Deval J, 2014, CURR OPIN VIROL, V9, P1, DOI 10.1016/j.coviro.2014.08.004
   Eldrup AB, 2004, J MED CHEM, V47, P2283, DOI 10.1021/jm030424e
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Flint M, 2014, ANTIMICROB AGENTS CH, V58, P3206, DOI 10.1128/AAC.02393-14
   Hosmane RS, 2003, ANTIVIR RES, V57, pA87
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Julander JG, 2014, ANTIMICROB AGENTS CH, V58, P6607, DOI 10.1128/AAC.03368-14
   KOZUCH O, 1975, ACTA VIROL, V19, P498
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Sakai M, 2014, J GEN VIROL, V95, P823, DOI 10.1099/vir.0.060046-0
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
NR 21
TC 27
Z9 30
U1 3
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2017
VL 142
BP 63
EP 67
DI 10.1016/j.antiviral.2017.03.012
PG 5
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EU7GK
UT WOS:000401203100008
PM 28336346
DA 2020-07-08
ER

PT J
AU Mahawaththa, MC
   Pearce, BJG
   Szabo, M
   Graham, B
   Klein, CD
   Nitsche, C
   Otting, G
AF Mahawaththa, Mithun C.
   Pearce, Benjamin J. G.
   Szabo, Monika
   Graham, Bim
   Klein, Christian D.
   Nitsche, Christoph
   Otting, Gottfried
TI Solution conformations of a linked construct of the Zika virus NS2B-NS3
   protease
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Inhibitor; NMR spectroscopy; NS2B-NS3 protease; Pseudocontact shifts;
   Zika
ID WEST-NILE-VIRUS; PSEUDOCONTACT SHIFTS; ESCHERICHIA-COLI; NS3 PROTEASE;
   FLAVIVIRAL PROTEASES; MEDICINAL CHEMISTRY; CRYSTAL-STRUCTURE;
   NMR-SPECTROSCOPY; BINDING MODE; DENGUE
AB The Zika virus presents a serious risk for global health. Crystal structures of different constructs of the Zika virus NS2B-NS3 protease (NS2B-NS3pro) have been determined with the aim to provide a basis for rational drug discovery. In these structures, the C-terminal beta-hairpin of NS2B, NS2Bc, was observed to be either disordered (open conformation) or bound to NS3pro complementing the substrate binding site (closed conformation). Enzymatically active constructs of flaviviral NS2B-NS3 proteases commonly used for inhibitor testing contain a covalent peptide linker between NS2B and NS3pro. Using a linked construct of Zika virus NS2B-NS3pro, we studied the location of NS2Bc relative to NS3pro in solution by pseudocontact shifts generated by a paramagnetic lanthanide tag attached to NS3pro. Both closed and open conformations were observed with different inhibitors. As the NS2B co-factor is involved in substrate binding of flaviviral NS2B-NS3 proteases, the destabilization of the closed conformation in the linked construct makes it an attractive tool to search for inhibitors that interfere with the formation of the enzymatically active, closed conformation. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Mahawaththa, Mithun C.; Pearce, Benjamin J. G.; Nitsche, Christoph; Otting, Gottfried] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
   [Szabo, Monika; Graham, Bim] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.
   [Klein, Christian D.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Med Chem, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
RP Nitsche, C; Otting, G (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
EM christoph.nitsche@anu.edu.au; gottfried.otting@anu.edu.au
RI Don, Mithun Mahawaththage/N-9503-2019; Szabo, Monika/AAR-8071-2020;
   Otting, Gottfried/H-8413-2014
OI Szabo, Monika/0000-0003-2369-3869; Otting,
   Gottfried/0000-0002-0563-0146; Klein, Christian/0000-0003-3522-9182;
   Pearce, Benjamin/0000-0001-7949-8603
FU Australian Research CouncilAustralian Research Council; Alexander von
   Humbolt FoundationAlexander von Humboldt Foundation; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [KL 1356/3]
FX We thank Professor Rolf Hilgenfeld for valuable comments regarding the
   construct design. C.N. thanks the Alexander von Humbolt Foundation for a
   Feodor-Lynen fellowship. Financial support by the Australian Research
   Council is gratefully acknowledged. C.K. acknowledges support by the
   Deutsche Forschungsgemeinschaft, grant KL 1356/3.
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Apponyi Margit A., 2008, V426, P257, DOI 10.1007/978-1-60327-058-8_16
   Boldescu V., 2017, NAT REV DRU IN PRESS
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804
   Chen WN, 2016, J AM CHEM SOC, V138, P4539, DOI 10.1021/jacs.6b00416
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Graham B, 2011, BIOCONJUGATE CHEM, V22, P2118, DOI 10.1021/bc200353c
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   KAINOSHO M, 1982, BIOCHEMISTRY-US, V21, P6273, DOI 10.1021/bi00267a036
   Kim YH, 2013, 2013 IEEE CONSUMER COMMUNICATIONS AND NETWORKING CONFERENCE (CCNC), P288, DOI 10.1109/CCNC.2013.6488460
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Lim L., 2016, BIORXIV
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w
   Nitsche C, 2017, PROG NUCL MAG RES SP, V98-99, P20, DOI 10.1016/j.pnmrs.2016.11.001
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Ozawa K, 2004, EUR J BIOCHEM, V271, P4084, DOI 10.1111/j.1432-1033.2004.04346.x
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Schmitz C, 2008, J BIOMOL NMR, V41, P179, DOI 10.1007/s10858-008-9249-z
   Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102
   Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Wu PSC, 2007, ANGEW CHEM INT EDIT, V46, P3356, DOI 10.1002/anie.200605237
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 36
TC 28
Z9 28
U1 2
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2017
VL 142
BP 141
EP 147
DI 10.1016/j.antiviral.2017.03.011
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EU7GK
UT WOS:000401203100014
PM 28336347
DA 2020-07-08
ER

PT J
AU Mounce, BC
   Cesaro, T
   Carrau, L
   Vallet, T
   Vignuzzi, M
AF Mounce, Bryan C.
   Cesaro, Teresa
   Carrau, Lucia
   Vallet, Thomas
   Vignuzzi, Marco
TI Curcumin inhibits Zika and chikungunya virus infection by inhibiting
   cell binding
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Curcumin; Enveloped virus; Viral binding
ID APOPTOSIS; ACETYLTRANSFERASE; REPLICATION
AB Several compounds extracted from spices and herbs exhibit antiviral effects in vitro, suggesting potential pharmacological uses. Curcumin, a component of turmeric, has been used as a food additive and herbal supplement due to its potential medicinal properties. Previously, curcumin exhibited antiviral properties against several viruses, including dengue virus and hepatitis C virus, among others. Here, we describe the antiviral effect of curcumin on Zika and chikungunya viruses, two mosquito-borne outbreak viruses. Both viruses responded to treatment of cells with up to 5 pM curumin without impacting cellular viability. We observed that direct treatment of virus with curcumin reduced infectivity of virus in a dose- and time dependent manner for these enveloped viruses, as well as vesicular stomatitis virus. In contrast, we found no change in infectivity for Coxsackievirus B3, a non-enveloped virus. Derivatives of curcumin also exhibited antiviral activity against enveloped viruses. Further examination revealed that curcumin interfered with the binding of the enveloped viruses to cells in a dose-dependent manner, though the integrity of the viral RNA was maintained. Together, these results expand the family of viruses sensitive to curcumin and provide a mechanism of action for curcumin's effect on these enveloped viruses. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Mounce, Bryan C.; Cesaro, Teresa; Carrau, Lucia; Vallet, Thomas; Vignuzzi, Marco] Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, 25-28 Rue Dr Roux, Paris, France.
   [Carrau, Lucia] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France.
   [Cesaro, Teresa] Catholic Univ Louvain, de Duve Inst, VIRO B1-74-07,74 Ave Hippocrate, B-1200 Brussels, Belgium.
RP Vignuzzi, M (corresponding author), Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, 25-28 Rue Dr Roux, Paris, France.
EM marco.vignuzzi@pasteur.fr
OI Vignuzzi, Marco/0000-0002-4400-771X; Mounce, Bryan/0000-0003-1710-5362
FU Laboratoire d'Excellence "Integrative Biology of Emerging Infectious
   Diseases" [ANR-10-LABX-62-IBEID]; Institut Pasteur Defeat Dengue
   Program; Erasmus + Unipharma-Graduates Program
FX This work was supported by Laboratoire d'Excellence "Integrative Biology
   of Emerging Infectious Diseases" (grant no ANR-10-LABX-62-IBEID to
   B.C.M. and M.V.), Institut Pasteur Defeat Dengue Program (to B.C.M. and
   M.V.), and Erasmus + Unipharma-Graduates Program (to T.C.).
CR Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Anggakusuma, 2014, GUT, V63, P1137, DOI 10.1136/gutjnl-2012-304299
   Chen TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062482
   Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002
   Devassy JG, 2015, NUTR REV, V73, P155, DOI 10.1093/nutrit/nuu064
   Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Jaruga E, 1998, EXP CELL RES, V245, P303, DOI 10.1006/excr.1998.4225
   Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019
   Kumari N, 2015, DRUG DES DEV THER, V9, P5051, DOI 10.2147/DDDT.S86558
   Kuo ML, 1996, BBA-MOL BASIS DIS, V1317, P95, DOI 10.1016/S0925-4439(96)00032-4
   Kurita T, 2013, ANTICANCER RES, V33, P2807
   Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028
   Lv YL, 2014, ENVIRON TOXICOL PHAR, V37, P1140, DOI 10.1016/j.etap.2014.04.017
   MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Narayanan A, 2012, J BIOL CHEM, V287, P33198, DOI 10.1074/jbc.M112.356535
   Padilla L, 2014, ARCH VIROL, V159, P573, DOI 10.1007/s00705-013-1849-6
   Samaha HS, 1997, CANCER RES, V57, P1301
   Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916
   Shome S., 2016, J PHARM PHARM
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Si XN, 2007, J VIROL, V81, P3142, DOI 10.1128/JVI.02028-06
   SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 27
TC 51
Z9 52
U1 4
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2017
VL 142
BP 148
EP 157
DI 10.1016/j.antiviral.2017.03.014
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EU7GK
UT WOS:000401203100015
PM 28343845
OA Other Gold
DA 2020-07-08
ER

PT J
AU Tian, CR
   Ruan, SG
AF Tian, Canrong
   Ruan, Shigui
TI A free boundary problem for Aedes aegypti mosquito invasion
SO APPLIED MATHEMATICAL MODELLING
LA English
DT Article
DE Mosquito invasion; Advection-reaction-diffusion model; Free boundary;
   Travelling wave
ID TRAVELING-WAVES; FEVER; MODEL; DISEASE; RISK; ZIKA
AB An advection-reaction-diffusion model with free boundary is proposed to investigate the invasive process of Aedes aegypti mosquitoes. By analyzing the free boundary problem, we show that there are two main scenarios of invasive regime: vanishing regime or spreading regime, depending on a threshold in terms of model parameters. Once the mortality rate of the mosquito becomes large with a small specific rate of maturation, the invasive mosquito will go extinct. By introducing the definition of asymptotic spreading speed to describe the spreading front, we provide an estimate to show that the boundary moving speed cannot be faster than the minimal traveling wave speed. By numerical simulations, we consider that the mosquitoes invasive ability and wind driven advection effect on the boundary moving speed. The greater the mosquito invasive ability or advection, the larger the boundary moving speed. Our results indicate that the mosquitoes asymptotic spreading speed can be controlled by modulating the invasive ability of winged mosquitoes. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Tian, Canrong] Yancheng Inst Technol, Dept Basic Sci, Yancheng 224003, Jiangsu, Peoples R China.
   [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33146 USA.
RP Ruan, SG (corresponding author), Univ Miami, Dept Math, Coral Gables, FL 33146 USA.
EM tiancanrong@163.com; ruan@math.miami.edu
RI Ruan, Shigui/AAF-9165-2020; Tian, Canrong/I-1755-2019
OI Ruan, Shigui/0000-0002-6348-8205; Tian, Canrong/0000-0002-4380-8160
FU Overseas Study Program of Talent Young Teachers of Jiangsu Province;
   NSFNational Science Foundation (NSF) [DMS-1412454]
FX The authors would like to thank the handling editor and three anonymous
   reviewers for their helpful comments and suggestions. Research of the
   first author (CT) was supported by the Overseas Study Program of Talent
   Young Teachers of Jiangsu Province. Research of the second author (SR)
   was partially supported by NSF grant DMS-1412454.
CR Ahn I, 2016, APPL MATH MODEL, V40, P7082, DOI 10.1016/j.apm.2016.02.038
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carbajo AE, 2001, TROP MED INT HEALTH, V6, P170, DOI 10.1046/j.1365-3156.2001.00693.x
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Du YH, 2010, SIAM J MATH ANAL, V42, P377, DOI 10.1137/090771089
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Ge J, 2015, J DIFFER EQUATIONS, V259, P5486, DOI 10.1016/j.jde.2015.06.035
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guo JS, 2012, J DYN DIFFER EQU, V24, P873, DOI 10.1007/s10884-012-9267-0
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Lei CX, 2014, J DIFFER EQUATIONS, V257, P145, DOI 10.1016/j.jde.2014.03.015
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Lin Z.G., 2016, ARXIV160601987
   Lin ZG, 2007, NONLINEARITY, V20, P1883, DOI 10.1088/0951-7715/20/8/004
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   PAO CV, 1995, J MATH ANAL APPL, V195, P702, DOI 10.1006/jmaa.1995.1384
   Petrovskii S, 2005, B MATH BIOL, V67, P637, DOI 10.1016/j.bulm.2004.09.003
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Smith HL, 2010, INTRO DELAY DIFFEREN
   Stefanescu R, 2009, LECT NOTES COMPUT SC, V5434, P548
   Takahashi LT, 2005, B MATH BIOL, V67, P509, DOI 10.1016/j.bulm.2004.08.005
   Tarboush AK, 2017, SCI CHINA MATH, V60, P841, DOI 10.1007/s11425-016-0367-4
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vasconcelos PFC, 1999, WHO DENGUE B NEW DEL, V23, P55
   Wang MD, 2015, J ENG-JOE, P1, DOI 10.1049/joe.2015.0043
   WHO, 1998, DENG HEM FEV DIAGN T
   World Health Organization Dengue and dengue hemorrhagic fever, 2002, DENGUE DENGUE HEMORR
NR 33
TC 14
Z9 15
U1 2
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0307-904X
EI 1872-8480
J9 APPL MATH MODEL
JI Appl. Math. Model.
PD JUN
PY 2017
VL 46
BP 203
EP 217
DI 10.1016/j.apm.2017.01.050
PG 15
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications; Mechanics
SC Engineering; Mathematics; Mechanics
GA EY1RC
UT WOS:000403742000013
OA Bronze
DA 2020-07-08
ER

PT J
AU Schwartz, DA
AF Schwartz, David A.
TI Viral infection, proliferation, and hyperplasia of Hofbauer cells and
   absence of inflammation characterize the placental pathology of fetuses
   with congenital Zika virus infection
SO ARCHIVES OF GYNECOLOGY AND OBSTETRICS
LA English
DT Review
DE Placenta; Zika; Infection; Microcephaly; Pathology; Virus
ID TRANSMISSION; PREGNANCY; AUTOPSY; TYPE-1
AB Attention is increasingly focused on the potential mechanism(s) for Zika virus infection to be transmitted from an infected mother to her fetus. This communication addresses current evidence for the role of the placenta in vertical transmission of the Zika virus.
   Placentas from second and third trimester fetuses with confirmed intrauterine Zika virus infection were examined with routine staining to determine the spectrum of pathologic changes. In addition, immunohistochemical staining for macrophages and nuclear proliferation antigens was performed. Viral localization was identified using RNA hybridization. These observations were combined with the recent published results of placental pathology to increase the strength of the pathology data. Results were correlated with published data from experimental studies of Zika virus infection in placental cells and chorionic villous explants.
   Placentas from fetuses with congenital Zika virus infection are concordant in not having viral-induced placental inflammation. Special stains reveal proliferation and prominent hyperplasia of placental stromal macrophages, termed Hofbauer cells, in the chorionic villi of infected placentas. Zika virus infection is present in Hofbauer cells from second and third trimester placentas. Experimental studies and placentae from infected fetuses reveal that the spectrum of placental cell types infected with the Zika virus is broader during the first trimester than later in gestation.
   Inflammatory abnormalities of the placenta are not a component of vertical transmission of the Zika virus. The major placental response in second and third trimester transplacental Zika virus infection is proliferation and hyperplasia of Hofbauer cells, which also demonstrate viral infection.
C1 [Schwartz, David A.] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA.
RP Schwartz, DA (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA.
EM davidalanschwartz@gmail.com
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Backe E, 1994, TROPHOBLAST RES, V8, P271
   Backe Eva, 1993, Placenta, V14, pA3, DOI 10.1016/S0143-4004(05)80471-0
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, DOI [10.3201/eid2303, DOI 10.3201/EID2303]
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Lora J, 1993, P AM SOC TROP MED HY
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schwartz DA, 1997, ARCH PATHOL LAB MED, V121, P776
   Schwartz DA, 1996, CLIN INFECT DIS, V23, P248, DOI 10.1093/clinids/23.2.248
   SCHWARTZ DA, 1995, AM J PATHOL, V147, P1525
   SCHWARTZ DA, 1992, ARCH PATHOL LAB MED, V116, P21
   Schwartz DA, 2000, J INFECT DIS, V182, P1652, DOI 10.1086/317634
   Schwartz DA, 2016, PATHOLOGY HELPS UNDE
   SCHWARTZ DA, 1994, TROPHOBLAST RES, V8, P223
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Sheridan MA, 2017, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS.1616097114
   STLOUIS ME, 1993, JAMA-J AM MED ASSOC, V269, P2853, DOI 10.1001/jama.269.22.2853
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   Van Dyke RB, 1999, J INFECT DIS, V179, P319, DOI 10.1086/314580
   Vicenzi E, 2017, 1 INT C ZIK VIR WASH
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
NR 35
TC 31
Z9 31
U1 0
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0932-0067
EI 1432-0711
J9 ARCH GYNECOL OBSTET
JI Arch. Gynecol. Obstet.
PD JUN
PY 2017
VL 295
IS 6
BP 1361
EP 1368
DI 10.1007/s00404-017-4361-5
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EU9DI
UT WOS:000401337700007
PM 28396992
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Petric, M
   Lalic, B
   Ducheyne, E
   Djurdjevic, V
   Petric, D
AF Petric, M.
   Lalic, B.
   Ducheyne, E.
   Djurdjevic, V.
   Petric, D.
TI Modelling the regional impact of climate change on the suitability of
   the establishment of the Asian tiger mosquito (Aedes albopictus) in
   Serbia
SO CLIMATIC CHANGE
LA English
DT Article
ID CALIFORNIA; CULICIDAE; DIPTERA
AB The Asian tiger mosquito, Aedes albopictus, is one of the world's most dangerous invasive species. It has vector competence for a wide range of arboviruses such as chikungunya, dengue, Zika and Rift Valley fever viruses. The vector originated in Asia but has recently spread to the temperate regions of Europe and North America. Further spread to the north and the east and a shift to higher altitudes could be expected as a result of climate change. This makes modelling the regional climatic suitability for the establishment of A. albopictus in na < ve regions a pressing issue. The future suitability and subsequent seasonal activity of the vector were investigated using three mechanistic models, with climatic data from the Eta Belgrade University-Princeton Ocean Model regional climate model. The results showed that after a slight decrease in suitability for the first part of the century, most of Serbia would become significantly more suitable for the establishment of A. albopictus. This is due to the simulated rise in seasonal and annual temperatures by the end of the twenty-first century. This study allows for the incorporation of regional heterogeneity in vector modelling. The spatial resolution of the maps obtained from a regional analysis is much higher than that acquired by a global model, allowing for detailed risk assessment and planning of surveillance focused on the habitats where the main introduction routes and climatic suitability are coupled. This work should be applied to all countries in the region with the risk of introduction or further spread of A. albopictus.
C1 [Petric, M.] Univ Novi Sad, Dept Phys, Fac Sci, Trg Dositeja Obradov 3, Novi Sad 21000, Serbia.
   [Lalic, B.] Univ Novi Sad, Dept Field & Vegetable Crops, Fac Agr, Trg Dositeja Obradov 8, Novi Sad 21000, Serbia.
   [Ducheyne, E.] Avia GIS, Risschotlei 33, B-2980 Zoersel, Belgium.
   [Djurdjevic, V.] Univ Belgrade, Inst Meteorol, Fac Phys, Dobracina 16, Belgrade 11000, Serbia.
   [Petric, D.] Univ Novi Sad, Lab Med & Vet Entomol, Fac Agr, Trg Dositeja Obradov 8, Novi Sad 21000, Serbia.
RP Petric, M (corresponding author), Univ Novi Sad, Dept Phys, Fac Sci, Trg Dositeja Obradov 3, Novi Sad 21000, Serbia.
EM petricmina9@gmail.com
FU Ministry of Education and Science of the Republic of Serbia [III 43007];
   ECDC/EFSA
FX The research described in the present paper was partly undertaken as a
   part of the project "Studying climate change and its influence on the
   environment: impacts, adaptation and mitigation" (III 43007) financed by
   the Ministry of Education and Science of the Republic of Serbia and
   ECDC/EFSA. Furthermore, the authors would like to acknowledge the
   contribution of the EurNegVec COST Action TD1303.
CR Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   CGIAR, 2008, SRTM 90M DIG EL DAT
   Dettinger MD, 2004, CLIMATIC CHANGE, V62, P283, DOI 10.1023/B:CLIM.0000013683.13346.4f
   ECDC, 2007, CHIK IT JOINT ECDC W
   ECDC, 2006, CONS CHIK RISK ASS E
   European Centre for Disease Prevention and Control (ECDC), 2009, DEV AED ALB RISK MAP
   Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008
   FORSYTHE WC, 1995, ECOL MODEL, V80, P87, DOI 10.1016/0304-3800(94)00034-F
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Jungclaus, 2006, J CLIMATOL, V19, P3952, DOI [10.1175/JCLI3827.1, DOI 10.1175/JCLI3827.1]
   Klobucar A, 2006, J AM MOSQUITO CONTR, V22, P147, DOI 10.2987/8756-971X(2006)22[147:FROAAI]2.0.CO;2
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Koch LK, 2016, PARASITOL RES, V115, P957, DOI 10.1007/s00436-015-4822-3
   Linden VD, 2009, ENSEMLBES CLIMATE CH
   Madon MB, 2003, J AM MOSQUITO CONTR, V19, P297
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Petric D, 2012, INT S CURR TRENDS PL
   Petric D, 2001, S SERB ENT 2001 ENT
   Petrovic V, 2016, TRAVEL MED INFECT DI, V14, P60, DOI 10.1016/j.tmaid.2016.01.001
   Piani C, 2010, THEOR APPL CLIMATOL, V99, P187, DOI 10.1007/s00704-009-0134-9
   Rajkovic B, 2012, ADV ENV MODELING MEA, P23
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Roeckner, 2003, MPI REPORT, V349, P1, DOI [10.1029/2010JD014036, DOI 10.1029/2010JD014036]
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   Savic, 2015, DIROFILARIOSIS LEISH
   Scholte Ernst-Jan, 2007, European Mosquito Bulletin, V22, P5
   SHROYER DA, 1986, J AM MOSQUITO CONTR, V2, P424
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 30
TC 10
Z9 10
U1 1
U2 42
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-0009
EI 1573-1480
J9 CLIMATIC CHANGE
JI Clim. Change
PD JUN
PY 2017
VL 142
IS 3-4
BP 361
EP 374
DI 10.1007/s10584-017-1946-8
PG 14
WC Environmental Sciences; Meteorology & Atmospheric Sciences
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences
GA EV0RS
UT WOS:000401452700005
DA 2020-07-08
ER

PT J
AU Minhas, AM
   Nayab, A
   Iyer, S
   Narmeen, M
   Fatima, K
   Khan, MS
   Constantin, J
AF Minhas, Abdul M.
   Nayab, Asra
   Iyer, Shobana
   Narmeen, Mehek
   Fatima, Kaneez
   Khan, Muhammad S.
   Constantin, Jonathan
TI Association of Zika Virus with Myocarditis, Heart Failure, and
   Arrhythmias: A Literature Review
SO CUREUS
LA English
DT Review
DE cardiovascular complications; zika virus
ID DENGUE; EMERGENCE
AB As the concerns regarding Zika virus (ZIKV) are mostly of neurological disorders, especially in neonates and infants, other possible threats of the virus may have been overlooked. Our study focuses on the potential threat that ZIKV may pose to the heart like that of similar arboviral diseases. We conducted a literature search of multiple terms in March 2017 using the search engines, PubMed, Embase, and SCOPUS. Articles were then reviewed by two independent reviewers, adhering strictly to our review criteria. No discriminations were made whether the studies were conducted on human or non-human subjects. Three relevant studies were shortlisted and finalized. The nature of the studies is as follows: prospective observational multicenter study (n = 9), case report (n = 1), and animal studies (n = 5). The studies suggested an association between cardiovascular complications and ZIKV in the acute phase of the infection. We recognize the limitations of our study owing to the paucity of the sample size of our literature review. However, the significant findings have also proved the dire need to conduct more research to further back the possibility of ZIKV's influence on the cardiac cells. Closely studying these associations can eventually help develop a vaccine for ZIKV in the near future.
C1 [Minhas, Abdul M.; Iyer, Shobana] Orange Pk Med Ctr, Internal Med, Orange Pk, FL 32073 USA.
   [Nayab, Asra] Orange Pk Med Ctr, Radiol, Orange Pk, FL USA.
   [Narmeen, Mehek; Fatima, Kaneez] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan.
   [Khan, Muhammad S.] John H Stroger J Hosp Cook Cty, Internal Med, Chicago, IL USA.
   [Constantin, Jonathan] Orange Pk Med Ctr, Cardiol, Orange Pk, FL USA.
RP Minhas, AM (corresponding author), Orange Pk Med Ctr, Internal Med, Orange Pk, FL 32073 USA.
EM abdulmannan331@hotmail.com
RI Khan, Shahzeb/AAN-1515-2020
CR Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burt CC, 2009, BJA EDUC, V9, P44, DOI 10.1093/bjaceaccp/mkp005
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joob B, 2016, ANATOL J CARDIOL, V16, P455, DOI 10.14744/AnatolJCardiol.2016.7140
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray JS, 2017, J SPEC PEDIATR NURS, V22, DOI 10.1111/jspn.12164
   OBEYESEKERE I, 1973, AM HEART J, V85, P186, DOI 10.1016/0002-8703(73)90459-6
   Peh AEK, 2013, BIOSENS BIOELECTRON, V42, P391, DOI 10.1016/j.bios.2012.10.054
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 33
TC 9
Z9 9
U1 0
U2 1
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD JUN
PY 2017
VL 9
IS 6
AR UNSP e1399
DI 10.7759/cureus.1399
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA HE7MQ
UT WOS:000453622200099
PM 28856072
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Liu, LE
   Dehning, M
   Phipps, A
   Swienton, RE
   Harris, CA
   Klein, KR
AF Liu, Liang E.
   Dehning, Meaghan
   Phipps, Ashley
   Swienton, Ray E.
   Harris, Curtis A.
   Klein, Kelly R.
TI Clinical Update on Dengue, Chikungunya, and Zika: What We Know at the
   Time of Article Submission
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE dengue; Zika; chikungunya; clinical update; mosquito
ID UNITED-STATES; VIRUS; TRANSMISSION; TRAVELERS; OUTBREAK; BURDEN; FEVER
AB Objective: Mosquito-borne diseases pose a threat to individual health and population health on both a local and a global level. The threat is even more exaggerated during disasters, whether manmade or environmental. With the recent Zika virus outbreak, it is important to highlight other infections that can mimic the Zika virus and to better understand what can be done as public health officials and health care providers.
   Methods: This article reviews the recent literature on the Zika virus as well as chikungunya virus and dengue virus.
   Results: The present findings give a better understanding of the similarities and differences between the 3 infections in terms of their characteristics, clinical presentation, diagnosis methodology, and treatment and what can be done for prevention. Additionally, the article highlights a special population that has received much focus in the latest outbreak, the pregnant individual.
   Conclusion: Education and training are instrumental in controlling the outbreak, and early detection can be lifesaving.
C1 [Liu, Liang E.; Dehning, Meaghan; Phipps, Ashley] Parkland Hlth & Hosp Syst, Dept Emergency Med, Dallas, TX USA.
   [Swienton, Ray E.; Klein, Kelly R.] Univ Texas Med Ctr, Dept Emergency Med, Div Emergency & Disaster Global Hlth, 5323 Harry Hines Blvd MC 8890, Dallas, TX 75390 USA.
   [Harris, Curtis A.] Univ Georgia, Inst Disaster Management, Coll Publ Hlth, Athens, GA 30602 USA.
RP Klein, KR (corresponding author), Univ Texas Med Ctr, Dept Emergency Med, Div Emergency & Disaster Global Hlth, 5323 Harry Hines Blvd MC 8890, Dallas, TX 75390 USA.
EM Kelly.Klein@utsouthwestern.edu
RI amsalu, ribka/G-8780-2019
OI Liu, E. Liang/0000-0003-3273-9021
CR Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bettadapura J, 2013, INDIAN J MED RES, V138, P762
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280
   Centers for Disease Control and Prevention, CLIN GUID DENG VIR
   Centers for Disease Control and Prevention, AB ZIK
   Centers for Disease Control and Prevention, CHIK VIR
   Centers for Disease Control and Prevention, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, IS IT CHIK DENG
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Centers for Disease Control and Prevention United States Geological Survey, DENG VIR DAT CDC USG
   Centers for Disease Control and Prevention United States Geological Survey, CDC USGS DIS MAPS 20
   Centres for Disease Control and Prevention, DENGUE
   Chen LH, 2012, CURR OPIN INFECT DIS, V25, P523, DOI 10.1097/QCO.0b013e328356ffd5
   Christofferson RC, 2016, AM J TROP MED HYG, V15
   Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184
   Gerardin P, 2008, PLOS MED, V18, P3
   Gopakumar H, 2012, J CLIN NEONATOL, V1, P155, DOI 10.4103/2249-4847.101704
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 1991, HUNTERS TROPICAL MED, P981
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nemes Z, 2004, EMERG INFECT DIS, V10, P1880, DOI 10.3201/eid1010.040464
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Shepherd SM, DENGUE
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   VONALLMEN SD, 1979, AM J TROP MED HYG, V28, P1040, DOI 10.4269/ajtmh.1979.28.1040
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   World Health Organization, DENG SEV DENG
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, FACT SHEET WORLD MAL
NR 45
TC 6
Z9 6
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD JUN
PY 2017
VL 11
IS 3
BP 290
EP 299
DI 10.1017/dmp.2016.144
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FA7WM
UT WOS:000405658100004
PM 27572514
OA Bronze
DA 2020-07-08
ER

PT J
AU Weber, DS
   Alroy, KA
   Scheiner, SM
AF Weber, Diana S.
   Alroy, Karen A.
   Scheiner, Samuel M.
TI Phylogenetic Insight into Zika and Emerging Viruses for a Perspective on
   Potential Hosts
SO ECOHEALTH
LA English
DT Editorial Material
DE Flavivirus; Zika; Hosts; Phylogenetic associations; Emerging viruses;
   Arthropod vectors; Reservoirs
ID ZOONOTIC DISEASE; WILD PRIMATES; SPECIFICITY; PATTERNS; HUMANS
AB Global viral diversity is substantial, but viruses that contribute little to the public health burden or to agricultural damage receive minimal attention until a seemingly unimportant virus becomes a threat. The Zika virus (ZIKV) illustrated this, as there was limited information and awareness of the virus when it was identified as a public health emergency in February 2016. Predicting which virus may pose a future threat is difficult. This is in part because significant knowledge gaps in the basic biology and ecology of an emerging virus can impede policy development, delay decision making, and hinder public health action. We suggest using a phylogenetic framework of pathogens and their infected host species for insight into which animals may serve as reservoirs. For example, examining flaviviruses closely related to ZIKV, the phylogenetic framework indicates New World monkeys are the most likely candidates to be potential reservoirs for ZIKV. Secondarily, mammals that are in close proximity to humans should be considered because of the increased opportunity for pathogen exchange. The increase in human-mediated environmental change is accelerating the probability of another previously overlooked virus becoming a significant concern. By investing in basic science research and organizing our knowledge into an evolutionary framework, we will be better prepared to respond to the next emerging infectious disease.
C1 [Weber, Diana S.] Amer Assoc Advancement Sci, S&T Policy Fellowship, 1200 New York Ave NW, Washington, DC 20005 USA.
   [Alroy, Karen A.; Scheiner, Samuel M.] Natl Sci Fdn, Div Environm Biol, 4201 Wilson Blvd, Arlington, VA 22230 USA.
RP Weber, DS (corresponding author), Amer Assoc Advancement Sci, S&T Policy Fellowship, 1200 New York Ave NW, Washington, DC 20005 USA.
EM diana.weber@gmail.com
RI Scheiner, Samuel M./A-4320-2009
OI Scheiner, Samuel M./0000-0003-1677-9752
FU AAAS Science & Technology at the National Science Foundation
FX This work was done by DSW as an activity supported by an AAAS Science &
   Technology Policy Fellowship served at the National Science Foundation.
   This work was done by KAA during off NSF duty time. This work was done
   by SMS while serving at the US National Science Foundation. The views
   expressed in this paper do not necessarily reflect those of the National
   Science Foundation, the United States Government, or the American
   Association for the Advancement of Science.
CR Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138900
   Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Azarian T, 2015, INFECT CONT HOSP EP, V36, P777, DOI 10.1017/ice.2015.73
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Favoretto S, 2016, BIORXIV
   Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007
   Haydon DT, 2002, EMERG INFECT DIS, V8, P1468
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kuhn JH, 2010, ARCH VIROL, V155, P445, DOI 10.1007/s00705-010-0600-9
   Levinson J, 2013, EMERG INFECT DIS, V19, P743, DOI 10.3201/eid1905.121042
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pedersen AB, 2005, INT J PARASITOL, V35, P647, DOI 10.1016/j.ijpara.2005.01.005
   Simmonds P., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003
   The International Committee on Taxonomy of Viruses, 2012, VIRUS TAXONOMY CLASS
   Woolhouse MEJ, 2013, MICROBIOL SPECTR, V1, DOI 10.1128/microbiolspec.OH-0001-2012
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   Zhao GP, 2007, PHILOS T R SOC B, V362, P1063, DOI 10.1098/rstb.2007.2034
NR 23
TC 4
Z9 4
U1 2
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD JUN
PY 2017
VL 14
IS 2
BP 214
EP 218
DI 10.1007/s10393-017-1237-x
PG 5
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA EY7FD
UT WOS:000404153600006
PM 28421292
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zucker, J
   Neu, N
   Chiriboga, CA
   Hinton, VJ
   Leonardo, M
   Sheikh, A
   Thakur, K
AF Zucker, Jason
   Neu, Natalie
   Chiriboga, Claudia A.
   Hinton, Veronica J.
   Leonardo, Marc
   Sheikh, Arif
   Thakur, Kiran
TI Zika Virus-Associated Cognitive Impairment in Adolescent, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB Incidence of neurologic manifestations associated with Zika virus infection has been increasing. In 2016, neuropsychological and cognitive changes developed in an adolescent after travel to a Zika virus-endemic area. Single-photon emission computed tomography and neuropsychological testing raised the possibility that Zika virus infection may lead to neuropsychiatric and cognitive symptoms.
C1 [Zucker, Jason] Columbia Univ, Med Ctr, Adult & Pediat Infect Dis, New York, NY USA.
   [Neu, Natalie; Chiriboga, Claudia A.; Hinton, Veronica J.; Sheikh, Arif; Thakur, Kiran] Columbia Univ, Med Ctr, 622 West 168th St,PH4 West 474, New York, NY 10032 USA.
RP Zucker, J (corresponding author), Columbia Univ, Med Ctr, 622 West 168th St,PH4 West 474, New York, NY 10032 USA.
EM jz2700@cumc.columbia.edu
RI Zucker, Jason/H-7241-2019; Sheikh, Arif/AAI-3622-2020
OI Zucker, Jason/0000-0001-6987-6412; Hinton, Veronica/0000-0003-2196-2631
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; National Institutes
   of Health trainingUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32 AI007531]
FX K.T., who helped edit the manuscript, is a World Health Organization
   consultant on neurologic manifestations in the context of the Zika virus
   outbreak, receives an honorarium as chief consult editor on Zika virus
   for Medscape consults, and participates in Zika research through the
   Neuroviruses Emerging in the Americas Study. K.T. receives funding
   support from the National Institutes of Health, and J.Z. receives
   funding support from a National Institutes of Health training grant (T32
   AI007531).
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
NR 5
TC 8
Z9 8
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2017
VL 23
IS 6
BP 1047
EP 1048
DI 10.3201/eid2306.162029
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EW1OB
UT WOS:000402259100037
PM 28518023
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ozkurt, Z
   Tanriverdi, EC
AF Ozkurt, Zulal
   Tanriverdi, Esra Cinar
TI Global Alert: Zika Virus-an Emerging Arbovirus
SO EURASIAN JOURNAL OF MEDICINE
LA English
DT Review
DE Zika virus; Flavivirus; microcephaly; Guillain-Barre Syndrome; aedes;
   arbovirus
ID BIRTH-DEFECTS; TRANSMISSION; BRAZIL; INFECTION; OUTBREAK; INFANTS;
   EPIDEMIOLOGY; STATES; BRAIN; SEMEN
AB Zika virus (ZIKV) is an arbovirus of the Flavivirus genus, and it has an envelope and a single RNA molecule. In early 2016, the World Health Organization declared ZIKV infection to be an emerging global health threat. The major transmission route of the virus to humans is Aedes mosquitoes. ZIKV can be transmitted between humans by transplacental, perinatal, and sexual routes and via blood and body fluids. ZIKV infection usually results in a mild and self-limiting disease with low-grade fever, conjunctivitis, and periorbital edema. Neurological complications such as Guillain-Barre syndrome, meningoencephalitis, acute disseminated encephalomyelitis, acute myelitis, and transverse myelitis have been reported during ZIKV infection. Intrauterine and congenital ZIKV infections have strong teratogenic effects on the fetus. Intrauterine or congenital ZIKV infection can lead to microcephaly, ocular anomalies (such as macular atrophy, pigment mottling, and optic nerve anomalies), and cardiac anomalies (such as atrial or ventricular septal defect). Calcification in the brain between the cortical and subcortical areas, ventriculomegaly, cerebellar hypoplasia, corpus callosum hypoplasia, cortical/subcortical atrophy, delayed myelination, enlarged cisterna magna, and craniofacial disproportion have been reported as brain development defects. ZIKV infection usually results in a mild disease, and it does not require specific therapy. However, complications of infection during the early period of life are serious. Thus, many drugs have been investigated, and vaccine development studies have been conducted to prevent ZIKV infection. Vector control and personal protection from mosquito-borne transmission are important for decreasing the prevalence of ZIKV infection. In particular, pregnant residents or travelers to endemic areas should be carefully protected against mosquito-borne transmission.
C1 [Ozkurt, Zulal] Ataturk Univ, Dept Infect Dis, Sch Med, Erzurum, Turkey.
   [Tanriverdi, Esra Cinar] Ataturk Univ, Dept Med Educ, Sch Med, Erzurum, Turkey.
RP Ozkurt, Z (corresponding author), Ataturk Univ, Dept Infect Dis, Sch Med, Erzurum, Turkey.
EM zulalozkurt@atauni.edu.tr
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EURO SURVEILL, V21
   FRIEDRICH M, 2017, JAMA, V317, P246
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D., 2014, EURO SURVEILL, V19
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46772
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2017, NAT MED
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Vannice KS, 2016, VACCINE
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura L. O., 2017, J AAPOS
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wu J, 2016, CHINESE MED J-PEKING, V129, P2347, DOI 10.4103/0366-6999.190672
   Yepez JB, 2017, JAMA OPHTHALMOL
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zare Mehrjardi M, 2017, JPN J RADIOL
   Zika Virus Microcephaly Guillain-Barre Syndrome, 2016, 3 WHO
NR 66
TC 10
Z9 10
U1 1
U2 13
PU AVES
PI SISLI
PA BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY
SN 1308-8734
EI 1308-8742
J9 EURASIAN J MED
JI Eurasian J. Med.
PD JUN
PY 2017
VL 49
IS 2
BP 142
EP 147
DI 10.5152/eurasianjmed.2017.17147
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA EX9NF
UT WOS:000403584100013
PM 28638259
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcia, M
   Wehbe, M
   Leveque, N
   Bodet, C
AF Garcia, Magali
   Wehbe, Michel
   Leveque, Nicolas
   Bodet, Charles
TI Skin innate immune response to flaviviral infection
SO EUROPEAN CYTOKINE NETWORK
LA English
DT Review
DE flavivirus; inflammation; signalling pathway; RIG-I; TLR3; MDA5
ID WEST-NILE-VIRUS; TOLL-LIKE RECEPTOR; PLASMACYTOID DENDRITIC CELLS;
   INTERFERON REGULATORY FACTOR-3; DERMAL ENDOTHELIAL-CELLS;
   TUMOR-NECROSIS-FACTOR; DOUBLE-STRANDED-RNA; KILLER T-CELLS; RIG-I;
   DENGUE VIRUS
AB Skin is a complex organ and the largest interface of the human body exposed to numerous stress and pathogens. Skin is composed of different cell types that together perform essential functions such as pathogen sensing, barrier maintenance and immunity, at once providing the first line of defense against microbial infections and ensuring skin homeostasis. Being inoculated directly through the epidermis and the dermis during a vector blood meal, emerging Dengue, Zika and West Nile mosquito-borne viruses lead to the initiation of the innate immune response in resident skin cells and to the activation of dendritic cells, which migrate to the draining lymph node to elicit an adaptive response. This literature review aims to describe the inflammatory response and the innate immune signalization pathways involved in human skin cells during Dengue, Zika and West Nile virus infections.
C1 [Garcia, Magali; Wehbe, Michel; Leveque, Nicolas; Bodet, Charles] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytoki EA 4331, Poitiers, France.
   [Garcia, Magali; Leveque, Nicolas] CHU Poitiers, Lab Virol & Mycobacteriol, Poitiers, France.
RP Bodet, C (corresponding author), Univ Poitiers, LITEC EA 4331, B36 1 Rue Georges Bonnet,TSA 51106, F-86073 Poitiers 9, France.
EM charles.bodet@univ-poitiers.fr
RI Garcia, Magali/AAF-1828-2020; Bodet, Charles/Z-4585-2019
OI Bodet, Charles/0000-0002-8016-0324; Garcia, Magali/0000-0001-6611-8683
CR Akira S, 2006, CURR TOP MICROBIOL, V311, P1
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Arnold SJ, 2004, VIROLOGY, V324, P286, DOI 10.1016/j.virol.2004.03.036
   Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416
   Bustos-Arriaga J, 2016, IMMUNOL RES, V64, P392, DOI 10.1007/s12026-015-8675-8
   Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420
   Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chu YT, 2015, IMMUNOLOGY, V146, P163, DOI 10.1111/imm.12492
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Cumberbatch M, 1997, IMMUNOLOGY, V92, P388, DOI 10.1046/j.1365-2567.1997.00360.x
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012
   Di Sabatino D, 2014, BIOMED RES INT, DOI 10.1155/2014/907852
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gasque P, 2015, J INFECTION, V71, P413, DOI 10.1016/j.jinf.2015.06.006
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hoover LI, 2014, VIRUSES-BASEL, V6, P1424, DOI 10.3390/v6031424
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Johnston LJ, 1996, J VIROL, V70, P4761, DOI 10.1128/JVI.70.7.4761-4766.1996
   Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020
   Kovats S, 2016, CLIN EXP IMMUNOL, V186, P214, DOI 10.1111/cei.12850
   Krow-Lucal E, 2017, MMWR-MORBID MORTAL W, V66, P51, DOI 10.15585/mmwr.mm6602a3
   Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527
   Kulka M, 2006, J LEUKOCYTE BIOL, V79, P339, DOI 10.1189/jlb.1004600
   KURANE I, 1992, ARCH VIROL, V124, P21, DOI 10.1007/BF01314622
   Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229
   Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001
   Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530
   Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Manokaran G, 2015, SCIENCE
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moser LA, 2016, J VIROL, V90, P292, DOI 10.1128/JVI.02280-15
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x
   Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622
   O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Proost P, 2003, EUR J IMMUNOL, V33, P3146, DOI 10.1002/eji.200324136
   Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Rawle DJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0279-3
   Renn CN, 2006, J IMMUNOL, V177, P298, DOI 10.4049/jimmunol.177.1.298
   Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107
   Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008
   Schmid ET, 2016, ELIFE, V5, DOI 10.7554/eLife.12414
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018
   Shipley JG, 2012, VIROLOGY, V432, P232, DOI 10.1016/j.virol.2012.06.009
   Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Surasombatpattana P, 2012, J INVEST DERMATOL, V132, P2103, DOI 10.1038/jid.2012.76
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Suthar MS, 2012, IMMUNITY, V37, P235, DOI 10.1016/j.immuni.2012.07.004
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Tamagawa-Mineoka R, 2015, J DERMATOL SCI, V77, P93, DOI 10.1016/j.jdermsci.2014.10.003
   Taweechaisupapong Suwimol, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P664
   Troupin A, 2016, J IMMUNOL, V197, P4382, DOI 10.4049/jimmunol.1600846
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0
   Westaway EG, 1999, VIROLOGY, V258, P108, DOI 10.1006/viro.1999.9683
   WHO, 2008, SCI WORK GROUP REP D
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yu N, 2009, J DERMATOL SCI, V56, P113, DOI 10.1016/j.jdermsci.2009.08.003
   Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611
NR 120
TC 12
Z9 12
U1 1
U2 9
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
EI 1952-4005
J9 EUR CYTOKINE NETW
JI Eur. Cytokine Netw.
PD JUN
PY 2017
VL 28
IS 2
BP 41
EP 51
DI 10.1684/ecn.2017.0394
PG 11
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA FE5EV
UT WOS:000408235700001
PM 28840835
OA Bronze
DA 2020-07-08
ER

PT J
AU Lim, SK
   Lim, JK
   Yoon, IK
AF Lim, Sl-Ki
   Lim, Jacqueline Kyungah
   Yoon, In-Kyu
TI An Update on Zika Virus in Asia
SO INFECTION AND CHEMOTHERAPY
LA English
DT Review
DE Zika; Asia; Congenital Zika syndrome; Guillain-Barre syndrome
ID INFECTION; TRANSMISSION; ARBOVIRUSES; CAMBODIA
AB Zika virus (ZIKV) was first isolated in Asia from mosquitoes from Malaysia in 1966. However, the incidence of Zika and Zika-related neurological complications in Asia is not well known. The few studies of Zika in Asia have been inconsistent in pointing to likely transmission levels, with some studies suggesting substantial transmission and others not. Interpretation of existing epidemiological and public health data from Asia is constrained by the non-specific symptomatology of Zika, the high proportion of subclinical ZIKV infections, relatively low viremia, and the lack of accurate serological assays. Here, we update the status of Zika cases from countries in Asia, and highlight some key knowledge gaps. In particular, accurate determinations of the incidence of Zika-related congenital Zika syndrome should be a priority for Zika research in Asia. Additional information will be critical to make informed strategies for the prevention and control of this global public health threat.
C1 [Lim, Sl-Ki; Lim, Jacqueline Kyungah; Yoon, In-Kyu] Int Vaccine Inst, 1 Gwanak Ro, Seoul 08826, South Korea.
RP Yoon, IK (corresponding author), Int Vaccine Inst, 1 Gwanak Ro, Seoul 08826, South Korea.
EM inkyu.yoon@ivi.int
OI Yoon, In-Kyu/0000-0001-5077-6470
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2017, ABS CBN NEWS    0203
   [Anonymous], EM ZIK SIT REP
   [Anonymous], PRO EDR ZIK VIR 11 A
   [Anonymous], 2016, OUTBREAK NEWS T 1031
   Asia & Pacific Edition, CAMB CONF 1 CAS ZIK
   Asia & Pacific Edition, VIETN REP 232 ZIK IN
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Butt AM, 2016, LANCET GLOB HEALTH, V4, pE913, DOI 10.1016/S2214-109X(16)30246-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Dyer O, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5577
   Embassy of Japan in Singapore, ZIK VIR INF JAP
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Institute Pasteur du Laos, ARB SURV
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kindhauser MK, ZIKA ORIGIN SPREAD M
   Korean Centers for Disease Control and Prevention (KCDC), 2017, 18 CAS ZIK VIR INF W
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169256
   Liu L, 2017, INFECT GENET EVOL, V48, P40, DOI 10.1016/j.meegid.2016.10.023
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Ministry of Health, 1 CAS LOC TRANSM ZIK
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   National Environment Agency, ZIK CAS CLUST NUMB Z
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   ProMed-mail, PRO MBDS ZIK VIR CHI
   ProMed-mail, PRO AH EDR ZIK VIR 2
   ProMed-mail, PRO SOAS ZIK VIR 02
   ProMed-mail, 2017, ZIK VIR 08 AM AS RES
   ProMed-mail, PRO MBDS ZIK VIR THA
   ProMed-mail, PRO EDR ZIK VIR IND
   ProMed-mail, PRO EDR ZIK VIR JAP
   ProMed-mail, PRO SOAS ZIK VIR 13
   ProMed-mail, PRO MBDS ZIK VIR MYA
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Singapore Zika Study Group, 2017, LANCET INFECT DIS
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Taiwan National Infectious Disease Statistics System, ZIK VIR INF NAT IND
   Tam M, MALAYSIAS 8 ZIKA CAS
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337
   Tsang H, CHINADAILY ASIA
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization (WHO), EM SIT REP ZIK VIR M
   World Health Organization (WHO), EM PREP RESP ZIK VIR
   Xiang B, 2017, J INFECTION, V74, P328, DOI 10.1016/j.jinf.2017.01.004
   Yun SI, 2016, GENOME ANNOUNC, V4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
NR 81
TC 36
Z9 36
U1 2
U2 2
PU KOREAN SOC CHEMOTHERAPY
PI SEOUL
PA 806, SEOCHO TOWN TRAPALACE, 23 SEOCHO-DAERO 74-GIL, SEOCHO-GU, SEOUL,
   06621, SOUTH KOREA
SN 2093-2340
EI 2092-6448
J9 INFECT CHEMOTHER
JI Infect. Chemother.
PD JUN
PY 2017
VL 49
IS 2
BP 91
EP 100
DI 10.3947/ic.2017.49.2.91
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA FJ1PZ
UT WOS:000412491200001
PM 28681575
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Arevalo, JF
   Yepez, JB
   Murati, FA
   Pettito, M
   Penaranda, C
   De Yepez, L
   Maestre, G
AF Arevalo, J. Fernando
   Yepez, Juan B.
   Murati, Felipe A.
   Pettito, Michele
   Penaranda, Carlos
   De Yepez, Lazmin
   Maestre, Gladys
TI Ocular Features of Zika Virus in Infants with Microcephaly in Colombia
   and Venezuela
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Arevalo, J. Fernando] Johns Hopkins Univ, Wilmer Eye Inst, Retina Div, Baltimore, MD 21218 USA.
   [Arevalo, J. Fernando] Johns Hopkins Bayview Med Ctr, Ophthalmol, Baltimore, MD USA.
   [Yepez, Juan B.; Murati, Felipe A.; Pettito, Michele; De Yepez, Lazmin] Clin Ojos Maracaibo, Maracaibo, Venezuela.
   [Penaranda, Carlos] Clin Oftalmol Penaranda, Cucuta, Colombia.
   [Maestre, Gladys] Univ Texas Rio Grande Valley Sch Med, Biomed Sci, Brownsville, TX USA.
RI Aracena, Javier/AAN-4562-2020
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 3605
PG 2
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176301179
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kalatzis, V
   Erkilic, N
   Damodar, K
   Moles, JP
   Fourrier-Wirth, C
   Nagot, N
   Van de Perre, P
   Simonin, Y
   Salinas, S
AF Kalatzis, Vasiliki
   Erkilic, Nejla
   Damodar, Krishna
   Moles, Jean-Pierre
   Fourrier-Wirth, Chantal
   Nagot, Nicolas
   Van de Perre, Philippe
   Simonin, Yannick
   Salinas, Sara
TI ZIKA virus efficiently replicates in human retinal pigment epithelium
   and disturbs its permeability
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Kalatzis, Vasiliki; Erkilic, Nejla; Damodar, Krishna] INSERM, U1051, Montpellier, France.
   [Moles, Jean-Pierre; Nagot, Nicolas; Van de Perre, Philippe; Simonin, Yannick; Salinas, Sara] INSERM, UMR1058, Montpellier, France.
   [Fourrier-Wirth, Chantal] Etab Francais Sang, Montpellier, France.
RI Van de Perre, Philippe/B-9692-2008
OI Van de Perre, Philippe/0000-0002-3912-0427
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 3629
PG 2
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176301203
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Singh, PK
   Guest, JM
   Kanwar, M
   Boss, J
   Gao, N
   Abrams, GW
   Yu, FX
   Kumar, A
AF Singh, Pawan Kumar
   Guest, John-Michael
   Kanwar, Mamta
   Boss, Joseph
   Gao, Nan
   Abrams, Gary W.
   Yu, Fushin X.
   Kumar, Ashok
TI Zika Virus Causes Chorioretinal Atrophy in Mouse Eyes and Infects
   Primary Human Cells Lining the Blood-Retinal Barrier
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Singh, Pawan Kumar; Guest, John-Michael; Kanwar, Mamta; Boss, Joseph; Gao, Nan; Abrams, Gary W.; Yu, Fushin X.; Kumar, Ashok] Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA.
   [Singh, Pawan Kumar; Yu, Fushin X.; Kumar, Ashok] Wayne State Univ, Sch Med, Anat & Cell Biol, Detroit, MI USA.
FU RPB Unrestricted Grant
FX Support RPB Unrestricted Grant to Kresge eye Institute.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 2992
PG 3
WC Ophthalmology
SC Ophthalmology
GA GF7TE
UT WOS:000432170307262
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Ventura, LO
   Lawrence, L
   Miller, MT
AF Ventura, Camila V.
   Ventura, Liana O.
   Lawrence, Linda
   Miller, Marilyn T.
TI Congenital Zika Syndrome: Visual Impairment in Children with Ocular and
   Neurological Findings
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Ventura, Camila V.; Ventura, Liana O.] Altino Ventura Fdn, Ophthalmol, Miami, FL USA.
   [Ventura, Camila V.] Bascom Palmer Eye Inst, Ophthalmol, Miami, FL 33136 USA.
   [Miller, Marilyn T.] Univ Illinois, Ophthalmol, Chicago, IL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 4717
PG 2
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176304042
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zin, A
   Rosseto, J
   Tsui, I
   Zin, O
   Silveira, J
   Vasconcelos, Z
   Moreira, MEL
AF Zin, Andrea
   Rosseto, Julia
   Tsui, Irena
   Zin, Olivia
   Silveira, Joel
   Vasconcelos, Zilton
   Lopes Moreira, Maria Elisabeth
TI Prescription of overplus of+3.00 D to Infants with Severe Visual
   Impairment due to Congenital Zika Virus Syndrome
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Zin, Andrea; Rosseto, Julia; Silveira, Joel; Vasconcelos, Zilton; Lopes Moreira, Maria Elisabeth] Fernandes Figueira Inst, Clin Res Unit, Rio De Janeiro, RJ, Brazil.
   [Tsui, Irena] Jules Stein Eye Inst, Ophthalmol, Los Angeles, CA 90024 USA.
   [Zin, Olivia] Hosp Fed Servidores Estado, Ophthalmol, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 4673
PG 2
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176303417
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rahman, MT
AF Rahman, Md Tanvir
TI Chikungunya virus infection in developing countries - What should we do?
SO JOURNAL OF ADVANCED VETERINARY AND ANIMAL RESEARCH
LA English
DT Review
DE Chikungunya fever; Dengue; Diagnosis; Epidemiology; Vaccine; Zika;
   Zoonoses
AB Chikungunya fever, a serious global public health problem, is a mosquito-bome disease caused by Chikungunya virus belonging to the family Togaviridae. The virus was first detected in Tanzania in 1953. At present, the virus has been detected over 60 countries across the globe. The virus is transmitted mainly through Aedes mosquitoes. Although not fatal, the affected persons suffer a lot from high fever, severe pain and other complications. Currently there is no effective treatment or vaccine for the Chikungunya virus. The situation is severe in developing countries that lack sufficient diagnostic facilities and control measures. Adequate coordinated efforts comprising active surveillance, early detection, vector control and public awareness at local, national and international level need to be adopted in endemic areas for the effective control of Chikungunya virus infection. This mini review highlights some of the advances recently have made in our understanding of Chikungunya virus.
C1 [Rahman, Md Tanvir] Bangladesh Agr Univ, Fac Vet Sci, Dept Microbiol & Hyg, Mymensingh 2202, Bangladesh.
RP Rahman, MT (corresponding author), Bangladesh Agr Univ, Fac Vet Sci, Dept Microbiol & Hyg, Mymensingh 2202, Bangladesh.
EM tanvirahman@bau.edu.bd
OI Rahman, Dr.Md.Tanvir/0000-0001-5432-480X
CR Adam A, 2016, VECTOR-BORNE ZOONOT, V16, P290, DOI 10.1089/vbz.2015.1897
   Adebajo Adewale O., 1996, Current Opinion in Rheumatology, V8, P85, DOI 10.1097/00002281-199601000-00015
   Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   Beltran-Silva SL, 2016, REV MED HOSP GEN MEX
   Bettadapura J, 2013, INDIAN J MED RES, V138, P762
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Capinha C, 2014, ECOHEALTH, V11, P420, DOI 10.1007/s10393-014-0918-y
   Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169
   Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169
   Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5, DOI 10.4103/0255-0857.38850
   Chowdhury F. I., 2012, Journal of Medicine, V13, P60
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   Derraik JGB, 2010, AM J TROP MED HYG, V83, P755, DOI 10.4269/ajtmh.2010.10-0123
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Faruque LI, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2239-6
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Hassan Rashedul, 2014, J Med Case Rep, V8, P67, DOI 10.1186/1752-1947-8-67
   Hoque MS, 2012, DS CHILD HJ, V28, P115
   Islam Mohammad Nazrul, 2011, J IMA, V43, P58, DOI 10.5915/43-2-7871
   Khatun S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003907
   Khormi HM, 2014, GEOSPAT HLTH, P405
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Mathew AJ, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0680-7
   Murugan SB, 2016, ASIAN PAC J TROP MED, V9, P910, DOI 10.1016/j.apjtm.2016.07.020
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Pun SB, 2014, J INFECT DEV COUNTR, V8, P790, DOI 10.3855/jidc.3701
   ROBINSON M. C., 1955, TANGANYIKA TERRITORY IN 1952 53 I TRANS ROY SOC TROP MED AND HYG, V49, P28, DOI 10.1016/0035-9203(55)90080-8
   Roques P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.83527
   Schwartz O, 2016, NATURE REV MICROBIOL, V8, P491
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   Taylor A, 2017, MBIO, V8, DOI 10.1128/mBio.01970-16
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   2013, EMERG INFECT DIS, V19, P1681, DOI DOI 10.3201/EID1910.130453
   2012, EMERG INFECT DIS, V18, P2066, DOI DOI 10.3201/EID1812.120471
NR 38
TC 1
Z9 1
U1 0
U2 0
PU NETWORK VETERINARIANS BANGLADESH
PI MYMENSINGH
PA FAC VETERINARY SCIENCE, BANGLADESH AGRICULTURAL UNIV, MYMENSINGH, 2202,
   BANGLADESH
EI 2311-7710
J9 J ADV VET ANIM RES
JI J. Adv. Vet. Anim. Res.
PD JUN
PY 2017
VL 4
IS 2
BP 125
EP 131
DI 10.5455/javar.2017.d211
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA VI2XY
UT WOS:000468277100002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kang, S
   Odom, OW
   Thangamani, S
   Herrin, DL
AF Kang, Seongjoon
   Odom, Obed W.
   Thangamani, Saravanan
   Herrin, David L.
TI Toward mosquito control with a green alga: expression of Cry toxins of
   Bacillus thuringiensis subsp. israelensis (Bti) in the chloroplast of
   Chlamydomonas
SO JOURNAL OF APPLIED PHYCOLOGY
LA English
DT Article
DE Green algae; Bacillus thuringiensis subsp israelensis; Chlamydomonas;
   Crytoxins; Mosquitocontrol; West Nile; Zika
ID GENE-EXPRESSION; LARVICIDAL ACTIVITY; ANOPHELES-GAMBIAE; AMINO-ACID;
   REINHARDTII; PROTEIN; LARVAE; PEPTIDE; STRAIN
AB We are developing Chlamydomonas strains that can be used for safe and sustainable control of mosquitoes, because they produce proteins from Bacillus thuringiensis subsp. israelensis (Bti) in the chloroplast. Chlamydomonas has a number of advantages for this approach, including genetic controls that are not generally available with industrial algae. The Bti toxin has been used for mosquito control for > 30 years and does not engender resistance; it contains three Cry proteins, Cry4Aa (135 kDa), Cry4Ba (128 kDa) and Cry11Aa (72 kDa), and Cyt1Aa (25 kDa). To express the Cry proteins in the chloroplast, the three genes were resynthesized and cry4Aa was truncated to the first 700 amino acids (cry4Aa (700) ); also, since they can be toxic to host cells, the inducible Cyc6:Nac2-psbD expression system was used. Western blots of total protein from the chloroplast transformants showed accumulation of the intact polypeptides, and the relative expression level was Cry11Aa > Cry4Aa(700) > Cry4Ba. Quantitative western blots with purified Cry11Aa as a standard showed that Cry11Aa accumulated to 0.35% of the total cell protein. Live cell bioassays in dH(2)0 demonstrated toxicity of the cry4Aa (700) and cry11Aa transformants to larvae of Aedes aegypti and Culex quinquefasciatus. These results demonstrate that the Cry proteins that are most toxic to Aedes and Culex mosquitoes, Cry4Aa and Cry11Aa, can be successfully expressed in the chloroplast of Chlamydomonas.
C1 [Kang, Seongjoon; Odom, Obed W.; Herrin, David L.] Univ Texas Austin, Dept Mol Biosci, 205 W 24th St STOP A6700, Austin, TX 78712 USA.
   [Kang, Seongjoon; Herrin, David L.] Pond Life Technol LLC, Cedar Pk, TX 78613 USA.
   [Thangamani, Saravanan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Herrin, DL (corresponding author), Univ Texas Austin, Dept Mol Biosci, 205 W 24th St STOP A6700, Austin, TX 78712 USA.; Herrin, DL (corresponding author), Pond Life Technol LLC, Cedar Pk, TX 78613 USA.
EM herrin@utexas.edu
RI Herrin, David/M-1372-2019; Thangamani, Saravanan/E-7371-2010
OI Thangamani, Saravanan/0000-0002-4269-5993
FU Bill and Melinda Gates FoundationGates Foundation [OPP1024635]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R41-AI115854A]
FX We are grateful to Dr. Jean-David Rochaix for providing the Ind41_18
   strain and BEI Resources (NIAID) for Culex quinquefasciatus. This work
   was supported by the Bill and Melinda Gates Foundation (grant OPP1024635
   to DLH) and the National Institutes of Health (grant R41-AI115854A to
   DLH).
CR ANGSUTHANASOMBAT C, 1989, APPL ENVIRON MICROB, V55, P2428, DOI 10.1128/AEM.55.9.2428-2430.1989
   ANGSUTHANASOMBAT C, 1992, FEMS MICROBIOL LETT, V94, P63, DOI 10.1111/j.1574-6968.1992.tb05290.x
   Ben-Dov E, 2003, J APPL ENTOMOL, V127, P146, DOI 10.1046/j.1439-0418.2003.00732.x
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   BOYNTON JE, 1993, METHOD ENZYMOL, V217, P510
   Braun-Galleani S, 2015, BIOTECHNOL J, V10, P1289, DOI 10.1002/biot.201400566
   Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006
   Chen HC, 2013, PLANT BIOTECHNOL J, V11, P818, DOI 10.1111/pbi.12073
   DEBARJAC H, 1990, BACTERIAL CONTROL MO
   Deist BR, 2014, TOXINS, V6, P3005, DOI 10.3390/toxins6103005
   DELECLUSE A, 1993, APPL ENVIRON MICROB, V59, P3922
   Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5
   FINNEY DL, 1977, PROBIT ANAL
   Fischer N, 1996, MOL GEN GENET, V251, P373, DOI 10.1007/s004380050179
   Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x
   GLARE TR, 2000, BACILLUS THURINGIENS
   GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665
   HARRIS EH, 1989, CHLAMYDOMONAS SOURCE
   Ibrahim MA, 2013, EXP BIOL MED, V238, P350, DOI 10.1177/1535370213477973
   Juntadech T., 2012, Advances in Bioscience and Biotechnology, V3, P362, DOI 10.4236/abb.2012.34052
   Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619
   Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2
   Khasdan V, 2003, FEMS MICROBIOL LETT, V227, P189, DOI 10.1016/S0378-1097(03)00679-7
   Kioulos I, 2014, PEST MANAG SCI, V70, P623, DOI 10.1002/ps.3595
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   KUMAR A., 2013, MALARIA WORLD J, V4, P1, DOI DOI 10.1038/NC0MMS3618
   Kwon T, 2014, METHODS MOL BIOL, V1123, P77, DOI 10.1007/978-1-62703-968-0_6
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAIRD M, 1988, NATURAL HIST LARVAL
   LIU YT, 1993, J INVERTEBR PATHOL, V62, P131, DOI 10.1006/jipa.1993.1088
   MARTEN GG, 1986, J TROP MED HYG, V89, P213
   Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100
   MEMON AR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P11, DOI 10.1016/0167-4889(93)90070-6
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   NEWMAN SM, 1990, GENETICS, V126, P875
   NEWMAN SM, 1992, GENETICS, V132, P413
   Nickelsen J, 1999, PLANT CELL, V11, P957, DOI 10.1105/tpc.11.5.957
   Odom OW, 2001, MOL CELL BIOL, V21, P3472, DOI 10.1128/MCB.21.10.3472-3481.2001
   OHANA B, 1987, APPL ENVIRON MICROB, V53, P828, DOI 10.1128/AEM.53.4.828-831.1987
   Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219
   Purton S, 2013, RUSS J PLANT PHYSL+, V60, P491, DOI 10.1134/S1021443713040146
   Quinn JM, 1998, METHOD ENZYMOL, V297, P263
   Raghava GPS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-59
   Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x
   SOLTESRAK E, 1995, MOL GEN GENET, V246, P301, DOI 10.1007/BF00288602
   STEVENS SE, 1994, J APPL PHYCOL, V6, P187, DOI 10.1007/BF02186072
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   Surzycki R, 2007, P NATL ACAD SCI USA, V104, P17548, DOI 10.1073/pnas.0704205104
   Surzycki R, 2009, BIOLOGICALS, V37, P133, DOI 10.1016/j.biologicals.2009.02.005
   Tetreau G, 2012, APPL ENVIRON MICROB, V78, P5189, DOI 10.1128/AEM.00903-12
   van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009
   Wang Y., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0110024
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6
   Wu XQ, 1997, APPL ENVIRON MICROB, V63, P4971, DOI 10.1128/AEM.63.12.4971-4974.1997
   YOSHIDA K, 1989, AGR BIOL CHEM TOKYO, V53, P2121, DOI 10.1080/00021369.1989.10869622
   Zaritsky Arieh, 2010, Bioeng Bugs, V1, P341, DOI 10.4161/bbug.1.5.13087
   Zedler JAZ, 2015, J APPL PHYCOL, V27, P2271, DOI 10.1007/s10811-014-0504-2
NR 58
TC 5
Z9 5
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-8971
EI 1573-5176
J9 J APPL PHYCOL
JI J. Appl. Phycol.
PD JUN
PY 2017
VL 29
IS 3
BP 1377
EP 1389
DI 10.1007/s10811-016-1008-z
PG 13
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA EV0KU
UT WOS:000401429300025
PM 28713202
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Chia, PY
   Sen Yew, H
   Ho, H
   Chow, A
   Sadarangani, SP
   Chan, M
   Kam, YW
   Chong, CY
   Thoon, KC
   Yung, CF
   Li, JH
   Lye, DC
   De, PP
   Ng, LFP
   Yeo, TW
   Leo, YS
AF Chia, Po Ying
   Sen Yew, Haur
   Ho, Hanley
   Chow, Angela
   Sadarangani, Sapna P.
   Chan, Monica
   Kam, Yiu Wing
   Chong, Chia Yin
   Thoon, Koh Cheng
   Yung, Chee Fu
   Li, Jia Hui
   Lye, David C.
   De, Partha Pratim
   Ng, Lisa F. P.
   Yeo, Tsin Wen
   Leo, Yee Sin
TI Clinical features of patients with Zika and dengue virus co-infection in
   Singapore
SO JOURNAL OF INFECTION
LA English
DT Letter
ID CHIKUNGUNYA VIRUS
C1 [Chia, Po Ying; Sen Yew, Haur; Sadarangani, Sapna P.; Chan, Monica; Lye, David C.; Yeo, Tsin Wen; Leo, Yee Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Moulmein Rd, Singapore 308433, Singapore.
   [Sen Yew, Haur; Chow, Angela; Sadarangani, Sapna P.; Chan, Monica; Lye, David C.; Yeo, Tsin Wen; Leo, Yee Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, 11 Mandalay Rd, Singapore 308232, Singapore.
   [Ho, Hanley; Chow, Angela] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Clin Epidemiol, Moulmein Rd, Singapore 308433, Singapore.
   [Kam, Yiu Wing; Ng, Lisa F. P.] Singapore Immunol Network SIgN 8A Biomed Grove, Agcy Sci Technol & Res A STAR, Singapore Immunol Network, Immunos Bldg,Level 4, Singapore 138648, Singapore.
   [Chong, Chia Yin; Thoon, Koh Cheng; Yung, Chee Fu; Li, Jia Hui] KK Womens & Children Hosp, Dept Paediat, 100 Bukit Timah Rd, Singapore 229899, Singapore.
   [De, Partha Pratim] Tan Tock Seng Hosp, Lab Med, Clin Microbiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
RP Leo, YS (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.; Yeo, TW (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Lee Kong Chian Sch Med, 60 Nanyang Ave 04n-15, Singapore 637551, Singapore.
EM yeotsinwen@ntu.edu.sg; yee_sin_leo@ttsh.com.sg
RI Yeo, Tsin Wen/F-9505-2015; Chia, Po Ying/AAN-9657-2020
OI Chia, Po Ying/0000-0002-8797-9527; Lye, David/0000-0003-0324-0205; , Yiu
   Wing/0000-0002-8360-9537; Sadarangani, Sapna/0000-0002-8781-0713; Ng,
   Lisa/0000-0003-4071-5222
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Yap S-HL Grace, 2016, ENB Q, V42, P3
NR 10
TC 11
Z9 11
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUN
PY 2017
VL 74
IS 6
BP 611
EP 615
DI 10.1016/j.jinf.2017.03.007
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA EY5MJ
UT WOS:000404021000010
PM 28344113
OA Bronze
DA 2020-07-08
ER

PT J
AU Uraki, R
   Jurado, KA
   Hwang, J
   Szigeti-Buck, K
   Horvath, TL
   Iwasaki, A
   Fikrig, E
AF Uraki, Ryuta
   Jurado, Kellie Ann
   Hwang, Jesse
   Szigeti-Buck, Klara
   Horvath, Tamas L.
   Iwasaki, Akiko
   Fikrig, Erol
TI Fetal Growth Restriction Caused by Sexual Transmission of Zika Virus in
   Mice
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; sexual transmission; fetal growth abnormalities; electron
   microscopy
ID MOUSE MODEL; INFECTION; SEMEN; LEADS
AB Zika virus (ZIKV) can be transmitted by mosquito bite or sexual contact. Using mice that lack the type I interferon receptor, we examined sexual transmission of ZIKV. Electron microscopy analyses showed association of virions with developing sperm within testes as well as with mature sperm within epididymis. When ZIKV-infected male mice were mated with naive female mice, the weight of fetuses at embryonic day 18.5 was significantly reduced compared with the control group. Additionally, we found ocular deformities in a minority of the fetuses. These results suggest that ZIKV causes fetal abnormalities after female mating with an infected male.
C1 [Uraki, Ryuta; Hwang, Jesse; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.
   [Jurado, Kellie Ann; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA.
   [Szigeti-Buck, Klara; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT USA.
   [Iwasaki, Akiko; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis,Anlyan Ctr Med Res & Educ, 300 Cedar St, New Haven, CT 06520 USA.
EM erol.fikrig@yale.edu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5T32 AI007019-40,
   4T32HL007974-15, R21AI131284]
FX This work was supported by the National Institutes of Health (5T32
   AI007019-40 to K. A. J.; 4T32HL007974-15 to J. H.; and R21AI131284 to A.
   I.). E. F. and A. I. are investigators within the Howard Hughes Medical
   Institute.
CR Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Purpura LJ, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30330-9
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 15
TC 24
Z9 25
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2017
VL 215
IS 11
BP 1720
EP 1724
DI 10.1093/infdis/jix204
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EX4UO
UT WOS:000403230600015
PM 28472297
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zhou, K
   Wang, L
   Yu, D
   Huang, HY
   Ji, H
   Mo, XM
AF Zhou, Kai
   Wang, Long
   Yu, Di
   Huang, Hesuyuan
   Ji, Hong
   Mo, Xuming
TI Molecular and cellular insights into Zika virus-related neuropathies
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Review
DE Zika virus; Guillain-Barre syndrome; Microcephaly; Neurodevelopment
ID BRAIN; INFECTION; TRANSMISSION; AMERICA; BIOLOGY; PATHOGENESIS;
   ORGANOIDS; BRAZIL
AB Zika virus (ZIKV), a relatively elusive Aedes mosquito-transmitted flavivirus, had been brought into spotlight until recent widespread outbreaks accompanied by unexpectedly severe clinical neuropathies, including fetal microcephaly and Guillain-Barr, syndrome (GBS) in the adult. In this review, we focus on the underlying cellular and molecular mechanisms by which vertically transmitted microorganisms reach the fetus and trigger neuropathies.
C1 [Zhou, Kai; Wang, Long; Yu, Di; Huang, Hesuyuan; Mo, Xuming] Nanjing Med Univ, Childrens Hosp, Dept Cardiothorac Surg, Nanjing 21008, Jiangsu, Peoples R China.
   [Zhou, Kai] Nanjing Med Univ, Childrens Hosp, Dept Infect Dis, Nanjing 21008, Jiangsu, Peoples R China.
   [Ji, Hong] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210008, Jiangsu, Peoples R China.
RP Mo, XM (corresponding author), Nanjing Med Univ, Childrens Hosp, Dept Cardiothorac Surg, Nanjing 21008, Jiangsu, Peoples R China.
EM xuming_mo@126.com
FU Nanjing Science and Technology Commission [201605048]; National Key
   Research and Development Program of China [2016YFC1101001]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81370279, 81370277]
FX The authors apologize to those whose work was not covered in detail
   owing to space restrictions and for inaccuracies or omissions resulting
   from the remarkably rapid pace of discovery in the Zika virus field.
   This work was supported by funding from the Nanjing Science and
   Technology Commission (No. 201605048), the National Key Research and
   Development Program of China (No. 2016YFC1101001), and the National
   Natural Science Foundation of China (Nos. 81370279 and 81370277).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams Waldorf K.M., 2016, NAT MED
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Baronti C, 2014, GENOME ANNOUNC, V2
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P., 2016, LANCET INFECT DIS
   Brasil P., 2016, NEW ENGLAND J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Dowd K.A., 2016, SCIENCE
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li H, 2016, CELL STEM CELL
   Liang Q., 2016, CELL STEM CELL
   Luethy LN, 2016, VIROLOGY, V487, P1, DOI 10.1016/j.virol.2015.09.019
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner J.J., 2016, CELL REP
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Parra B., 2016, NEW ENGLAND J MED
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson T.C., 2016, CELL
   Prisant N., 2016, LANCET INFECT DIS
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sun J, 2016, JAMA OPHTHALMOL
   Suter MA, 2016, NAT REV ENDOCRINOL, V12, P437, DOI 10.1038/nrendo.2016.101
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tabata T, 2016, CELL HOST MICROBE
   Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilsch-Brauninger M, 2016, CURR OPIN NEUROBIOL, V39, P122, DOI 10.1016/j.conb.2016.05.004
   Wollnik B, 2010, NAT GENET, V42, P923, DOI 10.1038/ng1110-923
   Woodworth MB, 2012, CELL, V151, P918, DOI 10.1016/j.cell.2012.10.004
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 70
TC 4
Z9 4
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2017
VL 23
IS 3
BP 341
EP 346
DI 10.1007/s13365-017-0514-3
PG 6
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA EV7FJ
UT WOS:000401940500002
PM 28127671
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Mosquito Control Practices and Zika Knowledge Among Outdoor Construction
   Workers: A Comment
SO JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
LA English
DT Letter
C1 [Joob, Beuy] Sanitat Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Osun, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat1 Med Acad Ctr, Bangkok 10330, Thailand.
EM beuyjoob@hotmail.com
CR Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Rodhain F, 1996, B SOC PATHOL EXOT, V89, P103
   Wiwanitkit S, 2016, ANN TROP MED PUBLIC, V9, P361, DOI 10.4103/1755-6783.190206
NR 3
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1076-2752
EI 1536-5948
J9 J OCCUP ENVIRON MED
JI J. Occup. Environ. Med.
PD JUN
PY 2017
VL 59
IS 6
BP E136
EP E136
DI 10.1097/JOM.0000000000001040
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EX2TQ
UT WOS:000403080200007
PM 28598943
DA 2020-07-08
ER

PT J
AU Moore, KJ
   Qualls, W
   Brennan, V
   Yang, X
   Caban-Martinez, AJ
AF Moore, Kevin J.
   Qualls, Whitney
   Brennan, Victoria
   Yang, Xuan
   Caban-Martinez, Alberto J.
TI Response to Comment on Mosquito Control Practices and Zika Knowledge
   Among Outdoor Construction Workers: A Comment
SO JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
LA English
DT Letter
ID MIAMI-DADE; FLORIDA
C1 [Moore, Kevin J.; Brennan, Victoria; Yang, Xuan; Caban-Martinez, Alberto J.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Qualls, Whitney] Dept State Hlth Serv, Zoonosis Control, Austin, TX USA.
RP Caban-Martinez, AJ (corresponding author), UM Leonard M Miller Sch Med, Dept Publ Hlth Sci, Don Soffer Clin Res Ctr, 1120 NW 14th St,10th Floor R-669,Rm 1025, Miami, FL 33136 USA.
EM acaban@med.miami.edu
RI , J/AAG-1499-2019
OI , J/0000-0002-5960-1308
FU National Institute for Occupational Safety and HealthUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USANational Institute for Occupational Safety & Health
   (NIOSH) [K01OH010485]
FX This study was supported in part by the National Institute for
   Occupational Safety and Health grant K01OH010485.
CR Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Roberts D, 2013, VARIABILITY MEASURED
NR 3
TC 1
Z9 1
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1076-2752
EI 1536-5948
J9 J OCCUP ENVIRON MED
JI J. Occup. Environ. Med.
PD JUN
PY 2017
VL 59
IS 6
BP E137
EP E137
DI 10.1097/JOM.0000000000001039
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EX2TQ
UT WOS:000403080200008
PM 28598944
DA 2020-07-08
ER

PT J
AU Daniel, JFS
   Silva, AA
   Nakagawa, DH
   de Medeiros, LS
   Carvalho, MG
   Tavares, LJ
   Abreu, LM
   Rodrigues, E
AF Daniel, Juliana F. S.
   Silva, Andressa A.
   Nakagawa, Danielle H.
   de Medeiros, Livia S.
   Carvalho, Mario G.
   Tavares, Lucineli J.
   Abreu, Lucas M.
   Rodrigues-Filho, Edson
TI Larvicidal Activity of Beauveria bassiana Extracts against Aedes aegypti
   and Identification of Beauvericins
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE cyclohexadepsipeptides; Dengue; Zika; beauvericins; UHPLC-HRMS/MS
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; VIRULENCE FACTOR;
   METABOLITES; ENNIATIN; FUNGI; BIOSYNTHESIS; GENETICS; MS/MS
AB Beauveria bassiana is an entomopathogenic fungus that has been well known for its capacity to act as biopesticide on various disease vectors. The analysis of organic extracts of strains CG71 and UNI40 led to identification of cyclodepsipeptides beauvericin, beauvericin A or F, beauvericin E and bassianolide by ultra-high pressure liquid chromatography-high resolution mass spectrometry in tandem mode (UHPLC-HRMS/MS). The larvicidal activity on 3(rd) instar of Aedes aegypti revealed LC50 0.9887 and 0.4653 ppm in 24 and 48 hours (CG71 methanolic extract), LC50 0.7834 ppm in 48 hours (CG71 ethyl acetate), LC50 0.7834 and 1.8149 ppm (UNI 40 for ethyl acetate and methanolic extracts, respectively) in 48 hours. These findings highlight the potential of B. bassiana metabolites for controlling the vector of Dengue and Zika diseases.
C1 [Daniel, Juliana F. S.; Silva, Andressa A.; Nakagawa, Danielle H.] Univ Tecnol Fed Parana UTFPR, Dept Quim, Ave Pioneiros 3131, BR-86036370 Londrina, PR, Brazil.
   [de Medeiros, Livia S.; Rodrigues-Filho, Edson] Univ Fed Sao Carlos UFSCar, Dept Quim, CP 676, BR-13565905 Sao Carlos, SP, Brazil.
   [Carvalho, Mario G.; Tavares, Lucineli J.] UFRRJ, ICE, Dept Quim, Rodovia BR 465,Km 7, Seropedica, RJ, Brazil.
   [Abreu, Lucas M.] Univ Fed Vicosa, Dept Fitopatol, BR-36570000 Vicosa, MG, Brazil.
RP Daniel, JFS (corresponding author), Univ Tecnol Fed Parana UTFPR, Dept Quim, Ave Pioneiros 3131, BR-86036370 Londrina, PR, Brazil.
EM julianasouza@utfpr.edu.br
RI Rodrigues-Filho, Edson/M-7657-2019; de Medeiros, Livia
   Soman/M-1115-2015; de Carvalho, Mario/D-8850-2015
OI de Medeiros, Livia Soman/0000-0001-8743-3340; de Carvalho,
   Mario/0000-0001-5805-734X; Algayer da Silva Moretti,
   Andressa/0000-0002-9616-0601
FU International Foundation of Science (IFS)International Foundation for
   Science [2010/F/4898-1]; DIRPPG (Diretoria de Pesquisa e Pos-Graduacao
   of Universidade Tecnologica Federal do Parana, Londrina Campus);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao AraucariaFundacao Araucaria
FX The authors would like to thank Dr Luis Francisco Angeli Alves and Prof
   Dr Pedro Manuel Oliveira Janeiro Neves for the fungal strains, and Prof
   Dr Ludwig H. Pfenning for infrastructure of DNA analyses. The authors
   thank the financial support from International Foundation of Science
   (IFS, grant 2010/F/4898-1) and DIRPPG (Diretoria de Pesquisa e
   Pos-Graduacao of Universidade Tecnologica Federal do Parana, Londrina
   Campus), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) and Fundacao Araucaria for scholarships.
CR Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bunyapaiboonsri T, 2011, PHYTOCHEM LETT, V4, P283, DOI 10.1016/j.phytol.2011.04.018
   Campos FF, 2015, MEM I OSWALDO CRUZ, V110, P65, DOI 10.1590/0074-02760140243
   Castlebury LA, 1999, WORLD J MICROB BIOT, V15, P131, DOI [10.1023/A:1008855406319, 10.1023/A:1008895421989]
   Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6
   Dal Bello GM, 2000, REV TOXICOL, V17, P36
   Daniel JFD, 2007, NAT PROD REP, V24, P1128, DOI 10.1039/b618086h
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   De la Rosa W, 2000, J ECON ENTOMOL, V93, P1409, DOI 10.1603/0022-0493-93.5.1409
   Devreese M, 2013, TALANTA, V106, P212, DOI 10.1016/j.talanta.2012.11.068
   Domsch KH, 2007, COMPENDIUM SOIL FUNG
   El-Elimat T, 2013, J NAT PROD, V76, P1709, DOI 10.1021/np4004307
   Fornelli F, 2004, J INVERTEBR PATHOL, V85, P74, DOI 10.1016/j.jip.2004.01.002
   Fukuda T, 2004, J ANTIBIOT, V57, P117, DOI 10.7164/antibiotics.57.117
   GOETTEL MS, 2005, COMPREHENSIVE MOL IN, V6, P361, DOI DOI 10.1016/B0-44-451924-6/00088-0
   Gonzalez DJ, 2012, J PROTEOMICS, V75, P5069, DOI 10.1016/j.jprot.2012.05.036
   GROVE JF, 1980, MYCOPATHOLOGIA, V70, P103, DOI 10.1007/BF00443075
   GUPTA S, 1991, MYCOPATHOLOGIA, V115, P185, DOI 10.1007/BF00462223
   GUPTA S, 1995, J NAT PRODUCTS, V58, P733, DOI 10.1021/np50119a012
   HAMILL RL, 1969, TETRAHEDRON LETT, P4255
   Herebian D, 2009, J SEP SCI, V32, P939, DOI 10.1002/jssc.200800589
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Isaka M, 2005, ACCOUNTS CHEM RES, V38, P813, DOI 10.1021/ar040247r
   KHACHATOURIANS GG, 1992, J INVERTEBR PATHOL, V59, P212, DOI 10.1016/0022-2011(92)90038-6
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuzma M, 2001, J MASS SPECTROM, V36, P1108, DOI 10.1002/jms.213
   Langenfeld A, 2011, J NAT PROD, V74, P825, DOI 10.1021/np100890n
   LEATHERS TD, 1993, J IND MICROBIOL, V12, P69, DOI 10.1007/BF01569904
   Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092
   Loureiro E. S., 2004, ARQUIVOS I BIOL SAO, V71, P35
   MCINNES AG, 1974, J CHEM SOC CHEM COMM, P281, DOI 10.1039/c39740000281
   Quesada-Moraga E, 2004, MYCOL RES, V108, P441, DOI 10.1017/S0953756204009724
   Rehner SA, 2011, MYCOLOGIA, V103, P1055, DOI 10.3852/10-302
   Roberts D.W., 1992, PESQUI AGROPECU BRAS, V27, P325
   Santoro PH, 2008, J INVERTEBR PATHOL, V97, P83, DOI 10.1016/j.jip.2007.07.009
   Song HH, 2009, FOOD ADDIT CONTAM A, V26, P518, DOI 10.1080/02652030802562904
   STLEGER RJ, 1986, J INVERTEBR PATHOL, V48, P85, DOI 10.1016/0022-2011(86)90146-1
   SUZUKI A, 1977, TETRAHEDRON LETT, P2167, DOI 10.1016/S0040-4039(01)83709-6
   Takahashi S, 1998, J ANTIBIOT, V51, P596, DOI 10.7164/antibiotics.51.596
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Toman P, 2011, MONATSH CHEM, V142, P779, DOI 10.1007/s00706-011-0499-1
   VINING LC, 1962, CAN J MICROBIOL, V8, P931, DOI 10.1139/m62-122
   von Dohren H, 2004, ADV BIOCHEM ENG BIOT, V88, P217, DOI 10.1007/b99262
   Watjen W, 2014, TOXICOL LETT, V231, P9, DOI 10.1016/j.toxlet.2014.08.021
   Wang QG, 2012, MOLECULES, V17, P2367, DOI 10.3390/molecules17032367
   Wu Y., 1999, J BEIJING NORMAL U N, V35, P114
   WULFSON NS, 1965, TETRAHEDRON LETT, P2793
   Xu YQ, 2008, CHEM BIOL, V15, P898, DOI 10.1016/j.chembiol.2008.07.011
   Xu YQ, 2009, FUNGAL GENET BIOL, V46, P353, DOI 10.1016/j.fgb.2009.03.001
NR 51
TC 5
Z9 5
U1 1
U2 14
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD JUN
PY 2017
VL 28
IS 6
BP 1003
EP 1013
DI 10.21577/0103-5053.20160253
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA EV1WK
UT WOS:000401540200010
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McNeil, CJ
   Shetty, AK
AF McNeil, Candice J.
   Shetty, Avinash K.
TI Zika Virus: A Serious Global Health Threat
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Review
DE Zika virus; microcephaly; public health; global health
ID UPDATE INTERIM GUIDANCE; MALE SEXUAL TRANSMISSION; UNITED-STATES;
   PREGNANT-WOMEN; INFECTION; TRAVELERS; OUTBREAK
AB In February 2016, the World Health Organization declared Zika virus (ZIKV) infection a public health emergency of international concern, given the precipitous spread of the virus across the Americas. Unlike arboviruses such as Chikungunya and Dengue, which have also recently emerged in the western hemisphere, ZIKV was identified in communities where concurrent neurologic conditions such as microcephaly and Guillain-Barre (GB) syndrome were occurring at alarming rates. Thus, investigations to systematically evaluate the link between ZIKV, congenital malformations (including microcephaly) and GB syndrome remain a top priority.
C1 [McNeil, Candice J.] Wake Forest Univ, Dept Med, Sch Med, Winston Salem, NC 27157 USA.
   [Shetty, Avinash K.] Wake Forest Univ, Dept Pediat, Sch Med, Winston Salem, NC 27157 USA.
RP McNeil, CJ (corresponding author), Dept Med, Sect Infect Dis, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM cmcneil@wakehealth.edu
RI amsalu, ribka/G-8780-2019
OI Shetty, Avinash/0000-0002-4575-8996
CR [Anonymous], 2016, VECT CONTR OP FRAM Z
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Brasil P, 2016, N ENGL J MED
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, 2016, ZIK VIR PREV
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pan American Health Organization/ World Health Organization, 2016, ZIK EP REP BRAZ SEPT
   Pan American Health Organization/ World Health Organization, 2016, CUM ZIK SUSP CONF CA
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Soares de Souza A, 2016, CLIN INFECT DIS
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   WHO, 2016, PREV SEX TRANSM ZIK
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2016, ASS INF MICR CONT ZI
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 40
TC 3
Z9 3
U1 1
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD JUN
PY 2017
VL 63
IS 3
BP 242
EP 248
DI 10.1093/tropej/fmw080
PG 7
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA EZ1HA
UT WOS:000404459900012
PM 27923889
OA Bronze
DA 2020-07-08
ER

PT J
AU Xin, QL
   Deng, CL
   Chen, X
   Wang, J
   Wang, SB
   Wang, W
   Deng, F
   Zhang, B
   Xiao, GF
   Zhang, LK
AF Xin, Qi-Lin
   Deng, Cheng-Lin
   Chen, Xi
   Wang, Jun
   Wang, Shao-Bo
   Wang, Wei
   Deng, Fei
   Zhang, Bo
   Xiao, Gengfu
   Zhang, Lei-Ke
TI Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host
   Proteins Involved in Zika Virus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; quantitative proteomics; virus-host interaction; ubiquitin
   proteasome system; bortezomib
ID UBIQUITIN-PROTEASOME SYSTEM; IMMUNE-RESPONSE; IDENTIFICATION; PATHWAY;
   CORONAVIRUS; PROVIDES; ENTRY
AB Zika virus (ZIKV) is an emerging arbovirus belonging to the genus Flavivirus of the family Flaviviridae. During replication processes, flavivirus manipulates host cell systems to facilitate its replication, while the host cells activate antiviral responses. Identification of host proteins involved in the flavivirus replication process may lead to the discovery of antiviral targets. The mosquitoes Aedes aegypti and Aedes albopictus are epidemiologically important vectors for ZIKV, and effective restrictions of ZIKV replication in mosquitoes will be vital in controlling the spread of virus. In this study, an iTRAQ-based quantitative proteomic analysis of ZIKV-infected Aedes albopictus C6/36 cells was performed to investigate host proteins involved in the ZIKV infection process. A total of 3,544 host proteins were quantified, with 200 being differentially regulated, among which CHCHD2 can be upregulated by ZIKV infection in both mosquito C6/36 and human HeLa cells. Our further study indicated that CHCHD2 can promote ZIKV replication and inhibit beta interferon (IFN-beta) production in HeLa cells, suggesting that ZIKV infection may upregulate CHCHD2 to inhibit IFN-I production and thus promote virus replication. Bioinformatics analysis of regulated host proteins highlighted several ZIKV infection-regulated biological processes. Further study indicated that the ubiquitin proteasome system (UPS) plays roles in the ZIKV entry process and that an FDA-approved inhibitor of the 20S proteasome, bortezomib, can inhibit ZIKV infection in vivo. Our study illustrated how host cells respond to ZIKV infection and also provided a candidate drug for the control of ZIKV infection in mosquitoes and treatment of ZIKV infection in patients.
   IMPORTANCE ZIKV infection poses great threats to human health, and there is no FDA-approved drug available for the treatment of ZIKV infection. During replication, ZIKV manipulates host cell systems to facilitate its replication, while host cells activate antiviral responses. Identification of host proteins involved in the ZIKV replication process may lead to the discovery of antiviral targets. In this study, the first quantitative proteomic analysis of ZIKV-infected cells was performed to investigate host proteins involved in the ZIKV replication process. Bioinformatics analysis highlighted several ZIKV infection-regulated biological processes. Further study indicated that the ubiquitin proteasome system (UPS) plays roles in the ZIKV entry process and that an FDA-approved inhibitor of the UPS, bortezomib, can inhibit ZIKV infection in vivo. Our study not only illustrated how host cells respond to ZIKV infection but also provided a candidate drug for the control of ZIKV infection in mosquitoes and treatment of ZIKV infection in patients.
C1 [Wang, Wei; Deng, Fei; Xiao, Gengfu; Zhang, Lei-Ke] State Key Lab Virol, Wuhan, Peoples R China.
   [Xin, Qi-Lin; Deng, Cheng-Lin; Wang, Jun; Wang, Shao-Bo; Wang, Wei; Deng, Fei; Zhang, Bo; Xiao, Gengfu; Zhang, Lei-Ke] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China.
   [Chen, Xi] Wuhan Inst Biotechnol, Wuhan, Peoples R China.
   [Chen, Xi] Wuhan Univ, Med Res Inst, Wuhan, Peoples R China.
RP Xiao, GF; Zhang, LK (corresponding author), State Key Lab Virol, Wuhan, Peoples R China.; Xiao, GF; Zhang, LK (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China.
EM xiaogf@wh.iov.cn; zhangleike@wh.iov.cn
OI Wang, Wei/0000-0002-8696-9773
FU Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2016YFC1200400]; Chinese Academy of SciencesChinese
   Academy of Sciences [ZDRW-ZS-2016-4]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [31500144]
FX We acknowledge financial support from the Ministry of Science and
   Technology of China (2016YFC1200400), the Chinese Academy of Sciences
   (ZDRW-ZS-2016-4), and the National Natural Science Foundation of China
   (31500144 to L.-K.Z.).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chai F, 2015, BBA-PROTEINS PROTEOM, V1854, P967, DOI 10.1016/j.bbapap.2015.04.016
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004227
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emmott E, 2014, JOVE-J VIS EXP, DOI 10.3791/51656
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121
   Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021
   Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HY, 2015, PROTEOMICS, V15, P3629, DOI 10.1002/pmic.201500180
   Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200
   Ma-Lauer Y, 2012, CURR OPIN VIROL, V2, P614, DOI 10.1016/j.coviro.2012.09.003
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10
   Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shi PY, 2014, CELL HOST MICROBE, V16, P269, DOI 10.1016/j.chom.2014.08.011
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Troupin A, 2016, BBA-GEN SUBJECTS, V1860, P1898, DOI 10.1016/j.bbagen.2016.05.033
   Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012
   Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839
   Wang SB, 2016, VIROLOGY, V498, P116, DOI 10.1016/j.virol.2016.08.013
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yu GY, 2005, J VIROL, V79, P644, DOI 10.1128/JVI.79.1.644-648.2005
   Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 59
TC 20
Z9 20
U1 1
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2017
VL 91
IS 12
AR UNSP e00554
DI 10.1128/JVI.00554-17
PG 17
WC Virology
SC Virology
GA EW0HH
UT WOS:000402169500026
PM 28404849
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Shan, C
   Muruato, AE
   Nunes, BTD
   Luo, HL
   Xie, XP
   Medeiros, DBA
   Wakamiya, M
   Tesh, RB
   Barrett, AD
   Wang, T
   Weaver, SC
   Vasconcelos, PFC
   Rossi, SL
   Shi, PY
AF Shan, Chao
   Muruato, Antonio E.
   Nunes, Bruno T. D.
   Luo, Huanle
   Xie, Xuping
   Medeiros, Daniele B. A.
   Wakamiya, Maki
   Tesh, Robert B.
   Barrett, Alan D.
   Wang, Tian
   Weaver, Scott C.
   Vasconcelos, Pedro F. C.
   Rossi, Shannan L.
   Shi, Pei-Yong
TI A live-attenuated Zika virus vaccine candidate induces sterilizing
   immunity in mouse models
SO NATURE MEDICINE
LA English
DT Article
ID YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; CD8(+) T-CELLS; RNA REPLICATION;
   PROTECTIVE ROLE; INFECTION; MICE; TRANSCOMPLEMENTATION; TRANSLATION;
   POLYMERASE
AB Zika virus (ZIKV) infection of pregnant women can cause a wide range of congenital abnormalities, including microcephaly, in the infant, a condition now collectively known as congenital ZIKV syndrome(1). A vaccine to prevent or significantly attenuate viremia in pregnant women who are residents of or travelers to epidemic or endemic regions is needed to avert congenital ZIKV syndrome, and might also help to suppress epidemic transmission. Here we report on a live-attenuated vaccine candidate that contains a 10-nucleotide deletion in the 3' untranslated region of the ZIKV genome (10-del ZIKV). The 10-del ZIKV is highly attenuated, immunogenic, and protective in type 1 interferon receptor-deficient A129 mice. Crucially, a single dose of 10-del ZIKV induced sterilizing immunity with a saturated neutralizing antibody titer, which no longer increased after challenge with an epidemic ZIKV, and completely prevented viremia. The immunized mice also developed a robust T cell response. Intracranial inoculation of 1-d-old immunocompetent CD-1 mice with 1 x 10(4) infectious focus units (IFU) of 10-del ZIKV caused no mortality, whereas infections with 10 IFU of wild-type ZIKV were lethal. Mechanistically, the attenuated virulence of 10-del ZIKV may be due to decreased viral RNA synthesis and increased sensitivity to type-1-interferon inhibition. The attenuated 10-del ZIKV was incapable of infecting mosquitoes after oral feeding of spiked-blood meals, representing an additional safety feature. Collectively, the safety and efficacy results suggest that further development of this promising, live-attenuated ZIKV vaccine candidate is warranted.
C1 [Shan, Chao; Nunes, Bruno T. D.; Xie, Xuping; Medeiros, Daniele B. A.; Wakamiya, Maki; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Tesh, Robert B.; Barrett, Alan D.; Weaver, Scott C.; Rossi, Shannan L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Muruato, Antonio E.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
   [Luo, Huanle; Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Tesh, Robert B.; Barrett, Alan D.; Wang, Tian; Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Tesh, Robert B.; Barrett, Alan D.; Wang, Tian; Rossi, Shannan L.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Wang, Tian; Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Vasconcelos, Pedro F. C.] Para State Univ, Dept Pathol, Belem, Para, Brazil.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
EM slrossi@utmb.edu; peshi@utmb.edu
RI amsalu, ribka/G-8780-2019; Xie, Xuping/AAD-7406-2019; Weaver, Scott
   C/D-6490-2011; Vasconcelos, Pedro/AAH-3142-2019
OI Weaver, Scott C/0000-0001-8016-8556; Shan, Chao/0000-0002-3953-3782
FU University of Texas Medical Branch (UTMB) start-up award; UTMB
   Innovation and Commercialization award; University of Texas STARs Award;
   CDC grant for the Western Gulf Center of Excellence for Vector-Borne
   Diseases; Pan American Health Organization [SCON2016-01353]; UTMB
   CTSAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR-001439]; US National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI120942]
FX We thank colleagues at the University of Texas Medical Branch for their
   helpful discussions during the course of this study. We are grateful to
   M.A. Garcia-Blanco and S.S. Brarick for providing lab space and
   equipment during the early stage of this work. P.-Y.S. was supported by
   a University of Texas Medical Branch (UTMB) start-up award, UTMB
   Innovation and Commercialization award, University of Texas STARs Award,
   CDC grant for the Western Gulf Center of Excellence for Vector-Borne
   Diseases, Pan American Health Organization grant SCON2016-01353, and
   UTMB CTSA UL1TR-001439. This research was also partially supported by a
   US National Institutes of Health grant AI120942 to S.C.W.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   BARRETT ADT, 1986, J GEN VIROL, V67, P631, DOI 10.1099/0022-1317-67-4-631
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845
   Khromykh AA, 1999, J VIROL, V73, P9247, DOI 10.1128/JVI.73.11.9247-9255.1999
   Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004
   Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   *WHO, 1987, WHO TECH REP SER, V747, P1
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yun SI, 2016, J GEN VIROL, V97, P2575, DOI 10.1099/jgv.0.000574
NR 36
TC 124
Z9 130
U1 4
U2 54
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JUN
PY 2017
VL 23
IS 6
BP 763
EP +
DI 10.1038/nm.4322
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA EW8KQ
UT WOS:000402768000019
PM 28394328
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wen, JS
   Tang, WW
   Sheets, N
   Ellison, J
   Sette, A
   Kim, K
   Shresta, S
AF Wen, Jinsheng
   Tang, William Weihao
   Sheets, Nicholas
   Ellison, Julia
   Sette, Alessandro
   Kim, Kenneth
   Shresta, Sujan
TI Identification of Zika virus epitopes reveals immunodominant and
   protective roles for dengue virus cross-reactive CD8(+) T cells
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; SEXUAL TRANSMISSION; MOUSE MODEL;
   INFECTION; RESPONSES; MICE; VACCINE; PREGNANCY; CD4(+); REPLICATION
AB CD8(+) T cells play an important role in controlling Flavivirus infection, including Zika virus (ZIKV). Here, we have identified 25 HLA-B* 0702-restricted epitopes and 1 HLA-A* 0101-restricted epitope using interferon (IFN)-gamma enzyme-linked immunospot (ELISPOT) and intracellular cytokine staining (ICS) in ZIKV-infected IFN-alpha/beta receptor-deficient HLA transgenic mice. The cross-reactivity of ZIKV epitopes to dengue virus (DENV) was tested using IFN-gamma-ELISPOT and IFN-gamma-ICS on CD8(+) T cells from DENV-infected mice, and five cross-reactive HLA-B* 0702-binding peptides were identified by both assays. ZIKV/DENV cross-reactive CD8(+) T cells in DENV-immune mice expanded post ZIKV challenge and dominated in the subsequent CD8(+) T cell response. ZIKV challenge following immunization of mice with ZIKV-specific and ZIKV/DENV cross-reactive epitopes elicited CD8(+) T cell responses that reduced infectious ZIKV levels, and CD8(+) T cell depletions confirmed that CD8(+) T cells mediated this protection. These results identify ZIKV-specific and ZIKV/DENV cross-reactive epitopes and demonstrate both an altered immunodominance pattern in the DENV-immune setting relative to naive, as well as a protective role for epitope-specific CD8(+) T cells against ZIKV. These results have important implications for ZIKV vaccine development and provide a mouse model for evaluating anti-ZIKV CD8(+) T cell responses of human relevance.
C1 [Wen, Jinsheng; Tang, William Weihao; Sheets, Nicholas; Ellison, Julia; Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Wen, Jinsheng] Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.
   [Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM sujan@lji.org
FU National Institute of Allergy and Infectious Diseases/National
   Institutes of Health (NIAID/NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [1R01 AI116813];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HHSN272200900042C, HHSN27220140045C];
   La Jolla Institute for Allergy Immunology
FX This research was funded by National Institute of Allergy and Infectious
   Diseases/National Institutes of Health (NIAID/NIH) grant no. 1R01
   AI116813 (S.S.), NIH contracts (nos. HHSN272200900042C and
   HHSN27220140045C, to A.S.) and the La Jolla Institute for Allergy &
   Immunology institutional support (to S.S.).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Huang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22303
   Hunter P, 2002, ONDERSTEPOORT J VET, V69, P95
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, pe2520, DOI [10.1371/journal.pntd.0002520, DOI 10.1371/J0URNAL.PNTD.0002520]
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
NR 50
TC 81
Z9 83
U1 8
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD JUN
PY 2017
VL 2
IS 6
AR 17036
DI 10.1038/nmicrobiol.2017.36
PG 11
WC Microbiology
SC Microbiology
GA FB2VI
UT WOS:000406000900008
PM 28288094
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Quick, J
   Grubaugh, ND
   Pullan, ST
   Claro, IM
   Smith, AD
   Gangavarapu, K
   Oliveira, G
   Robles-Sikisaka, R
   Rogers, TF
   Beutler, NA
   Burton, DR
   Lewis-Ximenez, LL
   de Jesus, JG
   Giovanetti, M
   Hill, SC
   Black, A
   Bedford, T
   Carroll, MW
   Nunes, M
   Alcantara, LC
   Sabino, EC
   Baylis, SA
   Faria, NR
   Loose, M
   Simpson, JT
   Pybus, OG
   Andersen, KG
   Loman, NJ
AF Quick, Joshua
   Grubaugh, Nathan D.
   Pullan, Steven T.
   Claro, Ingra M.
   Smith, Andrew D.
   Gangavarapu, Karthik
   Oliveira, Glenn
   Robles-Sikisaka, Refugio
   Rogers, Thomas F.
   Beutler, Nathan A.
   Burton, Dennis R.
   Lewis-Ximenez, Lia Laura
   de Jesus, Jaqueline Goes
   Giovanetti, Marta
   Hill, Sarah C.
   Black, Allison
   Bedford, Trevor
   Carroll, Miles W.
   Nunes, Marcio
   Alcantara, Luiz Carlos, Jr.
   Sabino, Ester C.
   Baylis, Sally A.
   Faria, Nuno R.
   Loose, Matthew
   Simpson, Jared T.
   Pybus, Oliver G.
   Andersen, Kristian G.
   Loman, Nicholas J.
TI Multiplex PCR method for MinION and Illumina sequencing of Zika and
   other virus genomes directly from clinical samples
SO NATURE PROTOCOLS
LA English
DT Article
ID SURESELECT TARGET ENRICHMENT; REAL-TIME; EBOLA; SURVEILLANCE;
   AMPLIFICATION; EVOLUTION; INSIGHTS; PASSAGES; ROBUST; LASSA
AB Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly from clinical samples (i.e., without isolation and culture) remains challenging for viruses such as Zika, for which metagenomic sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence-complete genomes, comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimized library preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an Internet connection for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences can be achieved in 1-2 d by starting with clinical samples and following a simple laboratory workflow. This method has been successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in the Americas. The protocol can be used to sequence other viral genomes using the online Primal Scheme primer designer software. It is suitable for sequencing either RNA or DNA viruses in the field during outbreaks or as an inexpensive, convenient method for use in the lab.
C1 [Quick, Joshua; Smith, Andrew D.; Loman, Nicholas J.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Grubaugh, Nathan D.; Gangavarapu, Karthik; Robles-Sikisaka, Refugio; Rogers, Thomas F.; Beutler, Nathan A.; Burton, Dennis R.; Andersen, Kristian G.] Scripps Res Inst, La Jolla, CA 92037 USA.
   [Pullan, Steven T.; Carroll, Miles W.; Andersen, Kristian G.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Oliveira, Glenn; Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA USA.
   [Rogers, Thomas F.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Lewis-Ximenez, Lia Laura] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [de Jesus, Jaqueline Goes; Giovanetti, Marta; Alcantara, Luiz Carlos, Jr.] Fiocruz MS, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Rome, Tor Vergata, Italy.
   [Hill, Sarah C.; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Black, Allison; Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Black, Allison] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Carroll, Miles W.] Univ Southampton, South Gen Hosp, Southampton, Hants, England.
   [Nunes, Marcio] Inst Evandro Chagas, Belem, Para, Brazil.
   [Baylis, Sally A.] Paul Ehrlich Inst, Langen, Germany.
   [Loose, Matthew] Univ Nottingham, Sch Life Sci, DeepSeq, Nottingham, England.
   [Simpson, Jared T.] OICR, Toronto, ON, Canada.
RP Loman, NJ (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.
EM n.j.loman@bham.ac.uk
RI Faria, Nuno/I-2975-2012; Loman, Nicholas/Z-1573-2019; Pybus, Oliver
   g/B-2640-2012; Sabino, Ester Cerdeira/F-7750-2010; Giovanetti,
   Marta/AAK-7408-2020
OI Faria, Nuno/0000-0001-8839-2798; Pybus, Oliver g/0000-0002-8797-2667;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Beutler,
   Nathan/0000-0003-3240-9524; Loman, Nicholas/0000-0002-9843-8988; Hill,
   Sarah/0000-0002-2995-2596; Alcantara, Luiz/0000-0002-6769-9931;
   Grubaugh, Nathan/0000-0003-2031-1933; Giovanetti,
   Marta/0000-0002-5849-7326; Pullan, Steven/0000-0002-8983-599X; Loose,
   Matthew/0000-0002-5264-0929; Black, Allison/0000-0002-6618-4127
FU Brazilian Ministry of Health and the Latin American Community Engagement
   Networks (LACENs); Medical Research Council/Wellcome Trust/Newton Fund
   Zika Rapid Response Initiative [ZK/16-078]; Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project; National Institutes of Health
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33]; NIH National Center
   for Advancing Translational Studies Clinical and Translational Science
   Award [UL1TR001114]; National Institute of Allergy and Infectious
   Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201400048C]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R35 GM119774, U54 GM111274]; National Science
   Foundation Graduate Research Fellowship ProgramNational Science
   Foundation (NSF) [DGE-1256082]; Sir Henry Dale Fellowship (Wellcome
   Trust/Royal Society) [204311/Z/16/Z]; grant ('Sicherheit von
   Blut(produkten) und Geweben hinsichtlich der Abwesenheit von Zikaviren')
   from the German Ministry of Health; USAID Emerging Pandemic Threats
   Program-2 PREDICT-2United States Agency for International Development
   (USAID) [AID-OAA-A-14-00102]
FX The authors thank the Brazilian Ministry of Health and the Latin
   American Community Engagement Networks (LACENs) of Natal, Joao Pessoa,
   Recife, Maceio and Salvador for their support. We thank T. Fredeking
   from Antibody Systems for providing the Zika virus samples from
   Colombia. We thank K. Brunker for testing the Primal Scheme software.
   The Zika in Brazil Real-time Analysis (ZiBRA) project
   (http://www.zibraproject.org) is supported by the Medical Research
   Council/Wellcome Trust/Newton Fund Zika Rapid Response Initiative (grant
   no, ZK/16-078), which also provides J.Q.'s salary. N.J.L. is supported
   by a Medical Research Council Bioinformatics Fellowship as part of the
   Cloud Infrastructure for Microbial Bioinformatics (CLIMB) project.
   Primal Scheme is hosted on the CLIMB platform, where pipeline
   development and MinION data analysis was performed<SUP>59</SUP>. N.D.G.
   is supported by National Institutes of Health (NIH) training grant
   5T32AI007244-33. K.G.A. is a PEW Biomedical Scholar, and his work is
   supported by NIH National Center for Advancing Translational Studies
   Clinical and Translational Science Award UL1TR001114 and National
   Institute of Allergy and Infectious Diseases (NIAID) contract
   HHSN272201400048C. A.B. and T.B. were supported by NIH awards R35
   GM119774 and U54 GM111274. T.B. is a Pew Biomedical Scholar. A.B. is
   supported by the National Science Foundation Graduate Research
   Fellowship Program under Grant no. DGE-1256082. N.R.F. was funded by a
   Sir Henry Dale Fellowship (Wellcome Trust/Royal Society grant
   204311/Z/16/Z). Work at the Paul-Ehrlich-Institut was supported by a
   grant ('Sicherheit von Blut(produkten) und Geweben hinsichtlich der
   Abwesenheit von Zikaviren') from the German Ministry of Health. This
   study was supported by USAID Emerging Pandemic Threats Program-2
   PREDICT-2 (cooperative agreement AID-OAA-A-14-00102). The contents of
   this article are the responsibility of the authors and do not
   necessarily reflect the views of USAID or the US government.
CR Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Batty EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066129
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown JR, 2015, J CLIN VIROL, V70, pS12, DOI 10.1016/j.jcv.2015.07.037
   Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16
   Carrillo C, 2007, J VIROL, V81, P11341, DOI 10.1128/JVI.00930-07
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chan M, 2016, J APPL LAB MED, V1, P25, DOI 10.1373/jalm.2016.020131
   Connor TR, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000086
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087
   Faria N. R., 2017, NATURE
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Gardner Shea N., 2014, Advances in Bioinformatics, V2014, P101894, DOI 10.1155/2014/101894
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh N. D., 2017, NATURE
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Hysom DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034560
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z
   Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480
   KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999
   KWOK S, 1994, PCR METH APPL, V3, pS39
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261
   Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198
   Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419
   Marquez S, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.01673-16, 10.1128/genomea.01673-16]
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Metsky HC, 2017, NATURE
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666
   Misencik MJ, 2016, VECTOR-BORNE ZOONOT, V16, P181, DOI 10.1089/vbz.2015.1889
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219
   Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013
   Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480
   Sipos B., 2016, BIORXIV
   Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Yu Q, 2011, BIOINFORMATICS, V27, P266, DOI 10.1093/bioinformatics/btq624
   Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000
NR 59
TC 130
Z9 132
U1 6
U2 98
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PD JUN
PY 2017
VL 12
IS 6
BP 1261
EP 1276
DI 10.1038/nprot.2017.066
PG 16
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA EV9RK
UT WOS:000402122900001
PM 28538739
OA Green Published, Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Puschnik, AS
   Majzoub, K
   Ooi, YS
   Carette, JE
AF Puschnik, Andreas S.
   Majzoub, Karim
   Ooi, Yaw Shin
   Carette, Jan E.
TI A CRISPR toolbox to study virus-host interactions
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID HEPATITIS-C VIRUS; EMBRYONIC STEM-CELLS; NIEMANN-PICK C1; MOSQUITO
   AEDES-AEGYPTI; ESSENTIAL GENES; B-VIRUS; HUMAN GENOME; FUNCTIONAL
   GENOMICS; ENTRY REQUIRES; IN-VIVO
AB Viruses depend on their hosts to complete their replication cycles; they exploit cellular receptors for entry and hijack cellular functions to replicate their genome, assemble progeny virions and spread. Recently, genome-scale CRISPR-Cas screens have been used to identify host factors that are required for virus replication, including the replication of clinically relevant viruses such as Zika virus, West Nile virus, dengue virus and hepatitis C virus. In this Review, we discuss the technical aspects of genome-scale knockout screens using CRISPR-Cas technology, and we compare these screens with alternative genetic screening technologies. The relative ease of use and reproducibility of CRISPR-Cas make it a powerful tool for probing virus-host interactions and for identifying new antiviral targets.
C1 [Puschnik, Andreas S.; Majzoub, Karim; Ooi, Yaw Shin; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
RP Carette, JE (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM carette@stanford.edu
OI Carette, Jan/0000-0002-5187-8070; Ooi, Yaw Shin/0000-0001-9014-1365;
   Majzoub, Karim/0000-0001-7345-6840
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI109662, DP2 AI104557]
CR Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573
   Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048
   Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113
   Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9
   Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020
   Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Belser JA, 2016, MICROBIOL MOL BIOL R, V80, P733, DOI 10.1128/MMBR.00022-16
   Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090
   Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557
   Blondel CJ, 2016, CELL HOST MICROBE, V20, P226, DOI 10.1016/j.chom.2016.06.010
   Bornholdt ZA, 2016, MBIO, V7, DOI 10.1128/mBio.02154-15
   Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854
   BRENNER S, 1974, GENETICS, V77, P71
   BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033
   Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857
   Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001
   Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]
   DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]
   Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886
   Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/NMETH.2641, 10.1038/nmeth.2641]
   Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014
   Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038
   Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437
   Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2
   Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015
   East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802
   Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012
   Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114
   Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654
   Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536
   Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095
   Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523
   Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029
   Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044
   Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022
   Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710
   Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113
   Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11
   Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015
   HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352
   Harvey R, 2009, ANTIVIR RES, V82, P1, DOI 10.1016/j.antiviral.2008.12.015
   Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272
   Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07
   Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480
   Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675
   Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039
   Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452
   Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016
   Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41
   Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044
   Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15
   Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089
   Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136
   Kou ZH, 2015, CELL RES, V25, P1372, DOI 10.1038/cr.2015.130
   Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209
   Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x
   Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448
   Lei SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25222
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139
   Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020
   Liu SJ, 2016, SCIENCE, V355
   Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159
   Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110
   LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002
   Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386
   Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703
   Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53
   Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0
   Nag A, 2012, J VIROL, V86, P12616, DOI 10.1128/JVI.01351-12
   Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027
   NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0
   O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769
   Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980
   Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185
   Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220
   Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370
   Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741
   Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003
   Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911
   Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465
   Pillay S, 2015, ANNU REV VIROL, V2, P219, DOI 10.1146/annurev-virology-100114-055119
   Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684
   Popov LM, 2015, P NATL ACAD SCI USA, V112, P14337, DOI 10.1073/pnas.1510265112
   Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0
   Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112
   Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238
   Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833
   Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299
   Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15
   Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801
   Saeed M, 2015, NATURE, V524, P471, DOI 10.1038/nature14899
   Sagi I, 2016, NATURE, V532, P107, DOI 10.1038/nature17408
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514
   Shwetha S, 2015, J VIROL, V89, P11356, DOI 10.1128/JVI.01714-15
   Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019
   SIMOES EAF, 1991, J VIROL, V65, P913, DOI 10.1128/JVI.65.2.913-921.1991
   Staring J, 2017, NATURE, V541, P412, DOI 10.1038/nature21032
   Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004
   Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786
   TRONO D, 1988, SCIENCE, V241, P445, DOI 10.1126/science.2839901
   Tschaharganeh DF, 2016, FEBS J, V283, P3194, DOI 10.1111/febs.13750
   Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013
   van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701
   Virreira Winter S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24242
   Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044
   Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.2
   Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108
   Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776
   Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998
   Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413
   Wutz A, 2014, ANNU REV CELL DEV BI, V30, P705, DOI 10.1146/annurev-cellbio-100913-012920
   XIONG C, 1989, SCIENCE, V243, P1188, DOI 10.1126/science.2922607
   Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15
   Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2
   Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166
NR 167
TC 39
Z9 39
U1 1
U2 65
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD JUN
PY 2017
VL 15
IS 6
BP 351
EP 364
DI 10.1038/nrmicro.2017.29
PG 14
WC Microbiology
SC Microbiology
GA EU5HK
UT WOS:000401062000010
PM 28420884
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Rao, R
   Gaw, SL
   Han, CS
   Platt, LD
   Silverman, NS
AF Rao, Rashmi
   Gaw, Stephanie L.
   Han, Christina S.
   Platt, Lawrence D.
   Silverman, Neil S.
TI Zika Risk and Pregnancy in Clinical Practice Ongoing Experience as the
   Outbreak Evolves
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID VIRUS-INFECTION; UNITED-STATES; WOMEN; ULTRASOUND; FETUSES
AB OBJECTIVE: To describe a single U.S. perinatal center's ongoing experience with evaluating pregnant patients with potential exposure to Zika virus infection.
   METHODS: This is an institutional review board-approved longitudinal observational study from January to August 2016 from a single perinatal referral center. Patients who had traveled to or had sexual contact with a person who traveled to a region with documented local Zika virus transmission were included in the study. The aim of the study was to identify the rate of confirmed infection among pregnant women referred to our center with established risk factors for Zika virus acquisition. We also sought to characterize travel patterns that constituted risk, to identify rates of symptoms suggesting infection, and to potentially describe findings suggestive of congenital Zika virus infection in prenatal ultrasound evaluations.
   RESULTS: We evaluated 185 pregnant women with potential Zika virus exposure. Testing was offered in accordance with the version of the Centers for Disease Control and Prevention guidelines in place at the time of the consultation visit. Geographic exposure data showed Mexico (44%), the Caribbean (17%), North America (16%), South America (13%), and Central America (9%) to be the most common areas in which potential exposure occurred. One hundred twenty-three (67%) patients reported insect bites and 19 (10%) patients reported symptoms. Overall, five (3% of all) patients had prenatal ultrasound findings suggestive of possible fetal Zika virus infection; all their Zika virus test results returned negative. These findings included microcephaly, echogenic intracardiac foci, and ventricular calcifications. Of the 153 Zika virus screening tests ordered, eight (5%) immunoglobulin M results returned positive or equivocal with only one positive through confirmatory testing. Overall, 1 of 185 (0.5%) of all those consulted and 1 of 153 (0.7%) of those tested had a confirmed Zika virus infection with no confirmed fetal or neonatal infections.
   CONCLUSION: We identified low rates of confirmed maternal Zika virus infection in our cohort, but the number of patients described here demonstrates the magnitude of concern existing among both patients and physicians regarding possible perinatal Zika virus infection. It also underscores the need for health care providers to be prepared to answer questions, explain laboratory and ultrasound results, and describe testing options for concerned patients and their families.
C1 UCLA, David Geffen Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA USA.
   Univ Calif San Francisco, Dept Obstet & Gynecol, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
RP Rao, R (corresponding author), 6310 San Vicente Blvd,Suite 520, Los Angeles, CA 90048 USA.
EM rrao@mednet.ucla.edu
RI Han, Christina S/AAC-8967-2019; Gaw, Stephanie/K-4592-2019
OI Han, Christina S/0000-0003-1627-3057; Gaw, Stephanie/0000-0003-0891-6964
FU GE Medical Systems
FX Dr. Platt has been a speaker for Illumina and serves on their medical
   advisory board and is Treasurer of the Perinatal Quality Foundation. He
   provides research support and is part of the speaker bureau for GE
   Medical Systems. The other authors did not report any potential
   conflicts of interest.
CR Agencia Saude, 2015, MICR MIN SAUD DIV B
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, 2016, CDC GUID TRAV TEST P
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuhn JH, 2015, HARRISONS PRINCIPLES
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Norton ME, 2017, AM J OBSTET GYNECOL, V216, pB2, DOI 10.1016/j.ajog.2017.01.005
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   WHO, 2016, PREGN MAN CONT ZIK V
NR 22
TC 6
Z9 6
U1 2
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD JUN
PY 2017
VL 129
IS 6
BP 1098
EP 1103
DI 10.1097/AOG.0000000000002049
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7SA
UT WOS:000402714100024
PM 28486369
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Edupuganti, S
   Natrajan, MS
   Rouphael, N
   Lai, LL
   Xu, YX
   Feldharnmer, M
   Hill, C
   Patel, SM
   Johnson, SJ
   Bower, M
   Gorchakov, R
   Berry, R
   Murray, KO
   Mulligan, MJ
AF Edupuganti, Srilatha
   Natrajan, Muktha S.
   Rouphael, Nadine
   Lai, Lilin
   Xu, Yongxian
   Feldharnmer, Matthew
   Hill, Charles
   Patel, Shital M.
   Johnson, Sara Jo
   Bower, Mary
   Gorchakov, Rodion
   Berry, Rebecca
   Murray, Kristy O.
   Mulligan, Mark J.
TI Biphasic Zika Illness With Rash and Joint Pain
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE joint pains; rash; relapse; Zika illness
ID VIRUS
AB During the current Zika virus (ZIKV) outbreak, acute symptomatic ZIKV infection in adults appears to be a mild-to-moderate, self-limited illness. We present a case of ZIKV rash illness that improved and then relapsed without repeat exposure to ZIKV. Clinicians should be alert for relapses in patients with ZIKV infection.
C1 [Edupuganti, Srilatha; Natrajan, Muktha S.; Rouphael, Nadine; Lai, Lilin; Xu, Yongxian; Johnson, Sara Jo; Bower, Mary; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Feldharnmer, Matthew; Hill, Charles] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Edupuganti, Srilatha; Natrajan, Muktha S.; Rouphael, Nadine; Lai, Lilin; Xu, Yongxian; Johnson, Sara Jo; Bower, Mary; Mulligan, Mark J.] Emory Univ, Sch Med, Emory Vaccine Ctr, Hope Clin, Decatur, GA 30033 USA.
   [Patel, Shital M.] Baylor Coll Med, Dept Med & Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Gorchakov, Rodion; Berry, Rebecca; Murray, Kristy O.] Texas Childrens Hosp, Baylor Coll Med, Pediat Trop Med, Houston, TX 77030 USA.
RP Edupuganti, S (corresponding author), 000 Irvin Ct,Suite 200, Decatur, GA 30030 USA.
EM sedu-pug@ernory.edu
RI Mulligan, Mark/V-9275-2019
OI Lai, Lilin/0000-0002-9528-6990; Natrajan, Muktha/0000-0003-1854-0382
FU National Institutes of Health/National Institutes of Allergy and
   Infectious Diseases/Division of Microbiology and Infectious
   Diseases/Vaccine and Treatment Evaluation Units at Emory University
   [HHSN272201300018I, DMID 16-0017]; Baylor College of Medicine
   [HHSN27220130015I]; Georgia Research Alliance
FX This work was funded by the National Institutes of Health/National
   Institutes of Allergy and Infectious Diseases/Division of Microbiology
   and Infectious Diseases/Vaccine and Treatment Evaluation Units at Emory
   University (Contract No. HHSN272201300018I funding the DMID 16-0017
   study) and at the Baylor College of Medicine (Contract No.
   HHSN27220130015I). Additional funding was provided by the Georgia
   Research Alliance.
CR Bennett J. E., 2015, MANDELL DOUGLAS BENN
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Centers for Disease Control and Prevention, ZIK VIR 2017 CAS COU
   Chen L, 2017, NEW ENGL J MED, V376, P400, DOI 10.1056/NEJMc1610614
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Ng DHL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167025
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
NR 14
TC 7
Z9 7
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD SUM
PY 2017
VL 4
IS 3
AR UNSP ofx133
DI 10.1093/ofid/ofx133
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FI9VL
UT WOS:000412357400041
PM 28761900
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, SY
   Li, B
   Linhardt, RJ
AF Kim, So Young
   Li, Bing
   Linhardt, Robert J.
TI Pathogenesis and Inhibition of Flaviviruses from a Carbohydrate
   Perspective
SO PHARMACEUTICALS
LA English
DT Review
DE dengue virus; DC-SIGN; envelope protein; flavivirus; flavivirus
   inhibitors; glycosaminoglycans; Japanese encephalitis virus;
   proteoglycans; viral infection; West Nile virus; yellow fever virus;
   Zika virus
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; HUMAN DENDRITIC CELLS;
   YELLOW-FEVER VIRUS; COLI POLYSACCHARIDE DERIVATIVES; SULFATE
   BINDING-SITES; INFECTION IN-VITRO; C-TYPE LECTINS; DENGUE-VIRUS;
   HEPARAN-SULFATE
AB Flaviviruses are enveloped, positive single stranded ribonucleic acid (RNA) viruses with various routes of transmission. While the type and severity of symptoms caused by pathogenic flaviviruses vary from hemorrhagic fever to fetal abnormalities, their general mechanism of host cell entry is similar. All pathogenic flaviviruses, such as dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, and Zika virus, bind to glycosaminglycans (GAGs) through the putative GAG binding sites within their envelope proteins to gain access to the surface of host cells. GAGs are long, linear, anionic polysaccharides with a repeating disaccharide unit and are involved in many biological processes, such as cellular signaling, cell adhesion, and pathogenesis. Flavivirus envelope proteins are N-glycosylated surface proteins, which interact with C-type lectins, dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) through their glycans. In this review, we discuss both host and viral surface receptors that have the carbohydrate components, focusing on the surface interactions in the early stage of flavivirus entry. GAG-flavivirus envelope protein interactions as well as interactions between flavivirus envelope proteins and DC-SIGN are discussed in detail. This review also examines natural and synthetic inhibitors of flaviviruses that are carbohydrate-based or carbohydrate-targeting. Both advantages and drawbacks of these inhibitors are explored, as are potential strategies to improve their efficacy to ultimately help eradicate flavivirus infections.
C1 [Kim, So Young; Linhardt, Robert J.] Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Li, Bing] Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Guangzhou 510640, Guangdong, Peoples R China.
   [Li, Bing] South China Univ Technol, Sch Food Sci & Technol, Guangzhou 510640, Guangdong, Peoples R China.
   [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Linhardt, Robert J.] Rensselaer Polytech Inst, Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Li, B (corresponding author), Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Guangzhou 510640, Guangdong, Peoples R China.; Li, B (corresponding author), South China Univ Technol, Sch Food Sci & Technol, Guangzhou 510640, Guangdong, Peoples R China.; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
EM pinkes2@rpi.edu; lcbingli@scut.edu.cn; linhar@rpi.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HL125371]
FX We acknowledge the National Institutes of Health (grant HL125371) for
   funding our work on glycosaminoglycans.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Alen MMF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021658
   Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043
   ANDERSON W, 1965, J PHARM PHARMACOL, V17, P647, DOI 10.1111/j.2042-7158.1965.tb07577.x
   Anez G, 2009, J VIROL, V83, P10384, DOI 10.1128/JVI.01083-09
   Aoki C, 2006, J BIOCHEM, V139, P607, DOI 10.1093/jb/mvj067
   Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   BARROWCLIFFE TW, 1986, THROMB HAEMOSTASIS, V56, P202
   Batra G, 2010, J VIROL METHODS, V167, P10, DOI 10.1016/j.jviromet.2010.03.002
   Beesetti H, 2014, EXPERT OPIN THER PAT, V24, P1171, DOI 10.1517/13543776.2014.967212
   Bruno John G, 2012, BMC Res Notes, V5, P633, DOI 10.1186/1756-0500-5-633
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004
   Castilla V, 2015, FUTURE VIROL, V10, P625, DOI 10.2217/FVL.15.35
   Centers for Disease Control and Prevention, PREGN WOM ANY LAB EV
   Chen HL, 2010, BIOPOLYMERS, V94, P331, DOI 10.1002/bip.21371
   Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017
   Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19
   Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000
   Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Araujo CA, 2013, CARBOHYD POLYM, V91, P483, DOI 10.1016/j.carbpol.2012.08.034
   DEY PM, 1978, ADV CARBOHYD CHEM BI, V35, P341
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004
   Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945
   GORDON M, 1994, J MED, V25, P163
   Gu Baohua, 2007, Antiviral Chemistry & Chemotherapy, V18, P49
   Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X
   Herrero LJ, 2013, PHARMACOL THERAPEUT, V137, P266, DOI 10.1016/j.pharmthera.2012.10.007
   Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100
   Hidari KIPJ, 2013, VIRUSES-BASEL, V5, P605, DOI 10.3390/v5020605
   Hidari KIPJ, 2012, BIOCHEM BIOPH RES CO, V424, P573, DOI 10.1016/j.bbrc.2012.07.002
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Huang KC, 2008, PROTEINS, V70, P1116, DOI 10.1002/prot.21806
   Ichiyama K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002188
   Idris F, 2016, ARCH VIROL, V161, P1751, DOI 10.1007/s00705-016-2855-2
   Ishag HZA, 2016, VIRUS RES, V215, P50, DOI 10.1016/j.virusres.2016.01.016
   Ishag HZA, 2013, ARCH VIROL, V158, P349, DOI 10.1007/s00705-012-1489-2
   Ishak H, 2001, MICROBIOL IMMUNOL, V45, P327, DOI 10.1111/j.1348-0421.2001.tb02627.x
   ISHAK R, 1988, J GEN VIROL, V69, P325, DOI 10.1099/0022-1317-69-2-325
   Islam T, 2002, CARBOHYD RES, V337, P2239, DOI 10.1016/S0008-6215(02)00229-X
   Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Ji GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139741
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Kamhi E, 2013, BIOL REV, V88, P928, DOI 10.1111/brv.12034
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   KANEKO Y, 1990, BIOCHEM PHARMACOL, V39, P793
   Kariwa H, 2013, INT J ENV RES PUB HE, V10, P7144, DOI 10.3390/ijerph10127144
   Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002
   Khachigian LM, 2004, CARDIOVASC DRUG REV, V22, P1
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Lee JWM, 2006, J BIOL CHEM, V281, P1352, DOI 10.1074/jbc.M506614200
   Lei Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132122
   Lembo D, 2008, ANTIMICROB AGENTS CH, V52, P1374, DOI 10.1128/AAC.01467-07
   Lim SP, 2013, VIRUSES-BASEL, V5, P2977, DOI 10.3390/v5122977
   Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4
   LINHARDT RJ, 1988, J BIOL CHEM, V263, P13090
   Liu H, 2004, J MED VIROL, V72, P618, DOI 10.1002/jmv.20025
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2
   Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001
   Marks RM, 2001, J MED CHEM, V44, P2178, DOI 10.1021/jm000412i
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   Martinez-Barragan JD, 2001, J VIROL, V75, P7818, DOI 10.1128/JVI.75.17.7818-7827.2001
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Mendoza MY, 2002, AM J TROP MED HYG, V67, P76, DOI 10.4269/ajtmh.2002.67.76
   Mercado-Curiel RF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-85
   Mercorelli B, 2010, ANTIMICROB AGENTS CH, V54, P4561, DOI 10.1128/AAC.00721-10
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Murata R, 2010, AM J TROP MED HYG, V82, P696, DOI 10.4269/ajtmh.2010.09-0262
   Muschin T, 2016, INT J BIOL MACROMOL, V89, P415, DOI 10.1016/j.ijbiomac.2016.05.005
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09
   OLSON JJ, 1994, NEUROSURGERY, V34, P297, DOI 10.1227/00006123-199402000-00013
   Ono L, 2003, ANTIVIR RES, V60, P201, DOI 10.1016/S0166-3542(03)00175-X
   Opoku G, 2006, CARBOHYD POLYM, V65, P134, DOI 10.1016/j.carbpol.2005.12.033
   Patel S, 2012, BIO-TECHNOL, V2, P171, DOI DOI 10.1007/S13205-012-0061-9
   Pereira MG, 2005, CARBOHYD RES, V340, P2015, DOI 10.1016/j.carres.2005.05.018
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pinna D, 2008, ANTIMICROB AGENTS CH, V52, P3078, DOI 10.1128/AAC.00359-08
   Pitcher TJ, 2015, J GEN VIROL, V96, P288, DOI 10.1099/vir.0.070813-0
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Pujol CA, 2012, INT J BIOL MACROMOL, V51, P412, DOI 10.1016/j.ijbiomac.2012.05.028
   Putnak JR, 1997, NAT MED, V3, P828, DOI 10.1038/nm0897-828
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roehrig JT, 2013, VIROLOGY, V441, P114, DOI 10.1016/j.virol.2013.03.011
   Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225
   Rusnati M, 2009, PHARMACOL THERAPEUT, V123, P310, DOI 10.1016/j.pharmthera.2009.05.001
   Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283
   Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952
   Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745
   Scherret JH, 2001, ANN NY ACAD SCI, V951, P361, DOI 10.1111/j.1749-6632.2001.tb02719.x
   Shimojima M, 2014, ARCH VIROL, V159, P2023, DOI 10.1007/s00705-014-2042-2
   Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6
   Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI200113799
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986
   Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043
   Talarico LB, 2011, J GEN VIROL, V92, P1332, DOI 10.1099/vir.0.028522-0
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004
   Thepparit C, 2004, INTERVIROLOGY, V47, P78, DOI 10.1159/000077830
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031
   Vanheule V, 2016, BIOCHEM PHARMACOL, V100, P73, DOI 10.1016/j.bcp.2015.11.001
   VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x
   Varga N, 2014, BIOMATERIALS, V35, P4175, DOI 10.1016/j.biomaterials.2014.01.014
   Vervaeke P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074035
   Vicenzi E, 2003, AIDS, V17, P177, DOI 10.1097/00002030-200301240-00006
   Wadstrom T, 1999, J MED MICROBIOL, V48, P223, DOI 10.1099/00222615-48-3-223
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Wang QY, 2015, ACS INFECT DIS, V1, P428, DOI 10.1021/acsinfecdis.5b00066
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Whistler R. L., 1953, POLYSACCHARIDE CHEM, P292
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   WHO, MOSQ BORN DIS
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, DENG SEV DENG
   World Health Organization (WHO), VECT BORN DIS
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhu WY, 2011, BIOMED ENVIRON SCI, V24, P81, DOI 10.3967/0895-3988.2011.01.011
NR 164
TC 16
Z9 16
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JUN
PY 2017
VL 10
IS 2
AR UNSP 44
DI 10.3390/ph10020044
PG 24
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FH7FX
UT WOS:000411350700012
PM 28471403
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zarei, M
AF Zarei, Mohammad
TI Portable biosensing devices for point-of-care diagnostics: Recent
   developments and applications
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE Point-of-care; Smartphone; Infectious disease; Diagnostics; Sensor;
   Detection
ID LOW-COST; INSTRUMENT-FREE; ZIKA VIRUS; SMARTPHONE; PAPER; PLATFORM;
   SYSTEM; BLOOD; MICROSCOPY; SENSOR
AB Low-cost point-of-care (POC) diagnostics play several critical roles in healthcare strategies, particularly for detection, therapy, economy, health management, and surveillance. Any user can now perform rapid, efficient, inexpensive, and easy analysis anywhere at any time and various kind of hybrid biosensing devices improved the POC analyses. This review describes recent developments on the application of various types of portable biosensing devices with focus on smartphone-enabled biosensing in which analysis, diagnostics, and communications are coupled. Further, we provide an overview of recent biosensing platforms, from optical to electrochemical biosensors and consider future opportunities for POC devices for clinical analysis and infectious diseases assessment. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Zarei, Mohammad] Univ Kurdistan, Dept Chem & Civil Engn, POB 66177, Sanandaj, Iran.
RP Zarei, M (corresponding author), Univ Kurdistan, Dept Chem & Civil Engn, POB 66177, Sanandaj, Iran.
EM Mo.zarei@alumni.um.ac.ir
RI Zarei, Mohammad/V-1359-2017
OI Zarei, Mohammad/0000-0002-6351-5058
CR Ahrberg CD, 2016, ANAL CHEM, V88, P4803, DOI 10.1021/acs.analchem.6b00278
   Amukele T., 2016, DRONE TRANSPORTATION
   Amukele TK, 2016, J CLIN MICROBIOL, V54, P2622, DOI 10.1128/JCM.01204-16
   Aronoff-Spencer E, 2016, BIOSENS BIOELECTRON, V86, P690, DOI 10.1016/j.bios.2016.07.023
   Arts R, 2016, ANAL CHEM, V88, P4525, DOI 10.1021/acs.analchem.6b00534
   Askim JR, 2015, ANAL CHEM, V87, P7810, DOI 10.1021/acs.analchem.5b01499
   Ayas S, 2014, ACS PHOTONICS, V1, P17, DOI 10.1021/ph400108p
   Azzarelli JM, 2014, P NATL ACAD SCI USA, V111, P18162, DOI 10.1073/pnas.1415403111
   Barbosa AI, 2015, BIOSENS BIOELECTRON, V70, P5, DOI 10.1016/j.bios.2015.03.006
   Broadhurst MJ, 2015, LANCET, V386, P867, DOI 10.1016/S0140-6736(15)61042-X
   Bueno D, 2016, SENSOR ACTUAT B-CHEM, V232, P462, DOI 10.1016/j.snb.2016.03.140
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chen Y, 2015, BIOSENS BIOELECTRON, V67, P477, DOI 10.1016/j.bios.2014.09.010
   Chib A, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2013.864735
   Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h
   Cho S, 2015, BIOSENS BIOELECTRON, V74, P601, DOI 10.1016/j.bios.2015.07.014
   Choi JR, 2016, BIOSENS BIOELECTRON, V79, P98, DOI 10.1016/j.bios.2015.12.005
   Choi JR, 2016, LAB CHIP, V16, P611, DOI 10.1039/c5lc01388g
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   Coskun AF, 2013, LAB CHIP, V13, P4231, DOI 10.1039/c3lc50785h
   Coskun AF, 2013, LAB CHIP, V13, P636, DOI 10.1039/c2lc41152k
   D'Ambrosio MV, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3480
   Devadhasan JP, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.11.117001
   Djimde A. A., 2016, J PARASITOL VECTOR B, V8, P1
   Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0
   Dutta S, 2016, J BIOPHOTONICS, P1
   Feng S, 2014, ACS NANO, V8, P3069, DOI 10.1021/nn500614k
   Fu QQ, 2016, LAB CHIP, V16, P1927, DOI 10.1039/c6lc00083e
   Gallegos D, 2013, LAB CHIP, V13, P2124, DOI 10.1039/c3lc40991k
   Giavazzi F, 2014, BIOSENS BIOELECTRON, V58, P395, DOI 10.1016/j.bios.2014.02.077
   Guner H, 2017, SENSOR ACTUAT B-CHEM, V239, P571, DOI 10.1016/j.snb.2016.08.061
   Guo T, 2015, LAB CHIP, V15, P3514, DOI 10.1039/c5lc00609k
   Han KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep25710
   Hannan MA, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-79
   Hong JW, 2003, NAT BIOTECHNOL, V21, P1179, DOI 10.1038/nbt871
   Hussain I, 2016, RSC ADV, V6, P22374, DOI 10.1039/c6ra02483a
   Hutchison JR, 2015, ANALYST, V140, P6269, DOI [10.1039/c5an01304f, 10.1039/C5AN01304F]
   Im SH, 2016, SENSOR ACTUAT B-CHEM, V229, P166, DOI 10.1016/j.snb.2016.01.121
   Jiang J, 2014, SENSOR ACTUAT B-CHEM, V193, P653, DOI 10.1016/j.snb.2013.11.103
   Kadlec MW, 2014, JALA-J LAB AUTOM, V19, P258, DOI 10.1177/2211068213491095
   Kehoe E, 2013, J CHEM EDUC, V90, P1191, DOI 10.1021/ed300567p
   Khatua S, 2013, ACS NANO, V7, P8340, DOI 10.1021/nn405167q
   Kim H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40203
   Kim JH, 2015, BIOCHIP J, V9, P285, DOI 10.1007/s13206-015-9403-0
   Knutson TR, 2015, J CHEM EDUC, V92, P1692, DOI 10.1021/ed500876y
   Kosaka PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171899
   Koydemir HC, 2015, LAB CHIP, V15, P1284, DOI 10.1039/c4lc01358a
   Lafleur LK, 2016, LAB CHIP, V16, P3777, DOI 10.1039/c6lc00677a
   Laksanasopin T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0056
   Lebiga E, 2015, ANALYST, V140, P5006, DOI 10.1039/c5an00720h
   Leon SR, 2016, J CLIN MICROBIOL, V54, P492, DOI 10.1128/JCM.03152-15
   Levin S, 2016, SCI TOTAL ENVIRON, V551, P101, DOI 10.1016/j.scitotenv.2016.01.156
   Liang PS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05953
   Liao SC, 2016, SENSOR ACTUAT B-CHEM, V229, P232, DOI 10.1016/j.snb.2016.01.073
   Lillehoj PB, 2013, LAB CHIP, V13, P2950, DOI 10.1039/c3lc50306b
   Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12864
   McCracken KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27529
   Meng X, 2017, LAB CHIP, V17, P104, DOI 10.1039/c6lc01321j
   Ming K, 2015, ACS NANO, V9, P3060, DOI 10.1021/nn5072792
   Montangero M, 2015, J CHEM EDUC, V92, P1759, DOI 10.1021/acs.jchemed.5b00167
   Navruz I, 2013, LAB CHIP, V13, P4015, DOI 10.1039/c3lc50589h
   Nayak S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35069
   Nemiroski A, 2014, P NATL ACAD SCI USA, V111, P11984, DOI 10.1073/pnas.1405679111
   Nicolini AM, 2015, BIOSENS BIOELECTRON, V67, P560, DOI 10.1016/j.bios.2014.09.040
   Nie HJ, 2015, ANALYST, V140, P2771, DOI 10.1039/c4an02339k
   Otten L, 2013, J MATER CHEM B, V1, P2665, DOI 10.1039/c3tb20259c
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Park TS, 2015, IEEE SENS J, V15, P1902, DOI 10.1109/JSEN.2014.2367039
   Paterson AS, 2017, LAB CHIP, V17, P1051, DOI 10.1039/c6lc01167e
   Petryayeva E, 2015, ANALYST, V140, P4037, DOI 10.1039/c5an00475f
   Preechaburana P, 2012, ANGEW CHEM INT EDIT, V51, P11585, DOI 10.1002/anie.201206804
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Priye A, 2016, ANAL CHEM, V88, P4651, DOI 10.1021/acs.analchem.5b04153
   Protection P., 2010, PUBLIC LAW, V111, P48
   Quinten M, 2010, OPTICAL PROPERTIES N
   Rico-Yuste A, 2016, ANAL CHEM, V88, P3959, DOI 10.1021/acs.analchem.6b00167
   Roda A, 2014, ANALYST, V139, P6494, DOI 10.1039/c4an01612b
   Rodriguez NM, 2015, ANAL CHEM, V87, P7872, DOI 10.1021/acs.analchem.5b01594
   Rogers CI, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4905840
   Safavieh M, 2014, ANALYST, V139, P482, DOI 10.1039/c3an01859h
   Shafiee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08719
   Shembekar N, 2016, LAB CHIP, V16, P1314, DOI 10.1039/c6lc00249h
   Sia SK, 2008, LAB CHIP, V8, P1982, DOI 10.1039/b817915h
   Simmons LA, 2012, PERS MED, V9, P85, DOI [10.2217/pme.11.86, 10.2217/PME.11.86]
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Sumriddetchkajorn S, 2013, SENSOR ACTUAT B-CHEM, V182, P592, DOI 10.1016/j.snb.2013.03.080
   Sun AC, 2016, SENSOR ACTUAT B-CHEM, V235, P126, DOI 10.1016/j.snb.2016.05.010
   Thiha A, 2015, SENSORS-BASEL, V15, P11431, DOI 10.3390/s150511431
   Tian T, 2016, LAB CHIP, V16, P1139, DOI 10.1039/c5lc01562f
   Tricoli A, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201605271
   Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k
   Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001
   Verdoy D, 2012, BIOSENS BIOELECTRON, V32, P259, DOI 10.1016/j.bios.2011.12.032
   Vilela D, 2012, ANAL CHIM ACTA, V751, P24, DOI 10.1016/j.aca.2012.08.043
   Wang LJ, 2016, ACS SENSORS, V1, P366, DOI 10.1021/acssensors.5b00204
   Wang SQ, 2016, TRENDS BIOTECHNOL, V34, P909, DOI 10.1016/j.tibtech.2016.05.009
   Wang SQ, 2016, EXPERT REV MOL DIAGN, V16, P449, DOI 10.1586/14737159.2016.1142877
   Wei QS, 2014, ACS NANO, V8, P12725, DOI 10.1021/nn505821y
   Wei QS, 2013, ACS NANO, V7, P9147, DOI 10.1021/nn4037706
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Wu D, 2017, MICROFLUID NANOFLUID, V21, DOI 10.1007/s10404-017-1879-6
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   Yang X, 2016, BIOSENS BIOELECTRON, V75, P48, DOI 10.1016/j.bios.2015.08.020
   Yelleswarapu VR, 2017, LAB CHIP, V17, P1083, DOI 10.1039/c6lc01489e
   Yeo SJ, 2016, THERANOSTICS, V6, P231, DOI 10.7150/thno.14023
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   Yin Y. P., 2015, INT J GYNECOL OBSTET, V130
   Yu HJ, 2014, ANAL CHEM, V86, P8805, DOI 10.1021/ac502080t
   Zangheri M, 2015, BIOSENS BIOELECTRON, V64, P63, DOI 10.1016/j.bios.2014.08.048
   Zarei M, 2017, TRAC-TREND ANAL CHEM, V86, P56, DOI 10.1016/j.trac.2016.11.004
   Zhang CR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2067-x
   Zhang L, 2015, ANALYST, V140, P7399, DOI 10.1039/c5an01664a
   Zhang Y, 2016, SCI REP, V6
   Zhu HY, 2013, LAB CHIP, V13, P1282, DOI 10.1039/c3lc41408f
NR 115
TC 82
Z9 82
U1 22
U2 113
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0165-9936
EI 1879-3142
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD JUN
PY 2017
VL 91
BP 26
EP 41
DI 10.1016/j.trac.2017.04.001
PG 16
WC Chemistry, Analytical
SC Chemistry
GA EW2RT
UT WOS:000402344400003
DA 2020-07-08
ER

PT J
AU Ellingson, KD
   Sapiano, MRP
   Haass, KA
   Savinkina, AA
   Baker, ML
   Henry, RA
   Berger, JJ
   Kuehnert, MJ
   Basavaraju, SV
AF Ellingson, Katherine D.
   Sapiano, Mathew R. P.
   Haass, Kathryn A.
   Savinkina, Alexandra A.
   Baker, Misha L.
   Henry, Richard A.
   Berger, James J.
   Kuehnert, Matthew J.
   Basavaraju, Sridhar V.
TI Cost projections for implementation of safety interventions to prevent
   transfusion-transmitted Zika virus infection in the United States
SO TRANSFUSION
LA English
DT Article
ID BLOOD-DONATIONS; PUERTO-RICO; PLATELET COMPONENTS; TRANSMISSION;
   TECHNOLOGY; AMERICA; DONORS
AB BACKGROUNDIn August 2016, the Food and Drug Administration advised US blood centers to screen all whole blood and apheresis donations for Zika virus (ZIKV) with an individual-donor nucleic acid test (ID-NAT) or to use approved pathogen reduction technology (PRT). The cost of implementing this guidance nationally has not been assessed.
   STUDY DESIGN AND METHODSScenarios were constructed to characterize approaches to ZIKV screening, including universal ID-NAT, risk-based seasonal allowance of minipool (MP) NAT by state, and universal MP-NAT. Data from the 2015 National Blood Collection and Utilization Survey (NBCUS) were used to characterize the number of donations nationally and by state. For each scenario, the estimated cost per donor ($3-$9 for MP-NAT, $7-$13 for ID-NAT) was multiplied by the estimated number of relevant donations from the NBCUS. Cost of PRT was calculated by multiplying the cost per unit ($50-$125) by the number of units approved for PRT. Prediction intervals for costs were generated using Monte Carlo simulation methods.
   RESULTSScreening all donations in the 50 states and DC for ZIKV by ID-NAT would cost $137 million (95% confidence interval [CI], $109-$167) annually. Allowing seasonal MP-NAT in states with lower ZIKV risk could reduce NAT screening costs by 18% to 25%. Application of PRT to all platelet (PLT) and plasma units would cost $213 million (95% CI, $156-$304).
   CONCLUSIONUniversal ID-NAT screening for ZIKV will cost US blood centers more than $100 million annually. The high cost of PRT for apheresis PLTs and plasma could be mitigated if, once validated, testing for transfusion transmissible pathogens could be eliminated.
C1 [Ellingson, Katherine D.; Sapiano, Mathew R. P.; Haass, Kathryn A.; Savinkina, Alexandra A.; Baker, Misha L.; Kuehnert, Matthew J.; Basavaraju, Sridhar V.] Ctr Dis Control & Prevent, Off Blood Organ & Other Tissue Safety, Div Healthcare Qual Promot, Atlanta, GA USA.
   [Sapiano, Mathew R. P.] Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Ellingson, Katherine D.] Univ Arizona, Dept Epidemiol & Biostat, Coll Publ Hlth, Tucson, AZ USA.
   [Savinkina, Alexandra A.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Baker, Misha L.] Northrop Grumman Corp, Atlanta, GA USA.
   [Henry, Richard A.; Berger, James J.] US Dept HHS, Off HIV AIDS & Infect Dis Policy, Off Assistant Secretary Hlth, Washington, DC 20201 USA.
RP Ellingson, KD (corresponding author), Univ Arizona, Coll Publ Hlth, 1285 N Martin Ave,Room A224, Tucson, AZ 85724 USA.
EM kellingson@email.arizona.edu
OI Haass, Kathryn/0000-0003-0397-986X
FU Intramural CDC HHS [CC999999]
CR [Anonymous], 2016, 114 M BLOOD PROD ADV
   [Anonymous], 2016, USGS CDC DIS MAPS
   [Anonymous], 2010, GUID IND NUCL TEST N
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bell CF, 2003, CLIN THER, V25, P2464, DOI 10.1016/S0149-2918(03)80288-6
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2017, CAS COUNTS US
   Custer B, 2005, ANN INTERN MED, V143, P486, DOI 10.7326/0003-4819-143-7-200510040-00007
   Custer B, 2010, TRANSFUSION, V50, P2461, DOI 10.1111/j.1537-2995.2010.02704.x
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Ellingson K, 2017, TRANSFUSION IN PRESS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freour T., 2016, EURO SURVEILL, V21
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Girona-Llobera E, 2014, TRANSFUSION, V54, P158, DOI 10.1111/trf.12232
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x
   Kuehnert MJ, 2016, TRANSFUSION, V56, P1669, DOI 10.1111/trf.13673
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Marshall DA, 2004, VOX SANG, V86, P28, DOI 10.1111/j.0042-9007.2004.00379.x
   Monaghan Ai., 2016, PLOS CURR, V8
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shehata N, 2004, TRANSFUSION, V44, P217, DOI 10.1111/j.1537-2995.2004.00644.x
   Snyder EL, 2015, NEW ENGL J MED, V373, P882, DOI 10.1056/NEJMc1507761
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   U.S. Food and Drug Administration, 2016, REV REC RED RISK ZIK
   U.S. Food and Drug Administration, 2016, DON SCREEN REC RED R
   US Census Bureau, 2015, POP EST STAT AG
   US Food and Drug Administration, 2009, GUID IND US NUCL AC
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
NR 34
TC 11
Z9 11
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUN
PY 2017
VL 57
SU 2
SI SI
BP 1625
EP 1633
DI 10.1111/trf.14164
PG 9
WC Hematology
SC Hematology
GA EX3EX
UT WOS:000403115900004
PM 28591470
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Pomar, L
   Malinger, G
   Benoist, G
   Carles, G
   Ville, Y
   Rousset, D
   Hcini, N
   Pomar, C
   Jolivet, A
   Lambert, V
AF Pomar, L.
   Malinger, G.
   Benoist, G.
   Carles, G.
   Ville, Y.
   Rousset, D.
   Hcini, N.
   Pomar, C.
   Jolivet, A.
   Lambert, V.
TI Association between Zika virus and fetopathy: a prospective cohort study
   in French Guiana
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
DE congenital infection; congenital Zika virus syndrome; microcephaly;
   ultrasound; Zika virus
ID INTERIM GUIDANCE; PREGNANT-WOMEN; UNITED-STATES; INFECTION; BRAZIL
AB Objective To establish the incidence of fetal central nervous system (CNS) anomalies (including microcephaly), signs of congenital infection and fetal loss in pregnant women infected with Zika virus (ZIKV) and non-infected pregnant women in western French Guiana.
   Methods This prospective cohort study was conducted between 1 January and 15 July 2016. We evaluated and compared clinical and fetal ultrasound examinations of 301 pregnant women with biological confirmation of ZIKV infection and 399 pregnant women who were negative for ZIKV infection.
   Results Overall, the total number of fetuses with CNS involvement was higher in the infected than in the control group (9.0% vs 4.3%; relative risk, 2.11 (95% CI, 1.18-4.13)). Anomalies of the corpus callosum and presence of cerebral hyperechogenicities were significantly more common in the infected group. There was an increased risk of microcephaly in the infected compared with the control group (1.7% vs 0.3%; relative risk, 6.63 (95% CI, 0.78-57.83)), although this was not statistically significant. When the mother was infected during the first or second trimester, there was a greater risk of severe CNS involvement, more signs of infection and intrauterine fetal death than with infection in the third trimester. The rate of vertical transmission in the exposed group was 10.9%.
   Conclusion ZIKV infection during pregnancy is associated with a significant risk of fetal CNS involvement and intrauterine fetal death, particularly when infection occurs during the first or second trimesters. Microcephaly was not present in every case of congenital ZIKV syndrome that we observed. Until more is known about this disease, it is paramount to evaluate suspected cases by detailed neurosonography on a monthly basis, paying particular attention to the corpus callosum and the presence of hyperechogenic foci. Copyright (C) 2017 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Pomar, L.; Carles, G.; Hcini, N.; Pomar, C.; Lambert, V.] Ctr Hosp Ouest Guyanais, St Laurent du Maronis Hosp, Dept Obstet & Gynecol, St Laurent Du Maroni, French Guiana.
   [Malinger, G.] Tel Aviv Univ, Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Sackler Fac Med,Div Ultrasound Obstet & Gynecol, Tel Aviv, Israel.
   [Benoist, G.] Univ Caen, CHU Caen, Serv Gynecol Obstet & Med Reprod, Caen, Normandy, France.
   [Ville, Y.] Univ Paris 05, Hosp Necker Enfants Malades, Dept Obstet & Fetal Med, Paris, France.
   [Rousset, D.] Inst Pasteur French Guiana, Natl Referral Ctr Arboviruses, Virol Lab, Cayenne, French Guiana.
   [Jolivet, A.] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & St Publ,Dept Social, Paris, France.
   [Jolivet, A.] Ctr Hosp Ouest Guyanais, St Laurent du Maronis Hosp, Publ Hlth Dept, St Laurent Du Maroni, French Guiana.
RP Pomar, L (corresponding author), Ctr Hosp Ouest Guyanais Franck Joly, St Laurent du Maronis Hosp, Dept Obstet & Gynecol, 16 Blvd Gen Gaulle, F-97393 St Laurent Du Maroni, Guyane, France.
EM leo.pomar@live.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147; Jolivet,
   Anne/0000-0001-6233-1225; Pomar, Leo/0000-0002-3021-8129; benoist,
   guillaume/0000-0002-1415-6474
CR [Anonymous], 2016, EM VIR ZIK ANT GUYAN
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil Ministry of Health, 2015, SEM EP, V46
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carles G, 1999, CLIN INFECT DIS, V28, P637, DOI 10.1086/515144
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CFEF, AID EX ECH CAS RISQ
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pacheco O, 2016, N ENGL J MED
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   WHO, 2016, PREGN MAN CONT ZIK V
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 27
TC 33
Z9 33
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD JUN
PY 2017
VL 49
IS 6
BP 729
EP 736
DI 10.1002/uog.17404
PG 8
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA EW6TA
UT WOS:000402642000009
PM 28078779
OA Bronze
DA 2020-07-08
ER

PT J
AU Pomar, L
   Rousset, D
   Jolivet, A
   Pomar, C
   Lambert, V
AF Pomar, L.
   Rousset, D.
   Jolivet, A.
   Pomar, C.
   Lambert, V.
TI Ascertaining fetal Zika virus infection based on IgM antibody test in
   endemic settings Reply
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Letter
C1 [Pomar, L.; Pomar, C.; Lambert, V.] Ctr Hosp Ouest Guyanais, St Laurent du Maronis Hosp, Dept Obstet & Gynecol, St Laurent Du Maroni, French Guiana.
   [Rousset, D.] Natl Reference Ctr Arboviruses Cayenne, Lab Virol, Inst Pasteur French Guiana, Cayenne, French Guiana.
   [Jolivet, A.] Ctr Hosp Ouest Guyanais, St Laurent du Maronis Hosp, Publ Hlth Dept, St Laurent Du Maroni, French Guiana.
RP Pomar, C (corresponding author), Ctr Hosp Ouest Guyanais, St Laurent du Maronis Hosp, Dept Obstet & Gynecol, St Laurent Du Maroni, French Guiana.
EM leo.pomar@live.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147; Jolivet,
   Anne/0000-0001-6233-1225
CR [Anonymous], 2014, POINT EPIDEMIOLOGIQU
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
NR 3
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD JUN
PY 2017
VL 49
IS 6
DI 10.1002/uog.17510
PG 1
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA EW6TA
UT WOS:000402642000025
PM 28573771
OA Bronze
DA 2020-07-08
ER

PT J
AU Yang, Y
   Wong, G
   Ye, BG
   Li, SH
   Li, SQ
   Zheng, HX
   Wang, Q
   Liang, MF
   Gao, GF
   Liu, L
   Liu, YX
   Bi, YH
AF Yang, Yang
   Wong, Gary
   Ye, Baoguo
   Li, Shihua
   Li, Shanqin
   Zheng, Haixia
   Wang, Qiang
   Liang, Mifang
   Gao, George F.
   Liu, Lei
   Liu, Yingxia
   Bi, Yuhai
TI Development of a reverse transcription quantitative polymerase chain
   reaction-based assay for broad coverage detection of African and Asian
   Zika virus lineages
SO VIROLOGICA SINICA
LA English
DT Article
DE Flavivirus; Zika virus(ZIKV); molecular diagnostics; qRT-PCR
ID GENOMIC CHARACTERIZATION; TRANSMISSION; INFECTION; TESTES; CHINA
AB The Zika virus (ZIKV) is an arbovirus that has spread rapidly worldwide within recent times. There is accumulating evidence that associates ZIKV infections with Guillain-Barr, Syndrome (GBS) and microcephaly in humans. The ZIKV is genetically diverse and can be separated into Asian and African lineages. A rapid, sensitive, and specific assay is needed for the detection of ZIKV across various pandemic regions. So far, the available primers and probes do not cover the genetic diversity and geographic distribution of all ZIKV strains. To this end, we have developed a one-step quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay based on conserved sequences in the ZIKV envelope (E) gene. The detection limit of the assay was determined to be five RNA transcript copies and 2.94 x 10(-3) 50% tissue culture infectious doses (TCID50) of live ZIKV per reaction. The assay was highly specific and able to detect five different ZIKV strains covering the Asian and African lineages without nonspecific amplification, when tested against other flaviviruses. The assay was also successful in testing for ZIKV in clinical samples. Our assay represents an improvement over the current methods available for the detection ZIKV and would be valuable as a diagnostic tool in various pandemic regions.
C1 [Yang, Yang; Wong, Gary; Li, Shanqin; Zheng, Haixia; Wang, Qiang; Gao, George F.; Liu, Lei; Liu, Yingxia; Bi, Yuhai] Shenzhen Third Peoples Hosp, State Key Discipline Infect Dis, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
   [Yang, Yang; Wong, Gary; Li, Shihua; Wang, Qiang; Gao, George F.; Bi, Yuhai] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Collaborat Innovat Ctr Diag & Treatment Infect Di, CAS Key Lab Pathogen Microbiol & Immunol,Inst Mic, Beijing 100101, Peoples R China.
   [Ye, Baoguo] Jilin Univ, China Japan Union Hosp, Changchun 130033, Peoples R China.
   [Liang, Mifang] China CDC, Natl Inst Viral Dis Control & Prevent, NHFPC, Key Lab Med Virol, Beijing 102206, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent, Off Director Gen, Beijing 102206, Peoples R China.
   [Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
RP Liu, L; Liu, YX; Bi, YH (corresponding author), Shenzhen Third Peoples Hosp, State Key Discipline Infect Dis, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.; Bi, YH (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Collaborat Innovat Ctr Diag & Treatment Infect Di, CAS Key Lab Pathogen Microbiol & Immunol,Inst Mic, Beijing 100101, Peoples R China.
EM liulei3322@aliyun.com; yingxialiu@hotmail.com; beeyh@im.ac.cn
RI Liu, lei/V-9405-2018
OI Liu, lei/0000-0001-9612-6844
FU National Science and Technology Major Project [2016ZX10004222]; Sanming
   Project of Medicine in Shenzhen [ZDSYS2015 04301534057]; Key specialized
   fund for infectious diseases in Shenzhen City [201161]; Chinese Academy
   of SciencesChinese Academy of Sciences [KJZD-EW-L09, KJZD-EW-L15];
   Shenzhen Science and Technology Research and Development Project
   [JCYJ20160427151920801, JCYJ20160427153238750]; Youth Innovation
   Promotion Association of Chinese Academy of Sciences (CAS) [2017122];
   Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); President's International Fellowship Initiative
   from the CAS
FX This work was supported by the National Science and Technology Major
   Project (2016ZX10004222), the Sanming Project of Medicine in Shenzhen
   (ZDSYS2015 04301534057), the Key specialized fund for infectious
   diseases in Shenzhen City (No. 201161), the intramural special grant for
   influenza virus research from the Chinese Academy of Sciences
   (KJZD-EW-L09 and KJZD-EW-L15), and the Shenzhen Science and Technology
   Research and Development Project (JCYJ20160427151920801 and
   JCYJ20160427153238750). G.F.G. is a leading principal investigator of
   the National Natural Science Foundation of China (NSFC) Innovative
   Research Group (81621091). Y.B. is supported by the Youth Innovation
   Promotion Association of Chinese Academy of Sciences (CAS) (2017122).
   G.W. is the recipient of a Banting Postdoctoral Fellowship from the
   Canadian Institutes of Health Research (CIHR) and the President's
   International Fellowship Initiative from the CAS. We thank Dr. Chengfeng
   Qin and Gary Kobinger for supplying strains of DENVs and ZIKVs.
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu L., 2016, GENOME ANNOUNC, V4
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   WHO, 2017, POST DAT ZIK SIT REP
   WHO, 2016, POST DAT ZIK VIR COM
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong G, 2017, PROTEIN CELL, V8, P162, DOI 10.1007/s13238-016-0357-3
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 37
TC 3
Z9 3
U1 3
U2 15
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD JUN
PY 2017
VL 32
IS 3
BP 199
EP 206
DI 10.1007/s12250-017-3958-y
PG 8
WC Virology
SC Virology
GA EZ4WS
UT WOS:000404713800003
PM 28530022
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Hastings, AK
   Fikrig, E
AF Hastings, Andrew K.
   Fikrig, Erol
TI Zika Virus and Sexual Transmission: A New Route of Transmission for
   Mosquito-borne Flaviviruses
SO YALE JOURNAL OF BIOLOGY AND MEDICINE
LA English
DT Review
AB Beginning in 2015, concern over a new global epidemic has spread in the media, governmental agencies, legislative bodies and the public at large. This newly emerging threat has been reported to cause symptoms ranging from mild fever, rash, and body aches, to severe birth defects and acute onset paralysis. The causative agent of this disease, Zika virus, is closely related to two other important human pathogens, dengue and West Nile Virus (WNV+), but has some distinguishing features that has raised alarms from the scientific community. Like its two close relatives, this virus is a member of the Flaviviridae family, a class of single stranded RNA viruses with a positive sense genome and is spread primarily via the bite of an infected mosquito. However, this virus has demonstrated another route of transmission that is particularly concerning for people outside of the regions where the main mosquito vector for this virus is present. Sexual transmission of Zika virus has been increasingly reported, from both infected males and females to their partner, which has resulted in the World Health Organization (WHO) and the Center for Disease Control (CDC) issuing warnings to those living in or travelling to areas of Zika transmission to practice abstinence and/or avoid unprotected sexual contact for up to six months after infection with this virus. This perspective will outline the evidence for sexual transmission and persistence of viral infection in semen and vaginal secretions as well as review the animal models for sexual transmission of Zika virus.
C1 [Hastings, Andrew K.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis,Anlyan Ctr Med Res & Educ, 300 Cedar St, New Haven, CT 06510 USA.
EM erol.fikrig@yale.edu
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diaz-Nieto LM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001963
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Enserink M., 2011, SEX FIELD TRIP YIELD
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T., 2016, EURO SURVEILL, V21
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Govero J, 2016, NATURE
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Hamer DH, 2016, ANN INTERN MED
   Haneche F., 2016, EURO SURVEILL, V21
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ma W, 2016, CELL
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nicastri E., 2016, EURO SURVEILL, V21
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Osuna CE, 2016, NAT MED
   Prisant N, 2016, CLIN INFECT DIS
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2016, ZIK SIT REP
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 65
TC 28
Z9 29
U1 1
U2 1
PU YALE J BIOLOGY MEDICINE, INC
PI NEW HAVEN
PA 333 CEDAR ST, PO BOX 208000, NEW HAVEN, CT 06520-8000 USA
SN 0044-0086
EI 1551-4056
J9 YALE J BIOL MED
JI Yale J. Biol. Med.
PD JUN
PY 2017
VL 90
IS 2
BP 325
EP 330
PG 6
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA FB3ND
UT WOS:000406048500014
PM 28656018
DA 2020-07-08
ER

PT J
AU Kanokudom, S
   Vilaivan, T
   Wikan, N
   Thepparit, C
   Smith, DR
   Assavalapsakul, W
AF Kanokudom, Sitthichai
   Vilaivan, Tirayut
   Wikan, Nitwara
   Thepparit, Chutima
   Smith, Duncan R.
   Assavalapsakul, Wanchai
TI miR-21 promotes dengue virus serotype 2 replication in HepG2 cells
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Dengue virus serotype 2 (DENV 2); HepG2; MicroRNA (miRNA); miRNA-21
   (miR-21); Anti-miRNA-21 oligonucleotide (AMO-21); Peptide nucleic
   acid-21 (PNA-21)
ID PEPTIDE NUCLEIC-ACIDS; SMALL RNAS; INFECTION; MICRORNAS; EXPRESSION;
   MIR-146A; PROTEIN; IDENTIFICATION; BIOGENESIS; COMPLEX
AB Infection with the mosquito transmitted dengue virus (DENV) remains a significant worldwide public health problem. While the majority of infections are asymptomatic, infection can result in a range of symptoms. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through repression or degradation of mRNAs. To understand the contribution of miRNAs to DENV 2 replication, we screened a number of candidate miRNAs for variations in expression levels during DENV 2 infection of HepG2 (liver) cells. Seven miRNAs were identified as differentially expressed, and one, miR-21, was differentially expressed at all time points examined. Interestingly, miR-21 was also differentially regulated in DENV 2 infection under conditions of antibody dependent enhancement of infection, and in direct Zika virus infection, but not in DENV 4 infection. The role of miR-21 during DENV infection was further examined by treating HepG2 cells with an anti-miR-21 (AMO-21) before DENV infection. The results showed a significant reduction in DENV 2 production, clearly suggesting that miR-21 plays a key role in DENV 2 replication. To further confirm the role of miR-21 in DENV infection, a peptide nucleic acid-21 (PNA-21) construct with a nucleotide sequence complementary to AMO-21, was co-administered with AMO-21 as an AMO-21/PNA-21 complex followed by DENV 2 infection. The results showed that AMO-21 significantly reduced DENV 2 titer, PNA-21 significantly increased DENV 2 titer and the combined AMO-21/PNA-21 showed no difference from non-treated infection controls. Taken together, the results show that miR-21 promotes DENV 2 replication, and this mechanism could serve as a possible therapeutic intervention point. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Kanokudom, Sitthichai; Assavalapsakul, Wanchai] Chulalongkorn Univ, Dept Microbiol, Fac Sci, 254 Phayathai, Bangkok 10330, Thailand.
   [Vilaivan, Tirayut] Chulalongkorn Univ, Dept Chem, Organ Synth Res Unit, Fac Sci, Bangkok 10330, Thailand.
   [Wikan, Nitwara; Thepparit, Chutima; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom 73170, Thailand.
RP Assavalapsakul, W (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Sci, 254 Phayathai, Bangkok 10330, Thailand.
EM wanchai.a@chula.ac.th
RI Kanokudom, Sitthichai/H-4999-2015; Vilaivan, Tirayut/H-3876-2011;
   Vilaivan, Tirayut/AAC-3732-2019; Assavalapsakul, Wanchai/H-8471-2015;
   Smith, Duncan R/C-6891-2011
OI Vilaivan, Tirayut/0000-0002-9184-9506; Assavalapsakul,
   Wanchai/0000-0003-2739-3177; Smith, Duncan R/0000-0002-6592-9852
FU Royal Golden Jubilee Ph.D. ProgramThailand Research Fund (TRF)
   [PHD/0239/2553]; Thailand Research FundThailand Research Fund (TRF)
   [RSA5580052, DPG5780002]; Asahi Glass Foundation; Chulalongkorn
   University Centenary Academic Development Project; 90th Anniversary of
   Chulalongkorn University, Rachadapisek Sompote Fund; Office of Higher
   Education Commission, Ministry of Education
FX This work was financially supported by the Royal Golden Jubilee Ph.D.
   Program (PHD/0239/2553 to S.K.), the Thailand Research Fund (RSA5580052)
   to W.A. and (DPG5780002 to T.V.), The Asahi Glass Foundation,
   Chulalongkorn University Centenary Academic Development Project to W.A.;
   The 90th Anniversary of Chulalongkorn University, Rachadapisek Sompote
   Fund and the Office of Higher Education Commission, Ministry of
   Education. We would like to thank Armed Forces Research Institute of
   Medical Sciences (AFRIMS) and the Department of Disease Control,
   Ministry of Public Health, Thailand for providing the Zika virus isolate
   used in this study.
CR Anastasiadou E, 2015, INT J CANCER, V137, P1491, DOI 10.1002/ijc.29489
   Castillo JA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1364-y
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167
   Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001
   Chen RF, 2014, J INFECTION, V69, P366, DOI 10.1016/j.jinf.2014.05.013
   Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641
   Das I, 2012, J MED CHEM, V55, P6021, DOI 10.1021/jm300253q
   El-Diwany R, 2015, J VIROL, V89, P9454, DOI 10.1128/JVI.00955-15
   Escalera-Cueto M, 2015, VIRUS RES, V196, P105, DOI 10.1016/j.virusres.2014.11.010
   Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629
   Felekkis K, 2010, HIPPOKRATIA, V14, P236
   Felekkis K, 2006, HIPPOKRATIA, V10, P112
   Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57
   Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504
   Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012
   Ingle H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3183
   Israelow B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6408
   Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010
   Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957
   Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Mortimer SA, 2013, NUCLEIC ACIDS RES, V41, P4230, DOI 10.1093/nar/gkt075
   Mukherjee A, 2015, J VIROL, V89, P3356, DOI 10.1128/JVI.03085-14
   Nielsen PE, 2010, CHEM BIODIVERS, V7, P786, DOI 10.1002/cbdv.201000005
   Ouyang XX, 2016, INT J MED SCI, V13, P195, DOI 10.7150/ijms.13996
   Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010
   Qi YM, 2013, MOL MED REP, V7, P791, DOI 10.3892/mmr.2013.1288
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Rosato P, 2012, LEUKEMIA, V26, P2343, DOI 10.1038/leu.2012.108
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   Sakoonwatanyoo P, 2006, INTERVIROLOGY, V49, P161, DOI 10.1159/000089377
   Sharma N, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0249-0
   Sithisarn P, 2003, J MED VIROL, V71, P532, DOI 10.1002/jmv.10520
   Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17
   Thepparit C, 2004, INTERVIROLOGY, V47, P78, DOI 10.1159/000077830
   Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12
   Vilaivan Chotima, 2011, Artif DNA PNA XNA, V2, P50
   Vilaivan T, 2006, ORG LETT, V8, P1897, DOI 10.1021/ol060448q
   Vilaivan T, 2015, ACCOUNTS CHEM RES, V48, P1645, DOI 10.1021/acs.accounts.5b00080
   Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655
   WHO, 2009, WHOHTMNTDDEN20091
   Wu N, 2014, MICROBES INFECT, V16, P911, DOI 10.1016/j.micinf.2014.08.011
   Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003
   Zhang Y, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2014-6
   Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088
NR 52
TC 13
Z9 14
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2017
VL 142
BP 169
EP 177
DI 10.1016/j.antiviral.2017.03.020
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EU7GK
UT WOS:000401203100017
PM 28365456
DA 2020-07-08
ER

PT J
AU Oliveira, SJGD
   dos Reis, CL
   Cipolotti, R
   Gurgel, RQ
   Santos, VS
   Martins, PRS
AF Gomes dos Santos Oliveira, Sheila Jaqueline
   dos Reis, Caroline Lima
   Cipolotti, Rosana
   Gurgel, Ricardo Queiroz
   Santos, Victor Santana
   Saquete Martins-Filho, Paulo Ricardo
TI Anxiety, depression, and quality of life in mothers of newborns with
   microcephaly and presumed congenital Zika virus infection: a follow-up
   study during the first year after birth
SO ARCHIVES OF WOMENS MENTAL HEALTH
LA English
DT Letter
ID DISABILITY; INFANTS; BRAZIL
C1 [Gomes dos Santos Oliveira, Sheila Jaqueline; Cipolotti, Rosana; Gurgel, Ricardo Queiroz; Santos, Victor Santana; Saquete Martins-Filho, Paulo Ricardo] Univ Fed Sergipe, Postgrad Program Hlth Sci, Aracaju, Brazil.
   [Gomes dos Santos Oliveira, Sheila Jaqueline; dos Reis, Caroline Lima; Santos, Victor Santana] Univ Tiradentes, Aracaju, Brazil.
   [Cipolotti, Rosana; Gurgel, Ricardo Queiroz] Univ Fed Sergipe, Dept Med, Aracaju, Brazil.
   [Saquete Martins-Filho, Paulo Ricardo] Univ Fed Sergipe, Invest Pathol Lab, Aracaju, Brazil.
   [Saquete Martins-Filho, Paulo Ricardo] Univ Fed Sergipe, Univ Hosp, Lab Patol Invest, Rua Claudio Batista S-N, BR-49060100 Aracaju, Sergipe, Brazil.
RP Martins, PRS (corresponding author), Univ Fed Sergipe, Postgrad Program Hlth Sci, Aracaju, Brazil.; Martins, PRS (corresponding author), Univ Fed Sergipe, Invest Pathol Lab, Aracaju, Brazil.; Martins, PRS (corresponding author), Univ Fed Sergipe, Univ Hosp, Lab Patol Invest, Rua Claudio Batista S-N, BR-49060100 Aracaju, Sergipe, Brazil.
EM martins-filho@ufs.br
RI Santos, Victor/M-5710-2019; Gurgel, RQ/N-5105-2018; Martins-Filho,
   Paulo/AAC-4773-2019; Santos, Victor S/B-8738-2014
OI Santos, Victor/0000-0003-0194-7397; Gurgel, RQ/0000-0001-9651-3713;
   Santos, Victor S/0000-0003-0194-7397; Rosana,
   Cipolotti/0000-0001-9070-2302; Martins-Filho, Paulo
   Ricardo/0000-0001-8779-0727
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Feizi A, 2014, J RES MED SCI, V19, P145
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Nicol-Harper R, 2007, INFANT BEHAV DEV, V30, P161, DOI 10.1016/j.infbeh.2006.08.005
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Seltzer MM, 2001, AM J MENT RETARD, V106, P265
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Topper S, 2011, CLIN GENET, V80, P117, DOI 10.1111/j.1399-0004.2011.01720.x
NR 12
TC 6
Z9 6
U1 2
U2 5
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 1434-1816
EI 1435-1102
J9 ARCH WOMEN MENT HLTH
JI Arch. Womens Ment. Health
PD JUN
PY 2017
VL 20
IS 3
BP 473
EP 475
DI 10.1007/s00737-017-0724-y
PG 3
WC Psychiatry
SC Psychiatry
GA EU4HK
UT WOS:000400990200013
PM 28429099
DA 2020-07-08
ER

PT J
AU Russo, FB
   Jungmann, P
   Beltrao-Braga, PCB
AF Russo, Fabiele Baldino
   Jungmann, Patricia
   Baleeiro Beltrao-Braga, Patricia Cristina
TI Zika infection and the development of neurological defects
SO CELLULAR MICROBIOLOGY
LA English
DT Review
DE brain damage; congenital Zika syndrome; flaviviruses; microcephaly;
   Zika; ZIKV
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; NEURAL PROGENITORS; CEREBRAL
   ORGANOIDS; STEM-CELLS; BRAIN; TRANSMISSION; PREGNANCY; NEUROGENESIS;
   ACTIVATION
AB Starting with the outbreak in Brazil, Zika virus (ZIKV) infection has been correlated with severe syndromes such as congenital Zika syndrome and Guillain-Barre syndrome. Here, we review the status of Zika virus pathogenesis in the central nervous system (CNS). One of the main concerns about ZIKV exposure during pregnancy is abnormal brain development, which results in microcephaly in newborns. Recent advances in in vitro research show that ZIKV can infect and obliterate cells from the CNS, such as progenitors, neurons, and glial cells. Neural progenitor cells seem to be the main target of the virus, with infection leading to less cell migration, neurogenesis impairment, cell death and, consequently, microcephaly in newborns. The downsizing of the brain can be directly associated with defective development of the cortical layer. In addition, in vivo investigations in mice reveal that ZIKV can cross the placenta and migrate to fetuses, but with a significant neurotropism, which results in brain damage for the pups. Another finding shows that hydrocephaly is an additional consequence of ZIKV infection, being detected during embryonic and fetal development in mouse, as well as after birth in humans. In spite of the advances in ZIKV research in the last year, the mechanisms underlying ZIKV infection in the CNS require further investigation particularly as there are currently no treatments or vaccines against ZIKV infection.
C1 [Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Surg, Sao Paulo, Brazil.
   [Russo, Fabiele Baldino; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Microbiol, Sao Paulo, Brazil.
   [Jungmann, Patricia] Univ Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Sch Arts Sci & Human, Dept Obstet, Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (corresponding author), Ave Prof Dr Orlando Marques Paiva,87 Cidade Univ, BR-05508270 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br
RI Russo, Fabiele/N-4340-2017; Beltrao-Braga, Patricia C B/D-6450-2013
OI Russo, Fabiele/0000-0002-4076-1846; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P., 2016, NEW ENGLAND J MED
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Gabriel E., 2017, CELL STEM CELL, P1
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Johnson K, 2015, NEURAL REGEN RES, V10, P344, DOI 10.4103/1673-5374.153671
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Velho T., 2016, ASS ZIKA VIRUS INFEC, V3099, P1
   Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 62
TC 38
Z9 38
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD JUN
PY 2017
VL 19
IS 6
AR e12744
DI 10.1111/cmi.12744
PG 6
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA EU6YZ
UT WOS:000401183200002
PM 28370966
OA Bronze
DA 2020-07-08
ER

PT J
AU Cordeiro, CN
   Bano, R
   Cross, CIW
   Segars, JH
AF Cordeiro, Christina N.
   Bano, Rashda
   Cross, Chantel I. Washington
   Segars, James H.
TI Zika virus and assisted reproduction
SO CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE assisted reproduction; egg donation; IVF; sperm donation; Zika virus
ID SEXUAL TRANSMISSION; PREGNANCY; INFECTION; SEMEN
AB Purpose of review
   Due to the fact that the Zika virus can be sexually transmitted, there is a potential risk for disease transmission at several stages of assisted reproduction. Such a possibility poses a serious challenge to couples pursing fertility with reproductive technologies. Here, we discuss what is known regarding Zika virus infection with respect to sexual transmission and correlate this knowledge with recent recommendations in the realm of infertility treatment.
   Recent findings
   Zika virus can be transmitted from infected men and women through vaginal, oral or anal intercourse. Zika virus RNA has been detected in blood, semen, cervical mucus and vaginal fluid. Currently, the Centers for Disease Control recommends that infected men wait 6 months, and infected women 8 weeks, prior to attempting pregnancy. Reproductive tissue donors should wait 6 months before giving a specimen.
   Summary
   Further study of Zika virus transmission in different reproductive tissues and establishment of validated testing methods for viral disease transmissibility are urgently needed. Reproductive technologists need to establish screening, testing and laboratory protocols aimed to reduce the risk of Zika virus transmission during assisted reproduction.
C1 [Cordeiro, Christina N.; Cross, Chantel I. Washington; Segars, James H.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Bano, Rashda] EFREC, Edinburgh, Midlothian, Scotland.
RP Segars, JH (corresponding author), Johns Hopkins Univ, Dept Gynecol & Obstet, Sch Med, 720 Rutland Ave,Room 624 Ross Bldg, Baltimore, MD 21205 USA.
EM jsegars2@jhmi.edu
RI Mitchell, Christina/C-5129-2018
OI Mitchell, Christina/0000-0002-0402-2536
FU Howard and Georgeanna Seegar Jones Endowment
FX The work was supported, in part, by the Howard and Georgeanna Seegar
   Jones Endowment.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Centers for Disease Control and Prevention, 2016, OUTC PREGN LAB EV PO
   CHAN PJ, 1992, J ASSIST REPROD GEN, V9, P531, DOI 10.1007/BF01204249
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Devaux A, 2003, HUM REPROD, V18, P2342, DOI 10.1093/humrep/deg431
   Foresta C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015036
   Frank C, 2016, EUROSURVEILLANCE, V9
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gimenes F, 2014, NAT REV UROL, V11, P672, DOI 10.1038/nrurol.2014.285
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Ma MF, 2016, CLIN LAB, V62, P1, DOI 10.7754/Clin.Lab.2015.150706
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Sheffield J, 2016, SEMIN REPROD MED, V34, P259, DOI 10.1055/s-0036-1592065
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   U. S. Department of Health and Human Services Centers for Disease Control Center for Disease Control and Prevention, 2016, TRANSM RISKS
   U. S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, DON SCR REC RED RISK
   Vanroose G, 1997, THERIOGENOLOGY, V47, P1389, DOI 10.1016/S0093-691X(97)00130-1
   Washington CI, 2016, SEMIN REPROD MED, V34, P293, DOI 10.1055/s-0036-1592067
   Zika Virus Guidance Task Force, 2016, GUID PROV CAR WOM ME
NR 26
TC 4
Z9 4
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-872X
EI 1473-656X
J9 CURR OPIN OBSTET GYN
JI Curr. Opin. Obstet. Gynecol.
PD JUN
PY 2017
VL 29
IS 3
BP 175
EP 179
DI 10.1097/GCO.0000000000000366
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EU8KY
UT WOS:000401289000011
PM 28410349
DA 2020-07-08
ER

PT J
AU Johnson, C
AF Johnson, Candace
TI Pregnant woman versus mosquito: A feminist epidemiology of Zika virus
SO JOURNAL OF INTERNATIONAL POLITICAL THEORY
LA English
DT Article
DE Feminist theory; reproductive rights; stratified reproduction; Zika
   virus
ID REPRODUCTION
AB This article investigates the contradictions between public health protocols and infection containment efforts concerning Zika virus and reproductive rights. In El Salvador, for example, women are being advised to avoid pregnancy until 2018, at which time local authorities hope that the virus will be under control. This is not so easy, however, as there is limited access to contraception, abortion is illegal in all instances, and women tend to have little household authority. In this article, I examine the policy, legal, and political contradictions related to the global proliferation of Zika virus in the context of ongoing debates about stratified reproduction. This term conceptualizes the phenomenon that accords different values to reproductive tasks undertaken by women in different socioeconomic, cultural, and national contexts. Whereas reproduction and reproductive autonomy tend to be highly respected and protected for relatively privileged women in the Global North, they tend to be much less so for women of the Global South. Furthermore, the adherence to public and private divisions in both national and transnational contexts segregates reproductive rights from the mainstream of political negotiation and public health intervention, and in doing so frustrates progress toward the realization of global reproductive rights.
C1 [Johnson, Candace] Univ Guelph, Guelph, ON, Canada.
RP Johnson, C (corresponding author), Univ Guelph, Dept Polit Sci, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.
EM cajohnso@uoguelph.ca
CR Amnesty International, 2015, PROH TOT AB EL SALV
   [Anonymous], 2014, IMPROVING HLTH MOTHE
   [Anonymous], 2016, CANADAS ONGOING LEAD
   BBC, 2016, BBC
   Bongat M, 2016, LATIN POST      0204
   Brum E., 2016, GUARDIAN
   CBC News, 2016, CBC NEWS
   CDC and US Centers for Disease Control, 2017, PREGN WOM
   CDC Centers for Disease Control and Prevention, 2017, AR ZIK
   Colen Shellee, 1995, CONCEIVING NEW WORLD, P78
   Farmer P, 2013, CALIF SER PUB ANTHR, V26, P1
   Farmer P, 2003, PATHOLOGIES POWER HL
   Farmer P, 1999, INFECT INEQUALITIES
   Garrett L, 2016, FOREIGN POLICY  0128
   GINSBURG F, 1991, ANNU REV ANTHROPOL, V20, P311
   Greene J, 2013, CALIF SER PUB ANTHR, V26, P33
   Grimes S, 1998, THIRD WORLD Q, V19, P375, DOI 10.1080/01436599814307
   Hanna B, 2013, CALIF SER PUB ANTHR, V26, P15
   Hough CA, 2010, SOC SCI MED, V71, P1757, DOI 10.1016/j.socscimed.2010.05.001
   Jelmayer R, 2016, WALL STREET J
   LaFrance A, 2016, ATLANTIC
   Marc Santora, 2016, NY TIMES
   McDonald B., 2016, NY TIMES
   McDougall L, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0157-9
   McNeil Jr Donald G., 2016, NY TIMES
   Mercer Greg, 2016, ATLANTIC
   Mohanty C. T., 2003, FEMINISM BORDERS DEC
   Mohanty CT, 2013, SIGNS, V38, P967, DOI 10.1086/669576
   MOHANTY CT, 1984, BOUNDARY TWO, V13, P333, DOI 10.1057/fr.1988.42
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   plus55, 2016, BRAZ SUPR COURT TAK
   Rapp R, 2001, PUBLIC CULTURE, V13, P533, DOI 10.1215/08992363-13-3-533
   Rapp Rayna, 2000, TESTING WOMEN TESTIN
   Roberts D., 1997, KILLING BLACK BODY R
   Schoen J, 2005, GENDER AMER CULT, P1
   Sherwood H., 2016, GUARDIAN
   United States Agency for International Development (USAID), 2016, USAID ANN 30 MILL GR
   Whaley EP, 2004, GLOBAL POPULATION PO
   Whittaker A, 2010, MED ANTHROPOL, V29, P363, DOI 10.1080/01459740.2010.501313
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2016, DISP RUM ZIK COMPL
   Yamin AE, 2016, EL PAIS         0209
   Young I.M., 2011, RESPONSIBILITY JUSTI
NR 44
TC 5
Z9 5
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1755-0882
EI 1755-1722
J9 J INT POLIT THEORY
JI J. Int. Polit. Theory
PD JUN
PY 2017
VL 13
IS 2
BP 233
EP 250
DI 10.1177/1755088217702671
PG 18
WC Political Science
SC Government & Law
GA EU1FU
UT WOS:000400760800006
DA 2020-07-08
ER

PT J
AU Shi, Y
   Gao, GF
AF Shi, Yi
   Gao, George F.
TI Structural Biology of the Zika Virus
SO TRENDS IN BIOCHEMICAL SCIENCES
LA English
DT Review
ID WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; DEPENDENT RNA-POLYMERASE;
   FC-GAMMA-RECEPTOR; DENGUE VIRUS; CRYSTAL-STRUCTURE; PROTEIN NS1;
   NS2B-NS3 PROTEASE; MEMBRANE ASSOCIATION; ENVELOPE PROTEIN
AB Zika virus (ZIKV), a Flaviviridae family member transmitted to humans by mosquitoes, has emerged as a major health concern. ZIKV infections can cause serious neurological complications in adults, and infection in pregnant women can cause congenital malformations, including fetal and newborn microcephaly. In response to this emerging concern, the structural virology field was quick to explore the features of ZIKV. These efforts have provided significant insights into ZIKV pathogenesis, and have identified targets for drug design. Here, we review the remarkable progress in structure-based ZIKV research and discuss the current challenges and future opportunities.
C1 [Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Shi, Yi; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
EM shiyi@im.ac.cn; gaof@im.ac.cn
RI amsalu, ribka/G-8780-2019
FU Center for Influenza Research and Early-Warning (CASCIRE) of the Chinese
   Academy of Sciences (CAS); China Ministry of Science and Technology
   National 973 Project [2013CB531502, 2014CB542503]; National Natural
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China [81641001]; Task-Force of Zika Virus Research of CAS; Strategic
   Priority Research Program of CAS [XDB08020100]; NSFCNational Natural
   Science Foundation of China [81622031]; Excellent Young Scientist
   Program of CAS; Youth Innovation Promotion Association of CAS [2015078];
   NSFC Innovative Research Group [81621091]
FX This work was supported by the Center for Influenza Research and
   Early-Warning (CASCIRE) of the Chinese Academy of Sciences (CAS), the
   China Ministry of Science and Technology National 973 Project (Grant No.
   2013CB531502 and 2014CB542503), the Emergency Task-Force Project (Grant
   No. 81641001) of the National Natural Science Foundation of China
   (NSFC), the Task-Force of Zika Virus Research of CAS, and the Strategic
   Priority Research Program of CAS (XDB08020100). Y.S. is supported by the
   Excellent Young Scientist Program from the NSFC (No. 81622031), the
   Excellent Young Scientist Program of CAS, and the Youth Innovation
   Promotion Association of CAS (2015078). G.F.G. is supported partly as a
   leading principal investigator in the NSFC Innovative Research Group
   (Grant No. 81621091).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chuang YC, 2014, J VIROL, V88, P13759, DOI 10.1128/JVI.02166-14
   Chuang YC, 2011, J IMMUNOL, V187, P6483, DOI 10.4049/jimmunol.1102218
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan W, 2017, EMBO J
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HAMPTON T, 2016, JAMA J AM MED ASSOC, V316, P1755
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Richter MKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098785
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Sun DS, 2015, J IMMUNOL, V195, P2743, DOI 10.4049/jimmunol.1500136
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Varshney D, 2016, NUCLEIC ACIDS RES, V44, P10423, DOI 10.1093/nar/gkw637
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yin Y, 2013, VIRAL IMMUNOL, V26, P185, DOI 10.1089/vim.2012.0063
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou H., 2017, ONCOTARGET
NR 93
TC 39
Z9 45
U1 6
U2 66
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0968-0004
EI 1362-4326
J9 TRENDS BIOCHEM SCI
JI Trends Biochem.Sci.
PD JUN
PY 2017
VL 42
IS 6
BP 443
EP 456
DI 10.1016/j.tibs.2017.02.009
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EV3ZA
UT WOS:000401696500007
PM 28318966
DA 2020-07-08
ER

PT J
AU Peredy, TR
   Aleguas, A
AF Peredy, Tamas R.
   Aleguas, Alfred
TI Impact of Zika virus spread on a Florida Poison Information Center
SO CLINICAL TOXICOLOGY
LA English
DT Meeting Abstract
C1 [Peredy, Tamas R.] Univ S Florida, Tampa, FL USA.
   [Aleguas, Alfred] Tampa Gen Hosp, Tampa, FL 33606 USA.
CR Darracq MA, 2014, J MED TOXICOL, V10, P19, DOI 10.1007/s13181-013-0315-x
NR 1
TC 0
Z9 0
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1556-3650
EI 1556-9519
J9 CLIN TOXICOL
JI Clin. Toxicol.
PD JUN
PY 2017
VL 55
IS 5
MA 83
BP 406
EP 406
PG 1
WC Toxicology
SC Toxicology
GA ES8IQ
UT WOS:000399800900097
DA 2020-07-08
ER

PT J
AU Routhu, NK
   Byrareddy, SN
AF Routhu, Nanda Kishore
   Byrareddy, Siddappa N.
TI Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Review
DE Host-virus interaction; Zika virus; Virus glycosylation; Immunity;
   Neuropathogenesis
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; WEST-NILE; NONSTRUCTURAL
   PROTEINS; NEURAL PROGENITORS; CRYSTAL-STRUCTURE; RNA-POLYMERASE;
   YELLOW-FEVER; CEREBRAL ORGANOIDS; COMPLEX-FORMATION
AB The Zika virus (ZIKV) is a newly emerging pathogen that has resulted in a worldwide epidemic. It primarily spreads either through infected Aedes aegypti or Aedes albopictus mosquitos leading to severe neurological disorders such as microcephaly and Guillain-Barr, syndrome in susceptible individuals. The mode of ZIKV entry into specific cell types such as: epidermal keratinocytes, fibroblasts, immature dendritic cells (iDCs), and stem-cell-derived human neural progenitors has been determined through its major surface envelope glycoprotein. It has been known that oligosaccharides that are covalently linked to viral envelope proteins are crucial in defining host-virus interactions. However, the role of sugars/glycans in exploiting host-immune mechanisms and aiding receptor-mediated virus entry is not well defined. Therefore, this review focuses on host-pathogen interactions to better understand ZIKV pathogenesis.
C1 [Routhu, Nanda Kishore; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
RP Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
EM sid.byrareddy@unmc.edu
RI Routhu, Nanda Kishore/U-4106-2019
OI Routhu, Nanda Kishore/0000-0003-2080-819X
FU Nebraska Neuroscience Alliance Endowed Fund Award;  [R01AI113883]
FX This work is supported in part by R01AI113883 and Nebraska Neuroscience
   Alliance Endowed Fund Award to SNB, and we thank Dr. Norgren and Robin
   Taylor for critical reading of the manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   [Anonymous], 2016, B WORLD HEALTH ORGAN, V94, P562, DOI 10.2471/BLT.16.020816
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brinkworth RI, 1999, J GEN VIROL, V80, P1167, DOI 10.1099/0022-1317-80-5-1167
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chang YS, 1999, J VIROL, V73, P6257, DOI 10.1128/JVI.73.8.6257-6264.1999
   Che PL, 2013, VIROLOGY, V446, P303, DOI 10.1016/j.virol.2013.08.009
   Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799
   Chotiwan N, 2014, VIROLOGY, V456, P238, DOI 10.1016/j.virol.2014.03.031
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Droll DA, 2000, VIROLOGY, V275, P335, DOI 10.1006/viro.2000.0488
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110
   Holmes EC, 1998, BRIT MED BULL, V54, P533
   Hombach J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5923
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Jaspan HB, 2006, AIDS, V20, P483, DOI 10.1097/01.aids.0000210602.40267.60
   Feito MJ, 2008, VIRUS RES, V135, P166, DOI 10.1016/j.virusres.2008.03.008
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Lupton K., 2016, BR J NURS, V25, P200
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munoz-Jordan JL, 2010, CURR TOP MICROBIOL, V338, P35, DOI 10.1007/978-3-642-02215-9_3
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005
   PEIRIS JSM, 1979, NATURE, V282, P509, DOI 10.1038/282509a0
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pryor MJ, 1998, J GEN VIROL, V79, P2631, DOI 10.1099/0022-1317-79-11-2631
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tautz N, 2000, VIROLOGY, V273, P351, DOI 10.1006/viro.2000.0425
   Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0
   Vasconcelos-Santos DV, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1313
   Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 131
TC 12
Z9 13
U1 1
U2 29
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD JUN
PY 2017
VL 12
IS 2
BP 219
EP 232
DI 10.1007/s11481-017-9736-7
PG 14
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA ET2DA
UT WOS:000400077600003
PM 28349242
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Shu, HY
   Wang, XS
AF Shu, Hongying
   Wang, Xiang-Sheng
TI GLOBAL DYNAMICS OF A COUPLED EPIDEMIC MODEL
SO DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B
LA English
DT Article
DE Global dynamics; epidemic models; direct disease transmission; indirect
   disease transmission; basic reproduction number
ID TO-CELL TRANSMISSION; NONLINEAR INCIDENCE; REPRODUCTION NUMBERS;
   INFECTION; VIRUS; STABILITY; HIV-1; SPREAD; SIR
AB In this paper, we propose a novel epidemic model coupling direct and indirect transmission of disease and study the global dynamic of the model system. Despite the nonlinearity and complexity of the system, the basic reproduction number exhibits a nice linear property: it is simply the sum of two basic reproduction numbers for direct and indirect disease transmissions respectively. We further demonstrate that the local and global dynamics of the system are related to the basic reproduction number. The new model has the advantage that it generalizes or connects to various disease models on HIV, Zika virus, avian influenza, H1N1 and so on.
C1 [Shu, Hongying] Tongji Univ, Dept Math, Shanghai 200092, Peoples R China.
   [Wang, Xiang-Sheng] Univ Louisiana Lafayette, Dept Math, Lafayette, LA 70503 USA.
RP Wang, XS (corresponding author), Univ Louisiana Lafayette, Dept Math, Lafayette, LA 70503 USA.
EM hshu@tongji.edu.cn; xswang@louisiana.edu
OI Wang, Xiang-Sheng/0000-0003-0410-4643
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11601392, 11571257]; Pujiang Talent Program of
   Shanghai [16PJ1409100]; Program for Young Excellent Talents at Tongji
   University
FX The first author is supported by the National Natural Science Foundation
   of China (No.11601392, 11571257), Pujiang Talent Program of Shanghai
   (No.16PJ1409100) and the Program for Young Excellent Talents at Tongji
   University.
CR Allen LJS, 2015, MATH BIOSCI, V270, P237, DOI 10.1016/j.mbs.2015.04.001
   Bani-Yaghoub M, 2012, J BIOL DYNAM, V6, P923, DOI 10.1080/17513758.2012.693206
   Brauer F, 2013, MATH BIOSCI ENG, V10, P1335, DOI 10.3934/mbe.2013.10.1335
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O, 1995, JOURNAL OF BIOLOGICAL SYSTEMS, VOL 3, P519, DOI 10.1142/S0218339095000484
   Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Korobeinikov A, 2007, B MATH BIOL, V69, P1871, DOI 10.1007/s11538-007-9196-y
   Korobeinikov A, 2006, B MATH BIOL, V68, P615, DOI 10.1007/s11538-005-9037-9
   Kribs-Zaleta CM, 2004, MATH BIOSCI, V192, P137, DOI 10.1016/j.mbs.2004.11.001
   Kuang Y, 1993, DELAY DIFFERENTIAL E
   Lai XL, 2015, J MATH ANAL APPL, V426, P563, DOI 10.1016/j.jmaa.2014.10.086
   Lai XL, 2014, SIAM J APPL MATH, V74, P898, DOI 10.1137/130930145
   McCluskey CC, 2010, MATH BIOSCI ENG, V7, P837, DOI 10.3934/mbe.2010.7.837
   Muroya Y, 2015, DISCRETE CONT DYN-B, V20, P3057, DOI 10.3934/dcdsb.2015.20.3057
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   Pourbashash H, 2014, DISCRETE CONT DYN-B, V19, P3341, DOI 10.3934/dcdsb.2014.19.3341
   Shuai ZS, 2011, MATH BIOSCI, V234, P118, DOI 10.1016/j.mbs.2011.09.003
   Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wang XS, 2012, J THEOR BIOL, V313, P12, DOI 10.1016/j.jtbi.2012.07.024
   Wiggins S., 1990, TEXTS APPL MATH
   Xiao YY, 2016, J MATH BIOL, V72, P343, DOI 10.1007/s00285-015-0887-y
NR 24
TC 1
Z9 1
U1 0
U2 148
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1531-3492
EI 1553-524X
J9 DISCRETE CONT DYN-B
JI Discrete Contin. Dyn. Syst.-Ser. B
PD JUN
PY 2017
VL 22
IS 4
BP 1575
EP 1585
DI 10.3934/dcdsb.2017076
PG 11
WC Mathematics, Applied
SC Mathematics
GA EN3ZN
UT WOS:000395946700018
OA Other Gold
DA 2020-07-08
ER

PT J
AU Cousins, S
AF Cousins, Sophie
TI Three Zika cases are found in India after random tests
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR WHO, 2016, PREV SEX TRANSM ZIK
NR 1
TC 0
Z9 0
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 31
PY 2017
VL 357
AR j2654
DI 10.1136/bmj.j2654
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EW6MZ
UT WOS:000402626000011
PM 28566359
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Dhillon, RS
   Srikrishna, D
   Beier, D
AF Dhillon, Ranu S.
   Srikrishna, Devabhaktuni
   Beier, David
TI ZIKA Halting Zika's resurgence with new rapid tests for the virus
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Letter
C1 [Dhillon, Ranu S.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.
   [Dhillon, Ranu S.] Harvard Med Sch Boston, Boston, MA 02115 USA.
   [Srikrishna, Devabhaktuni] Patient KnowHow San Mateo, San Mateo, CA USA.
   [Beier, David] Bay City Capital, San Francisco, CA USA.
RP Dhillon, RS (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Dhillon, RS (corresponding author), Harvard Med Sch Boston, Boston, MA 02115 USA.
EM dhillon.ranu.s@gmail.com
CR Chang D, 2017, MIAMI HERALD    0131
   Dhillon RS, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j379
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   McNeil D. G., 2017, NY TIMES
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Sun LH, 2017, WASHINGTON POST
NR 6
TC 0
Z9 0
U1 1
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 31
PY 2017
VL 357
AR j2657
DI 10.1136/bmj.j2657
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EW6MZ
UT WOS:000402626000012
PM 28566270
DA 2020-07-08
ER

PT J
AU Lee, AJ
   Bhattacharya, R
   Scheuermann, RH
   Pickett, BE
AF Lee, Alexandra J.
   Bhattacharya, Roshni
   Scheuermann, Richard H.
   Pickett, Brett E.
TI Identification of diagnostic peptide regions that distinguish Zika virus
   from related mosquito-borne Flaviviruses
SO PLOS ONE
LA English
DT Article
ID WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; DENGUE VIRUS; SWISS-MODEL;
   ENVELOPE GLYCOPROTEIN; PROTEIN; EPITOPES; SEROPREVALENCE; INFECTION;
   DATABASE
AB Zika virus (ZIKV) is a member of the Flavivirus genus of positive-sense single-stranded RNA viruses, which includes Dengue, West Nile, Yellow Fever, and other mosquito-borne arboviruses. Infection by ZIKV can be difficult to distinguish from infection by other mosquito -borne Flaviviruses due to high sequence similarity, serum antibody cross-reactivity, and virus co-circulation in endemic areas. Indeed, existing serological methods are not able to consistently differentiate ZIKV from other Flaviviruses, which makes it extremely difficult to accurately calculate the incidence rate of Zika-associated Guillain-Barre in adults, microcephaly in newborns, or asymptomatic infections within a geographical area. In order to identify Zika-specific peptide regions that could be used as serology reagents, we have applied comparative genomics and protein structure analyses to identify amino acid residues that distinguish each of 10 Flavivirus species and subtypes from each other by calculating the specificity, sensitivity, and surface exposure of each residue in relevant target proteins. For ZIKV we identified 104 and 116 15-mer peptides in the E glycoprotein and NS1 non-structural protein, respectively, that contain multiple diagnostic sites and are located in surface-exposed regions in the tertiary protein structure. These sensitive, specific, and surface -exposed peptide regions should serve as useful reagents for seroprevalence studies to better distinguish between prior infections with any of these mosquito-borne Flaviviruses. The development of better detection methods and diagnostic tools will enable clinicians and public health workers to more accurately estimate the true incidence rate of asymptomatic infections, neurological syndromes, and birth defects associated with ZIKV infection.
C1 [Lee, Alexandra J.; Bhattacharya, Roshni; Scheuermann, Richard H.; Pickett, Brett E.] J Craig Venter Inst, La Jolla, CA 92037 USA.
   [Bhattacharya, Roshni] San Diego State Univ, Biol & Med Informat, San Diego, CA 92182 USA.
   [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.
   [Scheuermann, Richard H.] La Jolla Inst Allergy & Immunol, La Jolla, CA USA.
RP Pickett, BE (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.
EM bpickett@jcvi.org
RI Pickett, Brett/AAE-3582-2020
OI Pickett, Brett/0000-0001-7930-8160; Lee, Alexandra/0000-0002-0208-3730
FU United States National Institute of Allergy and Infectious Diseases from
   the National Institute of Allergy and Infectious Diseases of the
   National Institutes of Health, Department of Health and Human Services
   [HHSN272201400028C, U19A1110819]
FX This work was funded by the United States National Institute of Allergy
   and Infectious Diseases (www.niaid.nih.gov) under contract number
   HHSN272201400028C, U19A1110819 (Genomic Centers for Infectious Diseases)
   from the National Institute of Allergy and Infectious Diseases of the
   National Institutes of Health, Department of Health and Human Services.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Bartley LM, 2002, EPIDEMIOL INFECT, V128, P213, DOI 10.1017/S0950268801006495
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Christofferson RC, 2016, AM J TROP MED HYG
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Conlan JV, 2015, AM J TROP MED HYG, V93, P1010, DOI 10.4269/ajtmh.15-0072
   CRASKE J, 1990, VOX SANG, V59, P160, DOI 10.1111/j.1423-0410.1990.tb00851.x
   Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ergunay K, 2010, VECTOR-BORNE ZOONOT, V10, P771, DOI 10.1089/vbz.2009.0130
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FONG TL, 1991, HEPATOLOGY, V14, P64, DOI 10.1002/hep.1840140111
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Linderman SL, 2014, P NATL ACAD SCI USA, V111, P15798, DOI 10.1073/pnas.1409171111
   Maharajan MK, 2016, CLIN REV ALLERGY IMM
   Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Organization WH, 2016, ZIK SIT REP
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/nmeth.1818, 10.1038/NMETH.1818]
   Roze B, 2016, EURO SURVEILL, P21
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Saqi MAS, 1998, PROTEIN ENG, V11, P627, DOI 10.1093/protein/11.8.627
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stave JW, 2013, J IMMUNOL, V191, P1428, DOI 10.4049/jimmunol.1203198
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Venturi G, 2016, EURO SURVEILL, V21
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 54
TC 16
Z9 17
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2017
VL 12
IS 5
AR e0178199
DI 10.1371/journal.pone.0178199
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6GY
UT WOS:000402608700046
PM 28562637
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Buhagiar, TS
   Devine, GJ
   Ritchie, SA
AF Buhagiar, Tamara S.
   Devine, Gregor J.
   Ritchie, Scott A.
TI Metofluthrin: investigations into the use of a volatile spatial
   pyrethroid in a global spread of dengue, chikungunya and Zika viruses
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Spatial repellents; Metofluthrin; Pyrethroids; Mosquito
   control; Dengue fever; Zika virus; Chikungunya
ID TROPICAL INFECTIOUS-DISEASES; IMPREGNATED PLASTIC STRIPS; AEDES-AEGYPTI
   DIPTERA; MOSQUITO VECTORS; FIELD-EVALUATION; REPELLENCY; WOLBACHIA;
   FEVER; CULICIDAE; IMPACT
AB Background: Metofluthrin reduces biting activity in Aedes aegypti through the confusion, knockdown, and subsequent kill of a mosquito. A geographical spread in dengue, chikungunya, and Zika viruses, increases intervention demands. Response to a Zika outbreak may require a different strategy than dengue, as high-risk individuals, specifically pregnant women, need to be targeted.
   Methods: In semi-field conditions within a residential property in Cairns, Queensland, the impacts of metofluthrin on biting behaviour of free-flying Wolbachia-infected Ae. aegypti were evaluated.
   Results: Mortality in Ae. aegypti exposed to metofluthrin over a 22 h period was 100% compared to 2.7% in an untreated room. No biting activity was observed in mosquitoes up to 5 m from the emanator after 10 min of metofluthrin exposure. Use of metofluthrin reduced biting activity up to 8 m, regardless of the host's proximity (near or far) to a dark harbourage area (HA) (P < 0.0001 and P = 0.006), respectively. In the presence or absence of the metofluthrin emanator, the host was most likely bitten when located immediately next to a HA (within 1 m) versus 8 m away from the HA (P = 0.006). The addition of a ceiling fan (0.8 m/s airflow) prevented all biting activity after 10 min of metofluthrin exposure. Previously unexposed Ae. aegypti were less likely to reach the host in a metofluthrin-treated room (<(X)over bar> = 31%) compared to an untreated room ((X) over bar = 100%) (P < 0.0001). In a treated room, if the mosquito had not reached the host within 30 s, they never would. Upon activation, the time required for metofluthrin to infiltrate protected locations within a room causing knockdown in caged mosquitoes, required more time than exposed locations (P < 0.003); however exposed and protected locations do eventually reach equilibrium, affecting mosquitoes equally throughout the room.
   Conclusion: Metofluthrin is effective in interrupting indoor host-seeking in Ae. aegypti. Metofluthrin's efficacy is increased by centrally locating the emanator in the room, and by using a fan to increase airflow. Newly treated rooms may require a period of 2-4 h for sufficient distribution of the metofluthrin into protected locations where mosquitoes may be resting.
C1 [Buhagiar, Tamara S.; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, POB 6811QLD, Cairns 4870, Australia.
   [Devine, Gregor J.] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld 4006, Australia.
RP Buhagiar, TS (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, POB 6811QLD, Cairns 4870, Australia.
EM Tamara.Buhagiar@jcu.edu.au
RI Devine, Gregor J/H-1141-2014; amsalu, ribka/G-8780-2019
OI Devine, Gregor J/0000-0001-6312-0390; 
FU Deployed Warfighter Deployment Grant [W911QY-15-1-0006]; National Health
   and Medical Research CouncilNational Health and Medical Research Council
   of Australia;  [1044698]
FX The study was funded by a Deployed Warfighter Deployment Grant (grant
   #W911QY-15-1-0006) held by QIMR Berghofer. Dr. Scott A. Ritchie is
   supported by the National Health and Medical Research Council. Senior
   Research Fellowship #1044698.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Bennett S, 2015, QUEENSLAND DENGUE MA
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Darbro JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2004-0
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hogarh J, 2016, MALARIA J, V15, P1126
   Katsuda Yoshio, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P48
   Katsuda Y, 2009, SE ASIAN J TROP MED, V40, P929
   Kawada H, 2005, AM J TROP MED HYG, V73, P350, DOI 10.4269/ajtmh.2005.73.350
   Kawada H, 2005, J VECTOR ECOL, V30, P181
   Kawada H, 2006, AM J TROP MED HYG, V75, P1153, DOI 10.4269/ajtmh.2006.75.1153
   KAY BH, 1984, MED J AUSTRALIA, V140, P264, DOI 10.5694/j.1326-5377.1984.tb104033.x
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Krieger RI, 2003, ENVIRON HEALTH PERSP, V111, P1439, DOI 10.1289/ehp.6177
   Liu WL, 2003, ENVIRON HEALTH PERSP, V111, P1454, DOI 10.1289/ehp.6286
   Lucas JR, 2007, J AM MOSQUITO CONTR, V23, P47, DOI 10.2987/8756-971X(2007)23[47:ULAFTO]2.0.CO;2
   MacKenzie JS, 1996, J MED MICROBIOL, V45, P159, DOI 10.1099/00222615-45-3-159
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Rapley LP, 2009, AM J TROP MED HYG, V81, P94, DOI 10.4269/ajtmh.2009.81.94
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Ujihara K, 2004, BIOSCI BIOTECH BIOCH, V68, P170, DOI 10.1271/bbb.68.170
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   World Health Organization-Special Programme for Res. and Training on Tropical Diseases, 2016, EB SIT REP, pvii 1
NR 29
TC 6
Z9 6
U1 1
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 30
PY 2017
VL 10
AR 270
DI 10.1186/s13071-017-2219-0
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EW2OD
UT WOS:000402335000008
PM 28558804
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Perkins, TA
AF Perkins, T. Alex
TI Retracing Zika's footsteps across the Americas with computational
   modeling
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Editorial Material
ID DISEASE; VIRUS
C1 [Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
RP Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
EM taperkins@nd.edu
FU RAPID award from the National Science Foundation [DEB 1641130]; Young
   Faculty Award from the Defense Advanced Research Projects Agency
   [D16AP00114]; National Institutes of Health/National Institutes of
   Allergy and Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [1P01AI098670-01A1]
FX The author's research is supported by a RAPID award from the National
   Science Foundation (DEB 1641130), a Young Faculty Award from the Defense
   Advanced Research Projects Agency (D16AP00114), and a grant from the
   National Institutes of Health/National Institutes of Allergy and
   Infectious Disease (1P01AI098670-01A1).
CR Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Bedford T, 2016, NEXT STRAIN REAL TIM
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chretien JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002109
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lofgren ET, 2014, P NATL ACAD SCI USA, V111, P18095, DOI 10.1073/pnas.1421551111
   Matsuura K., 2016, TERRESTRIAL AIR TEMP
   Miles T, 2016, WHO SAYS ZIKA VIRUS
   Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695
   Riley S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.157, 10.1038/NMICROBIOL.2016.157]
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   World Health Organization, 2016, SAUDI MED J
   Zhang Q, 2016, PROJECTED SPREAD ZIK
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 25
TC 6
Z9 6
U1 0
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 30
PY 2017
VL 114
IS 22
BP 5558
EP 5560
DI 10.1073/pnas.1705969114
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW1ZV
UT WOS:000402296700030
PM 28533416
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zhang, Q
   Sun, KY
   Chinazzi, M
   Piontti, APY
   Dean, NE
   Rojas, DP
   Merler, S
   Mistry, D
   Poletti, P
   Rossi, L
   Bray, M
   Halloran, ME
   Longini, IM
   Vespignani, A
AF Zhang, Qian
   Sun, Kaiyuan
   Chinazzi, Matteo
   Pastore y Piontti, Ana
   Dean, Natalie E.
   Rojas, Diana Patricia
   Merler, Stefano
   Mistry, Dina
   Poletti, Piero
   Rossi, Luca
   Bray, Margaret
   Halloran, M. Elizabeth
   Longini, Ira M., Jr.
   Vespignani, Alessandro
TI Spread of Zika virus in the Americas
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; computational epidemiology; metapopulation network model;
   vector-borne diseases
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; OUTBREAK; RISK; EPIDEMIOLOGY;
   CHIKUNGUNYA; INFECTION; BRAZIL
AB We use a data-driven global stochastic epidemic model to analyze the spread of the Zika virus (ZIKV) in the Americas. The model has high spatial and temporal resolution and integrates real-world demographic, human mobility, socioeconomic, temperature, and vector density data. We estimate that the first introduction of ZIKV to Brazil likely occurred between August 2013 and April 2014 (90% credible interval). We provide simulated epidemic profiles of incident ZIKV infections for several countries in the Americas through February 2017. The ZIKV epidemic is characterized by slow growth and high spatial and seasonal heterogeneity, attributable to the dynamics of the mosquito vector and to the characteristics and mobility of the human populations. We project the expected timing and number of pregnancies infected with ZIKV during the first trimester and provide estimates of microcephaly cases assuming different levels of risk as reported in empirical retrospective studies. Our approach represents a modeling effort aimed at understanding the potential magnitude and timing of the ZIKV epidemic and it can be potentially used as a template for the analysis of future mosquito-borne epidemics.
C1 [Zhang, Qian; Sun, Kaiyuan; Chinazzi, Matteo; Pastore y Piontti, Ana; Mistry, Dina; Bray, Margaret; Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.
   [Dean, Natalie E.; Longini, Ira M., Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL 32611 USA.
   [Rojas, Diana Patricia] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32611 USA.
   [Merler, Stefano] Bruno Kessler Fdn, I-38123 Trento, Italy.
   [Poletti, Piero] Univ Commerciale L Bocconi, Dondena Ctr Res Social Dynam & Publ Policy, I-20136 Milan, Italy.
   [Rossi, Luca; Vespignani, Alessandro] Inst Sci Interchange Fdn, I-10126 Turin, Italy.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
RP Vespignani, A (corresponding author), Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.; Vespignani, A (corresponding author), Inst Sci Interchange Fdn, I-10126 Turin, Italy.
EM a.vespignani@northeastern.edu
RI Zhang, Qian/M-5476-2017; Mistry, Dina/AAR-4654-2020; Pastore y Piontti,
   Ana/M-6624-2014; merler, stefano/I-3557-2017; Rojas, Diana
   Patricia/AAC-2469-2019
OI Zhang, Qian/0000-0002-6157-9912; Mistry, Dina/0000-0002-1598-1388;
   Pastore y Piontti, Ana/0000-0002-2894-0489; merler,
   stefano/0000-0002-5117-0611; Rojas, Diana Patricia/0000-0003-0241-6416;
   Vespignani, Alessandro/0000-0003-3419-4205; Chinazzi,
   Matteo/0000-0002-5955-1929
FU Models of Infectious Disease Agent Study; National Institute of General
   Medical Sciences GrantUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U54GM111274]; European
   CommissionEuropean Commission Joint Research Centre [641191]; Colombian
   Department of Science and Technology Fulbright-Colciencias scholarship
FX This work was supported by Models of Infectious Disease Agent Study,
   National Institute of General Medical Sciences Grant U54GM111274,
   European Commission Horizon 2020 CIMPLEX Grant 641191, and a Colombian
   Department of Science and Technology Fulbright-Colciencias scholarship
   (to D.P.R.).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Allard A, 2016, 090324 BIORXIV
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castro LA, 2016, BIORXIV
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Controland Prevention, 2016, COUNTR TERR AM ACT Z
   Centers for Disease Controland Prevention, 2016, CAS COUNTS US
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Melo Freire CC, 2015, 032839 BIORXIV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gomes M.F., 2014, PLOS CURR, V6
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Health Ministry of Puerto Rico, 2017, INF ZIK MUN
   Instituto Nacional de Salud, B EP SEM
   Instituto Nacional de Salud, 2017, B EP SEM
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Manore C, 2016, BIORXIV, DOI DOI 10.1016/J.JTBI.2014.04.033
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miller JC, 2017, MATH MODELS SIR DIS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nelson B, 2016, TRAVEL VOLUME US COU
   Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organisation, 2016, REG ZIK EP UPD AM
   Pan-American Health Organization, 2016, ZIK EP REP BRAZ
   Pan-American Health Organization, 2016, ZIK EP REP HOND
   Pan-American Health Organization, 2016, ZIK EP REP VEN
   Pan-American Health Organization, 2016, ZIK EP REP EI SALV
   Pan-American Health Organization, 2016, COUNTR TERR AUT TRAN
   Pan-American Health Organization, 2016, ZIK EP REP MEX
   Pan-American Health Organization, 2016, ZIK EP REP PUERT RIC
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riley S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.157, 10.1038/NMICROBIOL.2016.157]
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rojas DP, 2016, EUROSURVEILLANCE, V21
   Schuler-Faccini L, 2016, POSSIBLE ASS ZIKA VI
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK VIR
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zhang Q, 2015, LECT NOTES ARTIF INT, V9286, P237, DOI 10.1007/978-3-319-23461-8_21
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 72
TC 87
Z9 87
U1 4
U2 46
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 30
PY 2017
VL 114
IS 22
BP E4334
EP E4343
DI 10.1073/pnas.1620161114
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW1ZV
UT WOS:000402296700006
PM 28442561
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Butler, D
AF Butler, Declan
TI Decline in Zika throws trials into doubt
SO NATURE
LA English
DT News Item
NR 0
TC 5
Z9 5
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 25
PY 2017
VL 545
IS 7655
BP 396
EP 397
DI 10.1038/545396a
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV6TH
UT WOS:000401906500019
PM 28541340
DA 2020-07-08
ER

PT J
AU Liu, Y
   Liu, JY
   Du, SY
   Shan, C
   Nie, KX
   Zhang, R
   Li, XF
   Zhang, R
   Wang, T
   Qin, CF
   Wang, P
   Shi, PY
   Cheng, G
AF Liu, Yang
   Liu, Jianying
   Du, Senyan
   Shan, Chao
   Nie, Kaixiao
   Zhang, Rudian
   Li, Xiao-Feng
   Zhang, Renli
   Wang, Tao
   Qin, Cheng-Feng
   Wang, Penghua
   Shi, Pei-Yong
   Cheng, Gong
TI Evolutionary enhancement of Zika virus infectivity in Aedes aegypti
   mosquitoes
SO NATURE
LA English
DT Article
ID FLAVIVIRUS NS1 PROTEIN; PATHOGENESIS; EMERGENCE; SERA
AB Zika virus (ZIKV) remained obscure until the recent explosive outbreaks in French Polynesia (2013-2014) and South America (2015-2016)(1-3). Phylogenetic studies have shown that ZIKV has evolved into African and Asian lineages. The Asian lineage of ZIKV was responsible for the recent epidemics in the Americas(1,3). However, the underlying mechanisms through which ZIKV rapidly and explosively spread from Asia to the Americas are unclear. Non-structural protein 1 (NS1) facilitates flavivirus acquisition by mosquitoes from an infected mammalian host and subsequently enhances viral prevalence in mosquitoes(4). Here we show that NS1 antigenaemia determines ZIKV infectivity in its mosquito vector Aedes aegypti, which acquires ZIKV via a blood meal. Clinical isolates from the most recent outbreak in the Americas were much more infectious in mosquitoes than the FSS13025 strain, which was isolated in Cambodia in 2010. Further analyses showed that these epidemic strains have higher NS1 antigenaemia than the FSS13025 strain because of an alanine-to-valine amino acid substitution at residue 188 in NS1. ZIKV infectivity was enhanced by this amino acid substitution in the ZIKV FSS13025 strain in mosquitoes that acquired ZIKV from a viraemic C57BL/6 mouse deficient in type I and II interferon (IFN) receptors (AG6 mouse). Our results reveal that ZIKV evolved to acquire a spontaneous mutation in its NS1 protein, resulting in increased NS1 antigenaemia. Enhancement of NS1 antigenaemia in infected hosts promotes ZIKV infectivity and prevalence in mosquitoes, which could have facilitated transmission during recent ZIKV epidemics.
C1 [Liu, Yang; Liu, Jianying; Du, Senyan; Nie, Kaixiao; Zhang, Rudian; Cheng, Gong] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.
   [Liu, Yang; Zhang, Rudian] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Liu, Yang; Liu, Jianying; Zhang, Renli; Wang, Tao; Cheng, Gong] Shenzhen Ctr Dis Control & Prevent, SZCDC SUSTech Joint Key Lab Trop Dis, Shenzhen 518055, Guangdong, Peoples R China.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Wang, Tao] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China.
   [Wang, Penghua] New York Med Coll, Sch Med, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
RP Cheng, G (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Cheng, G (corresponding author), Shenzhen Ctr Dis Control & Prevent, SZCDC SUSTech Joint Key Lab Trop Dis, Shenzhen 518055, Guangdong, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu; gongcheng@mail.tsinghua.edu.cn
RI Qin, Cheng-Feng/I-6839-2019; 张, 入典/D-2513-2017
OI Qin, Cheng-Feng/0000-0002-0632-2807; 张, 入典/0000-0003-2214-4892; Shan,
   Chao/0000-0002-3953-3782
FU National Key Research and Development Plan of China [2016YFD0500400,
   2016ZX10004001-008, 2017ZX09101-005, 2016YFC1201000, 2016YFD0500300];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81422028, 81571975, 81522025, 31300600]; National
   Key Basic Research Program of ChinaNational Basic Research Program of
   China [2013CB911500, SZSTI-JCYJ2016033111585 3521]; National Institutes
   of Health of the United StatesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI087856,
   AI103807]; Shenzhen San-Ming Project; Academy of Medical SciencesAcademy
   of Medical Sciences (AMS); Newton Fund; University of Texas Medical
   Branch (UTMB); University of Texas STARs Award
FX This work was funded by grants from the National Key Research and
   Development Plan of China (2016YFD0500400, 2016ZX10004001-008,
   2017ZX09101-005, 2016YFC1201000, 2016YFD0500300), the National Natural
   Science Foundation of China (81422028, 81571975, 81522025, 31300600),
   the National Key Basic Research Program of China (2013CB911500,
   SZSTI-JCYJ2016033111585 3521), the National Institutes of Health of the
   United States (R01AI087856, AI103807), and Shenzhen San-Ming Project for
   prevention and research on vector-borne diseases. G.C. is a Newton
   Advanced Fellow awarded by the Academy of Medical Sciences and the
   Newton Fund. G.C. is also a Janssen Investigator at Tsinghua University.
   P.-Y.S. was supported by a University of Texas Medical Branch (UTMB)
   startup award and a University of Texas STARs Award. We thank the core
   facilities of the Center for Life Sciences and Center of Biomedical
   Analysis (Tsinghua University) for technical assistance.
CR Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Takamatsu Y, 2014, J GEN VIROL, V95, P373, DOI 10.1099/vir.0.057968-0
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 30
TC 160
Z9 168
U1 5
U2 85
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 25
PY 2017
VL 545
IS 7655
BP 482
EP +
DI 10.1038/nature22365
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV6TH
UT WOS:000401906500052
PM 28514450
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Borena, W
   Hofer, T
   Stiasny, K
   Aberle, SW
   Gaber, M
   Von Laer, D
   Schennach, H
AF Borena, Wegene
   Hofer, Tamara
   Stiasny, Karin
   Aberle, Stephan W.
   Gaber, Manfred
   Von Laer, Dorothee
   Schennach, Harald
TI No molecular or serological evidence of Zikavirus infection among
   healthy blood donors living in or travelling to regions where Aedes
   albopictus circulates
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; MOSQUITOS
AB Background
   Previous studies have shown that Zika virus can infect and be transmitted by A. albopictus. The World Health organization (WHO) has raised concerns of autochthonous transmission of the virus in regions where the vector is endemic. The aim of this pilot study was to assess the occurrence of Zika virus (ZIKV) in western Austria (Tyrol) especially after a history of travel to A. albopictus endemic regions.
   Methods
   The study participants were healthy blood donors at randomly selected donation sites in the west Austrian region Tyrol. Rest blood (plasma) samples were tested for the presence of ZIKV nucleic acid and antibodies against the virus.
   Results
   Mean age of the study participants was 44.6 (SD = 12.9) and 58.8% were men. Eighty percent reported to have received vaccine against TBEV, whereas only 4.9 and 0.9% had received YFV and JEV vaccines. Three out of 1001 (0.03%) participants tested positive solely for ZIKV IgM antibody but not for other flaviviruses. Only one individual had ZIKV IgG antibody. All four donors were negative in the neutralization (confirmation) assay. No viral RNA was detected in any of the samples.
   Conclusion
   The null finding of our study refutes WHO's initial fear of global expansion of ZIKV infection including its occurrence in Europe. There appears to be no urgent need to introduce universal screening of donated blood for ZIKV in central Europe at least until the next warm season. Further, Euroimmun anti-Zika ELISA proved to be a highly suitable and reliable test system in populations with high prevalence of TBEV infection and/or immunization.
C1 [Borena, Wegene; Hofer, Tamara; Von Laer, Dorothee] Med Univ Innsbruck, Div Virol, Innsbruck, Austria.
   [Stiasny, Karin; Aberle, Stephan W.] Med Univ Vienna, Ctr Virol, Vienna, Austria.
   [Gaber, Manfred] Tyrolean Red Cross Blood Donor Serv, Innsbruck, Austria.
   [Schennach, Harald] Med Univ Hosp Innsbruck, Cent Inst Blood Transfus & Immunol, Innsbruck, Austria.
RP Borena, W (corresponding author), Med Univ Innsbruck, Div Virol, Innsbruck, Austria.
EM wegene.borena@i-med.ac.at
OI Stiasny, Karin/0000-0002-1902-8674; Borena, Wegene/0000-0001-8011-5825
FU MFF Tirol [271]
FX Support was provided by MFF Tirol, project Nr. 271. The fund provided
   was used to buy test kits.
CR Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gallian P, 2016, BLOOD
   Gulland A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2887
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huzly D, 2016, EURO SURVEILL, V21
   Kunze U, 2015, CENT EUR J PUBL HEAL, V23, P223
   Lupton Kelly, 2016, Br J Nurs, V25, P200, DOI 10.12968/bjon.2016.25.4.198
   Musso D., 2014, EURO SURVEILL, V19
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Stiasny K., 2013, EURO SURVEILL, V18, P20614
   WHO, WHO DIR GEN SUMM OUT
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 17
TC 4
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 24
PY 2017
VL 12
IS 5
AR e0178175
DI 10.1371/journal.pone.0178175
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV8VE
UT WOS:000402061500069
PM 28542611
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Watts, AG
   Miniota, J
   Joseph, HA
   Brady, OJ
   Kraemer, MUG
   Grills, AW
   Morrison, S
   Esposito, DH
   Nicolucci, A
   German, M
   Creatore, MI
   Nelson, B
   Johansson, MA
   Brunette, G
   Hay, SI
   Khan, K
   Cetron, M
AF Watts, Alexander G.
   Miniota, Jennifer
   Joseph, Heather A.
   Brady, Oliver J.
   Kraemer, Moritz U. G.
   Grills, Ardath W.
   Morrison, Stephanie
   Esposito, Douglas H.
   Nicolucci, Adriano
   German, Matthew
   Creatore, Maria I.
   Nelson, Bradley
   Johansson, Michael A.
   Brunette, Gary
   Hay, Simon I.
   Khan, Kamran
   Cetron, Marty
TI Elevation as a proxy for mosquito-borne Zika virus transmission in the
   Americas
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI; VECTORIAL CAPACITY; DENGUE; ALBOPICTUS; CHIKUNGUNYA;
   BEHAVIOR; CLIMATE; IMPACT; FEVER; RISK
AB Introduction
   When Zika virus (ZIKV) first began its spread from Brazil to other parts of the Americas, national-level travel notices were issued, carrying with them significant economic consequences to affected countries. Although regions of some affected countries were likely unsuitable for mosquito-borne transmission of ZIKV, the absence of high quality, timely surveillance data made it difficult to confidently demarcate infection risk at a sub-national level. In the absence of reliable data on ZIKV activity, a pragmatic approach was needed to identify subnational geographic areas where the risk of ZIKV infection via mosquitoes was expected to be negligible. To address this urgent need, we evaluated elevation as a proxy for mosquito-borne ZIKV transmission.
   Methods
   For sixteen countries with local ZIKV transmission in the Americas, we analyzed (i) modelled occurrence of the primary vector for ZIKV, Aedes aegypti, (ii) human population counts, and (iii) reported historical dengue cases, specifically across 100-meter elevation levels between 1,500m and 2,500m. Specifically, we quantified land area, population size, and the number of observed dengue cases above each elevation level to identify a threshold where the predicted risks of encountering Ae. aegypti become negligible.
   Results
   Above 1,600m, less than 1% of each country's total land area was predicted to have Ae. aegypti occurrence. Above 1,900m, less than 1% of each country's resident population lived in areas where Ae. aegypti was predicted to occur. Across all 16 countries, 1.1% of historical dengue cases were reported above 2,000m.
   Discussion
   These results suggest low potential for mosquito-borne ZIKV transmission above 2,000m in the Americas. Although elevation is a crude predictor of environmental suitability for ZIKV transmission, its constancy made it a pragmatic input for policy decision-making during this public health emergency.
C1 [Watts, Alexander G.; Miniota, Jennifer; Nicolucci, Adriano; German, Matthew; Creatore, Maria I.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Joseph, Heather A.; Grills, Ardath W.; Morrison, Stephanie; Esposito, Douglas H.; Nelson, Bradley; Brunette, Gary; Cetron, Marty] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Brady, Oliver J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England.
   [Kraemer, Moritz U. G.; Hay, Simon I.] Univ Oxford, Oxford Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.
   [Morrison, Stephanie] Ctr Dis Control & Prevent, Eagle Med Serv, LLC Div Global Migrat & Quarantine, Atlanta, GA USA.
   [Creatore, Maria I.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
RP Watts, AG (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
EM wattsa@smh.ca
RI Hay, Simon I/F-8967-2015
OI Hay, Simon I/0000-0002-0611-7272; Johansson, Michael/0000-0002-5090-7722
FU U.S. Centers for Disease Control and PreventionUnited States Department
   of Health & Human ServicesCenters for Disease Control & Prevention -
   USA; Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR); Bill & Melinda Gates FoundationGates Foundation
   [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Senior Research
   Fellowship from the Wellcome Trust [095066]; RAPIDD program of the
   Science & Technology Directorate; Department of Homeland SecurityUnited
   States Department of Homeland Security (DHS); International Research
   Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS;
   European Commission 7th Framework Programme) [21893]
FX Funding for this research came in part from the U.S. Centers for Disease
   Control and Prevention and the Canadian Institutes of Health Research.
   OJB is funded by a grant from the Bill & Melinda Gates Foundation
   (OPP1119467). SIH is funded by a Senior Research Fellowship from the
   Wellcome Trust (#095066), and grants from the Bill & Melinda Gates
   Foundation (OPP1119467, OPP1093011, OPP1106023 and OPP1132415). SIH
   would also like to acknowledge funding support from the RAPIDD program
   of the Science & Technology Directorate, and the Department of Homeland
   Security. MUGK receives funding from the International Research
   Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS;
   European Commission 7th Framework Programme (#21893).
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164
   Danielson J, 2011, 20111073 US GEOL SUR, V2010, P26, DOI [DOI 10.1038/NGEO2668, 10.1186/1476-072X-12-36]
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Fong IW, 2017, EMERG INF DIS 21ST C, P101, DOI 10.1007/978-3-319-50890-0_6
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Grard G, 2014, PLOS NEGLECT TROP D, P8
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   ORNL, 2014, LANDSCAN 2013
   Pan American Health Organization ; World Health Organization, 2016, ZIK EP UPD
   Paz-Bailey G, 2017, N ENGL J MED
   Peterson AT, 2016, PLOS CURR, V8, P9
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Shlim DR, 2009, CDC HLTH INFORM INT, P242
   Stone CM, 2012, AM J TROP MED HYG, V87, P727, DOI 10.4269/ajtmh.2012.12-0123
   Suarez M. F., 1981, Biomedica, V1, P225
   Thavara U, 2001, J VECTOR ECOL, V26, P172
   Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280
   US Census Bureau, 2013, WORLD POP HIST EST W
   Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150
   WHO, 2017, DENG SEV DENG
   Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387
   World Health Organization, 2005, INT HLTH REG, P82
NR 39
TC 14
Z9 14
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 24
PY 2017
VL 12
IS 5
AR e0178211
DI 10.1371/journal.pone.0178211
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV8VE
UT WOS:000402061500072
PM 28542540
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Hicks, SD
   Wang, M
   Fry, K
   Doraiswamy, V
   Wohlford-, EM
AF Hicks, Steven D.
   Wang, Ming
   Fry, Katherine
   Doraiswamy, Vignesh
   Wohlford-, Eric M.
TI Neurodevelopmental Delay Diagnosis Rates Are Increased in a Region with
   Aerial Pesticide Application
SO FRONTIERS IN PEDIATRICS
LA English
DT Article
DE autism spectrum disorder; pyrethroid; neurodevelopmental disorder;
   pesticide; environment
ID WEST-NILE-VIRUS; EXPOSURE; CHILDREN; AUTISM; BRAIN; MECHANISMS;
   DISORDERS; RECEPTORS; DIELDRIN; LINDANE
AB A number of studies have implicated pesticides in childhood developmental delay (DD) and autism spectrum disorder (ASD). The influence of the route of pesticide exposure on neurodevelopmental delay is not well defined. To study this factor, we examined ASD/ DD diagnoses rates in an area near our regional medical center that employs yearly aerial pyrethroid pesticide applications to combat mosquito-borne encephalitis. The aim of this study was to determine if areas with aerial pesticide exposure had higher rates of ASD/ DD diagnoses. This regional study identified higher rates of ASD/DD diagnoses in an area with aerial pesticides application. Zip codes with aerial pyrethroid exposure were 37% more likely to have higher rates of ASD/DD (adjusted RR = 1.37, 95% CI = 1.06-1.78, p = 0.02). A Poisson regression model controlling for regional characteristics (poverty, pesticide use, population density, and distance to medical center), subject characteristics (race and sex), and local birth characteristics (prematurity, low birthweight, and birth rates) identified a significant relationship between aerial pesticide use and ASD/ DD rates. The relationship between pesticide application and human neurodevelopment deserves additional study to develop safe and effective methods of mosquito prevention, particularly as communities develop plans for Zika virus control.
C1 [Hicks, Steven D.; Fry, Katherine; Wohlford-, Eric M.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA.
   [Hicks, Steven D.; Doraiswamy, Vignesh] Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Hershey, PA 17033 USA.
   [Wang, Ming] Penn State Univ, Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA 17033 USA.
   [Fry, Katherine] Palo Alto Med Fdn, Dept Pediat, Palo Alto, CA USA.
   [Wohlford-, Eric M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA.
RP Hicks, SD (corresponding author), SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA.; Hicks, SD (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Hershey, PA 17033 USA.
EM shicks1@hmc.psu.edu
OI Doraiswamy, Vignesh/0000-0002-5908-2974; Hicks,
   Steven/0000-0002-9579-6798; Wang, Ming/0000-0002-9977-7041
FU SUNY Upstate Medical University; Penn State College of MedicineUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
FX This research did not receive any specific grant from funding agencies
   in the public, commercial, or not-for-profit sectors. The authors' time
   was supported by SUNY Upstate Medical University and Penn State College
   of Medicine.
CR Brannen KC, 1998, DEV NEUROSCI-BASEL, V20, P34, DOI 10.1159/000017296
   Briz V, 2011, TOXICOL SCI, V120, P413, DOI 10.1093/toxsci/kfr019
   Brown DA, 2010, J MOL NEUROSCI, V41, P340, DOI 10.1007/s12031-010-9377-2
   Deutsch SI, 2010, CLIN NEUROPHARMACOL, V33, P114, DOI 10.1097/WNF.0b013e3181d6f7ad
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828
   Grubesic T.H., 2006, INT J HEALTH GEOGR, V5, P1, DOI DOI 10.1186/1476-072X-5-1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hossain MM, 2005, LIFE SCI, V77, P795, DOI 10.1016/j.lfs.2005.01.014
   Krishnan S., 2015, AAP GRAND ROUNDS, V33, P16, DOI [10.1542/gr.33-2-16, DOI 10.1542/GR.33-2-16]
   Mahoney JA, 2016, FREQUENTLY ASKED QUE
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Pearson BL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11173
   Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009
   Roberts EM, 2007, ENVIRON HEALTH PERSP, V115, P1482, DOI 10.1289/ehp.10168
   Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.1307044
   Shelton JF, 2012, ENVIRON HEALTH PERSP, V120, P944, DOI 10.1289/ehp.1104553
   Smith JC, 2014, J INFECTION, V69, pS70, DOI 10.1016/j.jinf.2014.07.019
   Viel JF, 2015, ENVIRON INT, V82, P69, DOI 10.1016/j.envint.2015.05.009
   Williams MK, 2006, ENV HLTH PERSPECT, V116, P1681, DOI DOI 10.1289/EHP.11367
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
NR 20
TC 6
Z9 6
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 2296-2360
J9 FRONT PEDIATR
JI Front. Pediatr.
PD MAY 24
PY 2017
VL 5
AR 116
DI 10.3389/fped.2017.00116
PG 9
WC Pediatrics
SC Pediatrics
GA EV7HR
UT WOS:000401947000001
PM 28596952
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU van Boheemen, S
   Tas, A
   Anvar, SY
   van Grootveld, R
   Albulescu, IC
   Bauer, MP
   Feltkamp, MC
   Bredenbeek, PJ
   van Hemert, MJ
AF van Boheemen, Sander
   Tas, Ali
   Anvar, S. Yahya
   van Grootveld, Rebecca
   Albulescu, Irina C.
   Bauer, Martijn P.
   Feltkamp, Mariet C.
   Bredenbeek, Peter J.
   van Hemert, Martijn J.
TI Quasispecies composition and evolution of a typical Zika virus clinical
   isolate from Suriname
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TYPE-2 ENVELOPE PROTEIN; GUILLAIN-BARRE-SYNDROME; DOMAIN-III; SEXUAL
   TRANSMISSION; MUTATION; INFECTION; OUTBREAK; BINDING; STATES
AB The arthropod-borne Zika virus (ZIKV) is currently causing a major international public health threat in the Americas. This study describes the isolation of ZIKV from the plasma of a 29-year-old female traveler that developed typical symptoms, like rash, fever and headache upon return from Suriname. The complete genome sequence including the 5' and 3' untranslated regions was determined and phylogenetic analysis showed the isolate clustering within the Asian lineage, close to other viruses that have recently been isolated in the Americas. In addition, the viral quasispecies composition was analyzed by single molecule real time sequencing, which suggested a mutation frequency of 1.4 x 10(-4) for this ZIKV isolate. Continued passaging of the virus in cell culture led to the selection of variants with mutations in NS1 and the E protein. The latter might influence virus binding to cell surface heparan sulfate.
C1 [van Boheemen, Sander; Tas, Ali; van Grootveld, Rebecca; Albulescu, Irina C.; Feltkamp, Mariet C.; Bredenbeek, Peter J.; van Hemert, Martijn J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.
   [Anvar, S. Yahya] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.
   [Bauer, Martijn P.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.
RP van Hemert, MJ (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.
EM M.J.van_Hemert@lumc.nl
RI Feltkamp, Mariet/A-3788-2010
OI Feltkamp, Mariet/0000-0001-5993-9846; van Hemert,
   Martijn/0000-0002-2617-9243
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Government F. S, 2016, GOV SCOTT LIK MOSQ B
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1
   Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   McAuley AJ, 2016, J VIROL, V90, P4757, DOI 10.1128/JVI.02861-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roehrig JT, 2013, VIROLOGY, V441, P114, DOI 10.1016/j.virol.2013.03.011
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 13
Z9 13
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 24
PY 2017
VL 7
AR 2368
DI 10.1038/s41598-017-02652-w
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX2SO
UT WOS:000425912000003
PM 28539654
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chibueze, EC
   Parsons, AJQ
   Lopes, KD
   Yo, T
   Swa, T
   Nagata, C
   Horita, N
   Morisaki, N
   Balogun, OO
   Dagvadorj, A
   Ota, E
   Mori, R
   Oladapo, OT
AF Chibueze, Ezinne C.
   Parsons, Alex J. Q.
   Lopes, Katharina da Silva
   Yo, Takemoto
   Swa, Toshiyuki
   Nagata, Chie
   Horita, Nobuyuki
   Morisaki, Naho
   Balogun, Olukunmi O.
   Dagvadorj, Amarjargal
   Ota, Erika
   Mori, Rintaro
   Oladapo, Olufemi T.
TI Diagnostic Accuracy of Ultrasound Scanning for Prenatal Microcephaly in
   the context of Zika Virus Infection: A Systematic Review and
   Meta-analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FETAL HEAD; GESTATIONAL-AGE; ULTRASONOGRAPHY; 2ND-TRIMESTER; PREDICTION
AB To assess the accuracy of ultrasound measurements of fetal biometric parameters for prenatal diagnosis of microcephaly in the context of Zika virus (ZIKV) infection, we searched bibliographic databases for studies published until March 3rd, 2016. We extracted the numbers of true positives, false positives, true negatives, and false negatives and performed a meta-analysis to estimate group sensitivity and specificity. Predictive values for ZIKV-infected pregnancies were extrapolated from those obtained for pregnancies unrelated to ZIKV. Of 111 eligible full texts, nine studies met our inclusion criteria. Pooled estimates from two studies showed that at 3, 4 and 5 standard deviations (SDs) < mean, sensitivities were 84%, 68% and 58% for head circumference (HC); 76%, 58% and 58% for occipitofrontal diameter (OFD); and 94%, 85% and 59% for biparietal diameter (BPD). Specificities at 3, 4 and 5 SDs below the mean were 70%, 91% and 97% for HC; 84%, 97% and 97% for OFD; and 16%, 46% and 80% for BPD. No study including ZIKV-infected pregnant women was identified. OFD and HC were more consistent in specificity and sensitivity at lower thresholds compared to higher thresholds. Therefore, prenatal ultrasound appears more accurate in detecting the absence of microcephaly than its presence.
C1 [Chibueze, Ezinne C.; Parsons, Alex J. Q.; Lopes, Katharina da Silva; Yo, Takemoto; Swa, Toshiyuki; Balogun, Olukunmi O.; Dagvadorj, Amarjargal; Ota, Erika; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan.
   [Parsons, Alex J. Q.] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.
   [Swa, Toshiyuki] Osaka Univ, Grad Sch Human Sci, Osaka, Japan.
   [Nagata, Chie] Natl Ctr Child Hlth & Dev, Dept Educ Clin Res, Tokyo, Japan.
   [Horita, Nobuyuki] Yokohama City Univ, Grad Sch Med, Pulmonol, Yokohama, Kanagawa, Japan.
   [Morisaki, Naho] Natl Ctr Child Hlth & Dev, Dept Social Med, Tokyo, Japan.
   [Dagvadorj, Amarjargal] Kyoto Univ, Dept Hlth Informat, Syako Ku, Yoshida Konoe Cho, Kyoto, Japan.
   [Ota, Erika] St Lukes Int Univ, Grad Sch Nursing, Global Hlth Nursing, Tokyo, Japan.
   [Oladapo, Olufemi T.] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland.
RP Chibueze, EC (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan.
EM ezinne.chibueze@gmail.com
RI Chibueze, Ezinne C/C-9403-2016
OI Chibueze, Ezinne C/0000-0002-7881-7374; Ota, Erika/0000-0002-3945-7441;
   Morisaki, Naho/0000-0001-6151-4513; Mori, Rintaro/0000-0001-7656-6156
FU Research on Global Health Issues, Japan Agency for Medical Research and
   Development (AMED)Japan Agency for Medical Research and Development
   (AMED); Japan Agency for Medical Research and Development (AMED)Japan
   Agency for Medical Research and Development (AMED); National Center for
   Child Health and Development (NCCHD); UNDP/UNFPA/UNICEF/WHO/World Bank
   Special Programme of Research, Development and Research Training in
   Human Reproduction (HRP), Department of Reproductive Health and
   Research, World Health Organization
FX We are grateful to Chiemi Kataoka and Miwako Segawa for their help with
   full-text retrieval. The preparation of this review was financially
   supported by grants from the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP), Department of Reproductive Health and Research,
   World Health Organization; Research on Global Health Issues, Japan
   Agency for Medical Research and Development (AMED); Clinical Research
   Program for Child Health and Development from Japan Agency for Medical
   Research and Development (AMED) and the National Center for Child Health
   and Development (NCCHD). The manuscript represents the views of the
   named authors only.
CR Adcock LM, 1998, PEDIATR NEUROL, V19, P263, DOI 10.1016/S0887-8994(98)00041-1
   Aubry MC, 2003, CHILD NERV SYST, V19, P391, DOI 10.1007/s00381-003-0768-3
   Benoist G, 2008, ULTRASOUND OBST GYN, V32, P900, DOI 10.1002/uog.6129
   BENSON CB, 1991, AM J ROENTGENOL, V157, P1275, DOI 10.2214/ajr.157.6.1950881
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   CAMPBELL S, 1983, CLIN OBSTET GYNAECOL, V10, P475
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHERVENAK FA, 1984, AM J OBSTET GYNECOL, V149, P512, DOI 10.1016/0002-9378(84)90027-9
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   DETER RL, 1982, J CLIN ULTRASOUND, V10, P357, DOI 10.1002/jcu.1870100803
   DOUBILET PM, 1984, AM J ROENTGENOL, V142, P797, DOI 10.2214/ajr.142.4.797
   GONCALVES LF, 1994, AM J OBSTET GYNECOL, V171, P1606, DOI 10.1016/0002-9378(94)90411-1
   GRANNUM P, 1987, SEMIN PERINATOL, V11, P85
   Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Levy HL, 1996, PRENATAL DIAG, V16, P599, DOI 10.1002/(SICI)1097-0223(199607)16:7<599::AID-PD915>3.0.CO;2-5
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P51, DOI 10.1046/j.1469-0705.2002.00743.x
   MANDELL J, 1995, J UROLOGY, V153, P1994, DOI 10.1016/S0022-5347(01)67389-0
   Melamed N, 2011, ULTRASOUND OBST GYN, V37, P65, DOI 10.1002/uog.7760
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Reitsma H., 2009, 9 ASSESSING METHODOL
   Schwarzler P, 2003, ULTRASOUND OBST GYN, V22, P640, DOI 10.1002/uog.910
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   WHO, 2016, PREGN MAN CONT ZIK V
   WILSON R D, 1989, Fetal Therapy, V4, P49
   Wong J, 2012, AM J OBSTET GYNECOL, V206, pS164, DOI 10.1016/j.ajog.2011.10.366
   World Health Organization, 2016, ZIK SIT REP ZIK POT
NR 28
TC 9
Z9 9
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 23
PY 2017
VL 7
AR 2310
DI 10.1038/s41598-017-01991-y
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV5ZD
UT WOS:000401847800056
PM 28536443
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rouvinski, A
   Dejnirattisai, W
   Guardado-Calvo, P
   Vaney, MC
   Sharma, A
   Duquerroy, S
   Supasa, P
   Wongwiwat, W
   Haouz, A
   Barba-Spaeth, G
   Mongkolsapaya, J
   Rey, FA
   Screaton, GR
AF Rouvinski, Alexander
   Dejnirattisai, Wanwisa
   Guardado-Calvo, Pablo
   Vaney, Marie-Christine
   Sharma, Arvind
   Duquerroy, Stephane
   Supasa, Piyada
   Wongwiwat, Wiyada
   Haouz, Ahmed
   Barba-Spaeth, Giovanna
   Mongkolsapaya, Juthathip
   Rey, Felix A.
   Screaton, Gavin R.
TI Covalently linked dengue virus envelope glycoprotein dimers reduce
   exposure of the immunodominant fusion loop epitope
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; ZIKA VIRUS; MACROMOLECULAR
   CRYSTALLOGRAPHY; NEUTRALIZING ANTIBODIES; CROSS-NEUTRALIZATION;
   MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; HIGHLY POTENT; SEROTYPE 3;
   INFECTION
AB A problem in the search for an efficient vaccine against dengue virus is the immunodominance of the fusion loop epitope (FLE), a segment of the envelope protein E that is buried at the interface of the E dimers coating mature viral particles. Anti-FLE antibodies are broadly cross-reactive but poorly neutralizing, displaying a strong infection enhancing potential. FLE exposure takes place via dynamic 'breathing' of E dimers at the virion surface. In contrast, antibodies targeting the E dimer epitope (EDE), readily exposed at the E dimer interface over the region of the conserved fusion loop, are very potent and broadly neutralizing. We here engineer E dimers locked by inter-subunit disulfide bonds, and show by X-ray crystallography and by binding to a panel of human antibodies that these engineered dimers do not expose the FLE, while retaining the EDE exposure. These locked dimers are strong immunogen candidates for a next-generation vaccine.
C1 [Rouvinski, Alexander; Guardado-Calvo, Pablo; Vaney, Marie-Christine; Sharma, Arvind; Duquerroy, Stephane; Barba-Spaeth, Giovanna; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.
   [Rouvinski, Alexander; Guardado-Calvo, Pablo; Vaney, Marie-Christine; Sharma, Arvind; Duquerroy, Stephane; Barba-Spaeth, Giovanna; Rey, Felix A.] CNRS UMR Virol 3569, F-75724 Paris 15, France.
   [Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Hosp Campus, London W12 0NN, England.
   [Duquerroy, Stephane] Univ Paris 11, Fac Sci, F-91405 Orsay, France.
   [Haouz, Ahmed] Inst Pasteur, Proteopole, CNRS UMR 3528, F-75724 Paris 15, France.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Off Res & Dev, Dengue Haemorrhag Fever Res Unit,Fac Med, Bangkok 10700, Thailand.
   [Rouvinski, Alexander] Hebrew Univ Jerusalem, Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet,Kuvin Ctr Study Infect, Jerusalem, Israel.
RP Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.; Rey, FA (corresponding author), CNRS UMR Virol 3569, F-75724 Paris 15, France.; Mongkolsapaya, J; Screaton, GR (corresponding author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Hosp Campus, London W12 0NN, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Siriraj Hosp, Off Res & Dev, Dengue Haemorrhag Fever Res Unit,Fac Med, Bangkok 10700, Thailand.
EM j.mongkolsapaya@imperial.ac.uk; felix.rey@pasteur.fr;
   g.screaton@imperial.ac.uk
RI Guardado-Calvo, Pablo/O-5145-2019
OI Guardado-Calvo, Pablo/0000-0001-7292-5270; Screaton,
   Gavin/0000-0002-3549-4309; HAOUZ, Ahmed/0000-0003-1196-1635; Duquerroy,
   Stephane/0000-0003-4386-8013; Sharma, Arvind/0000-0002-7029-9867; Barba
   Spaeth, Giovanna/0000-0003-2069-9501
FU European CommissionEuropean Commission Joint Research Centre [282
   378FP7]; 'Integrative Biology of Emerging Infectious Diseases' Labex
   (Laboratoire d'Excellence) grant [ANR-10-LABX-62-IBEID]; National
   Institute for Health Research Biomedical Research Centre, Funding
   Scheme, UK; NEUTRAVIR grant from Region Ile-de-France (DIM-Maladies
   Infectieuses)
FX We thank Watchara Kasinrerk and Chunya Putthikhunt for anti-dengue
   anti-DomIII mAb 2C8; J. Freire and G. Bowler for help and discussion;
   the staff at the crystallogenesis and chemogenomic & biological
   screening facilities at Institut Pasteur; the staff at beamlines PX1 and
   PX2 at SOLEIL synchrotron (Saclay, France), the staff at beamlines
   ID23-1, ID23-2, ID29 and IB30B at the European Synchrotron Radiation
   Facility (Grenoble, France); Fabrice Agou at Institut Pasteur for the
   MALS system. We acknowledge support from the European Commission FP7
   Programme for the DEN-FREE project under Grant Agreement number 282
   378FP7 (F.A.R., J.M. and G.R.S.); the 'Integrative Biology of Emerging
   Infectious Diseases' Labex (Laboratoire d'Excellence) grant number
   ANR-10-LABX-62-IBEID (French Government's 'Investissements d'Avenir'
   program) (F.A.R.) the National Institute for Health Research Biomedical
   Research Centre, Funding Scheme, UK (G.R.S.); and the NEUTRAVIR grant
   from Region Ile-de-France (DIM-Maladies Infectieuses) (F.A.R.). G.R.S.
   is a Wellcome Trust Senior Investigator.
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Liu C, 2014, J MOL BIOL, V426, P980, DOI 10.1016/j.jmb.2013.11.014
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SITTISOMBUT N, 1995, J MED VIROL, V45, P43, DOI 10.1002/jmv.1890450109
   Smith SA, 2013, J INFECT DIS, V207, P1898, DOI 10.1093/infdis/jit119
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thangudu RR, 2005, PROTEINS, V58, P866, DOI 10.1002/prot.20369
   Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2
   World Health Organization, 2016, STRAT ADV GROUP EXP
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 50
TC 29
Z9 31
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 23
PY 2017
VL 8
AR 15411
DI 10.1038/ncomms15411
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV5ZK
UT WOS:000401848600001
PM 28534525
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Costa, CF
   dos Passos, RA
   Lima, JBP
   Roque, RA
   Sampaio, VD
   Campolina, TB
   Secundino, NFC
   Pimenta, PFP
AF da Costa, Cristiano Fernandes
   dos Passos, Ricardo Augusto
   Pereira Lima, Jose Bento
   Roque, Rosemary Aparecida
   Sampaio, Vanderson de Souza
   Campolina, Thais Bonifacio
   Costa Secundino, Nagila Francinete
   Paolucci Pimenta, Paulo Filemon
TI Transovarial transmission of DENV in Aedes aegypti in the Amazon basin:
   a local model of xenomonitoring
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Ovitraps; Transovarial transmission; Dengue;
   Xenosurveillance; Monitoring; Control
ID DENGUE-VIRUS TRANSMISSION; VERTICAL TRANSMISSION; ALBOPICTUS DIPTERA;
   ZIKA VIRUS; CULICIDAE; STATE; PERSISTENCE; GENERATIONS; INFECTION;
   MOSQUITOS
AB Background: Transovarial transmission of dengue virus in Aedes spp. mosquitoes is considered an important mechanism for the maintenance of the virus in nature and may be implicated in the occurrence of outbreaks and epidemics of the disease. However, there are few studies involving transovarial transmission and viral vector monitoring as a surveillance tool and control strategy. The present study evaluated transovarial transmission of dengue virus in Aedes aegypti populations as a xenomonitoring strategy in municipalities of the Amazonas state.
   Results: Aedes sp. eggs (13.164) were collected, with 30% viability of third- and fourth-instar larvae. Transovarial transmission of DENV was detected in all municipalities. The transovarial infection rate ( TOR) in the municipalities was 46% of the DENV positive samples. The minimum infection rate (MIR) was 17.7 in the state, varying from 11.4 to 24.1 per 1,000 larvae tested in the respective municipalities. Four DENV serotypes were identified, with DENV I and IV being present in all municipalities investigated. The number of reported dengue fever cases varied during this period.
   Conclusions: Our results suggest that transovarial transmission may be an important mechanism for the maintenance and spreading of the disease in Amazonas municipalities. Using qRT-PCR, it was possible to identify the four DENV serotypes in larval samples. The methodology used in the present study proved suitable as a DENV xenomonitoring model in immature mosquitoes, contributing to the development of systems for early detection of viral circulation and predictive models for the occurrence of outbreaks and epidemics of this disease.
C1 [da Costa, Cristiano Fernandes; dos Passos, Ricardo Augusto; Sampaio, Vanderson de Souza] Hlth Surveillance Fdn Amazonas State FVS AM, Dept Environm Surveillance, Av Torquato Tapajos 6132, BR-69093018 Manaus, Amazonas, Brazil.
   [da Costa, Cristiano Fernandes] Univ Nilton Lins, Programa Pro Reitoria Pesquisa & Posgrad, UNICTR, Lab Entomol Aplicada, Off 160,Av Prof Nilton Lins 3259, BR-69058030 Manaus, Amazonas, Brazil.
   [dos Passos, Ricardo Augusto; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil.
   [Roque, Rosemary Aparecida] Natl Inst Amazonian Res INPA, Malaria & Dengue Lab, Av Andre Araujo,2-936 Petropolis,POB 2223, BR-69080971 Manaus, Amazonas, Brazil.
   [Campolina, Thais Bonifacio; Costa Secundino, Nagila Francinete; Paolucci Pimenta, Paulo Filemon] Fundacao Oswaldo Cruz, Lab Med Entomol, Rene Rachou Res Ctr, BR-30190002 Belo Horizonte, MG, Brazil.
RP dos Passos, RA (corresponding author), Hlth Surveillance Fdn Amazonas State FVS AM, Dept Environm Surveillance, Av Torquato Tapajos 6132, BR-69093018 Manaus, Amazonas, Brazil.; dos Passos, RA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil.
EM ricdospassos@gmail.com
RI Sampaio, Vanderson/AAQ-1418-2020; Pimenta, Paulo/AAH-1502-2020;
   Secundino, Nagila/AAM-4553-2020; Sampaio, Vanderson/M-4337-2015
OI Sampaio, Vanderson/0000-0001-7307-8851; Sampaio,
   Vanderson/0000-0001-7307-8851; Dos Passos/0000-0002-2155-9351
FU Oswaldo Cruz Foundation (FIOCRUZ); National Counsel of Technological and
   Scientific Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Coordination for the Improvement of
   Higher Education Personnel (CAPES)CAPES; Research Support Foundation of
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   Research Support Foundation of Amazonas (FAPEAM) through PPSUS project
FX Oswaldo Cruz Foundation (FIOCRUZ), National Counsel of Technological and
   Scientific Development (CNPq), Coordination for the Improvement of
   Higher Education Personnel (CAPES), Research Support Foundation of Minas
   Gerais (FAPEMIG) and Research Support Foundation of Amazonas (FAPEAM)
   through PPSUS project supported this study. PFPP is level 1 fellow from
   CNPq. JBPL and PFPP are a visiting senior researcher fellow PVS
   PECTI-SAUDE (Amazonas State Research Support Foundation - FAPEAM).
CR Akbar M. R., 2008, P ASEAN C TROP MED P, V3, P84
   Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56
   Avendanha J, 2007, MINAS GERAIS REV I A, V66, P207
   Bangs MJ, 2007, J MED ENTOMOL, V44, P163, DOI 10.1603/0022-2585(2007)44[163:PODVRI]2.0.CO;2
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biosystems A., 2013, CREATING STANDARD CU
   Blanton RE, 2008, EUR J HUM GENET, V16, P762, DOI 10.1038/ejhg.2008.4
   BOSIO CF, 1992, J MED ENTOMOL, V29, P985, DOI 10.1093/jmedent/29.6.985
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Dalla Bona AC, 2011, B MALARIOL SALUD AMB, V51, P107
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   da Cruz LCDA, 2015, REV SOC BRAS MED TRO, V48, P18, DOI 10.1590/0037-8682-0264-2014
   de Vigilancia Secretaria, 2013, LEV RAP IND AED AEG
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Amaral RJV, 2013, TOPICOS AVANCADOS EN
   Donalisio Maria Rita, 2015, Rev. bras. epidemiol., V18, P283, DOI 10.1590/1980-5497201500010022
   GOMES AC, 1998, INF EPIDEMIOL SUS, V7, P49
   Guedes D., 2012, ANALISE COMPETENCIA
   Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hutamai Songwut, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P448
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   KHIN MM, 1983, AM J TROP MED HYG, V32, P590, DOI 10.4269/ajtmh.1983.32.590
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Pessanha JEM, 2001, REV SOC BRAS MED TRO, V44, P103
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   ROSEN L, 1987, AM J TROP MED HYG, V37, P398
   SHROYER DA, 1990, J AM MOSQUITO CONTR, V6, P312
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Thongrungkiat S, 2011, J VECTOR ECOL, V36, P147, DOI 10.1111/j.1948-7134.2011.00151.x
   Vasconcelos P. F. C., 2015, REV PANAMAZ SAUDE, V2, P9
   WALTER SD, 1980, AM J EPIDEMIOL, V112, P124, DOI 10.1093/oxfordjournals.aje.a112961
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zeidler Julianna Dias, 2008, Rev. Saúde Pública, V42, P986, DOI 10.1590/s0034-89102008000600002
NR 42
TC 14
Z9 15
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 19
PY 2017
VL 10
AR 249
DI 10.1186/s13071-017-2194-5
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EV3OH
UT WOS:000401668300006
PM 28526066
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ruckert, C
   Weger-Lucarelli, J
   Garcia-Luna, SM
   Young, MC
   Byas, AD
   Murrieta, RA
   Fauver, JR
   Ebel, GD
AF Rueckert, Claudia
   Weger-Lucarelli, James
   Garcia-Luna, Selene M.
   Young, Michael C.
   Byas, Alex D.
   Murrieta, Reyes A.
   Fauver, Joseph R.
   Ebel, Gregory D.
TI Impact of simultaneous exposure to arboviruses on infection and
   transmission by Aedes aegypti mosquitoes
SO NATURE COMMUNICATIONS
LA English
DT Article
ID DENGUE VIRUS TYPE-2; CHIKUNGUNYA VIRUS; ZIKA VIRUS; RNA INTERFERENCE;
   CELLS; COINFECTION; ALBOPICTUS; STATE; REPLICATION; SUPPRESSOR
AB The recent emergence of both chikungunya and Zika viruses in the Americas has significantly expanded their distribution and has thus increased the possibility that individuals may become infected by more than one Aedes aegypti-borne virus at a time. Recent clinical data support an increase in the frequency of coinfection in human patients, raising the likelihood that mosquitoes could be exposed to multiple arboviruses during one feeding episode. The impact of coinfection on the ability of relevant vector species to transmit any of these viruses (that is, their vector competence) has not been determined. Thus, we here expose Ae. aegypti mosquitoes to chikungunya, dengue-2 or Zika viruses, both individually and as double and triple infections. Our results show that these mosquitoes can be infected with and can transmit all combinations of these viruses simultaneously. Importantly, infection, dissemination and transmission rates in mosquitoes are only mildly affected by coinfection.
C1 [Rueckert, Claudia; Weger-Lucarelli, James; Garcia-Luna, Selene M.; Young, Michael C.; Byas, Alex D.; Murrieta, Reyes A.; Fauver, Joseph R.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RP Ebel, GD (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM gregory.ebel@colostate.edu
OI Byas, Alexandria/0000-0002-0762-7389; Ruckert,
   Claudia/0000-0003-3732-6752; Garcia-Luna, Selene M./0000-0001-8420-5078;
   Weger-Lucarelli, James/0000-0002-9483-1694
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI067380]; NIH Fogarty grant
   [2D43TW001130-0681]; Colorado State University GAUSSI fellowship (NSF
   grant) [DGE-1450032]
FX The authors would like to acknowledge William Black IV for providing the
   DENV-2 strain and Brandy Russel (CDC, Fort Collins) for providing the
   CHIKV and ZIKV strains used in this study. Furthermore, we would like to
   acknowledge Nisha Duggal (CDC, Fort Collins) for providing the A549
   cells, Daniel Hartman and Nicolas Bergren for assistance with mosquito
   dissections, as well as Muhammad Mahdi Karim for providing an Aedes
   aegypti image that we modified for use in Fig. 2d. This work was
   supported by NIH grant AI067380. S.M.G.-L. was supported by the NIH
   Fogarty grant 2D43TW001130-0681 and R.A.M. was supported by the Colorado
   State University GAUSSI fellowship 2016-2017 (NSF grant DGE-1450032).
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Amraoui F, 2016, CURR OPIN VIROL, V21, P146, DOI 10.1016/j.coviro.2016.09.014
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grubaugh ND, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003628
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Lorono-Pino MA, 2004, AM J TROP MED HYG, V71, P485
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Musso D, 2016, J MED VIROL
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Omarjee R., 2014, EURO SURVEILL, V19
   Potiwat R, 2011, SE ASIAN J TROP MED, V42, P1388
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P443
   Ruckert Claudia, 2014, VirusDisease, V25, P249, DOI 10.1007/s13337-014-0217-9
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 47
TC 67
Z9 69
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 19
PY 2017
VL 8
AR 15412
DI 10.1038/ncomms15412
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV3AH
UT WOS:000401628700001
PM 28524874
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schwarz, NG
   Mertens, E
   Winter, D
   Maiga-Ascofare, O
   Dekker, D
   Jansen, S
   Tappe, D
   Randriamampionona, N
   May, J
   Rakotozandrindrainy, R
   Schmidt-Chanasit, J
AF Schwarz, Norbert Georg
   Mertens, Eva
   Winter, Doris
   Maiga-Ascofare, Oumou
   Dekker, Denise
   Jansen, Stephanie
   Tappe, Dennis
   Randriamampionona, Njary
   May, Juergen
   Rakotozandrindrainy, Raphael
   Schmidt-Chanasit, Jonas
TI No serological evidence for Zika virus infection and low specificity for
   anti-Zika virus ELISA in malaria positive individuals among pregnant
   women from Madagascar in 2010
SO PLOS ONE
LA English
DT Article
ID SEROPREVALENCE; OUTBREAK; DENGUE; CHIKUNGUNYA; ANTIBODIES
AB It was previously reported that a malaria infection may interfere with the specificity of a commercial ELISA test against Zika virus (ZIKV). We analyzed 1,216 plasma samples from healthy, pregnant women collected in two sites in Madagascar in 2010 for ZIKV antibodies using a commercial ELISA and for Plasmodium infection by PCR. This screen revealed six putative ZIKV-positive samples by ELISA. These results could not be confirmed by indirect immunofluorescence assays or virus neutralization tests. Four of these six samples were also positive for P. falciparum. We noted that the frequency of malaria positivity was higher in ZIKV-ELISA positive samples (50% and 100% in the two study sites) than ZIKV-negative samples (17% and 10%, respectively), suggesting that malaria may have led to false ZIKV-ELISA positives.
C1 [Schwarz, Norbert Georg; Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; May, Juergen] Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Hamburg, Germany.
   [Mertens, Eva; Winter, Doris; Maiga-Ascofare, Oumou; Dekker, Denise; May, Juergen] German Ctr Infect Res, Hamburg Borstel Lubeck, Germany.
   [Maiga-Ascofare, Oumou] Kumasi Ctr Collaborat Res, Res Grp Med Trop, Kumasi, Ghana.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Hamburg, Germany.
   [Tappe, Dennis] Bernhard Nocht Inst Trop Med, Res Grp Zoonoses, Hamburg, Germany.
   [Randriamampionona, Njary; Rakotozandrindrainy, Raphael] Univ Antananarivo, Dept Microbiol & Parasitol, Antananarivo, Madagascar.
RP Mertens, E (corresponding author), Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Hamburg, Germany.; Mertens, E (corresponding author), German Ctr Infect Res, Hamburg Borstel Lubeck, Germany.
EM mertens@bnitm.de
RI amsalu, ribka/G-8780-2019; Schwarz, Norbert G/C-8797-2012
OI Schwarz, Norbert G/0000-0002-8387-2837; May, Jurgen/0000-0001-7831-8420;
   Maiga Ascofare, Oumou/0000-0003-2947-5651
FU Bernhard Nocht Institute for Tropical Medicine
FX This study was financed by in house resources of the Bernhard Nocht
   Institute for Tropical Medicine. The funders had no role in study
   design, data collection and analysis, decision to publish,or preparation
   of the manuscript.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FONTENILLE D, 1989, J AM MOSQUITO CONTR, V5, P219
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Huzly D, 2016, EURO SURVEILL, V21
   Maiga-Ascofare O, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0704-5
   Meersman K, 2016, EURO SURVEILL, V21
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pan American Health Organization ; World Health Organization, 2016, ZIK EP UPD
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510
   Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036
   Steinhagen K, 2016, EURO SURVEILL
   Tappe D, 2010, J CLIN VIROL, V49, P148, DOI 10.1016/j.jcv.2010.05.012
   Tappe D, 2009, MED MICROBIOL IMMUN, V198, P271, DOI 10.1007/s00430-009-0122-9
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 25
TC 3
Z9 3
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2017
VL 12
IS 5
AR e0176708
DI 10.1371/journal.pone.0176708
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV1DC
UT WOS:000401485500008
PM 28510593
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Salam, AP
   Rojek, A
   Dunning, J
   Horby, PW
AF Salam, Alex P.
   Rojek, Amanda
   Dunning, Jake
   Horby, Peter W.
TI Clinical Trials of Therapeutics for the Prevention of Congenital Zika
   Virus Disease: Challenges and Potential Solutions
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Article
ID BRAIN-DEVELOPMENT; CYTOMEGALOVIRUS-INFECTION; PREGNANT-WOMEN;
   IDENTIFICATION; IMMUNIZATION; ACTIVATION; INHIBITORS; PERFUSION;
   IMMUNITY; OUTCOMES
AB Zika virus (ZIKV) infection in pregnancy is associated with adverse fetal outcomes, such as microcephaly and other congenital malformations. No therapeutic options are available to pregnant women with ZIKV infection to prevent these effects. Drug trials in pregnancy raise several scientific, ethical, and logistic challenges, which are compounded further in ZIKV because of limited knowledge of the disease pathophysiology and a product development pipeline in its infancy. We evaluate the major challenges in choosing therapeutics to prevent congenital ZIKV disease and conducting clinical trials of these treatments, with a focus on preventing congenital central nervous system malformations. These challenges must be characterized and planned for now so that clinical trials can progress expediently and effectively in the future.
C1 Univ Oxford, Oxford, England.
   [Salam, Alex P.; Rojek, Amanda; Dunning, Jake; Horby, Peter W.] Univ Oxford, Nuffield Dept Med Res Bldg, Ctr Trop Med & Global Hlth, Epidem Dis Res Grp Oxford, Old Rd Campus,Roosevelt Dr, Oxford OX3 7FZ, England.
RP Salam, AP (corresponding author), Univ Oxford, Nuffield Dept Med Res Bldg, Ctr Trop Med & Global Hlth, Epidem Dis Res Grp Oxford, Old Rd Campus,Roosevelt Dr, Oxford OX3 7FZ, England.
EM alexsalam@doctors.org.uk
RI Dunning, Jake/U-7181-2019
OI Dunning, Jake/0000-0002-4035-4562; Horby, Peter/0000-0002-9822-1586;
   Rojek, Amanda/0000-0002-3948-0756
FU Wellcome Trust of Great BritainWellcome Trust [107834/Z/15/Z,
   106491/Z/14/Z]; European Union FP7 project PREPARE (Platform for
   European Preparedness Against [Re-]emerging Epidemics) [602525]; Medical
   Research Council UKMedical Research Council UK (MRC) [MC_PC_15001];
   Rhodes Scholarship
FX Peter Horby is supported by the Wellcome Trust of Great Britain (grants
   107834/Z/15/Z and 106491/Z/14/Z), European Union FP7 project PREPARE
   (Platform for European Preparedness Against [Re-]emerging Epidemics;
   grant 602525), and Medical Research Council UK (MC_PC_15001). Dr. Rojek
   is funded by a Rhodes Scholarship.
CR Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Ala-Kokko TI, 2000, INT J OBSTET ANESTH, V9, P26, DOI 10.1054/ijoa.1999.0312
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Ben-Hur H, 2005, INT J MOL MED, V16, P401
   Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carty M, 2014, TRENDS IMMUNOL, V35, P79, DOI 10.1016/j.it.2013.10.012
   Casadevall A, 2003, TRENDS IMMUNOL, V24, P474, DOI 10.1016/S1471-4906(03)00228-X
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014
   Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Custer DA, 2000, J DEV BEHAV PEDIATR, V21, P12, DOI 10.1097/00004703-200002000-00003
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delorme-Axford E, 2013, AUTOPHAGY, V9, P2173, DOI 10.4161/auto.26558
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Griffiths SK, 2015, BJA EDUC, V15, P84, DOI 10.1093/bjaceaccp/mku013
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x
   Hutson JR, 2011, CLIN PHARMACOL THER, V90, P67, DOI 10.1038/clpt.2011.66
   Ilekis JV, 2016, AM J OBSTET GYNECOL, V215, pS1, DOI 10.1016/j.ajog.2016.03.001
   Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lazzarotto T, 2000, J PEDIATR-US, V137, P90, DOI 10.1067/mpd.2000.107110
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634
   Marin M, 2013, MMWR-MORBID MORTAL W, V62, P574
   McLean HQ, 2015, MMWR-MORBID MORTAL W, V64, P259
   McLean HQ, 2013, MMWR RECOMM REP, V62, P1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Nigro G, 2012, J INFECT DIS, V205, P215, DOI 10.1093/infdis/jir718
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierce AM, 2014, BRAIN RES, V1542, P206, DOI 10.1016/j.brainres.2013.10.049
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rasmussen SA, 2014, CLIN INFECT DIS, V59, pS428, DOI 10.1093/cid/ciu738
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023
   Sacramento CQ, 2016, CLIN APPROVED ANTIVI
   Schachter AD, 2011, REPROD TOXICOL, V31, P562, DOI 10.1016/j.reprotox.2010.11.008
   SELLS CJ, 1977, PEDIATRICS, V59, P262
   Sheffield JS, 2014, CLIN INFECT DIS, V59, pS437, DOI 10.1093/cid/ciu709
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Solozobova V, 2012, STEM CELL REV REP, V8, P813, DOI 10.1007/s12015-012-9381-8
   Stricker RB, 2002, CLIN APPL IMMUNOL RE, V2, P187
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Visentin S, 2012, CLIN INFECT DIS, V55, P497, DOI 10.1093/cid/cis423
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2016, ZIK STRAT RESP FRAM
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 69
TC 4
Z9 4
U1 0
U2 6
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 16
PY 2017
VL 166
IS 10
BP 725
EP +
DI 10.7326/M16-2530
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA EU7UM
UT WOS:000401240200016
PM 28319995
DA 2020-07-08
ER

PT J
AU Miner, JJ
   Diamond, MS
AF Miner, Jonathan J.
   Diamond, Michael S.
TI Dengue Antibodies, then Zika: A Fatal Sequence in Mice
SO IMMUNITY
LA English
DT Editorial Material
ID VIRUS; PATHOGENESIS; ENHANCEMENT
AB Anti-Dengue virus (DENV) antibodies can be either protective or pathogenic in humans with prior DENV infection. In a recent issue of Science, Bardina et al. (2017) demonstrated that passive transfer of immune plasma against DENV and West Nile virus (WNV) can enhance Zika virus (ZIKV) infection and pathogenesis in mice.
C1 [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.
RP Miner, JJ; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Miner, JJ; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Miner, JJ; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.
EM miner@wustl.edu; diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
NR 10
TC 10
Z9 10
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD MAY 16
PY 2017
VL 46
IS 5
BP 771
EP 773
DI 10.1016/j.immuni.2017.04.023
PG 3
WC Immunology
SC Immunology
GA EU8VJ
UT WOS:000401316300012
PM 28514683
OA Bronze
DA 2020-07-08
ER

PT J
AU Bracho-Churio, YT
   Martinez-Vega, RA
   Rodriguez-Morales, AJ
   Diaz-Quijano, RG
   Luna-Gonzalez, ML
   Diaz-Quijano, FA
AF Bracho-Churio, Yalil T.
   Martinez-Vega, Ruth A.
   Rodriguez-Morales, Alfonso J.
   Diaz-Quijano, Ronald G.
   Luna-Gonzalez, Maria L.
   Diaz-Quijano, Fredi A.
TI Determinants of felt demand for dengue vaccines in the North Caribbean
   region of Colombia
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Article
ID WILLINGNESS-TO-PAY; VIRUS-INFECTION; PUBLIC-HEALTH; ACCEPTANCE; AMERICA;
   THREAT; ZIKA
AB Background: The increasing burden associated with dengue in Latin America makes it essential to understand the community's interest in acquiring vaccines, as an input to plan its introduction in endemic regions. The objective of this study is to learn the felt demand for dengue vaccines by estimating the willingness to pay and its associated factors in endemic communities of the North Caribbean region of Colombia.
   Methods: A population survey was administered from October to December 2015, including 1037 families in 11 municipalities in Colombia. One adult per family was interviewed on their perception and history of dengue. Participants received a description of four hypothetical scenarios of dengue vaccines, administered in a single dose or in 3 doses, with an effectiveness of 70% for 5 years or 95% for 30 years. The willingness to pay for each one of these vaccines was inquired vs. 5 hypothetical prices in Colombian pesos.
   Results: Most participants recognized dengue as a serious disease in children (99.3%) and adults (98.6%). 33 (3.2%) of the total respondents reported having suffered dengue and 19 (57.6%) of them required hospitalization. The price of the vaccine was inversely related to the willingness to pay. In addition, single dose vaccines (compared to 3 doses) and one with a protection of 95% for 30 years (compared to an effectiveness of 70% for 5 years), were associated with greater willingness to pay. Greater willingness to pay was observed among the respondents who considered it likely to get the disease, either themselves (OR 1.56; CI 95% 1.08-2.26) or their children (OR 1.89; CI 95% 1.28-2.81), in the next 5 years. The participants who have been diagnosed with dengue also showed greater willingness to pay (OR 1.89; CI 95% 1.01-3.54) compared to those who did not have this history.
   Conclusion: Factors such as price, number of doses and effectiveness can independently influence the decision to purchase a vaccine against an endemic disease, such as dengue. Additionally, this study reveals that background and perceptions of the disease can affect individuals' interest in acquiring this type of preventive interventions.
C1 [Bracho-Churio, Yalil T.; Martinez-Vega, Ruth A.; Rodriguez-Morales, Alfonso J.; Diaz-Quijano, Ronald G.; Luna-Gonzalez, Maria L.] Org Latinoamer Fomento Invest Salud, Santander, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Diaz-Quijano, Fredi A.] Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
RP Diaz-Quijano, FA (corresponding author), Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM frediazq@msn.com
RI Diaz-Quijano, Fredi Alexander/I-3740-2012; AJ,
   Rodriguez-Morales/R-9765-2016; Martinez-Vega, Ruth/AAD-3601-2019
OI Diaz-Quijano, Fredi Alexander/0000-0002-1134-1930; AJ,
   Rodriguez-Morales/0000-0001-9773-2192; Martinez-Vega,
   Ruth/0000-0002-6477-334X; Luna Gonzalez, Maria
   Lucrecia/0000-0003-2846-6868
FU Department of La Guajira; Organizacion Latinoamericana para el Fomento
   de la Investigacion en Salud [Latin American Organization for the
   Promotion of Research in Health] (OLFIS) [019/2014]
FX The project was funded by the Department of La Guajira in an agreement
   with Organizacion Latinoamericana para el Fomento de la Investigacion en
   Salud [Latin American Organization for the Promotion of Research in
   Health] (OLFIS). Convention 019/2014.
CR Martinez-Vega RA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2055-4
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   DANE, 2005, GEOP DANE CENS GEN
   Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074
   Dickinson KL, 2016, AM J TROP MED HYG, V94, P775, DOI 10.4269/ajtmh.15-0666
   Durham DP, 2013, VACCINE, V31, P3957, DOI 10.1016/j.vaccine.2013.06.036
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Godoi IP, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00041
   Godoi IP, 2017, J COMP EFFECT RES, V6, P165, DOI 10.2217/cer-2016-0045
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hadisoemarto PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002427
   Halstead SB, 2016, TRAVEL MED INFECT DI
   Harapan H, 2017, HUM VACC IMMUNOTHER, V13, P786, DOI 10.1080/21645515.2016.1259045
   Harapan H, 2017, ACTA TROP, V166, P249, DOI 10.1016/j.actatropica.2016.11.035
   Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026
   Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810
   National Department of Statistics (DANE)-Republic of Colombia, PROYECC POBL
   PAHO/ WHO, 2017, NUMB REP CAS DENG SE
   Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011
   Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331
   Precioso AR, 2015, VACCINE, V33, P7121, DOI 10.1016/j.vaccine.2015.09.105
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Siddiqui TR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005129
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Timothy C. H., 2002, VALUING ENV NATURAL
   Torresi J, 2017, HUM VACC IMMUNOTHER, P1
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Villabona-Arenas CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004653
   Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   World Health Organization, 2016, DENG VACC WHO POS PA, P1200
NR 34
TC 3
Z9 3
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD MAY 15
PY 2017
VL 16
AR 38
DI 10.1186/s12941-017-0213-1
PG 10
WC Microbiology
SC Microbiology
GA EV6JE
UT WOS:000401874900001
PM 28506229
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fleck-Derderian, S
   Jones, AM
   Simon, EL
   Newsome, K
   Lee, EH
   Ahmad, N
   Dunn, JE
   Smith, LC
   White, JL
   Honein, MA
AF Fleck-Derderian, S.
   Jones, A. M.
   Simon, E. L.
   Newsome, K.
   Lee, E. H.
   Ahmad, N.
   Dunn, J. E.
   Smith, L. C.
   White, J. L.
   Honein, M. A.
TI Prevalence of Small for Gestational Age and Preterm Birth Among Infants
   Born to Women with Laboratory Evidence of Possible Zika Virus Infection
   during Pregnancy, US Zika Pregnancy Registry, December 2015-December
   2016
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Fleck-Derderian, S.; Jones, A. M.; Simon, E. L.; Newsome, K.; Honein, M. A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Lee, E. H.] New York City Dept Hlth & Mental Hyg, New York, NY USA.
   [Ahmad, N.; Smith, L. C.; White, J. L.] New York State Dept Hlth, Albany, NY USA.
   [Dunn, J. E.] Massachusetts Dept Publ Hlth, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA S10
BP 628
EP 628
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300010
DA 2020-07-08
ER

PT J
AU Khan, S
   Rice, ME
   Reynolds, MR
   Reagan-Steiner, S
   Brown, CM
   Lee, EH
   Ahmad, N
   Macdonald, J
   Sommer, JN
   Smith, LC
   Honein, MA
AF Khan, S.
   Rice, M. E.
   Reynolds, M. R.
   Reagan-Steiner, S.
   Brown, C. M.
   Lee, E. H.
   Ahmad, N.
   Macdonald, J.
   Sommer, J. N.
   Smith, L. C.
   Honein, M. A.
TI Distribution by Week and Trimester of Onset among Pregnant Women, US
   Zika Pregnancy Registry, 2015-2016
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Khan, S.; Rice, M. E.; Reynolds, M. R.; Reagan-Steiner, S.; Honein, M. A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Ahmad, N.; Sommer, J. N.; Smith, L. C.] New York State Dept Hlth, Albany, NY USA.
   [Macdonald, J.] Virginia Dept Hlth, Richmond, VA USA.
   [Lee, E. H.] New York City Dept Hlth & Mental Hyg, Queens, NY USA.
   [Brown, C. M.] Massachusetts Dept Publ Hlth, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA S11
BP 628
EP 628
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300011
DA 2020-07-08
ER

PT J
AU Honein, M
   Meaney-Delman, D
   Boyle, C
AF Honein, M.
   Meaney-Delman, D.
   Boyle, C.
TI The Zika Epidemic: An Update from the CDC
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Honein, M.; Meaney-Delman, D.; Boyle, C.] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA S47
BP 644
EP 644
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300045
DA 2020-07-08
ER

PT J
AU Van der Linden, V
AF Van der Linden, V.
TI Neurobehavioral Aspects of Zika Virus
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Van der Linden, V.] Assoc Assistance Disabled Children AACD, Recife, PE, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA S48
BP 644
EP 644
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300046
DA 2020-07-08
ER

PT J
AU Muotri, AR
AF Muotri, A. R.
TI Zika Infection: From Basic Science to Treatment
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Muotri, A. R.] Univ Calif San Diego, La Jolla, CA 92093 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA S49
BP 645
EP 645
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300047
DA 2020-07-08
ER

PT J
AU Turay, KR
   Earle-Richardson, G
   Medina-Martinez, G
   Romero-Perez, M
   Chavez, P
   Vega, MC
   Thomas, D
   Rivera-Garcia, B
   Prue, C
AF Turay, K. R.
   Earle-Richardson, G.
   Medina-Martinez, G.
   Romero-Perez, M.
   Chavez, P.
   Vega, M. C.
   Thomas, D.
   Rivera-Garcia, B.
   Prue, C.
TI An Evaluation of Household Environments and Zika Risk Perceptions,
   Prevention Behaviors, and Prevention Knowledge among Pregnant Women in
   Puerto Rico
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Turay, K. R.; Earle-Richardson, G.; Prue, C.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Medina-Martinez, G.; Romero-Perez, M.] Caduceus Staffing, Atlanta, GA USA.
   [Chavez, P.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.
   [Thomas, D.] Ctr Dis Control & Prevent, Off Publ Hlth Preparedness & Response, Atlanta, GA USA.
   [Vega, M. C.; Thomas, D.; Rivera-Garcia, B.] Puerto Rico Dept Hlth, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA 19
BP 662
EP 662
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300076
DA 2020-07-08
ER

PT J
AU Del Campo, M
   Feitosa, IML
   Garcia-Alix, A
   Schuler-Faccini, L
AF Del Campo, M.
   Feitosa, I. M. L.
   Garcia-Alix, A.
   Schuler-Faccini, L.
TI Clinical Variability of the Congenital Zika Syndrome
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Del Campo, M.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Feitosa, I. M. L.; Schuler-Faccini, L.] Univ Fed Rio Grande do Sul, Porto Alegre, Rgds, Brazil.
   [Garcia-Alix, A.] Hosp St Joan Deu, Inst Recerca Pediat, Barcelona, Catalunya, Spain.
RI Garcia-Alix, Alfredo/AAG-4474-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA 30
BP 667
EP 667
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300087
DA 2020-07-08
ER

PT J
AU Anderson, KN
AF Anderson, K. N.
CA Colombian Inst Nacl Salud
   US Ctr Dis Control Prevention
TI Overview of Zika en Embarazadas y Ninos en Colombia (ZEN): A Prospective
   Cohort Study Examining Zika Virus Infection during Pregnancy and Risk of
   Adverse Pregnancy, Birth, and Infant Outcomes
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Colombian Inst Nacl Salud] Colombian Inst Nacl Salud, Bogota, Colombia.
   [Anderson, K. N.; US Ctr Dis Control Prevention] US Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA P1
BP 669
EP 669
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300088
DA 2020-07-08
ER

PT J
AU O'Hara, MF
   Ramachandra, R
AF O'Hara, M. F.
   Ramachandra, R.
TI An Evaluation of the New Zealand White Rabbit Model for Zika Virus
   Infection during Gestation and Microcephaly in the Offspring
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [O'Hara, M. F.] Covance Drug Dev, Greenfield, IN USA.
   [Ramachandra, R.] Covance Immunol Serv, Denver, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA P16
BP 676
EP 676
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300103
DA 2020-07-08
ER

PT J
AU Wambuguh, L
   Garrett, L
   Sapkota, A
   Mccarthy, E
AF Wambuguh, L.
   Garrett, L.
   Sapkota, A.
   Mccarthy, E.
TI Zika Related Birth Defect Surveillance in Missouri
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Wambuguh, L.; Garrett, L.; Sapkota, A.; Mccarthy, E.] Bur Vital Stat, Missouri Dept Hlth & Senior Serv, Jefferson City, MO USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA P15
BP 676
EP 676
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300102
DA 2020-07-08
ER

PT J
AU Polen, K
   Hillard, C
   Johnston, E
   Abercrombie, J
   Moore, J
AF Polen, K.
   Hillard, C.
   Johnston, E.
   Abercrombie, J.
   Moore, J.
TI Tools to Facilitate Implementation of Clinical Guidance during the CDC's
   Zika Virus Response
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Polen, K.; Hillard, C.; Johnston, E.; Abercrombie, J.; Moore, J.] Ctr Dis Control & Prevent, Pregnancy & Birth Defects Task Force, Zika Virus Response 2016, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA 5
BP 706
EP 706
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300135
DA 2020-07-08
ER

PT J
AU Quinn, D
   Stallman, C
AF Quinn, D.
   Stallman, C.
TI Zika Virus in Pregnancy and Breastfeeding: A Model to Guide TIS
   Responses to Emerging Infectious Diseases
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Quinn, D.; Stallman, C.] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2017
VL 109
IS 9
SI SI
MA 14
BP 714
EP 714
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EU8GA
UT WOS:000401275300149
DA 2020-07-08
ER

PT J
AU Garcia, LL
   Padilla, L
   Castano, JC
AF Garcia, Leidy L.
   Padilla, Leonardo
   Castano, Jhon C.
TI Inhibitors compounds of the flavivirus replication process
SO VIROLOGY JOURNAL
LA English
DT Review
DE Flavivirus; NS5 protein; Inhibitors
ID DEPENDENT RNA-POLYMERASE; NONSTRUCTURAL PROTEIN 5; DENGUE VIRUS
   INHIBITOR; YELLOW-FEVER VIRUS; DRUG DISCOVERY; NS3 PROTEIN; IN-VITRO;
   ALLOSTERIC INHIBITORS; NUCLEOSIDE ANALOGS; CRYSTAL-STRUCTURE
AB Flaviviruses are small viruses with single-stranded RNA, which include the yellow fever virus, dengue virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, and Zika virus; and are causal agents of the most important emerging diseases that have no available treatment to date. In recent years, the strategy has focused on the development of replication inhibitors of these viruses designed to act mainly by affecting the activity of enzyme proteins, such as NS3 and NS5, which perform important functions in the viral replication process. This article describes the importance of flaviviruses and the development of molecules used as inhibitors of viral replication in this genus.
C1 [Garcia, Leidy L.; Padilla, Leonardo; Castano, Jhon C.] Univ Quindio, Grp Mol Immunol, Armenia, Quindio, Colombia.
RP Garcia, LL (corresponding author), Univ Quindio, Grp Mol Immunol, Armenia, Quindio, Colombia.
EM llgarciaa@uqvirtual.edu.co
RI Padilla-S, Leonardo/Y-5791-2019; Castano-Osorio, Jhon/AAE-5905-2020
OI Padilla-S, Leonardo/0000-0001-5811-2791; Castano-Osorio,
   Jhon/0000-0002-7639-3053; garcia, leidy/0000-0003-1994-0775
FU Group of Molecular Immunology at Universidad del Quindio and project of
   Colciencias [1113-56933424]
FX The authors thank the Group of Molecular Immunology at Universidad del
   Quindio and project of Colciencias code 1113-56933424.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Badani H, 2014, BBA-BIOMEMBRANES, V1838, P2180, DOI 10.1016/j.bbamem.2014.04.015
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Betzi S, 2009, ANTIVIR RES, V84, P48, DOI 10.1016/j.antiviral.2009.06.009
   Bhattacharya D, 2008, VIROLOGY, V380, P276, DOI 10.1016/j.virol.2008.07.013
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Brault JB, 2011, VIROLOGY, V417, P369, DOI 10.1016/j.virol.2011.06.022
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006
   Chang JH, 2011, ANTIVIR RES, V89, P26, DOI 10.1016/j.antiviral.2010.11.002
   Chatelain G, 2013, EUR J MED CHEM, V65, P249, DOI 10.1016/j.ejmech.2013.04.034
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10
   Chu JJH, 2015, ANTIVIR RES, V118, P68, DOI 10.1016/j.antiviral.2015.03.010
   De Burghgraeve T, 2013, ANTIVIR RES, V98, P242, DOI 10.1016/j.antiviral.2013.01.011
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198
   Garry R, 2008, United States patent, Patent No. [US7416733 B2, 7416733]
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Indenbaum V, 2012, VIRUS RES, V166, P68, DOI 10.1016/j.virusres.2012.03.004
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Lai JH, 2017, BIOCHEM PHARMACOL, V129, P14, DOI 10.1016/j.bcp.2017.01.005
   Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Li J, 2008, United States patent, Patent No. [US20080032917 A1, 20080032917]
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   MALINOSKI FJ, 1990, ANTIVIR RES, V13, P139, DOI 10.1016/0166-3542(90)90029-7
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Meguellati A, 2014, EUR J MED CHEM, V80, P579, DOI 10.1016/j.ejmech.2014.04.005
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Najera I, 2013, CURR OPIN VIROL, V3, P508, DOI 10.1016/j.coviro.2013.08.011
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Padilla L, 2014, ARCH VIROL, V159, P573, DOI 10.1007/s00705-013-1849-6
   Padmanabhan R, 2013, United States patent, Patent No. [US8563580 B2, 8563580]
   Padmanabhan R, 2015, United States patent, Patent No. [US20150272976 A1, 20150272976]
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Prusis P, 2013, BIOCHEM BIOPH RES CO, V434, P767, DOI 10.1016/j.bbrc.2013.03.139
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Saudi M, 2014, EUR J MED CHEM, V87, P529, DOI 10.1016/j.ejmech.2014.09.062
   Saudi M, 2014, EUR J MED CHEM, V76, P98, DOI 10.1016/j.ejmech.2014.02.011
   Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Taylor RT, 2011, METHODS, V55, P166, DOI 10.1016/j.ymeth.2011.08.003
   Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 74
TC 20
Z9 21
U1 1
U2 27
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD MAY 15
PY 2017
VL 14
AR 95
DI 10.1186/s12985-017-0761-1
PG 12
WC Virology
SC Virology
GA EU8ID
UT WOS:000401281400001
PM 28506240
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Meneses, JD
   Ishigami, AC
   de Mello, LM
   de Albuquerque, LL
   de Brito, CAA
   Cordeiro, MT
   Pena, LJ
AF Meneses, Jucille do Amaral
   Ishigami, Ana Catarina
   de Mello, Luisa Medeiros
   de Albuquerque, Luciano Lira
   Antunes de Brito, Carlos Alexandre
   Cordeiro, Marli Tenorio
   Pena, Lindomar Jose
TI Lessons Learned at the Epicenter of Brazil's Congenital Zika Epidemic:
   Evidence From 87 Confirmed Cases
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome (CZS); microcephaly; diaphragm paralysis; Zika
   virus; immunoglobulin M
ID VIRUS-INFECTION; DIAPHRAGMATIC PARALYSIS; ASSOCIATION; ANTIBODY; INFANTS
AB Congenital Zika virus infection has stimulated great international concern. A prospective case series of 87 infants with laboratory- confirmed congenital Zika syndrome (CZS) at the epicenter of the Brazilian Zika epidemic in Pernambuco state is presented. Mothers were interviewed for symptoms of possible Zika virus (ZIKV) infection during pregnancy, and fetal ultrasounds were obtained. Infant cerebrospinal fluid (CSF) samples were tested for ZIKV-specific antibodies, and sera were screened for other congenital infections. Neuroimaging and ophthalmologic evaluations were also performed. Sixty-six mothers (76%) reported symptoms of ZIKV infection during gestation. Fetal ultrasounds were available from 90% of the mothers, and all demonstrated brain structural abnormalities. All of the CSF samples tested positive for ZIKV immunoglobulin M. The majority of infants (89%) were term; the mean birth weight was 2577 +/- 260 g, and the mean head circumference was 28.1 +/- 1.8 cm. Severe microcephaly, defined as head circumference 3 SD below the mean for sex and gestational age, was found in 72 (82%) infants. All infants had an abnormal neurological exam, and 18 (20.7%) had arthrogryposis. The main abnormalities detected in computed tomography scans were calcifications (99%), followed by ventricular enlargement (94%), cortical hypogyration (81%), and less commonly, cerebellar hypoplasia (52%). Unilateral diaphragm paralysis was identified in 3 infants. Maternal young age, term infant, small for gestational age, and the presence of ophthalmologic abnormalities were significantly associated with a smaller head circumference Z score. Our findings, based on laboratory-confirmed ZIKV infection, add valuable evidence for the understanding of CZS.
C1 [Meneses, Jucille do Amaral; Ishigami, Ana Catarina; de Mello, Luisa Medeiros; de Albuquerque, Luciano Lira] Prof Fernando Figueira Integral Med Inst, Div Neonatol, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio; Pena, Lindomar Jose] Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
RP Pena, LJ (corresponding author), Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
EM lindomar.pena@cpqam.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FACEPE (Foundation of Science and Technology of Pernambuco
   State)
FX L. J. P. is supported by grants from CNPq and FACEPE (Foundation of
   Science and Technology of Pernambuco State).
CR Ansari MK, 2010, NEUROL INDIA, V58, P596, DOI 10.4103/0028-3886.68662
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Klein Jessica L, 2016, Cerebellum Ataxias, V3, P1, DOI 10.1186/s40673-016-0039-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Pan American Health Organization/World Health Organization, 2016, ZIK SUSP CONF CAS RE
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ratnayake EC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-46
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 27
TC 42
Z9 42
U1 1
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 15
PY 2017
VL 64
IS 10
BP 1302
EP 1308
DI 10.1093/cid/cix166
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EU3EX
UT WOS:000400912500002
PM 28329257
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, JH
   Chong, CY
   Tan, NWH
   Yung, CF
   Tee, NWS
   Thoon, KC
AF Li, Jiahui
   Chong, Chia Yin
   Tan, Natalie W. H.
   Yung, Chee Fu
   Tee, Nancy W. S.
   Thoon, Koh Cheng
TI Characteristics of Zika Virus Disease in Children: Clinical,
   Hematological, and Virological Findings from an Outbreak in Singapore
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Southeast Asia; pediatric; dengue virus; clinical features
AB In the first reported pediatric case series of virologically confirmed Zika virus (ZIKV) infections from Southeast Asia, ZIKV infection was generally mild. Routine screening of children with suspected ZIKV infection for dengue virus coinfection should be considered in dengue-endemic countries.
C1 [Li, Jiahui] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore.
   [Chong, Chia Yin; Tan, Natalie W. H.; Yung, Chee Fu; Thoon, Koh Cheng] KK Womens & Childrens Hosp, Infect Dis Serv, Singapore, Singapore.
   [Tee, Nancy W. S.] KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore.
RP Yung, CF (corresponding author), KK Womens & Childrens Hosp, Dept Paediat Med, Infect Dis Serv, Singapore, Singapore.
EM yung.chee.fu@singhealth.com.sg
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V25, P84
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Goodman AB, 2016, MMWR-MORBID MORTAL W, V65, P38
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Sadarangani SP, 2016, ANN ACAD MED SINGAP, V45, P381
NR 10
TC 16
Z9 17
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 15
PY 2017
VL 64
IS 10
BP 1445
EP 1448
DI 10.1093/cid/cix137
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EU3EX
UT WOS:000400912500021
PM 28186536
OA Bronze
DA 2020-07-08
ER

PT J
AU Herrera, BB
   Chang, CA
   Hamel, DJ
   Mboup, S
   Ndiaye, D
   Imade, G
   Okpokwu, J
   Agbaji, O
   Bei, AK
   Kanki, PJ
AF Herrera, Bobby Brooke
   Chang, Charlotte A.
   Hamel, Donald J.
   Mboup, Souleymane
   Ndiaye, Daouda
   Imade, Godwin
   Okpokwu, Jonathan
   Agbaji, Oche
   Bei, Amy K.
   Kanki, Phyllis J.
TI Continued Transmission of Zika Virus in Humans in West Africa, 1992-2016
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Seroprevalence; HIV; Malaria; Senegal; Nigeria; Africa
ID MALARIA; SENEGAL; STATES
AB First identified in 1947 in Uganda, Zika virus (ZIKV) has remained largely unstudied until the recent outbreak in Latin America. This study aimed to measure the prevalence of ZIKV in febrile patients in Senegal and Nigeria in samples collected from 1992 to 2016. The seroprevalence of ZIKV was 6.2% based on ZIKV immunoglobulin M and negative for dengue reactivity. ZIKV envelope was amplified from 4 samples. Phylogenetic analysis showed that the ZIKVs belonged to the African lineage, grouping with either the Nigerian or MR766 sublineages. This study provides evidence that ZIKV has been silently circulating in West Africa for 2 decades.
C1 [Herrera, Bobby Brooke; Chang, Charlotte A.; Hamel, Donald J.; Bei, Amy K.; Kanki, Phyllis J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 651 Huntington Ave, Boston, MA 02115 USA.
   [Mboup, Souleymane; Ndiaye, Daouda; Bei, Amy K.] Cheikh Anta Diop Univ, Dept Parasitol & Mycol, Dakar, Senegal.
   [Mboup, Souleymane; Ndiaye, Daouda; Bei, Amy K.] Le Dantec Hosp, Dakar, Senegal.
   [Mboup, Souleymane] Inst Hlth Res Epidemiol Surveillance & Training, Dakar, Senegal.
   [Imade, Godwin; Okpokwu, Jonathan] Univ Jos, Jos Univ, Teaching Hosp, Jos, Nigeria.
RP Kanki, PJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 651 Huntington Ave, Boston, MA 02115 USA.
EM pkanki@hsph.harvard.edu
RI Agbaji, Oche/AAD-5263-2019
OI Herrera, Bobby Brooke/0000-0002-2438-6716
FU US Department of DefenseUnited States Department of Defense
   [DAMD-17-87-7072]; National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI301795, CA39805]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01GM061351,
   D43TW001503, K23AI072033, AI034969]; Malaria Diversity grant from the
   Bill & Melinda Gates Foundation; Ellison Medical FoundationLawrence
   Ellison Foundation; Fogarty International CenterUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [5D43TW001503]; International Centers
   of Excellence for Malaria Research [U19AI089696]; US Department of
   Health and Human Services, Health Resources and Services
   AdministrationUnited States Department of Health & Human ServicesUnited
   States Health Resources & Service Administration (HRSA) [U51HA02522];
   Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   APIN [PS001058]
FX The Senegalese FSW study was supported in part by the US Department of
   Defense (grant number DAMD-17-87-7072) and the National Institutes of
   Health (NIH; grant numbers AI301795 and CA39805). The Senegalese malaria
   sample collection in Thies was supported by NIH grants R01GM061351 and
   D43TW001503, the Malaria Diversity grant from the Bill & Melinda Gates
   Foundation, and the Ellison Medical Foundation. The Senegalese sample
   collection in Velingara was supported in part by grant 5D43TW001503 from
   the Fogarty International Center, grant U19AI089696 from the
   International Centers of Excellence for Malaria Research, and NIH grants
   K23AI072033 and AI034969. The Nigerian HIV cohort was supported in part
   by the US Department of Health and Human Services, Health Resources and
   Services Administration (U51HA02522) and the Centers for Disease Control
   and Prevention through a cooperative agreement with APIN (PS001058).
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311
   Daniels RF, 2015, P NATL ACAD SCI USA, V112, P7067, DOI 10.1073/pnas.1505691112
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Meloni ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164030
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, HIST ZIK VIR
NR 15
TC 26
Z9 26
U1 1
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAY 15
PY 2017
VL 215
IS 10
BP 1546
EP 1550
DI 10.1093/infdis/jix182
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW9FI
UT WOS:000402821800009
PM 28398562
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Walani, SR
   Biermann, J
AF Walani, Salimah R.
   Biermann, Janis
TI March of Dimes Foundation: leading the way to birth defects prevention
SO PUBLIC HEALTH REVIEWS
LA English
DT Editorial Material
DE March of Dimes; Birth defects; Preterm birth; Babies; Zika; Prematurity
ID UNITED-STATES; HEALTH
AB Birth defects are a major cause of mortality among children under five. In accordance with its mission, the March of Dimes Foundation is dedicated to reducing the toll of birth defects on children, families, and society. Founded in 1938 to fight polio, March of Dimes currently focuses on prevention of birth defects and preterm birth and has had a major influence on surveillance, research, advocacy, awareness, and education related to birth defects prevention and care. In the USA, it has played an active role in promoting and advocating for newborn screening for early diagnosis and treatment of congenital disorders, folic acid fortification of grains for prevention of neural tube defects, and more recently on raising awareness about birth defects related to Zika virus infection. March of Dimes has played a major role in promoting prevention of birth defects globally by publishing data-based reports and papers related to the toll of birth defects and by supporting surveillance and preconception health education programs. March of Dimes birth defects health education materials directed for raising awareness among families are used worldwide. Additionally, March of Dimes had equipped health care workers and policy makers with essential information about birth defects through published materials and sponsoring of conferences that allow for networking and knowledge exchange. March of Dimes remains committed to prevention of birth defects through supporting research related to causes of birth defects, empowering women and girls with health knowledge, and advocating for policies and programs at national and global levels for giving every child an opportunity to attain his or her optimal level of health.
C1 [Walani, Salimah R.] March Dimes Fdn, Global Hlth Programs, White Plains, NY 10605 USA.
   [Biermann, Janis] March Dimes Fdn, Educ & Hlth Promot, White Plains, NY USA.
RP Walani, SR (corresponding author), March Dimes Fdn, Global Hlth Programs, White Plains, NY 10605 USA.
EM swalani@marchofdimes.org
CR [Anonymous], 2004, FOL AC PREV BIRTH DE, P3
   Centers for Disease Control and Prevention, 2016, FOL AC BIRTH DEF COU
   Charafeddine L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-774
   Christianson A, 2006, MARCH DIMES GLOBAL R
   Darmstadt GL, 2016, JAMA PEDIATR, V170, P790, DOI 10.1001/jamapediatrics.2016.0388
   Howse JL, 2006, CRITICAL ROLE MARCH, DOI [10.1002/mrdd.20129, DOI 10.1002/MRDD.20129]
   Howson C, 2012, BORN TOO SOON GLOBAL
   McNeil Jr D.G, 2015, NY TIMES
   Vanderbilt AA, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.22503
   Williams J, 2015, MMWR-MORBID MORTAL W, V64, P1
   World Health Organization, 2010, BIRTH DEFECTS
NR 11
TC 1
Z9 1
U1 1
U2 71
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 0301-0422
EI 2107-6952
J9 PUBLIC HEALTH REV
JI Public Health Rev.
PD MAY 12
PY 2017
VL 38
AR UNSP 12
DI 10.1186/s40985-017-0058-3
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EX7QA
UT WOS:000403441700001
PM 29450084
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thomas, SJ
AF Thomas, Stephen J.
TI Zika Virus Vaccines - A Full Field and Looking for the Closers
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID PROTECTION; VACCINATION
C1 [Thomas, Stephen J.] SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA.
RP Thomas, SJ (corresponding author), SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   HAMPTON T, 2016, JAMA J AM MED ASSOC, V316, P1755
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
NR 7
TC 8
Z9 9
U1 0
U2 11
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 11
PY 2017
VL 376
IS 19
BP 1883
EP 1886
DI 10.1056/NEJMcibr1701402
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA EU2WR
UT WOS:000400891100017
PM 28490001
DA 2020-07-08
ER

PT J
AU Wen, JS
   Shresta, S
AF Wen, Jinsheng
   Shresta, Sujan
TI ADE-ing and Abetting Zika
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID VIRUS-INFECTION; DENGUE; ENHANCEMENT
AB Although dengue virus (DENV) antibodies can neutralize or enhance Zika virus (ZIKV) infection in vitro, their contribution to ZIKV infection in vivo remains unclear. In a recent issue of Science, Bardina et al. (2017) explore the protective versus pathogenic roles of DENV-immune antibodies in ZIKV infection using a mouse model.
C1 [Wen, Jinsheng; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Wen, Jinsheng] Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM sujan@lji.org
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI116813]
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
NR 10
TC 0
Z9 0
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 10
PY 2017
VL 21
IS 5
BP 557
EP 558
DI 10.1016/j.chom.2017.04.006
PG 2
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EU2XF
UT WOS:000400892500005
PM 28494235
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Arora, N
   Sadovsky, Y
   Dermody, TS
   Coyne, CB
AF Arora, Nitin
   Sadovsky, Yoel
   Dermody, Terence S.
   Coyne, Carolyn B.
TI Microbial Vertical Transmission during Human Pregnancy
SO CELL HOST & MICROBE
LA English
DT Review
ID HUMAN CYTOMEGALOVIRUS-INFECTION; MATERNAL-FETAL TRANSMISSION; TOLL-LIKE
   RECEPTORS; G MESSENGER-RNA; HUMAN-PLACENTA; ZIKA VIRUS;
   TOXOPLASMA-GONDII; CONGENITAL TOXOPLASMOSIS; HLA-G; TROPHOBLAST CELLS
AB Congenital infections with pathogens such as Zika virus, Toxoplasma gondii, Listeria monocytogenes, Treponema pallidium, parvovirus, HIV, varicella zoster virus, Rubella, Cytomegalovirus, and Herpesviruses are a major cause of morbidity and mortality worldwide. Despite the devastating impact of microbial infections on the developing fetus, relatively little is known about how pathogens associated with congenital disease breach the placental barrier to transit vertically during human pregnancy. In this Review, we focus on transplacental transmission of pathogens during human gestation. We introduce the structure of the human placenta and describe the innate mechanisms by which the placenta restricts microbial access to the intrauterine compartment. Based on current knowledge, we also discuss the potential pathways employed by microorganisms to overcome the placental barrier and prospects for the future.
C1 [Arora, Nitin; Dermody, Terence S.; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA.
   [Arora, Nitin; Dermody, Terence S.; Coyne, Carolyn B.] Childrens Hosp Pittsburgh UPMC, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
   [Sadovsky, Yoel] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15261 USA.
   [Sadovsky, Yoel] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA.
   [Dermody, Terence S.; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
RP Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA.; Coyne, CB (corresponding author), Childrens Hosp Pittsburgh UPMC, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
EM coynec2@pitt.edu
OI Arora, Nitin/0000-0001-6840-4333; Sadovsky, Yoel/0000-0003-2969-6737
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 HD075665, R01 AI081759, R01
   AI123348]; Burroughs Wellcome Investigators in the Pathogenesis of
   Infectious Disease AwardBurroughs Wellcome Fund
FX Our work on the human placenta is supported by NIH R01 HD075665 (C.B.C.
   and Y.S.) and a Burroughs Wellcome Investigators in the Pathogenesis of
   Infectious Disease Award (C.B.C.). Additional support comes from NIH R01
   AI081759 (C.B.C.) and R01 AI123348 (T.S.D.).
CR Abbasi M, 2003, J INFECT DIS, V188, P608, DOI 10.1086/377132
   Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayer A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.060
   Blanco O, 2008, HUM REPROD, V23, P144, DOI 10.1093/humrep/dem326
   Boily-Larouche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040706
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRIGHT NA, 1995, J HISTOCHEM CYTOCHEM, V43, P933, DOI 10.1177/43.9.7642966
   BROSSARD Y, 1995, AIDS, V9, P359, DOI 10.1097/00002030-199509040-00007
   BULMER JN, 1988, REPROD NUTR DEV, V28, P1599, DOI 10.1051/rnd:19881006
   BUXTON D, 1986, J COMP PATHOL, V96, P319, DOI 10.1016/0021-9975(86)90052-6
   Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70
   CANTLE SJ, 1987, PLACENTA, V8, P221, DOI 10.1016/0143-4004(87)90046-4
   CHUMBLEY G, 1993, HUM IMMUNOL, V37, P17, DOI 10.1016/0198-8859(93)90138-Q
   Costello MJ, 2007, AM J REPROD IMMUNOL, V57, P67, DOI 10.1111/j.1600-0897.2006.00447.x
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DANCIS J, 1961, AM J OBSTET GYNECOL, V82, P167, DOI 10.1016/S0002-9378(16)36111-7
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003
   Faucher B, 2012, J INFECTION, V64, P104, DOI 10.1016/j.jinf.2011.10.008
   Ferro EAV, 2002, INFECT IMMUN, V70, P7089, DOI 10.1128/IAI.70.12.7089-7094.2002
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Gabrielli L, 2001, J MED VIROL, V64, P499, DOI 10.1002/jmv.1077
   GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667, DOI 10.1128/CDLI.1.6.667-669.1994
   GUSDON JP, 1969, AM J OBSTET GYNECOL, V103, P895, DOI 10.1016/S0002-9378(16)34434-9
   Halwachs-Baumann G, 1998, J VIROL, V72, P7598, DOI 10.1128/JVI.72.9.7598-7602.1998
   Halwachs-Baumann G, 2006, J CLIN VIROL, V37, P91, DOI 10.1016/j.jcv.2006.06.006
   HAMILTON WJ, 1960, J ANAT, V94, P297
   Hemmings DG, 1998, J VIROL, V72, P4970, DOI 10.1128/JVI.72.6.4970-4979.1998
   Hemmings DG, 2002, J VIROL, V76, P6710, DOI 10.1128/JVI.76.13.6710-6717.2002
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jones CJP, 2008, PLACENTA, V29, P215, DOI 10.1016/j.placenta.2007.11.004
   Juliano PB, 2006, PLACENTA, V27, P750, DOI 10.1016/j.placenta.2005.07.008
   King A, 1997, IMMUNOL TODAY, V18, P64, DOI 10.1016/S0167-5699(97)01001-3
   King AE, 2007, PLACENTA, V28, P161, DOI 10.1016/j.placenta.2006.01.006
   Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325
   KOPPE JG, 1986, LANCET, V1, P254
   Lindsay DS, 2011, PARASITOLOGY, V138, P1829, DOI 10.1017/S0031182011001478
   Ma Y, 2007, PLACENTA, V28, P1024, DOI 10.1016/j.placenta.2007.05.003
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Maidji E, 2002, VIROLOGY, V304, P53, DOI 10.1006/viro.2002.1661
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Manaster I, 2010, AM J REPROD IMMUNOL, V63, P434, DOI 10.1111/j.1600-0897.2009.00794.x
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   McDonagh S, 2006, J CLIN VIROL, V35, P210, DOI 10.1016/j.jcv.2005.08.011
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   Mor G, 2006, METH MOLEC MED, V122, P149
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Mori M, 2007, BIOL REPROD, V76, P164, DOI 10.1095/biolreprod.106.056127
   MOSTOUFIZADEH M, 1984, ARCH PATHOL LAB MED, V108, P403
   MUHLEMANN K, 1992, HUM PATHOL, V23, P1234, DOI 10.1016/0046-8177(92)90290-J
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Ouyang YS, 2016, PLACENTA, V47, P86, DOI 10.1016/j.placenta.2016.09.008
   Patni S, 2009, BIOL REPROD, V80, P243, DOI 10.1095/biolreprod.108.069252
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Peyron F, 2011, PEDIATR INFECT DIS J, V30, P597, DOI 10.1097/INF.0b013e31820bb5f3
   Pezerico SB, 2009, EXP PARASITOL, V123, P168, DOI 10.1016/j.exppara.2009.06.015
   Proll J, 1999, AM J REPROD IMMUNOL, V42, P30
   Pudney J, 2016, PLACENTA, V46, P1, DOI 10.1016/j.placenta.2016.07.005
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Red-Horse Kristy, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007720
   Revello MG, 2004, J CLIN VIROL, V29, P71, DOI 10.1016/j.jcv.2003.09.012
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Schleiss MR, 2007, PEDIATR RES, V61, P565, DOI 10.1203/pdr.0b013e318045be6d
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shiono Y, 2007, PARASITOL INT, V56, P141, DOI 10.1016/j.parint.2007.01.008
   Svinarich DM, 1997, AM J REPROD IMMUNOL, V38, P252
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tangeras LH, 2014, J REPROD IMMUNOL, V106, P89, DOI 10.1016/j.jri.2014.04.004
   Trincado DE, 2005, J INFECT DIS, V192, P650, DOI 10.1086/431999
   Van Dyke RB, 1999, J INFECT DIS, V179, P319, DOI 10.1086/314580
   Weisblum Y, 2014, SEMIN IMMUNOPATHOL, V36, P615, DOI 10.1007/s00281-014-0449-1
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wicherek L, 2009, AM J REPROD IMMUNOL, V61, P303, DOI 10.1111/j.1600-0897.2009.00696.x
   YELAVARTHI KK, 1991, J IMMUNOL, V146, P2847
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
   Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005
   Zenclussen AC, 2013, AM J REPROD IMMUNOL, V69, P291, DOI 10.1111/aji.12097
NR 84
TC 68
Z9 72
U1 5
U2 43
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 10
PY 2017
VL 21
IS 5
BP 561
EP 567
DI 10.1016/j.chom.2017.04.007
PG 7
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EU2XF
UT WOS:000400892500007
PM 28494237
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Priyamvada, L
   Hudson, W
   Ahmed, R
   Wrammert, J
AF Priyamvada, Lalita
   Hudson, William
   Ahmed, Rafi
   Wrammert, Jens
TI Humoral cross-reactivity between Zika and dengue viruses: implications
   for protection and pathology
SO EMERGING MICROBES & INFECTIONS
LA English
DT Review
DE antibody-dependent enhancement; cross-protection; cross-reactive
   antibodies; DENV; ZIKV
ID ANTIBODY-DEPENDENT ENHANCEMENT; NEUTRALIZING HUMAN-ANTIBODIES;
   STRUCTURAL BASIS; HIGHLY POTENT; INFECTION; OUTBREAK; DISEASE;
   TRANSMISSION; ARBOVIRUSES; RESPONSES
AB Zika virus (ZIKV) is a re-emerging mosquito-borne flavivirus that has recently caused extensive outbreaks in Central and South America and the Caribbean. Given its association with Guillain-Barre syndrome in adults and neurological and ocular malformities in neonates, ZIKV has become a pathogen of significant public health concern worldwide. ZIKV shares a considerable degree of genetic identity and structural homology with other flaviviruses, including dengue virus (DENV). In particular, the surface glycoprotein envelope (E), which is involved in viral fusion and entry and is therefore a chief target for neutralizing antibody responses, contains regions that are highly conserved between the two viruses. This results in immunological cross-reactivity, which in the context of prior DENV exposure, may have significant implications for the generation of immune responses to ZIKV and affect disease outcomes. Here we address the issue of humoral cross-reactivity between DENV and ZIKV, reviewing the evidence for and discussing the potential impact of this cross-recognition on the functional quality of antibody responses against ZIKV. These considerations are both timely and relevant to future vaccine design efforts, in view of the existing overlap in the distribution of ZIKV and DENV and the likely spread of ZIKV to additional DENV-naive and experienced populations.
C1 [Priyamvada, Lalita; Wrammert, Jens] Emory Univ, Div Infect Dis, Dept Pediat, Sch Med, Atlanta, GA 30322 USA.
   [Priyamvada, Lalita; Hudson, William; Ahmed, Rafi; Wrammert, Jens] Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA.
   [Hudson, William; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA.
RP Wrammert, J (corresponding author), Emory Univ, Div Infect Dis, Dept Pediat, Sch Med, Atlanta, GA 30322 USA.; Wrammert, J (corresponding author), Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA.
EM jwramme@emory.edu
RI Hudson, William/E-6622-2012; Priyamvada, Lalita/J-6252-2019
OI Hudson, William/0000-0002-2513-1213; Priyamvada,
   Lalita/0000-0002-0479-0164
FU NIH/NIAID Grant [U19AI057266, 1U01AI115651]; Cancer Research Institute
FX This work was funded in part by NIH/NIAID Grant U19AI057266 and
   1U01AI115651 to RA and JW. WH is a Cancer Research Institute Irvington
   Fellow supported by the Cancer Research Institute. All three authors are
   affiliated with Emory University School of Medicine, Atlanta, GA 30322,
   USA.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Friberg H, 2012, VIRAL IMMUNOL, V25, P348, DOI 10.1089/vim.2012.0010
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO/ WHO, 2017, AM              0310
   PAHO/ WHO, 2016, ZIK CAS CONG SYNDR A
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 71
TC 52
Z9 52
U1 1
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAY 10
PY 2017
VL 6
AR e33
DI 10.1038/emi.2017.42
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EW1ZY
UT WOS:000402297000005
PM 28487557
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gerardin, P
   Cao-Lormeau, VM
   Tournebize, P
   Cerny, T
AF Gerardin, Patrick
   Cao-Lormeau, Van-Mai
   Tournebize, Patrice
   Cerny, Thomas
TI LETTER RE: ACUTE ZIKA INFECTION WITH CONCURRENT ONSET OF GUILLAIN-BARRE
   SYNDROME
SO NEUROLOGY
LA English
DT Letter
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480
NR 0
TC 2
Z9 2
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY 9
PY 2017
VL 88
IS 19
BP 1874
EP 1874
DI 10.1212/WNL.0000000000003927
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA EU1DA
UT WOS:000400752000017
PM 28483991
DA 2020-07-08
ER

PT J
AU Timmings, PL
   Siu, R
   Bukhari, W
   Todd, A
   Gunn, W
AF Timmings, Paul L.
   Siu, Ronald
   Bukhari, Wajih
   Todd, Angela
   Gunn, Wendy
TI AUTHOR RESPONSE: ACUTE ZIKA INFECTION WITH CONCURRENT ONSET OF
   GUILLAIN-BARRE SYNDROME
SO NEUROLOGY
LA English
DT Letter
OI Siu, Ronald/0000-0003-0348-6678
CR Velandia ML, 2012, VIRAL GENOMES - MOLECULAR STRUCTURE, DIVERSITY, GENE EXPRESSION MECHANISMS AND HOST-VIRUS INTERACTIONS, P219
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
NR 3
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY 9
PY 2017
VL 88
IS 19
BP 1874
EP 1875
DI 10.1212/WNL.0000000000003928
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EU1DA
UT WOS:000400752000018
PM 28483992
DA 2020-07-08
ER

PT J
AU Jain, R
   Butler, KV
   Coloma, J
   Jin, J
   Aggarwal, AK
AF Jain, Rinku
   Butler, Kyle V.
   Coloma, Javier
   Jin, Jian
   Aggarwal, Aneel K.
TI Development of a S-adenosylmethionine analog that intrudes the RNA-cap
   binding site of Zika methyltransferase
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NS5 METHYLTRANSFERASE; VIRUS; VALIDATION; TRANSMISSION; INHIBITORS
AB The Zika virus (ZIKV) has emerged as a major health hazard. We present here a high resolution structure (1.55 angstrom) of ZIKV NS5 methyltransferase bound to a novel S-adenosylmethionine (SAM) analog in which a 4-fluorophenyl moiety substitutes for the methyl group. We show that the 4-fluorophenyl moiety extends into a portion of the RNA binding tunnel that typically contains the adenosine 2'OH of the RNA-cap moiety. Together, the new SAM analog and the high-resolution crystal structure are a step towards the development of antivirals against ZIKV and other flaviviruses.
C1 [Jain, Rinku; Butler, Kyle V.; Coloma, Javier; Jin, Jian; Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, 1425 Madison Ave, New York, NY 10029 USA.
RP Aggarwal, AK (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, 1425 Madison Ave, New York, NY 10029 USA.
EM aneel.aggarwal@mssm.edu
FU National Cancer InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [ACB-12002]; National Institute of General Medical
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [AGM-12006]; DOE Office of ScienceUnited States
   Department of Energy (DOE) [DE-AC02-06CH11357]; U.S. National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01GM103893, R01GM122749]
FX We thank the staff at GM/CA@APS beamline 23ID-D (APS) at the Argonne
   National Laboratory for facilitating data collection. GM/CA@APS has been
   funded in whole or in part with Federal funds from the National Cancer
   Institute (ACB-12002) and the National Institute of General Medical
   Sciences (AGM-12006). This research used resources of the Advanced
   Photon Source, a U.S. Department of Energy (DOE) Office of Science User
   Facility operated for the DOE Office of Science by Argonne National
   Laboratory under Contract No. DE-AC02-06CH11357. This research was also
   supported in part by grants R01GM103893 and R01GM122749 (to J.J.) from
   the U.S. National Institutes of Health.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x
   Lazear H. M., 2016, J VIROL
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Shi C, 2013, ACS MED CHEM LETT, V4, P1213, DOI 10.1021/ml400328a
   Smietanski M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4004
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 28
TC 11
Z9 13
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 9
PY 2017
VL 7
AR 1632
DI 10.1038/s41598-017-01756-7
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU2PD
UT WOS:000400870500022
PM 28487506
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Castro, LA
   Fox, SJ
   Chen, X
   Liu, K
   Bellan, SE
   Dimitrov, NB
   Galvani, AP
   Meyers, LA
AF Castro, Lauren A.
   Fox, Spencer J.
   Chen, Xi
   Liu, Kai
   Bellan, Steven E.
   Dimitrov, Nedialko B.
   Galvani, Alison P.
   Meyers, Lauren Ancel
TI Assessing real-time Zika risk in the United States
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika; ZIKV; Importation risk; Autochthonous transmission risk
ID AEDES-AEGYPTI; VIRUS; DENGUE; INFECTIONS; RECAPTURE; SURVIVAL; ISLAND
AB Background: Confirmed local transmission of Zika Virus (ZIKV) in Texas and Florida have heightened the need for early and accurate indicators of self-sustaining transmission in high risk areas across the southern United States. Given ZIKV's low reporting rates and the geographic variability in suitable conditions, a cluster of reported cases may reflect diverse scenarios, ranging from independent introductions to a self-sustaining local epidemic.
   Methods: We present a quantitative framework for real-time ZIKV risk assessment that captures uncertainty in case reporting, importations, and vector-human transmission dynamics.
   Results: We assessed county-level risk throughout Texas, as of summer 2016, and found that importation risk was concentrated in large metropolitan regions, while sustained ZIKV transmission risk is concentrated in the southeastern counties including the Houston metropolitan region and the Texas-Mexico border (where the sole autochthonous cases have occurred in 2016). We found that counties most likely to detect cases are not necessarily the most likely to experience epidemics, and used our framework to identify triggers to signal the start of an epidemic based on a policymakers propensity for risk.
   Conclusions: This framework can inform the strategic timing and spatial allocation of public health resources to combat ZIKV throughout the US, and highlights the need to develop methods to obtain reliable estimates of key epidemiological parameters.
C1 [Castro, Lauren A.; Fox, Spencer J.; Meyers, Lauren Ancel] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
   [Chen, Xi; Dimitrov, Nedialko B.] Univ Texas Austin, Grad Program Operat Res & Ind Engn, Austin, TX 78712 USA.
   [Liu, Kai] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.
   [Bellan, Steven E.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Bellan, Steven E.] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA.
   [Galvani, Alison P.] Yale Univ, Dept Ecol & Evolut, New Haven, CT USA.
   [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA.
RP Fox, SJ (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
EM spncrfx@gmail.com
OI Meyers, Lauren/0000-0002-5828-8874
FU National Institute of General Medical Sciences MIDASUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [U01GM087719]; NIGMSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U01GM105627]; Defense Threat
   Reduction AgencyUnited States Department of DefenseDefense Threat
   Reduction Agency [HDTRA-14-C-0114]; International Clinics on Infectious
   Disease Dynamics and Data (ICI3D) program - NIGMS [R25GM102149]; Texas
   Department of State Health Services [2015-047259-001]
FX LAC, SEB, LAM, and APG were supported by a National Institute of General
   Medical Sciences MIDAS grant to LAM and APG (U01GM087719), and APG
   received additional NIGMS support (U01GM105627). SJF, KL, and LAM were
   funded through a grant from the Defense Threat Reduction Agency to LAM
   (HDTRA-14-C-0114). SEB was additionally supported by the International
   Clinics on Infectious Disease Dynamics and Data (ICI3D) program, which
   is funded by a NIGMS grant (R25GM102149). NBD and XC were partially
   supported by a contract with the Texas Department of State Health
   Services (2015-047259-001). The funders did not contribute to the
   design, of the study, analysis, or interpretation of data.
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Blumberg S, 2013, EPIDEMICS-NETH, V5, P131, DOI 10.1016/j.epidem.2013.05.002
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399
   Centers for Disease Control and Prevention, 2016, INT CDC REC ZIK VECT
   Centers for Disease Control and Protection, 2016, EST RANG AED AEG AED
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Dechant EJ, 1999, AM J TROP MED HYG, V61, P574, DOI 10.4269/ajtmh.1999.61.574
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620
   Kucharski AJ, 2016, BIORXIV, P1
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Lloyd-Smith JO, 2014, 9 CHALLENGES MODELLI, V10, P35, DOI [10.1016/j.epidem.2014.09.002, DOI 10.1016/J.EPIDEM.2014.09.002]
   Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Office of Travel & Tourism Industries, 2014, US MONTHL ARR TREND
   PAHO and WHO, 2016, ZIK EP REP MEX
   PAHO and WHO, 2016, ZIK EP REP ANG, P1
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Scarpino SV, 2015, CLIN INFECT DIS, V60, P1079, DOI 10.1093/cid/ciu1131
   Sidwa TJ, 2016, MOSQUITO SURVEILLANC
   Texas Department of State Health and Human Services, TEX ANN LOC ZIK VIR
   Texas Department of State Health and Human Services, 2014, ARB ACT TEX 2014 SUR
   Texas Department of State Health and Human Services, 2016, ZIK TEX
   Texas Department of State Health and Human Services, 2014, ARB ACT TEX 2013 SUR
   Wolsey L. A., 1998, INTEGER PROGRAMMING, V42
   Zhang QJ, 2016, BIORXIV
NR 32
TC 17
Z9 17
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 4
PY 2017
VL 17
AR 284
DI 10.1186/s12879-017-2394-9
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA ET6XV
UT WOS:000400437800001
PM 28468671
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Robbiani, DF
   Bozzacco, L
   Keeffe, JR
   Khouri, R
   Olsen, PC
   Gazumyan, A
   Schaefer-Babajew, D
   Avila-Rios, S
   Nogueira, L
   Patel, R
   Azzopardi, SA
   Uhl, LFK
   Saeed, M
   Sevilla-Reyes, EE
   Agudelo, M
   Yao, KH
   Golijanin, J
   Gristick, HB
   Lee, YE
   Hurley, A
   Caskey, M
   Pai, J
   Oliveira, T
   Wunder, EA
   Sacramento, G
   Nery, N
   Orge, C
   Costa, F
   Reis, MG
   Thomas, NM
   Eisenreich, T
   Weinberger, DM
   de Almeida, ARP
   West, AP
   Rice, CM
   Bjorkman, PJ
   Reyes-Teran, G
   Ko, AI
   MacDonald, MR
   Nussenzweig, MC
AF Robbiani, Davide F.
   Bozzacco, Leonia
   Keeffe, Jennifer R.
   Khouri, Ricardo
   Olsen, Priscilla C.
   Gazumyan, Anna
   Schaefer-Babajew, Dennis
   Avila-Rios, Santiago
   Nogueira, Lilian
   Patel, Roshni
   Azzopardi, Stephanie A.
   Uhl, Lion F. K.
   Saeed, Mohsan
   Sevilla-Reyes, Edgar E.
   Agudelo, Marianna
   Yao, Kai-Hui
   Golijanin, Jovana
   Gristick, Harry B.
   Lee, Yu E.
   Hurley, Arlene
   Caskey, Marina
   Pai, Joy
   Oliveira, Thiago
   Wunder, Elsio A., Jr.
   Sacramento, Gielson
   Nery, Nivison, Jr.
   Orge, Cibele
   Costa, Federico
   Reis, Mitermayer G.
   Thomas, Neena M.
   Eisenreich, Thomas
   Weinberger, Daniel M.
   de Almeida, Antonio R. P.
   West, Anthony P., Jr.
   Rice, Charles M.
   Bjorkman, Pamela J.
   Reyes-Teran, Gustavo
   Ko, Albert I.
   MacDonald, Margaret R.
   Nussenzweig, Michel C.
TI Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil
   and Mexico
SO CELL
LA English
DT Article
ID DENGUE VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; MEDIATED
   NEUTRALIZATION; CROSS-REACTIVITY; DOMAIN-III; HIV-1; ENHANCEMENT; BROAD;
   GLYCOPROTEIN
AB Antibodies to Zika virus (ZIKV) can be protective. To examine the antibody response in individuals who develop high titers of anti-ZIKV antibodies, we screened cohorts in Brazil and Mexico for ZIKV envelope domain III (ZEDIII) binding and neutralization. We find that serologic reactivity to dengue 1 virus (DENV1) EDIII before ZIKV exposure is associated with increased ZIKV neutralizing titers after exposure. Antibody cloning shows that donors with high ZIKV neutralizing antibody titers have expanded clones of memory B cells that express the same immunoglobulin VH3-23/VK1-5 genes. These recurring antibodies cross-react with DENV1, but not other flaviviruses, neutralize both DENV1 and ZIKV, and protect mice against ZIKV challenge. Structural analyses reveal the mechanism of recognition of the ZEDIII lateral ridge by VH3-23/VK1-5 antibodies. Serologic testing shows that antibodies to this region correlate with serumneutralizing activity to ZIKV. Thus, high neutralizing responses to ZIKV are associated with pre-existing reactivity to DENV1 in humans.
C1 [Robbiani, Davide F.; Olsen, Priscilla C.; Gazumyan, Anna; Schaefer-Babajew, Dennis; Nogueira, Lilian; Patel, Roshni; Uhl, Lion F. K.; Agudelo, Marianna; Yao, Kai-Hui; Golijanin, Jovana; Hurley, Arlene; Caskey, Marina; Pai, Joy; Oliveira, Thiago; Thomas, Neena M.; Eisenreich, Thomas; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
   [Bozzacco, Leonia; Azzopardi, Stephanie A.; Saeed, Mohsan; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Keeffe, Jennifer R.; Gristick, Harry B.; Lee, Yu E.; West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Khouri, Ricardo; Wunder, Elsio A., Jr.; Sacramento, Gielson; Nery, Nivison, Jr.; Orge, Cibele; Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Avila-Rios, Santiago; Sevilla-Reyes, Edgar E.; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Mexico City 14080, DF, Mexico.
   [Wunder, Elsio A., Jr.; Costa, Federico; Reis, Mitermayer G.; Weinberger, Daniel M.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med Bahia, BR-40296710 Salvador, BA, Brazil.
   [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, BR-40296710 Salvador, BA, Brazil.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
RP Robbiani, DF; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; MacDonald, MR (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
EM drobbiani@rockefeller.edu; macdonm@rockefeller.edu;
   nussen@rockefeller.edu
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015; Khouri,
   Ricardo/M-3184-2018; Olsen, Priscilla C/I-8994-2012; Robbiani, Davide
   F./AAF-7662-2019; Avila-Rios, Santiago/AAB-4383-2020; Nussenzweig,
   Michel/AAE-7292-2019; Wunder, Elsio Augusto/C-2733-2013; Reis,
   Mitermayer/AAO-9742-2020; Oliveira, Thiago/B-7073-2014
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Khouri, Ricardo/0000-0001-5664-4436;
   Olsen, Priscilla C/0000-0002-8795-037X; Robbiani, Davide
   F./0000-0001-7379-3484; Wunder, Elsio Augusto/0000-0002-5239-8511; Reis,
   Mitermayer/0000-0002-3051-9060; Caskey, Marina/0000-0003-1727-8693;
   Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602; Oliveira,
   Thiago/0000-0002-2654-0879
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI111825, UL1TR001866, R01AI037526,
   UM1AI100663, R01AI121207, R01TW009504, R25TW009338, U01AI088752,
   R01AI124690, U19AI057229]; Molecular Observatory at Caltech - Gordon and
   Betty Moore Foundation; Robertson Therapeutic Development Fund; Pew
   Latin American Fellows Program in the Biomedical Sciences;
   Studienstiftung des deutschen Volkes; Austrian Marshall Plan Foundation;
   Red INMUNOCANEI-Conacyt
FX We would especially like to thank the members of the Santa Maria
   Mixtequilla and Pau da Lima communities who agreed to participate in
   this study, as well as the Fiocruz community research team and staff of
   Hospital Geral Roberto Santos for their assistance with the clinical
   protocols. We thank members of the Nussenzweig and Rice labs for helpful
   discussions and suggestions. A particular thank you to Lotta von
   Boehmer, Christian Mayer, Yotam Bar-On, Irina Shimeliovich, and Julio
   Cetrulo Lorenzi for sharing expertise, protocols, and reagents. We thank
   Ted Pierson for plasmids pWNVII-Rep-REN-IB and pZIKV/HPF/CprME, Aaron
   Brault (CDC) for ZIKV PRVABC59, Bob Tesh for DENV1 PUO-359, Matt Evans
   for ZIKV MR766 cDNA, and Greg Ebel, James Weger, and Brian Geiss for
   ZIKV PRVABC59 cDNA. We are grateful to Laura Kramer (NYSDOH) and Robert
   Lanciotti (CDC) for PRNT advice and protocols, Kimberly Dowd for RVP
   advice, and Muhammad Arshad for cloning assistance. We thank Barbara
   Johnson, Ann Powers, Christin Goodman, Claire Huang, Brandy Russell
   (CDC), and Claudia Duarte dos Santos for sharing ZIKV information early
   on. Moreover, we are thankful to Mary Ellen Castillo for facilitating
   virus work in the cell culture core, Alison Ashbrook for help with PRNT
   assays, Natalia Frias-Staheli for generation of the DENV1 stock, Corrine
   Quirk for assistance with mouse colonies, Tiffany Luong, Alisa Voll, and
   the Caltech Protein Expression Center for cloning, expression, and
   purification of proteins for crystallography, and Christopher Barnes and
   Beth Stadtmueller for help with crystallographic methods. This work was
   supported by NIH pilot awards U19AI111825 (to D.F.R.) and UL1TR001866
   (to D.F.R. and L.B.), grants R01AI037526, UM1AI100663, U19AI111825, and
   UL1TR001866 (to M.C.N.), grants R01AI121207, R01TW009504, R25TW009338,
   and U01AI088752 (to A.I.K.), grants R01AI124690 (to C.M.R.) and
   U19AI057229 (CCHI Opportunity Fund Project to C.M.R. and M.R.M.), donors
   to the Zika Fund at Rockefeller University and anonymous donors (to
   C.M.R.), and the Molecular Observatory at Caltech supported by the
   Gordon and Betty Moore Foundation (P.J.B.). Operations at the Stanford
   Synchrotron Radiation Lightsource are supported by the US Department of
   Energy and the NIH. Support was also provided by the Robertson
   Therapeutic Development Fund (to D.F.R. and M.C.N.). P.C.O. is supported
   by the Pew Latin American Fellows Program in the Biomedical Sciences,
   D.S.-B. by Studienstiftung des deutschen Volkes, L.F.K.U. by the
   Austrian Marshall Plan Foundation, and E.E.S.-R. is partly supported by
   Red INMUNOCANEI-Conacyt. M.C.N. is an HHMI Investigator. In connection
   with this work, D.F.R. and M.C.N. have a provisional patent application
   with the U.S. Patent and Trademark Office (62/483,001). The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of any of the funding agencies or
   individuals.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L., 2016, EURO SURVEILL, V21
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509
   Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774
   SABIN AB, 1950, BACTERIOL REV, V14, P225
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942
   von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110
   West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
   Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819
NR 73
TC 112
Z9 115
U1 0
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 4
PY 2017
VL 169
IS 4
BP 597
EP 609
DI 10.1016/j.cell.2017.04.024
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ET8PD
UT WOS:000400560900007
PM 28475892
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Aid, M
   Abbink, P
   Larocca, RA
   Boyd, M
   Nityanandam, R
   Nanayakkara, O
   Martinot, AJ
   Moseley, ET
   Blass, E
   Borducchi, EN
   Chandrashekar, A
   Brinkman, AL
   Molloy, K
   Jetton, D
   Tartaglia, LJ
   Liu, JY
   Best, K
   Perelson, AS
   De la Barrera, RA
   Lewis, MG
   Barouch, DH
AF Aid, Malika
   Abbink, Peter
   Larocca, Rafael A.
   Boyd, Michael
   Nityanandam, Ramya
   Nanayakkara, Ovini
   Martinot, Amanda J.
   Moseley, Edward T.
   Blass, Eryn
   Borducchi, Erica N.
   Chandrashekar, Abishek
   Brinkman, Amanda L.
   Molloy, Katherine
   Jetton, David
   Tartaglia, Lawrence J.
   Liu, Jinyan
   Best, Katharine
   Perelson, Alan S.
   De la Barrera, Rafael A.
   Lewis, Mark G.
   Barouch, Dan H.
TI Zika Virus Persistence in the Central Nervous System and Lymph Nodes of
   Rhesus Monkeys
SO CELL
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; CROSS-REACTIVITY; BIRTH-DEFECTS;
   INFECTION; BRAIN; SIGNATURES; BIOLOGY; REPLICATION
AB Zika virus (ZIKV) is associated with severe neuropathology in neonates as well as Guillain-Barre syndrome and other neurologic disorders in adults. Prolonged viral shedding has been reported in semen, suggesting the presence of anatomic viral reservoirs. Here we show that ZIKV can persist in cerebrospinal fluid (CSF) and lymph nodes (LN) of infected rhesus monkeys for weeks after virus has been cleared from peripheral blood, urine, and mucosal secretions. ZIKV-specific neutralizing antibodies correlated with rapid clearance of virus in peripheral blood but remained undetectable in CSF for the duration of the study. Viral persistence in both CSF and LN correlated with upregulation of mechanistic target of rapamycin (mTOR), proinflammatory, and antiapoptotic signaling pathways, as well as downregulation of extracellular matrix signaling pathways. These data raise the possibility that persistent or occult neurologic and lymphoid disease may occur following clearance of peripheral virus in ZIKV-infected individuals.
C1 [Aid, Malika; Abbink, Peter; Larocca, Rafael A.; Boyd, Michael; Nityanandam, Ramya; Nanayakkara, Ovini; Martinot, Amanda J.; Moseley, Edward T.; Blass, Eryn; Borducchi, Erica N.; Chandrashekar, Abishek; Brinkman, Amanda L.; Molloy, Katherine; Jetton, David; Tartaglia, Lawrence J.; Liu, Jinyan; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Best, Katharine; Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [De la Barrera, Rafael A.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA.
   [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
RI Perelson, Alan S/Z-1959-2019; Barouch, Dan/Y-3918-2019; Chandrashekar,
   Abishek/P-2610-2019
OI Perelson, Alan S/0000-0002-2455-0002; Chandrashekar,
   Abishek/0000-0001-7821-5552; Jetton, David/0000-0002-1615-9986
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [OD011095, AI028433,
   AI078881, AI095985, AI096040, AI100663, AI124377]; Ragon Institute of
   MGH, MIT, and Harvard
FX We thank N. Michael, K. Eckels, S. Thomas, R. Jarman, J. Misamore, B.
   Finneyfrock, A. Cook, M. Ferguson, K. Kabra, N. Botero, C. Springer, G.
   Ballarini, R. Olson, R. Ribeiro, C. Cabral, M. Kirilova, Z. Li, D.
   Ng'ang'a, N. Mercado, B. Lee, S. Mojta, J. Mondesir, and F. Stephens for
   generous advice, assistance, and reagents. We also thank Y. Alekseyev
   and A. LeClerc from the Boston University Genomics Core Facility. We
   acknowledge support from the National Institutes of Health (OD011095,
   AI028433, AI078881, AI095985, AI096040, AI100663, AI124377) and the
   Ragon Institute of MGH, MIT, and Harvard.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Afroz S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33752
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021
   Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Boer E, 2016, MOL IMAGING BIOL, V18, P232, DOI 10.1007/s11307-015-0892-y
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588
   Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024
   Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Switon K, 2017, NEUROSCIENCE, V341, P112, DOI 10.1016/j.neuroscience.2016.11.017
   Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030
   Thoreen CC, 2017, BIOCHEM SOC T, V45, P213, DOI 10.1042/BST20160072
   Tichauer KM, 2014, NAT MED, V20, P1348, DOI 10.1038/nm.3732
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 48
TC 89
Z9 91
U1 1
U2 55
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 4
PY 2017
VL 169
IS 4
BP 610
EP 620
DI 10.1016/j.cell.2017.04.008
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ET8PD
UT WOS:000400560900008
PM 28457610
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Chotiwan, N
   Brewster, CD
   Magalhaes, T
   Weger-Lucarelli, J
   Duggal, NK
   Ruckert, C
   Nguyen, C
   Luna, SMG
   Fauver, JR
   Andre, B
   Gray, M
   Black, WC
   Kading, RC
   Ebel, GD
   Kuan, G
   Balmaseda, A
   Jaenisch, T
   Marques, ETA
   Brault, AC
   Harris, E
   Foy, BD
   Quackenbush, SL
   Perera, R
   Rovnak, J
AF Chotiwan, Nunya
   Brewster, Connie D.
   Magalhaes, Tereza
   Weger-Lucarelli, James
   Duggal, Nisha K.
   Ruckert, Claudia
   Chilinh Nguyen
   Luna, Selene M. Garcia
   Fauver, Joseph R.
   Andre, Barb
   Gray, Meg
   Black, William C.
   Kading, Rebekah C.
   Ebel, Gregory D.
   Kuan, Guillermina
   Balmaseda, Angel
   Jaenisch, Thomas
   Marques, Ernesto T. A.
   Brault, Aaron C.
   Harris, Eva
   Foy, Brian D.
   Quackenbush, Sandra L.
   Perera, Rushika
   Rovnak, Joel
TI Rapid and specific detection of Asian- and African-lineage Zika viruses
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID MEDIATED ISOTHERMAL AMPLIFICATION; REAL-TIME DETECTION;
   CHIKUNGUNYA-VIRUS; DENGUE VIRUS; CLINICAL-EVALUATION; FRENCH-POLYNESIA;
   TRANSMISSION; ASSAY; IDENTIFICATION; PHYLOGENY
AB Understanding the dynamics of Zika virus transmission and formulating rational strategies for its control require precise diagnostic tools that are also appropriate for resource-poor environments. We have developed a rapid and sensitive loop-mediated isothermal amplification (LAMP) assay that distinguishes Zika viruses of Asian and African lineages. The assay does not detect chikungunya virus or flaviviruses such as dengue, yellow fever, or West Nile viruses. The assay conditions allowed direct detection of Zika virus RNA in cultured infected cells; in mosquitoes; in virus-spiked samples of human blood, plasma, saliva, urine, and semen; and in infected patient serum, plasma, and semen samples without the need for RNA isolation or reverse transcription. The assay offers rapid, specific, sensitive, and inexpensive detection of the Asian-lineage Zika virus strain that is currently circulating in the Western hemisphere, and can also detect the African-lineage Zika virus strain using separate, specific primers.
C1 [Chotiwan, Nunya; Brewster, Connie D.; Weger-Lucarelli, James; Ruckert, Claudia; Chilinh Nguyen; Luna, Selene M. Garcia; Fauver, Joseph R.; Andre, Barb; Gray, Meg; Black, William C.; Kading, Rebekah C.; Ebel, Gregory D.; Foy, Brian D.; Quackenbush, Sandra L.; Perera, Rushika; Rovnak, Joel] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Chotiwan, Nunya; Magalhaes, Tereza; Weger-Lucarelli, James; Ruckert, Claudia; Chilinh Nguyen; Luna, Selene M. Garcia; Fauver, Joseph R.; Gray, Meg; Black, William C.; Kading, Rebekah C.; Ebel, Gregory D.; Foy, Brian D.; Perera, Rushika] Colorado State Univ, Coll Vet Med & Biomed Sci, Arthropod Borne Infect Dis Labs, Ft Collins, CO 80523 USA.
   [Magalhaes, Tereza; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Expt Therapeut, Recife, PE, Brazil.
   [Duggal, Nisha K.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Res DZIF, Partner Site Heidelberg, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Sch Publ Hlth, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Rovnak, J (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM joel.rovnak@colostate.edu
RI Marques, Ernesto T. A/L-4967-2013; Magalhaes, Tereza/V-6632-2019;
   Rovnak, Joel/I-7379-2017; Foy, Brian/E-6230-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; Rovnak,
   Joel/0000-0003-4518-9030; Graham, Barbara/0000-0002-4221-1979;
   Garcia-Luna, Selene M./0000-0001-8420-5078; Foy,
   Brian/0000-0002-9117-203X; Ruckert, Claudia/0000-0003-3732-6752;
   Weger-Lucarelli, James/0000-0002-9483-1694; Fauver,
   Joseph/0000-0001-8099-2991; Chotiwan, Nunya/0000-0003-3214-6605
FU National Institute of Allergy and Infectious Diseases (NIAID) of the
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [RO1AI067380, R01AI0833680, R21AI129464,
   R01AI099631, R21AI129488-01]; NIH/NIAID International Collaborations in
   Infectious Disease Research Program [U01AI088647]; Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco [APQ-0302-4.01/13];
   European UnionEuropean Union (EU) [(FP7-281803 IDAMS) (41)]; Fogarty
   Training Grant [2D43TW001130-08]; Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA; Department of Microbiology,
   Immunology, and Pathology; College of Veterinary Medicine and Biomedical
   Sciences at Colorado State University; Office of the Vice President for
   Research, Colorado State University
FX The research reported in this publication was supported by the National
   Institute of Allergy and Infectious Diseases (NIAID) of the NIH (award
   nos. RO1AI067380 to J.W.-L., C.R., J.R.F., and G.D.E.; R01AI0833680 to
   W.C.B.; R21AI129464 to B.D.F., C.N., M.G., T.M., and E.T.A.M.;
   R01AI099631 to A.B.; and R21AI129488-01 to R.P. and J.R.) and the
   NIH/NIAID International Collaborations in Infectious Disease Research
   Program (U01AI088647). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   NIH. Additional support was provided by the Fundacao de Amparo a Ciencia
   e Tecnologia do Estado de Pernambuco (APQ-0302-4.01/13 to E.T.A.M.) and
   the European Union (FP7-281803 IDAMS) (41). S.M.G.L. is supported by
   Fogarty Training Grant 2D43TW001130-08 "Training in dengue prevention
   and control." N.K.D. and A.C.B. were supported by the Centers for
   Disease Control and Prevention. This submission represents the views
   solely of the authors and does not constitute those of the Centers for
   Disease Control and Prevention or the U.S. government. B.A., C.D.B.,
   R.P., R.C.K., S.L.Q., and J.R. were supported by the Department of
   Microbiology, Immunology, and Pathology and the College of Veterinary
   Medicine and Biomedical Sciences at Colorado State University, and
   B.D.F., R.P., T.M., and N.C. were supported by the Office of the Vice
   President for Research, Colorado State University.
CR Balmaseda A, 1999, AM J TROP MED HYG, V61, P893, DOI 10.4269/ajtmh.1999.61.893
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kwallah AO, 2013, J VIROL METHODS, V193, P23, DOI 10.1016/j.jviromet.2013.05.004
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Le Roux CA, 2009, J CLIN MICROBIOL, V47, P645, DOI 10.1128/JCM.01412-08
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lu X, 2012, AM J TROP MED HYG, V87, P947, DOI 10.4269/ajtmh.2012.11-0721
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005
   Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Parida MM, 2006, J CLIN MICROBIOL, V44, P4172, DOI 10.1128/JCM.01487-06
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peyrefitte CN, 2008, J CLIN MICROBIOL, V46, P3653, DOI 10.1128/JCM.01188-08
   Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tanner N. A., 2014, CURR PROTOC MOL BIOL, V105
   Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
NR 50
TC 35
Z9 37
U1 6
U2 25
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD MAY 3
PY 2017
VL 9
IS 388
AR eaag0538
DI 10.1126/scitranslmed.aag0538
PG 13
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA ET7HC
UT WOS:000400464700003
PM 28469032
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Gomez Ponce De Leon, R
AF Gomez Ponce De Leon, Rodolfo
TI NEW UNDERSTANDINGS OF THE CONCEPT "PROCREATION" AND SEXUAL AND
   REPRODUCTIVE DILEMMAS FOR SPECIFIC GROUPS AND POPULATIONS
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Meeting Abstract
DE procreation; new parenting models; gaps; contraception; Zika;
   counselling
C1 [Gomez Ponce De Leon, Rodolfo] WHO, CLAP WRH PAHO, Montevideo, Uruguay.
FU PAHO
FX PAHO
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD MAY
PY 2017
VL 14
IS 5
SU 4
BP E230
EP E230
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA FU9VQ
UT WOS:000424205700091
DA 2020-07-08
ER

PT J
AU Golos, TG
AF Golos, T. G.
TI Nonhuman Primate Modeling of Zika Virus Vertical Transmission
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Neural-Therapy-and-Repair
CY APR 27-29, 2017
CL Clearwater Beach, FL
SP Amer Soc Neural Therapy & Repair
C1 [Golos, T. G.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.
   [Golos, T. G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PD MAY
PY 2017
VL 26
SU 1
BP 711
EP 711
PG 1
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA FO2QY
UT WOS:000416626200026
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lossia, OV
   Tree, MO
   Goldthorpe, SC
   Srinageshwar, B
   Dunbar, GL
   Conway, MJ
   Rossignol, J
AF Lossia, O. V.
   Tree, M. O.
   Goldthorpe, S. C.
   Srinageshwar, B.
   Dunbar, G. L.
   Conway, M. J.
   Rossignol, J.
TI Zika Virus Dysregulates Gene Expression and Alters Protein Secretion in
   Neural Stem Cells
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Neural-Therapy-and-Repair
CY APR 27-29, 2017
CL Clearwater Beach, FL
SP Amer Soc Neural Therapy & Repair
C1 [Lossia, O. V.; Srinageshwar, B.; Dunbar, G. L.; Rossignol, J.] Cent Michigan Univ, Field Neurosci Inst Restorat Neurosci, Mt Pleasant, MI 48859 USA.
   [Lossia, O. V.; Srinageshwar, B.; Dunbar, G. L.; Rossignol, J.] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA.
   [Lossia, O. V.; Tree, M. O.; Goldthorpe, S. C.; Conway, M. J.; Rossignol, J.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA.
   [Dunbar, G. L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.
   [Dunbar, G. L.] Field Neurosci Inst, Saginaw, MI USA.
RI Srinageshwar, Bhairavi/K-8754-2019; Rossignol, Julien/I-1013-2019
OI Srinageshwar, Bhairavi/0000-0002-8763-545X; Rossignol,
   Julien/0000-0002-8662-0547
FU College of Medicine, Field Neurosciences Institute; John G. Kulhavi
   Professorship in Neuroscience at CMU
FX Support for this study was provided by the College of Medicine, Field
   Neurosciences Institute, and the John G. Kulhavi Professorship in
   Neuroscience at CMU. We also thank contributors to our Experiment.com
   crowdfunding campaign, "Does Zika virus replicate in neural cells?"
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PD MAY
PY 2017
VL 26
SU 1
BP 716
EP 716
PG 1
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA FO2QY
UT WOS:000416626200042
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Muotri, AR
AF Muotri, A. R.
TI Brain Organoids as a Model for Zika Infection: From Basic Science to
   Treatment
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Neural-Therapy-and-Repair
CY APR 27-29, 2017
CL Clearwater Beach, FL
SP Amer Soc Neural Therapy & Repair
C1 [Muotri, A. R.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.
   [Muotri, A. R.] Rady Childrens Hosp San Diego, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PD MAY
PY 2017
VL 26
SU 1
BP 718
EP 718
PG 1
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA FO2QY
UT WOS:000416626200047
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hossini, H
   Pirsaheb, M
   Hossaini, H
   Limoee, M
AF Hossini, Hooshyar
   Pirsaheb, Meghdad
   Hossaini, Hiwa
   Limoee, Mojtaba
TI Zika Virus (ZIKV) and Wastewater Treatment Plants
SO HEALTH SCOPE
LA English
DT Letter
DE Zika; Virus; Wastewater; Vector; Hydrocephaly
C1 [Hossini, Hooshyar; Pirsaheb, Meghdad; Hossaini, Hiwa; Limoee, Mojtaba] Kermanshah Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Kermanshah, Iran.
RP Hossaini, H (corresponding author), Kermanshah Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Kermanshah, Iran.
EM Hiwa_Hossaini@yahoo.com
CR Becker N, 2003, MOSQUITOES THEIR CON, DOI [10.1007/978-1-4757-5897-9, DOI 10.1007/978-1-4757-5897-9]
   Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, SURV CONTR AED AEG A, V7
   Dehghani R, 2007, FAUNA AQUATIC INSECT, V18, P88
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Kengne IM, 2003, ECOL ENG, V21, P53, DOI 10.1016/j.ecoleng.2003.08.006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhtar Muhammad, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P72
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   World Health Organization, ZIK VIR 2016
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 12
TC 0
Z9 0
U1 0
U2 2
PU KOWSAR PUBL
PI HOENSBROEK
PA PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS
SN 2251-8959
EI 2251-9513
J9 HEALTH SCOPE
JI Health Scope
PD MAY
PY 2017
VL 6
IS 2
AR e39789
DI 10.5812/jhealthscope.39789
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FH9KP
UT WOS:000411529700013
OA Other Gold
DA 2020-07-08
ER

PT J
AU Duarte, G
   Moron, AF
   Timerman, A
   Fernandes, CE
   Neto, CM
   de Almeida, GL
   Werner, H
   Santo, HFBD
   Steibel, JAP
   Bortoletti, J
   de Andrade, JBB
   Burla, M
   de Sa, MFS
   Busso, NE
   Giraldo, PC
   de Sa, RAM
   Passini, R
   Mattar, R
   Francisco, RPV
AF Duarte, Geraldo
   Moron, Antonio Fernandes
   Timerman, Artur
   Fernandes, Cesar Eduardo
   Mariani Neto, Corintio
   de Almeida Filho, Gutemberg Leao
   Werner Junior, Heron
   Barra do Espirito Santo, Hilka Flavia
   Piffero Steibel, Joao Alfredo
   Bortoletti Filho, Joao
   Borriello de Andrade, Juvenal Barreto
   Burla, Marcelo
   Silva de Sa, Marcos Felipe
   Busso, Newton Eduardo
   Giraldo, Paulo Cesar
   Moreira de Sa, Renato Augusto
   Passini Junior, Renato
   Mattar, Rosiane
   Vieira Francisco, Rossana Pulcineli
TI Zika Virus Infection in Pregnant Women and Microcephaly
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE pregnancy complications; Zika virus; arbovirus infections;
   microcephaly/ultrasonography; real-time polymerase chain reaction;
   deafness/etiology; blindness/etiology
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; REPRODUCTIVE AGE; TRANSMISSION;
   ULTRASOUND; OUTBREAK; STANDARDS; EXPOSURE; BRAZIL; CHIKUNGUNYA
AB From the discovery of the Zika virus (ZIKV) in 1947 in Uganda ( Africa), until its arrival in South America, it was not known that it would affect human reproductive life so severely. Today, damage to the central nervous system is known to be multiple, and microcephaly is considered the tip of the iceberg. Microcephaly actually represents the epilogue of this infection's devastating process on the central nervous system of embryos and fetuses. As a result of central nervous system aggression by the ZIKV, this infection brings the possibility of arthrogryposis, dysphagia, deafness and visual impairment. All of these changes of varying severity directly or indirectly compromise the future life of these children, and are already considered a congenital syndrome linked to the ZIKV. Diagnosis is one of the main difficulties in the approach of this infection. Considering the clinical part, it has manifestations common to infections by the dengue virus and the chikungunya fever, varying only in subjective intensities. The most frequent clinical variables are rash, febrile state, non-purulent conjunctivitis and arthralgia, among others. In terms of laboratory resources, there are also limitations to the subsidiary diagnosis. Molecular biology tests are based on polymerase chain reaction (PCR) with reverse transcriptase (RT) action, since the ZIKV is a ribonucleic acid (RNA) virus. The RT-PCR shows serum or plasma positivity for a short period of time, no more than five days after the onset of the signs and symptoms. The ZIKV urine test is positive for a longer period, up to 14 days. There are still no reliable techniques for the serological diagnosis of this infection. If there are no complications (meningoencephalitis or Guillain-Barre syndrome), further examination is unnecessary to assess systemic impairment. However, evidence is needed to rule out other infections that also cause rashes, such as dengue, chikungunya, syphilis, toxoplasmosis, cytomegalovirus, rubella, and herpes. There is no specific antiviral therapy against ZIKV, and the therapeutic approach to infected pregnant women is limited to the use of antipyretics and analgesics. Anti-inflammatory drugs should be avoided until the diagnosis of dengue is discarded. There is no need to modify the schedule of prenatal visits for pregnant women infected by ZIKV, but it is necessary to guarantee three ultrasound examinations during pregnancy for low-risk pregnancies, and monthly for pregnant women with confirmed ZIKV infection. Vaginal delivery and natural breastfeeding are advised.
C1 [Duarte, Geraldo; Silva de Sa, Marcos Felipe] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
   [Moron, Antonio Fernandes; Bortoletti Filho, Joao; Mattar, Rosiane] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.
   [Timerman, Artur] Hosp Prof Edmundo Vasconcelos, Sao Paulo, SP, Brazil.
   [Fernandes, Cesar Eduardo] Fac Med ABC, Santo Andre, SP, Brazil.
   [Mariani Neto, Corintio] Hosp Maternidade Leonor Mendes de Barros, Sao Paulo, SP, Brazil.
   [de Almeida Filho, Gutemberg Leao] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Werner Junior, Heron] Alta Excelencia Diagnost, Rio De Janeiro, RJ, Brazil.
   [Barra do Espirito Santo, Hilka Flavia] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Piffero Steibel, Joao Alfredo] Pontificia Univ Catolica, Porto Alegre, RS, Brazil.
   [Borriello de Andrade, Juvenal Barreto] Consultario Med Juvenal Barreto Borriello de Andr, Sao Paulo, SP, Brazil.
   [Burla, Marcelo] Clin Marcelo Burla, Rio De Janeiro, RJ, Brazil.
   [Busso, Newton Eduardo] Fac Ciencias Med Santa Casa Sao Paulo, Sao Paulo, SP, Brazil.
   [Giraldo, Paulo Cesar; Passini Junior, Renato] Univ Estadual Campinas, Campinas, SP, Brazil.
   [Moreira de Sa, Renato Augusto] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Vieira Francisco, Rossana Pulcineli] Univ Sao Paulo, Sao Paulo, SP, Brazil.
RP Duarte, G (corresponding author), Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM gduarte@fmrp.usp.br
RI Francisco, Rossana PV/C-5648-2012; amsalu, ribka/G-8780-2019; de Sa,
   Renato Augusto Moreira/B-4778-2014; Francisco, Rossana Pulcineli
   Vieira/AAG-7461-2020; Werner, Heron/W-1578-2019; MORON, ANTONIO
   F./H-4987-2013
OI Francisco, Rossana PV/0000-0002-9981-8069; Francisco, Rossana Pulcineli
   Vieira/0000-0002-9981-8069; MORON, ANTONIO F./0000-0002-7963-1758;
   MOREIRA DE SA, RENATO A/0000-0001-6357-7702
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ambros-Rudolph CM, 2011, ANN DERMATOL, V23, P265, DOI 10.5021/ad.2011.23.3.265
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Bailao Luiz Antonio, 2005, Ultrasound Q, V21, P295, DOI 10.1097/01.ruq.0000187025.61943.ff
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brasil. Ministerio da Saude do Brasil, 2015, MIN SAUD CONF REL EN
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centro de Operacoes de Emergencias em Saude Publica Sobre Microcefalias (COESP), 2016, 23 COESP
   CHERVENAK FA, 1984, AM J OBSTET GYNECOL, V149, P512, DOI 10.1016/0002-9378(84)90027-9
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Cunha MS, 2016, GENOME ANNOUNC, V4, P16
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Duarte G., 2016, FEMINA, V44, P26
   Duarte G., CARTILHA INFECCAO PE
   Duarte G, 2016, REV BRAS GINECOL OBS, V38, P263, DOI 10.1055/s-0036-1584206
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Fuwa K, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12605
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1813
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude (MS) Secretaria de Vigilancia em Saude Departamento de Vigilancia das Doencas Transmissiveis., 2015, PROT VIG RESP OC MIC, P1
   MINISTERIO DE AGRICULTURA PESCA Y ALIMENTACION, 2016, PROC SER AD VIG FEBR, P1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization (PAHO), 2015, AL EP SINDR NEUR AN
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V48, P719, DOI 10.1002/uog.15894
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sao Paulo State Government. Secretaria de Estado da Saude 7 Coordenadoria de Controle de Doencas Centro de Vigilancia Epidemiologica Instituto Adolfo Lutz, 2015, 1 SAO PAUL STAT GOV, P1
   Sao Paulo State Government. Secretaria de Estado da Saude. Centro de Vigilancia Epidemiologica da SESP-SP, 2016, PROT VIG GEST COM EX
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Villar J, 2015, LANCET GLOB HEALTH, V3, pE681, DOI 10.1016/S2214-109X(15)00163-1
   WHO, 2009, WHO TECH REP SER, V958, P1
   World Health Organization, 2017, WORLD MALARIA REPORT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   World Health Organization, 2016, PREV SEX TRANSM ZIK, P1
   World Health Organization, 2014, INT MAN CHILDH ILLN, P1, DOI DOI 10.1016/B978-0-12-801238-3.00084-2
NR 71
TC 12
Z9 13
U1 0
U2 15
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD MAY
PY 2017
VL 39
IS 5
BP 235
EP 248
DI 10.1055/s-0037-1603450
PG 14
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4RC
UT WOS:000410252100007
PM 28575919
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh R.
   Shrivastava, Prateek S.
   Ramasamy, Jegadeesh
TI Social and health inequalities augment the incidence of Zika virus
   disease and its after effects
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Editorial Material
C1 Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Madras, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Guduvanchery Main Rd, Kanchipuram, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Baraka V, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00110
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   Lotufo PA, 2016, SAO PAULO MED J, V134, P95, DOI 10.1590/1516-3180.2016.13421602
   UNFPA, 2016, POV IN HEART ZIK OUT
   World Health Organization, 2016, ZIK VIR FACT SHEET N
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 521
EP 522
DI 10.4103/1755-6783.213168
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300015
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Dengue Viremia in Blood Donors and What to be Expected in Cases of Zika
   Virus
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
ID EMERGING PATHOGENS
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Mangwana Sadhana, 2015, Asian J Transfus Sci, V9, P177, DOI 10.4103/0973-6247.154253
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 5
TC 0
Z9 0
U1 0
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 742
EP +
DI 10.4103/1755-6783.213128
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300059
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Emergency contraception in a public health emergency "Zika virus
   outbreak"
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Roa M., 2016, LANCET, V27, P387
   Tavares MP, 2016, CONTRACEPTION
NR 2
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 748
EP 748
DI 10.4103/1755-6783.213131
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300064
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Liver Problem in Zika Virus Infection: Possibility?
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy; Wiwanitkit, Viroj] Sanitat 1 Medial Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Medial Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit Viroj, 2007, J Ayub Med Coll Abbottabad, V19, P10
   Zammarchi L, 2015, EUROSURVEILLANCE, V11, P21153
NR 8
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 751
EP +
DI 10.4103/1755-6783.213134
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300068
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika Virus Infection and Breastfeeding
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit V, 2015, INT J NURS PRACT, V21, P682, DOI 10.1111/ijn.12346
NR 5
TC 0
Z9 0
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 752
EP 752
DI 10.4103/1755-6783.188503
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300069
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Prenatal MRI in Zika Virus Infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 755
EP +
DI 10.4103/1755-6783.213138
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300072
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Triple coinfection - dengue, chikungunya, and Zika virus infection: risk
   and next possibility for "more than three" combination
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Faccini-Martinez AA, 2016, J INFECT PUBLIC HLTH, Vi
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
NR 3
TC 0
Z9 0
U1 0
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 757
EP +
DI 10.4103/1755-6783.188508
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300075
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh R.
   Shrivastava, Prateek S.
   Ramasamy, Jegadeesh
TI Zika virus disease: Potential risk for the athletes and the
   international visitors in the Rio Olympic Games, 2016
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Shrivastava, Saurabh R.; Shrivastava, Prateek S.; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Madras, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvanchery Main Rd, Kanchipuram, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Shrivastava SR, 2016, SIFA MED J, V3, P56
   Simoes R, 2016, REV ASSOC MED BRAS, V62, P108, DOI [10.1590/1806-9282.62.02.106, 10.1590/1806-9282.62.02.108]
   Speciale Anna Maria, 2016, Pract Midwife, V19, P6
   WHO, 2016, ZIK VIR OL PAR GAM R
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 762
EP +
DI 10.4103/1755-6783.188514
PG 3
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300080
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh R.
   Shrivastava, Prateek S.
   Ramasamy, Jegadeesh
TI Potential risk of Zika virus outbreak in the European region: Public
   health alert
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Shrivastava, Saurabh R.; Shrivastava, Prateek S.; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Madras, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvanchery Main Rd, Kanchipuram, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   World Health Organisation, 2016, INT TECHN NOT US CHO, P1
   World Health Organization WHO calls on countries to prepare as Zika virus expected to spread in Europe in late spring and summer, 2016, WHO WHO CALLS COUNTR
NR 5
TC 1
Z9 1
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 764
EP +
DI 10.4103/1755-6783.213140
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300081
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanikit, V
AF Joob, Beuy
   Wiwanikit, Viroj
TI Expected risk of Zika virus infection for foreign visitors to the 2016
   Summer Olympic Games in Brazil
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
ID RIO-DE-JANEIRO
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanikit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 5
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
BP 774
EP 774
DI 10.4103/1755-6783.213156
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300090
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Reactome analysis of Zika virus genes: Implication for pathogenesis
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072
   Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
NR 4
TC 0
Z9 0
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD MAY-JUN
PY 2017
VL 10
IS 3
DI 10.4103/1755-6783.188507
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA FF6AL
UT WOS:000409084300073
DA 2020-07-08
ER

PT J
AU Bhaumik, SK
   Priyamvada, L
   Kauffman, R
   Mulligan, M
   Wrammert, J
AF Bhaumik, Siddhartha Kumar
   Priyamvada, Lalita
   Kauffman, Robert
   Mulligan, Mark
   Wrammert, Jens
TI Acute phase human B cell response after ZIKV infection
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
RI Priyamvada, Lalita/J-6252-2019; Mulligan, Mark/V-9275-2019
OI Priyamvada, Lalita/0000-0002-0479-0164; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 122.7
PG 4
WC Immunology
SC Immunology
GA FD8BO
UT WOS:000407750400137
DA 2020-07-08
ER

PT J
AU Cruz, MM
   Puerta-Guardo, HN
   Schildhauer, S
   Katzeltnick, L
   Balmaseda, AL
   Harris, E
AF Cruz, Magelda Montoya
   Puerta-Guardo, Henry Nelson
   Schildhauer, Sam
   Katzeltnick, Leah
   Balmaseda, Angel Lazaro
   Harris, Eva
TI Immune cross-reactivity between Dengue and Zika viruses in two pediatric
   studies in Nicaragua
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 210.5
PG 4
WC Immunology
SC Immunology
GA FD8BO
UT WOS:000407750400888
DA 2020-07-08
ER

PT J
AU Dennina, AV
   Lutwanna, JJ
   Hertz, T
   Lobel, L
AF Dennina, Anna Vladimirovna
   Lutwanna, Julius J.
   Hertz, Tomer
   Lobel, Leslie
TI Assessing the serological antibody repertoire to Flaviviruses in the
   endemic population of the Zika forest in Uganda
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
RI Hertz, Tomer/S-5744-2016
OI Hertz, Tomer/0000-0002-0561-1578
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 122.12
PG 4
WC Immunology
SC Immunology
GA FD8BO
UT WOS:000407750400125
DA 2020-07-08
ER

PT J
AU Gao, XJ
   Wen, YF
   Li, CL
   Wang, J
   Zhang, FC
   Yu, L
AF Gao, Xiujie
   Wen, Yingfen
   Li, Chunlin
   Wang, Jian
   Zhang, Fuchun
   Yu, Lei
TI High specific of human antibody response to nonstructural protein NS1
   elicited by Zika virus infection.
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 125.29
PG 4
WC Immunology
SC Immunology
GA FD8BO
UT WOS:000407750400447
DA 2020-07-08
ER

PT J
AU Winkler, CW
   Myers, LM
   Woods, TA
   Messer, RJ
   Carmody, AB
   McNally, KL
   Scott, DP
   Hasenkrug, KJ
   Best, SM
   Peterson, KE
AF Winkler, Clayton W.
   Myers, Lara M.
   Woods, Tyson A.
   Messer, Ron J.
   Carmody, Aaron B.
   McNally, Kristin L.
   Scott, Dana P.
   Hasenkrug, Kim J.
   Best, Sonja M.
   Peterson, Karin E.
TI Adaptive immune responses to Zika virus are important for controlling
   virus infection and preventing infection in brain and testes
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 122.3
PG 4
WC Immunology
SC Immunology
GA FD8BO
UT WOS:000407750400133
DA 2020-07-08
ER

PT J
AU Andrade, PE
   Coloma, J
   Michlmayr, D
   Balnnaseda, AL
   Harris, E
AF Andrade, Paulina E.
   Coloma, Josefina
   Michlmayr, Daniela
   Balnnaseda, Angel Lazaro
   Harris, Eva
TI Zika and Dengue Virus Specific and Cross-reactive Memory B Cell
   Responses
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
RI Michlmayr, Daniela/Q-1216-2018
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 214.7
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000075
DA 2020-07-08
ER

PT J
AU Chen, JL
   Liang, YJ
   Yi, PP
   Azar, S
   Rossi, S
   Sun, JR
AF Chen, Jinling
   Liang, Yuejin
   Yi, Panpan
   Azar, Sasha
   Rossi, Shannan
   Sun, Jiaren
TI Outcomes of congenital Zika disease depend on timing of infection and
   maternal-fetal imrnunophysiological conditions
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
RI Liang, Yuejin/X-5250-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 158.4
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000870
DA 2020-07-08
ER

PT J
AU Ireland, DDC
   Manangeeswaran, M
   Miller-Novak, L
   Sykes, J
   Verthelyi, D
AF Ireland, Derek D. C.
   Manangeeswaran, Mohanraj
   Miller-Novak, Leia
   Sykes, Jacob
   Verthelyi, Daniela
TI T cell infiltration associated with neurodegeneration and Zika virus
   control in the CNS of imrnunocompetent, neonatal mice
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 78.38
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000336
DA 2020-07-08
ER

PT J
AU Manangeeswaran, M
   Ireland, DDC
   Sykes, J
   McWilliams, I
   Verthelyi, D
AF Manangeeswaran, Mohanraj
   Ireland, Derek D. C.
   Sykes, Jacob
   McWilliams, Ian
   Verthelyi, Daniela
TI Neonatal mouse model to study Zika virus pathogenesis: Host immune
   response determines ZIKV tropism and outcome of disease
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 78.34
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000332
DA 2020-07-08
ER

PT J
AU Ngono, AE
   Vizcarra, EA
   Tang, WW
   Sheets, N
   Joo, Y
   Kim, K
   Gorman, M
   Diamond, MS
   Shresta, S
AF Ngono, Annie Elong
   Vizcarra, Edward A.
   Tang, William W.
   Sheets, Nicholas
   Joo, Yunichel
   Kim, Kenneth
   Gorman, Matthew
   Diamond, Michael S.
   Shresta, Sujan
TI Investigation of CD8(+) T Cell Immunity in Zika Virus Infection Using
   Mouse Models
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 78.9
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000348
DA 2020-07-08
ER

PT J
AU Siemann, DN
   Strange, D
   Maharaj, P
   Verma, S
AF Siemann, David N.
   Strange, Daniel
   Maharaj, Payal
   Verma, Saguna
TI Zika virus infects human Sertoli cells and trespass the blood-testes
   barrier to migrate across the seminiferous epithelium
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 158.20
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000854
DA 2020-07-08
ER

PT J
AU Swaminathan, K
   Majzoub, K
   Lund, PJ
   Marceau, C
   Olsson, N
   Davis, MM
   Carette, J
   Elias, J
AF Swaminathan, Kavya
   Majzoub, Karim
   Lund, Peder J.
   Marceau, Caleb
   Olsson, Niclas
   Davis, Mark M.
   Carette, Jan
   Elias, Joshua
TI Immuno-proteomic interrogation of antigen presentation during Dengue and
   Zika infections reveals novel targets for the design of broad acting
   T-cell vaccines
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 146.3
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000168
DA 2020-07-08
ER

PT J
AU Venkatesvvaran, N
   Sarvvar, J
   Parameswaran, N
   Fecteau, T
   O'Connor, D
   Nelson, WM
   Venkateswaran, K
AF Venkatesvvaran, Neeraja
   Sarvvar, Jawad
   Parameswaran, Nishnath
   Fecteau, Tracy
   O'Connor, David
   Nelson, William M.
   Venkateswaran, Kodunnudi
TI Development and testing of a novel multiplex serodiagnostic assay for
   Zika and other arboviruses
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 81.26
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000706
DA 2020-07-08
ER

PT J
AU Xu, JQ
   Zhang, XY
   Liu, J
AF Xu, Jianqing
   Zhang, Xiaoyan
   Liu, Jia
TI AXL Promotes Zika Virus Infection in Astrocytes by Antagonizing Type I
   Interferon Signaling Pathway
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
NR 0
TC 0
Z9 0
U1 1
U2 8
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 214.2
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000071
DA 2020-07-08
ER

PT J
AU Yi, PP
   Liang, YJ
   Chen, JL
   Hood, B
   Azar, S
   Rossi, S
   Sun, JR
AF Yi, Panpan
   Liang, Yuejin
   Chen, Jinling
   Hood, Brandon
   Azar, Sasha
   Rossi, Shannan
   Sun, Jiaren
TI IL-22 signaling contributes to modulate the pathogenesis of Zika virus
   infection
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 12-16, 2017
CL Washington, DC
SP Amer Assoc Immunologists
RI Liang, Yuejin/X-5250-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 1
SU S
MA 158.8
PG 4
WC Immunology
SC Immunology
GA FD8EC
UT WOS:000407757000874
DA 2020-07-08
ER

PT J
AU Begum, R
   Aseena, R
   Rasheed, N
   Mohammad, AS
AF Begum, Rafiya
   Aseena, Raafia
   Rasheed, Nuha
   Mohammad, Abdul Saleem
TI A REVIEW ON ZIKA VIRUS (ZIKV) -A DREADFUL MEMBER OF THE VIRUS FAMILY
   FLAVIVIRIDAE
SO INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE Zika; virus; transmission; fatal; flaviviridae; pathogenesis; diagnosis;
   NSAIDS
AB Research on zika virus examine the virus that is spread to humans through a mosquito bite, with symptoms that include fever, rash, joint pain, and conjuctivities. For most people zika virus is not necessarily anything to worry, as it is not fatal and symptoms are generally mild for period up to a week. Hospitalization because of zika virus is almost always not necessary. However, the zika virus can be extremely dangerous to pregnant womes.
C1 [Begum, Rafiya; Aseena, Raafia] Nizam Inst Pharm, Dept Pharma D, Telangana 508284, India.
   [Rasheed, Nuha] Nizam Inst Pharm, Dept Pharmaceut, Telangana 508284, India.
   [Mohammad, Abdul Saleem] Nizam Inst Pharm, Dept Pharmaceut Anal & Qual Assurance, Telangana 508284, India.
RP Mohammad, AS (corresponding author), Nizam Inst Pharm, Dept Pharmaceut Anal & Qual Assurance, Telangana 508284, India.
EM mohdsaleempharma@gmail.com
CR Goldsmith Cynthia, 2005, ZIKA VIRUS
NR 1
TC 0
Z9 0
U1 0
U2 4
PU SSJ COLL PHARMACY-SSJCP
PI NAGPUR
PA 125B-125 SANTRANJIPURA, TLIPHONE EXCHANGE RD, NAGPUR, 440001, INDIA
SN 2349-7750
J9 INDO AM J PHARM SCI
JI Indo Am. J. Pharm. Sci.
PD MAY
PY 2017
VL 4
IS 5
BP 1221
EP 1223
DI 10.5281/zenodo.583709
PG 3
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA FB9GX
UT WOS:000406448700025
DA 2020-07-08
ER

PT J
AU Qiu, J
AF Qiu, Jane
TI One world, one health: combating infectious diseases in the age of
   globalization
SO NATIONAL SCIENCE REVIEW
LA English
DT Editorial Material
AB There has been a resurgence of the H7N9 bird-flu virus in China since last winter, resulting in over 460 human infections-the largest number since the first outbreak in 2013-raising serious concerns about its further spread and the effectiveness of existing anti-viral drugs. This is just the latest example of the increasing threat from emerging infectious diseases. Due to a combination of factors related to farming practices, human behaviour, international travel, globalization and climate change, there has been a succession of such pandemics in recent years, such as Severe Acute Respiration Syndrome (SARS), Nipah, Middle East Respiratory Syndrome (MERS), Ebola and Zika, posing an unprecedented challenge to scientists and health workers worldwide.
   In a forum organized by National Science Review at the World Life Science Conference last November, an international panel of scientists discussed the lessons that have learned from a string of pandemics in recent years, the importance of international collaboration and sharing research benefits more equitably, why there is an urgent need to move towards the one-health approach, and how China could play a leading role in the global effort to combat infectious diseases.
NR 0
TC 0
Z9 0
U1 3
U2 31
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2095-5138
EI 2053-714X
J9 NATL SCI REV
JI Natl. Sci. Rev.
PD MAY
PY 2017
VL 4
IS 3
BP 493
EP 499
DI 10.1093/nsr/nwx047
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC1QF
UT WOS:000406611700019
PM 32288961
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Setoh, YX
   Prow, NA
   Peng, N
   Hugo, LE
   Devine, G
   Hazlewood, JE
   Suhrbier, A
   Khromykh, AA
AF Setoh, Yin Xiang
   Prow, Natalie A.
   Peng, Nias
   Hugo, Leon E.
   Devine, Gregor
   Hazlewood, Jessamine E.
   Suhrbier, Andreas
   Khromykh, Alexander A.
TI De Novo Generation and Characterization of New Zika Virus Isolate Using
   Sequence Data from a Microcephaly Case
SO MSPHERE
LA English
DT Article
DE infectious DNA; Zika virus; flavivirus; mouse model
ID WEST NILE; INTERFERON RESPONSE; DIARRHEA VIRUS; INFECTION; MICE;
   TRANSMISSION; MODELS; PREGNANCY; VIRULENCE
AB Zika virus (ZIKV) has recently emerged and is the etiological agent of congenital Zika syndrome (CZS), a spectrum of congenital abnormalities arising from neural tissue infections in utero. Herein, we describe the de novo generation of a new ZIKV isolate, ZIKV(Natal), using a modified circular polymerase extension reaction protocol and sequence data obtained from a ZIKV-infected fetus with microcephaly. ZIKVNatal thus has no laboratory passage history and is unequivocally associated with CZS. ZIKVNatal could be used to establish a fetal brain infection model in IFNAR(-/-) mice (including intrauterine growth restriction) without causing symptomatic infections in dams. ZIKVNatal was also able to be transmitted by Aedes aegypti mosquitoes. ZIKVNatal thus retains key aspects of circulating pathogenic ZIKVs and illustrates a novel methodology for obtaining an authentic functional viral isolate by using data from deep sequencing of infected tissues.
   IMPORTANCE The major complications of an ongoing Zika virus outbreak in the Americas and Asia are congenital defects caused by the virus's ability to cross the placenta and infect the fetal brain. The ability to generate molecular tools to analyze viral isolates from the current outbreak is essential for furthering our understanding of how these viruses cause congenital defects. The majority of existing viral isolates and infectious cDNA clones generated from them have undergone various numbers of passages in cell culture and/or suckling mice, which is likely to result in the accumulation of adaptive mutations that may affect viral properties. The approach described herein allows rapid generation of new, fully functional Zika virus isolates directly from deep sequencing data from virus-infected tissues without the need for prior virus passaging and for the generation and propagation of full-length cDNA clones. The approach should be applicable to other medically important flaviviruses and perhaps other positive-strand RNA viruses.
C1 [Setoh, Yin Xiang; Peng, Nias; Khromykh, Alexander A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.
   [Prow, Natalie A.; Hazlewood, Jessamine E.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld, Australia.
   [Hugo, Leon E.; Devine, Gregor] QIMR Berghofer Med Res Inst, Mosquito Control Grp, Brisbane, Qld, Australia.
RP Khromykh, AA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.; Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld, Australia.
EM Andreas.Suhrbier@qimrberghofer.edu.au; alexander.khromykh@uq.edu.au
RI Khromykh, Alexander/X-7200-2018; Setoh, Yin Xiang/K-4503-2012; Devine,
   Gregor J/H-1141-2014; Hugo, R. Leon E/O-3013-2018; Peng, Nias
   Y./J-9329-2017
OI Khromykh, Alexander/0000-0001-6206-6935; Setoh, Yin
   Xiang/0000-0002-1683-3555; Devine, Gregor J/0000-0001-6312-0390; Hugo,
   R. Leon E/0000-0002-6767-9850; Peng, Nias Y./0000-0002-7488-5441
FU Australian Infectious Diseases Research Centre
FX This work was primarily funded by a seeding grant from the Australian
   Infectious Diseases Research Centre.
CR Amarilla AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44642
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Clark DC, 2012, ARCH VIROL, V157, P1423, DOI 10.1007/s00705-012-1337-4
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Fredriksen B, 1999, VET MICROBIOL, V64, P109, DOI 10.1016/S0378-1135(98)00263-6
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hansen TR, 2015, ANIM HEALTH RES REV, V16, P15, DOI 10.1017/S1466252315000122
   Hugo LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1838-1
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Melian EB, 2013, J GEN VIROL, V94, P308, DOI 10.1099/vir.0.047076-0
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Poole-Smith BK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003462
   Prow NA, 2014, J VIROL, V88, P9947, DOI 10.1128/JVI.01304-14
   Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2015, J GEN VIROL, V96, P1297, DOI 10.1099/vir.0.000069
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 49
TC 20
Z9 20
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAY-JUN
PY 2017
VL 2
IS 3
AR e00190-17
DI 10.1128/mSphereDirect.00190-17
PG 11
WC Microbiology
SC Microbiology
GA FB9ZG
UT WOS:000406497300022
PM 28529976
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ai, AA
AF Ai, Al-Afaleq
TI Zika Virus Disease (vol 5, pg 2, 2017)
SO SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES
LA English
DT Correction
CR Al-Afaleq AI, 2017, SAUDI J MED MED SCI, V5, P2, DOI 10.4103/1658-631X.194260
NR 1
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 2321-4856
J9 SAUDI J MED MED SCI
JI Saudi J. Med. Med. Sci.
PD MAY-AUG
PY 2017
VL 5
IS 2
BP 197
EP 197
DI 10.4103/1658-631X.204877
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FA3TF
UT WOS:000405366600025
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Prescod, JP
AF Prescod, J. P.
TI A ZIKA COSTING MODEL FOR SOCIAL INSURANCE SYSTEMS: THE CASE OF THE
   NATIONAL INSURANCE BOARD OF TRINIDAD AND TOBAGO
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Prescod, J. P.] Natl Insurance Board Trinidad & Tobago, Newtown, Trinidad Tobago.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD MAY
PY 2017
VL 20
IS 5
MA PHS199
BP A382
EP A382
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA FA4XU
UT WOS:000405448004537
DA 2020-07-08
ER

PT J
AU Pryke, KM
   Abraham, J
   Sali, TM
   Gall, BJ
   Archer, I
   Liu, A
   Bambina, S
   Baird, J
   Gough, M
   Chakhtoura, M
   Haddad, EK
   Kirby, IT
   Nilsen, A
   Streblow, DN
   Hirsch, AJ
   Smith, JL
   DeFilippis, VR
AF Pryke, Kara M.
   Abraham, Jinu
   Sali, Tina M.
   Gall, Bryan J.
   Archer, Iris
   Liu, Andrew
   Bambina, Shelly
   Baird, Jason
   Gough, Michael
   Chakhtoura, Marita
   Haddad, Elias K.
   Kirby, Ilsa T.
   Nilsen, Aaron
   Streblow, Daniel N.
   Hirsch, Alec J.
   Smith, Jessica L.
   DeFilippis, Victor R.
TI A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory
   to Replication of Zika, Chikungunya, and Dengue Viruses
SO MBIO
LA English
DT Article
DE antiviral agents; emerging virus; innate immunity; interferons
ID WEST NILE VIRUS; INNATE IMMUNE-RESPONSE; NF-KAPPA-B;
   INTERFERON-INDUCIBLE PROTEIN; DOMAIN-CONTAINING ADAPTER;
   MONOPHOSPHORYL-LIPID-A; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; RIG-I;
   ANTIVIRAL RESPONSE
AB The ongoing concurrent outbreaks of Zika, Chikungunya, and dengue viruses in Latin America and the Caribbean highlight the need for development of broad-spectrum antiviral treatments. The type I interferon (IFN) system has evolved in vertebrates to generate tissue responses that actively block replication of multiple known and potentially zoonotic viruses. As such, its control and activation through pharmacological agents may represent a novel therapeutic strategy for simultaneously impairing growth of multiple virus types and rendering host populations resistant to virus spread. In light of this strategy's potential, we undertook a screen to identify novel interferon-activating small molecules. Here, we describe 1-(2-fluorophenyl)2-( 5-isopropyl-1,3,4-thiadiazol-2-yl)-1,2-dihydrochromeno[2,3-c]pyrrole-3,9-dione, which we termed AV-C. Treatment of human cells with AV-C activates innate and interferon-associated responses that strongly inhibit replication of Zika, Chikungunya, and dengue viruses. By utilizing genome editing, we investigated the host proteins essential to AV-C-induced cellular states. This showed that the compound requires a TRIF-dependent signaling cascade that culminates in IFN regulatory factor 3 (IRF3)-ependent expression and secretion of type I interferon to elicit antiviral responses. The other canonical IRF3-terminal adaptor proteins STING and IPS-1/MAVS were dispensable for AV-C-induced phenotypes. However, our work revealed an important inhibitory role for IPS-1/MAVS, but not TRIF, in flavivirus replication, implying that TRIF-directed viral evasion may not occur. Additionally, we show that in response to AV-C, primary human peripheral blood mononuclear cells secrete proinflammatory cytokines that are linked with establishment of adaptive immunity to viral pathogens. Ultimately, synthetic innate immune activators such as AV-C may serve multiple therapeutic purposes, including direct antimicrobial responses and facilitation of pathogen-directed adaptive immunity.
   IMPORTANCE The type I interferon system is part of the innate immune response that has evolved in vertebrates as a first line of broad-spectrum immunological defense against an unknowable diversity of microbial, especially viral, pathogens. Here, we characterize a novel small molecule that artificially activates this response and in so doing generates a cellular state antagonistic to growth of currently emerging viruses: Zika virus, Chikungunya virus, and dengue virus. We also show that this molecule is capable of eliciting cellular responses that are predictive of establishment of adaptive immunity. As such, this agent may represent a powerful and multipronged therapeutic tool to combat emerging and other viral diseases.
C1 [Pryke, Kara M.; Abraham, Jinu; Sali, Tina M.; Gall, Bryan J.; Archer, Iris; Liu, Andrew; Streblow, Daniel N.; Hirsch, Alec J.; Smith, Jessica L.; DeFilippis, Victor R.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.
   [Kirby, Ilsa T.; Nilsen, Aaron] Vet Affairs Med Ctr, Portland, OR USA.
   [Bambina, Shelly; Baird, Jason; Gough, Michael] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA.
   [Chakhtoura, Marita; Haddad, Elias K.] Drexel Coll Med, Div Infect Dis & HIV Med, Philadelphia, PA USA.
RP DeFilippis, VR (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.
EM defilipp@ohsu.edu
OI Gough, Michael/0000-0002-5575-0074; Jones, Iris/0000-0003-4468-614X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI081680, AI109680,
   AI2013168]
FX This work was supported by the National Institutes of Health grants
   AI081680, AI109680, and AI2013168.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106
   BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bedard KM, 2012, J VIROL, V86, P7334, DOI 10.1128/JVI.06867-11
   Beljanski V, 2015, J VIROL, V89, P10612, DOI 10.1128/JVI.01526-15
   BHARTIYA D, 1992, J CELL PHYSIOL, V150, P312, DOI 10.1002/jcp.1041500214
   Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551
   Botto S, 2011, BLOOD, V117, P352, DOI 10.1182/blood-2010-06-291245
   Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963
   Bresnahan WA, 2000, J VIROL, V74, P10816, DOI 10.1128/JVI.74.22.10816-10818.2000
   Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429
   Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200
   Chakrabarti A, 2008, J BIOL CHEM, V283, P25132, DOI 10.1074/jbc.M804770200
   Chattopadhyay S, 2014, J INTERF CYTOK RES, V34, P427, DOI 10.1089/jir.2014.0034
   CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0
   Chiang C, 2015, J VIROL, V89, P8011, DOI 10.1128/JVI.00845-15
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   DeFilippis VR, 2010, J VIROL, V84, P8913, DOI 10.1128/JVI.00169-10
   DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009
   Du YK, 2016, ANTIVIR RES, V131, P9, DOI 10.1016/j.antiviral.2016.04.005
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Es-Saad S, 2012, CURR OPIN VIROL, V2, P622, DOI 10.1016/j.coviro.2012.08.009
   Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200
   Fritz-French C, 2012, CYTOKINE GROWTH F R, V23, P7, DOI 10.1016/j.cytogfr.2012.01.001
   Fros JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060166
   Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759
   Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gray PM, 2012, CELL IMMUNOL, V278, P113, DOI 10.1016/j.cellimm.2012.07.006
   Guo F, 2015, ANTIMICROB AGENTS CH, V59, P1273, DOI 10.1128/AAC.04321-14
   Guo F, 2014, ANTIVIR RES, V107, P56, DOI 10.1016/j.antiviral.2014.04.010
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Hernandez A, 2016, J LEUKOCYTE BIOL, V100, P1311, DOI 10.1189/jlb.1A0216-072R
   Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184
   Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002
   Hochheiser K, 2016, J IMMUNOL, V196, P2439, DOI 10.4049/jimmunol.1501958
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Katsounas A, 2011, INT REV IMMUNOL, V30, P366, DOI 10.3109/08830185.2011.593105
   Kavanagh D, 2016, BLOOD, V128, P2824, DOI 10.1182/blood-2016-05-715987
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   Kolanowski STHM, 2014, INNATE IMMUN-LONDON, V20, P423, DOI 10.1177/1753425913498626
   Konerman MA, 2016, CLIN LIVER DIS, V20, P645, DOI 10.1016/j.cld.2016.06.002
   Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lin FC, 2014, CYTOKINE GROWTH F R, V25, P369, DOI 10.1016/j.cytogfr.2014.07.015
   Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120
   Liu Q, 2015, J IMMUNOL, V195, P801, DOI 10.4049/jimmunol.1402358
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Long D, 2016, J EMERG MED, V50, P832, DOI 10.1016/j.jemermed.2016.03.033
   Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Mori N, 1997, EUR J HAEMATOL, V59, P162
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Ortiz A, 2017, CYTOKINE, V89, P4, DOI 10.1016/j.cyto.2016.01.010
   Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886
   Pattabhi S, 2016, J VIROL, V90, P2372, DOI 10.1128/JVI.02202-15
   Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297
   Pfeffer LM, 2011, J INTERF CYTOK RES, V31, P553, DOI 10.1089/jir.2011.0028
   PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z
   Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048
   PINTO AJ, 1990, J INTERFERON RES, V10, P293, DOI 10.1089/jir.1990.10.293
   Planes R, 2016, J VIROL, V90, P5886, DOI 10.1128/JVI.00262-16
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Sali TM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005324
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sanin DE, 2015, J IMMUNOL, V195, P1218, DOI 10.4049/jimmunol.1500146
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schwarz TF, 2009, ADV THER, V26, P983, DOI 10.1007/s12325-009-0079-5
   Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315
   Smith JL, 2014, J VIROL, V88, P5533, DOI 10.1128/JVI.00365-14
   Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11
   Sotolongo J, 2011, J EXP MED, V208, P2705, DOI 10.1084/jem.20110547
   STAEHELI P, 1985, J BIOL CHEM, V260, P1821
   Sulkowski MS, 2011, NAT REV GASTRO HEPAT, V8, P212, DOI 10.1038/nrgastro.2011.21
   Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   tenOever BR, 2016, CELL HOST MICROBE, V19, P142, DOI 10.1016/j.chom.2016.01.006
   Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920
   Ullah MO, 2016, J LEUKOCYTE BIOL, V100, P27, DOI 10.1189/jlb.2RI1115-531R
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   Ve T, 2012, CURR DRUG TARGETS, V13, P1360, DOI 10.2174/138945012803530260
   Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Wang X, 2016, CELL HOST MICROBE, V20, P329, DOI 10.1016/j.chom.2016.08.002
   White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668
   Yarilina A, 2007, J IMMUNOL, V178, P2204, DOI 10.4049/jimmunol.178.4.2204
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
   Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235
NR 118
TC 21
Z9 21
U1 2
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2017
VL 8
IS 3
AR e00452
DI 10.1128/mBio.00452-17
PG 22
WC Microbiology
SC Microbiology
GA EZ5DU
UT WOS:000404733300020
PM 28465426
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bookstaver, PB
   Mohorn, PL
   Shah, A
   Tesh, LD
   Quidley, AM
   Kothari, R
   Bland, CM
   Weissman, S
AF Bookstaver, P. Brandon
   Mohorn, Phillip L.
   Shah, Ansal
   Tesh, Lauren D.
   Quidley, April M.
   Kothari, Ravish
   Bland, Christopher M.
   Weissman, Sharon
TI Management of Viral Central Nervous System Infections: A Primer for
   Clinicians
SO JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE
LA English
DT Article
DE Central nervous system; antivirals; encephalitis; meningoencephalitis
ID ACUTE DISSEMINATED ENCEPHALOMYELITIS; HERPES-SIMPLEX ENCEPHALITIS;
   WEST-NILE-VIRUS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
   POLYMERASE-CHAIN-REACTION; PROTON MR SPECTROSCOPY; EPSTEIN-BARR-VIRUS;
   CEREBROSPINAL-FLUID; ZIKA VIRUS; JAPANESE ENCEPHALITIS
AB Viruses are a common cause of central nervous system (CNS) infections with many host, agent, and environmental factors influencing the expression of viral diseases. Viruses can be responsible for CNS disease through a variety of mechanisms including direct infection and replication within the CNS resulting in encephalitis, infection limited to the meninges, or immune-related processes such as acute disseminated encephalomyelitis. Common pathogens including herpes simplex virus, varicella zoster, and enterovirus are responsible for the greatest number of cases in immunocompetent hosts. Other herpes viruses (eg, cytomegalovirus, John Cunningham virus) are more common in immunocompromised hosts. Arboviruses such as Japanese encephalitis virus and Zika virus are important pathogens globally, but the prevalence varies significantly by geographic region and often season. Early diagnosis from radiographic evidence and molecular (eg, rapid) diagnostics is important for targeted therapy. Antivirals may be used effectively against some pathogens, although several viruses have no effective treatment. This article provides a review of epidemiology, diagnostics, and management of common viral pathogens in CNS disease.
C1 [Bookstaver, P. Brandon] Univ South Carolina, Coll Pharm, Dept Clin Pharm & Outcomes Sci, Columbia, SC 29208 USA.
   [Mohorn, Phillip L.] Spartanburg Reg Healthcare Syst, Spartanburg Med Ctr, Dept Pharm, Spartanburg, SC USA.
   [Shah, Ansal] Univ South Carolina, Sch Med, Div Infect Dis, Columbia, SC USA.
   [Tesh, Lauren D.] US FDA, Div Advisory Comm & Consultant Management, Off Execut Programs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.
   [Quidley, April M.] Vidant Med Ctr, Dept Pharm Serv, Greenville, NC USA.
   [Kothari, Ravish] Univ South Carolina, Palmetto Med Grp, Dept Neurol, Columbia, SC USA.
   [Bland, Christopher M.] Univ Georgia, Coll Pharm, Dept Clin & Adm Pharm, Savannah, GA USA.
   [Weissman, Sharon] Univ South Carolina, Sch Med, Dept Internal Med, Div Infect Dis, Columbia, SC USA.
RP Bookstaver, PB (corresponding author), Univ South Carolina, Coll Pharm, Dept Clin Pharm & Outcomes Sci, Columbia, SC 29208 USA.
EM bookstaver@cop.sc.edu
RI Bland, Christopher M./E-5294-2019; Bookstaver, P. Brandon/H-7790-2019
OI Bland, Christopher M./0000-0001-8806-4583; Bookstaver, P.
   Brandon/0000-0002-4409-0963
CR Anduze-Faris BM, 2000, AIDS, V14, P517, DOI 10.1097/00002030-200003310-00007
   [Anonymous], 1996, PI Perspect, P14
   [Anonymous], 2016, VALNIVUDINE FV 100
   [Anonymous], 2015, RESEARCH DEV
   [Anonymous], 2006, FOSCAVIR
   [Anonymous], 2009, ADV THERAPIES INFECT
   ATLAS SW, 1986, J COMPUT ASSIST TOMO, V10, P798, DOI 10.1097/00004728-198609000-00017
   Balasubramanya KS, 2007, NEURORADIOLOGY, V49, P177, DOI 10.1007/s00234-006-0164-2
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Buckle C, 2010, AM J NEURORADIOL, V31, P1031, DOI 10.3174/ajnr.A2024
   Bulakbasi N, 2008, NEUROIMAG CLIN N AM, V18, P53, DOI 10.1016/j.nic.2007.12.001
   Caicedo Y, 2015, PEDIATR INFECT DIS J, V34, P520, DOI 10.1097/INF.0000000000000624
   Caldes A, 2009, ANTIMICROB AGENTS CH, V53, P4816, DOI 10.1128/AAC.00085-09
   Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Center For Disease Control and Prevention, 2015, W NIL VIR
   Centers for Disease Control and Prevention, 2015, JAP ENC VIR
   Centers for Disease Control and Prevention, 2016, ENT D68
   Centers for Disease Control and Prevention, 2016, CYTOM CMV CONG CMV I
   Centers for Disease Control and Prevention, 2016, RABIES
   Chimerix, 2015, CHIM COMPL TARG ENR
   Davis RL, 1991, INT C ANT AG CHEM
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   de Ory F, 2013, J MED VIROL, V85, P554, DOI 10.1002/jmv.23470
   Duniewicz M, 1976, Infection, V4, P55, DOI 10.1007/BF01638352
   Garrels K, 1996, AM J NEURORADIOL, V17, P597
   Gershburg E, 2005, J ANTIMICROB CHEMOTH, V56, P277, DOI 10.1093/jac/dki240
   Gilden D, 2004, HERPES, V11, P89
   Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6
   Gilden DH, 2008, NEUROLOGY, V70, P84, DOI 10.1212/01.wnl.0000286937.09760.e4
   Gnann JW, 2015, CLIN INFECT DIS, V61, P683, DOI 10.1093/cid/civ369
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Gross AE, 2015, ANN PHARMACOTHER, V49, P1125, DOI 10.1177/1060028015597449
   Gupta RK, 2001, MR IMAGING AND SPECTROSCOPY OF CENTRAL NERVOUS SYSTEM INFECTION, P147
   Hagiya H, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-225
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   Hamborsky J., 2015, EPIDEMIOLOGY PREVENT
   Handique SK, 2008, AM J NEURORADIOL, V29, P170, DOI [10.3174/ajnr.A0769, 10.3174/ajnr.A0862]
   Hernandez JO, 2009, AM J HEALTH-SYST PH, V66, P1288, DOI 10.2146/ajhp080307
   Hirsch Hans H., 1998, Clin Microbiol Infect, V4, P577, DOI 10.1111/j.1469-0691.1998.tb00040.x
   Honkaniemi J, 2001, AM J NEURORADIOL, V22, P1117
   Iranzo A, 1999, J NEUROL NEUROSUR PS, V66, P520, DOI 10.1136/jnnp.66.4.520
   Jackson AC, 2013, ANTIVIR RES, V99, P61, DOI 10.1016/j.antiviral.2013.01.003
   Jain S, 2014, PATHOG GLOB HEALTH, V108, P216, DOI 10.1179/2047773214Y.0000000145
   James SH, 2014, CURR OPIN VIROL, V8, P54, DOI 10.1016/j.coviro.2014.06.003
   Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6
   Kawamura N, 2012, FUTURE VIROL, V7, P901, DOI 10.2217/FVL.12.75
   Ketelslegers IA, 2011, MULT SCLER J, V17, P441, DOI 10.1177/1352458510390068
   Khan Feras, 2015, Emerg Med Clin North Am, V33, pe19
   Kramer AH, 2013, CRIT CARE CLIN, V29, P621, DOI 10.1016/j.ccc.2013.03.011
   Kumar S, 1997, NEURORADIOLOGY, V39, P180, DOI 10.1007/s002340050388
   LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857
   Laubenberger J, 1996, RADIOLOGY, V199, P805, DOI 10.1148/radiology.199.3.8638009
   Lea AP, 1996, DRUGS, V52, P225, DOI 10.2165/00003495-199652020-00006
   Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326
   Ljungman P, 2011, HEMATOL ONCOL CLIN N, V25, P151, DOI 10.1016/j.hoc.2010.11.011
   Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419
   Marshall GS, 1997, PEDIATR INFECT DIS J, V16, P1086, DOI 10.1097/00006454-199711000-00015
   Martinez-Torres F, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-40
   Maschke M, 2004, CURR OPIN NEUROL, V17, P475, DOI 10.1097/01.wco.0000137540.29857.bf
   Mehra S, 2012, J INDIAN ACAD CLIN M, V13, P338
   Moon SM, 2014, J MED VIROL, V86, P1766, DOI 10.1002/jmv.23999
   Nagel MA, 2014, CURR OPIN NEUROL, V27, P356, DOI 10.1097/WCO.0000000000000092
   Natale F, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0132-8
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Ohry A, 2001, SPINAL CORD, V39, P662, DOI 10.1038/sj.sc.3101228
   Olsan AD, 2003, AM J ROENTGENOL, V181, P591, DOI 10.2214/ajr.181.2.1810591
   OLSON LC, 1967, NEW ENGL J MED, V277, P1271, DOI 10.1056/NEJM196712142772401
   Parisi SG, 2016, INT J INFECT DIS, V44, P8, DOI 10.1016/j.ijid.2016.01.012
   Patel SH, 2003, AM J NEURORADIOL, V24, P1587
   Peredo Inti, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-207694
   Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peyriere H, 2006, ANN PHARMACOTHER, V40, P143, DOI 10.1345/aph.1G214
   Polso AK, 2014, J CLIN PHARM THER, V39, P584, DOI 10.1111/jcpt.12200
   POSCHER ME, 1994, AIDS, V8, P1115, DOI 10.1097/00002030-199408000-00012
   Pouplin T, 2011, ANTIMICROB AGENTS CH, V55, P3624, DOI 10.1128/AAC.01023-10
   Prakash M, 2004, J COMPUT ASSIST TOMO, V28, P756, DOI 10.1097/00004728-200411000-00005
   Rafailidis PI, 2010, J CLIN VIROL, V49, P151, DOI 10.1016/j.jcv.2010.07.008
   Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Rayamajhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122608
   Read more about Globavir's Drug Discovery Platform (GDDP), 2016, GLOB LEV ITS DAT DRI
   Rotbart HA, 2001, CLIN INFECT DIS, V32, P228, DOI 10.1086/318452
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sakamoto H, 2013, CASE REP NEUROL, V5, P183, DOI 10.1159/000355638
   Schwarz S, 2001, NEUROLOGY, V56, P1313, DOI 10.1212/WNL.56.10.1313
   Sejvar J, 2014, HAND CLINIC, V123, P67, DOI 10.1016/B978-0-444-53488-0.00003-1
   Serabe BM, 1999, CANCER CHEMOTH PHARM, V43, P415, DOI 10.1007/s002800050916
   Shah R, 2010, CLIN RADIOL, V65, P431, DOI 10.1016/j.crad.2010.03.001
   Singh S, 1999, AM J ROENTGENOL, V173, P1101, DOI 10.2214/ajr.173.4.10511187
   Smee DF, 2016, ANTIVIR RES, V131, P61, DOI 10.1016/j.antiviral.2016.04.003
   Smith AB, 2008, RADIOGRAPHICS, V28, P2033, DOI 10.1148/rg.287085135
   Soderberg-Naucler C, 2013, NEW ENGL J MED, V369, P985, DOI 10.1056/NEJMc1302145
   Tachikawa N, 1999, INTERNAL MED, V38, P556, DOI 10.2169/internalmedicine.38.556
   Tebas P, 1998, AM J MED, V105, P287, DOI 10.1016/S0002-9343(98)00259-9
   Teixeira J, 2001, NEURORADIOLOGY, V43, P1031, DOI 10.1007/s002340100625
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   van der Knaap MS, 2005, MAGNETIC RESONANCE M, P604
   VANLANDINGHAM KE, 1988, JAMA-J AM MED ASSOC, V259, P1051
   Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001
   Vidwan G, 2003, CLIN INFECT DIS, V37, pE91, DOI 10.1086/377263
   WAGSTAFF AJ, 1994, DRUGS, V48, P199, DOI 10.2165/00003495-199448020-00007
   Wang JN, 2006, PEDIATR INT, V48, P250, DOI 10.1111/j.1442-200X.2006.02198.x
   Webster ADB, 2005, J CLIN VIROL, V32, P1, DOI 10.1016/j.jcv.2004.06.006
   Weil AA, 2002, CLIN INFECT DIS, V34, P1154, DOI 10.1086/339550
   WHITLEY RJ, 1995, CLIN INFECT DIS, V20, P414, DOI 10.1093/clinids/20.2.414
   Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004
   WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303
   Wildemann B, 1997, NEUROLOGY, V48, P1341, DOI 10.1212/WNL.48.5.1341
   WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304
   Young NP, 2008, SEMIN NEUROL, V28, P84, DOI 10.1055/s-2007-1019130
   Zak IT, 2005, AM J ROENTGENOL, V184, P957, DOI 10.2214/ajr.184.3.01840957
NR 116
TC 11
Z9 12
U1 0
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1179-5735
J9 J CENT NERV SYST DIS
JI J. Cent. Nerv. Syst. Dis.
PD MAY 1
PY 2017
VL 9
AR UNSP 1179573517703342
DI 10.1177/1179573517703342
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA EZ4LN
UT WOS:000404684700001
PM 28579869
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shacham, E
   Nelson, EJ
   Hoft, DF
   Schootman, M
   Garza, A
AF Shacham, Enbal
   Nelson, Erik J.
   Hoft, Daniel F.
   Schootman, Mario
   Garza, Alexander
TI Potential High-Risk Areas for Zika Virus Transmission in the Contiguous
   United States
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID DISPARITIES; PATTERNS
AB Objectives. To understand where transmission of Zika virus has the highest likelihood to occur in the contiguous United States with regard to its transmission both sexually and via Aedes aegypti mosquito bites.
   Methods. We evaluated the 2 routes of transmission risk with predictors of sexually transmitted infections (percentage women of childbearing age, birthrate, gonorrhea and chlamydia rates, concentrated disadvantage) as a surrogate for unprotected sexual activity and the demographic distribution of the A. aegypti mosquito across 3108 counties in the contiguous United States.
   Results. We found that 507 counties had the highest risk of virus exposure via mosquito vector or unprotected sexual activity; these were concentrated in southern states extending northward along the Atlantic coast and southern California, with the highest predicted risk in Mississippi counties.
   Conclusions. Identifying areas with higher transmission risk can inform prevention strategies and vector control, and assist in planning for diagnosis and treatment.
C1 [Shacham, Enbal] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Behav Sci & Hlth Educ, 3545 Lafayette Ave, St Louis, MO 63104 USA.
   [Nelson, Erik J.] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA.
   [Hoft, Daniel F.] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63103 USA.
   [Hoft, Daniel F.] St Louis Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63103 USA.
   [Schootman, Mario; Garza, Alexander] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA.
RP Shacham, E (corresponding author), St Louis Univ, Coll Publ Hlth & Social Justice, Dept Behav Sci & Hlth Educ, 3545 Lafayette Ave, St Louis, MO 63104 USA.
EM eshacham@slu.edu
RI Nelson, Erik/R-7239-2019
OI Nelson, Erik/0000-0003-1658-8294
CR Association of Maternal and Child Health Programs, 2013, LIF COURS IND CONC D
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barnes JC, 2014, CRIMINOLOGY, V52, P588, DOI 10.1111/1745-9125.12049
   Beer L, 2014, AIDS, V28, P105, DOI 10.1097/QAD.0000000000000021
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Bivand RS, 2008, USE R, P1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, 2016, NCHHSTP ATL
   Finer LB, 1999, FAM PLANN PERSPECT, V31, P228, DOI 10.2307/2991570
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gindi RM, 2011, SEX TRANSM DIS, V38, P260, DOI 10.1097/OLQ.0b013e3181f7d7f4
   Kershaw TS, 2007, PERSPECT SEX REPRO H, V39, P141, DOI 10.1363/3914107
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Minnesota Population Center, 2014, NAT HIST GEOGR INF S
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P457, DOI 10.1097/00007435-199810000-00003
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918
   Shacham E, 2016, SEX TRANSM INFECT, V92, P194, DOI 10.1136/sextrans-2015-052144
   Soares de Araujo JS, 2016, B WHO
   US Census Bureau, 2014, AM COMM SURV
   US Centers for Disease Control and Prevention (CDC), 2015, SEX TRANSM DIS SURV, P2016
   Waller L. A., 2004, APPL SPATIAL STAT PU
   WHO, 2016, ZIK VIR FACT SHEET
   WHO, 2016, PREGN MAN CONT ZIK V
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
NR 34
TC 12
Z9 12
U1 0
U2 8
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD MAY
PY 2017
VL 107
IS 5
BP 724
EP 731
DI 10.2105/AJPH.2017.303670
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EZ0IG
UT WOS:000404385600039
PM 28323468
OA Green Published
DA 2020-07-08
ER

PT J
AU Carrion, M
   Madoff, LC
AF Carrion, Malwina
   Madoff, Lawrence C.
TI ProMED-mail: 22 years of digital surveillance of emerging infectious
   diseases
SO INTERNATIONAL HEALTH
LA English
DT Review
DE Emerging infectious diseases; EpiCore; Outbreaks; ProMED-mail;
   Surveillance
AB ProMED-mail (ProMED) was launched in 1994 as an email service to identify unusual health events related to emerging and re-emerging infectious diseases and toxins affecting humans, animals and plants. It is used daily by public health leaders, government officials at all levels, physicians, veterinarians and other healthcare workers, researchers, private companies, journalists and the general public. Reports are produced and commentary provided by a global team of subject matter experts in a variety of fields including virology, parasitology, epidemiology, entomology, veterinary and plant disease specialists. ProMED operates 24 hours a day, 7 days a week and has over 83 000 subscribers, representing every country in the world. Additionally, ProMED disseminates information via its website and through social media channels such as Twitter and Facebook as well as through RSS feeds. Over the last 22 years, it has been the first to report on numerous major and minor disease outbreaks including SARS, MERS, Ebola and the early spread of Zika. ProMED is transparent, apolitical, open to all and free of charge, making it an important and longstanding contributor to global health surveillance.
C1 [Carrion, Malwina; Madoff, Lawrence C.] Int Soc Infect Dis, Brookline, MA 02446 USA.
   [Madoff, Lawrence C.] Univ Massachusetts, Sch Med, Worcester, MA USA.
RP Carrion, M (corresponding author), Int Soc Infect Dis, Brookline, MA 02446 USA.
EM maja@promedmail.org
RI Carrion, Malwina/AAM-1046-2020
FU Wellcome TrustWellcome Trust; Skoll Global Threats Fund; CRDF Global;
   OIE; HealthMap
FX ProMED is a program of the International Society for Infectious Diseases
   (ISID). We thank our staff and participants. The ISID receives support
   for ProMED from the Wellcome Trust, the Skoll Global Threats Fund, CRDF
   Global, OIE and generous donors. HealthMap provides in- kind support.
   Thank you to John Ramatowski of ISID for creating the word cloud in
   Figure 4.
CR Barboza P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090536
   Bijkerk P, 2017, EUROSURVEILLANCE, V22, P19, DOI [10.2807/1560-7917.es.2017.22.14.30502, 10.2807/1560-7917.ES.2017.22.14.30502]
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Calisher CH, 2016, EMERG INFECT DIS, V22, P1859, DOI 10.3201/eid2210.160875
   Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107
   Hartley DM, 2013, CLIN MICROBIOL INFEC, V19, P1006, DOI 10.1111/1469-0691.12273
   ISID, INT SOC INF DIS
   Madoff LC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.OH-0015-2012
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   Woodall JP, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.107.9921
NR 12
TC 10
Z9 11
U1 2
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1876-3413
EI 1876-3405
J9 INT HEALTH
JI Int. Health
PD MAY
PY 2017
VL 9
IS 3
BP 177
EP 183
DI 10.1093/inthealth/ihx014
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EY5TW
UT WOS:000404044000009
PM 28582558
OA Green Published
DA 2020-07-08
ER

PT J
AU Holbrook, MR
AF Holbrook, Michael R.
TI Historical Perspectives on Flavivirus Research
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; yellow fever; West Nile; Japanese encephalitis; tick-borne
   encephalitis; Zika; dengue
ID TICK-BORNE ENCEPHALITIS; TETRAVALENT DENGUE VACCINE; YELLOW-FEVER
   VACCINE; WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS; UNITED-STATES;
   USUTU-VIRUS; HEMORRHAGIC-FEVER; ZIKA VIRUS; T-CELLS
AB The flaviviruses are small single-stranded RNA viruses that are typically transmitted by mosquito or tick vectors. These "arboviruses" are found around the world and account for a significant number of cases of human disease. The flaviviruses cause diseases ranging from mild or sub-clinical infections to lethal hemorrhagic fever or encephalitis. In many cases, survivors of neurologic flavivirus infections suffer long-term debilitating sequelae. Much like the emergence of West Nile virus in the United States in 1999, the recent emergence of Zika virus in the Americas has significantly increased the awareness of mosquito-borne viruses. The diseases caused by several flaviviruses have been recognized for decades, if not centuries. However, there is still a lot that is unknown about the flaviviruses as the recent experience with Zika virus has taught us. The objective of this review is to provide a general overview and some historical perspective on several flaviviruses that cause significant human disease. In addition, available medical countermeasures and significant gaps in our understanding of flavivirus biology are also discussed.
C1 [Holbrook, Michael R.] NIAID, Integrated Res Facil, 8200 Res Plaza, Frederick, MD 21702 USA.
RP Holbrook, MR (corresponding author), NIAID, Integrated Res Facil, 8200 Res Plaza, Frederick, MD 21702 USA.
EM Michael.holbrook@nih.gov
CR Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545
   Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   [Anonymous], 2002, JAMA, V288, P1976
   Ashburn PM, 1907, J INFECT DIS, V4, P440, DOI 10.1093/infdis/4.3.440
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   BANCROFT TL, 1906, AUSTRALAS MED GAZ, V25, P17
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Bassi MR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004464
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Blom K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004622
   Bloom K.J., 1993, MISSISSIPPI VALLEYS, P296
   BODEMANN HH, 1977, MED WELT, V28, P1779
   Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6
   Cadar D., 2016, EURO SURVEILL, V22
   CALISHER CH, 1988, ACTA VIROL, V32, P469
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   CAREY DE, 1963, NATURE, V200, P1024, DOI 10.1038/2001024b0
   Carter H.R., 1931, YELLOW FEVER EPIDEMI
   CASALS J, 1954, J EXP MED, V99, P429, DOI 10.1084/jem.99.5.429
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   CHANDLER A. C., 1923, American Journal of Tropical Medicine, V3, P233
   CHUMAKOV M P, 1963, Vopr Virusol, V29, P415
   CLARKE DH, 1965, VIRAL RICKETTSIAL IN
   Cleland J.B., 1916, MED J AUSTRALIA, V11, P179
   Cleland JB, 1919, J HYG-CAMBRIDGE, V18, P217, DOI 10.1017/S0022172400007476
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Coudeville L, 2016, VACCINE, V34, P6426, DOI 10.1016/j.vaccine.2016.08.050
   Coudeville L, 2016, VACCINE, V34, P6417, DOI 10.1016/j.vaccine.2015.11.023
   DENNIS LH, 1969, BRIT J HAEMATOL, V17, P455, DOI 10.1111/j.1365-2141.1969.tb01393.x
   Dunham EJ, 2007, J MOL EVOL, V64, P656, DOI 10.1007/s00239-006-0278-5
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Fauquet C.M., 2005, VIRUS TAXONOMY
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Finlay C., 1881, AN R ACAD CIEN MED H, V18, P147
   Finlay C., 1881, NEW ORL MED SURG J, V9, P601
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garrison F.H., 1921, INTRO HIST MED
   Girgsdies OE, 1996, VACCINE, V14, P1421, DOI 10.1016/S0264-410X(96)00081-3
   Griffiths MJ, 2014, HAND CLINIC, V123, P561, DOI 10.1016/B978-0-444-53488-0.00026-2
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   Holbrook MR, 2008, ANTIVIR RES, V78, P69, DOI 10.1016/j.antiviral.2007.10.004
   Horstick O, 2015, PATHOG GLOB HEALTH, V109, P19, DOI 10.1179/2047773215Y.0000000003
   Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003
   Igarashi A, 2002, CURR TOP MICROBIOL, V267, P139
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4
   KENYON RH, 1992, MICROB PATHOGENESIS, V13, P399, DOI 10.1016/0882-4010(92)90083-Z
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Le Flohic G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002208
   Lehrer AT, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P713, DOI 10.1016/B978-0-12-369408-9.00038-X
   Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231
   Lindow JC, 2013, VACCINE, V31, P3347, DOI 10.1016/j.vaccine.2013.05.075
   Liu P, 2017, TRAFFIC, V18, P218, DOI 10.1111/tra.12469
   Maciel M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003693
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   McArthur MA, 2003, J VIROL, V77, P1462, DOI 10.1128/JVI.77.2.1462-1468.2003
   McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Memish ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085564
   MITAMURA TOKUSHIRO, 1950, JAPANESE MED JOUR, V3, P257
   Mlera L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005346
   Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   MONATH TP, 1981, AM J TROP MED HYG, V30, P431, DOI 10.4269/ajtmh.1981.30.431
   Moreira J., 2017, CLIN MICROBIOL INFEC
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Osorio JE, 2015, VACCINE, V33, P7112, DOI 10.1016/j.vaccine.2015.11.022
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   PEPPER P, 1941, ANN MED HIST, V3, P363
   Pereira RC, 2015, VACCINE, V33, P4261, DOI 10.1016/j.vaccine.2015.03.077
   Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0
   POGODINA VV, 1981, ACTA VIROL, V25, P344
   POGODINA VV, 1981, ACTA VIROL, V25, P337
   POGODINA VV, 1981, ACTA VIROL, V25, P352
   Poponnikova TV, 2006, INT J MED MICROBIOL, V296, P59, DOI 10.1016/j.ijmm.2006.01.023
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004
   Reed W, 1900, Public Health Pap Rep, V26, P37
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143
   Rush B., 1796, MED INQUIRIES OBSERV, V4
   Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023
   Ruzek D, 2010, LANCET, V376, P2104, DOI 10.1016/S0140-6736(10)61120-8
   Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004
   Sabin A.B., 1948, VIRAL RICKETTSIAL IN, P445
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SABIN ALBERT B., 1948, PROC SOC EXPTL BIOL AND MED, V69, P478, DOI 10.3181/00379727-69-16761P
   Sadanandane C, 2017, TICKS TICK-BORNE DIS, V8, P25, DOI 10.1016/j.ttbdis.2016.09.010
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Schafer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024505
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Seligman SJ, 2014, VACCINE, V32, P5769, DOI 10.1016/j.vaccine.2014.08.051
   Silber L. A., 1946, American Review of Soviet Medicine NY Spec Suppl, V[3 4], P1
   SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1
   SILER JF, 1935, GEOGRAPHY DIS, P402
   SIMMONS JAMES STEVENS, 1931, PHILIPPINE JOUR SCI, V44, P1
   Slovak M, 2014, TICKS TICK-BORNE DIS, V5, P962, DOI 10.1016/j.ttbdis.2014.07.019
   Smart W R, 1877, Br Med J, V1, P382
   SMORODINTSEFF A. A., 1941, ARCH GES VIRUSFORSCH, V2, P1, DOI 10.1007/BF01240711
   SMORODINTSEV AA, 1958, PROG MED VIROL, V1, P210
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647
   STOKES ADRIAN, 1928, AMER JOUR TROP MED, V8, P103
   SWEET BH, 1954, J IMMUNOL, V73, P363
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449
   Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Thomas DL, 2016, EMERG INFECT DIS, V22, P1002, DOI 10.3201/eid2206.152000
   Thomas RE, 2016, DRUG DES DEV THER, V10, P3345, DOI 10.2147/DDDT.S99600
   Thomas SJ, 2015, AM J PREV MED, V49, pS334, DOI 10.1016/j.amepre.2015.09.006
   Thomas SJ, 2014, ANN NY ACAD SCI, V1323, P140, DOI 10.1111/nyas.12413
   Tolou H, 2000, BIOCHEM BIOPH RES CO, V277, P89, DOI 10.1006/bbrc.2000.3640
   Tretyakova I, 2014, VIROLOGY, V468, P28, DOI 10.1016/j.virol.2014.07.050
   VEZZA AC, 1980, AM J TROP MED HYG, V29, P643, DOI 10.4269/ajtmh.1980.29.643
   Wang T, 2013, VIRUSES-BASEL, V5, P2298, DOI 10.3390/v5092298
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   WHO, 2016, VACCINE, V34, P302, DOI 10.1016/j.vaccine.2015.07.057
   Wieten RW, 2016, J INFECTION, V72, P713, DOI 10.1016/j.jinf.2016.02.017
   Wieten RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149871
   WOODALL JP, 1964, P E AFR ACAD, V2, P141
   Woodson SE, 2013, VIRUS RES, V175, P155, DOI 10.1016/j.virusres.2013.04.013
   Woodson SE, 2011, J GEN VIROL, V92, P2262, DOI 10.1099/vir.0.031617-0
   Woodson SE, 2011, VIROLOGY, V412, P188, DOI 10.1016/j.virol.2011.01.012
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, DENG SEV DENG
   World Health Organization, 1997, DENG HAEM FEV DIAGN, P1
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   ZANOTTO PMD, 1995, VIROLOGY, V210, P152
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
   Zent O, 2005, EXPERT REV VACCINES, V4, P747, DOI 10.1586/14760584.4.5.747
NR 165
TC 37
Z9 38
U1 2
U2 19
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2017
VL 9
IS 5
AR 97
DI 10.3390/v9050097
PG 19
WC Virology
SC Virology
GA EY8DY
UT WOS:000404226000005
PM 28468299
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Melo, ASD
   Reis, BLFS
   Azevedo, GS
   Tavares, JD
   Marinho, JRL
   Amorim, MM
AF de Oliveira Melo, Adriana Suely
   Fonseca Schamber Reis, Bruno Luiz
   Azevedo, Girlene Souza
   Tavares, Jousilene de Sales
   Loureiro Marinho, Jacqueline Ramos
   Amorim, Melania M.
TI N Fetal Damage in Congenital Zika Virus Infection: Cohort Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [de Oliveira Melo, Adriana Suely; Fonseca Schamber Reis, Bruno Luiz; Azevedo, Girlene Souza; Tavares, Jousilene de Sales; Loureiro Marinho, Jacqueline Ramos; Amorim, Melania M.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, PB, Brazil.
RI Melo, Adriana S O/H-5650-2016; Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 3P
BP 164S
EP 164S
DI 10.1097/01.AOG.0000514076.77258.39
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800590
DA 2020-07-08
ER

PT J
AU Melo, ASD
   Carneiro, JG
   Melo, FD
   Manhaes, CBD
   Silva, MB
   Amorim, MM
AF de Oliveira Melo, Adriana Suely
   Carneiro, Juliana Garcia
   Melo, Fabiana de Oliveira
   de Souza Manhaes, Claudia Bianka
   Silva, Mariana Balbino
   Amorim, Melania M.
TI Sonographic Findings in Congenital Zika Virus Infection: Cohort Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [de Oliveira Melo, Adriana Suely; Carneiro, Juliana Garcia; Melo, Fabiana de Oliveira; de Souza Manhaes, Claudia Bianka; Silva, Mariana Balbino; Amorim, Melania M.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, PB, Brazil.
RI Melo, Adriana S O/H-5650-2016; Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 4P
BP 164S
EP 165S
DI 10.1097/01.AOG.0000514077.54388.3c
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800591
DA 2020-07-08
ER

PT J
AU Nugent, EK
   Nugent, AK
   Nugent, R
   Nugent, K
AF Nugent, Elizabeth K.
   Nugent, Anne K.
   Nugent, Rebecca
   Nugent, Kenneth
TI Zika Virus: Epidemiology, Pathogenesis and Human Disease
SO AMERICAN JOURNAL OF THE MEDICAL SCIENCES
LA English
DT Review
DE Arbovirus; Zika virus; Mosquitoes; Guillain-Barre syndrome; Fetal
   microcephaly
ID INFECTION; TRANSMISSION; AMERICA; FLORIDA
AB The Zika virus is a positive sense, single-stranded RNA arbovirus in the Flaviviridae family, genus Flavivirus. This virus was initially isolated in Africa and is transmitted to nonhuman primates and humans by mosquitoes. Initial reports describe sporadic mild viral infection with fever, arthralgia, myalgia and conjunctivitis in Africa and Asia. However, its geographic distribution has significantly increased, and it has caused large outbreaks in the Yap Islands in 2007, in French Polynesia in 2013 and in Brazil in 2015. Multiple cases of Guillain-Barre syndrome occurred in French Polynesia and Columbia during outbreaks, and infections in pregnant women in Brazil have been associated with microcephaly and fetal loss. The viremic phase in humans is short, and diagnosis usually depends on positive immunoglobulin M titers with serum neutralization tests for confirmation. Treatment is directed at symptoms; there are no antiviral drugs available. Transmission can also occur through sexual contact with infected men and through blood transfusion. Prevention is important in women and includes limiting travel to endemic areas when possible, control of mosquito populations and condom use when appropriate. The Centers for Disease Control and Prevention is actively involved in tracking these infections and providing up-to-date information.
C1 [Nugent, Elizabeth K.] Univ Texas Hlth Sci Ctr Houston, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Nugent, Anne K.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA.
   [Nugent, Rebecca] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.
   [Nugent, Kenneth] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, 3601 4th St, Lubbock, TX 79430 USA.
RP Nugent, K (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, 3601 4th St, Lubbock, TX 79430 USA.
EM kenneth.nugent@ttuhsc.edu
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blumel J, 2016, TRANSFUSION
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Di Luca M, 2016, EURO SURVEILL, V21
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Guzzetta G, 2016, EURO SURVEILL, V21
   Hahn MB, 2016, J MED ENTOMOL, V53
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrower J, 2016, EMERG INFECT DIS
   Hofer U, 2016, NAT REV MICROBIOL, V14, P401, DOI 10.1038/nrmicro.2016.80
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   LaRocque RL, 2016, ANN INTERN MED, V165, P589, DOI 10.7326/M16-1397
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Microcephaly Epidemic Group, 2016, EMERG INFECT DIS
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thiery G, INTENSIVE CARE MED
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 43
TC 16
Z9 15
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9629
EI 1538-2990
J9 AM J MED SCI
JI Am. J. Med. Sci.
PD MAY
PY 2017
VL 353
IS 5
BP 466
EP 473
DI 10.1016/j.amjms.2016.12.018
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA EY1XL
UT WOS:000403761400010
PM 28502333
DA 2020-07-08
ER

PT J
AU Van Meer, R
   Hohenadel, K
   Fitzgerald-Husek, A
   Warshawsky, B
   Sider, D
   Schwartz, B
   Nelder, MP
AF Van Meer, Ryan
   Hohenadel, Karin
   Fitzgerald-Husek, Alanna
   Warshawsky, Bryna
   Sider, Doug
   Schwartz, Brian
   Nelder, Mark P.
TI ZIKA VIRUS IN ONTARIO: EVALUATING A RAPID RISK ASSESSMENT TOOL FOR
   EMERGING INFECTIOUS DISEASE THREATS
SO HEALTH SECURITY
LA English
DT Article
DE Infectious diseases; Public health preparedness and response; Rapid risk
   assessment guidance tool
AB To determine the Ontario-specific risk of local and travel-related Zika virus transmission in the context of a public health emergency of international concern, Public Health Ontario (PHO) completed a rapid risk assessment (RRA) on January 29, 2016, using a newly developed RRA guidance tool. The RRA concluded that risk of local mosquito-borne transmission was low, with a high risk of imported cases through travel. The RRA was updated 3 times based on predetermined triggers. An independent evaluation assessed both the application of the RRA guidance tool (process evaluation) and the usefulness of the RRA (outcome evaluation). We conducted face-to-face, semi-structured interviews with 7 individuals who participated in the creation or review of the Zika virus RRA and 4 end-users at PHO and the Ministry of Health and Long-Term Care. An inductive thematic analysis of responses was undertaken, whereby themes were directly informed by the data. The process evaluation determined that most steps outlined in the RRA guidance tool were adhered to, including forming a cross-functional writing team, clarifying the scope and describing context, completing the RRA summary report, and updating the RRA based on predefined triggers. The outcome evaluation found that end-users judged the Zika virus RRA as evidence-informed, useful, consistent, and timely. The evaluation established that the locally tailored guidance tool, adapted from national and international approaches to RRAs, facilitated a systematic, evidence-informed, and timely formal RRA process at PHO for the Zika virus RRA, which met the needs of end-users. Based on the evaluation, PHO will modify future RRAs by incorporating some flexibility into the literature review process to support timeliness of the RRA, explicitly describing the limitations of studies used to inform the RRA, and refining risk algorithms to better suit emerging infectious disease threats. It is anticipated that these refinements will improve upon the timely assessment of novel or reemerging infectious diseases.
C1 [Van Meer, Ryan] McMaster Univ, Publ Hlth & Prevent Med Residency Program, Hamilton, ON, Canada.
   [Hohenadel, Karin] Publ Hlth Ontario, Communicable Dis Emergency Preparedness & Respons, Communicable Dis, Toronto, ON, Canada.
   [Fitzgerald-Husek, Alanna; Warshawsky, Bryna; Sider, Doug; Nelder, Mark P.] Publ Hlth Ontario, Communicable Dis Emergency Preparedness & Respons, Toronto, ON, Canada.
   [Schwartz, Brian] Publ Hlth Ontario, Sci & Hlth Protect, Toronto, ON, Canada.
RP Nelder, MP (corresponding author), Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis Unit, Communicable Dis Emergency Preparedness & Respons, 480 Univ Ave,9th Floor, Toronto, ON M5G 1V2, Canada.
EM Mark.Nelder@oahpp.ca
CR Adlam B., 2012, RISK ASSESSMENT TOOL
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Canadian Tourism Research Institute, 2015, OUTB CAN TRAV TRENDS
   Centers for Disease Control and Prevention, 2009, DAT COLL METH PROGR
   Centers for Disease Control and Prevention, 2013, GOOD EV QUEST CHECKL
   Cox R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068338
   European Centre for Disease Prevention and Control, 2011, OP GUID RAP RISK ASS
   Giessen JWBvander, 2010, EMERGING ZOONOSES EA
   Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1
   Kindhauser MK, 2016, ZIKA ORIGIN SPREAD M
   Morgan D, 2009, EPIDEMIOL INFECT, V137, P1521, DOI 10.1017/S0950268809990227
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, GUID DOC DISC RAP RI
   Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2016, RAP RISK ASS ZIK VIR
   Ontario Ministry of Tourism, 2008, OUT OF PROV TRAV RES
   Opdenakker R, 2006, FORUM QUALITATIVE SO, V7, P11, DOI DOI 10.17169/FQS-7.4.175
   Palmer S, 2005, BMJ-BRIT MED J, V331, P1256, DOI 10.1136/bmj.331.7527.1256
   Palmer S, 2013, EUROSURVEILLANCE, V18, P26
   Pan American Health Organisation, 2016, REG ZIK EP UPD AM
   Public Health Agency of Canada, 2016, RAP RISK ASS RISK ZI
   Rossiter JC., 2009, THESIS
   Schmidt K, 2013, ZOONOSES PUBLIC HLTH, V60, P528, DOI 10.1111/zph.12045
   Trock SC, 2012, AVIAN DIS, V56, P1058, DOI 10.1637/10204-041412-ResNote.1
   University of California Los Angeles Center for Health Policy Research, 2016, HLTH DATA PROGR DAT
   University of Illinois at Urbana-Champaign, 2016, PROGR PLANN ASS KEY
   World Health Organization, 2012, RAP RISK ASS AC PUBL
NR 26
TC 1
Z9 1
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD MAY-JUN
PY 2017
VL 15
IS 3
BP 230
EP 237
DI 10.1089/hs.2016.0127
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EY3PJ
UT WOS:000403884300003
PM 28636449
DA 2020-07-08
ER

PT J
AU Cordero, JF
AF Cordero, Jose F.
TI Eliminating Congenital Zika Syndrome: Lessons Learned from Rubella
   Elimination (TS Josef Warkany Lecture)
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Meeting Abstract
CT 41st Anniversary Annual Meeting of the
   Developmental-Neurotoxicology-Society held in Conjunction with the 57th
   Annual Meeting of the Teratology-Society
CY JUN 24-28, 2017
CL Denver, CO
SP Dev Neurotoxicol Soc, Teratol Soc
C1 [Cordero, Jose F.] Univ Georgia, Athens, GA 30602 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD MAY-JUN
PY 2017
VL 61
MA DNTS 01
BP 144
EP 144
PG 1
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA EX8PM
UT WOS:000403512700020
DA 2020-07-08
ER

PT J
AU Honein, M
   Meaney-Delman, D
   Boyle, C
AF Honein, Margaret
   Meaney-Delman, Dana
   Boyle, Coleen
TI The Zika Epidemic: An Update from the CDC
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Meeting Abstract
CT 41st Anniversary Annual Meeting of the
   Developmental-Neurotoxicology-Society held in Conjunction with the 57th
   Annual Meeting of the Teratology-Society
CY JUN 24-28, 2017
CL Denver, CO
SP Dev Neurotoxicol Soc, Teratol Soc
C1 [Honein, Margaret; Meaney-Delman, Dana; Boyle, Coleen] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD MAY-JUN
PY 2017
VL 61
MA DNTS46
BP 156
EP 157
PG 2
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA EX8PM
UT WOS:000403512700064
DA 2020-07-08
ER

PT J
AU Muotri, AR
AF Muotri, Alysson R.
TI Zika Infection: From Basic Science to Treatment
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Meeting Abstract
CT 41st Anniversary Annual Meeting of the
   Developmental-Neurotoxicology-Society held in Conjunction with the 57th
   Annual Meeting of the Teratology-Society
CY JUN 24-28, 2017
CL Denver, CO
SP Dev Neurotoxicol Soc, Teratol Soc
C1 [Muotri, Alysson R.] Univ Calif San Diego, La Jolla, CA 92093 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD MAY-JUN
PY 2017
VL 61
MA DNTS 48
BP 157
EP 157
PG 1
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA EX8PM
UT WOS:000403512700066
DA 2020-07-08
ER

PT J
AU van der Linden, V
AF van der Linden, Vanessa
TI Neurobehavioral Aspects of Zika Virus
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Meeting Abstract
CT 41st Anniversary Annual Meeting of the
   Developmental-Neurotoxicology-Society held in Conjunction with the 57th
   Annual Meeting of the Teratology-Society
CY JUN 24-28, 2017
CL Denver, CO
SP Dev Neurotoxicol Soc, Teratol Soc
C1 [van der Linden, Vanessa] Assoc Assistance Disabled Children AACD, Recife, PE, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD MAY-JUN
PY 2017
VL 61
MA DNTS47
BP 157
EP 157
PG 1
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA EX8PM
UT WOS:000403512700065
DA 2020-07-08
ER

PT J
AU Sorbera, LA
   Stringer, M
AF Sorbera, L. A.
   Stringer, M.
TI Therapeutic targets for Zika virus infection
SO DRUGS OF THE FUTURE
LA English
DT Article
DE Zika virus; Targets; Envelope protein E; Non-structural proteins;
   Peptide pr; Peptide prM; Protein C; Serine protease NS3; RNA-directed
   RNA polymerase NS5
ID INSIGHT; NS5
AB Zika virus infection is a mosquito-borne viral disease caused by the Zika virus (ZIKV), a member of the Flaviviridae family that is related to other vector-borne flaviviruses such as dengue, West Nile, Spondweni and Japanese encephalitis viruses. Common symptoms of ZIKV infection include mild fever, maculopapular rash, headache, arthralgia, myalgia, asthenia and nonpurulent conjunctivitis. Approximately 20% of infected individuals develop symptoms, which typically appear between 2 and 7 days subsequent to the mosquito vector bite. Affected individuals usually undergo a mild form of the disease, with symptoms typically lasting from several days to a week. Episodes of severe disease that require hospitalization and may result in death are unusual. At present, only symptomatic treatment options are available, primarily comprising analgesics such as paracetamol, together with rest and the sufficient fluid intake. Convalescing viremic patients ought to be protected from mosquito bites so that they do not transmit the virus back to the vector and disseminate the outbreak further. There is an urgent need for broad-spectrum antiviral agents that are capable of treating infections caused by emerging arboviruses. However, the use of antiviral therapeutic entities may not be an adequate practical approach in the case of Zika as it is predominantly a self-limiting infection with a short duration. Furthermore, individuals considered to be most vulnerable to Zika infection are pregnant women, a population that may not be particularly amenable to treatment with experimental drugs. As the search continues for adequate therapeutic options, the identification of novel targets is an important step in this process.
C1 [Sorbera, L. A.; Stringer, M.] Clarivate Analyt, Barcelona, Spain.
RP Sorbera, LA (corresponding author), Clarivate Analyt, Barcelona, Spain.
RI amsalu, ribka/G-8780-2019
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cunha M. S., 2016, GENOME ANNOUNC, V4, DOI 2
   Dar HA, 2017, INFECT GENET EVOL, V51, P143, DOI 10.1016/j.meegid.2017.03.027
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HEINZ FX, 1994, ARCH VIROL, P339
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuiper B. D., 2017, BIOCH BIOPHYS RES CO
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 41
TC 0
Z9 0
U1 0
U2 6
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD MAY
PY 2017
VL 42
IS 5
BP 285
EP 291
DI 10.1358/dof.2017.042.05.2638227
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EX8NM
UT WOS:000403507200004
DA 2020-07-08
ER

PT J
AU Ramos, A
   Ramos, DE
AF Ramos, Adriana
   Ramos, Diana E.
TI Zika: Preconception & Perinatal Opportunities in Los Angeles County
   (LAC)
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Ramos, Adriana] LA Cty Publ Hlth, Los Angeles, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 21A
BP 14S
EP 15S
DI 10.1097/01.AOG.0000514255.03004.7a
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800045
DA 2020-07-08
ER

PT J
AU Canabal, JA
   Cay, C
   De La Vega, A
AF Acevedo Canabal, Jorge
   Cay, Carolina
   De La Vega, Alberto
TI Symptomatology of Zika Virus Infection During Pregnancy
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Acevedo Canabal, Jorge; Cay, Carolina; De La Vega, Alberto] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA.
RI CANABAL, JORGE M ACEVEDO/AAD-5823-2019
OI CANABAL, JORGE M ACEVEDO/0000-0003-2153-3415
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 20C
BP 35S
EP 35S
DI 10.1097/01.AOG.0000514333.47783.46
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800122
DA 2020-07-08
ER

PT J
AU Rac, M
   Eppes, C
   Dempster, C
   Ballas, J
   Davidson, C
   Aagaard, K
AF Rac, Martha
   Eppes, Catherine
   Dempster, Carrie
   Ballas, Jerasimos
   Davidson, Christina
   Aagaard, Kjersti
TI Screening for Zika Virus in a High-Risk NonEndemic Urban Population:
   Patient Characteristics and Testing Outcomes
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Rac, Martha; Eppes, Catherine; Dempster, Carrie; Ballas, Jerasimos; Davidson, Christina; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 2
Z9 2
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 19C
BP 35S
EP 35S
DI 10.1097/01.AOG.0000514332.47783.0f
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800121
DA 2020-07-08
ER

PT J
AU Billero, V
   Fein, LA
   Tse, C
   Hellerstein, L
   Messore, M
   Curry, C
AF Billero, Victoria
   Fein, Lydia A.
   Tse, Colette
   Hellerstein, Leah
   Messore, Marisa
   Curry, Christine
TI Knowledge and Perceptions of Zika Virus Among Reproductive-aged Women in
   Miami, Florida
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Billero, Victoria; Fein, Lydia A.; Tse, Colette; Hellerstein, Leah; Messore, Marisa; Curry, Christine] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 11I
BP 95S
EP 95S
DI 10.1097/01.AOG.0000514950.25726.2b
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800339
DA 2020-07-08
ER

PT J
AU Menchaca, R
   Page-Ramsey, SM
   Rodriguez, E
   Gray, J
   Ireland, K
   Ramsey, PS
AF Menchaca, Ryan
   Page-Ramsey, Sarah M.
   Rodriguez, Emma
   Gray, Jordan
   Ireland, Kayla
   Ramsey, Patrick S.
TI Patient Information About Zika Virus and Perinatal Risks on State Health
   Department Websites in the United States
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Menchaca, Ryan] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 17I
BP 97S
EP 97S
DI 10.1097/01.AOG.0000514956.12264.6b
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800345
DA 2020-07-08
ER

PT J
AU Rivera, JO
   Page-Ramsey, S
   Rodriguez, E
   Menchaca, R
   Ireland, K
   Ramsey, P
AF Rivera, Joshua O.
   Page-Ramsey, Sarah
   Rodriguez, Emma
   Menchaca, Ryan
   Ireland, Kayla
   Ramsey, Patrick
TI Factors Associated With Enhanced Availability of Zika Virus Testing
   Information on Health Department Websites
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Rivera, Joshua O.; Page-Ramsey, Sarah; Rodriguez, Emma; Menchaca, Ryan; Ireland, Kayla; Ramsey, Patrick] UT Hlth Sci Ctr San Antonio, San Antonio, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 29K
BP 119S
EP 119S
DI 10.1097/01.AOG.0000514622.06375.b2
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800425
DA 2020-07-08
ER

PT J
AU Bhat, S
   Gabbur, N
AF Bhat, Samhita
   Gabbur, Nagaraj
TI Zika Knowledge Among Pregnant Woman in an Inner-City Urban Hospital
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Bhat, Samhita; Gabbur, Nagaraj] SUNY Downstate Coll Med, Brooklyn, NY USA.
NR 0
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 10M
BP 135S
EP 135S
DI 10.1097/01.AOG.0000514681.98545.97
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800481
DA 2020-07-08
ER

PT J
AU Cuvillier, J
   Page-Ramsey, SM
   Rodriguez, E
   Ireland, K
   Adesomo, A
   Ramsey, PS
AF Cuvillier, James
   Page-Ramsey, Sarah M.
   Rodriguez, Emma
   Ireland, Kayla
   Adesomo, Adebayo
   Ramsey, Patrick S.
TI Factors Associated With Zika Virus Information on County Health
   Department Websites in the State of Texas
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Cuvillier, James; Page-Ramsey, Sarah M.; Rodriguez, Emma; Ireland, Kayla; Adesomo, Adebayo; Ramsey, Patrick S.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 11M
BP 135S
EP 135S
DI 10.1097/01.AOG.0000514682.98545.4c
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800482
DA 2020-07-08
ER

PT J
AU Eppes, C
   Rac, M
   Dempster, C
   Ballas, J
   Davidson, C
   Aagaard, K
AF Eppes, Catherine
   Rac, Martha
   Dempster, Carrie
   Ballas, Jerasimo
   Davidson, Christina
   Aagaard, Kjersti
TI Zika Virus in a Non-Endemic Urban Population: Patient Characteristics
   and Ultrasound Findings
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Eppes, Catherine; Rac, Martha; Dempster, Carrie; Ballas, Jerasimo; Davidson, Christina; Aagaard, Kjersti] Baylor Coll Med, Obstet & Gynecol, Houston, TX 77030 USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 12M
BP 135S
EP 135S
DI 10.1097/01.AOG.0000514683.06169.08
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800483
DA 2020-07-08
ER

PT J
AU Al-Ibraheemi, Z
   Ashmead, G
   Porat, N
   Taylor, D
   Sinha, A
AF Al-Ibraheemi, Zainab
   Ashmead, Graham
   Porat, Natalie
   Taylor, Dyese
   Sinha, Anila
TI Zika Screening Beyond Brazil: Zika Madness and Cost of Reassurance?
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Al-Ibraheemi, Zainab; Ashmead, Graham; Porat, Natalie; Taylor, Dyese; Sinha, Anila] Mt Sinai West Hosp, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 15M
BP 136S
EP 136S
DI 10.1097/01.AOG.0000514686.29040.4b
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800486
DA 2020-07-08
ER

PT J
AU Tse, C
   Picon, M
   Rodriguez, P
   Gonzalez, I
   Starker, R
   Curry, C
AF Tse, Colette
   Picon, Michelle
   Rodriguez, Patricia
   Gonzalez, Ivan
   Starker, Rebecca
   Curry, Christine
TI The Effects of Zika in Pregnancy: The Miami Experience
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Tse, Colette; Picon, Michelle; Rodriguez, Patricia; Gonzalez, Ivan; Starker, Rebecca; Curry, Christine] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
NR 0
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 20M
BP 137S
EP 138S
DI 10.1097/01.AOG.0000514691.21416.35
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800491
DA 2020-07-08
ER

PT J
AU Adesomo, A
   Page-Ramsey, SM
   Ireland, K
   Sullivan, A
   Rodriguez, E
   Ramsey, PS
AF Adesomo, Adebayo
   Page-Ramsey, Sarah M.
   Ireland, Kayla
   Sullivan, Adriana
   Rodriguez, Emma
   Ramsey, Patrick S.
TI Availability of Zika Virus Testing Information on Local Health
   Department Websites in the State of Texas
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Adesomo, Adebayo; Page-Ramsey, Sarah M.; Ireland, Kayla; Sullivan, Adriana; Rodriguez, Emma; Ramsey, Patrick S.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 14O
BP 156S
EP 157S
DI 10.1097/01.AOG.0000514763.48339.41
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800562
DA 2020-07-08
ER

PT J
AU Gray, J
   Page-Ramsey, SM
   Ireland, K
   Rivera, J
   Rodriguez, E
   Ramsey, PS
AF Gray, Jordan
   Page-Ramsey, Sarah M.
   Ireland, Kayla
   Rivera, Joshua
   Rodriguez, Emma
   Ramsey, Patrick S.
TI N Availability of Provider Information About Zika Virus and Perinatal
   Risks on State Health Department Websites
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Gray, Jordan; Page-Ramsey, Sarah M.; Ireland, Kayla; Rivera, Joshua; Rodriguez, Emma; Ramsey, Patrick S.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 21O
BP 158S
EP 158S
DI 10.1097/01.AOG.0000514770.16952.07
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800568
DA 2020-07-08
ER

PT J
AU Sullivan, A
   Page-Ramsey, SM
   Ireland, K
   Cuvillier, J
   Ramsey, PS
   Rodriguez, E
AF Sullivan, Adriana
   Page-Ramsey, Sarah M.
   Ireland, Kayla
   Cuvillier, James
   Ramsey, Patrick S.
   Rodriguez, Emma
TI Availability of Zika Virus Information on County and Regional Health
   Department Websites in the State of Texas
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Sullivan, Adriana; Page-Ramsey, Sarah M.; Ireland, Kayla; Cuvillier, James; Ramsey, Patrick S.; Rodriguez, Emma] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 20O
BP 158S
EP 158S
DI 10.1097/01.AOG.0000514769.78833.6e
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800567
DA 2020-07-08
ER

PT J
AU Sullivan, A
   Ramsey, PS
   Adesomo, A
   Cuvillier, J
   Ireland, K
   Page-Ramsey, S
AF Sullivan, Adriana
   Ramsey, Patrick S.
   Adesomo, Adebayo
   Cuvillier, James
   Ireland, Kayla
   Page-Ramsey, Sarah
TI Prevalence of Zika Virus Cases in the State of Texas
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Sullivan, Adriana] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 37Q
BP 182S
EP 182S
DI 10.1097/01.AOG.0000514234.49537.68
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800657
DA 2020-07-08
ER

PT J
AU Gonzalez, PV
   Costa, AA
   Masuh, HM
AF Gonzalez, Paula V.
   Alvarez Costa, Agustin
   Masuh, Hector M.
TI A Video-Tracking Analysis-Based Behavioral Assay for Larvae of Anopheles
   pseudopunctipennis and Aedes aegypti (Diptera: Culicidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Anopheles pseudopunctipennis; Aedes aegypti; mosquito; larva; behavior
ID TRIATOMA-INFESTANS; LOCOMOTOR BEHAVIOR; FEEDING-BEHAVIOR; NYMPHS;
   THIGMOTAXIS; PERFORMANCE; ZEBRAFISH; PREDATION; MOSQUITOS; RESPONSES
AB Aedes aegypti (L.) is the primary vector of dengue, yellow fever, Zika, and chikungunya viruses, whereas Anopheles pseudopunctipennis (Theobald) is the principal vector for malaria in Latin America. The larval stage of these mosquitoes occurs in very different development habitats, and the study of their respective behaviors could give us valuable information to improve larval control. The aim of this study was to set up a bioassay to study basic larval behaviors using a video-tracking software. Larvae of An. pseudopunctipennis came from two localities in Salta Province, Argentina, while Ae. aegypti larvae were of the Rockefeller laboratory strain. Behaviors of individual fourth-instar larvae were documented in an experimental petri dish arena using EthoVision XT10.1 video-tracking software. The overall level of movement of larval An. pseudopunctipennis was lower than that for Ae. aegypti, and, while moving, larval An. pseudopunctipennis spent significantly more time swimming near the wall of the arena (thigmotaxis). This is the first study that analyzes the behavior of An. pseudopunctipennis larvae. The experimental system described here may be useful for future studies on the effect of physiological, toxicological, and chemosensory stimuli on larval behaviors.
C1 [Gonzalez, Paula V.; Alvarez Costa, Agustin; Masuh, Hector M.] Ctr Invest Plagas & Insecticidas UNIDEF CITEDEF C, Juan Bautista de La Salle 4397 B1603ALO, Buenos Aires, DF, Argentina.
RP Masuh, HM (corresponding author), Ctr Invest Plagas & Insecticidas UNIDEF CITEDEF C, Juan Bautista de La Salle 4397 B1603ALO, Buenos Aires, DF, Argentina.
EM pgonzalez@citedef.gob.ar; aalvarezcosta@citedef.gob.ar;
   hmasuh@citedef.gob.ar
RI Costa, Agustin Alvarez/L-5040-2019; Gonzalez, Paula/L-2041-2019
FU Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of
   ArgentinaANPCyT [PICT 2012-1857]; CONICETConsejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET)
FX This study received financial support by Agencia Nacional de Promocion
   Cientifica y Tecnologica (ANPCyT) of Argentina (PICT 2012-1857). P.G.
   and A.A.C. have fellowships from CONICET. H.M. is a member of the
   CONICET scientific staff. Dr. L. Harburguer (CONICET) provided
   constructive suggestions and criticisms on an earlier version of this
   manuscript. We also would like to thank two anonymous reviewers for
   their valuable comments and suggestions, which helped improve the
   quality of this short communication.
CR Alzogaray RA, 1997, ARCH INSECT BIOCHEM, V35, P323, DOI 10.1002/(SICI)1520-6327(199705)35:3<323::AID-ARCH6>3.0.CO;2-U
   Alzogaray RA, 2000, MED VET ENTOMOL, V14, P6, DOI 10.1046/j.1365-2915.2000.00213.x
   Belkin J.N., 1962, MOSQUITOES S PACIFIC, VI
   Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111
   Brackenbury J, 1999, J EXP BIOL, V202, P2521
   Bugoro H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-262
   BURESOVA O, 1986, BEHAV NEUROSCI, V100, P476, DOI 10.1037/0735-7044.100.4.476
   CHRISTOPHERS S. R., 1929, Transactions 7th Congress Far Eastern Assoc. Trop. Med., 1927, V2, P736
   Clements A.N, 1999, BIOL MOSQUITOES SENS, V2
   Clements A. N., 1992, BIOL MOSQUITOES DEV, V1
   Denoel M, 2013, CHEMOSPHERE, V90, P945, DOI 10.1016/j.chemosphere.2012.06.037
   Di Rienzo JA, 2014, INFOSTAT VERSION
   FERNANDEZSALAS I, 1994, J AM MOSQUITO CONTR, V10, P477
   Ferrari MCO, 2007, CHEMOECOLOGY, V17, P223, DOI 10.1007/s00049-007-0380-1
   Gimonneau G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-65
   Gonzalez PV, 2016, PARASITOL RES, V115, P2185, DOI 10.1007/s00436-016-4960-2
   Gonzalez PV, 2015, J MED ENTOMOL, V52, P1315, DOI 10.1093/jme/tjv136
   Grieco F., 2010, ETHOVISION XT REFERE
   Hoy JB, 2000, VET HUM TOXICOL, V42, P65
   Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301
   KASAP M, 1981, Communications de la Faculte des Sciences de l'Universite d'Ankara Serie C III Zoologie, V25, P25
   Kasap M., 1980, COMMUNICATIONS DE LA FACULTE DES SCIENCES DE L'UNIVERSITE D'ANKARA SERIE C SCIENCES NATURELLES, V24, P43
   Kembro J, 2009, PARASITOL RES, V104, P1119, DOI 10.1007/s00436-008-1296-6
   Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015259
   Kinney MP, 2014, J EXP BIOL, V217, P935, DOI 10.1242/jeb.094904
   Lardeux F, 2007, CR BIOL, V330, P571, DOI 10.1016/j.crvi.2007.04.002
   Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467
   Manguin S., 1996, CHARACTERIZATION ANO
   Marechal JP, 2004, BIOFOULING, V20, P211, DOI 10.1080/08927010400011674
   Matthews RW, 1978, INSECT BEHAV
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394
   PAHO (Pan American Health Organization), 1991, STAT MAL PROGR AM
   Parker JEA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13392
   Pinheiro J. C., 2000, MIXED EFFECTS MODELS
   Richendrfer H, 2012, BEHAV BRAIN RES, V228, P99, DOI 10.1016/j.bbr.2011.11.041
   Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Seccacini E, 2006, ACTA TROP, V97, P1, DOI 10.1016/j.actatropica.2005.05.014
   SIH A, 1986, ECOLOGY, V67, P434, DOI 10.2307/1938587
   SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6
   Spruijt B. M., 1998, P MEAS BEH 98 2 INT, P264
   THOMSON R. C. M., 1940, Journal of the Malaria Institute of India, V3, P295
   Tome HW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-195
   Turesson H, 2009, J EXP BIOL, V212, P2925, DOI 10.1242/jeb.032953
   ULANOSKI JT, 1972, PHYSIOL ZOOL, V45, P97, DOI 10.1086/physzool.45.2.30155573
   Valenca MA, 2013, NEOTROP ENTOMOL, V42, P311, DOI 10.1007/s13744-013-0118-4
   Veeralin LN, 2016, 19 WHOPES WORK GROUP
   Wigglesworth V. B, 1972, PRINCIPLES INSECT PH
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
   Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115
NR 51
TC 2
Z9 2
U1 0
U2 21
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAY
PY 2017
VL 54
IS 3
BP 793
EP 797
DI 10.1093/jme/tjw229
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA EX3ST
UT WOS:000403153400034
PM 28399206
DA 2020-07-08
ER

PT J
AU Boigard, H
   Alimova, A
   Martin, GR
   Al Katz
   Gottlieb, P
   Galarza, JM
AF Boigard, Helene
   Alimova, Alexandra
   Martin, George R.
   Al Katz
   Gottlieb, Paul
   Galarza, Jose M.
TI Zika virus-like particle (VLP) based vaccine
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TICK-BORNE ENCEPHALITIS; DENGUE VIRUS; NEUTRALIZING ANTIBODIES; SUBVIRAL
   PARTICLES; TRANSMISSION; IMMUNOGENICITY; IDENTIFICATION; DETERMINANTS;
   PROTECTION; INFECTION
AB The newly emerged mosquito-borne Zika virus poses a major public challenge due to its ability to cause significant birth defects and neurological disorders. The impact of sexual transmission is unclear but raises further concerns about virus dissemination. No specific treatment or vaccine is currently available, thus the development of a safe and effective vaccine is paramount. Here we describe a novel strategy to assemble Zika virus-like particles (VLPs) by co-expressing the structural (CprME) and non-structural (NS2B/NS3) proteins, and demonstrate their effectiveness as vaccines. VLPs are produced in a suspension culture of mammalian cells and self-assembled into particles closely resembling Zika viruses as shown by electron microscopy studies. We tested various VLP vaccines and compared them to analogous compositions of an inactivated Zika virus (In-ZIKV) used as a reference. VLP immunizations elicited high titers of antibodies, as did the In-ZIKV controls. However, in mice the VLP vaccine stimulated significantly higher virus neutralizing antibody titers than comparable formulations of the In-ZIKV vaccine. The serum neutralizing activity elicited by the VLP vaccine was enhanced using a higher VLP dose and with the addition of an adjuvant, reaching neutralizing titers greater than those detected in the serum of a patient who recovered from a Zika infection in Brazil in 2015. Discrepancies in neutralization levels between the VLP vaccine and the In-ZIKV suggest that chemical inactivation has deleterious effects on neutralizing epitopes within the E protein. This along with the inability of a VLP vaccine to cause infection makes it a preferable candidate for vaccine development.
C1 [Boigard, Helene; Martin, George R.; Galarza, Jose M.] TechnoVax Inc, Tarrytown, NY 10591 USA.
   [Alimova, Alexandra; Gottlieb, Paul] CUNY, Sch Med, Dept Mol Cellular & Biomed Sci, New York, NY 10031 USA.
   [Al Katz] CUNY City Coll, Phys Dept, New York, NY 10031 USA.
RP Galarza, JM (corresponding author), TechnoVax Inc, Tarrytown, NY 10591 USA.
EM jmgalarza@technovax.com
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA
FX This work was supported in part by NIH. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Baronti C, 2014, GENOME ANNOUNC, V2
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK VIR DIS US 2015
   CDC, 2016, OUTC PREGN LAB EV PO
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NATURE IMMUNOLOGY
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eckels Kenneth H, 2003, Adv Virus Res, V61, P395, DOI 10.1016/S0065-3527(03)61010-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Finney D.J., 1952, PROBIT ANAL
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE
   Lindenbach BD, 2013, FIELDS VIROLOGY, P713
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/ERV.12.140, 10.1586/erv.12.140]
   Pan American Health Organization (PAHO), 2016, REG ZIK EP UPD AM
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970
   Suphatrakul A, 2015, VACCINE, V33, P5613, DOI 10.1016/j.vaccine.2015.08.090
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
   Valentine G, 2016, J PEDIAT INFECT DIS
   WHO, 2007, GUID PLAQ RED NEUTR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang J, 2015, NEW ENGL J MED, V372, P914, DOI 10.1056/NEJMoa1406011
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 47
TC 57
Z9 59
U1 1
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2017
VL 11
IS 5
AR e0005608
DI 10.1371/journal.pntd.0005608
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EX0RA
UT WOS:000402927300052
PM 28481898
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, CH
   Wong, PJ
   Li, MI
   Yang, HT
   Ng, LC
   O'Neill, SL
AF Tan, Cheong Huat
   Wong, PeiSze Jeslyn
   Li, Meizhi Irene
   Yang, HuiTing
   Ng, Lee Ching
   O'Neill, Scott Leslie
TI wMel limits zika and chikungunya virus infection in a Singapore
   Wolbachia-introgressed Ae. aegypti strain, wMel-Sg
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE; MOSQUITOS; TRANSMISSION; POPULATIONS; OUTBREAK
AB Background
   Zika (ZIKV) and Chikungunya (CHIKV) viruses are emerging Aedes-borne viruses that are spreading outside their known geographic range and causing wide-scale epidemics. It has been reported that these viruses can be transmitted efficiently by Ae. aegypti. Recent studies have shown that Ae. aegypti when transinfected with certain Wolbachia strains shows a reduced replication and dissemination of dengue (DENV), Chikungunya (CHIKV), and Yellow Fever (YFV) viruses. The aim of this study was to determine whether the wMel strain of Wolbachia introgressed onto a Singapore Ae. aegypti genetic background was able to limit ZIKV and CHIKV infection in the mosquito.
   Methodology/Principal findings
   Five to seven-day old mosquitoes either infected or uninfected with wMel Wolbachia were orally infected with a Ugandan strain of ZIKV and several outbreak strains of CHIKV. The midgut and salivary glands of each mosquito were sampled at days 6, 9 and 13 days post infectious blood meal to determine midgut infection and salivary glands dissemination rates, respectively. In general, all wild type Ae. aegypti were found to have high ZIKV and CHIKV infections in their midguts and salivary glands, across all sampling days, compared to Wolbachia infected counterparts. Median viral titre for all viruses in Wolbachia infected mosquitoes were significantly lower across all time points when compared to wild type mosquitoes. Most significantly, all but two and one of the wMel infected mosquitoes had no detectable ZIKV and CHIKV, respectively, in their salivary glands at 14 days post-infectious blood meal.
   Conclusions
   Our results showed that wMel limits both ZIKV and CHIKV infection when introgressed into a Singapore Ae. aegypti genetic background. These results also strongly suggest that female Aedes aegypti carrying Wolbachia will have a reduced capacity to transmit ZIKV and CHIKV.
C1 [Tan, Cheong Huat; Wong, PeiSze Jeslyn; Li, Meizhi Irene; Yang, HuiTing; Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
   [Tan, Cheong Huat; O'Neill, Scott Leslie] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.
   [Ng, Lee Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
RP Tan, CH; Ng, LC (corresponding author), Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.; Tan, CH (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.; Ng, LC (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
EM tan_cheong_huat@nea.gov.sg; ng_lee_ching@nea.gov.sg
RI O'Neill, Scott L/B-3568-2009
OI O'Neill, Scott L/0000-0002-4131-3615
FU Ministry of Finance, Singapore under Reinvestment Fund
FX This study was funded by the Ministry of Finance, Singapore under the
   Reinvestment Fund (New approaches in dengue surveillance and control) as
   part of NEA's feasibility study to determine the potential of Wolbachia
   as a biological control tool to suppress local Ae. aegypti population.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Brelsfoard C.L., 2009, ASIA PAC J MOL BIOL, V17, P55
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   HAMMON WM, 1964, AM J TROP MED HYG, V13, P629, DOI 10.4269/ajtmh.1964.13.629
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Higgs S., 1997, The molecular biology of insect disease vectors: a methods manual., P459
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Miller WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004069
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Ng L. C., 2013, ANN ACAD OF MED, P697
   Ng LC, 2011, WEST PAC SURVEILL RE, V2, P1, DOI [10.5365/WPSAR.2011.2.2.001, 10.5365/wpsar.2011.2.2.001]
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   Rainey SM, 2014, J GEN VIROL, V95, P517, DOI 10.1099/vir.0.057422-0
   Roques P, 2015, VECTOR-BORNE ZOONOT, V15, P221, DOI 10.1089/vbz.2015.9001.int
   Roth A, 2014, EURO SURVEILL, V19
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P383, DOI 10.1089/vbz.2010.0022
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 27
TC 20
Z9 20
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2017
VL 11
IS 5
AR e0005496
DI 10.1371/journal.pntd.0005496
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EX0RA
UT WOS:000402927300014
PM 28542240
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Whitehead, SS
   Durbin, AP
   Pierce, KK
   Elwood, D
   McElvany, BD
   Fraser, EA
   Carmolli, MP
   Tibery, CM
   Hynes, NA
   Jo, M
   Lovchik, JM
   Larsson, CJ
   Doty, EA
   Dickson, DM
   Luke, CJ
   Subbarao, K
   Diehl, SA
   Kirkpatrick, BD
AF Whitehead, Stephen S.
   Durbin, Anna P.
   Pierce, Kristen K.
   Elwood, Dan
   McElvany, Benjamin D.
   Fraser, Ellen A.
   Carmolli, Marya P.
   Tibery, Cecilia M.
   Hynes, Noreen A.
   Jo, Matthew
   Lovchik, Janece M.
   Larsson, Catherine J.
   Doty, Elena A.
   Dickson, Dorothy M.
   Luke, Catherine J.
   Subbarao, Kanta
   Diehl, Sean A.
   Kirkpatrick, Beth D.
TI In a randomized trial, the live attenuated tetravalent dengue vaccine
   TV003 is well-tolerated and highly immunogenic in subjects with
   flavivirus exposure prior to vaccination
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ARTHROPOD-BORNE VIRUSES; T-CELL RESPONSES; HEMORRHAGIC-FEVER;
   ANTIBODY-RESPONSE; DISEASE SEVERITY; NAIVE ADULTS; HEALTHY; SAFE;
   CANDIDATE; PATHOGENESIS
AB Infection caused by the four serotypes of dengue virus (DENV-1-4) is a leading cause of mosquito-borne disease. Clinically-severe dengue disease is more common when secondary dengue infection occurs following prior infection with a heterologous dengue serotype. Other flaviviruses such as yellow fever virus, Japanese encephalitis virus, and Zika virus, can also elicit antibodies which are cross-reactive to DENV. As candidate dengue vaccines become available in endemic settings and for individuals who have received other flavivirus vaccines, it is important to examine vaccine safety and immunogenicity in these flavivirus-experienced populations. We performed a randomized, controlled trial of the National Institutes of Health live attenuated tetravalent dengue vaccine candidate (TV003) in fifty-eight individuals with prior exposure to flavivirus infection or vaccine. As in prior studies of this vaccine in flavivirus-naive volunteers, flavivirus-experienced subjects received two doses of vaccine six months apart and were followed closely for clinical events, laboratory changes, viremia, and neutralizing antibody titers. TV003 was well tolerated with few adverse events other than rash, which was predominately mild. Following one dose, 87% of vaccinees had an antibody response to all four serotypes (tetravalent response), suggesting a robust immune response. In addition, 76% of vaccinees were viremic; mean peak titers ranged from 0.68-1.1 log(10) PFU/mL and did not differ by serotype. The second dose of TV003 was not associated with viremia, rash, or a sustained boost in antibody titers indicating that a single dose of the vaccine is likely sufficient to prevent viral replication and thus protect against disease. In comparison to the viremia and neutralizing antibody response elicited by TV003 in flavivirus-naive subjects from prior studies, we found that subjects who were flavivirus-exposed prior to vaccination exhibited slightly higher DENV-3 viremia, higher neutralizing antibody titers to DENV-2, -3, and -4, and a higher tetravalent response frequency after TV003 administration. In summary, we demonstrate that the NIH tetravalent dengue vaccine TV003 is well-tolerated in flavivirus-experienced individuals and elicits robust post-vaccination neutralizing antibody titers.
C1 [Whitehead, Stephen S.; Luke, Catherine J.; Subbarao, Kanta] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Durbin, Anna P.; Elwood, Dan; Tibery, Cecilia M.; Hynes, Noreen A.; Jo, Matthew; Lovchik, Janece M.] Johns Hopkins Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Pierce, Kristen K.; McElvany, Benjamin D.; Fraser, Ellen A.; Carmolli, Marya P.; Larsson, Catherine J.; Doty, Elena A.; Dickson, Dorothy M.; Diehl, Sean A.; Kirkpatrick, Beth D.] Univ Vermont, Larner Coll Med, Vaccine Testing Ctr, Dept Med, Burlington, VT 05405 USA.
RP Diehl, SA; Kirkpatrick, BD (corresponding author), Univ Vermont, Larner Coll Med, Vaccine Testing Ctr, Dept Med, Burlington, VT 05405 USA.
EM sean.diehl@med.uvm.edu; beth.kirkpatrick@uvm.med.edu
RI Hynes, Noreen/AAA-2550-2020; Whitehead, Stephen/AAG-2787-2019; Diehl,
   Sean/AAE-2779-2020
OI Diehl, Sean/0000-0001-9700-235X
FU National Institutes of Allergy and Infectious Diseases Intramural
   Research Program, National Institutes of Health [HHSN272200900010C]
FX This work was supported by the National Institutes of Allergy and
   Infectious Diseases Intramural Research Program, National Institutes of
   Health (contract HHSN272200900010C). The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript
CR Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Angelo MA, 2016, J VIROL
   Bauer K, 2015, AM J TROP MED HYG, V93, P441, DOI 10.4269/ajtmh.14-0625
   Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaney JE, 2006, VIRAL IMMUNOL, V19, P10, DOI 10.1089/vim.2006.19.10
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Durbin AP, 2006, HUM VACCINES, V2, P167, DOI 10.4161/hv.2.4.2944
   Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Durbin AP, 2013, J INFECT DIS, V207, P697, DOI 10.1093/infdis/jis749
   Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023
   Durbin AP, 2005, J INFECT DIS, V191, P710, DOI 10.1086/427780
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Durbin AP, 2016, J INFECT DIS
   George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hadinegoro SR, 2015, N ENGL J MED
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350
   Henein S, 2016, J INFECT DIS
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   (PAHO/ WHO) PAHOWHO, 2014, 5 FOLD INCR DENG CAS
   Qiao M, 2011, AM J TROP MED HYG, V85, P724, DOI 10.4269/ajtmh.2011.10-0436
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SCOTT RM, 1983, J INFECT DIS, V148, P1055, DOI 10.1093/infdis/148.6.1055
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   WISSEMAN CL, 1966, AM J TROP MED HYG, V15, P588, DOI 10.4269/ajtmh.1966.15.588
   WISSEMAN CL, 1962, AM J TROP MED HYG, V11, P550, DOI 10.4269/ajtmh.1962.11.550
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V30, P349
NR 45
TC 36
Z9 37
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2017
VL 11
IS 5
AR e0005584
DI 10.1371/journal.pntd.0005584
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EX0RA
UT WOS:000402927300037
PM 28481883
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, W
   Bailey-Elkin, B
   Knaap, RCM
   Khare, B
   Dalebout, TJ
   Johnson, GG
   van Kasteren, PB
   McLeish, NJ
   Gu, J
   He, WG
   Kikkert, M
   Mark, BL
   Sidhu, SS
AF Zhang, Wei
   Bailey-Elkin, Ben A.
   Knaap, Robert C. M.
   Khare, Baldeep
   Dalebout, Tim J.
   Johnson, Garrett G.
   van Kasteren, Puck B.
   McLeish, Nigel J.
   Gu, Jun
   He, Wenguang
   Kikkert, Marjolein
   Mark, Brian L.
   Sidhu, Sachdev S.
TI Potent and selective inhibition of pathogenic viruses by engineered
   ubiquitin variants
SO PLOS PATHOGENS
LA English
DT Article
ID PAPAIN-LIKE PROTEASE; RESPIRATORY-SYNDROME-CORONAVIRUS; MERS-COV
   INFECTION; MOUSE MODEL; DEUBIQUITINATING ACTIVITY;
   INTERFERON-PRODUCTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ENZYME; SARS
AB The recent Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola and Zika virus outbreaks exemplify the continued threat of (re-) emerging viruses to human health, and our inability to rapidly develop effective therapeutic countermeasures. Many viruses, including MERS-CoV and the Crimean-Congo hemorrhagic fever virus (CCHFV) encode deubiquitinating (DUB) enzymes that are critical for viral replication and pathogenicity. They bind and remove ubiquitin (Ub) and interferon stimulated gene 15 (ISG15) from cellular proteins to suppress host antiviral innate immune responses. A variety of viral DUBs (vDUBs), including the MERS-CoV papain-like protease, are responsible for cleaving the viral replicase polyproteins during replication, and are thereby critical components of the viral replication cycle. Together, this makes vDUBs highly attractive antiviral drug targets. However, structural similarity between the catalytic cores of vDUBs and human DUBs complicates the development of selective small molecule vDUB inhibitors. We have thus developed an alternative strategy to target the vDUB activity through a rational protein design approach. Here, we report the use of phage-displayed ubiquitin variant (UbV) libraries to rapidly identify potent and highly selective protein-based inhibitors targeting the DUB domains of MERSCoV and CCHFV. UbVs bound the vDUBs with high affinity and specificity to inhibit deubiquitination, deISGylation and in the case of MERS-CoV also viral replicative polyprotein processing. Co-crystallization studies further revealed critical molecular interactions between UbVs and MERS-CoV or CCHFV vDUBs, accounting for the observed binding specificity and high affinity. Finally, expression of UbVs during MERS-CoV infection reduced infectious progeny titers by more than four orders of magnitude, demonstrating the remarkable potency of UbVs as antiviral agents. Our results thereby establish a strategy to produce protein- based inhibitors that could protect against a diverse range of viruses by providing UbVs via mRNA or protein delivery technologies or through transgenic techniques.
C1 [Zhang, Wei; Gu, Jun; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON, Canada.
   [Zhang, Wei; Gu, Jun; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.
   [Bailey-Elkin, Ben A.; Khare, Baldeep; Johnson, Garrett G.; McLeish, Nigel J.; He, Wenguang; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.
   [Knaap, Robert C. M.; Dalebout, Tim J.; van Kasteren, Puck B.; Kikkert, Marjolein] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.
RP Sidhu, SS (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON, Canada.; Sidhu, SS (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Mark, BL (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.; Kikkert, M (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.
EM m.kikkert@lumc.nl; brian.mark@umanitoba.ca; sachdev.sidhu@utoronto.ca
RI Kikkert, Marjolein/AAK-5514-2020; Khare, Baldeep/AAO-7409-2020; van
   Kasteren, Puck/H-6203-2019
OI van Kasteren, Puck/0000-0003-4369-6055; /0000-0002-6829-8312; Zhang,
   Wei/0000-0001-5813-240X
FU Division of Chemical Sciences of the Netherlands Organization for
   Scientific Research (NWO-CW) through Excellent Chemical Research (ECHO)
   [700.59.008]; Natural Sciences and Engineering Research Council of
   Canada (NSERC)Natural Sciences and Engineering Research Council of
   Canada [RGPIN-2015-05310]; NSERC Postgraduate Scholarship
   (PGS-Doctoral); Mitacs Elevate program; Mitacs Inc.; Centre for the
   Commercialization of Antibodies and Biologics (CCAB); Canadian
   Institutes of Health Research (CIHR)Canadian Institutes of Health
   Research (CIHR) [MOP -136956, PJT-148510]
FX MK is supported by the Division of Chemical Sciences of the Netherlands
   Organization for Scientific Research (NWO-CW) through Excellent Chemical
   Research (ECHO) grant (700.59.008). BLM is a Manitoba Research Chair and
   is supported by the Natural Sciences and Engineering Research Council of
   Canada (NSERC) grant (RGPIN-2015-05310). BABE holds an NSERC
   Postgraduate Scholarship (PGS-Doctoral). WZ is supported by Mitacs
   Elevate program with funds from Mitacs Inc. and Centre for the
   Commercialization of Antibodies and Biologics (CCAB). SSS is supported
   by Canadian Institutes of Health Research (CIHR) grants (MOP -136956 and
   PJT-148510). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14
   Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108
   [Anonymous], 2015, PYMOL MOL GRAPH SYST
   Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001
   Auger A, 2015, MOL PHARMACEUT, V12, P2962, DOI 10.1021/acs.molpharmaceut.5b00233
   Baez-Santos YM, 2015, ANTIVIR RES, V115, P21, DOI 10.1016/j.antiviral.2014.12.015
   Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644
   Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005
   Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09
   Calistri A, 2014, CELLS-BASEL, V3, P386, DOI 10.3390/cells3020386
   Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021
   Chen ZB, 2007, J VIROL, V81, P6007, DOI 10.1128/JVI.02747-06
   Chenon M, 2012, EMBO J, V31, P741, DOI 10.1038/emboj.2011.424
   Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040
   Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09
   Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226
   D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652
   D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Deng X, 2014, J VIROL, V88, P11886, DOI 10.1128/JVI.01528-14
   Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200
   Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161
   Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014
   Gaj T, 2014, ACS CHEM BIOL, V9, P1662, DOI 10.1021/cb500282g
   Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810
   Haagmans BL, 2016, SCIENCE, V351, P77, DOI 10.1126/science.aad1283
   Heideker J, 2015, BIOCHEM J, V465, P1, DOI 10.1042/BJ20140496
   Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936
   Inn KS, 2011, J VIROL, V85, P10899, DOI 10.1128/JVI.00690-11
   Ireton GC, 2004, ACTA CRYSTALLOGR D, V60, P601, DOI 10.1107/S0907444903029664
   Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012
   James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108
   Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111
   Kemp M, 2016, PROGR MED CHEM, V55, P149, DOI 10.1016/bs.pmch.2015.10.002
   Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Lee H, 2015, ACS CHEM BIOL, V10, P1456, DOI 10.1021/cb500917m
   Lei J, 2014, ANTIVIR RES, V109, P72, DOI 10.1016/j.antiviral.2014.06.011
   Leung I, 2016, P NATL ACAD SCI US
   Li K, 2017, P NATL ACAD SCI US
   Li K, 2016, J INFECT DIS, V213, P712, DOI 10.1093/infdis/jiv499
   Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005
   Lombardi C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003560
   Miao XY, 2013, CELL MOL LIFE SCI, V70, P815, DOI 10.1007/s00018-012-1081-7
   Mielech AM, 2014, VIRUS RES, V194, P184, DOI 10.1016/j.virusres.2014.01.025
   Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040
   Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041
   Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112
   Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103
   Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151
   Uppalapati M, 2016, ACS CHEM BIOL, V11, P1058, DOI 10.1021/acschembio.5b01006
   van den Worm SHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032857
   van Doremalen N, 2015, ANTIVIR RES, V122, P28, DOI 10.1016/j.antiviral.2015.07.005
   van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110
   Wang S, 2013, J VIROL, V87, P11851, DOI 10.1128/JVI.01211-13
   Xing YL, 2013, J GEN VIROL, V94, P1554, DOI 10.1099/vir.0.051169-0
   Yang XX, 2014, J GEN VIROL, V95, P614, DOI 10.1099/vir.0.059014-0
   Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358
   Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005
   Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111
   Zheng DH, 2008, CELL RES, V18, P1105, DOI 10.1038/cr.2008.294
   Ziebuhr J, 2007, J VIROL, V81, P3922, DOI 10.1128/JVI.02091-06
NR 62
TC 15
Z9 15
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2017
VL 13
IS 5
AR e1006372
DI 10.1371/journal.ppat.1006372
PG 21
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EW9ZK
UT WOS:000402877700027
PM 28542609
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Warbanski, ML
   Marques, P
   Frauendorf, TC
   Phillip, DAT
   El-Sabaawi, RW
AF Warbanski, Misha L.
   Marques, Piata
   Frauendorf, Therese C.
   Phillip, Dawn A. T.
   El-Sabaawi, Rana W.
TI Implications of guppy (Poecilia reticulata) life-history phenotype for
   mosquito control
SO ECOLOGY AND EVOLUTION
LA English
DT Article
DE biological vector control; Dengue; invasive species;
   mosquito-transmitted disease; Zika
ID AEDES-AEGYPTI; CONTAINER SIZE; DENGUE VECTOR; PREDATION; LARVAE; FISH;
   CULICIDAE; COMMUNITY; AMMONIUM; DIPTERA
AB Guppies (Poecilia reticulata) are frequently introduced to both natural and artificial water bodies as a mosquito control. Laboratory studies have demonstrated that guppies can consume large numbers of larval mosquitoes. Our study investigates how intraspecific variability in guppy phenotype affects their importance as a mosquito biocontrol and how habitat conditions (natural ponds vs. water storage containers) may influence insect biomass and guppy feeding. Using a blocked experimental design, we established stream-side mesocosm ponds with half receiving gravel substrate to simulate pond-bottom habitat. To provide realistic diet choices and insect abundances, we allowed the mesocosms to colonize naturally with aquatic insect larvae for 1 month before introducing guppies. We tested two distinct guppy phenotypes (from high- and low-predation streams) alongside fish-free controls. After 1 month, we measured insect biomass in the mesocosms and examined guppy gut contents to document direct predation. While overall insect biomass was not significantly different across the three fish treatments, we observed a significant reduction in mosquito biomass in fish treatments compared to fish-free controls, as well as intraspecific differences in feeding. Overall insect biomass was significantly higher in mesocosms without gravel, while habitat condition had no effect on mosquito biomass. As guppy phenotype responds to changes in their environments, it is an important consideration for biocontrol policy to anticipate potential ecosystem effects. We close by relating our findings to other studies and by discussing the implications and potential risks of using guppies to control mosquitoes.
C1 [Warbanski, Misha L.; Marques, Piata; Frauendorf, Therese C.; El-Sabaawi, Rana W.] Univ Victoria, Biol Dept, Victoria, BC, Canada.
   [Phillip, Dawn A. T.] Univ West Indies, Dept Life Sci, St Augustine, Trinidad Tobago.
RP Warbanski, ML; El-Sabaawi, RW (corresponding author), Univ Victoria, Biol Dept, Victoria, BC, Canada.
EM misha.warbanski@gmail.com; rana@uvic.ca
FU NSERC USRA fellowshipNatural Sciences and Engineering Research Council
   of Canada; Irving K. Barber scholarship; Latin America Research Exchange
   Grant from the Association of Universities and Colleges of Canada
FX NSERC USRA fellowship; Irving K. Barber scholarship; Latin America
   Research Exchange Grant from the Association of Universities and
   Colleges of Canada.
CR [Anonymous], 2013, THE EXPRESS TRIBUNE
   Arar E., 1997, 445 EPA NAT EXP RES, P1, DOI DOI 10.1007/BF02229570
   Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107
   Bates D., 2015, LME4 LINEAR MIXED EF
   Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Centres for Disease Control and Prevention, DENGUE
   Centres for Disease Control and Prevention, MAL
   Davis TJ, 2016, J MED ENTOMOL, V53, P273, DOI 10.1093/jme/tjv201
   Deacon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024416
   Dua VK, 2007, J AM MOSQUITO CONTR, V23, P481, DOI 10.2987/5560.1
   El-Sabaawi RW, 2015, OIKOS, V124, P1181, DOI 10.1111/oik.01769
   Elias M, 1995, Bangladesh Med Res Counc Bull, V21, P81
   Fraser DF, 2013, ECOLOGY, V94, P640, DOI 10.1890/12-0803.1
   Guyton KZ, 2015, LANCET ONCOL, V16, P490, DOI 10.1016/S1470-2045(15)70134-8
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Haskins C. P., 1961, POLYMORPHISM POPULAT
   Heatherly T., 2012, THESIS U NEBRASKA LI
   Holitzki TM, 2013, ECOL APPL, V23, P1367, DOI 10.1890/12-0529.1
   Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801
   HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421
   Kusumawathie PHD, 2008, ASIA-PAC J PUBLIC HE, V20, P56, DOI 10.1177/1010539507308507
   Kusumawathie PHD, 2006, J MED ENTOMOL, V43, P79, DOI 10.1603/0022-2585(2006)043[0079:LPOFSF]2.0.CO;2
   Lawal M.O., 2012, West African Journal of Applied Ecology, V20, P1
   LOEB SL, 1981, LIMNOL OCEANOGR, V26, P394, DOI 10.4319/lo.1981.26.2.0394
   Magurran A. E., 2005, EVOLUTIONARY ECOLOGY
   Manna Barnali, 2008, Journal of Vector Borne Diseases, V45, P200
   Merritt R. W., 2008, INTRO AQUATIC INSECT
   Palkovacs EP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018879
   Pimsamarn S., 2009, Dengue Bulletin, V33, P194
   Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reuters, 2016, REUTERS
   REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x
   Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627
   Saleeza SNR, 2014, SE ASIAN J TROP MED, V45, P299
   Samson DM, 2015, J VECTOR ECOL, V40, P46, DOI 10.1111/jvec.12131
   Seng CM, 2008, J VECTOR ECOL, V33, P139, DOI 10.3376/1081-1710(2008)33[139:CUOTLF]2.0.CO;2
   Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107
   Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2
   Tsuzuki A., 2009, Dengue Bulletin, V33, P161
   University of Alberta, AQ INV KEYS ALB U AL
   Vezzani D, 2005, ACTA TROP, V95, P123, DOI 10.1016/j.actatropica.2005.03.010
   Voshell J.R., 2002, GUIDE COMMON FRESHWA
   WEBER JM, 1983, CAN J FISH AQUAT SCI, V40, P1583, DOI 10.1139/f83-183
   Wijesinghe W. M. G. S., 2009, Dengue Bulletin, V33, P140
   World Health Organization, DENG CONTR
   World Health Organization, 2014, DENGUE B, V38
   Zandona E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136079
   Zandona E, 2011, FUNCT ECOL, V25, P964, DOI 10.1111/j.1365-2435.2011.01865.x
NR 53
TC 4
Z9 5
U1 0
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-7758
J9 ECOL EVOL
JI Ecol. Evol.
PD MAY
PY 2017
VL 7
IS 10
BP 3324
EP 3334
DI 10.1002/ece3.2666
PG 11
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA EW5OB
UT WOS:000402554700003
PM 28515869
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mendoza, I
   Carta, KKG
   Britto, IM
   Morr, I
   Allison, T
   Misticchio, F
   Meza, Y
   Finizola, V
AF Mendoza, I.
   Carta, K. Karina Gonzalez
   Britto, I. Mendoza
   Morr, I.
   Allison, T.
   Misticchio, F.
   Meza, Y.
   Finizola, V.
TI First report of heart failure due to zika myocarditis
SO EUROPEAN JOURNAL OF HEART FAILURE
LA English
DT Meeting Abstract
C1 [Mendoza, I.; Morr, I.; Misticchio, F.; Meza, Y.] Cent Univ Venezuela UCV, Inst Med Trop, Caracas, Venezuela.
   [Carta, K. Karina Gonzalez; Allison, T.] Mayo Clin, Cardiovasc Dis, Rochester, MN USA.
   [Britto, I. Mendoza] Jackson Mem Hosp, Cardiac Electrophysiol, Miami, FL 33136 USA.
   [Finizola, V.] Lisandro Alvarado Univ, ASCARDIO, Barquisimeto, Venezuela.
RI Mendoza, Ines/T-4733-2017
OI Mendoza, Ines/0000-0002-8266-2598
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1388-9842
EI 1879-0844
J9 EUR J HEART FAIL
JI Eur. J. Heart Fail.
PD MAY
PY 2017
VL 19
SU 1
SI SI
MA 212
BP 29
EP 30
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EU4NC
UT WOS:000401005300058
DA 2020-07-08
ER

PT J
AU Diouf, K
   Nour, NM
AF Diouf, Khady
   Nour, Nawal M.
TI Mosquito-Borne Diseases as a Global Health Problem: Implications for
   Pregnancy and Travel
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Article
ID YELLOW-FEVER; VIRUS-INFECTION; JAPANESE ENCEPHALITIS; ZIKA VIRUS;
   WUCHERERIA-BANCROFTI; VIVAX MALARIA; TRANSMISSION; IMMUNIZATION; BURDEN;
   DENGUE
AB Importance: Mosquitoes are the most common disease vectors worldwide. A combination of factors, including changes in public health policy, climate change, and global travel, has led to the resurgence and spread of these diseases in our modern world. Pregnant women are vulnerable to a number of these illnesses, and obstetricians are likely to encounter pregnant travelers who have been exposed.
   Objective: This review was conducted to summarize knowledge of mosquito-borne diseases and their relevance in pregnancy. This will allow obstetricians to provide proper advice regarding travel and prepare providers to recognize manifestations of these illnesses in the pregnant woman.
   Evidence Acquisition: A review of the current literature was performed to summarize the various manifestations of mosquito-borne illnesses in pregnant women and discuss obstetric outcomes and management of disease in pregnancy.
   Results: Mosquito-borne illnesses usually manifest after a period of incubation lasting from days to weeks. Symptoms usually include a febrile illness but may be nonspecific and may masquerade as pregnancy-specific illnesses such as preeclampsia or HELLP (hemolysis, elevated liver enzyme levels, and low platelet levels); a large number of patients remain asymptomatic. Pregnancy-related outcomes include spontaneous abortion, intrauterine fetal demise, intrauterine transmission to the fetus, and congenital anomalies. Management during pregnancy is mainly supportive. Precautions against disease include protective clothing and insect repellents. Vaccines are either available or in development.
   Conclusions and Relevance: Mosquito-borne disease should be considered in pregnant women who present with a febrile illness and a relevant exposure history. Prompt recognition can allow supportive treatment to the mother and fetal resuscitation and surveillance.
   Target Audience: Obstetricians and gynecologists, family physicians.
   Learning Objectives: After completing this activity, the learner should be better able to describe the presentation, symptoms, and diagnosis of mosquito-borne diseases including malaria, chikungunya, dengue, yellow fever, West Nile virus, Zika, and filariasis; describe the risks of mosquito-borne diseases to the pregnant woman and her fetus; and outline the management considerations for pregnant women with specific mosquito-borne infections.
C1 [Diouf, Khady; Nour, Nawal M.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Global Hlth, 75 Francis St, Boston, MA 02115 USA.
   [Diouf, Khady; Nour, Nawal M.] Harvard Med Sch, Obstet Gynecol & Reprod Hlth Sci, Boston, MA USA.
RP Diouf, K (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, ASB 3rd Floor,75 Francis St, Boston, MA 02115 USA.
EM kdiouf@partners.org
RI amsalu, ribka/G-8780-2019
CR Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bodkin B L, 2012, Pregnancy Hypertens, V2, P189, DOI 10.1016/j.preghy.2012.04.026
   Boucau S., 2014, EUROSURVEILLANCE, V19, P1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Diagne N, 2000, NEW ENGL J MED, V343, P598, DOI 10.1056/NEJM200008313430901
   Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EBERHARD ML, 1993, J PARASITOL, V79, P62, DOI 10.2307/3283278
   Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1
   FONTICIELLA M, 1995, PEDIATR RADIOL, V25, P171, DOI 10.1007/BF02021524
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kakuru A, 2016, NEW ENGL J MED, V374, P928, DOI 10.1056/NEJMoa1509150
   Malhotra I, 2003, INFECT IMMUN, V71, P5231, DOI 10.1128/IAI.71.9.5231-5237.2003
   MATHUR A, 1985, INDIAN J MED RES, V81, P9
   Mayor A, 2015, NEW ENGL J MED, V373, P1607, DOI 10.1056/NEJMoa1406459
   McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NASIDI A, 1993, T ROY SOC TROP MED H, V87, P337, DOI 10.1016/0035-9203(93)90156-K
   Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pekyi D, 2016, NEW ENGL J MED, V374, P913, DOI 10.1056/NEJMoa1508606
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1
   SICE A., 1940, Bulletin de la Societe de Pathologie Exotique, V33, P66
   Sicuri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013407
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28
   Suzano CES, 2006, VACCINE, V24, P1421, DOI 10.1016/j.vaccine.2005.09.033
   Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425
   Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41
   Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419
   Bich TD, 2015, LANCET, V385, P1260, DOI 10.1016/S0140-6736(15)60239-2
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WHO, GLOB BRIEF VECT BORN
   WHO, 2015, GUID TREATM MAL
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 59
TC 2
Z9 2
U1 2
U2 24
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD MAY
PY 2017
VL 72
IS 5
BP 309
EP 318
DI 10.1097/OGX.0000000000000433
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EV7FR
UT WOS:000401941500020
PM 28558118
DA 2020-07-08
ER

PT J
AU Beigi, RH
AF Beigi, Richard H.
TI Emerging Infectious Diseases in Pregnancy
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID CARE PROVIDERS NEED; 2009 H1N1 INFLUENZA; PANDEMIC INFLUENZA; ZIKA
   VIRUS; WOMEN; OUTCOMES; IMMUNIZATION; OUTBREAKS
AB It has been recognized for centuries that pregnant women have unique susceptibilities to many infectious diseases that predispose them to untoward outcomes compared with the general adult population. It is thought a combination of adaptive alterations in immunity to allow for the fetal allograft combined with changes in anatomy and physiology accompanying pregnancy underlie these susceptibilities. Emerging infectious diseases are defined as those whose incidence in humans has increased in the past two decades or threaten to increase in the near future. The past decade alone has witnessed many such outbreaks, each with its own unique implications for pregnant women and their unborn fetuses as well as lessons for the health care community regarding response and mitigation. Examples of such outbreaks include, but are not limited to, severe acute respiratory syndrome, the 2009 H1N1 pandemic influenza, Ebola virus, and, most recently, the Zika virus. Although each emerging pathogen has unique features requiring specific considerations, there are many underlying principles that are shared in the recognition, communication, and mitigation of such infectious outbreaks. Some of these key principles include disease-specific delineation of transmission dynamics, understanding of pathogen-specific effects on both mothers and fetuses, and advance planning and contemporaneous management that prioritize communication among public health experts, clinicians, and patients. The productive and effective working collaboration among the Centers for Disease Control and Prevention, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine has been a key partnership in the successful communication and management of such outbreaks for women's health care providers and patients alike. Going forward, the knowledge gained over the past decade will undoubtedly continue to inform future responses and will serve to optimize the education and care given to pregnant women in the face of current and future emerging infectious disease outbreaks.
C1 [Beigi, Richard H.] UPMC, Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, 300 Halket St, Pittsburgh, PA 15213 USA.
RP Beigi, RH (corresponding author), UPMC, Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, 300 Halket St, Pittsburgh, PA 15213 USA.
EM rbeigi@mail.magee.edu
RI amsalu, ribka/G-8780-2019
CR American College of Obstetricians and Gynecologists, ACOG ZIK VIR RES SUM
   [Anonymous], 2013, OBSTET GYNECOL, V121, P1138
   Beigi RH, 2007, OBSTET GYNECOL, V109, P1193, DOI 10.1097/01.AOG.0000262051.71925.ac
   Beigi RH, 2014, OBSTET GYN CLIN N AM, V41, P535, DOI 10.1016/j.ogc.2014.08.002
   Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708
   Beigi RH, 2012, CLIN OBSTET GYNECOL, V55, P914, DOI 10.1097/GRF.0b013e31827146bd
   Beigi RH, 2010, CRIT CARE, V14, DOI 10.1186/cc8928
   Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
   Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996
   Caluwaerts S, 2016, CLIN INFECT DIS, V62, P903, DOI 10.1093/cid/civ1024
   Centers for Disease Control and Prevention, 2014 2016 EB OUTBR W
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, EMERGING INFECT DIS
   Centers for Disease Control and Prevention, VACC 2009 H1N1 INFL
   Centers for Disease Control and Prevention, US ZIK PREGN REG
   Centers for Disease Control and Prevention, ZIK ACT PREG SURV SY
   Centers for Disease Control and Prevention, PREGN LAB DEL EB VIR
   Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Gellin BG, 2016, VACCINE, V34, P5391, DOI 10.1016/j.vaccine.2016.09.023
   Gerdts C, 2016, OBSTET GYNECOL, V128, P405, DOI 10.1097/AOG.0000000000001540
   Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66
   Gordon CL, 2010, CLIN INFECT DIS, V50, P672, DOI 10.1086/650462
   Hayden EC, MAT HLTH EBOLAS LAST
   Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460
   *I MED, 1992, EM INF MICR THREATS
   Institute of Medicine, 2003, MICROBIAL THREATS HL
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Jamieson DJ, 2006, AM J OBSTET GYNECOL, V194, P1546, DOI 10.1016/j.ajog.2005.06.062
   Jamieson DJ, 2014, OBSTET GYNECOL, V124, P1005, DOI 10.1097/AOG.0000000000000533
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Jamieson DJ, 2004, OBSTET GYNECOL, V103, P754, DOI 10.1097/01.AOG.0000114987.76424.6d
   Jefferson T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001265
   Kinlaw K, 2009, DISASTER MED PUBLIC, V3, pS185, DOI 10.1097/DMP.0b013e3181ac194f
   Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P18, DOI 10.1001/jama.2013.7130
   Lam CM, 2004, BJOG-INT J OBSTET GY, V111, P771, DOI 10.1111/j.1471-0528.2004.00199.x
   Lederman MM, 1984, CHEST, V86, P6, DOI DOI 10.1378/chest.86.3_Supplement.6S
   Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mitka M, 2006, JAMA-J AM MED ASSOC, V295, P2707, DOI 10.1001/jama.295.23.2707
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289
   Naresh A, 2013, J PERINATOL, V33, P939, DOI 10.1038/jp.2013.110
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Owolabi Titus, 2004, J Obstet Gynaecol Can, V26, P35
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852
   Sifferlin A, CDC SAYS ZIKA DEFINI
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   White DB, 2009, ANN INTERN MED, V150, P132, DOI 10.7326/0003-4819-150-2-200901200-00011
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
NR 54
TC 5
Z9 6
U1 6
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
IS 5
BP 896
EP 906
DI 10.1097/AOG.0000000000001978
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EV9NQ
UT WOS:000402113100020
PM 28383378
DA 2020-07-08
ER

PT J
AU Wen, ZX
   Song, HJ
   Ming, GL
AF Wen, Zhexing
   Song, Hongjun
   Ming, Guo-li
TI How does Zika virus cause microcephaly?
SO GENES & DEVELOPMENT
LA English
DT Review
DE brain development; microcephaly; Zika virus
ID NEURAL STEM-CELLS; HUMAN PLACENTAL TROPHOBLASTS; GENOMIC
   CHARACTERIZATION; SEXUAL TRANSMISSION; CEREBRAL ORGANOIDS; GLIAL-CELLS;
   HUMAN BRAIN; INFECTION; PROGENITORS; ACTIVATION
AB The re-emergence of Zika virus (ZIKV), a mosquito-borne and sexually transmitted flavivirus circulating in >70 countries and territories, poses a significant global threat to public health due to its ability to cause severe developmental defects in the human brain, such as microcephaly. Since the World Health Organization declared the ZIKV outbreak a Public Health Emergency of International Concern, remarkable progress has been made to gain insight into cellular targets, pathogenesis, and underlying biological mechanisms of ZIKV infection. Here we review the current knowledge and progress in understanding the impact of ZIKV exposure on the mammalian brain development and discuss potential underlying mechanisms.
C1 [Wen, Zhexing] Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Dept Neurol, Sch Med, Atlanta, GA 30322 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
RP Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Dept Neurosci, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
EM gming@mail.med.upenn.edu
RI Wen, Zhexing/L-1228-2018
OI Wen, Zhexing/0000-0002-1518-3845; Ming, Guo-li/0000-0002-2517-6075
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01MH105128,
   R21MH110160, R35NS097370, U19AI131130, R37NS047344, U19MH106434,
   P01NS097206, R21HD086820]; Maryland Stem Cell Research Fund; Foundation
   for Prader-Willi Research; Emory University
FX We apologize for not citing many original papers due to space
   limitations. We thank Kimberly M. Christian for comments. Research in
   the authors' laboratories was supported by grants from the National
   Institutes of Health (R01MH105128, R21MH110160, R35NS097370, and
   U19AI131130 to G.-L.M., and R37NS047344, U19MH106434, P01NS097206, and
   R21HD086820 to H.S.), the Maryland Stem Cell Research Fund (G.-L.M. and
   H.S.), and the Foundation for Prader-Willi Research (G.-L.M.) and
   start-up funds from Emory University (Z.W.).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3339/fnhum.2016.00566
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 86
TC 35
Z9 36
U1 0
U2 17
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD MAY 1
PY 2017
VL 31
IS 9
BP 849
EP 861
DI 10.1101/gad.298216.117
PG 13
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA EW3QR
UT WOS:000402416700002
PM 28566536
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Chan, JFW
   Yip, CCY
   Tee, KM
   Zhu, Z
   Tsang, JOL
   Chik, KKH
   Tsang, TGW
   Chan, CCS
   Poon, VKM
   Sridhar, S
   Yin, FF
   Hung, IFN
   Chau, SKY
   Zhang, AJ
   Chan, KH
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Yip, Cyril Chik-Yan
   Tee, Kah-Meng
   Zhu, Zheng
   Tsang, Jessica Oi-Ling
   Chik, Kenn Ka-Heng
   Tsang, Terance Gi-Wai
   Chan, Chris Chung-Sing
   Poon, Vincent Kwok-Man
   Sridhar, Siddharth
   Yin, Feifei
   Hung, Ivan Fan-Ngai
   Chau, Sandy Ka-Yee
   Zhang, Anna Jinxia
   Chan, Kwok-Hung
   Yuen, Kwok-Yung
TI Improved detection of Zika virus RNA in human and animal specimens by a
   novel, highly sensitive and specific real-time RT-PCR assay targeting
   the 5'-untranslated region of Zika virus
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Zika; virus; flavivirus; polymerase chain reaction; untranslated;
   diagnostics
ID REVERSE TRANSCRIPTION-PCR; MOLECULAR-DETECTION; SINGLE-REACTION; DENGUE;
   TRANSMISSION; CHIKUNGUNYA; DISEASE; MODEL; EMERGENCE; INFECTION
AB OBJECTIVE and method We developed and evaluated five novel real-time RT-PCR assays targeting conserved regions in the 5'-untranslated region (5'-UTR), envelope (E'), non-structural protein 2A (NS2A), NS5 and 3'-UTR of the ZIKV genome.
   RESULTS The ZIKV-5'-UTR assay exhibited the lowest in vitro limit of detection (5-10 RNA copies/reaction and 3.0 x 10(-1) plaque-forming units/ml). Compared to the modified version of a widely adopted RT-PCR assay targeting the ZIKV-E gene, the ZIKV-5'-UTR assay showed better sensitivity in human clinical specimens, and representative mouse specimens, including many organs which are known to be involved in human ZIKV infection but difficult to obtain in clinical settings. The ZIKV-5'-UTR assay detected ZIKV RNA in 84/84 (100.0%) ZIKV-E'-positive and an additional 30/296 (10.1%, P < 0.01) ZIKV-E'-negative mouse specimens. The higher sensitivity of the ZIKV-5'-UTR assay was most significant in kidney and testis/epididymis specimens (P < 0.01). No in vitro or in vivo cross-reactivity was found between the ZIKV-5'-UTR assay and dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus, hepatitis C virus and Chikungunya virus.
   CONCLUSIONS The highly sensitive and specific ZIKV-5'-UTR assay may help to improve the laboratory diagnosis of ZIKV infection.
C1 [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yip, Cyril Chik-Yan; Tee, Kah-Meng; Zhu, Zheng; Tsang, Jessica Oi-Ling; Chik, Kenn Ka-Heng; Tsang, Terance Gi-Wai; Chan, Chris Chung-Sing; Poon, Vincent Kwok-Man; Sridhar, Siddharth; Zhang, Anna Jinxia; Chan, Kwok-Hung; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Hung, Ivan Fan-Ngai; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Key Lab Trop Dis & Translat Med, Haikou, Peoples R China.
   [Hung, Ivan Fan-Ngai] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.
   [Chau, Sandy Ka-Yee] United Christian Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, State Key Lab Emerging Infect Dis,Carol Yu Ctr In, 102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
RI Chan, Jasper F. W./D-8007-2013; Sridhar, Siddharth/J-4061-2019; ZHU,
   ZHENG/P-2173-2016
OI Chan, Jasper F. W./0000-0001-6336-6657; Sridhar,
   Siddharth/0000-0002-2022-8307; ZHU, ZHENG/0000-0002-2035-0804; Hung,
   Ivan Fan Ngai/0000-0002-1556-2538; Yuen, Kwok-yung/0000-0002-2083-1552
FU Department of HealthDiabetes UK; Hong Kong Special Administrative
   Region; Food and Health Bureau; Government of the Hong Kong Special
   Administrative Region (ZIKA-HKU); Hong Kong University Foundation;
   Collaborative Innovation Center; Ministry of Education of ChinaMinistry
   of Education, China; European Union's Horizon research and innovation
   programme [653316]
FX We thank Ting-Hung Leung (Centre for Health Protection, Department of
   Health, The Government of the Hong Kong Special Administrative Region)
   and Janice Yee-Chi Lo (Public Health Laboratory Centre, Department of
   Health, Hong Kong Special Administrative Region) for provision of
   clinical specimens and facilitation of the study. This work was partly
   supported by the donations of Larry Chi-Kin Yung, and Hui Hoy and Chow
   Sin Lan Charity Fund Limited; and funding from the Consultancy Service
   for Enhancing Laboratory Surveillance of Emerging Infectious Diseases of
   the Department of Health, Hong Kong Special Administrative Region; the
   Food and Health Bureau, The Government of the Hong Kong Special
   Administrative Region (ZIKA-HKU); Hong Kong University Foundation; and
   the Collaborative Innovation Center for Diagnosis and Treatment of
   Infectious Diseases, the Ministry of Education of China; and the
   European Virus Archive goes Global (EVAg) project that has received
   funding from the European Union's Horizon 2020 research and innovation
   programme under grant agreement No 653316. The sponsors had no role in
   the design and conduct of the study, in the collection, analysis and
   interpretation of data or in the preparation, review or approval of the
   manuscript. Preliminary findings related to this work were presented as
   poster presentation at the 3<SUP>rd</SUP> Annual Microbiology &
   Infectious Diseases Asia Congress (Singapore).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chan JFW, 2015, J CLIN MICROBIOL, V53, P2722, DOI 10.1128/JCM.01224-15
   Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eiden M, 2010, J VET DIAGN INVEST, V22, P748, DOI 10.1177/104063871002200515
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Ritchie SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105846
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007
   To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Yip CCY, 2013, EMERG INFECT DIS, V19, P1285, DOI 10.3201/eid1908.121498
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 51
TC 24
Z9 24
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD MAY
PY 2017
VL 22
IS 5
BP 594
EP 603
DI 10.1111/tmi.12857
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EW0JW
UT WOS:000402177400010
PM 28214373
OA Bronze
DA 2020-07-08
ER

PT J
AU Fischer, S
AF Fischer, Shannon
TI Minibrain Storm Cerebral organoids aren't real brains-but they provide a
   powerful platform for modeling brain diseases like Zika infection,
   Alzheimer's, and even autism
SO IEEE PULSE
LA English
DT Article
CR Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
NR 6
TC 1
Z9 1
U1 1
U2 8
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2154-2287
J9 IEEE PULSE
JI IEEE Pulse
PD MAY-JUN
PY 2017
VL 8
IS 3
BP 31
EP 34
DI 10.1109/MPUL.2017.2680360
PG 4
WC Engineering, Biomedical
SC Engineering
GA EV7QY
UT WOS:000401976100006
PM 28534760
DA 2020-07-08
ER

PT J
AU Kumar, N
   Abdullah, M
   Faizan, MI
   Ahmed, A
   Alsenaidy, HA
   Dohare, R
   Parveen, S
AF Kumar, Narender
   Abdullah, Mohd
   Faizan, Md Imam
   Ahmed, Anwar
   Alsenaidy, Hytham A.
   Dohare, Ravins
   Parveen, Shama
TI Progression dynamics of Zika fever outbreak in El Salvador during
   2015-2016: a mathematical modeling approach
SO FUTURE VIROLOGY
LA English
DT Article
DE disease progression; El Salvador; outbreak; SEIR mathematical model;
   Zika virus
ID VIRUS OUTBREAK; TRANSMISSION; DISEASE
AB Aim: The aim of the study was to utilize mathematical modeling to investigate effect of different parameters that affected mosquito-borne transmission of Zika virus during 2015-2016 outbreak in El Salvador. The model can be used to predict outbreaks at various geographical regions utilizing different conditions. Materials & methods: A susceptibleexposed- infectious-recovered mathematical model was generated for disease progression. Results: The model correlated with actual number of reported cases and stability analysis. The value of reproduction number (R-o = 4.5537) indicated rapid spread of viral infection suggestive of an outbreak. Simulations revealed that transitional parameters affected disease progression. Conclusion: Investigation of progression of infection in a given population using mathematical models may assist in prediction of outbreaks and in formulation of control measures.
C1 [Kumar, Narender] Univ Delhi, Dept Math, Gargi Coll, New Delhi, India.
   [Kumar, Narender; Abdullah, Mohd; Faizan, Md Imam; Dohare, Ravins; Parveen, Shama] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India.
   [Abdullah, Mohd] Jaipur Natl Univ, Sch Life Sci, Jaipur, Rajasthan, India.
   [Ahmed, Anwar] King Saud Univ, Dept Biochem, Prot Res Chair, Riyadh, Saudi Arabia.
   [Alsenaidy, Hytham A.] Shaqra Univ, Coll Med, Shaqra, Saudi Arabia.
RP Dohare, R; Parveen, S (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India.
EM ravinsdohare@gmail.com; shamp25@yahoo.com
RI Dohare, Ravins/AAN-6883-2020
FU University Grants CommissionUniversity Grants Commission, India; Council
   of Scientific and Industrial Research (CSIR)Council of Scientific &
   Industrial Research (CSIR) - India; King Saud UniversityDeanship of
   Scientific Research at King Saud University
FX Md Imam Faizan is supported by Research Fellowship of the University
   Grants Commission. Grants in our laboratory are funded by Council of
   Scientific and Industrial Research (CSIR) and University Grants
   Commission. The study was supported by King Saud University, Vice Dean
   of Research Chairs. The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subject matter or materials
   discussed in the manuscript apart from those disclosed.
CR Al- Sheikh SA, 2013, GLOBAL J SCI FRONT R, V12, P2249
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   류수락, 2015, [Journal of the Korean Data And Information Science Sociaty, 한국데이터정보과학회지], V26, P301, DOI 10.7465/jkdi.2015.26.2.301
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   Derouich M, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NEDELMAN J, 1985, MATH BIOSCI, V73, P159, DOI 10.1016/0025-5564(85)90010-0
   PAHO, 2017, ZIK CAS CONG SYNDR A
   PAHO (WHO), REG ZIK EP UPD AM
   PAHO/WHO, 2016, ZIK EP UPD
   Shah NH, 2013, APPL MATH, V4, P13
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   WHO, 2017, ZIK VIR MICR GULL BA
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 0
Z9 0
U1 0
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD MAY
PY 2017
VL 12
IS 5
BP 271
EP 281
DI 10.2217/fvl-2017-0119
PG 11
WC Virology
SC Virology
GA EV3FJ
UT WOS:000401643100005
DA 2020-07-08
ER

PT J
AU Leyser, M
   Nascimento, OJM
AF Leyser, Marcio
   Nascimento, Osvaldo J. M.
TI Congenital Zika Virus Infection: Beyond Neonatal Microcephaly
SO JAMA NEUROLOGY
LA English
DT Letter
C1 [Leyser, Marcio; Nascimento, Osvaldo J. M.] Fed Fluminense Univ, Antonio Pedro Univ Hosp, Niteroi, RJ, Brazil.
RP Nascimento, OJM (corresponding author), Fed Fluminense Univ, Antonio Pedro Univ Hosp, NeuroUPC Clin Res Unit Neurol & Neurosci, Niteroi, RJ, Brazil.
EM osvaldo_nascimento@hotmail.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
NR 4
TC 3
Z9 3
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD MAY
PY 2017
VL 74
IS 5
BP 610
EP 610
DI 10.1001/jamaneurol.2017.0048
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA EU2EE
UT WOS:000400838900027
PM 28319237
DA 2020-07-08
ER

PT J
AU Bordelon, H
   Ricks, KM
   Pask, ME
   Russ, PK
   Solinas, F
   Baglia, ML
   Short, PA
   Nel, A
   Blackburn, J
   Dheda, K
   Zamudio, C
   Caceres, T
   Wright, DW
   Haselton, FR
   Pettit, AC
AF Bordelon, Hali
   Ricks, Keersten M.
   Pask, Megan E.
   Russ, Patricia K.
   Solinas, Francesca
   Baglia, Mark L.
   Short, Philip A.
   Nel, Andrew
   Blackburn, Jonathan
   Dheda, Keertan
   Zamudio, Carlos
   Caceres, Tatiana
   Wright, David W.
   Haselton, Frederick R.
   Pettit, April C.
TI Design and use of mouse control DNA for DNA biomarker extraction and PCR
   detection from urine: Application for transrenal Mycobacterium
   tuberculosis DNA detection
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; HIV-INFECTED PATIENTS; PULMONARY
   TUBERCULOSIS; DIAGNOSIS; RESOURCE; SAMPLES; STABILITY; VIRUS;
   IDENTIFICATION; SPECIMENS
AB Urine samples are increasingly used for diagnosing infections including Escherichia coli, Ebola virus, and Zika virus. However, extraction and concentration of nucleic acid biomarkers from urine is necessary for many molecular detection strategies such as polymerase chain reaction (PCR). Since urine samples typically have large volumes with dilute biomarker concentrations making them prone to false negatives, another impediment for urine-based diagnostics is the establishment of appropriate controls particularly to rule out false negatives. In this study, a mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH) DNA target was added to retrospectively collected urine samples from tuberculosis (TB)-infected and TB-uninfected patients to indicate extraction of intact DNA and removal of PCR inhibitors from urine samples. We tested this design on surrogate urine samples, retrospective 1 milliliter (mL) urine samples from patients in Lima, Peru and retrospective 5 mL urine samples from patients in Cape Town, South Africa. Extraction/PCR control DNA was detectable in 97% of clinical samples with no statistically significant differences among groups. Despite the inclusion of this control, there was no difference in the amount of TB IS6110 Tr-DNA detected between TB-infected and TB-uninfected groups except for samples from known HIV-infected patients. We found an increase in TB IS6110 Tr-DNA between TB/HIV co-infected patients compared to TB-uninfected/HIV-infected patients (N = 18, p = 0.037). The inclusion of an extraction/PCR control DNA to indicate successful DNA extraction and removal of PCR inhibitors should be easily adaptable as a sample preparation control for other acellular sample types. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Bordelon, Hali; Pask, Megan E.; Russ, Patricia K.; Solinas, Francesca; Baglia, Mark L.; Short, Philip A.; Haselton, Frederick R.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
   [Ricks, Keersten M.; Wright, David W.; Haselton, Frederick R.] Vanderbilt Univ, Dept Chem, Nashville, TN USA.
   [Nel, Andrew; Blackburn, Jonathan] Univ Cape Town, Dept Integrat Biomed Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa.
   [Dheda, Keertan] Univ Cape Town, Lung Infect & Immun Unit, Cape Town, South Africa.
   [Zamudio, Carlos; Caceres, Tatiana] Univ Peruana Cayetano Heredia, Med Trop Alexander von Humboldt, Lima, Peru.
   [Pettit, April C.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.
   [Blackburn, Jonathan; Wright, David W.; Haselton, Frederick R.; Pettit, April C.] Vanderbilt Univ, Sch Med, Div Infect Dis, TB Ctr,Dept Med, Nashville, TN 37212 USA.
   [Blackburn, Jonathan; Wright, David W.; Haselton, Frederick R.; Pettit, April C.] Vanderbilt Univ, Sch Med, Inst Global Hlth, Nashville, TN 37212 USA.
RP Pettit, AC (corresponding author), 1161 21st Ave North A-2200 MCN, Nashville, TN 37232 USA.
EM april.pettit@vanderbilt.edu
OI Zamudio, Carlos/0000-0001-7479-127X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K08AI104352];
   National Research Foundation, Republic of South AfricaNational Research
   Foundation - South Africa [64760]; Bill & Melinda Gates Foundation,
   Seattle, WAGates Foundation [OPP 1028749]; European and Developing
   Countries Clinical Trial Partnership
FX This study was supported in part by the National Institutes of Health
   [K08AI104352, A.C.P.], the National Research Foundation, Republic of
   South Africa [64760, J.B.], Bill & Melinda Gates Foundation, Seattle, WA
   [OPP 1028749, F.R.H & D.W.W], and urine sample collection by a grant
   from the European and Developing Countries Clinical Trial Partnership
   [TB-NEAT, K.D.].
CR Aceti A, 1999, THORAX, V54, P145, DOI 10.1136/thx.54.2.145
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Ardizzoni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144656
   Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209
   Bitting AL, 2016, JALA-J LAB AUTOM, V21, P732, DOI 10.1177/2211068215596139
   Bjerrum S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1151-1
   Bordelon H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068369
   Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009
   Cannas A, 2008, INT J TUBERC LUNG D, V12, P146
   Cannas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006985
   Davids M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141453
   Deng JR, 2015, J VIROL METHODS, V213, P98, DOI 10.1016/j.jviromet.2014.12.006
   Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8
   Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848
   Englen MD, 2000, LETT APPL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2672.2000.00841.x
   Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5
   Hanifa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156866
   Ingersoll J, 2008, J CLIN MICROBIOL, V46, P1628, DOI 10.1128/JCM.02486-07
   Iwasaki H, 2016, DIAGN MICR INFEC DIS, V84, P287, DOI 10.1016/j.diagmicrobio.2016.01.001
   Janvier F, 2016, EMERG INFECT DIS, V22, P292, DOI 10.3201/eid2202.151395
   LaCourse SM, 2016, JAIDS-J ACQ IMM DEF, V71, P219, DOI 10.1097/QAI.0000000000000826
   Lawn SD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0432-2
   LOMBARDERO M, 1990, J IMMUNOL, V144, P1353
   Milde A, 1999, INT J LEGAL MED, V112, P209, DOI 10.1007/s004140050237
   Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656
   Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a
   Peter JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039966
   Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2
   Petrucci R, 2015, J CLIN MICROBIOL, V53, P336, DOI 10.1128/JCM.02548-14
   Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X
   Sarhan Rania M, 2015, J Parasit Dis, V39, P499, DOI 10.1007/s12639-013-0385-3
   Sechi LA, 1997, MOL CELL PROBE, V11, P281, DOI 10.1006/mcpr.1997.0119
   Southern TR, 2015, J CLIN MICROBIOL, V53, P2956, DOI 10.1128/JCM.01317-15
   Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005
   van der Zee A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150755
   WHO, 2015, TUB PEOPL LIV HIV
   World Health Organization, 2013, XPERT MTB RIF ASS DI
NR 39
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD MAY
PY 2017
VL 136
BP 65
EP 70
DI 10.1016/j.mimet.2017.02.010
PG 6
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA EU5BX
UT WOS:000401047700011
PM 28285168
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Lin, KH
   Ali, A
   Rusere, L
   Soumana, DI
   Yilmaz, NK
   Schiffer, CA
AF Lin, Kuan-Hung
   Ali, Akbar
   Rusere, Linah
   Soumana, Djade I.
   Yilmaz, Nese Kurt
   Schiffer, Celia A.
TI Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE dengue fever; Zika; antimicrobial peptides; antiviral agents; drug
   design; protease inhibitors; receptor-ligand interaction; structural
   biology; substrate
ID NS3 PROTEASE; PEPTIDE INHIBITORS; NS2B-NS3 PROTEASE; HIV-1 PROTEASE;
   TETRAPEPTIDE; DYNAMICS; COFACTOR; HYBRIDS; TYPE-2
AB The mosquito-transmitted dengue virus (DENV) infects millions of people in tropical and subtropical regions. Maturation of DENV particles requires proper cleavage of the viral polyprotein, including processing of 8 of the 13 substrate cleavage sites by dengue virus NS2B/NS3 protease. With no available direct-acting antiviral targeting DENV, NS2/NS3 protease is a promising target for inhibitor design. Current design efforts focus on the nonprime side of the DENV protease active site, resulting in highly hydrophilic and nonspecific scaffolds. However, the prime side also significantly modulates DENV protease binding affinity, as revealed by engineering the binding loop of aprotinin, a small protein with high affinity for DENV protease. In this study, we designed a series of cyclic peptides interacting with both sides of the active site as inhibitors of dengue virus protease. The design was based on two aprotinin loops and aimed to leverage both key specific interactions of substrate sequences and the entropic advantage driving aprotinin's high affinity. By optimizing the cyclization linker, length, and amino acid sequence, the tightest cyclic peptide achieved a K-i value of 2.9 mu M against DENV3 wild-type (WT) protease. These inhibitors provide proof of concept that both sides of DENV protease active site can be exploited to potentially achieve specificity and lower hydrophilicity in the design of inhibitors targeting DENV.
   IMPORTANCE Viruses of the flaviviral family, including DENV and Zika virus transmitted by Aedes aegypti, continue to be a threat to global health by causing major outbreaks in tropical and subtropical regions, with no available direct-acting antivirals for treatment. A better understanding of the molecular requirements for the design of potent and specific inhibitors against flaviviral proteins will contribute to the development of targeted therapies for infections by these viruses. The cyclic peptides reported here as DENV protease inhibitors provide novel scaffolds that enable exploiting the prime side of the protease active site, with the aim of achieving better specificity and lower hydrophilicity than those of current scaffolds in the design of antiflaviviral inhibitors.
C1 [Lin, Kuan-Hung; Ali, Akbar; Rusere, Linah; Soumana, Djade I.; Yilmaz, Nese Kurt; Schiffer, Celia A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.
   [Lin, Kuan-Hung] Genentech Inc, San Francisco, CA USA.
   [Soumana, Djade I.] GE Healthcare Life Sci, Marlborough, MA USA.
RP Schiffer, CA (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.
EM celia.schiffer@umassmed.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI085051]
FX This work was supported by NIH grant R01 AI085051.
CR Ang MJ, 2016, J ENZYME INHIB MED C
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Lin KH, 2016, ACS INFECT DIS
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Mueller NH, 2007, INT J BIOCHEM CELL B, V39, P606, DOI 10.1016/j.biocel.2006.10.025
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Nitsche C, 2011, BIOORGAN MED CHEM, V19, P7318, DOI 10.1016/j.bmc.2011.10.061
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Ozen A, 2014, P NATL ACAD SCI USA, V111, P15993, DOI 10.1073/pnas.1414063111
   Ozen A, 2011, J MOL BIOL, V410, P726, DOI 10.1016/j.jmb.2011.03.053
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Salykin A, 2013, STEM CELL REV REP, V9, P786, DOI 10.1007/s12015-013-9454-3
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b
   Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
NR 29
TC 11
Z9 12
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2017
VL 91
IS 10
AR UNSP e00045-17
DI 10.1128/JVI.00045-17
PG 10
WC Virology
SC Virology
GA EU7PS
UT WOS:000401227300002
PM 28298600
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hofmann, D
   Lai, JR
AF Hofmann, Daniel
   Lai, Jonathan R.
TI Exploring Human Antimicrobial Antibody Responses on a Single B Cell
   Level
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
DE antibody discovery; immune responses; immunotherapy; single B cell
   sorting
ID DENGUE VIRUS-INFECTION; HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING
   ANTIBODIES; ZIKA VIRUS; POTENT; VACCINATION; DIVERSITY; PLASMABLAST;
   REPERTOIRE; GENERATION
AB Analysis of monoclonal antibodies (MAbs) derived from single B cell cloning has been highly beneficial for antimicrobial immunotherapy, vaccine design, and advancing our understanding of pathogen-triggered effects on the human immunoglobulin repertoire. Sequencing of variable domains of single B cells, and characterization of binding and functional activities of MAbs derived from those sequences, provides in-depth insight not only into sites of susceptibility for antibody-mediated neutralization or opsonization of the pathogen but also into the dynamics of protective antibody evolution during infection. This information can be utilized to rapidly develop novel immunotherapies of completely human origin and provides a roadmap for structure-based vaccine design that aims to elicit similar protective antibody responses. Here, we summarize recent aspects of the single B cell cloning approach.
C1 [Hofmann, Daniel] Evotec AG, Manfred Eigen Campus, Hamburg, Germany.
   [Lai, Jonathan R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.
RP Hofmann, D (corresponding author), Evotec AG, Manfred Eigen Campus, Hamburg, Germany.; Lai, JR (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.
EM daniel.hofmann@evotec.com; jon.lai@einstein.yu.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI109762, R41AI122403]; Irma T.
   Hirschl Charitable Trust
FX J.R.L. gratefully acknowledges funding from the NIH (U19AI109762 and
   R41AI122403) and from the Irma T. Hirschl Charitable Trust.
CR [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788
   Chen TT, 2016, J INFECT DIS, V214, P300, DOI 10.1093/infdis/jiw141
   Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966
   De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113
   DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743
   Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060
   Fu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12780
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007
   Hoehn KB, 2016, MOL BIOL EVOL, V33, P1147, DOI 10.1093/molbev/msw015
   Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150
   Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195
   Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111
   Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224
   Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053
   MARKOWITZ LE, 1990, PEDIATR INFECT DIS J, V9, P101, DOI 10.1097/00006454-199002000-00008
   Murugan R, 2015, EUR J IMMUNOL, V45, P2698, DOI 10.1002/eji.201545526
   Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Qiu XG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9875
   Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4
NR 35
TC 2
Z9 2
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
EI 1556-679X
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD MAY
PY 2017
VL 24
IS 5
AR UNSP e00544
DI 10.1128/CVI.00544-16
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EU0WI
UT WOS:000400732300001
PM 28356257
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Pepin, D
   Penn, M
AF Pepin, Dawn
   Penn, Matthew
TI Legal Authority for Mosquito Control and Pesticide Use in the United
   States
SO PUBLIC HEALTH REPORTS
LA English
DT Article
DE law; Zika; mosquito control; pesticide
C1 [Pepin, Dawn] Chenega Profess & Tech Serv LLC, Atlanta, GA USA.
   [Pepin, Dawn; Penn, Matthew] Ctr Dis Control & Prevent, Publ Hlth Law Program, Off State Tribal Local & Terr Support, 4770 Buford Hwy NE,MS E-70, Atlanta, GA 30341 USA.
RP Pepin, D (corresponding author), Ctr Dis Control & Prevent, Publ Hlth Law Program, Off State Tribal Local & Terr Support, 4770 Buford Hwy NE,MS E-70, Atlanta, GA 30341 USA.
EM dpepin@cdc.gov
OI Pepin, Dawn/0000-0002-0128-2949
CR Centers for Disease Control and Prevention, LOC DENG TRANSM KEY
   Centers for Disease Control and Prevention, CHIK VIR 2015 FIN DA
   Centers for Disease Control and Prevention, 2016, CDC UPD GUID PREGN W
   Centers for Disease Control and Prevention, 2017, ZIK VIR CAS COUNTS U
   Geggel L, 2016, LIVE SCI
   Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4
   O'Regan SM, 2016, THEOR ECOL-NETH, V9, P269, DOI 10.1007/s12080-015-0285-5
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 8
TC 0
Z9 0
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD MAY-JUN
PY 2017
VL 132
IS 3
BP 389
EP 391
DI 10.1177/0033354917704628
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ET8AH
UT WOS:000400520100017
PM 28395143
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Chevalier, MS
   Biggerstaff, BJ
   Basavaraju, SV
   Ocfemia, MCB
   Alsina, JO
   Climent-Peris, C
   Moseley, RR
   Chung, KW
   Rivera-Garcia, B
   Bello-Pagan, M
   Pate, LL
   Galel, SA
   Williamson, P
   Kuehnert, MJ
AF Chevalier, Michelle S.
   Biggerstaff, Brad J.
   Basavaraju, Sridhar V.
   Ocfemia, M. Cheryl Banez
   Alsina, Jose O.
   Climent-Peris, Consuelo
   Moseley, Robin R.
   Chung, Koo-Whang
   Rivera-Garcia, Brenda
   Bello-Pagan, Melissa
   Pate, Lisa L.
   Galel, Susan A.
   Williamson, Phillip
   Kuehnert, Matthew J.
TI Use of Blood Donor Screening Data to Estimate Zika Virus Incidence,
   Puerto Rico, April-August 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION; INFECTION; VIREMIA
AB Puerto Rico has been heavily impacted by Zika virus, a mosquitoborne flavivirus that emerged in the Americas during 2015. Although most persons with Zika virus show no symptoms, the virus can cause neurologic and other complications, including fetal microcephaly. Local Zika virus transmission in Puerto Rico has been reported since December 2015. To prevent transfusion-associated transmission, local blood collection ceased in March 2016 but resumed in April 2016 after Zika virus screening of blood donations became available. Using data from screening of blood donations collected by the 2 largest blood centers in Puerto Rico during April 3 August 12, 2016, and assuming a 9.9-day duration of viremia, we estimated that 469,321 persons in Puerto Rico were infected during this period, for an estimated cumulative incidence of 12.9%. Results from blood donation screening during arboviral outbreaks can supplement routine clinical and surveillance data for improved targeting of prevention efforts.
C1 [Chevalier, Michelle S.; Basavaraju, Sridhar V.; Ocfemia, M. Cheryl Banez; Moseley, Robin R.; Chung, Koo-Whang; Kuehnert, Matthew J.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E04, Atlanta, GA 30329 USA.
   [Biggerstaff, Brad J.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Alsina, Jose O.] Banco Sangre Serv Mutuos, San Juan, PR USA.
   [Climent-Peris, Consuelo] Banco Sangre Ctr Med, Adm Serv Med, San Juan, PR USA.
   [Rivera-Garcia, Brenda; Bello-Pagan, Melissa] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Pate, Lisa L.; Galel, Susan A.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Williamson, Phillip] Creat Testing Solut, Tempe, AZ USA.
RP Chevalier, MS (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E04, Atlanta, GA 30329 USA.
EM mchevalier@cdc.gov
FU Biomedical Advanced Research and Development Authority
FX We thank Sandra I. Santiago Montalvo, Edwin Velez, Jorge Pi, Ada M.
   Justiniano Soto, and Francisco Alvarado-Ramy for their support with data
   collection and preparation; Kalanthe Horiuchi for assistance with the
   population data; and the Biomedical Advanced Research and Development
   Authority for funding the blood donor screening at BSIS and ASEM.
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122
   Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, ZIKA VIRUS CASE COUN
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Food and Drug Administration, REC DON SCREEN DEF P
   Food and Drug Administration, REVISED RECOMMENDATI
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Puerto Rico Department of Health, ZIK REP MUN
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   U.S. Census Bureau, AM FACT FIND
   uerto Rico Department of Health, INF ZIK MUN
   Vasquez AM, 2016, AM J TRANSPLANT, V16, P2487, DOI 10.1111/ajt.13941
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 18
Z9 18
U1 0
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2017
VL 23
IS 5
BP 790
EP 795
DI 10.3201/eid2305.161873
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ET1PU
UT WOS:000400042100008
PM 28263141
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ciota, AT
   Bialosuknia, SM
   Ehrbar, DJ
   Kramer, LD
AF Ciota, Alexander T.
   Bialosuknia, Sean M.
   Ehrbar, Dylan J.
   Kramer, Laura D.
TI Vertical Transmission of Zika Virus by Aedes aegypti and Ae. albopictus
   Mosquitoes
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID WEST NILE VIRUS
AB To determine the potential role of vertical transmission in Zika virus expansion, we evaluated larval pools of perorally infected Aedes aegypti and Ae. albopictus adult female mosquitoes; approximate to 1/84 larvae tested were Zika virus positive; and rates varied among mosquito populations. Thus, vertical transmission may play a role in Zika virus spread and maintenance.
C1 [Ciota, Alexander T.; Bialosuknia, Sean M.; Ehrbar, Dylan J.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Slingerlands, NY USA.
   [Ciota, Alexander T.; Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
RP Ciota, AT (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Arbovirus Lab, 5668 State Farm Rd, Slingerlands, NY 12159 USA.
EM alexander.ciota@health.ny.gov
RI ; Ciota, Alexander/E-1634-2017
OI Ehrbar, Dylan/0000-0001-7872-3338; Ciota, Alexander/0000-0001-6589-4728
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [C06-RR-17715]
FX The construction of the Wadsworth Center Arbovirus Laboratory insectary
   facilities was partially funded-by the National Institutes of Health
   (NIH) grant C06-RR-17715.
CR Ciota AT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-71
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   NAYAR JK, 1986, AM J TROP MED HYG, V35, P1296, DOI 10.4269/ajtmh.1986.35.1296
   Nelms BM, 2013, J MED ENTOMOL, V50, P371, DOI 10.1603/ME12264
   Rabaan AA, 2016, J INFECT PUBLIC HEAL
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 10
TC 35
Z9 36
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2017
VL 23
IS 5
BP 880
EP 882
DI 10.3201/eid2305.162041
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ET1PU
UT WOS:000400042100036
PM 28277199
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus and pregnancy
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Citil-Dogan A, 2016, J MATERN-FETAL NEO M, P1
   Gomez-Romero FJ, 2016, REV ESP QUIM, V29, P76
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2015, ANN TROP MED PUBLIC, V8, P311, DOI 10.4103/1755-6783.162666
NR 5
TC 0
Z9 0
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD MAY
PY 2017
VL 30
IS 9
BP 1005
EP 1005
DI 10.1080/14767058.2016.1197901
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ET3GN
UT WOS:000400165900001
PM 27265775
DA 2020-07-08
ER

PT J
AU Byron, K
   Howard, D
AF Byron, Katie
   Howard, Dana
TI 'Hey everybody, don't get pregnant': Zika, WHO and an ethical framework
   for advising
SO JOURNAL OF MEDICAL ETHICS
LA English
DT Article
ID UNITED-STATES; VIRUS
AB WHO recently issued new guidance on the prevention of sexual transmission of Zika virus. The updated guidance states that '[c]ountry health programmes should ensure that... [i]n order to prevent adverse pregnancy and fetal outcomes, men and women of reproductive age, living in areas where local transmission of Zika virus is known to occur, be correctly informed and oriented to consider delaying pregnancy'. While the media has reported this advice as WHO telling couples in Zika-affected regions to avoid pregnancy, WHO states that they are not doing that. In an interview with the New York Times, a spokesperson from WHO stated, 'it's important to understand that this is not WHO saying, "Hey everybody, don't get pregnant." It's that they should be advised about this, so they themselves can make the final decision'. In this statement, the WHO's spokesperson distinguishes between actively directing individuals to delay pregnancy and advising them, which is portrayed as a merely informative act that facilitates but does not direct an individual's final decision. This paper proposes that advising should not be understood as a purely informational and non-directive act. The choices that agencies make in what advice to offer and to whom to offer the advice are ethical choices with practical implications. We will thus lay out a framework for considering the ethical issues that arise in the context of advising and demonstrate how it can be used to evaluate the WHO guidance.
C1 [Byron, Katie; Howard, Dana] NIH, Dept Bioeth, Ctr Clin, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.
RP Byron, K (corresponding author), NIH, Dept Bioeth, Ctr Clin, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.
EM Katie.byron@nih.gov
OI Byron, Katie/0000-0002-1382-9120
CR Austin J. L., 1962, DO THINGS WORDS
   Darwall S., 2006, 2 PERSON STANDPOINT
   McNeil D, 2016, NEW YORK TIMES  0610
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   SHIRKEY H, 1968, J PEDIATR-US, V72, P119, DOI 10.1016/S0022-3476(68)80414-7
   Shoemaker D, 2011, ETHICS, V121, P602, DOI 10.1086/659003
   The LGH, 2016, LANCET GLOB HLTH, V4, pe427
   WHO, 2016, PREV SEX TRANSM ZIK
NR 9
TC 6
Z9 6
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-6800
EI 1473-4257
J9 J MED ETHICS
JI J. Med. Ethics
PD MAY
PY 2017
VL 43
IS 5
BP 334
EP 338
DI 10.1136/medethics-2016-103862
PG 5
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA ET1IL
UT WOS:000400020800014
PM 27920162
DA 2020-07-08
ER

PT J
AU Onawole, AT
   Sulaiman, KO
   Adegoke, RO
   Kolapo, TU
AF Onawole, Abdulmujeeb T.
   Sulaiman, Kazeem O.
   Adegoke, Rukayat O.
   Kolapo, Temitope U.
TI Identification of potential inhibitors against the Zika virus using
   consensus scoring
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE Consensus scoring; Molecular docking; Virtual screening; Zika virus;
   Zoonotic disease
ID DRUG DISCOVERY; LIGAND EFFICIENCY; PERMEABILITY; SOLUBILITY; PREDICTION
AB The Zika virus (ZIKV) is a life threatening pathogen of zoonotic importance with prevalence in some parts of Africa and America. Unfortunately, there is yet to be a single approved vaccine or antiviral drug to treat the diseases and deformations being caused by the Zika virus infection. In this study, about 36 million compounds from MCULE database were virtually screened against a real matured ZIKV protein using a consensus scoring method to get improved hit rates. The consensus scoring method combined the result from the 25 top ranked molecules from both MCULE and Drug Score eXtended (DSX) docking programs which led to the selection of two hit compounds. The inhibition constant (Ki) values of 0.08 and 0.30 mu m were obtained for the two selected compounds MCULE-8830369631-0-1 and MCULE-9236850811-0-1 respectively, to remark them as hit compounds. The molecular interactions of the two selected hit compounds with the amino acids (ALA 48, ILE 49, ILE 468 and LEU 472) present in the ZIKV protein indicated that they both have similar binding modes. The result of the computationally predicted physicochemical properties including ADMET for the selected compounds showed their great potential in becoming lead compounds upon optimization and thus could be used in treating the Zika virus diseases. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Onawole, Abdulmujeeb T.; Sulaiman, Kazeem O.] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia.
   [Adegoke, Rukayat O.] Ladoke Akintola Univ Technol, Dept Pure & Appl Biol, PMB 4000, Ogbomosho, Nigeria.
   [Kolapo, Temitope U.] Univ Ilorin, Dept Vet Parasitol & Entomol, Fac Vet Med, PMB 1515, Ilorin, Nigeria.
RP Sulaiman, KO (corresponding author), King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia.
EM kosulaiman2008@yahoo.com
RI Onawole, Abdulmujeeb T/E-7401-2019; Onawole, Abdulmujeeb/I-9079-2019
OI Onawole, Abdulmujeeb T/0000-0002-4967-7245; Onawole,
   Abdulmujeeb/0000-0002-4967-7245
CR Al-Karadaghi S., INTRO PROTEIN HOMOLO
   [Anonymous], 2010, Drug Discov Today Technol, V7, pe147, DOI 10.1016/j.ddtec.2010.11.003
   [Anonymous], 1996, GUID IND SINGL DOS A
   Bajusz D, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0069-3
   Berman H.M., 2000, PROTEIN DATA BANK, P899
   BIOVIA D.S., 2015, DISCOVERY STUDIO MOD
   Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6
   Burlingham BT, 2003, J CHEM EDUC, V80, P214, DOI 10.1021/ed080p214
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Cerqueira NMFSA, 2015, ARCH BIOCHEM BIOPHYS, V582, P56, DOI 10.1016/j.abb.2015.05.011
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a
   Dallakyan S., 2010, SCREENING, P1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012
   Edwards MP, 2010, ANNU REP MED CHEM, V45, P381, DOI 10.1016/S0065-7743(10)45023-X
   Ekins S, 2014, J PHARMACOL TOX MET, V69, P115, DOI 10.1016/j.vascn.2013.12.003
   Epstein S., 2016, ZIKA RESPONSE FUNDIN
   Ertl P., 2007, MOL DRUG PROPERTIES
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Feher M, 2006, DRUG DISCOV TODAY, V11, P421, DOI 10.1016/j.drudis.2006.03.009
   Feranchuk S.B.S., 2016, COLD SPRING HARB LAB, P1
   Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7
   Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163
   Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x
   Jamali AA, 2016, DRUG DISCOV TODAY, V21, P718, DOI 10.1016/j.drudis.2016.01.007
   Kapetanovic IM, 2008, CHEM-BIOL INTERACT, V171, P165, DOI 10.1016/j.cbi.2006.12.006
   Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741
   Kelemen AA, 2016, J CHEM INF MODEL, V56, P412, DOI 10.1021/acs.jcim.5b00598
   Kiss R., 2012, J CHEMINFORM, V4
   KRIEGER E, 2003, STRUCTURAL BIOINFORM, P507
   LaMotte S., CDC ISSUES HIST TRAV
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li X, 2014, J CHEM INF MODEL, V54, P1061, DOI 10.1021/ci5000467
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Lipinski CA, 2000, J PHARMACOL TOXICOL, V44, P235, DOI 10.1016/S1056-8719(00)00107-6
   Lipinski CA, 2016, ADV DRUG DELIVER REV, V101, P34, DOI 10.1016/j.addr.2016.04.029
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6
   Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q
   Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reynolds CH, 2007, BIOORG MED CHEM LETT, V17, P4258, DOI 10.1016/j.bmcl.2007.05.038
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schultes S, 2015, J CHEM INF MODEL, V55, P1030, DOI 10.1021/ci500694c
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Tsaioun K., 2011, ADMET MED CHEM PRACT
   Van de Waterbeemd H., 2008, DRUG BIOAVAILABILITY
   WHO, 2016, ON YEAR ZIK OUTBR OB
   World Bank, 2016, SHORT TERM EC COSTS
   Zhu T, 2013, J MED CHEM, V56, P6560, DOI 10.1021/jm301916b
NR 55
TC 11
Z9 12
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1093-3263
EI 1873-4243
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD MAY
PY 2017
VL 73
BP 54
EP 61
DI 10.1016/j.jmgm.2017.01.018
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA ET3YK
UT WOS:000400215700008
PM 28236744
DA 2020-07-08
ER

PT J
AU Possas, C
   Brasil, P
   Marzochi, MCA
   Tanuri, A
   Martins, RM
   Marques, ETA
   Bonaldo, MC
   Ferreira, AGP
   Lourenco-de-Oliveira, R
   Nogueira, RMR
   Sequeira, PC
   Marzochi, KBF
   Homma, A
AF Possas, Cristina
   Brasil, Patricia
   Marzochi, Mauro C. A.
   Tanuri, Amilcar
   Martins, Reinaldo M.
   Marques, Ernesto T. A.
   Bonaldo, Myrna C.
   Ferreira, Antonio G. P.
   Lourenco-de-Oliveira, Ricardo
   Nogueira, Rita Maria R.
   Sequeira, Patricia C.
   Marzochi, Keyla B. F.
   Homma, Akira
TI Zika puzzle in Brazil: peculiar conditions of viral introduction and
   dissemination - A Review
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Review
DE Zika; microcephaly; congenital Zika syndrome; neurological disorders;
   pathogenesis; epidemiology
ID VIRUS-INFECTION; DENGUE VIRUS; SEXUAL TRANSMISSION; AEDES-AEGYPTI;
   PREGNANCY; JANUARY; AMERICA; WOMEN; SEMEN; BIRTH
AB This article discusses the peculiar conditions that favoured the unexpected introduction of Zika virus into the poorest northeastern region of Brazil in 2015, its speed of transmission to other Brazilian states, other Latin American countries and other regions, and the severity of related neurological disorders in newborns and adults. Contrasting with evidence that Zika had so far caused only mild cases in humans in the last six decades, the epidemiological scenario of this outbreak in Brazil indicates dramatic health effects: in 2015, an increase of 20-fold in notified cases of microcephaly and/or central nervous system (CNS) alterations suggestive of Zika congenital infection, followed by an exponential increase in 2016, with 2366 cumulative cases confirmed in the country by the end of December 2016. A significant increase in Guillain-Barre syndrome in adults has also been reported. Factors involved in viral dissemination, neural pathogenesis and routes of transmission in Brazil are examined, such as the role of social and environmental factors and the controversies involved in the hypothesis of antibody-dependent enhancement, to explain the incidence of congenital Zika syndrome in Brazil. Responses to the Zika outbreak and the development of new products are also discussed.
C1 [Possas, Cristina; Martins, Reinaldo M.; Homma, Akira] Fdn Oswaldo Cruz Fiocruz, Bio Manguinhos, Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Fdn Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Marzochi, Mauro C. A.; Marzochi, Keyla B. F.] Fdn Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin & Vigilincia Leishmaniose, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.
   [Marques, Ernesto T. A.] Fdn Oswaldo Cruz Fiocruz, Ctr Pesquisas Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Bonaldo, Myrna C.] Fdn Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Antonio G. P.] Fdn Oswaldo Cruz Fiocruz, Bio Manguinhos, Dept Reativos Diagnost, Rio De Janeiro, RJ, Brazil.
   [Lourenco-de-Oliveira, Ricardo] Fdn Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Nogueira, Rita Maria R.; Sequeira, Patricia C.] Fdn Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
RP Possas, C (corresponding author), Fdn Oswaldo Cruz Fiocruz, Bio Manguinhos, Rio De Janeiro, RJ, Brazil.
EM cristina.possas@bio.fiocruz.br
RI Martins, Reinaldo/I-3413-2015; Possas, Cristina/AAJ-3840-2020; Marques,
   Ernesto T. A/L-4967-2013
OI Martins, Reinaldo/0000-0002-0667-532X; Marques, Ernesto T.
   A/0000-0003-3826-9358
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FIOCRUZ
FX CNPq, FAPERJ, FIOCRUZ
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bonaldo MC, 2014, HUM VACC IMMUNOTHER, V10, P1256, DOI 10.4161/hv.28117
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favoretto S, 2016, BIORXIV
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Freire CCM, 2015, BIORXIV
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOLOGICO, V48, P10
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencia em Saude Publica sobre Febre Amarela, 2017, 282017 MS COES
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencias em Saude Publica sobre Microce-falias, 2017, 572016 MS CTR OP EM
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencias em Saude Publica sobre Microce-falias, 2016, 282016 MS CTR OP EM
   MS-Ministerio da Saude/Secretaria de Vigilancia em Saude/Centro de Operacoes de Emergencias em Saude Publica sobre Microce-falias, 2016, 562016 MS CTR OP EM
   Munoz LS, 2016, SEMIN REPROD MED
   NIAID/NIH-National Institute of Allergy and Infectious Diseases/National Institutes of Health, 2016, ZIK VIR TREATM RES
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   PAHO/WHO-Pan American Health Organization/World Healt Organization, 2016, ZIK EP REP BRAZ
   PAHO/WHO-Pan American Health Organization/World Health Organization, 2016, CAS DEF
   PAHO-Pan American Health Organization, 2017, REG ZIK EP LOG UPD A
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 62
TC 16
Z9 17
U1 0
U2 20
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2017
VL 112
IS 5
BP 319
EP 327
DI 10.1590/0074-02760160510
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA ET3EG
UT WOS:000400159600001
PM 28443985
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Verna, F
   Modesto, P
   Radaelli, MC
   Francese, DR
   Monaci, E
   Desiato, R
   Grattarola, C
   Peletto, S
   Mosca, A
   Savini, G
   Chianese, R
   Demicheli, V
   Prearo, M
   Chiavacci, L
   Pautasso, A
   Casalone, C
AF Verna, Federica
   Modesto, Paola
   Radaelli, Maria Cristina
   Francese, Danila Raffaella
   Monaci, Enrico
   Desiato, Rosanna
   Grattarola, Carla
   Peletto, Simone
   Mosca, Andrea
   Savini, Giovanni
   Chianese, Rosa
   Demicheli, Vittorio
   Prearo, Marino
   Chiavacci, Laura
   Pautasso, Alessandra
   Casalone, Cristina
TI Control of Mosquito-Borne Diseases in Northwestern Italy: Preparedness
   from One Season to the Next
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE flavivirus; mosquito(es); surveillance; vector-borne; West Nile
ID WEST-NILE-VIRUS; AUGUST-SEPTEMBER 2009; USUTU-VIRUS; CO-CIRCULATION;
   NEUROINVASIVE INFECTION; PCR ASSAY; LINEAGE 2; EUROPE; FLAVIVIRUS;
   EMERGENCE
AB Introduction: Mosquito-borne diseases (MBDs) are spreading worldwide due to globalization and climate change, representing a threat for both humans and animals. Of great concern are the infections caused by viruses belonging to the Flavivirus genus as West Nile virus (WNV) and Usutu virus (USUV) transmitted by Culex sp. or Dengue virus and Zika virus (ZIKV), transmitted by Aedes sp. This work describes the surveillance protocol enforced in Piedmont (Northwestern Italy) to control MBDs spread, focusing on the activities performed on mosquitoes during the 2015 vector season. Materials and Methods: From July to October, mosquitoes were fortnightly sampled in 50 selected sites according to risk factors with CDC dry ice-baited traps and BG-Sentinel traps baited with BG-Lure and dry ice. Adults were counted, identified to species level, pooled, and screened for flaviviruses using different reverse transcription-PCR protocols and sequencing. Finally, phylogenetic analysis was performed on a dataset including 2014 and 2015 WNV sequences and reference sequences retrieved from GenBank. Results and Discussion: A total of 17,000 mosquitoes, grouped in 730 pools, were tested. Five pools of Culex pipiens were positive for WNV Lineage 2 in Novara, Alessandria, Vercelli, and Torino Provinces. One pool of C. pipiens and one pool of Anopheles maculipennis s.l. were positive for USUV in Vercelli and Alessandria Provinces. In Vercelli Province one pool of C. pipiens resulted positive both for WNV and USUV. Control measures were quickly implemented. Phylogenetic analyses showed that the WNV Lin 2 sequences from Piedmont region cluster with those circulating in Northeastern Italy in the previous years. Given the positive trend in WNV activity compared to 2014 and the emergence caused by other flavivirus as ZIKV, the level of attention for the 2016 vector season may be increased and this surveillance protocol could represent an important tool for public health authorities.
C1 [Verna, Federica; Modesto, Paola; Radaelli, Maria Cristina; Francese, Danila Raffaella; Monaci, Enrico; Desiato, Rosanna; Grattarola, Carla; Peletto, Simone; Prearo, Marino; Chiavacci, Laura; Pautasso, Alessandra; Casalone, Cristina] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy.
   [Mosca, Andrea] IPLA, Turin, Italy.
   [Savini, Giovanni] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy.
   [Chianese, Rosa] Osped Ivrea, Ctr Reg Sangue Piemonte Presso ASL TO4, Ivrea, Italy.
   [Demicheli, Vittorio] Serv Sovrazonale Epidemiol SEREMI Presso ASL, Alessandria, Italy.
RP Pautasso, A (corresponding author), Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Neuropatol, Via Bologna 148, I-10054 Turin, Italy.
EM alessandra.pautasso@izsto.it
RI Casalone, Cristina/J-6763-2018; Verna, Federica/O-7406-2019; francese,
   danila raffaella/O-7222-2019; Peletto, Simone/K-2005-2016
OI Casalone, Cristina/0000-0001-5271-832X; Verna,
   Federica/0000-0003-0534-8965; francese, danila
   raffaella/0000-0002-4404-8802; Peletto, Simone/0000-0002-8684-898X;
   Pautasso, Alessandra/0000-0002-3135-5379; Savini,
   Giovanni/0000-0001-7933-7367
CR Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   Ben Hassine T, 2014, TRANSBOUND EMERG DIS, V61, P385, DOI 10.1111/tbed.12259
   Calzolari M, 2013, VET ITAL, V49, P315
   Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Cavrini F, 2011, J CLIN VIROL, V50, P221, DOI 10.1016/j.jcv.2010.11.008
   CNS, 2015, IND SORV PREV TRASM
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Del Amo J, 2013, J VIROL METHODS, V189, P321, DOI 10.1016/j.jviromet.2013.02.019
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Institute of Medicine (US) Forum on Microbial Threats, 2008, VECT BORN DIS UND EN
   Istituto Superiore di Sanita, 2015, BOLL W NIL
   Italian Ministry of Health, 2015, SORV CAS UM CHIK DEN
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Lelli R, 2008, ZOONOSES PUBLIC HLTH, V55, P361, DOI 10.1111/j.1863-2378.2008.01146.x
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Pautasso A, 2016, VECTOR-BORNE ZOONOT, V16, P292, DOI 10.1089/vbz.2015.1851
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Ravagnan S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1031-y
   Rizzo C, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.37.30340
   Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326
   Rovida F, 2015, VECTOR-BORNE ZOONOT, V15, P278, DOI 10.1089/vbz.2014.1711
   Rudolf I, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1139-0
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Steinmetz HW, 2011, VET MICROBIOL, V148, P207, DOI 10.1016/j.vetmic.2010.09.018
   Stojanovich CJ, 1997, MOSQUITOES ITALY MOS, P199
   Tamba M, 2011, VECTOR-BORNE ZOONOT, V11, P551, DOI 10.1089/vbz.2010.0055
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
NR 41
TC 0
Z9 0
U1 0
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAY
PY 2017
VL 17
IS 5
BP 331
EP 339
DI 10.1089/vbz.2016.2047
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA ET3MT
UT WOS:000400183900007
PM 28437184
DA 2020-07-08
ER

PT J
AU Florescu, SA
   Cotar, AI
   Popescu, CP
   Ceianu, CS
   Zaharia, M
   Vancea, G
   Codreanu, D
   Badescu, D
   Ceausu, E
AF Florescu, Simin Aysel
   Cotar, Ani Ioana
   Popescu, Corneliu Petru
   Ceianu, Cornelia Svetlana
   Zaharia, Mihaela
   Vancea, Geta
   Codreanu, Daniel
   Badescu, Daniela
   Ceausu, Emanoil
TI First Two Imported Cases of Zika Virus Infections in Romania
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE flaviviruses; molecular diagnosis; serology; travel; Zika virus
ID SPECIFICITY
AB We report the first two cases of imported Zika virus (ZIKV) infection in Romanian patients returning from areas with ongoing outbreaks and challenges for laboratory diagnostic; first one with a classical pattern of acute flaviviral infection and the second one with an interesting pattern of a secondary flaviviral (ZIKV) infection in a yellow fever-vaccinated child living abroad in an endemic area.
C1 [Florescu, Simin Aysel; Vancea, Geta] Carol Davila Univ Med & Pharm, Infect & Trop Dis Dept, Bucharest, Romania.
   [Florescu, Simin Aysel; Popescu, Corneliu Petru; Zaharia, Mihaela; Codreanu, Daniel; Ceausu, Emanoil] Dr Victor Babes Clin Hosp Infect & Trop Dis, Infect & Trop Dis Dept, Bucharest, Romania.
   [Cotar, Ani Ioana; Ceianu, Cornelia Svetlana; Badescu, Daniela] Cantacuzino Natl Inst Res, Lab Vector Borne Infect, Bucharest, Romania.
   [Popescu, Corneliu Petru] Carol Davila Univ Med & Pharm, Dept Virol, Sos Mihai Bravu 281,Sect 3, Bucharest 030303, Romania.
   [Vancea, Geta] Dr Victor Babes Clin Hosp Infect & Trop Dis, Dept Paediat, Bucharest, Romania.
RP Popescu, CP (corresponding author), Carol Davila Univ Med & Pharm, Dept Virol, Sos Mihai Bravu 281,Sect 3, Bucharest 030303, Romania.
EM cornel160@yahoo.com
RI Ceianu, Cornelia-Svetlana/A-7423-2018; Florescu, Simin/AAQ-8675-2020
OI Ceianu, Cornelia Svetlana/0000-0001-6222-0752
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i753
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prioteasa LF, 2015, J AM MOSQUITO CONTR, V31, P177, DOI 10.2987/14-6462R
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 10
TC 2
Z9 2
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAY
PY 2017
VL 17
IS 5
BP 354
EP 357
DI 10.1089/vbz.2016.2076
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA ET3MT
UT WOS:000400183900011
PM 28437183
DA 2020-07-08
ER

PT J
AU Chen, LM
   Liu, Y
   Wang, SB
   Sun, JH
   Wang, PL
   Xin, QL
   Zhang, LK
   Xiao, GF
   Wang, W
AF Chen, Liman
   Liu, Yang
   Wang, Shaobo
   Sun, Jianhong
   Wang, Peilin
   Xin, Qilin
   Zhang, Leike
   Xiao, Gengfu
   Wang, Wei
TI Antiviral activity of peptide inhibitors derived from the protein E stem
   against Japanese encephalitis and Zika viruses
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Peptide inhibitors; Japanese encephalitis virus; Zika virus;
   Glycoprotein; Stem
ID WEST-NILE; DENGUE VIRUS; MUTATIONAL ANALYSIS; ENVELOPE PROTEIN; ENTRY;
   INFECTION; CELLS; FLAVIVIRUSES; DRUG; MECHANISM
AB Japanese encephalitis virus (IEV) and Zika virus (ZIKV) are mosquito-borne viruses of the Flavivirus genus that cause viral encephalitis and congenital microcephaly, respectively, in humans, and thus present a risk to global public health. The envelope glycoprotein (E protein) of fiaviviruses is a class II viral fusion protein that mediates host cell entry through a series of conformational changes, including association between the stem region and domain II leading to virion-target cell membrane fusion. In this study, peptides derived from the JEV E protein stem were investigated for their ability to block JEV and ZIKV infection. Peptides from stem helix 2 inhibit JEV infection with the 50% inhibitory concentration (IC50) in the nanomolar range. One of these peptides (P5) protected mice against JEV-induced lethality by decreasing viral load, while abrogating histopathological changes associated with JEV infection. We also found that P5 blocked ZIKV infection with IC50 at the micromolar level. Moreover, P5 was proved to reduce the histopathological damages in brain and testes resulting from ZIKV infection in type I and II interferon receptor-deficient (AG6) mice. These findings provide a basis for the development of peptide based drugs against JEV and ZIKV. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Chen, Liman; Liu, Yang; Wang, Shaobo; Sun, Jianhong; Wang, Peilin; Xin, Qilin; Zhang, Leike; Xiao, Gengfu; Wang, Wei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Xiaohongshan 44, Wuhan 430071, Peoples R China.
   [Chen, Liman; Wang, Shaobo; Sun, Jianhong; Wang, Peilin; Xin, Qilin; Zhang, Leike; Xiao, Gengfu; Wang, Wei] Univ Chinese Acad Sci, Beijing, Peoples R China.
RP Wang, W (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Xiaohongshan 44, Wuhan 430071, Peoples R China.
EM wangwei@wh.iov.cn
OI Wang, Wei/0000-0002-8696-9773
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31670165, 31000089]
FX We thank Dr. Hanzhong Wang, Dr. Bo Zhang and Dr. Fei Deng of the Wuhan
   Institute of Virology, Chinese Academy of Sciences, China, for their
   advice, encouragement, and support in conducting this work. This study
   was supported by the National Natural Science Foundation of China (grant
   no. 31670165 and 31000089). We thank the Public Technology Service
   Center of Wuhan Institute of Virology for providing technical
   assistance.
CR Altmeyer R, 2004, CURR PHARM DESIGN, V10, P3701, DOI 10.2174/1381612043382729
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   BANKS WA, 1985, BRAIN RES BULL, V15, P287, DOI 10.1016/0361-9230(85)90153-4
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dyer O, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4740
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Fan Jingjing, 2013, Virologica Sinica, V28, P152, DOI 10.1007/s12250-013-3331-8
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2
   Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036
   Koehler JW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002430
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Liao MF, 2010, J VIROL, V84, P5730, DOI 10.1128/JVI.00170-10
   Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075
   Liu HB, 2015, J VIROL, V89, P5668, DOI 10.1128/JVI.00293-15
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0
   Nawa M, 2007, JPN J INFECT DIS, V60, P118
   Pangerl K, 2011, J VIROL, V85, P8495, DOI 10.1128/JVI.05129-11
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rodrigues LC, 2016, LANCET INFECT DIS
   Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002
   VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087
   Wang SB, 2016, VIROLOGY, V498, P116, DOI 10.1016/j.virol.2016.08.013
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-80
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zu XY, 2014, ANTIVIR RES, V104, P7, DOI 10.1016/j.antiviral.2014.01.011
NR 60
TC 22
Z9 23
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAY
PY 2017
VL 141
BP 140
EP 149
DI 10.1016/j.antiviral.2017.02.009
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA ES4LG
UT WOS:000399506200015
PM 28232248
DA 2020-07-08
ER

PT J
AU Luz, C
   Marques, CS
   Rodrigues, J
   de Sousa, NA
   Fernandes, EKK
AF Luz, C.
   Marques, C. S.
   Rodrigues, J.
   de Sousa, N. A.
   Fernandes, E. K. K.
TI Survival and development of immature Aedes aegypti in artificial
   desiccating breeding sites under laboratory conditions
SO JOURNAL OF APPLIED ENTOMOLOGY
LA English
DT Article
DE egg; larva; mosquito; pupa; transient breeding site; water stress
ID DIPTERA-CULICIDAE; METARHIZIUM-ANISOPLIAE; INSECTICIDE RESISTANCE;
   ANOPHELES-GAMBIAE; OVICIDAL ACTIVITY; LARVAL; DENGUE; ALBOPICTUS;
   MOSQUITOS; VIRUS
AB The ability of aquatic stages of Aedes aegypti (Diptera: Culicidae), key vector of dengue, chikungunya and Zika viruses, to survive in minimal residues of water has remained unstudied. We found that larvae eclosed from up to 50% of eggs set in permanent water films on water agar (at 1-2% agar), and some (9.5%) of these first-instar larvae developed to second instar (L2). Mean larval survival was about 2weeks; the longest periods of survival were 31.6 and 38.7days in a water film and in free water controls, respectively. In another test, L3 moved in the films, with the greatest displacements of the larvae being up to 45mm per day in the first 3days; subsequent displacements in the water film were distinctly reduced during the next 20days by which time all L3 had died. L3 did not detect or move in any directed manner in the film towards nearby small quantities of free water. Most pupae (93.7%) placed into water films or in water survived and developed to adults within 3days. The unexpected survival of aquatic immature stages in desiccating breeding sites might be a reason for both the tenacious persistence of mosquito populations in seasons with infrequent rainfall and failures of classical control strategies against this important vector.
C1 [Luz, C.; Marques, C. S.; Rodrigues, J.; de Sousa, N. A.; Fernandes, E. K. K.] Univ Fed Goias, IPTSP, Ave Esperanca S-N,Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
RP Luz, C (corresponding author), Univ Fed Goias, IPTSP, Ave Esperanca S-N,Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
EM wchrisluz@hotmail.com
RI , Fernandes/I-4890-2012
OI , Fernandes/0000-0001-7062-3295
FU National Council of Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX The authors thank Richard A. Humber (USDA-ARS, Ithaca, New York) for the
   critical review of the manuscript and the National Council of Scientific
   and Technological Development (CNPq) for financial support.
CR Ahmad I, 2011, PAK J ENTOMOL, V26, P157
   Bisset JA, 2014, J AM MOSQUITO CONTR, V30, P298, DOI 10.2987/14-6431.1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x
   Johansson MA, 2015, TRENDS PARASITOL, V31, P43, DOI 10.1016/j.pt.2014.12.008
   Koenraadt CJM, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-20
   Lima WP, 2009, REV SOC BRAS MED TRO, V42, P638, DOI 10.1590/S0037-86822009000600005
   Luz C, 2008, MEM I OSWALDO CRUZ, V103, P214, DOI 10.1590/S0074-02762008000200016
   Luz C, 2007, J MED ENTOMOL, V44, P799, DOI 10.1603/0022-2585(2007)44[799:OAOEHO]2.0.CO;2
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Miller JR, 2007, NATURWISSENSCHAFTEN, V94, P195, DOI 10.1007/s00114-006-0178-y
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Monteiro LCC, 2007, NEOTROP ENTOMOL, V36, P966, DOI 10.1590/S1519-566X2007000600021
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409
   Roberts DM, 2001, MED VET ENTOMOL, V15, P215, DOI 10.1046/j.0269-283x.2001.00303.x
   Sousa NA, 2013, LETT APPL MICROBIOL, V57, P193, DOI 10.1111/lam.12097
   THRONE JE, 1995, J ECON ENTOMOL, V88, P1510, DOI 10.1093/jee/88.5.1510
   Troyo A, 2008, J VECTOR ECOL, V33, P76, DOI 10.3376/1081-1710(2008)33[76:SPOAAD]2.0.CO;2
   Varejao JBM, 2005, REV SOC BRAS MED TRO, V38, P238, DOI 10.1590/S0037-86822005000300006
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
NR 24
TC 0
Z9 0
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2048
EI 1439-0418
J9 J APPL ENTOMOL
JI J. Appl. Entomol.
PD MAY
PY 2017
VL 141
IS 4
BP 315
EP 321
DI 10.1111/jen.12348
PG 7
WC Entomology
SC Entomology
GA ES5TI
UT WOS:000399606800009
DA 2020-07-08
ER

PT J
AU Teng, Y
   Bi, DH
   Xie, GG
   Jin, Y
   Huang, Y
   Lin, BH
   An, XP
   Tong, YG
   Feng, D
AF Teng, Yue
   Bi, Dehua
   Xie, Guigang
   Jin, Yuan
   Huang, Yong
   Lin, Baihan
   An, Xiaoping
   Tong, Yigang
   Feng, Dan
TI Model-informed risk assessment for Zika virus outbreaks in the
   Asia-Pacific regions
SO JOURNAL OF INFECTION
LA English
DT Article
DE Zika virus; Endemic; Risk factors; Modeling; Forecasting; Surveillance
ID AMERICA; SPREAD; H7N9
AB Recently, Zika virus (ZIKV) has been recognized as a significant threat to global public health. The disease was present in large parts of the Americas, the Caribbean, and also the western Pacific area with southern Asia during 2015 and 2016. However, little is known about the factors affecting the transmission of ZIKV. We used Gradient Boosted Regression Tree models to investigate the effects of various potential explanatory variables on the spread of ZIKV, and used current with historical information from a range of sources to assess the risks of future ZIKV outbreaks. Our results indicated that the probability of ZIKV outbreaks increases with vapor pressure, the occurrence of Dengue virus, and population density but decreases as health expenditure, GDP, and numbers of travelers. The predictive results revealed the potential risk countries of ZIKV infection in the Asia-Pacific regions between October 2016 and January 2017. We believe that the high-risk conditions would continue in South Asia and Australia over this period. By integrating information on eco-environmental, social-economical, and ZIKV-related niche factors, this study estimated the probability for locally acquired mosquito-borne ZIKV infections in the Asia-Pacific region and improves the ability to forecast, and possibly even prevent, future outbreaks of ZIKV. (C) 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Teng, Yue; Huang, Yong; An, Xiaoping; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, Beijing 100071, Peoples R China.
   [Teng, Yue; Bi, Dehua; Xie, Guigang; Jin, Yuan; Huang, Yong; An, Xiaoping; Tong, Yigang] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Bi, Dehua] Univ Waterloo, Dept Mech & Mechatron Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
   [Jin, Yuan] Beijing Inst Biotechnol, Beijing 100071, Peoples R China.
   [Lin, Baihan] Univ Washington, Inst Prot Design, Dept Psychol Phys & Comp Sci & Engn, Computat Neurosci Program, Seattle, WA 98195 USA.
   [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Inst Hosp Management, Div Standard Operat Management, Beijing 100853, Peoples R China.
RP Feng, D (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Hosp Management, Div Standard Operat Management, Beijing 100853, Peoples R China.; Teng, Y; Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dong Da St, Beijing 100071, Peoples R China.
EM yueteng@sklpb.org; tong.yigang@gmail.com; danfeng@sklpb.org
OI Tong, Yigang/0000-0002-8503-8045; Lin, Baihan/0000-0002-7979-5509
FU State Key Laboratory of Pathogen and Biosecurity Program [SKLPBS1408,
   SKLPBS1451]
FX Study funded by grants from the State Key Laboratory of Pathogen and
   Biosecurity Program (No. SKLPBS1408 and No. SKLPBS1451).
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fang LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02722
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guzzetta G, 2016, EURO SURVEILL, V21
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Li XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep18610
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 23
TC 6
Z9 6
U1 0
U2 5
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD MAY
PY 2017
VL 74
IS 5
BP 484
EP 491
DI 10.1016/j.jinf.2017.01.015
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA ES4GE
UT WOS:000399488700007
PM 28189711
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, V.
TI Zika virus infection, immune thrombocytopenic purpura and antinuclear
   antibodies positivity
SO LUPUS
LA English
DT Letter
C1 [Wiwanitkit, V.] Hainan Med Univ, Haikou, Peoples R China.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Zea-Vera AF, 2017, LUPUS, V26, P890, DOI 10.1177/0961203316671816
NR 2
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0961-2033
EI 1477-0962
J9 LUPUS
JI Lupus
PD MAY
PY 2017
VL 26
IS 6
BP 670
EP 670
DI 10.1177/0961203316678678
PG 1
WC Rheumatology
SC Rheumatology
GA ES1RP
UT WOS:000399305000016
PM 27821513
DA 2020-07-08
ER

PT J
AU Peralta-Aros, C
   Garcia-Nieto, V
AF Peralta-Aros, Carolina
   Garcia-Nieto, Victor
TI Does Zika virus infection induce prolonged remissions in children with
   idiopathic nephrotic syndrome?
SO PEDIATRIC NEPHROLOGY
LA English
DT Article
DE Idiopathic nephrotic syndrome; Zika virus infection; Viral infections;
   Flavivirus
ID MEASLES-VIRUS; T-CELL; SOLUBLE FACTOR; SUPPRESSION; LYMPHOCYTES;
   ACTIVATION; APOPTOSIS; MOUSE
AB Zika is an emerging mosquito-borne flavivirus. We report two pediatric patients diagnosed with idiopathic nephrotic syndrome who achieved complete remission of the disease after suffering Zika virus (ZIKV) infection.
   The first patient was a young girl aged 2.5 years with steroid-dependent nephrotic syndrome who was subsequently diagnosed with ZIKV infection. Following the infection, the steroid dose could be reduced until complete withdrawal. The patient persists in complete remission. The second patient was a steroid-resistant boy aged 7 years who was scheduled for a renal biopsy when he was diagnosed with ZIKV infection. A week after the recovery phase of the acute rash, proteinuria was noted to be gradually falling. Today, 12 months later, he is in complete remission of the disease.
   We are aware that the improvement observed in our two patients after ZIKV infection may be be random. However, it is also possible that future studies will discover that ZIKV infection has some effect on the cellular immune system similar to that of measles infection.
C1 [Peralta-Aros, Carolina] Hosp Uyapar, Puerto Ordaz, Venezuela.
   [Garcia-Nieto, Victor] Hosp Nuestra Senora Candelaria, Pediat Nephrol Serv, Santa Cruz De Tenerife, Canary Islands, Spain.
RP Peralta-Aros, C (corresponding author), Hosp Uyapar, Puerto Ordaz, Venezuela.
EM carolinaperalt@gmail.com
CR Aldrich CA, 1926, AM J DIS CHILD, V32, P163
   Atabani SF, 2001, J INFECT DIS, V184, P1, DOI 10.1086/321009
   Auwaerter PG, 1996, J VIROL, V70, P3734, DOI 10.1128/JVI.70.6.3734-3740.1996
   BARNETT HL, 1950, AM J DIS CHILD, V80, P519
   BLOCK WM, 1948, PEDIATRICS, V1, P733
   BLUMBERG RW, 1947, AM J DIS CHILD, V73, P151
   BYRNE EAJ, 1952, LANCET, V259, P844, DOI 10.1016/S0140-6736(52)90797-6
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Finkel A, 1973, PATHOBIOL ANN, V3, P47
   FIREMAN P, 1969, PEDIATRICS, V43, P264
   Fujinami RS, 1998, J VIROL, V72, P9421, DOI 10.1128/JVI.72.12.9421-9427.1998
   GARIN EH, 1994, KIDNEY INT, V45, P1311, DOI 10.1038/ki.1994.171
   GRIFFIN DE, 1990, CLIN EXP IMMUNOL, V81, P218
   GRIFFIN DE, 1993, J INFECT DIS, V168, P275, DOI 10.1093/infdis/168.2.275
   HEYMANN W, 1946, J PEDIATR-US, V28, P117, DOI 10.1016/S0022-3476(46)80248-8
   HUTCHINS G, 1947, AM J DIS CHILD, V73, P242
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   KELLEY VC, 1952, J PEDIATR-US, V41, P505, DOI 10.1016/S0022-3476(52)80095-2
   Kemper MJ, 2003, CLIN NEPHROL, V60, P242
   LAGRUE G, 1975, BIOMED EXPRESS, V23, P37
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   MARUYAMA K, 1989, NEPHRON, V51, P73, DOI 10.1159/000185246
   MCFARLAND HF, 1974, J IMMUNOL, V113, P1978
   MEIZLIK EH, 1948, AM J DIS CHILD, V76, P83, DOI 10.1001/archpedi.1948.02030030090010
   MOLL GH, 1948, T ASSOC AM PHYSICIAN, V61, P108
   RAPOPORT M, 1951, AMA AM J DIS CHILD, V82, P248
   ROSENBLUM AH, 1949, J PEDIATR-US, V35, P574, DOI 10.1016/S0022-3476(49)80142-9
   Servet-Delprat C, 2000, J VIROL, V74, P4387, DOI 10.1128/JVI.74.9.4387-4393.2000
   SULLIVAN JL, 1975, J IMMUNOL, V114, P1458
   Sun XM, 1998, VIROLOGY, V246, P24, DOI 10.1006/viro.1998.9186
   Takahashi S, 2007, PEDIATR NEPHROL, V22, P232, DOI 10.1007/s00467-006-0316-y
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   TAYLOR RD, 1950, J LAB CLIN MED, V36, P996
   von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297
   WHITTLE HC, 1978, J CLIN INVEST, V62, P678, DOI 10.1172/JCI109175
   ZWEIMAN B, 1971, INT ARCH ALLER A IMM, V40, P834, DOI 10.1159/000230466
NR 36
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD MAY
PY 2017
VL 32
IS 5
BP 897
EP 900
DI 10.1007/s00467-017-3588-5
PG 4
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA ER6QZ
UT WOS:000398933200023
PM 28175986
DA 2020-07-08
ER

PT J
AU Serruya, SJ
AF Serruya, Suzanne J.
TI Challenges in fetal surveillance of pregnant women with Zika virus
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Serruya, Suzanne J.] WHO, PAHO, Latin Amer Ctr Perinatol, Woman & Reprod Hlth Unit, Montevideo 11300, Uruguay.
RP Serruya, SJ (corresponding author), WHO, PAHO, Latin Amer Ctr Perinatol, Woman & Reprod Hlth Unit, Montevideo 11300, Uruguay.
EM Serruyas@clap.ops-oms.org
CR [Anonymous], 2016, WHO 1 M INT HLTH REG
   Pan American Health Organization, STRAT ENH NAT CAP RE
   Schaub B, 2017, LANCET INFECT DIS
   World Health Organization, 2016, ZIK STRAT RESP PLAN
NR 4
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2017
VL 17
IS 5
BP 466
EP 467
DI 10.1016/S1473-3099(17)30082-8
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA ES4RG
UT WOS:000399521800005
PM 28209337
OA Bronze
DA 2020-07-08
ER

PT J
AU Vadivalagan, C
   Karthika, P
   Murugan, K
   Panneerselvam, C
   Del Serrone, P
   Benelli, G
AF Vadivalagan, Chithravel
   Karthika, Pushparaj
   Murugan, Kadarkarai
   Panneerselvam, Chellasamy
   Del Serrone, Paola
   Benelli, Giovanni
TI Exploring genetic variation in haplotypes of the filariasis vector Culex
   quinquefasciatus (Diptera: Culicidae) through DNA barcoding
SO ACTA TROPICA
LA English
DT Article
DE CO1; DNA divergence; Genetic drift; Polymorphism; Rift Valley fever
   virus; West Nile virus
ID RIBOSOMAL-RNA; BORNE DISEASES; ZIKA VIRUS; MOSQUITOS; DIVERSITY;
   REVEALS; MALARIA; IDENTIFICATION; DENGUE; POPULATIONS
AB Culex quinquefasciatus (Diptera: Culicidae) is a vector of many pathogens and parasites of humans, as well as domestic and wild animals. In urban and semi-urban Asian countries, Cx. quinquefasciatus is a main vector of nematodes causing lymphatic filariasis. In the African region, it vectors the Rift Valley fever virus, while in the USA it transmits West Nile, St. Louis encephalitis and Western equine encephalitis virus. In this study, DNA barcoding was used to explore the genetic variation of Cx. quinquefasciatus populations from 88 geographical regions. We presented a comprehensive approach analyzing the effectiveness of two gene markers, i.e. CO1 and 16S rRNA. The high threshold genetic divergence of CO1 (0.47%) gene was reported as an ideal marker for molecular identification of this mosquito vector. Furthermore, null substitutions were lower in CO1 if compared to 16S rRNA, which influenced its differentiating potential among Indian haplotypes. NJ tree was well supported with high branch values for CO1 gene than 16S rRNA, indicating ideal genetic differentiation among haplotypes. TCS haplotype network revealed 14 distinct clusters. The intra- and inter-population polymorphism were calculated among the global and Indian Cx. quinquefasciatus lineages. The genetic diversity index Tajima' D showed negative values for all the 4 intra-population clusters (G2-4, G10). Fu's FS showed negative value for G10 cluster, which was significant and indicated recent population expansion. However, the G2-G4 (i.e. Indian lineages) had positive values, suggesting a bottleneck effect. Overall, our research firstly shed light on the genetic differences among the haplotypes of Cx. quinquefasciatus species complex, adding basic knowledge to the molecular ecology of this important mosquito vector. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Vadivalagan, Chithravel; Murugan, Kadarkarai] Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Karthika, Pushparaj] Avinashilingam Inst Home Sci & Higher Educ Women, Dept Zool, Coimbatore 641043, Tamil Nadu, India.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Dept Biotechnol, Vellore 632115, Tamil Nadu, India.
   [Panneerselvam, Chellasamy] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [Del Serrone, Paola] Council Agr Res & Econ CREA, Anim Prod Res Ctr, Via Salaria 31, I-00016 Monterotondo, Italy.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Murugan, Kadarkarai/AAP-3937-2020; Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; VADIVALAGAN,
   Chithravel/0000-0002-1751-4361; Panneerselvam,
   Chellasamy/0000-0003-3994-8141
FU Regione Toscana PROAPI (PRAF 2015) and University of Pisa, Department of
   Agriculture, Food and Environment [COFIN2015_22]
FX J. Beier and two anonymous reviewers improved an earlier version of this
   study. The authors are grateful to the authorities Department of
   Zoology, Bharathiar University, India to conduct the experimental work.
   C. Vadivalagan would like to thank the SAARP Trust (Coimbatore, India),
   P. Karthika is grateful to DST (Department of Science and Technology)
   INSPIRE program (IF 130010). G. Benelli is sponsored by Regione Toscana
   PROAPI (PRAF 2015) and University of Pisa, Department of Agriculture,
   Food and Environment (Grant ID: COFIN2015_22). Founding sponsors had no
   role in the design of the study; in the collection, analyses, or
   interpretation of data, in the writing of the manuscript, and in the
   decision to publish the results.
CR Adeleke M A, 2008, Tanzan J Health Res, V10, P103
   Angel B., 2008, J VECTOR DIS, V45, P56259
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73
   Bourke BP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-111
   Wilke ABB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0468-8
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Chen B, 2002, MED VET ENTOMOL, V16, P253, DOI 10.1046/j.1365-2915.2002.00373.x
   Chu KH, 2006, BIOINFORMATICS, V22, P1690, DOI 10.1093/bioinformatics/btl146
   Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063
   Foster WA, 2002, MED ENTOMOL, P245
   Gaffigan T, 2015, SYSTEMATIC CATALOG C
   Garvey K., 2016, ARE CULEX MOSQUITOES
   Guedes D.R., 2016, BIORXIV
   Gunay F, 2015, ACTA TROP, V143, P112, DOI 10.1016/j.actatropica.2014.10.013
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   JUKES T H, 1969, P21
   Karthika P., 2016, KARBALA INT J MOD SC, V2, P156, DOI DOI 10.1016/J.KIJ0MS.2016.03.006
   Karthika P, 2017, J ASIA-PAC ENTOMOL, V20, P23, DOI 10.1016/j.aspen.2016.11.011
   Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336
   Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005
   Marrelli MT, 1999, J MED ENTOMOL, V36, P679, DOI 10.1093/jmedent/36.6.679
   Merget B, 2012, JOVE-J VIS EXP, DOI 10.3791/3806
   Mousson L., 2005, GENET RES CAMB, V86, P1211
   Murugan K, 2016, PARASITOL RES, V115, P107, DOI 10.1007/s00436-015-4726-2
   Oshaghi MA, 2007, ACTA TROP, V101, P241, DOI 10.1016/j.actatropica.2007.02.006
   Pakalapati D, 2013, PATHOG GLOB HEALTH, V107, P180, DOI 10.1179/2047773213Y.0000000090
   Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x
   Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507
   Vadivalagan C, 2016, PARASITOL RES, V115, P1149, DOI 10.1007/s00436-015-4847-7
   Webster BL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001882
   Zhong Daibin, 2013, PLoS ONE, V8, P1
NR 48
TC 25
Z9 25
U1 2
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2017
VL 169
BP 43
EP 50
DI 10.1016/j.actatropica.2017.01.020
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EO8QE
UT WOS:000396954000006
PM 28126462
DA 2020-07-08
ER

PT J
AU Aragao, MFVV
   Brainer-Lima, AM
   Holanda, AC
   van der Linden, V
   Aragao, LV
   Silva, MLM
   Sarteschi, C
   Petribu, NCL
   Valenca, MM
AF Aragao, M. F. V. V.
   Brainer-Lima, A. M.
   Holanda, A. C.
   van der Linden, V.
   Vasco Aragao, L.
   Silva Junior, M. L. M.
   Sarteschi, C.
   Petribu, N. C. L.
   Valenca, M. M.
TI Spectrum of Spinal Cord, Spinal Root, and Brain MRI Abnormalities in
   Congenital Zika Syndrome with and without Arthrogryposis
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article
ID MULTIPLEX-CONGENITA; VIRUS-INFECTION; OUTBREAK; BRAZIL
AB BACKGROUND AND PURPOSE: Arthrogryposis is among the malformations of congenital Zika syndrome. Similar to the brain, there might exist a spectrum of spinal cord abnormalities. The purpose of this study was to explore and describe in detail the MR imaging features found in the spinal cords, nerve roots, and brains of children with congenital Zika syndrome with and without arthrogryposis.
   MATERIALS AND METHODS: Twelve infants with congenital Zika syndrome (4 with arthrogryposis and 8 without) who had undergone brain and spinal cord MR imaging were retrospectively selected. Qualitative and quantitative analyses were performed and compared between groups.
   RESULTS: At visual inspection, both groups showed reduced thoracic spinal cord thickness:75% (6/8) of the group without arthrogryposis and 100% (4/4) of the arthrogryposis group. However, the latter had the entire spinal cord reduced and more severely reduced conus medullaris anterior roots (respectively, P = .002 and.007). Quantitative differences were found for conus medullaris base and cervical and lumbar intumescences diameters (respectively, P = .008, .048, .008), with more prominent reduction in arthrogryposis. Periventricular calcifications were more frequent in infants with arthrogryposis (P = .018).
   CONCLUSIONS: Most infants had some degree of spinal cord thickness reduction, predominant in the thoracic segment (without arthrogryposis) or in the entire spinal cord (with arthrogryposis). The conus medullaris anterior roots were reduced in both groups (thinner in arthrogryposis). A prominent anterior median fissure of the spinal cord was absent in infants without arthrogryposis. Brain stem hypoplasia was present in all infants with arthrogryposis, periventricular calcifications, in the majority, and polymicrogyria was absent.
C1 [Aragao, M. F. V. V.] Ctr Diagnost Multimagem, Rua Frei Matias Teves,194 Ilha do Leite, BR-5007045 Recife, PE, Brazil.
   [Brainer-Lima, A. M.] Univ Pernambuco, PROCAPE, Recife, PE, Brazil.
   [Aragao, M. F. V. V.; Brainer-Lima, A. M.] Mauricio de Nassau Univ, Recife, PE, Brazil.
   [Holanda, A. C.; Silva Junior, M. L. M.; Valenca, M. M.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [van der Linden, V.] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [van der Linden, V.; Petribu, N. C. L.] Barao de Lucena Hosp, Recife, PE, Brazil.
   [Vasco Aragao, L.] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [Sarteschi, C.] Fundacao Oswaldo Cruz Fiocruz PE, Recife, PE, Brazil.
RP Aragao, MFVV (corresponding author), Ctr Diagnost Multimagem, Rua Frei Matias Teves,194 Ilha do Leite, BR-5007045 Recife, PE, Brazil.
EM fatima.vascoaragao@gmail.com
RI Valenca, Marcelo/A-4302-2013
OI Valenca, Marcelo/0000-0003-0678-3782; Cintia Brainer de Queiroz Lima,
   Alessandra/0000-0003-0096-4101
CR Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281
   BANKER BQ, 1986, HUM PATHOL, V17, P656, DOI 10.1016/S0046-8177(86)80177-0
   BARKOVICH AJ, 1992, AM J NEURORADIOL, V13, P423
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FEDRIZZI E, 1993, PEDIATR NEUROL, V9, P343, DOI 10.1016/0887-8994(93)90102-I
   Gordon N, 1998, BRAIN DEV-JPN, V20, P507, DOI 10.1016/S0387-7604(98)00037-0
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Kalampokas E, 2012, ISRN OBSTET GYNECOL
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mennen U, 2005, J HAND SURG-BRIT EUR, V30B, P468, DOI 10.1016/j.jhsb.2005.06.004
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   WILSON DA, 1989, AM J ROENTGENOL, V152, P1029, DOI 10.2214/ajr.152.5.1029
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Yousem D, 2010, NEURORADIOLOGY REQUI, P515
NR 29
TC 17
Z9 18
U1 0
U2 1
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD MAY
PY 2017
VL 38
IS 5
BP 1045
EP 1053
DI 10.3174/ajnr.A5125
PG 9
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA EV8HT
UT WOS:000402022000029
PM 28364011
OA Other Gold
DA 2020-07-08
ER

PT J
AU Chan, JFW
   Chik, KKH
   Yuan, SF
   Yip, CCY
   Zhu, Z
   Tee, KM
   Tsang, JOL
   Chan, CCS
   Poon, VKM
   Lu, G
   Zhang, AJX
   Lai, KK
   Chan, KH
   Kao, RYT
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Chik, Kenn Ka-Heng
   Yuan, Shuofeng
   Yip, Cyril Chik-Yan
   Zhu, Zheng
   Tee, Kah-Meng
   Tsang, Jessica Oi-Ling
   Chan, Chris Chung-Sing
   Poon, Vincent Kwok-Man
   Lu, Gang
   Zhang, Anna Jinxia
   Lai, Kin-Kui
   Chan, Kwok-Hung
   Kao, Richard Yi-Tsun
   Yuen, Kwok-Yung
TI Novel antiviral activity and mechanism of bromocriptine as a Zika virus
   NS2B-NS3 protease inhibitor
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika; Antiviral; Treatment; Protease; Bromocriptine; Interferon
ID APPROVED DRUGS; IN-VITRO; INFECTION; DISEASE; REPLICATION; PROLACTIN
AB Zika virus (ZIKV) infection is associated with congenital malformations in infected fetuses and severe neurological and other systemic complications in adults. There are currently limited anti-ZIKV treatment options that are readily available and safe for use in pregnancy. In this drug repurposing study, bromocriptine was found to have inhibitory effects on ZIKV replication in cytopathic effect inhibition, virus yield reduction, and plaque reduction assays. Time-of-drug-addition assay showed that bromocriptine exerted anti-ZIKV activity between 0 and 12 h post-ZIKV inoculation, corroborating with post entry events in the virus replication cycle prior to budding. Our docking model showed that bromocriptine interacted with several active site residues of the proteolytic cavity involving 1-151 and S135 in the ZIKV-NS2B-NS3 protease protein, and might occupy the active site and inhibit the protease activity of the ZIKV-NS2B-NS3 protein. A fluorescence-based protease inhibition assay confirmed that bromocriptine inhibited ZIKV protease activity. Moreover, bromocriptine exhibited synergistic effect with interferon -cab against ZIKV replication in cytopathic effect inhibition assay. The availability of per vagina administration of bromocriptine as suppositories or vaginoadhesive discs and the synergistic anti-ZIKV activity between bromocriptine and type I interferon may make bromocriptine a potentially useful and readily available treatment option for ZIKV infection. The anti-ZIKV effects of bromocriptine should be evaluated in a suitable animal model. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Chan, Jasper Fuk-Woo; Kao, Richard Yi-Tsun; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Chik, Kenn Ka-Heng; Yuan, Shuofeng; Yip, Cyril Chik-Yan; Zhu, Zheng; Tee, Kah-Meng; Tsang, Jessica Oi-Ling; Chan, Chris Chung-Sing; Poon, Vincent Kwok-Man; Zhang, Anna Jinxia; Lai, Kin-Kui; Chan, Kwok-Hung; Kao, Richard Yi-Tsun; Yuen, Kwok-Yung] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Chan, Kwok-Hung; Kao, Richard Yi-Tsun; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Chan, Kwok-Hung; Kao, Richard Yi-Tsun; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
   [Lu, Gang] Hainan Med Univ, Dept Pathogen Biol, Haikou, Hainan, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Carol Yu Ctr Infect, Dept Microbiol,State Key Lab Emerging Infect Dis, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
RI ZHU, ZHENG/P-2173-2016; Chan, Jasper F. W./D-8007-2013
OI ZHU, ZHENG/0000-0002-2035-0804; Chan, Jasper F. W./0000-0001-6336-6657;
   Yuen, Kwok-yung/0000-0002-2083-1552; Yuan, Shuofeng/0000-0001-7996-1119
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases of the Department of Health; Emerging Arbovirus
   Research fund; Food and Health Bureau; Collaborative Innovation Center
   for Diagnosis and Treatment of Infectious Diseases; Ministry of
   Education of ChinaMinistry of Education, China; Government of the Hong
   Kong Special Administrative Region; Hong Kong Special Administrative
   Region
FX This work was partly supported by the donations of Larry Chi-Kin Yung,
   and Hui Hoy and Chow Sin Lan Charity Fund Limited; and funding from the
   Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases of the Department of Health, Hong Kong Special
   Administrative Region; Emerging Arbovirus Research fund; the Food and
   Health Bureau, The Government of the Hong Kong Special Administrative
   Region; and the Collaborative Innovation Center for Diagnosis and
   Treatment of Infectious Diseases, the Ministry of Education of China.
   The sponsors had no role in the design and conduct of the study, in the
   collection, analysis and interpretation of data, or in the preparation,
   review or approval of the manuscript. Preliminary findings related to
   this work were submitted as K.K.H.C's thesis for the degree of Master of
   Medical Sciences (MMedSc) at The University of Hong Kong.
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Darwish AM, 2005, FERTIL STERIL, V83, P1053, DOI 10.1016/j.fertnstert.2004.09.024
   Darwish AM, 2008, FERTIL STERIL, V90, P1864, DOI 10.1016/j.fertnstert.2007.09.029
   Delaney WE, 2004, ANTIMICROB AGENTS CH, V48, P3702, DOI 10.1128/AAC.48.10.3702-3710.2004
   DELPOZO E, 1986, EUR J CLIN PHARMACOL, V29, P615, DOI 10.1007/BF00635902
   Delvecchio R., 2016, BIORXIV
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dutta K, 2011, INDIAN J MED RES, V133, P467
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   FLOGSTAD AK, 1994, J CLIN ENDOCR METAB, V79, P461, DOI 10.1210/jc.79.2.461
   Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091
   Ginther OJ, 2012, THERIOGENOLOGY, V78, P1969, DOI 10.1016/j.theriogenology.2012.08.003
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ho WE, 2014, PHARMACOL THERAPEUT, V142, P126, DOI 10.1016/j.pharmthera.2013.12.001
   INGLOT AD, 1969, J GEN VIROL, V4, P203, DOI 10.1099/0022-1317-4-2-203
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Perachon S, 1999, EUR J PHARMACOL, V366, P293, DOI 10.1016/S0014-2999(98)00896-6
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   PLOCKINGER U, 1991, J ENDOCRINOL INVEST, V14, P943
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   REICHARD O, 1993, J MED VIROL, V41, P99, DOI 10.1002/jmv.1890410203
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tallarida Ronald J, 2011, Genes Cancer, V2, P1003, DOI 10.1177/1947601912440575
   Thiel S, 2016, MULT SCLER J, V22, P801, DOI 10.1177/1352458516634872
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Wang QY, 2011, ANTIMICROB AGENTS CH, V55, P4072, DOI 10.1128/AAC.00620-11
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang Y, 1999, METABOLISM, V48, P1033, DOI 10.1016/S0026-0495(99)90202-0
   Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 62
TC 50
Z9 51
U1 3
U2 84
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAY
PY 2017
VL 141
BP 29
EP 37
DI 10.1016/j.antiviral.2017.02.002
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA ES4LG
UT WOS:000399506200004
PM 28185815
DA 2020-07-08
ER

PT J
AU Saw, WG
   Pan, A
   Manimekalai, MSS
   Gruber, G
AF Saw, Wuan Geok
   Pan, Ankita
   Manimekalai, Malathy Sony Subramanian
   Grueber, Gerhard
TI Structural features of Zika virus non-structural proteins 3 and-5 and
   its individual domains in solution as well as insights into NS3
   inhibition
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Flavivirus; Zika; Nonstructural proteins; Viral polymerase;
   Methyltransferase; Protease; Helicase; Small-angle X-ray scattering
ID AMINO-ACID-RESIDUES; DENGUE-VIRUS; CRYSTAL-STRUCTURE; NS2B-NS3 PROTEASE;
   LINKER REGION; HELICASE; SCATTERING; SEROTYPES; METHYLTRANSFERASE;
   MACROMOLECULES
AB Zika virus (ZIKV) has emerged as a pathogen of major health concern. The virus relies on its nonstructural protein 5 (NS5) including a methyl-transferase (MTase) and a RNA-dependent RNA polymerase (RdRp) for capping and synthesis of the viral RNA and the nonstructural protein 3 (NS3) with its protease and helicase domain for polyprotein possessing, unwinding dsRNA proceeding replication, and NTPaseiRTPase activities. In this study we present for the first time insights into the overall structure of the entire French Polynesia ZIKV NS3 in solution. The protein is elongated and flexible in solution. Solution studies of the individual protease-and helicase domains show the compactness of the two monomeric enzymes as well as the contribution of the 10-residues linker region to the flexibility of the entire NS3. We show also the solution X-ray scattering data of the French Polynesia ZIKV NS5, which is dimeric in solution and switches to oligomers in a concentration-dependent manner. The solution shapes of the MTase and RdRp domains are described. The dimer arrangement of ZIKV NS5 is discussed in terms of its importance for MTase-RdRp communication and concerted interaction with its flexible and monomeric counterpart NS3 during viral replication and capping. The comparison of ZIKV NS3 and-NS5 solution data with the related DENY nonstructural proteins shed light into the similarities and diversities of these classes of enzymes. Finally, the effect of ATPase inhibitors to the enzymatic active ZIKV NS3 and the individual helicase are provided. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Saw, Wuan Geok; Pan, Ankita; Manimekalai, Malathy Sony Subramanian; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
RP Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
EM ggrueber@ntu.edu.sg
FU Ministry of Education MOE Tier 3, Singapore [MOE2012-T3-1-008]
FX This work as well as the research scholarship of Ankita Pan was
   supported by the Ministry of Education MOE Tier 3 (MOE2012-T3-1-008),
   Singapore to G.G. We thank Dr. Ardina Gruber (School of Biological
   Sciences, NTU, Singapore) for her support in the first cloning steps.
CR Abba Y, 2015, ADV VIROL, V2015, DOI 10.1155/2015/184241
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   Campagna M, 2010, BIOCHEM SOC T, V38, P50, DOI 10.1042/BST0380050
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B., 2016, J VIROL
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233
   Dreiss CA, 2006, J APPL CRYSTALLOGR, V39, P32, DOI 10.1107/S0021889805033091
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gledhill JR, 2005, BIOCHEM J, V386, P591, DOI 10.1042/BJ20041513
   Guinier A., 1939, Annales de Physique, V12, P161
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Han YS, 2017, J MED VIROL, V89, P397, DOI 10.1002/jmv.24660
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Ho J, 2015, J MOL BIOL, V427, P1866, DOI 10.1016/j.jmb.2015.01.024
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kamariah N, 2016, J STRUCT BIOL, V193, P13, DOI 10.1016/j.jsb.2015.11.004
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu H, 2006, BIOCHEM SOC T, V34, P35, DOI 10.1042/BST0340035
   Longenecker K. L., 2017, CRYSTAL STR IN PRESS
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Manimekalai MSS, 2016, ACTA CRYSTALLOGR D, V72, P795, DOI 10.1107/S2059798316006665
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389
   Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Svergun Dmitri I., 2013, SMALL ANGLE XRAY NEU
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 78
TC 14
Z9 14
U1 2
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAY
PY 2017
VL 141
BP 73
EP 90
DI 10.1016/j.antiviral.2017.02.005
PG 18
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA ES4LG
UT WOS:000399506200008
PM 28202376
DA 2020-07-08
ER

PT J
AU Artika, IM
   Ma'roef, CN
AF Artika, I. Made
   Ma'roef, Chairin Nisa
TI Laboratory biosafety for handling emerging viruses
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
ID ACUTE RESPIRATORY SYNDROME; ZIKA VIRUS; EBOLA-VIRUS;
   INFECTIOUS-DISEASES; FEBRILE ILLNESS; SOUTHEAST-ASIA; INDONESIA;
   TRANSMISSION; MANAGEMENT; SPECIMENS
AB Emerging viruses are viruses whose occurrence has risen within the past twenty years, or whose presence is likely to increase in the near future. Diseases caused by emerging viruses are a major threat to global public health. In spite of greater awareness of safety and containment procedures, the handling of pathogenic viruses remains a likely source of infection, and mortality, among laboratory workers. There is a steady increase in both the number of laboratories and scientist handling emerging viruses for diagnostics and research. The potential for harm associated to work with these infectious agents can be minimized through the application of sound biosafety concepts and practices. The main factors to the prevention of laboratory-acquired infection are well-trained personnel who are knowledgable and biohazard aware, who are perceptive of the various ways of transmission, and who are professional in safe laboratory practice management. In addition, we should emphasize that appropriate facilities, practices and procedures are to be used by the laboratory workers for the handling of emerging viruses in a safe and secure manner. This review is aimed at providing researchers and laboratory personnel with basic biosafety principles to protect themselves from exposure to emerging viruses while working in the laboratory. This paper focuses on what emerging viruses are, why emerging viruses can cause laboratory-acquired infection, how to assess the risk of working with emerging viruses, and how laboratory-acquired infection can be prevented. Control measures used in the laboratory designed as such that they protect workers from emerging viruses and safeguard the public through the safe disposal of infectious wastes are also addressed.
C1 [Artika, I. Made] Eijkman Inst Mol Biol, Biosafety Level Unit 3, Jalan Diponegoro 69, Jakarta 10430, Indonesia.
   [Artika, I. Made] Bogor Agr Univ, Fac Math & Nat Sci, Dept Biochem, Darmaga Campus, Bogor 16680, Indonesia.
   [Ma'roef, Chairin Nisa] Eijkman Inst Mol Biol, Emerging Virus Res Unit, Jalan Diponegoro 69, Jakarta 10430, Indonesia.
RP Artika, IM (corresponding author), Eijkman Inst Mol Biol, Biosafety Level Unit 3, Jalan Diponegoro 69, Jakarta 10430, Indonesia.
EM imart@eijkman.go.id
OI Artika, I/0000-0003-4293-3389
CR Adisasmito W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-571
   [Anonymous], 2011, 15793 CWA
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Baldo A, 2013, APPL BIOSAF, V18, P6
   Bennett A, 2006, J APPL MICROBIOL, V100, P658, DOI 10.1111/j.1365-2672.2005.02798.x
   Biosafety in microbiological and biomedical laboratories (BMBL), 2009, US DEP HLTH HUM SERV
   Bossart KN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004241
   Britton S, 2011, PLOS NEGLECT TROP D, V5, P1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caskey S, 2010, BIOSAFETY RISK ASSES
   Cenciarelli O., 2013, DEFENCE S T TECH B, V6, P111
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1171
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1133
   Cowling BJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2922
   Das S, 2010, Med J Armed Forces India, V66, P255, DOI 10.1016/S0377-1237(10)80051-6
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Dubov A, 2016, ARCH PATHOL LAB MED, V140, P171, DOI 10.5858/arpa.2015-0134-RA
   Eterpi M., 2010, APPL BIOSAF, V15, P165, DOI DOI 10.1177/153567601001500402
   Field H, 2015, PLOS ONE, V10, P1
   Gaudioso J, 2007, APPL BIOSAF, V12, P260
   Geoghegan JL, 2016, P NATL ACAD SCI USA, V113, P4170, DOI 10.1073/pnas.1521582113
   Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298
   Gustin KM, 2013, J VIROL, V87, P7864, DOI 10.1128/JVI.00719-13
   Health Canada, 2004, LAB BIOS GUID
   Horby PW, 2013, EMERG INFECT DIS, V19, P853, DOI 10.3201/eid1906.121783
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.14
   Hsu CH, 2015, MMWR-MORBID MORTAL W, V64, P435
   Hung LS, 2003, J ROY SOC MED, V96, P374, DOI 10.1258/jrsm.96.8.374
   Jackson AC, 2003, CLIN INFECT DIS, V36, P60, DOI 10.1086/344905
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kallfass C, 2015, J VERBRAUCH LEBENSM, V10, P259, DOI 10.1007/s00003-015-0960-x
   Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118
   Lam SK, 2002, CLIN INFECT DIS, V34, pS48, DOI 10.1086/338818
   Langevin S, 2012, J TRAVEL MED, V19, P127, DOI 10.1111/j.1708-8305.2011.00582.x
   Lee C, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0104-5
   Lewis FMT, 2004, EMERG INFECT DIS, V2006, P134, DOI [10.3201/eid1201.051126, DOI 10.3201/EID1201.051126]
   Lim PL, 2004, NEW ENGL J MED, V350, P1740, DOI 10.1056/NEJMoa032565
   Looi Lai-Meng, 2007, Malays J Pathol, V29, P63
   Lorcheim K., 2011, APPL BIOSAFETY, V16, P26
   Lu L, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.39
   McKinney KR, 2006, J ENVIRON HEALTH, V68, P26
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadam Saeed Reza Jamali, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P260, DOI 10.1016/S2221-1691(15)30341-5
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Morse SA, 2003, ASM NEWS, V69, P433
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Myint KSA, 2014, AM J TROP MED HYG, V90, P260, DOI 10.4269/ajtmh.13-0445
   National Institutes of Health, 2016, NIH GUID RES INV REC
   Nichol ST, 2000, P NATL ACAD SCI USA, V97, P12411, DOI 10.1073/pnas.210382297
   Nikitin N, 2014, ADV VIROL, V2014, P1, DOI DOI 10.1155/2014/859090)
   Pauli U, 2014, APPL BIOSAFETY, V19, P184
   Peacock G, 2014, JAMA PEDIATR, V168, P1087, DOI 10.1001/jamapediatrics.2014.2835
   Pedrosa PBS, 2011, INT J INFECT DIS, V15, pE366, DOI 10.1016/j.ijid.2011.03.005
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Public Health Agency of Canada, 2011, JAP ENC VIR MAT SAF
   Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017
   Rosenberg R, 2013, P NATL ACAD SCI USA, V110, P13961, DOI 10.1073/pnas.1307243110
   Sargent EV, 2003, ILAR J, V44, P52, DOI 10.1093/ilar.44.1.52
   Sasmono RT, 2015, INFECT GENET EVOL, V32, P165, DOI 10.1016/j.meegid.2015.03.006
   Sattar SA, 2007, J AOAC INT, V90, P1655
   Sewell David L, 2006, Clin Microbiol Newsl, V28, P1, DOI 10.1016/j.clinmicnews.2005.12.004
   SEWELL DL, 1995, CLIN MICROBIOL REV, V8, P389, DOI 10.1128/CMR.8.3.389
   Shlim DR, 2002, CLIN INFECT DIS, V35, P183, DOI 10.1086/341247
   Singh K, 2009, CLIN INFECT DIS, V49, P142, DOI 10.1086/599104
   Tappe D, 2014, EUROSURVEILLANCE, V19, P1
   Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426
   Tian D, 2014, PLOS ONE, V9, P1
   Tun T, 2006, APPL BIOSAF, V11, P15
   US News, 2016, ZIKA VIRUS LAB ACQUI
   Wagener S, 2008, APPL BIOSAF, V13, P169
   Wigginton KR, 2012, ENVIRON SCI TECHNOL, V46, P12069, DOI 10.1021/es3029473
   Wiyatno A, 2016, J INFECT DEV COUNTR, V10, P880, DOI 10.3855/jidc.7573
   Wong JJW, 2016, P NATL ACAD SCI USA, V113, P1056, DOI 10.1073/pnas.1523303113
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization, 2013, INT LAB BIOS GUID HA
   World Health Organization, 2014, INT GUID LAB DIAGN E
   World Health Organization (WHO), 2016, CUM NUMB CONF HUM CA
   World Health Organization (WHO), 2004, LAB BIOS MAN
   Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867
NR 80
TC 3
Z9 3
U1 2
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD MAY
PY 2017
VL 7
IS 5
BP 483
EP 491
DI 10.1016/j.apjtb.2017.01.020
PG 9
WC Tropical Medicine
SC Tropical Medicine
GA ER5NI
UT WOS:000398848200019
PM 32289025
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moreira, J
   Peixoto, TM
   Siqueira, AM
   Lamas, CC
AF Moreira, J.
   Peixoto, T. M.
   Siqueira, A. M.
   Lamas, C. C.
TI Sexually acquired Zika virus: a systematic review
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Semen; Sex; Zika; Review; Febrile illness
ID VECTOR-BORNE TRANSMISSION; UNITED-STATES; INFECTION; SEMEN; PERSISTENCE;
   WOMEN
AB Background: Zika virus (ZIKV) is transmitted to humans primarily by Aedes mosquito bites. However, circumstantial evidence points to a sexual transmission route.
   Objectives: To assess the sexually acquired ZIKV cases and to investigate the shedding of ZIKV in genital fluids.
   Data sources: PubMed, Scopus, Pro-MED-mail and WHO ZIKV notification databases from inception to December 2016.
   Selection criteria: Reports describing ZIKV acquisition through sex and studies reporting the detection or isolation of ZIKV in the genital fluids were included.
   Risk-of-bias assessment: The risk of bias was assessed using the National Institute of Health Tool.
   Results: Eighteen studies reporting on sex-acquired ZIKV and 21 describing the presence of ZIKV in genital fluids were included. The overall risk of bias was moderate. Sexual transmission was male-female (92.5%), female-male (3.7%) and male-male (3.7%). Modes of sexual transmission were unprotected vaginal (96.2%), oral (18.5%) and anal (7.4%) intercourse. The median time between onset of symptoms in the index partner and presumed sexual transmission was 13 days (range 4-44 days). ZIKV RNA was detected in semen as late as 188 days (range 3-188 days) following symptom onset, and infectious virus was isolated in semen up to 69 days after symptom onset. No study reported ZIKV isolation from female genital samples, but detection did occur up to 13 days after symptom onset.
   Conclusions: ZIKV is potentially sexually transmitted and persists in male genital secretions for a prolonged period after symptom onset. PROSPERO systematic review registration number CRD42016041475. J. Moreira, Clin Microbiol Infect 2017;23:296 (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Moreira, J.; Siqueira, A. M.; Lamas, C. C.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, Ave Brasil,4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil.
   [Peixoto, T. M.; Lamas, C. C.] Univ Grande Rio Unigranrio, Rio De Janeiro, Brazil.
   [Lamas, C. C.] Inst Nacl Cardiol, Unidade Pesquisa Cardiovasc, Rio De Janeiro, Brazil.
RP Moreira, J (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, Ave Brasil,4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil.
EM jose.moreira@ini.fiocruz.br
RI Siqueira, Andre M/G-1340-2010
OI Siqueira, Andre M/0000-0003-2208-0294
FU Programa de Estudantes-Convenio de Pos-graduacao (PEC-PG, CAPES/CNPQ)
FX Jose Moreira is supported by a scholarship from Programa de
   Estudantes-Convenio de Pos-graduacao (PEC-PG, CAPES/CNPQ) for his
   postgraduate research studies in Brazil. We thank Dr Michael Bruce
   Macrae for his assistance with language editing.
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057
   Barzon L., 2016, EURO SURVEILL, V21
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan DPC, 2016, INT J INFECT DIS, V49, P47, DOI [10.1016/j.ijid.2016.05.030, 10.1016/j]
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EURO SURVEILL, V21
   Freour T., 2016, EURO SURVEILL, V21
   Gaskell KM, 2016, EMERGING INFECT DIS, V23
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E., 2016, EURO SURVEILL, V21
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   (NIH) NIoH, 2014, NIH NIOH SER
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Prisant N, 2017, LANCET INFECT DIS, V23, P137
   Ralph MHGHuits, 2016, B WHO
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2016, EURO SURVEILL, V21
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EURO SURVEILL, V21
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844
   WHO, 2016, WHO ZIK VIR INF DIS
   WHO, 2016, WHO ZIK VIR INT CAS
   WHO, 2016, ZIK VIR SIT REP ZIK
   WHO, 2016, PREV SEX TRANSM ZIK, P5
   WHO, 2016, 5 M EM COMM UND INT
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, SIT REP
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
NR 54
TC 111
Z9 115
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAY
PY 2017
VL 23
IS 5
BP 296
EP 305
DI 10.1016/j.cmi.2016.12.027
PG 10
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EZ1KM
UT WOS:000404469900007
PM 28062314
OA Bronze
DA 2020-07-08
ER

PT J
AU Collins, MH
   McGowan, E
   Jadi, R
   Young, E
   Lopez, CA
   Baric, RS
   Lazear, HM
   de Silva, AM
AF Collins, Matthew H.
   McGowan, Eileen
   Jadi, Ramesh
   Young, Ellen
   Lopez, Cesar A.
   Baric, Ralph S.
   Lazear, Helen M.
   de Silva, Aravinda M.
TI Lack of Durable Cross-Neutralizing Antibodies against Zika Virus from
   Dengue Virus Infection
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID STRUCTURAL BASIS; DETERMINANTS; VACCINATION; REACTIVITY; RESPONSES;
   POTENT
AB Cross-reactive antibodies elicited by dengue virus (DENV) infection might affect Zika virus infection and confound serologic tests. Recent data demonstrate neutralization of Zika virus by monoclonal antibodies or human serum collected early after DENV infection. Whether this finding is true in late DENV convalescence (>= 6 months after infection) is unknown. We studied late convalescent serum samples from persons with prior DENV or Zika virus exposure. Despite extensive cross-reactivity in IgG binding, Zika virus neutralization was not observed among primary DENV infections. We observed low-frequency (23%) Zika virus cross-neutralization in repeat DENV infections. DENV-immune persons who had Zika virus as a secondary infection had distinct populations of antibodies that neutralized DENVs and Zika virus, as shown by DENV-reactive antibody depletion experiments. These data suggest that most DENV infections do not induce durable, high-level Zika virus cross-neutralizing antibodies. Zika virus specific antibody populations develop after Zika virus infection irrespective of prior DENV immunity.
C1 [Collins, Matthew H.; McGowan, Eileen; Jadi, Ramesh; Young, Ellen; Lopez, Cesar A.; Baric, Ralph S.; Lazear, Helen M.; de Silva, Aravinda M.] Univ N Carolina, Chapel Hill, NC USA.
RP Collins, MH (corresponding author), Univ N Carolina, Sch Med, Infect Dis, ID Clin 1,Fl Mem Hosp, 101 Manning Dr, Chapel Hill, NC 27514 USA.
EM matthew.collins@unchealth.unc.edu; desilva@med.unc.edu
OI Lopez, Cesar/0000-0001-9301-4177
FU National Institutes of Health grantsUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01-AI107731,
   P01 AI106695]
FX This study was supported by National Institutes of Health grants
   R01-AI107731 (to A.d.S.) and P01 AI106695 (subcontract to A.d.S;
   principal investigator Eva Harris, University of California, Berkeley).
CR Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   Barba-Spaeth G, 2016, NATURE, V539, DOI 10.1038/nature19780
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Food and Drug Administration, FDA WARNS HLTH CAR P
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moreira J., 2017, CLIN MICROBIOL INFEC
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Paulke-Korinek M, 2015, VACCINE, V33, P3600, DOI 10.1016/j.vaccine.2015.05.037
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047
   Wittermann C, 2015, VACCINE, V33, P1824, DOI 10.1016/j.vaccine.2015.02.038
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 47
TC 78
Z9 78
U1 0
U2 8
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2017
VL 23
IS 5
BP 773
EP 781
DI 10.3201/eid2305.161630
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ET1PU
UT WOS:000400042100006
PM 28418292
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Krow-Lucal, ER
   Biggerstaff, BJ
   Staples, JE
AF Krow-Lucal, Elisabeth R.
   Biggerstaff, Brad J.
   Staples, J. Erin
TI Estimated Incubation Period for Zika Virus Disease
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INTERIM GUIDANCE; TRANSMISSION
AB Information about the Zika virus disease incubation period can help identify risk periods and local virus transmission. In 2015-2016, data from 197 symptomatic travelers with recent Zika virus infection indicated an estimated incubation period of 3-14 days. For symptomatic persons with symptoms >2 weeks after travel, transmission might be not travel associated.
C1 [Krow-Lucal, Elisabeth R.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Krow-Lucal, Elisabeth R.; Biggerstaff, Brad J.; Staples, J. Erin] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Staples, JE (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd,Mailstop P02, Ft Collins, CO 80521 USA.
EM estaples@cdc.gov
CR Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Centers for Disease Control and Prevention, 2002, JAMA-J AM MED ASSOC, V288, P1465
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler JT, TIMES KEY EVENTS COU
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 25
Z9 25
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2017
VL 23
IS 5
BP 841
EP 844
DI 10.3201/eid2305.161715
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ET1PU
UT WOS:000400042100020
PM 28277198
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sotelo, JR
   Sotelo, AB
   Sotelo, FJB
   Doi, AM
   Pinho, JRR
   Oliveira, RD
   Bezerra, AMPS
   Deutsch, AD
   Villas-Boas, LS
   Felix, AC
   Romano, CM
   Machado, CM
   Mendes-Correa, MCJ
   Santana, RAF
   Menezes, FG
   Mangueira, CLP
AF Sotelo, Jose R.
   Sotelo, Andre B.
   Sotelo, Fabio J. B.
   Doi, Andre M.
   Pinho, Joao R. R.
   Oliveira, Rita de Cassia
   Bezerra, Alanna M. P. S.
   Deutsch, Alice D.
   Villas-Boas, Lucy S.
   Felix, Alvina C.
   Romano, Camila M.
   Machado, Clarisse M.
   Mendes-Correa, Maria C. J.
   Santana, Rubia A. F.
   Menezes, Fernando G.
   Mangueira, Cristovao L. P.
TI Persistence of Zika Virus in Breast Milk after Infection in Late Stage
   of Pregnancy
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We detected Zika virus in breast milk of a woman in Brazil infected with the virus during the 36th week of pregnancy. Virus was detected 33 days after onset of signs and symptoms and 9 days after delivery. No abnormalities were found during fetal assessment or after birth of the infant.
C1 [Sotelo, Jose R.; Sotelo, Andre B.; Sotelo, Fabio J. B.] Sotelo Clin, Sao Paulo, Brazil.
   [Sotelo, Jose R.; Sotelo, Andre B.; Sotelo, Fabio J. B.; Doi, Andre M.; Pinho, Joao R. R.; Oliveira, Rita de Cassia; Bezerra, Alanna M. P. S.; Deutsch, Alice D.; Santana, Rubia A. F.; Menezes, Fernando G.; Mangueira, Cristovao L. P.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Pinho, Joao R. R.; Villas-Boas, Lucy S.; Felix, Alvina C.; Romano, Camila M.; Machado, Clarisse M.; Mendes-Correa, Maria C. J.] Univ Sao Paulo, Sao Paulo, Brazil.
RP Doi, AM (corresponding author), Hosp Israelita Albert Einstein, Clin Lab, 627 Albert Einstein Ave,2nd Floor,Bldg E, BR-05652900 Sao Paulo, Brazil.
EM andre.doi@einstein.br
RI Santana, Rubia/N-4034-2017; Pinho, Joao R. R./G-2850-2012
OI Pinho, Joao R. R./0000-0003-3999-0489; Mangueira,
   Cristovao/0000-0002-4227-3723
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, 2016, ZIK VIR INF UPD EV C
NR 9
TC 38
Z9 38
U1 0
U2 14
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2017
VL 23
IS 5
BP 854
EP 856
DI 10.3201/eid2305.161538
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ET1PU
UT WOS:000400042100023
PM 28192072
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mansuy, JM
   Mengelle, C
   Pasquier, C
   Chapuy-Regaud, S
   Delobel, P
   Martin-Blondel, G
   Izopet, J
AF Mansuy, Jean Michel
   Mengelle, Catherine
   Pasquier, Christophe
   Chapuy-Regaud, Sabine
   Delobel, Pierre
   Martin-Blondel, Guillaume
   Izopet, Jacques
TI Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We tested whole-blood and plasma samples from immunocompetent patients who had had benign Zika virus infections and found that Zika virus RNA persisted in whole blood substantially longer than in plasma. This finding may have implications for diagnosis of acute symptomatic and asymptomatic infections and for testing of blood donations.
C1 [Mansuy, Jean Michel; Mengelle, Catherine; Pasquier, Christophe; Chapuy-Regaud, Sabine; Delobel, Pierre; Martin-Blondel, Guillaume; Izopet, Jacques] CHU Purpan, Toulouse, France.
   [Pasquier, Christophe; Chapuy-Regaud, Sabine; Delobel, Pierre; Martin-Blondel, Guillaume; Izopet, Jacques] Inst Natl Sante & Rech Med, Toulouse, France.
   [Pasquier, Christophe; Chapuy-Regaud, Sabine; Delobel, Pierre; Izopet, Jacques] Univ Paul Sabatier, Toulouse, France.
RP Mansuy, JM (corresponding author), Inst Federatif Biol, Lab Virol, 330 Ave Grande Bretagne,TSA 40031, F-31059 Toulouse 9, France.
EM mansuy.jm@chu-toulouse.fr
RI Martin-Blondel, Guillaume/K-6762-2014; Delobel, Pierre/Q-6028-2019
OI Martin-Blondel, Guillaume/0000-0002-8363-7028; Delobel,
   Pierre/0000-0002-2874-3581; IZOPET, JACQUES/0000-0002-8462-3234;
   PASQUIER, Christophe/0000-0001-9223-0150
CR European Center for Disease Prevention and Control, ECDC SCI ADV ZIK VIR
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   U. S. Department of Health and Human Services. Food and Drug Administration, REV REC RED RISK ZIK
NR 7
TC 51
Z9 51
U1 1
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2017
VL 23
IS 5
BP 863
EP 865
DI 10.3201/eid2305.161631
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ET1PU
UT WOS:000400042100028
PM 28257281
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Erten, EY
   Lizier, JT
   Piraveenan, M
   Prokopenko, M
AF Erten, E. Yagmur
   Lizier, Joseph T.
   Piraveenan, Mahendra
   Prokopenko, Mikhail
TI Criticality and Information Dynamics in Epidemiological Models
SO ENTROPY
LA English
DT Article
DE epidemiology; criticality; information dynamics; phase transitions;
   agent-based simulation
ID AVALANCHES; EMERGENCE; EVOLUTION; NETWORKS; DISEASES; EDGE; FLOW
AB Understanding epidemic dynamics has always been a challenge. As witnessed from the ongoing Zika or the seasonal Influenza epidemics, we still need to improve our analytical methods to better understand and control epidemics. While the emergence of complex sciences in the turn of the millennium have resulted in their implementation in modelling epidemics, there is still a need for improving our understanding of critical dynamics in epidemics. In this study, using agent-based modelling, we simulate a Susceptible-Infected-Susceptible (SIS) epidemic on a homogeneous network. We use transfer entropy and active information storage from information dynamics framework to characterise the critical transition in epidemiological models. Our study shows that both (bias-corrected) transfer entropy and active information storage maximise after the critical threshold (R-0 = 1). This is the first step toward an information dynamics approach to epidemics. Understanding the dynamics around the criticality in epidemiological models can provide us insights about emergent diseases and disease control.
C1 [Erten, E. Yagmur; Lizier, Joseph T.; Piraveenan, Mahendra; Prokopenko, Mikhail] Univ Sydney, Fac Engn & IT, Ctr Complex Syst, Sydney, NSW 2006, Australia.
   [Prokopenko, Mikhail] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW 2145, Australia.
RP Erten, EY (corresponding author), Univ Sydney, Fac Engn & IT, Ctr Complex Syst, Sydney, NSW 2006, Australia.
EM yagmur.erten@ieu.uzh.ch; joseph.lizier@sydney.edu.au;
   mahendrarajah.piraveenan@sydney.edu.au; mikhail.prokopenko@sydney.edu.au
RI Prokopenko, Mikhail/A-3995-2008; Erten, E. Yagmur/AAD-7551-2020; Lizier,
   Joseph/B-8093-2008
OI Prokopenko, Mikhail/0000-0002-4215-0344; Erten, E.
   Yagmur/0000-0001-9736-0405; Lizier, Joseph/0000-0002-9910-8972
FU Australian Research Council Discovery grantAustralian Research Council
   [DP160102742]; Australian Research Council DECRA grantAustralian
   Research Council [DE160100630]
FX Joseph T. Lizier, Mahendra Piraveenan and Mikhail Prokopenko were
   supported through the Australian Research Council Discovery grant
   DP160102742, and Joseph T. Lizier was supported through the Australian
   Research Council DECRA grant DE160100630.
CR Amador J, 2013, J FRANKLIN I, V350, P1112, DOI 10.1016/j.jfranklin.2013.02.008
   ANDERSON R M, 1991
   Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104
   Artalejo JR, 2014, APPL MATH MODEL, V38, P4371, DOI 10.1016/j.apm.2014.02.017
   Artalejo JR, 2013, B MATH BIOL, V75, P1031, DOI 10.1007/s11538-013-9836-3
   Artalejo JR, 2011, THEOR POPUL BIOL, V80, P256, DOI 10.1016/j.tpb.2011.09.005
   Barnett L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.177203
   Bauer F, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/68007
   Beggs JM, 2003, J NEUROSCI, V23, P11167
   Bernoulli D, 1766, MEM MATH PHYS ACAD R, P1
   Boedecker J, 2012, THEOR BIOSCI, V131, P205, DOI 10.1007/s12064-011-0146-8
   Cliff OM, 2017, ARTIF LIFE, V23, P34, DOI 10.1162/ARTL_a_00221
   Cover T., 1991, ELEMENTS INFORM THEO
   Garland J, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022221
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Heesterbeek J. A. P., 1996, STAT NEERL, V50, P89, DOI DOI 10.1111/J.1467-9574.1996.TB01482.X
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Keeling M. J., 2008, MODELING INFECT DIS
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Leventhal GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7101
   Lizier J. T., 2009, P EUR C COMPL SYST E, P54
   Lizier J. T., 2008, P 11 INT C SIM SYNTH, P374
   Lizier J. T., 2014, ARXIV14083270
   Lizier JT, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026110
   Lizier JT, 2014, EMERGENCE COMPLEX CO, V9, P115, DOI 10.1007/978-3-642-53734-9_5
   Lizier JT, 2014, UNDERST COMPLEX SYST, P161, DOI 10.1007/978-3-642-54474-3_7
   Lizier JT, 2012, THEOR BIOSCI, V131, P193, DOI 10.1007/s12064-011-0145-9
   Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016
   Lizier JT, 2011, ARTIF LIFE, V17, P293, DOI 10.1162/artl_a_00040
   Lizier JT, 2010, CHAOS, V20, DOI 10.1063/1.3486801
   Lizier JT, 2013, LOCAL INFORM DYNAMIC
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Marschinski R, 2002, EUR PHYS J B, V30, P275, DOI 10.1140/epjb/e2002-00379-2
   Meier J, 2017, NEUROIMAGE, V152, P639, DOI 10.1016/j.neuroimage.2017.02.007
   O'Regan SM, 2013, THEOR ECOL-NETH, V6, P333, DOI 10.1007/s12080-013-0185-5
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Priesemann V, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00108
   Priesemann V, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-40
   Prokopenko M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041116
   Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038
   Scarpino S. V., 2017, ARXIV170307317
   Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012
   Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Spinney RE, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.032319
   Wang XR, 2011, ARTIF LIFE, V17, P315, DOI 10.1162/artl_a_00041
   Yeomans J. M., 1992, STAT MECH PHASE TRAN
NR 47
TC 14
Z9 14
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1099-4300
J9 ENTROPY-SWITZ
JI Entropy
PD MAY
PY 2017
VL 19
IS 5
AR 194
DI 10.3390/e19050194
PG 11
WC Physics, Multidisciplinary
SC Physics
GA EZ1EU
UT WOS:000404453700013
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Salata, C
   Calistri, A
   Parolin, C
   Baritussio, A
   Palu, G
AF Salata, Cristiano
   Calistri, Arianna
   Parolin, Cristina
   Baritussio, Aldo
   Palu, Giorgio
TI Antiviral activity of cationic amphiphilic drugs
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE Amiodarone; antivirals; cationic amphiphilic drugs; chloroquine;
   chikungunya virus; Crimean-Congo hemorrhagic fever virus; dengue virus;
   ebola virus; emerging viruses; enterovirus; hepatitis C virus; Herpes
   simplex virus; ion channel blockers; protein kinase inhibitors;
   psychoactive drug; selective estrogen receptor modulators; U18666A; Zika
   virus
ID CHOLESTEROL TRANSPORT INHIBITOR; SMALL-MOLECULE INHIBITORS; C
   VIRUS-INFECTION; EBOLA-VIRUS; DENGUE VIRUS; MEDIATED ENDOCYTOSIS;
   VIRAL-INFECTIONS; LATE ENDOSOMES; CHLOROQUINE; AMIODARONE
AB Introduction: Emerging and reemerging viral infections represent a major concern for human and veterinary public health and there is an urgent need for the development of broad-spectrum antivirals.Areas covered: A recent strategy in antiviral research is based on the identification of molecules targeting host functions required for infection of multiple viruses. A number of FDA-approved drugs used to treat several human diseases are cationic amphiphilic drugs (CADs) that have the ability to accumulate inside cells affecting several structures/functions hijacked by viruses during infection. In this review we summarized the CADs' chemical properties and effects on the cells and reported the main FDA-approved CADs that have been identified so far as potential antivirals in drug repurposing studies.Expert commentary: Although there have been concerns regarding the efficacy and the possible side effects of the off-label use of CADs as antivirals, they seem to represent a promising starting point for the development of broad-spectrum antiviral strategies. Further knowledge about their mechanism of action is required to improve their antiviral activity and to reduce the risk of side effects.
C1 [Salata, Cristiano; Calistri, Arianna; Parolin, Cristina; Palu, Giorgio] Univ Padua, Dept Mol Med, Via Aristide Gabelli 63, I-35121 Padua, Italy.
   [Baritussio, Aldo] Univ Padua, Dept Med, Clin Med 1, Padua, Italy.
RP Salata, C (corresponding author), Univ Padua, Dept Mol Med, Via Aristide Gabelli 63, I-35121 Padua, Italy.
EM cristiano.salata@unipd.it
RI Salata, Cristiano/W-8609-2019
OI Salata, Cristiano/0000-0002-5136-7406
FU University of Padova
FX This work was supported by University of Padova grants (ex60%
   2009-2015).
CR Abdelnabi R, 2016, METHODS MOL BIOL, V1426, P243, DOI 10.1007/978-1-4939-3618-2_22
   Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Ahmad N, 2017, J MOL GRAPH MODEL, V72, P266, DOI 10.1016/j.jmgm.2016.12.010
   Akpovwa H, 2016, CELL BIOCHEM FUNCT, V34, P191, DOI 10.1002/cbf.3182
   Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061
   Avota E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001290
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Baritussio A, 2001, AM J PHYSIOL-LUNG C, V281, pL1189
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015
   Bigler L, 2007, EUR J MED CHEM, V42, P861, DOI 10.1016/j.ejmech.2006.12.031
   Brouwers J, 2008, VIROLOGY, V378, P306, DOI 10.1016/j.virol.2008.06.005
   Calistri A, 2009, REV MED VIROL, V19, P31, DOI 10.1002/rmv.588
   Calistri A, 2013, EXPERT REV ANTI-INFE, V11, P877, DOI 10.1586/14787210.2013.827883
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7
   Chapuy-Regaud S, 2013, BIOCHIMIE, V95, P1677, DOI 10.1016/j.biochi.2013.05.019
   CHATELAIN P, 1985, BIOCHEM BIOPH RES CO, V129, P148, DOI 10.1016/0006-291X(85)91415-9
   Chauhan A, 2015, HIV MED, V16, P585, DOI 10.1111/hiv.12295
   Cheng H, 2015, J VIROL, V89, P9932, DOI 10.1128/JVI.01337-15
   Cheng YL, 2013, CLIN SCI, V125, P439, DOI 10.1042/CS20120594
   Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380
   Daniel JA, 2015, TRAFFIC, V16, P635, DOI 10.1111/tra.12272
   Dash PK, 2016, J VIROL METHODS, V234, P107, DOI 10.1016/j.jviromet.2016.04.011
   Davis W, 2008, CURR ALZHEIMER RES, V5, P448, DOI 10.2174/156720508785908900
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Diaconu I, 2010, J GENE MED, V12, P435, DOI 10.1002/jgm.1453
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Edinger TO, 2015, MBIO, V6, DOI 10.1128/mBio.00297-15
   Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16
   Ferraris O, 2015, ANTIVIR RES, V118, P75, DOI 10.1016/j.antiviral.2015.03.005
   Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802
   Gao HN, 2016, FRONT MED-PRC, V10, P377, DOI 10.1007/s11684-016-0466-7
   Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500
   Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091
   Gignoux E, 2016, NEW ENGL J MED, V374, P23, DOI 10.1056/NEJMoa1504605
   Gnirss K, 2012, VIROLOGY, V424, P3, DOI 10.1016/j.virol.2011.11.031
   Gupta-Wright A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h272
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Jiang BF, 2016, J VIROL, V90, P3330, DOI 10.1128/JVI.03109-15
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   Klintworth A, 2015, ANTIVIR RES, V124, P122, DOI 10.1016/j.antiviral.2015.10.017
   Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101
   Lanini S, 2015, J CLIN INVEST, V125, P4692, DOI 10.1172/JCI83111
   Lee B, 2012, CURR TOP MICROBIOL, V359, P1, DOI 10.1007/978-3-642-29819-6
   Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   McClain L, 2015, ANTIVIR RES, V121, P16, DOI 10.1016/j.antiviral.2015.06.005
   Mendoza EJ, 2016, TRENDS MOL MED, V22, P164, DOI 10.1016/j.molmed.2015.12.005
   Mercer J, 2012, CURR OPIN MICROBIOL, V15, P490, DOI 10.1016/j.mib.2012.05.016
   Miller ME, 2012, J VIROL, V86, P7473, DOI 10.1128/JVI.00136-12
   Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021
   Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010
   Munegato D, 2014, 12 ANN C IT SOC VIR
   Murakami Y, 2013, MICROBES INFECT, V15, P45, DOI 10.1016/j.micinf.2012.10.003
   Nelson EA, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080206
   Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845
   Osman S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18536
   Pakkanen K, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046004
   Paton NI, 2012, JAMA-J AM MED ASSOC, V308, P353, DOI 10.1001/jama.2012.6936
   Paton NI, 2011, LANCET INFECT DIS, V11, P677, DOI 10.1016/S1473-3099(11)70065-2
   Pattanakitsakul SN, 2010, J PROTEOME RES, V9, P4640, DOI 10.1021/pr100357f
   Pernet O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6342
   Piccoli E, 2011, BIOCHEM PHARMACOL, V82, P1234, DOI 10.1016/j.bcp.2011.07.090
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Preston ND, 2013, CURR TOP MICROBIOL, V365, P83, DOI 10.1007/82_2013_317
   Quaglino D, 2004, AM J PHYSIOL-LUNG C, V287, pL438, DOI 10.1152/ajplung.00434.2003
   Roth SL, 2011, FEBS LETT, V585, P865, DOI 10.1016/j.febslet.2011.02.015
   Salata C, 2016, J ANTIMICROB CHEMOTH, V71, P280, DOI 10.1093/jac/dkv305
   Salata C, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv032
   Santos DC, 2015, J MEMBRANE BIOL, V248, P215, DOI 10.1007/s00232-014-9761-x
   Satolli R, 2015, EUR J INTERN MED, V26, P80, DOI 10.1016/j.ejim.2015.01.011
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   SCHLESINGER MJ, 1989, VIROLOGY, V168, P187, DOI 10.1016/0042-6822(89)90421-2
   Schneider-Schaulies J, 2015, BIOL CHEM, V396, P585, DOI 10.1515/hsz-2014-0273
   Shivanna V, 2014, VIROLOGY, V464, P287, DOI 10.1016/j.virol.2014.07.025
   Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Stadler K, 2008, AM J RESP CELL MOL, V39, P142, DOI 10.1165/rcmb.2007-0217OC
   Sun W, 2017, ANTIVIR RES, V137, P165, DOI 10.1016/j.antiviral.2016.11.017
   Takano T, 2011, J HEPATOL, V55, P512, DOI 10.1016/j.jhep.2010.12.011
   Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09
   Tani H, 2014, J VIROL, V88, P7317, DOI 10.1128/JVI.00512-14
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   Wang J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0309
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
   Wolf T, 2015, LANCET, V385, P1428, DOI 10.1016/S0140-6736(14)62384-9
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Wu LQ, 2015, J MED VIROL, V87, P1096, DOI 10.1002/jmv.24135
   Yamasaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106516
   Yan YW, 2013, CELL RES, V23, P300, DOI 10.1038/cr.2012.165
   YANG L, 2016, TOXICOL SCI, V108
   Yang MT, 2016, ANTIVIR RES, V133, P223, DOI 10.1016/j.antiviral.2016.08.010
   Yang ST, 2016, CHEM PHYS LIPIDS, V199, P136, DOI 10.1016/j.chemphyslip.2016.05.003
   Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615
   Zheng K, 2014, BIOCHEM BIOPH RES CO, V446, P990, DOI 10.1016/j.bbrc.2014.03.050
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
NR 105
TC 15
Z9 17
U1 11
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD MAY
PY 2017
VL 15
IS 5
BP 483
EP 492
DI 10.1080/14787210.2017.1305888
PG 10
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA ES5RI
UT WOS:000399600200008
PM 28286997
OA Green Published
DA 2020-07-08
ER

PT J
AU Baaijens, JA
   El Aabidine, AZ
   Rivals, E
   Schonhuth, A
AF Baaijens, Jasmijn A.
   El Aabidine, Amal Zine
   Rivals, Eric
   Schoenhuth, Alexander
TI De novo assembly of viral quasispecies using overlap graphs
SO GENOME RESEARCH
LA English
DT Article
ID GENERATION SEQUENCING DATA; RECONSTRUCTION; INFERENCE; GENOMES; SAMPLE;
   MODEL; TOOL
AB A viral quasispecies, the ensemble of viral strains populating an infected person, can be highly diverse. For optimal assessment of virulence, pathogenesis, and therapy selection, determining the haplotypes of the individual strains can play a key role. As many viruses are subject to high mutation and recombination rates, high-quality reference genomes are often not available at the time of a new disease outbreak. We present SAVAGE, a computational tool for reconstructing individual haplotypes of intra-host virus strains without the need for a high-quality reference genome. SAVAGE makes use of either FM-index-based data structures or ad hoc consensus reference sequence for constructing overlap graphs from patient sample data. In this overlap graph, nodes represent reads and/or contigs, while edges reflect that two reads/contigs, based on sound statistical considerations, represent identical haplotypic sequence. Following an iterative scheme, a new overlap assembly algorithm that is based on the enumeration of statistically well-calibrated groups of reads/contigs then efficiently reconstructs the individual haplotypes from this overlap graph. In benchmark experiments on simulated and on real deep-coverage data, SAVAGE drastically outperforms generic de novo assemblers as well as the only specialized de novo viral quasispecies assembler available so far. When run on ad hoc consensus reference sequence, SAVAGE performs very favorably in comparison with state-of-the-art reference genome-guided tools. We also apply SAVAGE on two deep-coverage samples of patients infected by the Zika and the hepatitis C virus, respectively, which sheds light on the genetic structures of the respective viral quasispecies.
C1 [Baaijens, Jasmijn A.; Schoenhuth, Alexander] Ctr Wiskunde & Informat, NL-1098 XG Amsterdam, Netherlands.
   [El Aabidine, Amal Zine; Rivals, Eric] CNRS, LIRMM, F-34095 Montpellier, France.
   [El Aabidine, Amal Zine; Rivals, Eric] Univ Montpellier, F-34095 Montpellier, France.
   [Rivals, Eric] CNRS, Inst Biol Computat, F-34095 Montpellier, France.
RP Schonhuth, A (corresponding author), Ctr Wiskunde & Informat, NL-1098 XG Amsterdam, Netherlands.; Rivals, E (corresponding author), CNRS, LIRMM, F-34095 Montpellier, France.; Rivals, E (corresponding author), Univ Montpellier, F-34095 Montpellier, France.; Rivals, E (corresponding author), CNRS, Inst Biol Computat, F-34095 Montpellier, France.
EM rivals@lirmm.fr; alexander.schoenhuth@cwi.nl
OI Rivals, Eric/0000-0003-3791-3973; Schonhuth,
   Alexander/0000-0003-3529-0856; Baaijens, Jasmijn/0000-0001-5661-0658
FU Vidi grant by the Netherlands Organisation for Scientific Research (NWO)
   [639.072.309]; Institut de Biologie Computationnelle [ANR-11-BINF-0002];
   ATGC bioinformatics platform; ANR Colib'readFrench National Research
   Agency (ANR) [ANR-12-BS02-0008]; France Genomique
FX A.S. acknowledges funding through Vidi grant 639.072.309, provided by
   the Netherlands Organisation for Scientific Research (NWO). E.R., and
   A.Z.E.A. are supported by the Institut de Biologie Computationnelle
   (ANR-11-BINF-0002), the ATGC bioinformatics platform, ANR Colib'read
   (ANR-12-BS02-0008), and France Genomique.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10
   Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519
   Di Giallonardo F, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku537
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   Eppstein D, 2010, LECT NOTES COMPUT SC, V6506, P403, DOI 10.1007/978-3-642-17517-6_36
   Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086
   Huang Austin, 2011, In Silico Biology, V11, P193, DOI 10.3233/ISB-2012-0454
   Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120
   LI H, 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352
   Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18
   Malhotra R., 2016, ARXIV150204239
   Malhotra R, 2016, ARXIV160404803
   Mangul S, 2014, BIOINFORMATICS, V30, P329, DOI 10.1093/bioinformatics/btu295
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Medvedev P, 2011, J COMPUT BIOL, V18, P1625, DOI 10.1089/cmb.2011.0151
   Mikheenko A, 2016, BIOINFORMATICS, V32, P1088, DOI 10.1093/bioinformatics/btv697
   Prabhakaran S, 2014, IEEE ACM T COMPUT BI, V11, P182, DOI 10.1109/TCBB.2013.145
   Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627
   Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38
   Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111
   Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111
   Topfer A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003515
   Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232
   Valimaki N, 2012, INFORM COMPUT, V213, P49, DOI 10.1016/j.ic.2012.02.002
   Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475
   Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119
   Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
NR 33
TC 17
Z9 18
U1 0
U2 3
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD MAY
PY 2017
VL 27
IS 5
BP 835
EP 848
DI 10.1101/gr.215038.116
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA ET6HP
UT WOS:000400392400018
PM 28396522
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Whilde, J
   Martindale, MQ
   Duffy, DJ
AF Whilde, Jenny
   Martindale, Mark Q.
   Duffy, David J.
TI Precision wildlife medicine: applications of the human-centred precision
   medicine revolution to species conservation
SO GLOBAL CHANGE BIOLOGY
LA English
DT Editorial Material
DE chytridiomycosis; EcoHealth; emerging disease; environmental DNA (eDNA);
   epizootic disease; fibropapillomatosis; One Health; systems medicine;
   wildlife cancer; wildlife disease
ID ST-LAWRENCE ESTUARY; INFECTIOUS-DISEASES; TRANSMISSIBLE CANCER; SYSTEMS
   MEDICINE; GREEN TURTLES; EBOLA-VIRUS; ZIKA VIRUS;
   BATRACHOCHYTRIUM-DENDROBATIDIS; AMPHIBIAN CHYTRIDIOMYCOSIS; PERSONALIZED
   MEDICINE
AB The current species extinction crisis is being exacerbated by an increased rate of emergence of epizootic disease. Human-induced factors including habitat degradation, loss of biodiversity and wildlife population reductions resulting in reduced genetic variation are accelerating disease emergence. Novel, efficient and effective approaches are required to combat these epizootic events. Here, we present the case for the application of human precision medicine approaches to wildlife medicine in order to enhance species conservation efforts. We consider how the precision medicine revolution, coupled with the advances made in genomics, may provide a powerful and feasible approach to identifying and treating wildlife diseases in a targeted, effective and streamlined manner. A number of case studies of threatened species are presented which demonstrate the applicability of precision medicine to wildlife conservation, including sea turtles, amphibians and Tasmanian devils. These examples show how species conservation could be improved by using precision medicine techniques to determine novel treatments and management strategies for the specific medical conditions hampering efforts to restore population levels. Additionally, a precision medicine approach to wildlife health has in turn the potential to provide deeper insights into human health and the possibility of stemming and alleviating the impacts of zoonotic diseases. The integration of the currently emerging Precision Medicine Initiative with the concepts of EcoHealth (aiming for sustainable health of people, animals and ecosystems through transdisciplinary action research) and One Health (recognizing the intimate connection of humans, animal and ecosystem health and addressing a wide range of risks at the animal-human-ecosystem interface through a coordinated, collaborative, interdisciplinary approach) has great potential to deliver a deeper and broader interdisciplinary- based understanding of both wildlife and human diseases.
C1 [Whilde, Jenny; Martindale, Mark Q.; Duffy, David J.] Univ Florida, Whitney Lab Marine Biosci, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.
   [Whilde, Jenny; Martindale, Mark Q.; Duffy, David J.] Univ Florida, Sea Turtle Hosp, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.
   [Duffy, David J.] Univ Coll Dublin, Syst Biol Ireland, Sci Link Bldg, Dublin 4, Ireland.
RP Duffy, DJ (corresponding author), Univ Florida, Whitney Lab Marine Biosci, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.; Duffy, DJ (corresponding author), Univ Florida, Sea Turtle Hosp, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.; Duffy, DJ (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Sci Link Bldg, Dublin 4, Ireland.
EM duffy@whitney.ufl.edu
OI Duffy, David/0000-0002-6075-8855
FU Save Our Seas Foundation [SOSF 356]
FX Warmest thanks to the veterinary and rehabilitation staff of the Sea
   Turtle Hospital at the Whitney Laboratory for such stimulating
   discussions: Catherine Eastman, Rachel Thomas, Brooke Burkhalter, Devon
   Rollinson and Steven Nelson. We are also grateful to three anonymous
   reviewers whose comments helped to improve and strengthen the
   manuscript. Funding was generously provided by the Save Our Seas
   Foundation under project number SOSF 356.
CR Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134
   Aceves Hernandez Christian Arturo, 2014, International Journal of Aquatic Science, V5, P94
   Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016887
   AGUIRRE A. A. AND LUTZ, 2004, ECOHEALTH, V1, P275, DOI DOI 10.1007/S10393-004-0097-3
   [Anonymous], 2012, ECOHEALTH, V9, P371, DOI 10.1007/s10393-013-0812-z
   Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551
   Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037
   Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829
   Bodewes R, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.2
   Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003
   Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009
   Broderick AC, 2006, GLOBAL ECOL BIOGEOGR, V15, P21, DOI 10.1111/j.1466-822x.2006.00195.x
   Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029
   Burkard M, 2015, AQUAT TOXICOL, V167, P240, DOI 10.1016/j.aquatox.2015.08.005
   Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10
   Castagnino N, 2016, WIRES SYST BIOL MED, V8, P314, DOI 10.1002/wsbm.1342
   Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002
   Ciardiello F, 2014, ANN ONCOL, V25, P1673, DOI 10.1093/annonc/mdu217
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL
   Cox-Witton K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095127
   Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054
   Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0
   de Castro DG, 2013, CLIN PHARMACOL THER, V93, P252, DOI 10.1038/clpt.2012.237
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7
   De Vries RD, 2013, GENOME ANNOUNCEMENTS, V1
   Deakin JE, 2012, ANNU REV GENOM HUM G, V13, P207, DOI 10.1146/annurev-genom-090711-163852
   Derville S, 2015, CHELONIAN CONSERV BI, V14, P11, DOI 10.2744/ccab-14-01-11-20.1
   DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425
   Di Guardo G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00112
   Dittmer DP, 2015, CURR OPIN VIROL, V14, P145, DOI 10.1016/j.coviro.2015.09.006
   dos Santos RG, 2010, DIS AQUAT ORGAN, V89, P87, DOI 10.3354/dao02178
   Duarte A, 2012, ARCH VIROL, V157, P1155, DOI 10.1007/s00705-012-1285-z
   Dudgeon CL, 2015, CONSERV GENET, V16, P1443, DOI 10.1007/s10592-015-0752-y
   Duffy DJ, 2016, BRIEF BIOINFORM, V17, P494, DOI 10.1093/bib/bbv060
   Duffy DJ, 2015, ONCOTARGET, V6, P43182, DOI 10.18632/oncotarget.6568
   Ellison AR, 2015, GENOME BIOL EVOL, V7, P286, DOI 10.1093/gbe/evu285
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Flores M, 2013, PERS MED, V10, P565, DOI 10.2217/pme.13.57
   Foley A. M., 2007, DISTRIBUTIONS RELATI
   Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x
   Frank U, 2007, EVOL DEV, V9, P521, DOI 10.1111/j.1525-142X.2007.00191.x
   Gadbury GL, 2004, STAT METHODS MED RES, V13, P325, DOI 10.1191/0962280204sm369ra
   Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gonzalez JP, 2013, CURR TOP MICROBIOL, V365, P337, DOI 10.1007/82_2012_304
   Greaves M, 2015, JAMA-J AM MED ASSOC, V314, P1806, DOI 10.1001/jama.2015.13153
   Grueber CE, 2015, TRENDS GENET, V31, P528, DOI 10.1016/j.tig.2015.05.001
   Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304
   Hamede RK, 2015, P ROY SOC B-BIOL SCI, V282, P122, DOI 10.1098/rspb.2015.1468
   Heard MJ, 2013, CONSERV BIOL, V27, P1378, DOI 10.1111/cobi.12143
   Hirama Shigetomo, 2007, Florida Scientist, V70, P435
   Hoffmann M, 2008, NATURE, V454, P159, DOI 10.1038/454159a
   Hollings T, 2014, CONSERV BIOL, V28, P63, DOI 10.1111/cobi.12152
   Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227
   Hopkin M, 2007, NATURE, V449, P127, DOI 10.1038/449127a
   Hosey G., 2013, ZOO ANIMALS BEHAV MA
   James TY, 2015, ECOL EVOL, V5, P4079, DOI 10.1002/ece3.1672
   Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104
   Jenkins EJ, 2015, TRENDS PARASITOL, V31, P174, DOI 10.1016/j.pt.2015.01.002
   Jones K, 2016, VET J, V212, P48, DOI 10.1016/j.tvjl.2015.10.041
   Karimuribo Esron D., 2012, Onderstepoort j. vet. res., V79, P31
   Kelly DJ, 2011, EUR J WILDLIFE RES, V57, P767, DOI 10.1007/s10344-010-0485-7
   Kingsley Michael C.S., 2002, NAMMCO Scientific Publications, V4, P239
   Lair S, 2016, VET PATHOL, V53, P22, DOI 10.1177/0300985815604726
   Lamb JB, 2011, CONSERV BIOL, V25, P1044, DOI 10.1111/j.1523-1739.2011.01724.x
   Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528
   Martineau D, 2002, ENVIRON HEALTH PERSP, V110, P285, DOI 10.1289/ehp.02110285
   MASAHITO P, 1988, JPN J CANCER RES, V79, P545, DOI 10.1111/j.1349-7006.1988.tb00021.x
   Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a
   McAloose D, 2009, NAT REV CANCER, V9, P517, DOI 10.1038/nrc2665
   McCollister M, 2016, USE UNMANNED AERIAL
   McFarlane R, 2012, ECOHEALTH, V9, P24, DOI 10.1007/s10393-012-0763-9
   McMahon BJ, 2014, EVOL APPL, V7, P999, DOI 10.1111/eva.12193
   Metz TL, 2014, TRACKING INCIDENCE F
   Metzger MJ, 2016, NATURE, V534, P705, DOI 10.1038/nature18599
   Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042
   Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866
   Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065
   Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051
   Muyembe-Tamfum JJ, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.451
   Ostrander EA, 2016, TRENDS GENET, V32, P1, DOI 10.1016/j.tig.2015.10.001
   Page-Karjian A, 2015, ENDANGER SPECIES RES, V28, P135, DOI 10.3354/esr00687
   Page-Karjian A, 2014, J ZOO WILDLIFE MED, V45, P507, DOI 10.1638/2013-0132R1.1
   Page-Karjian A, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-35
   Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Parodi S, 2016, METHODS MOL BIOL, V1386, P181, DOI 10.1007/978-1-4939-3283-2_10
   Pereira PLL, 2013, REV SCI TECH OIE, V32, P857
   Pokorska-Bocci A, 2014, PERS MED, V11, P197, DOI 10.2217/pme.13.107
   Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006
   Pye RJ, 2016, P NATL ACAD SCI USA, V113, P374, DOI 10.1073/pnas.1519691113
   Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10
   Rapisuwon S, 2016, COMPUT STRUCT BIOTEC, V14, P211, DOI 10.1016/j.csbj.2016.05.004
   Rebollar EA, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00063, 10.3389/fmicb.2016.00068]
   Reif JS, 2011, PUBLIC HEALTH REP, V126, P50, DOI 10.1177/00333549111260S108
   Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080
   Roskens VA, 2010, J PROTEOME RES, V9, P5484, DOI 10.1021/pr100284n
   Saito M, 2016, CANCER SCI, V107, P713, DOI 10.1111/cas.12941
   Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1
   Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066
   Shea M, 2016, THER ADV RESPIR DIS, V10, P113, DOI 10.1177/1753465815617871
   Skerratt LF, 2016, WILDLIFE RES, V43, P105, DOI 10.1071/WR15071
   Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x
   The CASyM Consortium, 2014, CASYM ROADM IMPL SYS
   Thompson RCA, 2013, INT J PARASITOL, V43, P1079, DOI 10.1016/j.ijpara.2013.06.007
   Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019
   Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450
   Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219
   Tompkins DM, 2015, TRENDS PARASITOL, V31, P149, DOI 10.1016/j.pt.2015.01.007
   Tortolina L, 2015, ONCOTARGET, V6, P5041, DOI 10.18632/oncotarget.3238
   *US DEP HHS, 1995, TOX PROF POL AR HYDR
   Vandamme D, 2013, QJM-INT J MED, V106, P891, DOI 10.1093/qjmed/hct163
   Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56
   Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2
   Walker SF, 2007, DIS AQUAT ORGAN, V77, P105, DOI 10.3354/dao01850
   Welsh JS, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2010-0301
   Wiethoelter AK, 2015, P NATL ACAD SCI USA, V112, P9662, DOI 10.1073/pnas.1422741112
   Williams Ernest H. Jr., 1994, Journal of Aquatic Animal Health, V6, P70, DOI 10.1577/1548-8667(1994)006&lt;0070:AEOCFI&gt;2.3.CO;2
   Wolf TM, 2014, AM J PRIMATOL, V76, P2, DOI 10.1002/ajp.22197
   Woods GM, 2015, J IMMUNOL, V195, P23, DOI 10.4049/jimmunol.1500131
   Yap TA, 2015, SCIENCE, V349, P481, DOI 10.1126/science.aab1052
   Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381
NR 128
TC 7
Z9 7
U1 5
U2 75
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-1013
EI 1365-2486
J9 GLOBAL CHANGE BIOL
JI Glob. Change Biol.
PD MAY
PY 2017
VL 23
IS 5
BP 1792
EP 1805
DI 10.1111/gcb.13548
PG 14
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA EQ1AB
UT WOS:000397800600005
PM 27809394
DA 2020-07-08
ER

PT J
AU Garcia-Minambres, A
   Eid, SG
   Mangan, NE
   Pade, C
   Lim, SS
   Matthews, AY
   de Weerd, NA
   Hertzog, PJ
   Mak, J
AF Garcia-Minambres, Albert
   Eid, Sahar G.
   Mangan, Niamh E.
   Pade, Corinna
   Lim, San S.
   Matthews, Antony Y.
   de Weerd, Nicole A.
   Hertzog, Paul J.
   Mak, Johnson
TI Interferon epsilon promotes HIV restriction at multiple steps of viral
   replication
SO IMMUNOLOGY AND CELL BIOLOGY
LA English
DT Article
ID FEMALE GENITAL-TRACT; MENSTRUAL-CYCLE; RHESUS MACAQUES; ZIKA VIRUS;
   INFECTION; TRANSMISSION; RELEASE; PROTEIN; GENES; IFN
AB Interferon epsilon (IFN epsilon) is a type I IFN that is expressed constitutively in the female reproductive tract (FRT), and contributes to protection in models of sexually transmitted infections. Using multiple cell systems, including reporter cell lines and activated peripheral blood lymphocytes (PBLs), we show that recombinant IFN epsilon impairs HIV infection at stage(s) post HIV entry and up to the translation of viral proteins. Consistent with this, IFN epsilon upregulated a number of host cell restriction factors that block HIV at these stages of the replication cycle. The potency of IFNe induction of these HIV restriction factors was comparable to conventional type I IFNs, namely IFN alpha and IFN beta. IFNe also significantly reduced the infectivity of progeny virion particles likely by inducing expression of HIV restriction factors, such as IFITM3, which act at that stage of infection. Thus, our data demonstrate that human IFN epsilon suppresses HIV replication at multiple stages of infection.
C1 [Garcia-Minambres, Albert; Eid, Sahar G.; Pade, Corinna; Mak, Johnson] Deakin Univ, Sch Med, 75 Pigdons Rd, Geelong, Vic 3220, Australia.
   [Garcia-Minambres, Albert; Eid, Sahar G.; Pade, Corinna; Mak, Johnson] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.
   [Mangan, Niamh E.; Lim, San S.; Matthews, Antony Y.; de Weerd, Nicole A.; Hertzog, Paul J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.
   [Mangan, Niamh E.; Lim, San S.; Matthews, Antony Y.; de Weerd, Nicole A.; Hertzog, Paul J.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia.
RP Mak, J (corresponding author), Deakin Univ, Sch Med, 75 Pigdons Rd, Geelong, Vic 3220, Australia.; Hertzog, PJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.
EM paul.hertzog@hudson.org.au; johnson.mak@deakin.edu.au
RI de Weerd, Nicole/X-5886-2019; mak, johnson/H-4605-2014; mak,
   johnson/S-2457-2019; Hertzog, Paul/I-7053-2013
OI de Weerd, Nicole/0000-0002-7985-189X; mak, johnson/0000-0002-5229-5707;
   mak, johnson/0000-0002-5229-5707; Mangan, Niamh/0000-0003-3844-0709;
   Hertzog, Paul/0000-0002-1373-8472
FU Australian National Health and Medical Research Council (NHMRC)National
   Health and Medical Research Council of Australia [APP1027020,
   APP1049686]; Australian Research Council FellowshipAustralian Research
   Council [DP110103616]; Australian NHMRC ProjectNational Health and
   Medical Research Council of Australia [APP1070782]; Australian Centre
   for HIV and Hepatitis Virology Research [2013-34, 2015-12]; Monash
   University Faculty of Medicine, Nursing and Health Sciences Strategic
   Platform Grant [ECP003]; Deakin University scholarships; Victorian
   Government's Operational Infrastructure Support Program; National
   Collaborative Research Infrastructure Strategy (NCRIS)Australian
   GovernmentDepartment of Industry, Innovation and Science; Australian
   Microscopy & Microanalysis Research Facility linked laboratory at the
   CSIRO Australian Animal Health laboratories
FX This work was supported by: an Australian National Health and Medical
   Research Council (NHMRC) Senior Principal Research Fellowship
   (APP1027020) and Project Grant (APP1049686) awarded to PJH; an
   Australian Research Council Fellowship awarded to NEM (DP110103616); an
   Australian NHMRC Project Grant awarded to NAdW (APP1070782); grants
   awarded to PJH, NEM and JM by the Australian Centre for HIV and
   Hepatitis Virology Research (2013-34; 2015-12); a Monash University
   Faculty of Medicine, Nursing and Health Sciences Strategic Platform
   Grant (ECP003) awarded to NEM; and a Deakin University scholarships to
   AGM and CP. Research at the Hudson Institute is supported by the
   Victorian Government's Operational Infrastructure Support Program. We
   thank Rebecca Smith for her critical evaluation of the manuscript. The
   authors acknowledge the technical assistance from Megan Dearnley and
   staff in the Pathology and Pathogenesis team and the facilities
   partially funded by the National Collaborative Research Infrastructure
   Strategy (NCRIS) and the Australian Microscopy & Microanalysis Research
   Facility linked laboratory at the CSIRO Australian Animal Health
   laboratories.
CR Abdulhaqq SA, 2016, MUCOSAL IMMUNOL, V9, P1027, DOI 10.1038/mi.2015.116
   Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997
   Byrne EH, 2016, LANCET INFECT DIS, V16, P441, DOI 10.1016/S1473-3099(15)00429-6
   Coelho AVC, 2015, CURR HIV RES, V13, P125, DOI 10.2174/1570162X13999150317155040
   Curlin ME, 2013, J INFECT DIS, V207, P1616, DOI 10.1093/infdis/jit063
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Demers A, 2014, J LEUKOCYTE BIOL, V96, P1101, DOI 10.1189/jlb.3A0214-088RRR
   Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449
   Eid SG, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.23
   Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321
   Fuss IJ, 2001, CURR PROTOC IMMUNOL
   Gomez AM, 2015, J IMMUNOL, V194, P2300, DOI 10.4049/jimmunol.1402147
   Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542
   Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448
   Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653
   Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483
   Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015
   Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10
   Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084
   Montefiori D.C., 2005, CURR PROTOC IMMUNOL, V12, P11, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]
   Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778
   Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553
   Noguchi LM, 2015, LANCET HIV, V2, pE279, DOI 10.1016/S2352-3018(15)00058-2
   Peng FW, 2007, PROTEIN EXPRES PURIF, V53, P356, DOI 10.1016/j.pep.2006.12.013
   Ralph LJ, 2015, LANCET INFECT DIS, V15, P181, DOI 10.1016/S1473-3099(14)71052-7
   Saba E, 2013, MUCOSAL IMMUNOL, V6, P1081, DOI 10.1038/mi.2013.2
   Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939
   Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156
   Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y
   Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001
   Veazey RS, 2016, MUCOSAL IMMUNOL, V9, P1528, DOI 10.1038/mi.2015.146
   Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3
   Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778
   Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4
   Woods MW, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-95
   Woods MW, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-27
NR 41
TC 19
Z9 21
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0818-9641
EI 1440-1711
J9 IMMUNOL CELL BIOL
JI Immunol. Cell Biol.
PD MAY-JUN
PY 2017
VL 95
IS 5
BP 478
EP 483
DI 10.1038/icb.2016.123
PG 6
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA EW3JU
UT WOS:000402392400010
PM 28045025
DA 2020-07-08
ER

PT J
AU Melo, ASD
   Chimelli, L
   Tanuri, A
AF de Oliveira Melo, Adriana Suely
   Chimelli, Leila
   Tanuri, Amilcar
TI Congenital Zika Virus Infection: Beyond Neonatal Microcephaly Reply
SO JAMA NEUROLOGY
LA English
DT Letter
ID CASE SERIES
C1 [de Oliveira Melo, Adriana Suely] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely] Inst Saude Elpidio Almeida, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely] Hosp Municipal Pedro I, Campina Grande, Paraiba, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, CCS Bloco A Sala 121, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM atanuri1@gmail.com
RI Melo, Adriana S O/H-5650-2016
CR Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
NR 5
TC 4
Z9 5
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD MAY
PY 2017
VL 74
IS 5
BP 610
EP 611
DI 10.1001/jamaneurol.2017.0051
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA EU2EE
UT WOS:000400838900028
PM 28319244
DA 2020-07-08
ER

PT J
AU Yepez, JB
   Murati, FA
   Pettito, M
   Penaranda, CF
   de Yepez, J
   Maestre, G
   Arevalo, JF
AF Yepez, Juan B.
   Murati, Felipe A.
   Pettito, Michele
   Penaranda, Carlos F.
   de Yepez, Jazmin
   Maestre, Gladys
   Arevalo, J. Fernando
CA Johns Hopkins Zika Ctr
TI Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and
   Venezuela
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID VIRUS; TRANSMISSION; STATES; BRAZIL
AB IMPORTANCE The ocular manifestations and sequelae of Zika virus infection are not well known. Recently, theWorld Health Organization changed the declaration of Zika as a public health emergency and designated the viral outbreak and related microcephaly clusters as a long-term program of work. This change indicates the urgent need to evaluate and document ophthalmic manifestations in patients for timely management of this disease. In addition, confirmation whether the public health problem in Brazil extends to other regions in South America is needed.
   OBJECTIVE To report the ocular manifestations of congenital Zika syndrome with microcephaly in Colombia and Venezuela.
   DESIGN, SETTING, AND PARTICIPANTS This prospective case series included 43 patients from 2 ophthalmic centers in Colombia and Venezuela who underwent evaluation from October 1, 2015, through June 30, 2016, and were clinically diagnosed with congenital Zika syndrome. Twenty patients were Hispanic; 13, African; 8, white; and 2, Native American. INTERVENTIONS Ophthalmic and systemic evaluations and serologic testing were performed on all infants. Patients underwent external ocular examination and dilated ophthalmoscopy. Serologic testing ruled out toxoplasmosis, rubella, cytomegalovirus, syphilis, and human immunodeficiency virus.
   MAIN OUTCOMES AND MEASURES Ophthalmic manifestations of congenital Zika syndrome.
   RESULTS Of the 43 patients included in this series (28 female and 15 male), the mean (SD) age at examination was 2.1 (1.5) months. The mothers of all the children had no ophthalmic findings and did not report ocular symptoms during pregnancy. All patients had bilateral ophthalmic manifestations. Optic nerve findings included hypoplasia with the double-ring sign, pallor, and increased cup-disc ratio in 5 patients (11.6%). Macular abnormalities included mild to severe pigment mottling in 27 patients (63%) and lacunar maculopathy in 3 (6.9%). Chorioretinal scarring was present in 3 patients (7%). Eleven patients (26%) had a combination of lesions in the posterior pole. Five patients (12%) were diagnosed with congenital glaucoma, characterized by the clinical triad of epiphora, photophobia, and blepharospasm; increased intraocular pressure; corneal clouding at birth; and buphthalmos. These data reveal that 12%(95% CI, 5%-24%) of cases of congenital Zika with microcephaly had anterior segment abnormalities and 88%(95% CI, 76%-94%) had important macular and optic nerve abnormalities. The visual sequelae of these ophthalmic manifestations remain unknown.
   CONCLUSIONS AND RELEVANCE Congenital Zika syndrome in the current study had severe ocular abnormalities, and all patients had bilateral involvement. Ocular findings were focal macular pigment mottling, chorioretinal atrophy with a predilection for the macular area, congenital glaucoma and optical nerve hypoplasia, and optic disc abnormalities. Ophthalmic examination is recommended in patients with congenital Zika syndrome.
C1 [Arevalo, J. Fernando] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Retina Div, 600 N Wolfe St,Maumenee 708, Baltimore, MD 21287 USA.
   [Yepez, Juan B.; Murati, Felipe A.] Clin Ojos, Dept Vitreoretinal Surg, Maracaibo, Venezuela.
   [Yepez, Juan B.] King Khalid Eye Specialist Hosp, Vitreoretinal Div, Riyadh, Saudi Arabia.
   [Pettito, Michele] Clin Ojos, Dept Glaucoma, Maracaibo, Venezuela.
   [Penaranda, Carlos F.] Clin Oftalmol Penaranda, Cucuta, Colombia.
   [de Yepez, Jazmin] Clin Ojos, Dept Pediat Ophthalmol, Maracaibo, Venezuela.
   [Maestre, Gladys] Univ Texas Brownsville, Rio Grande Valley Sch Med, Dept Biomed Sci, Div Neurosci, Brownsville, TX 78520 USA.
   [Arevalo, J. Fernando] Johns Hopkins Univ, Sch Med, Johns Hopkins Zika Ctr, Baltimore, MD USA.
RP Arevalo, JF (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Retina Div, 600 N Wolfe St,Maumenee 708, Baltimore, MD 21287 USA.
EM arevalojf@jhmi.edu
RI Aracena, Javier/AAN-4562-2020; , Gladys/L-5092-2015
OI , Gladys/0000-0001-5690-8833
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053
   GIVENS KT, 1993, BRIT J OPHTHALMOL, V77, P358, DOI 10.1136/bjo.77.6.358
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E, 2014, EURO SURVEILL, V19
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization, 2017, REG ZIK EP UPD AM FE
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization (WHO), 5 M EM COMM INT HLTH
NR 24
TC 37
Z9 37
U1 4
U2 20
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAY
PY 2017
VL 135
IS 5
BP 440
EP 445
DI 10.1001/jamaophthalmol.2017.0561
PG 6
WC Ophthalmology
SC Ophthalmology
GA EU5ZN
UT WOS:000401113400011
PM 28418539
OA Green Published
DA 2020-07-08
ER

PT J
AU Kapogiannis, BG
   Chakhtoura, N
   Hazra, R
   Spong, CY
AF Kapogiannis, Bill G.
   Chakhtoura, Nahida
   Hazra, Rohan
   Spong, Catherine Y.
TI Bridging Knowledge Gaps to Understand HowZika Virus Exposure and
   Infection Affect Child Development
SO JAMA PEDIATRICS
LA English
DT Review
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; FRAGILE-X-SYNDROME; AUTISM
   SPECTRUM DISORDERS; ZIKA VIRUS; MATERNAL INFECTION; CEREBRAL MALARIA;
   BIRTH-DEFECTS; INFANTS; BRAIN; PREGNANCY
AB IMPORTANCE The Zika virus (ZIKV) epidemic has profoundly affected the lives of children and families across the Americas. As the number of children born with ZIKV-related complications continues to grow, the long-term developmental trajectory for these children and the effect on their families remains largely unknown. In September 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human Development and partner National Institutes of Health institutes convened a workshop to develop a research agenda to improve the evaluation, monitoring, and management of neonates, infants, or children affected by ZIKV and its complications. The agenda also aims to optimally address the prospective effect of ZIKV exposure on the developing child.
   OBSERVATIONS The full clinical spectrum of congenital ZIKV syndrome has yet to be elucidated. In addition to the well-described anatomic and neurologic manifestations, clinicians are now describing infants with exaggerated primitive reflexes, epilepsy, acquired hydrocephalus and microcephaly, neurodevelopmental delay, gastrointestinal motility problems, and respiratory complications, such as pneumonia. While we are still learning more about themyriad clinical presentations in these severely affected children, it is also paramount to address the larger proportion of ZIKV-exposed infants who are asymptomatic at birth but, we assume, may develop problems later in life. The available evidence for neurologic, neurodevelopmental, neurobehavioral, auditory, and vision assessments and management for infants with congenital ZIKV syndrome was critically evaluated. Lessons from other congenital infections provide valuable clues about the complexities of management and the optimal approaches for evaluating, treating, and caring for the children, which include engaging and involving parents and caregivers in their treatment.
   CONCLUSIONS AND RELEVANCE Rigorous research is key to improving the identification of ZIKV-infected mothers and babies. Research also is critical to increasing basic understanding of the neuropathogenesis of congenital ZIKV disease and of the spectrum of clinical presentations of ZIKV infection so that agents to prevent and treat this devastating disease can be rapidly developed and studied.
C1 [Kapogiannis, Bill G.; Chakhtoura, Nahida; Hazra, Rohan; Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA.
RP Kapogiannis, BG (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Maternal & Pediat Infect Dis Branch, 6710B Rockledge Dr,Rm 2150,MSC 7002, Bethesda, MD 20892 USA.
EM kapogiannisb@mail.nih.gov
CR Abbeduto L, 2004, AM J MENT RETARD, V109, P237, DOI 10.1352/0895-8017(2004)109<237:PWACIM>2.0.CO;2
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293
   Bordley J E, 1968, Acta Otolaryngol, V66, P1, DOI 10.3109/00016486809126266
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BROOKHOUSER PE, 1973, ARCH OTOLARYNGOL, V98, P252
   Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   CONBOY TJ, 1987, J PEDIATR-US, V111, P343, DOI 10.1016/S0022-3476(87)80451-1
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dahle A J, 2000, J Am Acad Audiol, V11, P283
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Paula Freitas B, JAMA OPHTHALMOL
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Greenberg JS, 2006, AM J MENT RETARD, V111, P229, DOI 10.1352/0895-8017(2006)111[229:BEOEEA]2.0.CO;2
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Idro R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1233-6
   Jiang HY, 2016, BRAIN BEHAV IMMUN, V58, P165, DOI 10.1016/j.bbi.2016.06.005
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Leal MC, BRAZ J OTORHINOLARYN
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   McDuffie A, 2016, AM J SPEECH-LANG PAT, V25, P46, DOI 10.1044/2015_AJSLP-14-0137
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pinninti SG, 2016, PEDIATR INFECT DIS J, V35, P924, DOI 10.1097/INF.0000000000001194
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105
   Rogers SJ, 2014, J AUTISM DEV DISORD, V44, P2981, DOI 10.1007/s10803-014-2202-y
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Semrud-Clikeman M, CHILD NEUROPSYCHOL
   Siller M, 2002, J AUTISM DEV DISORD, V32, P77, DOI 10.1023/A:1014884404276
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   US Centers for Disease Control and Prevention, 2016, UPD INT GUID EV MAN
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Warren SF, 2010, AJIDD-AM J INTELLECT, V115, P54, DOI 10.1352/1944-7558-115.1.54
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 68
TC 32
Z9 34
U1 0
U2 13
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD MAY
PY 2017
VL 171
IS 5
BP 478
EP 485
DI 10.1001/jamapediatrics.2017.0002
PG 8
WC Pediatrics
SC Pediatrics
GA ET6EU
UT WOS:000400384600020
PM 28241263
DA 2020-07-08
ER

PT J
AU Racicot, K
   Mor, G
AF Racicot, Karen
   Mor, Gil
TI Risks associated with viral infections during pregnancy
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Review
ID HERPES-SIMPLEX-VIRUS; HUMAN FETOPLACENTAL VASCULOGENESIS;
   EPSTEIN-BARR-VIRUS; INFLUENZA-A H1N1; CONGENITAL
   CYTOMEGALOVIRUS-INFECTION; FETAL-BRAIN DEVELOPMENT; ZIKA VIRUS;
   HUMAN-PAPILLOMAVIRUS; GENITAL HERPES; UNITED-STATES
AB Despite the prevalence of viral infections in the American population, we still have a limited understanding of how they affect pregnancy and fetal development. Viruses can gain access to the decidua and placenta by ascending from the lower reproductive tract or via hematogenous transmission. Viral tropism for the decidua and placenta is then dependent on viral entry receptor expression in these tissues as well as on the maternal immune response to the virus. These factors vary by cell type and gestational age and can be affected by changes to the in utero environment and maternal immunity. Some viruses can directly infect the fetus at specific times during gestation, while some only infect the placenta. Both scenarios can result in severe birth defects or pregnancy loss. Systemic maternal viral infections can also affect the pregnancy, and these can be especially dangerous, because pregnant women suffer higher virus-associated morbidity and mortality than do nonpregnant counterparts. In this Review, we discuss the potential contributions of maternal, placental, and fetal viral infection to pregnancy outcome, fetal development, and maternal well-being.
C1 [Racicot, Karen] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA.
   [Mor, Gil] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
RP Mor, G (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, 333 Cedar St,LSOG 305A, New Haven, CT 06520 USA.
EM gil.mor@yale.edu
OI Mor, Gil/0000-0002-5499-3912
FU National Institute of Allergy and Infectious Diseases (NIAID), NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [1R56AI124356-01]
FX This work was funded in part by a grant from the National Institute of
   Allergy and Infectious Diseases (NIAID), NIH (1R56AI124356-01).
CR AHLFORS K, 1986, PEDIATRICS, V78, P1058
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Anderson BL, 2011, AM J OBSTET GYNECOL, V204, pS31, DOI 10.1016/j.ajog.2011.02.040
   ANZIC INV, 2010, BMJ-BRIT MED J, V340, pC1279, DOI DOI 10.1136/bmj.c1279
   Arechavaleta-Velasco F, 2008, HUM REPROD, V23, P29, DOI 10.1093/humrep/dem360
   Arechavaleta-Velasco F, 2002, J REPROD IMMUNOL, V55, P113, DOI 10.1016/S0165-0378(01)00143-7
   Arechavaleta-Velasco F, 2006, AM J PATHOL, V168, P1951, DOI 10.2353/ajpath.2006.050781
   ATMAR RL, 1992, CLIN INFECT DIS, V14, P217, DOI 10.1093/clinids/14.1.217
   Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bello O. O., 2016, CASE REP OBSTET GYNE, V2016
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052
   Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774
   Brown ZA, 1996, OBSTET GYNECOL, V87, P483, DOI 10.1016/0029-7844(95)00457-2
   BROWN ZA, 1987, NEW ENGL J MED, V317, P1246, DOI 10.1056/NEJM198711123172002
   Buka SL, 2001, BRAIN BEHAV IMMUN, V15, P411, DOI 10.1006/brbi.2001.0644
   Buka SL, 2008, BIOL PSYCHIAT, V63, P809, DOI 10.1016/j.biopsych.2007.09.022
   Burd I, 2016, ADV PHARMACOL, V76, P85, DOI 10.1016/bs.apha.2016.02.003
   Burguete T, 1999, HUM REPROD, V14, P2396, DOI 10.1093/humrep/14.9.2396
   Callaghan WM, 2010, OBSTET GYNECOL, V115, P919, DOI 10.1097/AOG.0b013e3181d99d85
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Caserta MT, 2007, J INFECT DIS, V196, P1296, DOI 10.1086/522430
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757
   Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Choi G, 2016, SCIENCE, V351
   Chou D, 2006, AM J OBSTET GYNECOL, V194, P535, DOI 10.1016/j.ajog.2005.07.073
   CHRISTENSEN PE, 1953, ACTA MED SCAND, V144, P430
   COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192
   Cordeiro CN, 2015, OBSTET GYNECOL SURV, V70, P644, DOI 10.1097/OGX.0000000000000236
   Clemens SAC, 2010, REV SAUDE PUBL, V44, P726, DOI [10.1590/S0034-89102010000400017, 10.1590/s0034-89102010000400017]
   Creanga AA, 2011, AM J OBSTET GYNECOL, V204, pS38, DOI 10.1016/j.ajog.2011.02.037
   Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dell'Ovo V, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.05.007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Ellington SR, 2011, AM J OBSTET GYNECOL, V204, pS21, DOI 10.1016/j.ajog.2011.02.038
   Enright Andrea M, 2002, Semin Neonatol, V7, P283, DOI 10.1053/siny.2002.0115
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101
   Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606
   Finger-Jardim F, 2014, J MED VIROL, V86, P519, DOI 10.1002/jmv.23817
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gibson CS, 2006, BRIT MED J, V332, P76, DOI 10.1136/bmj.38668.616806.3A
   Goldstein JM, 2014, PSYCHOL MED, V44, P3249, DOI 10.1017/S0033291714000683
   Gomez LM, 2008, HUM REPROD, V23, P709, DOI 10.1093/humrep/dem404
   GRANAT M, 1986, ISRAEL J MED SCI, V22, P455
   GREGG NM, 1991, EPIDEMIOL INFECT, V107, pR3, DOI 10.1017/S0950268800048627
   GRIFFITHS PD, 1984, BRIT J OBSTET GYNAEC, V91, P307, DOI 10.1111/j.1471-0528.1984.tb05915.x
   GRONROOS M, 1983, BRIT J OBSTET GYNAEC, V90, P167, DOI 10.1111/j.1471-0528.1983.tb08903.x
   HAAKE DA, 1990, REV INFECT DIS, V12, P788
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182
   Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hollier LM, 2005, CLIN PERINATOL, V32, P671, DOI 10.1016/j.clp.2005.05.003
   Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959
   Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Jones CA, 2009, DRUGS, V69, P421, DOI 10.2165/00003495-200969040-00003
   Jun Y, 2000, J IMMUNOL, V164, P805, DOI 10.4049/jimmunol.164.2.805
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x
   Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x
   Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325
   Koi H, 2001, BIOL REPROD, V64, P1001, DOI 10.1095/biolreprod64.3.1001
   Li DK, 2014, AM J EPIDEMIOL, V180, P1109, DOI 10.1093/aje/kwu242
   Liu T, 2015, INT J CLIN EXP MED, V8, P17248
   Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcelin G, 2011, J VIROL, V85, P11208, DOI 10.1128/JVI.00654-11
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   McGee D, 2016, AM J REPROD IMMUNOL, V76, pG86
   MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013
   Meissner HC, 2006, PEDIATRICS, V117, P933, DOI 10.1542/peds.2005-1760
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Michaan N, 2012, J MATERN-FETAL NEO M, V25, P130, DOI 10.3109/14767058.2011.562569
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nakai A, 2012, J OBSTET GYNAECOL RE, V38, P757, DOI 10.1111/j.1447-0756.2011.01812.x
   NORSKOVLAURITSEN N, 1992, J MED VIROL, V36, P162, DOI 10.1002/jmv.1890360303
   Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763
   Parry S, 1998, AM J PATHOL, V152, P1521
   PARYANI SG, 1986, NEW ENGL J MED, V314, P1542, DOI 10.1056/NEJM198606123142403
   Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003
   Piccinni Marie-Pierre, 2016, Clin Mol Allergy, V14, P11, DOI 10.1186/s12948-016-0048-x
   PRICE ME, 1988, BRIT MED J, V297, P584, DOI 10.1136/bmj.297.6648.584
   Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824
   Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501
   Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rasmussen SA, 2011, AM J OBSTET GYNECOL, V204, pS13, DOI 10.1016/j.ajog.2011.01.048
   Reddick KLB, 2011, J VIRAL HEPATITIS, V18, pE394, DOI 10.1111/j.1365-2893.2011.01436.x
   Reef SE, 2002, JAMA-J AM MED ASSOC, V287, P464, DOI 10.1001/jama.287.4.464
   Reef SE, 2006, CLIN INFECT DIS, V43, pS123, DOI 10.1086/505943
   Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045
   ROBB JA, 1986, HUM PATHOL, V17, P1196, DOI 10.1016/S0046-8177(86)80561-5
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Rombaldi RL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-106
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Salzberger B, 1997, J INFECT DIS, V176, P778, DOI 10.1086/517300
   Sarkola M, 2008, ACTA OBSTET GYN SCAN, V87, P1181, DOI 10.1080/00016340802468308
   Schust DJ, 1996, J IMMUNOL, V157, P3375
   Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Slatter TL, 2015, MODERN PATHOL, V28, P1369, DOI 10.1038/modpathol.2015.88
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tanaka K, 2006, J MED VIROL, V78, P757, DOI 10.1002/jmv.20619
   TAYLOR Y, 1994, J CLIN PATHOL, V47, P92, DOI 10.1136/jcp.47.1.92
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   TOBIASCH E, 1994, J MED VIROL, V44, P215, DOI 10.1002/jmv.1890440218
   Vanarsdall AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002905
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   von Dadelszen P, 2003, BJOG-INT J OBSTET GY, V110, P725, DOI 10.1111/j.1471-0528.2003.02481.x
   Watanabe T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001218
   Weyn C, 2011, J INFECT DIS, V203, P341, DOI 10.1093/infdis/jiq056
   Xie F, 2014, AM J REPROD IMMUNOL, V71, P379, DOI 10.1111/aji.12199
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zuo Z, 2011, AM J CLIN PATHOL, V136, P260, DOI 10.1309/AJCP93JMIUEKRPIW
   이상협, 2013, [The Journal of Korea Robotics Society, 로봇학회 논문지], V8, P8, DOI 10.7746/jkros.2013.8.1.008
NR 142
TC 28
Z9 29
U1 0
U2 20
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD MAY 1
PY 2017
VL 127
IS 5
BP 1591
EP 1599
DI 10.1172/JCI87490
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ET6DM
UT WOS:000400381000001
PM 28459427
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU L'Huillier, AG
   Lombos, E
   Tang, E
   Perusini, S
   Eshaghi, A
   Nagra, S
   Frantz, C
   Olsha, R
   Kristjanson, E
   Dimitrova, K
   Safronetz, D
   Drebot, M
   Gubbay, JB
AF L'Huillier, Arnaud G.
   Lombos, Ernesto
   Tang, Elaine
   Perusini, Stephen
   Eshaghi, Alireza
   Nagra, Sandeep
   Frantz, Christine
   Olsha, Romy
   Kristjanson, Erik
   Dimitrova, Kristina
   Safronetz, David
   Drebot, Mike
   Gubbay, Jonathan B.
TI Evaluation of Altona Diagnostics RealStar Zika Virus Reverse
   Transcription-PCR Test Kit for Zika Virus PCR Testing
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE diagnostic testing; PCR; Zika virus; flavivirus
ID TIME RT-PCR; CHIKUNGUNYA VIRUS; INTERIM GUIDANCE; OUTBREAK; RNA;
   EPIDEMIC; DISEASE; STATES; ISLAND; URINE
AB With the emerging Zika virus (ZIKV) epidemic, accessible real-time reverse transcription-PCR (rRT-PCR) assays are needed to streamline testing. The commercial Altona Diagnostics RealStar ZIKV rRT-PCR test kit (Altona PCR) has been approved for emergency use authorization by the U.S. FDA. Our aim was to verify the Altona PCR by comparing it to the CDC-designed dual-target ZIKV rRT-PCR reference assay (reference PCR) and describe the demographics of patients tested for ZIKV by rRT-PCR in Ontario, Canada. A large set of clinical specimens was tested for ZIKV by the Altona PCR and the reference PCR. Positive or equivocal specimens underwent PCR and Sanger sequencing targeting the ZIKV NS5 gene. A total of 671 serum specimens were tested by the reference PCR: 58 (8.6%) were positive, 193 (28.8%) were equivocal, and 420 (62.6%) were negative. Ninety percent of the reference PCR-positive patients were tested in the first 5 days after symptom onset. The Altona PCR was performed on 284/671 specimens tested by the reference PCR. The Altona PCR was positive for 53/58 (91%) reference PCR-positive specimens and 16/193 (8%) reference PCR-equivocal specimens; the ZIKV NS5 PCR was positive for all 68 Altona PCR-positive specimens and negative for all 181 Altona PCR-negative specimens that underwent the NS5 PCR. The Altona PCR has very good sensitivity (91%) and specificity (97%) compared to the reference PCR. The Altona PCR can be used for ZIKV diagnostic testing and has less extensive verification requirements than a laboratory-developed test.
C1 [L'Huillier, Arnaud G.; Gubbay, Jonathan B.] Hosp Sick Children, Toronto, ON, Canada.
   [Lombos, Ernesto; Tang, Elaine; Perusini, Stephen; Eshaghi, Alireza; Nagra, Sandeep; Frantz, Christine; Olsha, Romy; Kristjanson, Erik; Gubbay, Jonathan B.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Dimitrova, Kristina; Safronetz, David; Drebot, Mike] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Gubbay, Jonathan B.] Univ Toronto, Toronto, ON, Canada.
RP Gubbay, JB (corresponding author), Hosp Sick Children, Toronto, ON, Canada.; Gubbay, JB (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Gubbay, JB (corresponding author), Univ Toronto, Toronto, ON, Canada.
EM jonathan.gubbay@oahpp.ca
RI Gubbay, Jonathan/Q-8580-2019; L'Huillier, Arnaud/AAI-1872-2019
OI Gubbay, Jonathan/0000-0003-0026-3786; L'Huillier,
   Arnaud/0000-0001-9230-7285; Eshaghi, Alireza/0000-0001-5150-483X
FU Public Health Ontario; GlaxoSmithKline Inc.GlaxoSmithKline; Hoffman-La
   Roche Ltd.; Pfizer IncPfizer
FX This study was supported by Public Health Ontario.; Jonathan B. Gubbay
   has received research grants from GlaxoSmithKline Inc. and Hoffman-La
   Roche Ltd. to study antiviral resistance in influenza virus and from
   Pfizer Inc. to conduct microbiological surveillance of Streptococcus
   pneumoniae. The other authors have no conflict of interest to disclose.
CR Altona Diagnostics GmbH, 2015, REALSTAR ZIKA VIR RT
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pessoa R, 2016, EURO SURVEILL, V21
   Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   U.S. Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   U.S. Food and Drug Administration, 2007, STAT GUID REP RES ST
   U.S. Food and Drug Administration, 2016, EM US AUTH ALT DIAGN
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 28
TC 20
Z9 21
U1 2
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAY
PY 2017
VL 55
IS 5
BP 1576
EP 1584
DI 10.1128/JCM.02153-16
PG 9
WC Microbiology
SC Microbiology
GA ET1GA
UT WOS:000400014400037
PM 28298448
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Winkler, CW
   Myers, LM
   Woods, TA
   Messer, RJ
   Carmody, AB
   McNally, KL
   Scott, DP
   Hasenkrug, KJ
   Best, SM
   Peterson, KE
AF Winkler, Clayton W.
   Myers, Lara M.
   Woods, Tyson A.
   Messer, Ronald J.
   Carmody, Aaron B.
   McNally, Kristin L.
   Scott, Dana P.
   Hasenkrug, Kim J.
   Best, Sonja M.
   Peterson, Karin E.
TI Adaptive Immune Responses to Zika Virus Are Important for Controlling
   Virus Infection and Preventing Infection in Brain and Testes
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID LANGAT VIRUS; FRIEND VIRUS; MOUSE MODEL; BRAZIL; MICE; PATHOGENESIS;
   REPLICATION; SPECIFICITY; PREGNANCY; NEURONS
AB The recent association between Zika virus (ZIKV) and neurologic complications, including Guillain-Barre syndrome in adults and CNS abnormalities in fetuses, highlights the importance in understanding the immunological mechanisms controlling this emerging infection. Studies have indicated that ZIKV evades the human type I IFN response, suggesting a role for the adaptive immune response in resolving infection. However, the inability of ZIKV to antagonize the mouse IFN response renders the virus highly susceptible to circulating IFN in murine models. Thus, as we show in this article, although wild-type C57BL/6 mice mount cell mediated and humoral adaptive immune responses to ZIKV, these responses were not required to prevent disease. However, when the type I IFN response of mice was suppressed, then the adaptive immune responses became critical. For example, when type I IFN signaling was blocked by Abs in Rag1(-/-) mice, the mice showed dramatic weight loss and ZIKV infection in the brain and testes. This phenotype was not observed in Ig-treated Rag1(-/-) mice or wild-type mice treated with anti type I IFNR alone. Furthermore, we found that the CD8(+) T cell responses of pregnant mice to ZIKV infection were diminished compared with nonpregnant mice. It is possible that diminished cell-mediated immunity during pregnancy could increase virus spread to the fetus. These results demonstrate an important role for the adaptive immune response in the control of ZIKV infection and imply that vaccination may prevent ZIKV-related disease, particularly when the type I IFN response is suppressed as it is in humans.
C1 [Winkler, Clayton W.; Myers, Lara M.; Woods, Tyson A.; Messer, Ronald J.; Hasenkrug, Kim J.; Peterson, Karin E.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, 903 S 4th St, Hamilton, MT 59840 USA.
   [Carmody, Aaron B.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
   [McNally, Kristin L.; Best, Sonja M.] NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
   [Scott, Dana P.] NIAID, Rocky Mt Vet Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
RP Peterson, KE (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, 903 S 4th St, Hamilton, MT 59840 USA.
EM petersonka@niaid.nih.gov
RI Winkler, Clayton/F-8031-2018; Best, Sonja M/G-7301-2017
OI Winkler, Clayton/0000-0002-4460-3378; Best, Sonja M/0000-0003-0206-297X
FU Division of Intramural Research, National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID)
FX This work was supported by the Division of Intramural Research, National
   Institute of Allergy and Infectious Diseases.
CR Baker DG, 2013, J GEN VIROL, V94, P336, DOI 10.1099/vir.0.043984-0
   Butchi NB, 2011, AM J PATHOL, V179, P783, DOI 10.1016/j.ajpath.2011.04.011
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donadieu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084473
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuwar RB, 2015, J NEUROL SCI, V358, P243, DOI 10.1016/j.jns.2015.09.003
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Maffioli C, 2014, J NEUROPATH EXP NEUR, V73, P1107, DOI 10.1097/NEN.0000000000000131
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   ROBERTSON MN, 1992, J VIROL, V66, P3271, DOI 10.1128/JVI.66.6.3271-3277.1992
   Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 28
TC 52
Z9 53
U1 0
U2 12
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2017
VL 198
IS 9
BP 3526
EP 3535
DI 10.4049/jimmunol.1601949
PG 10
WC Immunology
SC Immunology
GA EU6HN
UT WOS:000401135200020
PM 28330900
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Marcondes, CB
   Contigiani, M
   Gleiser, RM
AF Marcondes, Carlos Brisola
   Contigiani, Marta
   Miranda Gleiser, Raquel
TI Emergent and Reemergent Arboviruses in South America and the Caribbean:
   Why So Many and Why Now?
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE arbovirus; Aedes aegypti; ecology; dengue; Zika; urbanization
ID WEST-NILE-VIRUS; VENEZUELAN-EQUINE-ENCEPHALITIS; ST-LOUIS ENCEPHALITIS;
   AEGYPTI DIPTERA-CULICIDAE; CACHE VALLEY VIRUS; SAO-PAULO STATE;
   ARTHROPOD-BORNE VIRUSES; YELLOW-FEVER VIRUS; AEDES-ALBIFASCIATUS
   DIPTERA; BUNYAMWERA SEROGROUP VIRUS
AB Several arboviruses have emerged and/or reemerged in the New World in the past decades. Zika and chikungunya viruses, formerly restricted to Africa and perhaps Asia, invaded the continent, causing great concern. Dengue virus outbreaks have continued to occur in almost all countries, with millions of cases per year. West Nile virus rapidly invaded North America, and now cases have been found in Central and South America. Other arboviruses, such as Mayaro and Eastern equine encephalitis viruses, have increased their activity and have been found in new regions. Changes in pathogenicity have been documented for some viruses leading to unexpected disease. A diverse mosquito fauna, changing climate and vegetation, increased travel, and unplanned urbanization producing conditions for the proliferation of Aedes aegypti (L.), Culex quinquefasciatus Say, and other vectors have combined to strongly influence changes in the distribution and incidence of several arboviruses. The need for thorough studies of the mosquito fauna and modifications of environmental conditions, mostly in urban areas strongly influenced by social, political, and economic factors, is emphasized.
C1 [Marcondes, Carlos Brisola] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Ctr Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil.
   [Contigiani, Marta] Natl Univ Cordoba, Inst Virol Dr JM Vanella, Enfermera Gordillo Gomez S-N,Ciudad Univ, Cordoba, Argentina.
   [Miranda Gleiser, Raquel] UNC, Ctr Relevamiento & Evaluac Recursos Agr & Nat CRE, Inst Multidisciplinario Biol Vegetal IMBIV, Cordoba, Argentina.
   [Miranda Gleiser, Raquel] Consejo Nacl Invest Cient & Tecn, Cordoba, Argentina.
RP Marcondes, CB (corresponding author), Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Ctr Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil.
EM cbrisolamarcondes@gmail.com; martacontigiani@gmail.com;
   raquelgleiser@hotmail.com
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   Adams AP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001875
   Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239
   Diaz LA, 2008, EMERG INFECT DIS, V14, P689, DOI 10.3201/eid1404.071257
   Diaz LA, 2013, T ROY SOC TROP MED H, V107, P332, DOI 10.1093/trstmh/trt023
   Diaz LA, 2011, J ORNITHOL, V152, P21, DOI 10.1007/s10336-010-0538-4
   Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   Aguilar PV, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000514
   Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634
   AITKEN THG, 1959, AM J TROP MED HYG, V8, P41, DOI 10.4269/ajtmh.1959.8.41
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Andreadis TG, 2014, VECTOR-BORNE ZOONOT, V14, P763, DOI 10.1089/vbz.2014.1669
   [Anonymous], 2016, LANCET INFECT DIS, V16, P619, DOI 10.1016/S1473-3099(16)30069-X
   Anyamba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092538
   Apandi Y, 2009, J GEN MOL VIROL, P35
   Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Armstrong PM, 2010, EMERG INFECT DIS, V16, P1869, DOI 10.3201/eid1612.100640
   ARNELL J H, 1976, Contributions of the American Entomological Institute, V13, P1
   Arrigo NC, 2010, J VIROL, V84, P1014, DOI 10.1128/JVI.01586-09
   Assuncao-Miranda I, 2013, BIOMED RES INT, DOI 10.1155/2013/973516
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   AVILES G, 1992, J MED ENTOMOL, V29, P850, DOI 10.1093/jmedent/29.5.850
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barbosa J. P., 1929, ARQ HYG, V3, P329
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bejarano J. F. R., 1979, TROP MED INT HLTH
   Pisano MB, 2014, INFECT GENET EVOL, V26, P72, DOI 10.1016/j.meegid.2014.05.011
   Pisano MB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002551
   Pisano MB, 2012, MEM I OSWALDO CRUZ, V107, P125, DOI 10.1590/S0074-02762012000100017
   Pisano MB, 2010, VECTOR-BORNE ZOONOT, V10, P199, DOI 10.1089/vbz.2008.0156
   Beltran FJ, 2015, REV ARGENT MICROBIOL, V47, P312, DOI 10.1016/j.ram.2015.09.002
   Berkeley George, 1710, TREATISE PRINCIPLES
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, J MED ENTOMOL, V53, P473, DOI 10.1093/jme/tjv195
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101
   Brault AC, 1999, AM J TROP MED HYG, V61, P579, DOI 10.4269/ajtmh.1999.61.579
   BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164
   Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   CALISHER CH, 1971, AM J EPIDEMIOL, V94, P172, DOI 10.1093/oxfordjournals.aje.a121309
   CALISHER CH, 1982, AM J TROP MED HYG, V31, P1260, DOI 10.4269/ajtmh.1982.31.1260
   Cámara Alicia, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P201, DOI 10.1590/S0036-46652003000400005
   Campbell GL, 2006, EMERG INFECT DIS, V12, P854, DOI 10.3201/eid1205.051625
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x
   Carbajo AE, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-26
   Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   CASALS J, 1964, J EXP MED, V119, P547, DOI 10.1084/jem.119.4.547
   Causey O. R., 1962, REV SERVICIO ESPECIA, V12, P39
   CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chastel C, 2012, Bull Soc Pathol Exot, V105, P251, DOI 10.1007/s13149-012-0255-8
   Chen CI, 2010, AM J TROP MED HYG, V83, P1249, DOI 10.4269/ajtmh.2010.10-0290
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Coffey LL, 2005, AM J TROP MED HYG, V73, P11, DOI 10.4269/ajtmh.2005.73.1.0730011
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Colon-Gonzalez F. J., 2013, PLOS NEGLECT TROP D, V7, pe253
   Contigiani M. S., 1993, REV ARGENT MICROBIOL, V14, P212
   Cupp EW, 2004, J MED ENTOMOL, V41, P495, DOI 10.1603/0022-2585-41.3.495
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   De Majo MS, 2013, J MED ENTOMOL, V50, P543, DOI 10.1603/ME12211
   Deardorff ER, 2010, AM J TROP MED HYG, V82, P1047, DOI 10.4269/ajtmh.2010.09-0556
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Derraik JGB, 2009, J VECTOR ECOL, V34, P157, DOI [10.1111/j.1948-7134.2009.00020.x, 10.3376/038.034.0120]
   Derraik Jose G. B., 2008, New Zealand Entomologist, V31, P31
   Diaz LA, 2008, VECTOR-BORNE ZOONOT, V8, P277, DOI 10.1089/vbz.2007.0168
   Diaz LA, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00493
   Diaz-Nieto LM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001963
   Dibo M. R., 2012, REV SOC BRAS MED TRO, V44, P496
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dutra H. L. C., 2016, WOLBACHIA BLOCKS CUR
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   EDWARDS JF, 1994, VET CLIN N AM-FOOD A, V10, P515, DOI 10.1016/S0749-0720(15)30536-3
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6
   Estrada-Franco JG, 2003, EMERG INFECT DIS, V9, P1604, DOI 10.3201/eid0912.030564
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favoretto S., 2016, BIORV
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Fernandez ML, 2013, PAP PHYS-LA PLATA, V5, DOI 10.4279/PIP.050002
   Fernandez Z, 2003, J MED ENTOMOL, V40, P522, DOI 10.1603/0022-2585-40.4.522
   Figueiredo LTM, 1999, REV MED RIBEIRAO PRE, V32, P154
   Fischer S., 2016, B ENTOMOL R IN PRESS
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FREIER JE, 1984, AM J TROP MED HYG, V33, P708, DOI 10.4269/ajtmh.1984.33.708
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Geiser RM, 2010, B ENTOMOL RES, V100, P153, DOI 10.1017/S0007485309006919
   Gleiser RM, 2000, J MED ENTOMOL, V37, P21, DOI 10.1603/0022-2585-37.1.21
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gomes AD, 1999, REV SAUDE PUBL, V33, P95, DOI 10.1590/S0034-89101999000100012
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Guagliardo SA, 2015, J MED ENTOMOL, V52, P726, DOI 10.1093/jme/tjv048
   Guagliardo SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003648
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guedes D. R. D., 2016, BIORXIV
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hartwig A., 2016, NEWHORIZ TRANSL MED, V2, P128
   Hayes CG, 2001, ANN NY ACAD SCI, V951, P25
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hemme RR, 2016, AM J TROP MED HYG, V94, P1095, DOI 10.4269/ajtmh.15-0262
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   HOLDEN P, 1959, SCIENCE, V130, P1187, DOI 10.1126/science.130.3383.1187
   Hommel D, 2000, CLIN INFECT DIS, V30, P188, DOI 10.1086/313611
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   ICTV, 2014, VIR TAX 2014 REL
   IVERSSON LB, 1984, REV SAUDE PUBL, V18, P323, DOI 10.1590/S0034-89101984000400007
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Johnson K M, 1974, Adv Vet Sci Comp Med, V18, P79
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2
   Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364
   Klenk K, 2004, EMERG INFECT DIS, V10, P2150, DOI 10.3201/eid1012.040264
   Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006
   Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   KRAMER LD, 1983, AM J TROP MED HYG, V32, P1130, DOI 10.4269/ajtmh.1983.32.1130
   Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007
   Kuno G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004101
   LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Laporta GZ, 2008, REV BRAS ENTOMOL, V52, P663, DOI 10.1590/S0085-56262008000400019
   Lecuit M., 2015, NEW ENGL J MED, V372, P13
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   LINLEY JR, 1990, P ENTOMOL SOC WASH, V92, P497
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   LOPES OD, 1981, AM J EPIDEMIOL, V113, P122
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031
   Luciani K, 2015, AM J TROP MED HYG, V92, P1130, DOI 10.4269/ajtmh.14-0845
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Mackay AJ, 2009, J AM MOSQUITO CONTR, V25, P409, DOI 10.2987/09-5888.1
   MANGIAFICO JA, 1988, AM J TROP MED HYG, V39, P593, DOI 10.4269/ajtmh.1988.39.593
   Mangudo C, 2015, B ENTOMOL RES, V105, P679, DOI 10.1017/S0007485315000590
   Marcondes C. B., 2010, REV SOC BRAS MED TRO, V44, P263
   Alarcon-Elbal PM, 2014, MEM I OSWALDO CRUZ, V109, P782, DOI 10.1590/0074-0276140214
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/s0034-89102003000400013
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Melandri V, 2012, MEM I OSWALDO CRUZ, V107, P1073, DOI 10.1590/S0074-02762012000800020
   Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220
   METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937
   Micieli MV, 2013, J MED ENTOMOL, V50, P853, DOI 10.1603/ME12226
   MILLER BR, 1989, T ROY SOC TROP MED H, V83, P252, DOI 10.1016/0035-9203(89)90667-6
   Ministerio de Salud de la Nacion. Republica Argentina, 2016, B INTEGR VIGIL, V311, P21
   MITCHELL CJ, 1987, AM J TROP MED HYG, V36, P107, DOI 10.4269/ajtmh.1987.36.107
   MITCHELL CJ, 1986, REV SAUDE PUBL, V20, P171, DOI 10.1590/S0034-89101986000300001
   MITCHELL CJ, 1981, AM J TROP MED HYG, V30, P465, DOI 10.4269/ajtmh.1981.30.465
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   Molaei G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004347
   Molaei G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1145-2
   Monath T. P., 2016, NEW ENGL J MED, V357, P2222
   Monath T. P., 1980, AM PUBL HLTH ASS
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath Thomas P., 1993, P138
   MONATH TP, 1985, AM J TROP MED HYG, V34, P966, DOI 10.4269/ajtmh.1985.34.966
   Monath TP, 1989, ARBOVIRUSES EPIDEMIO, V5, P139
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244
   Coimbra TLM, 2008, REV INST MED TROP SP, V50, P89, DOI 10.1590/S0036-46652008000200005
   Morales A., 2016, 10 JORN REG MOSQ MAR
   Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Moura P. M., 2014, CAD UNIFOA, V24, P81
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Nett RJ, 2009, VECTOR-BORNE ZOONOT, V9, P511, DOI 10.1089/vbz.2008.0052
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Nogueira P., 2009, YELL FEV S COMM CARL
   Oliveira RD, 2014, ARCH VIROL, V159, P2615, DOI 10.1007/s00705-014-2121-4
   OPS-OMS, 2016, ZIK ACT EP
   Ortiz DI, 2008, J MED ENTOMOL, V45, P1117, DOI 10.1603/0022-2585(2008)45[1117:SOAADC]2.0.CO;2
   Osorio JE, 2012, AM J TROP MED HYG, V87, P565, DOI 10.4269/ajtmh.2012.11-0655
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2
   Packard RM, 2016, B HIST MED, V90, P193, DOI 10.1353/bhm.2016.0041
   PAHO, 2016, EP AL YELL FEV
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551
   Patz J. A., 2003, CLIMATE CHANGE HUMAN
   Paupy C., 2013, MICROB INFECT, V11, P1187
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318
   Pauvolid-Correa A, 2010, MEM I OSWALDO CRUZ, V105, P829, DOI 10.1590/S0074-02762010000600017
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Peterson AT, 2015, J VECTOR ECOL, V40, P191, DOI 10.1111/jvec.12151
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P172, DOI 10.4269/ajtmh.1981.30.172
   Pires DA, 2010, J VECTOR ECOL, V35, P401, DOI 10.1111/j.1948-7134.2010.00099.x
   Pisano MB, 2010, TROP MED INT HEALTH, V15, P865, DOI 10.1111/j.1365-3156.2010.02541.x
   Plyusnin A., 2012, VIRUS TAXONOMY
   Pollack A, 2011, NY TIMES
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0
   Pujhari S., 2016, PEERJ PREPRINTS
   Quaglia AI, 2014, ECOHEALTH, V11, P603, DOI 10.1007/s10393-014-0956-5
   Quian Jorge, 2016, Arch. Pediatr. Urug., V87, P3
   Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Receveur MC, 2010, EUROSURVEILLANCE, V15, P6
   Reed Kurt D, 2003, Clin Med Res, V1, P5
   Reeves WC, 2001, J VECTOR ECOL, V26, P1
   REEVES WC, 1946, J EXP MED, V83, P185, DOI 10.1084/jem.83.3.185
   REINERT JF, 1975, MOSQ SYST, V7, P105
   Reisen W. K., 2015, CLIMATE CHANGE PUBLI
   Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Reisen WK, 2013, VIRUSES-BASEL, V5, P2079, DOI 10.3390/v5092079
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Rezza G, 2009, EUR J PUBLIC HEALTH, V19, P236, DOI 10.1093/eurpub/ckn135
   Rivas F, 1997, J INFECT DIS, V175, P828, DOI 10.1086/513978
   Rocheleau JP, 2013, VECTOR-BORNE ZOONOT, V13, P712, DOI 10.1089/vbz.2012.1242
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Duenas JCR, 2009, J MED ENTOMOL, V46, P1344, DOI 10.1603/033.046.0613
   Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537
   Rossi GC, 1999, J AM MOSQUITO CONTR, V15, P422
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004854
   SABATTINI MS, 1985, AM J TROP MED HYG, V34, P937, DOI 10.4269/ajtmh.1985.34.937
   SABATTINI MS, 1998, OVERVIEW ARBOVIROLOG, P113
   Sabattini MS, 1998, OVERVIEW ARBOVIROLOG, P135
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   SANMARTIN C, 1973, B OFIC SANIT PANAM, V74, P108
   Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617
   Saxton-Shaw KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128712
   Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   Schmaljohn C, 2006, FIELDS VIROLOGY, P1741
   SCOTT TW, 1989, ADV VIRUS RES, V37, P277, DOI 10.1016/S0065-3527(08)60838-6
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Sexton DJ, 1997, NEW ENGL J MED, V336, P547, DOI 10.1056/NEJM199702203360804
   SHOPE RE, 1964, AM J TROP MED HYG, V13, P723, DOI 10.4269/ajtmh.1964.13.723
   Silva JR, 2014, REV SOC BRAS MED TRO, V47, P414, DOI 10.1590/0037-8682-0117-2014
   Silva MLCR, 2011, J VET DIAGN INVEST, V23, P570, DOI 10.1177/1040638711403414
   Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008
   Slegers CAD, 2014, J CLIN VIROL, V60, P317, DOI 10.1016/j.jcv.2014.04.020
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   Soares Gil Luiz Herman, 2015, Revista Pan-Amazonica de Saude, V6, P73
   De Majo MS, 2017, J MED ENTOMOL, V54, P106, DOI 10.1093/jme/tjw131
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Soper FL, 1933, AM J HYG, V18, P555, DOI 10.1093/oxfordjournals.aje.a117967
   SPENCE L, 1968, West Indian Medical Journal, V17, P83
   Spence L. P., 1980, AM PUBLIC HLTH ASS, P451
   Spielman A., 2002, MOSQUITO NATURAL HIS
   Spinsanti L, 2003, EMERG INFECT DIS, V9, P271
   Spinsanti LI, 2008, J CLIN VIROL, V42, P27, DOI 10.1016/j.jcv.2007.11.022
   Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508
   Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2
   Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564
   Tabachnick WJ, 2011, J AM MOSQUITO CONTR, V27, P165, DOI 10.2987/10-6084.1
   TAKASHIMA I, 1989, J MED ENTOMOL, V26, P454, DOI 10.1093/jmedent/26.5.454
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tauro LB, 2015, VET J, V206, P111, DOI 10.1016/j.tvjl.2015.06.013
   Tauro LB, 2012, J CLIN VIROL, V54, P98, DOI 10.1016/j.jcv.2012.01.023
   Teixeira M. G., 1996, CIENCIA SAUDE COLETI, V1, P122, DOI DOI 10.1590/1413-812319961101582014
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Thomas SM, 2014, INT J ENV RES PUB HE, V11, P3360, DOI 10.3390/ijerph110303360
   Thomas SJ, 2011, J INFECT DIS, V203, P299, DOI 10.1093/infdis/jiq060
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Turell MJ, 2008, J MED ENTOMOL, V45, P720, DOI 10.1603/0022-2585(2008)45[720:SOPMTE]2.0.CO;2
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49
   Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589
   van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   VASCONCELOS PFC, 2003, REV SOC BRAS MED TRO, V36, P275, DOI DOI 10.1590/S0037-86822003000200012
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
   Venkat H, 2015, MMWR-MORBID MORTAL W, V64, P1349, DOI 10.15585/mmwr.mm6448a5
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vittor AY, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004554
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Waterman SH, 2015, AM J TROP MED HYG, V92, P996, DOI 10.4269/ajtmh.14-0016
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2012, ANTIVIR RES, V94, P242, DOI 10.1016/j.antiviral.2012.04.002
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wieten RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149871
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   Williges E, 2008, J AM MOSQUITO CONTR, V24, P591, DOI 10.2987/5714.1
   Wilson ME, 2016, TRAVEL MED INFECT DI, V14, P1, DOI 10.1016/j.tmaid.2016.01.010
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   World Health Organization (WHO), 2016, DENG SEV DENG
   Xiao SY, 2003, AM J TROP MED HYG, V68, P695, DOI 10.4269/ajtmh.2003.68.695
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yan-Jang S. H., 2016, VECTOR-BORNE ZOONOT, V20, P1
   Young DS, 2008, EMERG INFECT DIS, V14, P454, DOI 10.3201/eid1403.070816
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 340
TC 21
Z9 21
U1 5
U2 32
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAY
PY 2017
VL 54
IS 3
BP 509
EP 532
DI 10.1093/jme/tjw209
PG 24
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA EX3ST
UT WOS:000403153400002
PM 28399216
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus infection in Taiwan: An expectation on possible asymptomatic
   cases and local transmission
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Med Ctr, Bangkok 10330, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Trop Med, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Med Ctr, Bangkok 10330, Thailand.
EM beuyjoob@hotmail.com
CR Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, J FORMOS MED ASSOC, V115, P684, DOI 10.1016/j.jfma.2016.03.008
NR 5
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD MAY
PY 2017
VL 116
IS 5
BP 406
EP 406
DI 10.1016/j.jfma.2016.07.011
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EW4IC
UT WOS:000402464200014
PM 27729201
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Schaub, B
   Vouga, M
   Najioullah, F
   Gueneret, M
   Monthieux, A
   Harte, C
   Muller, F
   Jolivet, E
   Adenet, C
   Dreux, S
   Leparc-Goffart, I
   Cesaire, R
   Volumenie, JL
   Baud, D
AF Schaub, Bruno
   Vouga, Manon
   Najioullah, Fatiha
   Gueneret, Michele
   Monthieux, Alice
   Harte, Caroline
   Muller, Francoise
   Jolivet, Eugenie
   Adenet, Clara
   Dreux, Sophie
   Leparc-Goffart, Isabelle
   Cesaire, Raymond
   Volumenie, Jean-Luc
   Baud, David
TI Analysis of blood from Zika virus-infected fetuses: a prospective case
   series
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID GAMMA-GLUTAMYL-TRANSFERASE; PREGNANT-WOMEN; CYTOMEGALOVIRUS-INFECTION;
   CLINICAL MANAGEMENT; PRENATAL-DIAGNOSIS; FETAL; INFANT; MARKER
AB Background Zika virus has spread through the Americas and the Caribbean since early 2015 and was rapidly declared a Public Health Emergency of International Concern by WHO because of the potential association with fetal anomalies. We analysed fetal and maternal fluids and tissues in fetuses with confirmed Zika virus infection prospectively monitored in Martinique, a French Caribbean island.
   Methods Since the beginning of the Zika virus outbreak in Martinique, all pregnant women undergo monthly fetal ultrasound examination surveillance. In this study, we prospectively studied all patients with fetal anomalies and a positive amniotic fluid for Zika virus by RT-PCR. Maternal and fetal blood, urine, amniotic fluid, placenta, and fetal tissues were tested for Zika virus by RT-PCR. Fetal blood was analysed to identify haematological and biological anomalies.
   Findings Between Jan 1, 2016, and Nov 10, 2016, we recruited eight cases of Zika virus infection. All but two cases were symptomatic during the first trimester. Fetal anomalies were only detected after 20 weeks' gestation. After an initial positive result, amniocentesis became negative in two cases and fetal blood was transiently Zika virus positive in six cases. Fetal blood analyses showed a cholestatic pattern, anaemia, and infectious response.
   Interpretation Normalisation of amniotic fluid and fetal blood for Zika virus, as well as maternal blood and urine, shows the limitations of the performance of these investigations, due to the possibility of false negative results. Abnormal fetal blood needs to be investigated further to establish prognostic factors of severe Zika virus infections.
C1 [Schaub, Bruno; Gueneret, Michele; Jolivet, Eugenie; Adenet, Clara; Volumenie, Jean-Luc] Ctr Pluridisciplinaire Diagnost Prenatal Martin, Paris, France.
   [Schaub, Bruno; Gueneret, Michele; Monthieux, Alice; Harte, Caroline; Jolivet, Eugenie; Volumenie, Jean-Luc] Univ Martin, Ctr Hosp, Serv Gynecol Obstetr, Fort De France, France.
   [Adenet, Clara] Univ Martin, Ctr Hosp, Serv Radiol, Fort De France, France.
   [Schaub, Bruno] Univ Martin, Ctr Hosp, Registre Malformat Antilles, Fort De France, France.
   [Muller, Francoise; Cesaire, Raymond] Univ Martin, Ctr Hosp, Maison Femme Mere & Enfant, Fort De France, France.
   [Najioullah, Fatiha; Cesaire, Raymond] Univ Martin, Ctr Hosp, Hop Meynard, Serv Virol, Fort De France, France.
   [Vouga, Manon; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Hosp, Lausanne, Switzerland.
   [Leparc-Goffart, Isabelle] Inst Rech Biomed Armees, Ctr Natl Reference Arboviroses, Marseille, France.
   [Muller, Francoise; Dreux, Sophie] Hop Robert Debre, Lab Biochim, Paris, France.
   [Cesaire, Raymond] Univ Antilles, Fort De France, France.
RP Baud, D (corresponding author), Univ Vaudois, Ctr Hosp, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
OI Baud, David/0000-0001-9914-6496
CR Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cignini P, 2014, J ULTRAS MED, V33, P1065, DOI 10.7863/ultra.33.6.1065
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dreux S, 2006, PRENATAL DIAG, V26, P471, DOI 10.1002/pd.1441
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   FORESTIER F, 1991, BLOOD, V77, P2360, DOI 10.1182/blood.V77.11.2360.2360
   HALLAK M, 1994, FETAL DIAGN THER, V9, P165, DOI 10.1159/000263926
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Leibovitz Z, 2014, ULTRASOUND OBST GYN, V44, P575, DOI 10.1002/uog.13308
   Leruez-Ville M, 2017, BEST PRACT RES CL OB, V38, P97, DOI 10.1016/j.bpobgyn.2016.10.005
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.052
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   LYNCH L, 1991, AM J OBSTET GYNECOL, V165, P714, DOI 10.1016/0002-9378(91)90315-I
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mirlesse V, 1996, BIOL NEONATE, V70, P193
   Munro SC, 2005, J PAEDIATR CHILD H, V41, P449, DOI 10.1111/j.1440-1754.2005.00665.x
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Revello MG, 2004, J CLIN VIROL, V29, P71, DOI 10.1016/j.jcv.2003.09.012
   Salomon LJ, 2006, ULTRASOUND OBST GYN, V28, P193, DOI 10.1002/uog.2733
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Yinon Y, 2010, OBSTET GYNECOL SURV, V65, P736, DOI 10.1097/OGX.0b013e31821102b4
   Yinon Y, 2010, J OBSTET GYNAECOL CA, V32, P348, DOI 10.1016/S1701-2163(16)34480-2
NR 32
TC 42
Z9 44
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2017
VL 17
IS 5
BP 520
EP 527
DI 10.1016/S1473-3099(17)30102-0
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA ES4RG
UT WOS:000399521800041
PM 28209336
OA Bronze
DA 2020-07-08
ER

PT J
AU Ahrens, KA
   Hutcheon, JA
   Gavin, L
   Moskosky, S
AF Ahrens, Katherine A.
   Hutcheon, Jennifer A.
   Gavin, Loretta
   Moskosky, Susan
TI Reducing Unintended Pregnancies as a Strategy to Avert Zika-Related
   Microcephaly Births in the United States: A Simulation Study
SO MATERNAL AND CHILD HEALTH JOURNAL
LA English
DT Article
DE Zika; Microcephaly; Contraception; Vaccination
ID VIRUS; CONTRACEPTION; COST; RISK
AB Introduction There is increasing evidence that infection with the Zika virus (ZIKV) during pregnancy can lead to severe brain abnormalities in infants exposed in utero. The objective of our analysis was to estimate the contribution of enhanced contraception access to averting ZIKV-related microcephaly births in the United States, alone and in combination with another possible strategy, anti-ZIKV vaccination. Methods We used Monte Carlo sampling techniques (n = 100,000 simulations) to estimate the number of microcephaly births expected under strategies of enhanced contraception only, vaccination only, both enhanced contraception and vaccination, and status quo (no intervention). Enhanced contraceptive access was assumed to reduce unintended pregnancy rates by 46% and anti-ZIKV vaccination was assumed to be 90% effective. Plausible values for effectiveness of enhanced contraceptive access, ZIKV cumulative incidence, ZIKV-related microcephaly risk, and anti-ZIKV vaccination parameters were derived from the literature or best available knowledge. Results Enhanced contraceptive access alone reduced the median number of ZIKV-related microcephaly births by 16% (95% simulation interval: 5, 23), while the anti-ZIKV vaccine alone reduced these births by 9% (95% SI: 0, 18), 45% (95% SI: 36, 54), and 81% (95% SI: 71, 91), under conservative (10% vaccine uptake), moderate (50% vaccine uptake), and optimistic (90% vaccine uptake) scenarios, respectively. The reduction in ZIKV-related microcephaly births was always greater if both interventions were employed. Discussion Enhanced contraceptive access alone has the ability to produce a meaningful reduction in microcephaly births, and could provide an important adjuvant prevention strategy even following the development of a highly-effective anti-ZIKV vaccine.
C1 [Ahrens, Katherine A.; Gavin, Loretta; Moskosky, Susan] US Dept HHS, Off Populat Affairs, Off Assistant Secretary Hlth, 1101 Wootton Pkwy,Suite 700, Rockville, MD 20852 USA.
   [Hutcheon, Jennifer A.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.
RP Ahrens, KA (corresponding author), US Dept HHS, Off Populat Affairs, Off Assistant Secretary Hlth, 1101 Wootton Pkwy,Suite 700, Rockville, MD 20852 USA.
EM kate.ahrens@hhs.gov
OI Hutcheon, Jennifer/0000-0002-6618-6018; Ahrens,
   Katherine/0000-0001-5139-9208
CR Aiken A, 2016, BJOG
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burke A, 2016, SEMIN REPROD MED, V34, P305, DOI 10.1055/s-0036-1592068
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Clinicaltrials.gov, 2016, VRCZKADNA08500VP
   Dehlendorf C, 2017, CONTRACEPTION, V95, P1, DOI 10.1016/j.contraception.2016.08.013
   Dionne-Odom J, 2016, AM J OBSTET GYNECOL, V214, P6, DOI 10.1016/j.ajog.2015.09.100
   Dreweke J., 2016, GUTTMACHER POLICY RE, V19, P23
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FDA, 2016, REV REC RED RISK ZIK
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Foster DG, 2013, WOMEN HEALTH ISS, V23, P265
   Fox J., 2016, JAMA
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frieden T, 2016, WEB BRIEFIND MEDIA Z
   Frieden T. R., 2016, JAMA
   Goldthwaite LM, 2016, CURR OPIN OBSTET GYN, V28, P499, DOI 10.1097/GCO.0000000000000323
   Hahn M. B., 2016, J MED ENTOMOLOGY
   Harper CC, 2015, LANCET, V386, P562, DOI 10.1016/S0140-6736(14)62460-0
   Honein MA, 2016, JAMA
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Martin JA, 2013, NATL VITAL STAT REP, V62, P72
   Melo A. S., 2016, JAMA NEUROLOGY
   Moore CA, 2016, JAMA PEDIAT
   New York Times, 2016, NY TIMES
   Pacheco O., 2016, NEW ENGL J MED, V374, P1981
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506
   Trussell J, 2013, CONTRACEPTION, V87, P154, DOI 10.1016/j.contraception.2012.07.016
   U.S. Census Bureau Population Division., 2016, ANN EST RES POP SEX
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 35
TC 4
Z9 4
U1 0
U2 3
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1092-7875
EI 1573-6628
J9 MATERN CHILD HLTH J
JI Matern. Child Health J.
PD MAY
PY 2017
VL 21
IS 5
BP 982
EP 987
DI 10.1007/s10995-017-2275-2
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES3EE
UT WOS:000399410300004
PM 28102503
DA 2020-07-08
ER

PT J
AU Sirohi, D
   Kuhn, RJ
AF Sirohi, Devika
   Kuhn, Richard J.
TI Can an FDA-Approved Alzheimer's Drug Be Repurposed for Alleviating
   Neuronal Symptoms of Zika Virus?
SO MBIO
LA English
DT Editorial Material
DE Zika virus; antiviral agents; neurodegeneration; NMDAR; memantine
ID GLUTAMATE
AB Zika virus caught the world by surprise by its rapid spread and frightening disease outcomes. This major epidemic motivated many scientists to focus their attention on controlling this emerging pathogen. As many as 45 vaccine candidates are being developed, but progress in the antiviral arena has been slower. In a recent article (mBio 8: e00350-17, 2017, https://doi. org/10.1128/mBio. 00350-17), Costa and colleagues showed that an FDA-approved drug used to treat Alzheimer's disease may moderate Zika virus-induced neuronal damage. This work is based on the premise that overstimulation of N-methyl-D-aspartate receptors (NMDARs) may drive neurodegeneration and that this may be responsible for neuronal cell death associated with Zika virus infection of the central nervous system (CNS). Thus, blockage of the NMDAR channel activity with FDA-approved memantine or other antagonists may reduce neurological complications associated with Zika virus infection. Repurposing a preapproved drug and targeting the host represent intriguing strategies and yet require more analysis prior to moving into clinical trials.
C1 [Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
RP Kuhn, RJ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
EM kuhnr@purdue.edu
OI Sirohi, Devika/0000-0001-8601-6211
CR Bagasrawala I, 2016, CEREB CORTEX
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brison E, 2014, J VIROL, V88, P1548, DOI 10.1128/JVI.02972-13
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Domercq M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00049
   Hardingham GE, 2016, NAT REV NEUROSCI, V17, P1, DOI 10.1038/nrn.2015.19
   Jansson LC, 2014, J NEURAL TRANSM, V121, P819, DOI 10.1007/s00702-014-1174-6
   Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916
   Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 12
TC 4
Z9 4
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2017
VL 8
IS 3
AR e00916
DI 10.1128/mBio.00916-17
PG 6
WC Microbiology
SC Microbiology
GA EZ5DU
UT WOS:000404733300073
PM 28655823
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bramley, JC
   Drummond, CG
   Lennemann, NJ
   Good, CA
   Kim, KS
   Coyne, CB
AF Bramley, John C.
   Drummond, Coyne G.
   Lennemann, Nicholas J.
   Good, Charles A.
   Kim, Kwang Sik
   Coyne, Carolyn B.
TI A Three-Dimensional Cell Culture System To Model RNA Virus Infections at
   the Blood-Brain Barrier
SO MSPHERE
LA English
DT Article
DE blood-brain barrier; coxsackievirus; dengue virus; echovirus; tight
   junction; Zika virus; enterovirus; flavivirus
ID ENDOTHELIAL-CELLS; SHEAR-STRESS; ZIKA VIRUS; TNF-ALPHA; GENE;
   EXPRESSION; MECHANISMS; RECEPTORS; IMMEDIATE; MONOCYTES
AB The blood-brain barrier (BBB) comprises the foremost protective barrier in the brain and is composed in part of a layer of microvascular endothelial cells that line the capillaries surrounding the brain. Here, we describe a human three-dimensional (3-D) cell-based model of the BBB microvascular endothelium that recapitulates properties of these cells in vivo, including physiologically relevant transcriptional profiles, the capacity to induce potent antimicrobial innate immune signaling, and the ability to resist infection by diverse RNA viruses, including members of the enterovirus (coxsackievirus B, echovirus 11, enterovirus 71, poliovirus) and flavivirus (dengue virus, Zika virus [ZIKV]) families. We show that disruption of apical tight junctions by proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) sensitizes 3-D-cultured BBB cells to ZIKV infection and that 3-D derived BBB cells can be used to model the transmigration of ZIKV-infected monocytes across the endothelial barrier to access underlying astrocytes. Taken together, our findings show that human BBB microvascular endothelial cells cultured in 3-D can be used to model the mechanisms by which RNA viruses access the central nervous system (CNS), which could be used for the development and screening of therapeutics to limit this event.
   IMPORTANCE Neurotropic viral infections are significant sources of global morbidity and mortality. The blood-brain barrier (BBB) is composed in part of a layer of microvascular endothelial cells and functions to restrict viral access to the brain. In vitro models that recapitulate many of the properties of the human BBB endothelium are lacking, particularly with respect to the unique cellular and immunological mechanisms by which these cells restrict viral infections of the brain. Here, we developed a three-dimensional cell culture model that recapitulates many of the morphological and functional properties of the BBB microvasculature and apply this model to the study of RNA virus infections. The model we describe can therefore be used to study a variety of aspects of BBB physiology, including the mechanisms by which viruses might access the CNS, and could be used for the development and screening of antiviral therapeutics to limit this important step in viral pathogenesis.
C1 [Bramley, John C.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.
   [Drummond, Coyne G.; Lennemann, Nicholas J.; Good, Charles A.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA.
   [Drummond, Coyne G.; Lennemann, Nicholas J.; Good, Charles A.; Coyne, Carolyn B.] UPMC, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15260 USA.
   [Kim, Kwang Sik] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA.
RP Coyne, CB (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA.; Coyne, CB (corresponding author), UPMC, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15260 USA.
EM coynec2@pitt.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01-AI081759]; Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious Disease AwardBurroughs
   Wellcome Fund
FX This project was supported by NIH R01-AI081759 (C.B.C.). In addition,
   C.B.C. is supported by the Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Award.
CR Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522
   Bicker J, 2014, EUR J PHARM BIOPHARM, V87, P409, DOI 10.1016/j.ejpb.2014.03.012
   BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285
   BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243
   Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0
   Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40
   Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34
   Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513
   Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741
   Edinger AL, 1997, P NATL ACAD SCI USA, V94, P14742, DOI 10.1073/pnas.94.26.14742
   Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33
   Espina LM, 2003, AM J TROP MED HYG, V68, P48, DOI 10.4269/ajtmh.2003.68.48
   Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hober D, 1996, IMMUNOL LETT, V53, P115, DOI 10.1016/S0165-2478(96)02620-X
   Hu PR, 2000, GENOMICS, V67, P83, DOI 10.1006/geno.2000.6219
   Huntley MA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00355
   Kalari KR, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00071
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Maes T, 2002, GENOMICS, V80, P21, DOI 10.1006/geno.2002.6799
   Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Morosky S, 2016, J VIROL, V90, P5098, DOI 10.1128/JVI.00170-16
   Ouyang YS, 2016, PLACENTA, V47, P86, DOI 10.1016/j.placenta.2016.09.008
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744
   Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029
   Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816
   Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149
   van der Helm MW, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1142493
   Vasilakis N, 2008, EMERG INFECT DIS, V14, P502, DOI 10.3201/eid1403.070843
   Vu K, 2009, EUKARYOT CELL, V8, P1803, DOI 10.1128/EC.00240-09
   Williams DW, 2014, CURR HIV RES, V12, P85, DOI 10.2174/1570162X12666140526114526
NR 43
TC 19
Z9 19
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAY-JUN
PY 2017
VL 2
IS 3
AR e00206-17
DI 10.1128/mSphere.00206-17
PG 18
WC Microbiology
SC Microbiology
GA FB9ZG
UT WOS:000406497300027
PM 28656176
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Varjak, M
   Maringer, K
   Watson, M
   Sreenu, VB
   Fredericks, AC
   Pondeville, E
   Donald, CL
   Sterk, J
   Kean, J
   Vazeille, M
   Failloux, AB
   Kohl, A
   Schnettler, E
AF Varjak, Margus
   Maringer, Kevin
   Watson, Mick
   Sreenu, Vattipally B.
   Fredericks, Anthony C.
   Pondeville, Emilie
   Donald, Claire L.
   Sterk, Jelle
   Kean, Joy
   Vazeille, Marie
   Failloux, Anna-Bella
   Kohl, Alain
   Schnettler, Esther
TI Aedes aegypti Piwi4 Is a Noncanonical PIWI Protein Involved in Antiviral
   Responses
SO MSPHERE
LA English
DT Article
DE Aedes aegypti; PIWI; RNA interference; antiviral response; arbovirus;
   innate immunity
ID SMALL SILENCING RNAS; MOSQUITO CELLS; PIRNA PATHWAY;
   DROSOPHILA-MELANOGASTER; VECTOR MOSQUITOS; VIRUS-INFECTION;
   INTERFERENCE; DEFENSE; ARBOVIRUS; REPLICATION
AB The small interfering RNA (siRNA) pathway is a major antiviral response in mosquitoes; however, another RNA interference pathway, the PIWI-interacting RNA (piRNA) pathway, has been suggested to be antiviral in mosquitoes. Piwi4 has been reported to be a key mediator of this response in mosquitoes, but it is not involved in the production of virus-specific piRNAs. Here, we show that Piwi4 associates with members of the antiviral exogenous siRNA pathway (Ago2 and Dcr2), as well as with proteins of the piRNA pathway (Ago3, Piwi5, and Piwi6) in an Aedes aegypti-derived cell line, Aag2. Analysis of small RNAs captured by Piwi4 revealed that it is predominantly associated with virus-specific siRNAs in Semliki Forest virus-infected cells and, to a lesser extent, with viral piRNAs. By using a Dcr2 knockout cell line, we showed directly that Ago2 lost its antiviral activity, as it was no longer bound to siRNAs, but Piwi4 retained its antiviral activity in the absence of the siRNA pathway. These results demonstrate a complex interaction between the siRNA and piRNA pathways in A. aegypti and identify Piwi4 as a noncanonical PIWI protein that interacts with members of the siRNA and piRNA pathways, and its antiviral activities may be independent of either pathway.
   IMPORTANCE Mosquitoes transmit several pathogenic viruses, for example, the chikungunya and Zika viruses. In mosquito cells, virus replication intermediates in the form of double-stranded RNA are cleaved by Dcr2 into 21-nucleotide-long siRNAs, which in turn are used by Ago2 to target the virus genome. A different class of virus-derived small RNAs, PIWI-interacting RNAs (piRNAs), have also been found in infected insect cells. These piRNAs are longer and are produced in a Dcr2-independent manner. The only known antiviral protein in the PIWI family is Piwi4, which is not involved in piRNA production. It is associated with key proteins of the siRNA and piRNA pathways, although its antiviral function is independent of their actions.
C1 [Varjak, Margus; Sreenu, Vattipally B.; Pondeville, Emilie; Donald, Claire L.; Sterk, Jelle; Kean, Joy; Kohl, Alain; Schnettler, Esther] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Maringer, Kevin; Fredericks, Anthony C.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Watson, Mick] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.
   [Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors Unit, Dept Virol, Paris, France.
   [Maringer, Kevin] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial Sci, Guildford, Surrey, England.
   [Schnettler, Esther] BNITM, Hamburg, Germany.
RP Varjak, M (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
EM Margus.Varjak@glasgow.ac.uk; schnettler@bnitm.de
RI Donald, Claire/AAC-7556-2019
OI Donald, Claire/0000-0002-4370-0707; Maringer, Kevin/0000-0003-0977-8807;
   Vattipally, Bala Sreenu/0000-0001-6673-4697; Watson,
   Mick/0000-0003-4211-0358; Varjak, Margus/0000-0003-2608-5148
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014]; Wellcome TrustWellcome Trust [096062]; European Union's
   Horizon Research and Innovation program under the Marie Sklodowska-Curie
   grant [661232]
FX This work was funded by the UK Medical Research Council (MC_UU_12014 to
   E.S. and A.K.) and the Wellcome Trust (Sir Henry Wellcome Fellowship
   096062 to K.M.). This project has received funding from the European
   Union's Horizon 2020 Research and Innovation program under the Marie
   Sklodowska-Curie grant agreement number 661232 (M. Varjak).
CR Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x
   Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484
   Bassett AR, 2014, BIOL OPEN, V3, P42, DOI 10.1242/bio.20137120
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Cenik ES, 2011, CURR BIOL, V21, pR446, DOI 10.1016/j.cub.2011.05.020
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021
   Diao FQ, 2012, GENETICS, V190, P1139, DOI 10.1534/genetics.111.136291
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0
   Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   Petit M, 2016, P NATL ACAD SCI USA, V113, pE4218, DOI 10.1073/pnas.1607952113
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007
   Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806
   Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   Tamberg N, 2007, J GEN VIROL, V88, P1225, DOI 10.1099/vir.0.82436-0
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Watson M, 2013, BIOINFORMATICS, V29, P1902, DOI 10.1093/bioinformatics/btt297
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
NR 46
TC 32
Z9 33
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAY-JUN
PY 2017
VL 2
IS 3
AR e00144-17
DI 10.1128/mSphere.00144-17
PG 16
WC Microbiology
SC Microbiology
GA FB9ZG
UT WOS:000406497300013
PM 28497119
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Zhang, B
   Pinsky, BA
   Ananta, JS
   Zhao, S
   Arulkumar, S
   Wan, H
   Sahoo, MK
   Abeynayake, J
   Waggoner, JJ
   Hopes, C
   Tang, MJ
   Dai, HJ
AF Zhang, Bo
   Pinsky, Benjamin A.
   Ananta, Jeyarama S.
   Zhao, Su
   Arulkumar, Shylaja
   Wan, Hao
   Sahoo, Malaya K.
   Abeynayake, Janaki
   Waggoner, Jesse J.
   Hopes, Clay
   Tang, Meijie
   Dai, Hongjie
TI Diagnosis of Zika virus infection on a nanotechnology platform
SO NATURE MEDICINE
LA English
DT Article
AB We developed a multiplexed assay on a plasmonic-gold platform for measuring IgG and IgA antibodies and IgG avidity against both Zika virus (ZIKV) and dengue virus (DENV) infections. In contrast to IgM cross-reactivity, IgG and IgA antibodies against ZIKV nonstructural protein 1 (NS1) antigen were specific to ZIKV infection, and IgG avidity revealed recent ZIKV infection and past DENV-2 infection in patients in dengue-endemic regions. This assay could enable specific diagnosis of ZIKV infection over other flaviviral infections.
C1 [Zhang, Bo; Ananta, Jeyarama S.; Zhao, Su; Arulkumar, Shylaja; Hopes, Clay; Tang, Meijie] Nirmidas Biotech, Palo Alto, CA 94303 USA.
   [Pinsky, Benjamin A.; Sahoo, Malaya K.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA.
   [Wan, Hao] South Univ Sci & Technol China, Dept Mat Sci & Engn, Shenzhen, Peoples R China.
   [Abeynayake, Janaki] Med Res Inst, Colombo, Sri Lanka.
   [Waggoner, Jesse J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
RP Zhang, B (corresponding author), Nirmidas Biotech, Palo Alto, CA 94303 USA.; Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
EM bo.zhang@nirmidas.com; hdai1@stanford.edu
RI Zhang, Bo/J-9536-2018
OI Zhang, Bo/0000-0003-0743-4816; Pinsky, Benjamin/0000-0001-8751-4810;
   Sahoo, Malaya/0000-0001-9837-4032
CR Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Li X, 2016, J CLIN MICROBIOL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tabakman SM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1477
   US Centers for Disease Control and Prevention-Division of Vector-Borne Diseases, 2016, MEM
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WELLIVER RC, 1980, J PEDIATR-US, V96, P808, DOI 10.1016/S0022-3476(80)80547-6
   Wong S. J., 2017, EBIOMEDICINE
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang B, 2014, NAT MED, V20, P948, DOI 10.1038/nm.3619
NR 15
TC 53
Z9 57
U1 14
U2 86
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD MAY
PY 2017
VL 23
IS 5
BP 548
EP +
DI 10.1038/nm.4302
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA ET9TI
UT WOS:000400650700009
PM 28263312
DA 2020-07-08
ER

PT J
AU Brecher, M
   Li, Z
   Liu, BB
   Zhang, J
   Koetzner, CA
   Alifarag, A
   Jones, SA
   Lin, QS
   Kramer, LD
   Li, HM
AF Brecher, Matthew
   Li, Zhong
   Liu, Binbin
   Zhang, Jing
   Koetzner, Cheri A.
   Alifarag, Adham
   Jones, Susan A.
   Lin, Qishan
   Kramer, Laura D.
   Li, Hongmin
TI A conformational switch high-throughput screening assay and allosteric
   inhibition of the flavivirus NS2B-NS3 protease
SO PLOS PATHOGENS
LA English
DT Article
ID WEST-NILE-VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; YELLOW-FEVER VIRUS; DENGUE
   VIRUS; ZIKA VIRUS; DRUG DISCOVERY; NS3 PROTEIN; FIREFLY LUCIFERASE;
   CRYSTAL-STRUCTURE; NMR ANALYSIS
AB The flavivirus genome encodes a single polyprotein precursor requiring multiple cleavages by host and viral proteases in order to produce the individual proteins that constitute an infectious virion. Previous studies have revealed that the NS2B cofactor of the viral NS2B-NS3 heterocomplex protease displays a conformational dynamic between active and inactive states. Here, we developed a conformational switch assay based on split luciferase complementation (SLC) to monitor the conformational change of NS2B and to characterize candidate allosteric inhibitors. Binding of an active-site inhibitor to the protease resulted in a conformational change of NS2B and led to significant SLC enhancement. Mutagenesis of key residues at an allosteric site abolished this induced conformational change and SLC enhancement. We also performed a virtual screen of NCI library compounds to identify allosteric inhibitors, followed by in vitro biochemical screening of the resultant candidates. Only three of these compounds, NSC135618, 260594, and 146771, significantly inhibited the protease of Dengue virus 2 (DENV2) in vitro, with IC50 values of 1.8 mu M, 11.4 mu M, and 4.8 mu M, respectively. Among the three compounds, only NSC135618 significantly suppressed the SLC enhancement triggered by binding of active-site inhibitor in a dose-dependent manner, indicating that it inhibits the conformational change of NS2B. Results from virus titer reduction assays revealed that NSC135618 is a broad spectrum flavivirus protease inhibitor, and can significantly reduce titers of DENV2, Zika virus (ZIKV), West Nile virus (WNV), and Yellow fever virus (YFV) on A549 cells in vivo, with EC50 values in low micromolar range. In contrast, the cytotoxicity of NSC135618 is only moderate with CC50 of 48.8 mu M on A549 cells. Moreover, NSC135618 inhibited ZIKV in human placental and neural progenitor cells relevant to ZIKV pathogenesis. Results from binding, kinetics, Western blot, mass spectrometry and mutagenesis experiments unambiguously demonstrated an allosteric mechanism for inhibition of the viral protease by NSC135618.
C1 [Brecher, Matthew; Li, Zhong; Liu, Binbin; Zhang, Jing; Koetzner, Cheri A.; Alifarag, Adham; Jones, Susan A.; Kramer, Laura D.; Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12203 USA.
   [Liu, Binbin] Guangdong Ocean Univ, Dept Food Sci, Coll Food Sci & Technol, Zhanjiang, Guangdong, Peoples R China.
   [Lin, Qishan] SUNY Albany, Ctr Funct Genom, Rensselaer, NY USA.
   [Kramer, Laura D.; Li, Hongmin] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA.
RP Li, HM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12203 USA.; Li, HM (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA.
EM Hongmin.li@health.ny.gov
OI Brecher, Matthew/0000-0003-1151-2290; kramer, laura/0000-0002-8707-0778;
   Li, Hongmin/0000-0002-8684-5308; Li, Zhong/0000-0002-1039-7000
FU Wadsworth Center flavivirus drug discovery initiative fund; NIH
   Biodefense and Emerging Infectious Disease training grant [AI055429];
   National Science Foundation REU Program Grant [DBI1062963]; Guangdong
   Ocean University
FX This research was partially supported by the Wadsworth Center flavivirus
   drug discovery initiative fund. MB was partially supported by the NIH
   Biodefense and Emerging Infectious Disease training grant AI055429. AA
   was supported by the National Science Foundation REU Program Grant
   DBI1062963. BL was partially supported by a visiting scholarship
   sponsored by Guangdong Ocean University. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Azad T, 2014, ANAL BIOANAL CHEM, V406, P5541, DOI 10.1007/s00216-014-7980-8
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   Burke DS, 2001, FLAVIVIRUSES
   Calvet G., 2016, LANCET INFECT DIS
   CDC, 2014, GLOB DENQ
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chappell KJ, 2008, J GEN VIROL, V89, P1010, DOI 10.1099/vir.0.83447-0
   Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076900
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Chen L.H, 2016, ANN INTERN MED
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Ekonomiuk D, 2009, PROTEIN SCI, V18, P1003, DOI 10.1002/pro.110
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414
   Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Jester BW, 2010, J AM CHEM SOC, V132, P11727, DOI 10.1021/ja104491h
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Kim SB, 2008, ACS CHEM BIOL, V3, P359, DOI 10.1021/cb800004s
   Kim SB, 2007, ACS CHEM BIOL, V2, P484, DOI 10.1021/cb7000439
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Li H, 2014, FEBS LETT, V588, P2794, DOI 10.1016/j.febslet.2014.05.063
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Su XC, 2009, FEBS J, V276, P4244, DOI 10.1111/j.1742-4658.2009.07132.x
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taneoka A, 2009, BIOSENS BIOELECTRON, V25, P76, DOI 10.1016/j.bios.2009.06.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TERUELLOPEZ E, 1991, INVEST CLIN, V32, P201
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   Ung PMU, 2014, J MED CHEM, V57, P6468, DOI 10.1021/jm5008352
   Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103
   Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Zhang F, 2016, NUCL ACIDS RES
   Zhou V, 2009, ANAL BIOCHEM, V385, P300, DOI 10.1016/j.ab.2008.11.015
   Zhu L, 2015, BIOCHEM BIOPH RES CO, V461, P677, DOI 10.1016/j.bbrc.2015.04.090
NR 74
TC 42
Z9 45
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2017
VL 13
IS 5
AR e1006411
DI 10.1371/journal.ppat.1006411
PG 29
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EW9ZK
UT WOS:000402877700052
PM 28542603
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nguyen, SM
   Antony, KM
   Dudley, DM
   Kohn, S
   Simmons, HA
   Wolfe, B
   Salamat, MS
   Teixeira, LBC
   Wiepz, GJ
   Thoong, TH
   Aliota, MT
   Weiler, AM
   Barry, GL
   Weisgrau, KL
   Vosler, LJ
   Mohns, MS
   Breitbach, ME
   Stewart, LM
   Rasheed, MN
   Newman, CM
   Graham, ME
   Wieben, OE
   Turski, PA
   Johnson, KM
   Post, J
   Hayes, JM
   Schultz-Darken, N
   Schotzko, ML
   Eudailey, JA
   Permar, SR
   Rakasz, EG
   Mohr, EL
   Capuano, S
   Tarantal, AF
   Osorio, JE
   O'Connor, SL
   Friedrich, TC
   O'Connor, DH
   Golos, TG
AF Nguyen, Sydney M.
   Antony, Kathleen M.
   Dudley, Dawn M.
   Kohn, Sarah
   Simmons, Heather A.
   Wolfe, Bryce
   Salamat, M. Shahriar
   Teixeira, Leandro B. C.
   Wiepz, Gregory J.
   Thoong, Troy H.
   Aliota, Matthew T.
   Weiler, Andrea M.
   Barry, Gabrielle L.
   Weisgrau, Kim L.
   Vosler, Logan J.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Stewart, Laurel M.
   Rasheed, Mustafa N.
   Newman, Christina M.
   Graham, Michael E.
   Wieben, Oliver E.
   Turski, Patrick A.
   Johnson, Kevin M.
   Post, Jennifer
   Hayes, Jennifer M.
   Schultz-Darken, Nancy
   Schotzko, Michele L.
   Eudailey, Josh A.
   Permar, Sallie R.
   Rakasz, Eva G.
   Mohr, Emma L.
   Capuano, Saverio, III
   Tarantal, Alice F.
   Osorio, Jorge E.
   O'Connor, Shelby L.
   Friedrich, Thomas C.
   O'Connor, David H.
   Golos, Thaddeus G.
TI Highly efficient maternal-fetal Zika virus transmission in pregnant
   rhesus macaques
SO PLOS PATHOGENS
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; PASSIVE-IMMUNIZATION; MACACA-MULATTA;
   BIRTH-DEFECTS; UNITED-STATES; INFECTION; CYTOMEGALOVIRUS; ULTRASOUND;
   CYNOMOLGUS; INFANTS
AB Infection with Zika virus (ZIKV) is associated with human congenital fetal anomalies. To model fetal outcomes in nonhuman primates, we administered Asian-lineage ZIKV subcutaneously to four pregnant rhesus macaques. While non-pregnant animals in a previous study contemporary with the current report clear viremia within 10-12 days, maternal viremia was prolonged in 3 of 4 pregnancies. Fetal head growth velocity in the last month of gestation determined by ultrasound assessment of head circumference was decreased in comparison with biparietal diameter and femur length within each fetus, both within normal range. ZIKV RNA was detected in tissues from all four fetuses at term cesarean section. In all pregnancies, neutrophilic infiltration was present at the maternal-fetal interface (decidua, placenta, fetal membranes), in various fetal tissues, and in fetal retina, choroid, and optic nerve (first trimester infection only). Consistent vertical transmission in this primate model may provide a platform to assess risk factors and test therapeutic interventions for interruption of fetal infection. The results may also suggest that maternal-fetal ZIKV transmission in human pregnancy may be more frequent than currently appreciated.
C1 [Nguyen, Sydney M.; Antony, Kathleen M.; Golos, Thaddeus G.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.
   [Dudley, Dawn M.; Wolfe, Bryce; Salamat, M. Shahriar; Mohns, Mariel S.; Breitbach, Meghan E.; Stewart, Laurel M.; Rasheed, Mustafa N.; Newman, Christina M.; Graham, Michael E.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Kohn, Sarah; Wieben, Oliver E.; Turski, Patrick A.; Johnson, Kevin M.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA.
   [Simmons, Heather A.; Thoong, Troy H.; Weiler, Andrea M.; Barry, Gabrielle L.; Weisgrau, Kim L.; Vosler, Logan J.; Post, Jennifer; Hayes, Jennifer M.; Schultz-Darken, Nancy; Schotzko, Michele L.; Rakasz, Eva G.; Capuano, Saverio, III; Friedrich, Thomas C.; O'Connor, David H.; Golos, Thaddeus G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Teixeira, Leandro B. C.] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA.
   [Wiepz, Gregory J.; Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.
   [Aliota, Matthew T.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Eudailey, Josh A.; Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.
   [Eudailey, Josh A.; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA.
   [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Madison, WI USA.
   [Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Dept Pediat, Davis, CA 95616 USA.
   [Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.
RP Golos, TG (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.; Golos, TG (corresponding author), Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.
EM golos@primate.wisc.edu
RI Rakasz, Eva G/H-9197-2019; Teixeira, Leandro B C/H-9272-2015
OI Teixeira, Leandro B C/0000-0001-9960-678X; Aliota,
   Matthew/0000-0002-6902-9149; Antony, Kathleen M/0000-0003-3537-8030;
   Nguyen, Sydney/0000-0002-1354-7078; Wolfe, Bryce/0000-0003-0418-8816
FU National Institutes of Health grantsUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI107157-01A1, R01 AI116382-01A1S1, DP2HD075699, P51 OD011106]; Research
   Facilities Improvement ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR15459-01, RR020141-01]
FX This work was supported by National Institutes of Health grants R01
   AI107157-01A1 to TGG, R01 AI116382-01A1S1 to DHO, DP2HD075699 to SRP and
   P51 OD011106 to the Wisconsin National Primate Research Center. This
   research was conducted in part at a facility constructed with support
   from Research Facilities Improvement Program grant numbers RR15459-01
   and RR020141-01. The content is solely the responsibility of the authors
   and does not necessarily represent the official views of Office of
   Research Infrastructure Program or the National Institutes of Health;
   https://www.nih.gov/, http://dpcpsi.nih.gov/orip/index. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Altman DG, 1997, ULTRASOUND OBST GYN, V10, P174, DOI 10.1046/j.1469-0705.1997.10030174.x
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bialas KM, 2015, P NATL ACAD SCI USA, V112, P13645, DOI 10.1073/pnas.1511526112
   BLANKENSHIP TN, 1993, CELL TISSUE RES, V272, P227, DOI 10.1007/BF00302728
   Bondarenko GI, 2007, J IMMUNOL, V179, P8042, DOI 10.4049/jimmunol.179.12.8042
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DETER RL, 1981, J CLIN ULTRASOUND, V9, P481, DOI 10.1002/jcu.1870090905
   Driggers RW, 2016, N ENGL J MED
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Enders AC, 2007, PLACENTA, V28, P794, DOI 10.1016/j.placenta.2006.11.001
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hahn M. B., 2016, J MED ENTOMOL
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Juckstock J, 2015, PHARMACOLOGY, V95, P209, DOI 10.1159/000381626
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2016, JAMA PEDIAT
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nyberg DA, 2003, DIAGNOSTIC IMAGING F, p[32, 32]
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pomplun N, 2015, CYTOM PART A, V87A, P890, DOI 10.1002/cyto.a.22727
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   SchoondermarkvandeVen EME, 1997, EUR J OBSTET GYN R B, V74, P183, DOI 10.1016/S0301-2115(97)00119-X
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SHEPARD M, 1982, J ULTRAS MED, V1, P145
   Smith MA, 2008, INFECT IMMUN, V76, P726, DOI 10.1128/IAI.01366-06
   TARANTAL AF, 1988, AM J PRIMATOL, V15, P309, DOI 10.1002/ajp.1350150405
   Tarantal AF, 1998, J INFECT DIS, V177, P446, DOI 10.1086/514206
   TARANTAL AF, 1988, J MED PRIMATOL, V17, P105
   Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wolfe B, 2017, MBIO, V8, DOI 10.1128/mBio.01938-16
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 58
TC 89
Z9 91
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2017
VL 13
IS 5
AR e1006378
DI 10.1371/journal.ppat.1006378
PG 22
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EW9ZK
UT WOS:000402877700032
PM 28542585
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alvis-Guzman, N
   Zakzuk-Sierra, J
   Vargas-Moranth, R
   Alcocer-Olaciregui, A
   Parra-Padilla, D
AF Alvis-Guzman, Nelson
   Zakzuk-Sierra, Josefina
   Vargas-Moranth, Rusvelt
   Alcocer-Olaciregui, Adalgisa
   Parra-Padilla, Devian
TI Dengue, Chikunguna and Zika in Colombia 2015-2016
SO REVISTA MVZ CORDOBA
LA English
DT Article
DE Dengue; Chikungunya; Zika (Sources: DeSC, CAB)
ID OUTBREAK; BURDEN
AB Objective: To describe the epidemiological trends during 2015 - 2016 of three of the most important arthropod-borne virus infections occurred in the country in recent years: Zika, Dengue and Chikunguna. Materials and Methods: A descriptive study, in which the behavior of these diseases is analyzed from bulletins of the National Institute of Health, during the fifty-two epidemiological weeks of 2016. Results: In 2016, 103.822 cases were reported in the country Dengue (49.9% female), 19.566 of Chikunguna (63.3% female) and 106.559 of Zika (66.4% female). The most affected population was in the range of 25 to 39 years-old, but significant differences in the average age of the three conditions (p<0.05) were observed. Most reports about Zika infection were based on clinical diagnosis. Conclusions: Implementation of mechanisms that allows a better understanding of the etiology and clinical behavior of these diseases by health actors is required.
C1 [Alvis-Guzman, Nelson; Zakzuk-Sierra, Josefina; Vargas-Moranth, Rusvelt; Parra-Padilla, Devian] Univ Cartagena, GIES, Cartagena, Colombia.
   [Alvis-Guzman, Nelson] Univ Costa, ALZAK Fdn, Grp Invest Gest Hosp & Polit Salud, Barranquilla, Colombia.
   [Alcocer-Olaciregui, Adalgisa] Univ Metropolitana, Subsistema Inst Invest SIDI, Grp Invest Sanus Viventium, Barranquilla, Colombia.
RP Alvis-Guzman, N (corresponding author), Univ Cartagena, GIES, Cartagena, Colombia.; Alvis-Guzman, N (corresponding author), Univ Costa, ALZAK Fdn, Grp Invest Gest Hosp & Polit Salud, Barranquilla, Colombia.
EM nalvis@yahoo.com
RI Alvis-Guzman, Nelson/D-4913-2013; Alcocer Olaciregui, Adalgisa
   Esther/Q-3429-2017
OI Alvis-Guzman, Nelson/0000-0001-9458-864X; Zakzuk,
   Josefina/0000-0002-6007-5376; Alcocer Olaciregui, Adalgisa
   Esther/0000-0002-9509-8914; Parra Padilla, Devian/0000-0002-0781-8441
CR Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Direccion de Vigilancia y Analisis del Riesgo en Salud Publica, 2016, B EP SEM SEM EP, V13
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   INS, 2017, B EPIDEMIOLOGICO
   Instituto Nacional de Salud, 2016, PROT VIG SAL PUBL CH
   Instituto Nacional de Salud, 2016, PROT VIG SAL PUBL EN
   Instituto Nacional de Salud, 2014, PROT VIG SAL PUBL DE
   Moya J, PAN AM J PUBLIC HEAL, V36
   Nava-Frias M, 2016, B MED HOSP INFANT M, V73, P67, DOI 10.1016/j.bmhimx.2016.03.001
   Organizacion Panamericana de la Salud, 2016, ZIK ACT EP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Romero-Vega Liliana, 2014, Rev. Saúde Pública, V48, P899, DOI [10.1590/S0034-8910.2014048005321, 10.1590/s0034-8910.2014048005321]
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Vong S, 2012, EPIDEMIOL INFECT, V140, P491, DOI 10.1017/S0950268811001191
NR 23
TC 6
Z9 6
U1 0
U2 0
PU UNIV CORDOBA
PI MONTERIA
PA FAC MEDICINA VETERINARIA Y ZOOTECNIA, KM 26, VIA CIENEGA DE ORO,
   APARTADO AEREO NO 354, MONTERIA, 00000, COLOMBIA
SN 0122-0268
J9 REV MVZ CORDOBA
JI Rev. MVZ Cordoba
PD MAY
PY 2017
VL 22
SU S
BP 5994
EP 6003
DI 10.21897/rmvz.1069
PG 10
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA GT0AF
UT WOS:000444089100002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Schaub, B
   Monthieux, A
   Najioullah, F
   Adenet, C
   Muller, F
   Cesaire, R
AF Schaub, B.
   Monthieux, A.
   Najioullah, F.
   Adenet, C.
   Muller, F.
   Cesaire, R.
TI Persistent maternal Zika viremia: a marker of fetal infection
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Letter
C1 [Schaub, B.; Monthieux, A.; Adenet, C.] CHU Martinique, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, Maison Femme Mere & Enfant, BP 632, F-97261 Fort De France, Martinique, France.
   [Najioullah, F.; Cesaire, R.] CHU Martinique, Serv Virol, Fort De France, Martinique, France.
   [Muller, F.] Hop Robert Debre, Lab Biochim, Paris, France.
RP Schaub, B (corresponding author), CHU Martinique, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, Maison Femme Mere & Enfant, BP 632, F-97261 Fort De France, Martinique, France.
EM bruno.schaub@chu-martinique.fr
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 5
TC 5
Z9 5
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD MAY
PY 2017
VL 49
IS 5
BP 658
EP +
DI 10.1002/uog.17210
PG 3
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA EU1NP
UT WOS:000400787400019
PM 27485955
OA Bronze
DA 2020-07-08
ER

PT J
AU Cumberworth, SL
   Clark, JJ
   Kohl, A
   Donald, CL
AF Cumberworth, Stephanie L.
   Clark, Jordan J.
   Kohl, Alain
   Donald, Claire L.
TI Inhibition of type I interferon induction and signalling by
   mosquito-borne flaviviruses
SO CELLULAR MICROBIOLOGY
LA English
DT Review
DE Flavivirus; interferon antagonists; sfRNA; type I interferon
ID WEST-NILE-VIRUS; NONSTRUCTURAL PROTEIN NS2A; JAPANESE ENCEPHALITIS;
   SUBGENOMIC RNA; ZIKA VIRUS; ANTAGONIST FUNCTION; NS5 PROTEIN; DENGUE;
   MANIPULATION; ACTIVATION
AB The Flavivirus genus (Flaviviridae family) contains a number of important human pathogens, including dengue and Zika viruses, which have the potential to cause severe disease. In order to efficiently establish a productive infection in mammalian cells, flaviviruses have developed key strategies to counteract host immune defences, including the type I interferon response. They employ different mechanisms to control interferon signal transduction and effector pathways, and key research generated over the past couple of decades has uncovered new insights into their abilities to actively decrease interferon antiviral activity. Given the lack of antivirals or prophylactic treatments for many flaviviral infections, it is important to fully understand how these viruses affect cellular processes to influence pathogenesis and disease outcome. This review will discuss the strategies mosquito-borne flaviviruses have evolved to antagonise type I interferon mediated immune responses.
C1 [Cumberworth, Stephanie L.; Clark, Jordan J.; Kohl, Alain; Donald, Claire L.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
RP Donald, CL (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
EM claire.donald@glasgow.ac.uk
RI Donald, Claire/AAC-7556-2019
OI Donald, Claire/0000-0002-4370-0707; Clark, Jordan/0000-0003-1790-7883
FU United Kingdom Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014, MR/N017552/1]
FX United Kingdom Medical Research Council, Grant/Award Number: MC_UU_12014
   and MR/N017552/1
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chang YS, 1999, J VIROL, V73, P6257, DOI 10.1128/JVI.73.8.6257-6264.1999
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Cobos Jimenez V., 2015, RNA VIROLOGY, V486, P94, DOI [10.1016/j.virol.2015.09.007 26432022, DOI 10.1016/J.VIROL.2015.09.007]
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gack MU, 2014, J VIROL, V88, P5213, DOI 10.1128/JVI.03370-13
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Humoud MN, 2016, J VIROL, V90, P6489, DOI 10.1128/JVI.00647-16
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lindenbach BD, 2013, FIELDS VIROLOGY, P712
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Ma Z, 2016, CELL HOST MICROBE, V19, P150, DOI 10.1016/j.chom.2016.01.010
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   McElroy KL, 2006, AM J TROP MED HYG, V75, P1158, DOI 10.4269/ajtmh.2006.75.1158
   Melian EB, 2013, J GEN VIROL, V94, P308, DOI 10.1099/vir.0.047076-0
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Munoz-Jordan JL, 2010, CURR TOP MICROBIOL, V338, P35, DOI 10.1007/978-3-642-02215-9_3
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
NR 79
TC 11
Z9 12
U1 1
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD MAY
PY 2017
VL 19
IS 5
AR e12737
DI 10.1111/cmi.12737
PG 8
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA ER3EG
UT WOS:000398678000011
PM 28273394
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wen, ZX
AF Wen, Zhexing
TI Modeling neurodevelopmental and psychiatric diseases with human iPSCs
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Review
DE human-induced pluripotent stem cells; disease modeling; drug discovery;
   neurodevelopmental disorders; psychiatric disorders
ID PLURIPOTENT STEM-CELLS; NEURAL PROGENITOR CELLS; ZIKA VIRUS-INFECTION;
   HUMAN ES CELLS; DIRECTED DIFFERENTIATION; BIPOLAR DISORDER; FUNCTIONAL
   MATURATION; L1 RETROTRANSPOSITION; EFFICIENT GENERATION; CORTICAL
   DEVELOPMENT
AB Neurodevelopmental and psychiatric disorders, including autism spectrum disorder and schizophrenia, are complex and heterogeneous disorders that affect a large portion of the world's population. While the causes are still poorly understood, currently available treatments are limited; the development of rational therapeutics based on an understanding of the etiology and pathogenesis of the disease is imperative. The breakthrough technology of deriving induced pluripotent stem cells (iPSCs), reprogrammed from somatic cells of healthy subjects or patients, offers an unprecedented opportunity to recapitulate both normal and pathological development of human tissue, thereby opening up a new avenue for disease modeling and drug development in a more genetically tractable and disease-relevant system. Here, I review the recent progress in the use of human iPSCs for modeling neurodevelopmental and psychiatric disorders and developing novel therapeutic strategies, and discuss challenges in this rapidly moving field. (c) 2017 Wiley Periodicals, Inc.
C1 [Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Whitehead Biomed Res Bldg 447,615 Michael St, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Cell Biol, Whitehead Biomed Res Bldg 447,615 Michael St, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Neurol, Whitehead Biomed Res Bldg 447,615 Michael St, Atlanta, GA 30322 USA.
RP Wen, ZX (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Whitehead Biomed Res Bldg 447,615 Michael St, Atlanta, GA 30322 USA.; Wen, ZX (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Whitehead Biomed Res Bldg 447,615 Michael St, Atlanta, GA 30322 USA.; Wen, ZX (corresponding author), Emory Univ, Sch Med, Dept Neurol, Whitehead Biomed Res Bldg 447,615 Michael St, Atlanta, GA 30322 USA.
EM zwen3@emory.edu
RI Wen, Zhexing/L-1228-2018
OI Wen, Zhexing/0000-0002-1518-3845
FU Emory University
FX I thank Drs. Hongjun Song and Guo-li Ming at Johns Hopkins University
   School of Medicine for their support. The research in the author's
   laboratory was supported by a start-up fund from Emory University.
CR Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169
   Al-Harbi KS, 2012, PATIENT PREFER ADHER, V6, P369, DOI 10.2147/PPA.S29716
   Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255
   Bavamian S, 2015, MOL PSYCHIATR, V20, P573, DOI 10.1038/mp.2014.176
   Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448
   Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979
   Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Bundo M, 2014, NEURON, V81, P306, DOI 10.1016/j.neuron.2013.10.053
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582
   Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12
   Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093
   Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005
   Cox DM, 2015, INT J MOL SCI, V16, P4068, DOI 10.3390/ijms16024068
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002
   Doherty JL, 2014, GENOME MED, V6, DOI 10.1186/gm546
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305
   Ehninger D, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.39
   Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225
   Gonzalez-Burgos G, 2015, BIOL PSYCHIAT, V77, P1031, DOI 10.1016/j.biopsych.2015.03.010
   Gorris R, 2015, GLIA, V63, P2152, DOI 10.1002/glia.22882
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Hashimoto-Torii K, 2014, NEURON, V82, P560, DOI 10.1016/j.neuron.2014.03.002
   Hook V, 2014, STEM CELL REP, V3, P531, DOI 10.1016/j.stemcr.2014.08.001
   Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186
   Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Jonas RK, 2014, BIOL PSYCHIAT, V75, P351, DOI 10.1016/j.biopsych.2013.07.019
   Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kolaja K, 2014, J BIOL CHEM, V289, P4555, DOI 10.1074/jbc.R113.481028
   Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Kunisato A, 2011, STEM CELLS DEV, V20, P159, DOI 10.1089/scd.2010.0063
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Le Belle JE, 2014, STEM CELL REP, V3, P725, DOI 10.1016/j.stemcr.2014.09.004
   Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320
   Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648
   Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624
   Liu HS, 2011, CELL MOL LIFE SCI, V68, P3995, DOI 10.1007/s00018-011-0770-y
   Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106
   Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565
   Ma LX, 2011, METHODS MOL BIOL, V767, P411, DOI 10.1007/978-1-61779-201-4_30
   Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002
   Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7
   Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155
   Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008
   Martinez RA, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv164
   McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006
   Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544
   Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005
   Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612
   Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791
   Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566
   Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67
   Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150
   Sanches M, 2008, PROG NEURO-PSYCHOPH, V32, P1617, DOI 10.1016/j.pnpbp.2008.04.017
   Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001
   Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009
   Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013
   Siever LJ, 2004, AM J PSYCHIAT, V161, P398, DOI 10.1176/appi.ajp.161.3.398
   Sohal VS, 2012, BIOL PSYCHIAT, V71, P1039, DOI 10.1016/j.biopsych.2012.01.024
   Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011
   Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240
   Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang X, 2016, P NATL ACAD SCI USA, V113, P751, DOI 10.1073/pnas.1524013113
   Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5
   Topol A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.118
   Topol A, 2016, CELL REP, V15, P1024, DOI 10.1016/j.celrep.2016.03.090
   Topol A, 2015, BIOL PSYCHIAT, V78, pE29, DOI 10.1016/j.biopsych.2014.12.028
   Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56
   Wattanapanitch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106952
   Wen ZX, 2016, CURR OPIN NEUROBIOL, V36, P118, DOI 10.1016/j.conb.2015.11.003
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Xu JC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0623
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu Z, 2016, MOL PSYCHIATR, V21, P62, DOI 10.1038/mp.2015.101
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
   Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
   Zhang ZN, 2016, P NATL ACAD SCI USA, V113, P3185, DOI 10.1073/pnas.1521255113
   Zhao WN, 2012, J BIOMOL SCREEN, V17, P1252, DOI 10.1177/1087057112456876
NR 119
TC 9
Z9 9
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0360-4012
EI 1097-4547
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD MAY
PY 2017
VL 95
IS 5
BP 1097
EP 1109
DI 10.1002/jnr.24031
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA EP7UV
UT WOS:000397583600002
PM 28186671
DA 2020-07-08
ER

PT J
AU Yamanaka, A
   Moi, ML
   Takasaki, T
   Kurane, I
   Matsuda, M
   Suzuki, R
   Konishi, E
AF Yamanaka, Atsushi
   Moi, Meng Ling
   Takasaki, Tomohiko
   Kurane, Ichiro
   Matsuda, Mami
   Suzuki, Ryosuke
   Konishi, Eiji
TI Utility of Japanese encephalitis virus subgenomic replicon-based
   single-round infectious particles as antigens in neutralization tests
   for Zika virus and three other flaviviruses
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Flavivirus; Zika virus; Neutralization tests; Recombinant proteins;
   Antigens viral
ID LINKED-IMMUNOSORBENT-ASSAY; RECOMBINANT ANTIGEN; ANTIBODIES; DENGUE;
   VACCINES; PROTEIN; AFRICA
AB The introduction of a foreign virus into an area may cause an outbreak, as with the Zika virus (ZIKV) outbreak in the Americas. Preparedness for handling a viral outbreak involves the development of tests for the serodiagnosis of foreign virus infections. We previously established a gene-based technology to generate some flaviviral antigens useful for functional antibody assays. The technology utilizes a Japanese encephalitis virus subgenomic replicon to generate single-round infectious particles (SRIPs) that possess designed surface antigens. In the present study, we successfully expanded the capacity of SRIPs to four human-pathogenic mosquito-borne flaviviruses that could potentially be introduced from endemic to non-endemic countries: ZIKV, Sepik virus, Wesselsbron virus, and Usutu virus. Flavivirus-crossreactive monoclonal antibodies dose-dependently neutralized these SRIPs. ZIKV-SRIPs also produced antibody dose-dependent neutralization curves equivalent to those shown by authentic ZIKV particles using sera from a Zika fever patient. The faithful expression of designed surface antigens on SRIPs will allow their use in neutralization tests to diagnose foreign flaviviral infections. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Yamanaka, Atsushi; Konishi, Eiji] Mahidol Univ, BIKEN Endowed Dept Dengue Vaccine Dev, Fac Trop Med, 420-6 Ratchathewi Rd, Bangkok 10400, Thailand.
   [Yamanaka, Atsushi; Konishi, Eiji] Osaka Univ, BIKEN Endowed Dept Dengue Vaccine Dev, Res Inst Microbial Dis, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.
   [Moi, Meng Ling; Takasaki, Tomohiko] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Kurane, Ichiro] Natl Inst Infect Dis, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Matsuda, Mami; Suzuki, Ryosuke] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Moi, Meng Ling] Nagasaki Univ, Inst Trop Med, Nagasaki, Japan.
   [Takasaki, Tomohiko] Kanagawa Prefectural Inst Publ Hlth, Yokohama, Kanagawa, Japan.
   Osaka Univ, Res Fdn Microbial Dis, Osaka, Japan.
   Osaka Univ, Res Inst Microbial Dis, Osaka, Japan.
RP Yamanaka, A (corresponding author), Mahidol Univ, BIKEN Endowed Dept Dengue Vaccine Dev, Fac Trop Med, 420-6 Ratchathewi Rd, Bangkok 10400, Thailand.
EM knmya@biken.osaka-u.ac.jp
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [H26shinkou-jitsuyouka-007]
FX This work was partially supported by funding from the Japan Agency for
   Medical Research and Development (AMED, H26shinkou-jitsuyouka-007). The
   BIKEN Endowed Department of Dengue Vaccine Development is endowed by the
   Research Foundation for Microbial Diseases of Osaka University, Osaka,
   Japan, to the Research Institute for Microbial Diseases, Osaka
   University, Osaka, Japan. The funding bodies had no role in the study
   design; in the collection, analysis, or interpretation of the data; in
   writing the report; or in the decision to submit the article for
   publication.
CR CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Centers for Disease Control and Prevention, ARB CAT
   Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Jupp PG, 1998, J AM MOSQUITO CONTR, V14, P40
   King A.M.Q., 2012, VIRUS TAXONOMY CLASS
   Konishi E, 2004, J CLIN MICROBIOL, V42, P5087, DOI 10.1128/JCM.42.11.5087-5093.2004
   Konishi E, 2000, REC RES DEV VIROL, V2, P1
   Konishi E, 2008, JPN J INFECT DIS, V61, P410
   Kuno G, 2006, AM J TROP MED HYG, V75, P1165, DOI 10.4269/ajtmh.2006.75.1165
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministry of Economy, 2009, SEC EXP CONTR POL
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Purdy DE, 2004, J CLIN MICROBIOL, V42, P4709, DOI 10.1128/JCM.42.10.4709-4717.2004
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Russell BJ, 2007, J VIROL METHODS, V145, P62, DOI 10.1016/j.jviromet.2007.05.008
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Smith D. R., 2012, FLAVIVIRUS COMPENDIU
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   United Nations, 2011, NAG PROT ACC GEN RES
   Vazquez A, 2011, EUROSURVEILLANCE, V16, P22
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
   Yamanaka A, 2014, VACCINE, V32, P4289, DOI 10.1016/j.vaccine.2014.06.017
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 36
TC 2
Z9 2
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD MAY
PY 2017
VL 243
BP 164
EP 171
DI 10.1016/j.jviromet.2017.02.011
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA ER2SK
UT WOS:000398643900028
PM 28219763
DA 2020-07-08
ER

PT J
AU Baraniuk, C
AF Baraniuk, Chris
TI Zika may have led to fewer babies in Rio
SO NEW SCIENTIST
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU REED BUSINESS INFORMATION LTD
PI SUTTON
PA QUADRANT HOUSE THE QUADRANT, SUTTON SM2 5AS, SURREY, ENGLAND
SN 0262-4079
J9 NEW SCI
JI New Sci.
PD APR 29
PY 2017
VL 234
IS 3123
BP 9
EP 9
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET5IA
UT WOS:000400316200008
DA 2020-07-08
ER

PT J
AU Gootenberg, JS
   Abudayyeh, OO
   Lee, JW
   Essletzbichler, P
   Dy, AJ
   Joung, J
   Verdine, V
   Donghia, N
   Daringer, NM
   Freije, CA
   Myhrvold, C
   Bhattacharyya, RP
   Livny, J
   Regev, A
   Koonin, EV
   Hung, DT
   Sabeti, PC
   Collins, JJ
   Zhang, F
AF Gootenberg, Jonathan S.
   Abudayyeh, Omar O.
   Lee, Jeong Wook
   Essletzbichler, Patrick
   Dy, Aaron J.
   Joung, Julia
   Verdine, Vanessa
   Donghia, Nina
   Daringer, Nichole M.
   Freije, Catherine A.
   Myhrvold, Cameron
   Bhattacharyya, Roby P.
   Livny, Jonathan
   Regev, Aviv
   Koonin, Eugene V.
   Hung, Deborah T.
   Sabeti, Pardis C.
   Collins, James J.
   Zhang, Feng
TI Nucleic acid detection with CRISPR-Cas13a/C2c2
SO SCIENCE
LA English
DT Article
ID CIRCULATING TUMOR DNA; CRISPR-CAS SYSTEMS; ZIKA VIRUS; AMPLIFICATION;
   PROTEINS
AB Rapid, inexpensive, and sensitive nucleic acid detection may aid point-of-care pathogen detection, genotyping, and disease monitoring. The RNA-guided, RNA-targeting clustered regularly interspaced short palindromic repeats (CRISPR) effector Cas13a (previously known as C2c2) exhibits a "collateral effect" of promiscuous ribonuclease activity upon target recognition. We combine the collateral effect of Cas13a with isothermal amplification to establish a CRISPR-based diagnostic (CRISPR-Dx), providing rapid DNA or RNA detection with attomolar sensitivity and single-base mismatch specificity. We use this Cas13a-based molecular detection platform, termed Specific High-Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK), to detect specific strains of Zika and Dengue virus, distinguish pathogenic bacteria, genotype human DNA, and identify mutations in cell-free tumor DNA. Furthermore, SHERLOCK reaction reagents can be lyophilized for cold-chain independence and long-term storage and be readily reconstituted on paper for field applications.
C1 [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Dy, Aaron J.; Joung, Julia; Verdine, Vanessa; Freije, Catherine A.; Myhrvold, Cameron; Bhattacharyya, Roby P.; Livny, Jonathan; Regev, Aviv; Hung, Deborah T.; Sabeti, Pardis C.; Collins, James J.; Zhang, Feng] Broad Inst & MIT Harvard, Cambridge, MA 02142 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Essletzbichler, Patrick; Dy, Aaron J.; Joung, Julia; Verdine, Vanessa; Collins, James J.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
   [Abudayyeh, Omar O.; Collins, James J.] MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Lee, Jeong Wook; Donghia, Nina; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Dy, Aaron J.; Daringer, Nichole M.; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Freije, Catherine A.; Myhrvold, Cameron; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.
   [Regev, Aviv] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.
   [Sabeti, Pardis C.] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Collins, JJ; Zhang, F (corresponding author), Broad Inst & MIT Harvard, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Collins, JJ; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM jimjc@mit.edu; zhang@broadinstitute.org
RI Bhattacharyya, Roby/AAF-7670-2019; /H-7052-2016
OI Bhattacharyya, Roby/0000-0001-6955-5088; Lee, Jeong
   Wook/0000-0003-0705-0177; /0000-0003-0319-5416; Abudayyeh,
   Omar/0000-0002-7979-3220; Gootenberg, Jonathan/0000-0003-2757-2175;
   Essletzbichler, Patrick/0000-0003-2237-0005
FU Paul and Daisy Soros Fellowship; National Defense Science and
   Engineering FellowshipUnited States Department of Defense; U.S.
   Department of Energy Computational Science Graduate FellowshipUnited
   States Department of Energy (DOE); NIH through a National Institute of
   Allergies and Infectious Diseases grant [R01AI117043]; NSF Graduate
   Research FellowshipNational Science Foundation (NSF); Air Force Office
   of Scientific Research grantUnited States Department of DefenseAir Force
   Office of Scientific Research (AFOSR) [FA9550-14-1-0060]; M. and L.
   Benioff; J. and A. Bekenstein; Howard Hughes Medical InstituteHoward
   Hughes Medical Institute; Defense Threat Reduction Agency grantUnited
   States Department of DefenseDefense Threat Reduction Agency
   [HDTRA1-14-1-0006]; Paul G. Allen Frontiers Group; Wyss Institute; NIH
   through National Institute of Mental Health grants [5DP1-MH100706,
   1R01-MH110049]; NSFNational Science Foundation (NSF); New York Stem
   Cell; Simons Foundation; Vallee Foundation; Paul G. Allen Family
   Foundation
FX We thank F. Chen, V. Rusu, R. Gupta, D. Daniels, C. Garvie, I.
   Finkelstein, V. Adalsteinsson, A. Das, E. S. Lander, R. Macrae, and R.
   Belliveau for discussions and support. Human genotyping data were
   collected with the informed consent of the subjects and in consent with
   the guidelines of the approved Massachusetts Institute of Technology
   (MIT) institutional review board (IRB) protocol IRB-4062. O.O.A. is
   supported by a Paul and Daisy Soros Fellowship and a National Defense
   Science and Engineering Fellowship. J.S.G. is supported by a U.S.
   Department of Energy Computational Science Graduate Fellowship. R.P.B,
   J.L, and D.T.H. are supported by the NIH through a National Institute of
   Allergies and Infectious Diseases grant (R01AI117043). A.J.D. is
   supported by an NSF Graduate Research Fellowship and an Air Force Office
   of Scientific Research grant (FA9550-14-1-0060). Zika work was partially
   funded by M. and L. Benioff to P.C.S., and antibiotic resistance work
   was partially funded by J. and A. Bekenstein to D.T.H. A. R. is
   supported by the Howard Hughes Medical Institute. J. J. C. is supported
   by the Defense Threat Reduction Agency grant HDTRA1-14-1-0006, the Paul
   G. Allen Frontiers Group, and the Wyss Institute. F.Z. is a New York
   Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the
   NIH through National Institute of Mental Health grants (5DP1-MH100706
   and 1R01-MH110049); the NSF; the Howard Hughes Medical Institute; the
   New York Stem Cell, Simons, Paul G. Allen Family, and Vallee
   Foundations; and J. and P. Poitras, R. Metcalfe, and D. Cheng. A. R. is
   a member of the Scientific Advisory Board for ThermoFisher Scientific.
   J. S. G., O.O.A., R.P.B., A. R., E.V.K., D.T.H., P. C. S., J. J. C., and
   F.Z. have filed patent applications relating to the work in this
   manuscript, including J. S. G., O.O.A., E.V.K., and F.Z. on
   international application no. PCT/US2016/038258 filed 18 June 2015
   (CRISPR-C2c2 systems and uses thereof); J. S. G., O.O.A., and F.Z. on
   U.S. provisional patent application no. 62/351,662 filed 17 June 2016
   (CRISPR-C2c2 systems and diagnostic uses thereof); J. S. G., O.O.A., J.
   J. C., and F.Z. on U.S. provisional patent application no. 62/432,553
   filed 9 December 2016 (SHERLOCK diagnostic); J. S. G., O.O.A., P. C. S.,
   J. J. C., and F.Z. on U.S. provisional patent application no. 62/471,917
   filed 15 March 2017 (viral application of SHERLOCK); J. S. G., O.O.A.,
   A. R., J. J. C., and F.Z. on U.S. provisional patent application no.
   62/471,931 filed 15 March 2017 (mutation detection with SHERLOCK); J. S.
   G., O.O.A., R.P.B., D.T.H., J. J. C., and F.Z. on U.S. provisional
   patent application no. 62/471,936 filed 15 March 2017 (bacterial
   applications of SHERLOCK); and J. S. G., O.O.A., J. J. C., and F.Z. on
   U.S. provisional patent application no. 62/471,940 filed 15 March 2017
   (devices). Each patent application relates to CRISPR-C2c2 systems,
   specific uses, and improved uses thereof for diagnostic application
   filed by Broad, Harvard, Massachusetts General Hospital, MIT, and NIH.
   Cas13a/C2c2 expression plasmids are available from Addgene under a
   Uniform Biological Material Transfer Agreement.
CR Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573
   Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN
   Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Du Y, 2017, ANGEW CHEM INT EDIT, V56, P992, DOI 10.1002/anie.201609108
   East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802
   Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011
   Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202
   Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920
   Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Paz-Bailey G., 2017, NEW ENGL J MED
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Qin Z, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0092-4
   Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184
   Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008
   Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023
   Song LA, 2013, ANAL CHEM, V85, P1932, DOI 10.1021/ac303426b
   Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448
   Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038
NR 24
TC 356
Z9 380
U1 112
U2 522
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 28
PY 2017
VL 356
IS 6336
BP 438
EP +
DI 10.1126/science.aam9321
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET2YU
UT WOS:000400143000054
PM 28408723
OA Bronze, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Yi, L
   Pimentel, H
   Pachter, L
AF Yi, Lynn
   Pimentel, Harold
   Pachter, Lior
TI Zika infection of neural progenitor cells perturbs transcription in
   neurodevelopmental pathways
SO PLOS ONE
LA English
DT Article
ID EXPRESSION; GENE
AB Background A recent study of the gene expression patterns of Zika virus (ZIKV) infected human neural progenitor cells (hNPCs) revealed transcriptional dysregulation and identified cell cyclerelated pathways that are affected by infection. However deeper exploration of the information present in the RNA-Seq data can be used to further elucidate the manner in which Zika infection of hNPCs affects the transcriptome, refining pathway predictions and revealing isoform-specific dynamics.
   Methodology/ Principal findings We analyzed data published by Tang et al. using state-of-the-art tools for transcriptome analysis. By accounting for the experimental design and estimation of technical and inferential variance we were able to pinpoint Zika infection affected pathways that highlight Zika's neural tropism. The examination of differential genes reveals cases of isoform divergence.
   Conclusions Transcriptome analysis of Zika infected hNPCs has the potential to identify the molecular signatures of Zika infected neural cells. These signatures may be useful for diagnostics and for the resolution of infection pathways that can be used to harvest specific targets for further study.
C1 [Yi, Lynn; Pachter, Lior] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Yi, Lynn] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Pimentel, Harold] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA.
   [Pachter, Lior] CALTECH, Comp & Math Sci, Pasadena, CA 91125 USA.
RP Pachter, L (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Pachter, L (corresponding author), CALTECH, Comp & Math Sci, Pasadena, CA 91125 USA.
EM lpachter@caltech.edu
OI Yi, Lynn/0000-0003-4575-0158
FU UCLA/Caltech Medical Scientist Training Program; Walter and Sylvia
   Treadway Endowment; NIH T32 (NRSA); NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   DK094699]
FX LY was supported by funding from the UCLA/Caltech Medical Scientist
   Training Program, The Walter and Sylvia Treadway Endowment, and the NIH
   T32 (NRSA). LP was partially funded by NIH R01 DK094699. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102
   Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564
   Pimentel HJ, 058164 BIORXIV
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Wang Zichen, 2016, F1000Res, V5, P1574, DOI 10.12688/f1000research.9110.1
NR 11
TC 1
Z9 1
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2017
VL 12
IS 4
AR e175744
DI 10.1371/journal.pone.0175744
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET6EL
UT WOS:000400383600023
PM 28448519
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Pompon, J
   Morales-Vargas, R
   Manuel, M
   Tan, CH
   Vial, T
   Tan, JH
   Sessions, OM
   Vasconcelos, PD
   Ng, LC
   Misse, D
AF Pompon, Julien
   Morales-Vargas, Ronald
   Manuel, Menchie
   Cheong Huat Tan
   Vial, Thomas
   Tan, Jun Hao
   Sessions, October M.
   Vasconcelos, Pedro da Costa
   Ng, Lee Ching
   Misse, Dorothee
TI A Zika virus from America is more efficiently transmitted than an Asian
   virus by Aedes aegypti mosquitoes from Asia
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TRANSMISSION; INFECTION; SUSCEPTIBILITY; STRAINS; VECTOR; INSECT
AB Zika is a mosquito-borne disease associated with neurological disorders that causes an on-going pandemic. The first outbreak was recorded in Micronesia in 2007, then in French Polynesia in 2014 from which it spread to South America in 2015 and ignited a widespread epidemic. Interestingly, Zika outbreaks in Asia remained of moderate intensity although the virus is circulating. To understand these epidemiological variations, we investigated the entomological determinants of ZIKV transmission in Asia. We used oral infection of mosquitoes collected in Singapore to identify the vector species, to quantify the blood infection threshold and to compare transmissibility between an Asian ZIKV strain (H/PF13) and an American strain collected in Brazil (BE H 815744). We have confirmed the vector status of Aedes aegypti and determined that 10(3) pfu/ml of blood is sufficient to infect mosquitoes. We showed that only the American strain was present in the saliva 3 days post-infection, and that this strain had a 30-40% higher rate of saliva infection in Ae. aegypti from 3 to 14 days post-infection than the Asian strain. Our data suggests that American strains are more efficiently transmitted than Asian strains, which raises concerns about the introduction of American strains in Asia.
C1 [Pompon, Julien; Manuel, Menchie; Tan, Jun Hao; Sessions, October M.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Pompon, Julien; Misse, Dorothee] MIVEGEC UMR IRD CNRS UM 224 5290, IRD, Montpellier, France.
   [Morales-Vargas, Ronald] Mahidol Univ, Fac Trop Med, Dept Med Entomol, Bangkok, Thailand.
   [Cheong Huat Tan; Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
   [Vial, Thomas] Univ Toulouse, UMR Pharma DEV 152, IRD, Toulouse, France.
   [Vasconcelos, Pedro da Costa] Inst Evandro Chagas, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
RP Pompon, J (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.; Pompon, J; Misse, D (corresponding author), MIVEGEC UMR IRD CNRS UM 224 5290, IRD, Montpellier, France.
EM Julien.pompon@duke-nus.edu.sg; dorothee.misse@ird.fr
RI Vasconcelos, Pedro/AAH-3142-2019
OI Vial, Thomas/0000-0003-3347-7342
FU National Research Foundation SingaporeSingapore National Research
   Foundation [NMRC/BNIG/2032/2015]; Duke-NUS Signature Research Programme
   - Agency for Science, Technology and Research (A*STAR), SingaporeAgency
   for Science Technology & Research (ASTAR)National University of
   Singapore; Ministry of Health, SingaporeMinistry of Health-Singapore;
   IRD through JEAI DENCHICTHAI; Brazilian Ministry of Health, IEC; CAPES
   (Coordenacao de Apoio aos Profissionais de Nivel Superior do Ministerio
   da Educacao - Coordination of Professionals of High Level Degree of
   Ministry of Education)CAPES; CNPq (Conselho Nacional para o
   Desenvolvimento Cientifico e Tecnologico - the Brazilian Agency for
   Scientific and Technological Deveelopment)National Council for
   Scientific and Technological Development (CNPq) [301641/2010-2,
   303999/2016-0, 439971/2016-0, 440405/2016-5]; FINEP (Financiadora de
   Estudos e Projetos do Ministerio da Ciencia, Tecnologia e Inovacao-
   Agency for Financial support of Studies and Projects of the Ministry of
   Science, Technology and Innovation)
FX We are grateful to Duane J. Gubler for helping to gain access to the
   Brazilian strain of Zika virus. We are also in depth to Mariano
   Garcia-Blanco for constant support. We thank EVA for sharing its stock
   of H/PF13. Support for this research came from a grant from the National
   Research Foundation Singapore under its NIG scheme (NMRC/BNIG/2032/2015)
   awarded to J.P. and from the Duke-NUS Signature Research Programme
   funded by the Agency for Science, Technology and Research (A*STAR),
   Singapore, and the Ministry of Health, Singapore. RMV was partially
   supported by IRD through JEAI DENCHICTHAI. PFCV was partially supported
   by the Brazilian Ministry of Health, IEC and grants received from CAPES
   (Zika fast track grant; Coordenacao de Apoio aos Profissionais de Nivel
   Superior do Ministerio da Educacao - Coordination of Professionals of
   High Level Degree of Ministry of Education); CNPq (grants:
   301641/2010-2,303999/2016-0, 439971/2016-0 and 440405/2016-5; Conselho
   Nacional para o Desenvolvimento Cientifico e Tecnologico - the Brazilian
   Agency for Scientific and Technological Deveelopment), and FINEP (Zika
   call; Financiadora de Estudos e Projetos do Ministerio da Ciencia,
   Tecnologia e Inovacao- Agency for Financial support of Studies and
   Projects of the Ministry of Science, Technology and Innovation).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Andrews S., 2010, FQC QUALITY CONTROL
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huang Y. S., 2016, VECTOR-BORNE ZOONOT, V24, P24
   KNAUS RM, 1993, J AM MOSQUITO CONTR, V9, P264
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Pongsiri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092971
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 53
TC 37
Z9 38
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 27
PY 2017
VL 7
AR 1215
DI 10.1038/s41598-017-01282-6
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET3OM
UT WOS:000400189100005
PM 28450714
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liang, D
   Leung, RKK
   Lee, SS
   Kam, KM
AF Liang, Dachao
   Leung, Ross Ka Kit
   Lee, Shui Shan
   Kam, Kai Man
TI Insights into intercontinental spread of Zika virus
SO PLOS ONE
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; NUCLEOTIDE SUBSTITUTIONS; BIOLOGY;
   RECONSTRUCTION; INFERENCE; OUTBREAK; NUMBER
AB The epidemic of Zika virus (ZIKV) infection in South America has led to World Health Organization's declaration of a Public Health Emergency of International Concern. To further inform effective public health policy, an understanding of ZIKV's transmission mechanisms is crucial. To characterize the intercontinental transmission of ZIKV, we compiled and analyzed more than 250 gene sequences together with their sequence-related geographic and temporal information, sampled across 27 countries spanning from 1947 to 2016. After filtering and selecting appropriate sequences, extensive phylogenetic analyses were performed. Although phylogeographic reconstruction supported the transmission route of the virus in Africa, South-eastern Asia, Oceania and Latin America, we discovered that the Eastern Africa origin of ZIKV was disputable. On a molecular level, purifying selection was found to be largely responsible for the evolution of non-structural protein 5 and envelope protein E. Our dataset and ancestral sequences reconstruction analysis captured previously unidentified amino acid changes during evolution. Finally, based on the estimation of the time to the most recent common ancestors for the non-structural protein 5 gene, we hypothesized potential specific historic events that occurred in the 1940s and might have facilitated the spread of Zika virus from Africa to South-eastern Asia. Our findings provide new insights into the transmission characteristics of ZIKV, while further genetic and serologic studies are warranted to support the design of tailored prevention strategies.
C1 [Liang, Dachao; Leung, Ross Ka Kit; Lee, Shui Shan; Kam, Kai Man] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Leung, Ross Ka Kit] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
RP Kam, KM (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
EM kmkam@cuhk.edu.hk
RI KAM, Kai Man/K-4546-2012; Lee, Shui Shan/B-9374-2008
OI KAM, Kai Man/0000-0003-0579-0307; Lee, Shui Shan/0000-0003-1448-765X
CR Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hattori T, 1953, COMPLETE HIST GREATE
   Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li Z, 2008, J MED CHEM, V51, P4660, DOI 10.1021/jm800412d
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   PUFFER RL, 1994, LIBR J, V119, P110
   Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   TAMURA K, 1992, MOL BIOL EVOL, V9, P678
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   United Nations. Statistical Division, 1999, STAND COUNTR AR COD, Vvii
   USCDC, 2016, ADV PEOPL LIV TRAV B
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu CH, 2013, MOL BIOL EVOL, V30, P669, DOI 10.1093/molbev/mss258
   Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 63
TC 6
Z9 8
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2017
VL 12
IS 4
AR e0176710
DI 10.1371/journal.pone.0176710
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET6EL
UT WOS:000400383600122
PM 28448611
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, CX
   Guo, XX
   Deng, YQ
   Xing, D
   Sun, AJ
   Liu, QM
   Wu, Q
   Dong, YD
   Zhang, YM
   Zhang, HD
   Cao, WC
   Qin, CF
   Zhao, TY
AF Li, Chun-xiao
   Guo, Xiao-xia
   Deng, Yong-qiang
   Xing, Dan
   Sun, Ai-juan
   Liu, Qin-mei
   Wu, Qun
   Dong, Yan-de
   Zhang, Ying-mei
   Zhang, Heng-duan
   Cao, Wu-chun
   Qin, Cheng-feng
   Zhao, Tong-yan
TI Vector competence and transovarial transmission of two Aedes aegypti
   strains to Zika virus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Aedes aegypti; transovarial transmission; vector competence; Zika virus
ID WEST-NILE-VIRUS; EXPERIMENTAL VERTICAL TRANSMISSION; MOSQUITOS
   DIPTERA-CULICIDAE; JAPANESE ENCEPHALITIS-VIRUS; DENGUE VIRUSES;
   CHIKUNGUNYA VIRUS; STEGOMYIA AEGYPTI; YELLOW-FEVER; ALBOPICTUS;
   INFECTION
AB Zika virus (ZIKV) has become a serious threat to global health since the outbreak in Brazil in 2015. Additional Chinese cases have continuously been reported since the first case of laboratory-confirmed ZIKV infection in China on 6 February 2016. Aedes aegypti is the most important vector for ZIKV. This study shows that two strains from China exhibit high levels of midgut infection and highly disseminated infection of salivary glands and ovaries. Both strains can transmit ZIKV to infant mice bitten by infectious mosquitoes. Moreover, the results provide the evidence of transovarial transmission of ZIKV in mosquitoes. The study indicates that the two Ae. aegypti strains are not only effective transmission vectors but also persistent survival hosts for ZIKV during unfavorable inter-epidemic periods. This function as a reservoir of infection has epidemiological implications that further enhance the risk of potential future outbreaks.
C1 [Li, Chun-xiao; Guo, Xiao-xia; Xing, Dan; Sun, Ai-juan; Liu, Qin-mei; Wu, Qun; Dong, Yan-de; Zhao, Tong-yan] Inst Microbiol & Epidemiol, Dept Vector Biol & Control, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Deng, Yong-qiang; Qin, Cheng-feng] Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhang, Ying-mei; Zhang, Heng-duan; Cao, Wu-chun] Inst Microbiol & Epidemiol, Dept Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
RP Zhao, TY (corresponding author), Inst Microbiol & Epidemiol, Dept Vector Biol & Control, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn; tongyanzhao@126.com
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU National Key Technology Support ProgramNational Key Technology R&D
   Program [2012ZX10004219]; Zika Prevention and Control Project of China
   [2014BAI13B01]
FX This work was supported by grants from the Infective Diseases Prevention
   and Cure Project of China (NO. 2012ZX10004219), the National Key
   Technology Support Program (NO. 2014BAI13B01) and the Zika Prevention
   and Control Project of China.
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Anderson JF, 2008, J MED ENTOMOL, V45, P445, DOI 10.1603/0022-2585(2008)45[445:EIPFHA]2.0.CO;2
   BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cornet M, 1979, CAH ORSTOM EMP, V27, P47
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo M, 2000, AM J TROP MED HYG, V62, P151, DOI 10.4269/ajtmh.2000.62.151
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edillo FE, 2015, J VECTOR ECOL, V40, P282, DOI 10.1111/jvec.12166
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Espinosa M, 2014, REV INST MED TROP SP, V56, P165, DOI 10.1590/S0036-46652014000200013
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Lu BL, 1997, FAUNA SINICA INSECT, V8, P221
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240
   MILLER BR, 1979, AM J TROP MED HYG, V28, P897, DOI 10.4269/ajtmh.1979.28.897
   MITCHELL CJ, 1990, J AM MOSQUITO CONTR, V6, P251
   Mourya DT, 2001, ACTA VIROL, V45, P67
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   ROSEN L, 1989, AM J TROP MED HYG, V40, P548, DOI 10.4269/ajtmh.1989.40.548
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thavara U, 2009, SE ASIAN J TROP MED, V40, P951
   Wu C, 2006, CHINA TROP MED, V6, P1933
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
NR 39
TC 22
Z9 22
U1 1
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD APR 26
PY 2017
VL 6
AR e23
DI 10.1038/emi.2017.8
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EU3PC
UT WOS:000400942500002
PM 28442754
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tiwari, SK
   Dang, J
   Qin, Y
   Lichinchi, G
   Bansal, V
   Rana, TM
AF Tiwari, Shashi Kant
   Dang, Jason
   Qin, Yue
   Lichinchi, Gianluigi
   Bansal, Vikas
   Rana, Tariq M.
TI Zika virus infection reprograms global transcription of host cells to
   allow sustained infection
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE metabolic inhibitor; transcriptome; viral response; Zika virus
ID SEXUAL TRANSMISSION; DENDRITIC CELLS; ACTIVATION; DENGUE; FLAVIVIRUSES;
   INHIBITION; SUSCEPTIBILITY; PATHOGENESIS; REPLICATION; METABOLISM
AB Zika virus (ZIKV) is an emerging virus causally linked to neurological disorders, including congenital microcephaly and Guillain-Barre syndrome. There are currently no targeted therapies for ZIKV infection. To identify novel antiviral targets and to elucidate the mechanisms by which ZIKV exploits the host cell machinery to support sustained replication, we analyzed the transcriptomic landscape of human microglia, fibroblast, embryonic kidney and monocyte-derived macrophage cell lines before and after ZIKV infection. The four cell types differed in their susceptibility to ZIKV infection, consistent with differences in their expression of viral response genes before infection. Clustering and network analyses of genes differentially expressed after ZIKV infection revealed changes related to the adaptive immune system, angiogenesis and host metabolic processes that are conducive to sustained viral production. Genes related to the adaptive immune response were downregulated in microglia cells, suggesting that ZIKV effectively evades the immune response after reaching the central nervous system. Like other viruses, ZIKV diverts host cell resources and reprograms the metabolic machinery to support RNA metabolism, ATP production and glycolysis. Consistent with these transcriptomic analyses, nucleoside metabolic inhibitors abrogated ZIKV replication in microglia cells.
C1 [Tiwari, Shashi Kant; Dang, Jason; Qin, Yue; Lichinchi, Gianluigi; Bansal, Vikas; Rana, Tariq M.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
   [Dang, Jason] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Lichinchi, Gianluigi] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Rana, Tariq M.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
RP Rana, TM (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
EM trana@ucsd.edu
RI Tiwari, Shashi Kant/R-8533-2018
OI Tiwari, Shashi Kant/0000-0002-6121-6249
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI43198, AI125103,
   DA039562]
FX We thank Dr Jon Karn (Case Western Reserve University, Cleveland, OH,
   USA) for providing us human microglia cell line. We also thank Steve
   Head (The Scripps Research Institute, La Jolla, CA, USA) and the staff
   of the Next Generation Sequencing core facility at The Scripps Research
   Institute for help with the HT-seq and data analysis, and members of the
   Rana lab for helpful discussions and advice. This work was supported in
   part by grants (AI43198, AI125103 and DA039562) from the National
   Institutes of Health.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo-Gil E, 2010, J INTERF CYTOK RES, V30, P171, DOI 10.1089/jir.2009.0037
   Fischer MA, 2013, J VIROL, V87, P9411, DOI 10.1128/JVI.00101-13
   Goodwin CM, 2015, TRENDS MICROBIOL, V23, P789, DOI 10.1016/j.tim.2015.08.007
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu P, 2009, J INFECT DIS, V200, P191, DOI 10.1086/599795
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maynard ND, 2010, BIOTECHNOL J, V5, P686, DOI 10.1002/biot.201000080
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Nourollahpour Shiadeh M, 2016, J MATERN-FETAL NEO M, V30, P562
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009
   Torres S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002060
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Wang L, 2011, CELL BIOCHEM BIOPHYS, V60, P199, DOI 10.1007/s12013-010-9140-x
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Xiang J, 2009, J IMMUNOL, V183, P7860, DOI 10.4049/jimmunol.0902276
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
NR 44
TC 20
Z9 20
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD APR 26
PY 2017
VL 6
AR e24
DI 10.1038/emi.2017.9
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EU3PC
UT WOS:000400942500003
PM 28442752
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Fauver, JR
   Ruckert, C
   Weger-Lucarelli, J
   Garcia-Luna, S
   Murrieta, RA
   Gendernalik, A
   Smith, DR
   Brackney, DE
   Ebel, GD
AF Grubaugh, Nathan D.
   Fauver, Joseph R.
   Ruckert, Claudia
   Weger-Lucarelli, James
   Garcia-Luna, Selene
   Murrieta, Reyes A.
   Gendernalik, Alex
   Smith, Darci R.
   Brackney, Doug E.
   Ebel, Gregory D.
TI Mosquitoes Transmit Unique West Nile Virus Populations during Each
   Feeding Episode
SO CELL REPORTS
LA English
DT Article
ID CULEX-TARSALIS DIPTERA; EQUINE ENCEPHALOMYELITIS VIRUS;
   PIPIENS-QUINQUEFASCIATUS; PURIFYING SELECTION; CULICIDAE; INFECTION;
   DIVERSITY
AB Arthropod-borne viruses (arboviruses), such as Zika virus, chikungunya virus, and West Nile virus (WNV), pose continuous threats to emerge and cause large epidemics. Often, these events are associated with novel virus variants optimized for local transmission that first arise as minorities within a host. Thus, the conditions that regulate the frequency of intrahost variants are important determinants of emergence. Here, we describe the dynamics of WNV genetic diversity during its transmission cycle. By temporally sampling saliva from individual mosquitoes, we demonstrate that virus populations expectorated by mosquitoes are highly diverse and unique to each feeding episode. After transmission to birds, however, most genetic diversity is removed by strong purifying selection. Further, transmission of potentially mosquito-adaptive WNV variants is strongly influenced by genetic drift in mosquitoes. These results highlight the complex evolutionary forces a novel virus variant must overcome to alter infection phenotypes at the population level.
C1 [Grubaugh, Nathan D.; Fauver, Joseph R.; Ruckert, Claudia; Weger-Lucarelli, James; Garcia-Luna, Selene; Murrieta, Reyes A.; Gendernalik, Alex; Smith, Darci R.; Brackney, Doug E.; Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Grubaugh, Nathan D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Smith, Darci R.] US Army Med Res Inst Infect Dis, Virol Div, Frederick, MD 21702 USA.
   [Brackney, Doug E.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06511 USA.
RP Grubaugh, ND; Ebel, GD (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Grubaugh, ND (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
EM grubaugh@scripps.edu; gregory.ebel@colostate.edu
OI Ruckert, Claudia/0000-0003-3732-6752; Weger-Lucarelli,
   James/0000-0002-9483-1694; Grubaugh, Nathan/0000-0003-2031-1933;
   Garcia-Luna, Selene M./0000-0001-8420-5078; Murrieta,
   Reyes/0000-0003-2289-962X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [2D43TW001130-0681, AI067380]; Colorado
   State University GAUSSI fellowship (NSF grant) [DGE-1450032]; NIH
   GrantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA
FX We thank C. Nguyen for providing mosquitoes and E. Petrilli, P. Buxton,
   S. Taylor, S. Schell, W. Black, and K. Andersen for laboratory support
   and/or discussions. We also thank three anonymous reviewers for helping
   us to improve a previous version of this manuscript. S.G.L. was
   supported by the NIH Fogarty grant 2D43TW001130-0681, and R.A.M. was
   supported by the Colorado State University GAUSSI fellowship 2016-2017
   (NSF grant DGE-1450032). G.D.E. and his lab are supported by the NIH
   Grant AI067380.
CR Alto BW, 2014, J VECTOR ECOL, V39, P123, DOI 10.1111/j.1948-7134.2014.12078.x
   Brackney DE, 2015, J VIROL, V89, P4035, DOI 10.1128/JVI.02612-14
   Brackney DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024466
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Cantor C, 1969, EVOLUTION PROTEIN MO, V3
   Ciota AT, 2012, INFECT GENET EVOL, V12, P557, DOI 10.1016/j.meegid.2012.01.022
   Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Fumagalli M, 2013, GENETICS, V195, P979, DOI 10.1534/genetics.113.154740
   Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Grubaugh ND, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004874
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006
   Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Lee JH, 2000, J MED ENTOMOL, V37, P187, DOI 10.1603/0022-2585-37.1.187
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Mahmood F, 2004, J MED ENTOMOL, V41, P982, DOI 10.1603/0022-2585-41.5.982
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2
   Sessions OM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004044
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   TAKAHASHI M, 1979, AM J TROP MED HYG, V28, P122, DOI 10.4269/ajtmh.1979.28.122
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059
   Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09
NR 37
TC 28
Z9 28
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR 25
PY 2017
VL 19
IS 4
BP 709
EP 718
DI 10.1016/j.celrep.2017.03.076
PG 10
WC Cell Biology
SC Cell Biology
GA EU6GY
UT WOS:000401133700006
PM 28445723
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Sacramento, CQ
   de Melo, GR
   de Freitas, CS
   Rocha, N
   Hoelz, LVB
   Miranda, M
   Fintelman-Rodrigues, N
   Marttorelli, A
   Ferreira, AC
   Barbosa-Lima, G
   Abrantes, JL
   Vieira, YR
   Bastos, MM
   Volotao, EDM
   Nunes, EP
   Tschoeke, DA
   Leomil, L
   Loiola, EC
   Trindade, P
   Rehen, SK
   Bozza, FA
   Bozza, PT
   Boechat, N
   Thompson, FL
   de Filippis, AMB
   Bruning, K
   Souza, TML
AF Sacramento, Carolina Q.
   de Melo, Gabrielle R.
   de Freitas, Caroline S.
   Rocha, Natasha
   Hoelz, Lucas Villas Boas
   Miranda, Milene
   Fintelman-Rodrigues, Natalia
   Marttorelli, Andressa
   Ferreira, Andre C.
   Barbosa-Lima, Giselle
   Abrantes, Juliana L.
   Vieira, Yasmine Rangel
   Bastos, Monica M.
   Volotao, Eduardo de Mello
   Nunes, Estevao Portela
   Tschoeke, Diogo A.
   Leomil, Luciana
   Loiola, Erick Correia
   Trindade, Pablo
   Rehen, Stevens K.
   Bozza, Fernando A.
   Bozza, Patricia T.
   Boechat, Nubia
   Thompson, Fabiano L.
   de Filippis, Ana M. B.
   Bruning, Karin
   Souza, Thiago Moreno L.
TI The clinically approved antiviral drug sofosbuvir inhibits Zika virus
   replication (vol 7, 40920, 2017)
SO SCIENTIFIC REPORTS
LA English
DT Correction
RI Boechat, Nubia/K-2520-2019; Rehen, Stevens K/J-5874-2012; Boechat,
   Nubia/N-1406-2014
OI Boechat, Nubia/0000-0003-0146-2218; Rehen, Stevens
   K/0000-0003-4216-9501; Boechat, Nubia/0000-0003-0146-2218; Bozza,
   Fernando Augusto/0000-0003-4878-0256; Bozza,
   Patricia/0000-0001-8349-9529; Souza, Thiago/0000-0003-2212-3899
CR Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
NR 1
TC 1
Z9 1
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 24
PY 2017
VL 7
AR 46772
DI 10.1038/srep46772
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET1XW
UT WOS:000400063400001
PM 28436989
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nutt, C
   Adams, P
AF Nutt, Cameron
   Adams, Patrick
TI Zika in Africa-the invisible epidemic?
SO LANCET
LA English
DT Editorial Material
NR 0
TC 20
Z9 20
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 22
PY 2017
VL 389
IS 10079
BP 1595
EP 1596
DI 10.1016/S0140-6736(17)31051-6
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA ES5EK
UT WOS:000399560000010
PM 28593839
OA Bronze
DA 2020-07-08
ER

PT J
AU Blanchard, K
   Starrs, AM
AF Blanchard, Kelly
   Starrs, Ann M.
TI Contraception, safe abortion, and the Zika response
SO LANCET
LA English
DT Letter
C1 [Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA 02140 USA.
   [Starrs, Ann M.] Guttmacher Inst, New York, NY USA.
RP Blanchard, K (corresponding author), Ibis Reprod Hlth, Cambridge, MA 02140 USA.
EM kblanchard@ibisreproductivehealth.org
CR [Anonymous], 2017, LANCET, V389, P573
NR 1
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 22
PY 2017
VL 389
IS 10079
BP 1603
EP 1603
DI 10.1016/S0140-6736(17)31010-3
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA ES5EK
UT WOS:000399560000014
PM 28443546
OA Bronze
DA 2020-07-08
ER

PT J
AU Yaren, O
   Alto, BW
   Gangodkar, PV
   Ranade, SR
   Patil, KN
   Bradley, KM
   Yang, ZY
   Phadke, N
   Benner, SA
AF Yaren, Ozlem
   Alto, Barry W.
   Gangodkar, Priyanka V.
   Ranade, Shatakshi R.
   Patil, Kunal N.
   Bradley, Kevin M.
   Yang, Zunyi
   Phadke, Nikhil
   Benner, Steven A.
TI Point of sampling detection of Zika virus within a multiplexed kit
   capable of detecting dengue and chikungunya
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Point-of-care diagnostics; Multiplexed isothermal amplification; Zika
   detection; Fluorescence read-out; Sample preparation; Mosquito
   surveillance; Virus detection
ID ISOTHERMAL AMPLIFICATION; URINE; FLUORESCENCE; ALIGNMENT; SALIVA; ACID;
   PCR
AB Background: Zika, dengue, and chikungunya are three mosquito-borne viruses having overlapping transmission vectors. They cause diseases having similar symptoms in human patients, but requiring different immediate management steps. Therefore, rapid (< one hour) discrimination of these three viruses in patient samples and trapped mosquitoes is needed. The need for speed precludes any assay that requires complex up-front sample preparation, such as extraction of nucleic acids from the sample. Also precluded in robust point-of-sampling assays is downstream release of the amplicon mixture, as this risks contamination of future samples that will give false positives.
   Methods: Procedures are reported that directly test urine and plasma (for patient diagnostics) or crushed mosquito carcasses (for environmental surveillance). Carcasses are captured on paper samples carrying quaternary ammonium groups (Q-paper), which may be directly introduced into the assay. To avoid the time and instrumentation requirements of PCR, the procedure uses loop-mediated isothermal amplification (LAMP). Downstream detection is done in sealed tubes, with dTTP-dUTP mixtures in the LAMP with a thermolabile uracil DNA glycosylase (UDG); this offers a second mechanism to prevent forward contamination. Reverse transcription LAMP (RT-LAMP) reagents are distributed dry without requiring a continuous chain of refrigeration.
   Results: The tests detect viral RNA in unprocessed urine and other biological samples, distinguishing Zika, chikungunya, and dengue in urine and in mosquitoes infected with live Zika and chikungunya viruses. The limits of detection (LODs) are similar to 0.71 pfu equivalent viral RNAs for Zika, similar to 1.22 pfu equivalent viral RNAs for dengue, and similar to 38 copies of chikungunya viral RNA. A handheld, battery-powered device with an orange filter was constructed to visualize the output. Preliminary data showed that this architecture, working with pre-prepared tubes holding lyophilized reagent/enzyme mixtures and shipped without a chain of refrigeration, also worked with human plasma samples to detect chikungunya and dengue in Pune, India.
   Conclusions: A kit, complete with a visualization device, is now available for point-of-sampling detection of Zika, chikungunya, and dengue. The assay output is read in ca. 30 min by visualizing (human eye) three-color coded fluorescence signals. Assay in dried format allows it to be run in low-resource environments.
C1 [Yaren, Ozlem; Bradley, Kevin M.; Yang, Zunyi; Benner, Steven A.] Fdn Appl Mol Evolut FfAME, Gainesville, FL 32615 USA.
   [Alto, Barry W.] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL USA.
   [Gangodkar, Priyanka V.; Ranade, Shatakshi R.; Patil, Kunal N.; Phadke, Nikhil] GenePath Dx, Causeway Healthcare, Pune, Maharashtra, India.
   [Benner, Steven A.] Firebird Biomol Sci LLC, Alachua, FL 32605 USA.
RP Benner, SA (corresponding author), Fdn Appl Mol Evolut FfAME, Gainesville, FL 32615 USA.; Benner, SA (corresponding author), Firebird Biomol Sci LLC, Alachua, FL 32605 USA.
EM sbenner@ffame.org
FU Department of the Defense, Defense Threat Reduction AgencyUnited States
   Department of DefenseDefense Threat Reduction Agency; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [1R21AI128188-01];  [HDTRA1-13-1-0004]
FX The work was supported in part by HDTRA1-13-1-0004 and NIAID
   1R21AI128188-01. The project was sponsored in part by the Department of
   the Defense, Defense Threat Reduction Agency. The content of the
   information does not necessarily reflect the position or the policy of
   the federal government, and no official endorsement should be inferred.
   Research reported in this publication was supported in part by the
   National Institutes of Health. The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the NIH.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Dasgupta S, 2012, INT J CANCER, V131, P158, DOI 10.1002/ijc.26357
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edwards T, 2014, J CLIN MICROBIOL, V52, P2163, DOI 10.1128/JCM.00314-14
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   Glushakova LG, 2015, J VIROL METHODS, V214, P60, DOI 10.1016/j.jviromet.2015.01.003
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671
   Jones PHOC, 2015, J INFECT DIS THER, V3
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Li J, 2015, BIOSENS BIOELECTRON, V64, P196, DOI 10.1016/j.bios.2014.08.069
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422
   Reiskind MH, 2010, J VECTOR ECOL, V35, P61, DOI 10.1111/j.1948-7134.2010.00029.x
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Thomas AH, 2002, PHOTOCH PHOTOBIO SCI, V1, P421, DOI 10.1039/b202114e
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Wu D, 1999, MED VET ENTOMOL, V13, P48, DOI 10.1046/j.1365-2915.1999.00144.x
   Yang F, 2013, WATER SCI TECHNOL, V67, P2560, DOI 10.2166/wst.2013.140
NR 36
TC 28
Z9 29
U1 3
U2 34
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD APR 20
PY 2017
VL 17
AR 293
DI 10.1186/s12879-017-2382-0
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA ES8BK
UT WOS:000399775400007
PM 28427352
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Di Cavalcanti, D
   Alves, LV
   Furtado, GJ
   Santos, CC
   Feitosa, FG
   Ribeiro, MC
   Menge, P
   Lira, IM
   Alves, JG
AF Di Cavalcanti, Danielle
   Alves, Lucas V.
   Furtado, Geraldo J.
   Santos, Cleusa C.
   Feitosa, Fabiana G.
   Ribeiro, Maria C.
   Menge, Paulo
   Lira, Izabelle M.
   Alves, Joao G.
TI Echocardiographic findings in infants with presumed congenital Zika
   syndrome: Retrospective case series study
SO PLOS ONE
LA English
DT Article
ID ATRIAL SEPTAL-DEFECT; HEART-DISEASE; CHILDREN
AB Objective
   To report the echocardiographic evaluation of 103 infants with presumed congenital Zika syndrome.
   Methods
   An observational retrospective study was performed at Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil. 103 infants with presumed congenital Zika syndrome. All infants had microcephaly and head computed tomography findings compatible with congenital Zika syndrome. Zika IgM antibody was detected in cerebrospinal fluid samples of 23 infants. In 80 infants, the test was not performed because it was not available at that time. All infants had negative serology for HIV, syphilis, rubella, cytomegalovirus and toxoplasmosis. A complete transthoracic two-dimensional, M-mode, continuous wave and pulsed wave Doppler and color Doppler echocardiographic (PHILIPS HD11XE or HD15) examination was performed on all infants.
   Results
   14/103 (13.5%) echocardiograms were compatible with congenital heart disease: 5 with an ostium secundum atrial septal defect, 8 had a hemodynamically insignificant small apical muscular ventricular septal defect and one infant with dyspnea had a large membranous ventricular septal defect. The echocardiograms considered normal included 45 infants with a persistent foramen ovale and 16 with a minimum patent ductus arteriosus.
   Conclusions
   Preliminarily this study suggests that congenital Zika syndrome may be associated with an increase prevalence of congenital heart disease. However the types of defects noted were septal defects, a proportion of which would not be hemodynamically significant.
C1 [Di Cavalcanti, Danielle; Alves, Lucas V.; Furtado, Geraldo J.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE, Brazil.
   [Santos, Cleusa C.; Feitosa, Fabiana G.; Ribeiro, Maria C.; Menge, Paulo; Lira, Izabelle M.; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat Cardiol, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat Cardiol, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR Brassard M, 1999, AM J CARDIOL, V83, P1552, DOI 10.1016/S0002-9149(99)00146-0
   Brazilian Ministry of Health, 2015, MICR EP B
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Hanslik A, 2006, PEDIATRICS, V118, P1560, DOI 10.1542/peds.2005-3037
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ishikawa T, 2011, ACTA PAEDIATR, V100, pE55, DOI 10.1111/j.1651-2227.2011.02248.x
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   MITCHELL SC, 1957, J PEDIATR-US, V51, P12, DOI 10.1016/S0022-3476(57)80275-3
   MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323
   Ramussen AS, 2016, NEW ENGL J MED, V374, P1981
   Smith BG, 2012, J PAEDIATR CHILD H, V48, P1082, DOI 10.1111/j.1440-1754.2012.02467.x
   Zhang Jun, 2015, Proc (Bayl Univ Med Cent), V28, P516
NR 16
TC 4
Z9 4
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 20
PY 2017
VL 12
IS 4
AR e0175065
DI 10.1371/journal.pone.0175065
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES9KM
UT WOS:000399875900017
PM 28426680
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kam, YW
   Lee, CYP
   Teo, TH
   Howland, SW
   Amrun, SN
   Lum, FM
   See, P
   Kng, NQR
   Huber, RG
   Xu, MH
   Tan, HL
   Choo, A
   Maurer-Stroh, S
   Ginhoux, F
   Fink, K
   Wang, CI
   Ng, LFP
   Renia, L
AF Kam, Yiu-Wing
   Lee, Cheryl Yi-Pin
   Teo, Teck-Hui
   Howland, Shanshan W.
   Amrun, Siti Naqiah
   Lum, Fok-Moon
   See, Peter
   Kng, Nicholas Qing-Rong
   Huber, Roland G.
   Xu, Mei-Hui
   Tan, Heng-Liang
   Choo, Andre
   Maurer-Stroh, Sebastian
   Ginhoux, Florent
   Fink, Katja
   Wang, Cheng-I
   Ng, Lisa F. P.
   Renia, Laurent
TI Cross-reactive dengue human monoclonal antibody prevents severe
   pathologies and death from Zika virus infections
SO JCI INSIGHT
LA English
DT Article
ID DEPENDENT ENHANCEMENT; CHIKUNGUNYA VIRUS; STRUCTURAL BASIS; CELL
   RESPONSES; OUTBREAK; REPLICATION; PREGNANCY; EPIDEMIC; VACCINE
AB Zika virus (ZIKV) infections have been linked with neurological complications and congenital Zika syndrome. Given the high level of homology between ZIKV and the related flavivirus dengue virus (DENV), we investigated the level of cross-reactivity with ZIKV using a panel of DENV human mAbs. A majority of the mAbs showed binding to ZIKV virions, with several exhibiting neutralizing capacities against ZIKV in vitro. Three of the best ZIKV-neutralizing mAbs were found to recognize diverse epitopes on the envelope (E) glycoprotein: the highly conserved fusion-loop peptide, a conformation-specific epitope on the E monomer, and a quaternary epitope on the virion surface. The most potent ZIKV-neutralizing mAb (SIgN-3C) was assessed in 2 type I interferon receptor-deficient (IFNAR(-/-)) mouse models of ZIKV infection. Treatment of adult nonpregnant mice with SIgN-3C rescued mice from virus-induced weight loss and mortality. The SIgN-3C variant with Leuto-Ala mutations in the Fc region (SIgN-3C-LALA) did not induce antibody-dependent enhancement (ADE) in vitro but provided similar levels of protection in vivo. In pregnant ZIKV-infected IFNAR(-/-)mice, treatment with SIgN-3C or SIgN-3C-LALA significantly reduced viral load in the fetal organs and placenta and abrogated virus-induced fetal growth retardation. Therefore, SIgN-3C-LALA holds promise as a ZIKV prophylactic and therapeutic agent.
C1 [Kam, Yiu-Wing; Lee, Cheryl Yi-Pin; Teo, Teck-Hui; Howland, Shanshan W.; Amrun, Siti Naqiah; Lum, Fok-Moon; See, Peter; Kng, Nicholas Qing-Rong; Xu, Mei-Hui; Ginhoux, Florent; Fink, Katja; Wang, Cheng-I; Ng, Lisa F. P.; Renia, Laurent] Agcy Technol & Res A STAR, Biopolis, Singapore Immunol Network, 8A Biomed Grove,04-06 Immunos Bldg, Singapore, Singapore.
   [Lee, Cheryl Yi-Pin] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Huber, Roland G.; Maurer-Stroh, Sebastian] ASTAR, Biopolis, Bioinformat Inst, Singapore, Singapore.
   [Tan, Heng-Liang; Choo, Andre] ASTAR, Biopolis, Bioproc Technol Inst, Singapore, Singapore.
   [Choo, Andre] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Singapore, Singapore.
   [Maurer-Stroh, Sebastian] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Maurer-Stroh, Sebastian] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
   [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochim, Singapore, Singapore.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Ng, LFP; Renia, L (corresponding author), Agcy Technol & Res A STAR, Biopolis, Singapore Immunol Network, 8A Biomed Grove,04-06 Immunos Bldg, Singapore, Singapore.
EM lisa_ng@immunol.a-star.edu.sg; renia_laurent@immunol.a-star.edu.sg
RI Maurer-Stroh, Sebastian/Q-9476-2019; amsalu, ribka/G-8780-2019; Huber,
   Roland/AAG-6353-2019; Howland, Shanshan/I-2245-2014
OI Maurer-Stroh, Sebastian/0000-0003-0813-9640; Huber,
   Roland/0000-0001-5093-5988; See, Peter/0000-0003-4428-7763; Lum, Fok
   Moon/0000-0002-5645-7048; Howland, Shanshan/0000-0003-4794-1564
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium Fund, A*STAR,
   Singapore [15/1/82/27/001]
FX We thank the EVA for providing us with the ZIKV H/PF/2013 strain. We
   also thank Alain Kohl from the Centre for Virus Research, University of
   Glasgow for providing us with the Brazilian ZIKV PE243 strain. This work
   is supported by core research grants provided to the Singapore
   Immunology Network by the Biomedical Research Council (BMRC), and also
   partially supported by the BMRC A*STAR-led Zika Virus Consortium Fund
   (project number: 15/1/82/27/001), A*STAR, Singapore. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814
   Alvarez M, 2006, AM J TROP MED HYG, V75, P1113, DOI 10.4269/ajtmh.2006.75.1113
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2014, MICROBIOL SPECTR, V2
   Halstead SB, 2016, AM J TROP MED HYG, V95, P741, DOI 10.4269/ajtmh.16-0222
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001
   Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roth A, 2014, EUROSURVEILLANCE, V19
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Veljkovic Veljko, 2016, F1000Res, V5, P190, DOI 10.12688/f1000research.8102.2
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   World Health Organization (WHO), ZIK SIT REP
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, NPJ VACCINE IN PRESS
   Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 57
TC 32
Z9 33
U1 0
U2 3
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD APR 20
PY 2017
VL 2
IS 8
AR e92428
DI 10.1172/jci.insight.92428
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ES8YP
UT WOS:000399843100012
PM 28422757
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU de Oliveira, WK
   Espinal, MA
   Dye, C
AF de Oliveira, Wanderson K.
   Espinal, Marcos A.
   Dye, Christopher
TI Zika Virus Infection and Associated Neurologic Disorders in Brazil
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID AMERICA
C1 [de Oliveira, Wanderson K.] Minist Hlth, Brasilia, DF, Brazil.
   [Espinal, Marcos A.] Pan Amer Hlth Org, Washington, DC USA.
   [Dye, Christopher] WHO, Geneva, Switzerland.
RP Dye, C (corresponding author), WHO, Geneva, Switzerland.
EM dyec@who.int
RI Oliveira, Wanderson/AAF-5182-2019
OI Oliveira, Wanderson/0000-0002-9662-1930; Dye,
   Christopher/0000-0002-2957-1793
FU Ministry of Health in Brazil; Pan American Health Organization; World
   Health OrganizationWorld Health Organization
FX Supported by the Ministry of Health in Brazil, the Pan American Health
   Organization, and the World Health Organization.
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
NR 5
TC 46
Z9 47
U1 0
U2 9
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 20
PY 2017
VL 376
IS 16
BP 1591
EP 1593
DI 10.1056/NEJMc1608612
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA ES4VV
UT WOS:000399534600016
PM 28402236
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Campos, JLS
   Marchese, S
   Rana, J
   Mossenta, M
   Poggianella, M
   Bestagno, M
   Burrone, OR
AF Campos, J. L. Slon
   Marchese, S.
   Rana, J.
   Mossenta, M.
   Poggianella, M.
   Bestagno, M.
   Burrone, O. R.
TI Temperature-dependent folding allows stable dimerization of secretory
   and virus-associated E proteins of Dengue and Zika viruses in mammalian
   cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES;
   MONOCLONAL-ANTIBODIES; HIGHLY POTENT; CROSS-REACTIVITY; STRUCTURAL
   BASIS; DOMAIN-III; GLYCOPROTEIN; INFECTION
AB Dengue and Zika are two of the most important human viral pathogens worldwide. In both cases, the envelope glycoprotein E is the main target of the antibody response. Recently, new complex quaternary epitopes were identified which are the consequence of the arrangement of the antiparallel E dimers on the viral surface. Such epitopes can be exploited to develop more efficient cross-neutralizing vaccines. Here we describe a successful covalent stabilization of E dimers from Dengue and Zika viruses in mammalian cells. Folding and dimerization of secretory E was found to be strongly dependent on temperature but independent of PrM co-expression. In addition, we found that, due to the close relationship between flaviviruses, Dengue and Zika viruses E proteins can form heterodimers and assemble into mosaic viral particles. Finally, we present new virus-free analytical platforms to study and screen antibody responses against Dengue and Zika, which allow for differentiation of epitopes restricted to specific domains, dimers and higher order arrangements of E.
C1 [Campos, J. L. Slon; Marchese, S.; Rana, J.; Mossenta, M.; Poggianella, M.; Bestagno, M.; Burrone, O. R.] Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, I-34149 Trieste, Italy.
RP Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, I-34149 Trieste, Italy.
EM burrone@icgeb.org
RI Rana, Jyoti/AAP-3614-2020
OI Rana, Jyoti/0000-0001-9683-4592; Slon Campos, Jose
   Luis/0000-0002-0012-5247
FU Arturo Falaschi ICGEB
FX We would like to Prof. Aravinda de Silva (University of North Carolina,
   Chapel Hill, NC, USA), Prof. Jonathan R. Lai (Albert Einstein College of
   Medicine, NY, USA) and Dr. Theodore Pierson (National Institute of
   Allergies and Infectious Diseases, MD, USA) for kindly providing us
   valuable materials and reagents. J.L.S.C. and J.R. were supported by
   Arturo Falaschi ICGEB pre-doctoral and post-doctoral fellowships,
   respectively.
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Baker SF, 2014, J VIROL, V88, P10778, DOI 10.1128/JVI.01440-14
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Butrapet S, 2011, VIROLOGY, V413, P118, DOI 10.1016/j.virol.2011.01.030
   Campos JLS, 2015, J GEN VIROL, V96, P3265, DOI 10.1099/jgv.0.000278
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Frei JC, 2015, VIROLOGY, V485, P371, DOI 10.1016/j.virol.2015.08.011
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hsieh SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100641
   King AMQ, 2011, VIRUS TAXONOMY
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li EQ, 1997, PROTEIN ENG, V10, P731, DOI 10.1093/protein/10.6.731
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sambrook J., 1989, MOL CLONING LAB MANU
   Schibli DJ, 2004, MOL MEMBR BIOL, V21, P361, DOI 10.1080/09687860400017784
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sepulveda J, 2003, J MOL BIOL, V333, P355, DOI 10.1016/j.jmb.2003.08.033
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157
NR 66
TC 17
Z9 17
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 19
PY 2017
VL 7
AR 966
DI 10.1038/s41598-017-01097-5
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES4WK
UT WOS:000399536300022
PM 28424472
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Haddi, K
   Tome, HVV
   Du, YZ
   Valbon, WR
   Nomura, Y
   Martins, GF
   Dong, K
   Oliveira, EE
AF Haddi, Khalid
   Tome, Hudson V. V.
   Du, Yuzhe
   Valbon, Wilson R.
   Nomura, Yoshiko
   Martins, Gustavo F.
   Dong, Ke
   Oliveira, Eugenio E.
TI Detection of a new pyrethroid resistance mutation (V410L) in the sodium
   channel of Aedes aegypti: a potential challenge for mosquito control
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INSECTICIDE RESISTANCE; POPULATIONS; MECHANISMS; SITES
AB The yellow fever mosquito, Aedes aegypti, particularly in Neotropical regions, is the principal vector of dengue, yellow fever, Zika and Chikungunya viruses. Pyrethroids remain one of the most used insecticides to control Aedes mosquitoes, despite the development of pyrethroid resistance in many mosquito populations worldwide. Here, we report a Brazilian strain of A. aegypti with high levels (approximately 100-60,000 fold) of resistance to both type I and type II pyrethroids. We detected two mutations (V410L and F1534C) in the sodium channel from this resistant strain. This study is the first report of the V410L mutation in mosquitoes. Alone or in combination with the F1534C mutation, the V410L mutation drastically reduced the sensitivity of mosquito sodium channels expressed in Xenopus oocytes to both type I and type II pyrethroids. The V410L mutation presents a serious challenge for the control of A. aegypti and will compromise the use of pyrethroids for the control of A. aegypti in Brazil; therefore, early monitoring of the frequency of the V410L mutation will be a key resistance management strategy to preserve the effectiveness of pyrethroid insecticides.
C1 [Haddi, Khalid; Tome, Hudson V. V.; Valbon, Wilson R.; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.
   [Haddi, Khalid] Univ Fed Vicosa, Programa Posgrad Entomol, BR-36570900 Vicosa, MG, Brazil.
   [Tome, Hudson V. V.] EAG Labs, 13709 Progress Blvd 24,Suite S163, Alachua, FL 32615 USA.
   [Tome, Hudson V. V.] Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA.
   [Du, Yuzhe; Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA.
   [Martins, Gustavo F.] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil.
RP Haddi, K; Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.; Haddi, K (corresponding author), Univ Fed Vicosa, Programa Posgrad Entomol, BR-36570900 Vicosa, MG, Brazil.
EM khalid.haddi@ufv.br; eugenio@ufv.br
RI de Oliveira, Eugenio Eduardo/F-4045-2016; Valbon, Wilson
   Rodrigues/AAH-6951-2020; Martins, Gustavo Ferreira/AAL-7744-2020; Tome,
   Hudson V.V./E-6957-2014; Haddi, Khalid/K-6387-2018; Valbon,
   Wilson/H-9742-2017
OI Valbon, Wilson Rodrigues/0000-0003-2038-5684; Martins, Gustavo
   Ferreira/0000-0003-0614-8551; Haddi, Khalid/0000-0002-2655-4365; Valbon,
   Wilson/0000-0003-2038-5684
FU Science without Borders Program of the CAPES Foundation; National
   Council of Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq); Arthur
   Bernardes Foundation (FUNARBE); Minas Gerais State Foundation for
   Research Aid (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
FX We thank Dr. Ademir de Jesus Martins Junior and Jose Bento Pereira Lima
   (Instituto Oswaldo Cruz, IOC-Fiocruz, Rio de Janeiro) for kindly
   providing the mosquito eggs of the F2 Oiapoque population. We thank also
   Dr. Constancia Flavia Junqueira Ayres Lopes (CPqAM/Fiocruz-PE) for
   generously giving the DNA samples, Grants from the Science without
   Borders Program of the CAPES Foundation and the National Council of
   Scientific and Technological Development (CNPq) to KH; grants from the
   Arthur Bernardes Foundation (FUNARBE), the Minas Gerais State Foundation
   for Research Aid (FAPEMIG) and the National Council of Scientific and
   Technological Development (CNPq) to EEO, GFM, HVVT and WRV; and grants
   from the National Institute of Health (NIH) to KD and YD supported this
   work.
CR [Anonymous], 2016, VECT CONTR OP FRAM Z
   Araujo A, 2013, THESIS
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du YZ, 2015, MOL PHARMACOL, V88, P273, DOI 10.1124/mol.115.098707
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Du YZ, 2010, TOXICOL APPL PHARM, V247, P53, DOI 10.1016/j.taap.2010.05.016
   FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1
   Feyereisen R., 2005, P1
   Chapadense FGG, 2015, REV SOC BRAS MED TRO, V48, P607, DOI 10.1590/0037-8682-0046-2015
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hu ZN, 2011, INSECT BIOCHEM MOLEC, V41, P9, DOI 10.1016/j.ibmb.2010.09.005
   Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403
   Marriel NB, 2016, ACTA TROP, V158, P88, DOI 10.1016/j.actatropica.2016.02.021
   O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925
   Oliveira EE, 2013, NEUROTOXICOLOGY, V38, P42, DOI 10.1016/j.neuro.2013.06.001
   RANSON H, 2005, PHARMACOLOGY, V5, P383, DOI DOI 10.1016/B0-44-451924-6/00074-0
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Reiter P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004769
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Robertson J.L., 2007, PESTICIDE BIOASSAYS
   Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7
   Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7
   Smith L. B., 2016, PESTICIDE BIOCH PHYS
   Soderlund D.M., 2005, P1
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   Soderlund DM, 2010, PESTIC BIOCHEM PHYS, V97, P78, DOI 10.1016/j.pestbp.2009.06.010
   Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205
   TATEBAYASHI H, 1994, J PHARMACOL EXP THER, V270, P595
   Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305
   Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   WORLD HEALTH ORGANIATION, 2013, OP MAN IND RES SPRAY
   Zhorov B. S., 2016, NEUROTOXICOLOGY, DOI http://dx.doi.org/10.1016/j.neuro.2016.08.013
NR 43
TC 40
Z9 40
U1 2
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 19
PY 2017
VL 7
AR 46549
DI 10.1038/srep46549
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES7GD
UT WOS:000399716900001
PM 28422157
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Estoppey, D
   Lee, CM
   Janoschke, M
   Lee, BH
   Wan, KF
   Dong, HP
   Mathys, P
   Filipuzzi, I
   Schuhmann, T
   Riedl, R
   Aust, T
   Galuba, O
   McAllister, G
   Russ, C
   Spiess, M
   Bouwmeester, T
   Bonamy, GMC
   Hoepfner, D
AF Estoppey, David
   Lee, Chia Min
   Janoschke, Marco
   Lee, Boon Heng
   Wan, Kah Fei
   Dong, Hongping
   Mathys, Philippe
   Filipuzzi, Ireos
   Schuhmann, Tim
   Riedl, Ralph
   Aust, Thomas
   Galuba, Olaf
   McAllister, Gregory
   Russ, Carsten
   Spiess, Martin
   Bouwmeester, Tewis
   Bonamy, Ghislain M. C.
   Hoepfner, Dominic
TI The Natural Product Cavinafungin Selectively Interferes with Zika and
   Dengue Virus Replication by Inhibition of the Host Signal Peptidase
SO CELL REPORTS
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; VASOPRESSIN PRECURSOR; IDENTIFICATION; PROTEINS;
   GENE; DISSECTION; MECHANISM; MUTANTS; SCREENS; TISSUES
AB Flavivirus infections by Zika and dengue virus impose a significant global healthcare threat with no US Food and Drug Administration (FDA)-approved vaccination or specific antiviral treatment available. Here, we present the discovery of an anti-flaviviral natural product named cavinafungin. Cavinafungin is a potent and selectively active compound against Zika and all four dengue virus serotypes. Unbiased, genomewide genomic profiling in human cells using a novel CRISPR/Cas9 protocol identified the endoplasmicreticulum- localized signal peptidase as the efficacy target of cavinafungin. Orthogonal profiling in S. cerevisiae followed by the selection of resistant mutants pinpointed the catalytic subunit of the signal peptidase SEC11 as the evolutionary conserved target. Biochemical analysis confirmed a rapid block of signal sequence cleavage of both host and viral proteins by cavinafungin. This study provides an effective compound against the eukaryotic signal peptidase and independent confirmation of the recently identified critical role of the signal peptidase in the replicative cycle of flaviviruses.
C1 [Estoppey, David; Mathys, Philippe; Filipuzzi, Ireos; Schuhmann, Tim; Riedl, Ralph; Aust, Thomas; Galuba, Olaf; Bouwmeester, Tewis; Hoepfner, Dominic] Novartis Pharma AG, Novartis Inst BioMed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland.
   [Lee, Chia Min; Lee, Boon Heng; Wan, Kah Fei; Dong, Hongping; Bonamy, Ghislain M. C.] Novartis Inst Trop Dis, 10 Biopolis Rd,Chromos 05-01, Singapore 138670, Singapore.
   [Janoschke, Marco; Spiess, Martin; Hoepfner, Dominic] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
   [McAllister, Gregory; Russ, Carsten] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Hoepfner, D (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland.; Bonamy, GMC (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd,Chromos 05-01, Singapore 138670, Singapore.; Hoepfner, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM bonamgh1@gmail.com; dominic.hoepfner@novartis.com
OI Bonamy, Ghislain/0000-0002-2826-5225; Spiess, Martin/0000-0001-7139-0550
CR Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Craney A, 2015, BIOORG MED CHEM LETT, V25, P4761, DOI 10.1016/j.bmcl.2015.07.072
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui JQ, 2015, J BIOL CHEM, V290, P28131, DOI 10.1074/jbc.M115.692350
   Estoppey D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42728
   Fang H, 1997, J BIOL CHEM, V272, P13152, DOI 10.1074/jbc.272.20.13152
   Friberg MA, 2004, J BIOL CHEM, V279, P19441, DOI 10.1074/jbc.M310249200
   Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789
   Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791
   Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x
   Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6
   Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004
   Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015
   Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100
   Huang Z, 2013, CELL REP, V3, P577, DOI 10.1016/j.celrep.2013.01.019
   Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jones DC, 2010, BIOCHEM PHARMACOL, V80, P1478, DOI 10.1016/j.bcp.2010.07.038
   Junne T, 2015, J CELL SCI, V128, P1217, DOI 10.1242/jcs.165746
   Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089
   Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159
   Mullins C, 1996, J BIOL CHEM, V271, P29094, DOI 10.1074/jbc.271.46.29094
   Ortiz-Lopez FJ, 2015, J NAT PROD, V78, P468, DOI 10.1021/np500854j
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SHELNESS GS, 1993, J BIOL CHEM, V268, P5201
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635
   Xie XP, 2014, VIROLOGY, V450, P250, DOI 10.1016/j.virol.2013.12.025
   Yang ZG, 2015, INT J MED SCI, V12, P256, DOI 10.7150/ijms.10735
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Young PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099135
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 42
TC 29
Z9 31
U1 1
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR 18
PY 2017
VL 19
IS 3
BP 451
EP 460
DI 10.1016/j.celrep.2017.03.071
PG 10
WC Cell Biology
SC Cell Biology
GA EU6GS
UT WOS:000401133100002
PM 28423309
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hastings, AK
   Yockey, LJ
   Jagger, BW
   Hwang, J
   Uraki, R
   Gaitsch, HF
   Parnell, LA
   Cao, B
   Mysorekar, IU
   Rothlin, CV
   Fikrig, E
   Diamond, MS
   Iwasaki, A
AF Hastings, Andrew K.
   Yockey, Laura J.
   Jagger, Brett W.
   Hwang, Jesse
   Uraki, Ryuta
   Gaitsch, Hallie F.
   Parnell, Lindsay A.
   Cao, Bin
   Mysorekar, Indira U.
   Rothlin, Carla V.
   Fikrig, Erol
   Diamond, Michael S.
   Iwasaki, Akiko
TI TAM Receptors Are Not Required for Zika Virus Infection in Mice
SO CELL REPORTS
LA English
DT Article
ID INNATE IMMUNE-RESPONSES; HUMAN DENDRITIC CELLS; TYROSINE KINASES; MOUSE
   MODEL; AXL; ENTRY; BRAIN; IDENTIFICATION; TRANSMISSION; PREGNANCY
AB Tyro3, Axl, and Mertk (TAM) receptors are candidate entry receptors for infection with the Zika virus (ZIKV), an emerging flavivirus of global public health concern. To investigate the requirement of TAM receptors for ZIKV infection, we used several routes of viral inoculation and compared viral replication in wild-type versus Axl(-/-), Mertk (-/-), Axl (-/-) Mertk (-/-), and Axl (-/-) Tyro3 (-/-) mice in various organs. Pregnant and non-pregnant mice treated with interferon-a-receptor (IFNAR)-blocking (MAR1-5A3) antibody and infected subcutaneously with ZIKV showed no reliance on TAMs for infection. In the absence of IFNAR-blocking antibody, adult female mice challenged intravaginally with ZIKV showed no difference in mucosal viral titers. Similarly, in young mice that were infected with ZIKV intracranially or intraperitoneally, ZIKV replication occurred in the absence of TAM receptors, and no differences in cell tropism were observed. These findings indicate that, in mice, TAM receptors are not required for ZIKV entry and infection.
C1 [Hastings, Andrew K.; Hwang, Jesse; Uraki, Ryuta; Gaitsch, Hallie F.; Fikrig, Erol] Yale Univ, Infect Dis Sect, Dept Internal Med, Sch Med, New Haven, CT 06520 USA.
   [Yockey, Laura J.; Rothlin, Carla V.; Iwasaki, Akiko] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.
   [Jagger, Brett W.; Diamond, Michael S.] Washington Univ, Div Infect Dis, Dept Med, Sch Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA.
   [Parnell, Lindsay A.; Cao, Bin; Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Dept Obstet & Gynecol, Sch Med, St Louis, MO 63110 USA.
   [Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.
   [Fikrig, Erol; Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Fikrig, E (corresponding author), Yale Univ, Infect Dis Sect, Dept Internal Med, Sch Med, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.; Diamond, MS (corresponding author), Washington Univ, Div Infect Dis, Dept Med, Sch Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Dept Obstet & Gynecol, Sch Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.; Fikrig, E; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM erol.fikrig@yale.edu; diamond@wusm.wustl.edu; akiko.iwasaki@yale.edu
RI Diamond, Michael/AAH-1733-2019; Iwasaki, Akiko/Z-1591-2019
OI Diamond, Michael/0000-0002-8791-3165; Iwasaki,
   Akiko/0000-0002-7824-9856; Gaitsch, Hallie/0000-0002-6656-607X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI089824, R01 AI073755, R01
   AI101400, R01 AI104972, 2R01-AI101400-05, AI054359, R21 AI131284,
   T32GM007205, 4T32HL007974-15, 2T32GM007067-42, 2T32AI007172-36A1]; March
   of Dimes PRI Investigator award [21-FY13-28]; Moderna;
   SanofiSanofi-Aventis; Visterra
FX We thank M. Mercau; E. Louis; S. Ghosh; and members of the Rothlin lab
   for providing protocols, reagents, mice, and helpful discussion. We
   thank K. Jurado, H. Dong, and M. Linehan for technical assistance; A.
   van den Pol for providing the ZIKV-immune rat serum, and B. Lindenbach
   for providing Cambodian virus stocks. This study was supported by grants
   from the NIH (R01AI089824 to C. V. R., R01 AI073755, R01 AI101400, R01
   AI104972, and 2R01-AI101400-05 to M.S.D. and R01 AI054359 and R21
   AI131284 to A.I.) and the March of Dimes PRI Investigator award
   21-FY13-28 (to I.U.M.). E.F. and A.I. are investigators with the Howard
   Hughes Medical Institute. C.V.R. is a Howard Hughes Faculty Scholar. I.
   U. M. is an Investigator in Reproductive Sciences awardee from the
   Burroughs Wellcome Fund. L.J.Y. is supported by NIH training grant
   T32GM007205, J.H. is supported by NIH training grant 4T32HL007974-15,
   L.A.P. is supported by NIH grant 2T32GM007067-42, and B.W.J. is
   supported by NIH grant 2T32AI007172-36A1. M.S.D. is a consultant for
   Inbios, Visterra, and Takeda Pharmaceuticals; is on the scientific
   advisory boards of Moderna and OraGene; and is a recipient of research
   grants from Moderna, Sanofi, and Visterra.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110
   Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Coan PM, 2005, J ANAT, V207, P783, DOI 10.1111/j.1469-7580.2005.00488.x
   Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kreit M, 2014, J VIROL, V88, P3874, DOI 10.1128/JVI.03018-13
   Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Vega-Almeida TO, 2013, ARCH VIROL, V158, P1189, DOI 10.1007/s00705-012-1596-0
   Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schmid ET, 2016, ELIFE, V5, DOI 10.7554/eLife.12414
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594
   Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   World Health Organization, 2016, ZIK SIT REP
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 63
TC 57
Z9 58
U1 1
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR 18
PY 2017
VL 19
IS 3
BP 558
EP 568
DI 10.1016/j.celrep.2017.03.058
PG 11
WC Cell Biology
SC Cell Biology
GA EU6GS
UT WOS:000401133100012
PM 28423319
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Kawiecki, AB
   Mayton, EH
   Dutuze, MF
   Goupil, BA
   Langohr, IM
   Del Piero, F
   Christofferson, RC
AF Kawiecki, Anna B.
   Mayton, E. Handly
   Dutuze, M. Fausta
   Goupil, Brad A.
   Langohr, Ingeborg M.
   Del Piero, Fabio
   Christofferson, Rebecca C.
TI Tissue tropisms, infection kinetics, histologic lesions, and antibody
   response of the MR766 strain of Zika virus in a murine model
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Mouse model; Neutralizing antibody; Pathogenesis; Histology;
   Immunohistochemistry
ID TRANSMISSION; EPIDEMIC
AB Background: The appearance of severe Zika virus (ZIKV) disease in the most recent outbreak has prompted researchers to respond through the development of tools to quickly characterize transmission and pathology. We describe here another such tool, a mouse model of ZIKV infection and pathogenesis using the MR766 strain of virus that adds to the growing body of knowledge regarding ZIKV kinetics in small animal models.
   Methods: We infected mice with the MR766 strain of ZIKV to determine infection kinetics via serum viremia. We further evaluated infection-induced lesions via histopathology and visualized viral antigen via immunohistochemical labeling. We also investigated the antibody response of recovered animals to both the MR766 and a strain from the current outbreak (PRVABC59).
   Results: We demonstrate that the IRF3/7 DKO mouse is a susceptible, mostly non-lethal model well suited for the study of infection kinetics, pathological progression, and antibody response. Infected mice presented lesions in tissues that have been associated with ZIKV infection in the human population, such as the eyes, male gonads, and central nervous system. In addition, we demonstrate that infection with the MR766 strain produces cross-neutralizing antibodies to the PRVABC59 strain of the Asian lineage.
   Conclusions: This model provides an additional tool for future studies into the transmission routes of ZIKV, as well as for the development of antivirals and other therapeutics, and should be included in the growing list of available tools for investigations of ZIKV infection and pathogenesis.
C1 [Kawiecki, Anna B.; Mayton, E. Handly; Dutuze, M. Fausta; Goupil, Brad A.; Langohr, Ingeborg M.; Del Piero, Fabio; Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
RP Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
EM rcarri1@lsu.edu
RI Langohr, Ingeborg/H-5570-2019
OI Langohr, Ingeborg/0000-0001-7366-4391
FU NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32 OD011124]
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Didier M, 2015, EMERG INFECT DIS, V21, P359
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fokam E B, 2010, East Afr Med J, V87, P262
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Oliveira Souto I., 2016, ENFERM INFECC MICROB
   Pacheco O, 2016, N ENGL J MED
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Riley SP, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv101
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sirivichayakul C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-48
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WHO, 2007, GUID PLAQ RED NEUTR
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 44
TC 13
Z9 14
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD APR 18
PY 2017
VL 14
AR 82
DI 10.1186/s12985-017-0749-x
PG 10
WC Virology
SC Virology
GA ES3XU
UT WOS:000399464200002
PM 28420392
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bloom, DE
   Black, S
   Rappuoli, R
AF Bloom, David E.
   Black, Steven
   Rappuoli, Rino
TI Emerging infectious diseases: A proactive approach
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE emerging infectious diseases; vaccines; human monoclonals; Ebola; Zika
ID ECONOMIC-IMPACT; CHALLENGE; MALARIA; BURDEN
AB Infectious diseases are now emerging or reemerging almost every year. This trend will continue because a number of factors, including the increased global population, aging, travel, urbanization, and climate change, favor the emergence, evolution, and spread of new pathogens. The approach used so far for emerging infectious diseases (EIDs) does not work from the technical point of view, and it is not sustainable. However, the advent of platform technologies offers vaccine manufacturers an opportunity to develop new vaccines faster and to reduce the investment to build manufacturing facilities, in addition to allowing for the possible streamlining of regulatory processes. The new technologies also make possible the rapid development of human monoclonal antibodies that could become a potent immediate response to an emergency. So far, several proposals to approach EIDs have been made independently by scientists, the private sector, national governments, and international organizations such as the World Health Organization (WHO). While each of them has merit, there is a need for a global governance that is capable of taking a strong leadership role and making it attractive to all partners to come to the same table and to coordinate the global approach.
C1 [Bloom, David E.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH 45229 USA.
   [Rappuoli, Rino] GlaxoSmithKline Vaccines, I-53100 Siena, Italy.
RP Rappuoli, R (corresponding author), GlaxoSmithKline Vaccines, I-53100 Siena, Italy.
EM rino.r.rappuoli@gsk.com
CR Acuna-Soto R, 2002, EMERG INFECT DIS, V8, P360, DOI 10.3201/eid0804.010175
   [Anonymous], 2014, STAT TROP 2014 REP
   Bartsch SM, 2015, PATHOG GLOB HEALTH, V109, P4, DOI 10.1179/2047773214Y.0000000169
   Burns A, 2008, 47417 WORLD BANK GRO
   Cohen J., 2016, SCIENCE
   Cohen J, 2017, SCIENCE, V355, P237, DOI 10.1126/science.355.6322.237
   Ewer KJ, 2016, CURR OPIN IMMUNOL, V41, P47, DOI 10.1016/j.coi.2016.05.014
   Fan VY, 2016, 22137 NBER
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85
   Jonas OB, 2013, PANDEMIC RISK
   Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x
   Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Sands P, 2016, LANCET, V388, P2443, DOI 10.1016/S0140-6736(16)30594-3
   Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929
   Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Thomas MR, 2015, EC IMPACT EBOLA SUBS
   World Bank, 2016, SHORT TERM EC COSTS
   World Health Organization, 2016, R D BLUEPR ACT PRINT
NR 24
TC 36
Z9 37
U1 3
U2 33
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 18
PY 2017
VL 114
IS 16
BP 4055
EP 4059
DI 10.1073/pnas.1701410114
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES2WA
UT WOS:000399387400037
PM 28396438
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Betancourt, D
   de Queiroz, NMGP
   Xia, TL
   Ahn, J
   Barber, GN
AF Betancourt, Dillon
   de Queiroz, Nina M. G. P.
   Xia, Tianli
   Ahn, Jeonghyun
   Barber, Glen N.
TI Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus
   Expressing Zika Virus Proteins Confers Protective Immunity
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID THERAPY
AB Zika virus (ZIKV) has become a serious public health concern because of its link to brain damage in developing human fetuses. Recombinant vesicular stomatitis virus (rVSV) was shown to be a highly effective and safe vector for the delivery of foreign immunogens for vaccine purposes. In this study, we generated rVSVs (wildtype and attenuated VSV with mutated matrix protein [ VSVm] versions) that express either the full length ZIKV envelope protein (ZENV) alone or include the ZENV precursor to themembrane protein upstream of the envelope protein, and our rVSV-ZIKV constructs showed efficient immunogenicity in murine models. We also demonstrated maternal protective immunity in challenged newborn mice born to female mice vaccinated with VSVm-ZENV containing the transmembrane domain. Our data indicate that rVSVm may be a suitable strategy for the design of effective vaccines against ZIKV.
C1 [Betancourt, Dillon; de Queiroz, Nina M. G. P.; Xia, Tianli; Ahn, Jeonghyun; Barber, Glen N.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
RP Barber, GN (corresponding author), Univ Miami, Miller Sch Med, 511 Papanicolaou Bldg Fox Annex,1550 NW 10th Ave, Miami, FL 33136 USA.
EM gbarber@med.miami.edu
OI Betancourt, Dillon/0000-0001-5654-7935
CR Balachandran S, 2000, IUBMB LIFE, V50, P135, DOI 10.1080/713803696
   CUTCHINS E, 1960, J IMMUNOL, V85, P275
   Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023
   Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Heiber JF, 2011, J VIROL, V85, P10440, DOI 10.1128/JVI.05408-11
   Iyer AV, 2009, VACCINE, V27, P893, DOI 10.1016/j.vaccine.2008.11.087
   KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Obuchi M, 2003, J VIROL, V77, P8843, DOI 10.1128/JVI.77.16.8843-8856.2003
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wertz GW, 2002, J VIROL, V76, P7642, DOI 10.1128/JVI.76.15.7642-7650.2002
NR 15
TC 27
Z9 28
U1 0
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD APR 15
PY 2017
VL 198
IS 8
BP 3023
EP 3028
DI 10.4049/jimmunol.1602180
PG 6
WC Immunology
SC Immunology
GA EU6ET
UT WOS:000401127500003
PM 28289159
OA Bronze
DA 2020-07-08
ER

PT J
AU Miller, E
   Becker, Z
   Shalev, D
   Lee, CT
   Cioroiu, C
   Thakur, K
AF Miller, Eliza
   Becker, Zoe
   Shalev, Daniel
   Lee, Christopher T.
   Cioroiu, Comana
   Thakur, Kiran
TI Probable Zika virus-associated Guillain-Barre syndrome: Challenges with
   clinico-laboratory diagnosis
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome; Flavivirus
AB A 55 year old woman in New York City presented in May 2016 with progressive weakness, ataxia, paresthesia, and areflexia, shortly after returning from the Dominican Republic. Lumbar puncture revealed cytoalbuminological dissociation. Due to her recent travel, Zika-associated Guillain Barre syndrome (GBS) was suspected and she underwent evaluation for recent flavivirus exposure. Zika virus RNA was not detected in serum, but Zika virus immunoglobulin M (IgM) was detected in both serum and cerebrospinal fluid. Dengue virus IgM in serum was equivocal and dengue virus lgG was detected in the serum. Plaque-reduction neutralization testing showed elevated titers to both Zika virus and dengue virus, providing evidence of recent infection with a flavivirus. The patient was diagnosed with probable Zika virus-associated GBS based on clinical findings, ancillary testing, and laboratory assays according to current guidance from the Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists. Zika virus transmission in the Americas is resulting in increasing numbers of patients presenting with Zika virus associated neurological syndromes. Clinical and laboratory diagnosis in these cases can be challenging and may be aided by consultation with CDC, and state and local public health agencies. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Miller, Eliza; Cioroiu, Comana; Thakur, Kiran] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   [Becker, Zoe] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.
   [Shalev, Daniel] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA.
   [Lee, Christopher T.] New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY USA.
   [Lee, Christopher T.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
RP Thakur, K (corresponding author), Columbia Univ, Med Ctr, Div Crit Care & Hospitalist Neurol, Milstein Hosp, 177 Ft Washington Ave,8GS-300, New York, NY 10032 USA.
EM ktt2115@cumc.columbia.edu
RI Miller, Eliza C./AAF-5332-2020; Shalev, Daniel/AAA-8397-2019
OI Miller, Eliza C./0000-0002-7108-8906; Lee,
   Christopher/0000-0001-7957-1524
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01HD074944-01A1]
FX Dr. Thakur receives funding support from the National Institutes of
   Health (R01HD074944-01A1).
CR Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers, NAT NOT DIS SURV SYS
   Dos Santos T, 2016, N ENGL J MED
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   NYCDOH, 2016, REP CAS ZIK NEW YORK
   NYSDOH, HLTH ADV ZIK VIR UPD
   Pan American Health Organization, 2016, REG ZIK EP UPD
   Pan American Health Organization, 2015, GEOGR DISTR CONF AUT
   Pan American Health Organization, DENG PAHO WHO DAT MA
   Pan American Health Organization, ZIK EP REP
   Parra B., 2016, N ENGL J MED
   Rabe I.B., 2016, MORBIDITY MORTALITY, V65
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, GUILL BARR SYNDR FRA
   World Health Organization, ZIK VIR INF DOM REP
   World Health Organization, GUILL BARR SYNDR BRA
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 18
TC 8
Z9 8
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2017
VL 375
BP 367
EP 370
DI 10.1016/j.jns.2017.02.029
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ER4EN
UT WOS:000398752000073
PM 28320169
DA 2020-07-08
ER

PT J
AU Koo, B
   Jin, CE
   Lee, TY
   Lee, JL
   Park, MK
   Sung, H
   Park, SY
   Lee, HJ
   Kim, SM
   Kim, JY
   Kim, SH
   Shin, Y
AF Koo, Bonhan
   Jin, Choong Eun
   Lee, Tae Yoon
   Lee, Jeong Loon
   Park, Mi Kyoung
   Sung, Heungsup
   Park, Se Yoon
   Lee, Hyun Jung
   Kim, Sun Mi
   Kim, Ji Yeun
   Kim, Sung-Han
   Shin, Yong
TI An isothermal, label-free, and rapid one-step RNA
   amplification/detection assay for diagnosis of respiratory viral
   infections
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Respiratory disease; Emerging infectious disease; RNA
   amplification/detection; Label-free biosensor
ID REAL-TIME PCR; SYNCYTIAL VIRUS; MULTIPLEX PCR; MICRORING RESONATOR;
   INFLUENZA; QUANTIFICATION; BIOSENSOR
AB Recently, RNA viral infections caused by respiratory viruses, such as influenza, parainfluenza, respiratory syncytial virus, coronavirus, and Middle East respiratory syndrome-coronavirus (MERS-CoV), and Zika virus, are a major public health threats in the world. Although myriads of diagnostic methods based on RNA amplification have been developed in the last decades, they continue to lack speed, sensitivity, and specificity for clinical use. A rapid and accurate diagnostic method is needed for appropriate control, including isolation and treatment of the patients. Here, we report an isothermal, label-free, one-step RNA amplification and detection system, termed as iROAD, for the diagnosis of respiratory diseases. It couples a one-step isothermal RNA amplification method and a bio-optical sensor for simultaneous viral RNA amplification/detection in a label free and real-time manner. The iROAD assay offers a one-step viral RNA amplification/detection example to rapid analysis (<20 min). The detection limit of iROAD assay was found to be 10-times more sensitive than that of real-time reverse transcription-PCR method. We confirmed the clinical utility of the iROAD assay by detecting viral RNAs obtained from 63 human respiratory samples. We envision that the iROAD assay will be useful and potentially adaptable for better diagnosis of emerging infectious diseases including respiratory diseases.
C1 [Koo, Bonhan; Jin, Choong Eun; Shin, Yong] Univ Ulsan, Dept Convergence Med, Asan Med Ctr, Coll Med,Biomed Engn Res Ctr,Asan Inst Life Sci, 88 Olympicro 43gil, Seoul, South Korea.
   [Lee, Tae Yoon] Chungnam Natl Univ, Dept Technol Educ, Daejeon 34134, South Korea.
   [Lee, Jeong Loon] Kwangwoon Univ, Dept Elect Engn, 447-1 Wolgye, Seoul 136791, South Korea.
   [Park, Mi Kyoung] One BioMed Pte Ltd, 60 Biopolis St,Genome 02-01, Singapore 138672, Singapore.
   [Sung, Heungsup] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, 88 Olympicro 43gil, Seoul, South Korea.
   [Park, Se Yoon; Lee, Hyun Jung; Kim, Sun Mi; Kim, Ji Yeun; Kim, Sung-Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, 88 Olympicro 43gil, Seoul, South Korea.
   [Park, Se Yoon] Soonchunhyang Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.
RP Shin, Y (corresponding author), Univ Ulsan, Dept Convergence Med, Asan Med Ctr, Coll Med,Biomed Engn Res Ctr,Asan Inst Life Sci, 88 Olympicro 43gil, Seoul, South Korea.; Kim, SH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, 88 Olympicro 43gil, Seoul, South Korea.
EM kimsunghanmd@hotmail.com; shinyongno1@gmail.com
OI Jin, Choong Eun/0000-0002-4462-2333; Lee, Tae Yoon/0000-0003-1139-6269
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI); Ministry of Health & Welfare, Republic of
   KoreaMinistry of Health & Welfare, Republic of Korea
   [HI15C-2774-020015]; Asan Institute for Life Sciences, Asan Medical
   Center, Seoul, Republic of Korea [W16-701]
FX This work was supported by the grant of the Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI),
   funded by the Ministry of Health & Welfare, Republic of Korea
   (HI15C-2774-020015), and also supported by a grant (W16-701) from the
   Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic
   of Korea.
CR Abd El Wahed A, 2015, J CLIN VIROL, V69, P16, DOI 10.1016/j.jcv.2015.05.004
   Agrawal N, 2007, ANGEW CHEM INT EDIT, V46, P4316, DOI 10.1002/anie.200700306
   Amer HM, 2013, J VIROL METHODS, V193, P337, DOI 10.1016/j.jviromet.2013.06.027
   Baeumner AJ, 2003, BIOSENS BIOELECTRON, V18, P405, DOI 10.1016/S0956-5663(02)00162-8
   Bogaerts W, 2012, LASER PHOTONICS REV, V6, P47, DOI 10.1002/lpor.201100017
   Borg I, 2003, EUR RESPIR J, V21, P944, DOI 10.1183/09031936.03.00088102
   Bourgeois FT, 2009, PEDIATRICS, V124, pE1072, DOI 10.1542/peds.2008-3074
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Caliendo AM, 2011, CLIN INFECT DIS, V52, pS326, DOI 10.1093/cid/cir047
   Cho S. Y., 2016, LANCET, V16, P30623
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407
   De Vos K, 2007, OPT EXPRESS, V15, P7610, DOI 10.1364/OE.15.007610
   De Vos K, 2009, BIOSENS BIOELECTRON, V24, P2528, DOI 10.1016/j.bios.2009.01.009
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guy JS, 2000, J CLIN MICROBIOL, V38, P4523, DOI 10.1128/JCM.38.12.4523-4526.2000
   Hammond SP, 2012, J CLIN MICROBIOL, V50, P3216, DOI 10.1128/JCM.00538-12
   Iqbal M, 2010, IEEE J SEL TOP QUANT, V16, P654, DOI 10.1109/JSTQE.2009.2032510
   Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239
   Landry ML, 2009, CLIN LAB MED, V29, P635, DOI 10.1016/j.cll.2009.07.003
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189
   Liu Q, 2016, BIOSENS BIOELECTRON, V82, P1, DOI 10.1016/j.bios.2016.03.050
   Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898
   Loeffelholz M., 2010, INT J MICROBIOL
   Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06
   Mentel R, 2003, J MED MICROBIOL, V52, P893, DOI 10.1099/jmm.0.05290-0
   Moesker FM, 2016, J CLIN VIROL, V79, P12, DOI 10.1016/j.jcv.2016.03.022
   Moll PR, 2004, ANAL BIOCHEM, V334, P164, DOI 10.1016/j.ab.2004.07.013
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Olofsson S, 2011, EXPERT REV ANTI-INFE, V9, P615, DOI [10.1586/eri.11.75, 10.1586/ERI.11.75]
   Park MK, 2013, SENSOR ACTUAT B-CHEM, V176, P552, DOI 10.1016/j.snb.2012.08.078
   Patel PA, 2011, J CLIN MICROBIOL, V49, P2266, DOI 10.1128/JCM.02431-10
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Pillet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072174
   Pozzetto B, 2010, EXPERT REV ANTI-INFE, V8, P251, DOI [10.1586/eri.09.131, 10.1586/ERI.09.131]
   Renois F, 2010, J CLIN MICROBIOL, V48, P3836, DOI 10.1128/JCM.00733-10
   Shin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14127
   Shin Y, 2015, BIOSENS BIOELECTRON, V68, P390, DOI 10.1016/j.bios.2015.01.030
   Shin Y, 2013, LAB CHIP, V13, P2106, DOI [10.1039/c3lc50129a, 10.1039/c31c50129a]
   Shin Y, 2013, SENSOR ACTUAT B-CHEM, V177, P404, DOI 10.1016/j.snb.2012.11.058
   Teoh BT, 2015, J CLIN MICROBIOL, V53, P830, DOI 10.1128/JCM.02648-14
   Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200
   Wang SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20816
   Welch DF, 2010, J CLIN MICROBIOL, V48, P22, DOI 10.1128/JCM.02268-09
   Yang MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26943
   Zhou AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081146
NR 49
TC 14
Z9 15
U1 13
U2 157
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD APR 15
PY 2017
VL 90
BP 187
EP 194
DI 10.1016/j.bios.2016.11.051
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA EI8OW
UT WOS:000392768000025
PM 27894035
OA Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira, DB
   Candiani, TM
   Franco-Luiz, APM
   Almeida, GMF
   Abrahao, JS
   Rios, M
   Coimbra, RS
   Kroon, EG
AF de Oliveira, Danilo B.
   Candiani, Talitah M.
   Franco-Luiz, Ana Paula M.
   Almeida, Gabriel M. F.
   Abrahao, Jonatas S.
   Rios, Maria
   Coimbra, Roney S.
   Kroon, Erna G.
TI Etiological agents of viral meningitis in children from a dengue-endemic
   area, Southeast region of Brazil
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Viral meningitis; Molecular diagnosis; Epidemiology; Dengue virus in CNS
ID RT-PCR ASSAY; NERVOUS-SYSTEM; ASEPTIC-MENINGITIS; ZIKA VIRUS; INFECTION;
   ENCEPHALITIS; ENTEROVIRUS
AB Meningitis is a disease with a global distribution that constitutes a worldwide burden, with viruses as the primary etiologic agents. The range of viral meningitis severity depends mainly on age, immune status and etiological agent. The aim of this work was to investigate the suspected cases of viral meningitis using molecular techniques to confirm the viral infection. The diagnosed virus was correlated with clinical findings and cytochemical parameters in cerebrospinal liquid (CSF) of patients. CSF of 70 children with the presumptive diagnosis of viral meningitis was analyzed by real time PCR (qPCR). Viruses were identified by qPCR in 44 CSF samples (62.9%). Among them, 31 were identified as Enterovirus (ENTV) (70.4%), six as Human herpes virus 3 (HHV-3) (13.6%), five as Dengue virus (DENV) (11.7%), one as Human herpes virus 1-2 (2.3%) and one as Human herpes virus 5 (2.3%). Patients in the HHV-positive groups had increased percentage of polymorphonuclear neutrophils (PMN) (mean of 81%) while the groups of patients with DENV and ENTV had a mean of 30.9%.
   This study contributes to the knowledge of the epidemiological distribution of viral agents in CNS infections in children. In addition, it raises the relevance of DENV as an agent of CNS infection, and reinforces the importance for molecular in the cases of CNV infection. (C) 2017 Elsevier B.V. All rights reserved.
C1 [de Oliveira, Danilo B.; Franco-Luiz, Ana Paula M.; Almeida, Gabriel M. F.; Abrahao, Jonatas S.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Candiani, Talitah M.] FHEMIG, Hosp Infantil Joao Paulo 2, BR-30130110 Belo Horizonte, MG, Brazil.
   [Rios, Maria] US FDA, Ctr Biol Res & Review, Silver Spring, MD 20993 USA.
   [Coimbra, Roney S.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Neurogen, BR-30190002 Belo Horizonte, MG, Brazil.
   [de Oliveira, Danilo B.] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med Diamantina, BR-39100000 Diamantina, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Lab Virus, Dept Microbiol, Inst Ciencias Biol, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Coimbra, Roney/B-3102-2013; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015; Almeida, Gabriel MF/I-8910-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; Almeida, Gabriel
   MF/0000-0003-2317-5092; Coimbra, Roney/0000-0002-9204-0573
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG) [PPM
   00686-15]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [448185/2014-8]; CAPESCAPES [08/2014]
FX Financial support was provided by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (PPM 00686-15).
   D.B. Oliveira received fellowships from CNPq (448185/2014-8) and G.M.F
   Almeida received from CAPES (until 08/2014). E.G. Kroon, G.S. Trindade
   and J.S. Abrahao are researchers from CNPq.
CR Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   BERLIN LE, 1993, J INFECT DIS, V168, P888, DOI 10.1093/infdis/168.4.888
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chadwick DR, 2005, BRIT MED BULL, V75-76, P1, DOI 10.1093/bmb/ldh057
   Chan JF, 2016, J INFECT
   Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854
   Michos AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000674
   Organizaca'o pan-americana da saude (OPAS), DAD DENG BRAS
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sinan, BRAZ NAT MAND DIS RE
   Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Somand D, 2009, EMERG MED CLIN N AM, V27, P89, DOI 10.1016/j.emc.2008.07.004
NR 20
TC 3
Z9 5
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2017
VL 375
BP 390
EP 394
DI 10.1016/j.jns.2017.02.025
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ER4EN
UT WOS:000398752000078
PM 28320174
DA 2020-07-08
ER

PT J
AU Bardina, SV
   Bunduc, P
   Tripathi, S
   Duehr, J
   Frere, JJ
   Brown, JA
   Nachbagauer, R
   Foster, GA
   Krysztof, D
   Tortorella, D
   Stramer, SL
   Garcia-Sastre, A
   Krammer, F
   Lim, JK
AF Bardina, Susana V.
   Bunduc, Paul
   Tripathi, Shashank
   Duehr, James
   Frere, Justin J.
   Brown, Julia A.
   Nachbagauer, Raffael
   Foster, Gregory A.
   Krysztof, David
   Tortorella, Domenico
   Stramer, Susan L.
   Garcia-Sastre, Adolfo
   Krammer, Florian
   Lim, Jean K.
TI Enhancement of Zika virus pathogenesis by preexisting antiflavivirus
   immunity
SO SCIENCE
LA English
DT Article
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE
   HEMORRHAGIC-FEVER; CROSS-REACTIVITY; INFECTION; FC; FLAVIVIRUSES;
   EPIDEMIOLOGY; ACTIVATION; CORRELATE
AB Zika virus (ZIKV) is spreading rapidly into regions around the world where other flaviviruses, such as dengue virus (DENV) and West Nile virus (WNV), are endemic. Antibody-dependent enhancement has been implicated in more severe forms of flavivirus disease, but whether this also applies to ZIKV infection is unclear. Using convalescent plasma from DENV- and WNV-infected individuals, we found substantial enhancement of ZIKV infection in vitro that was mediated through immunoglobulin G engagement of Fcg receptors. Administration of DENV- or WNV-convalescent plasma into ZIKV-susceptible mice resulted in increased morbidity-including fever, viremia, and viral loads in spinal cord and testes-and increased mortality. Antibody-dependent enhancement may explain the severe disease manifestations associated with recent ZIKV outbreaks and highlights the need to exert great caution when designing flavivirus vaccines.
C1 [Bardina, Susana V.; Bunduc, Paul; Tripathi, Shashank; Duehr, James; Frere, Justin J.; Brown, Julia A.; Nachbagauer, Raffael; Tortorella, Domenico; Garcia-Sastre, Adolfo; Krammer, Florian; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Tripathi, Shashank; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Foster, Gregory A.; Krysztof, David] Amer Red Cross, Gaithersburg, MD 20877 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
RP Garcia-Sastre, A; Krammer, F; Lim, JK (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.; Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
EM adolfo.garcia-sastre@mssm.edu; florian.krammer@mssm.edu;
   jean.lim@mssm.edu
RI Nachbagauer, Raffael/H-7798-2019; Krammer, Florian/H-3237-2019
OI Nachbagauer, Raffael/0000-0001-5568-5420; Krammer,
   Florian/0000-0003-4121-776X; Frere, Justin/0000-0002-7514-8873; Duehr,
   James/0000-0003-2077-6685; tripathi, shashank/0000-0002-1254-9979
FU  [U19AI118610];  [R21AI130299]
FX We thank R. Cadagan, O. Lizardo, and F. Amanat for excellent technical
   assistance; M. Evans's laboratory for providing the RNA standards for
   determination of ZIKV load by Taqman PCR assay; C. Schindler for
   providing the original Stat2<SUP>-/-</SUP> mouse strain; A.
   Fernandez-Sesma for ZIKV and DENV strains; D. Bogunovic for invaluable
   evaluation of our manuscript; the microscopy core at Icahn School of
   Medicine at Mount Sinai for their support and technical assistance; and
   G. Estrella and J. Bethea at the Center for Comparative Medicine at the
   Icahn School of Medicine at Mount Sinai for their efforts to rapidly
   accommodate ZIKV studies in our vivarium. The following reagents were
   obtained through BEI Resources, NIAID (National Institute of Allergy and
   Infectious Diseases), NIH: Pre-Immune Dengue Virus Type 1 Sera,
   NR-41782; Pre-Immune Dengue Virus Type 2 Sera NR-41783; Pre-Immune
   Dengue Virus Type 3 Sera NR-41784; Pre-Immune Dengue Virus Type 4 Sera
   NR-41785; Early-Immune Dengue Virus Type 1 Antiserum NR-30247;
   Early-Immune Dengue Virus Type 2 Antiserum NR-29321; Early-Immune Dengue
   Virus Type 3 Antiserum NR-29323; Early-Immune Dengue Virus Type 4
   Antiserum NR-29327; Late-Immune Dengue Virus Type 1 Antisera NR-41786;
   Late-Immune Dengue Virus Type 2 Antisera NR-41787; Late-Immune Dengue
   Virus Type 3 Antisera NR-41788; Late-Immune Dengue Virus Type 4 Antisera
   NR-41789; Pre-Immune Yellow Fever Virus Sera NR-42556, NR-42564, and
   NR-42565; Early-Immune Yellow Fever Virus Antisera NR-29335, NR-29337,
   and NR-29338; and Late-Immune Yellow Fever Virus Antisera NR-42567,
   NR-42575, and NR-42576. This work was partially supported by a
   supplement to NIAID grant U19AI118610 and NIAID grant R21AI130299. Human
   sample institutional review board protocols include Nucleic Acid Testing
   (NAT) for West Nile Virus (WNV) Protocol #2003-011 and Dengue Virus
   (Gen-Probe Procleix) Clinical Protocol #2012-016. All the data
   supporting our conclusions are contained in this manuscript.
CR Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Baba S. S., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P343, DOI 10.1590/S0036-46651998000600002
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guy B, 2004, VACCINE, V22, P3563, DOI 10.1016/j.vaccine.2004.03.042
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6
   Kao D, 2015, CELL REP, V13, P2376, DOI 10.1016/j.celrep.2015.11.027
   KLIKS S, 1990, AIDS RES HUM RETROV, V6, P993, DOI 10.1089/aid.1990.6.993
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   MADY BJ, 1993, J GEN VIROL, V74, P839, DOI 10.1099/0022-1317-74-5-839
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Orton SL, 2006, TRANSFUSION, V46, P272, DOI 10.1111/j.1537-2995.2006.00710.x
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Taketa-Graham M, 2010, AM J TROP MED HYG, V82, P501, DOI 10.4269/ajtmh.2010.09-0297
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
NR 39
TC 226
Z9 232
U1 2
U2 85
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 14
PY 2017
VL 356
IS 6334
BP 175
EP 180
DI 10.1126/science.aal4365
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER7SM
UT WOS:000399013800033
PM 28360135
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Sumathy, K
   Kulkarni, B
   Gondu, RK
   Ponnuru, SK
   Bonguram, N
   Eligeti, R
   Gadiyaram, S
   Praturi, U
   Chougule, B
   Karunakaran, L
   Ella, KM
AF Sumathy, K.
   Kulkarni, Bharathi
   Gondu, Ravi Kumar
   Ponnuru, Sampath Kumar
   Bonguram, Nagaraju
   Eligeti, Rakesh
   Gadiyaram, Sindhuja
   Praturi, Usha
   Chougule, Bhushan
   Karunakaran, Latha
   Ella, Krishna M.
TI Protective efficacy of Zika vaccine in AG129 mouse model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; JAPANESE-ENCEPHALITIS-VIRUS; CROSS-REACTIVITY;
   DENGUE VIRUS; INFECTION; TRANSMISSION; SPECIFICITY; ANTIBODIES;
   CHALLENGE; COUNTRIES
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that causes asymptomatic infection or presents only mild symptoms in majority of those infected. However, vaccination for ZIKV is a public health priority due to serious congenital and neuropathological abnormalities observed as a sequelae of the virus infection in the recent epidemics. We have developed an inactivated virus vaccine with the African MR 766 strain. Here we show that two doses of the vaccine provided 100% efficacy against mortality and disease following challenge with homotypic MR 766 and the heterotypic FSS 13025 ZIKV strains in the Type I and Type II interferon deficient AG129 mice. Two doses of the vaccine elicited high titer of neutralizing antibodies in Balb/c mice, and the vaccine antisera conferred protection against virus challenge in passively immunized mice. The studies were useful to rationalize vaccine doses for protective efficacy. Furthermore, the vaccine antisera neutralized the homotypic and heterotypic ZIKV strains in vitro with equivalent efficiency. Our study suggests a single ZIKV serotype, and that the development of an effective vaccine may not be limited by the choice of virus strain.
C1 [Sumathy, K.; Kulkarni, Bharathi; Gondu, Ravi Kumar; Ponnuru, Sampath Kumar; Bonguram, Nagaraju; Eligeti, Rakesh; Gadiyaram, Sindhuja; Praturi, Usha; Chougule, Bhushan; Karunakaran, Latha; Ella, Krishna M.] Genome Valley, Bharat Biotech Int Ltd, R&D Dept, Hyderabad 500078, Telangana, India.
RP Sumathy, K (corresponding author), Genome Valley, Bharat Biotech Int Ltd, R&D Dept, Hyderabad 500078, Telangana, India.
EM sumathy@bharatbiotech.com
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Beasley DWC, 2004, VACCINE, V22, P3722, DOI 10.1016/j.vaccine.2004.03.027
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HOLZMANN H, 1992, VACCINE, V10, P345, DOI 10.1016/0264-410X(92)90376-U
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   HOMBACH J, 2016, THE BMJ, V355, pI5923
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Orlinger KK, 2011, J INFECT DIS, V203, P1556, DOI 10.1093/infdis/jir122
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Partidos CD, 2011, VACCINE, V29, P3067, DOI 10.1016/j.vaccine.2011.01.076
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tsarev SA, 2000, VACCINE, V18, P36, DOI 10.1016/S0264-410X(00)00039-6
   Zhu JG, 2007, J IMMUNOL, V178, P3505, DOI 10.4049/jimmunol.178.6.3505
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 40
TC 48
Z9 49
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 12
PY 2017
VL 7
AR 46375
DI 10.1038/srep46375
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER7KN
UT WOS:000398991800001
PM 28401907
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, YX
   Liu, QX
   Zhou, J
   Xie, WH
   Chen, C
   Wang, ZF
   Yang, HT
   Cui, J
AF Wu, Yaoxing
   Liu, Qingxiang
   Zhou, Jie
   Xie, Weihong
   Chen, Cheng
   Wang, Zefang
   Yang, Haitao
   Cui, Jun
TI Zika virus evades interferon-mediated antiviral response through the
   co-operation of multiple nonstructural proteins in vitro (vol 3, 17006,
   2017)
SO CELL DISCOVERY
LA English
DT Correction
C1 [Wu, Yaoxing; Liu, Qingxiang; Zhou, Jie; Xie, Weihong; Cui, Jun] Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ,State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.
   [Chen, Cheng; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China.
   [Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin, Peoples R China.
   [Cui, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.
RP Wu, YX (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ,State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.
CR Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
NR 1
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD APR 11
PY 2017
VL 3
AR UNSP 17014
DI 10.1038/celldisc.2017.14
PG 1
WC Cell Biology
SC Cell Biology
GA FM3NJ
UT WOS:000414912900001
PM 28417013
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Usman Mirza, M
   Rafique, S
   Ali, A
   Munir, M
   Ikram, N
   Manan, A
   Salo-Ahen, OMH
   Idrees, M
AF Usman Mirza, Muhammad
   Rafique, Shazia
   Ali, Amjad
   Munir, Mobeen
   Ikram, Nazia
   Manan, Abdul
   Salo-Ahen, Outi M. H.
   Idrees, Muhammad
TI Towards peptide vaccines against Zika virus: Immunoinformatics combined
   with molecular dynamics simulations to predict antigenic epitopes of
   Zika viral proteins (vol 6, 37313, 2017)
SO SCIENTIFIC REPORTS
LA English
DT Correction
C1 [Usman Mirza, Muhammad] Univ Lahore, CRiMM, Lahore, Pakistan.
   [Usman Mirza, Muhammad] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Rega Inst Med Res, Med Chem, Leuven, Belgium.
RP Usman Mirza, M (corresponding author), Univ Lahore, CRiMM, Lahore, Pakistan.; Usman Mirza, M (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Rega Inst Med Res, Med Chem, Leuven, Belgium.
RI Salo-Ahen, Outi M. H./J-9901-2019; Idrees, Muhammad/K-6032-2012; Mirza,
   Muhammad Usman/F-4150-2015; Mirza, Muhammad Usman/I-5970-2019
OI Salo-Ahen, Outi M. H./0000-0003-0725-126X; Idrees,
   Muhammad/0000-0002-3081-7631; Mirza, Muhammad Usman/0000-0001-9120-2414;
   Mirza, Muhammad Usman/0000-0001-9120-2414
CR Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
NR 1
TC 0
Z9 0
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 11
PY 2017
VL 7
AR 44633
DI 10.1038/srep44633
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER6KN
UT WOS:000398914300001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Machado, CM
   Pereira, BBD
   Felix, AC
   Oliveira, MC
   Darrigo, LG
   de Souza, MP
   Paton, EJD
   Neves, F
   Colturato, VR
   Simoes, BP
AF Machado, Clarisse Martins
   de Souza Pereira, Barbara Brito
   Felix, Alvina Clara
   Oliveira, Maria Carolina
   Darrigo, Luiz Guilherme, Jr.
   de Souza, Mair Pedro
   de Alencar Paton, Eduardo Jose
   Neves, Fabia
   Colturato, Vergilio Rensi
   Simoes, Belinda Pinto
TI Zika and chikungunya virus infections in hematopoietic stem cell
   transplant recipients and oncohematological patients
SO BLOOD ADVANCES
LA English
DT Article
ID TIME RT-PCR; DENGUE; TRANSMISSION; MICRONESIA; BRAZIL
AB Aedes mosquitoes are well adapted in domestic environments and widespread in tropical regions. Since 2015, Brazil has been experiencing a triple epidemic of dengue (DENV), chikungunya (CHKV), and Zika (ZIKV) viruses. The last 2 viruses are likely following the path of DENV, which has been endemic in most parts of the country since the 1980s. Given this triple epidemic, we proposed a prospective and collaborative study to assess the prevalence, morbidity, andmortality of DENV, CHKV, and ZIKV infections in hematopoietic stem cell transplant (HSCT) recipients and oncohematological patients. A case definition strategy (fever and rash) was used to prompt diagnostic investigation of DENV, ZIKV, and CHKV, which was accomplished by real-time polymerase chain reaction with plasma and urine samples. Clinical follow-up was performed 7 and 30 days after symptom onset. We report here the first cases of ZIKV and CHKV infections diagnosed in this ongoing study. From February to May 2016, 9 of the 26 patients (34.6%) fulfilling case definition criteria were diagnosed with DENV (3 cases), ZIKV (4 cases), or CHKV (2 cases) infections. Prolonged viremia and viruria were observed in dengue and Zika fever cases, respectively. Thrombocytopenia was the most frequent complication. Delayed engraftment was noted in 1 patient who acquired ZIKV 25 days before HSCT. All patients survived without sequelae. With the geographic expansion of arboviruses, donor and recipient screening may become mandatory. Patients living in areas where these viruses are not endemic are also at risk, since these viruses can be transmitted by blood as well as organ or tissue transplantation
C1 [Machado, Clarisse Martins; de Souza Pereira, Barbara Brito; Felix, Alvina Clara] Univ Sao Paulo, Inst Trop Med, Virol Lab, Av Dr Eneas Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
   [Machado, Clarisse Martins; de Souza, Mair Pedro; Colturato, Vergilio Rensi] Amaral Carvalho Fdn, HSCT Program, Sao Paulo, Brazil.
   [Oliveira, Maria Carolina; Darrigo, Luiz Guilherme, Jr.; Simoes, Belinda Pinto] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [de Alencar Paton, Eduardo Jose] Hosp Cancer Barretos, HSCT Program, Sao Paulo, Brazil.
   [Neves, Fabia] Santa Casa Misericordia Itabuna, Salvador, Brazil.
RP Machado, CM (corresponding author), Univ Sao Paulo, Inst Trop Med, Virol Lab, Av Dr Eneas Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
EM clarimm@usp.br
RI JUNIOR, LUIZ GUILHERME DARRIGO/AAH-1776-2019; Simoes, Belinda
   P/M-7469-2016; Rodrigues, Maria Carolina Oliveira/A-2302-2012; Darrigo
   Junior, Luiz/A-2686-2019; CTC USP, CEPID 13 18/J-8951-2014
OI JUNIOR, LUIZ GUILHERME DARRIGO/0000-0001-6007-8908; Rodrigues, Maria
   Carolina Oliveira/0000-0003-0691-2222; Darrigo Junior,
   Luiz/0000-0001-6007-8908; CTC USP, CEPID 13 18/0000-0002-7123-9524
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2015/06947-5]; Virology Laboratory of Institute of
   Tropical Medicine, University of Sao Paulo
FX This study was supported in part by the Sao Paulo Research Foundation
   (research grant 2015/06947-5) (C.M.M.) and by the Virology Laboratory of
   Institute of Tropical Medicine, University of Sao Paulo.
CR Agencia Nacional de Vigilancia Sanitaria (ANVISA), CRIT TECN GER RISC S
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Brazil. Associaca o Brasileira de Transplantes. Registro Brasileiro de Transplantes, DIM TRANSPL BRAS CAD
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Garcia JHP, 2006, TRANSPLANTATION, V82, P850, DOI 10.1097/01.tp.0000235151.60237.fe
   Gasperina DD, 2015, TRANSPL INFECT DIS, V17, P876, DOI 10.1111/tid.12453
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hepner Adriana, 2016, J Glob Oncol, V2, P250, DOI 10.1200/JGO.2016.003533
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Machado CM, 2009, REV INST MED TROP SP, V51, P309, DOI 10.1590/S0036-46652009000600002
   Musso D, 2014, EUROSURVEILLANCE, P19
   Nogueira ML, 2011, AM J TRANSPLANT, V17, P791
   Punzel M, 2014, EMERG INFECT DIS, V20, P1366, DOI 10.3201/eid2008.140508
   Renaud CJ, 2007, NEPHROLOGY, V12, P305, DOI 10.1111/j.1440-1797.2007.00785.x
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Sharma SK, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.039
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 6
Z9 6
U1 0
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 2473-9529
EI 2473-9537
J9 BLOOD ADV
JI Blood Adv.
PD APR 11
PY 2017
VL 1
IS 10
BP 624
EP 627
DI 10.1182/bloodadvances.2016003285
PG 4
WC Hematology
SC Hematology
GA ES2PX
UT WOS:000399371500006
PM 29296705
OA Green Published
DA 2020-07-08
ER

PT J
AU Kumar, M
   Krause, KK
   Azouz, F
   Nakano, E
   Nerurkar, VR
AF Kumar, Mukesh
   Krause, Keeton K.
   Azouz, Francine
   Nakano, Eileen
   Nerurkar, Vivek R.
TI A guinea pig model of Zika virus infection
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Microcephaly; Guinea pigs; Animal models; Flavivirus; Immune
   response; Pathogenesis
ID WEST NILE VIRUS; CYTOMEGALOVIRUS-INFECTION; FLAVIVIRUS INFECTIONS; EG101
   STRAIN; MOUSE MODEL; MICE; ENCEPHALITIS; PATHOGENESIS; DISEASE;
   INTERLEUKIN-18
AB Background: Animal models are critical to understand disease and to develop countermeasures for the ongoing epidemic of Zika virus (ZIKV). Here we report that immunocompetent guinea pigs are susceptible to infection by a contemporary American strain of ZIKV.
   Methods: Dunkin-Hartley guinea pigs were inoculated with 106 plaque-forming units of ZIKV via subcutaneous route and clinical signs were observed. Viremia, viral load in the tissues, anti-ZIKV neutralizing antibody titer, and protein levels of multiple cytokine and chemokines were analyzed using qRT-PCR, plaque assay, plaque reduction neutralization test (PRNT) and multiplex immunoassay.
   Results: Upon subcutaneous inoculation with PRVABC59 strain of ZIKV, guinea pigs demonstrated clinical signs of infection characterized by fever, lethargy, hunched back, ruffled fur, and decrease in mobility. ZIKV was detected in the whole blood and serum using qRT-PCR and plaque assay. Anti-ZIKV neutralizing antibody was detected in the infected animals using PRNT. ZIKV infection resulted in a dramatic increase in protein levels of multiple cytokines, chemokines and growth factors in the serum. ZIKV replication was observed in spleen and brain, with the highest viral load in the brain. This data demonstrate that after subcutaneous inoculation, the contemporary ZIKV strain is neurotropic in guinea pigs.
   Conclusion: The guinea pig model described here recapitulates various clinical features and viral kinetics observed in ZIKV-infected patients, and therefore may serve as a model to study ZIKV pathogenesis, including pregnancy outcomes and for evaluation of vaccines and therapeutics.
C1 [Kumar, Mukesh; Krause, Keeton K.; Azouz, Francine; Nakano, Eileen; Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, 651 Ilalo St,BSB 320, Honolulu, HI 96813 USA.
RP Kumar, M (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, 651 Ilalo St,BSB 320, Honolulu, HI 96813 USA.
EM mukesh@hawaii.edu
RI Nerurkar, Vivek R/F-5533-2011; Kumar, Mukesh/AAI-1046-2019; Kumar,
   Mukesh/N-8814-2015
OI Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875
FU Centers of Biomedical Research Excellence, National Institute of General
   Medical Sciences [P30GM114737]; National Institute of Neurological
   Disorders and Stroke, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [1R21NS099838-01]
FX This research was supported by a grant (P30GM114737) from the Centers of
   Biomedical Research Excellence, National Institute of General Medical
   Sciences, grant (1R21NS099838-01) from National Institute of
   Neurological Disorders and Stroke, National Institutes of Health, and
   Institutional funds. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003
   Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chen H, 2015, J OBSTET GYNAECOL RE, V41, P1506, DOI 10.1111/jog.12800
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowall SD, 2015, J GEN VIROL, V96, P3484, DOI 10.1099/jgv.0.000309
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fredericksen BL, 2014, J NEUROVIROL, V20, P113, DOI 10.1007/s13365-013-0180-z
   GRIFFITH BP, 1983, J INFECT DIS, V147, P990, DOI 10.1093/infdis/147.6.990
   GRIFFITH BP, 1985, J VIROL, V55, P402, DOI 10.1128/JVI.55.2.402-409.1985
   INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569, DOI 10.1111/j.1348-0421.1984.tb00709.x
   Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Keyel PA, 2014, CYTOKINE, V69, P136, DOI 10.1016/j.cyto.2014.03.007
   King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Kumar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005262
   Kumar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26350
   Kumar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0400-y
   Kumar M, 2014, VIRUSES-BASEL, V6, P2328, DOI 10.3390/v6062328
   Kumar M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-80
   Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044682
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee HH, 2012, APPL BIOCHEM BIOTECH, V167, P259, DOI 10.1007/s12010-012-9668-x
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mess A, 2007, PLACENTA, V28, P812, DOI 10.1016/j.placenta.2007.02.005
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Namekar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045851
   Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WICHER K, 1992, INFECT IMMUN, V60, P271, DOI 10.1128/IAI.60.1.271-277.1992
   Yue J, 2015, INT J MOL SCI, V16, P4180, DOI 10.3390/ijms16024180
NR 49
TC 29
Z9 30
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD APR 11
PY 2017
VL 14
AR 75
DI 10.1186/s12985-017-0750-4
PG 8
WC Virology
SC Virology
GA ER3OU
UT WOS:000398707400001
PM 28399888
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU do Prado, TM
   Cincotto, FH
   Machado, SAS
AF do Prado, Thiago M.
   Cincotto, Fernando H.
   Machado, Sergio A. S.
TI Spectroelectrochemical study of acetylsalicylic acid in neutral medium
   and its quantification in clinical and environmental samples
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE spectroelectrochemical; voltabsorptometry; graphene; gold nanoparticles;
   acetylsalicylic acid
ID ELECTROCHEMICAL SENSOR; PLATINUM-ELECTRODE; FREE-RADICALS; ZIKA FEVER;
   ASPIRIN; CHIKUNGUNYA; CAFFEINE; PHARMACEUTICALS; SEWAGE; OXIDE
AB This paper describes the application of simultaneous electrochemical reduction and UV absorbance methods (spectroelectrochemical techniques, highlighting the derivative linear scan voltabsorptometry) in the determination of acetylsalicylic acid in neutral medium, using a platinum gauze electrode modified with nanocomposite of reduced graphene oxide with gold nanoparticles (rGO/AuNPs). In solution, the process involving one electron to produce the radical acetylsalicylate was observed. Such mechanism was confirmed by electronic paramagnetic resonance (EPR). This study demonstrated that the voltabsorptometric sensor is highly sensitive for the determination of acetylsalicylic acid, with a limit of detection of 0.26 mu mol L (1). No significant interference was detected for ascorbic and uric acid in the determination of acetylsalicylic acid. The platinum gauze with rGO/AuNPs modified electrode device was successfully applied in the acetylsalicylic acid determination in an environmental samples (wastewater) and clinical (tablets of drugs and human urine) samples, and is a promising platform for a simple, rapid, direct and very sensitive analysis of acetylsalicylic acid. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [do Prado, Thiago M.; Machado, Sergio A. S.] Univ Sao Paulo, Sao Carlos Inst Chem, CP 380, BR-13566590 Sao Carlos, SP, Brazil.
   [Cincotto, Fernando H.] Univ Fed Sao Carlos, Chem Dept, BR-13565905 Sao Carlos, SP, Brazil.
RP do Prado, TM (corresponding author), Univ Sao Paulo, Sao Carlos Inst Chem, CP 380, BR-13566590 Sao Carlos, SP, Brazil.
EM thipra@gmail.com
RI Cincotto, Fernando Henrique/AAA-1007-2019
OI Cincotto, Fernando Henrique/0000-0001-7027-2480
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/17053-0, 2016/16565-5, 2006/53266-4]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [471389/2013-7];
   CAPESCAPES [1423455]
FX The authors thank FAPESP for funding resources through Processes no:
   2013/17053-0 and 2016/16565-5 (F. H. Cincotto), CNPq no: 471389/2013-7
   process and CAPES process no: 1423455 for granted doctoral fellowship to
   T. M. Prado as well as to Prof. Douglas Wagner Franco (in memoriam) by
   EPR analyzes performed on equipment purchased by FAPESP no 2006/53266-4
   process.
CR Abdelnabi R, 2015, ANTIVIR RES, V121, P59, DOI 10.1016/j.antiviral.2015.06.017
   Abu-Qare AW, 2001, J PHARMACEUT BIOMED, V26, P939, DOI 10.1016/S0731-7085(01)00448-4
   BANCROFT EE, 1981, ANAL CHEM, V53, P1390, DOI 10.1021/ac00232a021
   Bard A.J., 2001, ELECTROCHEMICAL METH
   Bozzini B, 2006, J APPL ELECTROCHEM, V36, P973, DOI 10.1007/s10800-006-9124-0
   BUETTNER GR, 1993, FREE RADICAL RES COM, V19, pS79, DOI 10.3109/10715769309056s79
   BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3
   Burnett T, 2013, IMMUNOL ALLERGY CLIN, V33, P223, DOI 10.1016/j.iac.2012.11.003
   Cariappa M P, 2015, Med J Armed Forces India, V71, P76, DOI [10.101, 10.1016/j.mjafi.2014.06.001]
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen QT, 2016, BIOSENS BIOELECTRON, V79, P364, DOI 10.1016/j.bios.2015.12.063
   Chrzescijanska E, 2014, J ELECTROANAL CHEM, V713, P17, DOI 10.1016/j.jelechem.2013.11.015
   Cincotto FH, 2014, CHEM-EUR J, V20, P4746, DOI 10.1002/chem.201304853
   Comeau F, 2008, SCI TOTAL ENVIRON, V396, P132, DOI 10.1016/j.scitotenv.2008.02.031
   da Silva OB, 2012, ANAL METHODS-UK, V4, P2348, DOI 10.1039/c2ay25111f
   EDWARDS LJ, 1950, T FARADAY SOC, V46, P723, DOI 10.1039/tf9504600723
   Elahi MY, 2011, ANAL BIOCHEM, V411, P176, DOI 10.1016/j.ab.2011.01.006
   Ertan B, 2016, J COLLOID INTERF SCI, V470, P14, DOI 10.1016/j.jcis.2016.02.036
   Floyd CN, 2014, PHARMACOL THERAPEUT, V141, P69, DOI 10.1016/j.pharmthera.2013.08.005
   Gerber M, 2006, INT J PHARMACEUT, V310, P31, DOI 10.1016/j.ijpharm.2005.11.018
   Gerson F., 2003, ELECT SPIN RESONANCE
   Ghadimi H., 2016, J TAIWAN I CHEM E
   Goyal RN, 2011, J ELECTROANAL CHEM, V655, P97, DOI 10.1016/j.jelechem.2011.03.008
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Leon L, 2013, SENSOR ACTUAT B-CHEM, V186, P263, DOI 10.1016/j.snb.2013.06.024
   Li F, 2012, CHEM COMMUN, V48, P127, DOI 10.1039/c1cc15694b
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Miller JN, 2005, STAT CHEMOMETRICS AN
   Mojovic M, 2005, J SERB CHEM SOC, V70, P177, DOI 10.2298/JSC0502177M
   Moliner-Martinez Y, 2011, J CHROMATOGR A, V1218, P2276, DOI 10.1016/j.chroma.2011.02.036
   Papageorgiou M, 2016, SCI TOTAL ENVIRON, V543, P547, DOI 10.1016/j.scitotenv.2015.11.047
   Parlak O, 2013, BIOSENS BIOELECTRON, V49, P53, DOI 10.1016/j.bios.2013.04.004
   Patil DB, 2008, ASIAN J CHEM, V20, P6494
   Pooja C, 2014, ASIAN PAC J TROP MED, V7, P169, DOI 10.1016/S1995-7645(14)60016-X
   Purushotham M, 2015, TALANTA, V143, P328, DOI 10.1016/j.talanta.2015.04.082
   Payan MR, 2010, TALANTA, V82, P854, DOI 10.1016/j.talanta.2010.05.022
   Rivera-Utrilla J, 2013, CHEMOSPHERE, V93, P1268, DOI 10.1016/j.chemosphere.2013.07.059
   Sanghavi BJ, 2010, ELECTROCHIM ACTA, V55, P8638, DOI 10.1016/j.electacta.2010.07.093
   Silvester DS, 2008, J PHYS CHEM C, V112, P12966, DOI 10.1021/jp802996q
   Stumpf M, 1999, SCI TOTAL ENVIRON, V225, P135, DOI 10.1016/S0048-9697(98)00339-8
   Tarabek J, 2005, ELECTROCHIM ACTA, V50, P1643, DOI 10.1016/j.electacta.2004.10.020
   Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2
   Wang Yan, 2012, J Pharm Anal, V2, P386, DOI 10.1016/j.jpha.2012.06.002
   Wang ZH, 2011, TALANTA, V85, P1672, DOI 10.1016/j.talanta.2011.06.067
   Wattal C, 2012, MED CLIN N AM, V96, P1225, DOI 10.1016/j.mcna.2012.08.004
   Wei Y, 2012, J PHYS CHEM C, V116, P1034, DOI 10.1021/jp209805c
   Wudarska E, 2013, ELECTROCHIM ACTA, V93, P189, DOI 10.1016/j.electacta.2013.01.107
   Xu XY, 2016, SENSOR ACTUAT B-CHEM, V230, P463, DOI 10.1016/j.snb.2016.02.101
   YAMAZAKI I, 1990, J BIOL CHEM, V265, P652
   Yigit A, 2016, TALANTA, V158, P21, DOI 10.1016/j.talanta.2016.05.046
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Ziylan A, 2011, J HAZARD MATER, V187, P24, DOI 10.1016/j.jhazmat.2011.01.057
   Zoski CG, 2007, HANDBOOK OF ELECTROCHEMISTRY, P1
NR 55
TC 4
Z9 4
U1 1
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD APR 10
PY 2017
VL 233
BP 105
EP 112
DI 10.1016/j.electacta.2017.03.038
PG 8
WC Electrochemistry
SC Electrochemistry
GA EQ8IL
UT WOS:000398328000012
DA 2020-07-08
ER

PT J
AU Jeong, YE
   Cha, GW
   Cho, JE
   Lee, EJ
   Jee, Y
   Lee, WJ
AF Jeong, Young Eui
   Cha, Go-Woon
   Cho, Jung Eun
   Lee, Eun Ju
   Jee, Youngmee
   Lee, Won-Ja
TI Viral and serological kinetics in Zika virus-infected patients in South
   Korea
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Chikungunya virus; Dengue virus; Reverse
   transcription-polymerase chain reaction; Enzyme-Linked Immunosorbent
   Assay; Phylogenetic analysis
ID SERUM; MICRONESIA; SALIVA; URINE
AB Zika virus is a mosquito-borne flavivirus that causes clinical symptoms similar to those observed in dengue and chikungunya virus infections. The Korea Centers for Disease Control and Prevention initiated laboratory testing using a real-time reverse transcription-polymerase chain reaction in January 2016. More than 1,000 suspected cases of infection were tested and nine were confirmed as imported cases of Zika virus infection from January to July 2016. The travel destinations of the infected individuals were Brazil, Philippines, Viet Nam, Guatemala, Puerto Rico, and the Dominican Republic. Phylogenetic analysis based on the partial envelope gene indicated that the viruses belonged to the Asian genotype circulating in South America. We further investigated the duration for which the viral RNA and virus-specific antibodies were detectable after the symptom onset. After the day of symptom onset, Zika virus was detectable until 6 days in serum, 14 days in urine and saliva, and 58 days in semen. Immunoglobulin M against Zika virus was detected as early as 2 days after the symptom onset and was maintained at these levels until 41 days, whereas Immunoglobulin G was detectable from 8 days after the symptom onset and was maintained until 52 days. These findings would help diagnostic laboratories improve their testing programs for Zika virus infection.
C1 [Jeong, Young Eui; Cha, Go-Woon; Cho, Jung Eun; Lee, Eun Ju; Lee, Won-Ja] Korea Ctr Dis Control & Prevent, Div Arboviruses, Natl Inst Hlth, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, Chungbuk Do, South Korea.
   [Jee, Youngmee] Korea Ctr Dis Control & Prevent, Cheongju 28159, Chungbuk Do, South Korea.
RP Lee, WJ (corresponding author), Korea Ctr Dis Control & Prevent, Div Arboviruses, Natl Inst Hlth, 187 Osongsaengmyeong 2 Ro, Cheongju 28159, Chungbuk Do, South Korea.
EM leewonja@gmail.com
FU Korea Centers for Disease Control and Prevention [4847-311-210-13,
   4837-301-210-13]
FX This study was supported by funding from the Korea Centers for Disease
   Control and Prevention (4847-311-210-13, 4837-301-210-13). The funding
   agency had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BURKE DS, 1985, J INFECT DIS, V151, P1093, DOI 10.1093/infdis/151.6.1093
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
NR 16
TC 17
Z9 18
U1 0
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD APR 7
PY 2017
VL 14
AR 70
DI 10.1186/s12985-017-0740-6
PG 6
WC Virology
SC Virology
GA EQ9KP
UT WOS:000398403700001
PM 28388922
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reynolds, MR
   Jones, AM
   Petersen, EE
   Lee, EH
   Rice, ME
   Bingham, A
   Ellington, SR
   Evert, N
   Reagan-Steiner, S
   Oduyebo, T
   Brown, CM
   Martin, S
   Ahmad, N
   Bhatnagar, J
   Macdonald, J
   Gould, C
   Fine, AD
   Polen, KD
   Lake-Burger, H
   Hillard, CL
   Hall, N
   Yazdy, MM
   Slaughter, K
   Sommer, JN
   Adamski, A
   Raycraft, M
   Fleck-Derderian, S
   Gupta, J
   Newsome, K
   Baez-Santiago, M
   Slavinski, S
   White, JL
   Moore, CA
   Shapiro-Mendoza, CK
   Petersen, L
   Boyle, C
   Jamieson, DJ
   Meaney-Delman, D
   Honein, MA
AF Reynolds, Megan R.
   Jones, Abbey M.
   Petersen, Emily E.
   Lee, Ellen H.
   Rice, Marion E.
   Bingham, Andrea
   Ellington, Sascha R.
   Evert, Nicole
   Reagan-Steiner, Sarah
   Oduyebo, Titilope
   Brown, Catherine M.
   Martin, Stacey
   Ahmad, Nina
   Bhatnagar, Julu
   Macdonald, Jennifer
   Gould, Carolyn
   Fine, Anne D.
   Polen, Kara D.
   Lake-Burger, Heather
   Hillard, Christina L.
   Hall, Noemi
   Yazdy, Mahsa M.
   Slaughter, Karnesha
   Sommer, Jamie N.
   Adamski, Alys
   Raycraft, Meghan
   Fleck-Derderian, Shannon
   Gupta, Jyoti
   Newsome, Kimberly
   Baez-Santiago, Madelyn
   Slavinski, Sally
   White, Jennifer L.
   Moore, Cynthia A.
   Shapiro-Mendoza, Carrie K.
   Petersen, Lyle
   Boyle, Coleen
   Jamieson, Denise J.
   Meaney-Delman, Dana
   Honein, Margaret A.
CA US Zika Pregnancy Registry
TI Vital Signs: Update on Zika Virus-Associated Birth Defects and
   Evaluation of All US Infants with Congenital Zika Virus Exposure - US
   Zika Pregnancy Registry, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID INTERIM GUIDANCE; UNITED-STATES; INFECTION; WOMEN
AB Background: In collaboration with state, tribal, local, and territorial health departments, CDC established the U.S. Zika Pregnancy Registry (USZPR) in early 2016 to monitor pregnant women with laboratory evidence of possible recent Zika virus infection and their infants.
   Methods: This report includes an analysis of completed pregnancies (which include live births and pregnancy losses, regardless of gestational age) in the 50 U.S. states and the District of Columbia (DC) with laboratory evidence of possible recent Zika virus infection reported to the USZPR from January 15 to December 27, 2016. Birth defects potentially associated with Zika virus infection during pregnancy include brain abnormalities and/or microcephaly, eye abnormalities, other consequences of central nervous system dysfunction, and neural tube defects and other early brain malformations.
   Results: During the analysis period, 1,297 pregnant women in 44 states were reported to the USZPR. Zika virus-associated birth defects were reported for 51 (5%) of the 972 fetuses/infants from completed pregnancies with laboratory evidence of possible recent Zika virus infection (95% confidence interval [CI] = 4%-7%); the proportion was higher when restricted to pregnancies with laboratory-confirmed Zika virus infection (24/250 completed pregnancies [10%, 95% CI = 7%-14%]). Birth defects were reported in 15% (95% CI = 8%-26%) of fetuses/infants of completed pregnancies with confirmed Zika virus infection in the first trimester. Among 895 liveborn infants from pregnancies with possible recent Zika virus infection, postnatal neuroimaging was reported for 221 (25%), and Zika virus testing of at least one infant specimen was reported for 585 (65%).
   Conclusions and Implications for Public Health Practice: These findings highlight why pregnant women should avoid Zika virus exposure. Because the full clinical spectrum of congenital Zika virus infection is not yet known, all infants born to women with laboratory evidence of possible recent Zika virus infection during pregnancy should receive postnatal neuroimaging and Zika virus testing in addition to a comprehensive newborn physical exam and hearing screen. Identification and follow-up care of infants born to women with laboratory evidence of possible recent Zika virus infection during pregnancy and infants with possible congenital Zika virus infection can ensure that appropriate clinical services are available.
C1 [Reynolds, Megan R.; Jones, Abbey M.; Rice, Marion E.; Polen, Kara D.; Hillard, Christina L.; Slaughter, Karnesha; Adamski, Alys; Newsome, Kimberly; Baez-Santiago, Madelyn; Moore, Cynthia A.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Petersen, Emily E.; Ellington, Sascha R.; Oduyebo, Titilope; Shapiro-Mendoza, Carrie K.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Lee, Ellen H.; Fine, Anne D.; Slavinski, Sally] New York City Dept Hlth & Mental Hyg, New York, NY USA.
   [Rice, Marion E.; Fleck-Derderian, Shannon] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Bingham, Andrea; Lake-Burger, Heather] Florida Dept Hlth, Tallahassee, FL USA.
   [Evert, Nicole; Hall, Noemi] Texas Dept State Hlth Serv, Austin, TX USA.
   [Reagan-Steiner, Sarah; Bhatnagar, Julu] CDC, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Brown, Catherine M.; Yazdy, Mahsa M.] Massachusetts Dept Publ Hlth, Boston, MA USA.
   [Martin, Stacey; Gould, Carolyn; Petersen, Lyle] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Ahmad, Nina; Sommer, Jamie N.; White, Jennifer L.] New York State Dept Hlth, Albany, NY USA.
   [Macdonald, Jennifer; Gupta, Jyoti] Virginia Dept Hlth, Richmond, VA USA.
   [Hall, Noemi] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Fleck-Derderian, Shannon; Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Boyle, Coleen] CDC, Off Director, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
RP Honein, MA (corresponding author), CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM eocbirthdef@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Neary,
   Jillian/0000-0003-1166-0760; Yazdy, Mahsa/0000-0002-7415-5350; Lee,
   Christopher/0000-0001-7957-1524; Jamieson, Denise/0000-0003-2597-1201
CR Alarcon A, 2016, NEONATOLOGY, V110, P277, DOI 10.1159/000446690
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS ZIK VIR
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 12
TC 117
Z9 117
U1 4
U2 242
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 7
PY 2017
VL 66
IS 13
BP 366
EP 373
DI 10.15585/mmwr.mm6613e1
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES1TH
UT WOS:000399309400004
PM 28384133
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Dudchenko, O
   Batra, SS
   Omer, AD
   Nyquist, SK
   Hoeger, M
   Durand, NC
   Shamim, MS
   Machol, I
   Lander, ES
   Aiden, AP
   Aiden, EL
AF Dudchenko, Olga
   Batra, Sanjit S.
   Omer, Arina D.
   Nyquist, Sarah K.
   Hoeger, Marie
   Durand, Neva C.
   Shamim, Muhammad S.
   Machol, Ido
   Lander, Eric S.
   Aiden, Aviva Presser
   Aiden, Erez Lieberman
TI De novo assembly of the Aedes aegypti genome using Hi-C yields
   chromosome-length scaffolds
SO SCIENCE
LA English
DT Article
ID MAMMALIAN GENOMES; LINKAGE MAP; SEQUENCE; PRINCIPLES; EVOLUTION;
   PROVIDES; VECTOR; SYSTEM
AB The Zika outbreak, spread by the Aedes aegypti mosquito, highlights the need to create high-quality assemblies of large genomes in a rapid and cost-effective way. Here we combine Hi-C data with existing draft assemblies to generate chromosome-length scaffolds. We validate this method by assembling a human genome, de novo, from short reads alone (67x coverage). We then combine our method with draft sequences to create genome assemblies of the mosquito disease vectors Ae. aegypti and Culex quinquefasciatus, each consisting of three scaffolds corresponding to the three chromosomes in each species. These assemblies indicate that almost all genomic rearrangements among these species occur within, rather than between, chromosome arms. The genome assembly procedure we describe is fast, inexpensive, and accurate, and can be applied to many species.
C1 [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Nyquist, Sarah K.; Hoeger, Marie; Durand, Neva C.; Shamim, Muhammad S.; Machol, Ido; Aiden, Aviva Presser; Aiden, Erez Lieberman] Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA.
   [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Durand, Neva C.; Shamim, Muhammad S.; Machol, Ido; Aiden, Aviva Presser; Aiden, Erez Lieberman] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Nyquist, Sarah K.; Hoeger, Marie; Durand, Neva C.; Shamim, Muhammad S.; Machol, Ido; Aiden, Erez Lieberman] Rice Univ, Dept Comp Sci & Computat & Appl Math, Houston, TX 77030 USA.
   [Dudchenko, Olga; Aiden, Erez Lieberman] Rice Univ, Ctr Theoret & Biol Phys, Houston, TX 77030 USA.
   [Lander, Eric S.; Aiden, Erez Lieberman] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02139 USA.
   [Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
   [Aiden, Aviva Presser] Rice Univ, Dept Bioengn, Houston, TX 77030 USA.
   [Aiden, Aviva Presser] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA.
RP Aiden, EL (corresponding author), Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Rice Univ, Dept Comp Sci & Computat & Appl Math, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Rice Univ, Ctr Theoret & Biol Phys, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02139 USA.
EM erez@erez.com
RI Aiden, Erez Lieberman/A-2908-2010
OI Shamim, Muhammad/0000-0002-2600-5147
FU Center for Theoretical Biological Physics; NIH New Innovator AwardUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [1DP2OD008540-01]; NSF Physics Frontier Center Award
   [PHY-1427654]; National Human Genome Research Institute (NHGRI) Center
   for Excellence for Genomic Sciences [HG006193]; Welch FoundationThe
   Welch Foundation [Q-1866]; NVIDIA Research Center Award; IBM University
   Challenge Award; Google Research Award; Cancer Prevention Research
   Institute of Texas Scholar Award [R1304]; McNair Medical Institute
   Scholar Award; NIH 4D Nucleome Grant [U01HL130010]; NIH Encyclopedia of
   DNA Elements Mapping Center Award [UM1HG009375]; President's Early
   Career Award in Science and Engineering
FX This work was supported by a Center for Theoretical Biological Physics
   postdoctoral fellowship to O.D., an NIH New Innovator Award
   (1DP2OD008540-01), an NSF Physics Frontier Center Award (PHY-1427654,
   Center for Theoretical Biological Physics), the National Human Genome
   Research Institute (NHGRI) Center for Excellence for Genomic Sciences
   (HG006193), the Welch Foundation (Q-1866), an NVIDIA Research Center
   Award, an IBM University Challenge Award, a Google Research Award, a
   Cancer Prevention Research Institute of Texas Scholar Award (R1304), a
   McNair Medical Institute Scholar Award, an NIH 4D Nucleome Grant
   (U01HL130010), an NIH Encyclopedia of DNA Elements Mapping Center Award
   (UM1HG009375), and the President's Early Career Award in Science and
   Engineering to E.L.A. We thank C. Nusbaum, L. Vosshall, B. Matthews, and
   R. Andino for their comments on this manuscript; J. Robinson and D.
   Turner for work on the Web interface; D. Neafsey, D. Jaffe, I.
   MacCallum, and members of the Aiden lab for helpful discussions; and S.
   Knemeyer for assistance with figures. All data sets reported in this
   paper are available at the Gene Expression Omnibus (GEO), series
   accession number GSE95797. The Hi-C maps for the final assemblies can be
   viewed at aidenlab. org/juicebox; the code is available at
   github.com/theaidenlab/3D-DNA, and additional resources are available at
   aidenlab. org/3D-DNA. O.D., S. S. B., A.D.O., S.K.N., N.C.D., E.S.L.,
   A.P.A., and E.L.A. are inventors on U.S. provisional patent application
   62/347,605, filed 8 June 2016, by the Baylor College of Medicine and the
   Broad Institute, relating to the assembly methods in this manuscript.
CR Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727
   Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012
   Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002
   Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199
   Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108
   Harmon Amy, 2016, NY TIMES
   Hickner PV, 2013, J HERED, V104, P649, DOI 10.1093/jhered/est040
   Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348
   Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369
   Love RR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2531-7
   Marie-Nelly H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6695
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]
   Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115
   Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021
   Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Williams LJS, 2012, GENOME RES, V22, P2241, DOI 10.1101/gr.138925.112
NR 23
TC 149
Z9 151
U1 3
U2 39
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 7
PY 2017
VL 356
IS 6333
BP 92
EP 95
DI 10.1126/science.aal3327
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER3IA
UT WOS:000398689100045
PM 28336562
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Bershteyn, M
   Nowakowski, TJ
   Pollen, AA
   Di Lullo, E
   Nene, A
   Wynshaw-Boris, A
   Kriegstein, AR
AF Bershteyn, Marina
   Nowakowski, Tomasz J.
   Pollen, Alex A.
   Di Lullo, Elizabeth
   Nene, Aishwarya
   Wynshaw-Boris, Anthony
   Kriegstein, Arnold R.
TI Human iPSC-Derived Cerebral Organoids Model Cellular Features of
   Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia
SO CELL STEM CELL
LA English
DT Article
ID MILLER-DIEKER SYNDROME; PLURIPOTENT STEM-CELLS; DEVELOPING HUMAN BRAIN;
   ZIKA VIRUS-INFECTION; NEURONAL MIGRATION; SUBVENTRICULAR ZONE; SPINDLE
   ORIENTATION; CYTOPLASMIC DYNEIN; NEURAL PROGENITORS; LIS1
AB Classical lissencephaly is a genetic neurological disorder associated with mental retardation and intractable epilepsy, and Miller-Dieker syndrome (MDS) is the most severe form of the disease. In this study, to investigate the effects of MDS on human progenitor subtypes that control neuronal output and influence brain topology, we analyzed cerebral organoids derived from control and MDS-induced pluripotent stem cells (iPSCs) using time-lapse imaging, immunostaining, and single-cell RNA sequencing. We saw a cell migration defect that was rescued when we corrected the MDS causative chromosomal deletion and severe apoptosis of the founder neuroepithelial stem cells, accompanied by increased horizontal cell divisions. We also identified a mitotic defect in outer radial glia, a progenitor subtype that is largely absent from lissencephalic rodents but critical for human neocortical expansion. Our study, therefore, deepens our understanding of MDS cellular pathogenesis and highlights the broad utility of cerebral organoids for modeling human neurodevelopmental disorders.
C1 [Bershteyn, Marina; Nowakowski, Tomasz J.; Pollen, Alex A.; Di Lullo, Elizabeth; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.
   [Bershteyn, Marina; Wynshaw-Boris, Anthony] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.
   [Nowakowski, Tomasz J.; Pollen, Alex A.; Di Lullo, Elizabeth; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.
   [Nene, Aishwarya] CALTECH, Pasadena, CA 91125 USA.
   [Wynshaw-Boris, Anthony] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.
   [Bershteyn, Marina] Neurona Therapeut, San Francisco, CA 94080 USA.
RP Bershteyn, M; Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Bershteyn, M; Wynshaw-Boris, A (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Kriegstein, AR (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Wynshaw-Boris, A (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Bershteyn, M (corresponding author), Neurona Therapeut, San Francisco, CA 94080 USA.
EM mbershteyn@gmail.com; ajw168@case.edu; kriegsteina@stemcell.ucsf.edu
OI Nene, Aishwarya/0000-0002-5160-5080
FU California Institute for Regenerative Medicine, CIRMCalifornia Institute
   for Regenerative Medicine [TG2-01153]; K99 career development award from
   the National Institute for Neurological Disorders and Stroke
   [5K99NS088572]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NS075998, MH105989];
   CIRMCalifornia Institute for Regenerative Medicine [GCIR-06673]
FX The authors are grateful to Joseph Loturco, Catherine Priest, Haim
   Belinson, Carmen Sandoval Espinosa, and members of the A.R.K. and A.W.B.
   labs for helpful feedback on the manuscript. We thank Melanie Bedolli,
   Lillian Adame, and Yinging Wang for technical support. M.B. was
   supported by a postdoctoral fellowship from the California Institute for
   Regenerative Medicine, CIRM (Grant TG2-01153), and a K99 career
   development award from the National Institute for Neurological Disorders
   and Stroke (Grant 5K99NS088572). This research was funded by NIH Grants
   NS075998 and MH105989 and CIRM Award GCIR-06673 (to A.R.K.).
CR ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56
   BARKOVICH AJ, 1991, ANN NEUROL, V30, P139, DOI 10.1002/ana.410300204
   Bershteyn M, 2014, NATURE, V507, P99, DOI 10.1038/nature12923
   Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032
   Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320
   CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109
   Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147
   DOBYNS WB, 1983, J PEDIATR-US, V102, P552, DOI 10.1016/S0022-3476(83)80183-8
   DOBYNS WB, 1991, AM J HUM GENET, V48, P584
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020
   Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571
   Gambello MJ, 2003, J NEUROSCI, V23, P1719
   Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287
   Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895
   Gertz CC, 2015, J NEUROSCI, V35, P14307, DOI 10.1523/JNEUROSCI.2198-15.2015
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   HANSEN PE, 1993, RADIOGRAPHICS, V13, P21, DOI 10.1148/radiographics.13.1.8426929
   HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0
   Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004
   Hevner RF, 2012, CEREB CORTEX, V22, P465, DOI 10.1093/cercor/bhr336
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hirotsune S, 1998, NAT GENET, V19, P333
   Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086
   Kreitzer FR, 2013, AM J STEM CELLS, V2, P119
   LaMonica BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2647
   Lanari M, 2012, EARLY HUM DEV, V88, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   LEDBETTER SA, 1992, AM J HUM GENET, V50, P182
   Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006
   LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032
   MARTIN E, 1988, J COMPUT ASSIST TOMO, V12, P917, DOI 10.1097/00004728-198811000-00002
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030
   Moon HM, 2014, HUM MOL GENET, V23, P449, DOI 10.1093/hmg/ddt436
   Nagamani SCS, 2009, J MED GENET, V46, P825, DOI 10.1136/jmg.2009.067637
   Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Ostrem BEL, 2014, CELL REP, V8, P656, DOI 10.1016/j.celrep.2014.06.058
   Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]
   Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144
   Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007
   Pilz DT, 1998, GENET MED, V1, P29
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238
   REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0
   Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sheen VL, 2006, ACTA NEUROPATHOL, V111, P489, DOI 10.1007/s00401-005-0010-3
   Sheen VL, 2006, ANN NEUROL, V60, P137, DOI 10.1002/ana.20843
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011
   Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030
   SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3
   Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527
   Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37
   Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000
   Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169
   Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807
   Xie YL, 2013, NEURON, V79, P254, DOI 10.1016/j.neuron.2013.05.027
   Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026
   Youn YH, 2009, J NEUROSCI, V29, P15520, DOI 10.1523/JNEUROSCI.4630-09.2009
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 87
TC 140
Z9 144
U1 3
U2 55
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD APR 6
PY 2017
VL 20
IS 4
BP 435
EP +
DI 10.1016/j.stem.2016.12.007
PG 19
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EQ8QO
UT WOS:000398350800009
PM 28111201
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Lucey, D
   Cummins, H
   Sholts, S
AF Lucey, Daniel
   Cummins, Hannah
   Sholts, Sabrina
TI Congenital Zika Syndrome in 2017
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID VIRUS-INFECTION; INFANTS; BIRTH
C1 [Lucey, Daniel] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.
   [Lucey, Daniel; Sholts, Sabrina] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA.
   [Cummins, Hannah] Georgetown Univ, Dept Int Hlth, Washington, DC USA.
RP Lucey, D (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.
EM drl23@georgetown.edu
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Honein MA, 2016, NEW ENGL J MED, V375, P2393, DOI 10.1056/NEJMe1613368
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Ruddiman WF, 2015, SCIENCE, V348, P38, DOI 10.1126/science.aaa7297
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1
NR 8
TC 16
Z9 18
U1 0
U2 6
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD APR 4
PY 2017
VL 317
IS 13
BP 1368
EP 1369
DI 10.1001/jama.2017.1553
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EQ9VR
UT WOS:000398434200021
PM 28384812
DA 2020-07-08
ER

PT J
AU Fernandez-Sanles, A
   Rios-Marco, P
   Romero-Lopez, C
   Berzal-Herranz, A
AF Fernandez-Sanles, Alba
   Rios-Marco, Pablo
   Romero-Lopez, Cristina
   Berzal-Herranz, Alfredo
TI Functional Information Stored in the Conserved Structural RNA Domains of
   Flavivirus Genomes
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE flavivirus RNA genome; functional RNA domains; RNA-RNA interactions; RNA
   structure/function; DENV; WNV
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; 3'
   UNTRANSLATED REGION; TICK-BORNE FLAVIVIRUSES; INSECT-SPECIFIC
   FLAVIVIRUSES; SECONDARY STRUCTURE-ANALYSIS; TRACT-BINDING PROTEIN; SMALL
   INTERFERING RNA; STEM-LOOP STRUCTURE
AB The genus Flavivirus comprises a large number of small, positive-sense single-stranded, RNA viruses able to replicate in the cytoplasm of certain arthropod and/or vertebrate host cells. The genus, which has some 70 member species, includes a number of emerging and re-emerging pathogens responsible for outbreaks of human disease around the world, such as the West Nile, dengue, Zika, yellow fever, Japanese encephalitis, St. Louis encephalitis, and tick-borne encephalitis viruses. Like other RNA viruses, flaviviruses have a compact RNA genome that efficiently stores all the information required for the completion of the infectious cycle. The efficiency of this storage system is attributable to supracoding elements, i.e., discrete, structural units with essential functions. This information storage system overlaps and complements the protein coding sequence and is highly conserved across the genus. It therefore offers interesting potential targets for novel therapeutic strategies. This review summarizes our knowledge of the features of flavivirus genome functional RNA domains. It also provides a brief overview of the main achievements reported in the design of antiviral nucleic acid-based drugs targeting functional genomic RNA elements.
C1 [Fernandez-Sanles, Alba; Rios-Marco, Pablo; Romero-Lopez, Cristina; Berzal-Herranz, Alfredo] CSIC, IPBLN, Dept Mol Biol, Granada, Spain.
RP Fernandez-Sanles, A (corresponding author), CSIC, IPBLN, Dept Mol Biol, Granada, Spain.
EM aberzalh@ipb.csic.es
RI Berzal-Herranz, Alfredo/K-8614-2014
OI Berzal-Herranz, Alfredo/0000-0003-3722-7973
FU Spanish Ministerio de Economa y Competitividad [BFU2012-31213,
   BFU201564359-P]; Consejeria de Economia Innovacion, Ciencia y Empleo,
   Junta de Andalucia [CVI-7430]; FEDER funds from the EUEuropean Union
   (EU)
FX Work in our laboratory is supported by the Spanish Ministerio de Economa
   y Competitividad (BFU2012-31213 and BFU201564359-P) and the Consejeria
   de Economia Innovacion, Ciencia y Empleo, Junta de Andalucia (CVI-7430).
   It is also partially funded by FEDER funds from the EU.
CR ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Anthony KG, 2009, ANTIVIR RES, V82, P166, DOI 10.1016/j.antiviral.2008.12.007
   Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239
   Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0
   Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507
   Basu M, 2011, VIROLOGY, V412, P220, DOI 10.1016/j.virol.2011.01.008
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bogachek MV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P472, DOI 10.1134/S0006297910040115
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   Brinton MA, 2001, ANN NY ACAD SCI, V951, P207
   Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654
   BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Bryant JE, 2005, J VIROL, V79, P3807, DOI 10.1128/JVI.79.6.3807-3821.2005
   CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052
   CASTLE E, 1987, ARCH VIROL, V92, P309, DOI 10.1007/BF01317487
   CASTLE E, 1985, VIROLOGY, V145, P227, DOI 10.1016/0042-6822(85)90156-4
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Charley PA, 2016, VIRUS RES, V212, P70, DOI 10.1016/j.virusres.2015.09.009
   Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   de Lamballerie X, 2002, J GEN VIROL, V83, P2443, DOI 10.1099/0022-1317-83-10-2443
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   Deas TS, 2007, ANTIMICROB AGENTS CH, V51, P2470, DOI 10.1128/AAC.00069-07
   Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005
   Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040
   Dong YC, 2015, INT J MOL MED, V35, P1683, DOI 10.3892/ijmm.2015.2169
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799
   Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Fernandez-Sanles A, 2015, MOLECULES, V20, P16030, DOI 10.3390/molecules200916030
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024
   Geiss BJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-53
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gritsun DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092056
   Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Gritsun TS, 1997, VIRUS RES, V49, P27, DOI 10.1016/S0168-1702(97)01451-2
   Groat-Carmona AM, 2012, VIROLOGY, V432, P511, DOI 10.1016/j.virol.2012.06.028
   Haasnoot Joost, 2009, V189, P243, DOI 10.1007/978-3-540-79086-0_9
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0
   Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004
   Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10
   Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kim SM, 2006, VIRUS RES, V115, P131, DOI 10.1016/j.virusres.2005.07.013
   Kofler RM, 2006, J VIROL, V80, P4099, DOI 10.1128/JVI.80.8.4099-4113.2006
   KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Leyssen P, 2002, VIROLOGY, V293, P125, DOI 10.1006/viro.2001.1241
   Li C, 2014, VIROLOGY, V449, P70, DOI 10.1016/j.virol.2013.11.008
   Li C, 2013, ANTIVIR RES, V100, P487, DOI 10.1016/j.antiviral.2013.09.002
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Li W, 2001, VIROLOGY, V287, P49, DOI 10.1006/viro.2001.1015
   Li XF, 2010, J GEN VIROL, V91, P1218, DOI 10.1099/vir.0.013854-0
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   MANDL CW, 1991, J VIROL, V65, P4070, DOI 10.1128/JVI.65.8.4070-4077.1991
   MANDL CW, 1993, VIROLOGY, V194, P173, DOI 10.1006/viro.1993.1247
   Mangada MNM, 1997, VIRUS GENES, V14, P5, DOI 10.1023/A:1007914520454
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Marton S, 2013, J VIRAL HEPATITIS, V20, P103, DOI 10.1111/j.1365-2893.2012.01629.x
   Marton S, 2012, PHARMACEUTICALS, V5, P49, DOI 10.3390/ph5010049
   McCown M, 2003, VIROLOGY, V313, P514, DOI 10.1016/S0042-6822(03)00341-6
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   NOWAK T, 1989, VIROLOGY, V169, P365, DOI 10.1016/0042-6822(89)90162-1
   Olsthoorn RCL, 2001, RNA, V7, P1370
   Ong SP, 2008, VIRUS RES, V135, P292, DOI 10.1016/j.virusres.2008.04.014
   Ong SP, 2006, ANTIVIR RES, V72, P216, DOI 10.1016/j.antiviral.2006.06.005
   Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08
   Proutski V, 1999, VIRUS RES, V64, P107, DOI 10.1016/S0168-1702(99)00079-9
   Pybus OG, 2002, SYST BIOL, V51, P881, DOI 10.1080/10635150290155881
   RAVIPRAKASH K, 1995, J VIROL, V69, P69, DOI 10.1128/JVI.69.1.69-74.1995
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Romero-Lopez C, 2013, REV MED VIROL, V23, P340, DOI 10.1002/rmv.1756
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Rouha H, 2011, VIROLOGY, V417, P79, DOI 10.1016/j.virol.2011.05.008
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Sanchez-Luque FJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06242
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schrauf S, 2009, J VIROL, V83, P11201, DOI 10.1128/JVI.01025-09
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   SCHUSTER P, 1993, ORIGINS LIFE EVOL B, V23, P373, DOI 10.1007/BF01582087
   Shi PY, 1996, BIOCHEMISTRY-US, V35, P4222, DOI 10.1021/bi952398v
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Silva RLA, 2008, VIRUS RES, V135, P320, DOI 10.1016/j.virusres.2008.03.007
   Song BH, 2008, RNA, V14, P1791, DOI 10.1261/rna.993608
   Suzuki R, 2008, J VIROL, V82, P6942, DOI 10.1128/JVI.00662-08
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Ta M, 2000, J VIROL, V74, P5108, DOI 10.1128/JVI.74.11.5108-5115.2000
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022
   Tsetsarkin KA, 2016, NUCLEIC ACIDS RES, V44, P3330, DOI 10.1093/nar/gkw061
   Tuplin A, 2011, NUCLEIC ACIDS RES, V39, P7034, DOI 10.1093/nar/gkr237
   Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23
   Vashist S, 2009, J GEN VIROL, V90, P1343, DOI 10.1099/vir.0.010850-0
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2013, J VIROL, V87, P9365, DOI 10.1128/JVI.00567-13
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Wei Y, 2009, AM J TROP MED HYG, V81, P817, DOI 10.4269/ajtmh.2009.08-0595
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1981, VIROLOGY, V113, P544, DOI 10.1016/0042-6822(81)90182-3
   WENGLER G, 1986, J GEN VIROL, V67, P1183, DOI 10.1099/0022-1317-67-6-1183
   WENGLER G, 1985, VIROLOGY, V147, P264, DOI 10.1016/0042-6822(85)90129-1
   Yang YB, 2008, J MED VIROL, V80, P930, DOI 10.1002/jmv.21164
   You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
   Zhang B, 2008, VIROLOGY, V382, P98, DOI 10.1016/j.virol.2008.08.044
   Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 159
TC 22
Z9 21
U1 0
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 3
PY 2017
VL 8
AR 546
DI 10.3389/fmicb.2017.00546
PG 16
WC Microbiology
SC Microbiology
GA EQ9VL
UT WOS:000398433500002
PM 28421048
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Duan, WQ
   Song, H
   Wang, HY
   Chai, Y
   Su, C
   Qi, JX
   Shi, Y
   Gao, GF
AF Duan, Wenqian
   Song, Hao
   Wang, Haiyuan
   Chai, Yan
   Su, Chao
   Qi, Jianxun
   Shi, Yi
   Gao, George F.
TI The crystal structure of Zika virus NS5 reveals conserved drug targets
SO EMBO JOURNAL
LA English
DT Article
DE crystal structure; methyltransferase; polymerase; RNA capping; Zika
   virus
ID DEPENDENT RNA-POLYMERASE; MALE SEXUAL TRANSMISSION; METHYLTRANSFERASE
   DOMAIN; MOLECULAR-BASIS; FLAVIVIRUS; CAP; RECOGNITION; METHYLATION;
   INHIBITION; HELICASE
AB Zika virus (ZIKV) has emerged as major health concern, as ZIKV infection has been shown to be associated with microcephaly, severe neurological disease and possibly male sterility. As the largest protein component within the ZIKV replication complex, NS5 plays key roles in the life cycle and survival of the virus through its N-terminal methyltransferase (MTase) and C-terminal RNA-dependent RNA polymerase (RdRp) domains. Here, we present the crystal structures of ZIKV NS5 MTase in complex with an RNA cap analogue (m7GpppA) and the free NS5 RdRp. We have identified the conserved features of ZIKV NS5 MTase and RdRp structures that could lead to development of current antiviral inhibitors being used against flaviviruses, including dengue virus and West Nile virus, to treat ZIKV infection. These results should inform and accelerate the structure-based design of antiviral compounds against ZIKV.
C1 [Duan, Wenqian; Wang, Haiyuan; Chai, Yan; Su, Chao; Qi, Jianxun; Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Duan, Wenqian; Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Song, Hao; Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.
   [Wang, Haiyuan] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Peoples R China.
   [Su, Chao] China Agr Univ, Coll Vet Med, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
EM shiyi@im.ac.cn; gaof@im.ac.cn
FU Emergency Task-Force Project of the National Natural Science Foundation
   of China (NSFC)National Natural Science Foundation of China [81641001];
   China Ministry of Science and Technology National 973 Project
   [2014CB542503]; Task-Force of ZIKV Research from the Chinese Academy of
   Sciences (CAS); National Key Plan for Scientific Research and
   Development of China [2016YFD0500300, 2016YFC1200305]; Zika Special
   Project of the Ministry of Science and Technology Reform and Development
   Project; Strategic Priority Research Program of CAS [XDB08020100];
   External Cooperation Program of CAS [153211KYSB20160001]; Excellent
   Young Scientist Program from NSFC [81622031]; Excellent Young Scientist
   Program of CAS; Youth Innovation Promotion Association CAS [2015078,
   2017117]; NSFC Innovative Research Group Grant [81621091]
FX This work was supported by the Emergency Task-Force Project (Grant No.
   81641001) of the National Natural Science Foundation of China (NSFC),
   the China Ministry of Science and Technology National 973 Project (Grant
   No. 2014CB542503), the Task-Force of ZIKV Research from the Chinese
   Academy of Sciences (CAS), the National Key Plan for Scientific Research
   and Development of China (2016YFD0500300 and 2016YFC1200305), Zika
   Special Project of the Ministry of Science and Technology Reform and
   Development Project and Strategic Priority Research Program of CAS
   (XDB08020100). This work is also supported in part by the External
   Cooperation Program of CAS (153211KYSB20160001). We thank the staff of
   BL17U beamline at SSRF and BL19U1 beamline at SSRF for assistance during
   data collection. Y.S. is supported by the Excellent Young Scientist
   Program from the NSFC (No. 81622031), the Excellent Young Scientist
   Program of CAS and the Youth Innovation Promotion Association CAS
   (2015078). H.S. is supported by the Youth Innovation Promotion
   Association CAS (2017117). G.F.G. is supported partly as a leading
   principal investigator of the NSFC Innovative Research Group (Grant No.
   81621091).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Bollati M, 2009, BIOCHEM BIOPH RES CO, V382, P200, DOI 10.1016/j.bbrc.2009.03.008
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Debreczeni JE, 2012, ACTA CRYSTALLOGR D, V68, P425, DOI 10.1107/S0907444912000200
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Jansson AM, 2009, ACTA CRYSTALLOGR D, V65, P796, DOI 10.1107/S0907444909017260
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mastrangelo E, 2007, PROTEIN SCI, V16, P1133, DOI 10.1110/ps.072758107
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Smietanski M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4004
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05
   Varshney D, 2016, NUCLEIC ACIDS RES, V44, P10423, DOI 10.1093/nar/gkw637
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 59
TC 44
Z9 47
U1 5
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD APR 3
PY 2017
VL 36
IS 7
BP 919
EP 933
DI 10.15252/embj.201696241
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EQ5XI
UT WOS:000398156000009
PM 28254839
OA Green Published
DA 2020-07-08
ER

PT J
AU Bekerman, E
   Neveu, G
   Shulla, A
   Brannan, J
   Pu, SY
   Wang, S
   Xiao, F
   Barouch-Bentov, R
   Bakken, RR
   Mateo, R
   Govero, J
   Nagamine, CM
   Diamond, MS
   De Jonghe, S
   Herdewijn, P
   Dye, JM
   Randall, G
   Einav, S
AF Bekerman, Elena
   Neveu, Gregory
   Shulla, Ana
   Brannan, Jennifer
   Pu, Szu-Yuan
   Wang, Stanley
   Xiao, Fei
   Barouch-Bentov, Rina
   Bakken, Russell R.
   Mateo, Roberto
   Govero, Jennifer
   Nagamine, Claude M.
   Diamond, Michael S.
   De Jonghe, Steven
   Herdewijn, Piet
   Dye, John M.
   Randall, Glenn
   Einav, Shirit
TI Anticancer kinase inhibitors impair intracellular viral trafficking and
   exert broad-spectrum antiviral effects
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID HEPATITIS-C-VIRUS; CELL LUNG-CANCER; CLATHRIN-MEDIATED ENDOCYTOSIS;
   SUNITINIB PLUS ERLOTINIB; DENGUE VIRUS; TYROSINE KINASE; ZIKA VIRUS;
   SORTING SIGNALS; ANTITUMOR-ACTIVITY; CROSS-REACTIVITY
AB Global health is threatened by emerging viral infections, which largely lack effective vaccines or therapies. Targeting host pathways that are exploited by multiple viruses could offer broad-spectrum solutions. We previously reported that AAK1 and GAK, kinase regulators of the host adaptor proteins AP1 and AP2, are essential for hepatitis C virus (HCV) infection, but the underlying mechanism and relevance to other viruses or in vivo infections remained unknown. Here, we have discovered that AP1 and AP2 cotraffic with HCV particles in live cells. Moreover, we found that multiple viruses, including dengue and Ebola, exploit AAK1 and GAK during entry and infectious virus production. In cultured cells, treatment with sunitinib and erlotinib, approved anticancer drugs that inhibit AAK1 or GAK activity, or with more selective compounds inhibited intracellular trafficking of HCV and multiple unrelated RNA viruses with a high barrier to resistance. In murine models of dengue and Ebola infection, sunitinib/erlotinib combination protected against morbidity and mortality. We validated sunitinib-and erlotinib-mediated inhibition of AAK1 and GAK activity as an important mechanism of antiviral action. Additionally, we revealed potential roles for additional kinase targets. These findings advance our understanding of virus-host interactions and establish a proof of principle for a repurposed, host-targeted approach to combat emerging viruses.
C1 [Bekerman, Elena; Neveu, Gregory; Pu, Szu-Yuan; Wang, Stanley; Xiao, Fei; Barouch-Bentov, Rina; Einav, Shirit] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA.
   [Bekerman, Elena; Neveu, Gregory; Pu, Szu-Yuan; Wang, Stanley; Xiao, Fei; Barouch-Bentov, Rina; Einav, Shirit] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA.
   [Shulla, Ana; Randall, Glenn] Univ Chicago, Dept Microbiol, Chicago, IL USA.
   [Brannan, Jennifer; Bakken, Russell R.; Dye, John M.] Viral Immunol Branch, US Army Med Res Inst Infect Dis, Ft Detrick, MD USA.
   [Mateo, Roberto] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA.
   [Mateo, Roberto] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA.
   [Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med Mol Microbiol, St Louis, MO USA.
   [Govero, Jennifer] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Nagamine, Claude M.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA USA.
   [Herdewijn, Piet] Katholieke Univ Leuven, Lab Med Chem Rega Inst Med Res, Leuven, Belgium.
RP Einav, S (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA.
EM seinav@stanford.edu
RI Diamond, Michael/AAH-1733-2019; Xiao, Fei/E-7133-2013; Pu,
   Szu-Yuan/G-5546-2013
OI Diamond, Michael/0000-0002-8791-3165; Xiao, Fei/0000-0001-7353-2700;
   Neveu, Gregory/0000-0002-2363-6031; Pu, Szu-Yuan/0000-0002-9805-6357;
   Dye, John/0000-0002-0883-5016; Herdewijn, Piet/0000-0003-3589-8503
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [1U19 AI10966201]; NIAIDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [U19
   AI083019]; American Cancer SocietyAmerican Cancer Society
   [RSG-14-110-01-MPC]; Stanford Bio-X; Stanford SPARK program; Stanford
   Translational Research and Applied Medicine program; Doris Duke
   Charitable FoundationDoris Duke Charitable Foundation (DDCF) [2013100];
   Department of Defense office of the Congressionally Directed Medical
   Research ProgramsUnited States Department of Defense [PR151090]; Child
   Health Research Institute; Lucile Packard Foundation for Children's
   Health; Stanford Clinical and Translational Science Award (CTSA)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS) [UL1 TR000093]; Taiwan Ministry of Science and
   Technology [103-2917-I-564-033]; Joint Science and Technology
   Office-Defense Threat Reduction AgencyUnited States Department of
   DefenseDefense Threat Reduction Agency [CB3958]; CTSAUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1 TR001085]
FX This work was supported by award 1U19 AI10966201 (Centers of Excellence
   for Translational Research) from the National Institute of Allergy and
   Infectious Diseases (NIAID) to SE, NIAID U19 AI083019 to MSD, grant
   RSG-14-110-01-MPC from the American Cancer Society to SE and GR, and
   grants from Stanford Bio-X, the Stanford SPARK program, and the Stanford
   Translational Research and Applied Medicine program. In vitro studies
   were also supported by grant 2013100 from the Doris Duke Charitable
   Foundation and grant PR151090 from the Department of Defense office of
   the Congressionally Directed Medical Research Programs. GN was supported
   by the Child Health Research Institute, Lucile Packard Foundation for
   Children's Health, as well as the Stanford Clinical and Translational
   Science Award (CTSA, grant UL1 TR000093). SYP was supported by Taiwan
   Ministry of Science and Technology grant 103-2917-I-564-033. JMD's work
   acknowledges the support of the Joint Science and Technology
   Office-Defense Threat Reduction Agency (CB3958) in completion of the
   live virus experiments. The opinions, interpretations, conclusions, and
   recommendations are those of the authors and are not necessarily
   endorsed by the US Army or the other funders. We thank Scott Weaver and
   Robert Tesh for the ZIKV (MR766), Mark N. Prichard for providing the
   Mac-Synergy II program, Kartik Chandran for the rVSV-GP EBOV construct,
   Eva Harris and Karla Kirkegaard for assistance with establishing dengue
   tissue culture and mouse models in our laboratory, and Alex McMillan
   (with support from CTSA UL1 TR001085) for assistance with the
   statistical analysis.
CR Agrawal T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01813
   Alconada A, 1996, EMBO J, V15, P6096, DOI 10.1002/j.1460-2075.1996.tb00998.x
   Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Benedicto I, 2015, J VIROL, V89, P4180, DOI 10.1128/JVI.03620-14
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharyya S, 2012, VIRUSES-BASEL, V4, P3647, DOI 10.3390/v4123647
   Bhattacharyya S, 2011, VIROLOGY, V419, P1, DOI 10.1016/j.virol.2011.07.018
   Blumenschein GR, 2012, J THORAC ONCOL, V7, P1406, DOI 10.1097/JTO.0b013e31825cca1c
   Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656
   Chee ELC, 2016, EUR J DRUG METAB PH, V41, P309, DOI 10.1007/s13318-015-0264-7
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466
   Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123
   Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dutta D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003510
   Fingerhut A, 2001, J BIOL CHEM, V276, P5476, DOI 10.1074/jbc.M009516200
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Ghosh P, 2003, J CELL BIOL, V160, P699, DOI 10.1083/jcb.200211080
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haznedar JO, 2009, CANCER CHEMOTH PHARM, V64, P691, DOI 10.1007/s00280-008-0917-1
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12
   Humphries AC, 2012, CELL HOST MICROBE, V12, P346, DOI 10.1016/j.chom.2012.08.002
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358
   Karthik R, 2014, INT J CURR RES, V6, P11040
   Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787
   Kostich W, 2016, J PHARMACOL EXP THER, V358, P371, DOI 10.1124/jpet.116.235333
   Kovackova S, 2015, J MED CHEM, V58, P3393, DOI 10.1021/jm501759m
   Lee DW, 2005, J CELL SCI, V118, P4311, DOI 10.1242/jcs.02548
   Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mendel DB, 2003, CLIN CANCER RES, V9, P327
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Neveu G, 2015, J VIROL, V89, P4387, DOI 10.1128/JVI.02705-14
   Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohka S, 2001, BIOCHEM BIOPH RES CO, V287, P941, DOI 10.1006/bbrc.2001.5660
   Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839
   Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069
   Poirier S, 2013, TRAFFIC, V14, P458, DOI 10.1111/tra.12046
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Prichard M N, 1996, Antivir Ther, V1, P9
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068
   Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055
   Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604
   Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Sorensen EB, 2008, TRAFFIC, V9, P1791, DOI 10.1111/j.1600-0854.2008.00790.x
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006
   Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Wacker I, 1997, J CELL SCI, V110, P1453
   Yang CC, 2013, ANTIVIR RES, V98, P228, DOI 10.1016/j.antiviral.2013.03.001
   Zerbe LK, 2008, CANCER CHEMOTH PHARM, V62, P605, DOI 10.1007/s00280-007-0644-z
   Zhang CX, 2005, TRAFFIC, V6, P1103, DOI 10.1111/j.1600-0854.2005.00346.x
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 71
TC 46
Z9 46
U1 2
U2 21
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD APR 3
PY 2017
VL 127
IS 4
BP 1338
EP 1352
DI 10.1172/JCI89857
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ6HV
UT WOS:000398183300024
PM 28240606
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Kim, S
   Zhao, J
   Liu, XY
   Lin, L
   Zhang, X
   Zhang, FM
   Linhardt, R
AF Kim, So
   Zhao, Jing
   Liu, Xinyue
   Lin, Lei
   Zhang, Xing
   Zhang, Fuming
   Linhardt, Robert
TI Host cell entry of Zika virus may be mediated by glycosaminoglycans
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes
CY APR 02-06, 2017
CL San Francisco, CA
SP Amer Chem Soc
C1 [Kim, So; Zhao, Jing; Liu, Xinyue; Lin, Lei; Zhang, Xing] Rensselaer Polytech Inst, Troy, NY USA.
   [Linhardt, Robert] Rensselaer Polytech Inst, Chem, Albany, NY USA.
   [Zhang, Fuming] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Watervliet, NY USA.
EM pigey.togepi.kimmie@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 2
PY 2017
VL 253
MA 299
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD5TC
UT WOS:000430568501065
DA 2020-07-08
ER

PT J
AU Nguyen, J
   Rascon, A
AF Nguyen, James
   Rascon, Alberto
TI In vitro biochemical studies of the midgut serine protease AaSPVII of
   the Zika vector Aedes aegypti
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes
CY APR 02-06, 2017
CL San Francisco, CA
SP Amer Chem Soc
C1 [Nguyen, James; Rascon, Alberto] San Jose State Univ, Chem, San Jose, CA 95192 USA.
EM james.t.nguyen91@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 2
PY 2017
VL 253
MA 137
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD5TC
UT WOS:000430568500890
DA 2020-07-08
ER

PT J
AU Rivera, M
   Sirimulla, S
AF Rivera, Miguel
   Sirimulla, Suman
TI Identification of ZIKA virus inhibitors using insilico screening
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 253rd National Meeting of the American-Chemical-Society (ACS) on
   Advanced Materials, Technologies, Systems, and Processes
CY APR 02-06, 2017
CL San Francisco, CA
SP Amer Chem Soc
C1 [Rivera, Miguel; Sirimulla, Suman] Univ Texas El Paso, Pharm, El Paso, TX 79968 USA.
EM mrivera20@miners.utep.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 2
PY 2017
VL 253
MA 360
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD5TC
UT WOS:000430568507440
DA 2020-07-08
ER

PT J
AU Cheyney, M
   Horan, H
AF Cheyney, Melissa
   Horan, Holly
TI Zika, Maternal Stress and Prematurity in Puerto Rico: Navigating
   Unforeseen Vulnerabilities
SO AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
LA English
DT Meeting Abstract
CT 86th Annual Meeting of the
   American-Association-of-Physical-Anthropologists (AAPA)
CY APR 19-22, 2017
CL New Orleans, LA
C1 [Cheyney, Melissa; Horan, Holly] Oregon State Univ, Anthropol, Corvallis, OR 97331 USA.
FU National Science FoundationNational Science Foundation (NSF) [1628643]
FX This project is funded by the National Science Foundation (Award ID
   1628643).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-9483
EI 1096-8644
J9 AM J PHYS ANTHROPOL
JI Am. J. Phys. Anthropol.
PD APR
PY 2017
VL 162
SU 64
BP 141
EP 142
PG 2
WC Anthropology; Evolutionary Biology
SC Anthropology; Evolutionary Biology
GA FT3QT
UT WOS:000423063102152
DA 2020-07-08
ER

PT J
AU Blish, C
AF Blish, C.
TI Zika virus infection induces cranial neural crest cells to produce
   cytokines at levels detrimental for neurogenesis
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Blish, C.] Stanford Univ, Stanford Sch Med, Stanford Immunol, Stanford, CA 94305 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2017
VL 12
SU 1
BP S9
EP S10
PG 2
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA FL4UT
UT WOS:000414227700005
DA 2020-07-08
ER

PT J
AU Huang, Y
   Li, Y
   Zhang, H
   Jing, R
   Xu, Y
   Zhao, R
   He, M
   Peer, J
   Zheng, J
AF Huang, Y.
   Li, Y.
   Zhang, H.
   Jing, R.
   Xu, Y.
   Zhao, R.
   He, M.
   Peer, J.
   Zheng, J.
TI Inhibition of extracellular vesicle biogenesis halts productive Zika
   virus infection in human fetal astrocytes
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Huang, Y.; Li, Y.; Zhang, H.; Jing, R.; Xu, Y.; Zhao, R.; He, M.; Peer, J.; Zheng, J.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [2R56NS041858-15A1,
   1R01NS097195-01, R03 NS094071-01]
FX Supported by National Institutes of Health: 2R56NS041858-15A1 (JZ),
   1R01NS097195-01 (JZ/YH), and R03 NS094071-01 (YH).
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2017
VL 12
SU 1
MA T24
BP S56
EP S56
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA FL4UT
UT WOS:000414227700133
DA 2020-07-08
ER

PT J
AU Veilleux, CA
AF Veilleux, C. A.
TI Productive Zika infection in the human brain
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Veilleux, C. A.] Rutgers State Univ, New Brunswick, NJ USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2017
VL 12
SU 1
BP S19
EP S20
PG 2
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA FL4UT
UT WOS:000414227700035
DA 2020-07-08
ER

PT J
AU Yockey, L
AF Yockey, L.
TI Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain
   Infection
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Meeting Abstract
C1 [Yockey, L.] Yale Univ, New Haven, CT USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD APR
PY 2017
VL 12
SU 1
BP S20
EP S20
PG 1
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA FL4UT
UT WOS:000414227700036
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Magnitude of Neurological Complications in Zika Virus Infected Thai
   Cases
SO ARCHIVES OF NEUROSCIENCE
LA English
DT Letter
DE Zika; Infection
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOWSAR CORP
PI TEHRAN
PA PO BOX 14155-3651, TEHRAN, 14155, IRAN
SN 2322-3944
EI 2322-5769
J9 ARCH NEUROSCI
JI Arch. Neurosci.
PD APR
PY 2017
VL 4
IS 2
AR UNSP e43675
DI 10.5812/archneurosci.43675
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA FF7RD
UT WOS:000409212800007
OA Other Gold
DA 2020-07-08
ER

PT J
AU Martinez, LE
   Contreras, D
   Jones, MK
   Gangalapudi, V
   Tang, J
   Wang, SM
   Arumugaswami, V
AF Martinez, Laura Elizabeth
   Contreras, Deisy
   Jones, Melissa Kaye
   Gangalapudi, Vineela
   Tang, Jie
   Wang, Shaomei
   Arumugaswami, Vaithilingaraja
TI Model Systems to Study the Pathogenesis of Zika Virus-Mediated Eye
   Disease
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Society-for-Pharmacology-and-Experimental-Therapeutics (ASPET)
   at Experimental Biology Meeting
CY APR 22-26, 2017
CL Chicago, IL
SP Amer Soc Pharmacol & Expt Therapeut, Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr
C1 [Martinez, Laura Elizabeth; Contreras, Deisy; Jones, Melissa Kaye; Wang, Shaomei; Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.
   [Gangalapudi, Vineela; Tang, Jie] Cedars Sinai Med Ctr, Genom Core, Los Angeles, CA 90048 USA.
FU Cedars-Sinai Medical Center
FX Cedars-Sinai Medical Center
NR 0
TC 0
Z9 0
U1 0
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2017
VL 31
SU 1
MA 658.12
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB2PU
UT WOS:000405986501234
DA 2020-07-08
ER

PT J
AU Ragan, I
   Blizzard, E
   Bowen, R
AF Ragan, Izabela
   Blizzard, Emily
   Bowen, Richard
TI Investigating the Potential Role of North American Animals as Hosts for
   Zika Virus
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Society-for-Pharmacology-and-Experimental-Therapeutics (ASPET)
   at Experimental Biology Meeting
CY APR 22-26, 2017
CL Chicago, IL
SP Amer Soc Pharmacol & Expt Therapeut, Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr
C1 [Ragan, Izabela] Kansas State Univ, Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
   [Blizzard, Emily; Bowen, Richard] Colorado State Univ, Biomed Sci, Ft Collins, CO 80523 USA.
FU Colorado State University Animal Models Core; U.S. Department of
   Homeland SecurityUnited States Department of Homeland Security (DHS)
   [DHS-2010-ST-061-AG0001]
FX This material is based upon work supported by Colorado State University
   Animal Models Core and the U.S. Department of Homeland Security under
   Grant Award Number DHS-2010-ST-061-AG0001. The views and conclusions
   contained in this document are those of the authors and should not be
   interpreted as necessarily representing the official policies, either
   expressed or implied, of the U.S. Department of Homeland Security.
NR 0
TC 0
Z9 0
U1 0
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2017
VL 31
SU 1
MA 658.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB2PU
UT WOS:000405986501239
DA 2020-07-08
ER

PT J
AU Fassler, A
   Shah, R
   Khan, H
   Shukla, A
   Schultz, K
AF Fassler, Amy
   Shah, Roma
   Khan, Haania
   Shukla, Ayush
   Schultz, Kyle
TI Host Cell-Zika Virus Interaction Determined by Envelope Protein
   Structure
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Society-for-Pharmacology-and-Experimental-Therapeutics (ASPET)
   at Experimental Biology Meeting
CY APR 22-26, 2017
CL Chicago, IL
SP Amer Soc Pharmacol & Expt Therapeut
C1 [Fassler, Amy] Sch Dist Marshfield, Sci, Marshfield, WI USA.
   [Shah, Roma; Khan, Haania; Shukla, Ayush; Schultz, Kyle] Marshfield High Sch, Marshfield, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2017
VL 31
SU 1
MA lb263
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FA5CY
UT WOS:000405461401512
DA 2020-07-08
ER

PT J
AU Grantl, F
   Arendt, N
   Ducheny, K
   Norton, M
   Ovsepyan, T
   Ruege, M
   Wildermuth, H
   Silvaggi, N
AF Grant, Fran
   Arendt, N.
   Ducheny, K.
   Norton, M.
   Ovsepyan, T.
   Ruege, M.
   Wildermuth, H.
   Silvaggi, Nicholas
TI "Buzz Off" Zika
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Society-for-Pharmacology-and-Experimental-Therapeutics (ASPET)
   at Experimental Biology Meeting
CY APR 22-26, 2017
CL Chicago, IL
SP Amer Soc Pharmacol & Expt Therapeut
C1 [Grant, Fran] Grafton High Sch, Sci, Grafton, WI USA.
   [Arendt, N.; Ducheny, K.; Norton, M.; Ovsepyan, T.; Ruege, M.; Wildermuth, H.] Grafton High Sch, Grafton, WI USA.
   [Silvaggi, Nicholas] Univ Wisconsin Milwaukee, Chem & Biochem, Milwaukee, WI USA.
FU National Institutes of of Health Science Education Partnership Award
   [NIH-SEPA 1R25OD010505-01]; National Institutes of Health Clinical and
   Translational Science AwardUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH-CTSA UL1RR031973]
FX This work was supported by the National Institutes of of Health Science
   Education Partnership Award (NIH-SEPA 1R25OD010505-01) and the National
   Institutes of Health Clinical and Translational Science Award (NIH-CTSA
   UL1RR031973).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2017
VL 31
SU 1
MA lb264
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FA5CY
UT WOS:000405461401493
DA 2020-07-08
ER

PT J
AU Zacharias, N
   Whitty, J
   Noblin, S
   Tsakiri, S
   Garcia, J
   Covinsky, M
   Bhattacharjee, M
   Saulino, D
   Tatevian, N
   Blackwell, S
AF Zacharias, Nikolaos
   Whitty, Janice
   Noblin, Sarah
   Tsakiri, Sophia
   Garcia, Jose
   Covinsky, Michael
   Bhattacharjee, Meenakshi
   Saulino, David
   Tatevian, Nina
   Blackwell, Sean
TI First Neonatal Demise with Travel-Associated Zika Virus Infection in the
   United States of America
SO AJP REPORTS
LA English
DT Article
DE Zika virus; prenatal ultrasound; fetal arthritis; Dandy-Walker
   malformation; single umbilical artery; congenital Zika virus syndrome;
   neonatal demise; prolonged maternal Zika virus seropositivity; perinatal
   universal precautions
AB Zika virus is increasingly recognized as a fetal pathogen worldwide. We describe the first case of neonatal demise with travel-associated Zika virus infection in the United States of America, including a novel prenatal ultrasound finding. A young Latina presented to our health care system in Southeast Texas for prenatal care at 23 weeks of gestation. Fetal Dandy-Walker malformation, asymmetric cerebral ventriculomegaly, single umbilical artery, hypoechoic fetal knee, dorsal foot edema, and mild polyhydramnios were noted upon initial screening prenatal sonography at 26 weeks. A growth-restricted, microcephalic, and arthrogrypotic infant was delivered alive at 36 weeks but died within an hour despite resuscitation. The neonatal karyotype was normal. Flavivirus IgM antibodies were identified in the serum of the puerpera, once she disclosed that she had traveled from El Salvador toTexas inthe early second trimester. Zika viruswas identified in theumbilical cord and neonatal brain. Fetal arthritis may precede congenital arthrogryposis in cases of Zika virus infection and may be detectable by prenatal sonography. Physician and health care system vigilance is required to optimally address the significant and enduring Zika virus global health threat.
C1 [Zacharias, Nikolaos; Whitty, Janice; Noblin, Sarah; Blackwell, Sean] UTHealth, Lyndon Baines Johnson Hosp, Div Maternal Fetal Med, Dept Obstet Gynecol & Reprod Sci,McGovern Med Sch, Houston, TX 77026 USA.
   [Tsakiri, Sophia; Garcia, Jose] UTHealth, McGovern Med Sch, Dept Pediat, Div Neonatol, Houston, TX 77026 USA.
   [Covinsky, Michael; Bhattacharjee, Meenakshi; Saulino, David; Tatevian, Nina] UTHealth, McGovern Med Sch, Dept Pathol, Houston, TX 77026 USA.
RP Zacharias, N (corresponding author), UTHealth, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med,Lyndon Baines Johnson Hosp, McGovern Med Sch,Antenatal Testing Unit,Labor & D, 5656 Kelley St, Houston, TX 77026 USA.
EM Nikolaos.M.Zacharias@uth.tmc.edu
CR Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, 2016, PREGN WOM AN LAB EV
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Gelber SE, 2017, J PERINAT MED, V45, P167, DOI 10.1515/jpm-2016-0220
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Platt L, INT SOC ULTRASOUND O
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
NR 12
TC 7
Z9 7
U1 0
U2 0
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 2157-6998
EI 2157-7005
J9 AJP REP
JI AJP Rep.
PD APR
PY 2017
VL 7
IS 2
BP 68
EP 73
DI 10.1055/s-0037-1601890
PG 6
WC Pediatrics
SC Pediatrics
GA FB8WN
UT WOS:000406420400002
PM 28413694
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McCarthy, MK
   Morrison, TE
AF McCarthy, Mary K.
   Morrison, Thomas E.
TI Persistent RNA virus infections: do PAMPS drive chronic disease?
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID WEST-NILE-VIRUS; HEPATITIS-C VIRUS; CHRONIC JOINT DISEASE; TOLL-LIKE
   RECEPTORS; EBOLA-VIRUS; CHIKUNGUNYA VIRUS; MEASLES-VIRUS; VIRAL
   PERSISTENCE; IMMUNE PRIVILEGE; SYNOVIAL TISSUE
AB Chronic disease associated with persistent RNA virus infections represents a key public health concern. While human immunodeficiency virus-1 and hepatitis C virus are perhaps the most well-known examples of persistent RNA viruses that cause chronic disease, evidence suggests that many other RNA viruses, including re-emerging viruses such as chikungunya virus, Ebola virus and Zika virus, establish persistent infections. The mechanisms by which RNA viruses drive chronic disease are poorly understood. Here, we discuss how the persistence of viral RNA may drive chronic disease manifestations via the activation of RNA sensing pathways.
C1 [McCarthy, Mary K.; Morrison, Thomas E.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Boulder, CO 80309 USA.
RP Morrison, TE (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Boulder, CO 80309 USA.
EM thomas.morrison@ucdenver.edu
FU Public Health Service grants from the National Institute of Allergy and
   Infectious Diseases [U19 AI109680, R01 AI108725, F32 AI122463]
FX The authors would like to thank Tess Tobolic for her contributions to
   the figure and Mark T. Heise for critical readings of this article. This
   work was supported by Public Health Service grants U19 AI109680 and R01
   AI108725 (T.E.M.) and F32 AI122463 (M.K.M.) from the National Institute
   of Allergy and Infectious Diseases.
CR Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543
   Baty SA, 2012, J INFECT DIS, V205, P1476, DOI 10.1093/infdis/jis221
   Bernardin F, 2007, VIROLOGY, V365, P446, DOI 10.1016/j.virol.2007.04.003
   Bokarewa M, 2008, EUR J IMMUNOL, V38, P3237, DOI 10.1002/eji.200838362
   Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Bosma TJ, 1998, J CLIN MICROBIOL, V36, P3524, DOI 10.1128/JCM.36.12.3524-3526.1998
   Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005
   Bourreau E, 2016, J INFECT DIS, V213, P105, DOI 10.1093/infdis/jiv355
   Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X
   Cantanhede LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004079
   Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939
   Cheroni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138546
   Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Deen GF, 2015, N ENGL J MED
   Eren RO, 2016, CELL HOST MICROBE, V2016, P1
   Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477
   Estripeaut D, 2008, J INFECT DIS, V198, P1435, DOI 10.1086/592714
   FRASER JRE, 1983, J CLIN PATHOL, V36, P1256, DOI 10.1136/jcp.36.11.1256
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gerardin P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-5
   Gibney KB, 2011, J INFECT DIS, V203, P344, DOI 10.1093/infdis/jiq057
   Govero J, 2016, NATURE, P1
   Griffin DE, 2014, MEASLES VIRUS NERVOU, V123
   Halsey ES, 2013, EMERG INFECT DIS J, V19
   Hartley MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005852
   Hartley MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00099
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Hawman DW, 2016, CELL CYCLE GEORGETOW, V2016, P1
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Howlett P, 2016, EMERG INFECT DIS, V22, P150, DOI 10.3201/eid2201.151212
   Hunt L, 2016, LANCET INFECT DIS, V16, P270, DOI 10.1016/S1473-3099(15)00546-0
   Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Jin L, 2002, J NEUROVIROL, V8, P335, DOI 10.1080/13550280290100752
   Joosten LAB, 2016, NAT REV RHEUMATOL, V12, P344, DOI 10.1038/nrrheum.2016.61
   Kiwanuka N, 1999, CLIN INFECT DIS, V29, P1243, DOI 10.1086/313462
   Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156
   Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35
   Kurkela S, 2005, J INFECT DIS, V191, P1820, DOI 10.1086/430007
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lin WHW, 2012, P NATL ACAD SCI USA, V109, P14989, DOI 10.1073/pnas.1211138109
   Lopez CB, 2014, J VIROL, V88, P8720, DOI 10.1128/JVI.00707-14
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Magnusson M, 2006, ARTHRITIS RHEUM-US, V54, P148, DOI 10.1002/art.21517
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2
   Mercado-Lopez X, 2013, VACCINE, V31, P5713, DOI 10.1016/j.vaccine.2013.09.040
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374
   Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07
   Ohtsuru S, 2013, J CLIN MICROBIOL, V51, P3645, DOI 10.1128/JCM.00676-13
   Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678
   Riddell MA, 2007, J CLIN VIROL, V39, P312, DOI 10.1016/j.jcv.2007.05.006
   Riedel F, 1997, EUR RESPIR J, V10, P639
   Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011
   SIDHU MS, 1994, VIROLOGY, V202, P631, DOI 10.1006/viro.1994.1384
   Sow MS, 2016, J INFECT DIS, V214, P1475, DOI 10.1093/infdis/jiw078
   Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224
   STREILEIN JW, 1993, CURR OPIN IMMUNOL, V5, P428, DOI 10.1016/0952-7915(93)90064-Y
   Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Tapia K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003703
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   TINGLE AJ, 1986, ANN RHEUM DIS, V45, P110, DOI 10.1136/ard.45.2.110
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   UHRLAUB JL, 2016, Patent No. 201612
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Wessely R, 1998, CIRCULATION, V98, P450, DOI 10.1161/01.CIR.98.5.450
   Wessely R, 1998, J CLIN INVEST, V102, P1444, DOI 10.1172/JCI1972
   Xiao SY, 2001, EMERG INFECT DIS, V7, P714
   Xiong DD, 2007, CIRCULATION, V115, P94, DOI 10.1161/CIRCULATIONAHA.106.631093
   Zare F, 2004, J IMMUNOL, V172, P5656, DOI 10.4049/jimmunol.172.9.5656
NR 87
TC 8
Z9 8
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2017
VL 23
BP 8
EP 15
DI 10.1016/j.coviro.2017.01.003
PG 8
WC Virology
SC Virology
GA EZ4SE
UT WOS:000404702000004
PM 28214732
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Scherwitzl, I
   Mongkolsapaja, J
   Screaton, G
AF Scherwitzl, Iris
   Mongkolsapaja, Juthathip
   Screaton, Gavin
TI Recent advances in human flavivirus vaccines
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID TETRAVALENT DENGUE VACCINE; CD8(+) T-CELLS; ANTIBODY-DEPENDENT
   ENHANCEMENT; NEUTRALIZING HUMAN-ANTIBODIES; NILE VIRUS-VACCINE; ZIKA
   VIRUS; HEALTHY-ADULTS; DNA VACCINE; PRECLINICAL EVALUATION; PROTECTIVE
   EFFICACY
AB Dengue (DENV), West Nile (WNV) and Zika (ZIKV) viruses are mosquito-transmitted flaviviruses that cause thousands of human deaths and millions of illnesses each year. In the last decades, epidemic outbreaks of all three flaviviruses emerged and caused a major health and economical problem in many parts of the world. The increasing and expanding burden of flaviviruses has highlighted the need for effective human vaccines against all three viruses. This review provides an overview of the recent progress in DENV, WNV and ZIKV vaccines development with specific focus on candidates in human clinical development.
C1 [Scherwitzl, Iris; Mongkolsapaja, Juthathip; Screaton, Gavin] Imperial Coll London, Dept Med, London W12 0NN, England.
   [Mongkolsapaja, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand.
RP Screaton, G (corresponding author), Imperial Coll London, Dept Med, London W12 0NN, England.
EM g.screaton@imperial.ac.uk
OI Screaton, Gavin/0000-0002-3549-4309
FU Medical Research Council UKMedical Research Council UK (MRC); Wellcome
   TrustWellcome Trust
FX This work was financially supported by the Medical Research Council UK
   and the Wellcome Trust (G.R.S.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Bardina SV, 2017, SCIENCE
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003
   Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CDC, 2016, W NIL VIR
   Charles A. S., 2016, PLOS CURR, V8
   Coller B. A, 2012, United States patent application, Patent No. [US20120141520A1, 20120141520]
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063
   De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179
   Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lieberman MM, 2007, VACCINE, V25, P414, DOI 10.1016/j.vaccine.2006.08.018
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Lim SK, 2016, CLIN EXP VACCINE RES, V5, P89, DOI 10.7774/cevr.2016.5.2.89
   Manoff SB, 2015, VACCINE, V33, P7126, DOI 10.1016/j.vaccine.2015.09.101
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12
   Pletnev AG, 2002, P NATL ACAD SCI USA, V99, P3036, DOI 10.1073/pnas.022652799
   Pletnev AG, 2006, VACCINE, V24, P6392, DOI 10.1016/j.vaccine.2006.06.008
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Raviprakash K, 2003, VIROLOGY, V315, P345, DOI 10.1016/S0042-6822(03)00542-7
   Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136
   Raviprakash K, 2012, HUM VACC IMMUNOTHER, V8, P1764, DOI 10.4161/hv.21806
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Rupp R, 2015, VACCINE, V33, P6351, DOI 10.1016/j.vaccine.2015.09.008
   SAGE W.H.O, 2016, SUMM APR M STRAT ADV, P1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Shrestha B, 2008, VACCINE, V26, P2020, DOI 10.1016/j.vaccine.2008.02.009
   Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Tesh RB, 2002, EMERG INFECT DIS, V8, P1392, DOI 10.3201/eid0812.020229
   Thomas SJ, 2015, VACCINE, V33, pD24, DOI 10.1016/j.vaccine.2015.05.095
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   Watts DM, 2007, VACCINE, V25, P2913, DOI 10.1016/j.vaccine.2006.08.008
   Yacoub S, 2016, F1000RESEARCH, V5
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 77
TC 26
Z9 26
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2017
VL 23
BP 95
EP 101
DI 10.1016/j.coviro.2017.04.002
PG 7
WC Virology
SC Virology
GA EZ4SE
UT WOS:000404702000016
PM 28486135
DA 2020-07-08
ER

PT J
AU Ebel, GD
AF Ebel, Gregory D.
TI Promiscuous viruses-how do viruses survive multiple unrelated hosts?
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID SUBGENOMIC FLAVIVIRUS RNA; INSECT-SPECIFIC FLAVIVIRUSES; ZIKA VIRUS;
   YELLOW-FEVER; MOSQUITOS; CELLS; INTERFERENCE; TRANSMISSION; INFECTION;
   CHIKUNGUNYA
AB Arthropod-borne viruses (arboviruses) require efficient replication in taxonomically divergent hosts in order to perpetuate in nature. This review discusses recent advances in our understanding of the phylogenetic position of arthropod borne viruses relative to insect-specific viruses, which appear to be more common and ecological requirements for successful adoption of the 'arbovirus phenotype.' Several molecular and other mechanisms that permit replication in divergent hosts are also discussed.
C1 [Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, 1690 Campus Delivery, Ft Collins, CO 80523 USA.
RP Ebel, GD (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, 1690 Campus Delivery, Ft Collins, CO 80523 USA.
EM gregory.ebel@colostate.edu
FU US National Institute of Allergy and Infectious Diseases, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI067380, AI129593, AI125996]
FX Research in the Ebel laboratory is funded by the US National Institute
   of Allergy and Infectious Diseases, National Institutes of Health, under
   grants AI067380, AI129593 and AI125996.
CR Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brackney DE, 2015, J VIROL, V89, P4035, DOI 10.1128/JVI.02612-14
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Grubaugh ND, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew033
   Grubaugh ND, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004874
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Ladner JT, 2016, CELL HOST MICROBE, V20, P357, DOI 10.1016/j.chom.2016.07.011
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liu JL, 2016, EVID-BASED COMPL ALT, DOI 10.1155/2016/9025036
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Misencik MJ, 2016, VECTOR-BORNE ZOONOT, V16, P181, DOI 10.1089/vbz.2015.1889
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Shi M, 2016, NATURE
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Troupin A, 2016, METHODS MOL BIOL, V1435, P15, DOI 10.1007/978-1-4939-3670-0_2
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
NR 41
TC 2
Z9 2
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2017
VL 23
BP 125
EP 129
DI 10.1016/j.coviro.2017.05.002
PG 5
WC Virology
SC Virology
GA EZ4SE
UT WOS:000404702000021
PM 28577474
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Canali, M
   Rivas-Morales, S
   Beutels, P
   Venturelli, C
AF Canali, Massimo
   Rivas-Morales, Stefano
   Beutels, Philippe
   Venturelli, Claudio
TI The Cost of Arbovirus Disease Prevention in Europe: Area-Wide Integrated
   Control of Tiger Mosquito, Aedes albopictus, in Emilia-Romagna, Northern
   Italy
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE cost of area-wide integrated control of arbovirus vectors; Aedes
   albopictus; tiger mosquito; chikungunya; arbovirus prevention in Europe
ID CHIKUNGUNYA OUTBREAK AREA; POPULATION-SIZE SURVEY; LA-REUNION; DALY
   LOST; EPIDEMIC; VIRUS; DENGUE; VECTOR; FRANCE; SYSTEM
AB Aedes albopictus (tiger mosquito) has become the most invasive mosquito species worldwide, in addition to being a well-known vector of diseases, with a proven capacity for the transmission of chikungunya and dengue viruses in Europe as well as the Zika virus in Africa and in laboratory settings. This research quantifies the cost that needs to be provided by public-health systems for area-wide prevention of arboviruses in Europe. This cost has been calculated by evaluating the expenditure of the plan for Aedes albopictus control set up in the Emilia-Romagna region (Northern Italy) after a chikungunya outbreak occurred in 2007. This plan involves more than 280 municipalities with a total of 4.2 million inhabitants. Public expenditure for plan implementation in 2008-2011 was examined through simple descriptive statistics. Annual expenditure was calculated to be approximately is an element of 1.3 per inhabitant, with a declining trend (from a total of is an element of 7.6 million to is an element of 5.3 million) and a significant variability at the municipality level. The preventative measures in the plan included antilarval treatments (about 75% of total expenditure), education for citizens and in schools, entomological surveillance, and emergency actions for suspected viremias. Ecological factors and the relevance of tourism showed a correlation with the territorial variability in expenditure. The median cost of one antilarval treatment in public areas was approximately is an element of 0.12 per inhabitant. Organizational aspects were also analyzed to identify possible improvements in resource use.
C1 [Canali, Massimo; Rivas-Morales, Stefano] Univ Bologna, Dept Agr & Food Sci, I-40127 Bologna, Italy.
   [Beutels, Philippe] Univ Antwerp, Vaccine & Infect Dis Inst, Fac Med & Hlth Sci, Ctr Hlth Econ Res & Modelling Infect Dis, B-2610 Antwerp, Belgium.
   [Venturelli, Claudio] Azienda Unita Sanitaria Locale Romagna Cesena, Dept Publ Hlth, I-47521 Cesena, Italy.
RP Canali, M (corresponding author), Univ Bologna, Dept Agr & Food Sci, I-40127 Bologna, Italy.
EM massimo.canali2@unibo.it; stefano.rivasmorale2@unibo.it;
   philippe.beutels@uantwerpen.be; claudio.venturelli@auslromagna.it
RI Canali, Massimo/J-8817-2016; Beutels, Philippe/A-1919-2010
OI Canali, Massimo/0000-0001-9516-681X; Beutels,
   Philippe/0000-0001-5034-3595
FU Local Health Authority "Azienda Unita Sanitaria Locale della Romagna
   (AUSL-Romagna)"; Regional Health Authority "Servizio Sanitario Regionale
   dell'Emilia-Romagna (SSR-ER)"; Entomological Working Group; Centro
   Agricoltura Ambiente-Giorgio Nicoli Srl (CAA)
FX This study received funding from the Local Health Authority "Azienda
   Unita Sanitaria Locale della Romagna (AUSL-Romagna)" and is based on
   work supported by the Regional Health Authority "Servizio Sanitario
   Regionale dell'Emilia-Romagna (SSR-ER)" in collaboration with its
   Entomological Working Group and the "Centro Agricoltura Ambiente-Giorgio
   Nicoli Srl (CAA)". Special thanks to Paola Angelini (SSR-ER) and to
   Romeo Bellini (CAA) for their precious technical advices and
   institutional support and to Federica Giovannini (CAA), Luciano Donati
   (CAA) and Carmela Matrangolo (AUSL-Romagna) for their contributions in
   collecting information and data. We are also very grateful to all the
   other members of the SSR-ER Entomological Working Group and to the
   officers of the Emilia-Romagna municipalities that kindly collaborated
   to the study. The precious support of the Antwerp Study Centre for
   Infectious Diseases (ASCID) at the University of Antwerp is also
   acknowledged.
CR Albieri A, 2010, B INSECTOL, V63, P209
   Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015
   Angelini P., 2008, Parassitologia (Rome), V50, P97
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Buhagiar Joseph A., 2009, European Mosquito Bulletin, V27, P65
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259
   Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230
   Carrieri M, 2008, J AM MOSQUITO CONTR, V24, P377, DOI 10.2987/5612.1
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Carrieri M, 2009, J AM MOSQUITO CONTR, V25, P149, DOI 10.2987/08-5852.1
   Cunze S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162116
   Estrada-Franco J. G., 1995, BIOL DIS RELATIONSHI
   European Center for Disease Prevention and Control, 2015, MOSQ MAPS AED ALB CU
   European Center for Disease Prevention and Control, EP UPD AUT CAS C HIK
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Gjenero-Margan I., 2011, EUROSURVEILLANCE, V16, P1188
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1
   HIRSHLEIFER J, 1983, PUBLIC CHOICE, V41, P371, DOI 10.1007/BF00141070
   Invasive Species Specialist Group. Global Invasive Species Database, 2017, GLOB INV SPEC DAT 20
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   La Torre G., 2009, ITAL J PUBLIC HLTH, V6, P93
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Mavalankar D, 2009, QUANTIFYING IMPACT C
   Monaghan A. J., 2016, CLIMATIC CHANGE, P1
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Perrings C, 2002, CONSERV ECOL, V6
   Perrings C., 2001, LAND USE WATER RESOU, V1, P1
   Regione Emilia-Romagna, POP ET SESS E R STAT
   Regione Emilia-Romagna, 2008, REG PLAN EM ROM REG
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Sambiri V, 2008, NEW MICROBIOL, V31, P303
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Servizio Sanitario Regionale Emilia-Romagna, 2008, STRAT INT LOTT ZANZ
   Seyler T, 2010, T ROY SOC TROP MED H, V104, P133, DOI 10.1016/j.trstmh.2009.07.014
   Shepard DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111014
   Snowden Frank M., 2006, CONQUEST MALARIA ITA
   Solet J. L., 2007, PLOS BIOL, V77, P727
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Thuilliez J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002609
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Venturelli C., 2008, Parassitologia (Rome), V50, P129
   World Health Organization Regional Office for Europe, ZIK VIR VECT RISK SP
   World Health Organization Regional Office for Europe, 2016, ZIKA VIRUS TECHN REP
NR 62
TC 6
Z9 6
U1 1
U2 12
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2017
VL 14
IS 4
AR 444
DI 10.3390/ijerph14040444
PG 22
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EY6PG
UT WOS:000404105100107
PM 28425959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mouchtouri, VA
   Papagiannis, D
   Katsioulis, A
   Rachiotis, G
   Dafopoulos, K
   Hadjichristodoulou, C
AF Mouchtouri, Varvara A.
   Papagiannis, Dimitrios
   Katsioulis, Antonios
   Rachiotis, Georgios
   Dafopoulos, Konstantinos
   Hadjichristodoulou, Christos
TI Knowledge, Attitudes, and Practices about the Prevention of Mosquito
   Bites and Zika Virus Disease in Pregnant Women in Greece
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE vector-borne infections; viral infections; pregnancy; Zika virus;
   Knowledge; Attitudes; Practice (KAP) study; pregnant; repellent
ID UNITED-STATES; OUTBREAK
AB A survey among 573 pregnant women in Greece was conducted through self-completion of a questionnaire in July 2016. Traveling abroad the last six months was declared by 10.5% and 13.0% of pregnant women and their male sex partners, respectively, while 77.4% (441/570) had heard about Zika virus disease (ZVD). A lack of knowledge about sexual transmission of ZVD was identified in 63.3% of pregnant women, and 24.1% of responders did not know the risks to the fetus and baby. Approximately 73% of responders believed that the mosquito bites can affect their fetus and baby and 18% did not take measures to prevent mosquito bites routinely. Multivariable logistic regression models showed that traveling abroad the last six months by pregnant women correlated with correctly answering the question about the transmission of ZVD through bites of infected mosquitoes (Odds Ratio, OR = 10.47, 95% CI = 1.11-98.41). Traveling abroad with a male sex partner over the last six months correlated (OR = 2.05, 95% CI = 0.99-4.23) with responding correctly to the four key questions about the transmission of ZVD through mosquito bites, the risk of microcephaly, and the risks of traveling to the affected countries. A score of similar to 5 for the nine responses given to questions of knowledge and attitudes was associated with a Bachelor of Science degree (OR = 1.54, 95% CI = 1.09-2.18), antenatal care at a public hospital (OR = 2.26, 95% CI = 1.28-3.98), being a civil servant as occupation (OR = 1.96, 95% CI = 1.10-3.48), and having gotten information about ZVD from the public health sector (OR = 2.04, 95% CI = 1.05-3.98). In conclusion, we found considerable knowledge gaps related to ZVD among Greek pregnant women. These study results are useful in targeting pregnant women for the prevention of potential Zika virus infections.
C1 [Mouchtouri, Varvara A.; Papagiannis, Dimitrios; Katsioulis, Antonios; Rachiotis, Georgios; Hadjichristodoulou, Christos] Univ Thessaly, Dept Hyg & Epidemiol, Larisa 41222, Greece.
   [Dafopoulos, Konstantinos] Univ Thessaly, Dept Obstet & Gynecol, Larisa 41222, Greece.
RP Hadjichristodoulou, C (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Larisa 41222, Greece.
EM mouchtourib@med.uth.gr; dpapajon@yahoo.gr; akatsioul@med.uth.gr;
   grachiotis@gmail.com; kdafop@yahoo.com; xhatzi@med.uth.gr
CR [Anonymous], 2016, LANCET, V388, P437
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Serrate PCF, 2016, MEDICC REV, V18, P48
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP PREP
   European Centre for Disease Prevention and Control (ECDC), 2016, ECDC POL BRIEF PREPA
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Hellenic Center for Disease Control and Prevention, ZIK VIR DIS ADV TRAV
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Patsoula E, 2006, J MED ENTOMOL, V43, P40, DOI 10.1603/0022-2585(2006)043[0040:MAMCOA]2.0.CO;2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schmitz C., 2015, LIMESURVEY OPEN SOUR
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2016, RISK COMM COMM ENG Z
NR 24
TC 21
Z9 23
U1 1
U2 5
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2017
VL 14
IS 4
AR 367
DI 10.3390/ijerph14040367
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EY6PG
UT WOS:000404105100031
PM 28362340
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, LSU
AF Lee, Lawrence Soon-U
TI Infectious diseases in Singapore and Asia: persistent challenges in a
   new era
SO SINGAPORE MEDICAL JOURNAL
LA English
DT Editorial Material
ID ACUTE RESPIRATORY SYNDROME; PULMONARY-FUNCTION; SURVIVORS; HEALTH; ZIKA
C1 [Lee, Lawrence Soon-U] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Lee, Lawrence Soon-U] Natl Univ Hlth Syst, Dept Med, NUHS Tower Block Level 10,1E Kent Ridge Rd, Singapore 119228, Singapore.
RP Lee, LSU (corresponding author), Natl Univ Hlth Syst, Dept Med, NUHS Tower Block Level 10,1E Kent Ridge Rd, Singapore 119228, Singapore.
EM lawrence_lee@nuhs.edu.sg
CR Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426
   Kawano Y, 2017, SINGAP MED J, V58, P196, DOI 10.11622/smedj.2016113
   Kwek SK, 2006, J PSYCHOSOM RES, V60, P513, DOI 10.1016/j.jpsychores.2005.08.020
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Leow MKS, 2005, CLIN ENDOCRINOL, V63, P197, DOI 10.1111/j.1365-2265.2005.02325.x
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Lysaght T, 2016, SINGAP MED J, V57, P528, DOI 10.11622/smedj.2016161
   Ong KC, 2005, CHEST, V128, P1393, DOI 10.1378/chest.128.3.1393
   Ong KC, 2004, EUR RESPIR J, V24, P436, DOI 10.1183/09031936.04.00007104
   Thong WY, 2017, SINGAP MED J, V58, P189, DOI 10.11622/smedj.2016099
   Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006
NR 11
TC 0
Z9 0
U1 1
U2 2
PU SINGAPORE MEDICAL ASSOC
PI SINGAPORE
PA LEVEL 2 ALUMNI MEDICAL CENTRE, 2 COLLEGE RD, SINGAPORE 169850, SINGAPORE
SN 0037-5675
J9 SINGAP MED J
JI Singap. Med. J.
PD APR
PY 2017
VL 58
IS 4
BP 169
EP 170
DI 10.11622/smedj.2017025
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EY7MR
UT WOS:000404176000001
PM 28429031
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lin, HZ
   Tambyah, PA
   Yong, EL
   Biswas, A
   Chan, SY
AF Lin, Harvard Zhenjia
   Tambyah, Paul Anantharajah
   Yong, Eu Leong
   Biswas, Arijit
   Chan, Shiao-Yng
TI A review of Zika virus infections in pregnancy and implications for
   antenatal care in Singapore
SO SINGAPORE MEDICAL JOURNAL
LA English
DT Review
DE infectious disease transmission (vertical); fetal development; nervous
   system malformations; pregnancy; Zika virus
ID GUILLAIN-BARRE-SYNDROME; PROLONGED DETECTION; BIRTH-DEFECTS;
   TRANSMISSION; BRAIN; BRAZIL; EPIDEMIC; OUTBREAK; EXPOSURE; FETUSES
AB Given the consensus that there is a causal relationship between Zika virus (ZIKV) infection in pregnancy and congenital Zika syndrome (CZS), clinicians must be prepared to manage affected patients despite the numerous gaps in current knowledge. The clinical course in pregnancy appears similar to that in non-pregnant women, although viraemia may be prolonged. ZIKV infection can be diagnosed by serum and urine reverse transcription-polymerase chain reaction, but commercially available serological tests are currently unreliable in dengue-endemic regions. Although vertical transmission can occur at any time during gestation, first-and second-trimester infections have the highest risk of developing central nervous system anomalies. Aberrant fetal growth and pregnancy loss may also occur. Serial ultrasonography should be conducted for infected cases. Without a vaccine, pregnant women should be advised to minimise mosquito bites and reduce sexual transmission risk. Overall, the absolute risk of CZS arising amid a ZIKV outbreak appears relatively low.
C1 [Lin, Harvard Zhenjia; Yong, Eu Leong; Biswas, Arijit; Chan, Shiao-Yng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, 1E Kent Ridge Rd,NUHS Tower Block,Level 12, Singapore 119228, Singapore.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med Infect Dis, Singapore, Singapore.
RP Chan, SY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, 1E Kent Ridge Rd,NUHS Tower Block,Level 12, Singapore 119228, Singapore.
EM obgchan@nus.edu.sg
RI amsalu, ribka/G-8780-2019
OI BISWAS, ARIJIT/0000-0002-3311-2135; Chan, Shiao/0000-0002-3530-3023
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Centers for Disease Control and Prevention, DIAGN TESTS ZIK VIR
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Gupta RK, 2005, J NEUROSCI RES, V81, P172, DOI 10.1002/jnr.20547
   Heft DE, 2008, J VECTOR ECOL, V33, P17, DOI 10.3376/1081-1710(2008)33[17:EOTENS]2.0.CO;2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Korenromp MJ, 2005, PRENATAL DIAG, V25, P253, DOI 10.1002/pd.1127
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lissauer D, 2016, BJOG-INT J OBSTET GY, V123, P1258, DOI 10.1111/1471-0528.14071
   Mallet HP, 2013, BILAN EPIDEMIE VIRUS
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Ministry of Health Singapore, MOH CLIN ADV GROUP Z
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nielsen KK, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30254-9
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pacheco O, 2016, N ENGL J MED
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pan American Health Organization, EP UPD NEUR SYNDR CO
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   The American Congress of Obstetricians and Gynecologists, PRACT ADV ZIK VIR
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   World Health Organization (WHO), ZIK SIT REP
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 68
TC 11
Z9 11
U1 0
U2 1
PU SINGAPORE MEDICAL ASSOC
PI SINGAPORE
PA LEVEL 2 ALUMNI MEDICAL CENTRE, 2 COLLEGE RD, SINGAPORE 169850, SINGAPORE
SN 0037-5675
J9 SINGAP MED J
JI Singap. Med. J.
PD APR
PY 2017
VL 58
IS 4
BP 171
EP 178
DI 10.11622/smedj.2017026
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA EY7MR
UT WOS:000404176000002
PM 28429036
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU El Sahili, A
   Lescar, J
AF El Sahili, Abbas
   Lescar, Julien
TI Dengue Virus Non-Structural Protein 5
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; dengue virus; NS5 polymerase
ID DEPENDENT RNA-POLYMERASE; AMINO-ACID-RESIDUES; HEPATITIS-C VIRUS;
   ZIKA-VIRUS; CRYSTAL-STRUCTURE; NS5 METHYLTRANSFERASE; DRUG DISCOVERY;
   FLAVIVIRUS METHYLTRANSFERASE; NUCLEAR-LOCALIZATION; 4 SEROTYPES
AB The World Health Organization estimates that the yearly number of dengue cases averages 390 million. This mosquito-borne virus disease is endemic in over 100 countries and will probably continue spreading, given the observed trend in global warming. So far, there is no antiviral drug available against dengue, but a vaccine has been recently marketed. Dengue virus also serves as a prototype for the study of other pathogenic flaviviruses that are emerging, like West Nile virus and Zika virus. Upon viral entry into the host cell and fusion of the viral lipid membrane with the endosomal membrane, the viral RNA is released and expressed as a polyprotein, that is then matured into three structural and seven non-structural (NS) proteins. The envelope, membrane and capsid proteins form the viral particle while NS1-NS2A-NS2B-NS3-NS4A-NS4B and NS5 assemble inside a cellular replication complex, which is embedded in endoplasmic reticulum (ER)-derived vesicles. In addition to their roles in RNA replication within the infected cell, NS proteins help the virus escape the host innate immunity and reshape the host-cell inner structure. This review focuses on recent progress in characterizing the structure and functions of NS5, a protein responsible for the replication and capping of viral RNA that represents a promising drug target.
C1 [El Sahili, Abbas; Lescar, Julien] Nanyang Technol Univ, Nanyang Inst Struct Biol, Sch Biol Sci, Expt Med Bldg,59 Nanyang Dr, Singapore 636921, Singapore.
RP El Sahili, A; Lescar, J (corresponding author), Nanyang Technol Univ, Nanyang Inst Struct Biol, Sch Biol Sci, Expt Med Bldg,59 Nanyang Dr, Singapore 636921, Singapore.
EM aelsahili@ntu.edu.sg; julien@ntu.edu.sg
OI El Sahili, Abbas/0000-0003-3973-686X
FU National Medical Research CouncilMedical Research Council UK (MRC)
   [CBRG14May051]; AcRF [RGC2/14];  [NMRC/CBRG/0073/2014]
FX Abbas El Sahili is supported by a National Medical Research Council
   grant CBRG14May051 (to Julien Lescar). Funding from a AcRF Tier1
   complexity grant RGC2/14 and the NMRC/CBRG/0073/2014 grant to JL are
   also gratefully acknowledged.
CR Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   [Anonymous], 2016, COMMUNICATION
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006
   Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chatel-Chaix L., 2016, CELL HOST MICROBE, P1
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10
   Chen Z, 2016, J VIROL, V90, P3722, DOI 10.1128/JVI.03242-15
   Choi KH, 2012, ADV EXP MED BIOL, V726, P267, DOI 10.1007/978-1-4614-0980-9_12
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B., 2016, J VIROL
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Gentile I, 2013, CURR MED CHEM, V20, P3733, DOI 10.2174/09298673113209990178
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gong P., 2013, PLOS ONE, P8
   Grant A., 2016, SHORT ARTICLE ZIKA V, P882
   Henderson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025795
   Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7
   Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Khunchai S, 2015, VIRUS RES, V197, P92, DOI 10.1016/j.virusres.2014.12.007
   Khunchai S, 2012, BIOCHEM BIOPH RES CO, V423, P398, DOI 10.1016/j.bbrc.2012.05.137
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Liang Q., 2016, CELL STEM CELL, P1
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Lu G., 2016, ANTIMICROB AGENTS CH
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Niyomrattanakit P, 2015, ANTIVIR RES, V119, P36, DOI 10.1016/j.antiviral.2015.04.007
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Shu B., 2017, RNA BIOL, P1
   Smith TM, 2015, J BIOMOL SCREEN, V20, P153, DOI 10.1177/1087057114551141
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Su CI, 2016, J VIROL, V90, P4308, DOI 10.1128/JVI.00223-16
   Szymanski MR, 2011, J BIOL CHEM, V286, P33095, DOI 10.1074/jbc.M111.255034
   Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Venkatesham A, 2017, EUR J MED CHEM, V126, P101, DOI 10.1016/j.ejmech.2016.10.008
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, DRAFT GLOB HLTH SECT, P1
   Wu JQ, 2015, J VIROL, V89, P249, DOI 10.1128/JVI.02085-14
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Yang XR, 2017, J BIOL CHEM, V292, P3810, DOI 10.1074/jbc.M116.750638
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Zhao Y., 2015, INT J DISTRIB SENS N, V2015, P1
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 106
TC 27
Z9 28
U1 2
U2 20
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2017
VL 9
IS 4
AR 91
DI 10.3390/v9040091
PG 20
WC Virology
SC Virology
GA EY8DJ
UT WOS:000404224400030
PM 28441781
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Watson, AM
   Klimstra, WB
AF Watson, Alan M.
   Klimstra, William B.
TI T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal
   Models
SO VIRUSES-BASEL
LA English
DT Review
DE yellow fever virus; YFV; flavivirus; 17D; 17DD; 17D-204; T cell;
   vaccine; animal models; dengue; West Nile; Zika; live attenuated
   vaccine; chimerivax; vaccine development
ID HUMAN DENDRITIC CELLS; INDIAN RHESUS MACAQUES; NEUTRALIZING ANTIBODY;
   17D VACCINE; VISCEROTROPIC DISEASE; ADAPTIVE IMMUNITY; DEFICIENT MICE;
   IFN-GAMMA; TNF-ALPHA; IN-VITRO
AB The 17D line of yellow fever virus vaccines is among the most effective vaccines ever created. The humoral and cellular immunity elicited by 17D has been well characterized in humans. Neutralizing antibodies have long been known to provide protection against challenge with a wild-type virus. However, a well characterized T cell immune response that is robust, long-lived and polyfunctional is also elicited by 17D. It remains unclear whether this arm of immunity is protective following challenge with a wild-type virus. Here we introduce the 17D line of yellow fever virus vaccines, describe the current state of knowledge regarding the immunity directed towards the vaccines in humans and conclude with a discussion of animal models that are useful for evaluating T cell-mediated immune protection to yellow fever virus.
C1 [Watson, Alan M.] Univ Pittsburgh, Ctr Vaccine Res, Dept Microbiol & Mol Genet, 3501 Fifth Ave, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Ctr Vaccine Res, Dept Immunol, 3501 Fifth Ave, Pittsburgh, PA 15261 USA.
RP Watson, AM (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Dept Microbiol & Mol Genet, 3501 Fifth Ave, Pittsburgh, PA 15261 USA.
EM alan.watson@pitt.edu; klimstra@pitt.edu
OI Watson, Alan/0000-0003-0632-8296
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI081886]
CR Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   BARRETT ADT, 1986, J GEN VIROL, V67, P631, DOI 10.1099/0022-1317-67-4-631
   Bassi MR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004464
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Belsher JL, 2007, VACCINE, V25, P8480, DOI 10.1016/j.vaccine.2007.08.061
   Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5
   Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234
   Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09
   Bredenbeek PJ, 2006, VIROLOGY, V345, P299, DOI 10.1016/j.virol.2005.12.001
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Bruni D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1552
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Campi-Azevedo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049828
   Chen K., 2017, J AUTOIMMUN
   Coulange Bodilis H, 2011, Bull Soc Pathol Exot, V104, P260, DOI 10.1007/s13149-011-0135-7
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028
   Deauvieau F, 2007, AM J TROP MED HYG, V76, P144, DOI 10.4269/ajtmh.2007.76.144
   DeWitt WS, 2015, J VIROL, V89, P4517, DOI 10.1128/JVI.03474-14
   Douam F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14781
   Franco D, 2010, VACCINE, V28, P5676, DOI 10.1016/j.vaccine.2010.06.052
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Greene JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002384
   Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   Hepburn MJ, 2006, VACCINE, V24, P2843, DOI 10.1016/j.vaccine.2005.12.055
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Li R., 2016, RADIOL INFECT DIS, V3, P143
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439
   Mandl JN, 2011, J IMMUNOL, V186, P6406, DOI 10.4049/jimmunol.1001191
   Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700
   Martins MA, 2007, CLIN EXP IMMUNOL, V148, P90, DOI 10.1111/j.1365-2249.2006.03317.x
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Monaghan AJ, 2016, PLOS CURR
   Monath TP, 1999, VACCINE, V17, P1869, DOI 10.1016/S0264-410X(98)00487-3
   Monath TP, 2012, VACCINES, P870
   Mudd PA, 2010, IMMUNOGENETICS, V62, P593, DOI 10.1007/s00251-010-0461-0
   Neves PCC, 2010, VACCINE, V28, P8183, DOI 10.1016/j.vaccine.2010.09.090
   Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x
   Nogueira RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059347
   Norrby E, 2007, J EXP MED, V204, P2779, DOI 10.1084/jem.20072290
   Palmer DR, 2007, J GEN VIROL, V88, P148, DOI 10.1099/vir.0.82272-0
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019
   Quaresma JAS, 2006, MED HYPOTHESES, V67, P618, DOI 10.1016/j.mehy.2006.01.060
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4
   Reed W, 1900, Public Health Pap Rep, V26, P37
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104
   Sellards AW, 1931, P NATL ACAD SCI USA, V17, P339, DOI 10.1073/pnas.17.6.339
   Silva ML, 2011, VACCINE, V29, P583, DOI 10.1016/j.vaccine.2010.08.046
   Stokes A, 1928, J AMER MED ASSOC, V90, P253, DOI 10.1001/jama.1928.02690310005002
   Stokes A., 1997, INT J INFECT DIS, V2, P54, DOI DOI 10.1016/S1201-9712(97)90015-1
   Stoyanov CT, 2010, VACCINE, V28, P4644, DOI 10.1016/j.vaccine.2010.04.071
   Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   THEILER MAX, 1928, ANN TROP MED & PARASITOL, V22, P449
   THEILER MAX, 1930, ANN TROP MED AND PARASITOL [LIVERPOOL], V24, P249
   Thibodeaux BA, 2012, VACCINE, V30, P3180, DOI 10.1016/j.vaccine.2012.03.003
   Thomas RE, 2011, VACCINE, V29, P4544, DOI 10.1016/j.vaccine.2011.04.055
   Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Watson A., UNPUB
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   *WHO, 1992, GLOB HLTH SIT PROJ E
   Wieten RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149871
NR 84
TC 10
Z9 10
U1 0
U2 2
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2017
VL 9
IS 4
AR 77
DI 10.3390/v9040077
PG 14
WC Virology
SC Virology
GA EY8DJ
UT WOS:000404224400016
PM 28398253
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lutz, EK
   Lahondere, C
   Vinauger, C
   Riffell, JA
AF Lutz, Eleanor K.
   Lahondere, Chloe
   Vinauger, Clement
   Riffell, Jeffrey A.
TI Olfactory learning and chemical ecology of olfaction in disease vector
   mosquitoes: a life history perspective
SO CURRENT OPINION IN INSECT SCIENCE
LA English
DT Article
ID AEDES-AEGYPTI; ANOPHELES-GAMBIAE; OVIPOSITION-ATTRACTANT; MALARIA
   MOSQUITO; RECEPTOR NEURONS; MAXILLARY PALP; FINE-STRUCTURE; DIPTERA;
   BEHAVIOR; MEMORY
AB Mosquitoes transmit many debilitating diseases including malaria, dengue and Zika. Odors mediate behaviors that directly impact disease transmission (blood-feeding) as well as life history events that contribute to mosquito survival and fitness (mating and oviposition, nectar foraging, larval foraging and predator avoidance). In addition to innate olfactionmediated behaviors, mosquitoes rely on olfactory experience throughout their life to inform advantageous choices in many of these important behaviors. Previous reviews have addressed either the chemical ecology of mosquitoes, or olfactory-driven behaviors including host-feeding or oviposition. Adding to this literature, we use a holistic life history perspective to integrate and compare innate and learned olfactory behavior at various stages of mosquito development.
C1 [Lutz, Eleanor K.; Lahondere, Chloe; Vinauger, Clement; Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA.
RP Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.
EM jriffell@uw.edu
OI Lahondere, Chloe/0000-0003-1949-7865; Lutz, Eleanor/0000-0002-2434-2254;
   Vinauger, Clement/0000-0002-3704-5427
FU Air Force Office of Sponsored ResearchUnited States Department of
   DefenseAir Force Office of Scientific Research (AFOSR)
   [FA9550-14-1-0398]; National Science FoundationNational Science
   Foundation (NSF) [DGE-1256082, IOS-1354159]; National Institute of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01DC013693]; Endowed Professorship
   for Excellence in Biology; Washington Research Foundation; Human
   Frontiers in Science ProgramHuman Frontier Science Program
   [HFSP-RGP0022]
FX We are grateful to Gabriella H. Wolff for her contribution of confocal
   scan images for Figure 2. We thank the three anonymous reviewers for
   their thoughtful comments, which helped us improve the manuscript. We
   acknowledge the support of the Air Force Office of Sponsored Research
   under grants FA9550-14-1-0398 (JAR) and FA9550-14-1-0398 (TLD and JAR);
   National Science Foundation under grants DGE-1256082 (EKL) and
   IOS-1354159 (JAR); the National Institute of Health under grant
   R01DC013693 (JAR); an Endowed Professorship for Excellence in Biology
   (JAR); The Washington Research Foundation; and the Human Frontiers in
   Science Program under grant HFSP-RGP0022 (JAR and CV).
CR Anton S, 2004, J COMP NEUROL, V475, P315, DOI 10.1002/cne.20174
   Audrain B, 2015, FEMS MICROBIOL REV, V2
   Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31
   BENTLEY MD, 1979, ENVIRON ENTOMOL, V8, P206, DOI 10.1093/ee/8.2.206
   BENTLEY MD, 1976, J MED ENTOMOL, V13, P112, DOI 10.1093/jmedent/13.1.112
   BENZON GL, 1988, J MED ENTOMOL, V25, P158, DOI 10.1093/jmedent/25.3.158
   Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k
   Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007
   Blaustein L, 2005, J VECTOR ECOL, V30, P299
   Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x
   Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x
   Bohbot JD, 2014, INSECT BIOCHEM MOLEC, V48, P29, DOI 10.1016/j.ibmb.2014.02.007
   BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042
   CHESSON J, 1984, ENVIRON ENTOMOL, V13, P531, DOI 10.1093/ee/13.2.531
   Chilaka N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-27
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x
   Distler PG, 1997, J EXP BIOL, V200, P1873
   EDMAN JD, 1974, J PARASITOL, V60, P874, DOI 10.2307/3278923
   EDMAN JD, 1968, SCIENCE, V161, P67, DOI 10.1126/science.161.3836.67
   Fawaz EY, 2014, J VECTOR ECOL, V39, P347, DOI 10.1111/jvec.12110
   Ferrari MCO, 2008, BEHAV ECOL SOCIOBIOL, V62, P1079, DOI 10.1007/s00265-007-0535-7
   Floore TG, 2006, J AM MOSQUITO CONTR, V22, P527, DOI 10.2987/8756-971X(2006)22[527:MLCPPA]2.0.CO;2
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Galili DS, 2014, CURR BIOL, V24, P1712, DOI 10.1016/j.cub.2014.06.062
   Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360
   Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066
   Gouagna LC, 2010, J VECTOR ECOL, V35, P267, DOI 10.1111/j.1948-7134.2010.00082.x
   GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475
   HASIBEDER G, 1988, THEOR POPUL BIOL, V33, P31, DOI 10.1016/0040-5809(88)90003-2
   Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800
   Jhumur US, 2008, J CHEM ECOL, V34, P14, DOI 10.1007/s10886-007-9392-0
   Jhumur US, 2006, J MED ENTOMOL, V43, P1164, DOI 10.1603/0022-2585(2006)43[1164:NACROC]2.0.CO;2
   Kaur JS, 2003, MED VET ENTOMOL, V17, P457, DOI 10.1111/j.1365-2915.2003.00455.x
   Kelly DW, 2000, PARASITOLOGY, V120, P319, DOI 10.1017/S0031182099005442
   Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2
   LANG JT, 1978, J MED ENTOMOL, V14, P448
   Lazzari CR, 2009, ADV INSECT PHYSIOL, V37, P1, DOI 10.1016/S0065-2806(09)37001-0
   Lindh JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0636-0
   Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467
   McCall PJ, 2002, TRENDS PARASITOL, V18, P429, DOI 10.1016/S1471-4922(02)02370-X
   McCall PJ, 2001, MED VET ENTOMOL, V15, P197, DOI 10.1046/j.0269-283x.2001.00304.x
   MCIVER S, 1978, J INSECT PHYSIOL, V24, P383, DOI 10.1016/0022-1910(78)90079-3
   MCIVER S, 1979, J INSECT PHYSIOL, V25, P21, DOI 10.1016/0022-1910(79)90032-5
   Menda G, 2013, J EXP BIOL, V216, P218, DOI 10.1242/jeb.074898
   Mendki MJ, 2000, CURR SCI INDIA, V78, P1295
   Mengoni SL, 2017, J INSECT PHYSIOL, V98, P23, DOI 10.1016/j.jinsphys.2016.10.018
   Montell C, 2016, ADV INSECT PHYSIOL, V51, P293, DOI 10.1016/bs.aiip.2016.04.007
   Muller GC, 2010, MALARIA J, V9, P1
   Mysore K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002215
   Mysore K, 2011, DEV GENES EVOL, V221, P281, DOI 10.1007/s00427-011-0376-2
   NIJHOUT HF, 1971, ENTOMOL EXP APPL, V14, P399, DOI 10.1007/BF00539936
   Nikbakhtzadeh MR, 2014, J VECTOR ECOL, V39, P372, DOI 10.1111/jvec.12113
   Nyasembe VO, 2014, PHYTOCHEM LETT, V8, P196, DOI 10.1016/j.phytol.2013.10.003
   Nyasembe VO, 2012, PARASITE VECTOR, V5, P1
   Ogbunugafor CB, 2008, J VECTOR ECOL, V33, P321, DOI 10.3376/1081-1710-33.2.321
   Otienoburu PE, 2012, J CHEM ECOL, V38, P873, DOI 10.1007/s10886-012-0150-6
   PETRANKA JW, 1991, COPEIA, P234, DOI 10.2307/1446271
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   Qualls WA, 2015, MALARIA J, V14, P1
   Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032
   Rejmankova E, 2005, J MED ENTOMOL, V42, P95, DOI 10.1603/0022-2585(2005)042[0095:VSFLHM]2.0.CO;2
   Riabinina O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13010
   Riffell JA, 2012, CURR OPIN NEUROBIOL, V22, P236, DOI 10.1016/j.conb.2012.02.013
   Sanford MR, 2013, J INSECT BEHAV, V26, P494, DOI 10.1007/s10905-012-9368-y
   Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024218
   Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2
   SIH A, 1986, ECOLOGY, V67, P434, DOI 10.2307/1938587
   Siju KP, 2008, ARTHROPOD STRUCT DEV, V37, P248, DOI 10.1016/j.asd.2007.12.001
   Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002
   Silberbush A, 2011, FUNCT ECOL, V25, P1091, DOI 10.1111/j.1365-2435.2011.01873.x
   Silberbush A, 2010, ECOL LETT, V13, P1129, DOI 10.1111/j.1461-0248.2010.01501.x
   Sparks JT, 2013, INSECT BIOCHEM MOLEC, V43, P1161, DOI 10.1016/j.ibmb.2013.10.005
   Stone C, 2013, ECOLOGY PARASITE VEC
   Suh E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149800
   Sumba Leunita A., 2004, International Journal of Tropical Insect Science, V24, P260, DOI 10.1079/IJT200433
   Syed Z, 2015, CURR OPIN INSECT SCI, V10, P83, DOI 10.1016/j.cois.2015.04.011
   Tchouassi DP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002007
   THIEN LB, 1970, AM J BOT, V57, P1031, DOI 10.2307/2441267
   Vinauger C, DOPAMINE MODUL UNPUB
   Vinauger C, 2016, TRENDS PARASITOL, V32, P761, DOI 10.1016/j.pt.2016.06.003
   Vinauger C, 2014, J EXP BIOL, V217, P2321, DOI 10.1242/jeb.101279
   Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005
   Wolff GH, 2015, CURR BIOL, V25, P38, DOI 10.1016/j.cub.2014.10.049
   Wondwosen B, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1656-0
   Wondwosen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep37930
   Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105
   ZACHARUK RY, 1971, J MORPHOL, V135, P273, DOI 10.1002/jmor.1051350303
   Zahiri NS, 2003, J MED ENTOMOL, V40, P672, DOI 10.1603/0022-2585-40.5.672
NR 91
TC 13
Z9 13
U1 3
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-5745
EI 2214-5753
J9 CURR OPIN INSECT SCI
JI Curr. Opin. Insect Sci.
PD APR
PY 2017
VL 20
BP 75
EP 83
DI 10.1016/j.cois.2017.03.002
PG 9
WC Biology; Ecology; Entomology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Entomology
GA EX2MK
UT WOS:000403060200014
PM 28602240
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ashby, J
   Moreno-Madrinan, MJ
   Yiannoutsos, CT
   Stanforth, A
AF Ashby, Jeffrey
   Moreno-Madrinan, Max J.
   Yiannoutsos, Constantin T.
   Stanforth, Austin
TI Niche Modeling of Dengue Fever Using Remotely Sensed Environmental
   Factors and Boosted Regression Trees
SO REMOTE SENSING
LA English
DT Article
DE Dengue; boosted regression tree; Aedes aegypti; remote sensing; GIS;
   vector modeling; neglected tropical diseases
ID VIRUS MOSQUITO VECTOR; AEDES-AEGYPTI; GLOBAL DISTRIBUTION;
   CLASSIFICATION; EPIDEMIOLOGY; COLOMBIA; BURDEN
AB Dengue fever (DF), a vector-borne flavivirus, is endemic to the tropical countries of the world with nearly 400 million people becoming infected each year and roughly one-third of the world's population living in areas of risk. The main vector for DF is the Aedes aegypti mosquito, which is also the same vector of yellow fever, chikungunya, and Zika viruses. To gain an understanding of the spatial aspects that can affect the epidemiological processes across the disease's geographical range, and the spatial interactions involved, we created and compared Bernoulli and Poisson family Boosted Regression Tree (BRT) models to quantify the overall annual risk of DF incidence by municipality, using the Magdalena River watershed of Colombia as a study site during the time period between 2012 and 2014. A wide range of environmental conditions make this site ideal to develop models that, with minor adjustments, could be applied in many other geographical areas. Our results show that these BRT methods can be successfully used to identify areas at risk and presents great potential for implementation in surveillance programs.
C1 [Ashby, Jeffrey; Moreno-Madrinan, Max J.] Indiana Univ, IUPUI, Fairbanks Sch Publ Hlth, Dept Environm Hlth Sci, Indianapolis, IN 46202 USA.
   [Yiannoutsos, Constantin T.] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46204 USA.
   [Stanforth, Austin] Indiana Univ, IUPUI, Dept Geog, Indianapolis, IN 46202 USA.
RP Moreno-Madrinan, MJ (corresponding author), Indiana Univ, IUPUI, Fairbanks Sch Publ Hlth, Dept Environm Hlth Sci, Indianapolis, IN 46202 USA.
EM jlashby@imail.iu.edu; mmorenom@iu.edu; cyiannou@iupui.edu;
   Austin.Stanforth@gmail.com
OI Ashby, Jeffrey/0000-0003-1755-1856
FU IUPUI Chancellor for Research-Research Support Funds Grant
FX This study was supported by the IUPUI Chancellor for Research-Research
   Support Funds Grant. The study was also possible because of the
   accessibility to public health data made available by the National
   Institute of Health (Instituto Nacional de Salud, INS) of Colombia. The
   authors would like to thank Mary Lefevers for her assistance in the data
   preprocessing and Victor E. Casallas-Bedoya from INS for his assistance
   with data information. The authors would also like to thank the
   reviewers for their insights and suggestions.
CR Aertsen W, 2012, PLANT SOIL, V354, P157, DOI 10.1007/s11104-011-1052-z
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Carty DM, 2015, FOREST PROD J, V65, P365, DOI 10.13073/FPJ-D-12-00085
   Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280
   Chareonviriyaphap Theeraphap, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P529
   Chen Chee Dhang, 2005, Trop Biomed, V22, P39
   Cheong YL, 2014, SPAT SPATIO-TEMPORAL, V10, P75, DOI 10.1016/j.sste.2014.05.002
   DAAC LP, LAND COV TYP YEARL L
   De la Hoz F., 2014, PUBLIC HLTH SURVEILL
   De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409
   Delmelle A.P.E., 2015, SPATIAL ANAL HLTH GE
   Departamento Administrativo Nacional de Estadistica (DANE), 2014, GOB COL
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3
   Heymann DL, 2008, CONTROL COMMUNICABLE
   Ibanez-Bernal S., 1987, Folia Entomologica Mexicana, V72, P163
   Instituto Nacional de Salud (INS), 2014, ENT ADSCR MIN SAL PR
   Kaushal M., EPIDEMIOLOGY DENGUE
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lawrence R, 2004, REMOTE SENS ENVIRON, V90, P331, DOI 10.1016/j.rse.2004.01.007
   Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Machault V, 2014, ISPRS INT J GEO-INF, V3, P1352, DOI 10.3390/ijgi3041352
   Meentemeyer RK, 2012, ANNU REV PHYTOPATHOL, V50, P379, DOI 10.1146/annurev-phyto-081211-172938
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2015, T ROY SOC TROP MED H, V109, P503, DOI 10.1093/trstmh/trv050
   Moreno-Madrinan M.J., 2017, J MED ENTOMOL
   Moreno-Madrinan MJ, 2014, ISPRS INT J GEO-INF, V3, P732, DOI 10.3390/ijgi3020732
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Pigott D.M., 2014, ELIFE, V3
   Ramon S., 2010, MODIS VEGETATION IND
   Ridgeway G., 2007, GEN BOOSTED MODELS G
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Ruiz-Lopez F, 2016, BIOMEDICA, V36, P303, DOI 10.7705/biomedica.v36i2.3301
   Shah DA, 2014, PHYTOPATHOLOGY, V104, P702, DOI 10.1094/PHYTO-10-13-0273-R
   Shi Y., 2015, ENV HLTH PERSPECT
   Stanforth A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090770
   Suarez M. F., 1981, Biomedica, V1, P225
   Wan-Norafikah O, 2012, SAINS MALAYS, V41, P1309
NR 47
TC 10
Z9 10
U1 2
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-4292
J9 REMOTE SENS-BASEL
JI Remote Sens.
PD APR
PY 2017
VL 9
IS 4
AR 328
DI 10.3390/rs9040328
PG 15
WC Remote Sensing
SC Remote Sensing
GA EW5UJ
UT WOS:000402571700027
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Piovezan, R
   Acorinthe, JPO
   de Souza, JHT
   Visockas, A
   de Azevedo, TS
   Von Zuben, CJ
AF Piovezan, Rafael
   Oliveira Acorinthe, Joao Paulo
   Teixeira de Souza, Jonas Henrique
   Visockas, Alexandre
   de Azevedo, Thiago Salomao
   Von Zuben, Claudio Jose
TI Spatial distribution of Culicidae (Diptera) larvae, and its implications
   for Public Health, in five areas of the Atlantic Forest biome, State of
   Sao Paulo, Brazil
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Dengue; Entomological surveillance;
   Spatial analysis
ID STEGOMYIA AEGYPTI LINNAEUS; AEDES-AEGYPTI; CHIKUNGUNYA VIRUS;
   ALBOPICTUS; DENGUE; COEXISTENCE; MOSQUITOS; DYNAMICS; VECTOR
AB In view of the adaptive ability of mosquitoes and their role in the transport of infective agents, entomological surveys undertaken in transitional environments are very important for the determination of the risk they represent for Public Health. Among the principal vectors of the infectious agents involved in the occurrence of important arboviruses, such as dengue, for example, are the Culicidae-insects capable of installing themselves in the urban nuclei, which exist within areas containing vestigial forests. This present study conducted a survey of mosquito species by means of traps to catch their larvae installed in five rural areas within the Atlantic Forest domain and containing its vestigial vegetation in the municipality of Santa Barbara D'Oeste, Sao Paulo, Brazil. A total of 13,241 larvae belonging to six mosquito species were collected on 920 occasions (32.52% of positive collections). Aedes albopictus (64.23%) and Aedes aegypti (32.75%) were the most frequent, followed by Culex quinquefasciatus (1.32%), Aedes fluvi-atilis (1.04%), Culex Complex Coronator (0.40%) and Toxorhynchites theobaldi (0.22%). Three areas were analyzed by means of Simpson's diversity index and the spatial analysis showed that the sites with the greatest abundance of Ae. aegypti presented lower diversity values and were associated with more highly consolidated urban nuclei. The vector of dengue, chikungunya and zika has great infesting ability in urban areas, which means that the early implementation of entomological surveillance and control activities in specific areas - such as transitional ones - is highly important. (C) 2017 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.
C1 [Piovezan, Rafael; Oliveira Acorinthe, Joao Paulo; Teixeira de Souza, Jonas Henrique; Visockas, Alexandre] Secretaria Municipal Meio Ambiente, Prefeitura Municipal, Santa Barbara Doeste, SP, Brazil.
   [Piovezan, Rafael; Von Zuben, Claudio Jose] Univ Estadual Paulista, Dept Zool, Rio Claro, SP, Brazil.
   [de Azevedo, Thiago Salomao] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, SP, Brazil.
RP Piovezan, R (corresponding author), Secretaria Municipal Meio Ambiente, Prefeitura Municipal, Santa Barbara Doeste, SP, Brazil.; Piovezan, R (corresponding author), Univ Estadual Paulista, Dept Zool, Rio Claro, SP, Brazil.
EM piovezan.rafael@gmail.com
RI Azevedo, Thiago Azevedo T. S./F-8343-2012
CR ALARCON-ELBAL P.M., 2013, MEMORIAS I O CRUZ, V109, P782
   Andriotti J.L.S., 2004, FUNDMENTOS ESTATISTI
   Barata EAMD, 2001, REV SAUDE PUBL, V35, P237, DOI 10.1590/S0034-89102001000300004
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   CEPAGRI-Centro de Pesquisas Meteorologicas e Climaticas Aplicadas a Agricultura, 2014, CLIM MUN PAUL
   Coelho CAS, 2016, CLIM DYNAM, V46, P3737, DOI 10.1007/s00382-015-2800-1
   Coelho CAS, 2016, THEOR APPL CLIMATOL, V125, P769, DOI 10.1007/s00704-015-1540-9
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Costa Monteiro Fred Julio, 2014, EntomoBrasilis, V7, P188, DOI 10.12741/ebrasilis.v7i3.419
   Costa Monteiro Fred Julio, 2014, ENTOMOTROPICA, V29, P95
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Esri, 1996, USING ARCVIEWGIS
   Fernandez Z, 2000, REV SAUDE PUBL, V34, P232, DOI 10.1590/S0034-89102000000300004
   Field V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-330
   Forattini O., 1992, ECOLOGIA EPIDEMIOLOG
   Forattini O.P., 2002, CULICIDOLOGIA MED ID, V2
   Forattini OP, 2000, REV SAUDE PUBL, V34, P543, DOI 10.1590/S0034-89102000000500016
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Golden Software INC, 1995, SURF WIND V 6 US GUI, V6
   Gonçalves Karen dos Santos, 2008, Biota Neotrop., V8, P235, DOI 10.1590/S1676-06032008000100027
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Harbach R.E., 2016, MOSQUITOE TAXONOMIC
   Isaaks E., 1989, INTRO APPL GEOSTATIS
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611
   KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   LOPES J, 1993, REV SAUDE PUBL, V27, P326, DOI 10.1590/S0034-89101993000500002
   Lopes J, 1997, REV SAUDE PUBL, V31, P370, DOI 10.1590/S0034-89101997000400006
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Magurran AE, 1988, ECOLOGICAL DIVERSITY
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Ministerio da Saude, 2002, PROGR NAC CONTR DENG
   Ministerio da Saude (BR), 2009, DIR NAC PREV CONTR E
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001
   Piovezan R, 2013, J VECTOR ECOL, V38, P317, DOI 10.1111/j.1948-7134.2013.12046.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Silva VC, 2009, REV SOC BRAS MED TRO, V42, P730, DOI 10.1590/S0037-86822009000600023
   Silverio E.C., 2007, AN 8 C EC BRAS CAX M
   Souza-Santos Reinaldo, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P373, DOI 10.1590/S0037-86821999000400007
   Superintendencia de Controle de Endemias, 2010, COORD CONTR DOENC PR
   Superintendencia de Controle de Endemias, 2001, VIG CONTR AED AEG NO
   Varejao JBM, 2005, REV SOC BRAS MED TRO, V38, P238, DOI 10.1590/S0037-86822005000300006
NR 50
TC 0
Z9 0
U1 0
U2 6
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PD APR-JUN
PY 2017
VL 61
IS 2
BP 123
EP 135
DI 10.1016/j.rbe.2016.12.007
PG 13
WC Entomology
SC Entomology
GA EW7LW
UT WOS:000402692600005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, BY
   Alfaro-Murillo, JA
   Parpia, AS
   Asti, L
   Wedlock, PT
   Hotez, PJ
   Galvani, AP
AF Lee, Bruce Y.
   Alfaro-Murillo, Jorge A.
   Parpia, Alyssa S.
   Asti, Lindsey
   Wedlock, Patrick T.
   Hotez, Peter J.
   Galvani, Alison P.
TI The potential economic burden of Zika in the continental United States
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS; EPIDEMIC; DENGUE
AB Background
   As the Zika virus epidemic continues to spread internationally, countries such as the United States must determine how much to invest in prevention, control, and response. Fundamental to these decisions is quantifying the potential economic burden of Zika under different scenarios.
   Methodology/Principle findings
   To inform such decision making, our team developed a computational model to forecast the potential economic burden of Zika across six states in the US (Alabama, Florida, Georgia, Louisiana, Mississippi, and Texas) which are at greatest risk of Zika emergence, under a wide range of attack rates, scenarios and circumstances. In order to accommodate a wide range of possibilities, different scenarios explored the effects of varying the attack rate from 0.01% to 10%. Across the six states, an attack rate of 0.01% is estimated to cost $183.4 million to society ($117.1 million in direct medical costs and $66.3 million in productivity losses), 0.025% would result in $198.6 million ($119.4 million and $79.2 million), 0.10% would result in $274.6 million ($130.8 million and $143.8 million) and 1% would result in $1.2 billion ($268.0 million and $919.2 million).
   Conclusions
   Our model and study show how direct medical costs, Medicaid costs, productivity losses, and total costs to society may vary with different attack rates across the six states and the circumstances at which they may exceed certain thresholds (e.g., Zika prevention and control funding allocations that are being debated by the US government). A Zika attack rate of 0.3% across the six states at greatest risk of Zika infection, would result in total costs that exceed $0.5 billion, an attack rate of 1% would exceed $ 1 billion, and an attack rate of 2% would exceed $ 2 billion.
C1 [Lee, Bruce Y.; Asti, Lindsey; Wedlock, Patrick T.] Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Computat & Operat Res PHICOR & Global O, Baltimore, MD 21205 USA.
   [Alfaro-Murillo, Jorge A.; Parpia, Alyssa S.; Galvani, Alison P.] Yale Univ, Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.
   [Hotez, Peter J.] Baylor Coll Med, Sabin Vaccine Inst, Houston, TX 77030 USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Natl Sch Trop Med, Ctr Vaccine Dev, Houston, TX 77030 USA.
RP Lee, BY; Galvani, AP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Computat & Operat Res PHICOR & Global O, Baltimore, MD 21205 USA.; Galvani, AP (corresponding author), Yale Univ, Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.
EM brucelee@jhu.edu; alison.galvani@yale.edu
OI Wedlock, Patrick/0000-0001-7635-5949
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U01 GM087719,
   U01 GM105627, U54HD070725, U01 HD086861]; USAIDUnited States Agency for
   International Development (USAID) [AID-OAA-A-15-00064]
FX This work was supported by the National Institutes of Health (NIH U01
   GM087719, U01 GM105627, U54HD070725, U01 HD086861). Agency for
   Healthcare Research and Quality (AHRQ R01HS023317), and USAID via grant
   AID-OAA-A-15-00064. The funders had no role in the design and conduct of
   the study; collection, management, analysis, and interpretation of the
   data; and preparation, review, or approval of the manuscript.
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Atif M, 2016, INFECTION
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Brasil P, 2016, N ENGL J MED
   Bureau of Labor Statistics, DAT TABL CALC SUBJ C
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, UPD INT PREGN GUID
   Centers for Medicare & Medicaid Services, FEE SCHED 2015
   Centers for Medicare & Medicaid Services, JUL SEPT 2015 MED MB
   DeBonis Mike, 2016, WASHINGTON POST
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343
   Hamilton B, 2015, NATL VITAL STAT REP, V64
   Handler A, 2012, MATERN CHILD HLTH J, V16, P393, DOI 10.1007/s10995-011-0763-3
   Lee BY, 2015, MED CARE, V53, P218, DOI 10.1097/MLR.0000000000000302
   Lee BY, 2010, VACCINE, V28, P5952, DOI 10.1016/j.vaccine.2010.07.003
   Lee BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011284
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marchaim D, 2011, INFECT CONT HOSP EP, V32, P861, DOI 10.1086/661597
   McCauley M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1116
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ministerio da Saude Brasil, PREV COMB DENG CHIK
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan Ai., 2016, PLOS CURR, V8
   Oehler E, 2014, EURO SURVEILL, V19
   Puccioni-Sohler M, 2017, ARQ NEURO-PSIQUIAT, V75, P123, DOI [10.1590/0004-282X20160189, 10.1590/0004-282x20160189]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shultz JM, 2015, JAMA-J AM MED ASSOC, V313, P567, DOI 10.1001/jama.2014.17934
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Smith AF, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-13
   United States Census Bureau, QUICKFACTS GEOGR
   United States Census Bureau. Population Division, ANN EST RES POP
   United States Department of Labor Bureau of Labor and Statistics, TABL 1 MED US WEEKL
   Washington Post, 2016, WASHINGTON POST
NR 38
TC 21
Z9 21
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2017
VL 11
IS 4
AR e0005531
DI 10.1371/journal.pntd.0005531
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1NH
UT WOS:000402256700057
PM 28448488
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maynard, AJ
   Ambrose, L
   Cooper, RD
   Chow, WK
   Davis, JB
   Muzari, MO
   van den Hurk, AF
   Hall-Mendelin, S
   Hasty, JM
   Burkot, TR
   Bangs, MJ
   Reimer, LJ
   Butafa, C
   Lobo, NF
   Syafruddin, D
   Maung, YNM
   Ahmad, R
   Beebe, NW
AF Maynard, Andrew J.
   Ambrose, Luke
   Cooper, Robert D.
   Chow, Weng K.
   Davis, Joseph B.
   Muzari, Mutizwa O.
   van den Hurk, Andrew F.
   Hall-Mendelin, Sonja
   Hasty, Jeomhee M.
   Burkot, Thomas R.
   Bangs, Michael J.
   Reimer, Lisa J.
   Butafa, Charles
   Lobo, Neil F.
   Syafruddin, Din
   Maung, Yan Naung Maung
   Ahmad, Rohani
   Beebe, Nigel W.
TI Tiger on the prowl: Invasion history and spatio-temporal genetic
   structure of the Asian tiger mosquito Aedes albopictus (Skuse 1894) in
   the Indo-Pacific
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEGYPTI MOSQUITOS; POPULATION-STRUCTURE; DIPTERA-CULICIDAE;
   MUTATION-RATES; ZIKA VIRUS; SOFTWARE; DIVERSITY; SEQUENCE; DENGUE; RANGE
AB Background
   Within the last century, increases in human movement and globalization of trade have facilitated the establishment of several highly invasive mosquito species in new geographic locations with concurrent major environmental, economic and health consequences. The Asian tiger mosquito, Aedes albopictus, is an extremely invasive and aggressive daytime-biting mosquito that is a major public health threat throughout its expanding range.
   Methodology/Principal findings
   We used 13 nuclear microsatellite loci (on 911 individuals) and mitochondrial COI sequences to gain a better understanding of the historical and contemporary movements of Ae. albopictus in the Indo-Pacific region and to characterize its population structure. Approximate Bayesian computation (ABC) was employed to test competing historical routes of invasion of Ae. albopictus within the Southeast (SE) Asian/Australasian region. Our ABC results show that Ae. albopictus was most likely introduced to New Guinea via mainland Southeast Asia, before colonizing the Solomon Islands via either Papua New Guinea or SE Asia. The analysis also supported that the recent incursion into northern Australia's Torres Strait Islands was seeded chiefly from Indonesia. For the first time documented in this invasive species, we provide evidence of a recently colonized population (the Torres Strait Islands) that has undergone rapid temporal changes in its genetic makeup, which could be the result of genetic drift or represent a secondary invasion from an unknown source.
   Conclusions/Significance
   There appears to be high spatial genetic structure and high gene flow between some geographically distant populations. The species' genetic structure in the region tends to favour a dispersal pattern driven mostly by human movements. Importantly, this study provides a more widespread sampling distribution of the species' native range, revealing more spatial population structure than previously shown. Additionally, we present the most probable invasion history of this species in the Australasian region using ABC analysis.
C1 [Maynard, Andrew J.; Ambrose, Luke; Beebe, Nigel W.] Univ Queensland, Brisbane, Qld, Australia.
   [Cooper, Robert D.; Chow, Weng K.] Australian Army Malaria Inst, Brisbane, Qld, Australia.
   [Davis, Joseph B.; Muzari, Mutizwa O.] Queensland Govt, Dept Hlth, Cairns & Hinterland Hosp & Hlth Serv, Cairns, Australia.
   [van den Hurk, Andrew F.; Hall-Mendelin, Sonja] Queensland Govt, Dept Hlth, Forens & Sci Serv, Brisbane, Qld, Australia.
   [Hasty, Jeomhee M.] Hawaii Dept Hlth, Honolulu, HI USA.
   [Burkot, Thomas R.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.
   [Burkot, Thomas R.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia.
   [Bangs, Michael J.] Int SOS & PT Freeport Indonesia, Publ Hlth & Malaria Control Program, Papua, Indonesia.
   [Reimer, Lisa J.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Butafa, Charles] Minist Hlth, Honiara, Solomon Islands.
   [Lobo, Neil F.] Univ Notre Dame, Notre Dame, IN 46556 USA.
   [Syafruddin, Din] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Maung, Yan Naung Maung] Dept Med Res, Yangon, Myanmar.
   [Ahmad, Rohani] Inst Med Res, Med Entomol Unit, Kuala Lumpur, Malaysia.
   [Beebe, Nigel W.] CSIRO, Dutton Pk, Brisbane, Qld, Australia.
RP Maynard, AJ (corresponding author), Univ Queensland, Brisbane, Qld, Australia.
EM andrew.maynard@uqconnect.edu.au
RI van den Hurk, Andrew/X-9831-2019; Beebe, Nigel W/C-5610-2008
OI van den Hurk, Andrew/0000-0001-6262-831X; Beebe, Nigel
   W/0000-0003-2877-0691; Ambrose, Luke/0000-0003-4048-9616; Reimer,
   Lisa/0000-0002-9711-4981
FU Commonwealth Scientific and Industrial Research Organisation
   (CSIRO)Commonwealth Scientific & Industrial Research Organisation
   (CSIRO); Western Australia Department of Health (FIMMWA) [MBDC004]
FX The study was supported by the Commonwealth Scientific and Industrial
   Research Organisation (CSIRO) Cluster Collaboration Fund 'Urbanism,
   Climate Change and Health' as well as Western Australia Department of
   Health 'Funding initiatives for mosquito management in Western
   Australia' (FIMMWA, MBDC004). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Battaglia V, 2016, FRONT GENET, P7
   Beebe NW, 2007, J MED ENTOMOL, V44, P376, DOI 10.1603/0022-2585(2007)44[376:APCRDT]2.0.CO;2
   Beebe NW, 2005, COMMUN DIS INTELL, V29, P299
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006
   Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762
   Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x
   Birungi J, 2002, ANN ENTOMOLOGICAL SO, P95
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Clement M, 2002, TCS ESTIMATING GENEA
   Colless DH, 1962, P LINNEAN SOC NEW S, P312
   COOPER RD, 1994, J AUST ENTOMOL SOC, V33, P115
   Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763
   DFAT, 2016, SOL ISL
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ELLIOTT SA, 1980, T ROY SOC TROP MED H, V74, P747, DOI 10.1016/0035-9203(80)90192-3
   Excoffier L, 2010, MOL ECOLOGY RESOURCE, V10
   Frazer I, 1997, CONTEMP PACIFIC, V9, P39
   Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goubert C, 2016, HEREDITY
   Guillaumot L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-247
   Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   Huang Y-M, 1972, CONTR AM ENTOMOL I, V9, P109
   Hulce D., 2011, J BIOMOL TECH, V22, pS35, DOI DOI 10.1111/J.1556-4029.2010.01565.X
   Ismail NA, 2015, J AM MOSQUITO CONTR, V31, P305, DOI 10.2987/moco-31-04-305-312.1
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jombart T., TUTORIAL DISCRIMINAN
   Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LEE DJ, 1987, CULICIDAE AUSTRALASI, V4
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Linnaeus C, 1762, REISE NACH PALESTINA, V1749, P267
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Medley KA, 2015, MOL ECOLOGY, V24
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x
   Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Muzari MO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005286
   Nicholson J, 2014, J MED ENTOMOL, V51, P948, DOI 10.1603/ME14079
   Ong CW, 2016, INTERN MED J, V46, P525, DOI 10.1111/imj.13059
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x
   Piry S, 1999, J HEREDITY, V90
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Pritchard JK, 2000, GENETICS, V155, P945
   Pritchard JK, 2009, DOCUMENTATION STRUCT
   Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   RStudioTeam, 2015, RSTUDIO INT DEV R
   SCHOENIG E, 1972, Philippine Scientist, V9, P61
   Schug MD, 1998, MOL BIOL EVOL, V15, P1751, DOI 10.1093/oxfordjournals.molbev.a025901
   Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99
   Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013
   Skuse FAA, 1894, INDIAN MUSEUM NOTES, V3
   Sutton JT, 2011, MOL ECOL RESOUR, V11, P514, DOI 10.1111/j.1755-0998.2011.02981.x
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   Vazeille M, 2016, SCI REPORTS, V7, P6, DOI [10.1038/srep2964, DOI 10.1038/SREP2964]
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WALKER F, 1858, J P LINNEAN SOC LOND, V3, P77
   Williams CR, 2012, T ROY SOC SOUTH AUST, V136, P128, DOI 10.1080/03721426.2012.10887167
   Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5
   Zawani MKN, 2014, GENET MOL RES, V13, P8184, DOI 10.4238/2014.October.7.13
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 88
TC 22
Z9 24
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2017
VL 11
IS 4
AR e0005546
DI 10.1371/journal.pntd.0005546
PG 27
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1NH
UT WOS:000402256700066
PM 28410388
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, JHM
   Talyuli, OAC
   Goncalves, RLS
   Paiva-Silva, GO
   Sorgine, MHF
   Alvarenga, PH
   Oliveira, PL
AF Oliveira, Jose Henrique M.
   Talyuli, Octavio A. C.
   Goncalves, Renata L. S.
   Paiva-Silva, Gabriela Oliveira
   Sorgine, Marcos Henrique F.
   Alvarenga, Patricia Hessab
   Oliveira, Pedro L.
TI Catalase protects Aedes aegypti from oxidative stress and increases
   midgut infection prevalence of Dengue but not Zika
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DETOXIFICATION; OXIDASE; HEME; SUSCEPTIBILITY; IMMUNITY; INSECT; VIRUS
AB Background
   Digestion of blood in the midgut of Aedes aegypti results in the release of pro-oxidant molecules that can be toxic to the mosquito. We hypothesized that after a blood meal, the antioxidant capacity of the midgut is increased to protect cells against oxidative stress. Concomitantly, pathogens present in the blood ingested by mosquitoes, such as the arboviruses Dengue and Zika, also have to overcome the same oxidative challenge, and the antioxidant program induced by the insect is likely to influence infection status of the mosquito and its vectorial competence.
   Methodology/Principal findings
   We found that blood-induced catalase mRNA and activity in the midgut peaked 24 h after feeding and returned to basal levels after the completion of digestion. RNAi-mediated silencing of catalase (AAEL013407-RB) reduced enzyme activity in the midgut epithelia, increased H2O2 leakage and decreased fecundity and lifespan when mosquitoes were fed H2O2. When infected with Dengue 4 and Zika virus, catalase-silenced mosquitoes showed no alteration in infection intensity (number of plaque forming units/midgut) 7 days after the infectious meal. However, catalase knockdown reduced Dengue 4, but not Zika, infection prevalence (percent of infected midguts).
   Conclusion/Significance
   Here, we showed that blood ingestion triggers an antioxidant response in the midgut through the induction of catalase. This protection facilitates the establishment of Dengue virus in the midgut. Importantly, this mechanism appears to be specific for Dengue because catalase silencing did not change Zika virus prevalence. In summary, our data suggest that redox balance in the midgut modulates mosquito vectorial competence to arboviral infections.
C1 [Oliveira, Jose Henrique M.; Talyuli, Octavio A. C.; Goncalves, Renata L. S.; Paiva-Silva, Gabriela Oliveira; Sorgine, Marcos Henrique F.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Programa Biol Mol & Biotecnol, Lab Bioquim Artropodes Hematofagos, Rio De Janeiro, Brazil.
   [Paiva-Silva, Gabriela Oliveira; Sorgine, Marcos Henrique F.; Alvarenga, Patricia Hessab; Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
   [Alvarenga, Patricia Hessab] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo Meis, Lab Bioquim Resposta Estresse, Rio De Janeiro, Brazil.
   [Oliveira, Jose Henrique M.] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
   [Goncalves, Renata L. S.] Harvard Sch Publ Health, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA USA.
RP Oliveira, JHM (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Programa Biol Mol & Biotecnol, Lab Bioquim Artropodes Hematofagos, Rio De Janeiro, Brazil.; Oliveira, JHM (corresponding author), Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
EM jose.oliveira@ufsc.br
RI Alvarenga, Patricia Hessab/I-2272-2012; Oliveira, Pedro/A-9438-2010
OI /0000-0003-3814-5312; Oliveira, Pedro/0000-0003-0307-354X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia em Entomologia
   Molecular (INCTEM); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa de Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e
   Tecnologia em Entomologia Molecular (INCTEM); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES); and Fundacao de
   Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Bahia AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057014
   Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Citelli M, 2007, MOL BIOCHEM PARASIT, V151, P81, DOI 10.1016/j.molbiopara.2006.10.008
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   deAlmeidaNogueira NP, 2011, PLOS ONE, V6
   DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104
   Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gandara ACP, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160061
   Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645
   Goncalves R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048469
   Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311
   Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011
   Jaramillo-Gutierrez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011168
   Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100
   Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008
   Lara FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134779
   Lima VLA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038349
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nogueira NP, PLOS ONE
   Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9
   Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678
   Oliveira JHM, 2011, INSECT BIOCHEM MOLEC, V41, P349, DOI 10.1016/j.ibmb.2011.02.001
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058
   Paiva CN, 2014, ANTIOXID REDOX SIGN, V20, P1000, DOI 10.1089/ars.2013.5447
   Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sim C, 2011, J INSECT PHYSIOL, V57, P628, DOI 10.1016/j.jinsphys.2011.01.012
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8
   Walter-Nuno AB, 2013, J BIOL CHEM, V288, P29323, DOI 10.1074/jbc.M113.504985
   Winskill P, 2015, PLOS NEGLECT TROP D, V9, P1
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
NR 55
TC 20
Z9 20
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2017
VL 11
IS 4
AR e0005525
DI 10.1371/journal.pntd.0005525
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1NH
UT WOS:000402256700052
PM 28379952
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ali, A
   Wahid, B
   Rafique, S
   Idrees, M
AF Ali, Amjad
   Wahid, Braira
   Rafique, Shazia
   Idrees, Muhammad
TI Advances in research on Zika virus
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
DE Zika virus; Molecular evolution; Neurological complications;
   Transmission; Diagnosis; Pathogenesis
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; STRUCTURAL BASIS; WEST-NILE;
   INFECTION; OUTBREAK; DENGUE; VACCINE; BRAIN; LEADS
AB Zika virus (ZIKV) is rapidly spreading across the America and its devastating outcomes for pregnant women and infants have driven this previously ignored pathogen into the limelight. Clinical manifestations are fever, joint pain or rash and conjunctivitis. Emergence of ZIKV started with a first outbreak in the Pacific area in 2007, a second large outbreak occurred in the Pacific in 2013/2014 and subsequently the virus spread in other Pacific islands. Threat of explosive global pandemic and severe clinical complications linked with the more immediate and recurrent epidemics necessitate the development of an effective vaccine. Several vaccine platforms such as DNA vaccine, recombinant subunit vaccine, ZIKV purified inactivated vaccine, and chimeric vaccines have shown potent efficacy in vitro and in vivo trials. Moreover, number of drugs such as Sofosbuvir, BCX4450, NITD008 and 7-DMA are ready to enter phase I clinical trial because of proven anti-ZIKV activity. Monoclonal based antibodies offer promise as an intervention effective for use in pregnant women. In this review, we describe the advances in research on ZIKV such as research strategies for the development of antiviral drugs & vaccines, molecular evolution, epidemiology emergence. neurological complications and other teratogenic outcomes as well as pathogenesis.
C1 [Ali, Amjad; Wahid, Braira; Rafique, Shazia; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore 53700, Pakistan.
   [Idrees, Muhammad] Hazara Univ, Mansehra, Pakistan.
RP Idrees, M (corresponding author), Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore 53700, Pakistan.; Idrees, M (corresponding author), Hazara Univ, Mansehra, Pakistan.
EM Idrees.camb@pu.edu.pk
RI Idrees, Muhammad/K-6032-2012; amsalu, ribka/G-8780-2019
OI Idrees, Muhammad/0000-0002-3081-7631; 
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Awasthi S., 2016, J ANTIVIR ANTIRETROV, V8, P61, DOI DOI 10.4172/JAA.1000E130
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Bullerdiek J, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0240-1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Colt S, B WHO
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Melo Freire C. C., 2015, SPREAD PANDEMIC ZIKA
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ghouzzi VE, 2016, CELL DEATH DIS, V7, P266
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kuperman AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0636-0
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V10
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Narayanan R, 2016, MOJ PROTEOM BIOINFOR, V3
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Perez S, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.24.30261, DOI 10.2807/1560-7917.E5.2016.21.24.30261]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Renault P, 2012, MED MALADIES INFECT, V42, P93, DOI 10.1016/j.medmal.2011.12.002
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Ubogu EE, 2015, ACTA NEUROPATHOL, V130, P445, DOI 10.1007/s00401-015-1466-4
   Sallent LV, 2016, MED CLIN-BARCELONA, V147, P300, DOI 10.1016/j.medcli.2016.03.012
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wahid B, 2016, ASIAN PAC J TROP MED, V9, P723, DOI 10.1016/j.apjtm.2016.06.019
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weltman J., 2016, J MED MICROB DIAGN, V5, DOI [10.4172/2161-0703.1000228, DOI 10.4172/2161-0703.1000228]
   Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 91
TC 14
Z9 14
U1 1
U2 13
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD APR
PY 2017
VL 10
IS 4
BP 301
EP 312
DI 10.1016/j.apjtm.2017.03.020
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EU7NH
UT WOS:000401221000001
PM 28552102
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU da Silva, JLR
   Schwalm, FU
   Silva, CE
   da Costa, M
   Heermann, R
   da Silva, OS
AF Rosa da Silva, Joao Luiz
   Schwalm, Fernanda Undurraga
   Silva, Carlos Eugenio
   da Costa, Marisa
   Heermann, Ralf
   da Silva, Onilda Santos
TI Larvicidal and Growth-Inhibitory Activity of Entomopathogenic Bacteria
   Culture Fluids Against Aedes aegypti (Diptera: Culicidae)
SO JOURNAL OF ECONOMIC ENTOMOLOGY
LA English
DT Article
DE Xenorhabdus nematophila; Photorhabdus luminescens; mosquito; larvicidal
   activity; biopesticide
ID CHIKUNGUNYA VIRUS; INSECTICIDAL TOXIN; PHOTORHABDUS; XENORHABDUS;
   DENGUE; METABOLITES; ALBOPICTUS; COMPLEX; SUSCEPTIBILITY; TRANSMISSION
AB Dengue, Chikungunya, and Zika are important vector-borne diseases, and Aedes aegypti L. is their main transmitter. As the disease management is mainly based on mosquito control strategies, the search for alternative and cost-effective approaches is ongoing. The Gram-negative bacteria Xenorhabdus nematophila and Photorhabdus luminescens are symbiotically associated with entomopathogenic nematodes and are highly pathogenic for insect larvae. After we have recently confirmed the toxicity of these bacteria in Ae. aegypti larvae, we here evaluated the toxic activity of culture fluids on the development of this mosquito species. Larval susceptibility was assessed by exposing larvae to different concentrations of P. luminescens or X. nematophila culture fluids to confirm whether secondary metabolites might cause the mosquitos' death. Xenorhabdus nematophila culture fluid was more effective and stable during the mosquito pathogenicity bioassays compared to that of P. luminescens. Larval mortality started a few hours after exposure of the insects to the fluids. Furthermore, the residual effect of larvicidal activity of X. nematophila fluid persisted at full efficiency for 4 d. Particularly, larval mortality was still higher than 50% for up to 8 d. Exposure of larvae to a sublethal dose of X. nematophila fluid delayed pupation as well as emergence of adult mosquitoes and caused cumulative larval mortality higher than 90% by day 14. Here, we describe for the first time the use of stable culture fluids and therefore secondary metabolites of P. luminescens and X. nematophila as a promising basis for the use as biopesticide for control of Ae. aegypti in the future.
C1 [Rosa da Silva, Joao Luiz; Schwalm, Fernanda Undurraga; Silva, Carlos Eugenio; da Costa, Marisa; da Silva, Onilda Santos] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Microbiol Imunol & Parasitol, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
   [Heermann, Ralf] Ludwig Maximilians Univ Munchen, Biozentrum, Bereich Mikrobiol, Grosshaderner Str 2-4, D-82152 Martinsried, Germany.
RP da Silva, OS (corresponding author), Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Microbiol Imunol & Parasitol, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
EM ralf.heermann@lrz.uni-muenchen.de; onilda.silva@ufrgs.br
RI da Silva, Onilda Santos/AAE-7457-2020; Heermann, Ralf/E-1793-2013; da
   Silva, Onilda Santos/K-3606-2013
OI Heermann, Ralf/0000-0003-0631-6156; 
FU Brazilian Agency "Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico" (CNPq)National Council for Scientific and Technological
   Development (CNPq); Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [HE-5247/4-2]
FX The first author would like to thank the Brazilian Agency "Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) for
   scholarship.; Research of R.H. was supported by the Deutsche
   Forschungsgemeinschaft (HE-5247/4-2). We thank Dr. Frank Landgraf for
   critical reading of the manuscript.
CR Ahantarig A, 2009, APPL ENVIRON MICROB, V75, P4627, DOI 10.1128/AEM.00221-09
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Blackburn M, 1998, APPL ENVIRON MICROB, V64, P3036
   Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037
   Bowen DJ, 1998, APPL ENVIRON MICROB, V64, P3029
   Burt F, 2014, LANCET INFECT DIS, V14, P789, DOI 10.1016/S1473-3099(14)70869-2
   Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909
   da Silva OS, 2013, PARASITOL RES, V112, P2891, DOI 10.1007/s00436-013-3460-x
   Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019
   Finney D.T., 1971, PROBIT ANAL
   Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645
   Fodor A., 2008, IOBC WPRS B INSECT P, P157
   Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Higgs S, 2014, VECTOR-BORNE ZOONOT, V14, P535, DOI 10.1089/vbz.2014.14.8.edit
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Ji D, 2004, FEMS MICROBIOL LETT, V239, P241, DOI 10.1016/j.femsle.2004.08.041
   Jindal H, 2014, HUM VACC IMMUNOTHER, V10, P2245, DOI 10.4161/hv.28953
   Konan LY, 2012, VECTOR-BORNE ZOONOT, V12, P325, DOI 10.1089/vbz.2011.0617
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LACEY L. A., 1997, MANUAL TECHNIQUES IN
   Li J., 1998, CHEM HETEROCYCL COMP, V34, P1331
   LI JX, 1995, J NAT PRODUCTS, V58, P1081, DOI 10.1021/np50121a016
   MCINERNEY BV, 1991, J NAT PROD, V54, P785, DOI 10.1021/np50075a006
   MCINERNEY BV, 1991, J NAT PROD, V54, P774, DOI 10.1021/np50075a005
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Patil CD, 2013, PARASITOL RES, V112, P3283, DOI 10.1007/s00436-013-3507-z
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pontes RJS, 2005, REV SOC BRAS MED TRO, V38, P316, DOI 10.1590/S0037-86822005000400007
   Prophiro JS, 2011, REV SOC BRAS MED TRO, V44, P300, DOI [10.1590/s0037-86822011005000025, 10.1590/S0037-86822011005000025]
   Sheets JJ, 2011, J BIOL CHEM, V286, P22742, DOI 10.1074/jbc.M111.227009
   Shrestha YK, 2012, J INVERTEBR PATHOL, V109, P91, DOI 10.1016/j.jip.2011.10.011
   Shrestha YK, 2011, J ASIA-PAC ENTOMOL, V14, P127, DOI 10.1016/j.aspen.2010.10.007
   Pontes RJS, 2010, MEM I OSWALDO CRUZ, V105, P220, DOI 10.1590/S0074-02762010000200019
   Soo KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154760
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Thanwisai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043835
   THOMAS GM, 1979, INT J SYST BACTERIOL, V29, P352, DOI 10.1099/00207713-29-4-352
   Trip RA., 2016, EXPERT REV VACCINES, V6, P1
   Valerio Sallent L., 2016, MED CLIN BARC
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vorou R., 2016, INT J INFECT DIS, V18
   WALTHER CJ, 1986, APPL ENVIRON MICROB, V52, P650, DOI 10.1128/AEM.52.4.650-653.1986
   WHO, 1981, WHOVBC81 WHO
NR 46
TC 5
Z9 5
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-0493
EI 1938-291X
J9 J ECON ENTOMOL
JI J. Econ. Entomol.
PD APR
PY 2017
VL 110
IS 2
BP 378
EP 385
DI 10.1093/jee/tow224
PG 8
WC Entomology
SC Entomology
GA EV0WY
UT WOS:000401468700008
PM 28062794
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus infection in pregnancy and impact
SO REVISTA CHILENA DE INFECTOLOGIA
LA English
DT Letter
C1 [Joob, Beuy] Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Med Acad Ctr, Bangkok, Thailand.
CR Coronell-Rodriguez W, 2016, REV CHIL INFECTOL, V33, P665, DOI 10.4067/S0716-10182016000600009
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 4
PU SOC CHILENA INFECTOLOGIA
PI PROVIDENCIA
PA BERNARDA MORIN 488, 2 PISO, PROVIDENCIA, SANTIAGO 00000, CHILE
SN 0716-1018
EI 0717-6341
J9 REV CHIL INFECTOL
JI Rev. Chil. Infectol.
PD APR
PY 2017
VL 34
IS 2
BP 194
EP 194
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA EU1TJ
UT WOS:000400803900017
PM 28632838
OA Bronze, Other Gold
DA 2020-07-08
ER

PT J
AU Wang, JZ
   Guo, XH
   Xu, DG
AF Wang, Jing-Zhang
   Guo, Xin-Hua
   Xu, Dian-Guo
TI Anatomical, animal, and cellular evidence for Zika-induced pathogenesis
   of fetal microcephaly
SO BRAIN & DEVELOPMENT
LA English
DT Review
DE Zika virus; Microcephaly; Human pathology; Animal neural development;
   Neuro-cytotoxicity
ID COMPOUND HETEROZYGOUS MUTATIONS; VIRUS; ORGANOIDS; SIBLINGS; GROWTH
AB Several recent articles published by Brain and Development in 2016 demonstrated some rare, but innovative, genetic mechanisms for microcephaly. This concise mini-review presented another novel pathogenic mechanism for microcephaly, which has actually been a worldwide medical challenge since the World Health Organization (WHO) defined the outbreak of the Zika virus (ZIKV) as an International Public Health Emergency on 1 Feb, 2016. As a recent noteworthy clinical phenomenon, the ZIKV outbreak was accompanied by a dramatically increased number of microcephalus fetuses. However, no direct evidence supporting the suspected pathogenic effects of ZIKV on fetal microcephaly was shown previously before 2016. Herein, we evaluated the most important human pathological, animal developmental, and neuro-cytotoxic findings released in 2016, and highlighted the original experimental evidence that strengthens the potential link between ZIKV and the high incidence of microcephaly in new-born babies. Because killing mosquitoes via insecticides is currently the only effective way to suppress ZIKV-induced disorders, the animal and cellular models described in this mini-review are very beneficial to anti-ZIKV drug development and vaccine assessment. (C) 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Wang, Jing-Zhang; Guo, Xin-Hua; Xu, Dian-Guo] Hebei Univ Engn, Affiliated Hosp, Coll Med, Handan 056002, Hebei Province, Peoples R China.
RP Wang, JZ (corresponding author), Hebei Univ Engn, Dept Med Technol, Coll Med, Affiliated Hosp, 81 83 Cong Tai Rd, Handan 056002, Hebei Province, Peoples R China.
EM wangjingzhang1981@gmail.com
FU Science and Technology Department of Hebei Province of China
   [12276104D-58]
FX The authors gratefully thank the funding from Science and Technology
   Department of Hebei Province of China (No. 12276104D-58).
CR Asahina M, 2016, BRAIN DEV-JPN, V38, P337, DOI 10.1016/j.braindev.2015.09.006
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   England JD, 2016, J NEUROL SCI, V366, P125, DOI 10.1016/j.jns.2016.05.003
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hirabayashi S, 2016, BRAIN DEV-JPN, V38, P118, DOI 10.1016/j.braindev.2015.05.004
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Milone R, 2016, EUR J MED GENET, V59, P278, DOI 10.1016/j.ejmg.2016.03.003
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nozaki F, 2016, BRAIN DEV-JPN, V38, P678, DOI 10.1016/j.braindev.2016.01.003
   Pavone P, 2016, EUR J MED GENET, V59, P283, DOI 10.1016/j.ejmg.2016.03.002
   Pinto AM, 2016, BRAIN DEV-JPN, V38, P590, DOI 10.1016/j.braindev.2015.12.006
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Shimojima K, 2016, EUR J MED GENET, V59, P502, DOI 10.1016/j.ejmg.2016.09.008
   Yilmaz S, 2016, BRAIN DEV-JPN, V38, P124, DOI 10.1016/j.braindev.2015.06.004
NR 19
TC 2
Z9 3
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD APR
PY 2017
VL 39
IS 4
BP 294
EP 297
DI 10.1016/j.braindev.2016.10.012
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA ET3UH
UT WOS:000400204500002
PM 27876396
DA 2020-07-08
ER

PT J
AU John, CC
   Black, MM
   Nelson, CA
AF John, Chandy C.
   Black, Maureen M.
   Nelson, Charles A., III
TI Neurodevelopment: The Impact of Nutrition and Inflammation During Early
   to Middle Childhood in Low-Resource Settings
SO PEDIATRICS
LA English
DT Article
ID SCHOOL-AGE-CHILDREN; CONGENITAL CYTOMEGALOVIRUS-INFECTION; COGNITIVE
   FUNCTION; DEVELOPING-COUNTRIES; BRAIN-DEVELOPMENT; HIV-INFECTION;
   PRIMARY SCHOOLCHILDREN; SYSTEMIC INFLAMMATION; FALCIPARUM-MALARIA;
   HELMINTH INFECTION
AB The early to middle childhood years are a critical period for child neurodevelopment. Nutritional deficiencies, infection, and inflammation are major contributors to impaired child neurodevelopment in these years, particularly in low-resource settings. This review identifies global research priorities relating to nutrition, infection, and inflammation in early to middle childhood neurodevelopment. The research priority areas identified include: (1) assessment of how nutrition, infection, or inflammation in the preconception, prenatal, and infancy periods (or interventions in these periods) affect function in early to middle childhood; (2) assessment of whether effects of nutritional interventions vary by poverty or inflammation; (3) determination of the feasibility of preschool-and school-based integrated nutritional interventions; (4) improved assessment of the epidemiology of infection-and inflammation-related neurodevelopmental impairment (NDI); (5) identification of mechanisms through which infection causes NDI; (6) identification of noninfectious causes of inflammation-related NDI and interventions for causes already identified (eg, environmental factors); and (7) studies on the effects of interactions between nutritional, infectious, and inflammatory factors on neurodevelopment in early to middle childhood. Areas of emerging importance that require additional study include the effects of maternal Zika virus infection, childhood environmental enteropathy, and alterations in the child's microbiome on neurodevelopment in early to middle childhood. Research in these key areas will be critical to the development of interventions to optimize the neurodevelopmental potential of children worldwide in the early to middle childhood years.
C1 [John, Chandy C.] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, 1044 W Walnut St,R4 402D, Indianapolis, IN 46202 USA.
   [Black, Maureen M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA.
   [Black, Maureen M.] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA.
   [Black, Maureen M.] RTI Int, Res Triangle Pk, NC USA.
   [Nelson, Charles A., III] Boston Childrens Hosp, Labs Cognit Neurosci, Boston, MA USA.
   [Nelson, Charles A., III] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [Nelson, Charles A., III] Harvard Grad Sch Educ, Dept Human Dev, Cambridge, MA USA.
RP John, CC (corresponding author), Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, 1044 W Walnut St,R4 402D, Indianapolis, IN 46202 USA.
EM chjohn@iu.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development (NICHD) at the United States National Institutes of Health
   (NIH)
FX This supplement was supported by the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development (NICHD) at the United
   States National Institutes of Health (NIH).
CR Ahmed T, 2014, ANN NY ACAD SCI, V1332, P22, DOI 10.1111/nyas.12487
   Alimenti A, 2006, PEDIATRICS, V118, pE1139, DOI 10.1542/peds.2006-0525
   Allen LH, 2005, AM J CLIN NUTR, V81, p1206S
   Anjos T, 2013, EUR J NUTR, V52, P1825, DOI 10.1007/s00394-013-0560-4
   Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293
   Berlinski S, INTERAMERICAN DEV BA
   Best C, 2011, NUTR REV, V69, P186, DOI 10.1111/j.1753-4887.2011.00378.x
   Bhate V, 2008, FOOD NUTR BULL, V29, P249, DOI 10.1177/156482650802900401
   Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4
   Black MM, 2011, WOODHEAD PUBL FOOD S, P79
   Black MM, 2007, J CHILD PSYCHOL PSYC, V48, P764, DOI 10.1111/j.1469-7610.2007.01752.x
   Black MM, 2014, ANN NY ACAD SCI, V1308, P1, DOI 10.1111/nyas.12351
   Blair C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112393
   Blair C, 2014, DEV PSYCHOL, V50, P554, DOI 10.1037/a0033647
   Blanchette N, 2002, DEV NEUROPSYCHOL, V21, P223, DOI 10.1207/S15326942DN2103_1
   Bougma K, 2013, NUTRIENTS, V5, P1384, DOI 10.3390/nu5041384
   Calderon-Garciduenas L, 2011, BRAIN COGNITION, V77, P345, DOI 10.1016/j.bandc.2011.09.006
   Calderon-Garciduenas L, 2009, TOXICOL PATHOL, V37, P161, DOI 10.1177/0192623308329340
   Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x
   Christian P, 2010, JAMA-J AM MED ASSOC, V304, P2716, DOI 10.1001/jama.2010.1861
   Colombo J, 2014, J NUTR, V144, P1298, DOI 10.3945/jn.113.189365
   Crowell CS, 2015, AIDS, V29, P295, DOI 10.1097/QAD.0000000000000528
   Eilander A, 2010, AM J CLIN NUTR, V91, P115, DOI 10.3945/ajcn.2009.28376
   Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3
   Engle PL, 2011, J NUTR, V141, P508, DOI 10.3945/jn.110.130039
   Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fundaro C, 1998, AIDS PATIENT CARE ST, V12, P135, DOI 10.1089/apc.1998.12.135
   Gilmartin AA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0143
   Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4
   Grantham-McGregor SM, 2014, ANN NY ACAD SCI, V1308, P11, DOI 10.1111/nyas.12284
   Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707
   Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010
   Halliday KE, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001594
   Hoddinott J, 2013, AM J CLIN NUTR, V98, P1170, DOI 10.3945/ajcn.113.064584
   Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1
   Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]
   John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075
   Jomaa LH, 2011, NUTR REV, V69, P83, DOI 10.1111/j.1753-4887.2010.00369.x
   Keunen K, 2015, PEDIATR RES, V77, P148, DOI 10.1038/pr.2014.171
   Koekkoek S, 2008, EUR J PAEDIATR NEURO, V12, P290, DOI 10.1016/j.ejpn.2007.09.002
   KVALSVIG JD, 1991, ANN TROP MED PARASIT, V85, P551, DOI 10.1080/00034983.1991.11812608
   Le Doare K, 2012, PEDIATRICS, V130, pE1326, DOI 10.1542/peds.2012-0405
   Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053
   Lorntz B, 2006, PEDIATR INFECT DIS J, V25, P513, DOI 10.1097/01.inf.0000219524.64448.90
   Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004
   Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139
   McDonald CR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005140
   McLaughlin KA, 2015, P NATL ACAD SCI USA, V112, P5637, DOI 10.1073/pnas.1423363112
   Mireku MO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003463
   Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108
   Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633
   Nelson CA, 2008, J AM ACAD CHILD PSY, V47, P1252, DOI 10.1097/CHI.0b013e318185a6d8
   Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330
   Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590
   Nokes C, 1999, AM J TROP MED HYG, V60, P556, DOI 10.4269/ajtmh.1999.60.556
   NOKES C, 1992, P ROY SOC B-BIOL SCI, V247, P77, DOI 10.1098/rspb.1992.0011
   Nores M, 2010, ECON EDUC REV, V29, P271, DOI 10.1016/j.econedurev.2009.09.001
   Nowakowsk RS, 2012, DEV DYSLEXIA EARLY P
   Noyola DE, 2000, PEDIATR INFECT DIS J, V19, P505, DOI 10.1097/00006454-200006000-00003
   Olson CL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000533
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pasricha SR, 2013, LANCET GLOB HEALTH, V1, pE77, DOI 10.1016/S2214-109X(13)70046-9
   Pepper MR, 2011, SEMIN CELL DEV BIOL, V22, P619, DOI 10.1016/j.semcdb.2011.05.005
   Perera FP, 2005, NEUROTOXICOLOGY, V26, P573, DOI 10.1016/j.neuro.2004.07.007
   Pongcharoen T, 2012, ARCH PEDIAT ADOL MED, V166, P411, DOI 10.1001/archpediatrics.2011.1413
   Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102
   Puthanakit T, 2010, AIDS PATIENT CARE ST, V24, P141, DOI 10.1089/apc.2009.0314
   Rao N, ED RIGOROUS LIT REV
   Rao N, 2012, CHILD DEV, V83, P864, DOI 10.1111/j.1467-8624.2012.01746.x
   Rauh VA, 2004, NEUROTOXICOL TERATOL, V26, P373, DOI 10.1016/j.ntt.2004.01.002
   Reynolds AJ, 2008, ANNU REV CLIN PSYCHO, V4, P109, DOI 10.1146/annurev.clinpsy.3.022806.091411
   Sakti H, 1999, TROP MED INT HEALTH, V4, P322, DOI 10.1046/j.1365-3156.1999.00410.x
   Sandstead HH, 1998, AM J CLIN NUTR, V68, p470S, DOI 10.1093/ajcn/68.2.470S
   Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663
   Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008
   Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591
   Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111
   TARDIEU M, 1995, J PEDIATR-US, V126, P375, DOI 10.1016/S0022-3476(95)70451-5
   Tarleton JL, 2006, AM J TROP MED HYG, V74, P475, DOI 10.4269/ajtmh.2006.74.475
   Temple RO, 2000, J DEV BEHAV PEDIATR, V21, P417, DOI 10.1097/00004703-200012000-00003
   Vanderwert RE, 2016, DEV COGN NEUROS-NETH, V17, P68, DOI 10.1016/j.dcn.2015.12.004
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   Wachs TD, 2014, ANN NY ACAD SCI, V1308, P89, DOI 10.1111/nyas.12314
   Walker SP, 2015, J NUTR, V145, P823, DOI 10.3945/jn.114.200261
   Wang CM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2473081
   Whitehead N, 2014, AIDS CARE, V26, P497, DOI 10.1080/09540121.2013.841828
   Zhang XW, 2007, J CLIN VIROL, V40, P180, DOI 10.1016/j.jcv.2007.08.018
NR 90
TC 2
Z9 2
U1 0
U2 10
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD APR
PY 2017
VL 139
SU 1
DI 10.1542/peds.2016-2828H
PG 15
WC Pediatrics
SC Pediatrics
GA ET6AF
UT WOS:000400372000007
PM 28562249
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Vest, KG
AF Vest, Kelly G.
TI Zika Virus Update: More on an Emerging Arboviral Disease in the Western
   Hemisphere
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE Zika virus; microcephaly; neurologic disease; arbovirus; sexual
   transmission
ID UNITED-STATES; SEXUAL TRANSMISSION; INTERIM GUIDANCE
AB Zika virus has captivated the world with its quick spread throughout the Western Hemisphere. Increased emphasis has been placed on the infection of pregnant women and subsequent adverse and severe effects in the developing fetus and newborn. This article supplements a previous article and provides updated information on new and evolving evidence that strengthens the association between Zika virus and unique congenital and neurologic diseases, updates what is known about the epidemiology of the disease, and provides new and updated material for primary care providers as they counsel patients who may be exposed or infected. With the extent of disease spread, it is expected that Zika virus will become endemic to the Western Hemisphere and will change the public health parameters and approach in this area of the world.
C1 [Vest, Kelly G.] Uniformed Serv Univ Hlth Sci, Ctr Global Hlth Engagement, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.
RP Vest, KG (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Global Hlth Engagement, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.
EM kvest@cghe.org
CR American Academy of Neurology, ZIK VIR MAY NOW TIED
   American Association of Blood Banks, AM ASS BLOOD BANKS A
   [Anonymous], ZIK SIT REP ZIK VIR
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Centers for Disease Control and Prevention, HIV INF ZIK VIR
   Centers for Disease Control and Prevention, 2016, CDCS RESP ZIK EST RA
   Centers for Disease Control and Prevention, CONG MICR CAS DEF
   Centers for Disease Control and Prevention, 2016, MMWR MORB MORTAL WKL, V65
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS UN STAT
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Departamento de Salud de Puerto Rico, INF SEM ENF ARB
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Food and Drug Administration, FDA ALLOWS USE INV T
   Food and Drug Administration, DON SCREEN REC RED R
   Food and Drug Administration, REC DON SCREEN DEF P
   Food and Drug Administration. Emergency Use Authorizations, EM US AUTH TRIOPL RE
   Food and Drug Administration. Emergency Use Authorizations, EM US AUTH REALST ZI
   Food and Drug Administration. Emergency Use Authorizations, EM US AUTH ZIK MAC E
   Food and Drug Administration. Emergency Use Authorizations, EM US AUTH ZIK VIR R
   Garcez PP, SCIENCE, DOI [10.1126/science.aaf6116, DOI 10.1126/SCIENCE.AAF6116.]
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Major League Baseball, MLB MLBPA ANN POSTP
   Microcephaly Epidemic Research Group, 2016, EMERG INFECT DIS, V22
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naccache SN, BIORXIV, DOI [10.1101/049916, DOI 10.1101/049916]
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Occupational Safety and Health Administration National Institute for Occupational Safety and Health, INT GUID PROT WORK O
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization, ZIK EP UPDAT
   PAN Americna Health Organization, ZIK EP UPD
   Paul LM, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112.]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
NR 43
TC 2
Z9 2
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD APR
PY 2017
VL 11
IS 2
BP 163
EP 167
DI 10.1017/dmp.2016.105
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ET1CR
UT WOS:000400004000004
PM 28430097
OA Bronze
DA 2020-07-08
ER

PT J
AU Rosa, R
   Abbo, LM
   Kapur, G
   Paige, P
   Jean, R
   Rico, E
   Memon, AM
AF Rosa, Rossana
   Abbo, Lilian M.
   Kapur, Girish
   Paige, Peter
   Jean, Reynald
   Rico, Edhelene
   Memon, Abdul M.
TI Development and Implementation of a Zika Virus Disease Response Protocol
   at a Large Academic Medical Center
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE Zika; quality of health care; health care facilities; manpower; services
ID TRANSMISSION
AB The rapid spread of Zika virus represents a threat to public health and demands significant preparation from hospitals and health care systems. Establishment of procedures for the identification of cases of Zika virus infection is a fundamental aspect of response planning. We describe the steps taken in the development and implementation of a protocol for the diagnosis and management of suspected cases of Zika virus infection in a large academic medical center.
C1 [Rosa, Rossana] Jackson Mem Hosp, Dept Med, Miami, FL 33136 USA.
   [Rosa, Rossana; Abbo, Lilian M.] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA.
   [Abbo, Lilian M.] Jackson Hlth Syst, Dept Infect Control & Antimicrobial Stewardship, Miami, FL 33136 USA.
   [Kapur, Girish] Jackson Mem Hosp, Dept Emergency Med, Miami, FL 33136 USA.
   [Paige, Peter] Jackson Hlth Syst, Miami, FL 33136 USA.
   [Jean, Reynald; Rico, Edhelene] Florida Dept Hlth Miami Dade Cty, Miami, FL USA.
   [Memon, Abdul M.] Jackson Hlth Syst, Div Disaster & Emergency Preparedness, Miami, FL 33136 USA.
RP Memon, AM (corresponding author), Jackson Hlth Syst, Inst Annex Bldg Room 336, Miami, FL 33136 USA.; Rosa, R (corresponding author), Jackson Hlth Syst, Cent Bldg,Room 766, Miami, FL 33136 USA.
EM rossana.m.rosa@gmail.com; amemon@jhsmiami.org
CR [Anonymous], ZIK VIR COLL SUBM FE
   [Anonymous], CLIN GUID
   [Anonymous], 2016, GOV RICK DIR PUBL HL
   [Anonymous], 2015, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, 2016, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2016, CDC ISS INT TRAV GUI
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Department of Health Daily Zika Update, 2016, DEP HLTH DAIL ZIK UP
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 12
TC 1
Z9 1
U1 0
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD APR
PY 2017
VL 11
IS 2
BP 256
EP 258
DI 10.1017/dmp.2016.116
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ET1CR
UT WOS:000400004000017
PM 27431802
OA Bronze
DA 2020-07-08
ER

PT J
AU Heard-Garris, N
   Arora, S
   Lurie, N
AF Heard-Garris, Nia
   Arora, Sanjeev
   Lurie, Nicole
TI Building Physician Networks as Part of the Zika Response
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE communication; emergency preparedness; Zika; physician networks
ID DISEASE; CARE
AB The global community needs to easily identify and respond to new and reemerging threats, such as H1N1, Ebola, and most recently Zika. Clinicians are often the first-line providers to recognize these threats, but yet have few opportunities to learn from each other in real time. In this concept article, we describe the ways clinical information is traditionally shared during a public health emergency and then introduce new mechanisms to facilitate physician communication and learning as a part of the response to Zika.
C1 [Heard-Garris, Nia] Univ Michigan, Sch Med, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI USA.
   [Heard-Garris, Nia] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.
   [Arora, Sanjeev] Project ECHO, Albuquerque, NM USA.
   [Arora, Sanjeev] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA.
   [Lurie, Nicole] US Dept HHS, Washington, DC 20201 USA.
RP Heard-Garris, N (corresponding author), North Campus Res Complex,2800 Plymouth Rd,Bldg 14, Ann Arbor, MI 48109 USA.
EM niaheard@umich.edu
OI Heard-Garris, Nia J./0000-0002-2852-678X
CR Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370
   Arora S, 2011, HEALTH AFFAIR, V30, P1176, DOI 10.1377/hlthaff.2011.0278
   CDC, 2016, PREGN WOM AN LAB EV
   Dorsey ER, 2016, NEW ENGL J MED, V375, P154, DOI 10.1056/NEJMra1601705
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Ushahidi-Haiti at Tufts University, HAIT 2010 EARTHQ HAI
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
NR 7
TC 0
Z9 0
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD APR
PY 2017
VL 11
IS 2
BP 259
EP 261
DI 10.1017/dmp.2017.24
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ET1CR
UT WOS:000400004000018
PM 28430098
DA 2020-07-08
ER

PT J
AU Zayed, H
   Doss, CGP
   El Zowalaty, ME
AF Zayed, Hatem
   Doss, George Priya C.
   El Zowalaty, Mohamed Ezzat
TI Potential routes of spread of Zika virus to the Middle East, North
   Africa and Asia: action must be taken
SO FUTURE VIROLOGY
LA English
DT Editorial Material
ID AEDES-AEGYPTI; TRANSMISSION; INFECTIONS; NIGERIA; THREAT; BRAZIL; FEVER
C1 [Zayed, Hatem] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar.
   [Doss, George Priya C.] VIT Univ, Sch Biosci & Technol, Dept Integrat Biol, Vellore, Tamil Nadu, India.
   [El Zowalaty, Mohamed Ezzat] Univ KwaZulu Natal, Sch Hlth Sci, Westville Campus, ZA-4001 Durban, South Africa.
RP Zayed, H (corresponding author), Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar.; El Zowalaty, ME (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Westville Campus, ZA-4001 Durban, South Africa.
EM hatem.zayed@qu.edu.qa; elzow001@gmail.com
RI Zayed, Hatem/R-1800-2019
OI Zayed, Hatem/0000-0001-8838-6638; El Zowalaty,
   Mohamed/0000-0002-1056-4761; C, George Priya Doss/0000-0002-5971-8290
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caragata EP, 2016, FUTURE MICROBIOL, V11, P1499, DOI 10.2217/fmb-2016-0177
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, ZIK VIR CLIN EV DIS
   Dallas County Health and Human Services, DCHHS REP 1 ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, ZIK SUSP CONF CAS RE
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
NR 23
TC 1
Z9 1
U1 0
U2 4
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD APR
PY 2017
VL 12
IS 4
BP 159
EP 162
DI 10.2217/fvl-2016-0139
PG 4
WC Virology
SC Virology
GA ES6YZ
UT WOS:000399697900001
OA Bronze
DA 2020-07-08
ER

PT J
AU Pereira-Montecinos, C
   Valiente-Echeverria, F
   Soto-Rifo, R
AF Pereira-Montecinos, Camila
   Valiente-Echeverria, Fernando
   Soto-Rifo, Ricardo
TI Epitranscriptomic regulation of viral replication
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
LA English
DT Review
DE Epitranscriptomics; m(6)A; Gene expression; Viral replication; HIV-1;
   HCV; ZIKV
ID VESICULAR STOMATITIS-VIRUS; CONTAINING MESSENGER-RNA; TRANSLATIONAL
   CONTROL; RIBOSOMAL-RNA; METHYLATED NUCLEOSIDES; ADENOSINE DEAMINASES;
   MAPPING REVEALS; ENDONUCLEASE V; XENOPUS-LAEVIS; NUCLEAR-RNA
AB RNA plays central roles in biology and novel functions and regulation mechanisms are constantly emerging. To accomplish some of their functions within the cell, RNA molecules undergo hundreds of chemical modifications from which N6-methyladenosine (m(6)A), inosine (I), pseudouridine (psi) and 5-methylcytosine (5mC) have been described in eukaryotic mRNA. Interestingly, the m6A modification was shown to be reversible, adding novel layers of regulation of gene expression through what is now recognized as epitranscriptomics. The development of molecular mapping strategies coupled to next generation sequencing allowed the identification of thousand of modified transcripts in different tissues and under different physiological conditions such as viral infections. As intracellular parasites, viruses are confronted to cellular RNA modifying enzymes and, as a consequence, viral RNA can be chemically modified at some stages of the replication cycle. This review focuses on the chemical modifications of viral RNA and the impact that these modifications have on viral gene expression and the output of infection. A special emphasis is given to m(6)A, which was recently shown to play important yet controversial roles in different steps of the HIV-1, HCV and ZIKV replication cycles. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Pereira-Montecinos, Camila; Valiente-Echeverria, Fernando; Soto-Rifo, Ricardo] Univ Chile, Fac Med, Inst Biomed Sci, Mol & Cellular Virol Lab,Virol Program, Santiago 834100, Chile.
RP Soto-Rifo, R (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Mol & Cellular Virol Lab,Virol Program, Santiago 834100, Chile.
EM rsotorifo@med.uchile.cl
RI Valiente-Echeverria, Fernando/I-6881-2018
OI Valiente-Echeverria, Fernando/0000-0001-9156-2516
FU FONDECYT ProgramComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDECYT [1160176]; Anillo de Investigation
   en Ciencia y Tecnologia-PIA from CONICYT Chile [ACT1408]; Graduate
   School of the Faculty of Medicine at Universidad de Chile
FX Work at RSR laboratory is supported by the FONDECYT Program (Grant No.
   1160176) and Anillo de Investigation en Ciencia y Tecnologia-PIA ACT1408
   from CONICYT Chile. CPM holds a Doctoral fellowship from the Graduate
   School of the Faculty of Medicine at Universidad de Chile.
CR Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732
   ALONI Y, 1979, J VIROL, V32, P52, DOI 10.1128/JVI.32.1.52-60.1979
   Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008
   ARNEZ JG, 1994, BIOCHEMISTRY-US, V33, P7560, DOI 10.1021/bi00190a008
   Baker DL, 2005, GENE DEV, V19, P1238, DOI 10.1101/gad.1309605
   BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X
   Bass BL, 1997, RNA, V3, P947
   Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547
   BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X
   Bokar J.A., 2005, TOP CURR GENET, V12, P36
   Bokar JA, 1997, RNA, V3, P1233
   BOKAR JA, 1994, J BIOL CHEM, V269, P17697
   Breiling A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0016-6
   Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8
   Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0
   CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879
   Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802
   Charette M, 2000, IUBMB LIFE, V49, P341
   Charpentier B, 2005, NUCLEIC ACIDS RES, V33, P3133, DOI 10.1093/nar/gki630
   Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170
   Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647
   CHEN Y, 1993, BIOCHEMISTRY-US, V32, P10249, DOI 10.1021/bi00089a047
   Cheung MK, 2013, INT J OBESITY, V37, P744, DOI 10.1038/ijo.2012.77
   Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494
   Courtes FC, 2014, J BIOTECHNOL, V174, P16, DOI 10.1016/j.jbiotec.2014.01.024
   Cuevas JM, 2016, INFECT GENET EVOL, V41, P233, DOI 10.1016/j.meegid.2016.04.017
   Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020
   DAVIS FF, 1957, J BIOL CHEM, V227, P907
   DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Doria M, 2011, J GEN VIROL, V92, P1228, DOI 10.1099/vir.0.028043-0
   Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604
   Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626
   DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653
   DUBIN DT, 1977, VIROLOGY, V77, P457, DOI 10.1016/0042-6822(77)90471-8
   DUBIN DT, 1975, BIOCHEM BIOPH RES CO, V66, P1373, DOI 10.1016/0006-291X(75)90511-2
   Durbin AF, 2016, MBIO, V7, DOI 10.1128/mBio.00833-16
   Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3
   Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602
   Fray RG, 2015, CURR OPIN PLANT BIOL, V27, P17, DOI 10.1016/j.pbi.2015.05.015
   FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P1904, DOI 10.1073/pnas.72.5.1904
   Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002
   Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976
   Gray MW, 2012, BIOCHEMISTRY-US, V51, P5235, DOI 10.1021/bi300419r
   Grosjean H, 2005, TOP CURR GENET, V12, P1, DOI 10.1007/b106848
   HOTCHKISS RD, 1948, J BIOL CHEM, V175, P315
   HOUGH RF, 1994, J BIOL CHEM, V269, P9933
   Hussain S, 2013, GENOME BIOL, V14, DOI 10.1186/gb4143
   Jayan GC, 2002, J VIROL, V76, P12399, DOI 10.1128/JVI.76.23.12399-12404.2002
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165
   Kelley R.P.P.A.D.E., 1974, CELL, VI, P6
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566
   KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542
   Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732
   LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012
   Liao JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026463
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Licht K, 2016, J CELL BIOL, V213, P15, DOI 10.1083/jcb.201511041
   Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234
   Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070
   LUO GX, 1990, J VIROL, V64, P1021, DOI 10.1128/JVI.64.3.1021-1027.1990
   MADEN BEH, 1988, J MOL BIOL, V201, P289, DOI 10.1016/0022-2836(88)90139-8
   Martinez I, 2002, J GEN VIROL, V83, P1445, DOI [10.1099/vir.0.18337-0, 10.1099/0022-1317-83-6-1445]
   Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022
   Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012
   Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273
   MOSS B, 1977, J VIROL, V23, P234, DOI 10.1128/JVI.23.2.234-239.1977
   Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117
   MOYER SA, 1976, VIROLOGY, V70, P339, DOI 10.1016/0042-6822(76)90276-2
   NARAYAN P, 1987, MOL CELL BIOL, V7, P1572, DOI 10.1128/MCB.7.4.1572
   Newby MI, 2001, RNA, V7, P833, DOI 10.1017/S1355838201002308
   OHARA PJ, 1984, J VIROL, V49, P793, DOI 10.1128/JVI.49.3.793-798.1984
   Pape C, 2017, IEEE INT CONF COMP V, P1, DOI 10.1109/ICCVW.2017.7
   Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342
   Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120
   Phuphuakrat A, 2008, J VIROL, V82, P10864, DOI 10.1128/JVI.00238-08
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491
   POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004
   Popis MC, 2016, CURR OPIN ONCOL, V28, P65, DOI 10.1097/CCO.0000000000000252
   Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]
   REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8
   RESNICK RJ, 1983, PROG NUCLEIC ACID RE, V29, P214, DOI 10.1016/S0079-6603(08)60449-3
   Rojas-Araya B, 2015, VIRUSES-BASEL, V7, P4326, DOI 10.3390/v7082822
   Sarvestani ST, 2014, J VIROL, V88, P799, DOI 10.1128/JVI.01571-13
   Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710
   Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954
   Schattner P, 2006, RNA, V12, P15, DOI 10.1261/rna.2210406
   Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028
   Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047
   SHARMEEN L, 1991, P NATL ACAD SCI USA, V88, P8096, DOI 10.1073/pnas.88.18.8096
   SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8
   Shi HT, 2018, CRIT REV FOOD SCI, V58, P2164, DOI 10.1080/10408398.2017.1303769
   Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434
   SOMMER S, 1976, NUCLEIC ACIDS RES, V3, P749, DOI 10.1093/nar/3.3.749
   Spitale RC, 2015, NATURE, V527, P264, DOI 10.1038/nature15717
   Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144
   STOLTZFUS CM, 1976, J VIROL, V18, P586, DOI 10.1128/JVI.18.2.586-595.1976
   Suspene R, 2011, J VIROL, V85, P2458, DOI 10.1128/JVI.02138-10
   Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357
   Urban A, 2009, J BIOL CHEM, V284, P5845, DOI 10.1074/jbc.M807986200
   van den Hoogen BG, 2014, J GEN VIROL, V95, P1625, DOI 10.1099/vir.0.066100-0
   VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935
   Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271
   WAGNER RW, 1988, MOL CELL BIOL, V8, P770, DOI 10.1128/MCB.8.2.770
   Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041
   Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316
   Wu RF, 2016, MOL BIOTECHNOL, V58, P450, DOI 10.1007/s12033-016-9947-9
   Xiao M, 2009, RNA, V15, P176, DOI 10.1261/rna.1361509
   Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012
   Yang JH, 2003, IMMUNOLOGY, V109, P15, DOI 10.1046/j.1365-2567.2003.01598.x
   Zahn RC, 2007, J VIROL, V81, P457, DOI 10.1128/JVI.00067-06
   Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883
   Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377
   Zinshteyn B, 2009, WIRES SYST BIOL MED, V1, P202, DOI 10.1002/wsbm.10
NR 134
TC 2
Z9 2
U1 2
U2 24
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-9399
EI 1876-4320
J9 BBA-GENE REGUL MECH
JI Biochim. Biophys. Acta-Gene Regul. Mech.
PD APR
PY 2017
VL 1860
IS 4
BP 460
EP 471
DI 10.1016/j.bbagrm.2017.02.002
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA ES4MN
UT WOS:000399509500007
PM 28219769
DA 2020-07-08
ER

PT J
AU Cordel, N
   Birembaux, X
   Chaumont, H
   Delion, F
   Chosidow, O
   Tressieres, B
   Storck, CH
AF Cordel, Nadege
   Birembaux, Xavier
   Chaumont, Hugo
   Delion, Frederique
   Chosidow, Olivier
   Tressieres, Benoit
   Storck, Cecile Herrmann
TI Main Characteristics of Zika Virus Exanthema in Guadeloupe
SO JAMA DERMATOLOGY
LA English
DT Letter
C1 [Cordel, Nadege] Guadeloupe Univ Hosp, Dermatol & Internal Med Unit, BP 465, F-97159 Pointe a Pitre, Guadeloupe, France.
   [Cordel, Nadege] Antilles Univ, EA 4546, Pointe a Pitre, Guadeloupe, France.
   [Birembaux, Xavier] Off Paediat, Basseterre, Guadeloupe, France.
   [Chaumont, Hugo] Guadeloupe Univ Hosp, Dept Neurol, Pointe a Pitre, Guadeloupe, France.
   [Delion, Frederique] Guadeloupe Univ Hosp, Dept Pediat, Pointe a Pitre, Guadeloupe, France.
   [Chosidow, Olivier] Hop Henri Mondor, AP HP, Dept Dermatol, Creteil, France.
   [Tressieres, Benoit] Inserm CIC, Ctr Invest Clin Antilles Guyane, F-1424 Paris, France.
   [Storck, Cecile Herrmann] Guadeloupe Univ Hosp, Microbiol Lab, Pointe a Pitre, Guadeloupe, France.
RP Cordel, N (corresponding author), Guadeloupe Univ Hosp, Dermatol & Internal Med Unit, BP 465, F-97159 Pointe a Pitre, Guadeloupe, France.
EM nadege.cordel@chu-guadeloupe.fr
OI Chaumont, Hugo/0000-0002-1585-7512
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Misery L, 2014, EUR J DERMATOL, V24, P147, DOI 10.1684/ejd.2013.2189
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
NR 5
TC 9
Z9 9
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6068
EI 2168-6084
J9 JAMA DERMATOL
JI JAMA Dermatol.
PD APR 1
PY 2017
VL 153
IS 4
BP 326
EP 328
DI 10.1001/jamadermatol.2016.5442
PG 4
WC Dermatology
SC Dermatology
GA ES3JY
UT WOS:000399427100021
PM 28241170
OA Green Published
DA 2020-07-08
ER

PT J
AU Morrison, TE
   Diamond, MS
AF Morrison, Thomas E.
   Diamond, Michael S.
TI Animal Models of Zika Virus Infection, Pathogenesis, and Immunity
SO JOURNAL OF VIROLOGY
LA English
DT Review
DE Zika virus; animal models; flavivirus; viral pathogenesis
ID MALE SEXUAL TRANSMISSION; MOUSE MODEL; INTERFERON PROTECTS; VACCINE;
   MICE; BRAZIL; BRAIN; RHESUS; LEADS; PREGNANCY
AB Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that now causes epidemics affecting millions of people on multiple continents. The virus has received global attention because of some of its unusual epidemiological and clinical features, including persistent infection in the male reproductive tract and sexual transmission, an ability to cross the placenta during pregnancy and infect the developing fetus to cause congenital malformations, and its association with Guillain-Barre syndrome in adults. This past year has witnessed an intensive effort by the global scientific community to understand the biology of ZIKV and to develop pathogenesis models for the rapid testing of possible countermeasures. Here, we review the recent advances in and utility and limitations of newly developed mouse and nonhuman primate models of ZIKV infection and pathogenesis.
C1 [Morrison, Thomas E.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63130 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63130 USA.
RP Morrison, TE (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63130 USA.
EM Thomas.morrison@ucdenver.edu; diamond@borcim.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI08725, R01 AI073755, R01
   AI104972, P01AI106695]; Moderna; Visterra
FX This work was supported by NIH grants R01 AI08725 (T.E.M.) and R01
   AI073755, R01 AI104972, and P01AI106695 (M.S.D.).; M.S.D is a consultant
   for InBios, Aviana, and Visterra, a member of the Scientific Advisory
   Board of OraGene Moderna, and a recipient of research grants from
   Moderna and Visterra.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams Waldorf K.M., 2016, NAT MED
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, N ENGL J MED
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan JF, 2016, EBIOMEDICINE
   Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dos Santos T, 2016, N ENGL J MED
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandes NC, 2016, EXP TOXICOL PATHOL
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jimenez Corona ME, 2016, PLOS CURR
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247
   Kodati S, 2016, LANCET
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matsushima G. K., 1991, Immunological disorders in mice., P77
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2016, CLIN INFECT DIS
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Spindler KR, 2001, J VIROL, V75, P12039, DOI 10.1128/JVI.75.24.12039-12046.2001
   Stettler K., 2016, SCIENCE
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2016, CELL RES
   Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14
   Weger-Lucarelli J, 2016, J VIROL
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao H, 2016, CELL
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 115
TC 113
Z9 114
U1 0
U2 36
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2017
VL 91
IS 8
AR UNSP e00009
DI 10.1128/JVI.00009-17
PG 15
WC Virology
SC Virology
GA ES4AU
UT WOS:000399472200001
PM 28148798
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Vanya, M
AF Vanya, Melinda
TI Prevention of Zika virus and related complications
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE diagnosis; Guillain-Barre syndrome; microcephaly; prevention; treatment;
   Zika virus
ID TRANSMISSION; INFECTION
AB Zika virus disease is caused by a virus transmitted primarily by Aedes mosquitoes. People with Zika virus disease can have symptoms, including mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise, or headache. These symptoms normally last for 2-7 days. There is scientific consensus that Zika virus is a cause of microcephaly and Guillain-Barre syndrome. Association with other neurological complications are also being investigated. The aim of the present review is to summarize and discuss the evidence base data regarding Zika virus and related complications. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Vanya, Melinda] Univ Szeged, Fac Gen Med, Dept Obstet & Gynaecol, Albert Szent Gyorgyi Clin Ctr, Szeged, Hungary.
   [Vanya, Melinda] Mediteam Corp, Szeged, Hungary.
RP Vanya, M (corresponding author), Univ Szeged, Fac Gen Med, Dept Obstet & Gynaecol, Albert Szent Gyorgyi Clin Ctr, Szeged, Hungary.
EM vmelinda74@gmail.com
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Charrel RN, 2016, B WHO
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Mayor S, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5031
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Ticconi C, 2016, PATHOG GLOB HEALTH, P1
   WHO, 2015, GUID REG TRANSP INF
   World Health Organization, EM US ASS LIST EUAL
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
NR 21
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD APR
PY 2017
VL 28
IS 2
BP 75
EP 78
DI 10.1097/MRM.0000000000000096
PG 4
WC Microbiology
SC Microbiology
GA ES2BL
UT WOS:000399330600006
DA 2020-07-08
ER

PT J
AU Lowy, I
AF Lowy, Ilana
TI Leaking Containers: Success and Failure in Controlling the Mosquito
   Aedes aegypti in Brazil
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID ZIKA VIRUS; DENGUE; EPIDEMIC; HEALTH; TRANSMISSION; ERADICATION;
   REEMERGENCE; CHALLENGES; DISEASES; HISTORY
AB In 1958, the Pan American Health Organization declared that Brazil had successfully eradicated the mosquito Aedes aegypti, responsible for the transmission of yellow fever, dengue fever, chikungunya, and Zika virus. Yet in 2016 the Brazilian minister of health described the situation of dengue fever as "catastrophic." Discussing the recent epidemic of Zika virus, which amplified the crisis produced by the persistence of dengue fever, Brazil's president declared in January 2016 that "we are in the process of losing the war against the mosquito Aedes aegypti." I discuss the reasons for the failure to contain Aedes in Brazil and the consequences of this failure. A longue duree perspective favors a view of the Zika epidemic that does not present it as a health crisis to be contained with a technical solution alone but as a pathology that has the persistence of deeply entrenched structural problems and vulnerabilities.
C1 [Lowy, Ilana] Univ Paris V, CERMES INSERM 3, CNRS, EHESS, Paris, France.
RP Lowy, I (corresponding author), CERMES 3 Site CNRS, 7 Rue Guy Moquet, F-94801 Villejuif, France.
EM lowy@vjf.cnrs.fr
CR [Anonymous], 2016, TELEMUNDO       0126
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Benchimol JL, 2001, FEBRE AMARELA DOENCA
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831
   Castro A., 2010, PLAGUES EPIDEMICS IN, P231
   Costa ZG, 2011, REVISTA PAN AMAZONIC, V2, P11
   Cueto M., 2015, MED PUBLIC HLTH LATI
   CUETO M, 1994, MISSIONARIES SCI ROC
   Cueto Marcos, 2007, VALUE HLTH HIST PAN
   Cumming-Bruce N., 2016, NY TIMES
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Figueredo LTM, 2003, DENGUE B, V27, P25
   Fonseca C. O., 2001, FEBRE AMARELA DOENCA, P299
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Franco Odair, 1969, HIST FEBRE AMARELA B, P135
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Honein MA, 2016, NEW ENGL J MED, V375, P2393, DOI 10.1056/NEJMe1613368
   Lesser Jeffrey, 2016, NACLA REPORT AM, V48, P123, DOI [DOI 10.1080/10714839.2016.1201268, DOI 10.1080/10714839.2016.120168]
   Lotufo PA, 2016, SAO PAULO MED J, V134, P95, DOI 10.1590/1516-3180.2016.13421602
   Lowy I., 2001, VIRUS MOUSTIQUES MOD
   Magalhaes Rodrigo Cesar da Silva, 2016, ERRADICACAO AEDES AE, P148
   Margolis M., 2002, NEWSWEEK INT    0617, P60
   MARZOCHI KBF, 1994, MEM I OSWALDO CRUZ, V89, P235, DOI 10.1590/S0074-02761994000200023
   Moraes Helbio Fernandes, 1988, SUCAM SUA ORIG SUA H, VII, P23
   Morgan Lynn, 2009, ICONS LIFE CULTURAL
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Packard R M, 1994, Parassitologia, V36, P197
   Pan American Health Organization (PAHO), 1977, 30 M REG COMM WHO AM, P275
   Penna Maria Lucia F., 2003, Cad. Saúde Pública, V19, P305, DOI 10.1590/S0102-311X2003000100034
   Perelman J., 2010, FAVELA 4 DECADES LIV
   Pimenta D. N., 2015, DENGUE TEORIAS PRATI, P407
   Pinheiro F., 1997, Dengue Bulletin, V21, P16
   Reeves William, 1972, P S HELD 10 M PAHO A, p[7, 78]
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Roussef Dilma, 2016, INFOBAE AM      0129
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SAWYER WA, 1951, NEW ENGL J MED, V244, P217, DOI 10.1056/NEJM195102082440608
   SERUFO JC, 1993, REV SAUDE PUBL, V27, P157, DOI 10.1590/S0034-89101993000300002
   SHIDRAWI G R, 1957, Bull World Health Organ, V17, P377
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Soper F. L., 1977, VENTURES WORLD HLTH, P326
   SOPER FL, 1965, PUBLIC HEALTH REP, V80, P855, DOI 10.2307/4592559
   SOPER FL, 1965, AM J TROP MED HYG, V14, P887, DOI 10.4269/ajtmh.1965.14.887
   Soper FL, 1933, AM J HYG, V18, P555, DOI 10.1093/oxfordjournals.aje.a117967
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P645
   Soper FL, 1943, ANOPHELES GAMBIAE BR
   Soper Fred, 1942, ORG NATION WIDE ANTI
   Stepan N. L., 2011, ERADICATION RIDDING
   Stern AM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00081516
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Valle D, 2016, EPIDEMIOL SERV SAUDE, V25, P419, DOI [10.5123/S1679-49742016000200020, 10.5123/s1679-49742016000200020]
   Valle Denise, 2016, DENGUE TEORIAS PRATI, P407
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
NR 59
TC 10
Z9 10
U1 0
U2 11
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2017
VL 107
IS 4
BP 517
EP 524
DI 10.2105/AJPH.2017.303652
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ER4NC
UT WOS:000398775700023
PM 28207332
OA Green Published
DA 2020-07-08
ER

PT J
AU Rasanathan, JJK
   MacCarthy, S
   Diniz, D
   Torreele, E
   Gruskin, S
AF Rasanathan, Jennifer J. K.
   MacCarthy, Sarah
   Diniz, Debora
   Torreele, Els
   Gruskin, Sofia
TI Engaging Human Rights in the Response to the Evolving Zika Virus
   Epidemic
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID HEALTH
AB In late 2015, an increase in the number of infants born with microcephaly in poor communities in northeast Brazil prompted investigation of antenatal Zika infection as the cause. Zika now circulates in 69 countries, and has affected pregnancies of women in 29 countries.
   Public health officials, policymakers, and international organizations are considering interventions to address health consequences of the Zika epidemic. To date, public health responses have focused on mosquito vector eradication, sexual and reproductive health services, knowledge and technology including diagnostic test and vaccine development, and health system preparedness.
   We summarize responses to date and apply human rights and related principles including nondiscrimination, participation, the legal and policy context, and accountability to identify shortcomings and to offer suggestions for more equitable, effective, and sustainable Zika responses.
C1 [Rasanathan, Jennifer J. K.] Open Soc Fdn, Publ Hlth Program, New York, NY USA.
   [MacCarthy, Sarah] RAND Corp, Santa Monica, CA USA.
   [Diniz, Debora] Univ Brasilia, Fac Law, Brasilia, DF, Brazil.
   [Torreele, Els] Open Soc Fdn, Publ Hlth Program, Access Med & Innovat, New York, NY USA.
   [Gruskin, Sofia] Univ Southern Calif, Keck Sch Med, Gould Sch Law, Los Angeles, CA USA.
   [Gruskin, Sofia] Univ Southern Calif, Program Global Hlth & Human Rights, Inst Global Hlth, Los Angeles, CA USA.
RP Rasanathan, JJK (corresponding author), 224 W 57th St, New York, NY 10019 USA.
EM jjkrasanathan@gmail.com
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569
CR Aiken A, 2016, BJOG
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, CDC FDN PARTN LAUNCH
   [Anonymous], 2016, ALL WOM PREGN INF ZI
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brennan Hannah, 2013, HUMAN RIGHTS APPROAC
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, PREGN WOM LAB EV POS
   Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860
   Fried ST, 2016, LANCET GLOB HLTH BLO
   Gruskin S, 2007, LANCET, V370, P449, DOI 10.1016/S0140-6736(07)61200-8
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hotez PJ, 2016, NY TIMES
   Joint United Nations Programme on HIV/AIDS, 2015, SUST HUM RIGHTS RESP
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Maantay J, 2001, AM J PUBLIC HEALTH, V91, P1033, DOI 10.2105/AJPH.91.7.1033
   McNeil Jr Donald G., 2016, NY TIMES
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mutero CM, 2015, ENVIRON HEALTH PERSP, V123, P1145, DOI 10.1289/ehp.1408748
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Programme of Action of the International Conference on Population and Development, 1994, INT C POP DEV CAIR E
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sandy M., 2016, TIME             FEB
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Thomas Katie, 2016, NY TIMES
   Tobar G, 2016, NEWS NATL VICEMINIST
   UN Committee on Economic Social and Cultural Rights (CESCR), 2000, GEN COMM NO 14 RIGHT
   United Nations. General Assembly, 1966, INT COV CIV POL RIGH
   United Nations Human Rights Office of the High Commissioner, 2016, UPH WOM HUM RIGHTS E
   Women Enabled International, 2016, TALK POINTS ZIK MICR
   World Health Organization, ZIK VIR DIS
   World Health Organization, PLATF TECHN R D PREP
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Yale Law School, 2016, PET SEEKS PROT ZIK A
NR 38
TC 8
Z9 8
U1 1
U2 6
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2017
VL 107
IS 4
BP 525
EP 531
DI 10.2105/AJPH.2017.303658
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ER4NC
UT WOS:000398775700024
PM 28207337
OA Green Published
DA 2020-07-08
ER

PT J
AU Pinto-Diaz, CA
   Rodriguez, Y
   Monsalve, DM
   Acosta-Ampudia, Y
   Molano-Gonzalez, N
   Anaya, JM
   Ramirez-Santana, C
AF Pinto-Diaz, Carlos A.
   Rodriguez, Yhojan
   Monsalve, Diana M.
   Acosta-Ampudia, Yeny
   Molano-Gonzalez, Nicolas
   Anaya, Juan-Manuel
   Ramirez-Santana, Carolina
TI Autoimmunity in Guillain-Barre syndrome associated with Zika virus
   infection and beyond
SO AUTOIMMUNITY REVIEWS
LA English
DT Review
DE Autoimmune tautology; Polyautoimmunity; Mycoplasma pneumoniae;
   Witebsky's postulates; Colombia
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; MOTOR AXONAL NEUROPATHY; SEX-DIFFERENCES;
   PATIENT; DISEASE; ANTIBODIES; CYCLOPHOSPHAMIDE; SUSCEPTIBILITY;
   POLYMORPHISMS; PATHOGENESIS
AB Autoimmune diseases share common immunopathogenic mechanisms (i.e.; the autoimmune tautology), which explain the clinical similarities among them as well as their familial clustering. Guillain-Barre syndrome (GBS), an autoimmune peripheral neuropathy, has been recently associated with Zika virus (ZIKV) infection. Based on a series of cases, this review article provides a comparative analysis of GBS associated with ZIKV infection, contrasted with the general characteristics of GBS in light of the autoimmune tautology, including gender differences in prevalence, subphenotypes, polyautoimmunity, familial autoimmunity, age at onset, pathophysiology, ecology, genetics, ancestry, and treatment. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Pinto-Diaz, Carlos A.; Rodriguez, Yhojan; Monsalve, Diana M.; Acosta-Ampudia, Yeny; Molano-Gonzalez, Nicolas; Anaya, Juan-Manuel; Ramirez-Santana, Carolina] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-C-69, Bogota, Colombia.
RP Ramirez-Santana, C (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-C-69, Bogota, Colombia.
EM heily.ramirez@urosario.edu.co
RI Ramirez-Santana, Carolina/J-2363-2016; Anaya, Juan-Manuel/J-1960-2016;
   Monsalve, Diana M./J-2374-2016; Molano-Gonzalez, Nicolas/I-6806-2016;
   Acosta-Ampudia, Yeny/J-2401-2016
OI Ramirez-Santana, Carolina/0000-0003-2137-4899; Anaya,
   Juan-Manuel/0000-0002-6444-1249; Monsalve, Diana M./0000-0002-1145-1312;
   Rodriguez, Yhojan/0000-0002-0956-1491; Molano-Gonzalez,
   Nicolas/0000-0001-7002-8795; Acosta-Ampudia, Yeny/0000-0001-8491-9134
FU Universidad del Rosario [ABN-011]; Colciencias, Bogota,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [747-2016]
FX The authors thank the members of RAIZ project for contributions and
   fruitful discussion. This work was supported by Universidad del Rosario
   (ABN-011) and Colciencias (747-2016), Bogota, Colombia.
CR Acosta-Ampudia Y., 2016, MED BOGOTA, V38, P187
   Ali N, 2016, J COMMUNITY HOSP INT, V6, DOI 10.3402/jchimp.v6.30689
   Alvarez-Lario B, 2013, CLIN RHEUMATOL, V32, P1407, DOI 10.1007/s10067-013-2272-9
   Anaya JM, 2012, TAUTOLOGIA AUTOIMMUN
   Anaya JM., 2016, JOINT BONE SPINE
   Anaya JM, 2006, CLIN DEV IMMUNOL, V13, P185, DOI 10.1080/17402520600876762
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Anaya JM, 2016, AUTOIMMUN REV, V15, P833, DOI 10.1016/j.autrev.2016.06.005
   Anaya JM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00139
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Anaya JM, 2014, AUTOIMMUN REV, V13, P423, DOI 10.1016/j.autrev.2014.01.049
   Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004
   Aquil N, 2011, JCPSP-J COLL PHYSICI, V21, P179, DOI 03.2011/JCPSP.179181
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   ASBURY AK, 1990, ANN NEUROL, V27, pS2, DOI 10.1002/ana.410270703
   Awad A, 2010, MUSCLE NERVE, V42, P828, DOI 10.1002/mus.21830
   Barzegar M, 2012, ANN INDIAN ACAD NEUR, V15, P299, DOI 10.4103/0972-2327.104341
   BenSmith A, 1996, J NEUROL NEUROSUR PS, V61, P362, DOI 10.1136/jnnp.61.4.362
   Blum S, 2014, J PERIPHER NERV SYST, V19, P88, DOI 10.1111/jns5.12074
   Brannagan TH, 2003, J NEUROL SCI, V208, P39, DOI 10.1016/S0022-510X(02)00418-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73
   Caudie C, 2002, ANN BIOL CLIN-PARIS, V60, P589
   CHAUDHURI KR, 1989, BRIT J RHEUMATOL, V28, P440
   Cho YY, 2013, KOREAN J INTERN MED, V28, P724, DOI 10.3904/kjim.2013.28.6.724
   COOK SD, 1981, ANN NEUROL, V9, P70, DOI 10.1002/ana.410090712
   Departamento Administrativo Nacional de Estadistica (DANE), 2007, PROYECC POBL 2005 20
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433
   Gkogkolou P, 2017, SEVERE ANTIPHOSPHOLI, P1
   Guo Li, 2002, Zhonghua Nei Ke Za Zhi, V41, P381
   Ha-ou-nou FZ, 2014, REV MED INTERNE, V35, P65, DOI 10.1016/j.revmed.2012.11.010
   He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015
   Hsu TY, 2009, AM J EMERG MED, V27, DOI [10.1016/j.ajem.2008.11.006, DOI 10.1016/J.AJE7.2008.11.006]
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Jasti AK, 2016, EXPERT REV CLIN IMMU, V12, P1175, DOI 10.1080/1744666X.2016.1193006
   Jin PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131374
   Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856
   Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005
   Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0
   Kurmann PT, 2009, CLIN RHEUMATOL, V28, P93, DOI 10.1007/s10067-008-1017-7
   Li Xiangling, 2016, J Clin Med Res, V8, P555, DOI 10.14740/jocmr2550w
   Mendez PL, 2011, REUMATOL CLIN, V7, P401, DOI 10.1016/j.reuma.2011.01.009
   Lopez PH, 2010, J NEUROSCI, V30, P9533, DOI 10.1523/JNEUROSCI.2281-10.2010
   Louvet C, 2009, J EXP MED, V206, P507, DOI 10.1084/jem.20082113
   Magira EE, 2003, J IMMUNOL, V170, P3074, DOI 10.4049/jimmunol.170.6.3074
   Mahecha M. P., 2016, IMMUNOL RES
   Matsuki Y, 1999, INTERNAL MED, V38, P729, DOI 10.2169/internalmedicine.38.729
   MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P
   MILLETTE TJ, 1986, EUR NEUROL, V25, P397, DOI 10.1159/000116042
   Miyagawa S, 2000, BRIT J DERMATOL, V143, P1050, DOI 10.1046/j.1365-2133.2000.03942.x
   Mori M, 2000, BRAIN, V123, P2171, DOI 10.1093/brain/123.10.2171
   Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555
   Nadri Q, 2015, ANN SAUDI MED, V35, P263, DOI 10.5144/0256-4947.2015.263
   Naik KR, 2012, ANN INDIAN ACAD NEUR, V15, P44, DOI 10.4103/0972-2327.93278
   Nakajima H, 2001, Mod Rheumatol, V11, P155, DOI 10.3109/s101650170029
   Okoh HC, 2015, CASE REP RHEUMATOL, V2015
   Ortiz-Salas Paola, 2016, J Clin Neuromuscul Dis, V18, P1, DOI 10.1097/CND.0000000000000119
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perez-Fernandez OM, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/736384
   Peric S, 2016, J PERIPHER NERV SYST, V21, P105, DOI 10.1111/jns.12163
   Piliero PJ, 2003, CLIN INFECT DIS, V36, pE111, DOI 10.1086/368311
   Polizzi A, 2001, CLIN NEUROL NEUROSUR, V103, P151, DOI 10.1016/S0303-8467(01)00132-9
   Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882
   Rajeshwari GK, 2016, NATL MED J INDIA, V29, P14
   ROBSON MG, 1994, BRIT J RHEUMATOL, V33, P1074
   ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F
   Rupp A, 2013, J PERIPHER NERV SYST, V18, P75, DOI 10.1111/jns5.12011
   Santiago-Casas Y, 2013, LUPUS, V22, P324, DOI 10.1177/0961203313476358
   Schirmer L, 2016, J NEUROL, V263, P2105, DOI 10.1007/s00415-016-8237-6
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Shin ISJ, 2006, ARTHRITIS RHEUM-US, V54, P1429, DOI 10.1002/art.21814
   Shoenfeld Y, 1996, INT ARCH ALLERGY IMM, V109, P318, DOI 10.1159/000237258
   Sinha S, 2010, ACTA NEUROL SCAND, V122, P21, DOI 10.1111/j.1600-0404.2009.01229.x
   Smith L, 2015, SAMJ, S. Afr. med. j., V105, P876, DOI [10.7196/SAMJNEW.8768, 10.7196/SAMJnew.8768]
   Soliven B, 2014, ILAR J, V54, P282, DOI 10.1093/ilar/ilt054
   Srivastava A, 2016, CASE REP RHEUMATOL, V2016
   Stahl HD, 2000, CLIN RHEUMATOL, V19, P61
   Usuki S, 2010, J NEUROSCI RES, V88, P1651, DOI 10.1002/jnr.22330
   Vadasz Z, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-94
   Vaidya S, 1999, JCR-J CLIN RHEUMATOL, V5, P349, DOI 10.1097/00124743-199912000-00010
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   van Doorn PA, 2010, J CLIN IMMUNOL, V30, pS74, DOI 10.1007/s10875-010-9407-4
   van Laarhoven HWM, 2001, NEPHROL DIAL TRANSPL, V16, P840, DOI 10.1093/ndt/16.4.840
   Vetsch G, 2008, LANCET, V371, P1886, DOI 10.1016/S0140-6736(08)60803-X
   Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033
   Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802
   Wang JY, 2011, NEUROL SCI, V32, P515, DOI 10.1007/s10072-011-0579-3
   Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777
   Wu LY, 2012, J NEUROIMMUNOL, V243, P18, DOI 10.1016/j.jneuroim.2011.12.003
   Yang M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-5
   Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06
   Zhang B, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005848
NR 98
TC 21
Z9 21
U1 2
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD APR
PY 2017
VL 16
IS 4
BP 327
EP 334
DI 10.1016/j.autrev.2017.02.002
PG 8
WC Immunology
SC Immunology
GA ES1CT
UT WOS:000399266200001
PM 28216074
DA 2020-07-08
ER

PT J
AU Hamer, DH
   Wilson, ME
   Jean, J
   Chen, LH
AF Hamer, Davidson H.
   Wilson, Mary E.
   Jean, Jenny
   Chen, Lin H.
TI Epidemiology, Prevention, and Potential Future Treatments of Sexually
   Transmitted Zika Virus Infection
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Zika virus; Epidemiology; Sexual transmission; Semen
ID FRENCH-POLYNESIA; BORNE TRANSMISSION; MODEL; SEMEN; PERSISTENCE;
   OUTBREAK; LEADS
AB Purpose of Review While mosquitoes have been primarily responsible for outbreaks of Zika virus worldwide, most prominently in the Americas during 2015 and 2016, there has been increased recognition of the importance of sexual transmission. We review human reports and animal model studies of Zika sexual transmission and summarize potential therapeutic candidates.
   Recent Findings Male-to-female, male-to-male, and femaleto-male transmission has been reported, among unprotected sexual contacts of returning travelers. Human studies have shown the potential importance of long-term persistence of Zika virus in semen while animal models have begun to yield important insights into pathogenesis of Zika infection of the genital tract.
   Summary Adherence to federal and global guidelines for prevention of sexual transmission of Zika virus from travelers to their sexual partners represents the best strategy for reducing the risk of transmission outside of endemic areas. Active research on potential treatments may soon yield candidates for clinical trials.
C1 [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Crosstown 3rd Floor,801 Massachusetts Ave, Boston, MA 02118 USA.
   [Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.
   [Wilson, Mary E.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Wilson, Mary E.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Jean, Jenny] Boston Univ, Sch Med, Boston, MA 02118 USA.
   [Chen, Lin H.] Harvard Med Sch, Boston, MA USA.
   [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, Cambridge, MA USA.
RP Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.; Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Crosstown 3rd Floor,801 Massachusetts Ave, Boston, MA 02118 USA.; Hamer, DH (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.
EM dhamer@bu.edu
RI Hamer, Davidson/J-2020-2019
OI Hamer, Davidson/0000-0002-4700-1495; Chen, Lin/0000-0002-5684-8436
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carvalho CAM, BIORXIV
   CDC, 2016, ADV PEOPL LIV TRAV B
   CDC, INF TEST ZIK VIR
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyer L, 2016, J INFECT DIS, P1, DOI [10.1093/infdis/jiw226, DOI 10.1093/INFDIS/JIW226]
   Feranchuk S, 2016, BIORXIV, DOI [10.1101/060798, DOI 10.1101/060798]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, BIORXIV, V58883
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2016, CLIN INFECT DIS
   Sacramento CQ, 2016, BIORXIV
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, WHOZIKVMOC161
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 65
TC 20
Z9 20
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD APR
PY 2017
VL 19
IS 4
AR 16
DI 10.1007/s11908-017-0571-z
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA ES0TF
UT WOS:000399238700002
PM 28281082
DA 2020-07-08
ER

PT J
AU Gerold, G
   Bruening, J
   Weigel, B
   Pietschmann, T
AF Gerold, Gisa
   Bruening, Janina
   Weigel, Bettina
   Pietschmann, Thomas
TI Protein Interactions during the Flavivirus and Hepacivirus Life Cycle
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Review
ID HEPATITIS-C-VIRUS; WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS;
   TICK-BORNE ENCEPHALITIS; YELLOW-FEVER VIRUS; ANTIBODY-DEPENDENT
   ENHANCEMENT; HUMAN DENDRITIC CELLS; DENGUE-VIRUS; ZIKA VIRUS; DC-SIGN
AB Protein-protein interactions govern biological functions in cells, in the extracellular milieu, and at the border between cells and extracellular space. Viruses are small intracellular parasites and thus rely on protein interactions to produce progeny inside host cells and to spread from cell to cell. Usage of host proteins by viruses can have severe consequences e.g. apoptosis, metabolic disequilibria, or altered cell proliferation and mobility. Understanding protein interactions during virus infection can thus educate us on viral infection and pathogenesis mechanisms. Moreover, it has led to important clinical translations, including the development of new therapeutic and vaccination strategies. Here, we will discuss protein interactions of members of the Flaviviridae family, which are small enveloped RNA viruses. Dengue virus, Zika virus and hepatitis C virus belong to the most prominent human pathogenic Flaviviridae. With a genome of roughly ten kilobases encoding only ten viral proteins, Flaviviridae display intricate mechanisms to engage the host cell machinery for their purpose. In this review, we will highlight how dengue virus, hepatitis C virus, Japanese encephalitis virus, tick-borne encephalitis virus, West Nile virus, yellow fever virus, and Zika virus proteins engage host proteins and how this knowledge helps elucidate Flaviviridae infection. We will specifically address the protein composition of the virus particle as well as the protein interactions during virus entry, replication, particle assembly, and release from the host cell. Finally, we will give a perspective on future challenges in Flaviviridae interaction proteomics and why we believe these challenges should be met.
C1 [Gerold, Gisa; Bruening, Janina; Weigel, Bettina; Pietschmann, Thomas] Med Sch Hannover & Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Inst Expt Virol, Hannover, Germany.
RP Gerold, G (corresponding author), Med Sch Hannover & Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Inst Expt Virol, Hannover, Germany.
EM gisa.gerold@twincore.de
RI Pietschmann, Thomas/E-9241-2015
OI Pietschmann, Thomas/0000-0001-5138-6239; Gerold,
   Gisa/0000-0002-1326-5038; Bruning, Janina/0000-0002-8111-6122
FU German Research Foundation (DFG)German Research Foundation (DFG) [GE
   2145/3-1, SFB 900]; Helmholtz AssociationHelmholtz Association [SO-024]
FX This work was supported by fellowships from the German Research
   Foundation (DFG, GE 2145/3-1 and SFB 900, project A6) and the Helmholtz
   Association SO-024. Authors declare no conflict of interest.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09
   Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16
   BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200
   Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06
   BORROW P, 1992, J VIROL, V66, P7270, DOI 10.1128/JVI.66.12.7270-7281.1992
   Bukh J, 2016, J HEPATOL, V65, pS2, DOI 10.1016/j.jhep.2016.07.035
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Cabrera-Hernandez A, 2007, J MED VIROL, V79, P386, DOI 10.1002/jmv.20786
   Callens N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005476
   Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005
   Carpp LN, 2014, MOL CELL PROTEOMICS, V13, P2836, DOI 10.1074/mcp.M114.038984
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Chu JJH, 2003, VIROLOGY, V312, P458, DOI 10.1016/S0042-6822(03)00261-7
   Ciczora Y, 2005, J GEN VIROL, V86, P2793, DOI 10.1099/vir.0.81140-0
   Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06
   Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Corless L, 2010, J GEN VIROL, V91, P362, DOI 10.1099/vir.0.017285-0
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66
   Munoz MD, 2013, BIOMED RES INT, DOI 10.1155/2013/875958
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168
   El Omari K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5874
   Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06
   Fukuhara T, 2015, TRENDS MICROBIOL, V23, P618, DOI 10.1016/j.tim.2015.07.007
   Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534
   Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Gerold G, 2016, VIRUS RES, V218, P25, DOI 10.1016/j.virusres.2015.09.006
   Gerold G, 2015, CELL REP, V12, P864, DOI 10.1016/j.celrep.2015.06.063
   Gerold G, 2014, DIGEST DIS, V32, P525, DOI 10.1159/000360830
   Gonzalez O, 2009, HEPATOLOGY, V50, P1756, DOI 10.1002/hep.23232
   Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027
   GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993
   GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2010, CLIN INFECT DIS, V50, P1155, DOI 10.1086/651271
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Hosp F, 2015, MOL CELL PROTEOMICS, V14, P2030, DOI 10.1074/mcp.O115.049460
   Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104
   Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117
   Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876
   Kong L, 2016, J VIROL, V90, P3093, DOI 10.1128/JVI.01540-15
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Law GL, 2013, NAT REV MICROBIOL, V11, P455, DOI 10.1038/nrmicro3036
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098
   Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200
   Lum KK, 2016, EXPERT REV PROTEOMIC, V13, P325, DOI 10.1586/14789450.2016.1147353
   Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341
   Lussignol M, 2016, P NATL ACAD SCI USA, V113, P2484, DOI 10.1073/pnas.1518934113
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557
   Mercado-Curiel RF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-118
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monteiro J, 2016, CELL, V167, P39, DOI 10.1016/j.cell.2016.08.046
   Montpellier C, 2011, J BIOL CHEM, V286, P13954, DOI 10.1074/jbc.M111.220103
   Moradpour D, 2016, J HEPATOL, V65, pS143, DOI 10.1016/j.jhep.2016.07.026
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0
   Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Ploen D, 2013, EUR J CELL BIOL, V92, P374, DOI 10.1016/j.ejcb.2013.12.003
   Ploen D, 2013, J HEPATOL, V58, P1081, DOI 10.1016/j.jhep.2013.01.022
   Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684
   Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rosch K, 2016, CELL REP, V16, P3219, DOI 10.1016/j.celrep.2016.08.052
   Ross-Thriepland D, 2015, J VIROL, V89, P3123, DOI 10.1128/JVI.02995-14
   Rychlowska M, 2011, J GEN VIROL, V92, P2249, DOI 10.1099/vir.0.034314-0
   Sakoonwatanyoo P, 2006, INTERVIROLOGY, V49, P161, DOI 10.1159/000089377
   Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283
   SalasBenito JS, 1997, J VIROL, V71, P7246, DOI 10.1128/JVI.71.10.7246-7252.1997
   Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Schoneberg J, 2017, NAT REV MOL CELL BIO, V18, P5, DOI 10.1038/nrm.2016.121
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sharma NR, 2011, J BIOL CHEM, V286, P30361, DOI 10.1074/jbc.M111.263350
   Shimojima M, 2014, ARCH VIROL, V159, P2023, DOI 10.1007/s00705-014-2042-2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DR, 2012, INSECT MOL BIOL, V21, P1, DOI 10.1111/j.1365-2583.2011.01098.x
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08
   Suss J, 2010, TICKS TICK-BORNE DIS, V1, P1, DOI [10.1016/j.ttbdis.2010.01.003, 10.1016/j.ttbdis.2010.10.007]
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Tamai K, 2012, VIROLOGY, V422, P377, DOI 10.1016/j.virol.2011.11.009
   Tan JL, 2014, METHODS MOL BIOL, V1138, P41, DOI 10.1007/978-1-4939-0348-1_4
   Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   TAUTZ N, 1994, J VIROL, V68, P3289, DOI 10.1128/JVI.68.5.3289-3297.1994
   Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Tripathi LP, 2013, J PROTEOME RES, V12, P2537, DOI 10.1021/pr3011217
   Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Valentine G, 2016, EXPERT REV ANTI-INFE, V14, P1127, DOI 10.1080/14787210.2016.1245614
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Vogt A, 2013, VIROLOGY, V444, P1, DOI 10.1016/j.virol.2013.05.036
   Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302
   Voisset C, 2004, BIOL CELL, V96, P413, DOI 10.1016/j.biolcel.2004.03.008
   Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309
   Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087
   Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10
   Yamamoto S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005610
   Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhu YZ, 2012, VIROLOGY, V429, P112, DOI 10.1016/j.virol.2012.03.002
   Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006
NR 199
TC 20
Z9 22
U1 0
U2 17
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD APR
PY 2017
VL 16
IS 4
SU 1
BP S75
EP S91
DI 10.1074/mcp.R116.065649
PG 17
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA ER5AE
UT WOS:000398812800008
PM 28077444
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Benelli, G
   Govindarajan, M
   Rajeswary, M
   Senthilmurugan, S
   Vijayan, P
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
AF Benelli, Giovanni
   Govindarajan, Marimuthu
   Rajeswary, Mohan
   Senthilmurugan, Sengamalai
   Vijayan, Periasamy
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
TI Larvicidal activity of Blumea eriantha essential oil and its components
   against six mosquito species, including Zika virus vectors: the
   promising potential of (4E,6Z)-allo-ocimene, carvotanacetone and dodecyl
   acetate
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE biosafety; biopesticide; essential oil; larvicidal activity; GC-MS;
   non-target toxicity; WHO
ID ECO-FRIENDLY LARVICIDES; ZINGIBERACEAE ESSENTIAL OIL; SILVER
   NANOPARTICLES; CHEMICAL-COMPOSITION; AEDES-ALBOPICTUS; SYNTHESIZED
   NANOPARTICLES; CULEX-TRITAENIORHYNCHUS; INSECTICIDE RESISTANCE;
   VETERINARY IMPORTANCE; CRYPTOMERIA-JAPONICA
AB The effective and environmentally sustainable control of mosquitoes is a challenge of essential importance. This is due to the fact that some invasive mosquitoes, with special reference to the Aedes genus, are particularly difficult to control, due to their high ecological plasticity. Moreover, the indiscriminate overuse of synthetic insecticides resulted in undesirable effects on human health and non-target organisms, as well as resistance development in targeted vectors. Here, the leaf essential oil (EO) extracted from a scarcely studied plant of ethno-medicinal interest, Blumea eriantha (Asteraceae), was tested on the larvae of six mosquitoes, including Zika virus vectors. The B. eriantha EO was analyzed by GC and GC-MS. The B. eriantha EO showed high toxicity against 3rd instar larvae of six important mosquito species: Anopheles stephensi (LC50=41.61 mu g/ml), Aedes aegypti (LC50=44.82 mu g/ml), Culex quinquefasciatus (LC50 =48.92 mu g/ml), Anopheles subpictus (LC50=51.21 mu g/ml), Ae. albopictus (LC50=56.33 mu g/ml) and Culex tritaeniorhynchus (LC50=61.33 mu g/ml). The major components found in B. eriantha EO were (4E,6Z)-allo-ocimene (12.8%), carvotanacetone (10.6%), and dodecyl acetate (8.9%). Interestingly, two of the main EO components, (4E,6Z)-allo-ocimene and carvotanacetone, achieved LC50 lower than 10 mu g/ml on all tested mosquito species. The acute toxicity of B. eriantha EO and its major constituents on four aquatic predators of mosquito larval instars was limited, with LC50 ranging from 519 to 11.431 mu g/ml. Overall, the larvicidal activity of (4E,6Z)-allo-ocimene and carvotanacetone far exceed most of the LC50 calculated in current literature on mosquito botanical larvicides, allowing us to propose both of them as potentially alternatives for developing eco-friendly mosquito control tools.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Govindarajan, Marimuthu; Rajeswary, Mohan; Senthilmurugan, Sengamalai; Vijayan, Periasamy] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
EM benelli.giovanni@gmail.com; drgovind1979@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; /L-2836-2013; Benelli,
   Giovanni/A-9100-2013; Alharbi, Naiyf S/B-9402-2019; Khaled,
   Jamal/D-8188-2017
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; /0000-0001-7018-5379;
   Benelli, Giovanni/0000-0001-8971-6010; 
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [PRG-1437-36]
FX We are grateful to H. Mehlhorn and the anonymous reviewers for their
   useful suggestions on an earlier version of our study. The authors
   extend their sincere appreciations to the Deanship of Scientific
   Research at King Saud University for funding this Prolific Research
   Group (PRG-1437-36). The authors would like to thank Professor and Head,
   Department of Zoology, Annamalai University, for the laboratory
   facilities provided.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   ALKOFAHI A, 1989, ACS SYM SER, V387, P25
   AlShebly MM, 2017, ECOTOX ENVIRON SAFE, V137, P149, DOI 10.1016/j.ecoenv.2016.11.028
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Baranitharan M, 2017, PROCESS SAF ENVIRON, V106, P23, DOI 10.1016/j.psep.2016.12.003
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhuiyan MNI, 2009, BANGL J BOT, V38, P107
   Carolina A, 2016, J AGR FOOD SCI TECHN, V4, P552
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P465, DOI 10.1016/j.biortech.2007.11.060
   DEO P G, 1988, International Pest Control, V30, P118
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Dung NX, 1991, J ESSENT OIL RES, V3, P285
   El Ouali LA, 2016, J PHARMACOGN PHYTOCH, V8, P505
   El-Akhal Eouad, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P746
   Elango G, 2009, PARASITOL RES, V104, P1381, DOI 10.1007/s00436-009-1339-7
   Escartin Santi, 2014, Anales de Biologia, V36, P97, DOI 10.6018/analesbio.36.17
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, COMB CHEM HIGH T SCR, V19, P565, DOI 10.2174/1386207319666160506123520
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Jahan K., 2014, J PHARMACOGN PHYTOCH, V2, P104
   Jayaraman M, 2015, J EXP SCI, V6, P12
   Khair A, 2014, BRIT J PHARM RES, V4, P1677, DOI 10.9734/BJPR/2014/10001
   Khare CP, 2007, INDIAN MED PLANTS IL
   Kumar S, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00147
   LAAKSO I, 1989, Flavour and Fragrance Journal, V4, P73, DOI 10.1002/ffj.2730040208
   Macedo ME, 1997, MEM I OSWALDO CRUZ, V92, P565, DOI 10.1590/S0074-02761997000400024
   Mathalaimuthu Baranitharan, 2016, Journal of Coastal Life Medicine, V4, P969
   Mehlhorn H, 2015, ENCY PARASITOLOGY
   MEHTA S C, 1986, Indian Journal of Physiology and Pharmacology, V30, P149
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Mwangi JW, 1994, FLAVOUR FRAG J, V9, P233, DOI 10.1002/ffj.2730090506
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Norikura T, 2008, BIOSCI BIOTECH BIOCH, V72, P1183, DOI 10.1271/bbb.70586
   Owolabi MS, 2010, NAT PROD COMMUN, V5, P1135
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Pavela Roman, 2008, Journal of Biopesticides, V1, P81
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2017, J PEST SCI, V90, P369, DOI 10.1007/s10340-016-0763-6
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, PARASITOL RES, V105, P1365, DOI 10.1007/s00436-009-1571-1
   Pratheeba T, 2015, INT J ENTOMOL RES, V3, P67
   Sakee U, 2011, NAT PROD RES, V25, P1849, DOI 10.1080/14786419.2010.485573
   Senthilkumar A, 2008, PARASITOL RES, V103, P959, DOI 10.1007/s00436-008-1085-2
   Singh UP, 2011, INT J PHARM SCI, V4, P235
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Veni T, 2016, INT J PURE APPL ZOOL, V4, P149
   Verdian-Rizi M., 2009, IRANIAN J PHARM SCI, V5, P47
   Wang SY, 2006, J WOOD SCI, V52, P522, DOI 10.1007/s10086-006-0806-3
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Yakob L., 2016, LANCET GLOB HLTH
   Zhu L, 2011, EXCLI J, V10, P62
   Zhu L, 2011, PARASITOL RES, V109, P1417, DOI 10.1007/s00436-011-2388-2
NR 74
TC 19
Z9 19
U1 3
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD APR
PY 2017
VL 116
IS 4
BP 1175
EP 1188
DI 10.1007/s00436-017-5395-0
PG 14
WC Parasitology
SC Parasitology
GA ER3XZ
UT WOS:000398734700008
PM 28168560
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus infection and Wolbachia
SO BIOESSAYS
LA English
DT Letter
ID AEDES-AEGYPTI
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   Ruang-areerate T, 2006, P NATL ACAD SCI USA, V103, P12534, DOI 10.1073/pnas.0508879103
NR 3
TC 0
Z9 0
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD APR
PY 2017
VL 39
IS 4
AR 1600267
DI 10.1002/bies.201600267
PG 1
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA EQ2PW
UT WOS:000397913300012
PM 28156001
DA 2020-07-08
ER

PT J
AU Castillo, SA
   Pham, AK
   Dinulos, JG
AF Castillo, Stephanie A.
   Anh Khoa Pham
   Dinulos, James G.
TI Cutaneous manifestations of systemic viral diseases in neonates: an
   update
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE enterovirus; herpes simplex virus; neonatal infection; varicella zoster
   virus; Zika virus
ID HERPES-SIMPLEX-VIRUS; ZIKA VIRUS; ENTEROVIRUS INFECTIONS; UNITED-STATES;
   MANAGEMENT; VARICELLA; IMMUNOGLOBULIN; DIAGNOSIS; NEWBORN
AB Purpose of review
   Dermatologic findings may be the first signs of a neonatal viral infection. This review provides an update of the diagnostic features and therapies for selected viral illnesses [herpes simplex virus (HSV), varicella zoster virus, enterovirus, and Zika virus] that present with cutaneous manifestations in the neonate.
   Recent findings
   HSV DNA polymerase chain reaction of plasma and cerebrospinal fluid, routinely used in the diagnosis of neonatal HSV, may have expanded utility in assessing prognosis and acyclovir therapeutic efficacy. Maternal antiviral suppressive therapy may alter the clinical appearance of congenital HSV, resulting in delayed diagnosis and treatment. VariZIG, a varicella zoster immune globulin, is a US Food and Drug Administration approved form of prophylaxis for varicella. The Centers for Disease Control and Prevention has expanded the period of VariZIG eligibility for preterm infants, a group particularly susceptible to severe varicella infection. For severe neonatal enterovirus sepsis, the results of a randomized, double-blind, placebo-controlled trial of pleconaril, a viral capsid inhibitor, suggest that this compound is an effective therapy. Human Parechovirus type 3, a strain within a newly formed viral genus, has a similar, and potentially underestimated, clinical presentation to enterovirus sepsis. However, a distinctive erythematous palmoplantar rash may be specific to human Parechovirus type 3 infection. Perinatal Zika virus infection in the neonate may present with a nonspecific macular and papular rash. As this rash is not specific, obtaining a maternal travel history and, if appropriate, requesting additional diagnostic testing are critical for early diagnosis.
   Summary
   Neonatal rashes may be harmless and transient, whereas others may reflect the presence of a severe systemic illness. Recognizing key cutaneous features of viral-associated rashes may aid in the prompt and accurate diagnosis and treatment of neonatal viral illnesses.
C1 [Castillo, Stephanie A.; Dinulos, James G.] Geisel Sch Med Dartmouth, Hanover, NH USA.
   [Anh Khoa Pham] Dartmouth Hitchcock Med Ctr, Dept Surg, Dermatol Sect, Lebanon, NH 03766 USA.
   [Dinulos, James G.] Univ Connecticut, Farmington, CT USA.
   [Dinulos, James G.] Seacoast Dermatol, 330 Borthwick Ave,Suite 303, Portsmouth, NH 03801 USA.
RP Dinulos, JG (corresponding author), Seacoast Dermatol, 330 Borthwick Ave,Suite 303, Portsmouth, NH 03801 USA.
EM jdinulos@gmail.com
FU Medical Student Research Fellowship at the Geisel School of Medicine at
   Dartmouth
FX This project was funded in part by the Medical Student Research
   Fellowship at the Geisel School of Medicine at Dartmouth (S.A.C.).
CR Abzug MJ, 2016, J PEDIAT INF DIS SOC, V5, P53, DOI 10.1093/jpids/piv015
   Auriti C, 2009, FETAL DIAGN THER, V25, P224, DOI 10.1159/000220602
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Farahnik B, 2016, J AM ACAD DERMATOL, V74, P1286, DOI 10.1016/j.jaad.2016.02.1232
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Haston JC, 2015, PEDIATR ANN, V44, pE103, DOI 10.3928/00904481-20150512-09
   Hunt RD, 2015, NEONATAL INFANT DERM, P176
   James SH, 2015, INFECT DIS CLIN N AM, V29, P391, DOI 10.1016/j.idc.2015.05.001
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Khetsuriani N, 2006, PEDIATR INFECT DIS J, V25, P889, DOI 10.1097/01.inf.0000237798.07462.32
   Kimberlin DW, 2013, PEDIATRICS, V131, P383, DOI 10.1542/peds.2012-3217
   Kimberlin DW, 2015, RED BOOK 2015 REPORT, P432
   Lv XQ, 2016, J PAEDIATR CHILD H, V52, P837, DOI 10.1111/jpc.13193
   Mandelbrot L, 2012, PRENATAL DIAG, V32, P511, DOI 10.1002/pd.3843
   Marin M, 2013, MMWR-MORBID MORTAL W, V62, P574
   Marwah P, 2014, INDIAN J DERMATOL VE, V80, P65, DOI 10.4103/0378-6323.125535
   Melvin AJ, 2015, J PEDIATR-US, V166, P827, DOI 10.1016/j.jpeds.2014.11.011
   Mir N, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5390
   Miyauchi Y, 2016, PEDIATR DERMATOL, V33, P289, DOI 10.1111/pde.12796
   Muehlenbachs A, 2015, J PATHOL, V235, P217, DOI 10.1002/path.4438
   Pinninti SG, 2014, ARCH DIS CHILD-FETAL, V99, pF240, DOI 10.1136/archdischild-2013-303762
   Piralla A, 2014, EARLY HUM DEV, V90, pS75, DOI 10.1016/S0378-3782(14)70023-4
   Purewal R, 2016, J PEDIAT INF DIS SOC, V5, pE21, DOI 10.1093/jpids/piw013
   Schleiss MR, 2012, AVERYS DIS NEWBORN, P468
   Shoji K, 2014, PEDIATR DERMATOL, V31, P258, DOI 10.1111/j.1525-1470.2012.01819.x
   Shoji K, 2013, PEDIATR INFECT DIS J, V32, P233, DOI 10.1097/INF.0b013e31827b1fd0
   Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13
   Smith CK, 2009, SEMIN FETAL NEONAT M, V14, P209, DOI 10.1016/j.siny.2008.11.008
   Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852
   Tebruegge M, 2009, SEMIN FETAL NEONAT M, V14, P222, DOI 10.1016/j.siny.2009.02.002
   Tollefson MM, 2012, NEOREVIEWS, V13, pe285
   Yen MH, 2015, J CLIN VIROL, V64, P92, DOI 10.1016/j.jcv.2015.01.013
NR 35
TC 2
Z9 2
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8703
EI 1531-698X
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD APR
PY 2017
VL 29
IS 2
BP 240
EP 248
DI 10.1097/MOP.0000000000000469
PG 9
WC Pediatrics
SC Pediatrics
GA EN7YT
UT WOS:000396218800017
PM 28134705
DA 2020-07-08
ER

PT J
AU Halstead, SB
AF Halstead, Scott B.
TI Biologic Evidence Required for Zika Disease Enhancement by Dengue
   Antibodies
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; HEMORRHAGIC-FEVER; VIRUS-INFECTION; DEPENDENT
   ENHANCEMENT; PATHOGENESIS; INFANTS; MODEL; MICE; NEUTRALIZATION;
   MONOCYTES
AB The sudden appearance of overt human Zika virus infections that cross the placenta to damage fetal tissues, target sexual organs, and are followed in some instances by Guillain-Barre syndrome raises questions regarding whether these outcomes are caused by genetic mutations or if prior infection by other flaviviruses affects disease outcome. Because dengue and Zika viruses co-circulate in the urban Aedes aegypti mosquito-human cycle, a logical question, as suggested by in vitro data, is whether dengue virus infections result in antibody-dependent enhancement of Zika virus infections. This review emphasizes the critical role for epidemiologic studies (retrospective and prospective) in combination with the studies to identify specific sites of Zika virus infection in humans that are needed to establish antibody-dependent enhancement as a possibility or a reality.
C1 [Halstead, Scott B.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
RP Halstead, SB (corresponding author), Uniformed Serv Univ Hlth Sci, Prevent Med, 5824 Edson Ln N, Bethesda, MD 20852 USA.
EM halsteads@erols.com
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   ESOLEN LM, 1993, J INFECT DIS, V168, P47, DOI 10.1093/infdis/168.1.47
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Gomez JMM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004536
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
NR 49
TC 25
Z9 26
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2017
VL 23
IS 4
BP 569
EP 573
DI 10.3201/eid2304.161879
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EO6TC
UT WOS:000396824400001
PM 28322690
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aubry, M
   Teissier, A
   Huart, M
   Merceron, S
   Vanhomwegen, J
   Roche, C
   Vial, AL
   Teururai, S
   Sicard, S
   Paulous, S
   Despres, P
   Manuguerra, JC
   Mallet, HP
   Musso, D
   Deparis, X
   Cao-Lormeau, VM
AF Aubry, Maite
   Teissier, Anita
   Huart, Michael
   Merceron, Sebastien
   Vanhomwegen, Jessica
   Roche, Claudine
   Vial, Anne-Laure
   Teururai, Sylvianne
   Sicard, Sebastien
   Paulous, Sylvie
   Despres, Philippe
   Manuguerra, Jean-Claude
   Mallet, Henri-Pierre
   Musso, Didier
   Deparis, Xavier
   Cao-Lormeau, Van-Mai
TI Zika Virus Seroprevalence, French Polynesia, 2014-2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID DENGUE VIRUS; INFECTION
AB During 2013-2014, French Polynesia experienced an outbreak of Zika virus infection. Serosurveys conducted at the end of the outbreak and 18 months later showed lower than expected disease prevalence rates (49%) and asymptomatic: symptomatic case ratios (1: 1) in the general population but significantly different prevalence rates (66%) and asymptomatic: symptomatic ratios (1: 2) in schoolchildren.
C1 [Aubry, Maite; Teissier, Anita; Roche, Claudine; Teururai, Sylvianne; Musso, Didier; Cao-Lormeau, Van-Mai] Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
   [Huart, Michael; Sicard, Sebastien; Deparis, Xavier] Ctr Epidemiol & Sante Publ Armees, Marseille, France.
   [Huart, Michael; Sicard, Sebastien; Deparis, Xavier] Unite Mixte Rech Sci Econ & Sociales Sante & Trai, Marseille, France.
   [Merceron, Sebastien] Inst Stat Polynesie Francaise, Papeete, France.
   [Vanhomwegen, Jessica; Paulous, Sylvie; Manuguerra, Jean-Claude] Inst Pasteur, Paris, France.
   [Vial, Anne-Laure] Direct Dept Cohes Sociale & Protect Populat, Yonne, France.
   [Vial, Anne-Laure; Mallet, Henri-Pierre] Direct Sante Polynesie Francaise, Papeete, France.
   [Despres, Philippe] Univ La Reunion, St Clotilde, France.
   [Despres, Philippe] UMR PIMIT, St Clotilde, France.
RP Aubry, M (corresponding author), Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
EM maubry@ilm.pf
RI Cao-Lormeau, Van-Mai/H-4879-2018; Musso, Didier/AAO-8178-2020; Musso,
   Didier/P-7809-2016
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Aubry,
   Maite/0000-0002-9913-5794
FU Contrat de Projet Etat-Pays [7331/MSS/DSP]; French Government's
   Investissement d'Avenir Programme (Labex Integrative Biology of Emerging
   Infectious Diseases, IBEID)French National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]
FX This study received funding from the Contrat de Projet Etat-Pays
   (convention no. 7331/MSS/DSP du 31/08/12 modifiee) and from the French
   Government's Investissement d'Avenir Programme (Labex Integrative
   Biology of Emerging Infectious Diseases, IBEID, grant no.
   ANR-10-LABX-62-IBEID).
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Spiegel A, 1989, MED AFR NOIRE, V36, P740
NR 15
TC 82
Z9 86
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2017
VL 23
IS 4
BP 669
EP 672
DI 10.3201/eid2304.161549
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EO6TC
UT WOS:000396824400019
PM 28084987
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Burkhalter, KL
   Savage, HM
AF Burkhalter, Kristen L.
   Savage, Harry M.
TI Detection of Zika Virus in Desiccated Mosquitoes by Real-Time Reverse
   Transcription PCR and Plaque Assay
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VENEZUELAN EQUINE ENCEPHALITIS; HOLDING CONDITIONS; WEST-NILE; POOLS;
   RNA
AB We assayed Zika virus-infected mosquitoes stored at room temperature for <= 30 days for live virus by using plaque assay and virus RNA by using real-time reverse transcription PCR. Viable virus was detected in samples stored <= 10 days, and virus RNA was detected in samples held for 30 days.
C1 [Burkhalter, Kristen L.; Savage, Harry M.] Ctr Dis Control & Prevent, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
RP Burkhalter, KL (corresponding author), Ctr Dis Control & Prevent, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM ktb3@cdc.gov
CR Andrews ES, 2016, J AM MOSQUITO CONTR, V32, P51, DOI 10.2987/moco-32-01-51-54.1
   BEATY BJ, 1995, ARBOVIRUSES, P189
   Guzman H, 2005, AM J TROP MED HYG, V72, P474, DOI 10.4269/ajtmh.2005.72.474
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153
   Turell MJ, 2002, J MED ENTOMOL, V39, P1, DOI 10.1603/0022-2585-39.1.1
NR 7
TC 4
Z9 6
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2017
VL 23
IS 4
BP 680
EP 681
DI 10.3201/eid2304.161772
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EO6TC
UT WOS:000396824400022
PM 28075325
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Andersen, LK
   Azulay-Abulafia, L
   Davis, MDP
AF Andersen, Louise K.
   Azulay-Abulafia, Luna
   Davis, Mark D. P.
TI Zika virus: skin is commonly involved
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Letter
ID TRANSMISSION; INFECTION; TRAVELERS; STATES
C1 [Andersen, Louise K.] Aarhus Univ Hosp, Dept Dermatovenereol, Aarhus C, Denmark.
   [Azulay-Abulafia, Luna] Univ Estado Rio De Janeiro, Inst Dermatol Prof RD Azulay, Dept Dermatol, Rio De Janeiro, Brazil.
   [Davis, Mark D. P.] Mayo Clin, Div Clin Dermatol, Rochester, MN USA.
RP Andersen, LK (corresponding author), Aarhus Univ Hosp, Dept Dermatovenereol, Aarhus C, Denmark.
EM loand02@privat.dk
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD APR
PY 2017
VL 56
IS 4
BP e84
EP e86
DI 10.1111/ijd.13509
PG 3
WC Dermatology
SC Dermatology
GA EP7TQ
UT WOS:000397580500010
PM 28102537
DA 2020-07-08
ER

PT J
AU Muller, JA
   Harms, M
   Schubert, A
   Mayer, B
   Jansen, S
   Herbeuval, JP
   Michel, D
   Mertens, T
   Vapalahti, O
   Schmidt-Chanasit, J
   Munch, J
AF Mueller, Janis A.
   Harms, Mirja
   Schubert, Axel
   Mayer, Benjamin
   Jansen, Stephanie
   Herbeuval, Jean-Philippe
   Michel, Detlef
   Mertens, Thomas
   Vapalahti, Olli
   Schmidt-Chanasit, Jonas
   Muench, Jan
TI Development of a high-throughput colorimetric Zika virus infection assay
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE MTT; ZIKV; Zika virus; PRNT; Screening
ID HERPES-SIMPLEX-VIRUS; ANTIBODIES; INACTIVATION; REPLICATION
AB Zika virus (ZIKV) is an emerging pathogen that causes congenital infections which may result in birth defects, such as microcephaly. Currently, no approved treatment or vaccination is available. ZIKV can be readily detected in cell culture where virally infected cells are normally stained by specific antibodies. As ZIKV regularly causes a cytopathic effect, we were wondering whether this viral property can be used to quantitatively determine viral infectivity. We here describe the use of an 3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bromide-(MTT)-based cell viability assay that allows to determine ZIKV-induced cell death. We show that this colorimetric assay quantifies ZIKV infection over a broad range of viral dilutions in both monkey and human cells. It allows to determine inhibitory activities of antivirals that block ZIKV or to define the neutralizing antibody titers of ZIKV antisera. This MTT-based ZIKV detection assay can be evaluated by naked eye or computational tools, has a broad linear range, does not require large equipment or costly reagents, and thus represents a promising alternative to antibody-based assays, in particular in resource-poor settings. We propose to use this simple, fast, and cheap method for quantification of ZIKV neutralizing antibodies and testing of antiviral compounds.
C1 [Mueller, Janis A.; Harms, Mirja; Muench, Jan] Ulm Univ, Med Ctr, Inst Mol Virol, Ulm, Germany.
   [Schubert, Axel; Michel, Detlef; Mertens, Thomas] Ulm Univ, Med Ctr, Inst Virol, Ulm, Germany.
   [Mayer, Benjamin] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas] World Hlth Org Collaborating Ctr Arbovirus & Hemo, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas] German Ctr Infect Res, Partner Sites Hamburg Luebeck Borstel, Hamburg, Germany.
   [Herbeuval, Jean-Philippe] Univ Paris 05, CBMIT CNRS UMR 8601, CICB, Paris, France.
   [Vapalahti, Olli] Univ Helsinki, Dept Virol & Immunol, Helsinki, Finland.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki, Finland.
RP Munch, J (corresponding author), Ulm Univ, Med Ctr, Inst Mol Virol, Ulm, Germany.
EM jan.muench@uni-ulm.de
OI Jan, Munch/0000-0001-7316-7141; Vapalahti, Olli/0000-0003-2270-6824
CR Andersson P, 2005, J VIROL METHODS, V130, P117, DOI 10.1016/j.jviromet.2005.06.016
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   AYISI NK, 1991, J VIROL METHODS, V33, P335, DOI 10.1016/0166-0934(91)90033-V
   BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Berridge MV, 1993, ARCH BIOCH BIOPHYS
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Ifrah M, 1998, VIRAL IMMUNOL, V11, P49, DOI 10.1089/vim.1998.11.49
   Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lehtoranta L, 2009, J VIROL METHODS, V159, P271, DOI 10.1016/j.jviromet.2009.04.015
   Mo C, 2008, J VIROL METHODS, V150, P63, DOI 10.1016/j.jviromet.2008.03.006
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Nawa M, 2001, J VIROL METHODS, V92, P65, DOI 10.1016/S0166-0934(00)00274-3
   Park R, 2003, ANTIVIR RES, V58, P35, DOI 10.1016/S0166-3542(02)00165-1
   PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6
   Priyamvada L, 2016, HUMAN ANTIBODY RESPO, V113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Retallack H., 2016, ZIKA VIRUS HUMAN PLA
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Septfons A, 2016, EURO SURVEILL B EUR, V21
   Simonin Y, 2016, EBIOMEDICINE
   Steinhagen K, 2016, EURO SURVEI IN PRESS
   TAKEUCHI H, 1991, J VIROL METHODS, V33, P61, DOI 10.1016/0166-0934(91)90008-N
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   World Health Organization, 2016, ZIK VIR SIT REP
   Xie X, 2016, EBIO MED, P5
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 47
TC 15
Z9 16
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD APR
PY 2017
VL 206
IS 2
BP 175
EP 185
DI 10.1007/s00430-017-0493-2
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA ER1XX
UT WOS:000398589600009
PM 28176006
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Perkins, TA
   Siraj, AS
   Ruktanonchai, CW
   Kraemer, MUG
   Tatem, AJ
AF Perkins, T. Alex
   Siraj, Amir S.
   Ruktanonchai, Corrine W.
   Kraemer, Moritz U. G.
   Tatem, Andrew J.
TI Model-based projections of Zika virus infections in childbearing women
   in the Americas (vol 1, 16126, 2016)
SO NATURE MICROBIOLOGY
LA English
DT Correction
CR Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
NR 1
TC 3
Z9 3
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD APR
PY 2017
VL 2
IS 4
AR 17051
DI 10.1038/nmicrobiol.2017.51
PG 1
WC Microbiology
SC Microbiology
GA EQ6FS
UT WOS:000398177800024
PM 28319087
OA Bronze
DA 2020-07-08
ER

PT J
AU Darney, BG
   Aiken, ARA
   Kung, S
AF Darney, Blair G.
   Aiken, Abigail R. A.
   Kueng, Stephanie
TI Access to Contraception in the Context of Zika
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID INCREASING ACCESS; VIRUS EXPOSURE; UNITED-STATES; PUERTO-RICO; MEXICO;
   OUTBREAK; WOMEN; AGE
AB Women in areas of the Americas with endemic Aedes mosquito populations are at risk for exposure to Zika virus, which can cause fetal brain abnormalities and associated congenital microcephaly. Individual health care providers may encounter health system barriers to providing evidence-based care. We focus on Mexico and the state of Texas to highlight the role of health system factors in contraceptive access in the context of Zika and highlight efforts in Puerto Rico as an example of initiatives to improve access to contraception. In Mexico, states with the highest unmet need for contraception are low-lying coastal states. The government recently announced an investment to combat Zika but made no mention of family planning initiatives to assist women in preventing pregnancy. In Texas, the Department of State Health Services has issued recommendations to help women and men avoid mosquito bites; the issue of whether women should plan or avoid pregnancy is not addressed. Puerto Rico has the largest number of confirmed cases of Zika virus in the U.S. states and territories. Recently, the Centers for Disease Control and Prevention Foundation launched the Zika Contraception Access Network, which provides contraceptives at no cost to participating clinics in Puerto Rico. The Zika virus highlights weaknesses in health systems that make it difficult for women to use contraception if they want to delay births. Women across the globe, with or without Zika virus, need access to contraception to prevent unintended pregnancy, and health care providers require functioning health systems that offer support to ensure access is a reality.
C1 Ctr Invest Sistemas Salud, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.
   Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   Univ Texas Austin, LBJ Sch Publ Affairs, Austin, TX 78712 USA.
   Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA.
   Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
RP Darney, BG (corresponding author), 655 Av Univ, Cuernavaca 62100, MOR, Mexico.
EM Blair.darney@insp.mx
OI Darney, Blair/0000-0001-8120-028X
FU Junior Investigator Award from Society of Family Planning [SFPRF9-JI2];
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development of the National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [R24HD04284]
FX Dr. Darney is partially supported by a Junior Investigator Award from
   the Society of Family Planning (SFPRF9-JI2). Dr. Aiken is partially
   supported by an infrastructure grants for population research from the
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development of the National Institutes of Health (R24HD04284) and a
   Junior Investigator Award from the Society of Family Planning
   (SFPRF10-JI2).
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Allen-Leigh B, 2013, SALUD PUBLICA MEXICO, V55, pS235, DOI 10.21149/spm.v55s2.5120
   Consejo Nacional de Poblacion, 2014, ESTR NAC PREV EMB AD
   Darney BG, 2016, CONTRACEPTION, V93, P478, DOI 10.1016/j.contraception.2016.01.015
   Dehlendorf C, 2017, CONTRACEPTION, V95, P1, DOI 10.1016/j.contraception.2016.08.013
   Dreweke J., 2016, GUTTMACHER POLICY RE, V19, P23
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0
   Frost J. J., 2015, CONTRACEPTIVE NEEDS
   Gobierno de Mexico, 2016, CAS CONF ENF VIR ZIK
   Kost K., 2015, UNINTENDED PREGNANCY
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   McNeil Jr Donald G., 2016, NY TIMES
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Tozzi J., 2016, BLOOMBERG NEWS
NR 18
TC 6
Z9 6
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2017
VL 129
IS 4
BP 638
EP 642
DI 10.1097/AOG.0000000000001914
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EQ6BM
UT WOS:000398166800014
PM 28277362
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, V.
TI Zika virus infection and the Olympic Games 2016
SO REVISTA CLINICA ESPANOLA
LA English
DT Letter
C1 [Wiwanitkit, V.] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, V.] Dr DY Patil Univ, Mumbai, Maharashtra, India.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Peoples R China.; Wiwanitkit, V (corresponding author), Dr DY Patil Univ, Mumbai, Maharashtra, India.
EM wviroj@yahoo.com
CR Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Diaz-Menendez M, 2016, REV CLIN ESP
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
NR 4
TC 0
Z9 0
U1 0
U2 1
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0014-2565
EI 1578-1860
J9 REV CLIN ESP
JI Rev. Clin. Esp.
PD APR
PY 2017
VL 217
IS 3
BP 178
EP 179
DI 10.1016/j.rce.2016.12.005
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EO6KJ
UT WOS:000396800800013
PM 28117035
DA 2020-07-08
ER

PT J
AU He, M
   Wang, JX
   Chen, LM
   Liu, J
   Zeng, PB
AF He, Miao
   Wang, Jingxing
   Chen, Limin
   Liu, Jing
   Zeng, Peibin
TI The Impact of Emerging Infectious Diseases on Chinese Blood Safety
SO TRANSFUSION MEDICINE REVIEWS
LA English
DT Review
DE Emerging infectious diseases; Transfusion-transmitted infectious;
   Chinese blood safety
ID HEPATITIS-E VIRUS; THROMBOCYTOPENIA SYNDROME VIRUS; TO-PERSON
   TRANSMISSION; REPUBLIC-OF-CHINA; COXIELLA-BURNETII INFECTION; HUMAN
   PARVOVIRUS B19; SEVERE FEVER; LEISHMANIA-INFANTUM; ENDEMIC AREA; ZIKA
   VIRUS
AB Emerging infectious diseases (ElDs) have always been one of the major threats to public health. Although the implementation of mandatory testing for 4 classical transfusion-transmitted infectious human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis has reduced the transfusion risk of these pathogens, the potential threat of various EID agents and their constantly evolving variants to blood safety in China is not fully understood. This review presents 9 representative EID agents that are autochthonous and epidemic nationally or regionally in China. The epidemiologic status and distribution of these EID agents among donors and/or healthy populations are summarized. The potential risks of these EID agents to blood safety are discussed. The review also explores strategies to strengthen hemovigilance systems and studies to further evaluate the impact of EID agents on blood safety. (C) 2017 Elsevier Inc. All rights reserved.
C1 [He, Miao; Wang, Jingxing; Chen, Limin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China.
   [Liu, Jing] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA.
   [Zeng, Peibin] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.
RP Zeng, PB (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.
EM zengpeibin@live.cn
RI He, Miao/AAA-2953-2020; He, Miao/AAB-6972-2020; Chen, Limin/A-8813-2012
OI He, Miao/0000-0002-2815-1690; 
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81400096]; PUMC Youth Fund; Fundamental Research
   Funds for the Central UniversitiesFundamental Research Funds for the
   Central Universities [33320140190]; Funding of Scientific support,
   Science and Technology Department of Sichuan province [2014SZ0025]
FX The authors acknowledge Dr Hua Shan and Dr Ling Shi for their careful
   review of the paper. The review was supported by the National Natural
   Science Foundation of China (Grant No. 81400096); PUMC Youth Fund and
   the Fundamental Research Funds for the Central Universities (Grant
   No.33320140190); Funding of Scientific support, Science and Technology
   Department of Sichuan province (Grant No. 2014SZ0025).
CR ANDRE R, 1957, Bull Mem Soc Med Hop Paris, V73, P854
   Aquino LC, 2014, J MICROBIOL METH, V107, P189, DOI 10.1016/j.mimet.2014.10.013
   Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105
   Bai J, 2011, MOD ANIM HUSB, V31, P134
   Bai KZ, 2011, MOD ANIM HUSB, V24, P55
   Banu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089440
   Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732
   Benjamin RJ, 2012, TRANSFUSION, V52, P1913, DOI 10.1111/j.1537-2995.2011.03554.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2
   Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x
   BREMNER JAG, 1994, J INFECT DIS, V169, P938, DOI 10.1093/infdis/169.4.938a
   Brown Kevin E., 2001, Transfusion (Bethesda), V41, P130, DOI 10.1046/j.1537-2995.2001.41010130.x
   Cao F, 1998, VOX SANG, V75, P154, DOI 10.1046/j.1423-0410.1998.7520154.x
   Cao YJ, 2015, S CHINA J PREY MED, V41, P364
   Chen DJ, 1992, SICHUAN MED, V47, P102
   Chen HZ, 2011, J INT EPIDEMIOL INFE, V38, P360
   Chen J, 2015, TROP MED, V15, P1014
   Chen SB, 2015, PRACT PREY MED, V28, P87
   Chen SY, 2014, EMERG INFECT DIS, V20, P126, DOI 10.3201/eid2001.130324
   Cheng XF, 2012, WORLD J GASTROENTERO, V18, P986, DOI 10.3748/wjg.v18.i9.986
   COHEN C, 1991, LANCET, V338, P128, DOI 10.1016/0140-6736(91)90129-D
   Colomba C, 2005, TRANSFUS APHER SCI, V33, P311, DOI 10.1016/j.transci.2005.07.009
   Corcoran A, 2004, J MED MICROBIOL, V53, P459, DOI 10.1099/jmm.0.05485-0
   Cui Buyun, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P1035
   CUMMINS D, 1995, ARCH DIS CHILD, V72, P235, DOI 10.1136/adc.72.3.235
   Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x
   Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100
   Dinu LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104006
   Doganay M, 2001, J HOSP INFECT, V49, P151, DOI 10.1053/jhin.2001.1004
   Du JL, 2014, VIRUS RES, V191, P134, DOI 10.1016/j.virusres.2014.07.036
   Feng XY, 2010, MED ANIM PREY, V32, P219
   Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4
   Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776
   Giger U, 2002, TRANSFUSION, V42, P381, DOI 10.1046/j.1537-2995.2002.00061.x
   GROGL M, 1993, AM J TROP MED HYG, V49, P308, DOI 10.4269/ajtmh.1993.49.308
   Gubernot DM, 2009, CLIN INFECT DIS, V48, P25, DOI 10.1086/595010
   GUEVARA P, 1993, LANCET, V341, P1341, DOI 10.1016/0140-6736(93)90845-8
   Guo QS, 2010, J CLIN MICROBIOL, V48, P317, DOI 10.1128/JCM.01466-09
   He M, 2014, REP CHIN MICR IMM C, P2
   He M, 2012, BLOOD TRANSFUS-ITALY, V10, P502, DOI 10.2450/2012.0134-11
   Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002
   Hogema BM, 2012, TRANSFUSION, V52, P144, DOI 10.1111/j.1537-2995.2011.03250.x
   Huang C, 2015, J CHIN TRANSFUS, V48, P538
   Jia P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0763-9
   Jin X, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.3
   Jing LW, 1996, LIAONING MED J, V28, P162
   Johnson ST, 2009, TRANSFUSION, V49, P2574, DOI 10.1111/j.1537-2995.2009.02430.x
   Kagawa Frank T, 2003, Semin Respir Infect, V18, P183
   Ke L, 2011, TRANSFUSION, V51, P1909, DOI 10.1111/j.1537-2995.2011.03067.x
   Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1440-1746.2004.03437.x
   Kim WY, 2015, CLIN INFECT DIS, V60, P1681, DOI 10.1093/cid/civ128
   Kmush BL, 2015, EXPERT REV ANTI-INFE, V13, P41, DOI 10.1586/14787210.2015.981158
   Kreil TR, 2003, TRANSFUSION, V43, P1023, DOI 10.1046/j.1537-2995.2003.00496.x
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Lang XL, 2011, TROP ANIM HEALTH PRO, V43, P305, DOI 10.1007/s11250-010-9726-8
   le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999
   Lee CK, 2005, TRANSFUSION MED, V15, P133, DOI 10.1111/j.0958-7578.2005.00563.x
   Leiby DA, 2008, TRANSFUSION, V48, P2222, DOI 10.1111/j.1537-2995.2008.01825.x
   Leiby DA, 2008, J INFECT DIS, V198, P609, DOI 10.1086/590159
   Leiby DA, 2014, TRANSFUSION, V54, P2217, DOI 10.1111/trf.12622
   Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10
   Li D, 2011, CHIN J EXP CLIN VIRO, V25, P81
   Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332
   Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007
   Li W, 1995, MIL MED J, V37, P395
   Liang SY, 2014, AM J TROP MED HYG, V90, P256, DOI 10.4269/ajtmh.13-0423
   Lin XK, 2014, PORT HLTH CONTROL, V19, P33
   Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679
   Liu SL, 2014, REV MED VIROL, V24, P90, DOI 10.1002/rmv.1776
   Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758
   Lu GY, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-269
   Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1
   Marano G, 2016, TRANSFUSION, V56, P249, DOI 10.1111/trf.13329
   Mast EE, 1996, ANNU REV MED, V47, P257
   Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288
   Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x
   MAUNY I, 1993, PEDIATRIE, V48, P237
   Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518
   Ming JY, 2007, CHINA TROP MED, V7, P2007
   Mitsui T, 2004, J MED VIROL, V74, P563, DOI 10.1002/jmv.20215
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Nadjm B, 2012, INFECT DIS CLIN N AM, V26, P243, DOI 10.1016/j.idc.2012.03.010
   Nelson KE, 2014, TRANSFUSION, V54, P8, DOI 10.1111/trf.12504
   Ning PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068230
   NOCTON JJ, 1993, J PEDIATR-US, V122, P186, DOI 10.1016/S0022-3476(06)80111-3
   Owens SD, 2001, J AM VET MED ASSOC, V219, P1076, DOI 10.2460/javma.2001.219.1076
   POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415
   Qi XP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004159
   Qian P, 1993, MODERATE LEVEL J, V51, P22
   RAOULT D, 1990, ANN NY ACAD SCI, V590, P33, DOI 10.1111/j.1749-6632.1990.tb42204.x
   RAOULT D, 1990, ANN NY ACAD SCI, V590, P51, DOI 10.1111/j.1749-6632.1990.tb42206.x
   RAOULT D, 1993, AIDS, V7, P81, DOI 10.1097/00002030-199301000-00012
   Riera C, 2004, T ROY SOC TROP MED H, V98, P102, DOI 10.1016/S0035-9203(03)00015-4
   Riera C, 2008, TRANSFUSION, V48, P1383, DOI 10.1111/j.1537-2995.2008.01708.x
   Roberts LJ, 2000, BMJ-BRIT MED J, V321, P801, DOI 10.1136/bmj.321.7264.801
   Ruan W, 2014, CHIN PARASIT J, V41, P54
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Sabino EC, 2013, TRANSFUSION, V53, P1257, DOI 10.1111/j.1537-2995.2012.03902.x
   Scarlata F, 2008, T ROY SOC TROP MED H, V102, P394, DOI 10.1016/j.trstmh.2008.01.011
   Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2
   Shen YL, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-19
   Shi L, 2014, TRANSFUSION, V54, P471, DOI 10.1111/trf.12273
   Shimojima M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0412-3
   Shimojima Masayuki, 2013, Uirusu, V63, P7
   Shin J, 2015, EMERG INFECT DIS, V21, P1704, DOI 10.3201/eid2110.141928
   Skidmore SJ, 1999, LANCET, V354, P1049, DOI 10.1016/S0140-6736(99)00241-X
   Slot E, 2013, EUROSURVEILLANCE, P18
   Slot E, 2014, TRANSFUSION, V54, P2867, DOI 10.1111/trf.12749
   Stramer SL, 2007, ARCH PATHOL LAB MED, V131, P702
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Su XF, 1995, J BAI QIU EN MED SCH, V77, P64
   Su YP, 1996, J PRACT PARASIT RES, V56, P87
   Sun JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132968
   Sun JF, 2016, J INFECTION, V72, P80, DOI 10.1016/j.jinf.2015.10.007
   Tabor Edward, 2000, Transfusion (Bethesda), V40, P1273, DOI 10.1046/j.1537-2995.2000.40101273.x
   Tavil B, 2009, PEDIATR HEMAT ONCOL, V26, P63, DOI 10.1080/08880010902754735
   Tong R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064391
   Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183
   Van Dooren W., 2010, EUROPEAN SURVEILLANC, P15
   Vasquez AM, 2016, AM J TRANSPLANT, V16, P2487, DOI 10.1111/ajt.13941
   Vollmer T, 2012, J CLIN MICROBIOL, V50, P2708, DOI 10.1128/JCM.01119-12
   Wang G, 2006, MIL MED, V55, P556
   Wang HL, 2002, J CHIN TRANSFUS, V59, P417
   Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6
   Wang JY, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-31
   Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3
   Wang T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003677
   Wang WJ, 2015, TRANSFUSION, V55, P586, DOI 10.1111/trf.12853
   Wang YC, 2005, J MED VIROL, V76, P613, DOI 10.1002/jmv.20405
   Wang ZY, 2015, CHIN PARASIT RES, V23, P362
   WATTS RE, 1950, AM J VET RES, V11, P304
   Wei YJ, 2010, CHINA TROP MED, V10, P144
   WOOD EE, 1955, BRIT MED J, V1, P27, DOI 10.1136/bmj.1.4904.27
   Wu FQ, 1996, MODERATE LEVEL J, V13, P7
   Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755
   Wu MY, 2012, CHIN PARASITES RES, V20, P110
   XIE N, 1988, Weishengwu Xuebao, V28, P371
   Xie YT, 2015, LANCET INFECT DIS, V15, P145, DOI 10.1016/S1473-3099(14)70891-6
   Xie YW, 2008, TRANSFUSION, V48, P1342, DOI 10.1111/j.1537-2995.2008.01647.x
   Xiong WY, 2012, WEST PAC SURVEILL RE, V3, P61, DOI [10.5365/WPSAR.2012.3.4.002, 10.5365/wpsar.2012.3.4.002]
   Yang CH, 2013, TRANSFUS APHER SCI, V49, P631, DOI 10.1016/j.transci.2013.07.008
   Yin YH, 2015, TRANSFUSION, V55, P2523, DOI 10.1111/trf.13130
   Ying LH, 2014, ZHE JIANG PREY MED, V41, P1031
   Yoshikawa T, 2015, J INFECT DIS, V212, P889, DOI 10.1093/infdis/jiv144
   Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840
   [鱼爱水 Yu Aishui], 2015, [中国病原生物学杂志, Journal of Pathogen Biology], V10, P442
   Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Yun Y, 2015, AM J TROP MED HYG, V93, P468, DOI 10.4269/ajtmh.15-0047
   Zeng PB, 2015, TRANSFUSION, V55, P965, DOI 10.1111/trf.12953
   Zhang F, 2011, J CHIN PATHOG, V22, P183
   Zhang F, 2011, J CHIN PATHOG, V22, P235
   Zhang J, 2014, BMJ OPEN, V4
   Zhang J, 2016, J TRAVEL MED, P23
   Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108592
   Zhang L, 2014, EMERG INFECT DIS, V20, P1355, DOI 10.3201/eid2008.131796
   Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626
   Zhang W, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-194
   Zhang X, 2015, PUBLIC HEALTH, V129, P1132, DOI 10.1016/j.puhe.2015.02.029
   Zhang XS, 2013, SCI CHINA LIFE SCI, V56, P697, DOI 10.1007/s11427-013-4518-9
   Zhang YG, 2010, ANHUI PREV MED, V21, P98
   Zhang YG, 2010, ANHUI PREY MED, V21, P87
   Zhao HL, 1981, CHIN MED J, V61, P466
   Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345
   Zhao M, 1994, CHIN PRACT MED, V34, P624
   Zheng YJ, 2006, J INFECT DIS, V193, P1643, DOI 10.1086/504293
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
   Zhou BQ, 1994, CHIN PARASIT J, V67, P46
   [周健明 Zhou Jianming], 2012, [中国公共卫生, China Public Health], V28, P1628
   Zhou KC, 2013, APPL PREY MED, V19, P236
   ZHOU ZJ, 1981, B WORLD HEALTH ORGAN, V59, P931
   Zhu XY, 2008, J CHIN DIAGN, V22, P1130
NR 177
TC 5
Z9 5
U1 2
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0887-7963
EI 1532-9496
J9 TRANSFUS MED REV
JI Transf. Med. Rev.
PD APR
PY 2017
VL 31
IS 2
SI SI
BP 94
EP 101
DI 10.1016/j.tmrv.2016.10.002
PG 8
WC Hematology
SC Hematology
GA EQ5RA
UT WOS:000398139100004
PM 27923518
OA Green Published
DA 2020-07-08
ER

PT J
AU Kaushik, A
   Tiwari, S
   Jayant, RD
   Vashist, A
   Nikkhah-Moshaie, R
   Ei-Hage, N
   Nair, M
AF Kaushik, Ajeet
   Tiwari, Sneham
   Jayant, Rahul D.
   Vashist, Arti
   Nikkhah-Moshaie, Roozbeh
   Ei-Hage, Nazira
   Nair, Madhavan
TI Electrochemical Biosensors for Early Stage Zia Diagnostics
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID ZIKA VIRUS; LABEL-FREE; POINT; TECHNOLOGIES; MANAGEMENT; INFECTION;
   DISEASE; PCR
AB Health agencies have declared the recent Zika virus (ZIKV) infection an epidemic and a public health emergency of global concern due to its association with microcephaly and serious neurological disorders. The unavailability of effective drugs, vaccines, and diagnostic tools increases the demand for efficient analytical devices to detect ZIKV infection. However, high costs, longer diagnostic times, and stringent expertise requirements limit the utility of reverse transcriptase-PCR methods for rapid diagnostics. Therefore, developing portable, sensitive, selective, and cost-effective sensing systems to detect ZIKV at picomolar concentrations in biofluids would be a breakthrough in diagnostics and therapeutics. This paper highlights the advancements in developing smart sensing strategies to monitor ZIKV progression, with rapid point-of-care diagnostics as the ultimate aim.
C1 [Kaushik, Ajeet; Tiwari, Sneham; Jayant, Rahul D.; Vashist, Arti; Nikkhah-Moshaie, Roozbeh; Ei-Hage, Nazira; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Ctr Personalized Nanomed, Inst Neurolmmune Pharmacol,Dept Immunol, Miami, FL 33199 USA.
RP Kaushik, A; Nair, M (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Ctr Personalized Nanomed, Inst Neurolmmune Pharmacol,Dept Immunol, Miami, FL 33199 USA.
EM ajeet.npl@gmail.com; nairm@fiu.edu
RI Vashist, Arti/O-5204-2019; Kaushik, Ajeet/K-1289-2018; Jayant,
   Rahul/K-7934-2019; Vashist, Arti/AAH-5926-2020
OI Kaushik, Ajeet/0000-0003-4206-1541; Vashist, Arti/0000-0002-7519-1863
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01-DA027049,
   R01-DA034547, R01-DA037838, R01-DA040537, R01-DA042706A]
FX The authors acknowledge grants R01-DA027049, R01-DA034547, R01-DA037838,
   R01-DA040537, and R01-DA042706A awarded by National Institutes of
   Health.
CR Arugula MA, 2014, ANAL CHEM, V86, P119, DOI 10.1021/ac402898j
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Camacho E, 2016, COLOMBIA EMERG INFEC, V22, P927
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110
   Cruz AFD, 2014, BIOSENS BIOELECTRON, V62, P249, DOI 10.1016/j.bios.2014.06.053
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Fan CH, 2003, P NATL ACAD SCI USA, V100, P9134, DOI 10.1073/pnas.1633515100
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hofer U, 2016, NAT REV MICROBIOL, V14, P401, DOI 10.1038/nrmicro.2016.80
   Hsieh K, 2015, ACCOUNTS CHEM RES, V48, P911, DOI 10.1021/ar500456w
   Kaushik A, 2016, BIOSENS BIOELECTRON, V86, P426, DOI 10.1016/j.bios.2016.06.086
   Kaushik A, 2016, BIOSENS BIOELECTRON, V80, P273, DOI 10.1016/j.bios.2016.01.065
   Kaushik A, 2016, BIOSENS BIOELECTRON, V75, P254, DOI 10.1016/j.bios.2015.08.040
   Kaushik A, 2015, INT J NANOMED, V10, P677, DOI 10.2147/IJN.S75514
   Kaushik A, 2014, BIOSENS BIOELECTRON, V53, P499, DOI 10.1016/j.bios.2013.09.060
   Kaushik A, 2013, BIOSENS BIOELECTRON, V50, P35, DOI 10.1016/j.bios.2013.06.012
   Labib M, 2016, CHEM REV, V116, P9001, DOI 10.1021/acs.chemrev.6b00220
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liuzzi G, 2016, EUR J INTERN MED, V33, pE20, DOI 10.1016/j.ejim.2016.04.022
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moschopoulou G, 2008, BIOSENS BIOELECTRON, V24, P1027, DOI 10.1016/j.bios.2008.06.039
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nabel GJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4548
   Nair M, 2016, ADV DRUG DELIVER REV, V103, P202, DOI 10.1016/j.addr.2016.02.008
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Patterson AS, 2013, TRENDS BIOTECHNOL, V31, P704, DOI 10.1016/j.tibtech.2013.09.005
   Pejcic B, 2006, ANALYST, V131, P1079, DOI 10.1039/b603402k
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Seker E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125504
   Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Skottrup PD, 2008, BIOSENS BIOELECTRON, V24, P339, DOI 10.1016/j.bios.2008.06.045
   Solanki PR, 2011, NPG ASIA MATER, V3, P17, DOI 10.1038/asiamat.2010.137
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977
   Vasudev A, 2013, SENSOR ACTUAT B-CHEM, V182, P139, DOI 10.1016/j.snb.2013.02.096
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WANG J, 2006, ELECTROANAL, V17, P7, DOI DOI 10.1007/S10832-006-0507-8
   Xiao Y, 2005, ANGEW CHEM INT EDIT, V44, P5456, DOI 10.1002/anie.200500989
NR 59
TC 27
Z9 27
U1 4
U2 35
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
EI 1879-3096
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD APR
PY 2017
VL 35
IS 4
BP 308
EP 317
DI 10.1016/j.tibtech.2016.10.001
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA ER5UY
UT WOS:000398870500007
PM 28277248
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Santos, J
   Meneses, BM
AF Santos, Jose
   Meneses, Bruno M.
TI An integrated approach for the assessment of the Aedes aegypti and Aedes
   albopictus global spatial distribution, and determination of the zones
   susceptible to the development of Zika virus
SO ACTA TROPICA
LA English
DT Article
DE Ae. aegypti; Ae. albopictus; Spatial analysis; Susceptibility of Zika
   virus
ID CLIMATE-CHANGE; DISTRIBUTION MODELS; PREDICTION; INFECTION
AB The Zika virus, one of the new epidemic diseases, is reported to have affected millions of people in the past year. The suitable climate conditions of the areas where Zika virus has been reported, especially in areas with a high population density, are the main cause of the current outbreak and spread of the disease. Indeed, the suitable climatic conditions of certain territories constitute perfect breading nest for the propagation and outbreak of worldwide diseases. The main objective of this research is to analyze the global distribution and predicted areas of both mosquitoes Ae. aegypti and Ae. albopictus which are the main vectors of Zika virus. Physical (SRTM) and climatic variables (WorldClim) were used to obtain the susceptibility maps based on the optimum conditions for the development of these mosquitoes. The susceptibility model was developed using a Species Distribution Model - correlative model, namely the Maximum Entropy, that used as input the spatial references of both vectors (Dryad Digital Repository).
   The results show the most important classes of each independent variable used in assessing the presence of each species of mosquitoes and the areas susceptible to the presence of these vector species. It turns out that Ae. aegypti has greater global dispersion than the Ae. albopictus specie, although two common regions stand out as the most prone to the presence of both mosquito species (tropical and subtropical zones).
   The crossing of these areas of greater susceptibility with areas of greater population density (e.g. India, China, Se of USA and Brazil) shows some agreement, and these areas stand out due to the presence of several records of Zika virus (HealthMap Project).
   In this sense, through the intersection of susceptibility and human exposure the areas with increased risk of development and spread of Zika virus are pinpointed, suggesting that there may be a new outbreak of this virus in these places, if preventive measures are not adopted.(C) 2017 Elsevier B.V. All rights reserved.
C1 [Santos, Jose] Winning Sci Management, Alameda Oceanos 14,Parque Nacoes, P-1990203 Alameda, CA, Portugal.
   [Meneses, Bruno M.] Univ Lisbon, Inst Geog & Spatial Planning, Ctr Geog Studies, Rua Branca Edmee Marques, P-1600276 Lisbon, Portugal.
RP Meneses, BM (corresponding author), Univ Lisbon, Inst Geog & Spatial Planning, Ctr Geog Studies, Rua Branca Edmee Marques, P-1600276 Lisbon, Portugal.
EM jose.santos@winning.pt; bmeneses@campus.ul.pt
RI Meneses, Bruno/K-2257-2016
OI Meneses, Bruno/0000-0003-3348-6732
FU Universidade de Lisboa, IGOT-UL [BD2015]; Institute of Geography and
   Spatial Planning
FX This work was financed through a grant given by the Institute of
   Geography and Spatial Planning and Universidade de Lisboa, IGOT-UL
   (BD2015).
CR [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bell DM, 2016, ECOL MODEL, V330, P50, DOI 10.1016/j.ecolmodel.2016.03.012
   Bell R, 2004, MANAG INFORMAT SYST, V9, P197
   Bennetsen E, 2016, ECOL MODEL, V325, P1, DOI 10.1016/j.ecolmodel.2015.12.016
   Bierlaire D, 2014, TRANSFUS CLIN BIOL, V21, P234, DOI DOI 10.1016/J.TRACLI.2014.08.005
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Capinha C, 2014, ECOHEALTH, V11, P420, DOI 10.1007/s10393-014-0918-y
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005
   Goorhuis A., 2016, TRAVEL MED INFECT DI, P8
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jarnevich CS, 2015, ECOL INFORM, V29, P6, DOI 10.1016/j.ecoinf.2015.06.007
   Juliao R.P., 2009, ANPC DGOT
   Kappes MS, 2012, GEOMORPHOLOGY, V151, P139, DOI 10.1016/j.geomorph.2012.01.024
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Late M, 2016, NATIONSS HEAL AM PUB, V5, P14
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Luz C, 2008, MEM I OSWALDO CRUZ, V103, P214, DOI 10.1590/S0074-02762008000200016
   Meneses B.M, 2011, SUSCEPTIBILITY RISK
   Meneses BM, 2016, WATER-SUI, V8, DOI 10.3390/w8070289
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nhan T-X, 2014, REV FRANCOPH LAB, V467, P45
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7
   Pearson R.G, 2008, SPECIESS DISTRIBUTIO
   Petersen E., 2016, INT J INFEC IN PRESS
   Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI DOI 10.1145/1015330.1015412
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Rodriguez-Morales A.J., 2016, TRAVEL MED INFECT DI, P2015
   Schmidt J, 2011, NAT HAZARDS, V58, P1169, DOI 10.1007/s11069-011-9721-z
   Tehrany MS, 2013, J HYDROL, V504, P69, DOI 10.1016/j.jhydrol.2013.09.034
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wilson JW, 2013, BIOL CONSERV, V164, P170, DOI 10.1016/j.biocon.2013.04.021
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 52
TC 16
Z9 16
U1 2
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2017
VL 168
BP 80
EP 90
DI 10.1016/j.actatropica.2017.01.015
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EM3MR
UT WOS:000395219800013
PM 28111132
DA 2020-07-08
ER

PT J
AU Zylak, A
   Golombek, SG
AF Zylak, Anna
   Golombek, Sergio G.
TI Zika virus from a neonatologist's perspective
SO JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE
LA English
DT Review
DE Zika virus; pregnancy; transmission; newborn; neonatal outcomes;
   microcephaly
ID UNITED-STATES; INTERIM GUIDELINES; INFECTION; TRANSMISSION; BRAZIL
AB Zika virus has been known for more than half a century. Its clinical significance was just recently discovered, after the epidemic of Zika virus emerged in South and Central America. A task force established in 2015 by the Brazil Ministry of Health investigated the possible association between congenital Zika infection and microcephaly in fetuses and newborns. Since then more and more evidence emerged, supporting this hypothesis. The objective of this article is to review and summarize the currently available literature regarding Zika virus from a neonatologist's standpoint and provide some guidance to medical providers who may have to care for potentially exposed pregnant patients and their newborns.
C1 [Zylak, Anna; Golombek, Sergio G.] New York Med Coll, Dept Pediat, Maria Fareri Childrens Hosp,Westchester Med Ctr, Reg Neonatal Ctr,Div Newborn Med, Valhalla, NY 10595 USA.
RP Zylak, A (corresponding author), New York Med Coll, Dept Pediat, Maria Fareri Childrens Hosp,Westchester Med Ctr, Reg Neonatal Ctr,Div Newborn Med, Valhalla, NY 10595 USA.
EM anna.zylak@wmchealth.org
RI Golombek, Sergio G/A-7697-2008
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Larocca RA, 2016, NATURE
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tetro J., ZIKA VIRUS MAKING EP
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 28
TC 0
Z9 0
U1 0
U2 19
PU HYGEIA PRESS CORRIDORI MARINELLA
PI QUARTU SANT ELENA
PA VIA MONTECATINI 53, QUARTU SANT ELENA, CA09045, ITALY
SN 2281-0692
J9 J PEDIATR NEONATAL I
JI J. Pediatr. Neonatal Individ. Med.
PD APR
PY 2017
VL 6
IS 1
AR UNSP e060128
DI 10.7363/060128
PG 6
WC Pediatrics
SC Pediatrics
GA EO5LB
UT WOS:000396733500008
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lamb, L
   Bartolone, S
   Conway, M
   Tree, M
   Lossia, O
   Dunbar, G
   Rossignol, J
   Smith, C
   Chancellor, M
AF Lamb, Laura
   Bartolone, Sarah
   Conway, Michael
   Tree, Maya
   Lossia, Olivia
   Dunbar, Gary
   Rossignol, Julien
   Smith, Christopher
   Chancellor, Michael
TI URINE BASED RAPID MOLECULAR DIAGNOSIS OF ZIKA VIRUS
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Urological-Association (AUA)
CY MAY 12-16, 2017
CL Boston, MA
SP Amer Urol Assoc
RI Rossignol, Julien/I-1013-2019
OI Rossignol, Julien/0000-0002-8662-0547
FU Maureen and Ronald Hirsch family
FX This study was funded in part by the Maureen and Ronald Hirsch family
   philanthropic contribution.
NR 0
TC 0
Z9 0
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2017
VL 197
IS 4
SU S
MA MP23-03
BP E293
EP E294
DI 10.1016/j.juro.2017.02.731
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA EQ7PR
UT WOS:000398276601134
OA Bronze
DA 2020-07-08
ER

PT J
AU Rick, AM
   Domek, G
   Cunningham, M
   Olson, D
   Lamb, M
   Jimenez-Zambrano, A
   Heinrichs, G
   Berman, S
   Asturias, E
AF Rick, Anne-Marie
   Domek, Gretchen
   Cunningham, Maureen
   Olson, Daniel
   Lamb, Molly
   Jimenez-Zambrano, Andrea
   Heinrichs, Gretchen
   Berman, Stephen
   Asturias, Edwin
TI Baseline microcephaly prevalence in rural Guatemala: implications for
   neonatal screening for congenital Zika virus infection
SO LANCET GLOBAL HEALTH
LA English
DT Meeting Abstract
C1 [Rick, Anne-Marie; Domek, Gretchen; Cunningham, Maureen; Olson, Daniel; Lamb, Molly; Jimenez-Zambrano, Andrea; Heinrichs, Gretchen; Berman, Stephen; Asturias, Edwin] Ctr Global Hlth, Colorado Sch Publ Hlth, Aurora, CO USA.
   [Rick, Anne-Marie; Domek, Gretchen; Cunningham, Maureen; Olson, Daniel; Berman, Stephen; Asturias, Edwin] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.
   [Heinrichs, Gretchen] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA.
EM anne-marie.rick@childrenscolorado.org
FU Center for Global Health at the University of Colorado; Jose Fernando
   Bolanos Menendez Foundation
FX The Center for Global Health at the University of Colorado and the Jose
   Fernando Bolanos Menendez Foundation provided funding for the wellness
   programme.
NR 0
TC 2
Z9 3
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD APR
PY 2017
VL 5
SU 1
BP 16
EP 16
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EQ8VP
UT WOS:000398363900016
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Fu, BS
   Wang, LY
   Li, ST
   Dorf, ME
AF Fu, Bishi
   Wang, Lingyan
   Li, Shitao
   Dorf, Martin E.
TI ZMP STE24 defends against influenza and other pathogenic viruses
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID PRELAMIN-A; ZMPSTE24-DEFICIENT MICE; PROTEASE; DEFICIENCY; PROTEINS;
   DISEASE
AB Zinc metallopeptidase STE24 (ZMP STE 24) is a transmembrane metalloprotease whose catalytic activity is critical for processing lamin A on the inner nuclear membrane and clearing clogged translocons on the endoplasmic reticulum. We now report ZMP STE 24 is a virus-specific effector that restricts enveloped RNA and DNA viruses, including influenza A, Zika, Ebola, Sindbis, vesicular stomatitis, cowpox, and vaccinia, but not murine leukemia or adenovirus. ZMP STE 24-mediated antiviral action is independent of protease activity. Coimmunoprecipitation studies indicate ZMP STE 24 can complex with proteins of the interferon-induced transmembrane protein (IFITM) family. IFITM proteins impede viral entry, and ZMP STE 24 expression is necessary for IFITM antiviral activity. In vivo studies demonstrate ZMP STE 24-deficient mice display higher viral burdens, enhanced cytokine production, and increased mortality after influenza infection. Collectively, these findings identify ZMP STE 24 as an intrinsic broad-spectrum antiviral protein and provide insights into antiviral defense mechanisms.
C1 [Fu, Bishi; Dorf, Martin E.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Wang, Lingyan; Li, Shitao] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.
RP Dorf, ME (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Li, ST (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.
EM shitao.li@okstate.edu; dorf@hms.harvard.edu
OI Li, Shitao/0000-0002-1398-8519
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01-AI089829,
   R01-AI121288, P20-GM103648]; Research Equipment and DevelopmentFund
FX This work was supported by National Institutes of Health grants
   R01-AI089829 (to M.E. Dorf), R01-AI121288 (to M.E. Dorf), and
   P20-GM103648 (to S. Li) and the Research Equipment and DevelopmentFund
   (to S. Li).
CR Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233
   Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541
   Cossart P, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016972
   Cureton DK, 2012, J VIROL, V86, P655, DOI 10.1128/JVI.05810-11
   Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102
   Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125
   Fu BS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004960
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13
   Hildebrandt ER, 2016, J BIOL CHEM, V291, P14185, DOI 10.1074/jbc.M116.718197
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200
   Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120
   Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63
   Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12
   Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971
   Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048
   Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513
   Szretter Kristy J, 2006, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/0471729256.mc15g01s3
   Tscherne DM, 2011, CURR PROTOC CELL BIO
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Young SG, 2014, MOL CELL BIOL, V34, P2776, DOI 10.1128/MCB.00486-14
NR 28
TC 19
Z9 19
U1 1
U2 18
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD APR
PY 2017
VL 214
IS 4
BP 919
EP 929
DI 10.1084/jem.20161270
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EQ4MH
UT WOS:000398051100005
PM 28246125
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Benelli, G
   Pavela, R
   Canale, A
   Cianfaglione, K
   Ciaschetti, G
   Conti, F
   Nicoletti, M
   Senthil-Nathan, S
   Mehlhorn, H
   Maggi, F
AF Benelli, Giovanni
   Pavela, Roman
   Canale, Angelo
   Cianfaglione, Kevin
   Ciaschetti, Giampiero
   Conti, Fabio
   Nicoletti, Marcello
   Senthil-Nathan, Sengottayan
   Mehlhorn, Heinz
   Maggi, Filippo
TI Acute larvicidal toxicity of five essential oils (Pinus nigra, Hyssopus
   officinalis, Satureja montana, Aloysia citrodora and Pelargonium
   graveolens) against the filariasis vector Culex quinquefasciatus:
   Synergistic and antagonistic effects
SO PARASITOLOGY INTERNATIONAL
LA English
DT Article
DE Culicidae; Green pesticides; Essential oils; Integrated Vector
   Management; Mosquito control; St Louis encephalitis; West Nile
ID TRITAENIORHYNCHUS DIPTERA-CULICIDAE; ECO-FRIENDLY LARVICIDES; MOSQUITO
   VECTORS; VETERINARY IMPORTANCE; ANOPHELES-SUBPICTUS; ZIKA VIRUS; AEDES;
   NANOPARTICLES; INSECTICIDE; REPELLENTS
AB Mosquito vector control is facing a number of important and timely challenges, mainly due to the rapid development of pesticide resistance and environmental concerns. In this scenario, screening of botanical resources for their mosquitocidal activity may offer effective and eco-friendly tools against Culicidae vectors. Culex quinquefasciatus Say (Diptera: Culicidae) is a vector of lymphatic filariasis and of dangerous arboviral diseases, such as West Nile and St Louis encephalitis. In this study, the chemical composition of five essential oils obtained from different plants, namely Pinus nigra J.F. Arnold var. italica (Pinaceae), Hyssopus officinalis L subsp. aristatus (Lamiaceae), Satureja montana L. subsp. montana (Lamiaceae), Aloysia citriodora Palau (Verbenaceae) and Pelargonium graveolens L'Her (Geraniaceae), was investigated by GC-MS analysis. Furthermore, it was evaluated their acute toxicity on larvae of C. quinquefasciatus. Then, the most effective oils were selected, in order to focus on the potential synergistic and antagonistic effects, testing them in binary mixtures on C quinquefasciatus larvae. Results showed that the higher effectiveness was obtained by S. montana subsp. montana essential oil (LC50 = 25.6 mu L.L-1), followed by P. nigra var. italica (LC50 = 49.8 mu L.L-1) and A. citriodora (LC50 = 65.6 mu L.L-1), while the other essential oils showed LC50 values higher than 90 mu L.L-1. The larvicidal effectiveness can be enhanced by preparing simple binary mixtures of essential oils, such as S. montana + A. citriodora (ratio 1:1), which showed higher larvicidal toxicity (LC50 = 18.3 mu L.L-1). On the other hand, testing S. montana + P. nigra (1:1) an antagonistic effect was detected, leading to a LC50 (72.5 mu L.L-1) higher than the LC50 values calculated for the two oils tested separately. Overall, our results add useful knowledge to allow the employ of synergistic essential oil blends as effective, cheap and eco-friendly mosquito larvicides. (C) 2017 Elsevier Ireland Ltd. All rights reserved.
C1 [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Cianfaglione, Kevin] Univ Bretagne Occidentale, UFR Sci & Tech, Geoarchitecture, Brest, France.
   [Cianfaglione, Kevin] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy.
   [Ciaschetti, Giampiero] Majella Natl Pk, Sulmona, Italy.
   [Conti, Fabio] Univ Camerino, Ctr Ric Florist Appennino, Sch Biosci & Vet Med, San Colombo, Italy.
   [Nicoletti, Marcello] Sapienza Univ, Dept Environm Biol, Rome, Italy.
   [Senthil-Nathan, Sengottayan] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
   [Mehlhorn, Heinz] Heinrich Heine Univ, Dept Parasitol, Dusseldorf, Germany.
   [Maggi, Filippo] Univ Camerino, Sch Pharm, Camerino, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; Pavela, Roman/Q-8647-2016; Cianfaglione,
   Kevin/AAL-8874-2020; Conti, Fabio/K-4846-2015; Sengottayan,
   Senthil-Nathan/D-8979-2012
OI Benelli, Giovanni/0000-0001-8971-6010; Conti, Fabio/0000-0001-7391-6691;
   Sengottayan, Senthil-Nathan/0000-0003-0839-2021; Pavela,
   Roman/0000-0001-7866-4278
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]; Ministry of Agriculture of the Czech
   RepublicMinistry of Agriculture, Czech Republic [QJ1510160]; University
   of Camerino [FPI 000044]
FX G. Benelli is sponsored by PROAPI (PRAF 2015) and University of Pisa,
   Department of Agriculture, Food and Environment (Grant ID:
   COFIN2015_22). R. Pavela would like to thank the Ministry of Agriculture
   of the Czech Republic for its financial support concerning botanical
   pesticide research (Project NAZV No. QJ1510160). The authors are
   grateful to the University of Camerino (FAR 2014/15, Fondo di Ateneo per
   la Ricerca, FPI 000044) for financial support.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bruschi P., 2006, BIODIVERSITA VEGETAL, V3, P241
   Bruschi P., 2006, MAJELLA INFORM BOT I, V38, P357
   Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365
   Dua VK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-30
   Duke JA, 1985, HDB MED HERBS
   Ebadollahi Asgar, 2013, Ecologia Balkanica, V5, P149
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Guarrera PM, 2005, FITOTERAPIA, V76, P1, DOI 10.1016/j.fitote.2004.09.006
   Hornok L, 1992, CULTIVATION PROCESSI, P196
   Kalaivani K, 2012, PARASITOL RES, V110, P1261, DOI 10.1007/s00436-011-2623-x
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Manganelli REU, 2001, J ETHNOPHARMACOL, V78, P171, DOI 10.1016/S0378-8741(01)00341-5
   Mehlhorn H., 2015, ENCY PARASITOLOGY, P893
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044
   Pavela R., 2016, PARASITOL RES
   Pavela R., 2016, T PLANT SCI
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2016, EXP PARASITOL, V165, P51, DOI 10.1016/j.exppara.2016.03.016
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Pieroni A, 2004, J ETHNOPHARMACOL, V91, P331, DOI 10.1016/j.jep.2004.01.015
   Pieroni A, 2000, J ETHNOPHARMACOL, V70, P235, DOI 10.1016/S0378-8741(99)00207-X
   Ragone MI, 2010, LAT AM J PHARM, V29, P79
   Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359
   Van Hellemont J., 1986, COMPENDIUM PHYTOTHER, P234
   Venditti A, 2015, IND CROP PROD, V77, P353, DOI 10.1016/j.indcrop.2015.09.002
   Viegi L, 2003, J ETHNOPHARMACOL, V89, P221, DOI 10.1016/j.jep.2003.08.003
   WHO, 1996, CTDWHOPESIC961
   Yang P, 2005, J PESTIC SCI, V30, P84, DOI 10.1584/jpestics.30.84
NR 44
TC 54
Z9 55
U1 4
U2 56
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1383-5769
J9 PARASITOL INT
JI Parasitol. Int.
PD APR
PY 2017
VL 66
IS 2
BP 166
EP 171
DI 10.1016/j.parint.2017.01.012
PG 6
WC Parasitology
SC Parasitology
GA EL2UV
UT WOS:000394476700026
PM 28110082
DA 2020-07-08
ER

PT J
AU Vanickova, L
   Canale, A
   Benelli, G
AF Vanickova, Lucie
   Canale, Angelo
   Benelli, Giovanni
TI Sexual chemoecology of mosquitoes (Diptera, Culicidae): Current
   knowledge and implications for vector control programs
SO PARASITOLOGY INTERNATIONAL
LA English
DT Review
DE Aggregation pheromones; Courtship and mating; Cuticular hydrocarbons;
   Mate recognition; Mosquito-borne diseases; Sterile insect technique;
   Swarming behavior
ID AEDES-ALBOPICTUS DIPTERA; ASIAN TIGER MOSQUITO; MIDGE
   CULICOIDES-IMPUNCTATUS; STERILE INSECT TECHNIQUE; ANOPHELES-GAMBIAE;
   CUTICULAR HYDROCARBONS; MATING-BEHAVIOR; ESSENTIAL OILS; ZIKA VIRUS;
   VETERINARY IMPORTANCE
AB Mosquitoes (Diptera: Culicidae) act as vectors of medical and veterinary importance, due to their ability to transmit many pathogens and parasites. Renewed interest has been recently devoted to the potential of sterile insect technique (SIT) for mosquito suppression. However, the success of the SIT is mostly dependent on the ability of sterile males to compete for mates with the wild ones in the field. Nevertheless, little is known on the sexual chemical ecology of mosquitoes, with special reference to the role of chemical signals in males. We reviewed the current knowledge on mosquito sexual chemical ecology and other key cues affecting courtship and mating behavior. The information available on the aggregation and sex pheromones in mosquito males is rather limited. To the best of our knowledge, the components of the aggregation pheromone stimulating swarming mechanisms have been fully characterized only for Aedes aegypti, while evidence for aggregation pheromones in other mosquito species remains elusive. Further research on this issue is needed, as well as to dissect the relative importance of visual (with special reference to swarming landmarks), vibrational, olfactory and tactile cues perceived during swarming and mate. On the other hand, more knowledge is available for cuticular hydrocarbons, which modulate mating behavior in several species of economic importance. These compounds, coupled with volatile aggregation components, have potential interest for the development of monitoring and trapping systems. In addition, the analyses of cuticular hydrocarbons are essential for discrimination between closely related mosquito species and/or populations. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Vanickova, Lucie] Brno Univ Technol, Cent European Inst Technol, Purkynova 656-123, CZ-61600 Brno, Czech Republic.
   [Vanickova, Lucie] Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; Vanickova, Lucie/L-7034-2016
OI Benelli, Giovanni/0000-0001-8971-6010; Vanickova,
   Lucie/0000-0001-7744-3246
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]; Ministry of Education, Youth and Sports of
   the Czech RepublicMinistry of Education, Youth & Sports - Czech Republic
   [LQ1601]
FX We are grateful to K. Kita for inviting this review on Parasitology
   International. Three anonymous reviewers improved an earlier version of
   our manuscript. We would like to thank M. Nicoletti and R. Hanus for
   helpful discussions on an earlier version of the manuscript. G. Benelli
   is sponsored by PROAPI (PRAF 2015) and University of Pisa, Department of
   Agriculture, Food and Environment (Grant ID: COFIN2015_22). This
   research was partially funded by the Ministry of Education, Youth and
   Sports of the Czech Republic under the project CEITEC 2020 (LQ1601).
   Funders had no role in decision to publish, or preparation of the
   manuscript. The macrophotograph of Ae. aegypti was kindly provided by
   the Centers for Disease Control and Prevention, Public Health Image
   Library (courtesy of J. Gathany).
CR Al Ahmed AM, 2013, J MASS SPECTROM, V48, P1170, DOI 10.1002/jms.3282
   Allan SA, 1998, J MED ENTOMOL, V35, P943, DOI 10.1093/jmedent/35.6.943
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   BANFIELD WG, 1966, CANCER-AM CANCER SOC, V19, P1333, DOI 10.1002/1097-0142(196610)19:10<1333::AID-CNCR2820191002>3.0.CO;2-I
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   Benelli G, 2014, J PEST SCI, V87, P385, DOI 10.1007/s10340-014-0577-3
   Benelli G, 2014, PARASITOL RES, V113, P933, DOI 10.1007/s00436-013-3725-4
   Bernier U. R., 1999, ANAL CHEM, V71
   Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k
   Bhasin A, 2000, MED VET ENTOMOL, V14, P300, DOI 10.1046/j.1365-2915.2000.00247.x
   Bhasin A, 2001, MED VET ENTOMOL, V15, P147, DOI 10.1046/j.1365-2915.2001.00285.x
   Blomquist G. J., 1993, INSECT LIPIDS CHEM B
   Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Caputo B, 2007, INSECT BIOCHEM MOLEC, V37, P389, DOI 10.1016/j.ibmb.2007.01.002
   Caputo B, 2005, J MASS SPECTROM, V40, P1595, DOI 10.1002/jms.961
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   CARLSON DA, 1980, SCIENCE, V207, P1089, DOI 10.1126/science.7355276
   CARLSON DA, 1979, ANN TROP MED PARASIT, V73, P589, DOI 10.1080/00034983.1979.11687301
   Cator LJ, 2010, BEHAV ECOL, V21, P1033, DOI 10.1093/beheco/arq087
   Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541
   Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x
   Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184
   DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415
   EI-Sayed A. M., 2009, J ECON ENTOMOL, V102, P815
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fawaz EY, 2014, J VECTOR ECOL, V39, P347, DOI 10.1111/jvec.12110
   Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x
   Gibson G, 2006, CURR BIOL, V16, P1311, DOI 10.1016/j.cub.2006.05.053
   Gibson G, 2010, JARO-J ASSOC RES OTO, V11, P527, DOI 10.1007/s10162-010-0243-2
   GJULLIN C. M., 1967, MOSQUITO NEWS, V27, P382
   Gonzalez PV, 2014, ENTOMOL EXP APPL, V151, P191, DOI 10.1111/eea.12184
   GUBLER DJ, 1972, MOSQ NEWS, V32, P219
   Hamady D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-206
   Hapairai LK, 2013, J MED ENTOMOL, V50, P731, DOI 10.1603/ME12270
   HARTBERG WK, 1971, B WORLD HEALTH ORGAN, V45, P847
   Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196
   Hodges TK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1089
   Home GL, 2002, B ENTOMOL RES, V92, P287, DOI DOI 10.1079/BER2002170
   Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008
   Knols B. G. J., 1997, B ENTOMOL RES, V87, P151
   KRUGER EL, 1993, J MED ENTOMOL, V30, P544, DOI 10.1093/jmedent/30.3.544
   KRUGER EL, 1991, J MED ENTOMOL, V28, P859, DOI 10.1093/jmedent/28.6.859
   Lang J. T., 1977, J MED ENTOMOL, V3, P213
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Lehrer S, 2010, ANTICANCER RES, V30, P1371
   Lehrer S, 2010, MED HYPOTHESES, V74, P167, DOI 10.1016/j.mehy.2009.07.005
   Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047
   Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467
   LUMSDEN W. H. R., 1957, BULL ENT RES, V48, P769, DOI 10.1017/S0007485300002881
   Luntz AJM, 2003, BIOCHEM SOC T, V31, P128, DOI 10.1042/BST0310128
   Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020
   McCLELLAND G. A. H., 1959, BULL ENT RES, V50, P227, DOI 10.1017/S0007485300054547
   Mendki MJ, 2000, CURR SCI INDIA, V78, P1295
   Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   NIJHOUT HF, 1971, ENTOMOL EXP APPL, V14, P399, DOI 10.1007/BF00539936
   Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021
   Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   PAPPAS CD, 1994, J CHEM ECOL, V20, P1121, DOI 10.1007/BF02059748
   Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040
   Philips TK, 1996, J INSECT BEHAV, V9, P739, DOI 10.1007/BF02213554
   Pitts RJ, 2014, ACTA TROP, V132, pS26, DOI 10.1016/j.actatropica.2013.09.005
   Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271
   Polerstock AR, 2002, J MED ENTOMOL, V39, P545, DOI 10.1603/0022-2585-39.3.545
   POMONIS JG, 1978, J CHEM ECOL, V4, P27, DOI 10.1007/BF00988257
   ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604
   Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2
   Semmler M, 2014, PARASITOL RES, V113, P185, DOI 10.1007/s00436-013-3641-7
   Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009
   South SH, 2008, J INSECT BEHAV, V21, P451, DOI 10.1007/s10905-008-9137-0
   South SH, 2011, ANIM BEHAV, V81, P645, DOI 10.1016/j.anbehav.2010.12.014
   South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991
   Syed Z, 2015, CURR OPIN INSECT SCI, V10, P83, DOI 10.1016/j.cois.2015.04.011
   Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131
   Urbanski MJ., 2010, P R SOC B, V277, P2683
   Vanickova L, 2015, J APPL ENTOMOL, V139, P679, DOI 10.1111/jen.12204
   Vanickova L, 2014, B ENTOMOL RES, V104, P631, DOI 10.1017/S0007485314000406
   Vanickova L, 2015, ZOOKEYS, P507, DOI 10.3897/zookeys.540.9619
   Vanickova L, 2012, J CHEM ECOL, V38, P1133, DOI 10.1007/s10886-012-0177-8
   Vreysen MJB, 2007, AREA WIDE CONTROL IN
   Wagoner KM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-294
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   Wiwatanaratanabutr I, 2010, J AM MOSQUITO CONTR, V26, P265, DOI 10.2987/09-5937.1
   Wyatt T.D., 2003, PHEROMONES ANIMAL BE, P74
   Zsemlye JL, 2005, MED VET ENTOMOL, V19, P276, DOI 10.1111/j.1365-2915.2005.00570.x
   Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017
NR 112
TC 10
Z9 10
U1 1
U2 41
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1383-5769
J9 PARASITOL INT
JI Parasitol. Int.
PD APR
PY 2017
VL 66
IS 2
BP 190
EP 195
DI 10.1016/j.parint.2016.09.010
PG 6
WC Parasitology
SC Parasitology
GA EL2UV
UT WOS:000394476700030
PM 27692501
DA 2020-07-08
ER

PT J
AU He, A
   Brasil, P
   Siqueira, AM
   Calvet, GA
   Kwatra, SG
AF He, Alice
   Brasil, Patricia
   Siqueira, Andre M.
   Calvet, Guilherme A.
   Kwatra, Shawn G.
TI The Emerging Zika Virus Threat: A Guide for Dermatologists
SO AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
LA English
DT Review
ID UNITED-STATES; INFECTION; TRAVELERS; TRANSMISSION; INDONESIA; DENGUE;
   CHIKUNGUNYA; COINFECTION; OUTBREAK; PATIENT
AB We provide a guide for dermatologists to follow if they encounter patients with a rash and clinical history suspicious of Zika virus infection, including diagnostic testing and management options. We also provide an illustrative case report of a patient from Brazil who was diagnosed with Zika virus infection after presenting with a generalized pruritic rash. One of the most prominent symptoms of Zika virus infection is a cutaneous eruption. As such, it is especially necessary for dermatologists to understand this virus so that they may appropriately recognize this entity as a diagnostic consideration in the clinic. The rash associated with Zika virus infection is most commonly an erythematous maculopapular eruption that presents after an initial 3-4 days of fever, headache, and arthralgia or myalgia. The rash typically lasts for an average of 6 days, and can spread to involve any part of the body, including the face, torso, extremities, palms, and soles.
C1 [He, Alice; Kwatra, Shawn G.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.
   [Brasil, Patricia; Siqueira, Andre M.; Calvet, Guilherme A.] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
RP He, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.
EM ahe1@jhmi.edu
RI Siqueira, Andre M/G-1340-2010; Calvet, Guilherme/G-6959-2013
OI Siqueira, Andre M/0000-0003-2208-0294; Calvet,
   Guilherme/0000-0002-3545-5238
CR [Anonymous], 2016, CDC NEWSROOM
   [Anonymous], 2016, ZIKA VIRUS HLTH EFFE
   [Anonymous], 2016, ZIKA VIRUS
   [Anonymous], 2015, ZIKA VIRUS DIS US 20
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2016, ZIK VIR 2016
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li J., 2016, VENEZUELA        FEB
   Macesis N, 2015, CLIN INFECT DIS, V61, P1485
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sampathkumar P, 2003, MAYO CLIN PROC, V78, P1137, DOI 10.4065/78.9.1137
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2013, EURO SURVEILL, V19
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 53
TC 4
Z9 5
U1 0
U2 4
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1175-0561
EI 1179-1888
J9 AM J CLIN DERMATOL
JI Am. J. Clin. Dermatol.
PD APR
PY 2017
VL 18
IS 2
BP 231
EP 236
DI 10.1007/s40257-016-0243-z
PG 6
WC Dermatology
SC Dermatology
GA ER3RD
UT WOS:000398714400006
PM 28035650
DA 2020-07-08
ER

PT J
AU del Campo, M
   Feitosa, IML
   Ribeiro, EM
   Horovitz, DDG
   Pessoa, ALS
   Franca, GVA
   Garcia-Alix, A
   Doriqui, MJR
   Wanderley, HYC
   Sanseverino, MVT
   Neri, JICF
   Pina-Neto, JM
   Santos, ES
   Vercosa, I
   Cernach, MCSP
   Medeiros, PFV
   Kerbage, SC
   Silva, AA
   van der Linden, V
   Martelli, CMT
   Cordeiro, MT
   Dhalia, R
   Vianna, FSL
   Victora, CG
   Cavalcanti, DP
   Schuler-Faccini, L
AF del Campo, Miguel
   Feitosa, Ian M. L.
   Ribeiro, Erlane M.
   Horovitz, Dafne D. G.
   Pessoa, Andre L. S.
   Franca, Giovanny V. A.
   Garcia-Alix, Alfredo
   Doriqui, Maria J. R.
   Wanderley, Hector Y. C.
   Sanseverino, Maria V. T.
   Neri, Joao I. C. F.
   Pina-Neto, Joao M.
   Santos, Emerson S.
   Vercosa, Islane
   Cernach, Mirlene C. S. P.
   Medeiros, Paula F. V.
   Kerbage, Saile C.
   Silva, Andre A.
   van der Linden, Vanessa
   Martelli, Celina M. T.
   Cordeiro, Marli T.
   Dhalia, Rafael
   Vianna, Fernanda S. L.
   Victora, Cesar G.
   Cavalcanti, Denise P.
   Schuler-Faccini, Lavinia
CA Zika Embryopathy Task Force
TI The phenotypic spectrum of congenital Zika syndrome
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE congenital Zika infection; congenital Zika sequence; congenital Zika
   syndrome; disruption; disruptive sequence; dysmorphology; fetal brain
   disruption sequence; teratogen; teratology; Zika virus
ID BRAIN DISRUPTION SEQUENCE; VIRUS-INFECTION; HEAD CIRCUMFERENCE; LINGUAL
   FRENULA; BIRTH-DEFECTS; HUMAN PALMAR; FETAL SKULL; INFANTS; BRAZIL;
   FETUSES
AB In October 2015, Zika virus (ZIKV) outbreak the Brazilian Ministry of Health (MoH). In response, the Brazilian Society of Medical Genetics established a task force (SBGM-ZETF) to study the phenotype of infants born with microcephaly due to ZIKV congenital infection and delineate the phenotypic spectrum of this newly recognized teratogen. This study was based on the clinical evaluation and neuroimaging of 83 infants born during the period from July, 2015 to March, 2016 and registered by the SBGM-ZETF. All 83 infants had significant findings on neuroimaging consistent with ZIKV congenital infection and 12 had confirmed ZIKV IgM in CSF. A recognizable phenotype of microcephaly, anomalies of the shape of skull and redundancy of the scalp consistent with the Fetal Brain Disruption Sequence (FBDS) was present in 70% of infants, but was most often subtle. In addition, features consistent with fetal immobility, ranging from dimples (30.1%), distal hand/finger contractures (20.5%), and feet malpositions (15.7%), to generalized arthrogryposis (9.6%), were present in these infants. Some cases had milder microcephaly or even a normal head circumference (HC), and other less distinctive findings. The detailed observation of the dysmorphic and neurologic features in these infants provides insight into the mechanisms and timings of the brain disruption and the sequence of developmental anomalies that may occur after prenatal infection by the ZIKV.
C1 [del Campo, Miguel] Univ Calif San Diego, Dept Pediat, Div Dysmorphol & Teratol, San Diego, CA USA.
   [Feitosa, Ian M. L.; Silva, Andre A.; Vianna, Fernanda S. L.; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.
   [Feitosa, Ian M. L.] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Ribeiro, Erlane M.; Pessoa, Andre L. S.; Kerbage, Saile C.] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Horovitz, Dafne D. G.] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Franca, Giovanny V. A.] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Garcia-Alix, Alfredo] Univ Barcelona, Inst Recerca Pediat St Joan Deu, Barcelona, Spain.
   [Doriqui, Maria J. R.] Hosp Infantil Dr Juvencio Mattos, Sao Luis, Brazil.
   [Wanderley, Hector Y. C.] Secretaria Estado Saude Espirito Santo, Vitoria, Brazil.
   [Sanseverino, Maria V. T.; Silva, Andre A.; Vianna, Fernanda S. L.] Hosp Clin Porto Alegre, Med Genet Serv, SIAT Brazilian Teratogen Informat Serv, Porto Alegre, RS, Brazil.
   [Neri, Joao I. C. F.; Schuler-Faccini, Lavinia] Univ Potiguar, Natal, RN, Brazil.
   [Pina-Neto, Joao M.] Univ Sao Paolo, Dept Genet, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Santos, Emerson S.] Univ Fed Sergipe, Lagarto, Brazil.
   [Vercosa, Islane] Ctr Aperfeicoamento Visual Ver Esperanca Renas CA, Fortaleza, Ceara, Brazil.
   [Cernach, Mirlene C. S. P.] Univ Fed Sao Paolo UNIFESP, Dept Med Genet, Sao Paulo, Brazil.
   [Medeiros, Paula F. V.] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Silva, Andre A.] UNIVATES Univ, Porto Alegre, RS, Brazil.
   [van der Linden, Vanessa] Assoc Assistencia Crianca Deficiente AACD, Recife, PE, Brazil.
   [Martelli, Celina M. T.; Cordeiro, Marli T.; Dhalia, Rafael] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Victora, Cesar G.] Univ Fed Pelotas, Grad Program Epidemiol, Pelotas, RS, Brazil.
   [Cavalcanti, Denise P.] Univ Campinas UNICAMP, Dept Med Genet, Campinas, SP, Brazil.
RP del Campo, M (corresponding author), UCSD, Dept Pediat, 9500 Gilman Dr,MC0828, La Jolla, CA 92093 USA.; Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Hosp Clin Porto Alegre, Gen Med Serv, Caixa Postal 15053-Ag,Campus Agron, BR-91501970 Porto Alegre, RS, Brazil.
EM midelcampo@ucsd.edu; lavinia.faccini@ufrgs.br
RI Vianna, Fernanda Sales Luiz/O-4337-2019; Dhalia, Rafael/AAD-5432-2020;
   SCHULER-FACCINI, LAVINIA/C-8309-2013; SANSEVERINO, MARIA TERESA
   V/G-3884-2017; Garcia-Alix, Alfredo/AAG-4474-2019; Victora, Cesar
   Gomes/Y-2455-2019; de Franca, Giovanny Vinicius Araujo/L-7385-2018
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SANSEVERINO, MARIA TERESA
   V/0000-0002-7404-2911; Victora, Cesar Gomes/0000-0002-2465-2180; de
   Franca, Giovanny Vinicius Araujo/0000-0002-7530-2017; Turchi Martelli,
   Celina Maria/0000-0002-2491-0688; Pina Neto, Joao Monteiro
   de/0000-0003-2465-3527
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [306489/2010-4]; Brazilian Society of Medical Genetics
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Grant
   number: 306489/2010-4; Brazilian Society of Medical Genetics
CR Abdel-Salam GMH, 2008, AM J MED GENET A, V146A, P2929, DOI 10.1002/ajmg.a.32549
   Abdel-Salam GMH, 2015, AM J MED GENET A, V167, P1089, DOI 10.1002/ajmg.a.37010
   Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   ALEXANDER IE, 1995, EUR J PEDIATR, V154, P654, DOI 10.1007/BF02079071
   Anbeek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081895
   Averill LW, 2015, SEMIN ULTRASOUND CT, V36, P476, DOI 10.1053/j.sult.2015.04.001
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bonnemann C. G., 2000, J MED GENET, V27, P273
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P., 2016, NEW ENGL J MED
   Brasil P., 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Capretti MG, 2014, BRAIN DEV-JPN, V36, P203, DOI 10.1016/j.braindev.2013.04.001
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M., 2016, CLIN INFECT DIS, P1
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Felice C, 2001, LANCET, V357, P1500, DOI 10.1016/S0140-6736(00)04661-4
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Furdon Susan A, 2003, Adv Neonatal Care, V3, P286, DOI 10.1016/j.adnc.2003.09.005
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HANSON JW, 1976, J PEDIATR-US, V89, P54, DOI 10.1016/S0022-3476(76)80926-2
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   HUGHES HE, 1986, PEDIATRICS, V78, P85
   ILLINGWORTH RS, 1965, ARCH DIS CHILD, V40, P672, DOI 10.1136/adc.40.214.672
   Jones K. L., 2013, SMITHS RECOGNIZABLE
   JONES KL, 1980, PEDIATRICS, V66, P277
   KIMURA S, 1986, ANAT REC, V216, P191, DOI 10.1002/ar.1092160211
   Kumar A, 2014, INT J DERMATOL, V53, P789, DOI 10.1111/ijd.12376
   Kurjak A, 2008, J MATERN-FETAL NEO M, V21, P675, DOI 10.1080/14767050802212166
   Leal C., 2016, REPROD HLTH, V13
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Levine D., 2016, RADIOLOGY, V281
   Li H, 2016, CELL STEM CELL, V19, P1
   Machet L, 2010, AM J CLIN DERMATOL, V11, P269, DOI 10.2165/11530090-000000000-00000
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2010, AM J HUM GENET, V87, P882, DOI 10.1016/j.ajhg.2010.10.026
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Moore CA, 2016, JAMA PEDIAT
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   NISHI M, 1992, J CHILD NEUROL, V7, P400, DOI 10.1177/088307389200700413
   Paciorkowski AR, 2013, AM J MED GENET A, V161A, P1523, DOI 10.1002/ajmg.a.35969
   PAHO, 2015, NEUR SYNDR CONG MALF, P1
   Pessoa A., 2016, MMWR MORBIDITY MORTA
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rochelson B, 2006, ULTRASOUND OBST GYN, V27, P167, DOI 10.1002/uog.2629
   Rodrigues L. C., 2016, LANCET INFECT DIS, V3099, P1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sadler TW, 2015, LANGMANS MED EMBRYOL
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schram A, 2004, AM J MED GENET A, V127A, P172, DOI 10.1002/ajmg.a.20645
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMITH DW, 1973, J PEDIATR-US, V83, P374, DOI 10.1016/S0022-3476(73)80258-6
   STEVENS CA, 1988, J PEDIATR-US, V113, P128, DOI 10.1016/S0022-3476(88)80546-8
   STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verloes A., 1993, GENEREVIEWS, P1993
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Villo N, 2001, ARCH DIS CHILD-FETAL, V84, pF63, DOI 10.1136/fn.84.1.F63
   Zhang F., 2016, NUCLEIC ACIDS RES, V44
NR 90
TC 66
Z9 67
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR
PY 2017
VL 173
IS 4
BP 841
EP 857
DI 10.1002/ajmg.a.38170
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA EQ1US
UT WOS:000397855700003
PM 28328129
OA Bronze
DA 2020-07-08
ER

PT J
AU Calotta, NA
   Sacks, JM
   Kumar, AR
AF Calotta, Nicholas A.
   Sacks, Justin M.
   Kumar, Anand R.
TI Zika Virus Practical Information for the Plastic and Reconstructive
   Surgeon
SO ANNALS OF PLASTIC SURGERY
LA English
DT Review
DE Zika virus; plastic surgery; microcephaly
ID BLOOD-TRANSFUSION; INFECTION; OUTBREAK; BRAZIL; CARE
AB The ongoing Zika virus outbreak in South, Central, and, most recently, North America has become a global health care emergency. Originally thought to be a benign, self-limiting viral syndrome, the newest epidemic has provided convincing evidence that maternal Zika virus infection can lead to neonatal malformations, the so-called congenital Zika syndrome. The alarming number of microcephalic neonates being born during the current outbreak is most notable, though several other anomalies, such as arthrogryposis, redundant scalp tissue, and cranial collapse, have been reported. Additionally, Zika virus represents an occupational hazard to plastic and reconstructive surgeons and their teams, as well as an infectious risk to patients receiving blood and human tissue products. In this article, we aim to provide current disease-related information to help guide the practicing plastic surgeon in the safe and effective management of patients affected by congenital Zika syndrome and to educate plastic surgeons regarding occupational and transmissivity risks of Zika virus.
C1 [Calotta, Nicholas A.; Sacks, Justin M.; Kumar, Anand R.] Johns Hopkins Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA.
RP Kumar, AR (corresponding author), Dept Plast & Reconstruct Surg, Rubenstein Child Hlth Bldg,200N Wolfe St, Baltimore, MD 21287 USA.
EM akumar40@jhu.edu
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ezaki Marybeth, 2010, Tech Hand Up Extrem Surg, V14, P38, DOI 10.1097/BTH.0b013e3181d44583
   Foy CA, 2013, J BONE JOINT SURG AM, V95A, P1851, DOI 10.2106/JBJS.L.01122
   Gagnon E, 2000, PLAST RECONSTR SURG, V106, P1582, DOI 10.1097/00006534-200012000-00022
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Graf WD, 2010, NEUROLOGY, V74, P1080, DOI 10.1212/WNL.0b013e3181d5e077
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kay S, 2010, J PLAST RECONSTR AES, V63, P1142, DOI 10.1016/j.bjps.2009.05.021
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Masoomi H, 2015, PLAST RECONSTR SURG, V135, p861E, DOI 10.1097/PRS.0000000000001161
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization/World Health Organization (PAHO/WHO), 2015, EP AL E NEUR SYNDR C
   PIATT JH, 1989, PEDIATR NEUROSCI, V15, P233, DOI 10.1159/000120475
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stratton SJ, 2016, PREHOSP DISASTER MED, V31, P119, DOI 10.1017/S1049023X16000170
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Van Heest AE, 2013, J HAND SURG-AM, V38A, P265, DOI 10.1016/j.jhsa.2012.10.034
   Warren SM, 2012, PLAST RECONSTR SURG, V129, P731, DOI 10.1097/PRS.0b013e3182412a50
   Zlotolow Dan A, 2014, Tech Hand Up Extrem Surg, V18, P165, DOI 10.1097/BTH.0000000000000059
NR 30
TC 2
Z9 2
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0148-7043
EI 1536-3708
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD APR
PY 2017
VL 78
IS 4
BP 467
EP 470
DI 10.1097/SAP.0000000000000988
PG 4
WC Surgery
SC Surgery
GA EN4SY
UT WOS:000395998400019
PM 28177969
DA 2020-07-08
ER

PT J
AU Ghezzi, S
   Cooper, L
   Rubio, A
   Pagani, I
   Capobianchi, MR
   Ippolito, G
   Pelletier, J
   Meneghetti, MCZ
   Lima, MA
   Skidmore, MA
   Broccoli, V
   Yates, EA
   Vicenzi, E
AF Ghezzi, Silvia
   Cooper, Lynsay
   Rubio, Alicia
   Pagani, Isabel
   Capobianchi, Maria Rosaria
   Ippolito, Giuseppe
   Pelletier, Julien
   Meneghetti, Maria Cecilia Z.
   Lima, Marcelo A.
   Skidmore, Mark A.
   Broccoli, Vania
   Yates, Edwin A.
   Vicenzi, Elisa
TI Heparin prevents Zika virus induced-cytopathic effects in human neural
   progenitor cells
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus (ZIKV); Neural progenitor cells; Heparin; Cell death
ID HERPES-SIMPLEX-VIRUS; INFLAMMATORY RESPONSE; SEXUAL TRANSMISSION;
   INFECTION; DERIVATIVES; MECHANISM; SULFATE; ENTRY
AB The recent Zika virus (ZIKV) outbreak, which mainly affected Brazil and neighbouring states, demonstrated the paucity of information concerning the epidemiology of several flaviruses, but also highlighted the lack of available agents with which to treat such emerging diseases. Here, we show that heparin, a widely used anticoagulant, while exerting a modest inhibitory effect on Zika Virus replication, fully prevents virus-induced cell death of human neural progenitor cells (NPCs). (C) 2017 Elsevier B.V. All rights reserved.
C1 [Ghezzi, Silvia; Rubio, Alicia; Pagani, Isabel; Vicenzi, Elisa] Ist Sci San Raffaele, Via Olgettina, I-20132 Milan, Italy.
   [Cooper, Lynsay; Pelletier, Julien; Skidmore, Mark A.; Yates, Edwin A.] Keele Univ, Sch Life Sci, Keele ST5 5BG, Staffs, England.
   [Capobianchi, Maria Rosaria; Ippolito, Giuseppe] Lazzaro Spallanzani Natl Inst Infect Dis, Rome, Italy.
   [Pelletier, Julien] Univ Estadual Paulista Julio de Mesquito Filho, Inst Biotecnol, BR-18607440 Botucatu, SP, Brazil.
   [Meneghetti, Maria Cecilia Z.; Lima, Marcelo A.; Yates, Edwin A.] Univ Fed Sao Paulo, Dept Biochem, Rua Tres de Maio, BR-04044020 Sao Paulo, SP, Brazil.
   [Lima, Marcelo A.; Skidmore, Mark A.; Yates, Edwin A.] Univ Liverpool, Dept Biochem, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
   [Broccoli, Vania] CNR, CNR, Inst Neurosci, Milan, Italy.
RP Yates, EA (corresponding author), Univ Liverpool, Dept Biochem, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
EM eayates@liv.ac.uk
RI Meneghetti, Maria Cecilia Zorel/X-3425-2019; Ippolito,
   Giuseppe/J-7207-2017; Pagani, Isabel/AAB-3301-2019; ghezzi,
   silvia/AAN-4092-2020; Vicenzi, Elisa/AAL-3980-2020
OI Meneghetti, Maria Cecilia Zorel/0000-0003-1386-3211; Pagani,
   Isabel/0000-0001-5396-0740; Skidmore, Mark/0000-0002-0287-5594;
   Ippolito, Giuseppe/0000-0002-1076-2979; Ghezzi,
   Silvia/0000-0002-7586-663X; PERNO, CARLO FEDERICO/0000-0002-0825-5388;
   Broccoli, Vania/0000-0003-4050-0926
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES;
   Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [15/08782-3]; Conselho Nacional
   de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq); BBSRC/EPSRC for a New
   Investigator Award [BB/L023717/1]; Keele University for Seed Funding
   Award; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/L023717/1]
FX MAL and EAY gratefully acknowledge gs1:Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior, gs2:Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (15/08782-3) and gs3:Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico for financial support. MAS and EAY acknowledge
   the BBSRC/EPSRC for a New Investigator Award (BB/L023717/1) and Keele
   University for Seed Funding Award (MAS, EAY and MAL). GI acknowledges
   the European Union, Seventh Framework Programme and European Union's
   Horizon 2020 Research and Innovation Programme.
CR BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Herold BC, 1996, J VIROL, V70, P3461, DOI 10.1128/JVI.70.6.3461-3469.1996
   Katsi V, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0664-3
   Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NAHMIAS AJ, 1964, J BACTERIOL, V87, P1060, DOI 10.1128/JB.87.5.1060-1066.1964
   Olsson T, 1983, J Appl Biochem, V5, P437
   Orellana DI, 2016, EMBO MOL MED, V8, P1197, DOI 10.15252/emmm.201606391
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rusnati M, 2009, PHARMACOL THERAPEUT, V123, P310, DOI 10.1016/j.pharmthera.2009.05.001
   Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758
   Salas A, 2000, GUT, V47, P88, DOI 10.1136/gut.47.1.88
   Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI200113799
   Skidmore MA, 2015, MEDCHEMCOMM, V6, P640, DOI 10.1039/c4md00516c
   Spratte J, 2013, MOL HUM REPROD, V19, P227, DOI 10.1093/molehr/gas060
   Veraldi N, 2015, CARBOHYD POLYM, V117, P400, DOI 10.1016/j.carbpol.2014.09.079
   Vicenzi E, 2004, EMERG INFECT DIS, V10, P413, DOI 10.3201/eid1003.030683
NR 32
TC 16
Z9 16
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD APR
PY 2017
VL 140
BP 13
EP 17
DI 10.1016/j.antiviral.2016.12.023
PG 5
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EP0KQ
UT WOS:000397076600002
PM 28063994
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Potisopon, S
   Ferron, F
   Fattorini, V
   Selisko, B
   Canard, B
AF Potisopon, Supanee
   Ferron, Francois
   Fattorini, Veronique
   Selisko, Barbara
   Canard, Bruno
TI Substrate selectivity of Dengue and Zika virus NS5 polymerase towards
   2'-modified nucleotide analogues
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Dengue virus; Zika virus; NS5; RNA-dependent RNA polymerase; Elongation
   complex; 2'-modified NTP analogue
ID DEPENDENT-RNA-POLYMERASE; STATE KINETIC-ANALYSIS; DE-NOVO INITIATION;
   RIBONUCLEOTIDE INCORPORATION; STRUCTURAL BASIS; ELONGATION;
   RNA-POLYMERASE-(3D(POL)); INHIBITION; TEMPLATE; 3D(POL)
AB In targeting the essential viral RNA-dependent RNA-polymerase (RdRp), nucleotide analogues play a major role in antiviral therapies. In the Flaviviridae family, the hepatitis C virus (HCV) can be eradicated from chronically infected patients using a combination of drugs which generally include the 2'-modified uridine analogue Sofosbuvir, delivered as nucleotide prodrug. Dengue and Zika viruses are emerging flaviviruses whose RdRp is closely related to that of HCV, yet no nucleoside drug has been clinically approved for these acute infections. We have purified dengue and Zika virus full-length NS5, the viral RdRps, and used them to assemble a stable binary complex made of NS5 and virus-specific RNA primer/templates. The complex was used to assess the selectivity of NS5 towards nucleotide analogues bearing modifications at the 2'-position. We show that dengue and Zika virus RdRps exhibit the same discrimination pattern: 2'-0-Me > 2'-C-Me-2'-F > 2'-C-Me nucleoside analogues, unlike HCV RdRp for which the presence of the 2'-F is beneficial rendering the discrimination pattern 2'-0 -Me > 2'-C -Me > 2'-C-Me-2'-F. Both 2' -C-Me and 2'-C -Me-2'-F analogues act as non-obligate RNA chain terminators. The dengue and Zika NS5 nucleotide selectivity towards 2'-modified NTPs mirrors potency of the corresponding analogues in infected cell cultures.
C1 [Potisopon, Supanee; Ferron, Francois; Fattorini, Veronique; Selisko, Barbara; Canard, Bruno] Aix Marseille Univ, AFMB Lab Architecture & Fonct Macromol Biol UMR 7, 163 Ave Luminy, F-13288 Marseille, France.
   [Potisopon, Supanee; Ferron, Francois; Fattorini, Veronique; Selisko, Barbara; Canard, Bruno] CNRS, AFMB UMR 7257, 163 Ave Luminy, F-13288 Marseille, France.
   [Potisopon, Supanee] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
RP Selisko, B; Canard, B (corresponding author), Aix Marseille Univ, AFMB Lab Architecture & Fonct Macromol Biol UMR 7, 163 Ave Luminy, F-13288 Marseille, France.
EM barbara.selisko@afmb.univ-mrs.fr; bruno.canard@afmb.univ-mrs.fr
OI Ferron, Francois/0000-0002-8351-4992; Canard, Bruno/0000-0003-4924-1991
FU Fondation pour la Recherche MedicaleFondation pour la Recherche Medicale
   [DEQ20081213949, FDT20130928186]; Infectiopole-Sud; European
   UnionEuropean Union (EU) [260644]; European program H under the
   ZIKAlliance project [734548]; EVAg Research Infrastructure [653316]
FX We thank Alios BioPharma, Inc., Part of the Janssen Pharmaceutical
   Companies, South San Francisco, CA, USA for providing most of the 2'
   nucleotide analogs and especially Dr Jerome Deval for his precious help
   and for inspiring conversations and critically reading of the
   manuscript. We thank Dr Bruno Coutard for his help in obtaining the
   synthetic gene for ZIKV NS5. This work was supported by the Fondation
   pour la Recherche Medicale [Programme Equipe FRM to B. C.
   (DEQ20081213949) and Programme Espoirs de la Recherche to S.
   P.(FDT20130928186)]; by Infectiopole-Sud [PhD scholarship to S. P.]; by
   the European Union Seventh Framework Programme (FP7/2007-2013) through
   the SILVER (Small inhibitor leads against emerging RNA viruses) project
   [No 260644]; by the European program H2020 under the ZIKAlliance project
   (grant agreement No 734548) and the EVAg Research Infrastructure (grant
   agreement No 653316). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y
   Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q
   Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329
   Arnold JJ, 1999, J BIOL CHEM, V274, P37060, DOI 10.1074/jbc.274.52.37060
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Coats SJ, 2014, ANTIVIR RES, V102, P119, DOI 10.1016/j.antiviral.2013.11.008
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Deval J, 2014, CURR OPIN VIROL, V9, P1, DOI 10.1016/j.coviro.2014.08.004
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dutartre H, 2006, ANTIMICROB AGENTS CH, V50, P4161, DOI 10.1128/AAC.00433-06
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferron F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-255
   Fung A, 2014, ANTIMICROB AGENTS CH, V58, P3636, DOI 10.1128/AAC.02666-14
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Huang Y, 1997, BIOCHEMISTRY-US, V36, P13718, DOI 10.1021/bi971609o
   Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530
   Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Poranen MM, 2008, NUCLEIC ACIDS RES, V36, P6633, DOI 10.1093/nar/gkn632
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Shim JH, 2002, J VIROL, V76, P7030, DOI 10.1128/JVI.76.14.7030-7039.2002
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Vashishtha AK, 2016, J BIOL CHEM, V291, P20869, DOI 10.1074/jbc.R116.742494
   Wright S, 2012, J VIROL, V86, P2837, DOI 10.1128/JVI.05168-11
   Wu JQ, 2015, J VIROL, V89, P249, DOI 10.1128/JVI.02085-14
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 50
TC 16
Z9 16
U1 2
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD APR
PY 2017
VL 140
BP 25
EP 36
DI 10.1016/j.antiviral.2016.12.021
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EP0KQ
UT WOS:000397076600004
PM 28041959
DA 2020-07-08
ER

PT J
AU Keasey, SL
   Pugh, CL
   Jensen, SMR
   Smith, JL
   Hontz, RD
   Durbin, AP
   Dudley, DM
   O'Connor, DH
   Ulrich, RG
AF Keasey, Sarah L.
   Pugh, Christine L.
   Jensen, Stig M. R.
   Smith, Jessica L.
   Hontz, Robert D.
   Durbin, Anna P.
   Dudley, Dawn M.
   O'Connor, David H.
   Ulrich, Robert G.
TI Antibody Responses to Zika Virus Infections in Environments of
   Flavivirus Endemicity
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
DE Zika; cross-reactivity; flavivirus; humoral immunity; protein microarray
ID DENGUE VIRUS; ENCEPHALITIS-VIRUS; NEUTRALIZING ANTIBODIES;
   CROSS-REACTIVITY; TRANSMISSION; ENHANCEMENT; PERSISTENCE; PHYLOGENIES;
   BLOCKS; BRAZIL
AB Zika virus (ZIKV) infections occur in areas where dengue virus (DENV), West Nile virus (WNV), yellow fever virus (YFV), and other viruses of the genus Flavivirus cocirculate. The envelope (E) proteins of these closely related flaviviruses induce specific long-term immunity, yet subsequent infections are associated with cross-reactive antibody responses that may enhance disease susceptibility and severity. To gain a better understanding of ZIKV infections against a background of similar viral diseases, we examined serological immune responses to ZIKV, WNV, DENV, and YFV infections of humans and nonhuman primates (NHPs). Using printed microarrays, we detected very specific antibody responses to primary infections with probes of recombinant E proteins from 15 species and lineages of flaviviruses pathogenic to humans, while high cross-reactivity between ZIKV and DENV was observed with 11 printed native viruses. Notably, antibodies from human primary ZIKV or secondary DENV infections that occurred in areas where flavivirus is endemic broadly recognized E proteins from many flaviviruses, especially DENV, indicating a strong influence of infection history on immune responses. A predictive algorithm was used to tentatively identify previous encounters with specific flaviviruses based on serum antibody interactions with the multispecies panel of E proteins. These results illustrate the potential impact of exposure to related viruses on the outcome of ZIKV infection and offer considerations for development of vaccines and diagnostics.
C1 [Keasey, Sarah L.] Univ Maryland Baltimore Cty, Dept Biol, Baltimore, MD 21228 USA.
   [Keasey, Sarah L.; Pugh, Christine L.; Jensen, Stig M. R.; Smith, Jessica L.; Ulrich, Robert G.] US Army, Med Res Inst Infect Dis, Mol & Translat Sci Div, Frederick, MD 21702 USA.
   [Hontz, Robert D.] US Navy, Med Res Ctr, Silver Spring, MD USA.
   [Hontz, Robert D.] US Navy, Med Res Unit 6, NAMRU 6, Lima, Peru.
   [Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.
   [Ulrich, Robert G.] US Army, Med Res Inst Infect Dis, Virol Div, Frederick, MD 21702 USA.
   [Hontz, Robert D.] US Navy, Med Res Ctr, Biol Def Res Directorate, Ft Detrick, MD USA.
RP Ulrich, RG (corresponding author), US Army, Med Res Inst Infect Dis, Mol & Translat Sci Div, Frederick, MD 21702 USA.; Ulrich, RG (corresponding author), US Army, Med Res Inst Infect Dis, Virol Div, Frederick, MD 21702 USA.
EM robert.g.ulrich.civ@mail.mil
RI Jensen, Stig/H-2126-2019
OI Jensen, Stig/0000-0002-4256-3202
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI096215, R01AI116382-01A1]
FX We acknowledge grant support from NIAID to R.G.U. (R01AI096215) and
   D.H.O. (R01AI116382-01A1). This research was supported in part by the
   appointment of S.L.K. and C.L.P. to the Postgraduate Research
   Participation Program administered by the Oak Ridge Institute for
   Science and Education through an interagency agreement with the U.S.
   Department of Energy.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durieux C, 1956, MONOGRAPH SERIES WHO, P115
   Fernandez S, 2011, CLIN VACCINE IMMUNOL, V18, P523, DOI 10.1128/CVI.00016-11
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   HALSTEAD SB, 1976, P SOC EXP BIOL MED, V151, P136, DOI 10.3181/00379727-151-39160
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Klasse PJ, 2014, ADV BIOL, V2014, P1, DOI [10.1155/2014/157895, DOI 10.1155/2014/157895]
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsen CP, 2015, VACCINE, V33, P7075, DOI 10.1016/j.vaccine.2015.09.052
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Meyer D, 2015, SUPPORT VECTOR MACHI
   MONATH TP, 2008, VACCINES, P959
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605
   National Institutes of Health, 2012, WNV STUD VIR IMM PAR
   National Research Council, 2011, GUID CAR US LAB AN
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Palmer Ira, 2004, Curr Protoc Protein Sci, VChapter 6, DOI [10.1002/0471140864.ps0603s70, 10.1002/0471140864.ps0603s38]
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   RUSSELL PK, 1967, JPN J MED SCI BIOL, VS 20, P103
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164
   Tan JL, 2014, METHODS MOL BIOL, V1138, P41, DOI 10.1007/978-1-4939-0348-1_4
   US Department of Health Education and Welfare, 1979, BELM REP ETH PRINC G
   VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Weatherall D., 2006, USE NONHUMAN PRIMATE
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 67
TC 30
Z9 31
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
EI 1556-679X
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD APR
PY 2017
VL 24
IS 4
AR UNSP e00036
DI 10.1128/CVI.00036-17
PG 16
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ES2CA
UT WOS:000399332100004
PM 28228395
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lum, FM
   Low, DKS
   Fan, YP
   Tan, JJL
   Lee, B
   Chan, JKY
   Renia, L
   Ginhoux, F
   Ng, LFP
AF Lum, Fok-Moon
   Low, Donovan K. S.
   Fan, Yiping
   Tan, Jeslin J. L.
   Lee, Bernett
   Chan, Jerry K. Y.
   Renia, Laurent
   Ginhoux, Florent
   Ng, Lisa F. P.
TI Zika Virus Infects Human Fetal Brain Microglia and Induces Inflammation
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; inflammation; microglia
ID NEURAL PROGENITORS; SYSTEM; CELLS
AB Background. The unprecedented reemergence of Zika virus (ZIKV) has startled the world with reports of increased microcephaly in Brazil. ZIKV can infect human neural progenitors and impair brain growth. However, direct evidence of ZIKV infection in human fetal brain tissues remains elusive.
   Methods. Investigations were performed with brain cell preparations obtained from 9 donors. Virus infectivity was assessed by detection of virus antigen by flow cytometry together with various hematopoietic cell surface markers. Virus replication was determined by viral RNA quantification. Cytokine levels in supernatant obtained from virus-infected fetal brain cells were measured simultaneously in microbead-based immunoassays.
   Results. We also show that ZIKV infection was particularly evident in hematopoietic cells with microglia, the brain-resident macrophage population being one of the main targets. Infection induces high levels of proinflammatory immune mediators such as interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), and monocyte chemotactic protein 1 (MCP-1).
   Conclusions. Our results highlight an important role for microglia and neuroinflammation during congenital ZIKV pathogenesis.
C1 [Lum, Fok-Moon; Low, Donovan K. S.; Tan, Jeslin J. L.; Lee, Bernett; Chan, Jerry K. Y.; Renia, Laurent; Ginhoux, Florent; Ng, Lisa F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.
   [Fan, Yiping; Chan, Jerry K. Y.] Dept Reprod Med, Singapore, Singapore.
   [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore.
   [Chan, Jerry K. Y.] Duke NUS Med Sch, Canc & Stem Cell Program, Singapore, Singapore.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Ng, LFP (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
OI Ng, Lisa/0000-0003-4071-5222
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC Agency for Science, Technology and Research,
   Singapore (A* STAR)-led Zika Virus Consortium Fund [15/1/82/27/001]
FX This work was supported by core research grants provided to the
   Singapore Immunology Network by the Biomedical Research Council (BMRC),
   and also partially supported by the BMRC Agency for Science, Technology
   and Research, Singapore (A* STAR)-led Zika Virus Consortium Fund
   (project number 15/1/82/27/001).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Heidari Zohreh, 2014, Acta Med Iran, V52, P740
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   O'Koren EG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20636
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rustenhoven J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19371
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y
   Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wolf Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00026
   World Health Organization (WHO), ZIK SIT REP
NR 32
TC 48
Z9 48
U1 0
U2 41
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 1
PY 2017
VL 64
IS 7
BP 914
EP 920
DI 10.1093/cid/ciw878
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP5SS
UT WOS:000397439600017
PM 28362944
OA Bronze
DA 2020-07-08
ER

PT J
AU Araujo, E
   Carvalho, FHC
   Tonni, G
   Werner, H
AF Araujo Junior, Edward
   Carvalho, Francisco H. C.
   Tonni, Gabriele
   Werner, Heron
TI Prenatal imaging findings in fetal Zika virus infection
SO CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE computed tomography; intrauterine infection; microcephaly; MRI; Zika
   virus
ID 3-DIMENSIONAL ULTRASOUND; COMPUTED-TOMOGRAPHY; MANUFACTURING MODELS;
   PHYSICAL MODEL; FETUSES; EPIDEMIOLOGY; OUTBREAK; BIOMETRY; MRI
AB Purpose of review
   The aim of this review is to report the most recent observations concerning intrauterine Zika virus (ZIKV) infection and associated neuroimaging.
   Recent findings
   ZIKV outbreak in Brazil in 2015 was associated with an impressive registration of cases of congenital microcephaly in women with symptoms suggestive of ZIKV infection. Clinical and laboratory testing for ZIKV and hypothetic etiopathogenetic mechanisms are described. Diagnostic tests on blood, urine and amniotic fluid should be performed in all mothers with symptoms suggestive of intrauterine ZIKV infection. ZIKV causes multiple teratogenic malformations, mainly affecting the developing brain.
   Summary
   Neuroimaging investigation contributes to the prenatal detection of microcephaly and other brain abnormalities in cases of intrauterine ZIKV infection. Neuroimaging is based antenatally on two-dimensional and three-dimensional ultrasound and fetal MRI, whereas computed tomography scan is performed postnatally. Although neuropathology associated with intrauterine ZIKV infection is characterized by nonspecific findings of brain disorder, reduced cortical gyration and white-matter hypomyelination or dysmyelination and cerebellar hypoplasia have been consistently observed in the majority of fetuses and newborns. Prenatal or postnatal genetic workup should be carried out to exclude cases of primary microcephaly. Follow-up should rely upon MRI and computed tomography scan as well as neuropediatrician to better define developmental outcome in survivors.
C1 [Araujo Junior, Edward] Fed Unive Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, SP, Brazil.
   [Carvalho, Francisco H. C.] Fed Univ Ceara UFC, Dept Maternal & Child, Fortaleza, Ceara, Brazil.
   [Tonni, Gabriele] AUSL, Guastalla Civil Hosp, Dept Obstet & Gynecol, Reggio Emilia, Italy.
   [Werner, Heron] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, RJ, Brazil.
RP Araujo, E (corresponding author), Fed Unive Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
RI Tonni, Gabriele/AAM-9842-2020; Werner, Heron/W-1578-2019; Junior, Edward
   Araujo/E-1228-2012
OI Junior, Edward Araujo/0000-0002-6145-2532
CR Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Blondiaux E, 2013, ACTA RADIOL, V54, P1046, DOI 10.1258/ar.2012.120428
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cassart M, 2007, ULTRASOUND OBST GYN, V29, P537, DOI 10.1002/uog.4001
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dreha-Kulaczewski SF, 2012, J MAGN RESON IMAGING, V36, P1329, DOI 10.1002/jmri.23774
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude do Brasil, 2016, MIN SAUD BRAS B EP
   Ministry of Health of Brazil Secretary of Health of the State of Bahia, 2015, B EPIDEMIOL, V11
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montiel JF, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00022
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Safadi MAP, 2016, AM J PERINAT, V33, P1029, DOI 10.1055/s-0036-1586116
   Rajab A, 2007, AM J MED GENET A, V143A, P2761, DOI 10.1002/ajmg.a.31955
   Rizzo G, 2016, J MATERN-FETAL NEO M, V29, P2217, DOI 10.3109/14767058.2015.1081891
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Sarris I, 2013, ULTRASOUND OBST GYN, V42, P560, DOI 10.1002/uog.12410
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tilea B, 2009, ULTRASOUND OBST GYN, V33, P173, DOI 10.1002/uog.6276
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tonni G, 2014, PRENATAL DIAG, V34, P75, DOI 10.1002/pd.4258
   Tsai PY, 2012, ULTRASOUND OBST GYN, V39, P642, DOI 10.1002/uog.10104
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2010, ULTRASOUND OBST GYN, V36, P355, DOI 10.1002/uog.7619
   Werner H, 2016, ULTRASOUND OBSTET GY
   Werner H, 2016, PRENAT DIAGN, V36, P1
   Werner H, 2016, J MATERN-FETAL NEO M, V29, P2229, DOI 10.3109/14767058.2015.1085015
   Werner H, 2015, CHILD NERV SYST, V31, P511, DOI 10.1007/s00381-015-2641-6
   Werner H, 2014, ULTRASOUND Q, V30, P69, DOI 10.1097/RUQ.0000000000000048
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 9
Z9 9
U1 0
U2 25
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-872X
EI 1473-656X
J9 CURR OPIN OBSTET GYN
JI Curr. Opin. Obstet. Gynecol.
PD APR
PY 2017
VL 29
IS 2
BP 95
EP 105
DI 10.1097/GCO.0000000000000345
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EN3KW
UT WOS:000395908400007
PM 28134669
DA 2020-07-08
ER

PT J
AU Fernandez, E
   Diamond, MS
AF Fernandez, Estefania
   Diamond, Michael S.
TI Vaccination strategies against Zika virus
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT;
   NEUTRALIZING HUMAN-ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; MALE SEXUAL
   TRANSMISSION; GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; STRUCTURAL BASIS;
   CROSS-REACTIVITY; DNA VACCINE
AB The epidemic emergence of Zika virus (ZIKV) in 2015-2016 has been associated with congenital malformations and neurological sequela. Current efforts to develop a ZIKV vaccine build on technologies that successfully reduced infection or disease burden against closely related flaviviruses or other RNA viruses. Subunit-based (DNA plasmid and modified mRNA), viral vectored (adeno- and measles viruses) and inactivated viral vaccines are already advancing to clinical trials in humans after successful mouse and non-human primate studies. Among the greatest challenges for the rapid implementation of immunogenic and protective ZIKV vaccines will be addressing the potential for exacerbating Dengue virus infection or causing Guillain-Barre syndrome through production of cross-reactive immunity targeting related viral or host proteins. Here, we review vaccine strategies under development for ZIKV and the issues surrounding their usage.
C1 [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Immunol & Immunother, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Immunol & Immunother, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972, T32
   AI007163]
FX NIH grants (R01 AI073755 and R01 AI104972) to M.S.D supported this work.
   E.F. was supported by an NIH Pre-doctoral training grant award (T32
   AI007163).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE
   Barrett AD, 2014, VACCINES AVAILABLE A
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Bonaparte M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-156
   Bozzo P, 2011, CAN FAM PHYSICIAN, V57, P555
   Brasil P, 2016, N ENGL J MED
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Castro LA, 2016, REAL TIME ZIKA RISK
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Charles AS, 2016, PLOS CURR
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Durbin Anna P, 2016, J Infect Dis, V214, P832, DOI 10.1093/infdis/jiw067
   Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frieden TR, 2017, JAMA-J AM MED ASSOC, P2016
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kroger AT, 2016, MMWR-MORBID MORTAL W, V60, P1
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee E, 2000, J VIROL, V74, P8867, DOI 10.1128/JVI.74.19.8867-8875.2000
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037
   Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303
   Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023
   Monath TP, 2002, VACCINE, V20, P1004, DOI 10.1016/S0264-410X(01)00457-1
   Munoz FM, 2016, JAMA PEDIATR, V170, P832, DOI 10.1001/jamapediatrics.2016.1322
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paul LM, 2016, BIORXIV, V5, P50112
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Routh J, 2016, TESTING INVESTIGATIO
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Russell K, 2016, CLIN INFECT DIS, V64
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schaub B, 2017, LANCET, V3099, P26
   Schlake T, 2012, RNA BIOL, V9, P1319, DOI 10.4161/rna.22269
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sur DK, 2003, AM FAM PHYSICIAN, V68, P299
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Wang Q, 2016, SCI TRANS MED, V8, P1
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 97
TC 41
Z9 41
U1 1
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2017
VL 23
BP 59
EP 67
DI 10.1016/j.coviro.2017.03.006
PG 9
WC Virology
SC Virology
GA EZ4SE
UT WOS:000404702000011
PM 28432975
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Atkinson, B
   Thorburn, F
   Petridou, C
   Bailey, D
   Hewson, R
   Simpson, AJH
   Brooks, TJG
   Aarons, EJ
AF Atkinson, Barry
   Thorburn, Fiona
   Petridou, Christina
   Bailey, Daniel
   Hewson, Roger
   Simpson, Andrew J. H.
   Brooks, Timothy J. G.
   Aarons, Emma J.
TI Presence and Persistence of Zika Virus RNA in Semen, United Kingdom,
   2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SEXUAL TRANSMISSION; CROSS-REACTIVITY; INFECTION; EPIDEMIC; STATES
AB Zika virus RNA has been detected in semen collected several months after onset of symptoms of infection. Given the potential for sexual transmission of Zika virus and for serious fetal abnormalities resulting from infection during pregnancy, information regarding the persistence of Zika virus in semen is critical for advancing our understanding of potential risks. We tested serial semen samples from symptomatic male patients in the United Kingdom who had a diagnosis of imported Zika virus infection. Among the initial semen samples from 23 patients, Zika virus RNA was detected at high levels in 13 (56.5%) and was not detected in 9 (39.1%); detection was indeterminate in 1 sample (4.4%). After symptomatic infection, a substantial proportion of men have detectable Zika virus RNA at high copy numbers in semen during early convalescence, suggesting high risk for sexual transmission. Viral RNA clearance times are not consistent and can be prolonged.
C1 [Atkinson, Barry; Thorburn, Fiona; Petridou, Christina; Bailey, Daniel; Hewson, Roger; Simpson, Andrew J. H.; Brooks, Timothy J. G.; Aarons, Emma J.] Publ Hlth England, Porton Down, England.
   [Thorburn, Fiona] West Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland.
   [Petridou, Christina] Hampshire Hosp Natl Hlth Serv Fdn Trust, Basingstoke, Hants, England.
   [Petridou, Christina] Hampshire Hosp Natl Hlth Serv Fdn Trust, Winchester, Hants, England.
RP Aarons, EJ (corresponding author), Publ Hlth England, Rare & Imported Pathogens Lab, Salisbury SP4 0JG, Wilts, England.
EM emma.aarons@phe.gov.uk
OI Atkinson, Barry/0000-0002-1348-7204; Thorburn, Fiona/0000-0003-1202-4782
FU Public Health England
FX This work was funded by Public Health England.
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Govero J, 2016, NATURE
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huits R, 2016, BULL WORLD HEALTH OR
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, 2016, ZIKA SITUATION REPOR
NR 33
TC 51
Z9 52
U1 0
U2 4
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2017
VL 23
IS 4
BP 611
EP 615
DI 10.3201/eid2304.161692
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EO6TC
UT WOS:000396824400007
PM 27997333
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roundy, CM
   Azar, SR
   Rossi, SL
   Huang, JH
   Leal, G
   Yun, R
   Fernandez-Salas, I
   Vitek, CJ
   Paploski, IAD
   Kitron, U
   Ribeiro, GS
   Hanley, KA
   Weaver, SC
   Vasilakis, N
AF Roundy, Christopher M.
   Azar, Sasha R.
   Rossi, Shannan L.
   Huang, Jing H.
   Leal, Grace
   Yun, Ruimei
   Fernandez-Salas, Ildefonso
   Vitek, Christopher J.
   Paploski, Igor A. D.
   Kitron, Uriel
   Ribeiro, Guilherme S.
   Hanley, Kathryn A.
   Weaver, Scott C.
   Vasilakis, Nikos
TI Variation in Aedes aegypti Mosquito Competence for Zika Virus
   Transmission
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID EQUINE ENCEPHALOMYELITIS VIRUS; WEST-NILE-VIRUS; CHIKUNGUNYA VIRUS;
   CULEX-TARSALIS; BLOOD MEALS; INFECTION; ALBOPICTUS; FLAVIVIRUSES;
   SINGAPORE; LINEAGE
AB To test whether Zika virus has adapted for more efficient transmission by Aedes aegypti mosquitoes, leading to recent urban outbreaks, we fed mosquitoes from Brazil, the Dominican Republic, and the United States artificial blood meals containing 1 of 3 Zika virus strains (Senegal, Cambodia, Mexico) and monitored infection, dissemination, and virus in saliva. Contrary to our hypothesis, Cambodia and Mexica strains were less infectious than the Senegal strain. Only mosquitoes from the Dominican Republic transmitted the Cambodia and Mexica strains. However, blood meals from viremic mice were more infectious than artificial blood meals of comparable doses; the Cambodia strain was not transmitted by mosquitoes from Brazil after artificial blood meals, whereas 61% transmission occurred after a murine blood meal (saliva titers up to 4 log10 infectious units/collection). Although regional origins of vector populations and virus strain influence transmission efficiency, Ae. aegypti mosquitoes appear to be competent vectors of Zika virus in several regions of the Americas.
C1 [Roundy, Christopher M.; Azar, Sasha R.; Rossi, Shannan L.; Huang, Jing H.; Leal, Grace; Yun, Ruimei; Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Fernandez-Salas, Ildefonso] Ctr Reg Salud Publ, Tapachula, Mexico.
   [Vitek, Christopher J.] Univ Texas Rio Grande Valley, Brownsville, TX USA.
   [Paploski, Igor A. D.; Ribeiro, Guilherme S.] Minist Saude, Salvador, BA, Brazil.
   [Paploski, Igor A. D.; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
   [Hanley, Kathryn A.] New Mexico State Univ, Las Cruces, NM 88003 USA.
RP Weaver, SC; Vasilakis, N (corresponding author), Univ Texas Med Branch, Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
EM sweaver@utmb.edu; nivasila@utmb.edu
RI Weaver, Scott C/D-6490-2011; Paploski, Igor AD/D-7015-2014; Ribeiro,
   Guilherme/B-6624-2008
OI Weaver, Scott C/0000-0001-8016-8556; Paploski, Igor
   AD/0000-0002-3689-2042; Ribeiro, Guilherme/0000-0002-6798-2059
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24AI120942,
   1U01AI115577, 1R15AI113628-01]; Brazilian national Council of
   Technological and Scientific Development [440891/2016-7, 370
   400830/2013-2]; Brazilian Coordination for the Improvement of Higher
   Education [440891/2016-7]
FX This work was supported by a pilot grant from the Institute for Human
   Infections and Immunity, grants R24AI120942 and 1U01AI115577 from the
   National Institutes of Health, as well as by National Institutes of
   Health grant 1R15AI113628-01 ( to K.A.H.), Brazilian national Council of
   Technological and Scientific Development grants 440891/2016-7 and 370
   400830/2013-2 (GSR), and Brazilian Coordination for the Improvement of
   Higher Education grant 440891/2016-7 (GSR). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The authors have no conflicting financial
   interests.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2008, J GEN VIROL, V89, P1633, DOI 10.1099/vir.0.2008/000893-0
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   KRAMER LD, 1989, AM J TROP MED HYG, V41, P241, DOI 10.4269/ajtmh.1989.41.241
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   WEAVER SC, 1993, J MED ENTOMOL, V30, P391, DOI 10.1093/jmedent/30.2.391
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 67
Z9 68
U1 2
U2 22
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2017
VL 23
IS 4
BP 625
EP 632
DI 10.3201/eid2304.161484
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EO6TC
UT WOS:000396824400009
PM 28287375
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chow, A
   Ho, H
   Win, MK
   Leo, YS
AF Chow, Angela
   Ho, Hanley
   Win, Mar-Kyaw
   Leo, Yee-Sin
TI Assessing Sensitivity and Specificity of Surveillance Case Definitions
   for Zika Virus Disease
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MICRONESIA; SINGAPORE; OUTBREAK
AB We evaluated performance of 5 case definitions for Zika virus disease surveillance in a human cohort during an outbreak in Singapore, August 26-September 5, 2016. Because laboratory tests are largely inaccessible, use of case definitions that include rash as a required clinical feature are useful in identifying this disease.
C1 [Chow, Angela; Ho, Hanley; Win, Mar-Kyaw; Leo, Yee-Sin] Tan Tock Seng Hosp, Singapore, Singapore.
RP Chow, A (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, 11 Jalan Tan Tock Seng, Singapore, Singapore.
EM angela_chow@ttsh.com.sg
CR [Anonymous], 2016, ZIK CAS DEF
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR INF CAS DEF
   Giesecke Johan, 2002, MODERN INFECT DIS EP
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Ministry of Health Singapore, 2016, 1 CAS LOC TRANSM ZIK
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Sadarangani SP, 2016, ANN ACAD MED SINGAP, V45, P381
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   World Health Organization, 2016, ZIK VIR DIS INT CAS
NR 14
TC 9
Z9 9
U1 0
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2017
VL 23
IS 4
BP 677
EP 679
DI 10.3201/eid2304.161716
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EO6TC
UT WOS:000396824400021
PM 28117032
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chammard, TB
   Schepers, K
   Breurec, S
   Messiaen, T
   Destrem, AL
   Mahevas, M
   Soulillou, A
   Janaud, L
   Curlier, E
   Herrmann-Storck, C
   Hoen, B
AF Chammard, Timothee Boyer
   Schepers, Kinda
   Breurec, Sebastien
   Messiaen, Thierry
   Destrem, Anne-Laure
   Mahevas, Matthieu
   Soulillou, Adrien
   Janaud, Ludovic
   Curlier, Elodie
   Herrmann-Storck, Cecile
   Hoen, Bruno
TI Severe Thrombocytopenia after Zika Virus Infection, Guadeloupe, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB Severe thrombocytopenia during or after the course of Zika virus infection has been rarely reported. We report 7 cases of severe thrombocytopenia and hemorrhagic signs and symptoms in Guadeloupe after infection with this virus. Clinical course and laboratory findings strongly suggest a causal link between Zika virus infection and immune-mediated thrombocytopenia.
C1 [Chammard, Timothee Boyer; Schepers, Kinda; Breurec, Sebastien; Messiaen, Thierry; Destrem, Anne-Laure; Soulillou, Adrien; Janaud, Ludovic; Curlier, Elodie; Herrmann-Storck, Cecile; Hoen, Bruno] Ctr Hosp Univ, Pointe a Pitre, Guadeloupe, France.
   [Schepers, Kinda; Hoen, Bruno] Inst Natl Sante & Rech Med, Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien] Inst Pasteur Guadeloupe, Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien; Hoen, Bruno] Univ Antilles, Pointe a Pitre, Guadeloupe, France.
   [Mahevas, Matthieu] Ctr Hosp Univ Henri Mondor, Creteil, France.
RP Hoen, B (corresponding author), Univ Med Ctr Guadeloupe, Dept Infect Dis Dermatol & Internal Med, BP 465, F-97159 Pointe a Pitre, Guadeloupe, France.
EM bruno.hoen@chu-guadeloupe.fr
OI BOYER-CHAMMARD, Timothee/0000-0003-3399-0808
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rodrigues LC, 2016, LANCET INFECT DIS
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Williamson DR, 2013, CHEST, V144, P1207, DOI 10.1378/chest.13-0121
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zea-Vera AF, 2016, LUPUS
NR 15
TC 16
Z9 17
U1 0
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2017
VL 23
IS 4
BP 696
EP 698
DI 10.3201/eid2304.161967
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EO6TC
UT WOS:000396824400026
PM 27997330
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mazzu-Nascimento, T
   Melo, DG
   Morbioli, GG
   Carrilho, E
   Vianna, FSL
   da Silva, AA
   Schuler-Faccini, L
AF Mazzu-Nascimento, Thiago
   Melo, Debora Gusmao
   Morbioli, Giorgio Gianini
   Carrilho, Emanuel
   Luiz Vianna, Fernanda Sales
   da Silva, Andre Anjos
   Schuler-Faccini, Lavinia
TI Teratogens: a public health issue - a Brazilian overview
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Review
DE Birth defects; teratogens; Zika virus; pregnancy; public health
ID ZIKA VIRUS; BIRTH-DEFECTS; CONGENITAL-MALFORMATIONS; THALIDOMIDE
   EMBRYOPATHY; SEXUAL TRANSMISSION; INFANT-MORTALITY; SOUTHERN BRAZIL;
   UNITED-STATES; RISK-FACTORS; EXPOSURE
AB Congenital anomalies are already the second cause of infant mortality in Brazil, as in many other middle-income countries in Latin America. Birth defects are a result of both genetic and environmental factors, but a multifactorial etiology has been more frequently observed. Here, we address the environmental causes of birth defects-or teratogens - as a public health issue and present their mechanisms of action, categories and their respective maternal-fetal deleterious effects. We also present a survey from 2008 to 2013 of Brazilian cases involving congenital anomalies (annual average of 20,205), fetal deaths (annual average of 1,530), infant hospitalizations (annual average of 82,452), number of deaths of hospitalized infants (annual average of 2,175), and the average cost of hospitalizations (annual cost of $7,758). Moreover, we report on Brazilian cases of teratogenesis due to the recent Zika virus infection, and to the use of misoprostol, thalidomide, alcohol and illicit drugs. Special attention has been given to the Zika virus infection, now proven to be responsible for the microcephaly outbreak in Brazil, with 8,039 cases under investigation (from October 2015 to June 2016). From those cases, 1,616 were confirmed and 324 deaths occurred due to microcephaly complications or alterations on the central nervous system. Congenital anomalies impact life quality and raise costs in specialized care, justifying the classification of teratogens as a public health issue.
C1 [Mazzu-Nascimento, Thiago; Morbioli, Giorgio Gianini; Carrilho, Emanuel] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil.
   [Mazzu-Nascimento, Thiago; Morbioli, Giorgio Gianini; Carrilho, Emanuel] Inst Nacl Ciencia & Tecnol Bioanalit, Campinas, SP, Brazil.
   [Melo, Debora Gusmao] Univ Fed Sao Carlos, Dept Med, Ctr Ciencias Biol & Saude, Sao Carlos, SP, Brazil.
   [Morbioli, Giorgio Gianini] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   [Luiz Vianna, Fernanda Sales; da Silva, Andre Anjos; Schuler-Faccini, Lavinia] Hosp Clin Porto Alegre, Sistema Nacl Informacao Agentes Teratogen SIAT, Porto Alegre, RS, Brazil.
   [Luiz Vianna, Fernanda Sales; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.
   [da Silva, Andre Anjos] UNIVATES Univ, Lajeado, RS, Brazil.
RP Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Caixa Postal 15053,Campus Agron, BR-91501970 Porto Alegre, RS, Brazil.
EM lavinia.faccini@ufrgs.br
RI Carrilho, E./A-5845-2009; Vianna, Fernanda Sales Luiz/O-4337-2019;
   Mazzu, Thiago/N-9209-2016; SCHULER-FACCINI, LAVINIA/C-8309-2013
OI Carrilho, E./0000-0001-7351-8220; Mazzu, Thiago/0000-0002-1693-9149;
   SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2011/13997-8]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [311323/2011-1, 131306/2013-8, 205453/2014-7];
   CAPESCAPES
FX 5 The authors would like to thank the funding agencies FAPESP (Grant Nr.
   2011/13997-8), CNPq (Grants Nr. 311323/2011-1, Nr. 131306/2013-8 and
   205453/2014-7) and CAPES for scholarships and financial support.
CR ABEL EL, 1987, DRUG ALCOHOL DEPEN, V19, P51, DOI 10.1016/0376-8716(87)90087-1
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Allen Rebecca, 2009, Rev Obstet Gynecol, V2, P159
   ALVAN G, 1995, EUR J CLIN PHARMACOL, V48, P177
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BARROW MV, 1971, TERATOLOGY, V4, P119, DOI 10.1002/tera.1420040202
   de Moura LNB, 2014, CIENC SAUDE COLETIVA, V19, P853, DOI 10.1590/1413-81232014193.10902013
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brent Robert L., 2001, Congenital Anomalies, V41, P3, DOI 10.1111/j.1741-4520.2001.tb00869.x
   Bronberg R, 2014, J COMMUN GENET, V5, P269, DOI 10.1007/s12687-013-0170-0
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cassina M, 2012, REPROD TOXICOL, V34, P186, DOI 10.1016/j.reprotox.2012.05.004
   Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#
   Chapman SLC, 2012, RES DEV DISABIL, V33, P1147, DOI 10.1016/j.ridd.2012.02.009
   Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147
   CHERUKURI R, 1988, OBSTET GYNECOL, V72, P147
   COHLAN SQ, 1963, J PEDIATR-US, V63, P650, DOI 10.1016/S0022-3476(63)80375-3
   Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335
   Costa FS, 2008, REV SOC BRAS MED TRO, V41, P309, DOI 10.1590/S0037-86822008000300018
   Costa Gabriela de Moraes, 2012, J. bras. psiquiatr., V61, P8, DOI 10.1590/S0047-20852012000100003
   Costa SH, 1998, INT J GYNECOL OBSTET, V63, pS131, DOI 10.1016/S0020-7292(98)00195-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dal Pizzol TD, 2008, CAD SAUDE PUBLICA, V24, P1447, DOI 10.1590/S0102-311X2008000600025
   Dal Pizzol TD, 2006, REPROD TOXICOL, V22, P666, DOI 10.1016/j.reprotox.2006.03.015
   Di Renzo GC, 2015, INT J GYNECOL OBSTET, V131, P219, DOI 10.1016/j.ijgo.2015.09.002
   Edison RJ, 2004, NEW ENGL J MED, V350, P1579, DOI 10.1056/NEJM200404083501524
   Egbe A, 2015, PEDIATR NEONATOL, V56, P25, DOI 10.1016/j.pedneo.2014.03.010
   Finnell RH, 1999, J ALLERGY CLIN IMMUN, V103, pS337, DOI 10.1016/S0091-6749(99)70259-9
   Food and Drug Administration Department of Health and Human Services, 2014, DEP HLTH HUM SERV FO, P1
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcias GD, 2004, GENET MOL BIOL, V27, P147, DOI 10.1590/S1415-47572004000200003
   Giavini E, 2012, REPROD TOXICOL, V34, P180, DOI 10.1016/j.reprotox.2012.05.003
   Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99
   Gonzalez CH, 1998, LANCET, V351, P1624, DOI 10.1016/S0140-6736(97)12363-7
   Hale F, 1933, J HERED, V24, P105, DOI 10.1093/oxfordjournals.jhered.a103720
   Hansen Jason M., 2006, Birth Defects Research, V78, P293, DOI 10.1002/bdrc.20085
   Holbrook BD, 2014, OBSTET GYN CLIN N AM, V41, P229, DOI 10.1016/j.ogc.2014.02.008
   Holmes LB, 2002, AM J MED GENET, V112, P297, DOI 10.1002/ajmg.10781
   Horovitz Dafne Dain Gandelman, 2005, Cad. Saúde Pública, V21, P1055, DOI 10.1590/S0102-311X2005000400008
   Hwang LY, 2000, CLIN INFECT DIS, V31, P920, DOI 10.1086/318131
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kalter H, 2003, NEUROTOXICOL TERATOL, V25, P131, DOI 10.1016/S0892-0362(03)00010-2
   Kim JH, 2011, TOXICOL SCI, V122, P1, DOI 10.1093/toxsci/kfr088
   Vianna FSL, 2015, REPROD TOXICOL, V53, P63, DOI 10.1016/j.reprotox.2015.03.007
   Vianna FSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021735
   McMichael C, 2005, J PUBLIC HEALTH-UK, V27, P215, DOI 10.1093/pubmed/fdi024
   Menegola E, 2005, BIRTH DEFECTS RES B, V74, P392, DOI 10.1002/bdrb.20053
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Momino W, 2012, GENET MOL BIOL, V35, P960, DOI 10.1590/S1415-47572012000600011
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426
   Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259
   O'Leary C, 2013, DEV MED CHILD NEUROL, V55, P271, DOI 10.1111/dmcn.12029
   Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735
   Passos-Bueno MR, 2014, MOL GENET GENOM MED, V2, P280, DOI 10.1002/mgg3.95
   Petrini J, 2002, TERATOLOGY, V66, pS3, DOI 10.1002/tera.90002
   RAMANWILMS L, 1995, OBSTET GYNECOL, V85, P141, DOI 10.1016/0029-7844(94)00341-A
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reidpath DD, 2003, J EPIDEMIOL COMMUN H, V57, P344, DOI 10.1136/jech.57.5.344
   Rizk B, 1996, HUM REPROD UPDATE, V2, P43, DOI 10.1093/humupd/2.1.43
   Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s
   Schuler L, 1999, REPROD TOXICOL, V13, P147, DOI 10.1016/S0890-6238(98)00072-0
   Schuler-Faccini L, 2007, BIRTH DEFECTS RES A, V79, P671, DOI 10.1002/bdra.20384
   Shepard T H, 1979, Curr Probl Pediatr, V10, P1, DOI 10.1016/S0045-9380(79)80008-0
   SHEPARD TH, 1982, J PEDIATR-US, V101, P810, DOI 10.1016/S0022-3476(82)80338-7
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Stromland K, 2015, BIRTH DEFECTS RES A, V103, P178, DOI 10.1002/bdra.23326
   Tuzun B, 1999, CLIN DERMATOL, V17, P469, DOI 10.1016/S0738-081X(99)00035-8
   van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052
   Vargas FR, 2000, AM J MED GENET, V95, P302, DOI 10.1002/1096-8628(20001211)95:4<302::AID-AJMG2>3.0.CO;2-B
   Vieira DL, 2007, REV SAUDE PUBL, V41, P1
   Watemberg N, 2002, J CHILD NEUROL, V17, P117, DOI 10.1177/088307380201700205
   Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027
   Wells PG, 1997, MUTAT RES-FUND MOL M, V396, P65, DOI 10.1016/S0027-5107(97)00175-9
   Wilson J. G., 1977, HDB TERATOLOGY
   Winn LM, 1995, EUR J NEUROL, V2, P5
   Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1
NR 81
TC 9
Z9 9
U1 0
U2 11
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670
   RIBEIRAO PRET, BRAZIL
SN 1415-4757
EI 1678-4685
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PD APR-JUN
PY 2017
VL 40
IS 2
BP 387
EP 397
DI 10.1590/1678-4685-GMB-2016-0179
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EY6SW
UT WOS:000404114600001
PM 28534929
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chiroli, DMD
   Montilha, MM
   Samed, MMA
AF de Genaro Chiroli, Daiane Maria
   Montilha, Murillo Martins
   Altimari Samed, Marcia Marcondes
TI FEASIBILITY ANALYSIS OF UAV IN DENGUE CONTROL
SO INDEPENDENT JOURNAL OF MANAGEMENT & PRODUCTION
LA English
DT Article
DE Feasibility Analysis; Unmanned Aerial Vehicle; Drone; Aedes Mosquitoes;
   Dengue; Zika; Chikungunya
AB There are intensifying actions to combat the mosquito Aedes which is admittedly responsible for the transmission of diseases: chikungunya, dengue and zika. Among these dengue is a recurring problem that affects the entire world, especially the tropical areas. It is considered one of the world's greatest public health problems by the World Health Organization, which estimates that approximately 390 million people get infected by this disease each year worldwide. In Brazil, since the first report of the disease in 80's, dengue has continually occurred, alternating epidemic periods with peaks of increasing disease. Therefore, this study aims to assess the feasibility of using unmanned aerial vehicle, popularly known as drone, in aid of the dengue control program executed the Brazilian city of Maringa - PR. The results indicate that the use of this aircraft is feasible, since it is an economically attractive investment due to its low cost against the annual investment with manpower.
C1 [de Genaro Chiroli, Daiane Maria; Montilha, Murillo Martins; Altimari Samed, Marcia Marcondes] State Univ Maringa UEM, Dept Prod Engn, Maringa, Parana, Brazil.
RP Chiroli, DMD (corresponding author), State Univ Maringa UEM, Dept Prod Engn, Maringa, Parana, Brazil.
EM dmgenaro@hotmail.com; murillomontilha7@gmail.com; mmasamed@uem.br
RI CHIROLI, DAIANE MG/K-2761-2018
OI CHIROLI, DAIANE MG/0000-0002-9088-406X
CR BOWERSOX D. J., 2010, LOGISTICA EMPRESARIA
   BRUNI A. L., 2003, CADERNOS ANALISE REG, V1, P40
   COISSI J., 2015, CIDADES USAM DRONES
   DEPARTMENT OF DEFENSE-UNITED STATES OF AMERICA, 2005, UNM AIRCR SYST ROADM
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   HANGAR360, 2010, VANT VEIC AER NAO TR
   Larson R. C., 1999, URBAN OPERATIONS RES
   MINISTERIO DA SAUDE, 2009, SECR VIG EM SAUD DEP
   SECRETARIA MUNICIPAL DE SAUDE DE MARINGA, 2014, 4 LIRAA 2014
   SECRETARIA MUNICIPAL DE SAUDE DE MARINGA, 2013, 4 LIRAA 2013
NR 10
TC 1
Z9 1
U1 0
U2 0
PU INST FEDERAL EDUCACAO, CIENCIA & TECNOLOGIA SAO PAULO
PI SAO PAULO
PA RUA PEDRO VICENTE 625, CANINDE, SAO PAULO, 01109-010, BRAZIL
SN 2236-269X
J9 INDEP J MANAG PROD
JI Indep. J. Manag. Prod.
PD APR-JUN
PY 2017
VL 8
IS 2
BP 319
EP 334
DI 10.14807/ijmp.v8i2.539
PG 16
WC Management
SC Business & Economics
GA GX8JW
UT WOS:000448032200004
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wong, LP
   Alias, H
   Aghamohammadi, N
   Sam, IC
   Abu Bakar, S
AF Wong, Li Ping
   Alias, Haridah
   Aghamohammadi, Nasrin
   Sam, I-Ching
   Abu Bakar, Sazaly
TI The Self-Regulation Model of Illness: Comparison between Zika and Dengue
   and Its Application to Predict Mosquito Prevention Behaviours in
   Malaysia, a Dengue-Endemic Country (vol 13,pg 1210, 2016)
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Correction
C1 [Wong, Li Ping; Alias, Haridah; Aghamohammadi, Nasrin] Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Wong, Li Ping] Univ Malaya, JCUM, Kuala Lumpur 50603, Malaysia.
   [Aghamohammadi, Nasrin] Univ Malaya, Dept Social & Prevent Med, Fac Med, Ctr Occupat & Environm Hlth, Kuala Lumpur 50603, Malaysia.
   [Sam, I-Ching; Abu Bakar, Sazaly] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Abu Bakar, Sazaly] Univ Malaya, TIDREC, Kuala Lumpur 50603, Malaysia.
RP Wong, LP (corresponding author), Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur 50603, Malaysia.; Wong, LP (corresponding author), Univ Malaya, JCUM, Kuala Lumpur 50603, Malaysia.
EM wonglp@ummc.edu.my; haridahalias@gmail.com; nasrin@ummc.edu.my;
   jicsam@um.edu.my; sazaly@ummc.edu.my
RI Aghamohammadi, Nasrin/L-5822-2013; abubakar, sazaly/B-3957-2010;
   Aghamohammadi, Nasrin/G-9392-2013; Wong, Li Ping/B-2782-2010; ALIAS,
   HARIDAH/A-8075-2017; Sam, Jamal I-Ching/B-8688-2010
OI Aghamohammadi, Nasrin/0000-0002-7063-1671; abubakar,
   sazaly/0000-0002-9267-1420; Aghamohammadi, Nasrin/0000-0002-7063-1671;
   Wong, Li Ping/0000-0002-0107-0532; ALIAS, HARIDAH/0000-0002-1830-4761;
   Sam, Jamal I-Ching/0000-0002-1296-7898
CR Wong LP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121210
NR 1
TC 0
Z9 0
U1 0
U2 0
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2017
VL 14
IS 4
AR 433
DI 10.3390/ijerph14040433
PG 1
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EY6PG
UT WOS:000404105100097
PM 28422053
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cavalcanti, MG
   Cabral-Castro, MJ
   Goncalves, JLS
   Santana, LS
   Pimenta, ES
   Peralta, JM
AF Cavalcanti, Marta G.
   Cabral-Castro, Mauro J.
   Goncalves, Jorge L. S.
   Santana, Larissa S.
   Pimenta, Eduardo Scarlatelli
   Peralta, Jose M.
TI Zika virus shedding in human milk during lactation: an unlikely source
   of infection?
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Breast milk transmission; Acute infection
AB Zika virus (ZIKV) transmission through non-mosquito-dependent routes has become increasingly important since reports of sexual transmission. Breastfeeding is a potential means of ZIKV transmission, but data on this remain limited. The cases of four mothers with laboratory-proven infections are reported. No disease evolved in three of the breastfed babies despite detectable maternal viremia and viruria, the presence of viral RNA shedding, and the isolation of infective particles in one milk sample. Fever and rash in one infant of a ZIKV-infected mother proved to be related to chikungunya virus infection. The results suggest that the presence of infective particles in breast milk may not be sufficient for the efficient perinatal transmission of ZIKV. (C) 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Cavalcanti, Marta G.; Pimenta, Eduardo Scarlatelli] Univ Fed Rio de Janeiro HUCFF UFRJ, Serv Doencas Infecciosas & Parasitarias, Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Cavalcanti, Marta G.; Cabral-Castro, Mauro J.; Goncalves, Jorge L. S.; Santana, Larissa S.; Peralta, Jose M.] Univ Fed Rio de Janeiro IMPG UFRJ, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
RP Peralta, JM (corresponding author), Univ Fed Rio de Janeiro IMPG UFRJ, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
EM peralta@micro.ufrj.br
RI Cabral-Castro, Mauro Jorge/L-8868-2016
OI Cabral-Castro, Mauro Jorge/0000-0002-1755-999X
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX We acknowledge the financial support of Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) with great
   appreciation.
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, OBSTET GYNECOL SURV, V71, P331, DOI 10.1097/01.ogx.0000483239.08585.8d
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Percher F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020040
NR 11
TC 23
Z9 24
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2017
VL 57
BP 70
EP 72
DI 10.1016/j.ijid.2017.01.042
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EQ3CB
UT WOS:000397947500012
PM 28188933
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Henry, CR
   Al-Attar, L
   Cruz-Chacon, AM
   Davis, JL
AF Henry, Christopher R.
   Al-Attar, Luma
   Cruz-Chacon, Alexis M.
   Davis, Janet L.
TI Chorioretinal Lesions Presumed Secondary to Zika Virus Infection in an
   Immunocompromised Adult
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID PLACOID PIGMENT EPITHELIOPATHY; DISEASE; FEVER
AB IMPORTANCE Zika virus has spread rapidly throughout the Americas since 2015. The public health implications of Zika virus infection lend special importance to identifying the virus in unsuspected hosts.
   OBJECTIVE To describe relevant imaging studies and clinical features of chorioretinal lesions that are presumably associated with Zika virus and that share analogous features with chorioretinal lesions reported in cases of Dengue fever andWest Nile virus.
   DESIGN, SETTING, AND PARTICIPANTS This is a case report from an academic referral center in Miami, Florida, of a woman in her 60s from Guaynabo, Puerto Rico, who presented with reduced visual acuity and bilateral diffuse, subretinal, confluent, placoid, and multifocal chorioretinal lesions. The patient was observed over a 5-month period.
   MAIN OUTCOMES AND MEASURES Visual acuity, clinical course, and multimodal imaging study results.
   RESULTS Fluorescein angiography revealed early hypofluorescence and late staining of the chorioretinal lesions. Optical coherence tomography demonstrated outer retinal disruption in the placoid macular lesions. Zika RNA was detected in a plasma sample by real-time reverse transcription polymerase chain reaction testing and was suspected to be the cause of chorioretinal lesions after other viral and infectious causes were ruled out. Three weeks after the onset of symptoms, the patient's visual acuity had improved to 20/60 OD and 20/25 OS, with intraocular pressures of 18mmHg OD and 19mmHg OS. In 6 weeks, the chorioretinal lesions had healed and visual acuity had improved to 20/25 OD and 20/20 OS. Follow-up optical coherence tomography demonstrated interval recovery of the outer retina and photoreceptors.
   CONCLUSIONS AND RELEVANCE Acute-onset, self-resolving, placoid, or multifocal nonnecrotizing chorioretinal lesions may be a feature of active Zika virus chorioretinitis, as reported in other Flavivirus infections in adults. Similar findings in potentially exposed adults suggest that clinicians should consider IgMantibody or polymerase chain reaction testing for Zika virus as well as diagnostic testing for Dengue fever andWest Nile virus.
C1 [Henry, Christopher R.; Davis, Janet L.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [Henry, Christopher R.] Retina Consultants Houston, Houston, TX USA.
   [Al-Attar, Luma] Retina Ctr Puerto Rico, Manati, PR USA.
   [Cruz-Chacon, Alexis M.] Hosp Espanol Auxilio Mutuo, Dept Hematol & Med Oncol, San Juan, PR USA.
RP Davis, JL (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA.
EM jdavis@med.miami.edu
CR Centers for Disease Control and Prevention, AB ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Escott S, 2013, CLIN OPHTHALMOL, V7, P363, DOI 10.2147/OPTH.S37443
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   GASS JDM, 1968, ARCH OPHTHALMOL-CHIC, V80, P177
   Goldhardt R, 2016, OCUL IMMUNOL INFLAMM, V24, P610, DOI 10.3109/09273948.2015.1125513
   Jones BE, 2000, ARCH OPHTHALMOL-CHIC, V118, P931
   Knickelbein JE, 2016, J CLIN EXP OPHTHALMO, V7, P570
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   O'Halloran HS, 2001, OPHTHALMOLOGY, V108, P861, DOI 10.1016/S0161-6420(01)00565-6
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Sivakumar RR, 2013, OPHTHALMOLOGY, V120, P1820, DOI 10.1016/j.ophtha.2013.02.006
   Stangos A, 2006, OCUL IMMUNOL INFLAMM, V14, P301, DOI 10.1080/09273940600932311
NR 15
TC 13
Z9 13
U1 1
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD APR 1
PY 2017
VL 135
IS 4
BP 386
EP 389
DI 10.1001/jamaophthalmol.2017.0098
PG 4
WC Ophthalmology
SC Ophthalmology
GA ES3IQ
UT WOS:000399423700022
PM 28278327
DA 2020-07-08
ER

PT J
AU Roimicher, L
   Orlando, CJ
   Arruda, MB
   Tanuri, A
AF Roimicher, Luis
   Ferreira, Orlando C., Jr.
   Arruda, Monica B.
   Tanuri, Amilcar
TI Zika Virus in the Joint of a Patient with Rheumatoid Arthritis
SO JOURNAL OF RHEUMATOLOGY
LA English
DT Letter
C1 [Roimicher, Luis] Univ Fed Rio de Janeiro, Hosp Univ CFF, Dept Rheumatol Internal Med, Rheumatol, Rio De Janeiro, Brazil.
   [Ferreira, Orlando C., Jr.; Arruda, Monica B.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Lab Mol Virol, Rio De Janeiro, Brazil.
RP Roimicher, L (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ CFF, Dept Rheumatol Internal Med, Rua Prof Rodolpho Paulo Rocco 255,70 Andar, Rio De Janeiro, Brazil.
EM mail-luizroimicher@gmail.com
CR Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
NR 6
TC 5
Z9 5
U1 0
U2 0
PU J RHEUMATOL PUBL CO
PI TORONTO
PA 365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA
SN 0315-162X
EI 1499-2752
J9 J RHEUMATOL
JI J. Rheumatol.
PD APR
PY 2017
VL 44
IS 4
DI 10.3899/jrheum.160722
PG 1
WC Rheumatology
SC Rheumatology
GA EU5RE
UT WOS:000401089800021
PM 28604348
OA Bronze
DA 2020-07-08
ER

PT J
AU Smith, JL
   Jeng, S
   McWeeney, SK
   Hirsch, AJ
AF Smith, Jessica L.
   Jeng, Sophia
   McWeeney, Shannon K.
   Hirsch, Alec J.
TI A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of
   the Interferon Response during Flavivirus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Wnt signaling; flavivirus; interferons; microRNA
ID WEST-NILE-VIRUS; DENGUE VIRUS; CELLULAR MICRORNA; TUMOR-SUPPRESSOR;
   BETA-CATENIN; I INTERFERON; HOST FACTORS; REPLICATION; CANCER;
   INHIBITION
AB The impact of mosquito-borne flavivirus infections worldwide is significant, and many critical aspects of these viruses' biology, including virus-host interactions, host cell requirements for replication, and how virus-host interactions impact pathology, remain to be fully understood. The recent reemergence and spread of flaviviruses, including dengue virus (DENV), West Nile virus (WNV), and Zika virus (ZIKV), highlight the importance of performing basic research on this important group of pathogens. MicroRNAs (miRNAs) are small, noncoding RNAs that modulate gene expression posttranscriptionally and have been demonstrated to regulate a broad range of cellular processes. Our research is focused on identifying pro-and antiflaviviral miRNAs as a means of characterizing cellular pathways that support or limit viral replication. We have screened a library of known human miRNA mimics for their effect on the replication of three flaviviruses, DENV, WNV, and Japanese encephalitis virus (JEV), using a high-content immunofluorescence screen. Several families of miRNAs were identified as inhibiting multiple flaviviruses, including the miRNA miR-34, miR-15, and miR-517 families. Members of the miR-34 family, which have been extensively characterized for their ability to repress Wnt/beta-catenin signaling, demonstrated strong antiflaviviral effects, and this inhibitory activity extended to other viruses, including ZIKV, alphaviruses, and herpesviruses. Previous research suggested a possible link between the Wnt and type I interferon (IFN) signaling pathways. Therefore, we investigated the role of type I IFN induction in the antiviral effects of the miR-34 family and confirmed that these miRNAs potentiate interferon regulatory factor 3 (IRF3) phosphorylation and translocation to the nucleus, the induction of IFN-responsive genes, and the release of type I IFN from transfected cells. We further demonstrate that the intersection between the Wnt and IFN signaling pathways occurs at the point of glycogen synthase kinase 3 beta (GSK3 beta)-TANK-binding kinase 1 (TBK1) binding, inducing TBK1 to phosphorylate IRF3 and initiate downstream IFN signaling. In this way, we have identified a novel cellular signaling network with a critical role in regulating the replication of multiple virus families. These findings highlight the opportunities for using miRNAs as tools to discover and characterize unique cellular factors involved in supporting or limiting virus replication, opening up new avenues for antiviral research.
   IMPORTANCE MicroRNAs are a class of small regulatory RNAs that modulate cellular processes through the posttranscriptional repression of multiple transcripts. We hypothesized that individual miRNAs may be capable of inhibiting viral replication through their effects on host proteins or pathways. To test this, we performed a high-content screen for miRNAs that inhibit the replication of three medically relevant members of the flavivirus family: West Nile virus, Japanese encephalitis virus, and dengue virus 2. The results of this screen identify multiple miRNAs that inhibit one or more of these viruses. Extensive follow-up on members of the miR-34 family of miRNAs, which are active against all three viruses as well as the closely related Zika virus, demonstrated that miR-34 functions through increasing the infected cell's ability to respond to infection through the interferon-based innate immune pathway. Our results not only add to the knowledge of how viruses interact with cellular pathways but also provide a basis for more extensive data mining by providing a comprehensive list of miRNAs capable of inhibiting flavivirus replication. Finally, the miRNAs themselves or cellular pathways identified as modulating virus infection may prove to be novel candidates for the development of therapeutic interventions.
C1 [Smith, Jessica L.; Hirsch, Alec J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA.
   [Jeng, Sophia; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Div Bioinformat & Computat Biol, Oregon Clin & Translat Res Inst, Portland, OR USA.
RP Hirsch, AJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA.
EM hirschal@ohsu.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI101282, HHSN272201100017C]
FX This work was supported by NIH grants and contracts R21 AI101282 and
   HHSN272201100017C.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Aguado LC, 2015, CELL HOST MICROBE, V18, P714, DOI 10.1016/j.chom.2015.11.003
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Baril M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003416
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14
   Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823
   Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Cha YH, 2012, CELL CYCLE, V11, P1273, DOI 10.4161/cc.19618
   Chen Z, 2016, J VIROL, V90, P3722, DOI 10.1128/JVI.03242-15
   Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09
   Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829
   Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2
   Hack K, 2012, CLIN EXP DERMATOL, V37, P557, DOI 10.1111/j.1365-2230.2012.04362.x
   Harmon B, 2016, J VIROL, V90, P7084, DOI 10.1128/JVI.00543-16
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hayward S Diane, 2006, Sci STKE, V2006, pre4
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hillesheim A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-29
   Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001
   Khan KA, 2015, MOL CELL BIOL, V35, P3029, DOI 10.1128/MCB.00344-15
   Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Le Flohic G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002208
   Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021
   Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015
   Li G, 2010, CANCER LETT, V299, P29, DOI 10.1016/j.canlet.2010.07.021
   Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284
   Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08
   Misso G, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.47
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764
   Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373
   Qin YF, 2016, CELL RES, V26, P613, DOI 10.1038/cr.2016.27
   Sali TM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005324
   Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107
   Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shi MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5820
   Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321
   Slonchak A, 2016, J VIROL, V90, P2388, DOI 10.1128/JVI.02608-15
   Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11
   Special Programme for Research & Training in Tropical Diseases (TDR), 2007, REP DENG SCI WORK GR
   Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103
   Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48
   Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08
   Wang JT, 2014, INNATE IMMUN-LONDON, V20, P78, DOI 10.1177/1753425913485307
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655
   Xiao SY, 2001, EMERG INFECT DIS, V7, P714
   Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351
NR 65
TC 47
Z9 49
U1 0
U2 18
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2017
VL 91
IS 8
AR UNSP e02388
DI 10.1128/JVI.02388-16
PG 15
WC Virology
SC Virology
GA ES4AU
UT WOS:000399472200030
PM 28148804
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Weger-Lucarelli, J
   Duggal, NK
   Bullard-Feibelman, K
   Veselinovic, M
   Romo, H
   Nguyen, C
   Ruckert, C
   Brault, AC
   Bowen, RA
   Stenglein, M
   Geiss, BJ
   Ebel, GD
AF Weger-Lucarelli, James
   Duggal, Nisha K.
   Bullard-Feibelman, Kristen
   Veselinovic, Milena
   Romo, Hannah
   Nguyen, Chilinh
   Ruckert, Claudia
   Brault, Aaron C.
   Bowen, Richard A.
   Stenglein, Mark
   Geiss, Brian J.
   Ebel, Gregory D.
TI Development and Characterization of Recombinant Virus Generated from a
   New World Zika Virus Infectious Clone (vol 91, pg 1, 2017)
SO JOURNAL OF VIROLOGY
LA English
DT Correction
C1 [Weger-Lucarelli, James; Bullard-Feibelman, Kristen; Veselinovic, Milena; Romo, Hannah; Nguyen, Chilinh; Ruckert, Claudia; Bowen, Richard A.; Stenglein, Mark; Geiss, Brian J.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Duggal, Nisha K.; Romo, Hannah; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RP Weger-Lucarelli, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RI Geiss, Brian/J-3021-2017
OI Geiss, Brian/0000-0001-8180-5772; Weger-Lucarelli,
   James/0000-0002-9483-1694; Ruckert, Claudia/0000-0003-3732-6752
CR LUCARELLI JW, 2017, J VIROL, V91, P1, DOI DOI 10.1128/JVI.01765-16
NR 1
TC 1
Z9 1
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2017
VL 91
IS 8
AR UNSP e00172
DI 10.1128/JVI.00172-17
PG 1
WC Virology
SC Virology
GA ES4AU
UT WOS:000399472200007
PM 28356496
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Blohm, GM
   Lednicky, JA
   Marquez, M
   White, SK
   Loeb, JC
   Pacheco, CA
   Nolan, DJ
   Paisie, T
   Salemi, M
   Rodriguez-Morales, AJ
   Morris, JG
   Pulliam, JRC
   Carrillo, AS
   Plaza, JD
   Paniz-Mondolfi, AE
AF Blohm, Gabriela M.
   Lednicky, John A.
   Marquez, Marilianna
   White, Sarah K.
   Loeb, Julia C.
   Pacheco, Carlos A.
   Nolan, David J.
   Paisie, Taylor
   Salemi, Marco
   Rodriguez-Morales, Alfonso J.
   Morris, J. Glenn, Jr.
   Pulliam, Juliet R. C.
   Carrillo, Alejandra S.
   Plaza, Juan D.
   Paniz-Mondolfi, Alberto E.
TI Complete Genome Sequences of Identical Zika virus Isolates in a Nursing
   Mother and Her Infant
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Complete genome sequences were obtained for Zika viruses isolated from the breast milk of a Venezuelan patient and her child, who was exclusively breastfeeding at the time. These sequences are the first to be reported from a presumptive autochthonous postnatal transmission case from mother to child in Venezuela.
C1 [Blohm, Gabriela M.; Pulliam, Juliet R. C.] Univ Florida, Dept Biol, Coll Liberal Arts & Sci, Gainesville, FL USA.
   [Blohm, Gabriela M.; Marquez, Marilianna; Paniz-Mondolfi, Alberto E.] Hosp Int Barquisimeto, Dept Pathol & Lab Med, Lara, Barquisimeto, Venezuela.
   [Lednicky, John A.; White, Sarah K.; Nolan, David J.; Paisie, Taylor; Salemi, Marco; Morris, J. Glenn, Jr.; Pulliam, Juliet R. C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Lednicky, John A.; White, Sarah K.; Loeb, Julia C.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [Marquez, Marilianna] Univ Ctr Occidental Lisandro Alvarado, Hlth Sci Dept, Coll Med, Barquisimeto, Lara, Venezuela.
   [Pacheco, Carlos A.] Policlin Barquisimeto, Barquisimeto, Lara, Venezuela.
   [Nolan, David J.; Paisie, Taylor; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Hlth, Gainesville, FL USA.
   [Pulliam, Juliet R. C.] DST NRF Ctr Excellence Epidemiol Modelling & Anal, Matieland, South Africa.
   [Carrillo, Alejandra S.; Plaza, Juan D.] Univ Nacl Expt Francisco de Miranda, Hlth Sci Dept, Coll Med, Punto Fijo, Falcon, Venezuela.
RP Paniz-Mondolfi, AE (corresponding author), Hosp Int Barquisimeto, Dept Pathol & Lab Med, Lara, Barquisimeto, Venezuela.
EM albertopaniz@yahoo.com
RI Lednicky, John A/C-5678-2012; Pulliam, Juliet/L-3503-2019
OI Pulliam, Juliet/0000-0003-3314-8223
FU National Science FoundationNational Science Foundation (NSF) [1515734]
FX This work was supported by National Science Foundation Grant no.
   1515734. Any opinions, findings, and conclusions or recommendations
   expressed in this material are those of the authors and do not
   necessarily reflect the views of National Science Foundation.
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
NR 10
TC 3
Z9 3
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD APR
PY 2017
VL 5
IS 17
AR e00231-17
DI 10.1128/genomeA.00231-17
PG 2
WC Microbiology
SC Microbiology
GA VI1EL
UT WOS:000460695300012
PM 28450510
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Colt, S
   Garcia-Casal, MN
   Pena-Rosas, JP
   Finkelstein, JL
   Rayco-Solon, P
   Prinzo, ZCW
   Mehta, S
AF Colt, Susannah
   Garcia-Casal, Maria N.
   Pena-Rosas, Juan Pablo
   Finkelstein, Julia L.
   Rayco-Solon, Pura
   Prinzo, Zita C. Weise
   Mehta, Saurabh
TI Transmission of Zika virus through breast milk and other
   breastfeeding-related bodily-fluids: A systematic review
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID DENGUE VIRUS; NIGERIA; AEDES; CHIKUNGUNYA; MICRONESIA; INFECTIONS;
   EPIDEMIC; OUTBREAK; VECTOR; ISLAND
AB Background
   Zika virus (ZIKV) infection is an emerging mosquito-borne disease, which is associated with an increase in central nervous system malformations and newborn microcephaly cases. This review investigated evidence of breastfeeding transmission from ZIKV-infected mothers to their children and the presence of ZIKV infection in breastfeeding-related fluids.
   Methodology/Principal findings
   We conducted a systematic review of observational studies, case studies, and surveillance reports involving breastfeeding women with ZIKV infection in several international databases. Data extraction and analysis were conducted following a PROSPERO-registered protocol. From 472 non-duplicate records, two case reports met criteria for inclusion. We reviewed three cases of ZIKV infection among lactating mothers near the time of delivery. Two of the three (2/3) associated newborns had evidence of ZIKV infection. ZIKV was detected in breast milk of all three mothers. Breast milk detection results were positive in all mothers (3/3) by RT-PCR, one was positive by culture (1/3), and none was tested for ZIKV-specific antibodies. Serum samples were ZIKV positive in all mothers (3/3), and sweat was not tested for ZIKV.
   Conclusions/Significance
   We describe three cases of ZIKV-infected breastfeeding mothers who were symptomatic within three days of delivery, and two cases with ZIKV-infected newborns. While ZIKV was detected in the breast milk of all three mothers, the data are not sufficient to conclude ZIKV transmission via breastfeeding. More evidence is needed to distinguish breastfeeding transmission from other perinatal transmission routes.
C1 [Colt, Susannah; Finkelstein, Julia L.; Mehta, Saurabh] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Garcia-Casal, Maria N.; Pena-Rosas, Juan Pablo; Rayco-Solon, Pura; Prinzo, Zita C. Weise] WHO, Dept Nutr Hlth & Dev, Evidence & Programme Guidance, Geneva, Switzerland.
RP Mehta, S (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
EM smehta@cornell.edu
RI Pena-Rosas, Juan Pablo/I-3248-2019; Mehta, Saurabh/L-8490-2017
OI Pena-Rosas, Juan Pablo/0000-0002-6737-9831; Mehta,
   Saurabh/0000-0003-3788-0665; Colt, Susannah/0000-0002-1935-4197
FU World Health Organization Contingency Fund for Emergencies; Bill AMP;
   Melinda Gates Foundation
FX Support for this study was provided by the World Health Organization
   Contingency Fund for Emergencies and the Bill & Melinda Gates
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2016, REC MAN REP ZIK VIR
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Besnard M, 2014, EURO SURVEILLANCE B, V19
   Bridgman SL, 2016, J DEV ORIG HLTH DIS, V7, P68, DOI 10.1017/S2040174415007862
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF OUTBR BR
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higgins J, 2011, COCHRANE HANDBOOK FO
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Kesho Bora Study G, 2012, MAT HIV 1 DIS PROGR, P55
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EURO SURVEILLANCE B, V19
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EURO SURVEILLANCE B, V19
   Schunemann H, 2013, GRADE HDB GRADING QU
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   World Health Organization, 2015, ZIK VIR INF BRAZ COL
   World Health Organization, 2016, 165 WHO ZIKA MOC
   World Health Organization, 2009, 090145 WHO NMH NHD
   World Health Organization, 2016, 161 WHO ZIKV SUR
   World Health Organization Department of Immunization VaB, 2007, 0707 WHO IVB
   World Health Organization (WHO), INF YOUNG CHILD FEED
NR 47
TC 52
Z9 52
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2017
VL 11
IS 4
AR e0005528
DI 10.1371/journal.pntd.0005528
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1NH
UT WOS:000402256700054
PM 28394887
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mordecai, EA
   Cohen, JM
   Evans, MV
   Gudapati, P
   Johnson, LR
   Lippi, CA
   Miazgowicz, K
   Murdock, CC
   Rohr, JR
   Ryan, SJ
   Savage, V
   Shocket, MS
   Ibarra, AS
   Thomas, MB
   Weikel, DP
AF Mordecai, Erin A.
   Cohen, Jeremy M.
   Evans, Michelle V.
   Gudapati, Prithvi
   Johnson, Leah R.
   Lippi, Catherine A.
   Miazgowicz, Kerri
   Murdock, Courtney C.
   Rohr, Jason R.
   Ryan, Sadie J.
   Savage, Van
   Shocket, Marta S.
   Ibarra, Anna Stewart
   Thomas, Matthew B.
   Weikel, Daniel P.
TI Detecting the impact of temperature on transmission of Zika, dengue, and
   chikungunya using mechanistic models
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-ALBOPICTUS DIPTERA; EXTRINSIC INCUBATION PERIOD; LIFE-HISTORY
   TRAITS; VIRUS TRANSMISSION; DEPENDENT DEVELOPMENT; AEGYPTI DIPTERA;
   VECTOR; CULICIDAE; SURVIVAL; MOSQUITOS
AB Recent epidemics of Zika, dengue, and chikungunya have heightened the need to understand the seasonal and geographic range of transmission by Aedes aegypti and Ae. albopictus mosquitoes. We use mechanistic transmission models to derive predictions for how the probability and magnitude of transmission for Zika, chikungunya, and dengue change with mean temperature, and we show that these predictions are well matched by human case data. Across all three viruses, models and human case data both show that transmission occurs between 18-34 degrees C with maximal transmission occurring in a range from 26-29 degrees C. Controlling for population size and two socioeconomic factors, temperature-dependent transmission based on our mechanistic model is an important predictor of human transmission occurrence and incidence. Risk maps indicate that tropical and subtropical regions are suitable for extended seasonal or year-round transmission, but transmission in temperate areas is limited to at most three months per year even if vectors are present. Such brief transmission windows limit the likelihood of major epidemics following disease introduction in temperate zones.
C1 [Mordecai, Erin A.; Gudapati, Prithvi; Shocket, Marta S.] Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.
   [Cohen, Jeremy M.; Johnson, Leah R.; Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, 4202 East Fowler Ave,SCA110, Tampa, FL USA.
   [Evans, Michelle V.; Murdock, Courtney C.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Johnson, Leah R.] Virginia Polytech & State Univ, Dept Stat, 250 Drillfield Dr, Blacksburg, VA USA.
   [Lippi, Catherine A.; Ryan, Sadie J.] Univ Florida, Dept Geog, Turlington Hall, Gainesville, FL 32611 USA.
   [Miazgowicz, Kerri; Murdock, Courtney C.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Ctr Trop & Emerging Global Dis, 501 DW Brooks Dr, Athens, GA 30602 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Ryan, Sadie J.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Ctr Global Hlth & Translat Sci, Weiskotten Hall, Syracuse, NY 13210 USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Private Bag X01, Scottsville, KwaZulu Natal, South Africa.
   [Savage, Van] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.
   [Savage, Van] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA.
   [Savage, Van] Santa Fe Inst, Santa Fe, NM 87501 USA.
   [Shocket, Marta S.] Indiana Univ, Dept Biol, Jordan Hall 142, Bloomington, IN USA.
   [Ibarra, Anna Stewart] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Thomas, Matthew B.] Penn State Univ, Dept Entomol, 112 Merkle Lab, University Pk, PA 16802 USA.
   [Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, 112 Merkle Lab, University Pk, PA 16802 USA.
   [Weikel, Daniel P.] Univ Michigan, Dept Biostat, 1415 Washington Hts, Ann Arbor, MI 48109 USA.
RP Mordecai, EA (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.
EM emordeca@stanford.edu
RI Ryan, Sadie Jane/H-7488-2019; Evans, Michelle V./S-1027-2019
OI Ryan, Sadie Jane/0000-0002-4308-6321; Evans, Michelle
   V./0000-0002-5628-0502; Mordecai, Erin/0000-0002-4402-5547; Shocket,
   Marta/0000-0002-8995-4446
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1518681]; NSFNational Science Foundation (NSF) [EF-1241889,
   DEB-1640780]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01GM109499, R01TW010286-01]; US Department of AgricultureUnited States
   Department of Agriculture (USDA) [2009-35102-0543]; US Environmental
   Protection AgencyUnited States Environmental Protection Agency
   [83518801]; Stanford Woods Institute for the Environment; Stanford
   Center for Innovation in Global Health
FX EAM, MBT, VS, SJR, LRJ, ASI, JRR, MS, JC, and DPW were supported by the
   National Science Foundation (DEB-1518681; https://nsf. gay). JRR was
   supported by the NSF (EF-1241889; https://nsf.gov/), National Institutes
   of Health (R01GM109499 and R01TW010286-01; https.//www.nih.gov/), US
   Department of Agriculture (2009-35102-0543; https://www.usda.
   gov/wns/portal/usda/usdahome) and US Environmental Protection Agency
   (CAREER 83518801; https://www.epa.gov/). EAM and CCM were supported by
   the NSF (DEB-1640780; https.// nsf.gov/). EAM was supported by the
   Stanford Woods Institute for the Environment (https://
   woods.stanford.edu/research/environmental-venture-projects) and the
   Stanford Center for Innovation in Global Health
   (http.//globalhealth.stanford.edu.research/seed-grants.htm). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Beserra EB, 2009, IHERINGIA SER ZOOL
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Breheny P., 2016, VISREG VISUALIZATION
   Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566
   Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22
   Calado Daniéla C., 2002, Rev. Bras. entomol., V46, P93, DOI 10.1590/S0085-56262002000100011
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   Davis NC, 1932, AM J HYG, V16, P163, DOI 10.1093/oxfordjournals.aje.a117853
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Ezeakacha NF, 2015, THESIS
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johnson LR, 2015, ECOLOGY, V96, P203, DOI 10.1890/13-1964.1
   Kamimura Kiyoshi, 2002, Medical Entomology and Zoology, V53, P53
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Li J, 2011, COMPUT MATH METHOD M, DOI 10.1155/2011/527610
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040
   McLean DM, 1975, MOSQ NEWS
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mordecai E.A., 2017, MODEL CODE DATA OUTP
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Muturi EJ, 2011, J MED ENTOMOL, V48, P243, DOI 10.1603/ME10017
   Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240
   PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9
   Perkins T. A., 2015, PLOS CURR, V7, DOI 10.1371
   Plummer M., 2016, RJAGS BAYESIAN GRAPH
   R Development Core Team, 2014, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rohatgi A., 2015, WEBPLOTDIGITIZER
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Wesolowski A, 2015, P NATL ACAD SCI USA
   Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035
   Westbrook CJ, 2010, LARVAL ECOLOGY ADULT
   Wiwatanaratanabutr S, 2006, MED VET ENTOMOL, V20, P300, DOI 10.1111/j.1365-2915.2006.00640.x
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zhang QJ, 2016, BIORXIV
NR 58
TC 104
Z9 104
U1 5
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2017
VL 11
IS 4
AR e0005568
DI 10.1371/journal.pntd.0005568
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW1NH
UT WOS:000402256700072
PM 28448507
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joly, M
AF Joly, Marcel
TI Corruption: The shortcut to disaster
SO SUSTAINABLE PRODUCTION AND CONSUMPTION
LA English
DT Article
DE Climate; Complex systems; Ethics; Petroleum; Politics; Zika virus
ID MYCOBACTERIUM-TUBERCULOSIS; HIV-1 PATHOGENESIS; COMPLEX-SYSTEMS;
   DYNAMICS; ENVIRONMENT; OPERATIONS; INFECTION; MODELS
AB I invite readers to briefly explore the utility of mathematical modeling and systems thinking to properly address the impact of causal relationships associated with the higher levels of scattered corruption in the public administration on the constrained-based analysis of high-profile concerns for a sustainable economy. A recent and disastrous, but very educational, Brazilian experience is taken as the motivating example: the unequaled governmental corruption scandal hitherto known, which its epicenter has publicly being associated with the Brazilian state-owned energy company, Petrobras. Few, but remarkable, socio-environmental consequences thought to have been triggered by (or related to) the resulting political crisis, currently devastating the socioeconomic scenario in Brazil, are didactically selected for the in silico analysis proposed. Major findings show that: (a) a reductionist perspective may be illusive when comparing the distinct real-life production and consumption scenarios under corruption, and (b) nonlinear dynamics can efficiently provide theoretical plausibility for the emergent behaviors of the system, which are typically scenario-dependent and can drastically be altered when corruption evolves from a circumscribed into a scattered condition. In conclusion, these results corroborate the need for far greater attention to the issue of corruption - or more generally ethics - to aptly cope with a new array of complex global sustainability challenges that would have been unthinkable just a few decades, or years, ago. (C) 2016 Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Joly, Marcel] Fed Technol Univ Parana UTFPR, Dept Chem Engn, Curitiba, Parana, Brazil.
   [Joly, Marcel] Technol Res Inst State Sao Paulo SA CIAM IPT, Ctr Informat Technol Mobil & Automat, Sao Paulo, Brazil.
RP Joly, M (corresponding author), Fed Technol Univ Parana UTFPR, Ave Sete Setembro 3165, BR-80230901 Curitiba, Parana, Brazil.
EM mjoly@utfpr.edu.br
RI joly, marcel/J-3409-2013
OI joly, marcel/0000-0003-2942-6307
CR Acemoglu D, 2000, AM ECON REV, V90, P194, DOI 10.1257/aer.90.1.194
   Al-Shammari A, 2011, IND ENG CHEM RES, V50, P7065, DOI 10.1021/ie200313r
   Androulakis IP, 2014, COMPUT CHEM ENG, V71, P665, DOI 10.1016/j.compchemeng.2014.09.007
   Azapagic A, 2015, SUSTAIN PROD CONSUMP, V2, P1, DOI 10.1016/j.spc.2015.08.002
   BERTALANFFY LV, 1967, SOC SC INFORM, V6, P125
   BRANSFORD JD, 2000, COMMITTEE DEV SCI LE
   Broad C. D., 1925, MIND ITS PLACE NATUR
   Carter T. S., 1977, CRIME LAW SOCIAL CH, V26, P27
   Cole SW, 2013, AM J PUBLIC HEALTH, V103, P84, DOI 10.2105/AJPH.2012.301183
   Damania R, 2003, J ENVIRON ECON MANAG, V46, P490, DOI 10.1016/S0095-0696(03)00025-1
   Doig A, 1999, THIRD WORLD Q, V20, P657, DOI 10.1080/01436599913749
   ESTY DC, 2005, ENV SUSTAINABILITY I
   FAO (Food and Agriculture Organization of the United Nations), 2011, STAT WORLDS LAND WAT
   Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006
   Forum for the Future, 2006, SUST REP FRAM PUBL S
   Friedman A, 2008, EXP GERONTOL, V43, P275, DOI 10.1016/j.exger.2007.12.004
   GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7
   Guerena D, 2015, SUSTAIN PROD CONSUMP, V3, P59, DOI 10.1016/j.spc.2015.06.003
   GUNNINGHAM N, 1997, LAW POLICY, V19, P363, DOI DOI 10.1111/1467-9930.T01-1-00033
   Hasker William, 1999, THE EMERGENT SELF
   Hassimotto M. K., 2007, THESIS
   Hisamatsu Y, 2003, APPL ECON LETT, V10, P1, DOI 10.1080/13504850210165838
   HORGAN J, 1995, SCI AM, V272, P104, DOI 10.1038/scientificamerican0695-104
   HUSSERL E, 1910, PHENOMENOLOGY CRISIS
   Iachan R, 2009, INT T OPER RES, V16, P585, DOI 10.1111/j.1475-3995.2009.00717.x
   Islas-Espinoza M, 2015, SUSTAIN PROD CONSUMP, V2, P128, DOI 10.1016/j.spc.2015.07.003
   Joly M, 2006, AICHE J, V52, P856, DOI 10.1002/aic.10716
   Joly M, 2012, BRAZ J CHEM ENG, V29, P371, DOI 10.1590/S0104-66322012000200017
   Joly M, 2003, CHEM ENG RES DES, V81, P427, DOI 10.1205/026387603765173691
   Joly M, 2002, BRAZ J CHEM ENG, V19, P207, DOI 10.1590/S0104-66322002000200008
   Joly M, 2017, MATH COMPUT SIMULAT, V132, P1, DOI 10.1016/j.matcom.2015.06.010
   Joly M, 2016, COMPUT CHEM ENG, V84, P255, DOI 10.1016/j.compchemeng.2015.09.004
   Joly M, 2015, COMPUT CHEM ENG, V80, P114, DOI 10.1016/j.compchemeng.2015.05.017
   Joly M, 2013, J THEOR BIOL, V335, P57, DOI 10.1016/j.jtbi.2013.06.019
   Joly M, 2013, CHEM ENG SCI, V93, P445, DOI 10.1016/j.ces.2013.02.029
   Joly M, 2012, APPL MATH MODEL, V36, P5830, DOI 10.1016/j.apm.2012.01.042
   Joly M, 2012, MATH COMPUT MODEL, V55, P342, DOI 10.1016/j.mcm.2011.08.008
   Kahn F., 1922, LEBEN MENSCHEN VOLKS, VI
   KAUFFMAN SA, 1991, SCI AM, V265, P78, DOI 10.1038/scientificamerican0891-78
   Kauffman Stuart, 2009, ARXIV09072492
   Kim J, 1998, MIND PHYS WORLD
   Kiss IZ, 2003, AICHE J, V49, P2234, DOI 10.1002/aic.690490902
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lalountas DA, 2011, J POLICY MODEL, V33, P636, DOI 10.1016/j.jpolmod.2011.02.001
   Leiras A, 2010, ENG OPTIMIZ, V42, P1119, DOI 10.1080/03052151003686724
   Lewis M., 2006, 78 CTR GLOB DEV, DOI [10.2139/ssrn.984046, DOI 10.2139/SSRN.984046]
   Lopez R, 2000, J ENVIRON ECON MANAG, V40, P137, DOI 10.1006/jeem.1999.1107
   Mahler-Hutter M., 2009, THESIS
   Marashi SA, 2014, J THEOR BIOL, V355, P185, DOI 10.1016/j.jtbi.2014.04.011
   Mazzocchi F., 2011, E LOGOS ELECT J PHIL, V11, P1
   Morse S, 2006, ECOL SOC, V11
   Mossio M, 2009, BRIT J PHILOS SCI, V60, P813, DOI 10.1093/bjps/axp036
   Mukuve FM, 2015, SUSTAIN PROD CONSUMP, V2, P79, DOI 10.1016/j.spc.2015.07.009
   Nelson PW, 2000, MATH BIOSCI, V163, P201, DOI 10.1016/S0025-5564(99)00055-3
   Noble D, 2008, EXP PHYSIOL, V93, P16, DOI 10.1113/expphysiol.2007.038695
   OIN (O Imparcial Newspaper), 2016, O IMPARCIAL BRAZILIA
   ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641
   Ottino JM, 2004, NATURE, V427, P399, DOI 10.1038/427399a
   Ottino JM, 2003, AICHE J, V49, P292, DOI 10.1002/aic.690490202
   Ottino JM, 2011, AICHE J, V57, P1654, DOI 10.1002/aic.12686
   Pallaro E, 2015, SUSTAIN PROD CONSUMP, V4, P47, DOI 10.1016/j.spc.2015.07.002
   Peprah K, 2015, SUSTAIN PROD CONSUMP, V4, P2, DOI 10.1016/j.spc.2015.09.001
   Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107
   Pinto JM, 2000, COMPUT CHEM ENG, V24, P2259, DOI 10.1016/S0098-1354(00)00571-8
   Powell A, 2009, STUD HIST PHI PART C, V40, P54, DOI 10.1016/j.shpsc.2008.12.007
   Robeson P., 2009, TECHNICAL REPORT
   Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424
   Situngkir H., 2003, J SOCIAL COMPLEXITY, V1, P3
   Soto AM, 2005, J BIOSCIENCES, V30, P103, DOI 10.1007/BF02705155
   Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296
   United Nations, 1992, UN C ENV DEV RES AD
   Valipour Mohammad, 2015, International Journal of Hydrology Science and Technology, V5, P51, DOI 10.1504/IJHST.2015.069279
   VONBERTALANFFY L, 1949, NATURE, V163, P156, DOI 10.1038/163156a0
   VONBERTALANFFY L, 1968, GEN SYSTEMS THEORY F
   Welsch H, 2004, ENVIRON DEV ECON, V9, P663, DOI 10.1017/S1355770X04001500
   Wolkenhauer O, 2001, Brief Bioinform, V2, P258
   World Bank, 1997, STAT CHANG WORLD
   Zemanovicova D, 2002, EKON CAS, V50, P182
NR 78
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-5509
J9 SUSTAIN PROD CONSUMP
JI Sustain. Prod. Consump.
PD APR
PY 2017
VL 10
BP 133
EP 156
DI 10.1016/j.spc.2016.09.005
PG 24
WC Green & Sustainable Science & Technology; Environmental Studies
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA GZ0AI
UT WOS:000449016700012
DA 2020-07-08
ER

PT J
AU Ahmed, QA
   Memish, ZA
AF Ahmed, Qanta A.
   Memish, Ziad A.
TI Yellow fever from Angola and Congo: a storm gathers
SO TROPICAL DOCTOR
LA English
DT Review
DE Flaviviruses; public health emergency of international concern; Africa
ID VACCINE; VIRUS; EPIDEMIC; DISEASE; THREAT; HEALTH; ZIKA
AB In common with Zika, Chikungunya and Dengue, Yellow Fever (YF) is an arthropod-borne flavivirus. It is transmitted between humans and from monkeys by mosquitoes of the Aedes aegypti (its principal vector), haemogogus and albopictus varieties. Three cycles of transmission may occur: urban; sylvatic; and intermediate. Recently, sub-Saharan Africa has seen the resurgence of this neglected disease. The current YF outbreak in Angola began in December 2015 in the capital Luanda and by October 2016 there had been>4300 suspected cases, with 376 deaths (case fatality rate=8.8%). A total of 884 were laboratory confirmed but it is likely that case numbers may be seriously underestimated. YF has subsequently quickly spread to neighbouring Congo and further afield to Kenya and also China, this being of grave concern as this was a first introduction of YF to Asia. YF has recently hit Brazil, with 555 suspected cases and 107 deaths reported by the end of January 2017. Extremely rapid unplanned urban migration in Africa by non-immune rural populations to already densely populated cities, where high densities of mosquitoes co-exist with city dwellers in makeshift flimsy accommodation, poses a ready recipe for an epidemic of massive proportion. In such conditions, with enormously strained public services existing among the most needy and vulnerable populations, mosquito control programmes are nearly impossible. YF in Congo is a tempest barely restrained. However, it is one that can be controlled by focused and committed international collaboration, by intense and united political will and by the marriage of old and trusted techniques: a vaccine almost a century old and some of the most modern technologies available to man.
C1 [Ahmed, Qanta A.] Winthrop Univ Hosp, Dept Med, Div Pulm Dis & Crit Care Med, Mineola, NY 11501 USA.
   [Ahmed, Qanta A.] SUNY Stony Brook, Med, Stony Brook, NY 11794 USA.
   [Memish, Ziad A.] Prince Mohammed bin Abdulaziz Hosp, Minist Hlth, Infect Dis & Director Res Ctr, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
RP Memish, ZA (corresponding author), Saudi Minist Hlth, POB 54146, Riyadh 11514, Saudi Arabia.
EM Zmemish@yahoo.com
CR Agwu EJ, 2016, ACTA TROP, V161, P18, DOI 10.1016/j.actatropica.2016.05.005
   [Anonymous], NBC NEWS
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Calisher CH, 2016, EMERG INFECT DIS, V22, P1859, DOI 10.3201/eid2210.160875
   Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391
   Centers for Disease Control and Prevention, 2010, YELL FEV HIST EP VAC
   Chan M, 2016, LANCET, V387, P2165, DOI 10.1016/S0140-6736(16)30620-1
   CNN Money International, WORLDS WORST EC
   Elachola H, 2016, LANCET, V388, P1155, DOI 10.1016/S0140-6736(16)31546-X
   Finlay CJ, 1965, OBRAS COMPLETAS, V1, P263
   Goddard J, 2016, AM J MED, V129, P1149, DOI 10.1016/j.amjmed.2016.07.021
   Gorgas William, 1915, SANITATION IN PANAMA
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Norrby E, 2007, J EXP MED, V204, P2779, DOI 10.1084/jem.20072290
   Nott JC, 1848, NEW ORL MED SURG J, V4, P563
   Reed W, 1900, COMMUNICATION   1024
   Satterthwaite D., URBANIZATION SUBSAHA
   Sawyer I, COUNCIL FOREIGN RELA
   Sheridan J., YET ANOTHER OUTBREAK
   The Yellow Fever Epidemic in Philadelphia, 1793, YELL FEV EP PHIL
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Wafula L., 2016, BUSINESS DAILY  0421
   Waltz E, 2016, NATURE, V533, P450, DOI 10.1038/533450a
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   World Health Organization, YELLOW FEVER
   World Health Organization, 2016, WHO SIT REP YELL FEV
NR 27
TC 10
Z9 11
U1 1
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0049-4755
EI 1758-1133
J9 TROP DOCT
JI Trop. Dr.
PD APR
PY 2017
VL 47
IS 2
BP 92
EP 96
DI 10.1177/0049475517699726
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET2RQ
UT WOS:000400122200002
PM 28424031
DA 2020-07-08
ER

PT J
AU Hamel, R
   Ferraris, P
   Wichit, S
   Diop, F
   Talignani, L
   Pompon, J
   Garcia, D
   Liegeois, F
   Sall, AA
   Yssel, H
   Misse, D
AF Hamel, Rodolphe
   Ferraris, Pauline
   Wichit, Sineewanlaya
   Diop, Fode
   Talignani, Loic
   Pompon, Julien
   Garcia, Deborah
   Liegeois, Florian
   Sall, Amadou A.
   Yssel, Hans
   Misse, Dorothee
TI African and Asian Zika virus strains differentially induce early
   antiviral responses in primary human astrocytes
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE ZIKA; Astrocytes; Antiviral response; Innate immunity; Arbovirus
ID ORGANOIDS; BRAIN; CELLS
AB ZIKA virus (ZIKV) is a newly emerging arbovirus. Since its discovery 60 years ago in Uganda, it has spread throughout the Pacific, Latin America and the Caribbean, emphasizing the capacity of ZIKV to spread to non-endemic regions worldwide. Although infection with ZIKV often leads to mild disease, its recent emergence in the Americas has coincidedwith an increase in adults developing Guillain-Barre syndrome and neurological complications in new-borns, such as congenitalmicrocephaly. Many questions remain unanswered regarding the complications caused by different primary isolates of ZIKV. Here, we report the permissiveness of primary human astrocytes for two clinically relevant, Asian and African ZIKV strains and show that both isolates strongly induce antiviral immune responses in these cells albeitwith markedly different kinetics. This study describes for the first time the specific antiviral gene expression in infected primary human astrocytes, the major glial cells within the central nervous system. (C) 2017 Elsevier B. V. All rights reserved.
C1 [Hamel, Rodolphe; Ferraris, Pauline; Wichit, Sineewanlaya; Diop, Fode; Talignani, Loic; Pompon, Julien; Garcia, Deborah; Liegeois, Florian; Misse, Dorothee] UMR 224 IRD CNRS UM, Lab MIVEGEC, Montpellier, France.
   [Sall, Amadou A.] Inst Pasteur, Dakar, Senegal.
   [Yssel, Hans] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, INSERM,U1135,UPMC,Ctr Immunol & Malad Infect, Paris, France.
RP Misse, D (corresponding author), UMR 224 IRD CNRS UM, Lab MIVEGEC, Montpellier, France.
EM dorothee.misse@ird.fr
RI Ferraris, Pauline/F-9077-2017; Yssel, Hans/C-6406-2009; Florian,
   Liegeois/D-3798-2013; Hamel, Rodolphe/AAG-1714-2020
OI Ferraris, Pauline/0000-0002-8796-3074; Yssel, Hans/0000-0001-7454-1836;
   Florian, Liegeois/0000-0003-1048-0661; Hamel,
   Rodolphe/0000-0001-8603-7039
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-14-CE14-0029]; European UnionEuropean Union (EU) [734548]
FX We thank Dr. Xavier de Lamballerie for the French Polynesian ZIKV
   strain. This work was supported by grants from the Agence Nationale de
   la Recherche (ANR-14-CE14-0029) and the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement No.
   734548.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
NR 13
TC 34
Z9 34
U1 0
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2017
VL 49
BP 134
EP 137
DI 10.1016/j.meegid.2017.01.015
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EM7AN
UT WOS:000395463900020
PM 28095299
DA 2020-07-08
ER

PT J
AU Cohen, J
AF Cohen, Jon
TI Dengue may bring out the worst in Zika
SO SCIENCE
LA English
DT News Item
NR 0
TC 7
Z9 7
U1 0
U2 6
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAR 31
PY 2017
VL 355
IS 6332
BP 1362
EP 1362
DI 10.1126/science.355.6332.1362
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EQ1DL
UT WOS:000397809500014
PM 28360276
DA 2020-07-08
ER

PT J
AU Hou, WH
   Armstrong, N
   Obwolo, LA
   Thomas, M
   Pang, XW
   Jones, KS
   Tang, QY
AF Hou, Wangheng
   Armstrong, Najealicka
   Obwolo, Lilian Akello
   Thomas, Michael
   Pang, Xiaowu
   Jones, Kevin S.
   Tang, Qiyi
TI Determination of the Cell Permissiveness Spectrum, Mode of RNA
   Replication, and RNA-Protein Interaction of Zika Virus
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus (ZIKV); RNA in situ hybridization (RISH); Permissiveness; RNA
   Chromatin Immunoprecipitation (ChIP); RNA replication
ID INFECTION; TRANSMISSION; BIOLOGY; DNA
AB Background: Two lineages of Zika virus (ZIKV) have been classified according to the phylogenetic analysis: African and Asian lineages. It is unclear whether differences exist between the two strains in host cell permissiveness, this information is important for understanding viral pathogenesis and designing anti-viral strategies.
   Methods: In the present study, we comparatively studied the permissive spectrum of human cells for both the African (MR766) and Asian strains (PRVABC59) using an RNA in situ hybridization (RISH) to visualize RNA replication, an immunofluorescence technology, and a western blot assay to determine viral protein production, and a real-time RT-PCR to examine viral RNA multiplication level. The experiments were undertaken in the condition of cell culture.
   Results: We identified several human cell lines, including fibroblast, epithelial cells, brain cells, stem cells, and blood cells that are susceptible for the infection of both Asian and African strains. We did not find any differences between the MR766 and the PRVABC59 in the permissiveness, infection rate, and replication modes. Inconsistent to a previous report (Hamel et al. JVI 89: 8880-8896, 2015), using RISH or real-time RT-PCR, we found that human foreskin fibroblast cells were not permissive for ZIKV infection. Instead, human lung fibroblast cells (MRC-5) were fully permissive for ZIKV infection. Surprisingly, a direct interaction of ZIKV RNA with envelop (E) protein (a structure protein) was demonstrated by an RNA chromatin immunoprecipitation (ChIP) assay. Three binding sites were identified in the ZIKV RNA genome for the interaction with the E protein.
   Conclusion: Our results imply that the E protein may be important for viral RNA replication, and provide not only the information of ZIKV permissiveness that guides the usage of human cells for the ZIKV studies, but also the insight into the viral RNA-E protein interaction that may be targeted for intervention by designing small molecule drugs.
C1 [Hou, Wangheng; Armstrong, Najealicka; Obwolo, Lilian Akello; Tang, Qiyi] Howard Univ, Coll Med, Dept Microbiol, Seeley Mudd Bldg,Room 315,520 St, Washington, DC 20059 USA.
   [Pang, Xiaowu] Howard Univ, Coll Dent, Dept Oral Pathol, Washington, DC 20059 USA.
   [Thomas, Michael; Jones, Kevin S.] Howard Univ, Dept Biol, Washington, DC 20059 USA.
RP Tang, QY (corresponding author), Howard Univ, Coll Med, Dept Microbiol, Seeley Mudd Bldg,Room 315,520 St, Washington, DC 20059 USA.
EM qiyi.tang@howard.edu
FU American Cancer Society grantAmerican Cancer Society
   [RSG-090289-01-MPC]; NIH/NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [SC1AI112785]; National
   Institute on Minority Health and Health Disparities of the National
   Institutes of Health [G12MD007597]; NIH/NCIUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [P20CA192989]
FX An American Cancer Society grant (RSG-090289-01-MPC) (Q.T.), NIH/NIAID
   SC1AI112785 (Q.T.), National Institute on Minority Health and Health
   Disparities of the National Institutes of Health under Award Number
   G12MD007597 (Q.T.), and NIH/NCI grant P20CA192989 (X.P.).
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   LAFEMINA RL, 1988, J GEN VIROL, V69, P355, DOI 10.1099/0022-1317-69-2-355
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nagy PD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030068
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 27
TC 14
Z9 14
U1 1
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 31
PY 2017
VL 17
AR 239
DI 10.1186/s12879-017-2338-4
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA EP9YX
UT WOS:000397730000002
PM 28359304
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ikejezie, J
   Shapiro, CN
   Kim, J
   Chiu, M
   Almiron, M
   Ugarte, C
   Espinal, MA
   Aldighieri, S
AF Ikejezie, Juniorcaius
   Shapiro, Craig N.
   Kim, Jisoo
   Chiu, Monica
   Almiron, Maria
   Ugarte, Ciro
   Espinal, Marcos A.
   Aldighieri, Sylvain
TI Zika Virus Transmission - Region of the Americas, May 15, 2015-December
   15, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
AB What is already known about this topic?
   Zika virus, a flavivirus that is primarily transmitted by Aedes mosquitoes, has rapidly spread throughout the Region of the Americas since 2015. Zika virus infection during pregnancy is a known cause of microcephaly and other congenital abnormalities, and infection is also associated with neurologic disorders, including Guillain-Barre syndrome (GBS).
   What is added by this report?
   During May 15, 2015-December 15, 2016, autochthonous Zika virus transmission was confirmed in 48 countries and territories in the Region of the Americas. Rates of Zika virus disease peaked at different times in different subregions. During this period, the trend in reported GBS cases paralleled that of reported Zika virus disease cases.
   What are the implications for public health practice?
   Because of ongoing Zika virus transmission, the occurrence of associated complications, and the risk for recurrence of large outbreaks, countries where Aedes mosquitoes are present should continue surveillance for Zika virus disease, GBS, and congenital abnormalities; strengthen capacity for laboratory diagnosis of Zika virus and other arboviruses; and continue the implementation of vector control measures and other prevention activities.
C1 [Ikejezie, Juniorcaius; Kim, Jisoo; Chiu, Monica; Almiron, Maria; Ugarte, Ciro; Espinal, Marcos A.; Aldighieri, Sylvain] Pan Amer Hlth Org, Washington, DC 20037 USA.
   [Shapiro, Craig N.] CDC, Div Emergency Operat, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
RP Ikejezie, J (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.
EM ikejezijun@paho.org
CR Brazil Ministry of Health, 2016, PROC ZIK VIR SURV BR
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Pan American Health Organization, 2016, STRAT ENH NAT CAP RE
   Pan American Health Organization, 2016, PAHO WHO REG RES AG
   Pan American Health Organization/ World Health Organization, 2016, GUID SURV ZIK VIR DI
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 9
TC 35
Z9 36
U1 0
U2 14
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 31
PY 2017
VL 66
IS 12
BP 329
EP 334
DI 10.15585/mmwr.mm6612a4
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EQ1BH
UT WOS:000397803800004
PM 28358795
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Li, F
   Wang, PR
   Qu, LB
   Yi, CH
   Zhang, FC
   Tang, XP
   Zhang, LG
   Chen, L
AF Li, Feng
   Wang, Pei-Rong
   Qu, Lin-Bing
   Yi, Chang-Hua
   Zhang, Fu-Chun
   Tang, Xiao-Ping
   Zhang, Li-Guo
   Chen, Ling
TI AXL is not essential for Zika virus infection in the mouse brain
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID CELLS
C1 [Li, Feng; Zhang, Fu-Chun; Tang, Xiao-Ping] Guangzhou Med Univ, Inst Infect Dis, Guangzhou Eighth Peoples Hosp, Guangzhou 510060, Guangdong, Peoples R China.
   [Wang, Pei-Rong; Zhang, Li-Guo] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China.
   [Qu, Lin-Bing; Yi, Chang-Hua; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China.
RP Li, F (corresponding author), Guangzhou Med Univ, Inst Infect Dis, Guangzhou Eighth Peoples Hosp, Guangzhou 510060, Guangdong, Peoples R China.
EM Fengli_gz8h@126.com; chen_Ling@gibh.ac.cn
FU Guangzhou Science and Technology Program [201707010348, 2014Y2-00185,
   201508020262]
FX We thank Dr Wei-Qi Pan for providing the Zika virus stock. This work was
   supported by the Guangzhou Science and Technology Program (no.
   201707010348 (FL), 2014Y2-00185 (F-CZ), 201508020262 (X-PT)).
CR Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
NR 5
TC 21
Z9 21
U1 1
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 29
PY 2017
VL 6
AR e16
DI 10.1038/emi.2017.10
PG 2
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EQ1JI
UT WOS:000397825600002
PM 28352123
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, XL
   Hou, Y
   Saha, TT
   Pei, GF
   Raikhel, AS
   Zou, Z
AF Wang, Xueli
   Hou, Yuan
   Saha, Tusar T.
   Pei, Gaofeng
   Raikhel, Alexander S.
   Zou, Zhen
TI Hormone and receptor interplay in the regulation of mosquito lipid
   metabolism
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE juvenile hormone; 20-hydroxyecdysone; lipid; hepatocyte nuclear factor
   4; beta-oxidation
ID JUVENILE-HORMONE; AEDES-AEGYPTI; METHOPRENE-TOLERANT; NUCLEAR RECEPTORS;
   GENE-EXPRESSION; BETA-OXIDATION; YELLOW-FEVER; ZIKA VIRUS; DROSOPHILA;
   DISEASE
AB Mosquitoes transmit devastating human diseases because they need vertebrate blood for egg development. Metabolism in female mosquitoes is tightly coupled with blood meal-mediated reproduction, which requires an extremely high level of energy consumption. Functional analysis has shown that major genes encoding for enzymes involved in lipid metabolism (LM) in the mosquito fat bodies are down-regulated at the end of the juvenile hormone (JH)-controlled posteclosion (PE) phase but exhibit significant elevation in their transcript levels during the post-blood meal phase (PBM), which is regulated mainly by 20-hydroxyecdysone (20E). Reductions in the transcript levels of genes encoding triacylglycerol (TAG) catabolism and A-oxidation enzymes were observed to correlate with a dramatic accumulation of lipids in the PE phase; in contrast, these transcripts were elevated significantly and lipid stores were diminished during the PBM phase. The RNAi depletion of Methoprene-tolerant (Met) and ecdysone receptor (EcR), receptors for JH and 20E, respectively, reversed the LM gene expression and the levels of lipid stores and metabolites, demonstrating the critical roles of these hormones in LM regulation. Hepatocyte nuclear factor 4 (HNF4) RNAi-silenced mosquitoes exhibited down-regulation of the gene transcripts encoding TAG catabolism and A-oxidation enzymes and an inability to use lipids effectively, as manifested by TAG accumulation. The luciferase reporter assay showed direct regulation of LM-related genes by HNF4. Moreover, HNF4 gene expression was down-regulated by Met and activated by EcR and Target of rapamycin, providing a link between nutritional and hormonal regulation of LM in female mosquitoes.
C1 [Wang, Xueli; Hou, Yuan; Pei, Gaofeng; Zou, Zhen] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.
   [Wang, Xueli; Hou, Yuan; Pei, Gaofeng; Zou, Zhen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Saha, Tusar T.; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
RP Zou, Z (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.; Zou, Z (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
EM alexander.raikhel@ucr.edu; zouzhen@ioz.ac.cn
RI zou, zhen/C-6134-2016
OI zou, zhen/0000-0003-3550-7656
FU Strategic Priority Research Program of the Chinese Academy of
   SciencesChinese Academy of Sciences [XDB11030600]; National Basic
   Research Program of ChinaNational Basic Research Program of China
   [2014CB138405]; National Science Foundation of ChinaNational Natural
   Science Foundation of China [31672291, L1524009]; National Institutes of
   Health/National Institute of Allergy and Infectious DiseasesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [5R01 AI036959]
FX This work was supported by Strategic Priority Research Program of the
   Chinese Academy of Sciences Grant XDB11030600, National Basic Research
   Program of China Grant 2014CB138405, National Science Foundation of
   China Grants 31672291 and L1524009 (to Z.Z.), and National Institutes of
   Health/National Institute of Allergy and Infectious Diseases Award 5R01
   AI036959 (to A.S.R.).
CR Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761
   Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3
   Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200
   Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009
   Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251
   Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145
   Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025
   Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003
   Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410
   Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101
   Hou Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005309
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G
   Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108
   Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912
   Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006
   Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009
   Park JH, 2006, J BIOL CHEM, V281, P11167, DOI 10.1074/jbc.M601517200
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243
   Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013
   Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434
   Roy S, 2016, ADV INSECT PHYSIOL, V51, P115, DOI 10.1016/bs.aiip.2016.05.004
   Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969
   Roy SG, 2011, INSECT BIOCHEM MOLEC, V41, P62, DOI 10.1016/j.ibmb.2010.10.001
   Roy S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005450
   Saha TT, 2016, P NATL ACAD SCI USA, V113, pE735, DOI 10.1073/pnas.1523838113
   Schulman IG, 2010, ADV DRUG DELIVER REV, V62, P1307, DOI 10.1016/j.addr.2010.07.002
   Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109
   Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   VANHANDEL E, 1993, J INSECT PHYSIOL, V39, P831, DOI 10.1016/0022-1910(93)90115-8
   Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684
   Zhao B, 2016, INSECT BIOCHEM MOLEC, V77, P69, DOI 10.1016/j.ibmb.2016.08.003
   Zhou GL, 2009, J INSECT PHYSIOL, V55, P40, DOI 10.1016/j.jinsphys.2008.10.002
   Zhu J, 2016, ADV INSECT PHYSIOL, V51, P93, DOI [10.1007/978-981-10-0207-6_15, 10.1016/bs.aiip.2016.04.005]
   Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X
   Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 51
TC 20
Z9 21
U1 2
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 28
PY 2017
VL 114
IS 13
BP E2709
EP E2718
DI 10.1073/pnas.1619326114
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EP8DY
UT WOS:000397607300021
PM 28292900
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Aguirre-Obando, OA
   Martins, AJ
   Navarro-Silva, MA
AF Aguirre-Obando, Oscar Alexander
   Martins, Ademir Jesus
   Navarro-Silva, Mario Antonio
TI First report of the Phe1534Cys kdr mutation in natural populations of
   Aedes albopictus from Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Allele-specific PCR; Chikungunya; Dengue; Pyrethroid resistance; Vector
   control; Voltage-gated sodium channel; Zika
ID GATED SODIUM-CHANNEL; AEGYPTI DIPTERA-CULICIDAE; INSECTICIDE RESISTANCE;
   PYRETHROID RESISTANCE; KNOCKDOWN RESISTANCE; MOLECULAR-BIOLOGY; DENGUE;
   CHIKUNGUNYA; VIRUS; SUSCEPTIBILITY
AB Background: Knockdown resistance (kdr), caused by alterations in the voltage-gated sodium channel (Na-v), is one of the mechanisms responsible for pyrethroid (PY) resistance. In the Asian tiger mosquito, Aedes albopictus, at least four different mutations were described in the IIIS6 Na-v segment in populations from Asia, North America and Europe. In contrast, in Aedes aegypti at least 12 non-synonymous mutations have been reported at nine different codons, mostly in the IIS6 and IIIS6 Na-v segments. The Phe1534Cys kdr mutation in the IIIS6 Na-v segment is the most prevalent in populations of Ae. aegypti worldwide, also found in Ae. albopictus from Singapore. Herein, we investigated the DNA diversity corresponding to the IIS6 and IIIS6 Na-v segments in natural populations of Ae. albopictus from Brazil.
   Methods: DNA from eight Brazilian Ae. albopictus natural populations were individually extracted and pooled by states of origin, amplified, cloned and sequenced for the corresponding IIS6 and IIIS6 Na-v segments. Additionally, samples from each location were individually genotyped by an allelic specific PCR (AS-PCR) approach to obtain the genotypic and allelic frequencies for the 1534 Na-v site.
   Results: No non-synonymous substitutions were observed in the IIS6 sequences. However, the Phe1534Cys kdr mutation was evidenced in the Ae. albopictus Na-v IIIS6 segment sequences from Parana (PR) and Rondonia (RO) states, but not from Mato Grosso (MT) state. The 1534Cys(kdr) allele varied from 3% (Marilena/PR and Porto Velho/RO) to 10% ( Foz do lguacu/ PR). To our knowledge, this paper reports the first occurrence and provides distribution data of a possible kdr mutation in Ae. albopictus in South America.
   Conclusion: The emergence of a likely kdr mutation in Ae. albopitus natural populations is a signal of alert for vector control measures since PY are the most popular insecticides adopted by residents. Additionally, once the kdr allele is present, its frequency tends to increase faster under exposition to those compounds. Although the Asian tiger mosquito is not incriminated as an important vector of dengue, chikungunya and Zika viruses in South America, its importance in this regard has been extensively discussed since Ae. albopictus is rapidly spreading and can also migrate between sylvatic and urban environments. Therefore, insecticide resistance monitoring initiatives should also be extended to Ae. albopictus in Brazil in order to maintain chemical compounds as an efficient vector control tool when needed.
C1 [Martins, Ademir Jesus] Inst Oswaldo Cruz FIOCRUZ, Lab Fisiol & Controle Artropodes Vetor, Av Brasil 4365,RJPO Box, BR-2104900 Rio De Janeiro, Brazil.
   [Martins, Ademir Jesus] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
   [Aguirre-Obando, Oscar Alexander; Navarro-Silva, Mario Antonio] Univ Fed Parana, Dept Zool, Lab Entomol Med & Veterinrria, Setor Ciencias Biol, POB 19020, BR-81531980 Curitiba, Parana, Brazil.
RP Martins, AJ (corresponding author), Inst Oswaldo Cruz FIOCRUZ, Lab Fisiol & Controle Artropodes Vetor, Av Brasil 4365,RJPO Box, BR-2104900 Rio De Janeiro, Brazil.
EM ademirjr@ioc.fiocruz.br
RI Martins, Ademir/W-3251-2019; da Silva, Mario Antonio
   Navarro/C-5287-2013; Martins, Ademir J./B-4117-2009
OI Martins, Ademir/0000-0001-5739-1215; Navarro da Silva, Mario
   Antonio/0000-0002-9762-632X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnoligico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [140224/2013-0]; Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ) [E-26/110.168/2014]; Instituto
   Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT);
   National Institue of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [UO1 AI115595]
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnoligico (CNPq, 140224/2013-0), Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, E-26/110.168/2014),
   Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular
   (INCT) and the National Institue of Health (NIH UO1 AI115595).
CR Aguirre-Obando OA, 2015, ZOOLOGIA-CURITIBA, V32, P14, DOI 10.1590/S1984-46702015000100003
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Baldacchino F., 2015, PEST MANAG SCI, P1, DOI DOI 10.1115/GT2015-42663
   Belinato TA, 2016, INSECTICIDES RESISTANCE, P243, DOI 10.5772/61826
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   BROWN AWA, 1986, J AM MOSQUITO CONTR, V2, P123
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2
   Chen H, 2016, INFECT DIS POVERTY, V5, P8
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Dalla Bona AC, 2012, ZOOLOGIA-CURITIBA, V29, P540, DOI 10.1590/S1984-46702012000600005
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Donnelly MJ, 2016, TRENDS PARASITOL, V32, P197, DOI 10.1016/j.pt.2015.12.001
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duque L. Jonny E., 2010, Rev. Univ. Ind. Santander. Salud, V42, P113
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Forattini OP, 2002, CULICIDOLOGIA MEDICA, V2
   Genchi C, 2011, VECTOR-BORNE ZOONOT, V11, P1307, DOI 10.1089/vbz.2010.0247
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hartl DL, 2010, PRINCIPIOS GENETICA
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Higgs S, 2015, INT HEALTH, V7, P1, DOI 10.1093/inthealth/ihu092
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Lu H, 2013, MOL IMMUNOL, V54, P109, DOI 10.1016/j.molimm.2012.11.007
   Lucena L, 2011, REV PAN AMAZ SAUDE, V2, P19
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Martins AJ, 2009, AM J TROP MED HYG, V81, P108, DOI 10.4269/ajtmh.2009.81.108
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Okimoto R, 1996, BIOTECHNIQUES, V21, P20
   Prophiro JS, 2011, REV SOC BRAS MED TRO, V44, P300, DOI [10.1590/s0037-86822011005000025, 10.1590/S0037-86822011005000025]
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Rey JR, 2015, BIOMEDICA, V35, P177, DOI [10.1590/S0120-41572015000200005, 10.7705/biomedica.v35i2.2514]
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Rowland-Jones SL, 2016, T ROY SOC TROP MED H, V110, P85, DOI 10.1093/trstmh/trw002
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Sambrook J., 2001, MOL CLONING LAB MANU
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7
   Sun W, 2013, J INFECT DIS, V207, P700, DOI 10.1093/infdis/jis744
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   Vazeille M, 2011, BMC P, V5, pO8
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   WHOPES, 2006, WHOCDSNTDWHOPESGCDPP
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Yadav K, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0754-0
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 68
TC 13
Z9 14
U1 0
U2 36
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 27
PY 2017
VL 10
AR 160
DI 10.1186/s13071-017-2089-5
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EQ0OF
UT WOS:000397769800001
PM 28347326
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

EF